PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Du, N; Li, H; Sun, CS; He, BQ; Yang, T; Song, HH; Wang, YJ; Wang, YJ				Du, Nan; Li, Hui; Sun, Chunshuai; He, Bingqiang; Yang, Ting; Song, Honghua; Wang, Yingjie; Wang, Yongjun			Adult astrocytes from reptiles are resistant to proinflammatory activation via sustaining Vav1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION-INHIBITORY FACTOR; SPINAL-CORD REGENERATION; FIBRILLARY ACIDIC PROTEIN; KEY REGULATORS; CELLS; PHAGOCYTOSIS; ENVIRONMENT; PROGENITOR; MICROGLIA; PATHOLOGY	Adult mammalian astrocytes are sensitive to inflammatory stimuli in the context of neuropathology or mechanical injury, thereby affecting functional outcomes of the central nervous system (CNS). In contrast, glial cells residing in the spinal cord of regenerative vertebrates exhibit a weak astroglial reaction similar to those of mammals in embryonic stages. Macrophage migration inhibitory factor (MIF) participates in multiple neurological disorders by activation of glial and immune cells. However, the mechanism of astrocytes from regenerative species, such as gecko astrocytes (gAS), in resistance to MIF-mediated inflammation in the severed cords remains unclear. Here, we compared neural stem cell markers among gAS, as well as adult (rAS) and embryonic (eAS) rat astrocytes. We observed that gAS retained an immature phenotype resembling rat eAS. Proinflammatory activation of gAS with gecko (gMIF) or rat (rMIF) recombinant protein was unable to induce the production of inflammatory cytokines, despite its interaction with membrane CD74 receptor. Using cross-species screening of inflammation-related mediators from models of gMIF- and rMIF-induced gAS and rAS, we identified Vav1 as a key regulator in suppressing the inflammatory activation of gAS. The gAS with Vav1 deficiency displayed significantly restored sensitivity to inflammatory stimuli. Meanwhile, gMIF acts to promote the migration of gAS through regulation of CXCL8 following cord lesion. Taken together, our results suggest that Vav1 contributes to the regulation of astrocyte-mediated inflammation, which might be beneficial for the therapeutic development of neurological diseases.	[Wang, Yingjie; Wang, Yongjun] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China; Nantong Univ, Coinnovat Ctr Neuroregenerat, Minist Educ, Nantong, Peoples R China	Nantong University; Nantong University	Wang, YJ; Wang, YJ (corresponding author), Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China.	wyj2010@ntu.edu.cn; wyjbs@ntu.edu.cn		Wang, Yongjun/0000-0001-5040-8926	National Natural Science Foundation of China [31871211, 31702022]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	We are grateful to Prof. Mei Liu for providing the original data about the comparison of stem cell marker among gAS, eAS, and rAS. This study was supported by the National Natural Science Foundation of China (No. 31871211; 31702022) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Ahboucha S, 2003, J COMP NEUROL, V464, P159, DOI 10.1002/cne.10781; Alibardi L, 2020, J MORPHOL, V281, P95, DOI 10.1002/jmor.21082; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bradbury EJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11707-7; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Cox GM, 2013, J IMMUNOL, V191, P1043, DOI 10.4049/jimmunol.1200485; Davies Jeannette E, 2006, J Biol, V5, P7, DOI 10.1186/jbiol35; Diaz Quiroz JF, 2013, BIOCHEM J, V451, P353, DOI 10.1042/BJ20121807; Dong YY, 2013, J BIOL CHEM, V288, P18204, DOI 10.1074/jbc.M113.463810; Farago M, 2020, CELL SIGNAL, V65, DOI 10.1016/j.cellsig.2019.109438; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Flynn G, 2003, J NEUROIMMUNOL, V136, P84, DOI 10.1016/S0165-5728(03)00009-2; Fry AL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6579; Fujimoto Y, 2006, EUR SPINE J, V15, P223, DOI 10.1007/s00586-005-0933-3; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Gu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127663; Haas C, 2012, EXP NEUROL, V233, P717, DOI 10.1016/j.expneurol.2011.11.002; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Hill CE, 2004, EXP NEUROL, V190, P289, DOI 10.1016/j.expneurol.2004.05.043; Rehermann MI, 2009, J COMP NEUROL, V515, P197, DOI 10.1002/cne.22061; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kassem S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006185; Khalaf H, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-26; Koda M, 2004, ACTA NEUROPATHOL, V108, P31, DOI 10.1007/s00401-004-0853-z; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kuegler PB, 2010, ALTEX-ALTERN ANIM EX, V27, P17; Leyton-Jaimes MF, 2018, EXP NEUROL, V301, P83, DOI 10.1016/j.expneurol.2017.06.021; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Mamik MK, 2016, CURR DRUG TARGETS, V17, P111, DOI 10.2174/1389450116666150626124544; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; McLean KE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-50; MONZONMAYOR M, 1990, J COMP NEUROL, V295, P569, DOI 10.1002/cne.902950406; Nicholls J, 1996, TRENDS NEUROSCI, V19, P229, DOI 10.1016/0166-2236(96)10021-7; Nishio Y, 2009, ACTA NEUROPATHOL, V117, P321, DOI 10.1007/s00401-008-0476-x; Oikonomidi A, 2017, J ALZHEIMERS DIS, V60, P273, DOI 10.3233/JAD-170335; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Ramjeesingh R, 2003, FASEB J, V17, P1292, DOI 10.1096/fj.02-0560fje; Rasmussen JP, 2017, EXP NEUROL, V287, P318, DOI 10.1016/j.expneurol.2016.02.022; Roth S, 2016, CELL REP, V17, P2572, DOI 10.1016/j.celrep.2016.11.018; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shah VB, 2009, MOL IMMUNOL, V46, P1845, DOI 10.1016/j.molimm.2009.01.014; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Spurrell DR, 2009, J IMMUNOL, V183, P310, DOI 10.4049/jimmunol.0802096; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Tazaki A, 2017, DEV BIOL, V432, P63, DOI 10.1016/j.ydbio.2017.09.034; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Vandenbark AA, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1393-0; WANG JJ, 1995, NEUROSCIENCE, V65, P973, DOI 10.1016/0306-4522(94)00519-B; Wang YJ, 2019, FASEB J, V33, P14798, DOI 10.1096/fj.201801966RRR; Wheeler MA, 2019, CELL, V176, P581, DOI 10.1016/j.cell.2018.12.012; Wilsbacher Julie L, 2006, Cell Commun Signal, V4, P5, DOI 10.1186/1478-811X-4-5; Zenker S, 2014, J IMMUNOL, V192, P2830, DOI 10.4049/jimmunol.1300157; Zhang XJ, 2020, NEUROSCI BULL, V36, P778, DOI 10.1007/s12264-020-00493-8; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang YX, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1468-6; Zhou Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1297-z; Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1	65	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100527	10.1016/j.jbc.2021.100527	http://dx.doi.org/10.1016/j.jbc.2021.100527			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33705794	Green Published, gold			2022-12-28	WOS:000672866400501
J	Ghodke, PP; Gonzalez-Vasquez, G; Wang, H; Johnson, KM; Sedgeman, CA; Guengerich, FP				Ghodke, Pratibha P.; Gonzalez-Vasquez, Gabriela; Wang, Hui; Johnson, Kevin M.; Sedgeman, Carl A.; Guengerich, F. Peter			Enzymatic bypass of an N-6-deoxyadenosine DNA-ethylene dibromide-peptide cross-link by translesion DNA polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; BIS-ELECTROPHILES; GENOMIC INSTABILITY; REPLICATION BYPASS; 1,2-DIBROMOETHANE; ALKYLTRANSFERASE; ACTIVATION; MECHANISM; TOXICITY; OPPOSITE	Unrepaired DNA-protein cross-links, due to their bulky nature, can stall replication forks and result in genome instability. Large DNA-protein cross-links can be cleaved into DNA-peptide cross-links, but the extent to which these smaller fragments disrupt normal replication is not clear. Ethylene dibromide (1,2-dibromoethane) is a known carcinogen that can cross-link the repair protein O-6-alkylguanine-DNA alkyltransferase (AGT) to the N6 position of deoxyadenosine (dA) in DNA, as well as four other positions in DNA. We investigated the effect of a 15-mer peptide from the active site of AGT, crosslinked to the N6 position of dA, on DNA replication by human translesion synthesis DNA polymerases (Pols) eta, iota, and kappa. The peptide-DNA cross-link was bypassed by the three polymerases at different rates. In steady-state kinetics, the specificity constant (k(cat)/K-m) for incorporation of the correct nucleotide opposite to the adduct decreased by 220-fold with Pol kappa, tenfold with pol eta, and not at all with Pol iota. Pol eta incorporated all four nucleotides across from the lesion, with the preference dT > dC > dA > dG, while Pol iota and kappa only incorporated the correct nucleotide. However, LC-MS/MS analysis of the primer-template extension product revealed error-free bypass of the cross-linked 15-mer peptide by Pol eta. We conclude that a bulky 15-mer peptide cross-linked to the N6 position of dA can retard polymerization and cause miscoding but that overall fidelity is not compromised because only correct pairs are extended.	[Ghodke, Pratibha P.; Gonzalez-Vasquez, Gabriela; Wang, Hui; Johnson, Kevin M.; Sedgeman, Carl A.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	f.guengerich@vanderbilt.edu		Ghodke, Pratibha P./0000-0002-8402-3933; Wang, Hui/0000-0003-0054-6583; Gonzalez-Vasquez, Gabriela/0000-0002-0773-941X	National Institutes of Health [R01 ES010546]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health R01 ES010546 (F. P. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bhargava V, 2020, DEV CELL, V52, P38, DOI 10.1016/j.devcel.2019.11.007; Boche G, 2001, ENCY REAGENTS ORGANI; Borgermann N, 2019, EMBO J, V38, DOI 10.15252/embj.2019101496; Chan W, 2019, ANAL CHEM, V91, P4987, DOI 10.1021/acs.analchem.8b04306; Chandrasekar J, 2015, J AM CHEM SOC, V137, P9575, DOI 10.1021/jacs.5b06308; Chesner LN, 2018, DNA REPAIR, V62, P18, DOI 10.1016/j.dnarep.2018.01.004; Cho SH, 2013, CHEM RES TOXICOL, V26, P1765, DOI 10.1021/tx4003534; Cho SH, 2013, CHEM RES TOXICOL, V26, P1005, DOI 10.1021/tx400145e; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Chowdhury G., 2011, CURR PROTOC NUCL ACI; Chowdhury G, 2013, ANGEW CHEM INT EDIT, V52, P12879, DOI 10.1002/anie.201307580; CMARIK JL, 1992, J BIOL CHEM, V267, P6672; Colombo CV, 2020, BIOCHEM SOC T, V48, P677, DOI 10.1042/BST20191118; Dokshin GA, 2020, DEV CELL, V52, P53, DOI 10.1016/j.devcel.2019.11.006; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; Enderle J, 2019, PLANT CELL, V31, P775, DOI 10.1105/tpc.18.00824; Ghodke PP, 2020, J BIOL CHEM, V295, P6092, DOI 10.1074/jbc.RA120.012829; Ghodke Pratibha P, 2019, Curr Protoc Nucleic Acid Chem, V76, pe74, DOI 10.1002/cpnc.74; Groehler A, 2018, FREE RADICAL BIO MED, V120, P89, DOI 10.1016/j.freeradbiomed.2018.03.010; Groehler A, 2016, CHEM RES TOXICOL, V29, P190, DOI 10.1021/acs.chemrestox.5b00430; Ham YH, 2020, CHEM RES TOXICOL, V33, P2739, DOI 10.1021/acs.chemrestox.0c00289; HUFF JE, 1983, ENVIRON HEALTH PERSP, V47, P359, DOI 10.2307/3429524; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Isojima T, 2014, J BONE MINER RES, V29, P992, DOI 10.1002/jbmr.2091; Ji SF, 2019, J BIOL CHEM, V294, P18387, DOI 10.1074/jbc.RA119.009834; Ji SF, 2019, ACS CHEM BIOL, V14, P2564, DOI 10.1021/acschembio.9b00365; Ji SF, 2017, ANGEW CHEM INT EDIT, V56, P14130, DOI 10.1002/anie.201708286; Johnson KA, 2019, BEILSTEIN J ORG CHEM, V15, P16, DOI 10.3762/bjoc.15.2; Kalapila AG, 2010, MUTAT RES-FUND MOL M, V684, P35, DOI 10.1016/j.mrfmmm.2009.11.006; Kim MS, 1998, CHEM RES TOXICOL, V11, P311, DOI 10.1021/tx970206m; Kojima Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15170-7; Kotapati S, 2015, CHEM RES TOXICOL, V28, P1496, DOI 10.1021/acs.chemrestox.5b00166; Kuhbacher U, 2020, DNA REPAIR, V94, DOI 10.1016/j.dnarep.2020.102924; Larsen NB, 2019, MOL CELL, V73, P574, DOI 10.1016/j.molcel.2018.11.024; Lessel D, 2014, NAT GENET, V46, P1239, DOI 10.1038/ng.3103; Li FX, 2019, CELL REP, V26, P3336, DOI 10.1016/j.celrep.2019.02.082; Liu LP, 2004, CHEM RES TOXICOL, V17, P742, DOI 10.1021/tx049958o; Liu LP, 2004, J BIOL CHEM, V279, P4250, DOI 10.1074/jbc.M311105200; Liu LP, 2002, J BIOL CHEM, V277, P37920, DOI 10.1074/jbc.M205548200; Loeber RL, 2009, CHEM RES TOXICOL, V22, P1151, DOI 10.1021/tx900078y; Loecken EA, 2009, CHEM RES TOXICOL, V22, P1069, DOI 10.1021/tx900037u; Loecken EM, 2008, CHEM RES TOXICOL, V21, P453, DOI 10.1021/tx7003618; Lopez-Mosqueda J, 2016, ELIFE, V5, DOI 10.7554/eLife.21491; Maddukuri L, 2013, BIOCHEMISTRY-US, V52, P8766, DOI 10.1021/bi401103k; Maskey RS, 2017, NUCLEIC ACIDS RES, V45, P4564, DOI 10.1093/nar/gkx107; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Mohni KN, 2019, CELL, V176, P144, DOI 10.1016/j.cell.2018.10.055; Morocz M, 2017, NUCLEIC ACIDS RES, V45, P3172, DOI 10.1093/nar/gkw1315; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Naldiga S, 2019, J BIOL CHEM, V294, P10619, DOI 10.1074/jbc.RA119.008879; Niedernhofer LJ, 2018, ANNU REV BIOCHEM, V87, P295, DOI 10.1146/annurev-biochem-062917-012239; Pande P, 2017, CHEM RES TOXICOL, V30, P669, DOI 10.1021/acs.chemrestox.6b00397; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Pence MG, 2010, J BIOL CHEM, V285, P40666, DOI 10.1074/jbc.M110.183665; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; RANNUG U, 1979, CHEM-BIOL INTERACT, V24, P265, DOI 10.1016/0009-2797(79)90077-2; RANNUG U, 1980, MUTAT RES, V76, P269, DOI 10.1016/0165-1110(80)90020-2; Rechkoblit O, 2002, J BIOL CHEM, V277, P30488, DOI 10.1074/jbc.M201167200; Reinking HK, 2020, MOL CELL, V80, P102, DOI 10.1016/j.molcel.2020.08.003; Ruggiano A, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01539-3; Schipper-Krom S, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00056; Sedgeman CA, 2017, CHEM RES TOXICOL, V30, P1188, DOI 10.1021/acs.chemrestox.7b00022; Serrano-Bueno G, 2019, BBA-MOL CELL RES, V1866, P1019, DOI 10.1016/j.bbamcr.2019.02.015; Stingele J, 2017, NAT REV MOL CELL BIO, V18, P563, DOI 10.1038/nrm.2017.56; Stingele J, 2016, MOL CELL, V64, P688, DOI 10.1016/j.molcel.2016.09.031; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; Sun Y., 2019, CONSERVED SUMO UBIQU, DOI [10.1101/707661, DOI 10.1101/707661]; Svoboda M, 2019, DNA REPAIR, V80, P45, DOI 10.1016/j.dnarep.2019.06.008; Swanson AL, 2011, BIOCHEMISTRY-US, V50, P7666, DOI 10.1021/bi2007417; Thompson PS, 2019, NAT STRUCT MOL BIOL, V26, P613, DOI 10.1038/s41594-019-0255-5; Tretyakova NY, 2015, ACCOUNTS CHEM RES, V48, P1631, DOI 10.1021/acs.accounts.5b00056; Unger S, 2013, AM J HUM GENET, V92, P990, DOI 10.1016/j.ajhg.2013.04.020; Valadez JG, 2004, CHEM RES TOXICOL, V17, P972, DOI 10.1021/tx049897u; Valadez JG, 2004, J BIOL CHEM, V279, P13435, DOI 10.1074/jbc.M312358200; Vaz B., 2020, SPRTN PROTEASE SUMOY, DOI [10.1101/2020.02.14.949289, DOI 10.1101/2020.02.14.949289]; Vaz B, 2017, TRENDS BIOCHEM SCI, V42, P483, DOI 10.1016/j.tibs.2017.03.005; Vaz B, 2016, MOL CELL, V64, P704, DOI 10.1016/j.molcel.2016.09.032; Wickramaratne S, 2016, J BIOL CHEM, V291, P23589, DOI 10.1074/jbc.M116.745257; Wickramaratne S, 2015, J BIOL CHEM, V290, P775, DOI 10.1074/jbc.M114.613638; WONG LCK, 1982, TOXICOL APPL PHARM, V63, P155, DOI 10.1016/0041-008X(82)90036-9; Xu WY, 2019, P NATL ACAD SCI USA, V116, P17792, DOI 10.1073/pnas.1911252116; Yamanaka K, 2011, J BACTERIOL, V193, P3815, DOI 10.1128/JB.01550-10; Yang K, 2018, P NATL ACAD SCI USA, V115, pE11212, DOI 10.1073/pnas.1813338115; Yang W, 2018, ANNU REV BIOCHEM, V87, P239, DOI 10.1146/annurev-biochem-062917-012405; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s; Yeo JE, 2014, ACS CHEM BIOL, V9, P1860, DOI 10.1021/cb5001795; Yudkina AV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198480; Zhang HM, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-019-0366-z; Zhao S., 2020, NUCLEIC ACIDS RES, V49, P902	89	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100444	10.1016/j.jbc.2021.100444	http://dx.doi.org/10.1016/j.jbc.2021.100444			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33617883	Green Published, gold			2022-12-28	WOS:000672866400418
J	Jiang, YX; Luo, WQ; Wang, B; Yi, ZM; Gong, P; Xiong, Y				Jiang, Yixuan; Luo, Wenqiong; Wang, Bin; Yi, Zumu; Gong, Ping; Xiong, Yi			1 alpha,25-Dihydroxyvitamin D3 ameliorates diabetes-induced bone loss by attenuating FoxO1-mediated autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D; OSTEOBLAST PROLIFERATION; HIGH GLUCOSE; IN-VIVO; FOXO1; METABOLISM; INSULIN; AKT; DIFFERENTIATION; PATHOGENESIS	Autophagy is vital for maintaining cellular homeostasis through removing impaired organelles. It has recently been found to play pivotal roles in diabetes mellitus (DM), which is associated with increased bone fracture risk and loss of bone density. However, the mechanism whereby autophagy modulates DM-induced bone loss is not fully elucidated. Previous work has shown that 1 alpha,25-Dihydroxyvitamin D3 (1,25D) exerts positive effects on autophagy, thus affecting bone metabolism. Here, we investigated whether autophagy was involved in the regulation of diabetic bone metabolism. Using Micro-CT, Elisa, histology, and histomorphometry analysis, we demonstrated that 1,25D rescues glucose metabolism dysfunction and ameliorates bone loss in diabetic mice. In vitro, 1,25D alleviated primary osteoblast dysfunction and intracellular oxidative stress through reducing prolonged high-glucose-mediated excessive autophagy in primary osteoblasts, reflected by decreased protein level of Beclin1 and LC3. Of note, the autophagy activator rapamycin (RAP) ablated the positive effects of 1,25D in diabetic environment, leading to a marked increase in autolysosomes and autophagosomes, examined by mRFP-GFP-LC3 fluorescence double labeling. The excessive autophagy induced by high glucose was deleterious to proliferation and differentiation of primary osteoblasts. Additionally, biochemical studies identified that PI3K/Akt signaling could be activated by 1,25D, resulting in the inhibition of FoxO1. We confirmed that FoxO1 deficiency alleviated high-glucose-induced autophagy and improved biological functions of primary osteoblasts. Together, our results suggest that the PI3K/Akt/FoxO1 signaling pathway is involved in the osteoprotective effect of 1,25D by attenuating autophagy in diabetes, providing a novel insight for the prevention and treatment of diabetes-caused bone loss.	[Jiang, Yixuan; Luo, Wenqiong; Wang, Bin; Yi, Zumu; Gong, Ping; Xiong, Yi] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China; [Jiang, Yixuan; Luo, Wenqiong; Wang, Bin; Gong, Ping; Xiong, Yi] Sichuan Univ, West China Hosp Stomatol, Dept Oral Implantol, Chengdu, Peoples R China	Sichuan University; Sichuan University	Xiong, Y (corresponding author), Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China.; Xiong, Y (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral Implantol, Chengdu, Peoples R China.	xiongraise@163.com	XIONG, Yi/HGU-1217-2022	Xiong, Yi/0000-0002-6676-202X	Sichuan Science and Technology Program [2020JDRC0055]; West China Hospital Basic and Applied Basic Research Foundation [RD-02-201913]; China Postdoctoral Science Foundation [2019M653442]	Sichuan Science and Technology Program; West China Hospital Basic and Applied Basic Research Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Sichuan Science and Technology Program (2020JDRC0055), West China Hospital Basic and Applied Basic Research Foundation (RD-02-201913) and China Postdoctoral Science Foundation (2019M653442).	Amaravadi R, 2016, GENE DEV, V30, P1913, DOI 10.1101/gad.287524.116; Bartolome A, 2013, BIOCHEM J, V455, P329, DOI 10.1042/BJ20130562; Cao J, 2018, DIABETES, V67, P46, DOI 10.2337/db17-0546; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dusso AS, 2011, KIDNEY INT SUPPL, V1, P136, DOI 10.1038/kisup.2011.30; Epstein S, 2016, OSTEOPOROSIS INT, V27, P1931, DOI 10.1007/s00198-015-3454-x; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Guo F, 2018, BRAIN PATHOL, V28, P3, DOI 10.1111/bpa.12545; Guo XP, 2020, J NUTR BIOCHEM, V80, DOI 10.1016/j.jnutbio.2020.108380; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huang XJ, 2018, INT J BIOL SCI, V14, P1483, DOI 10.7150/ijbs.27173; Iyer S, 2017, J BONE MINER RES, V32, P60, DOI 10.1002/jbmr.2934; Kim J, 2018, MOL CELLS, V41, P11, DOI 10.14348/molcells.2018.2228; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Lecka-Czernik B, 2017, DIABETOLOGIA, V60, P1163, DOI 10.1007/s00125-017-4269-4; Lee CT, 2019, J STEROID BIOCHEM, V185, P200, DOI 10.1016/j.jsbmb.2018.09.002; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Levine B, 2015, TRENDS CELL BIOL, V25, P533, DOI 10.1016/j.tcb.2015.05.004; Li HX, 2018, AUTOPHAGY, V14, P1726, DOI 10.1080/15548627.2018.1483807; Liu LH, 2016, CELL CYCLE, V15, P2033, DOI 10.1080/15384101.2016.1192732; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Marasco MR, 2018, ENDOCRINOLOGY, V159, P2127, DOI 10.1210/en.2017-03273; Matsuzaki T, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan0746; Meng HZ, 2015, J BIOL CHEM, V290, P28189, DOI 10.1074/jbc.M115.669499; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Mitri J, 2014, ENDOCRIN METAB CLIN, V43, P205, DOI 10.1016/j.ecl.2013.09.010; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Napoli N, 2017, NAT REV ENDOCRINOL, V13, P208, DOI 10.1038/nrendo.2016.153; O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Ramalingam M, 2016, BIOMOL THER, V24, P589, DOI 10.4062/biomolther.2016.030; Sacerdote A, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1201-y; Saline M, 2019, J BIOL CHEM, V294, P13106, DOI 10.1074/jbc.RA119.008649; Schmidt AM, 2018, ARTERIOSCL THROM VAS, V38, pE1, DOI 10.1161/ATVBAHA.117.310221; Schreiber KH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11174-0; Sellmeyer DE, 2016, DIABETES, V65, P1757, DOI 10.2337/db16-0063; Teixeira CC, 2010, J BIOL CHEM, V285, P31055, DOI 10.1074/jbc.M109.079962; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang XJ, 2016, MOL CELL ENDOCRINOL, V429, P62, DOI 10.1016/j.mce.2016.03.036; Welsh J, 2018, J STEROID BIOCHEM, V177, P15, DOI 10.1016/j.jsbmb.2017.07.025; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xiong Y, 2017, J BIOL CHEM, V292, P20270, DOI 10.1074/jbc.M117.796367; Yamamoto Suguru, 2013, Biochem J, V456, pe1, DOI 10.1042/BJ20131282; Yan JT, 2018, PHARMACOL RES, V130, P466, DOI 10.1016/j.phrs.2017.12.026; Yang JH, 2010, CELL BIOCHEM FUNCT, V28, P334, DOI 10.1002/cbf.1668; Yao HL, 2018, MOL MED REP, V17, P6681, DOI 10.3892/mmr.2018.8657; Zhang XY, 2008, J BONE MINER RES, V23, P1238, DOI [10.1359/jbmr.080326, 10.1359/JBMR.080326]	53	7	7	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100287	10.1016/j.jbc.2021.100287	http://dx.doi.org/10.1016/j.jbc.2021.100287			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450223	Green Published, gold			2022-12-28	WOS:000672866400263
J	Katz, LS; Baumel-Alterzon, S; Scott, DK; Herman, MA				Katz, Liora S.; Baumel-Alterzon, Sharon; Scott, Donald K.; Herman, Mark A.			Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ELEMENT-BINDING PROTEIN; THIOREDOXIN-INTERACTING PROTEIN; SUGAR-SWEETENED BEVERAGE; DE-NOVO LIPOGENESIS; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; GENE-EXPRESSION; HEPATIC STEATOSIS; XYLULOSE 5-PHOSPHATE; ADIPOSE-TISSUE	Excessive sugar consumption is a contributor to the worldwide epidemic of cardiometabolic disease. Understanding mechanisms by which sugar is sensed and regulates metabolic processes may provide new opportunities to prevent and treat these epidemics. Carbohydrate Responsive-Element Binding Protein (ChREBP) is a sugar-sensing transcription factor that mediates genomic responses to changes in carbohydrate abundance in key metabolic tissues. Carbohydrate metabolites activate the canonical form of ChREBP, ChREBP-alpha, which stimulates production of a potent, constitutively active ChREBP isoform called ChREBP-beta. Carbohydrate metabolites and other metabolic signals may also regulate ChREBP activity via posttranslational modifications including phosphorylation, acetylation, and O-GlcNAcylation that can affect ChREBP's cellular localization, stability, binding to cofactors, and transcriptional activity. In this review, we discuss mechanisms regulating ChREBP activity and highlight phenotypes and controversies in ChREBP gain- and loss-of-function genetic rodent models focused on the liver and pancreatic islets.	[Katz, Liora S.; Baumel-Alterzon, Sharon; Scott, Donald K.] Icahn Sch Med Mt Sinai, Obes Diabet & Metab Inst, New York, NY 10029 USA; [Herman, Mark A.] Duke Univ, Med Ctr, Div Endocrinol & Metab, Durham, NC 27708 USA; [Herman, Mark A.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27708 USA	Icahn School of Medicine at Mount Sinai; Duke University; Duke University	Scott, DK (corresponding author), Icahn Sch Med Mt Sinai, Obes Diabet & Metab Inst, New York, NY 10029 USA.; Herman, MA (corresponding author), Duke Univ, Med Ctr, Div Endocrinol & Metab, Durham, NC 27708 USA.; Herman, MA (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27708 USA.	donald.scott@mssm.edu; mark.herman@duke.edu		Scott, Donald/0000-0002-1414-9223	National Institutes of Health [R01DK114338, R01DK108905, R01DK100425, R01DK121710]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by National Institutes of Health R01DK114338 (D. K. S.), R01DK108905 (D. K. S.), R01DK100425 (M. A. H.), and R01DK121710 (M. A. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abdul-Wahed A, 2017, CELL METAB, V26, P324, DOI 10.1016/j.cmet.2017.07.004; Agius L, 2016, ANNU REV NUTR, V36, P389, DOI 10.1146/annurev-nutr-071715-051145; Agius L, 2016, P NUTR SOC, V75, P10, DOI 10.1017/S0029665115002451; Ahn B, 2016, J CLIN INVEST, V126, P3567, DOI 10.1172/JCI87382; Arden C, 2012, BIOCHEM J, V443, P111, DOI 10.1042/BJ20111280; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Aune D, 2017, INT J EPIDEMIOL, V46, P1029, DOI 10.1093/ije/dyw319; BABA H, 1995, NUTRITION, V11, P149; Batunel-Alterzon S., 2020, TRENDS ENDOCRIN MET, V32, P19; Bence KK, 2020, MOL METAB, V50, DOI 10.1016/j.molmet.2020.101143; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Bizeau ME, 2005, METABOLISM, V54, P1189, DOI 10.1016/j.metabol.2005.04.004; Boergesen M, 2011, J BIOL CHEM, V286, P13214, DOI 10.1074/jbc.M110.215467; BORTZ WM, 1972, J CLIN INVEST, V51, P1537, DOI 10.1172/JCI106950; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen N, 2021, J CELL PHYSIOL, V236, P625, DOI 10.1002/jcp.29890; Chu AY, 2013, HUM MOL GENET, V22, P1895, DOI 10.1093/hmg/ddt032; Corbett JA, 2008, DIABETES, V57, P797, DOI 10.2337/db08-0055; Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; de Vries PS, 2019, BLOOD, V133, P967, DOI 10.1182/blood-2018-05-849240; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Dentin R, 2012, J HEPATOL, V56, P199, DOI 10.1016/j.jhep.2011.07.019; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Du HD, 2017, INT J EPIDEMIOL, V46, P1444, DOI 10.1093/ije/dyx042; Dubuquoy C, 2011, J HEPATOL, V55, P145, DOI 10.1016/j.jhep.2010.10.024; Dushay JR, 2015, MOL METAB, V4, P51, DOI 10.1016/j.molmet.2014.09.008; Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537; Erion DM, 2013, ENDOCRINOLOGY, V154, P36, DOI 10.1210/en.2012-1725; Fisher FM, 2017, MOL METAB, V6, P14, DOI 10.1016/j.molmet.2016.11.008; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; FROESCH ER, 1963, AM J MED, V34, P151, DOI 10.1016/0002-9343(63)90050-0; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Grefhorst A, 2010, BIOCHEM J, V432, P249, DOI 10.1042/BJ20101225; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Han XK, 2020, EUR J EPIDEMIOL, V35, P139, DOI 10.1007/s10654-019-00598-z; Hannou SA, 2018, J CLIN INVEST, V128, P545, DOI 10.1172/JCI96702; Havula E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003438; Heidenreich S, 2020, J BIOL CHEM, V295, P17158, DOI 10.1074/jbc.RA120.014402; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Ido-Kitamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047231; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111699; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Iroz A, 2017, CELL REP, V21, P403, DOI 10.1016/j.celrep.2017.09.065; Jensen T, 2018, J HEPATOL, V68, P1063, DOI 10.1016/j.jhep.2018.01.019; Jensen-Cody SO, 2020, CELL METAB, V32, P273, DOI 10.1016/j.cmet.2020.06.008; Jing G, 2016, MOL METAB, V5, P1208, DOI 10.1016/j.molmet.2016.09.010; Jois T, 2017, MOL METAB, V6, P1381, DOI 10.1016/j.molmet.2017.07.006; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Kato T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030340; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kersten S, 2017, NAT REV ENDOCRINOL, V13, P731, DOI 10.1038/nrendo.2017.119; Khan TA, 2016, EUR J NUTR, V55, pS25, DOI 10.1007/s00394-016-1345-3; Kim MS, 2016, J CLIN INVEST, V126, P4372, DOI 10.1172/JCI81993; Kim M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96703; Kishnani P. S., 2014, Genetics in Medicine, V16, pe1; Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943; Kliewer SA, 2019, CELL METAB, V29, P246, DOI 10.1016/j.cmet.2019.01.004; Koo HY, 2009, BIOCHEM BIOPH RES CO, V390, P285, DOI 10.1016/j.bbrc.2009.09.109; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Kumar A, 2018, DIABETES, V67, P1561, DOI 10.2337/db17-0943; Kursawe R, 2013, DIABETES, V62, P837, DOI 10.2337/db12-0889; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Lei Y, 2020, HEPATOLOGY, V72, P1638, DOI 10.1002/hep.31198; Li MV, 2010, BIOCHEM BIOPH RES CO, V395, P395, DOI 10.1016/j.bbrc.2010.04.028; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Li YK, 2019, J BIOL CHEM, V294, P14745, DOI 10.1074/jbc.RA119.007508; Linden AG, 2018, J LIPID RES, V59, P475, DOI 10.1194/jlr.M081836; Linner RK, 2019, NAT GENET, V51, P245, DOI 10.1038/s41588-018-0309-3; Liu Lei, 2020, Cell Metab, V32, P605, DOI 10.1016/j.cmet.2020.07.018; lizuka K., 2013, ENDOCR J, V60, P1145; Ma JT, 2015, J HEPATOL, V63, P462, DOI 10.1016/j.jhep.2015.03.032; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Marmier S, 2015, HEPATOLOGY, V62, P1086, DOI 10.1002/hep.27778; McFerrin LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034803; Mejhert N, 2020, MOL CELL, V77, P1251, DOI 10.1016/j.molcel.2020.01.014; Merino J, 2019, MOL PSYCHIATR, V24, P1920, DOI 10.1038/s41380-018-0079-4; Metukuri MR, 2012, DIABETES, V61, P2004, DOI 10.2337/db11-0802; Morigny P, 2019, NAT METAB, V1, P133, DOI 10.1038/s42255-018-0007-6; Nakagawa T, 2013, J BIOL CHEM, V288, P28358, DOI 10.1074/jbc.M113.498550; Nakatochi M, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0339-0; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Noordeen NA, 2010, DIABETES, V59, P153, DOI 10.2337/db08-0868; Oh AR, 2018, METABOLISM, V85, P286, DOI 10.1016/j.metabol.2018.04.006; Ortega-Prieto P, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00472; Ovalle F, 2018, NAT MED, V24, P1108, DOI 10.1038/s41591-018-0089-4; Park MJ, 2014, J BIOL CHEM, V289, P13519, DOI 10.1074/jbc.M113.530139; Pedersen KB, 2007, AM J PHYSIOL-ENDOC M, V292, pE788, DOI 10.1152/ajpendo.00510.2006; Piernas C, 2011, J NUTR, V141, P1159, DOI 10.3945/jn.111.138727; Poungvarin N, 2012, DIABETOLOGIA, V55, P1783, DOI 10.1007/s00125-012-2506-4; Poungvarin N, 2015, ENDOCRINOLOGY, V156, P1982, DOI 10.1210/en.2014-1666; PUHAKAINEN I, 1992, J CLIN ENDOCR METAB, V75, P789, DOI 10.1210/jc.75.3.789; Pulit SL, 2019, HUM MOL GENET, V28, P166, DOI 10.1093/hmg/ddy327; Rake JP, 2002, EUR J PEDIATR, V161, pS20, DOI 10.1007/s00431-002-0999-4; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Sargsyan A, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1195-5; Schmidt SF, 2016, CELL REP, V16, P2359, DOI 10.1016/j.celrep.2016.07.063; Shi JH, 2020, DIABETES, V69, P591, DOI 10.2337/db19-0388; Singhal G, 2018, MOL METAB, V13, P56, DOI 10.1016/j.molmet.2018.03.002; Smith GI, 2020, J CLIN INVEST, V130, P1453, DOI 10.1172/JCI134165; Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Talukdar S, 2016, CELL METAB, V23, P344, DOI 10.1016/j.cmet.2015.12.008; ter Horst KW, 2021, DIABETES CARE, V44, P489, DOI 10.2337/dc20-1644; ter Horst KW, 2017, MOL METAB, V6, P1493, DOI 10.1016/j.molmet.2017.08.014; ter Horst KW, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090981; Thielen LA, 2020, CELL METAB, V32, P353, DOI 10.1016/j.cmet.2020.07.002; Tong X, 2020, METABOLISM, V107, DOI 10.1016/j.metabol.2020.154222; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; Tsatsos NG, 2008, BIOCHEM J, V411, P261, DOI 10.1042/BJ20071156; Veniant MM, 2015, CELL METAB, V21, P731, DOI 10.1016/j.cmet.2015.04.019; von Holstein-Rathlou S, 2016, CELL METAB, V23, P335, DOI 10.1016/j.cmet.2015.12.003; von Wilamowitz-Moellendorff A, 2013, DIABETES, V62, P4070, DOI 10.2337/db13-0880; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Wang P, 2015, NAT REV ENDOCRINOL, V11, P201, DOI 10.1038/nrendo.2015.9; Wang PY, 2016, J DIABETES INVEST, V7, P56, DOI 10.1111/jdi.12376; White PJ, 2018, CELL METAB, V27, P1281, DOI 10.1016/j.cmet.2018.04.015; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yang AQ, 2017, MOL CELL PROTEOMICS, V16, P1233, DOI 10.1074/mcp.M116.061416; Zarei M, 2020, TRENDS PHARMACOL SCI, V41, P199, DOI 10.1016/j.tips.2019.12.005; Zhang DQ, 2017, J CLIN INVEST, V127, P2855, DOI 10.1172/JCI89934; Zhang P, 2015, DIABETES, V64, P4158, DOI 10.2337/db15-0239	136	8	7	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100623	10.1016/j.jbc.2021.100623	http://dx.doi.org/10.1016/j.jbc.2021.100623			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33812993	gold, Green Published			2022-12-28	WOS:000672866400594
J	Korwar, AM; Hossain, A; Lee, TJ; Shay, AE; Basrur, V; Conlon, K; Smith, PB; Carlson, BA; Salis, HM; Patterson, AD; Prabhu, KS				Korwar, Arvind M.; Hossain, Ayaan; Lee, Tai-Jung; Shay, Ashley E.; Basrur, Venkatesha; Conlon, Kevin; Smith, Philip B.; Carlson, Bradley A.; Salis, Howard M.; Patterson, Andrew D.; Prabhu, K. Sandeep			Selenium-dependent metabolic reprogramming during inflammation and resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-KINASE M2; MACROPHAGE POLARIZATION; ALTERNATIVE ACTIVATION; PPAR-GAMMA; EXPRESSION; IMMUNOMETABOLISM; SELENOPROTEINS; DEFICIENCY; IL-1-BETA; SUCCINATE	Trace element selenium (Se) is incorporated as the 21st amino acid, selenocysteine, into selenoproteins through tRNA([Ser]Sec). Selenoproteins act as gatekeepers of redox homeostasis and modulate immune function to effect anti-inflammation and resolution. However, mechanistic underpinnings involving metabolic reprogramming during inflammation and resolution remain poorly understood. Bacterial endotoxin lipopolysaccharide (LPS) activation of murine bone marrow-derived macrophages cultured in the presence or absence of Se (as selenite) was used to examine temporal changes in the proteome and metabolome by multiplexed tandem mass tag-quantitative proteomics, metabolomics, and machine-learning approaches. Kinetic deltagram and clustering analysis indicated that addition of Se led to extensive reprogramming of cellular metabolism upon stimulation with LPS enhancing the pentose phosphate pathway, tricarboxylic acid cycle, and oxidative phosphorylation, to aid in the phenotypic transition toward alternatively activated macrophages, synonymous with resolution of inflammation. Remodeling of metabolic pathways and consequent metabolic adaptation toward pro-resolving phenotypes began with Se treatment at 0 h and became most prominent around 8 h after LPS stimulation that included succinate dehydrogenase complex, pyruvate kinase, and sedoheptulokinase. Se-dependent modulation of these pathways predisposed bone marrow-derived macrophages to preferentially increase oxidative phosphorylation to efficiently regulate inflammation and its timely resolution. The use of macrophages lacking selenoproteins indicated that all three metabolic nodes were sensitive to selenoproteome expression. Furthermore, inhibition of succinate dehydrogenase complex with dimethylmalonate affected the proresolving effects of Se by increasing the resolution interval in a murine peritonitis model. In summary, our studies provide novel insights into the role of cellular Se via metabolic reprograming to facilitate anti-inflammation and proresolution.	[Korwar, Arvind M.; Lee, Tai-Jung; Shay, Ashley E.; Smith, Philip B.; Patterson, Andrew D.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Hossain, Ayaan; Salis, Howard M.] Penn State Univ, Bioinformat & Genom, University Pk, PA 16802 USA; [Hossain, Ayaan; Salis, Howard M.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Hossain, Ayaan; Salis, Howard M.] Penn State Univ, Dept Biol Engn, University Pk, PA 16802 USA; [Hossain, Ayaan; Salis, Howard M.] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Basrur, Venkatesha; Conlon, Kevin] Univ Michigan, Dept Pathol, Med Sch, Prote Resource Facil, Ann Arbor, MI 48109 USA; [Smith, Philip B.] Penn State Univ, Metabol Facil, Huck Inst Life Sci, University Pk, PA 16802 USA; [Carlson, Bradley A.] NCI, Mol Biol Selenium Sect, Mouse Canc Genet Program, NIH, Bethesda, MD 20892 USA; [Korwar, Arvind M.] Univ N Carolina, Greensboro, NC USA; [Shay, Ashley E.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Greensboro; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Prabhu, KS (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	ksp4@psu.edu	Hossain, Ayaan/ABB-9367-2021	Hossain, Ayaan/0000-0002-4781-5501	NIH; Office of Dietary Supplements NIH [DK077152]; USDA-NIFA Hatch Project [4605, 1010021]; Penn State Cancer Institute, Metabolomics Facility; Defense Advanced Research Projects Agency [FA8750-17-C-0254]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-NIFA Hatch Project; Penn State Cancer Institute, Metabolomics Facility; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	These studies were funded, in part, by grants from the NIH and Office of Dietary Supplements NIH DK077152, USDA-NIFA Hatch Project (Project #4605; Accession #1010021), Penn State Cancer Institute, Metabolomics Facility, and the Defense Advanced Research Projects Agency (FA8750-17-C-0254). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allman Erik L, 2016, Antimicrob Agents Chemother, V60, P6635, DOI 10.1128/AAC.01224-16; Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Avery JC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091203; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Blagih J, 2012, CELL METAB, V15, P793, DOI 10.1016/j.cmet.2012.05.008; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Carlson BA, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-57; Diwakar BT, 2017, ADV CANCER RES, V136, P153, DOI 10.1016/bs.acr.2017.07.003; DOHERTY NS, 1985, PROSTAGLANDINS, V30, P769, DOI 10.1016/0090-6980(85)90006-1; Finch ER, 2017, BLOOD, V129, P1802, DOI 10.1182/blood-2016-08-736405; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hawkes WC, 2010, BIOL TRACE ELEM RES, V134, P235, DOI 10.1007/s12011-010-8656-7; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kaushal N, 2014, J IMMUNOL, V193, P3683, DOI 10.4049/jimmunol.1400347; Korwar AM, 2019, J AM SOC MASS SPECTR, V30, P1276, DOI 10.1007/s13361-019-02192-9; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kudva AK, 2015, AM J PHYSIOL-GASTR L, V309, pG71, DOI 10.1152/ajpgi.00379.2014; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Misra S, 2015, NUTRIENTS, V7, P3536, DOI 10.3390/nu7053536; Nelson SM, 2016, J BIOL CHEM, V291, P2787, DOI 10.1074/jbc.M115.684738; Nelson SM, 2011, J NUTR, V141, P1754, DOI 10.3945/jn.111.141176; Nettleford SK, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7030036; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2015, IMMUNITY, V42, P393, DOI 10.1016/j.immuni.2015.02.017; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; O'Neill Luke A J, 2011, Biochem J, V438, pe5, DOI 10.1042/BJ20111386; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Patel U, 2017, DRUG DISCOV TODAY, V22, P186, DOI 10.1016/j.drudis.2016.08.006; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Price JV, 2014, IMMUNITY, V41, P685, DOI 10.1016/j.immuni.2014.10.015; Remmerie A, 2018, CELL IMMUNOL, V330, P27, DOI 10.1016/j.cellimm.2018.01.020; Schomburg L, 2014, CRIT CARE, V18, DOI 10.1186/cc13963; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Ternette N, 2013, CELL REP, V3, P689, DOI 10.1016/j.celrep.2013.02.013; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Vunta H, 2008, MOL NUTR FOOD RES, V52, P1316, DOI 10.1002/mnfr.200700346; WARBURG O, 1956, SCIENCE, V124, P269; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yim SH, 2019, CELL REP, V27, P2785, DOI 10.1016/j.celrep.2019.05.001	56	5	5	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100410	10.1016/j.jbc.2021.100410	http://dx.doi.org/10.1016/j.jbc.2021.100410			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581115	Green Submitted, Green Published, gold			2022-12-28	WOS:000672866400384
J	Li, F; Liu, C; Streckaite, S; Yang, CH; Xu, PQ; Llansola-Portoles, MJ; Ilioaia, C; Pascal, AA; Croce, R; Robert, B				Li, Fei; Liu, Cheng; Streckaite, Simona; Yang, Chunhong; Xu, Pengqi; Llansola-Portoles, Manuel J.; Ilioaia, Cristian; Pascal, Andrew A.; Croce, Roberta; Robert, Bruno			A new, unquenched intermediate of LHCII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING-COMPLEX; CIS-TRANS ISOMERS; RESONANCE RAMAN; PHOTOSYSTEM-II; BETA-CAROTENE; CHLOROPHYLL FLUORESCENCE; PHOTOSYNTHETIC BACTERIA; ELECTRONIC ABSORPTION; PIGMENT STRUCTURE; REACTION CENTERS	When plants are exposed to high-light conditions, the potentially harmful excess energy is dissipated as heat, a process called non-photochemical quenching. Efficient energy dissipation can also be induced in the major light-harvesting complex of photosystem II (LHCII) in vitro, by altering the structure and interactions of several bound cofactors. In both cases, the extent of quenching has been correlated with conformational changes (twisting) affecting two bound carotenoids, neoxanthin, and one of the two luteins (in site L1). This lutein is directly involved in the quenching process, whereas neoxanthin senses the overall change in state without playing a direct role in energy dissipation. Here we describe the isolation of an intermediate state of LHCII, using the detergent ndodecyl-alpha-D-maltoside, which exhibits the twisting of neoxanthin (along with changes in chlorophyll-protein interactions), in the absence of the L1 change or corresponding quenching. We demonstrate that neoxanthin is actually a reporter of the LHCII environment-probably reflecting a large-scale conformational change in the protein-whereas the appearance of excitation energy quenching is concomitant with the configuration change of the L1 carotenoid only, reflecting changes on a smaller scale. This unquenched LHCII intermediate, described here for the first time, provides for a deeper understanding of the molecular mechanism of quenching.	[Li, Fei; Liu, Cheng; Yang, Chunhong] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Streckaite, Simona; Llansola-Portoles, Manuel J.; Ilioaia, Cristian; Pascal, Andrew A.; Robert, Bruno] Univ Paris Saclay, CEA, CNRS, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Xu, Pengqi; Croce, Roberta] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Amsterdam, Netherlands	Chinese Academy of Sciences; Institute of Botany, CAS; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Vrije Universiteit Amsterdam	Ilioaia, C; Robert, B (corresponding author), Univ Paris Saclay, CEA, CNRS, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	cristian.ilioaia@cea.fr; bruno.robert@cea.fr	Simona, Streckaite/CAA-2120-2022; Robert, Bruno/D-1264-2012; Croce, Roberta/HGU-9554-2022; pascal, andrew a/B-6186-2014; Croce, Roberta/ABG-3595-2021; Llansola-Portoles, Manuel J./ABI-1060-2020; Croce, Roberta/N-4067-2014	Simona, Streckaite/0000-0003-0541-5806; Robert, Bruno/0000-0001-5999-4538; Croce, Roberta/0000-0003-3469-834X; pascal, andrew a/0000-0002-1844-6065; Croce, Roberta/0000-0003-3469-834X; Llansola-Portoles, Manuel J./0000-0002-8065-9459; Croce, Roberta/0000-0003-3469-834X; ILIOAIA, Cristian/0000-0001-7505-1900	French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INBS-05]; "Infrastructures en Biologie Sante et Agronomie" (IBiSA), Sino-French Cai Yuanpei Programme [Ou Liu Jin [2016] 6313]; National Natural Science Foundation of China [31570236]; De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [86510013]; China Scholarship Council (CSC) [201604490129]	French Infrastructure for Integrated Structural Biology (FRISBI); "Infrastructures en Biologie Sante et Agronomie" (IBiSA), Sino-French Cai Yuanpei Programme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INBS-05 and the "Infrastructures en Biologie Sante et Agronomie" (IBiSA), Sino-French Cai Yuanpei Programme, Ou Liu Jin [2016] 6313, the National Natural Science Foundation of China (Grant No. 31570236), and De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) through a Vici grant (86510013) to R. C. F. L. was recipient of a China Scholarship Council grant (CSC NO. 201604490129).	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Akhtar P, 2015, J BIOL CHEM, V290, P4877, DOI 10.1074/jbc.M114.607770; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Chmeliov J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.45, 10.1038/nplants.2016.45]; Crisafi E, 2017, BBA-BIOMEMBRANES, V1859, P40, DOI 10.1016/j.bbamem.2016.10.010; Croce R, 2020, SCIENCE, V369, P933, DOI 10.1126/science.aay2058; DOLGANOV NAM, 1995, P NATL ACAD SCI USA, V92, P636, DOI 10.1073/pnas.92.2.636; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Fox KF, 2017, PHYS CHEM CHEM PHYS, V19, P22957, DOI 10.1039/c7cp03535g; Gall A, 2015, BBA-BIOENERGETICS, V1847, P12, DOI 10.1016/j.bbabio.2014.09.009; Georgakopoulou S, 2007, BIOCHEMISTRY-US, V46, P4745, DOI 10.1021/bi062031y; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ilioaia C, 2011, J BIOL CHEM, V286, P27247, DOI 10.1074/jbc.M111.234617; KOYAMA Y, 1982, BIOCHIM BIOPHYS ACTA, V680, P109, DOI 10.1016/0005-2728(82)90001-9; Koyama Y, 1999, ADV PHOTOSYNTH, V8, P161; KOYAMA Y, 1983, PHOTOBIOCH PHOTOBIOP, V5, P139; KOYAMA Y, 1988, J RAMAN SPECTROSC, V19, P37, DOI 10.1002/jrs.1250190107; Kruger TPJ, 2012, BIOPHYS J, V102, P2669, DOI 10.1016/j.bpj.2012.04.044; Lampoura SS, 2002, BIOCHEMISTRY-US, V41, P9139, DOI 10.1021/bi025724x; Liguori N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02239-z; Liguori N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15661; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Llansola-Portoles MJ, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2019.148078; Llansola-Portoles MJ, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0504; Llansola-Portoles MJ, 2017, PHOTOSYNTH RES, V134, P51, DOI 10.1007/s11120-017-0407-6; Llansola-Portoles MJ, 2017, J BIOL CHEM, V292, P1396, DOI 10.1074/jbc.M116.753723; Llansola-Portoles MJ, 2016, BBA-BIOENERGETICS, V1857, P1759, DOI 10.1016/j.bbabio.2016.08.006; LUTZ M, 1987, BIOCHIM BIOPHYS ACTA, V894, P423, DOI 10.1016/0005-2728(87)90121-6; Mascoli V, 2020, CHEM SCI, V11, P5697, DOI 10.1039/d0sc00781a; Mascoli V, 2019, CHEM-US, V5, P2900, DOI 10.1016/j.chempr.2019.08.002; Mendes-Pinto MM, 2013, J PHYS CHEM B, V117, P11015, DOI 10.1021/jp309908r; MULLET JE, 1980, BIOCHIM BIOPHYS ACTA, V589, P100, DOI 10.1016/0005-2728(80)90135-8; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Park S, 2018, J AM CHEM SOC, V140, P11965, DOI 10.1021/jacs.8b04844; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pinnola A, 2018, BIOCHEM SOC T, V46, P467, DOI [10.1042/BST20170307, 10.1042/bst20170307]; RIMAI L, 1973, J AM CHEM SOC, V95, P4493, DOI 10.1021/ja00795a005; Robert B, 2009, PHOTOSYNTH RES, V101, P147, DOI 10.1007/s11120-009-9440-4; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; RUBAN AV, 1995, PLANT PHYSIOL, V108, P721, DOI 10.1104/pp.108.2.721; RUBAN AV, 1995, BIOCHEMISTRY-US, V34, P2333, DOI 10.1021/bi00007a029; Saccon F, 2020, J EXP BOT, V71, P3626, DOI 10.1093/jxb/eraa126; SAITO S, 1983, J RAMAN SPECTROSC, V14, P310, DOI 10.1002/jrs.1250140504; SALARES VR, 1977, J RAMAN SPECTROSC, V6, P282, DOI 10.1002/jrs.1250060605; Scholes GD, 2011, NAT CHEM, V3, P763, DOI [10.1038/NCHEM.1145, 10.1038/nchem.1145]; Son MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15074-6; Staleva H, 2015, NAT CHEM BIOL, V11, P287, DOI [10.1038/nchembio.1755, 10.1038/NCHEMBIO.1755]	53	3	3	7	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100322	10.1016/j.jbc.2021.100322	http://dx.doi.org/10.1016/j.jbc.2021.100322			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493515	gold, Green Published			2022-12-28	WOS:000672866400296
J	Liberato, MV; Prates, ET; Goncalves, TA; Bernardes, A; Vilela, N; Fattori, J; Ematsu, GC; Chinaglia, M; Gomes, ERM; Figueira, ACM; Damasio, A; Polikarpov, I; Skaf, MS; Squina, FM				Liberato, Marcelo Vizona; Prates, Erica Teixeira; Goncalves, Thiago Augusto; Bernardes, Amanda; Vilela, Nathalia; Fattori, Juliana; Ematsu, Gabriela Cristina; Chinaglia, Mariana; Machi Gomes, Emerson Rodrigo; Migliorini Figueira, Ana Carolina; Damasio, Andre; Polikarpov, Igor; Skaf, Munir S.; Squina, Fabio Marcio			Insights into the dual cleavage activity of the GH16 laminarinase enzyme class on beta-1,3 and beta-1,4 glycosidic bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-BASIS; TRANSGLYCOSYLATION; GLYCOSYNTHESIS; RECOGNITION; VALIDATION; MECHANISMS; DYNAMICS; BINDING; BIOMASS; MUTANT	Glycoside hydrolases (GHs) are involved in the degradation of a wide diversity of carbohydrates and present several biotechnological applications. Many GH families are composed of enzymes with a single well-defined specificity. In contrast, enzymes from the GH16 family can act on a range of different polysaccharides, including beta-glucans and galactans. SCLam, a GH16 member derived from a soil metagenome, an endo-beta 1,3(4)-glucanase (EC 3.2.1.6), can cleave both beta-1,3 and beta-1,4 glycosidic bonds in glucans, such as laminarin, barley beta-glucan, and cello-oligosaccharides. A similar cleavage pattern was previously reported for other GH16 family members. However, the molecular mechanisms for this dual cleavage activity on (1,3)- and (1,4)-beta-D-glycosidic bonds by laminarinases have not been elucidated. In this sense, we determined the X-ray structure of a presumably inactive form of SCLam cocrystallized with different oligosaccharides. The solved structures revealed general bound products that are formed owing to residual activities of hydrolysis and transglycosylation. Biochemical and biophysical analyses and molecular dynamics simulations help to rationalize differences in activity toward different substrates. Our results depicted a bulky aromatic residue near the catalytic site critical to select the preferable configuration of glycosidic bonds in the binding cleft. Altogether, these data contribute to understanding the structural basis of recognition and hydrolysis of beta-1,3 and beta-1,4 glycosidic linkages of the laminarinase enzyme class, which is valuable for future studies on the GH16 family members and applications related to biomass conversion into feedstocks and bioproducts.	[Liberato, Marcelo Vizona; Ematsu, Gabriela Cristina; Chinaglia, Mariana; Machi Gomes, Emerson Rodrigo] Ctr Nacl Pesquisa Energia & Mat CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [Liberato, Marcelo Vizona; Goncalves, Thiago Augusto; Vilela, Nathalia; Squina, Fabio Marcio] Univ Sorocaba, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil; [Prates, Erica Teixeira; Skaf, Munir S.] Univ Estadual Campinas, Inst Quim, Campinas, SP, Brazil; [Prates, Erica Teixeira; Skaf, Munir S.] Univ Estadual Campinas, Ctr Pesquisa Engn & Ciencias Computacionais, Campinas, SP, Brazil; [Goncalves, Thiago Augusto; Vilela, Nathalia; Damasio, Andre] Univ Estadual Campinas, Inst Biol, Dept Bioquim & Biol Tecidual, Campinas, SP, Brazil; [Bernardes, Amanda; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Fattori, Juliana; Migliorini Figueira, Ana Carolina] Ctr Nacl Pesquisa Energia & Mat CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Prates, Erica Teixeira] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Universidade de Sorocaba; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; United States Department of Energy (DOE); Oak Ridge National Laboratory	Squina, FM (corresponding author), Univ Sorocaba, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil.	fabio.squina@prof.uniso.br	Teixeira Prates, Erica/GLU-6833-2022; Squina, Fabio/J-8130-2012; Liberato, Marcelo V/J-3606-2014	Squina, Fabio/0000-0002-8154-7459; Liberato, Marcelo V/0000-0002-7609-7844; Vilela, Nathalia/0000-0002-1072-0568; Polikarpov, Igor/0000-0001-9496-4174	FAPESP [2013/15582-5, 2014/04105-4, 2015/50612-8, 2017/22669-0, 2013/08293-7, 17/16089-1, 17/08166-6, 2015/505904]; CNPq [428527/2018-3, 306279/2020-7, 404654/2018-5, 304816/2017-5, 158882/20148]; Center for Bioenergy Innovation, a DOE Bioenergy Research Center - Office of Biological and Environmental Research in the DOE Office of Science	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Center for Bioenergy Innovation, a DOE Bioenergy Research Center - Office of Biological and Environmental Research in the DOE Office of Science	The authors would like to acknowledge FAPESP for financial support to F. M. S. (2015/505904), E. T. P. (2013/15582-5), M. V. L. (2014/04105-4), A. D. (2015/50612-8; 2017/22669-0), M. S. S. (2013/08293-7), T. A. G. (17/16089-1), and N. V. (17/08166-6). We also acknowledge CNPq for financial support to F. M. S. (428527/2018-3 and 306279/2020-7), A. D. (404654/2018-5; 304816/2017-5), and M. V. L. (158882/20148) and the LEC and Robolab facilities from LNBio/CNPEM, Beamline MX-2 from LNLS/CNPEM and CTBE/CNPEM for structural support. E. T. P. also acknowledges funding from the Center for Bioenergy Innovation, a DOE Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science	Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Alvarez TM, 2015, APPL BIOCHEM BIOTECH, V177, P304, DOI 10.1007/s12010-015-1743-7; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bissaro B, 2015, BIOCHEM J, V467, P17, DOI 10.1042/BJ20141412; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng YS, 2014, BBA-PROTEINS PROTEOM, V1844, P366, DOI 10.1016/j.bbapap.2013.11.005; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cota J, 2011, BIOCHEM BIOPH RES CO, V406, P590, DOI 10.1016/j.bbrc.2011.02.098; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DESLANDES Y, 1980, MACROMOLECULES, V13, P1466, DOI 10.1021/ma60078a020; Ducros VMA, 2003, CHEM BIOL, V10, P619, DOI 10.1016/S1074-5521(03)00143-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EVANGELISTA RA, 1995, ANAL CHEM, V67, P2239, DOI 10.1021/ac00109a051; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KEITEL T, 1994, EUR J BIOCHEM, V222, P203, DOI 10.1111/j.1432-1033.1994.tb18858.x; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Krah M, 1998, EUR J BIOCHEM, V257, P101, DOI 10.1046/j.1432-1327.1998.2570101.x; Labourel A, 2015, ACTA CRYSTALLOGR D, V71, P173, DOI 10.1107/S139900471402450X; Lee Sang Hoon, 2015, Prev Nutr Food Sci, V20, P110, DOI 10.3746/pnf.2015.20.2.110; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malet C, 1998, FEBS LETT, V440, P208, DOI 10.1016/S0014-5793(98)01448-3; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; PARRISH FW, 1960, CAN J CHEM, V38, P2094, DOI 10.1139/v60-284; Qin HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11542-0; Qin Z, 2017, J BIOL CHEM, V292, P1666, DOI 10.1074/jbc.M116.762419; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Strohmeier M, 2004, PROTEIN SCI, V13, P3200, DOI 10.1110/ps.04828404; Tosh SM, 2004, CARBOHYD POLYM, V55, P425, DOI 10.1016/j.carbpol.2003.11.004; Vasur J, 2010, J AM CHEM SOC, V132, P1724, DOI 10.1021/ja909129b; Vasur J, 2009, FEBS J, V276, P4282, DOI 10.1111/j.1742-4658.2009.07099.x; Viborg AH, 2019, J BIOL CHEM, V294, P15973, DOI 10.1074/jbc.RA119.010619	42	3	3	6	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100385	10.1016/j.jbc.2021.100385	http://dx.doi.org/10.1016/j.jbc.2021.100385			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556371	Green Submitted, gold, Green Published			2022-12-28	WOS:000672866400359
J	Mahling, R; Rahlf, CR; Hansen, SC; Hayden, MR; Shea, MA				Mahling, Ryan; Rahlf, Cade R.; Hansen, Samuel C.; Hayden, Matthew R.; Shea, Madeline A.			Ca2+-saturated calmodulin binds tightly to the N-terminal domain of A-type fibroblast growth factor homologous factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL ALPHA-SUBUNIT; SODIUM-CHANNEL; CRYSTAL-STRUCTURE; CALCIUM AFFINITY; NERVOUS-SYSTEM; NA+ CHANNELS; IQ MOTIF; MUTATIONS; INACTIVATION; COMPLEX	Voltage-gated sodium channels (Na(v)s) are tightly regulated by multiple conserved auxiliary proteins, including the four fibroblast growth factor homologous factors (FGFs), which bind the Na-v EF-hand like domain (EFL), and calmodulin (CaM), a multifunctional messenger protein that binds the Na-V IQ motif. The EFL domain and IQ motif are contiguous regions of Na-V cytosolic C-terminal domains (CTD), placing CaM and FGF in close proximity. However, whether the FGFs and CaM act independently, directly associate, or operate through allosteric interactions to regulate channel function is unknown. Titrations monitored by steady-state fluorescence spectroscopy, structural studies with solution NMR, and computational modeling demonstrated for the first time that both domains of (Ca2+)(4)-CaM (but not apo CaM) directly bind two sites in the N-terminal domain (NTD) of A-type FGF splice variants (FGF11A, FGF12A, FGF13A, and FGF14A) with high affinity. The weaker of the (Ca2+)(4)-CaM-binding sites was known via electrophysiology to have a role in long-term inactivation of the channel but not known to bind CaM. FGF12A binding to a complex of CaM associated with a fragment of the Na(V)1.2 CTD increased the Ca2+-binding affinity of both CaM domains, consistent with (Ca2+)(4)-CaM interacting preferentially with its higher-affinity site in the FGF12A NTD. Thus, A-type FGFs can compete with Na-V IQ motifs for (Ca2+)(4)-CaM. During spikes in the cytosolic Ca2+ concentration that accompany an action potential, CaM may translocate from the Na-V IQ motif to the FGF NTD, or the A-type FGF NTD may recruit a second molecule of CaM to the channel.	[Mahling, Ryan; Rahlf, Cade R.; Hansen, Samuel C.; Hayden, Matthew R.; Shea, Madeline A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Shea, MA (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	madeline-shea@uiowa.edu		Rahlf, Cade/0000-0001-9748-247X; Hansen, Samuel/0000-0003-4114-1355; Hayden, Matthew/0000-0002-9680-6644; Shea, Madeline/0000-0003-0814-7069; Mahling, Ryan/0000-0002-4590-2724	Interdisciplinary Training in Pain Research Program National Institutes of Health [T32 NS045549]; University of Iowa ICRU Fellowship; University of Iowa Carver College of Medicine Biochemistry Summer Undergraduate Research Fellowship; US National Institutes of Health [R01 GM57001]	Interdisciplinary Training in Pain Research Program National Institutes of Health; University of Iowa ICRU Fellowship; University of Iowa Carver College of Medicine Biochemistry Summer Undergraduate Research Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by the Interdisciplinary Training in Pain Research Program National Institutes of Health T32 NS045549 (R. M.); University of Iowa ICRU Fellowship (C. R. R.); University of Iowa Carver College of Medicine Biochemistry Summer Undergraduate Research Fellowship (M. R. H.); the US National Institutes of Health R01 GM57001 (M. A. S.). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrams J, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.141736; AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ataman ZA, 2007, STRUCTURE, V15, P1603, DOI 10.1016/j.str.2007.10.012; Bankston JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001258; Ben-Johny M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13709; Biswas S, 2008, J GEN PHYSIOL, V131, P197, DOI 10.1085/jgp.200709863; Black DJ, 2006, BIOCHEMISTRY-US, V45, P6987, DOI 10.1021/bi052533w; Bosch MK, 2016, CHANNELS, V10, P297, DOI 10.1080/19336950.2016.1153203; CHAPMAN ER, 1991, J BIOL CHEM, V266, P207; Chen Y, 2016, SCIENCE, V353, DOI 10.1126/science.aad8266; CHEUNG WY, 1970, BIOCHEM BIOPH RES CO, V38, P533, DOI 10.1016/0006-291X(70)90747-3; Clatot J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02262-0; COOK WJ, 1994, BIOCHEMISTRY-US, V33, P15259, DOI 10.1021/bi00255a006; Damo Steven M, 2013, Methods Mol Biol, V963, P173, DOI 10.1007/978-1-62703-230-8_11; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dover K, 2010, J PHYSIOL-LONDON, V588, P3695, DOI 10.1113/jphysiol.2010.192559; Effraim Philip R, 2019, Neurobiol Pain, V6, P100029, DOI 10.1016/j.ynpai.2019.100029; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Evans TIA, 2009, PROTEINS, V76, P47, DOI 10.1002/prot.22317; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Feldkamp MD, 2015, PROTEINS, V83, P989, DOI 10.1002/prot.24781; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; Gabelli SB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6126; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; GERENDASY DD, 1994, J BIOL CHEM, V269, P22420; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741, DOI 10.1074/jbc.270.12.6741; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; HATHAWAY DR, 1981, J BIOL CHEM, V256, P8183; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Hovey L, 2017, BIOPHYS CHEM, V224, P1, DOI 10.1016/j.bpc.2017.02.006; HUBBARD MJ, 1987, J BIOL CHEM, V262, P15062; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Johnson CN, 2018, STRUCTURE, V26, P683, DOI 10.1016/j.str.2018.03.005; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim EY, 2008, STRUCTURE, V16, P1455, DOI 10.1016/j.str.2008.07.010; Kim EY, 2010, EMBO J, V29, P3924, DOI 10.1038/emboj.2010.260; KLEE CB, 1986, CIBA F SYMP, V122, P162; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Lee CH, 2018, SCIENCE, V360, P508, DOI 10.1126/science.aas9466; Li RZ, 2016, MOL BIOL CELL, V27, P3273, DOI 10.1091/mbc.E16-05-0338; Li ZG, 2017, J BIOL CHEM, V292, P4614, DOI 10.1074/jbc.M116.754804; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Mahling R, 2017, BIOMOL NMR ASSIGN, V11, P297, DOI 10.1007/s12104-017-9767-2; Maier LS, 2006, J MOL CELL CARDIOL, V41, P451, DOI 10.1016/j.yjmcc.2006.04.020; Mantegazza M, 2005, P NATL ACAD SCI USA, V102, P18177, DOI 10.1073/pnas.0506818102; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MESSNER DJ, 1985, J BIOL CHEM, V260, P597; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Mori MX, 2008, STRUCTURE, V16, P607, DOI 10.1016/j.str.2008.01.011; Munoz-Sanjuan I, 2000, J BIOL CHEM, V275, P2589, DOI 10.1074/jbc.275.4.2589; Newman RA, 2008, PROTEINS, V71, P1792, DOI 10.1002/prot.21861; Niu J, 2018, ELIFE, V7, DOI 10.7554/eLife.35222; O'Donnell SE, 2011, PROTEINS, V79, P765, DOI 10.1002/prot.22917; Ogiwara I, 2009, NEUROLOGY, V73, P1046, DOI 10.1212/WNL.0b013e3181b9cebc; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Pablo JL, 2017, P NATL ACAD SCI USA, V114, P154, DOI 10.1073/pnas.1610158114; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Potet F, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M806871200; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; Sarhan MF, 2009, J BIOL CHEM, V284, P33265, DOI 10.1074/jbc.M109.052910; Schaller KL, 2003, CEREBELLUM, V2, P2, DOI 10.1080/14734220309424; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; SCHULMAN H, 1978, NATURE, V271, P478, DOI 10.1038/271478a0; SCHULMAN H, 1992, CELL CALCIUM, V13, P401, DOI 10.1016/0143-4160(92)90053-U; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Shi XY, 2012, BRAIN DEV-JPN, V34, P541, DOI 10.1016/j.braindev.2011.09.016; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; Sorensen BR, 2002, BIOCHEMISTRY-US, V41, P15, DOI 10.1021/bi011718+; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Theoharis NT, 2008, BIOCHEMISTRY-US, V47, P112, DOI 10.1021/bi7013129; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Vertessy BG, 1998, BIOCHEMISTRY-US, V37, P15300, DOI 10.1021/bi980795a; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5896; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wang CJ, 2011, J BIOL CHEM, V286, P24253, DOI 10.1074/jbc.M111.245803; Wang C, 2011, CIRC RES, V109, P775, DOI 10.1161/CIRCRESAHA.111.247957; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang ZZ, 2020, CHANNELS, V14, P268, DOI 10.1080/19336950.2020.1805999; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Whitaker WRJ, 2000, J COMP NEUROL, V422, P123, DOI 10.1002/(SICI)1096-9861(20000619)422:1<123::AID-CNE8>3.0.CO;2-X; Wildburger NC, 2015, MOL CELL PROTEOMICS, V14, P1288, DOI 10.1074/mcp.M114.040055; Wu MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055212; Xiao ML, 2013, MOL CELL NEUROSCI, V56, P393, DOI 10.1016/j.mcn.2013.07.008; Yang J, 2016, CHANNELS, V10, P410, DOI 10.1080/19336950.2016.1190055; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yoder JB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09570-7; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	108	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100458	10.1016/j.jbc.2021.100458	http://dx.doi.org/10.1016/j.jbc.2021.100458			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639159	gold, Green Published			2022-12-28	WOS:000672866400432
J	Parvathaneni, S; Li, ZG; Sacks, DB				Parvathaneni, Swetha; Li, Zhigang; Sacks, David B.			Calmodulin influences MAPK signaling by binding KSR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IQGAP1 INTEGRATES CA2+/CALMODULIN; REGULATED KINASE PATHWAY; TARGET RECOGNITION; ACTIVATION; SCAFFOLD; RAS; CALCIUM; PROTEINS; TRANSLOCATION; INHIBITOR	The mitogen-activated protein kinase (MAPK) cascade is a fundamental signaling pathway that regulates cell fate decisions in response to external stimuli. Several scaffold proteins bind directly to kinase components of this pathway and regulate their activation by growth factors. One of the best studied MAPK scaffolds is kinase suppressor of Ras1 (KSR1), which is induced by epidermal growth factor (EGF) to translocate to the plasma membrane where it activates extracellular signal-regulated kinase (ERK). While Ca2+ has been shown to modulate MAPK signaling, the molecular mechanisms by which this occurs are incompletely understood. Here we tested the hypothesis that Ca2+ alters MAPK activity at least in part via KSR1. Using several approaches, including fusion proteins, immunoprecipitation, confocal microscopy, and a cell-permeable chemical inhibitor, we investigated the functional interaction between KSR1 and calmodulin. In vitro analysis with pure proteins reveals that calmodulin binds directly to KSR1. Moreover, endogenous calmodulin and KSR1 co-immunoprecipitate from mammalian cell lysates. Importantly, Ca2+ is required for the association between calmodulin and KSR1, both in vitro and in cells. The cell-permeable calmodulin antagonist CGS9343B significantly reduced activation of ERK by EGF in mouse embryo fibroblasts that overexpress KSR1, but not in control cells. Moreover, CGS9343B impaired the ability of EGF to induce KSR1 translocation to the plasma membrane and to stimulate formation of KSR1-ERK and KSR1-pERK (phosphorylated ERK) complexes in cells. Collectively, our data identify a previously unrecognized mechanism by which the scaffold protein KSR1 couples Ca2+ and calmodulin signaling to the MAPK cascade.	[Parvathaneni, Swetha; Li, Zhigang; Sacks, David B.] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Sacks, DB (corresponding author), NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA.	david.sacks2@nih.gov		Sacks, David/0000-0003-3100-0735	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is dedicated to the memory of Jay M. McDonald; mentor, colleague, and friend. We are grateful to Robert LewisY (University of Nebraska Medical Center) for generously donating the KSR1+/+ and KSR1-/-mouse embryonic fibroblasts and to Piero Crespo (Instituto de Biomedicina y Biotecnologia de Cantabria, Spain) for the gift of His-tagged KSR1. We thank Michael Kruhlak, Andy Tran, and Langston Lim (Experimental Immunology Branch, National Institutes of Health) for expert assistance with confocal microscopy. The study was supported by the Intramural Research Program of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bosch M, 1998, J BIOL CHEM, V273, P22145, DOI 10.1074/jbc.273.34.22145; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Egea J, 2000, MOL CELL BIOL, V20, P1931, DOI 10.1128/MCB.20.6.1931-1946.2000; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Garcia-Palmero I, 2012, FEBS LETT, V586, P1533, DOI 10.1016/j.febslet.2012.04.017; Gorisse L, 2018, BIOCHEM J, V475, P3073, DOI 10.1042/BCJ20180594; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Jagemann LR, 2008, J BIOL CHEM, V283, P17450, DOI 10.1074/jbc.M709185200; JAYANTHI LD, 1994, J BIOL CHEM, V269, P14424; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Ji QS, 2000, ONCOGENE, V19, P1853, DOI 10.1038/sj.onc.1203517; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Koveal D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003289; Kyosseva SV, 2016, OPHTHALMOL EYE DIS, V8, P23, DOI 10.4137/OED.S32200; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li ZG, 2000, BIOCHEMISTRY-US, V39, P5089, DOI 10.1021/bi992623z; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; MEDEMA JP, 1994, MOL CELL BIOL, V14, P7078, DOI 10.1128/MCB.14.11.7078; Miningou N, 2020, CELL SIGNAL, V68, DOI 10.1016/j.cellsig.2020.109541; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Nagao M, 2020, DIABETES, V69, P1193, DOI 10.2337/db19-0944; Neilsen BK, 2017, EXPERT OPIN THER TAR, V21, P499, DOI 10.1080/14728222.2017.1311325; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; NORMAN JA, 1987, MOL PHARMACOL, V31, P535; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; Roberson MS, 2005, MOL ENDOCRINOL, V19, P2412, DOI 10.1210/me.2005-0094; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Tajan M, 2018, ENDOCR REV, V39, P676, DOI 10.1210/er.2017-00232; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; Villalobo A, 2018, BBA-MOL CELL RES, V1865, P507, DOI 10.1016/j.bbamcr.2017.12.004; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wiegert JS, 2011, CELL CALCIUM, V49, P296, DOI 10.1016/j.ceca.2010.11.009; Yang CM, 2000, MOL ENDOCRINOL, V14, P317, DOI 10.1210/me.14.2.317; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X	63	3	3	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100577	10.1016/j.jbc.2021.100577	http://dx.doi.org/10.1016/j.jbc.2021.100577			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33766558	Green Published, gold			2022-12-28	WOS:000672866400550
J	Rapp, J; Rath, P; Kilian, J; Brilisauer, K; Grond, S; Forchhammer, K				Rapp, Johanna; Rath, Pascal; Kilian, Joachim; Brilisauer, Klaus; Grond, Stephanie; Forchhammer, Karl			A bioactive molecule made by unusual salvage of radical SAM enzyme byproduct 5-deoxyadenosine blurs the boundary of primary and secondary metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE; ESCHERICHIA-COLI; IDENTIFICATION; SUPERFAMILY; PHOSPHORYLASE; NUCLEOSIDASE; GENE; METHYLTHIOADENOSINE; 5'-DEOXYADENOSINE	5-Deoxyadenosine (5dAdo) is the byproduct of many radical S-adenosyl-L-methionine enzyme reactions in all domains of life. 5dAdo is also an inhibitor of the radical S-adenosyl-L-methionine enzymes themselves, making it necessary for cells to construct pathways to recycle or dispose of this toxic metabolite. However, the specific pathways involved have long remained unexplored. Recent research demonstrated a growth advantage in certain organisms by using 5dAdo or intermediates as a sole carbon source and elucidated the corresponding salvage pathway. We now provide evidence using supernatant analysis by GC-MS for another 5dAdo recycling route. Specifically, in the unicellular cyanobacterium Synechococcus elongatus PCC 7942 (S. elongatus), the activity of promiscuous enzymes leads to the synthesis and excretion first of 5-deoxyribose and subsequently of 7-deoxysedoheptulose. 7-Deoxysedoheptulose is an unusual deoxy-sugar, which acts as an antimetabolite of the shikimate pathway, thereby exhibiting antimicrobial and herbicidal activity. This strategy enables organisms with small genomes and lacking canonical gene clusters for the synthesis of secondary metabolites, like S. elongatus, to produce antimicrobial compounds from primary metabolism and enzymatic promiscuity. Our findings challenge the view of bioactive molecules as sole products of secondary metabolite gene clusters and expand the range of compounds that microorganisms can deploy to compete for their ecological niche.	[Rapp, Johanna; Brilisauer, Klaus; Forchhammer, Karl] Eberhard Karls Univ Tubingen, Interfac Inst Microbiol & Infect Med, Microbiol Organism Interact, Tubingen, Germany; [Rath, Pascal; Grond, Stephanie] Eberhard Karls Univ Tubingen, Inst Organ Chem, Tubingen, Germany; [Kilian, Joachim] Eberhard Karls Univ Tubingen, Ctr Plant Mol Biol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Forchhammer, K (corresponding author), Eberhard Karls Univ Tubingen, Interfac Inst Microbiol & Infect Med, Microbiol Organism Interact, Tubingen, Germany.	karl.forchhammer@uni-tuebinge.de			"Glycobiotechnology" initiative (Ministry for Science, Research and Arts Baden-Wurttemberg); Research Training Group "Molecular principles of bacterial survival strategies" [1708]; Institutional Strategy of the University of Tubingen (Deutsche Forschungsgemeinschaft) [ZUK 63]; DFG Cluster of Excellence [EXC 2124, 390838134]	"Glycobiotechnology" initiative (Ministry for Science, Research and Arts Baden-Wurttemberg); Research Training Group "Molecular principles of bacterial survival strategies"; Institutional Strategy of the University of Tubingen (Deutsche Forschungsgemeinschaft); DFG Cluster of Excellence(German Research Foundation (DFG))	The work is supported and funded by the "Glycobiotechnology" initiative (Ministry for Science, Research and Arts Baden-Wurttemberg), the Research Training Group 1708 "Molecular principles of bacterial survival strategies", and the Institutional Strategy of the University of Tubingen (Deutsche Forschungsgemeinschaft, ZUK 63). The work was further supported by infrastructural funding from the DFG Cluster of Excellence EXC 2124 Controlling Microbes to Fight Infections (project ID 390838134). We thank Dr Libera Lo Presti for critical reading of the article. We especially thank Tim Orthwein for fruitful discussions and Michaela Schuppe for the cultivation of Streptomyces setonensis.	Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Beaudoin GAW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05589-4; Blombach B, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00108; Booker Squire J, 2010, F1000 Biol Rep, V2, P52, DOI 10.3410/B2-52; Brilisauer K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08476-8; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Burnap Robert L., 2015, Life-Basel, V5, P348, DOI 10.3390/life5010348; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Challand MR, 2009, FEBS LETT, V583, P1358, DOI 10.1016/j.febslet.2009.03.044; Chattopadhyay MK, 2006, BIOCHEM BIOPH RES CO, V343, P203, DOI 10.1016/j.bbrc.2006.02.144; Choi-Rhee EJ, 2005, CHEM BIOL, V12, P589, DOI 10.1016/j.chembiol.2005.04.012; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Conradi FD, 2020, LIFE-BASEL, V10, DOI 10.3390/life10110252; Copeland A, 2014, COMPLETE SEQUENCE CH; Czerwik-Marcinkowska Joanna, 2011, Polish Botanical Journal, V56, P203; Farrar CE, 2010, BIOCHEMISTRY-US, V49, P9985, DOI 10.1021/bi101023c; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Furtauer L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01912; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Golden SS, 2019, NEW ZEAL J BOT, V57, P70, DOI 10.1080/0028825X.2018.1551805; Herter T, 2006, APPL MICROBIOL BIOT, V70, P60, DOI 10.1007/s00253-005-0024-8; Holliday GL, 2018, METHOD ENZYMOL, V606, P1, DOI 10.1016/bs.mie.2018.06.004; Hughes JA, 2006, CAN J MICROBIOL, V52, P599, DOI 10.1139/W06-008; ITO T, 1971, CARBOHYD RES, V17, P375, DOI 10.1016/S0008-6215(00)82545-8; KAMATANI N, 1980, CANCER RES, V40, P4178; KOBORI Y, 1992, J ORG CHEM, V57, P5899, DOI 10.1021/jo00048a023; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Lee JE, 2004, BIOCHEMISTRY-US, V43, P5159, DOI 10.1021/bi035492h; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Ma L, 2015, CHEM SCI, V6, P1414, DOI 10.1039/c4sc03540b; Marsh ENG, 2010, CHEMBIOCHEM, V11, P604, DOI 10.1002/cbic.200900777; Mattern H., 2018, BEITRAGE ALGEN BADEN, VI; Miller DV, 2018, MICROBIOL-SGM, V164, P969, DOI 10.1099/mic.0.000670; North JA, 2020, MOL MICROBIOL, V113, P923, DOI 10.1111/mmi.14459; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Palmer LD, 2013, J BIOL CHEM, V288, P30693, DOI 10.1074/jbc.M113.500280; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; PLAGEMANN PGW, 1983, BIOCHEM PHARMACOL, V32, P1433, DOI 10.1016/0006-2952(83)90458-6; PRADEL E, 1988, J BACTERIOL, V170, P4916, DOI 10.1128/jb.170.10.4916-4923.1988; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rossi Federico, 2015, Life-Basel, V5, P1218, DOI 10.3390/life5021218; Sairam P, 2003, CARBOHYD RES, V338, P303, DOI 10.1016/S0008-6215(02)00464-0; SAVARESE TM, 1981, BIOCHEM PHARMACOL, V30, P189, DOI 10.1016/0006-2952(81)90077-0; SCHROEDER HR, 1972, BIOCHIM BIOPHYS ACTA, V273, P254, DOI 10.1016/0304-4165(72)90215-2; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Sekowska A, 2019, MICROB BIOTECHNOL, V12, P77, DOI 10.1111/1751-7915.13324; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Selim KA, 2018, P NATL ACAD SCI USA, V115, pE4861, DOI 10.1073/pnas.1803790115; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Sugita C, 2007, PHOTOSYNTH RES, V93, P55, DOI 10.1007/s11120-006-9122-4; Suleimanova AD, 2015, APPL ENVIRON MICROB, V81, P6790, DOI 10.1128/AEM.01384-15; TURNER DH, 1960, BIOCHEM J, V74, P486, DOI 10.1042/bj0740486; Wang S. C., 2011, TRERDS BIOCH SCI, V32, P101; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; WRAY JW, 1995, J BIOL CHEM, V270, P3147, DOI 10.1074/jbc.270.7.3147; Yang YL, 2018, P NATL ACAD SCI USA, V115, pE12378, DOI 10.1073/pnas.1812871115; Zappia V, 1988, Adv Exp Med Biol, V250, P165; Zhang JT, 2013, ADV MATER RES-SWITZ, V781-784, P1184, DOI 10.4028/www.scientific.net/AMR.781-784.1184	61	4	4	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100621	10.1016/j.jbc.2021.100621	http://dx.doi.org/10.1016/j.jbc.2021.100621			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811856	Green Published, gold			2022-12-28	WOS:000672866400592
J	Worby, CA; Mayfield, JE; Pollak, AJ; Dixon, JE; Banerjee, S				Worby, Carolyn A.; Mayfield, Joshua E.; Pollak, Adam J.; Dixon, Jack E.; Banerjee, Sourav			The ABCs of the atypical Fam20 secretory pathway kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OSTEOSCLEROTIC BONE DYSPLASIA; PROTEIN DISULFIDE-ISOMERASE; AMINO-ACID-SEQUENCE; CASEIN KINASE; RAINE SYNDROME; AMELOGENESIS IMPERFECTA; GINGIVAL HYPERPLASIA; DENTAL ANOMALIES; PHOSPHORYLATION; MUTATIONS	The study of extracellular phosphorylation was initiated in late 19th century when the secreted milk protein, casein, and egg-yolk protein, phosvitin, were shown to be phosphorylated. However, it took more than a century to identify Fam20C, which phosphorylates both casein and phosvitin under physiological conditions. This kinase, along with its family members Fam20A and Fam20B, defined a new family with altered amino acid sequences highly atypical from the canonical 540 kinases comprising the kinome. Fam20B is a glycan kinase that phosphorylates xylose residues and triggers peptidoglycan biosynthesis, a role conserved from sponges to human. The protein kinase, Fam20C, conserved from nematodes to humans, phosphorylates well over 100 substrates in the secretory pathway with overall functions postulated to encompass endoplasmic reticulum homeostasis, nutrition, cardiac function, coagulation, and biomineralization. The preferred phosphorylation motif of Fam20C is SxE/pS, and structural studies revealed that related member Fam20A allosterically activates Fam20C by forming a heterodimeric/tetrameric complex. Fam20A, a pseudokinase, is observed only in vertebrates. Loss-of-function genetic alterations in the Fam20 family lead to human diseases such as amelogenesis imperfecta, nephrocalcinosis, lethal and nonlethal forms of Raine syndrome with major skeletal defects, and altered phosphate homeostasis. Together, these three members of the Fam20 family modulate a diverse network of secretory pathway components playing crucial roles in health and disease. The overarching theme of this review is to highlight the progress that has been made in the emerging field of extracellular phosphorylation and the key roles secretory pathway kinases play in an ever-expanding number of cellular processes.	[Worby, Carolyn A.; Mayfield, Joshua E.; Pollak, Adam J.; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Banerjee, Sourav] Univ Dundee, Sch Med, Div Cellular Med, Dundee, Scotland	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Dundee	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Dixon, JE (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Dixon, JE (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Banerjee, S (corresponding author), Univ Dundee, Sch Med, Div Cellular Med, Dundee, Scotland.	jedixon@ucsd.edu; s.y.banerjee@dundee.ac.uk	Banerjee, Sourav/J-3853-2019	Banerjee, Sourav/0000-0003-2043-2989	NIH; NIH [DK018849-41, DK018024-43]; Ninewells Cancer Campaign Cancer Research Award; Tayside Health Funds	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ninewells Cancer Campaign Cancer Research Award; Tayside Health Funds	The authors were supported by grants from the NIH PO1 (to C. A. W.), NIH DK018849-41 and DK018024-43 (to J. E. D./C. A. W.), Ninewells Cancer Campaign Cancer Research Award (to S. B.), and Tayside Health Funds (to S. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ababneh FK, 2013, AM J MED GENET A, V161, P3155, DOI 10.1002/ajmg.a.36160; Acevedo AC, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0154-5; Anema SG, 2013, J AGR FOOD CHEM, V61, P7142, DOI 10.1021/jf401270h; Arvanitis DA, 2011, J MOL CELL CARDIOL, V50, P43, DOI 10.1016/j.yjmcc.2010.08.021; Ashraf Y, 2020, FEBS J, V287, P3565, DOI 10.1111/febs.15212; Bahl JMC, 2008, ANAL CHEM, V80, P6308, DOI 10.1021/ac800835y; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bhattacharyya N, 2012, TRENDS ENDOCRIN MET, V23, P610, DOI 10.1016/j.tem.2012.07.002; Bilikova K, 2001, APIDOLOGIE, V32, P275, DOI 10.1051/apido:2001129; BINGHAM EW, 1972, J BIOL CHEM, V247, P8193; Black MH, 2019, SCIENCE, V364, P787, DOI 10.1126/science.aaw7446; BLOMBACK B, 1962, NATURE, V193, P883, DOI 10.1038/193883a0; Boissel S, 2018, GENET MED, V20, P745, DOI 10.1038/gim.2017.173; Bordoli MR, 2014, CELL, V158, P1033, DOI 10.1016/j.cell.2014.06.048; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Brunati AM, 2000, BIOCHEM J, V351, P765, DOI 10.1042/0264-6021:3510765; BURNETT G, 1954, J BIOL CHEM, V211, P969; BYRNE BM, 1984, BIOCHEMISTRY-US, V23, P4275, DOI 10.1021/bi00314a003; Cabral RM, 2013, J HUM GENET, V58, P566, DOI 10.1038/jhg.2013.44; Carrascal M, 2010, J PROTEOME RES, V9, P876, DOI 10.1021/pr900780s; Elalaoui SC, 2016, EUR J MED GENET, V59, P577, DOI 10.1016/j.ejmg.2016.09.018; Chai SJ, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/3857853; Chai SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130464; Cho SH, 2012, HUM MUTAT, V33, P91, DOI 10.1002/humu.21621; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cozza G., 2015, KINOMICS, P47; Cozza G, 2018, FEBS J, V285, P4674, DOI 10.1111/febs.14689; Cozza G, 2017, FEBS J, V284, P1246, DOI 10.1111/febs.14052; Cozza G, 2015, BBA-PROTEINS PROTEOM, V1854, P1718, DOI 10.1016/j.bbapap.2015.04.023; Cui JX, 2017, ELIFE, V6, DOI 10.7554/eLife.23990; Cui JX, 2015, ELIFE, V4, DOI 10.7554/eLife.06120; Da Q, 2019, J THROMB HAEMOST, V17, P866, DOI 10.1111/jth.14426; de Maat M., 1995, THESIS ERASMUS U ROT; Dourado MR, 2019, EUR J MED GENET, V62, DOI 10.1016/j.ejmg.2018.10.013; Du EX, 2015, INT J ORAL SCI, V7, P89, DOI 10.1038/ijos.2014.67; Du JZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21797-w; Du SN, 2020, ONCOTARGETS THER, V13, P11755, DOI 10.2147/OTT.S275452; Dudkiewicz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066427; Duncan JS, 2000, BIOCHEM J, V350, P463, DOI 10.1042/0264-6021:3500463; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Ekdahl KN, 1997, BIOCHEM J, V328, P625, DOI 10.1042/bj3280625; Eltan M, 2020, CALCIFIED TISSUE INT, V107, P96, DOI 10.1007/s00223-020-00694-3; Fang ZH, 2016, J DAIRY SCI, V99, P8168, DOI 10.3168/jds.2016-11250; Fradin M, 2011, CLIN GENET, V80, P177, DOI 10.1111/j.1399-0004.2010.01516.x; Gerson-Gurwitz A, 2019, J CELL BIOL, V218, P3795, DOI 10.1083/jcb.201807041; Hammarsten O., 1883, H-S Z PHYSIOL CHEM, V7, P227; Han B, 2014, J PROTEOME RES, V13, P5928, DOI 10.1021/pr500843j; HANNA LS, 1984, BIOCHEMISTRY-US, V23, P4681, DOI 10.1021/bi00315a025; Hareza A, 2018, PEERJ, V6, DOI 10.7717/peerj.4599; Harris E, 2017, NEUROMUSCULAR DISORD, V27, P861, DOI 10.1016/j.nmd.2017.05.002; Hassib NF, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2020.104045; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hecht TKH, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201910089; Hernandez-Zavala A, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020222; Holt C, 2013, J DAIRY SCI, V96, P6127, DOI 10.3168/jds.2013-6831; Hsu CY, 2018, CLIN CANCER RES, V24, P916, DOI 10.1158/1078-0432.CCR-17-1347; Hung CY, 2019, AM J MED GENET A, V179, P1866, DOI 10.1002/ajmg.a.61291; Hytonen MK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006037; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Jaouad IC, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-14; Jaureguiberry G, 2012, NEPHRON PHYSIOL, V122, P1, DOI 10.1159/000349989; Kang JU, 2013, MOL MED REP, V8, P1373, DOI 10.3892/mmr.2013.1686; Kang T, 2019, J PROTEOME RES, V18, P3245, DOI 10.1021/acs.jproteome.9b00160; Kantaputra PN, 2017, J HUM GENET, V62, P679, DOI 10.1038/jhg.2017.26; Kantaputra PN, 2014, AM J MED GENET A, V164, P2124, DOI 10.1002/ajmg.a.36579; Kantaputra PN, 2014, AM J MED GENET A, V164, P1, DOI 10.1002/ajmg.a.36187; Kinoshita Y, 2014, BONE, V67, P145, DOI 10.1016/j.bone.2014.07.009; Kochar GS, 2010, CLIN DYSMORPHOL, V19, P153, DOI 10.1097/MCD.0b013e32833a22c5; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; Koruyucu M, 2018, NEPHRON, V139, P189, DOI 10.1159/000486607; Kuroda Y, 2019, CLIN GENET, V95, P713, DOI 10.1111/cge.13530; Lasa M, 1997, EUR J BIOCHEM, V243, P719, DOI 10.1111/j.1432-1033.1997.00719.x; Lei J, 2021, CARTILAGE, V13, p818S, DOI 10.1177/1947603520932199; Leven P. A., 1900, HOPPER SEYLERS Z PHY, V31, P543; Li LL, 2016, INT J ORAL SCI, V8, P98, DOI 10.1038/ijos.2016.14; Lietz CB, 2018, J AM SOC MASS SPECTR, V29, P935, DOI 10.1007/s13361-018-1915-0; Lipmann F, 1933, BIOCHEM Z, V262, P3; Liu C, 2018, EXP CELL RES, V363, P188, DOI 10.1016/j.yexcr.2018.01.004; Liu C, 2018, J CELL PHYSIOL, V233, P3476, DOI 10.1002/jcp.26200; Liu PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114396; Liu XN, 2018, EUR J ORAL SCI, V126, P433, DOI 10.1111/eos.12563; Ma P, 2016, J DENT RES, V95, P1408, DOI 10.1177/0022034516661513; Ma P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29814; Mamedova E, 2019, CALCIFIED TISSUE INT, V105, P567, DOI 10.1007/s00223-019-00599-w; Mameli C, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01373-0; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MEGGIO F, 1988, EUR J BIOCHEM, V177, P281, DOI 10.1111/j.1432-1033.1988.tb14374.x; MERCIER JC, 1971, EUR J BIOCHEM, V23, P41, DOI 10.1111/j.1432-1033.1971.tb01590.x; MERCIER JC, 1981, BIOCHIMIE, V63, P1, DOI 10.1016/S0300-9084(81)80141-1; MOORE A, 1985, EUR J BIOCHEM, V152, P729, DOI 10.1111/j.1432-1033.1985.tb09254.x; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; Nitayavardhana I, 2020, MOL GENET GENOMICS, V295, P923, DOI 10.1007/s00438-020-01668-8; O'Sullivan J, 2011, AM J HUM GENET, V88, P616, DOI 10.1016/j.ajhg.2011.04.005; Ouadda AB, 2019, ARTERIOSCL THROM VAS, V39, P1996, DOI 10.1161/ATVBAHA.119.313247; Oya K, 2017, HISTOCHEM CELL BIOL, V147, P341, DOI 10.1007/s00418-016-1490-z; Park CS, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0344-2; Pego SPB, 2017, OR SURG OR MED OR PA, V123, P229, DOI 10.1016/j.oooo.2016.09.226; Pisani D, 2015, P NATL ACAD SCI USA, V112, P15402, DOI 10.1073/pnas.1518127112; Pollak AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.41378; Pollak AJ, 2017, P NATL ACAD SCI USA, V114, P9098, DOI 10.1073/pnas.1706441114; Poulter JA, 2015, MOL GENET GENOM MED, V3, P543, DOI 10.1002/mgg3.164; Probst B, 2007, DEV BIOL, V312, P461, DOI 10.1016/j.ydbio.2007.09.054; Qin ZY, 2016, MOL BIOSYST, V12, P2108, DOI 10.1039/c6mb00111d; Qiu YM, 2018, BIOPHYS J, V115, P2327, DOI 10.1016/j.bpj.2018.11.012; RABINOWITZ M, 1960, J BIOL CHEM, V235, P1043; Rafaelsen SH, 2013, J BONE MINER RES, V28, P1378, DOI 10.1002/jbmr.1850; RAINE J, 1989, J MED GENET, V26, P786, DOI 10.1136/jmg.26.12.786; Ramos-Molina B, 2015, MOL ENDOCRINOL, V29, P756, DOI 10.1210/me.2014-1394; REGANON E, 1989, CLIN CHIM ACTA, V184, P7, DOI 10.1016/0009-8981(89)90252-0; RODNIGHT R, 1964, BIOCHEM J, V93, P84, DOI 10.1042/bj0930084; Rolvien T, 2019, OSTEOPOROSIS INT, V30, P685, DOI 10.1007/s00198-018-4667-6; Schytte GN, 2020, J CELL BIOCHEM, V121, P4809, DOI 10.1002/jcb.29708; Seidahmed MZ, 2015, AM J MED GENET A, V167, P2394, DOI 10.1002/ajmg.a.37159; Sheth J, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0593-x; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; Simpson MA, 2009, CLIN GENET, V75, P271, DOI 10.1111/j.1399-0004.2008.01118.x; Sreelatha A, 2018, CELL, V175, P809, DOI 10.1016/j.cell.2018.08.046; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; Tagliabracci VS, 2013, BIOCHEM SOC T, V41, P1061, DOI 10.1042/BST20130059; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Takeyari S, 2014, BONE, V67, P56, DOI 10.1016/j.bone.2014.06.026; Tamai K, 2018, AM J MED GENET A, V176, P682, DOI 10.1002/ajmg.a.38598; TAMURA T, 1987, FOLIA PHARMACOL JPN, V89, P73, DOI 10.1254/fpj.89.73; Tennant-Eyles AJ, 2011, BIOCHEM BIOPH RES CO, V406, P471, DOI 10.1016/j.bbrc.2011.02.076; TERPSTRA P, 1988, J MOL BIOL, V202, P663, DOI 10.1016/0022-2836(88)90294-X; Tian Y, 2015, EUR J ORAL SCI, V123, P396, DOI 10.1111/eos.12222; Tibaldi E, 2006, CELL MOL LIFE SCI, V63, P378, DOI 10.1007/s00018-005-5506-4; Tibaldi E, 2020, FASEB J, V34, P1122, DOI 10.1096/fj.201900880R; Trendowski MR, 2020, CLIN CANCER RES, V26, P6550, DOI 10.1158/1078-0432.CCR-20-2682; Vogel P, 2012, VET PATHOL, V49, P998, DOI 10.1177/0300985812453177; Volodarsky M, 2015, ARCH ORAL BIOL, V60, P919, DOI 10.1016/j.archoralbio.2015.02.018; Walimbe AS, 2020, ELIFE, V9, DOI 10.7554/eLife.61388; Wang L, 2015, FREE RADICAL BIO MED, V83, P305, DOI 10.1016/j.freeradbiomed.2015.02.007; Wang SK, 2014, J DENT RES, V93, P42, DOI 10.1177/0022034513512653; Wang SK, 2013, J BONE MINER RES, V28, P2508, DOI 10.1002/jbmr.1990; Wang SK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003302; Wang X, 2013, J DENT RES, V92, P995, DOI 10.1177/0022034513504588; Wang XF, 2012, J BIOL CHEM, V287, P35934, DOI 10.1074/jbc.M112.386862; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wang XF, 2010, J HISTOCHEM CYTOCHEM, V58, P957, DOI 10.1369/jhc.2010.956565; Wang YP, 2019, J PERIODONTAL RES, V54, P653, DOI 10.1111/jre.12666; Wei Z, 2018, ACTA BIOCH BIOPH SIN, V50, P968, DOI 10.1093/abbs/gmy105; Wen JZ, 2014, P NATL ACAD SCI USA, V111, P15723, DOI 10.1073/pnas.1417993111; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; WHYTE M P, 1985, American Journal of Human Genetics, V37, pA82; Whyte MP, 2017, J BONE MINER RES, V32, P757, DOI 10.1002/jbmr.3034; Wu JY, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00813-4; Xiao JY, 2013, P NATL ACAD SCI USA, V110, P10574, DOI 10.1073/pnas.1309211110; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051; Yan WJ, 2017, INT J ORAL SCI, V9, P1, DOI 10.1038/ijos.2017.41; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yu JJ, 2020, EMBO J, V39, DOI 10.15252/embj.2019103841; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang H, 2020, CELLS TISSUES ORGANS, V208, P25, DOI 10.1159/000506005; Zhang H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03615-z; Zhang JC, 2018, EMBO J, V37, DOI 10.15252/embj.201798699; Zhou WD, 2009, J PROTEOME RES, V8, P5523, DOI 10.1021/pr900603n; Zhu QY, 2016, ELIFE, V5, DOI 10.7554/eLife.22238; Zipes D. P., 2000, PROFESSOR 33 YEARS C, P621, DOI DOI 10.1007/978-94-011-4110-9_60	165	8	8	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100267	10.1016/j.jbc.2021.100267	http://dx.doi.org/10.1016/j.jbc.2021.100267			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33759783	Green Published, gold			2022-12-28	WOS:000672866400243
J	Yang, J; Gong, WB; Wu, S; Zhang, H; Perrett, S				Yang, Jie; Gong, Weibin; Wu, Si; Zhang, Hong; Perrett, Sarah			PES inhibits human-inducible Hsp70 by covalent targeting of cysteine residues in the substrate-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; HEAT-SHOCK PROTEINS; OXIDATIVE STRESS; 2-PHENYLETHYNESULFONAMIDE; CANCER; DNAK; IDENTIFICATION; CONFORMATION; CHAPERONES; REVEALS	Hsp70 proteins are a family of ancient and conserved chaperones. They play important roles in vital cellular processes, such as protein quality control and the stress response. Hsp70 proteins are a potential drug target for treatment of disease, particularly cancer. PES (2-phenylethynesulfonamide or pifithrin-mu) has been reported to be an inhibitor of Hsp70. However, the mechanism of PES inhibition is still unclear. In this study we found that PES can undergo a Michael addition reaction with Cys-574 and Cys-603 in the SBD alpha of human HspA1A (hHsp70), resulting in covalent attachment of a PES molecule to each Cys residue. We previously showed that glutathionylation of Cys-574 and Cys-603 affects the structure and function of hHsp70. In this study, PES modification showed similar structural and functional effects on hHsp70 to glutathionylation. Further, we found that susceptibility to PES modification is influenced by changes in the conformational dynamics of the SBD alpha, such as are induced by interaction with adjacent domains, allosteric changes, and mutations. This study provides new avenues for development of covalent inhibitors of hHsp70.	[Yang, Jie; Gong, Weibin; Wu, Si; Zhang, Hong; Perrett, Sarah] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Yang, Jie; Wu, Si; Zhang, Hong; Perrett, Sarah] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, H; Perrett, S (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China.; Zhang, H; Perrett, S (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	zhangh@moon.ibp.ac.cn; sarah.perrett@cantab.net		Zhang, Hong/0000-0001-9204-2547; Gong, Weibin/0000-0001-7130-4093	Chinese Ministry of Science and Technology [2017YFA0504000]; National Natural Science Foundation of China [31770829, 31570780, 31920103011, 21673278]; Beijing Natural Science Foundation [5172026]; National Laboratory of Biomacromolecules; CAS Center of Excellence in Biomacromolecules	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Laboratory of Biomacromolecules; CAS Center of Excellence in Biomacromolecules	This work was supported by Chinese Ministry of Science and Technology (2017YFA0504000), National Natural Science Foundation of China (31770829, 31570780, 31920103011, 21673278), Beijing Natural Science Foundation (5172026), the National Laboratory of Biomacromolecules, and the CAS Center of Excellence in Biomacromolecules.	Bailey CK, 2015, CANCER BIOL THER, V16, P1422, DOI 10.1080/15384047.2015.1071743; Balaburski GM, 2013, MOL CANCER RES, V11, P219, DOI 10.1158/1541-7786.MCR-12-0547-T; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Colvin TA, 2014, CANCER RES, V74, P4731, DOI 10.1158/0008-5472.CAN-14-0747; Das D, 2020, MINI-REV MED CHEM, V20, P1732, DOI 10.2174/1389557520666200513121524; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fung E, 2015, BIOORG MED CHEM LETT, V25, P763, DOI 10.1016/j.bmcl.2014.12.094; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Gray VJ, 2014, J ORG CHEM, V79, P5869, DOI 10.1021/jo500814y; Hassan AQ, 2015, CHEM BIOL, V22, P87, DOI 10.1016/j.chembiol.2014.11.007; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jamil S, 2017, BIOCHEM BIOPH RES CO, V482, P154, DOI 10.1016/j.bbrc.2016.11.015; Johnston AN, 2020, P NATL ACAD SCI USA, V117, P6521, DOI 10.1073/pnas.1916503117; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kumar S, 2016, CANCER LETT, V374, P156, DOI 10.1016/j.canlet.2016.01.056; Leak RK, 2014, J CELL COMMUN SIGNAL, V8, P293, DOI 10.1007/s12079-014-0243-9; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Leu JIJ, 2014, ACS CHEM BIOL, V9, P2508, DOI 10.1021/cb500236y; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Mattiolo P, 2014, BIOCHEM PHARMACOL, V91, P301, DOI 10.1016/j.bcp.2014.08.005; McAulay K, 2020, J AM CHEM SOC, V142, P10358, DOI 10.1021/jacs.9b13391; McKeon AM, 2016, MOLECULES, V21, DOI 10.3390/molecules21070949; Meng WL, 2018, P NATL ACAD SCI USA, V115, P11970, DOI 10.1073/pnas.1811105115; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; Monma H, 2013, MOL CANCER THER, V12, P341, DOI 10.1158/1535-7163.MCT-12-0954; Mons E, 2019, J AM CHEM SOC, V141, P3507, DOI 10.1021/jacs.8b11027; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Ribas J, 2015, CURR DRUG TARGETS, V16, P31, DOI 10.2174/1389450115666141114153536; Ricci Laura, 2008, Curr Chem Genomics, V2, P90, DOI 10.2174/1875397300802010090; Rodina A, 2013, CHEM BIOL, V20, P1469, DOI 10.1016/j.chembiol.2013.10.008; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Sekihara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078772; Sherman MY, 2015, ONCOGENE, V34, P4153, DOI 10.1038/onc.2014.349; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Vahid S, 2017, RECENT PAT ANTI-CANC, V12, P35, DOI 10.2174/1574892811666161102125252; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Wu S, 2020, P NATL ACAD SCI USA, V117, P7814, DOI 10.1073/pnas.1914376117; Yang J, 2020, J BIOL CHEM, V295, P8302, DOI 10.1074/jbc.RA119.012372; Yeramian A, 2016, PIGM CELL MELANOMA R, V29, P352, DOI 10.1111/pcmr.12472; Zeng FX, 2014, AQUAT TOXICOL, V146, P45, DOI 10.1016/j.aquatox.2013.10.026; Zhang H, 2016, J BIOL CHEM, V291, P6967, DOI 10.1074/jbc.M115.673608; Zhang H, 2009, MOL MICROBIOL, V71, P702, DOI 10.1111/j.1365-2958.2008.06557.x; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zylicz M, 2001, IUBMB LIFE, V51, P283	57	4	5	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100210	10.1074/jbc.RA120.015440	http://dx.doi.org/10.1074/jbc.RA120.015440			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33835030	gold, Green Published			2022-12-28	WOS:000672866400188
J	York, NJ; Lockart, MM; Sardar, S; Khadka, N; Shi, WX; Stenkamp, RE; Zhang, JY; Kiser, PD; Pierce, BS				York, Nicholas J.; Lockart, Molly M.; Sardar, Sinjinee; Khadka, Nimesh; Shi, Wuxian; Stenkamp, Ronald E.; Zhang, Jianye; Kiser, Philip D.; Pierce, Brad S.			Structure of 3-mercaptopropionic acid dioxygenase with a substrate analog reveals bidentate substrate binding at the iron center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYR CROSS-LINK; CYSTEINE DIOXYGENASE; THIOL DIOXYGENASE; ACTIVE-SITE; AZOTOBACTER-VINELANDII; ELECTRONIC-STRUCTURE; REACTION CYCLE; COMPLEXES; OXIDATION; ENZYME	Thiol dioxygenases are a subset of nonheme iron oxygenases that catalyze the formation of sulfinic acids from sulfhydryl-containing substrates and dioxygen. Among this class, cysteine dioxygenases (CDOs) and 3-mercaptopropionic acid dioxygenases (3MDOs) are the best characterized, and the mode of substrate binding for CDOs is well understood. However, the manner in which 3-mercaptopropionic acid (3MPA) coordinates to the nonheme iron site in 3MDO remains a matter of debate. A model for bidentate 3MPA coordination at the 3MDO Fe-site has been proposed on the basis of computational docking, whereas steady-state kinetics and EPR spectroscopic measurements suggest a thiolate-only coordination of the substrate. To address this gap in knowledge, we determined the structure of Azobacter vinelandii 3MDO (Av3MDO) in complex with the substrate analog and competitive inhibitor, 3-hydroxypropionic acid (3HPA). The structure together with DFT computational modeling demonstrates that 3HPA and 3MPA associate with iron as chelate complexes with the substrate-carboxylate group forming an additional interaction with Arg168 and the thiol bound at the same position as in CDO. A chloride ligand was bound to iron in the coordination site assigned as the O-2-binding site. Supporting HYS-CORE spectroscopic experiments were performed on the (3MPA/NO)-bound Av3MDO iron nitrosyl (S = 3/2) site. In combination with spectroscopic simulations and optimized DFT models, this work provides an experimentally verified model of the Av3MDO enzyme-substrate complex, effectively resolving a debate in the literature regarding the preferred substrate-binding denticity. These results elegantly explain the observed 3MDO substrate specificity, but leave unanswered questions regarding the mechanism of substrate-gated reactivity with dioxygen.	[York, Nicholas J.; Lockart, Molly M.; Pierce, Brad S.] Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA; [Sardar, Sinjinee] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA; [Khadka, Nimesh] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Shi, Wuxian] Brookhaven Natl Lab, Natl Synchrotron Light Source 2, Upton, NY 11973 USA; [Stenkamp, Ronald E.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Stenkamp, Ronald E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Zhang, Jianye; Kiser, Philip D.] Univ Calif Irvine, Sch Med, Dept Ophthalmol, Irvine, CA 92717 USA; [Kiser, Philip D.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Kiser, Philip D.] VA Long Beach Healthcare Syst, Res Serv, Long Beach, CA 90822 USA	University of Alabama System; University of Alabama Tuscaloosa; University of Texas System; University of Texas Arlington; Case Western Reserve University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Pierce, BS (corresponding author), Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA.; Kiser, PD (corresponding author), Univ Calif Irvine, Sch Med, Dept Ophthalmol, Irvine, CA 92717 USA.; Kiser, PD (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA.; Kiser, PD (corresponding author), VA Long Beach Healthcare Syst, Res Serv, Long Beach, CA 90822 USA.	pkiser@uci.edu; bspierce1@ua.edu		Stenkamp, Ronald/0000-0003-4151-1336; York, Nicholas/0000-0001-7054-8336	Department of Veterans Affairs [I01BX004939]; National Institutes of Health [R01EY009339, 2 R15 GM117511-01]; Research to Prevent Blindness	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by grants from the Department of Veterans Affairs (I01BX004939 to P. D. K.) and the National Institutes of Health (R01EY009339 to P. D. K.) and (2 R15 GM117511-01 to B. S. P.). P. D. K. acknowledges an unrestricted grant to the UC Irvine Department of Ophthalmology from Research to Prevent Blindness.	Aloi S, 2019, BIOCHEMISTRY-US, V58, P2398, DOI 10.1021/acs.biochem.9b00079; ARCIERO DM, 1983, J BIOL CHEM, V258, P4981; BECKE AD, 1986, J CHEM PHYS, V84, P4524, DOI 10.1063/1.450025; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Blaesi EJ, 2015, BIOCHEMISTRY-US, V54, P2874, DOI 10.1021/acs.biochem.5b00171; Brandt U, 2014, J BIOL CHEM, V289, P30800, DOI 10.1074/jbc.M114.579730; Brines LM, 2015, J AM CHEM SOC, V137, P2253, DOI 10.1021/ja5068405; Brown CD, 2007, J AM CHEM SOC, V129, P7427, DOI 10.1021/ja071364v; Buhl M, 2006, J CHEM THEORY COMPUT, V2, P1282, DOI 10.1021/ct6001187; Bykov D, 2014, J BIOL INORG CHEM, V19, P97, DOI 10.1007/s00775-013-1065-6; Crowell JK, 2016, ARCH BIOCHEM BIOPHYS, V604, P86, DOI 10.1016/j.abb.2016.06.009; Crowell JK, 2014, BIOCHEMISTRY-US, V53, P7541, DOI 10.1021/bi501241d; Dajnowicz S, 2017, J BIOL CHEM, V292, P5970, DOI 10.1074/jbc.M116.774588; Davies CG, 2014, BIOCHEMISTRY-US, V53, P7961, DOI 10.1021/bi501277a; Deth R, 2008, NEUROTOXICOLOGY, V29, P190, DOI 10.1016/j.neuro.2007.09.010; Dikanov SA, 1998, J AM CHEM SOC, V120, P6797, DOI 10.1021/ja9742343; Dominy JE, 2008, J BIOL CHEM, V283, P12188, DOI 10.1074/jbc.M800044200; Dominy JE, 2006, J BACTERIOL, V188, P5561, DOI 10.1128/JB.00291-06; Driggers C. M., 2015, ENCY INORGANIC BIOIN; Driggers CM, 2016, J MOL BIOL, V428, P3999, DOI 10.1016/j.jmb.2016.07.012; Driggers CM, 2015, PROTEIN SCI, V24, P154, DOI 10.1002/pro.2587; Driggers CM, 2013, J MOL BIOL, V425, P3121, DOI 10.1016/j.jmb.2013.05.028; Dominy J, 2007, J BIOL CHEM, V282, P25189, DOI 10.1074/jbc.M703089200; Easson LH, 1933, BIOCHEM J, V27, P1257, DOI 10.1042/bj0271257; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENEMARK JH, 1974, COORDIN CHEM REV, V13, P339, DOI 10.1016/S0010-8545(00)80259-3; EWETZ L, 1966, BIOCHIM BIOPHYS ACTA, V128, P296, DOI 10.1016/0926-6593(66)90176-7; Fellner M, 2016, J BIOL INORG CHEM, V21, P501, DOI 10.1007/s00775-016-1360-0; Fellner M, 2016, BIOCHEMISTRY-US, V55, P1362, DOI 10.1021/acs.biochem.5b01203; Fernandez RL, 2020, BIOCHEMISTRY-US, V59, P2450, DOI 10.1021/acs.biochem.0c00267; Fischer AA, 2019, INORG CHEM, V58, P16487, DOI 10.1021/acs.inorgchem.9b02432; Fischer AA, 2016, INORG CHEM, V55, P11839, DOI 10.1021/acs.inorgchem.6b01931; GORDON C, 1992, LANCET, V339, P25, DOI 10.1016/0140-6736(92)90144-R; Gordon JB, 2018, J AM CHEM SOC, V140, P14807, DOI 10.1021/jacs.8b08349; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; HEAFIELD MT, 1990, NEUROSCI LETT, V110, P216, DOI 10.1016/0304-3940(90)90814-P; HENDRICH MP, 1992, J BIOL CHEM, V267, P261; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jers C, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00124; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kampa M, 2012, J BIOL INORG CHEM, V17, P1269, DOI 10.1007/s00775-012-0941-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar V, 2013, BIOTECHNOL ADV, V31, P945, DOI 10.1016/j.biotechadv.2013.02.008; Lebedev AA, 2006, ACTA CRYSTALLOGR D, V62, P83, DOI 10.1107/S0907444905036759; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Li W, 2015, ARCH BIOCHEM BIOPHYS, V565, P49, DOI 10.1016/j.abb.2014.11.004; Li W, 2013, BIOCHEMISTRY-US, V52, P9104, DOI 10.1021/bi4010232; LOMBARDINI JB, 1969, J BIOL CHEM, V244, P1172; Martinie RJ, 2015, J AM CHEM SOC, V137, P6912, DOI 10.1021/jacs.5b03370; Masson N, 2019, SCIENCE, V365, P65, DOI 10.1126/science.aaw0112; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; McCracken J, 2021, APPL MAGN RESON, V52, P971, DOI 10.1007/s00723-020-01288-w; McCracken J, 2015, BIOCHEMISTRY-US, V54, P3759, DOI 10.1021/acs.biochem.5b00363; Mitchell AJ, 2017, J AM CHEM SOC, V139, P13830, DOI 10.1021/jacs.7b07374; Morrow WP, 2017, ARCH BIOCHEM BIOPHYS, V631, P66, DOI 10.1016/j.abb.2017.08.013; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neese F, 2018, WIRES COMPUT MOL SCI, V8, DOI 10.1002/wcms.1327; Neese F, 2009, CHEM PHYS, V356, P98, DOI 10.1016/j.chemphys.2008.10.036; Njeri CW, 2014, ARCH BIOCHEM BIOPHYS, V558, P61, DOI 10.1016/j.abb.2014.06.001; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d; Pierce BS, 2015, BIOCHEMISTRY-US, V54, P7477, DOI 10.1021/acs.biochem.5b00636; Poon BK, 2010, ACTA CRYSTALLOGR D, V66, P503, DOI 10.1107/S0907444910001502; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Romelt M, 2009, INORG CHEM, V48, P784, DOI 10.1021/ic801535v; Salaudeen AA, 2008, POLYHEDRON, V27, P2569, DOI 10.1016/j.poly.2008.05.013; Sardar S, 2019, BIOCHEMISTRY-US, V58, P5135, DOI 10.1021/acs.biochem.9b00674; Silva AMN, 2009, BIOMETALS, V22, P771, DOI 10.1007/s10534-009-9224-5; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; SORBO B, 1965, BIOCHEM BIOPH RES CO, V18, P359, DOI 10.1016/0006-291X(65)90714-X; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tchesnokov EP, 2015, J BIOL CHEM, V290, P24424, DOI 10.1074/jbc.M114.635672; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tyler LA, 2003, INORG CHEM, V42, P5751, DOI 10.1021/ic030088s; VAHTRAS O, 1993, CHEM PHYS LETT, V213, P514, DOI 10.1016/0009-2614(93)89151-7; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Weits DA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4425; White MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14690; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200; Ye SF, 2010, J AM CHEM SOC, V132, P4739, DOI 10.1021/ja909715g; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Yu CP, 2018, J AM CHEM SOC, V140, P15190, DOI 10.1021/jacs.8b10077; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	92	7	7	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100492	10.1016/j.jbc.2021.100492	http://dx.doi.org/10.1016/j.jbc.2021.100492			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33662397	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400466
J	Rowe, SJ; Mecaskey, RJ; Nasef, M; Talton, RC; Sharkey, RE; Halliday, JC; Dunkle, JA				Rowe, Sebastian J.; Mecaskey, Ryan J.; Nasef, Mohamed; Talton, Rachel C.; Sharkey, Rory E.; Halliday, Joshua C.; Dunkle, Jack A.			Shared requirements for key residues in the antibiotic resistance enzymes ErmC and ErmE suggest a common mode of RNA recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						rRNA; rRNA methylation; RNA methyltransferase; RNA modification; antibiotic resistance; ribosomal ribonucleic acid; ribosomal RNA; erythromycin	DOMAIN-V; METHYLTRANSFERASE; RIBOSOME; ACCURACY; ELEMENTS; BINDING; TARGET; SITE	Erythromycin-resistance methyltransferases are SAM dependent Rossmann fold methyltransferases that convert A2058 of 23S rRNA to m(6) (2)A2058. This modification sterically blocks binding of several classes of antibiotics to 23S rRNA, resulting in a multidrug-resistant phenotype in bacteria expressing the enzyme. ErmC is an erythromycin resistance methyltransferase found in many Gram-positive pathogens, whereas ErmE is found in the soil bacterium that biosynthesizes erythromycin. Whether ErmC and ErmE, which possess only 24% sequence identity, use similar structural elements for rRNA substrate recognition and positioning is not known. To investigate this question, we used structural data from related proteins to guide site-saturation mutagenesis of key residues and characterized selected variants by antibiotic susceptibility testing, single turnover kinetics, and RNA affinity-binding assays. We demonstrate that residues in alpha 4, alpha 5, and the alpha 5-alpha 6 linker are essential for methyltransferase function, including an aromatic residue on alpha 4 that likely forms stacking interactions with the substrate adenosine and basic residues in alpha 5 and the alpha 5-alpha 6 linker that likely mediate conformational rearrangements in the protein and cognate rRNA upon interaction. The functional studies led us to a new structural model for the ErmC or ErmE-rRNA complex.	[Rowe, Sebastian J.; Mecaskey, Ryan J.; Nasef, Mohamed; Talton, Rachel C.; Sharkey, Rory E.; Halliday, Joshua C.; Dunkle, Jack A.] Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA	University of Alabama System; University of Alabama Tuscaloosa	Dunkle, JA (corresponding author), Univ Alabama, Dept Chem & Biochem, Tuscaloosa, AL 35487 USA.	jadunkle@ua.edu		Nasef, Mohamed/0000-0003-2056-6311; Rowe, Sebastian/0000-0002-0937-1524; Dunkle, Jack/0000-0001-6252-0587	NIAID, National Institutes of Health [R15AI131159]	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant R15AI131159 (to J. A. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Bhujbalrao R, 2019, J AM CHEM SOC, V141, P1425, DOI 10.1021/jacs.8b10277; Blackburn GM, 2006, NUCLEIC ACIDS IN CHEMISTRY AND BIOLOGY, THIRD EDITION, P1, DOI 10.1039/9781847555380; Boehringer D, 2012, J BIOL CHEM, V287, P10453, DOI 10.1074/jbc.M111.318121; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Czerwoniec A., 2009, DNA RNA MODIFICATION, P289; Dunkle JA, 2014, P NATL ACAD SCI USA, V111, P6275, DOI 10.1073/pnas.1402789111; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Hansen LH, 2011, CHEMBIOCHEM, V12, P610, DOI 10.1002/cbic.201000606; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Linpinsel Jo L, 2012, Methods Mol Biol, V941, P43, DOI 10.1007/978-1-62703-113-4_4; Liu XD, 2019, NUCLEIC ACIDS RES, V47, P7648, DOI 10.1093/nar/gkz505; Manickam N, 2016, NUCLEIC ACIDS RES, V44, P1871, DOI 10.1093/nar/gkv1506; Maravic G, 2003, J MOL BIOL, V332, P99, DOI 10.1016/S0022-2836(03)00863-5; Maravic G, 2003, NUCLEIC ACIDS RES, V31, P4941, DOI 10.1093/nar/gkg666; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Ranjan N, 2017, J AM CHEM SOC, V139, P5857, DOI 10.1021/jacs.7b00727; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schwalm EL, 2016, SCIENCE, V352, P309, DOI 10.1126/science.aad5367; Sergeeva OV, 2015, BIOCHIMIE, V117, P110, DOI 10.1016/j.biochi.2014.11.019; Stsiapanava A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51174-0; Sullivan B, 2013, ENZYME MICROB TECH, V53, P70, DOI 10.1016/j.enzmictec.2013.02.012; VESTER B, 1994, J BACTERIOL, V176, P6999, DOI 10.1128/JB.176.22.6999-7004.1994; Vester B, 1998, J MOL BIOL, V282, P255, DOI 10.1006/jmbi.1998.2024; Villsen ID, 1999, J MOL BIOL, V286, P365, DOI 10.1006/jmbi.1998.2504; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	32	2	2	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17476	17485		10.1074/jbc.RA120.014280	http://dx.doi.org/10.1074/jbc.RA120.014280			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453992	Green Published, hybrid			2022-12-28	WOS:000603272300008
J	Sullivan, ED; Longley, MJ; Copeland, WC				Sullivan, Eric D.; Longley, Matthew J.; Copeland, William C.			Polymerase gamma efficiently replicates through many natural template barriers but stalls at the HSP1 quadruplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA structure; DNA polymerase &#947; G-quadruplex; mtDNA deletion; DNA replication; heavy-strand promoter; mitochondrial DNA (mtDNA); mitochondrial DNA damage	HUMAN MITOCHONDRIAL-DNA; HEAVY-STRAND PROMOTER; BASE EXCISION-REPAIR; SUNLIGHT EXPOSURE; ACCESSORY SUBUNIT; RNA-POLYMERASE; DELETION; SEQUENCE; TRANSCRIPTION; MAINTENANCE	Faithful replication of the mitochondrial genome is carried out by a set of key nuclear-encoded proteins. DNA polymerase gamma is a core component of the mtDNA replisome and the only replicative DNA polymerase localized to mitochondria. The asynchronous mechanism of mtDNA replication predicts that the replication machinery encounters dsDNA and unique physical barriers such as structured genes, G-quadruplexes, and other obstacles. In vitro experiments here provide evidence that the polymerase gamma heterotrimer is well-adapted to efficiently synthesize DNA, despite the presence of many naturally occurring roadblocks. However, we identified a specific G-quadruplex-forming sequence at the heavy-strand promoter (HSP1) that has the potential to cause significant stalling of mtDNA replication. Furthermore, this structured region of DNA corresponds to the break site for a large (3,895 bp) deletion observed in mitochondrial disease patients. The presence of this deletion in humans correlates with UV exposure, and we have found that efficiency of polymerase gamma DNA synthesis is reduced after this quadruplex is exposed to UV in vitro.	[Sullivan, Eric D.; Longley, Matthew J.; Copeland, William C.] NIH, Mitochondrial DNA Replicat Grp, Natl Inst Environm Hlth Sci, Genome Integr & Struct Biol Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Copeland, WC (corresponding author), NIH, Mitochondrial DNA Replicat Grp, Natl Inst Environm Hlth Sci, Genome Integr & Struct Biol Lab, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953; Sullivan, Eric/0000-0002-7308-0529	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [ES065078]	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences Grant ES065078 (to W. C. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x; Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073; Bhattacharyya D, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00038; Brazda V, 2019, BIOINFORMATICS, V35, P3493, DOI 10.1093/bioinformatics/btz087; Butler TJ, 2020, HUM MOL GENET, V29, P1292, DOI 10.1093/hmg/ddaa043; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010; Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007; DeBalsi KL, 2017, J BIOL CHEM, V292, P4198, DOI 10.1074/jbc.M116.773341; Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677; Eddy S, 2016, BIOCHEMISTRY-US, V55, P5218, DOI 10.1021/acs.biochem.6b00374; Falabella M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41464-y; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527; Fuste JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; Gendron SP, 2013, MUTAGENESIS, V28, P197, DOI 10.1093/mutage/ges071; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213; Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; Harbottle A, 2010, BRIT J DERMATOL, V163, P1291, DOI 10.1111/j.1365-2133.2010.10001.x; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; KAGUNI LS, 1982, P NATL ACAD SCI-BIOL, V79, P983, DOI 10.1073/pnas.79.4.983; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; Kasiviswanathan R, 2013, J BIOL CHEM, V288, P14247, DOI 10.1074/jbc.M113.458802; Kasiviswanathan R, 2012, J BIOL CHEM, V287, P9222, DOI 10.1074/jbc.M111.306852; Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; Kaur P, 2018, NUCLEIC ACIDS RES, V46, P11287, DOI 10.1093/nar/gky875; Kazak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062340; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Lujan SA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02138-5; MORAES CT, 1991, MOL CELL BIOL, V11, P1631, DOI 10.1128/MCB.11.3.1631; MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359; Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200; Persson O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08673-5; Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0; Ray AJ, 2000, J INVEST DERMATOL, V115, P674, DOI 10.1046/j.1523-1747.2000.00092.x; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Smith JE, 2014, NUCLEIC ACIDS RES, V42, P5007, DOI 10.1093/nar/gku163; Smith-Carpenter JE, 2019, PHOTOCHEM PHOTOBIOL, V95, P252, DOI 10.1111/php.12991; Su DGT, 2009, P NATL ACAD SCI USA, V106, P12861, DOI 10.1073/pnas.0902386106; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; WONG TW, 1985, CELL, V42, P951, DOI 10.1016/0092-8674(85)90291-0; Wu CC, 2019, NUCLEIC ACIDS RES, V47, P5405, DOI 10.1093/nar/gkz241; Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109	64	5	5	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17802	17815		10.1074/jbc.RA120.015390	http://dx.doi.org/10.1074/jbc.RA120.015390			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454015	hybrid, Green Published			2022-12-28	WOS:000603272300031
J	Affandi, T; Ohm, AM; Gaillard, D; Haas, A; Reyland, ME				Affandi, Trisiani; Ohm, Angela M.; Gaillard, Dany; Haas, Ami; Reyland, Mary E.			Tyrosine kinase inhibitors protect the salivary gland from radiation damage by increasing DNA double-strand break repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-DELTA; C-ABL; NUCLEAR IMPORT; ACTIVATION; APOPTOSIS; IMATINIB; PHOSPHORYLATION; IDENTIFICATION; BCR/ABL; PATHWAY	We have previously shown that the tyrosine kinase inhibitors (TKIs) dasatinib and imatinib can protect salivary glands from irradiation (IR) damage without impacting tumor therapy. However, how they induce this protection is unknown. Here we show that TKIs mediate radioprotection by increasing the repair of DNA double-stranded breaks. DNA repair in IR-treated parotid cells, but not oral cancer cells, occurs more rapidly following pretreatment with imatinib or dasatinib and is accompanied by faster formation of DNA damage-induced foci. Similar results were observed in the parotid glands of mice pretreated with imatinib prior to IR, suggesting that TKIs "prime" cells for DNA repair. Mechanistically, we observed that TKIs increased IR-induced activation of DNA-PK, but not ATM. Pretreatment of parotid cells with the DNA-PK inhibitor NU7441 reversed the increase in DNA repair induced by TKIs. Reporter assays specific for homologous recombination (HR) or nonhomologous end joining (NHEJ) verified regulatation of both DNA repair pathways by imatinib. Moreover, TKIs also increased basal and IR-induced expression of genes associated with NHEJ (DNA ligase 4, Artemis, XLF) and HR (Rad50, Rad51 and BRCA1); depletion of DNA ligase 4 or BRCA1 reversed the increase in DNA repair mediated by TKIs. In addition, TKIs increased activation of the ERK survival pathway in parotid cells, and ERK was required for the increased survival of TKI-treated cells. Our studies demonstrate a dual mechanism by which TKIs provide radioprotection of the salivary gland tissues and support exploration of TKIs clinically in head and neck cancer patients undergoing IR therapy.	[Affandi, Trisiani; Ohm, Angela M.; Haas, Ami; Reyland, Mary E.] Univ Colorado, Dept Craniofacial Biol, Sch Dent Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Gaillard, Dany] Univ Colorado, Dept Cell & Dev Biol, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Gaillard, Dany] Univ Colorado, Rocky Mt Taste & Smell Ctr, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Reyland, ME (corresponding author), Univ Colorado, Dept Craniofacial Biol, Sch Dent Med, Anschutz Med Campus, Aurora, CO 80045 USA.	Mary.Reyland@cuanschutz.edu		Haas, Ami/0000-0001-9815-8954; Reyland, Mary/0000-0002-0747-9603	National Institutes of Health [T32 CA190216-03, F32 DE029116-01, R01DE015648, R01DE027517, R21DC016131]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health: T32 CA190216-03 and F32 DE029116-01 (T. A.), R01DE015648 and R01DE027517 (M. E. R.) and R21DC016131 (D. G.).	Adwan TS, 2011, J BIOL CHEM, V286, P35716, DOI 10.1074/jbc.M111.255950; Anderson SM, 1999, CELL DEATH DIFFER, V6, P454, DOI 10.1038/sj.cdd.4400507; Bhullar KS, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0804-2; Brooks HD, 2011, CANCER-AM CANCER SOC, V117, P2112, DOI 10.1002/cncr.25769; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chou RH, 2014, DEV CELL, V30, P224, DOI 10.1016/j.devcel.2014.06.008; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Collins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005; Cramer K, 2008, CANCER RES, V68, P6884, DOI 10.1158/0008-5472.CAN-08-1101; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Dierov J, 2009, LEUKEMIA, V23, P279, DOI 10.1038/leu.2008.308; Ding D, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.11; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2009, NAT MED, V15, P1149, DOI 10.1038/nm1009-1149; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Fernandes MS, 2009, BLOOD, V114, P1813, DOI 10.1182/blood-2008-07-172148; Gaillard D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54216-9; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Gudkov SV, 2010, DOKL BIOCHEM BIOPHYS, V430, P1, DOI 10.1134/S1607672910010011; Hasse HL, 2017, J IMMUNOL METHODS, V451, P71, DOI 10.1016/j.jim.2017.08.007; Hawkins PG, 2018, RADIOTHER ONCOL, V126, P68, DOI 10.1016/j.radonc.2017.08.002; Huang F, 2011, ACS CHEM BIOL, V6, P628, DOI 10.1021/cb100428c; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ivashkevich AN, 2011, MUTAT RES-FUND MOL M, V711, P49, DOI 10.1016/j.mrfmmm.2010.12.015; Iyer G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43763; Jensen S. B., 2019, J NATL CANCER INST M, V2019; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lindauer M, 2014, RECENT RESULTS CANC, V201, P27, DOI 10.1007/978-3-642-54490-3_2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombaert I, 2017, STEM CELLS, V35, P97, DOI 10.1002/stem.2455; Lombaert IMA, 2008, STEM CELLS, V26, P2595, DOI 10.1634/stemcells.2007-1034; Maiani E, 2011, BIOCHEM PHARMACOL, V82, P1269, DOI 10.1016/j.bcp.2011.07.001; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Masani S, 2016, P NATL ACAD SCI USA, V113, P1261, DOI 10.1073/pnas.1521630113; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Montor WR, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0792-2; Morii M, 2015, CELL BIOL INT, V39, P923, DOI 10.1002/cbin.10460; Ogata K, 2018, DIGESTION, V97, P20, DOI 10.1159/000484102; Ohm AM, 2019, J BIOL CHEM, V294, P4488, DOI 10.1074/jbc.RA118.006944; Pfeffer MR, 2007, ORAL ONCOL, V43, P33, DOI 10.1016/j.oraloncology.2005.12.026; Reyland ME, 2016, PHARMACOL THERAPEUT, V165, P1, DOI 10.1016/j.pharmthera.2016.05.001; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Salles D, 2011, CARCINOGENESIS, V32, P27, DOI 10.1093/carcin/bgq216; Santivasi WL, 2014, ANTIOXID REDOX SIGN, V21, P251, DOI 10.1089/ars.2013.5668; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shimizu H, 2009, BIOCHEM BIOPH RES CO, V382, P286, DOI 10.1016/j.bbrc.2009.03.020; Skorski T, 2008, LEUKEMIA LYMPHOMA, V49, P610, DOI 10.1080/03093640701859089; Soref CM, 2012, INT J RADIAT ONCOL, V82, pE701, DOI 10.1016/j.ijrobp.2011.11.038; Strup-Perrot C, 2016, RADIOTHER ONCOL, V120, P175, DOI 10.1016/j.radonc.2016.06.009; Symonds JM, 2016, ONCOTARGET, V7, P17905, DOI 10.18632/oncotarget.7560; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wie SM, 2017, MOL CANCER THER, V16, P1989, DOI 10.1158/1535-7163.MCT-17-0267; Wie SM, 2014, J BIOL CHEM, V289, P10900, DOI 10.1074/jbc.M114.551366; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	62	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100401	10.1016/j.jbc.2021.100401	http://dx.doi.org/10.1016/j.jbc.2021.100401			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571522	Green Published, gold			2022-12-28	WOS:000672866400375
J	Clark, EH; de la Torre, AV; Hoshikawa, T; Briston, T				Clark, Emily H.; de la Torre, Aurelio Vazquez; Hoshikawa, Tamaki; Briston, Thomas			Targeting mitophagy in Parkinson's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL COMPLEX-I; MAGNETIC-RESONANCE-SPECTROSCOPY; MOUSE MODEL; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; QUALITY-CONTROL; LIFE-SPAN; F-BOX; PINK1; DYSFUNCTION	The genetics and pathophysiology of Parkinson's disease (PD) strongly implicate mitochondria in disease aetiology. Elegant studies over the last two decades have elucidated complex molecular signaling governing the identification and removal of dysfunctional mitochondria from the cell, a process of mitochondrial quality control known as mitophagy. Mitochondrial deficits and specifically reduced mitophagy are evident in both sporadic and familial PD. Mendelian genetics attributes loss-of-function mutations in key mitophagy regulators PINK1 and Parkin to early-onset PD. Pharmacologically enhancing mitophagy and accelerating the removal of damaged mitochondria are of interest for developing a disease-modifying PD therapeutic. However, despite significant understanding of both PINK1-Parkin-dependent and -independent mitochondrial quality control pathways, the therapeutic potential of targeting mitophagy remains to be fully explored. Here, we provide a summary of the genetic evidence supporting the role for mitophagy failure as a pathogenic mechanism in PD. We assess the tractability of mitophagy pathways and prospects for drug discovery and consider intervention points for mitophagy enhancement. We explore the numerous hit molecules beginning to emerge from high-content/high-throughput screening as well as the biochemical and phenotypic assays that enabled these screens. The chemical and biological properties of these reference compounds suggest many could be used to interrogate and perturb mitochondrial biology to validate promising drug targets. Finally, we address key considerations and challenges in achieving preclinical proof-of-concept, including in vivo mitophagy reporter methodologies and disease models, as well as patient stratification and biomarker development for mitochondrial forms of the disease.	[Clark, Emily H.; de la Torre, Aurelio Vazquez; Hoshikawa, Tamaki; Briston, Thomas] Eisai Ltd, Neurol Innovat Ctr, Hatfield Res Labs, Hatfield, Herts, England	Eisai Co Ltd	Briston, T (corresponding author), Eisai Ltd, Neurol Innovat Ctr, Hatfield Res Labs, Hatfield, Herts, England.	Thomas_Briston@eisai.net	Clark, Emily/GVR-7159-2022	Clark, Emily/0000-0001-9464-0508; Hoshikawa, Tamaki/0000-0001-6583-8689; Briston, Thomas/0000-0002-7491-525X				Ahfeldt T, 2020, STEM CELL REP, V14, P75, DOI 10.1016/j.stemcr.2019.12.005; Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Antony PMA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58505-6; Antony PMA, 2015, ANN CLIN TRANSL NEUR, V2, P67, DOI 10.1002/acn3.151; Arena G, 2013, CELL DEATH DIFFER, V20, P920, DOI 10.1038/cdd.2013.19; Ashrafi G, 2014, J CELL BIOL, V206, P655, DOI 10.1083/jcb.201401070; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Billingsley KJ, 2019, NPJ PARKINSON DIS, V5, DOI 10.1038/s41531-019-0080-x; Blanch M, 2016, AM J PATHOL, V186, P385, DOI 10.1016/j.ajpath.2015.10.004; Booth TC, 2015, AM J NEURORADIOL, V36, P229, DOI 10.3174/ajnr.A3970; Borsche M, 2020, BRAIN, V143, P3041, DOI 10.1093/brain/awaa246; Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731; Bradshaw A. V., 2020, PINK1 PARKIN MITOPHA, DOI [10.1101/2020.02.12.945469, DOI 10.1101/2020.02.12.945469]; Briston T, 2018, BIOCHEM SOC T, V46, P829, DOI 10.1042/BST20180025; Burbulla LF, 2017, SCIENCE, V357, P1255, DOI 10.1126/science.aam9080; Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489; Camicioli RM, 2007, MOVEMENT DISORD, V22, P382, DOI 10.1002/mds.21288; Castellazzi M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56614-5; Cerqueira FM, 2020, BIOCHEM J, V477, P461, DOI 10.1042/BCJ20190616; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chen G, 2014, MOL CELL, V54, P362, DOI 10.1016/j.molcel.2014.02.034; Chen M, 2016, AUTOPHAGY, V12, P689, DOI 10.1080/15548627.2016.1151580; Chen ZH, 2017, EMBO REP, V18, P495, DOI 10.15252/embr.201643309; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Chung SY, 2016, STEM CELL REP, V7, P664, DOI 10.1016/j.stemcr.2016.08.012; Ciurleo R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/519816; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cleeter MWJ, 2013, NEUROCHEM INT, V62, P1, DOI 10.1016/j.neuint.2012.10.010; Cornelissen T, 2018, ELIFE, V7, DOI 10.7554/eLife.35878; Cornelissen T, 2014, HUM MOL GENET, V23, P5227, DOI 10.1093/hmg/ddu244; Creed RB, 2020, NEUROSCIENCE, V437, P64, DOI 10.1016/j.neuroscience.2020.04.032; Dave KD, 2014, NEUROBIOL DIS, V70, P190, DOI 10.1016/j.nbd.2014.06.009; Davis RL, 2020, NEUROL-CLIN PRACT, V10, P40, DOI 10.1212/CPJ.0000000000000702; de la Mata M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10903; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634; Di Rita A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05722-3; Dolgacheva LP, 2019, J BIOENERG BIOMEMBR, V51, P175, DOI 10.1007/s10863-019-09798-4; Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729; East DA, 2014, CHEM BIOL, V21, P1585, DOI 10.1016/j.chembiol.2014.09.019; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Emamzadeh FN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00612; Ermondi G, 2020, DRUG DISCOV TODAY, V25, P1585, DOI 10.1016/j.drudis.2020.06.015; Escobar-Henriques M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00517; Fang EF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13172-8; Fang EF, 2019, AUTOPHAGY, V15, P1112, DOI 10.1080/15548627.2019.1596497; Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Fritsch LE, 2020, J MOL BIOL, V432, P2510, DOI 10.1016/j.jmb.2019.10.015; Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2; Gaare JJ, 2018, MOVEMENT DISORD, V33, P1591, DOI 10.1002/mds.64; Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x; Gao F, 2015, HUM MOL GENET, V24, P2528, DOI 10.1093/hmg/ddv017; Gehrke S, 2015, CELL METAB, V21, P95, DOI 10.1016/j.cmet.2014.12.007; Ghaisas S, 2019, NEUROTOXICOLOGY, V75, P186, DOI 10.1016/j.neuro.2019.09.004; Gispert S, 2015, HUM MOL GENET, V24, P1061, DOI 10.1093/hmg/ddu520; Gladkova C, 2018, NATURE, V559, P411, DOI 10.1038/s41586-018-0224-x; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Gmitterova K, 2009, NEURODEGENER DIS, V6, P263, DOI 10.1159/000237221; Gotz ME, 2000, J NEURAL TRANSM, V107, P41, DOI 10.1007/s007020050003; Green HF, 2019, J PARKINSON DIS, V9, P705, DOI 10.3233/JPD-191699; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Grigoruta M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66745-9; Grunewald A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.035; Gui YX, 2015, PARKINSONISM RELAT D, V21, P282, DOI 10.1016/j.parkreldis.2014.12.030; Guzman JN, 2018, J CLIN INVEST, V128, P2266, DOI 10.1172/JCI95898; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Harada N, 2013, J LABELLED COMPD RAD, V56, P553, DOI 10.1002/jlcr.3056; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; Hauser DN, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0075-14.2015; Havelund JF, 2017, METABOLITES, V7, DOI 10.3390/metabo7030042; He RC, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00305; Hebron ML, 2013, HUM MOL GENET, V22, P3315, DOI 10.1093/hmg/ddt192; Henchcliffe C, 2008, ANN NY ACAD SCI, V1147, P206, DOI 10.1196/annals.1427.037; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Hirayama M, 2011, PARKINSONISM RELAT D, V17, P46, DOI 10.1016/j.parkreldis.2010.11.004; Hou X, 2018, AUTOPHAGY, V14, P1404, DOI 10.1080/15548627.2018.1461294; Hsieh CH, 2019, CELL METAB, V30, P1131, DOI 10.1016/j.cmet.2019.08.023; Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002; Hu MTM, 2000, BRAIN, V123, P340, DOI 10.1093/brain/123.2.340; Igarashi R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58315-w; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Isobe C, 2010, NEUROSCI LETT, V469, P159, DOI 10.1016/j.neulet.2009.11.065; Jang J, 2018, PARKINSONS DIS-US, V2018, DOI 10.1155/2018/1241757; Jang SY, 2012, J BIOL CHEM, V287, P19304, DOI 10.1074/jbc.M112.363747; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kalia LV, 2015, JAMA NEUROL, V72, P100, DOI 10.1001/jamaneurol.2014.2704; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Karpenko MN, 2018, CELL IMMUNOL, V327, P77, DOI 10.1016/j.cellimm.2018.02.011; Karuppagounder SS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04874; Kasten M, 2018, MOVEMENT DISORD, V33, P730, DOI 10.1002/mds.27352; Katayama H, 2020, CELL, V181, P1176, DOI 10.1016/j.cell.2020.04.025; Kazlauskaite A, 2015, EMBO REP, V16, P939, DOI 10.15252/embr.201540352; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kikuchi A, 2002, NEUROBIOL DIS, V9, P244, DOI 10.1006/nbdi.2002.0466; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klietz M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00777; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Korwitz A, 2016, J CELL BIOL, V212, P157, DOI 10.1083/jcb.201507022; Koyano F, 2019, J BIOL CHEM, V294, P10300, DOI 10.1074/jbc.RA118.006302; KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kumar N, 2018, J CELL BIOL, V217, P3625, DOI 10.1083/jcb.201807019; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200; Lee RG, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000276; Lesage S, 2016, AM J HUM GENET, V98, P500, DOI 10.1016/j.ajhg.2016.01.014; Levin BE, 2014, J NEUROIMAGING, V24, P39, DOI 10.1111/j.1552-6569.2012.00733.x; LeWitt PA, 2017, NEUROLOGY, V88, P862, DOI 10.1212/WNL.0000000000003663; Li HY, 2019, AUTOPHAGY, V15, P113, DOI 10.1080/15548627.2018.1509818; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071341; Little D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27058-0; Liu Y, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.131834; Lonskaya I, 2014, J MOL MED, V92, P373, DOI 10.1007/s00109-013-1112-3; Lowes H, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00362-y; Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009; Luo Y, 2015, INT J MOL SCI, V16, P20704, DOI 10.3390/ijms160920704; Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749; Lynch WB, 2018, MOVEMENT DISORD, V33, P1928, DOI 10.1002/mds.27541; Mansur A, 2018, J NUCL MED, V59; Marcassa E, 2018, EMBO REP, V19, DOI 10.15252/embr.201745595; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martin-Bastida A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01402-2; Matheoud D, 2019, NATURE, V571, P565, DOI 10.1038/s41586-019-1405-y; Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039; Matthews DC, 2018, NEUROIMAGE-CLIN, V20, P572, DOI 10.1016/j.nicl.2018.08.006; Mazuel L, 2016, RADIOLOGY, V278, P505, DOI 10.1148/radiol.2015142764; McLelland GL, 2016, J CELL BIOL, V214, P275, DOI 10.1083/jcb.201603105; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039; Milanese C, 2019, MOVEMENT DISORD, V34, P1192, DOI 10.1002/mds.27723; Mischley LK, 2012, J NEUROL SCI, V318, P72, DOI 10.1016/j.jns.2012.03.023; Moisoi N, 2014, NEUROPHARMACOLOGY, V77, P350, DOI 10.1016/j.neuropharm.2013.10.009; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Moskal N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13781-3; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Mouton-Liger F, 2018, GLIA, V66, P1736, DOI 10.1002/glia.23337; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Niu KF, 2020, AUTOPHAGY, V16, P724, DOI 10.1080/15548627.2019.1656957; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Osgerby L, 2017, J MED CHEM, V60, P3518, DOI 10.1021/acs.jmedchem.6b01897; Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050; Padmanabhan S, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9080296; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Park JS, 2014, HUM MOL GENET, V23, P2802, DOI 10.1093/hmg/ddt623; Pettus EH, 2000, J NEUROCHEM, V75, P383, DOI 10.1046/j.1471-4159.2000.0750383.x; Phu L, 2020, MOL CELL, V77, P1107, DOI 10.1016/j.molcel.2020.02.012; Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011; Pinto M, 2018, J NEUROSCI, V38, P1042, DOI 10.1523/JNEUROSCI.1384-17.2017; Pirooznia SK, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00363-x; Devoto VMP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05334-9; Prasuhn Jannik, 2019, Neurol Res Pract, V1, P31, DOI 10.1186/s42466-019-0033-1; Puri R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11636-5; Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033; Pyle A, 2015, ANN NEUROL, V78, P1000, DOI 10.1002/ana.24515; Qadri R, 2018, RESTOR NEUROL NEUROS, V36, P719, DOI 10.3233/RNN-180852; Qin XY, 2016, JAMA NEUROL, V73, P1316, DOI 10.1001/jamaneurol.2016.2742; Rasool S, 2018, EMBO REP, V19, DOI 10.15252/embr.201744981; Requejo-Aguilar R, 2016, FREE RADICAL BIO MED, V100, P123, DOI 10.1016/j.freeradbiomed.2016.04.012; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Rodolfo C, 2018, NEUROCHEM INT, V117, P156, DOI 10.1016/j.neuint.2017.08.004; Rusilowicz-Jones EV, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000768; Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003; Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132; Saito Y, 2009, NEUROSCI LETT, V465, P1, DOI 10.1016/j.neulet.2009.08.074; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sato S, 2005, NEUROLOGY, V64, P1081, DOI 10.1212/01.WNL.0000154597.24838.6B; Sauve V, 2018, NAT STRUCT MOL BIOL, V25, P623, DOI 10.1038/s41594-018-0088-7; Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059; Schubert AF, 2017, NATURE, V552, P51, DOI 10.1038/nature24645; Sekine S, 2019, MOL CELL, V73, P1028, DOI 10.1016/j.molcel.2019.01.002; Shaltouki A, 2018, ACTA NEUROPATHOL, V136, P607, DOI 10.1007/s00401-018-1873-4; Shetty RS, 2011, HUM MOL GENET, V20, P4093, DOI 10.1093/hmg/ddr333; Shiba-Fukushima K, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101048; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Singh A, 2019, BRAIN RES, V1702, P96, DOI 10.1016/j.brainres.2018.06.010; Sjodin S, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0533-9; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Smith AM, 2018, MOVEMENT DISORD, V33, P1580, DOI 10.1002/mds.104; Sohmiya M, 2004, J NEUROL SCI, V223, P161, DOI 10.1016/j.jns.2004.05.007; Song LY, 2017, NEUROBIOL DIS, V100, P30, DOI 10.1016/j.nbd.2016.12.024; Song LY, 2015, BRAIN RES, V1594, P82, DOI 10.1016/j.brainres.2014.11.013; Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Sowter HM, 2001, CANCER RES, V61, P6669; Stafa K, 2014, HUM MOL GENET, V23, P2055, DOI 10.1093/hmg/ddt600; Sterky FH, 2012, HUM MOL GENET, V21, P1078, DOI 10.1093/hmg/ddr537; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112; Stotland A, 2016, J MOL CELL CARDIOL, V90, P53, DOI 10.1016/j.yjmcc.2015.11.032; Sun N, 2017, NAT PROTOC, V12, P1576, DOI 10.1038/nprot.2017.060; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Takahashi D, 2019, MOL CELL, V76, P797, DOI 10.1016/j.molcel.2019.09.009; Takanashi M, 2016, NEUROLOGY, V86, P2212, DOI 10.1212/WNL.0000000000002744; Tang FL, 2015, CELL REP, V12, P1631, DOI 10.1016/j.celrep.2015.08.001; Tang MY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14697; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tsukada H, 2016, J NUCL MED, V57, P950, DOI 10.2967/jnumed.115.169615; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Vicario M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00388; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Wall CE, 2019, CELL REP, V29, P3280, DOI 10.1016/j.celrep.2019.10.130; Wang LM, 2018, CELL RES, V28, P787, DOI 10.1038/s41422-018-0056-0; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang YQ, 2015, AUTOPHAGY, V11, P595, DOI 10.1080/15548627.2015.1034408; Watzlawik JO, 2021, AUTOPHAGY, V17, P2613, DOI 10.1080/15548627.2020.1834712; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042; Wilson H, 2020, MOVEMENT DISORD, V35, P1416, DOI 10.1002/mds.28064; Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486; Woodall B. P., 2019, JCI INSIGHT, V5; Yakhine-Diop SMS, 2019, MOL NEUROBIOL, V56, P2466, DOI 10.1007/s12035-018-1206-6; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yi W, 2019, HUM MOL GENET, V28, P2811, DOI 10.1093/hmg/ddz080; Yun JN, 2014, ELIFE, V3, DOI 10.7554/eLife.01958; Zachari M, 2019, DEV CELL, V50, P627, DOI 10.1016/j.devcel.2019.06.016; Zambon F, 2019, HUM MOL GENET, V28, P2001, DOI 10.1093/hmg/ddz038; Zhou ZD, 2018, MUTAT RES-REV MUTAT, V778, P72, DOI 10.1016/j.mrrev.2018.10.001; Zhou ZD, 2015, HUM MOL GENET, V24, P6314, DOI 10.1093/hmg/ddv340; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	242	37	37	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100209	10.1074/jbc.REV120.014294	http://dx.doi.org/10.1074/jbc.REV120.014294			29	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33372898	Green Published, gold			2022-12-28	WOS:000672866400187
J	Collins, JF				Collins, James F.			Iron chelates hitch a ride on PAT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							NICOTIANAMINE; DMT1; ACID	The nicotianamine-iron chelate [NA-Fe2+], which is found in many plant-based foods, has been recently described as a new form of bioavailable iron in mice and chickens. How NA-Fe2+ is assimilated from the diet, however, remains unclear. The current investigation by Murata et al. has identified the proton-coupled amino acid transporter 1 (PAT1) as the main mechanism by which NA-Fe2+ is absorbed in the mammalian intestine. Discovery of this new form of dietary iron and elucidation of its pathway of intestinal absorption may lead to the development of improved iron supplementation approaches.	[Collins, James F.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Collins, JF (corresponding author), Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA.	jfcollins@ufl.edu		Collins, James Forrest/0000-0002-8765-0297	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK074867]; NIDDK [DK109717]; Office of Dietary Supplements	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by grant DK074867 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and grant DK109717 from NIDDK and the Office of Dietary Supplements.	Allen LH, 2002, NUTR REV, V60, pS18, DOI 10.1301/002966402320285047; Beasley JT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57598-3; Eagling T, 2014, J AGR FOOD CHEM, V62, P10320, DOI 10.1021/jf5026295; Gulec S, 2014, AM J PHYSIOL-GASTR L, V307, pG397, DOI 10.1152/ajpgi.00348.2013; Lee S, 2012, MOL CELLS, V33, P269, DOI 10.1007/s10059-012-2231-3; Mims MP, 2005, BLOOD, V105, P1337, DOI 10.1182/blood-2004-07-2966; Murata Y, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015861; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Shawki A, 2015, AM J PHYSIOL-GASTR L, V309, pG635, DOI 10.1152/ajpgi.00160.2015; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107	10	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100418	10.1016/j.jbc.2021.100418	http://dx.doi.org/10.1016/j.jbc.2021.100418			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837730	gold, Green Published			2022-12-28	WOS:000672866400392
J	Du, Y; Wang, TZ; Guo, J; Li, WT; Yang, TH; Szendrey, M; Zhang, ST				Du, Yuan; Wang, Tingzhong; Guo, Jun; Li, Wentao; Yang, Tonghua; Szendrey, Mark; Zhang, Shetuan			Kv1.5 channels are regulated by PKC-mediated endocytic degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RECTIFIER K+ CURRENT; SURFACE EXPRESSION; K(V)1.5 CHANNELS; TYROSINE KINASE; I-KUR; UBIQUITIN; PHOSPHORYLATION; TRANSPORTER; MODULATION	The voltage-gated potassium channel Kv1.5 plays important roles in the repolarization of atrial action potentials and regulation of the vascular tone. While the modulation of Kv1.5 function has been well studied, less is known about how the protein levels of Kv1.5 on the cell membrane are regulated. Here, through electrophysiological and biochemical analyses of Kv1.5 channels heterologously expressed in HEK293 cells and neonatal rat ventricular myocytes, as well as native Kv1.5 in human induced pluripotent stem cell (iPSC)-derived atrial cardiomyocytes, we found that activation of protein kinase C (PKC) with phorbol 12-myristate 13-acetate (PMA, 10 nM) diminished Kv1.5 current (I-Kv1.5) and protein levels of Kv1.5 in the plasma membrane. Mechanistically, PKC activation led to monoubiquitination and degradation of the mature Kv1.5 proteins. Overexpression of Vps24, a protein that sorts transmembrane proteins into lysosomes via the multivesicular body (MVB) pathway, accelerated, whereas the lysosome inhibitor bafilomycin A1 completely prevented PKC-mediated Kv1.5 degradation. Kv1.5, but not Kv1.1, Kv1.2, Kv1.3, or Kv1.4, was uniquely sensitive to PMA treatment. Sequence alignments suggested that residues within the N terminus of Kv1.5 are essential for PKC-mediated Kv1.5 reduction. UsingN-terminal truncation as well as site-directedmutagenesis, we identified that Thr15 is the target site for PKC that mediates endocytic degradation of Kv1.5 channels. These findings indicate that alteration of protein levels in the plasma membrane represents an important regulatory mechanism of Kv1.5 channel function under PKC activation conditions.	[Du, Yuan; Wang, Tingzhong] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Xian, Peoples R China; [Du, Yuan; Wang, Tingzhong; Guo, Jun; Li, Wentao; Yang, Tonghua; Szendrey, Mark; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Xi'an Jiaotong University; Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research [MOP 72911]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (Grant MOP 72911) to S. Z.	Aimond F, 2005, CIRC RES, V96, P451, DOI 10.1161/01.RES.0000156890.25876.63; Andersen MN, 2015, CHANNELS, V9, P121, DOI 10.1080/19336950.2015.1036205; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P591, DOI 10.1159/000185543; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Brandt DT, 2003, J BIOL CHEM, V278, P34073, DOI 10.1074/jbc.M211650200; Chen R, 2018, BIOCHEMISTRY-US, V57, P2704, DOI 10.1021/acs.biochem.8b00268; Choi BH, 2000, J PHARMACOL EXP THER, V293, P634; Choi WS, 2005, CIRC RES, V97, P363, DOI 10.1161/01.RES.0000179535.06458.f8; Christophersen IE, 2013, EUR HEART J, V34, P1517, DOI 10.1093/eurheartj/ehs442; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; David M, 2012, J BIOL CHEM, V287, P21416, DOI 10.1074/jbc.M111.328278; Eldstrom J, 2003, FEBS LETT, V547, P205, DOI 10.1016/S0014-5793(03)00668-9; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Fischer F, 2014, N-S ARCH PHARMACOL, V387, P469, DOI 10.1007/s00210-014-0965-5; Ford J, 2016, HEART RHYTHM, V13, P555, DOI 10.1016/j.hrthm.2015.10.003; Frankel EB, 2018, SEMIN CELL DEV BIOL, V74, P4, DOI 10.1016/j.semcdb.2017.08.020; Garcia-Tardon N, 2012, J BIOL CHEM, V287, P19177, DOI 10.1074/jbc.M112.355909; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Guo W, 1997, PFLUG ARCH EUR J PHY, V434, P206, DOI 10.1007/s004240050385; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Harmati G, 2011, N-S ARCH PHARMACOL, V383, P141, DOI 10.1007/s00210-010-0584-8; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Kanda VA, 2011, HEART RHYTHM, V8, P1641, DOI 10.1016/j.hrthm.2011.04.034; Kidd M, 2017, J PHYSIOL-LONDON, V595, P1607, DOI 10.1113/JP272893; Kwak YG, 1999, J BIOL CHEM, V274, P25355, DOI 10.1074/jbc.274.36.25355; Lamothe SM, 2018, J BIOL CHEM, V293, P15347, DOI 10.1074/jbc.RA118.004065; Lata S, 2009, BIOCHEM SOC T, V37, P156, DOI 10.1042/BST0370156; Li GR, 1996, CIRC RES, V78, P903, DOI 10.1161/01.RES.78.5.903; Li HL, 2005, J MOL CELL CARDIOL, V39, P121, DOI 10.1016/j.yjmcc.2005.03.013; Li PL, 2015, J MOL CELL CARDIOL, V86, P138, DOI 10.1016/j.yjmcc.2015.07.018; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin DH, 2005, P NATL ACAD SCI USA, V102, P4306, DOI 10.1073/pnas.0409767102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Mathur R, 2006, BIOCHEM BIOPH RES CO, V342, P1, DOI 10.1016/j.bbrc.2006.01.110; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nitabach MN, 2001, P NATL ACAD SCI USA, V98, P705, DOI 10.1073/pnas.031446198; Ohanyan V, 2015, CIRC RES, V117, P612, DOI 10.1161/CIRCRESAHA.115.306642; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Schumacher SM, 2009, CIRC RES, V104, P1390, DOI 10.1161/CIRCRESAHA.108.192773; Singh RM, 2017, HEART FAIL REV, V22, P843, DOI 10.1007/s10741-017-9634-3; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Sutherland-Deveen ME, 2019, MOL PHARMACOL, V96, P1, DOI 10.1124/mol.118.115188; Takeishi Y, 1999, AM J PHYSIOL-HEART C, V276, pH53, DOI 10.1152/ajpheart.1999.276.1.H53; Tschirhart JN, 2019, MOL PHARMACOL, V95, P386, DOI 10.1124/mol.118.114751; Voigt N, 2007, CARDIOVASC RES, V74, P426, DOI 10.1016/j.cardiores.2007.02.009; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Williams CP, 2002, J PHARMACOL EXP THER, V302, P545, DOI 10.1124/jpet.102.033357; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Yang T, 2010, HEART RHYTHM, V7, P1246, DOI 10.1016/j.hrthm.2010.05.032; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	61	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100514	10.1016/j.jbc.2021.100514	http://dx.doi.org/10.1016/j.jbc.2021.100514			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676894	Green Published, gold			2022-12-28	WOS:000672866400488
J	Fang, YC; Fu, SJ; Hsu, PH; Chang, PT; Huang, JJ; Chiu, YC; Liao, YF; Jow, GM; Tang, CY; Jeng, CJ				Fang, Ya-Ching; Fu, Ssu-Ju; Hsu, Po-Hao; Chang, Pei-Tzu; Huang, Jing-Jia; Chiu, Yi-Chih; Liao, Yi-Fan; Jow, Guey-Mei; Tang, Chih-Yung; Jeng, Chung-Jiuan			Identification of MKRN1 as a second E3 ligase for Eag1 potassium channels reveals regulation via differential degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER PROTEIN-1 MKRN1; FUNCTIONAL EXPRESSION; QUALITY-CONTROL; K+ CHANNELS; UBIQUITIN; RING; RAT; DROSOPHILA; FAMILY; ETHER	Mutations in the human gene encoding the neuron-specific Eag1 voltage-gated K+ channel are associated with neuro-developmental diseases, indicating an important role of Eag1 during brain development. A disease-causing Eag1 mutation is linked to decreased protein stability that involves enhanced protein degradation by the E3 ubiquitin ligase cullin 7 (CUL7). The general mechanisms governing protein homeostasis of plasma membrane- and endoplasmic reticulum (ER)-localized Eag1 K+ channels, however, remain unclear. By using yeast two-hybrid screening, we identified another E3 ubiquitin ligase, makorin ring finger protein 1 (MKRN1), as a novel binding partner primarily interacting with the carboxyl-terminal region of Eag1. MKRN1 mainly interacts with ER-localized immature core-glycosylated, as well as nascent nonglycosylated, Eag1 proteins. MKRN1 promotes polyubiquitination and ER-associated proteasomal degradation of immature Eag1 proteins. Although both CUL7 and MKRN1 contribute to ER quality control of immature core-glycosylated Eag1 proteins, MKRN1, but not CUL7, associates with and promotes degradation of nascent, nonglycosylated Eag1 proteins at the ER. In direct contrast to the role of CUL7 in regulating both ER and peripheral quality controls of Eag1, MKRN1 is exclusively responsible for the early stage of Eag1 maturation at the ER. We further demonstrated that both CUL7 and MKRN1 contribute to protein quality control of additional disease-causing Eag1 mutants associated with defective protein homeostasis. Our data suggest that the presence of this dual ubiquitination system differentially maintains Eag1 protein homeostasis and may ensure efficient removal of disease-associated misfolded Eag1 mutant channels.	[Fang, Ya-Ching; Hsu, Po-Hao; Chang, Pei-Tzu; Chiu, Yi-Chih; Liao, Yi-Fan; Jeng, Chung-Jiuan] Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei, Taiwan; [Fang, Ya-Ching; Fu, Ssu-Ju; Hsu, Po-Hao; Huang, Jing-Jia; Tang, Chih-Yung] Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei, Taiwan; [Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Jeng, Chung-Jiuan] Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; Fu Jen Catholic University; National Yang Ming Chiao Tung University	Jeng, CJ (corresponding author), Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei, Taiwan.; Tang, CY (corresponding author), Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei, Taiwan.; Jeng, CJ (corresponding author), Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan.	tang@ntu.edu.tw; cjjeng@ym.edu.tw		Jeng, Chung-Jiuan/0000-0001-6271-5704; TANG, CHIH-YUNG/0000-0003-1065-2865	Ministry of Science and Technology, Taiwan [105-2320-B-010-016-MY3, 108-2320-B-010-039-MY3]; Ministry of Education, Taiwan for The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project in Brain Research Center, National YangMing University [109BRC-B404]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan for The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project in Brain Research Center, National YangMing University	This work was supported by research grants to C. -J. J. from Ministry of Science and Technology, Taiwan (105-2320-B-010-016-MY3 and 108-2320-B-010-039MY3), and from Ministry of Education, Taiwan, for The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project in Brain Research Center, National YangMing University (109BRC-B404).	Bramswig NC, 2015, HUM GENET, V134, P1089, DOI 10.1007/s00439-015-1590-1; Cassar PA, 2015, EMBO REP, V16, P1334, DOI 10.15252/embr.201540974; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Herbert LM, 2016, AM J PHYSIOL-CELL PH, V310, pC390, DOI 10.1152/ajpcell.00091.2015; Hildebrandt A, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1814-0; Houck SA, 2012, BBA-BIOMEMBRANES, V1818, P1108, DOI 10.1016/j.bbamem.2011.11.007; Hsu PH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40825; Hutt D, 2010, SCIENCE, V329, P766, DOI 10.1126/science.1194160; Jensen CS, 2011, MOL CELL NEUROSCI, V48, P288, DOI 10.1016/j.mcn.2011.05.007; Ju M, 2002, FEBS LETT, V524, P204, DOI 10.1016/S0014-5793(02)03055-7; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Ko A, 2012, JNCI-J NATL CANCER I, V104, P1660, DOI 10.1093/jnci/djs424; Ko A, 2010, J VIROL, V84, P426, DOI 10.1128/JVI.00725-09; Kortum F, 2015, NAT GENET, V47, P661, DOI 10.1038/ng.3282; Lee EW, 2009, EMBO J, V28, P2100, DOI 10.1038/emboj.2009.164; Lee HK, 2018, ONCOGENE, V37, P4273, DOI 10.1038/s41388-018-0267-3; Lee MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05721-4; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Ludwig J, 2000, MOL CELL NEUROSCI, V16, P59, DOI 10.1006/mcne.2000.0851; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Maghsoudlou A, 2016, TRAFFIC, V17, P289, DOI 10.1111/tra.12353; Martin S, 2008, NEUROSCIENCE, V155, P833, DOI 10.1016/j.neuroscience.2008.05.019; Martin S, 2010, GENES BRAIN BEHAV, V9, P918, DOI 10.1111/j.1601-183X.2010.00632.x; Miroci H, 2012, J BIOL CHEM, V287, P1322, DOI 10.1074/jbc.M111.315291; Misonou H, 2010, NEUROSCIENTIST, V16, P51, DOI 10.1177/1073858409341085; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Omwancha J, 2006, ENDOCRINE, V29, P363, DOI 10.1385/ENDO:29:2:363; Saganich MJ, 1999, J NEUROSCI, V19, P10789, DOI 10.1523/JNEUROSCI.19-24-10789.1999; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Salvatico J, 2010, MOL CELL BIOCHEM, V342, P241, DOI 10.1007/s11010-010-0490-x; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; Shimada H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-232; Simons C, 2015, NAT GENET, V47, P73, DOI 10.1038/ng.3153; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Stengel R, 2012, J BIOL CHEM, V287, P35565, DOI 10.1074/jbc.M112.363978; Suzuki S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04258; Ufartes R, 2013, HUM MOL GENET, V22, P2247, DOI 10.1093/hmg/ddt076; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438	51	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100484	10.1016/j.jbc.2021.100484	http://dx.doi.org/10.1016/j.jbc.2021.100484			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33647316	gold, Green Published			2022-12-28	WOS:000672866400458
J	Han, YC; Zhang, JC; Huang, S; Cheng, NX; Zhang, CC; Li, YL; Wang, XN; Liu, JH; You, B; Du, J				Han, Yingchun; Zhang, Jichao; Huang, Shan; Cheng, Naixuan; Zhang, Congcong; Li, Yulin; Wang, Xiaonan; Liu, Jinghua; You, Bin; Du, Jie			MicroRNA-223-3p inhibits vascular calcification and the osteogenic switch of vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC KIDNEY-DISEASE; ARTERIAL; MIR-223; OSTEOCLASTOGENESIS; DEFICIENCY; ROLES	Vascular calcification is the ectopic deposition of calcium hydroxyapatite minerals in arterial wall, which involves the transdifferentiation of vascular smooth muscle cells (VSMCs) toward an osteogenic phenotype. However, the underlying molecular mechanisms regulating the VSMC osteogenic switch remain incompletely understood. In this study, we examined the roles of microRNAs (miRNAs) in vascular calcification. miRNA-seq transcriptome analysis identified miR-223-3p as a candidate miRNA in calcified mouse aortas. MiR-223-3p knockout aggravated calcification in both medial and atherosclerotic vascular calcification models. Further, RNA-seq transcriptome analysis verified JAK-STAT and PPAR signaling pathways were upregulated in both medial and atherosclerotic calcified aortas. Overlapping genes in these signaling pathways with predicted target genes of miR-223-3p derived from miRNA databases, we identified signal transducer and activator of transcription 3 (STAT3) as a potential target gene of miR-223-3p in vascular calcification. In vitro experiments showed that miR-223-3p blocked interleukin-6 (IL-6)/STAT3 signaling, thereby preventing the osteogenic switch and calcification of VSMCs. In contrast, overexpression of STAT3 diminished the effect of miR-223-3p. Taken together, the results indicate a protective role of miR-223-3p that inhibits both medial and atherosclerotic vascular calcification by regulating IL-6/STAT3 signaling-mediated VSMC transdifferentiation.	[Han, Yingchun; Zhang, Jichao; Huang, Shan; Cheng, Naixuan; Zhang, Congcong; Li, Yulin; Liu, Jinghua; You, Bin; Du, Jie] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Huang, Shan; Cheng, Naixuan] Capital Med Univ, Sch Basic Med Sci, Beijing, Peoples R China; [Wang, Xiaonan] Emory Univ, Dept Med, Renal Div, Atlanta, GA 30322 USA	Capital Medical University; Capital Medical University; Emory University	Du, J (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China.	jiedu@ccmu.edu.cn	Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022; li, Yu/HCI-9086-2022	HAN, YINGCHUN/0000-0002-9490-3205	National Natural Science Foundation of China [81861128025, 81790622, 8187020148, 81970291]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant no. 81861128025, 81790622 to J. D., 8187020148 to B. Y., 81970291 to J. L).	Abedin M, 2006, CIRC RES, V98, P727, DOI 10.1161/01.RES.0000216009.68958.e6; Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Bostrom KI, 2016, VASC PHARMACOL, V84, P8, DOI 10.1016/j.vph.2016.05.014; Cantoni C, 2017, ACTA NEUROPATHOL, V133, P61, DOI 10.1007/s00401-016-1621-6; Chen YB, 2020, ARTERIOSCL THROM VAS, V40, P1078, DOI 10.1161/ATVBAHA.120.313131; Cheng NX, 2020, J BIOL CHEM, V295, P10212, DOI 10.1074/jbc.RA119.012263; Clement T., 2014, BIOMED MAT ENG, V24; Dorhoi A, 2013, J CLIN INVEST, V123, P4836, DOI 10.1172/JCI67604; Du YY, 2012, ARTERIOSCL THROM VAS, V32, P2580, DOI 10.1161/ATVBAHA.112.300206; Furmanik M, 2020, CIRC RES, V127, P911, DOI 10.1161/CIRCRESAHA.119.316159; Goettsch C, 2011, AM J PATHOL, V179, P1594, DOI 10.1016/j.ajpath.2011.06.016; Gupta SK, 2020, J MOL CELL CARDIOL, V142, P14, DOI 10.1016/j.yjmcc.2020.03.015; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kramann R, 2016, CELL STEM CELL, V19, P628, DOI 10.1016/j.stem.2016.08.001; Kurozumi A, 2019, BONE, V124, P53, DOI 10.1016/j.bone.2019.04.006; Lacolley P, 2017, PHYSIOL REV, V97, P1555, DOI 10.1152/physrev.00003.2017; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Lau WL, 2012, KIDNEY INT, V82, P1261, DOI 10.1038/ki.2012.322; Li J, 2017, PHARMAZIE, V72, P680, DOI 10.1691/ph.2017.7606; Li M, 2017, GUT, V66, P705, DOI 10.1136/gutjnl-2016-311861; Liu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16099; Long HT, 2017, DNA CELL BIOL, V36, P715, DOI 10.1089/dna.2017.3657; M'Baya-Moutoula E, 2015, BBA-MOL BASIS DIS, V1852, P2202, DOI 10.1016/j.bbadis.2015.08.003; Mackenzie NCW, 2014, CELL BIOCHEM FUNCT, V32, P209, DOI 10.1002/cbf.3005; Qiao WW, 2014, CELL PHYSIOL BIOCHEM, V33, P1945, DOI 10.1159/000362971; Raaz U, 2015, CIRC RES, V117, P513, DOI 10.1161/CIRCRESAHA.115.306341; Rogers MA, 2019, NAT REV CARDIOL, V16, P261, DOI 10.1038/s41569-018-0123-8; Ruiz-Ortega M, 2020, NAT REV NEPHROL, V16, P269, DOI 10.1038/s41581-019-0248-y; Shan Z, 2015, J AM COLL CARDIOL, V65, P2526, DOI 10.1016/j.jacc.2015.03.570; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Taibi F, 2014, BBA-MOL BASIS DIS, V1842, P1001, DOI 10.1016/j.bbadis.2014.03.005; Taibi F, 2014, BBA-MOL BASIS DIS, V1842, P88, DOI 10.1016/j.bbadis.2013.10.005; Theriault S, 2019, CIRC-GENOM PRECIS ME, V12, P431, DOI 10.1161/CIRCGEN.119.002617; Ulbing M, 2017, BONE, V95, P115, DOI 10.1016/j.bone.2016.11.016; Woldt E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2087; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078769; Yuan XY, 2018, J LEUKOCYTE BIOL, V104, P515, DOI 10.1002/JLB.3MR0218-079R; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Zhang SJ, 2018, CELL PHYSIOL BIOCHEM, V47, P667, DOI 10.1159/000490021	42	11	11	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100483	10.1016/j.jbc.2021.100483	http://dx.doi.org/10.1016/j.jbc.2021.100483			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33647318	Green Published, gold			2022-12-28	WOS:000672866400457
J	Ivica, J; Lape, R; Jazbec, V; Yu, J; Zhu, HT; Gouaux, E; Gold, MG; Sivilotti, LG				Ivica, Josip; Lape, Remigijus; Jazbec, Vid; Yu, Jie; Zhu, Hongtao; Gouaux, Eric; Gold, Matthew G.; Sivilotti, Lucia G.			The intracellular domain of homomeric glycine receptors modulates agonist efficacy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; X-RAY-STRUCTURE; SINGLE-CHANNEL CONDUCTANCE; GATED ION CHANNELS; PROTEIN-KINASE; CHARGED RESIDUES; STRUCTURAL BASIS; M3-M4 LOOP; SUBUNIT; MECHANISM	Like other pentameric ligand-gated channels, glycine receptors (GlyRs) contain long intracellular domains (ICDs) between transmembrane helices 3 and 4. Structurally characterized GlyRs are generally engineered to have a very short ICD. We show here that for one such construct, zebrafish GlyR(EM), the agonists glycine, beta-alanine, taurine, and GABA have high efficacy and produce maximum single-channel open probabilities greater than 0.9. In contrast, for full-length human alpha 1 GlyR, taurine and GABA were clearly partial agonists, with maximum open probabilities of 0.46 and 0.09, respectively. We found that the elevated open probabilities in GlyR(EM) are not due to the limited sequence differences between the human and zebrafish orthologs, but rather to replacement of the native ICD with a short tripeptide ICD. Consistent with this interpretation, shortening the ICD in the human GlyR increased the maximum open probability produced by taurine and GABA to 0.90 and 0.70, respectively, but further engineering it to resemble GlyR(EM) (by introducing the zebrafish transmembrane helix 4 and C terminus) had no effect. Furthermore, reinstating the native ICD to GlyR(EM) converted taurine and GABA to partial agonists, with maximum open probabilities of 0.66 and 0.40, respectively. Structural comparison of transmembrane helices 3 and 4 in short- and long-ICD GlyR subunits revealed that ICD shortening does not distort the orientation of these helices within each subunit. This suggests that the effects of shortening the ICD stem from removing a modulatory effect of the native ICD on GlyR gating, revealing a new role for the ICD in pentameric ligand-gated channels.	[Ivica, Josip; Lape, Remigijus; Gold, Matthew G.; Sivilotti, Lucia G.] UCL, Dept Neurosci Physiol & Pharmacol, Div Biosci, London WC1E 6BT, England; [Jazbec, Vid] Natl Inst Chem, Dept Synthet Biol & Immunol, Hajdrihova 19, Ljubljana 1000, Slovenia; [Yu, Jie; Zhu, Hongtao] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	University of London; University College London; National Institute of Chemistry - Slovenia; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Sivilotti, LG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Div Biosci, London WC1E 6BT, England.	l.sivilotti@ucl.ac.uk	Gold, Matthew/AAL-2546-2021	Gold, Matthew/0000-0002-1281-0815; Ivica, Josip/0000-0001-7943-604X	Medical Research Council [MR/R009074/1]; Wellcome Trust; Royal Society [104194/Z/14/A]; Biotechnology and Biological Sciences Research Council [BB/N015274/1]; NIH [R01 GM100400]; BBSRC [BB/N015274/1] Funding Source: UKRI; MRC [MR/R009074/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council project Grant MR/R009074/1 (to L. G. S.), a Wellcome Trust and Royal Society Sir Henry Dale fellowship 104194/Z/14/A and Biotechnology and Biological Sciences Research Council Grant BB/N015274/1 (to M. G. G.) and NIH grant R01 GM100400 (to E.G.). E.G. is an investigator of the Howard Hughes Medical Institute.	Baptista-Hon DT, 2013, J BIOL CHEM, V288, P21558, DOI 10.1074/jbc.M113.481689; Basak S, 2018, NATURE, V563, P270, DOI 10.1038/s41586-018-0660-7; Basak S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02997-4; Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Breitinger U, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00154; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; Chen XB, 2009, MOL MEMBR BIOL, V26, P321, DOI 10.1080/09687680903120319; David-Watine B, 1999, NEUROSCIENCE, V90, P303, DOI 10.1016/S0306-4522(98)00430-8; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Ferraro NA, 2018, ANAL CHEM, V90, P2508, DOI 10.1021/acs.analchem.7b03639; Fucile S, 1999, J PHYSIOL-LONDON, V517, P369, DOI 10.1111/j.1469-7793.1999.0369t.x; Gentet LJ, 2002, J PHYSIOL-LONDON, V544, P97, DOI 10.1113/jphysiol.2001.015321; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Han L, 2013, ACS CHEM NEUROSCI, V4, P1361, DOI 10.1021/cn400097j; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Huang X, 2017, NAT STRUCT MOL BIOL, V24, P108, DOI 10.1038/nsmb.3329; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Langlhofer G, 2017, J NEUROCHEM, V142, P41, DOI 10.1111/jnc.14049; Langlhofer G, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00041; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lara CO, 2019, ACS CHEM NEUROSCI, V10, P2551, DOI 10.1021/acschemneuro.9b00050; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Masiulis S, 2019, NATURE, V565, P454, DOI 10.1038/s41586-018-0832-5; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Moraga-Cid G, 2011, ANESTHESIOLOGY, V115, P464, DOI 10.1097/ALN.0b013e31822550f7; Moroni M, 2011, J NEUROSCI, V31, P14095, DOI 10.1523/JNEUROSCI.1985-11.2011; Nabekura J, 1996, J NEUROPHYSIOL, V76, P2447, DOI 10.1152/jn.1996.76.4.2447; Pandhare A, 2019, J GEN PHYSIOL, V151, P1135, DOI 10.1085/jgp.201912421; Pandhare A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23921; Papke D, 2014, J NEUROSCI, V34, P7238, DOI 10.1523/JNEUROSCI.5105-13.2014; Pless SA, 2018, CURR OPIN PHYSIOL, V2, P19, DOI 10.1016/j.cophys.2017.12.012; Polovinkin L, 2018, NATURE, V563, P275, DOI 10.1038/s41586-018-0672-3; RUIZGOMEZ A, 1991, J BIOL CHEM, V266, P559; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; SCHONROCK B, 1995, NEUROREPORT, V6, P301, DOI 10.1097/00001756-199501000-00019; SONG Y, 1990, NATURE, V348, P242, DOI 10.1038/348242a0; Tapia JC, 1997, BRAIN RES, V769, P203, DOI 10.1016/S0006-8993(97)00672-0; UCHIYAMA M, 1994, MOL BRAIN RES, V24, P295, DOI 10.1016/0169-328X(94)90142-2; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2000, PHILOS T R SOC B, V355, P1813, DOI 10.1098/rstb.2000.0737; Unwin N, 2013, Q REV BIOPHYS, V46, P283, DOI 10.1017/S0033583513000061; Williams BM, 1998, NAT NEUROSCI, V1, P557, DOI 10.1038/2792; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yu J, 2021, CELL, V184, P957, DOI 10.1016/j.cell.2021.01.026	59	12	11	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100387	10.1074/jbc.RA119.012358	http://dx.doi.org/10.1074/jbc.RA119.012358			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33617876	Green Published, gold			2022-12-28	WOS:000672866400361
J	Johnson, JE; Olson, AJ				Johnson, John E.; Olson, Arthur J.			Icosahedral virus structures and the protein data bank	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BUSHY STUNT VIRUS; 3-DIMENSIONAL STRUCTURE; ATOMIC-STRUCTURE; CRYOELECTRON-MICROSCOPY; RELATIONAL DATABASE; CRYSTAL-STRUCTURE; INSECT VIRUS; CRYO-EM; MATURATION; POLIOVIRUS	The structural study of icosahedral viruses has a long and impactful history in both crystallographic methodology and molecular biology. The evolution of the Protein Data Bank has paralleled and supported these studies providing readily accessible formats dealing with novel features associated with viral particle symmetries and subunit interactions. This overview describes the growth in size and complexity of icosahedral viruses from the first early studies of small RNA plant viruses and human picornaviruses up to the larger and more complex bacterial phage, insect, and human disease viruses such as Zika, hepatitis B, Adeno and Polyoma virus. The analysis of icosahedral viral capsid protein domain folds has shown striking similarities, with the beta jelly roll motif observed across multiple evolutionarily divergent species. The icosahedral symmetry of viruses drove the development of noncrystallographic symmetry averaging as a powerful phasing method, and the constraints of maintaining this symmetry resulted in the concept of quasi-equivalence in viral structures. Symmetry also played an important early role in demonstrating the power of cryo-electron microscopy as an alternative to crystallography in generating atomic resolution structures of these viruses. The Protein Data Bank has been a critical resource for assembling and disseminating these structures to a wide community, and the virus particle explorer (VIPER) was developed to enable users to easily generate and view complete viral capsid structures from their asymmetric building blocks. Finally, we share a personal perspective on the early use of computer graphics to communicate the intricacies, interactions, and beauty of these virus structures.	[Johnson, John E.; Olson, Arthur J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Johnson, JE (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	jackj@scripps.edu	Johnson, Johnson/HDL-9124-2022	Johnson, John/0000-0001-9782-3721	US National Institutes of Health [GM120604, AI150472]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A. J. O. is supported by grants GM120604 and AI150472 from the US National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABADZAPATERO C, 1980, NATURE, V286, P33, DOI 10.1038/286033a0; Abrescia NGA, 2008, MOL CELL, V31, P749, DOI 10.1016/j.molcel.2008.06.026; Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; Baker ML, 2013, P NATL ACAD SCI USA, V110, P12301, DOI 10.1073/pnas.1309947110; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Bernal JD, 1938, NATURE, V142, P1075, DOI 10.1038/1421075a0; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; CASPAR DLD, 1956, NATURE, V177, P476, DOI 10.1038/177475a0; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chandrasekar V, 1998, STRUCTURE, V6, P157, DOI 10.1016/S0969-2126(98)00018-5; Chapman MS, 2003, ADV PROTEIN CHEM, V64, P125; CHEN ZG, 1989, SCIENCE, V245, P154, DOI 10.1126/science.2749253; CHOW M, 1985, P NATL ACAD SCI USA, V82, P910, DOI 10.1073/pnas.82.3.910; CRICK FHC, 1956, NATURE, V177, P473, DOI 10.1038/177473a0; Dai XH, 2017, J VIROL, V91, DOI 10.1128/JVI.00850-17; de Silva AM, 2018, ADV EXP MED BIOL, V1062, P107, DOI 10.1007/978-981-10-8727-1_8; Dokland T, 1997, NATURE, V389, P308, DOI 10.1038/38537; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Gan L, 2006, STRUCTURE, V14, P1655, DOI 10.1016/j.str.2006.09.006; Gertsman I, 2009, NATURE, V458, P646, DOI 10.1038/nature07686; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Guo F, 2014, P NATL ACAD SCI USA, V111, pE4606, DOI 10.1073/pnas.1407020111; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; Harrison SC, 2010, SCIENCE, V329, P1026, DOI 10.1126/science.1194922; He YN, 2000, P NATL ACAD SCI USA, V97, P79, DOI 10.1073/pnas.97.1.79; Hendrix RW, 2012, ADV EXP MED BIOL, V726, P351, DOI 10.1007/978-1-4614-0980-9_15; Hewat EA, 1997, EMBO J, V16, P1492, DOI 10.1093/emboj/16.7.1492; Ho PT, 2018, ANNU REV VIROL, V5, P477, DOI 10.1146/annurev-virology-092917-043405; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; HOSUR MV, 1987, PROTEINS, V2, P167, DOI 10.1002/prot.340020302; Johnson C. K., 1965, FORTRAN THERMAL ELLP, V3794; Johnson JE, 2013, MICROSCOPY-JPN, V62, P69, DOI 10.1093/jmicro/dfs097; KAESBERG P, 1990, J MOL BIOL, V214, P423, DOI 10.1016/0022-2836(90)90191-N; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lawson CL, 2008, ACTA CRYSTALLOGR D, V64, P874, DOI 10.1107/S0907444908017393; Lerch TF, 2012, STRUCTURE, V20, P1310, DOI 10.1016/j.str.2012.05.004; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; LUO M, 1987, SCIENCE, V235, P182, DOI 10.1126/science.3026048; Max N. L., 1983, COMPUTER GRAPHICS DI; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; MCKINLAY MA, 1989, ANNU REV PHARMACOL, V29, P111, DOI 10.1146/annurev.pa.29.040189.000551; Milazzo AC, 2005, ULTRAMICROSCOPY, V104, P152, DOI 10.1016/j.ultramic.2005.03.006; Morais MC, 2001, J STRUCT BIOL, V135, P38, DOI 10.1006/jsbi.2001.4379; Natchiar SK, 2018, J MOL BIOL, V430, P4132, DOI 10.1016/j.jmb.2018.08.011; O'Donnell T. J., 1981, Computer Graphics, V15, P133, DOI 10.1145/965161.806799; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; Reddy V. S., 2004, CONFORMATIONAL PROTE, P403; Reddy VS, 2010, SCIENCE, V329, P1071, DOI 10.1126/science.1187292; Reddy VS, 2001, J VIROL, V75, P11943, DOI 10.1128/JVI.75.24.11943-11947.2001; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; RICHARDS FM, 1968, J MOL BIOL, V37, P225, DOI 10.1016/0022-2836(68)90085-5; ROSSMANN M G, 1989, Viral Immunology, V2, P143, DOI 10.1089/vim.1989.2.143; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; San Martin C, 2002, NAT STRUCT BIOL, V9, P756, DOI 10.1038/nsb837; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schlicksup CJ, 2020, CURR OPIN VIROL, V45, P43, DOI 10.1016/j.coviro.2020.07.001; Shepherd CM, 2006, NUCLEIC ACIDS RES, V34, pD386, DOI 10.1093/nar/gkj032; SHERRY B, 1986, J VIROL, V57, P246, DOI 10.1128/JVI.57.1.246-257.1986; SMITH TJ, 1986, SCIENCE, V233, P1286, DOI 10.1126/science.3018924; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; Tan YZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06076-6; Tate J, 1999, NAT STRUCT BIOL, V6, P765, DOI 10.1038/11543; TSAO J, 1991, SCIENCE, V251, P1456, DOI 10.1126/science.2006420; VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0; Veesler D, 2013, P NATL ACAD SCI USA, V110, P5504, DOI 10.1073/pnas.1300601110; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; WERY JP, 1994, J MOL BIOL, V235, P565, DOI 10.1006/jmbi.1994.1014; Wikoff WR, 2006, J STRUCT BIOL, V153, P300, DOI 10.1016/j.jsb.2005.11.009; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; WINKLER FK, 1977, NATURE, V265, P509, DOI 10.1038/265509a0; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang W, 2002, J VIROL, V76, P11645, DOI 10.1128/JVI.76.22.11645-11658.2002	77	8	8	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100554	10.1016/j.jbc.2021.100554	http://dx.doi.org/10.1016/j.jbc.2021.100554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744290	gold, Green Published			2022-12-28	WOS:000672866400527
J	Nogami, M; Miyamoto, K; Hayakawa-Yano, Y; Nakanishi, A; Yano, M; Okano, H				Nogami, Masahiro; Miyamoto, Kazumasa; Hayakawa-Yano, Yoshika; Nakanishi, Atsushi; Yano, Masato; Okano, Hideyuki			DGCR8-dependent efficient pri-miRNA processing of human pri-miR-9-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY TRANSCRIPTS; PRIMARY MICRORNAS; MOUSE MODEL; SCHIZOPHRENIA; BIOGENESIS; NEUROGENESIS; ENVIRONMENT; EXPRESSION; MATURATION; DEFICITS	Microprocessor complex, including DiGeorge syndrome critical region gene 8 (DGCR8) and DROSHA, recognizes and cleaves primary transcripts of microRNAs (pri-miRNAs) in the maturation of canonical miRNAs. The study of DGCR8 haploinsufficiency reveals that the efficiency of this activity varies for different miRNA species. It is thought that this variation might be associated with the risk of schizophrenia with 22q11 deletion syndrome caused by disruption of the DGCR8 gene. However, the underlying mechanism for varying action of DGCR8 with each miRNA remains largely unknown. Here, we used in vivo monitoring to measure the efficiency of DGCR8-dependent microprocessor activity in cultured cells. We confirmed that this system recapitulates the microprocessor activity of endogenous pri-miRNA with expression of a ratio-metric fluorescence reporter. Using this system, we detected mir-9-2 as one of the most efficient targets. We also identified a novel DGCR8-responsive RNA element, which is highly conserved among mammalian species and could be regulated at the epi-transcriptome (RNA modification) level. This unique feature between DGCR8 and pri-miR-9-2 processing may suggest a link to the risk of schizophrenia.	[Nogami, Masahiro] Takeda Pharmaceut Co Ltd, Innovat Biol Labs, Neurosci Drug Discovery Unit, Res, Fujisawa, Kanagawa, Japan; [Nogami, Masahiro; Nakanishi, Atsushi] Takeda Pharmaceut Co Ltd, Shonan Incubat Labs, Fujisawa, Kanagawa, Japan; [Miyamoto, Kazumasa] Takeda Pharmaceut Co Ltd, Drug Safety Res Labs, Fujisawa, Kanagawa, Japan; [Hayakawa-Yano, Yoshika; Yano, Masato] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Nakanishi, Atsushi] Takeda Pharmaceut Co Ltd, Regenerat Med Unit, Fujisawa, Kanagawa, Japan; [Yano, Masato; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Niigata University; Takeda Pharmaceutical Company Ltd; Keio University	Nogami, M (corresponding author), Takeda Pharmaceut Co Ltd, Innovat Biol Labs, Neurosci Drug Discovery Unit, Res, Fujisawa, Kanagawa, Japan.; Nogami, M (corresponding author), Takeda Pharmaceut Co Ltd, Shonan Incubat Labs, Fujisawa, Kanagawa, Japan.; Yano, M (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan.; Yano, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo, Japan.	masahiro.nogami@takeda.com; myano@med.niigata-u.ac.jp		Nogami, Masahiro/0000-0002-7027-4766; Yano, Masato/0000-0003-0589-478X	SIL Research Fund from Takeda Pharmaceutical Company, Ltd, Japan; MEXT [JP17H05598, JP19H03543, JP20H00485]; Takeda Science Foundation, Japan; U-go grant at Niigata University, Japan; Serika Fund; Takeda COCKPI-T fund	SIL Research Fund from Takeda Pharmaceutical Company, Ltd, Japan; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation, Japan(Takeda Science Foundation (TSF)); U-go grant at Niigata University, Japan; Serika Fund; Takeda COCKPI-T fund	This work was supported by grants from the SIL Research Fund from Takeda Pharmaceutical Company, Ltd, Japan, and the MEXT Grant-in-Aid, Japan (grant no. JP20H00485) (to M. Y. and H. O.), the MEXT Grant-in-Aid, Japan (grant no. JP17H05598 and JP19H03543), the Takeda Science Foundation, Japan, U-go grant at Niigata University, Japan, the Serika Fund, and Takeda COCKPI-T fund (to M. Y.).	Abernathy DG, 2017, CELL STEM CELL, V21, P332, DOI 10.1016/j.stem.2017.08.002; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Ambros V, 2011, CURR OPIN GENET DEV, V21, P511, DOI 10.1016/j.gde.2011.04.003; Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bertolin AP, 2016, NUCLEIC ACIDS RES, V44, P7555, DOI 10.1093/nar/gkw372; Blahna MT, 2013, CURR OPIN CELL BIOL, V25, P233, DOI 10.1016/j.ceb.2012.12.005; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Cheng Y, 2018, NAT NEUROSCI, V21, P1689, DOI 10.1038/s41593-018-0261-7; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Davila JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094348; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Faller M, 2010, RNA, V16, P1570, DOI 10.1261/rna.2111310; Fenelon K, 2013, J NEUROSCI, V33, P14825, DOI 10.1523/JNEUROSCI.1611-13.2013; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hauberg ME, 2016, JAMA PSYCHIAT, V73, P369, DOI 10.1001/jamapsychiatry.2015.3018; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Ouchi Y, 2013, J NEUROSCI, V33, P9408, DOI 10.1523/JNEUROSCI.2700-12.2013; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Sakamoto K, 2018, AM J MED GENET B, V177, P242, DOI 10.1002/ajmg.b.32554; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Toyoshima M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.206; Weitz SH, 2014, P NATL ACAD SCI USA, V111, P1861, DOI 10.1073/pnas.1309915111; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019	47	4	4	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100409	10.1016/j.jbc.2021.100409	http://dx.doi.org/10.1016/j.jbc.2021.100409			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581109	Green Published, gold			2022-12-28	WOS:000672866400383
J	Scheffler, RJ; Sugimoto, Y; Bratton, BP; Ellison, CK; Koch, MD; Donia, MS; Gitai, Z				Scheffler, Robert J.; Sugimoto, Yuki; Bratton, Benjamin P.; Ellison, Courtney K.; Koch, Matthias D.; Donia, Mohamed S.; Gitai, Zemer			Pseudomonas aeruginosa detachment from surfaces via a self-made small molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOFILM RESISTANCE; MECHANISMS; MICROSCOPY; DISPERSION; MOTILITY; IMAGE	Pseudomonas aeruginosa is a significant threat in both healthcare and industrial biofouling. Surface attachment of P. aeruginosa is particularly problematic as surface association induces virulence and is necessary for the ensuing process of biofilm formation, which hampers antibiotic treatments. Previous efforts have searched for dispersal agents of mature biofilm collectives, but there are no known factors that specifically disperse individual surface-attached P. aeruginosa. In this study, we develop a quantitative single-cell surface-dispersal assay and use it to show that P. aeruginosa itself produces factors that can stimulate its dispersal. Through bioactivity-guided fractionation, mass spectrometry, and nuclear magnetic resonance, we elucidated the structure of one such factor, 2-methyl-4-hydroxyquinoline (MHQ). MHQ is an alkyl quinolone with a previously unknown activity and is synthesized by the PqsABC enzymes. Pure MHQ is sufficient to disperse P. aeruginosa, but the dispersal activity of natural P. aeruginosa conditioned media requires additional factors. Whereas other alkyl quinolones have been shown to act as antibiotics or membrane depolarizers, MHQ lacks these activities and known antibiotics do not induce dispersal. In contrast, we show that MHQ inhibits the activity of Type IV Pili (TFP) and that TFP targeting can explain its dispersal activity. Our work thus identifies single-cell surface dispersal as a new activity of P. aeruginosa-produced small molecules, characterizes MHQ as a promising dispersal agent, and establishes TFP inhibition as a viable mechanism for P. aeruginosa dispersal.	[Scheffler, Robert J.; Sugimoto, Yuki; Bratton, Benjamin P.; Ellison, Courtney K.; Koch, Matthias D.; Donia, Mohamed S.; Gitai, Zemer] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Bratton, Benjamin P.; Ellison, Courtney K.; Koch, Matthias D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University	Gitai, Z (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	zgitai@princeton.edu		Donia, Mohamed/0000-0002-9604-2912; Scheffler, Robert/0000-0002-8213-2626; Ellison, Courtney/0000-0003-3259-079X; Bratton, Benjamin/0000-0003-1128-2560; Koch, Matthias/0000-0003-4408-9900	National Institutes of Health [DP1AI124669, T32 GM007388, DP2AI124441]; National Science Foundation [NSF PHY-1734030]; Damon Runyon Cancer Research Foundation [DRG 2385-20]; German Research Foundation [DFG KO5239/1-1]; National Cancer Institute [NCI-CCSG P30CA072720-5921]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Damon Runyon Cancer Research Foundation; German Research Foundation(German Research Foundation (DFG)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided in part by National Institutes of Health (DP1AI124669: Z. G., B. P. B., and R. J. S.; T32 GM007388: R. J. S., and DP2AI124441: M. S. D.). Additional funding provided by the National Science Foundation (NSF PHY-1734030: B. P. B., M. D. K, and C. K. E.), Damon Runyon Cancer Research Foundation (DRG 2385-20: C. K. E.), the German Research Foundation (DFG KO5239/1-1: M. D. K), and for the FCRF by the National Cancer Institute (NCI-CCSG P30CA072720-5921). The opinions, findings, and conclusions or recommendations expressed in this material contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Aubey F, 2019, P NATL ACAD SCI USA, V116, P8481, DOI 10.1073/pnas.1817757116; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Chuang SK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12153-1; Conrad JC, 2011, BIOPHYS J, V100, P1608, DOI 10.1016/j.bpj.2011.02.020; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; de Anda J, 2017, ACS NANO, V11, P9340, DOI 10.1021/acsnano.7b04738; Denis K, 2019, NAT MICROBIOL, V4, P972, DOI 10.1038/s41564-019-0395-8; Drees SL, 2015, CHEM BIOL, V22, P611, DOI 10.1016/j.chembiol.2015.04.012; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI 10.1039/b803796p; Edelstein A. D., 2014, J BIOL METHODS, V1; Ellison CK, 2019, NAT PROTOC, V14, P1803, DOI 10.1038/s41596-019-0162-6; Ellison CK, 2017, SCIENCE, V358, P535, DOI 10.1126/science.aan5706; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; Hall S, 2016, TOXINS, V8, DOI 10.3390/toxins8080236; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Huang W, 2018, NUCLEIC ACIDS RES, V46, pD575, DOI 10.1093/nar/gkx1061; Kaletsky R, 2020, NATURE, V586, P445, DOI 10.1038/s41586-020-2699-5; Kang OY, 2019, ORG CHEM FRONT, V6, P183, DOI 10.1039/c8qo00884a; Koch M. D., 2020, COMPETITIVE BINDING, DOI [10.1101/2020.02.12.946426, DOI 10.1101/2020.02.12.946426]; Lee CK, 2020, MBIO, V11, DOI 10.1128/mBio.02644-19; Lee CK, 2018, P NATL ACAD SCI USA, V115, P4471, DOI 10.1073/pnas.1720071115; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Leiman SA, 2013, J BACTERIOL, V195, P5391, DOI 10.1128/JB.00975-13; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lin JS, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00230; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Martin JK, 2020, CELL, V181, P1518, DOI 10.1016/j.cell.2020.05.005; MORIHARA K, 1965, J BIOL CHEM, V240, P3295; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; Novo D, 1999, CYTOMETRY, V35, P55, DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Petrova OE, 2012, P NATL ACAD SCI USA, V109, P16690, DOI 10.1073/pnas.1207832109; Royt PW, 2007, BIOORG CHEM, V35, P175, DOI 10.1016/j.bioorg.2006.10.004; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siryaporn A, 2014, P NATL ACAD SCI USA, V111, P16860, DOI 10.1073/pnas.1415712111; Soberon-Chavez G, 2005, APPL MICROBIOL BIOT, V68, P718, DOI 10.1007/s00253-005-0150-3; SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125	45	4	4	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100279	10.1016/j.jbc.2021.100279	http://dx.doi.org/10.1016/j.jbc.2021.100279			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450229	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400255
J	Shinoda, Y; Haga, Y; Akagawa, K; Fukunaga, K				Shinoda, Yasuharu; Haga, Yudai; Akagawa, Koichiro; Fukunaga, Kohji			Wildtype sigma 1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						&#963; receptor; protein aggregation; oligomerization; cell death; subcellular fractionation; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); fluorescence recovery after photobleaching (FRAP)	ENDOPLASMIC-RETICULUM; DETERGENT INSOLUBILITY; ALKALINE-PHOSPHATASE; SQSTM1 MUTATIONS; MOTOR NEUROPATHY; BINDING-SITES; ER STRESS; PROTEIN; GENE; JUVENILE	Genetic mutations related to ALS, a progressive neurological disease, have been discovered in the gene encoding sigma-1 receptor (sigma 1R). We previously reported that sigma 1RE102Q elicits toxicity in cells. The sigma 1R forms oligomeric states that are regulated by ligands. Nevertheless, little is known about the effect of ALS-related mutations on oligomer formation. Here, we transfected NSC-34 cells, a motor neuronal cell line, and HEK293T cells with sigma 1R-mCherry (mCh), sigma 1RE102Q-mCh, or nontagged forms to investigate detergent solubility and subcellular distribution using immunocytochemistry and fluorescence recovery after photobleaching. The oligomeric state was determined using crosslinking procedure. sigma 1Rs were soluble to detergents, whereas the mutants accumulated in the insoluble fraction. Within the soluble fraction, peak distribution of mutants appeared in higher sucrose density fractions. Mutants formed intracellular aggregates that were co-stained with p62, ubiquitin, and phosphorylated pancreatic eukaryotic translation initiation factor-2-alpha kinase in NSC-34 cells but not in HEK293T cells. The aggregates had significantly lower recovery in fluorescence recovery after photobleaching. Acute treatment with sigma 1R agonist SA4503 failed to improve recovery, whereas prolonged treatment for 48 h significantly decreased sigma 1RE102Q-mCh insolubility and inhibited apoptosis. Whereas sigma 1R-mCh formed monomers and dimers, sigma 1RE102Q-mCh also formed trimers and tetramers. SA4503 reduced accumulation of the four types in the insoluble fraction and increased monomers in the soluble fraction. The sigma 1RE102Q insolubility was diminished by sigma 1R-mCh co-expression. These results suggest that the agonist and WT sigma 1R modify the detergent insolubility, toxicity, and oligomeric state of sigma 1RE102Q, which may lead to promising new treatments for sigma 1R-related ALS.	[Shinoda, Yasuharu; Haga, Yudai; Akagawa, Koichiro; Fukunaga, Kohji] Tohoku Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan	Tohoku University	Fukunaga, K (corresponding author), Tohoku Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan.	koji.fukunaga.c1@tohoku.ac.jp	Shinoda, Yasuharu/AAE-6135-2019; Fukunaga, Kohji/AAI-8811-2021	Shinoda, Yasuharu/0000-0001-9910-048X; 	JSPS [20K16128]; Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED [JP19dm0107071, JP20dm0107071]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was partly supported by JSPS Grant-in-Aid for Early-Career Scientists Grant number 20K16128 (Y. S.) and by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED (JP19dm0107071 and JP20dm0107071) (K. F.).	Abramyan AM, 2020, COMPUT STRUCT BIOTEC, V18, P199, DOI 10.1016/j.csbj.2019.12.012; Al-Chalabi A, 1998, HUM MOL GENET, V7, P2045, DOI 10.1093/hmg/7.13.2045; Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Almendra Luciano, 2018, Acta Myol, V37, P2; Bhuiyan MS, 2011, EUR J PHARMACOL, V650, P621, DOI 10.1016/j.ejphar.2010.10.055; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; CERNEUS DP, 1993, J BIOL CHEM, V268, P3150; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Chu UB, 2016, MOL PHARMACOL, V89, P142, DOI 10.1124/mol.115.101170; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dreser A, 2017, CELL DEATH DIFFER, V24, P1655, DOI 10.1038/cdd.2017.88; Fahed AC, 2014, ANN NEUROL, V75, P793, DOI 10.1002/ana.24164; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Fujimura K, 1997, BIOORGAN MED CHEM, V5, P1675, DOI 10.1016/S0968-0896(97)00093-X; Gomez-Soler M, 2014, J MED CHEM, V57, P238, DOI 10.1021/jm401529t; Gregianin E, 2016, HUM MOL GENET, V25, P3741, DOI 10.1093/hmg/ddw220; Gromek KA, 2014, J BIOL CHEM, V289, P20333, DOI 10.1074/jbc.M113.537993; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2011, HISTOCHEM CELL BIOL, V135, P627, DOI 10.1007/s00418-011-0811-5; Hayashi T, 2010, MOL PHARMACOL, V77, P517, DOI 10.1124/mol.109.062539; Hirano M, 2013, NEUROLOGY, V80, P458, DOI 10.1212/WNL.0b013e31827f0fe5; Hong WC, 2020, J PHARMACOL EXP THER, V373, P290, DOI 10.1124/jpet.119.262790; Horga A, 2016, NEUROLOGY, V87, P1607, DOI 10.1212/WNL.0000000000003212; Izumi Y, 2018, GERIATR GERONTOL INT, V18, P1519, DOI 10.1111/ggi.13506; Kubota H, 2011, METHODS, V53, P267, DOI 10.1016/j.ymeth.2010.12.035; Le Ber I, 2013, JAMA NEUROL, V70, P1403, DOI 10.1001/jamaneurol.2013.3849; Li XB, 2015, NEUROLOGY, V84, P2430, DOI 10.1212/WNL.0000000000001680; Marriott KSC, 2012, J PHARMACOL EXP THER, V343, P578, DOI 10.1124/jpet.112.198168; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Mavylutov T, 2018, PROTEIN CELL, V9, P733, DOI 10.1007/s13238-017-0468-5; MICKELSON MM, 1985, RES COMMUN CHEM PATH, V47, P255; Mishra AK, 2015, BIOCHEM J, V466, P263, DOI 10.1042/BJ20141321; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076941; Nandhagopal R, 2018, EUR J NEUROL, V25, P395, DOI 10.1111/ene.13519; Nango H, 2017, J PHARMACOL SCI, V135, P64, DOI 10.1016/j.jphs.2017.09.001; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Prause J, 2013, HUM MOL GENET, V22, P1581, DOI 10.1093/hmg/ddt008; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ramakrishnan NK, 2014, PSYCHOPHARMACOLOGY, V231, P3997, DOI 10.1007/s00213-014-3533-2; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schmidt HR, 2019, TRENDS PHARMACOL SCI, V40, P636, DOI 10.1016/j.tips.2019.07.006; Schmidt HR, 2016, NATURE, V532, P527, DOI 10.1038/nature17391; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shioda N, 2019, J NEUROSCI, V39, P7551, DOI 10.1523/JNEUROSCI.0079-19.2019; Shioda N, 2012, J BIOL CHEM, V287, P23318, DOI 10.1074/jbc.M112.349142; Singh NP, 2000, EXP CELL RES, V256, P328, DOI 10.1006/excr.2000.4810; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Su TP, 2016, TRENDS PHARMACOL SCI, V37, P262, DOI 10.1016/j.tips.2016.01.003; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Tagashira H, 2014, BBA-GEN SUBJECTS, V1840, P3320, DOI 10.1016/j.bbagen.2014.08.012; Tagashira H, 2013, BBA-GEN SUBJECTS, V1830, P3082, DOI 10.1016/j.bbagen.2012.12.029; TAM SW, 1984, P NATL ACAD SCI-BIOL, V81, P5618, DOI 10.1073/pnas.81.17.5618; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Van Den Bosch L, 1999, LIFE SCI, V65, P1597, DOI 10.1016/S0024-3205(99)00405-1; Ververis A, 2020, J MED GENET, V57, P178, DOI 10.1136/jmedgenet-2019-106108; Watanabe S, 2016, EMBO MOL MED, V8, P1421, DOI 10.15252/emmm.201606403; Wong AYC, 2016, MOL PHARMACOL, V90, P238, DOI 10.1124/mol.116.104018; Yano H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01356; Yano H, 2018, NEUROPHARMACOLOGY, V133, P264, DOI 10.1016/j.neuropharm.2018.01.042; Yu Z., 2013, BIO-PROTOCOL, V3, pe754, DOI [10.21769/BioProtoc.754, DOI 10.21769/BIOPROTOC.754, 10.7314/APJCP.2014.15.3.1465]	68	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17573	17587		10.1074/jbc.RA120.015012	http://dx.doi.org/10.1074/jbc.RA120.015012			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453999	hybrid, Green Published			2022-12-28	WOS:000603272300015
J	Dizhoor, AM; Olshevskaya, EV; Peshenko, IV				Dizhoor, Alexander M.; Olshevskaya, Elena, V; Peshenko, Igor, V			Retinal degeneration-3 protein promotes photoreceptor survival by suppressing activation of guanylyl cyclase rather than accelerating GMP recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RD3 PROTEIN; ROD; CALCIUM; BINDING; GCAPS; PHOTOTRANSDUCTION; SENSITIVITY; CLONING; RETGC; EXPRESSION	Retinal degeneration-3 protein (RD3) deficiency causes photoreceptor dysfunction and rapid degeneration in the rd3 mouse strain and in human Leber's congenital amaurosis, a congenital retinal dystrophy that results in early vision loss. However, the mechanisms responsible for photoreceptor death remain unclear. Here, we tested two hypothesized biochemical events that may underlie photoreceptor death: (i) the failure to prevent aberrant activation of retinal guanylyl cyclase (RetGC) by calcium-sensor proteins (GCAPs) versus (ii) the reduction of GMP phosphorylation rate, preventing its recycling to GDP/GTP. We found that GMP converts to GDP/GTP in the photoreceptor fraction of the retina similar to 24-fold faster in WT mice and similar to 400-fold faster in rd3 mice than GTP conversion to cGMP by RetGC. Adding purified RD3 to the retinal extracts inhibited RetGC 4-fold but did not affect GMP phosphorylation in wildtype or rd3 retinas. RD3-deficient photoreceptors rapidly degenerated in rd3 mice that were reared in constant darkness to prevent light-activated GTP consumption via RetGC and phosphodiesterase 6. In contrast, rd3 degeneration was alleviated by deletion of GCAPs. After 2.5 months, only similar to 40% of photoreceptors remained in rd3/rd3 retinas. Deletion of GCAP1 or GCAP2 alone preserved 68% and 57% of photoreceptors, respectively, whereas deletion of GCAP1 and GCAP2 together preserved 86%. Taken together, our in vitro and in vivo results support the hypothesis that RD3 prevents photoreceptor death primarily by suppressing activation of RetGC by both GCAP1 and GCAP2 but do not support the hypothesis that RD3 plays a significant role in GMP recycling.	[Dizhoor, Alexander M.; Olshevskaya, Elena, V; Peshenko, Igor, V] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA		Dizhoor, AM; Peshenko, IV (corresponding author), Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA.	dizhoor@salus.edu; ipenshenko@salus.edu			National Institutes of Health from NEI [EY11522]; Pennsylvania Department of Health	National Institutes of Health from NEI; Pennsylvania Department of Health	We thank Dr Nikolai Artemyev for a generous gift of purified PDE6. This work was supported by National Institutes of Health grant EY11522 from NEI and by a CURE Formula grant from Pennsylvania Department of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Berg J. M., 2015, BIOCHEMISTRY-US, V8th; BERGER SJ, 1980, J BIOL CHEM, V255, P3128; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Dizhoor AM, 2019, J BIOL CHEM, V294, P13729, DOI 10.1074/jbc.RA119.009948; Dizhoor AM, 2016, J BIOL CHEM, V291, P24504, DOI 10.1074/jbc.M116.755553; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; HALL SW, 1986, EUR J BIOCHEM, V161, P551, DOI 10.1111/j.1432-1033.1986.tb10477.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Kukekova AV, 2009, MAMM GENOME, V20, P109, DOI 10.1007/s00335-008-9163-4; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Olshevskaya E. V., 2004, J NEUROSCI; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Perrault I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051622; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2020, J BIOL CHEM, V295, P10781, DOI 10.1074/jbc.RA120.013789; Peshenko IV, 2019, J BIOL CHEM, V294, P2318, DOI 10.1074/jbc.RA118.006106; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Plana-Bonamaiso A, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2255-0; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sato S, 2018, J NEUROSCI, V38, P2990, DOI 10.1523/JNEUROSCI.2985-17.2018; Wimberg H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00052; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	43	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100362	10.1016/j.jbc.2021.100362	http://dx.doi.org/10.1016/j.jbc.2021.100362			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539922	gold, Green Published			2022-12-28	WOS:000672866400336
J	Harper, CB; Blumrich, EM; Cousin, MA				Harper, Callista B.; Blumrich, Eva-Maria; Cousin, Michael A.			Synaptophysin controls synaptobrevin-II retrieval via a cryptic C-terminal interaction site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE PROTEIN; COMPLEX; TRAFFICKING; ENDOCYTOSIS; DYNAMIN; PHOSPHORYLATION; SYNAPTOTAGMIN; MECHANISM; KINETICS; INFLUX	The accurate retrieval of synaptic vesicle (SV) proteins during endocytosis is essential for the maintenance of neuro-transmission. Synaptophysin (Syp) and synaptobrevin-II (SybII) are the most abundant proteins on SVs. Neurons lacking Syp display defects in the activity-dependent retrieval of SybII and a general slowing of SV endocytosis. To determine the role of the cytoplasmic C terminus of Syp in the control of these two events, we performed molecular replacement studies in primary cultures of Syp knockout neurons using genetically encoded reporters of SV cargo trafficking at physiological temperatures. Under these conditions, we discovered, 1) no slowing in SV endocytosis in Syp knockout neurons, and 2) a continued defect in SybII retrieval in knockout neurons expressing a form of Syp lacking its C terminus. Sequential truncations of the Syp C-terminus revealed a cryptic interaction site for the SNARE motif of SybII that was concealed in the full-length form. This suggests that a conformational change within the Syp C terminus is key to permitting SybII binding and thus its accurate retrieval. Furthermore, this study reveals that the sole presynaptic role of Syp is the control of SybII retrieval, since no defect in SV endocytosis kinetics was observed at physiological temperatures.	[Harper, Callista B.; Blumrich, Eva-Maria; Cousin, Michael A.] Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh EH8 9XD, Midlothian, Scotland; [Harper, Callista B.; Blumrich, Eva-Maria; Cousin, Michael A.] Univ Edinburgh, Muir Maxwell Epilepsy Ctr, Edinburgh EH8 9XD, Midlothian, Scotland; [Cousin, Michael A.] Univ Edinburgh, Simons Initiat Developing Brain, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Cousin, MA (corresponding author), Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh EH8 9XD, Midlothian, Scotland.; Cousin, MA (corresponding author), Univ Edinburgh, Muir Maxwell Epilepsy Ctr, Edinburgh EH8 9XD, Midlothian, Scotland.; Cousin, MA (corresponding author), Univ Edinburgh, Simons Initiat Developing Brain, Edinburgh EH8 9XD, Midlothian, Scotland.	M.Cousin@ed.ac.uk		Cousin, Michael/0000-0002-1762-160X	Biotechnology and Biological Sciences Research Council [BB/L019329/1]; Wellcome Trust [204954/Z/16/Z]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust)	Work funded by the Biotechnology and Biological Sciences Research Council (BB/L019329/1) and The Wellcome Trust (204954/Z/16/Z).	Adams DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13659; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Becher A, 1999, J NEUROSCI, V19, P1922; Bonanomi D, 2007, BIOCHEM J, V404, P525, DOI 10.1042/BJ20061907; Brunger AT, 2018, ANNU REV BIOPHYS, V47, P469, DOI 10.1146/annurev-biophys-070816-034117; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Egashira Y, 2015, J NEUROSCI, V35, P3701, DOI 10.1523/JNEUROSCI.4160-14.2015; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Felkl M, 2008, NEUROSCIENCE, V156, P344, DOI 10.1016/j.neuroscience.2008.07.033; Gordon SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149457; Gordon Sarah L, 2016, Front Synaptic Neurosci, V8, P1, DOI 10.3389/fnsyn.2016.00001; Gordon SL, 2013, J NEUROSCI, V33, P13695, DOI 10.1523/JNEUROSCI.0636-13.2013; Gordon SL, 2011, J NEUROSCI, V31, P14032, DOI 10.1523/JNEUROSCI.3162-11.2011; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harper CB, 2017, NEUROBIOL DIS, V108, P298, DOI 10.1016/j.nbd.2017.08.021; Hinz B, 2001, EUR J CELL BIOL, V80, P615, DOI 10.1078/0171-9335-00196; Horikawa HPM, 2002, MOL CELL NEUROSCI, V21, P454, DOI 10.1006/mcne.2002.1191; Japel M, 2020, CELL REP, V30, P409, DOI 10.1016/j.celrep.2019.12.035; Kaempf N, 2015, P NATL ACAD SCI USA, V112, P7297, DOI 10.1073/pnas.1501627112; Kelly BT, 2011, CURR OPIN CELL BIOL, V23, P404, DOI 10.1016/j.ceb.2011.03.004; Khvotchev MV, 2004, BIOCHEMISTRY-US, V43, P15037, DOI 10.1021/bi048290+; Kokotos AC, 2019, J NEUROCHEM, V151, P28, DOI 10.1111/jnc.14797; Kononenko NL, 2013, P NATL ACAD SCI USA, V110, pE526, DOI 10.1073/pnas.1218432110; Koo SJ, 2015, NEURON, V88, P330, DOI 10.1016/j.neuron.2015.08.034; Koo SJ, 2011, P NATL ACAD SCI USA, V108, P13540, DOI 10.1073/pnas.1107067108; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Milovanovic D, 2018, SCIENCE, V361, P604, DOI 10.1126/science.aat5671; Mitter D, 2003, J NEUROCHEM, V84, P35, DOI 10.1046/j.1471-4159.2003.01258.x; Rajappa R, 2016, CELL REP, V14, P1369, DOI 10.1016/j.celrep.2016.01.031; Reisinger C, 2004, J NEUROCHEM, V90, P1, DOI 10.1111/j.1471-4159.2004.02472.x; Rizo J, 2018, PROTEIN SCI, V27, P1364, DOI 10.1002/pro.3445; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Treppmann P, 2011, J NEUROCHEM, V117, P757, DOI 10.1111/j.1471-4159.2011.07247.x; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Yelamanchili SV, 2005, EUR J CELL BIOL, V84, P467, DOI 10.1016/j.ejcb.2004.11.007; Zhang N, 2015, J NEUROSCI, V35, P2492, DOI 10.1523/JNEUROSCI.4248-14.2015	48	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100266	10.1016/j.jbc.2021.100266	http://dx.doi.org/10.1016/j.jbc.2021.100266			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33769286	gold, Green Published, Green Accepted			2022-12-28	WOS:000672866400242
J	Huang, H; Chamness, LM; Vanoye, CG; Kuenze, G; Meiler, J; George, AL; Schlebach, JP; Sanders, CR				Huang, Hui; Chamness, Laura M.; Vanoye, Carlos G.; Kuenze, Georg; Meiler, Jens; George, Alfred L., Jr.; Schlebach, Jonathan Patrick; Sanders, Charles R.			Disease-linked supertrafficking of a potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; VOLTAGE-SENSOR DOMAIN; KCNQ1 MUTATION CAUSES; ATRIAL-FIBRILLATION; OF-FUNCTION; ELECTROSTATIC INTERACTIONS; MEMBRANE INSERTION; PATHOGENESIS; RECOGNITION; BRADYCARDIA	Gain-of-function (GOF) mutations in the voltage-gated potassium channel subfamilyQmember 1 (KCNQ1) can induce cardiac arrhythmia. In this study, it was tested whether any of the known human GOF disease mutations in KCNQ1 act by increasing the amount of KCNQ1 that reaches the cell surface-"supertrafficking." Seven of the 15 GOF mutants tested were seen to surface trafficmore efficiently than theWTchannel. Among these, wefound that the levels of R231CKCNQ1in the plasmamembrane were fivefold higher than theWT channel. This was shown to arise from the combined effects of enhanced efficiency of translocon-mediated membrane integration of the S4 voltage-sensor helix and fromenhanced post-translational folding/trafficking relatedto the energetic linkage of C231 with the V129 and F166 side chains. Whole-cell electrophysiology recordings confirmed that R231C KCNQ1 in complex with the voltage-gated potassium channel-regulatory subfamily E member 1 not only exhibited constitutive conductance but also revealed that the single-channel activity of this mutant is only20% that ofWT. TheGOFphenotype associated with R231C therefore reflects the effects of supertrafficking and constitutive channel activation, which together offset reduced channel activity. These investigations showthatmembrane protein supertrafficking can contribute to human disease.	[Huang, Hui; Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Huang, Hui; Meiler, Jens; Sanders, Charles R.] Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA; [Chamness, Laura M.; Schlebach, Jonathan Patrick] Indiana Univ, Dept Chem, Bloomington, IN USA; [Vanoye, Carlos G.; George, Alfred L., Jr.] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA; [Kuenze, Georg; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Kuenze, Georg; Meiler, Jens] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Kuenze, Georg; Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Bioinformat, Nashville, TN USA; [Sanders, Charles R.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Indiana University System; Indiana University Bloomington; Northwestern University; Feinberg School of Medicine; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Sanders, CR (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.; Sanders, CR (corresponding author), Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA.; Sanders, CR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA.	chuck.sanders@vanderbilt.edu	Huang, Hui/E-3030-2015	Huang, Hui/0000-0003-2958-257X; George, Alfred/0000-0002-3993-966X; Meiler, Jens/0000-0001-8945-193X; Kuenze, Georg/0000-0003-1799-346X; Sanders, Charles/0000-0003-2046-2862	US National Institutes of Health [R01 HL122010, R01 GM129261]; Vanderbilt University Department of Biochemistry William N. Pearson Fellowship	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Department of Biochemistry William N. Pearson Fellowship	This work was supported by US National Institutes of Health grants R01 HL122010 (to C. R. S., J. M., and A. L. G.) and R01 GM129261 (to J. P. S.). H. H. received partial support from a Vanderbilt University Department of Biochemistry William N. Pearson Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott GW, 2016, GENE, V576, P1, DOI 10.1016/j.gene.2015.09.059; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bartos DC, 2013, J CARDIOVASC ELECTR, V24, P562, DOI 10.1111/jce.12068; Bartos DC, 2011, HEART RHYTHM, V8, P48, DOI 10.1016/j.hrthm.2010.09.010; Bellocq C, 2004, CIRCULATION, V109, P2394, DOI 10.1161/01.CIR.0000130409.72142.FE; Bond PJ, 2007, P NATL ACAD SCI USA, V104, P2631, DOI 10.1073/pnas.0606822104; Brewer KR, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00550; Campuzano O, 2019, J CLIN MED, V8, DOI 10.3390/jcm8071035; Chan PJ, 2012, J GEN PHYSIOL, V139, P135, DOI 10.1085/jgp.201110672; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Das S, 2009, HEART RHYTHM, V6, P1146, DOI 10.1016/j.hrthm.2009.04.015; El Harchi A, 2010, J PHYSIOL PHARMACOL, V61, P123; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hasegawa K, 2014, HEART RHYTHM, V11, P67, DOI 10.1016/j.hrthm.2013.09.073; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Henrion U, 2012, CELL PHYSIOL BIOCHEM, V29, P809, DOI 10.1159/000178470; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hong K, 2005, CARDIOVASC RES, V68, P433, DOI 10.1016/j.cardiores.2005.06.023; Huang H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2631; Itoh H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P511, DOI 10.1161/CIRCEP.109.862649; Kanki H, 2004, J BIOL CHEM, V279, P33976, DOI 10.1074/jbc.M404539200; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Ki CS, 2014, PFLUG ARCH EUR J PHY, V466, P529, DOI 10.1007/s00424-013-1337-6; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Kuenze G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220415; Liin SI, 2015, J PHYSIOL-LONDON, V593, P2605, DOI 10.1113/jphysiol.2014.287607; Lundby A, 2007, HEART RHYTHM, V4, P1532, DOI 10.1016/j.hrthm.2007.07.022; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Lupoglazoff JM, 2004, J AM COLL CARDIOL, V43, P826, DOI 10.1016/j.jacc.2003.09.049; Marinko JT, 2019, CHEM REV, V119, P5537, DOI 10.1021/acs.chemrev.8b00532; Miceli F, 2015, J NEUROSCI, V35, P3782, DOI 10.1523/JNEUROSCI.4423-14.2015; Mishima E, 2016, BIOCHEM J, V473, P4361, DOI 10.1042/BCJ20160746; Moreno C, 2015, CARDIOVASC RES, V107, P613, DOI 10.1093/cvr/cvv196; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Olesen MS, 2014, HEART RHYTHM, V11, P246, DOI 10.1016/j.hrthm.2013.10.034; Otway R, 2007, J AM COLL CARDIOL, V49, P578, DOI 10.1016/j.jacc.2006.09.044; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Peng DG, 2014, BIOCHEMISTRY-US, V53, P2032, DOI 10.1021/bi500102w; Rhodes TE, 2008, J MOL CELL CARDIOL, V44, P571, DOI 10.1016/j.yjmcc.2007.11.015; Roushar FJ, 2019, J AM CHEM SOC, V141, P204, DOI 10.1021/jacs.8b08243; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036; Schlebach JP, 2015, J AM CHEM SOC, V137, P8758, DOI 10.1021/jacs.5b03743; Steffensen AB, 2015, J CARDIOVASC ELECTR, V26, P715, DOI 10.1111/jce.12666; Sun J, 2020, CELL, V180, P340, DOI 10.1016/j.cell.2019.12.003; Sun ZH, 2019, J CELL BIOL, V218, P3171, DOI 10.1083/jcb.201906047; Taylor KC, 2020, ELIFE, V9, DOI 10.7554/eLife.53901; Vanoye CG, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002345; Virkki MT, 2014, PROTEIN SCI, V23, P981, DOI 10.1002/pro.2483; Wang T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18723-y; Wu J, 2016, J ARRYTHM, V32, P381, DOI 10.1016/j.joa.2015.12.006; Yang T, 2009, CIRC-ARRHYTHMIA ELEC, V2, P417, DOI 10.1161/CIRCEP.109.850149; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104; Zhou X, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00259	57	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100423	10.1016/j.jbc.2021.100423	http://dx.doi.org/10.1016/j.jbc.2021.100423			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600800	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400397
J	Iadarola, DM; Joshi, A; Caldwell, CB; Gohil, VM				Iadarola, Donna M.; Joshi, Alaumy; Caldwell, Cameron B.; Gohil, Vishal M.			Choline restores respiration in Psd1-deficient yeast by replenishing mitochondrial phosphatidylethanolamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLSERINE DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; BIOSYNTHETIC PATHWAYS; CARDIOLIPIN; PHOSPHATIDYLCHOLINE; CLONING; GENE; METHYLTRANSFERASE; METHYLATION; STABILITY	Phosphatidylethanolamine (PE) is essential for mitochondrial respiration in yeast, Saccharomyces cerevisiae, whereas the most abundant mitochondrial phospholipid, phosphatidylcholine (PC), is largely dispensable. Surprisingly, choline (Cho), which is a biosynthetic precursor of PC, has been shown to rescue the respiratory growth of mitochondrial PE-deficient yeast; however, the mechanism underlying this rescue has remained unknown. Using a combination of yeast genetics, lipid biochemistry, and cell biological approaches, we uncover the mechanism by showing that Cho rescues mitochondrial respiration by partially replenishing mitochondrial PE levels in yeast cells lacking the mitochondrial PE-biosynthetic enzyme Psd1. This rescue is dependent on the conversion of Cho to PC via the Kennedy pathway as well as on Psd2, an enzyme catalyzing PE biosynthesis in the endosome. Metabolic labeling experiments reveal that in the absence of exogenously supplied Cho, PE biosynthesized via Psd2 is mostly directed to the methylation pathway for PC biosynthesis and is unavailable for replenishing mitochondrial PE in Psd1-deleted cells. In this setting, stimulating the Kennedy pathway for PC biosynthesis by Cho spares Psd2-synthesized PE from the methylation pathway and redirects it to the mitochondria. Cho-mediated elevation in mitochondrial PE is dependent on Vps39, which has been recently implicated in PE trafficking to the mitochondria. Accordingly, epistasis experiments placed Vps39 downstream of Psd2 in Cho-based rescue. Our work, thus, provides a mechanism of Cho-based rescue of mitochondrial PE deficiency and uncovers an intricate interorganelle phospholipid regulatory network that maintains mitochondrial PE homeostasis.	[Iadarola, Donna M.; Joshi, Alaumy; Caldwell, Cameron B.; Gohil, Vishal M.] Texas A&M Univ, Dept Biochem & Biophys, MS 3474, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gohil, VM (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, MS 3474, College Stn, TX 77843 USA.	vgohil@tamu.edu		Joshi, Alaumy/0000-0002-4637-5639; Gohil, Vishal/0000-0002-9920-2563; Caldwell, Cameron/0000-0002-4144-093X	Welch Foundation [A-1810]; NIH [R01GM111672]	Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by The Welch Foundation Grant (A-1810) and the NIH award R01GM111672 to V. M. G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amberg DC., 2005, METHODS YEAST GENETI; Baker CD, 2016, MOL BIOL CELL, V27, P2161, DOI 10.1091/mbc.E15-12-0865; Ball WB, 2018, FEBS LETT, V592, P1273, DOI 10.1002/1873-3468.12887; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Calzada E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09425-1; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Chan EYL, 2012, J BIOL CHEM, V287, P40131, DOI 10.1074/jbc.M112.399428; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Ghosh S, 2020, P NATL ACAD SCI USA, V117, P16383, DOI 10.1073/pnas.2000640117; Girisha KM, 2019, HUM MUTAT, V40, P299, DOI 10.1002/humu.23693; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gulshan K, 2010, MOL BIOL CELL, V21, P443, DOI 10.1091/mbc.E09-06-0519; Henneberry AL, 2001, MOL BIOL CELL, V12, P511, DOI 10.1091/mbc.12.3.511; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Iadarola DM, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158655; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Janssen MJFW, 2002, FEBS LETT, V513, P197, DOI 10.1016/S0014-5793(02)02298-6; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; KODAKI T, 1987, J BIOL CHEM, V262, P15428; MCGEE TP, 1994, J BACTERIOL, V176, P6861, DOI 10.1128/JB.176.22.6861-6868.1994; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mejia EM, 2016, J BIOENERG BIOMEMBR, V48, P99, DOI 10.1007/s10863-015-9601-4; Peter VG, 2019, GENET MED, V21, P2734, DOI 10.1038/s41436-019-0595-x; Schuler MH, 2016, J BIOL CHEM, V291, P18718, DOI 10.1074/jbc.M116.722694; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Zhao T, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900353	36	0	0	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100539	10.1016/j.jbc.2021.100539	http://dx.doi.org/10.1016/j.jbc.2021.100539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33722607	gold, Green Published			2022-12-28	WOS:000672866400512
J	Jardin, I; Diez-Bello, R; Falcon, D; Alvarado, S; Regodon, S; Salido, GM; Smani, T; Rosado, JA				Jardin, Isaac; Diez-Bello, Raquel; Falcon, Debora; Alvarado, Sandra; Regodon, Sergio; Salido, Gines M.; Smani, Tarik; Rosado, Juan A.			Melatonin downregulates TRPC6, impairing store-operated calcium entry in triple-negative breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED OXIDATIVE STRESS; EXPRESSION; HIPPOCAMPUS; MODULATION; APOPTOSIS; CHANNELS; TRPM2	Melatonin has been reported to induce effective reduction in growth and development in a variety of tumors, including breast cancer. In triple-negative breast cancer (TNBC) cells, melatonin attenuates a variety of cancer features, such as tumor growth and apoptosis resistance, through a number of still poorly characterized mechanisms. One biological process that is important for TNBC cells is store-operated Ca2+ entry (SOCE), which is modulated by TRPC6 expression and function. We wondered whether melatonin might intersect with this pathway as part of its anticancer activity. We show that melatonin, in the nanomolar range, significantly attenuates TNBC MDA-MB-231 cell viability, proliferation, and migration in a time- and concentration-dependent manner, without having any effect on nontumoral breast epithelial MCF10A cells. Pretreatment with different concentrations of melatonin significantly reduced SOCE in MDA-MB-231 cells without altering Ca2+ release from the intracellular stores. By contrast, SOCE in MCF10A cells was unaffected by melatonin. In the TNBC MDA-MB-468 cell line, melatonin not only attenuated viability, migration, and SOCE, but also reduced TRPC6 expression in a time- and concentration-dependent manner, without altering expression or function of the Ca2+ channel Orai1. The expression of exogenous TRPC6 overcame the effect of melatonin on SOCE and cell proliferation, and silencing or inhibition of TRPC6 impaired the inhibitory effect of melatonin on SOCE. These findings indicate that TRPC6 downregulation might be involved in melatonin's inhibitory effects on Ca2+ influx and the maintenance of cancer hallmarks and point toward a novel antitumoral mechanism of melatonin in TNBC cells.	[Jardin, Isaac; Diez-Bello, Raquel; Alvarado, Sandra; Salido, Gines M.; Rosado, Juan A.] Univ Extremadura, Inst Mol Pathol Biomarkers IMPB, Dept Physiol, Cellular Physiol Res Grp, Caceres, Spain; [Falcon, Debora] Inst Biomed Sevilla, Cardiovasc Physiopathol Grp, Seville, Spain; [Regodon, Sergio] Univ Extremadura, Dept Anim Med, Caceres, Spain; [Smani, Tarik] Inst Biomed Sevilla, Dept Med Physiol & Biophys, Seville, Spain	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)	Jardin, I (corresponding author), Univ Extremadura, Inst Mol Pathol Biomarkers IMPB, Dept Physiol, Cellular Physiol Res Grp, Caceres, Spain.	ijp@unex.es	Hajami, Tarik Smani/D-5372-2016; Falcón, Débora/GQZ-1602-2022; rosado, juan/H-3488-2015	Hajami, Tarik Smani/0000-0002-1877-7438; rosado, juan/0000-0002-9749-2325; Alvarado, Sandra/0000-0002-3851-5531	MICINN [BFU2016-74932-C2-1-P, BFU2016-74932-C2-2-P, PID2019-104084GB-C21, PID2019-104084GB-C22]; Junta de Extremadura-Fondo Europeo de Desarrollo Regional [IB16046, GR18061]; Junta de Extremadura-FEDER [TA18054]; CIBERCV (ISCIII, Madrid)	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Junta de Extremadura-Fondo Europeo de Desarrollo Regional; Junta de Extremadura-FEDER(European Commission); CIBERCV (ISCIII, Madrid)	Supported by MICINN (Grants BFU2016-74932-C2-1-P, BFU2016-74932-C2-2-P, PID2019-104084GB-C21 and PID2019-104084GB-C22) and Junta de Extremadura-Fondo Europeo de Desarrollo Regional (Grants IB16046 and GR18061). S. A., R. D.-B., and I. J. (contract TA18054) are supported by contracts from Junta de Extremadura-FEDER. D. F. is supported by Jordi Soler grant from CIBERCV (ISCIII, Madrid).	Al-Mahmood S, 2018, DRUG DELIV TRANSL RE, V8, P1483, DOI 10.1007/s13346-018-0551-3; Amin N, 2019, J CELL BIOCHEM, V120, P12208, DOI 10.1002/jcb.28832; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Azimi I, 2019, CANCERS, V11, DOI 10.3390/cancers11020208; Camello-Almaraz C, 2008, J PINEAL RES, V45, P191, DOI 10.1111/j.1600-079X.2008.00576.x; Cheng HY, 2016, ONCOTARGET, V7, P16866, DOI 10.18632/oncotarget.7619; Colombo J, 2018, ANTI-CANCER AGENT ME, V18, P1688, DOI 10.2174/1871520618666180131112304; Dhennin-Duthille I, 2011, CELL PHYSIOL BIOCHEM, V28, P813, DOI 10.1159/000335795; Diez-Bello R, 2019, BBA-MOL CELL RES, V1866, P474, DOI 10.1016/j.bbamcr.2018.10.010; El-Sokkary GH, 2019, J CELL BIOCHEM, V120, P3945, DOI 10.1002/jcb.27678; Ferreira LC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228062; Gilbert FJ, 2019, IDKD SPR SER, P155, DOI 10.1007/978-3-030-11149-6_13; Hasan M, 2019, MOL PHARMACOL, V96, P272, DOI 10.1124/mol.119.116202; Hasan M, 2017, J NAT PROD, V80, P3325, DOI 10.1021/acs.jnatprod.7b00853; Jardim-Perassi BV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37413-w; Jardim-Perassi BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085311; Jardin I, 2018, CANCERS, V10, DOI 10.3390/cancers10090331; Kahya MC, 2017, MOL NEUROBIOL, V54, P2345, DOI 10.1007/s12035-016-9727-3; Kim TH, 2017, ONCOL LETT, V14, P2511, DOI 10.3892/ol.2017.6434; Lacerda Jessica Zani, 2019, Microrna, V8, P237, DOI 10.2174/2211536608666190219095426; Lee JH, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12519; Lee KL, 2019, CANCERS, V11, DOI 10.3390/cancers11091334; Ma ZQ, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12587; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Oprea-Ilies G, 2013, BREAST CANCER RES TR, V137, P677, DOI 10.1007/s10549-012-2371-3; Ouadid-Ahidouch H, 2012, B CANCER, V99, P655, DOI 10.1684/bdc.2012.1595; Pohl NM, 2014, AM J RESP CRIT CARE, V189; Ponomarenko Dmitry M, 2020, Oncotarget, V11, P294, DOI 10.18632/oncotarget.27323; Proietti S, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12467; Regodon S, 2009, J PINEAL RES, V46, P275, DOI 10.1111/j.1600-079X.2008.00658.x; Reiter RJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040843; Sanchez-Barcelo EJ, 2005, J PINEAL RES, V38, P217, DOI 10.1111/j.1600-079X.2004.00207.x; Sanchez-Collado J, 2019, CANCERS, V11, DOI 10.3390/cancers11111624; Sonehara NM, 2019, ONCOL LETT, V17, P1635, DOI 10.3892/ol.2018.9758; Vriend J, 2015, MOL CELL ENDOCRINOL, V417, P1, DOI 10.1016/j.mce.2015.09.001; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3; Zbidi H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.190694; Zhang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09401; ZISAPEL N, 1983, BRAIN RES, V272, P378, DOI 10.1016/0006-8993(83)90588-7	39	10	10	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100254	10.1074/jbc.RA120.015769	http://dx.doi.org/10.1074/jbc.RA120.015769			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33380424	gold, Green Published			2022-12-28	WOS:000672866400230
J	Jin, XF; Zhang, ZM; Nie, ZP; Wang, CH; Meng, FL; Yi, QZ; Chen, MQ; Sun, JJ; Zou, J; Jiang, PP; Guan, MX				Jin, Xiaofen; Zhang, Zengming; Nie, Zhipeng; Wang, Chenghui; Meng, Feilong; Yi, Qiuzi; Chen, Mengquan; Sun, Jiji; Zou, Jian; Jiang, Pingping; Guan, Min-Xin			An animal model for mitochondrial tyrosyl-tRNA synthetase deficiency reveals links between oxidative phosphorylation and retinal function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTIC-ACIDOSIS; PHENOTYPIC MANIFESTATION; CAUSES MYOPATHY; MUTATION; YARS2; STRESS; METABOLISM; ACTIVATION; INHIBITION; ZEBRAFISH	Mitochondria maintain a distinct pool of ribosomal machinery, including tRNAs and tRNAs activating enzymes, such as mitochondrial tyrosyl-tRNA synthetase (YARS2). Mutations in YARS2, which typically lead to the impairment of mitochondrial protein synthesis, have been linked to an array of human diseases including optic neuropathy. However, the lack of YARS2 mutation animal model makes us difficult to elucidate the pathophysiology underlying YARS2 deficiency. To explore this system, we generated YARS2 knockout (KO) HeLa cells and zebrafish using CRISPR/Cas9 technology. We observed the aberrant tRNATyr aminoacylation overall and reductions in the levels in mitochondrion- and nucleus-encoding subunits of oxidative phosphorylation system(OXPHOS), which were especially pronounced effects in the subunits of complex I and complex IV. These deficiencies manifested the decreased levels of intact supercomplexes overall. Immunoprecipitation assays showed that YARS2 bound to specific subunits of complex I and complex IV, suggesting the post-translational stabilization of OXPHOS. Furthermore, YARS2 ablation caused defects in the stability and activities of OXPHOS complexes. These biochemical defects could be rescued by the overexpression of YARS2 cDNA in the YARS2(KO) cells. In zebrafish, the yars2(KO) larva conferred deficient COX activities in the retina, abnormal mitochondrial morphology, and numbers in the photoreceptor and retinal ganglion cells. The zebrafish further exhibited the retinal defects affecting both rods and cones. Vision defects in yars2(KO) zebrafish recapitulated the clinical phenotypes in the optic neuropathy patients carrying the YARS2 mutations. Our findings highlighted the critical role of YARS2 in the stability and activity of OXPHOS and its pathological consequence in vision impairments.	[Jin, Xiaofen; Guan, Min-Xin] Zhejiang Univ, Sch Med, Key Lab Reprod Genet, Minist Educ PRC,Womans Hosp, Hangzhou, Zhejiang, Peoples R China; [Jin, Xiaofen; Meng, Feilong; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Sch Med, Div Med Genet & Genom, Childrens Hosp, Hangzhou, Zhejiang, Peoples R China; [Jin, Xiaofen; Meng, Feilong; Jiang, Pingping; Guan, Min-Xin] Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China; [Jin, Xiaofen; Zhang, Zengming; Nie, Zhipeng; Wang, Chenghui; Meng, Feilong; Yi, Qiuzi; Sun, Jiji; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Chen, Mengquan] Wenzhou Hosp Tradit Chinese Med, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zou, Jian] Zhejiang Univ, Insitute Translat Med, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Zhejiang Prov Key Lab Genet & Dev Disorders, Hangzhou, Zhejiang, Peoples R China; [Guan, Min-Xin] Joint Inst Genet & Genome Med Zhejiang Univ & Uni, Div Mitochondrial Biomed, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Key Lab Reprod Genet, Minist Educ PRC,Womans Hosp, Hangzhou, Zhejiang, Peoples R China.; Jiang, PP; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Div Med Genet & Genom, Childrens Hosp, Hangzhou, Zhejiang, Peoples R China.; Jiang, PP; Guan, MX (corresponding author), Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China.; Jiang, PP; Guan, MX (corresponding author), Zhejiang Univ, Inst Genet, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Jiang, PP; Guan, MX (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Genet & Dev Disorders, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Joint Inst Genet & Genome Med Zhejiang Univ & Uni, Div Mitochondrial Biomed, Hangzhou, Zhejiang, Peoples R China.	ppjiang@zju.edu.cn; gminxin88@zju.edu.cn		JIANG, PINGPING/0000-0002-4975-4861	National Key Research and Development Program of China, China [2018YFC1004802]; National Natural Science Foundation of China, China [31970557, 31671303]; Zhejiang Provincial Medical and Health Research Program, China [2019RC149]	National Key Research and Development Program of China, China; National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Medical and Health Research Program, China	This work was supported by a grant from the National Key Research and Development Program of China, China (2018YFC1004802 to M.-X. G.), grants from National Natural Science Foundation of China, China (31970557 to M.-X. G., 31671303 to P. J.) and Zhejiang Provincial Medical and Health Research Program, China (2019RC149 to X. J.).	Agnew T, 2018, CELL REP, V25, P3315, DOI 10.1016/j.celrep.2018.11.080; Akaike T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01311-y; AMES A, 1992, CAN J PHYSIOL PHARM, V70, pS158, DOI 10.1139/y92-257; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Boczonadi V, 2018, ESSAYS BIOCHEM, V62, P321, DOI 10.1042/EBC20170103; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Bonnefond L, 2007, STRUCTURE, V15, P1505, DOI 10.1016/j.str.2007.09.018; Chen DN, 2019, NUCLEIC ACIDS RES, V47, P5341, DOI 10.1093/nar/gkz218; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Collery RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110699; Coughlin CR, 2015, J MED GENET, V52, P532, DOI 10.1136/jmedgenet-2015-103049; Country MW, 2017, BRAIN RES, V1672, P50, DOI 10.1016/j.brainres.2017.07.025; Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; Escobar-Alvarez S, 2010, MOL CELL BIOL, V30, P5099, DOI 10.1128/MCB.00469-10; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Fan WL, 2019, J BIOL CHEM, V294, P19292, DOI 10.1074/jbc.RA119.010598; Fang PF, 2017, METHODS, V113, P83, DOI 10.1016/j.ymeth.2016.11.014; Fine AS, 2019, J NEURODEV DISORD, V11, DOI 10.1186/s11689-019-9292-y; Finsteree J, 2017, J NEUROL SCI, V376, P117, DOI 10.1016/j.jns.2017.03.006; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Gonzales APW, 2014, METHOD ENZYMOL, V546, P377, DOI 10.1016/B978-0-12-801185-0.00018-0; Gonzalez-Serrano LE, 2019, J BIOL CHEM, V294, P5309, DOI 10.1074/jbc.REV118.002953; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Hyeon DY, 2019, J BIOL CHEM, V294, P5340, DOI 10.1074/jbc.REV118.002958; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Ji YC, 2019, HUM MOL GENET, V28, P1515, DOI 10.1093/hmg/ddy450; Jia ZD, 2019, NUCLEIC ACIDS RES, V47, P2056, DOI 10.1093/nar/gky1241; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KING MP, 1993, J BIOL CHEM, V268, P10228; Levi O, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000274; Liu Y, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.8.24; McMillan HJ, 2015, J CHILD NEUROL, V30, P1037, DOI 10.1177/0883073814553272; Meng FL, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1225; Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530; Mukherjee S, 2020, MITOCHONDRION, V53, P1, DOI 10.1016/j.mito.2020.04.002; Nakajima J, 2014, J HUM GENET, V59, P229, DOI 10.1038/jhg.2013.143; Ognjenovic J, 2018, RNA BIOL, V15, P623, DOI 10.1080/15476286.2017.1330245; Oprescu SN, 2017, METHODS, V113, P139, DOI 10.1016/j.ymeth.2016.11.013; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Peragallo JH, 2018, OPHTHALMIC GENET, V39, P99, DOI 10.1080/13816810.2017.1350723; Phillips MJ, 2010, INVEST OPHTH VIS SCI, V51, P6744, DOI 10.1167/iovs.10-5421; Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; Riley LG, 2018, HAEMATOLOGICA, V103, P2008, DOI 10.3324/haematol.2017.182659; Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; Rodina A, 2016, NATURE, V538, P397, DOI 10.1038/nature19807; Sasarman F, 2012, HUM MUTAT, V33, P1201, DOI 10.1002/humu.22098; Shahni R, 2013, AM J MED GENET A, V161, P2334, DOI 10.1002/ajmg.a.36065; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Signes A, 2018, ESSAYS BIOCHEM, V62, P255, DOI 10.1042/EBC20170098; Simon M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005097; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0; Sommerville EW, 2017, JAMA NEUROL, V74, P686, DOI 10.1001/jamaneurol.2016.4357; Son K, 2019, J CLIN INVEST, V129, P2088, DOI 10.1172/JCI122560; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Szczepanowska K, 2016, EMBO J, V35, P2566, DOI 10.15252/embj.201694253; Tarboush R, 2012, TISSUE CELL, V44, P264, DOI 10.1016/j.tice.2012.04.004; Truscott KN, 2010, BIOCHEM CELL BIOL, V88, P97, DOI [10.1139/O09-167, 10.1139/o09-167]; Tyynismaa H, 2014, EMBO MOL MED, V6, P155, DOI 10.1002/emmm.201303586; Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z; Wang M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12061; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Yu JL, 2020, J CLIN INVEST, V130, P4935, DOI 10.1172/JCI134965; Zhang JJ, 2018, MITOCHONDRION, V42, P84, DOI 10.1016/j.mito.2017.12.003; Zhang QH, 2018, NUCLEIC ACIDS RES, V46, P10930, DOI 10.1093/nar/gky758; Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317	79	7	7	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100437	10.1016/j.jbc.2021.100437	http://dx.doi.org/10.1016/j.jbc.2021.100437			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610547	gold, Green Published			2022-12-28	WOS:000672866400411
J	Knecht, KM; Hu, YX; Rubene, D; Cook, M; Ziegler, SJ; Jonsson, SR; Xiong, Y				Knecht, Kirsten M.; Hu, Yingxia; Rubene, Diana; Cook, Matthew; Ziegler, Samantha J.; Jonsson, Stefan R.; Xiong, Yong			Maedi-visna virus Vif protein uses motifs distinct from HIV-1 Vif to bind zinc and the cofactor required for A3 degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; CBF-BETA; STRUCTURAL BASIS; HCCH MOTIF; APOBEC3; LENTIVIRUSES; HOST; CYCLOPHILIN; HIJACKING; EVOLUTION	The mammalian apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3 or A3) family of cytidine deaminases restrict viral infections by mutating viral DNA and impeding reverse transcription. To overcome this antiviral activity, most lentiviruses express a viral accessory protein called the virion infectivity factor (Vif), which recruits A3 proteins to cullin-RING E3 ubiquitin ligases such as cullin-5 (Cul5) for ubiquitylation and subsequent proteasomal degradation. Although Vif proteins from primate lentiviruses such as HIV-1 utilize the transcription factor core-binding factor subunit beta as a noncanonical cofactor to stabilize the complex, the maedi-visna virus (MVV) Vif hijacks cyclophilin A (CypA) instead. Because core-binding factor subunit beta and CypA are both highly conserved among mammals, the requirement for two different cellular cofactors suggests that these two A3-targeting Vif proteins have different biochemical and structural properties. To investigate this topic, we used a combination of in vitro biochemical assays and in vivo A3 degradation assays to study motifs required for the MVV Vif to bind zinc ion, Cul5, and the cofactor CypA. Our results demonstrate that although some common motifs between the HIV-1 Vif and MVV Vif are involved in recruiting Cul5, different determinants in the MVV Vif are required for cofactor binding and stabilization of the E3 ligase complex, such as the zinc-binding motif and N- and C-terminal regions of the protein. Results from this study advance our understanding of the mechanism of MVV Vif recruitment of cellular factors and the evolution of lentiviral Vif proteins.	[Knecht, Kirsten M.; Hu, Yingxia; Cook, Matthew; Ziegler, Samantha J.; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Rubene, Diana; Jonsson, Stefan R.] Univ Iceland, Inst Expt Pathol, Keldur, Iceland	Yale University; University of Iceland	Xiong, Y (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	yong.xiong@yale.edu		Knecht, Kirsten/0000-0001-5892-3770	predoctoral program in Biophysics NIH [T32 GM008283]; National Institutes of Health [AI116313]; University of Iceland Research Fund	predoctoral program in Biophysics NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iceland Research Fund	K. M. K. was supported by the predoctoral program in Biophysics NIH T32 GM008283. This work was supported by the National Institutes of Health grant AI116313 (to Y. X.) and University of Iceland Research Fund (to S. R. J). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Aydin H, 2014, STRUCTURE, V22, P668, DOI 10.1016/j.str.2014.02.011; Barry Michele, 2006, Sci STKE, V2006, ppe21; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Fribourgh JL, 2014, J VIROL, V88, P3309, DOI 10.1128/JVI.03824-13; Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003; Gu QY, 2018, J VIROL, V92, DOI 10.1128/JVI.01697-17; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Harris RS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005958; Highland MA, 2017, VET PATHOL, V54, P353, DOI 10.1177/0300985817695517; Hu YX, 2019, NAT STRUCT MOL BIOL, V26, P1176, DOI 10.1038/s41594-019-0343-6; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Kane JR, 2015, CELL REP, V11, P1236, DOI 10.1016/j.celrep.2015.04.038; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Klase Z, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003997; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; da Cruz JCM, 2013, VIRUSES-BASEL, V5, P1867, DOI 10.3390/v5071867; Paul I, 2006, P NATL ACAD SCI USA, V103, P18475, DOI 10.1073/pnas.0604150103; Ramirez H, 2013, VIRUSES-BASEL, V5, P1175, DOI 10.3390/v5041175; Sabel CE, 2010, ANAL BIOCHEM, V397, P218, DOI 10.1016/j.ab.2009.10.037; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stern MA, 2010, J VIROL, V84, P7378, DOI 10.1128/JVI.00584-10; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Watashi K, 2007, DRUG TARGET INSIGHT, V2, P9; Xiao ZX, 2006, VIROLOGY, V349, P290, DOI 10.1016/j.virol.2006.02.002; Yoshikawa R, 2016, MICROBIOL IMMUNOL, V60, P427, DOI 10.1111/1348-0421.12387; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang WY, 2014, J VIROL, V88, P12528, DOI 10.1128/JVI.02072-14; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhao ZL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00565	37	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100045	10.1074/jbc.RA120.015828	http://dx.doi.org/10.1074/jbc.RA120.015828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465707	gold, Green Published			2022-12-28	WOS:000672866400028
J	Levitin, F; Lee, SCES; Hulme, S; Rumantir, RA; Wong, AS; Meester, MR; Koritzinsky, M				Levitin, Fiana; Lee, Sandy Che-Eun S.; Hulme, Stephanie; Rumantir, Ryan A.; Wong, Amy S.; Meester, Marmendia R.; Koritzinsky, Marianne			Oxygen-independent disulfide bond formation in VEGF-A and CA9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; PROTEIN; HYPOXIA; ISOMERASE; METABOLISM; SURVIVAL; HISTONE; PATHWAY; CELLS	Low levels of oxygen (hypoxia) occurs in many (patho) physiological situations. Adaptation to hypoxia is in part mediated by proteins expressed in the extracellular space that mature in the endoplasmic reticulum (ER) prior to traversing the secretory pathway. The majority of such ER cargo proteins require disulfide bonds for structural stability. Disulfide bonds are formed co- and posttranslationally in a redox relay that requires a terminal electron acceptor such as oxygen. We have previously demonstrated that some ER cargo proteins such as low-density lipoprotein receptor (LDLR) and influenza hemagglutinin (Flu-HA) are unable to complete disulfide bond formation in the absence of oxygen, limiting their ability to pass ER quality control and their ultimate expression. Here, using radioactive pulse-chase immunoprecipitation analysis, we demonstrate that hypoxia-induced ER cargo proteins such as carbonic anhydrase 9 (CA9) and vascular endothelial growth factor A (VEGF-A) complete disulfide bond formation and mature with similar kinetics under hypoxia and normoxia. A global in silico analysis of ER cargo revealed that hypoxia-induced proteins on average contain fewer free cysteines and shorter-range disulfide bonds in comparison to other ER cargo proteins. These data demonstrate the existence of alternative electron acceptors to oxygen for disulfide bond formation in cellulo. However, the ability of different proteins to utilize an oxygen-independent pathway for disulfide bond formation varies widely, contributing to differential gene expression in hypoxia. The superior ability of hypoxia-induced proteins such as VEGF-A and CA9 to mature in hypoxia may be conferred by a simpler disulfide architecture.	[Levitin, Fiana; Lee, Sandy Che-Eun S.; Hulme, Stephanie; Rumantir, Ryan A.; Wong, Amy S.; Meester, Marmendia R.; Koritzinsky, Marianne] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lee, Sandy Che-Eun S.; Hulme, Stephanie; Rumantir, Ryan A.; Wong, Amy S.; Meester, Marmendia R.; Koritzinsky, Marianne] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Koritzinsky, Marianne] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Koritzinsky, Marianne] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto	Koritzinsky, M (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Koritzinsky, M (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Koritzinsky, M (corresponding author), Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada.; Koritzinsky, M (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	Marianne.Koritzinsky@uhnresearch.ca		Koritzinsky, Marianne/0000-0003-0547-2480; Lee, Sandy Che-Eun/0000-0002-7691-8104	Terry Fox Research Institute [PPG14-1036, 1090]; Strategic Training Initiative for Excellence in Radiation Research for the 21st Century (EIRR21/STARS21); Canadian Graduate Scholarship-Masters Awards; Vanier Canadian Graduate Scholarship; Princess Margaret Cancer Centre; Princess Margaret Cancer Foundation; Ontario Ministry of Health	Terry Fox Research Institute; Strategic Training Initiative for Excellence in Radiation Research for the 21st Century (EIRR21/STARS21); Canadian Graduate Scholarship-Masters Awards; Vanier Canadian Graduate Scholarship; Princess Margaret Cancer Centre(University of Toronto); Princess Margaret Cancer Foundation(University of Toronto); Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario)	This work was financially supported by the Terry Fox Research Institute (New Investigator Award and New Frontiers Project Program Grant PPG14-1036 and PPG#1090 to M. K.), Strategic Training Initiative for Excellence in Radiation Research for the 21st Century (EIRR21/STARS21 to F. L. and S. C.-E. S. L.), Canadian Graduate Scholarship-Masters Awards (to S. C.-E. S. L., S. H., A. S. W.), Vanier Canadian Graduate Scholarship (to S. C.-E. S. L.), Princess Margaret Cancer Centre, The Princess Margaret Cancer Foundation, and Ontario Ministry of Health.	Alterio V, 2009, P NATL ACAD SCI USA, V106, P16233, DOI 10.1073/pnas.0908301106; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Braakman Ineke, 2017, Curr Protoc Protein Sci, V90, DOI 10.1002/cpps.43; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Iyer S, 2011, FEBS J, V278, P4304, DOI 10.1111/j.1742-4658.2011.08350.x; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koritzinsky M, 2013, J CELL BIOL, V203, P615, DOI 10.1083/jcb.201307185; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Muller YA, 2002, J BIOL CHEM, V277, P43410, DOI 10.1074/jbc.M206438200; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; POTGENS AJG, 1994, J BIOL CHEM, V269, P32879; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Rouschop KM, 2013, P NATL ACAD SCI USA, V110, P4622, DOI 10.1073/pnas.1210633110; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Sarris M, 2014, ONCOGENE, V33, P1207, DOI 10.1038/onc.2013.87; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sullivan DC, 2003, J BIOL CHEM, V278, P47079, DOI 10.1074/jbc.M308124200; Tanaka T, 2016, BRIT J CANCER, V114, P1227, DOI 10.1038/bjc.2016.105; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wykoff CC, 2000, CANCER RES, V60, P7075	39	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100505	10.1016/j.jbc.2021.100505	http://dx.doi.org/10.1016/j.jbc.2021.100505			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675747	Green Published, gold			2022-12-28	WOS:000672866400479
J	Pronin, A; Slepak, V				Pronin, Alexey; Slepak, Vladlen			Ectopically expressed olfactory receptors OR51E1 and OR51E2 suppress proliferation and promote cell death in a prostate cancer cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; FUNCTIONAL-CHARACTERIZATION; ODORANT RECEPTORS; ACTIVATION; PSGR; GENE; SECRETION; FAMILY; 51E1	Olfactory receptors (ORs), the largest family of G protein-coupled receptors, are expressed in the nasal epithelium where they mediate the sense of smell. However, ORs are also found in other non-nasal tissues, but the role of these ectopic ORs in cell signaling, proliferation, and survival is not well understood. Here, using an inducible expression system in the lymph node carcinoma of the prostate (LNCaP) cell line, we investigated two ectopic ORs, OR51E1 and OR51E2, which have been shown to be upregulated in prostate cancer. We found that, consistent with previous studies, OR51E1 stimulated adenylyl cyclase in response to treatment by short-chain to medium-chain organic acids (C3-C9) but not by acetate. OR51E2 responded to acetate and propionate but not to the longer chain organic acids. Stimulation of LNCaP cells with butyrate inhibited their growth, and the knockdown of the endogenous OR51E1 negated this cytostatic effect. Most significantly, overexpression of OR51E1 or OR51E2 suppressed LNCaP cell proliferation. Overexpression of another ectopic OR OR2AT4, beta 2-adrenergic receptor, or treatment of cells with forskolin did not suppress cell proliferation, indicating that a rise in cAMP is not sufficient to induce cytostasis. Overexpression of OR51E1 caused an upregulation of cytostatic and cell death markers including p27, p21, and p53, strongly increased annexin V staining, and stimulated extracellular signal-regulated protein kinases 1 and 2. Overexpression and/or activation of OR51E1 did not affect human embryonic kidney 293 cell proliferation, indicating that cytotoxicity of OR51E1/OR51E2 is specific for LNCaP cells. Together, our results further our understanding of prostate cancer etiology and suggest that ectopic ORs may be useful therapeutic targets.	[Pronin, Alexey; Slepak, Vladlen] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Pronin, A; Slepak, V (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	a.pronin@med.miami.edu; vslepak@med.miami.edu			National Institutes of Health [R56DK119262, IE92847, R44GM125390]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by National Institutes of Health grants R56DK119262 (to V. S.) and the subcontract IE92847 from R44GM125390 (to Anne-Marie Quinn). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abaffy T, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00162; Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Bellono NW, 2017, CELL, V170, DOI 10.1016/j.cell.2017.05.034; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; Chang AJ, 2015, NATURE, V527, P240, DOI 10.1038/nature15721; Cheret J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05973-0; Cui T, 2013, EUR J ENDOCRINOL, V168, P253, DOI 10.1530/EJE-12-0814; Dalesio NM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01673; Dey S, 2011, JOVE-J VIS EXP, DOI 10.3791/2405; Foster SR, 2014, PHARMACOL THERAPEUT, V142, P41, DOI 10.1016/j.pharmthera.2013.11.004; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Gelis L, 2016, J BIOL CHEM, V291, P17772, DOI 10.1074/jbc.M116.734517; Giandomenico V, 2013, J MOL ENDOCRINOL, V51, P277, DOI 10.1530/JME-13-0144; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Han YE, 2018, J ENDOCR SOC, V2, P1251, DOI 10.1210/js.2018-00165; Holleman J, 2014, MOL BIOL CELL, V25, P1892, DOI 10.1091/mbc.E13-10-0612; Jo M, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.105; Jovancevic N, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00888; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Kowarz E, 2015, BIOTECHNOL J, V10, P647, DOI 10.1002/biot.201400821; Kuhns VLH, 2019, AM J PHYSIOL-RENAL, V317, pF172, DOI 10.1152/ajprenal.00624.2018; Lee SJ, 2019, NAT REV DRUG DISCOV, V18, P116, DOI 10.1038/s41573-018-0002-3; Marchalant Y, 2014, J HISTOCHEM CYTOCHEM, V62, P395, DOI 10.1369/0022155414530995; Massberg D, 2016, ONCOTARGET, V7, P48231, DOI 10.18632/oncotarget.10197; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Niimura Yoshihito, 2009, Human Genomics, V4, P107; Nooh MM, 2017, METHOD CELL BIOL, V142, P67, DOI 10.1016/bs.mcb.2017.07.010; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Priori D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129501; Pronin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096435; Pronin AN, 2017, MOL PHARMACOL, V92, P601, DOI 10.1124/mol.117.109678; Rodriguez M, 2016, ONCOGENE, V35, P1153, DOI 10.1038/onc.2015.170; Rodriguez M, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.29; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Shepard BD, 2019, AM J PHYSIOL-RENAL, V316, pF372, DOI 10.1152/ajprenal.00069.2018; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Stone Louise, 2015, Nat Rev Urol, V12, P364, DOI 10.1038/nrurol.2015.147; Tewson P, 2018, SLAS DISCOV, V23, P898, DOI 10.1177/2472555218786238; Tewson PH, 2016, J BIOMOL SCREEN, V21, P298, DOI 10.1177/1087057115618608; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Wang JH, 2006, PROSTATE, V66, P847, DOI 10.1002/pros.20389; Wang Q, 2017, FASEB J, V31, P4734, DOI 10.1096/fj.201700197RR; Weng JS, 2005, J CELL BIOCHEM, V96, P1034, DOI 10.1002/jcb.20600; Wu LF, 2012, J BIOL CHEM, V287, P22287, DOI 10.1074/jbc.M112.345884; Xia CZ, 2001, ONCOGENE, V20, P5903, DOI 10.1038/sj.onc.1204803; Xie HJ, 2019, CANCER LETT, V453, P193, DOI 10.1016/j.canlet.2019.03.044; Xu LL, 2000, CANCER RES, V60, P6568; Xu LL, 2006, PROSTATE CANCER P D, V9, P56, DOI 10.1038/sj.pcan.4500836; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	52	7	7	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100475	10.1016/j.jbc.2021.100475	http://dx.doi.org/10.1016/j.jbc.2021.100475			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33640452	Green Published, gold			2022-12-28	WOS:000672866400449
J	Seepersaud, R; Anderson, AC; Bensing, BA; Choudhury, BP; Clarke, AJ; Sullam, PM				Seepersaud, Ravin; Anderson, Alexander C.; Bensing, Barbara A.; Choudhury, Biswa P.; Clarke, Anthony J.; Sullam, Paul M.			O-acetylation controls the glycosylation of bacterial serine-rich repeat glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSORY SEC SYSTEM; STREPTOCOCCUS-GORDONII; PROTEIN GSPB; BINDING; ADHESION; EXPORT; LOCUS; HOST; SRR1; PEPTIDOGLYCAN	The serine-rich repeat (SRR) glycoproteins of gram-positive bacteria are a family of adhesins that bind to a wide range of host ligands, and expression of SRR glycoproteins is linked with enhanced bacterial virulence. The biogenesis of these surface glycoproteins involves their intracellular glycosylation and export via the accessory Sec system. Although all accessory Sec components are required for SRR glycoprotein export, Asp2 of Streptococcus gordonii also functions as an O-acetyltransferase that modifies GlcNAc residues on the SRR adhesin gordonii surface protein B (GspB). Because these GlcNAc residues can also be modified by the glycosyltransferases Nss and Gly, it has been unclear whether the post-translational modification of GspB is coordinated. We now report that acetylation modulates the glycosylation of exported GspB. Loss of O-acetylation due to aps2 mutagenesis led to the export of GspB glycoforms with increased glucosylation of the GlcNAc moieties. Linkage analysis of the GspB glycan revealed that both O-acetylation and glucosylation occurred at the same C6 position on GlcNAc residues and that O-acetylation prevented Glc deposition. Whereas streptococci expressing nonacetylated GspB with increased glucosylation were significantly reduced in their ability to bind human platelets in vitro, deletion of the glycosyltransferases nss and gly in the asp2 mutant restored platelet binding to WT levels. These findings demonstrate that GlcNAc O-acetylation controls GspB glycosylation, such that binding via this adhesin is optimized. Moreover, becauseO-acetylation has comparable effects on the glycosylation of other SRR adhesins, acetylation may represent a conserved regulatory mechanism for the post-translational modification of the SRR glycoprotein family.	[Seepersaud, Ravin; Bensing, Barbara A.; Sullam, Paul M.] San Francisco VA Med Ctr, Dept Med, Div Infect Dis, San Francisco, CA 94121 USA; [Seepersaud, Ravin; Bensing, Barbara A.; Sullam, Paul M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Anderson, Alexander C.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Choudhury, Biswa P.] Univ Calif San Diego, GlycoAnalyt Core, San Diego, CA 92103 USA; [Clarke, Anthony J.] Wilfrid Laurier Univ, Dept Chem & Biochem, Waterloo, ON, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of Guelph; University of California System; University of California San Diego; Wilfrid Laurier University	Sullam, PM (corresponding author), San Francisco VA Med Ctr, Dept Med, Div Infect Dis, San Francisco, CA 94121 USA.; Sullam, PM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	paul.sullam@ucsf.edu		Anderson, Alexander C./0000-0002-1870-2903	Department of Veteran Affairs, NIH [RO1-AI041513, RO1-AI106987]; University of Guelph; Natural Sciences and Engineering Research Council of Canada [PGPIN3215-11]	Department of Veteran Affairs, NIH; University of Guelph; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Department of Veteran Affairs, NIH grants RO1-AI041513 and RO1-AI106987, and by the University of Guelph and the Natural Sciences and Engineering Research Council of Canada grant PGPIN3215-11. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2004, J BACTERIOL, V186, P638, DOI 10.1128/JB.186.3.638-645.2004; Bensing BA, 2001, INFECT IMMUN, V69, P1373, DOI 10.1128/IAI.69.3.1373-1380.2001; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bensing BA, 2016, GLYCOBIOLOGY, V26, P1222, DOI 10.1093/glycob/cww042; Bensing BA, 2014, BBA-MOL CELL RES, V1843, P1674, DOI 10.1016/j.bbamcr.2013.10.019; Braunstein M, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.PSIB-0025-2018; Bu S, 2008, J BACTERIOL, V190, P1256, DOI 10.1128/JB.01078-07; Chaze T, 2014, MOL CELL PROTEOMICS, V13, P2168, DOI 10.1074/mcp.M114.038075; Chen Y, 2018, J BIOL CHEM, V293, P5360, DOI 10.1074/jbc.RA117.000963; Chen Y, 2016, P NATL ACAD SCI USA, V113, pE1190, DOI 10.1073/pnas.1600494113; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Couvigny B, 2017, ENVIRON MICROBIOL, V19, P3579, DOI 10.1111/1462-2920.13853; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Garnett JA, 2012, BIOCHEM BIOPH RES CO, V417, P421, DOI 10.1016/j.bbrc.2011.11.131; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; Jiang YL, 2017, J BIOL CHEM, V292, P6213, DOI 10.1074/jbc.M116.770446; Latousakis D, 2020, GUT MICROBES, V11, P102, DOI 10.1080/19490976.2019.1602428; Latousakis D, 2019, GLYCOBIOLOGY, V29, P45, DOI 10.1093/glycob/cwy100; Li YR, 2014, CURR MICROBIOL, V69, P121, DOI 10.1007/s00284-014-0563-2; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Madoff LC, 1996, P NATL ACAD SCI USA, V93, P4131, DOI 10.1073/pnas.93.9.4131; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Moynihan PJ, 2014, BIOORG CHEM, V54, P44, DOI 10.1016/j.bioorg.2014.03.010; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; Pauly M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01210; Perepelov AV, 2012, FEMS IMMUNOL MED MIC, V66, P201, DOI 10.1111/j.1574-695X.2012.01000.x; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Schulte T, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130090; Seepersaud R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006558; Seepersaud R, 2012, J BACTERIOL, V194, P5564, DOI 10.1128/JB.01000-12; Seepersaud R, 2010, MOL MICROBIOL, V78, P490, DOI 10.1111/j.1365-2958.2010.07346.x; Seo HS, 2013, J BIOL CHEM, V288, P35982, DOI 10.1074/jbc.M113.513358; Seo HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001047; Sequeira S, 2018, P NATL ACAD SCI USA, V115, pE2706, DOI 10.1073/pnas.1715016115; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; SULLAM PM, 1987, INFECT IMMUN, V55, P1743, DOI 10.1128/IAI.55.8.1743-1750.1987; Sun QZ, 2014, J BACTERIOL, V196, P3656, DOI 10.1128/JB.02009-14; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Yakovenko O, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00160-18; Yang YH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004169; Yen YT, 2013, J BACTERIOL, V195, P682, DOI 10.1128/JB.01742-12; Zhang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5339; Zhu F, 2015, J DENT RES, V94, P659, DOI 10.1177/0022034515574865; Zhu F, 2016, J BIOL CHEM, V291, P27354, DOI 10.1074/jbc.M116.752998	53	1	2	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100249	10.1074/jbc.RA120.016116	http://dx.doi.org/10.1074/jbc.RA120.016116			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33384382	Green Published, gold			2022-12-28	WOS:000672866400225
J	Van, AAN; Kunkel, MT; Baffi, TR; Lorden, G; Antal, CE; Banerjee, S; Newton, AC				Van, An-Angela N.; Kunkel, Maya T.; Baffi, Timothy R.; Lorden, Gema; Antal, Corina E.; Banerjee, Sourav; Newton, Alexandra C.			Protein kinase C fusion proteins are paradoxically loss of function in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE FUSIONS; SLC44A1-PRKCA FUSION; ALPHA; PHOSPHORYLATION; ACTIVATION; LANDSCAPE; APOPTOSIS; ISOZYMES; DOMAIN; TRANSCRIPTOME	Within the AGC kinase superfamily, gene fusions resulting from chromosomal rearrangements have been most frequently described for protein kinase C (PKC), with gene fragments encoding either the C-terminal catalytic domain or the N-terminal regulatory moiety fused to other genes. Kinase fusions that eliminate regulatory domains are typically gain of function and often oncogenic. However, several quality control pathways prevent accumulation of aberrant PKC, suggesting that PKC fusions may paradoxically be loss of function. To explore this topic, we used biochemical, cellular, and genome editing approaches to investigate the function of fusions that retain the portion of the gene encoding either the catalytic domain or regulatory domain of PKC. Overexpression studies revealed that PKC catalytic domain fusions were constitutively active but vulnerable to degradation. Genome editing of endogenous genes to generate a cancer-associated PKC fusion resulted in cells with detectable levels of fusion transcript but no detectable protein. Hence, PKC catalytic domain fusions are paradoxically loss of function as a result of their instability, preventing appreciable accumulation of protein in cells. Overexpression of a PKC regulatory domain fusion suppressed both basal and agonist-induced endogenous PKC activity, acting in a dominant-negative manner by competing for diacylglycerol. For both catalytic and regulatory domain fusions, the PKC component of the fusion proteins mediated the effects of the full-length fusions on the parameters examined, suggesting that the partner protein is dispensable in these contexts. Taken together, our findings reveal that PKC gene fusions are distinct from oncogenic fusions and present a mechanism by which loss of PKC function occurs in cancer.	[Van, An-Angela N.; Kunkel, Maya T.; Baffi, Timothy R.; Lorden, Gema; Antal, Corina E.; Banerjee, Sourav; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Van, An-Angela N.; Baffi, Timothy R.; Antal, Corina E.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA USA; [Antal, Corina E.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Banerjee, Sourav] Univ Dundee, Sch Med, Div Cellular Med, Dundee DD1 9SY, Scotland	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; University of Dundee	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@health.ucsd.edu	Banerjee, Sourav/J-3853-2019	Banerjee, Sourav/0000-0003-2043-2989; Baffi, Timothy/0000-0003-2862-6155; Kunkel, Maya/0000-0002-0027-5149	NIH [GM43154, R35 GM122523]; University of California, San Diego Graduate Training Program in Cellular and Molecular Pharmacology [T32 GM007752]; Gates Millennium Scholars Program; NSF Graduate Research Fellowship [DGE1144086]; PhRMA Foundation PreDoctoral Fellowship in Pharmacology Toxicology [20183844]; Ninewells Cancer Campaign Cancer Research award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Graduate Training Program in Cellular and Molecular Pharmacology; Gates Millennium Scholars Program; NSF Graduate Research Fellowship(National Science Foundation (NSF)); PhRMA Foundation PreDoctoral Fellowship in Pharmacology Toxicology; Ninewells Cancer Campaign Cancer Research award	This work was supported by NIH R35 GM122523 and NIH GM43154 (A. C. N.). A.-A. N. V., T. R. B., and C. E. A. were supported in part by the University of California, San Diego Graduate Training Program in Cellular and Molecular Pharmacology (T32 GM007752). A.-A. N. V was supported by the Gates Millennium Scholars Program. C. E. A. was supported by the NSF Graduate Research Fellowship (DGE1144086) and T. R. B. by the PhRMA Foundation PreDoctoral Fellowship in Pharmacology Toxicology (#20183844). S. B. was supported by the Ninewells Cancer Campaign Cancer Research award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Antal CE, 2014, CHEM BIOL, V21, P459, DOI 10.1016/j.chembiol.2014.02.008; Baffi TR, 2019, MOL CELL, V74, P378, DOI 10.1016/j.molcel.2019.02.018; Barber KW, 2018, BIOCHEMISTRY-US, V57, P4717, DOI 10.1021/acs.biochem.8b00410; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Belot A, 2013, ARTHRITIS RHEUM-US, V65, P2161, DOI 10.1002/art.38008; Biebl MM, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a034017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bridge JA, 2013, BRAIN PATHOL, V23, P121, DOI 10.1111/j.1750-3639.2012.00612.x; Callender J. A., 2017, NEURONAL SIGNAL, V1, P1; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Dowling CM, 2016, ONCOTARGET, V7, P20919, DOI 10.18632/oncotarget.8062; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Dupain C, 2019, MOL THER, V27, P200, DOI 10.1016/j.ymthe.2018.10.022; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gao QS, 2018, CELL REP, V23, P227, DOI 10.1016/j.celrep.2018.03.050; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Gasperini AE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06884-8; Giorgione J, 2003, BIOCHEMISTRY-US, V42, P11194, DOI 10.1021/bi0350046; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Halvorsen AR, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.590755; Han S, 2010, J NEUROSCI, V30, P15102, DOI 10.1523/JNEUROSCI.3128-10.2010; Hantschel Oliver, 2012, Genes Cancer, V3, P436, DOI 10.1177/1947601912458584; Hedtke V, 2019, EXP BIOL MED, V244, P655, DOI 10.1177/1535370219830997; Hu J, 2015, MOL CELL BIOL, V35, P264, DOI 10.1128/MCB.00943-14; Hu X, 2018, NUCLEIC ACIDS RES, V46, pD1144, DOI 10.1093/nar/gkx1018; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; Kastenhuber ER, 2017, P NATL ACAD SCI USA, V114, P13076, DOI 10.1073/pnas.1716483114; Kaulich M, 2015, NUCLEIC ACID THER, V25, P287, DOI 10.1089/nat.2015.0545; Kaulich M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1403; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; Kim J, 2015, GENE CHROMOSOME CANC, V54, P681, DOI 10.1002/gcc.22279; Kim RN, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020502; KRAFT AS, 1982, J BIOL CHEM, V257, P13193; Kuehn HS, 2013, BLOOD, V121, P3117, DOI 10.1182/blood-2012-12-469544; LEACH KL, 1983, P NATL ACAD SCI-BIOL, V80, P4208, DOI 10.1073/pnas.80.14.4208; Lee M, 2017, NUCLEIC ACIDS RES, V45, pD784, DOI 10.1093/nar/gkw1083; Li FD, 2020, CYTOKINE GROWTH F R, V52, P56, DOI 10.1016/j.cytogfr.2019.12.005; Liu Y, 2017, NAT GENET, V49, P1211, DOI 10.1038/ng.3909; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2019, J THORAC ONCOL, V14, pE266, DOI 10.1016/j.jtho.2019.07.021; Matissek KJ, 2018, CANCER DISCOV, V8, P336, DOI 10.1158/2159-8290.CD-17-0535; Memi F, 2019, BRAIN STRUCT FUNCT, V224, P277, DOI 10.1007/s00429-018-1772-4; Mertens F, 2015, NAT REV CANCER, V15, P371, DOI 10.1038/nrc3947; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nagaishi M, 2016, J CLIN NEUROSCI, V23, P73, DOI 10.1016/j.jocn.2015.04.021; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Nelson Katelyn N, 2018, Oncotarget, V9, P34306, DOI 10.18632/oncotarget.26142; Newton AC, 2017, TRENDS PHARMACOL SCI, V38, P438, DOI 10.1016/j.tips.2017.02.002; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Noh H, 2007, KIDNEY INT, V72, pS49, DOI 10.1038/sj.ki.5002386; Okuda H, 1999, ONCOGENE, V18, P5604, DOI 10.1038/sj.onc.1202946; Pages M, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0264-5; Panagopoulos I, 2015, CANCER GENET-NY, V208, P545, DOI 10.1016/j.cancergen.2015.07.007; Peiris MN, 2020, HAEMATOLOGICA, V105, P1262, DOI 10.3324/haematol.2019.220871; Plaszczyca A, 2014, INT J BIOCHEM CELL B, V53, P475, DOI 10.1016/j.biocel.2014.03.027; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Ross BL, 2018, ELIFE, V7, DOI 10.7554/eLife.35458; Salzer E, 2013, BLOOD, V121, P3112, DOI 10.1182/blood-2012-10-460741; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shimizu T, 1998, J BIOL CHEM, V273, P8669, DOI 10.1074/jbc.273.15.8669; Sima S, 2018, BBA-MOL CELL RES, V1865, P889, DOI 10.1016/j.bbamcr.2018.03.008; Stransky N., 2020, PRKC FUSIONS US PATE; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tobias IS, 2016, J BIOL CHEM, V291, P13809, DOI 10.1074/jbc.M116.729483; Tomasini M. D., 2018, SCI REP-UK, V8, P1; Tovell H, 2021, BIOCHEM J, V478, P341, DOI 10.1042/BCJ20190765; Uphoff Cord C, 2013, Methods Mol Biol, V946, P1, DOI 10.1007/978-1-62703-128-8_1; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; von Einem B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129047; Walther C, 2015, LAB INVEST, V95, P1071, DOI 10.1038/labinvest.2015.83; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406	87	9	9	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100445	10.1016/j.jbc.2021.100445	http://dx.doi.org/10.1016/j.jbc.2021.100445			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33617877	gold, Green Published			2022-12-28	WOS:000672866400419
J	Wang, Y; Li, XY; Ge, JR; Liu, M; Pang, XM; Liu, JP; Luo, C; Xu, YC; Zhao, Q				Wang, Ying; Li, Xinyu; Ge, Jingru; Liu, Ming; Pang, Xiaming; Liu, Jianpeng; Luo, Cheng; Xu, Yichen; Zhao, Quan			The methyltransferase PRMT1 regulates gamma-globin translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FETAL-HEMOGLOBIN; GENE-EXPRESSION; BETA-THALASSEMIA; INITIATION; METHYLATION; INDUCTION; REVEALS; RECOGNITION; EFFICIENCY; INHIBITOR	Induction of fetal hemoglobin to overcome adult beta-globin gene deficiency is an effective therapeutic strategy to ameliorate human beta-hemoglobinopathies. Previous work has revealed that fetal gamma-globin can be translationally induced via integrated stress signaling, but other studies have indicated that activating stress may eventually suppress gamma-globin expression transcriptionally. The mechanism by which gamma-globin expression is regulated at the translational level remains largely unknown, limiting our ability to determine whether activating stress is a realistic therapeutic option for these disorders. In this study, we performed a functional CRISPR screen targeting protein arginine methyltransferases (PRMTs) to look for changes in gamma-globin expression in K562 cells. We not only discovered that several specific PRMTs may block gamma-globin transcription, but also revealed PRMT1 as a unique family member that is able to suppress gamma-globin synthesis specifically at the translational level. We further identified that a non-AUG uORF within the 5' untranslated region of gamma-globin serves as a barrier for translation, which is bypassed upon PRMT1 deficiency. Finally, we found that this novel mechanism of gamma-globin suppression could be pharmacologically targeted by the PRMT1 inhibitor, furamidine dihydrochloride. These data raise new questions regarding methyltransferase function and may offer a new therapeutic direction for beta-hemoglobinopathies.	[Wang, Ying; Li, Xinyu; Ge, Jingru; Liu, Ming; Liu, Jianpeng; Zhao, Quan] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Hematol,Sch Life Sci, Affiliated Drum Tower Hosp,Med Sch,China Australi, Nanjing, Peoples R China; [Wang, Ying; Pang, Xiaming; Xu, Yichen] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94110 USA; [Wang, Ying; Pang, Xiaming; Xu, Yichen] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Luo, Cheng] Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, CAS Key Lab Receptor Res,State Key Lab Drug Res, Shanghai, Peoples R China; [Xu, Yichen] Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou, Peoples R China	Nanjing University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Zhejiang University	Zhao, Q (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Hematol,Sch Life Sci, Affiliated Drum Tower Hosp,Med Sch,China Australi, Nanjing, Peoples R China.; Xu, YC (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94110 USA.; Xu, YC (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Xu, YC (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou, Peoples R China.	yichen_xu@zju.edu.cn; qzhao@nju.edu.cn	Xinyu, Li/AAG-1655-2021	Xinyu, Li/0000-0003-3694-4188; Zhao, Quan/0000-0002-8533-1938	National Natural Science Foundation of China NSFC [31770809, 31970615]	National Natural Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China NSFC (31770809 and 31970615).	Atkins C., 2020, HAEMATOLOGICA; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bank A, 2005, J CLIN INVEST, V115, P1470, DOI 10.1172/JCI25398; Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368; Chakalova L, 2005, BLOOD, V105, P2154, DOI 10.1182/blood-2003-11-4069; Cui SY, 2017, ADV EXP MED BIOL, V1013, P177, DOI 10.1007/978-1-4939-7299-9_7; DOVER GJ, 1994, BLOOD, V84, P339; Gao GZ, 2017, NUCLEIC ACIDS RES, V45, P4359, DOI 10.1093/nar/gkw1367; Gao J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.444; Ginder GD, 2015, TRANSL RES, V165, P115, DOI 10.1016/j.trsl.2014.05.002; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guccione E, 2019, NAT REV MOL CELL BIO, V20, P642, DOI 10.1038/s41580-019-0155-x; Guenther UP, 2018, NATURE, V559, P130, DOI 10.1038/s41586-018-0258-0; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Hahn CK, 2014, BLOOD, V124, P2730, DOI 10.1182/blood-2014-03-564302; Hahn CK, 2013, BLOOD, V122, P477, DOI 10.1182/blood-2013-03-491043; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Hsu JHR, 2017, CANCER RES, V77, P4613, DOI 10.1158/0008-5472.CAN-17-0216; Huang P, 2020, BLOOD, V135, P2121, DOI 10.1182/blood.2020005301; Hussain T, 2014, CELL, V159, P597, DOI 10.1016/j.cell.2014.10.001; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Larsen SC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7329; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; LOWREY CH, 1993, NEW ENGL J MED, V329, P845, DOI 10.1056/NEJM199309163291205; Masuda T, 2016, SCIENCE, V351, P285, DOI 10.1126/science.aad3312; Nie M, 2018, J BIOL CHEM, V293, P17454, DOI 10.1074/jbc.RA118.004028; PERRINE SP, 1993, NEW ENGL J MED, V328, P81, DOI 10.1056/NEJM199301143280202; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Rivers A, 2016, HAEMATOLOGICA, V101, P688, DOI 10.3324/haematol.2015.140749; Samir P, 2019, NATURE, V573, P590, DOI 10.1038/s41586-019-1551-2; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharma D, 2014, CRIT REV BIOCHEM MOL, V49, P343, DOI 10.3109/10409238.2014.931339; Shi LH, 2013, NAT MED, V19, P291, DOI 10.1038/nm.3101; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Wang C, 2017, J MED CHEM, V60, P8888, DOI 10.1021/acs.jmedchem.7b01134; Weinberg RS, 2005, BLOOD, V105, P1807, DOI 10.1182/blood-2004-02-0454; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Xu YC, 2020, ANNU REV CANC BIOL, V4, P437, DOI 10.1146/annurev-cancerbio-030419-033420; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhu XG, 2020, EXP BIOL MED, V245, P1308, DOI 10.1177/1535370220945305	48	3	3	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100417	10.1016/j.jbc.2021.100417	http://dx.doi.org/10.1016/j.jbc.2021.100417			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33587951	gold, Green Published			2022-12-28	WOS:000672866400391
J	Wilson, KA; Mostyn, SN; Frangos, ZJ; Shimmon, S; Rawling, T; Vandenberg, RJ; O'Mara, ML				Wilson, Katie A.; Mostyn, Shannon N.; Frangos, Zachary J.; Shimmon, Susan; Rawling, Tristan; Vandenberg, Robert J.; O'Mara, Megan L.			The allosteric inhibition of glycine transporter 2 by bioactive lipid analgesics is controlled by penetration into a deep lipid cavity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENT	The role of lipids in modulating membrane protein function is an emerging and rapidly growing area of research. The rational design of lipids that target membrane proteins for the treatment of pathological conditions is a novel extension in this field and provides a step forward in our understanding of membrane transporters. Bioactive lipids show considerable promise as analgesics for the treatment of chronic pain and bind to a high-affinity allosteric-binding site on the human glycine transporter 2 (GlyT2 or SLC6A5). Here, we use a combination of medicinal chemistry, electrophysiology, and computational modeling to develop a rational structure-activity relationship for lipid inhibitors and demonstrate the key role of the lipid tail interactions for GlyT2 inhibition. Specifically, we examine how lipid inhibitor head group stereochemistry, tail length, and double-bond position promote enhanced inhibition. Overall, the L-stereoisomer is generally a better inhibitor than the D-stereoisomer, longer tail length correlates with greater potency, and the position of the double bond influences the activity of the inhibitor. We propose that the binding of the lipid inhibitor deep into the allosteric-binding pocket is critical for inhibition. Furthermore, this provides insight into the mechanism of inhibition of GlyT2 and highlights how lipids can modulate the activity of membrane proteins by binding to cavities between helices. The principles identified in this work have broader implications for the development of a larger class of compounds that could target SLC6 transporters for disease treatment.	[Wilson, Katie A.; O'Mara, Megan L.] Australian Natl Univ, Coll Sci, Res Sch Chem, Canberra, ACT, Australia; [Mostyn, Shannon N.; Frangos, Zachary J.; Vandenberg, Robert J.] Univ Sydney, Sch Med Sci, Discipline Pharmacol, Sydney, NSW, Australia; [Shimmon, Susan; Rawling, Tristan] Univ Technol Sydney, Sch Math & Phys Sci, Sydney, NSW, Australia	Australian National University; University of Sydney; University of Technology Sydney	O'Mara, ML (corresponding author), Australian Natl Univ, Coll Sci, Res Sch Chem, Canberra, ACT, Australia.	megan.omara@anu.edu.au	Wilson, Katie/HHZ-4634-2022; O'Mara, Megan/AAY-5934-2021; Wilson, Katie/AAA-8566-2019; Vandenberg, Robert/E-6018-2016	O'Mara, Megan/0000-0002-8764-1585; Wilson, Katie/0000-0002-4951-127X; Frangos, Zachary/0000-0002-5499-4050; Vandenberg, Robert/0000-0003-1523-4814; Rawling, Tristan/0000-0002-6624-6586	National Health and Medical Research Council [APP1144429]; Australian Government; Government of Western Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR); Government of Western Australia	This work was supported by a grant from the National Health and Medical Research Council (APP1144429). This research was undertaken with the assistance of resources and services from the National Computational Infrastructure, which is supported by the Australian Government; and the Pawsey Supercomputing Centre, which is supported by the Australian Government and the Government of Western Australia.	Bai JY, 2015, BRIT J PHARMACOL, V172, P5281, DOI 10.1111/bph.13314; Carland JE, 2018, ACS CHEM NEUROSCI, V9, P603, DOI 10.1021/acschemneuro.7b00407; Caulfield WL, 2001, J MED CHEM, V44, P2679, DOI 10.1021/jm0011272; Cioffi CL, 2018, J MED CHEM, V61, P2652, DOI 10.1021/acs.jmedchem.7b00956; Eulenburg V, 2005, TRENDS BIOCHEM SCI, V30, P325, DOI 10.1016/j.tibs.2005.04.004; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hua T, 2016, CELL, V167, P750, DOI 10.1016/j.cell.2016.10.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Mostyn SN, 2020, ACS CHEM NEUROSCI, V11, P1250, DOI 10.1021/acschemneuro.9b00655; Mostyn SN, 2019, ELIFE, V8, DOI 10.7554/eLife.47150; Mostyn SN, 2019, J MED CHEM, V62, P2466, DOI 10.1021/acs.jmedchem.8b01775; Mostyn SN, 2017, ACS CHEM NEUROSCI, V8, P1949, DOI 10.1021/acschemneuro.7b00105; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Stroet M, 2018, J CHEM THEORY COMPUT, V14, P5834, DOI 10.1021/acs.jctc.8b00768; Subramanian N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157583; Takahashi E, 2014, BIOORG MED CHEM LETT, V24, P4603, DOI 10.1016/j.bmcl.2014.06.059; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vandenberg RJ, 2016, NEUROCHEM INT, V98, P89, DOI 10.1016/j.neuint.2015.12.007; Vandenberg RJ, 2014, TRENDS PHARMACOL SCI, V35, P423, DOI 10.1016/j.tips.2014.05.006; Volkow N, 2018, ANNU REV MED, V69, P451, DOI 10.1146/annurev-med-011817-044739; Xu TX, 2005, NEUROREPORT, V16, P1227, DOI 10.1097/00001756-200508010-00019; Zeppelin T, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005907	28	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100282	10.1016/j.jbc.2021.100282	http://dx.doi.org/10.1016/j.jbc.2021.100282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450225	Green Published, gold			2022-12-28	WOS:000672866400258
J	Yu, D; Kaur, G; Blumenthal, RM; Zhang, X; Cheng, XD				Yu, Dan; Kaur, Gundeep; Blumenthal, Robert M.; Zhang, Xing; Cheng, Xiaodong			Enzymatic characterization of three human RNA adenosine methyltransferases reveals diverse substrate affinities and reaction optima	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M(6)A METHYLTRANSFERASE; CRYSTAL-STRUCTURE; PROTEIN; N-6-METHYLADENOSINE; SCATTERING; METTL16; DOMAIN; METHYLATION; MECHANISM; SUGGESTS	RNA methylations of varied RNA species (mRNA, tRNA, rRNA, non-coding RNA) generate a range of modified nucleotides, including N6-methyladenosine. Here we study the enzymology of three human RNA methyltransferases that methylate the adenosine amino group in diverse contexts, when it is: the first transcribed nucleotide after the mRNA cap (PCIF1), at position 1832 of 18S rRNA (MettL5-Trm112 complex), and within a hairpin in the 30 UTR of the S-adenosyl-L-methionine synthetase (MettL16). Among these three enzymes, the catalytic efficiency ranges from PCIF1, with the fastest turnover rate of >230 h(-1) mu M-1 on mRNA cap analog, down to MettL16, which has the lowest rate of similar to 3 h(-1) mu M-1 acting on an RNA hairpin. Both PCIF1 and MettL5 have a binding affinity (K-m) of similar to 1 mu M or less for both substrates of SAM and RNA, whereas MettL16 has significantly lower binding affinities for both (Km >0.4 mM for SAM and similar to 10 mu M for RNA). The three enzymes are active over a wide pH range (similar to 5.4-9.4) and have different preferences for ionic strength. Sodium chloride at 200 mM markedly diminished methylation activity of MettL5-Trm112 complex, whereas MettL16 had higher activity in the range of 200 to 500 mM NaCl. Zinc ion inhibited activities of all three enzymes. Together, these results illustrate the diversity of RNA adenosine methyltransferases in their enzymatic mechanisms and substrate specificities and underline the need for assay optimization in their study.	[Yu, Dan; Kaur, Gundeep; Zhang, Xing; Cheng, Xiaodong] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Blumenthal, Robert M.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Blumenthal, Robert M.] Univ Toledo, Program Bioinformat, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Zhang, X; Cheng, XD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.	XZhang21@mdanderson.org; XCheng5@mdanderson.org		Cheng, Xiaodong/0000-0002-6967-6362	U.S. National Institutes of Health (NIH) [R35GM134744]; Cancer Prevention and Research Institute of Texas (CPRIT) [RR160029]; Department of Energy's Office of Biological and Environmental Research Integrated Diffraction Analysis Technology Program, NIGMS [P30 GM124169-01]; ALS-ENABLE; CPRIT [RP190602]	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); Department of Energy's Office of Biological and Environmental Research Integrated Diffraction Analysis Technology Program, NIGMS; ALS-ENABLE; CPRIT	This work was supported by U.S. National Institutes of Health (NIH) [R35GM134744 to X. C.]; Cancer Prevention and Research Institute of Texas (CPRIT) [RR160029 to X. C. who is a CPRIT Scholar in Cancer Research]. The SAXS data collection at SIBYLS beamline was supported by Department of Energy's Office of Biological and Environmental Research Integrated Diffraction Analysis Technology Program, NIGMS grant P30 GM124169-01, and ALS-ENABLE. CPRIT RP190602 partially supports the EM Core at Baylor College of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACHWAL CW, 1983, FEBS LETT, V158, P353, DOI 10.1016/0014-5793(83)80612-7; Akey DL, 2011, J MOL BIOL, V413, P438, DOI 10.1016/j.jmb.2011.08.040; Akichika S, 2019, SCIENCE, V363, P141, DOI 10.1126/science.aav0080; Ayadi L, 2019, BBA-GENE REGUL MECH, V1862, P253, DOI 10.1016/j.bbagrm.2018.11.009; Boo SH, 2020, EXP MOL MED, V52, P400, DOI 10.1038/s12276-020-0407-z; Boulias K, 2019, MOL CELL, V75, P631, DOI 10.1016/j.molcel.2019.06.006; Bourgeois G, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010007; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cheng X, 1999, S ADENOSYLMETHIONINE; Cozza G, 2018, FEBS J, V285, P4674, DOI 10.1111/febs.14689; Dai SB, 2020, J BIOL CHEM, V295, P10901, DOI 10.1074/jbc.RA120.014072; Dai SB, 2020, J BIOL CHEM, V295, P2582, DOI 10.1074/jbc.RA119.012319; Dai SB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11554-6; Deng X, 2015, NUCLEIC ACIDS RES, V43, P6557, DOI 10.1093/nar/gkv596; Dlugosz M, 2003, EUR BIOPHYS J BIOPHY, V31, P608, DOI 10.1007/s00249-002-0258-7; Dong GP, 2020, ACS COMB SCI, V22, P422, DOI 10.1021/acscombsci.0c00077; Douvlataniotis K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay3335; Doxtader KA, 2018, MOL CELL, V71, P1001, DOI 10.1016/j.molcel.2018.07.025; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Fan H, 2003, BIOCHEM BIOPH RES CO, V301, P378, DOI 10.1016/S0006-291X(02)03015-2; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Frye M, 2016, NAT REV GENET, V17, P365, DOI 10.1038/nrg.2016.47; Ganesan A, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0776-0; Garcia IG, 2010, J MOL BIOL, V395, P390, DOI 10.1016/j.jmb.2009.10.045; Greenberg MVC, 2019, NAT REV MOL CELL BIO, V20, P590, DOI 10.1038/s41580-019-0159-6; Hirose Y, 2008, BIOCHEM BIOPH RES CO, V369, P449, DOI 10.1016/j.bbrc.2008.02.042; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; Hsiao K, 2016, EPIGENOMICS-UK, V8, P321, DOI 10.2217/epi.15.113; Ignatova VV, 2020, GENE DEV, V34, P715, DOI [10.1101/gad.333369.119, 10.1126/sciadv.aaz4551]; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; KENNEDY CD, 1990, BIOCHEM EDUC, V18, P35, DOI 10.1016/0307-4412(90)90017-I; Kikhney AG, 2015, FEBS LETT, V589, P2570, DOI 10.1016/j.febslet.2015.08.027; Kilchert C, 2020, WIRES RNA, V11, DOI 10.1002/wrna.1582; Kolev SK, 2018, METALLOMICS, V10, P659, DOI 10.1039/c8mt00043c; Leismann J, 2020, EMBO REP, V21, DOI 10.15252/embr.201949443; Li WJ, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0121-y; Liu J, 2020, SCIENCE, V367, P580, DOI 10.1126/science.aay6018; Liu S, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02012-4; Liu XL, 2021, CELL RES, V31, P94, DOI 10.1038/s41422-020-0317-6; MADEN BEH, 1986, J MOL BIOL, V189, P681, DOI 10.1016/0022-2836(86)90498-5; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Maret W, 2013, BIOMETALS, V26, P197, DOI 10.1007/s10534-013-9613-7; Mendel M, 2018, MOL CELL, V71, P986, DOI 10.1016/j.molcel.2018.08.004; Murray IA, 2018, NUCLEIC ACIDS RES, V46, P840, DOI 10.1093/nar/gkx1191; Musheev MU, 2020, NAT CHEM BIOL, V16, P630, DOI 10.1038/s41589-020-0504-2; Tran NV, 2019, NUCLEIC ACIDS RES, V47, P7719, DOI 10.1093/nar/gkz619; Tran NV, 2018, NUCLEIC ACIDS RES, V46, P8483, DOI 10.1093/nar/gky638; Nye TM, 2020, CRIT REV BIOCHEM MOL, V55, P576, DOI 10.1080/10409238.2020.1828257; Pandey RR, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108038; Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rivas G, 2016, TRENDS BIOCHEM SCI, V41, P970, DOI 10.1016/j.tibs.2016.08.013; Rong BW, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108544; Ru WX, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200091; Sanchez-Romero MA, 2020, NAT REV MICROBIOL, V18, P7, DOI 10.1038/s41579-019-0286-2; Schiffers S, 2017, ANGEW CHEM INT EDIT, V56, P11268, DOI 10.1002/anie.201700424; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sendinc E, 2019, MOL CELL, V75, P620, DOI 10.1016/j.molcel.2019.05.030; Shima H, 2017, CELL REP, V21, P3354, DOI 10.1016/j.celrep.2017.11.092; Singh S, 2008, J BIOL CHEM, V283, P22628, DOI 10.1074/jbc.M800503200; Some D, 2019, JOVE-J VIS EXP, DOI 10.3791/59615; Sun HX, 2019, CELL RES, V29, P80, DOI 10.1038/s41422-018-0117-4; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Warda AS, 2017, EMBO REP, V18, P2004, DOI 10.15252/embr.201744940; Wolf A, 2013, BIOCHEM J, V453, P357, DOI 10.1042/BJ20130529; Woodcock CB, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0119-5; Wu TP, 2016, NATURE, V532, P329, DOI 10.1038/nature17640; Wyrzykowski J, 2003, J BACTERIOL, V185, P1701, DOI 10.1128/JB.185.5.1701-1704.2003; Xie Q, 2018, CELL, V175, P1228, DOI 10.1016/j.cell.2018.10.006; Xing M, 2020, EMBO REP, V21, DOI 10.15252/embr.201949863; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zeng Y, 2020, GENE DEV, V34, P1546, DOI 10.1101/gad.341925.120; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	79	7	7	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100270	10.1016/j.jbc.2021.100270	http://dx.doi.org/10.1016/j.jbc.2021.100270			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428944	Green Published, gold			2022-12-28	WOS:000672866400246
J	Yue, JJ; Dai, Q; Hao, SH; Zhu, SQ; Liu, XX; Tang, ZQ; Li, M; Fang, HT; Lin, CQ; Luo, ZJ				Yue, Junjie; Dai, Qian; Hao, Shaohua; Zhu, Shiqi; Liu, Xiaoxu; Tang, Zhiqun; Li, Meng; Fang, Haitong; Lin, Chengqi; Luo, Zhuojuan			Suppression of the NTS-CPS1 regulatory axis by AFF1 in lung adenocarcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME CONFORMATION CAPTURE; ACUTE LYMPHOBLASTIC-LEUKEMIA; ELONGATION COMPLEX; NEUROTENSIN RECEPTORS; NERVOUS-SYSTEM; CANCER; AF4; TRANSCRIPTION; ACTIVATION; CHROMATIN	Upregulation of the neuropeptide neurotensin (NTS) in a subgroup of lung cancers has been linked to poor prognosis. However, the regulatory pathway centered on NTS in lung cancer remains unclear. Here we identified the NTS-specific enhancer in lung adenocarcinoma cells. The AF4/FMR2 (AFF) family protein AFF1 occupies the NTS enhancer and inhibits NTS transcription. Clustering analysis of lung adenocarcinoma gene expression data demonstrated that NTS expression is highly positively correlated with the expression of the oncogenic factor CPS1. Detailed analyses demonstrated that the IL6 pathway antagonizes NTS in regulating CPS1. Thus, our analyses revealed a novel NTS-centered regulatory axis, consisting of AFF1 as a master transcription suppressor and IL6 as an antagonist in lung adenocarcinoma cells.	[Yue, Junjie; Dai, Qian; Hao, Shaohua; Zhu, Shiqi; Liu, Xiaoxu; Li, Meng; Fang, Haitong; Lin, Chengqi; Luo, Zhuojuan] Southeast Univ, Sch Life Sci & Technol, Key Lab Dev Genes & Human Dis, Nanjing, Peoples R China; [Tang, Zhiqun] Singapore Eye Res Inst, Singapore, Singapore; [Lin, Chengqi; Luo, Zhuojuan] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China	Southeast University - China; National University of Singapore; Singapore National Eye Center; Nantong University	Lin, CQ; Luo, ZJ (corresponding author), Southeast Univ, Sch Life Sci & Technol, Key Lab Dev Genes & Human Dis, Nanjing, Peoples R China.; Lin, CQ; Luo, ZJ (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China.	cqlin@seu.edu.cn; zjluo@seu.eau.cn		Fang, Haitong/0000-0003-1174-9191; Lin, Chengqi/0000-0002-2121-584X; Dai, Qian/0000-0002-5774-7469	National Key R&D Program of China [2018YFA0800100, 2018YFA0800103]; National Natural Science Foundation of China [32030017, 31970617, 31970626]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Studies in this article were supported by funds provided by National Key R&D Program of China (2018YFA0800100 to C. L.; 2018YFA0800103 to Z. L.), National Natural Science Foundation of China (32030017, 31970617 to C. L.; 31970626 to Z. L.).	Alifano M, 2010, CLIN CANCER RES, V16, P4401, DOI 10.1158/1078-0432.CCR-10-0659; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Behm FG, 1996, BLOOD, V87, P2870, DOI 10.1182/blood.V87.7.2870.bloodjournal8772870; Beilharz EJ, 1998, J NEUROSCI, V18, P9780; Bitoun E, 2009, CEREBELLUM, V8, P175, DOI 10.1007/s12311-009-0101-0; Bose P, 2015, PEPTIDES, V73, P43, DOI 10.1016/j.peptides.2015.08.008; Brunetti J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/173507; Carranza C, 2013, CANCER GENET-NY, V206, P227, DOI 10.1016/j.cancergen.2013.05.017; Celiktas M, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw231; Cen H, 2012, IMMUNOGENETICS, V64, P935, DOI 10.1007/s00251-012-0650-0; Chen FX, 2017, SCIENCE, V357, P1294, DOI 10.1126/science.aan3269; Choi S, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-27; Erfurth F, 2004, LEUKEMIA, V18, P92, DOI 10.1038/sj.leu.2403200; Ernst A, 2006, PEPTIDES, V27, P1787, DOI 10.1016/j.peptides.2006.01.021; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Fernandez-Minan A, 2016, METHOD CELL BIOL, V135, P413, DOI 10.1016/bs.mcb.2016.02.008; Huang HY, 2017, CANCER RES, V77, P5769, DOI 10.1158/0008-5472.CAN-17-0449; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Johansson B, 1998, LEUKEMIA, V12, P779, DOI 10.1038/sj.leu.2401012; Jones SA, 2018, NAT REV IMMUNOL, V18, P773, DOI 10.1038/s41577-018-0066-7; Kampmann M, 2018, ACS CHEM BIOL, V13, P406, DOI 10.1021/acschembio.7b00657; Kim J, 2017, NATURE, V546, P168, DOI 10.1038/nature22359; Kleczkowska P, 2013, EUR J PHARMACOL, V716, P54, DOI 10.1016/j.ejphar.2013.03.004; Kumari N, 2019, P NATL ACAD SCI USA, V116, P22140, DOI 10.1073/pnas.1907097116; Kurihara T, 2008, DIABETES, V57, P2191, DOI 10.2337/db07-1281; Kuzmina A, 2017, TRANSCR-AUSTIN, V8, P133, DOI 10.1080/21541264.2017.1295831; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li L, 2019, NATURE, V567, P253, DOI 10.1038/s41586-019-0996-7; Lin CQ, 2013, CELL, V152, P144, DOI 10.1016/j.cell.2012.12.015; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Lu HS, 2014, P NATL ACAD SCI USA, V111, pE15, DOI 10.1073/pnas.1318503111; Luo ZJ, 2016, GENE DEV, V30, P92, DOI 10.1101/gad.270413.115; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Matelot M, 2016, METHODS MOL BIOL, V1480, P223, DOI 10.1007/978-1-4939-6380-5_20; MILLER DC, 1990, HUM PATHOL, V21, P271, DOI 10.1016/0046-8177(90)90226-U; Moody TW, 2015, PEPTIDES, V72, P106, DOI 10.1016/j.peptides.2015.03.018; Moody TW, 2014, LIFE SCI, V100, P25, DOI 10.1016/j.lfs.2014.01.072; Mouritzen MV, 2018, J PEPT SCI, V24, DOI 10.1002/psc.3093; Okuda H, 2017, J CLIN INVEST, V127, P1918, DOI 10.1172/JCI91406; Oliver PL, 2004, P NATL ACAD SCI USA, V101, P14901, DOI 10.1073/pnas.0406196101; Ouyang Q, 2017, CLIN EXP PHARMACOL P, V44, P841, DOI 10.1111/1440-1681.12787; Ouyang Q, 2016, NEURO-ONCOLOGY, V18, P216, DOI 10.1093/neuonc/nov114; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Pham-Danis C, 2019, MOL CANCER RES, V17, P1351, DOI 10.1158/1541-7786.MCR-18-1068; REINECKE M, 1985, PROG HISTOCHEM CYTOC, V16, P1; Schwerd T, 2017, J EXP MED, V214, P2547, DOI 10.1084/jem.20161810; Seufferlein T, 1996, CANCER RES, V56, P5758; Sheng LM, 2013, INT J CANCER, V133, P2720, DOI 10.1002/ijc.28284; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; Su ZJ, 2019, GENE, V687, P143, DOI 10.1016/j.gene.2018.10.062; THEODORSSONNORHEIM E, 1983, GASTROENTEROLOGY, V85, P881; Torruella-Suarez ML, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2020.108005; Wang XF, 2006, CLIN CANCER RES, V12, P5346, DOI 10.1158/1078-0432.CCR-06-0968; Wang Y, 2017, NUCLEIC ACIDS RES, V45, P1177, DOI 10.1093/nar/gkw1051; Wu ZR, 2019, CANCER LETT, V444, P147, DOI 10.1016/j.canlet.2018.12.007; Wu ZR, 2017, CANCER LETT, V388, P73, DOI 10.1016/j.canlet.2016.11.032; Xiao P, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1440166; Zhang Y, 2019, J MOL CELL BIOL, V11, P761, DOI [10.1093/jmcb/mjy074, 10.1093/jmcb/mjyz074]; Zhou CC, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.44; Zhu SM, 2019, ONCOGENE, V38, P4875, DOI 10.1038/s41388-019-0750-5	61	4	4	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100319	10.1016/j.jbc.2021.100319	http://dx.doi.org/10.1016/j.jbc.2021.100319			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493519	gold, Green Published			2022-12-28	WOS:000672866400293
J	Guiney, SJ; Adlard, PA; Lei, P; Mawal, CH; Bush, AI; Finkelstein, DI; Ayton, S				Guiney, Stephanie J.; Adlard, Paul A.; Lei, Peng; Mawal, Celeste H.; Bush, Ashley, I; Finkelstein, David, I; Ayton, Scott			Fibrillar alpha-synuclein toxicity depends on functional lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein; cell viability; lysosomes; Parkinson&apos; s disease; alpha-synuclein (a-synuclein); lysosome; Parkinson disease; cell death; iron	Q-VD-OPH; PARKINSONS-DISEASE; CELL-DEATH; SUBSTANTIA-NIGRA; CATHEPSIN-B; MEMBRANE PERMEABILIZATION; PROTEIN-DEGRADATION; CEREBROSPINAL-FLUID; CASPASE INHIBITOR; IRON CONTENT	Neurodegeneration in Parkinson's disease (PD) can be recapitulated in animals by administration of alpha-synuclein preformed fibrils (PFFs) into the brain. However, the mechanism by which these PFFs induce toxicity is unknown. Iron is implicated in PD pathophysiology, so we investigated whether alpha-synuclein PFFs induce ferroptosis, an iron-dependent cell death pathway. A range of ferroptosis inhibitors were added to a striatal neuron-derived cell line (STHdhQ7/7 cells), a dopaminergic neuron-derived cell line (SN4741 cells), and WT primary cortical neurons, all of which had been intoxicated with alpha-synuclein PFFs. Viability was not recovered by these inhibitors except for liproxstatin-1, a best-in-class ferroptosis inhibitor, when used at high doses. High-dose liproxstatin-1 visibly enlarged the area of a cell that contained acidic vesicles and elevated the expression of several proteins associated with the autophagy-lysosomal pathway similarly to the known lysosomal inhibitors, chloroquine and bafilomycin A1. Consistent with high-dose liproxstatin-1 protecting via a lysosomal mechanism, we further de-monstrated that loss of viability induced by alpha-synuclein PFFs was attenuated by chloroquine and bafilomycin A1 as well as the lysosomal cysteine protease inhibitors, leupeptin, E-64D, and Ca-074-Me, but not other autophagy or lysosomal enzyme inhibitors. We confirmed using immunofluorescence microscopy that heparin prevented uptake of alpha-synuclein PFFs into cells but that chloroquine did not stop alpha-synuclein uptake into lysosomes despite impairing lysosomal function and inhibiting alpha-synuclein toxicity. Together, these data suggested that alpha-synuclein PFFs are toxic in functional lysosomes in vitro. Therapeutic strategies that prevent alpha-synuclein fibril uptake into lysosomes may be of benefit in PD.	[Guiney, Stephanie J.; Adlard, Paul A.; Lei, Peng; Mawal, Celeste H.; Bush, Ashley, I; Finkelstein, David, I; Ayton, Scott] Melbourne Dementia Res Ctr, Parkville, Vic, Australia; [Guiney, Stephanie J.; Adlard, Paul A.; Lei, Peng; Mawal, Celeste H.; Bush, Ashley, I; Finkelstein, David, I; Ayton, Scott] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Guiney, Stephanie J.; Adlard, Paul A.; Lei, Peng; Bush, Ashley, I; Finkelstein, David, I; Ayton, Scott] Univ Melbourne, Parkville, Vic, Australia; [Lei, Peng] Sichuan Univ, West China Hosp, Dept Neurol, Collaborat Ctr Biotherapy, Chengdu, Peoples R China; [Lei, Peng] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Collaborat Ctr Biotherapy, Chengdu, Peoples R China	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Sichuan University; Sichuan University	Ayton, S (corresponding author), Melbourne Dementia Res Ctr, Parkville, Vic, Australia.; Ayton, S (corresponding author), Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.; Ayton, S (corresponding author), Univ Melbourne, Parkville, Vic, Australia.	scott.ayton@florey.edu.au	Ayton, Scott/J-8000-2015; Finkelstein, David/B-9617-2009; Ayton, Scott/AAJ-3414-2021; Lei, Peng/F-6326-2010; Bush, Ashley I./A-1186-2007	Ayton, Scott/0000-0002-3479-2427; Finkelstein, David/0000-0002-8167-4917; Lei, Peng/0000-0001-5652-1962; Bush, Ashley I./0000-0001-8259-9069; Guiney, Stephanie/0000-0003-2864-6148	Australian National Health and Medical Research Council (NHMRC); Government of Victoria from the Operational Infrastructure Support Grant	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Government of Victoria from the Operational Infrastructure Support Grant	This work was supported by funds from the Australian National Health and Medical Research Council (NHMRC). The Florey Institute of Neuroscience and Mental Health is supported by the Government of Victoria, in particular funding from the Operational Infrastructure Support Grant.	Abdelmotilib H, 2017, NEUROBIOL DIS, V105, P84, DOI 10.1016/j.nbd.2017.05.014; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; AOYAGI T, 1969, J ANTIBIOT, V22, P558, DOI 10.7164/antibiotics.22.558; Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Ayton S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/581256; BAICI A, 1982, EUR J BIOCHEM, V129, P33, DOI 10.1111/j.1432-1033.1982.tb07017.x; Bandres-Ciga S, 2019, MOVEMENT DISORD, V34, P460, DOI 10.1002/mds.27614; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Brojatsch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095032; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Cleeter MWJ, 2013, NEUROCHEM INT, V62, P1, DOI 10.1016/j.neuint.2012.10.010; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Crabtree D, 2014, J NEUROCHEM, V128, P950, DOI 10.1111/jnc.12497; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Do Van B, 2016, NEUROBIOL DIS, V94, P169, DOI 10.1016/j.nbd.2016.05.011; Duffy MF, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1171-z; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Eusebi P, 2017, MOVEMENT DISORD, V32, P1389, DOI 10.1002/mds.27110; Fairfoul G, 2016, ANN CLIN TRANSL NEUR, V3, P812, DOI 10.1002/acn3.338; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fernandes HJR, 2016, STEM CELL REP, V6, P342, DOI 10.1016/j.stemcr.2016.01.013; FIRESTONE RA, 1979, J MED CHEM, V22, P1130, DOI 10.1021/jm00195a026; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Freeze B, 2018, NEUROIMAGE-CLIN, V18, P456, DOI 10.1016/j.nicl.2018.01.009; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Groveman BR, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0508-2; Guiney SJ, 2017, NEUROCHEM INT, V104, P34, DOI 10.1016/j.neuint.2017.01.004; Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021; Harms AS, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0494-9; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Henry AG, 2015, HUM MOL GENET, V24, P6013, DOI 10.1093/hmg/ddv314; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Huang ZW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003083; Ihse E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08720-5; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Karpowicz RJ, 2017, J BIOL CHEM, V292, P13482, DOI 10.1074/jbc.M117.780296; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Klionsky DJ, 2011, AUTOPHAGY, V7, P1, DOI 10.4161/auto.7.1.14130; Klucken J, 2012, AUTOPHAGY, V8, P754, DOI 10.4161/auto.19371; KNIGHT CG, 1976, BIOCHEM J, V155, P117, DOI 10.1042/bj1550117; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kuzelova K, 2011, J CELL BIOCHEM, V112, P3334, DOI 10.1002/jcb.23263; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lima H, 2013, CELL CYCLE, V12, P1868, DOI 10.4161/cc.24903; Lu SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173771; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Mahoney-Sanchez L, 2021, PROG NEUROBIOL, V196, DOI 10.1016/j.pneurobio.2020.101890; MARCINISZYN J, 1976, J BIOL CHEM, V251, P7088; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; Minakaki G, 2018, AUTOPHAGY, V14, P98, DOI 10.1080/15548627.2017.1395992; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; OHKUMA S, 1981, J CELL BIOL, V90, P656, DOI 10.1083/jcb.90.3.656; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Okada M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.579961; Onishi A, 2016, FRONT BIOSCI-LANDMRK, V21, P1372, DOI 10.2741/4462; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paumier KL, 2015, NEUROBIOL DIS, V82, P185, DOI 10.1016/j.nbd.2015.06.003; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Petrucci S, 2016, PARKINSONISM RELAT D, V22, pS16, DOI 10.1016/j.parkreldis.2015.08.015; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; RATAN RR, 1994, J NEUROCHEM, V62, P376; Ruiz-Irastorza G, 2010, ANN RHEUM DIS, V69, P20, DOI 10.1136/ard.2008.101766; Sacino AN, 2017, J NEUROCHEM, V140, P662, DOI 10.1111/jnc.13743; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; SATOYOSHI E, 1992, INTERNAL MED, V31, P841, DOI 10.2169/internalmedicine.31.841; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEGLEN PO, 1976, EXP CELL RES, V100, P276, DOI 10.1016/0014-4827(76)90148-8; Sheng XH, 2017, PHYS CHEM CHEM PHYS, V19, P13153, DOI 10.1039/c7cp00804j; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Steverding D., 2011, OPEN ENZYME INHIBITI, V4, P11, DOI [10.2174/1874940201104010011, DOI 10.2174/1874940201104010011]; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Teplova VV, 2007, J BIOENERG BIOMEMBR, V39, P321, DOI 10.1007/s10863-007-9095-9; Tessa C, 2014, HUM BRAIN MAPP, V35, P3932, DOI 10.1002/hbm.22449; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tsujimura A, 2015, NEUROBIOL DIS, V73, P244, DOI 10.1016/j.nbd.2014.10.011; UMEZAWA H, 1970, J ANTIBIOT, V23, P259, DOI 10.7164/antibiotics.23.259; Vandenabeele P, 2013, CELL DEATH DIFFER, V20, P185, DOI 10.1038/cdd.2012.151; Wang RQ, 2015, EXP THER MED, V9, P2088, DOI 10.3892/etm.2015.2432; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Xu J, 2007, BRAIN RES, V1139, P220, DOI 10.1016/j.brainres.2006.12.074; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	121	15	16	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17497	17513		10.1074/jbc.RA120.013428	http://dx.doi.org/10.1074/jbc.RA120.013428			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453994	Green Published, hybrid			2022-12-28	WOS:000603272300010
J	Chen, TC; Kuo, TY; Dandan, M; Lee, RA; Chang, M; Villivalam, SD; Liao, SC; Costello, D; Shankaran, M; Mohammed, H; Kang, S; Hellerstein, MK; Wang, JC				Chen, Tzu-Chieh; Kuo, Taiyi; Dandan, Mohamad; Lee, Rebecca A.; Chang, Maggie; Villivalam, Sneha D.; Liao, Szu-Chi; Costello, Damian; Shankaran, Mahalakshmi; Mohammed, Hussein; Kang, Sona; Hellerstein, Marc K.; Wang, Jen-Chywan			The role of striated muscle Pik3r1 in glucose and protein metabolism following chronic glucocorticoid exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; P85-ALPHA SUBUNIT; TRANSLATION INITIATION; REGULATORY SUBUNIT; RECEPTOR; PHOSPHORYLATION; EXPRESSION; GROWTH; P85; MECHANISMS	Chronic glucocorticoid exposure causes insulin resistance and muscle atrophy in skeletal muscle. We previously identified phosphoinositide-3-kinase regulatory subunit 1 (Pik3r1) as a primary target gene of skeletal muscle glucocorticoid receptors involved in the glucocorticoid-mediated suppression of insulin action. However, the in vivo functions of Pik3r1 remain unclear. Here, we generated striated muscle-specific Pik3r1 knockout (MKO) mice and treated them with a dexamethasone (DEX), a synthetic glucocorticoid. Treating wildtype (WT) mice with DEX attenuated insulin activated Akt activity in liver, epididymal white adipose tissue, and gastrocnemius (GA) muscle. This DEX effect was diminished in GA muscle of MKO mice, therefore, resulting in improved glucose and insulin tolerance in DEX-treated MKO mice. Stable isotope labeling techniques revealed that in WT mice, DEX treatment decreased protein fractional synthesis rates in GA muscle. Furthermore, histology showed that in WT mice, DEX treatment reduced GA myotube diameters. In MKO mice, myotube diameters were smaller than in WT mice, and there were more fast oxidative fibers. Importantly, DEX failed to further reduce myotube diameters. Pik3r1 knockout also decreased basal protein synthesis rate (likely caused by lower 4E-BP1 phosphorylation at Thr37/Thr46) and curbed the ability of DEX to attenuate protein synthesis rate. Finally, the ability of DEX to inhibit eIF2 alpha phosphorylation and insulin-induced 4E-BP1 phosphorylation was reduced in MKO mice. Taken together, these results demonstrate the role of Pik3r1 in glucocorticoid-mediated effects on glucose and protein metabolism in skeletal muscle.	[Chen, Tzu-Chieh; Dandan, Mohamad; Kang, Sona; Hellerstein, Marc K.; Wang, Jen-Chywan] Univ Calif Berkeley, Metab Biol Grad Program, Berkeley, CA 94720 USA; [Chen, Tzu-Chieh; Kuo, Taiyi; Dandan, Mohamad; Lee, Rebecca A.; Chang, Maggie; Villivalam, Sneha D.; Liao, Szu-Chi; Costello, Damian; Shankaran, Mahalakshmi; Mohammed, Hussein; Kang, Sona; Hellerstein, Marc K.; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Kuo, Taiyi; Lee, Rebecca A.; Chang, Maggie; Villivalam, Sneha D.; Liao, Szu-Chi; Costello, Damian; Kang, Sona; Hellerstein, Marc K.; Wang, Jen-Chywan] Univ Calif Berkeley, Endocrinol Grad Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wang, JC (corresponding author), Univ Calif Berkeley, Metab Biol Grad Program, Berkeley, CA 94720 USA.; Wang, JC (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.; Wang, JC (corresponding author), Univ Calif Berkeley, Endocrinol Grad Program, Berkeley, CA 94720 USA.	walwang@berkeley.edu	Wang, Jen-Chywan/AAX-4445-2020	Wang, Jen-Chywan/0000-0001-6030-6886; Liao, Szu-Chi/0000-0003-2744-363X; Chang, Maggie/0000-0002-4618-5958; Dandan, Mohamad/0000-0002-3751-8968	National Institutes of Health [DK08359, DK113019]; Muscular Dystrophy Association [186068]; NIH [DK116008]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health DK08359 and DK113019, and Muscular Dystrophy Association (Research Grant 186068) to J. C. W. This work was also supported by the NIH DK116008 to S. K. The content is solely the responsibility of the authors and does not necessarily represent the office views of the National Institutes of Health or the Muscular Dystrophy Association.	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845; Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Bergmeister K. D., 2017, J VIS EXP, V55441; Bodine SC, 2015, ADV EXP MED BIOL, V872, P145, DOI 10.1007/978-1-4939-2895-8_7; Bolster DR, 2003, EXERC SPORT SCI REV, V31, P111, DOI 10.1097/00003677-200307000-00002; Britto FA, 2014, AM J PHYSIOL-ENDOC M, V307, pE983, DOI 10.1152/ajpendo.00234.2014; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bulut GB, 2013, BLOOD, V122, P3964, DOI 10.1182/blood-2013-05-506212; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Cheung LWT, 2015, ELIFE, V4, DOI 10.7554/eLife.06866; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Fan WW, 2017, CELL METAB, V25, P1186, DOI 10.1016/j.cmet.2017.04.006; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Holmes WE, 2015, METHOD ENZYMOL, V561, P219, DOI 10.1016/bs.mie.2015.05.018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang-Doran I, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88766; Jean S, 2014, J CELL SCI, V127, P923, DOI 10.1242/jcs.093773; Kalvisa A, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006249; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Kuo TY, 2017, DIABETES, V66, P1601, DOI 10.2337/db16-0831; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; Kuo T, 2013, MOL CELL ENDOCRINOL, V380, P79, DOI 10.1016/j.mce.2013.03.003; Kuo TY, 2012, P NATL ACAD SCI USA, V109, P11160, DOI 10.1073/pnas.1111334109; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Luo J, 2005, MOL CELL BIOL, V25, P9491, DOI 10.1128/MCB.25.21.9491-9502.2005; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; Luo J, 2006, CELL METAB, V3, P355, DOI 10.1016/j.cmet.2006.04.003; Magomedova L, 2016, HANDB EXP PHARMACOL, V233, P73, DOI 10.1007/164_2015_1; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; McCurdy CE, 2012, DIABETES, V61, P2495, DOI 10.2337/db11-1433; Musa J, 2016, ONCOGENE, V35, P4675, DOI 10.1038/onc.2015.515; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; Papageorgopoulos C, 1999, ANAL BIOCHEM, V267, P1, DOI 10.1006/abio.1998.2958; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Ringseis R, 2020, METABOLITES, V10, DOI 10.3390/metabo10040138; Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007; Roux PP, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00070-18; Schakman O, 2009, HORM RES, V72, P36, DOI 10.1159/000229762; Schiaffino S, 2018, FEBS J, V285, P3688, DOI 10.1111/febs.14502; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE76, DOI 10.1152/ajpendo.2000.278.1.E76; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Taniguchi CM, 2007, MOL CELL BIOL, V27, P2830, DOI 10.1128/MCB.00079-07; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Thauvin-Robinet C, 2013, AM J HUM GENET, V93, P141, DOI 10.1016/j.ajhg.2013.05.019; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Waterlow J. C., 1978, PROTEIN TURNOVER MAM; Winnay JN, 2016, J CLIN INVEST, V126, P1401, DOI 10.1172/JCI84005; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480	61	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100395	10.1016/j.jbc.2021.100395	http://dx.doi.org/10.1016/j.jbc.2021.100395			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33567340	Green Published, gold			2022-12-28	WOS:000672866400369
J	Ha, JH; Tu, HC; Wilkens, S; Loh, SN				Ha, Jeung-Hoi; Tu, Ho-Chou; Wilkens, Stephan; Loh, Stewart N.			Loss of bound zinc facilitates amyloid fibril formation of leukocyte-cell-derived chemotaxin 2 (LECT2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; CHEMISTRY; PROTEIN	Aggregation of the circulating protein leukocyte-cell-derived chemotaxin 2 (LECT2) causes amyloidosis of LECT2 (ALECT2), one of the most prevalent forms of systemic amyloidosis affecting the kidney and liver. The I40V mutation is thought to be necessary but not sufficient for ALECT2, with a second, as-yet undetermined condition being required for the disease. EM, X-ray diffraction, NMR, and fluorescence experiments demonstrate that LECT2 forms amyloid fibrils in vitro in the absence of other proteins. Removal of LECT2's single bound Zn2+ appears to be obligatory for fibril formation. Zinc-binding affinity is strongly dependent on pH: 9-13 % of LECT2 is calculated to exist in the zinc-free state over the normal pH range of blood, with this fraction rising to 80 % at pH 6.5. The I40V mutation does not alter zinc-binding affinity or kinetics but destabilizes the zinc-free conformation. These results suggest a mechanism in which loss of zinc together with the I40V mutation leads to ALECT2.	[Ha, Jeung-Hoi; Wilkens, Stephan; Loh, Stewart N.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Tu, Ho-Chou] Alnylam Pharmaceut, Cambridge, MA USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Loh, SN (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	lohs@upstate.edu			NIH [GM058600]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S. W. is supported by NIH grant GM058600.	Ando K, 2012, MICROBIOL IMMUNOL, V56, P708, DOI 10.1111/j.1348-0421.2012.00488.x; Atrian-Blasco E, 2018, COORDIN CHEM REV, V371, P38, DOI 10.1016/j.ccr.2018.04.007; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Benson MD, 2008, KIDNEY INT, V74, P218, DOI 10.1038/ki.2008.152; Blindauer CA, 2009, J BIOL CHEM, V284, P23116, DOI 10.1074/jbc.M109.003459; Briefel RR, 2000, J NUTR, V130, p1367S, DOI 10.1093/jn/130.5.1367S; Chen CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep31398; Chen CK, 2014, HEPATOLOGY, V59, P974, DOI 10.1002/hep.26738; Dogan A, 2017, ANNU REV PATHOL-MECH, V12, P277, DOI 10.1146/annurev-pathol-052016-100200; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Hwang HJ, 2015, METABOLISM, V64, P1175, DOI 10.1016/j.metabol.2015.06.001; Kameoka Y, 2000, ARTHRITIS RHEUM, V43, P1419, DOI 10.1002/1529-0131(200006)43:6<1419::AID-ANR28>3.0.CO;2-I; Kocyla A, 2015, J INORG BIOCHEM, V152, P82, DOI 10.1016/j.jinorgbio.2015.08.024; Krezel A, 2016, ARCH BIOCHEM BIOPHYS, V611, P3, DOI 10.1016/j.abb.2016.04.010; L'Hermitte A, 2019, HEPATOLOGY, V69, P160, DOI 10.1002/hep.30140; Larsen CP, 2016, AMYLOID, V23, P119, DOI 10.3109/13506129.2016.1145110; Larsen CP, 2010, KIDNEY INT, V77, P816, DOI 10.1038/ki.2010.9; Lei P., 2021, J BIOL CHEM, V296; Lu XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12719; Lu XJ, 2013, J EXP MED, V210, P5, DOI 10.1084/jem.20121466; Malmos KG, 2017, AMYLOID, V24, P1, DOI 10.1080/13506129.2017.1304905; Mereuta OM, 2014, BLOOD, V123, P1479, DOI 10.1182/blood-2013-07-517938; Morris KL, 2012, METHODS MOL BIOL, V849, P121, DOI 10.1007/978-1-61779-551-0_9; Nasr SH, 2015, CLIN J AM SOC NEPHRO, V10, P2084, DOI 10.2215/CJN.12551214; Okumura A, 2013, FEBS LETT, V587, P404, DOI 10.1016/j.febslet.2013.01.025; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Said SM, 2014, KIDNEY INT, V86, P370, DOI 10.1038/ki.2013.558; Said SM, 2013, CLIN J AM SOC NEPHRO, V8, P1515, DOI 10.2215/CJN.10491012; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Shen HX, 2016, GENET MOL RES, V15, DOI 10.4238/gmr15048889; Slowik V, 2017, CTS-CLIN TRANSL SCI, V10, P249, DOI 10.1111/cts.12469; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Tsiolaki PL, 2019, J STRUCT BIOL, V207, P260, DOI 10.1016/j.jsb.2019.06.001; Wang ZL, 2018, DEV COMP IMMUNOL, V79, P75, DOI [10.1016/j.dci.2017.09.018, 10.1]; Xu M, 2019, CELL, V178, P1478, DOI 10.1016/j.cell.2019.07.021; Yamagoe S, 1998, GENOMICS, V48, P324, DOI 10.1006/geno.1997.5198; Yu X, 2014, ONCOTARGET, V5, P8879, DOI 10.18632/oncotarget.2432; Zalyapin EA, 2008, KIDNEY INT, V74, P1557, DOI 10.1038/ki.2008.412; Zheng H, 2016, J BIOL CHEM, V291, P17133, DOI 10.1074/jbc.M116.720375; Zheng H, 2013, PROTEIN EXPRES PURIF, V88, P221, DOI 10.1016/j.pep.2013.01.008	41	8	8	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100446	10.1016/j.jbc.2021.100446	http://dx.doi.org/10.1016/j.jbc.2021.100446			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33617884	gold, Green Published			2022-12-28	WOS:000672866400420
J	He, P; Schulz, P; Sierks, MR				He, Ping; Schulz, Philip; Sierks, Michael R.			A conformation-specific antibody against oligomeric beta-amyloid restores neuronal integrity in a mouse model of Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; PROTEIN; BRAIN; TOXICITY; PATHOLOGY; PEPTIDE; AGGREGATION; HYPOTHESIS; BIOMARKERS; SECRETASE	Conformationally distinct aggregates of the amyloid beta (A beta) peptide accumulate in brains of patients with Alzheimer's disease (AD), but the roles of the different aggregates in disease progression are not clear. We previously isolated two single-chain variable domain antibody fragments (scFvs), C6T and A4, that selectively bind different toxic conformational variants of oligomeric A beta. Here, we utilize these scFvs to localize the presence of these A beta variants in human AD brain and to demonstrate their potential as therapeutic agents for treating AD. Both A4 and C6T label oligomeric A beta in extracellular amyloid plaques, whereas C6T also labels intracellular oligomeric A beta in human AD brain tissue and in an AD mouse model. For therapeutic studies, the A4 and C6T scFvs were expressed in the AD mice by viral infection of liver cells. The scFvs were administered at 2 months of age, and mice sacrificed at 9 months. The scFvs contained a peptide tag to facilitate transport across the blood brain barrier. While treatment with C6T only slightly decreased A beta deposits and plaque-associated inflammation, it restored neuronal integrity to WT levels, significantly promoted growth of new neurons, and impressively rescued survival rates to WT levels. Treatment with A4 on the other hand significantly decreased A beta deposits but did not significantly decrease neuroinflammation or promote neuronal integrity, neurogenesis, or survival rate. These results suggest that the specific A beta conformation targeted in therapeutic applications greatly affects the outcome, and the location of the targeted A beta variants may also play a critical factor.	[He, Ping; Schulz, Philip; Sierks, Michael R.] Arizona State Univ, Dept Chem Engn, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sierks, MR (corresponding author), Arizona State Univ, Dept Chem Engn, Tempe, AZ 85287 USA.	ping.he.3@asu.edu; sierks@asu.edu		Sierks, Michael/0000-0001-7301-230X	National Institutes of Health; Alzheimer's Association; Catalyst Award from Arizona Technology Enterprises; National Institutes of Health Shared Instrumentation Grant [1 S10 RR027154-01A1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Catalyst Award from Arizona Technology Enterprises; National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grants from the National Institutes of Health and Alzheimer's Association and a Catalyst Award from Arizona Technology Enterprises. Image data were collected using a Leica TCS SP5 LSCM (National Institutes of Health Shared Instrumentation Grant award: 1 S10 RR027154-01A1) housed in the Regenerative Medicine Imaging Facility at Arizona State University, Tempe, AZ. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Bartolini M, 2011, ANAL BIOCHEM, V414, P215, DOI 10.1016/j.ab.2011.03.020; Barz B, 2018, J AM CHEM SOC, V140, P319, DOI 10.1021/jacs.7b10343; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bittner T, 2012, ACTA NEUROPATHOL, V124, P797, DOI 10.1007/s00401-012-1047-8; Boddapati S, 2012, J ALZHEIMERS DIS, V28, P961, DOI 10.3233/JAD-2011-111196; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Cline EN, 2018, J ALZHEIMERS DIS, V64, pS567, DOI 10.3233/JAD-179941; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Darlington D, 2015, CELL TRANSPLANT, V24, P2237, DOI 10.3727/096368915X688894; Economou NJ, 2016, J AM CHEM SOC, V138, P1772, DOI 10.1021/jacs.5b11913; Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191; Gandy S, 2010, ANN NEUROL, V68, P220, DOI 10.1002/ana.22052; Ghiso J, 2002, ADV DRUG DELIVER REV, V54, P1539, DOI 10.1016/S0169-409X(02)00149-7; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; He P, 2019, MOL NEUROBIOL, V56, P7420, DOI 10.1007/s12035-019-1597-z; He P, 2014, HUM MOL GENET, V23, P6512, DOI 10.1093/hmg/ddu370; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kasturirangan S, 2013, BIOTECHNOL PROGR, V29, P463, DOI 10.1002/btpr.1698; Kasturirangan S, 2012, NEUROBIOL AGING, V33, P1320, DOI 10.1016/j.neurobiolaging.2010.09.020; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kulic L, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.109; Liebscher S, 2014, MOL PSYCHIATR, V19, P937, DOI 10.1038/mp.2013.122; Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x; Mrdenovic D, 2019, LANGMUIR, V35, P11940, DOI 10.1021/acs.langmuir.9b01645; Parker MH, 2000, CHEMTRACTS ORG CHEM, V13, P51; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Sadigh-Eteghad S, 2015, MED PRIN PRACT, V24, P1, DOI 10.1159/000369101; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Spencer B, 2014, MOL THER, V22, P1753, DOI 10.1038/mt.2014.129; Spencer B, 2014, J BIOL CHEM, V289, P17917, DOI 10.1074/jbc.M114.557439; Spencer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016575; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Teplow DB, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt203; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Watanabe-Nakayama T, 2016, P NATL ACAD SCI USA, V113, P5835, DOI 10.1073/pnas.1524807113; Williams SM, 2017, J ALZHEIMERS DIS, V58, P23, DOI 10.3233/JAD-161116; Williams SM, 2016, EUR J NEUROSCI, V43, P3, DOI 10.1111/ejn.13056; Yan Q, 2003, J NEUROSCI, V23, P7504; Yang T, 2017, J NEUROSCI, V37, P152, DOI 10.1523/JNEUROSCI.1698-16.2016; Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068; Zhao LN, 2012, INT J MOL SCI, V13, P7303, DOI 10.3390/ijms13067303	57	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100241	10.1074/jbc.RA120.015327	http://dx.doi.org/10.1074/jbc.RA120.015327			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33376140	gold, Green Published			2022-12-28	WOS:000672866400219
J	Keller, MB; Badino, SF; Rojel, N; Sorensen, TH; Kari, J; McBrayer, B; Borch, K; Blossom, BM; Westh, P				Keller, Malene Billeskov; Badino, Silke Flindt; Rojel, Nanna; Sorensen, Trine Holst; Kari, Jeppe; McBrayer, Brett; Borch, Kim; Blossom, Benedikt M.; Westh, Peter			A comparative biochemical investigation of the impeding effect of C1-oxidizing LPMOs on cellobiohydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYTIC POLYSACCHARIDE MONOOXYGENASE; OXIDATIVE CLEAVAGE; TRICHODERMA-REESEI; CELLULOSE CHAIN; DEGRADATION; BINDING; BIODEGRADATION; PROCESSIVITY; CELLULASES; INSIGHTS	Lytic polysaccharide monooxygenases (LPMOs) are known to act synergistically with glycoside hydrolases in industrial cellulolytic cocktails. However, a few studies have reported severe impeding effects of C1-oxidizing LPMOs on the activity of reducing-end cellobiohydrolases. The mechanism for this effect remains unknown, but it may have important implications as reducing-end cellobiohydrolases make up a significant part of such cocktails. To elucidate whether the impeding effect is general for different reducing-end cellobiohydrolases and study the underlying mechanism, we conducted a comparative biochemical investigation of the cooperation between a C1-oxidizing LPMO from Thielavia terrestris and three reducing-end cellobiohydrolases; Trichoderma reesei (TrCel7A), T. terrestris (TtCel7A), and Myceliophthora heterothallica (MhCel7A). The enzymes were heterologously expressed in the same organism and thoroughly characterized biochemically. The data showed distinct differences in synergistic effects between the LPMO and the cellobiohydrolases; TrCel7A was severely impeded, TtCel7A was moderately impeded, while MhCel7A was slightly boosted by the LPMO. We investigated effects of C1-oxidations on cellulose chains on the activity of the cellobiohydrolases and found reduced activity against oxidized cellulose in steady-state and pre-steady-state experiments. The oxidations led to reduced maximal velocity of the cellobiohydrolases and reduced rates of substrate complexation. The extent of these effects differed for the cellobiohydrolases and scaled with the extent of the impeding effect observed in the synergy experiments. Based on these results, we suggest that C1-oxidized chain ends are poor attack sites for reducing-end cellobiohydrolases. The severity of the impeding effects varied considerably among the cellobiohydrolases, which may be relevant to consider for optimization of industrial cocktails.	[Keller, Malene Billeskov; Blossom, Benedikt M.] Univ Copenhagen, Dept Geosci & Nat Resource Management, Frederiksberg, Denmark; [Badino, Silke Flindt; Rojel, Nanna; Kari, Jeppe; Westh, Peter] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Sorensen, Trine Holst; Borch, Kim] Novozymes AS, Lyngby, Denmark; [McBrayer, Brett] Novozymes Inc, Davis, CA USA; [Rojel, Nanna] Novozymes AS, Bagsvaerd, Denmark	University of Copenhagen; Technical University of Denmark; Novozymes; Novozymes; Novozymes	Blossom, BM (corresponding author), Univ Copenhagen, Dept Geosci & Nat Resource Management, Frederiksberg, Denmark.; Westh, P (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark.	kbm@ign.ku.dk; petwe@dtu.dk	Kari, Jeppe/AAP-6649-2021	Kari, Jeppe/0000-0003-3792-3856; Billeskov Keller, Malene/0000-0001-7184-1032; Westh, Peter/0000-0002-6185-0637; Mollers Blossom, Benedikt/0000-0002-8326-6140	Innovation Fund, Denmark [7043-00016B, 5150-00020B]; Novo Nordisk Foundation [NNF15OC0016606, NNFSA170028392, NNF16OC0021832]; Carlsberg Foundation	Innovation Fund, Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation)	This study was funded by the Innovation Fund, Denmark (grant numbers: 7043-00016B and 5150-00020B), the Novo Nordisk Foundation (grant numbers: NNF15OC0016606, NNFSA170028392, and NNF16OC0021832), and the Carlsberg Foundation.	Aguilar-Pontes MV, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0460-y; Beeson WT, 2015, ANNU REV BIOCHEM, V84, P923, DOI 10.1146/annurev-biochem-060614-034439; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Blossom BM, 2020, ACS SUSTAIN CHEM ENG, V8, P9301, DOI 10.1021/acssuschemeng.0c00702; Boer H, 2003, EUR J BIOCHEM, V270, P841, DOI 10.1046/j.1432-1033.2003.03431.x; Boisset C, 2001, BIOTECHNOL BIOENG, V72, P339, DOI 10.1002/1097-0290(20010205)72:3<339::AID-BIT11>3.0.CO;2-#; Borch K., 2014, WIPO patent, Patent No. 2014138672; Brown K., 2005, WIPO patent, Patent No. 2005074647; Busk PK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1601-6; Cannella D, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-26; Christensen SJ, 2019, BIOCHEM J, V476, P2157, DOI 10.1042/BCJ20190185; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, BIOTECHNOL BIOENG, V109, P3199, DOI 10.1002/bit.24593; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Dotson W. D., 2006, US patent, Patent No. 20060005279; Eibinger M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01028-y; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Harris PV, 2014, CURR OPIN CHEM BIOL, V19, P162, DOI 10.1016/j.cbpa.2014.02.015; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Hu JG, 2016, GREEN CHEM, V18, P6329, DOI 10.1039/c6gc02288j; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Johansen KS, 2016, BIOCHEM SOC T, V44, P143, DOI 10.1042/BST20150204; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kari J, 2017, ACS CATAL, V7, P4904, DOI 10.1021/acscatal.7b00838; Kari J, 2017, BIOCHEMISTRY-US, V56, P167, DOI 10.1021/acs.biochem.6b00636; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Kato Y, 2002, CELLULOSE, V9, P75, DOI 10.1023/A:1015877416414; Keller MB, 2020, BIOTECHNOL LETT, V42, P93, DOI 10.1007/s10529-019-02760-9; Keller M. B., 2020, ACS SUSTAIN CHEM ENG, V11, P52; Kim IJ, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0721-4; Kont R, 2016, J BIOL CHEM, V291, P26013, DOI 10.1074/jbc.M116.756007; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; LEVER M, 1973, BIOCHEM MED METAB B, V7, P274, DOI 10.1016/0006-2944(73)90083-5; McIntyre AP, 2013, CARBOHYD RES, V380, P118, DOI 10.1016/j.carres.2013.06.008; Moreau C, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1501-0; Muller G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0376-y; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rojas J, 2011, J ADV PHARM TECHNOL, V2, P144, DOI 10.4103/2231-4040.85527; Rojel N, 2020, J BIOL CHEM, V295, P1454, DOI 10.1074/jbc.RA119.011420; Scott BR, 2016, BIOTECHNOL LETT, V38, P425, DOI 10.1007/s10529-015-1989-8; Song B, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1023-1; Sorensen TH, 2015, J BIOL CHEM, V290, P22193, DOI 10.1074/jbc.M115.658930; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Tokin R, 2020, BIOTECHNOL LETT, V42, P1975, DOI 10.1007/s10529-020-02922-0; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vermaas JV, 2015, J PHYS CHEM B, V119, P6129, DOI 10.1021/acs.jpcb.5b00778; Villares A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40262; WAFFENSCHMIDT S, 1987, ANAL BIOCHEM, V165, P337, DOI 10.1016/0003-2697(87)90278-8; Wilson David B, 2012, Methods Mol Biol, V908, P93, DOI 10.1007/978-1-61779-956-3_9; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Xu F, 2009, ENZYME MICROB TECH, V45, P203, DOI 10.1016/j.enzmictec.2009.06.002; Yan BX, 1997, J PROTEIN CHEM, V16, P681; Yang J, 2019, ACS SUSTAIN CHEM ENG, V7, P7071, DOI 10.1021/acssuschemeng.8b06850; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zhou HC, 2019, INT J BIOL MACROMOL, V139, P570, DOI 10.1016/j.ijbiomac.2019.08.004	63	8	8	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100504	10.1016/j.jbc.2021.100504	http://dx.doi.org/10.1016/j.jbc.2021.100504			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675751	Green Published, gold			2022-12-28	WOS:000672866400478
J	Kmezik, C; Mazurkewich, S; Meents, T; McKee, LS; Idstrom, A; Armeni, M; Savolainen, O; Branden, G; Larsbrink, J				Kmezik, Cathleen; Mazurkewich, Scott; Meents, Tomke; McKee, Lauren Sara; Idstrom, Alexander; Armeni, Marina; Savolainen, Otto; Branden, Gisela; Larsbrink, Johan			A polysaccharide utilization locus from the gut bacterium Dysgonomonas mossii encodes functionally distinct carbohydrate esterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; FERULOYL ESTERASE; SUBSTRATE-SPECIFICITY; MOLECULAR REPLACEMENT; ENZYMATIC DEGRADATION; AUTOMATED REFINEMENT; STRUCTURAL BASIS; MICROBIOTA; LIGNIN; STARCH	The gut microbiota plays a central role in human health by enzymatically degrading dietary fiber and concomitantly excreting short chain fatty acids that are associated with manifold health benefits. The polysaccharide xylan is abundant in dietary fiber but noncarbohydrate decorations hinder efficient cleavage by glycoside hydrolases (GHs) and need to be addressed by carbohydrate esterases (CEs). Enzymes from carbohydrate esterase families 1 and 6 (CE1 and 6) perform key roles in xylan degradation by removing feruloyl and acetate decorations, yet little is known about these enzyme families especially with regard to their diversity in activity. Bacteroidetes bacteria are dominant members of the microbiota and often encode their carbohydrate-active enzymes in multigene polysaccharide utilization loci (PULs). Here we present the characterization of three CEs found in a PUL encoded by the gut Bacteroidete Dysgonomonas mossii. We demonstrate that the CEs are functionally distinct, with one highly efficient CE6 acetyl esterase and two CE1 enzymes with feruloyl esterase activities. One multidomain CE1 enzyme contains two CE1 domains: an N-terminal domain feruloyl esterase, and a C-terminal domain with minimal activity on model substrates. We present the structure of the C-terminal CE1 domain with the carbohydrate-binding module that bridges the two CE1 domains, as well as a complex of the same protein fragment with methyl ferulate. The investment of D. mossii in producing multiple CEs suggests that improved accessibility of xylan for GHs and cleavage of covalent polysaccharide-polysaccharide and lignin-polysaccharide bonds are important enzyme activities in the gut environment.	[Kmezik, Cathleen; Mazurkewich, Scott; Meents, Tomke; Larsbrink, Johan] Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Gothenburg, Sweden; [McKee, Lauren Sara] Royal Inst Technol KTH, AlbaNova Univ Ctr, Dept Chem, Div Glycosci, Stockholm, Sweden; [McKee, Lauren Sara; Larsbrink, Johan] Wallenberg Wood Sci Ctr, Stockholm, Sweden; [Idstrom, Alexander] Chalmers Univ Technol, Dept Chem & Chem Engn, Gothenburg, Sweden; [Armeni, Marina; Savolainen, Otto] Chalmers Univ Technol, Chalmers Mass Spectrometry Infrastruct, Dept Biol & Biol Engn, Gothenburg, Sweden; [Savolainen, Otto] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland; [Branden, Gisela] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Meents, Tomke] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, Mendelssohnstr 1, D-38106 Braunschweig, Germany	Chalmers University of Technology; Royal Institute of Technology; Chalmers University of Technology; Chalmers University of Technology; University of Eastern Finland; University of Gothenburg; Braunschweig University of Technology	Larsbrink, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Gothenburg, Sweden.; Larsbrink, J (corresponding author), Wallenberg Wood Sci Ctr, Stockholm, Sweden.	johan.larsbrink@chalmers.se	Larsbrink, Johan/A-3053-2013	Larsbrink, Johan/0000-0001-8386-2914; Mazurkewich, Scott/0000-0002-9238-0615; /0000-0002-3372-8773	Swedish Research Council [Dnr 2016-03931]; Novo Nordisk Foundation [NNF17OC0027648]; Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center(Knut & Alice Wallenberg Foundation)	The work was supported by a Starting Grant (Dnr 2016-03931) from the Swedish Research Council and a Research project grant from the Novo Nordisk Foundation (Grant number NNF17OC0027648), respectively, awarded to J. L., as well as the Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center (J. L. and L. S. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Baath JA, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1115-y; Barapatre A, 2016, INT J BIOL MACROMOL, V86, P443, DOI 10.1016/j.ijbiomac.2016.01.109; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIELY P, 1986, BIO-TECHNOL, V4, P731, DOI 10.1038/nbt0886-731; Blum DL, 1999, APPL ENVIRON MICROB, V65, P3990; Bocker S, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0116-8; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Busse-Wicher M, 2016, PLANT PHYSIOL, V171, P2418, DOI 10.1104/pp.16.00539; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; D?hrkop K., 2020, BIORXIV, DOI [10.1101/2020.04.17.046672, DOI 10.1101/2020.04.17.046672]; De Rosso M, 2018, J MASS SPECTROM, V53, P763, DOI 10.1002/jms.4263; Della JN, 1996, J BACTERIOL, V178, P7180; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dilokpimol A, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0651-6; Djoumbou Feunang Yannick, 2016, J Cheminform, V8, P61; Duhrkop K, 2015, P NATL ACAD SCI USA, V112, P12580, DOI 10.1073/pnas.1509788112; Duhrkop K, 2019, NAT METHODS, V16, P299, DOI 10.1038/s41592-019-0344-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faulds CB, 2005, FEBS J, V272, P4362, DOI 10.1111/j.1742-4658.2005.04849.x; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Foley MH, 2016, CELL MOL LIFE SCI, V73, P2603, DOI 10.1007/s00018-016-2242-x; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; GILBERT HJ, 1992, MOL MICROBIOL, V6, P2065, DOI 10.1111/j.1365-2958.1992.tb01379.x; Gille S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00012; Grabber JH, 1998, J SCI FOOD AGR, V77, P193, DOI 10.1002/(SICI)1097-0010(199806)77:2<193::AID-JSFA25>3.0.CO;2-A; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Gruninger RJ, 2016, BIOCHEM J, V473, P839, DOI 10.1042/BJ20151153; Holck J, 2019, J BIOL CHEM, V294, P17339, DOI 10.1074/jbc.RA119.009523; Kabel MA, 2003, CARBOHYD RES, V338, P69, DOI 10.1016/S0008-6215(02)00351-8; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATO Y, 1985, CARBOHYD RES, V137, P139, DOI 10.1016/0008-6215(85)85155-7; Kelle S, 2016, BIOTECHNOL APPL BIOC, V63, P852, DOI 10.1002/bab.1430; Kmezik C, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-01698-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krska D, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-01709-9; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Larsbrink J, 2020, ADV APPL MICROBIOL, V110, P63, DOI 10.1016/bs.aambs.2019.11.001; Larsbrink J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0674-z; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lawson PA, 2002, SYST APPL MICROBIOL, V25, P194, DOI 10.1078/0723-2020-00107; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Linke D, 2013, APPL MICROBIOL BIOT, V97, P7241, DOI 10.1007/s00253-012-4598-7; Ludwig M., 2019, ZODIAC DATABASE INDE, DOI [10.1101/842740, DOI 10.1101/842740]; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Munir RI, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0711-x; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Niemi P, 2013, J AGR FOOD CHEM, V61, P6754, DOI 10.1021/jf401738x; Nishimura H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24328-9; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Vinardell MP, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061219; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schubot FD, 2001, BIOCHEMISTRY-US, V40, P12524, DOI 10.1021/bi011391c; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; SHAO WL, 1995, APPL ENVIRON MICROB, V61, P729, DOI 10.1128/AEM.61.2.729-733.1995; Sheridan PO, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000043; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; TANCULA E, 1992, J BACTERIOL, V174, P5609, DOI 10.1128/JB.174.17.5609-5616.1992; Tauzin AS, 2016, MBIO, V7, DOI 10.1128/mBio.02134-15; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Terrett OM, 2019, CURR OPIN BIOTECH, V56, P97, DOI 10.1016/j.copbio.2018.10.010; Timell T. E., 1967, Wood Science and Technology, V1, P45, DOI 10.1007/BF00592255; Vagin A, 2015, ACTA CRYSTALLOGR A, V71, pS19, DOI 10.1107/S2053273315099672; Wang L, 2014, APPL BIOCHEM BIOTECH, V172, P993, DOI 10.1007/s12010-013-0536-0; Wefers D, 2017, J MOL BIOL, V429, P2509, DOI 10.1016/j.jmb.2017.06.017; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015	81	8	8	3	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100500	10.1016/j.jbc.2021.100500	http://dx.doi.org/10.1016/j.jbc.2021.100500			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667545	Green Published, gold			2022-12-28	WOS:000672866400474
J	Lin, CSH; Chan, ACK; Vermeulen, J; Brockerman, J; Soni, AS; Tanner, ME; Gaynor, EC; McIntosh, LP; Simorre, JP; Murphy, MEP				Lin, Chang Sheng-Huei; Chan, Anson C. K.; Vermeulen, Jenny; Brockerman, Jacob; Soni, Arvind S.; Tanner, Martin E.; Gaynor, Erin C.; McIntosh, Lawrence P.; Simorre, Jean-Pierre; Murphy, Michael E. P.			Peptidoglycan binding by a pocket on the accessory NTF2-domain of Pgp2 directs helical cell shape of Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; PROTEIN; RESISTANCE; CRYSTALLOGRAPHY; EPIDEMIOLOGY; ORGANIZATION; PATHOGENESIS; EXPRESSION; SYSTEM; FAMILY	The helical morphology of Campylobacter jejuni, a bacterium involved in host gut colonization and pathogenesis in humans, is determined by the structure of the peptidoglycan (PG) layer. This structure is dictated by trimming of peptide stems by the LD-carboxypeptidase Pgp2 within the periplasm. The interaction interface between Pgp2 and PG to select sites for peptide trimming is unknown. We determined a 1.6 angstrom resolution crystal structure of Pgp2, which contains a conserved LD-carboxypeptidase domain and a previously uncharacterized domain with an NTF2-like fold (NTF2). We identified a pocket in the NTF2 domain formed by conserved residues and located similar to 40 angstrom from the LD-carboxypeptidase active site. Expression of pgp2 in trans with substitutions of charged (Lys257, Lys307, Glu324) and hydrophobic residues (Phe242 and Tyr233) within the pocket did not restore helical morphology to a pgp2 deletion strain. Muropeptide analysis indicated a decrease of murotripeptides in the deletion strain expressing these mutants, suggesting reduced Pgp2 catalytic activity. Pgp2 but not the K307A mutant was pulled down by C. jejuni Delta pgp2 PG sacculi, supporting a role for the pocket in PG binding. NMR spectroscopy was used to define the interaction interfaces of Pgp2 with several PG fragments, which bound to the active site within the LD-carboxypeptidase domain and the pocket of the NTF2 domain. We propose a model for Pgp2 binding to PG strands involving both the LD-carboxypeptidase domain and the accessory NTF2 domain to induce a helical cell shape.	[Lin, Chang Sheng-Huei; Chan, Anson C. K.; Vermeulen, Jenny; Gaynor, Erin C.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Brockerman, Jacob; McIntosh, Lawrence P.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Soni, Arvind S.; Tanner, Martin E.; McIntosh, Lawrence P.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; [Simorre, Jean-Pierre] Univ Grenoble Alpes, IBS, CEA, CNRS, Grenoble, France	University of British Columbia; University of British Columbia; University of British Columbia; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada.	michael.murphy@ubc.ca		Lin, Chang Sheng-Huei/0000-0002-6966-4417; simorre, jean-pierre/0000-0002-7943-1342	Canadian Institutes of Health Research (CIHR) [MOP-142176]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was funded by Canadian Institutes of Health Research (CIHR) grants MOP-142176 to M. E. P. M. and M. E. T. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Asakura H, 2010, MOL MICROBIOL, V78, P1130, DOI 10.1111/j.1365-2958.2010.07393.x; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bartlett TM, 2017, CELL, V168, P172, DOI 10.1016/j.cell.2016.12.019; Beeby M, 2016, P NATL ACAD SCI USA, V113, pE1917, DOI 10.1073/pnas.1518952113; Bielnicki J, 2006, PROTEINS, V62, P144, DOI 10.1002/prot.20702; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Blair KM, 2018, MOL MICROBIOL, V110, P114, DOI 10.1111/mmi.14087; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Cai ML, 2016, J BIOMOL NMR, V66, P85, DOI 10.1007/s10858-016-0052-y; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eberhardt RY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-327; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esson D, 2016, SCI REP-UK, V6, DOI 10.1038/srep38303; Frirdich E, 2014, J BIOL CHEM, V289, P8007, DOI 10.1074/jbc.M113.491829; Frirdich E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002602; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; GOODWIN SD, 1975, ARCH BIOCHEM BIOPHYS, V170, P23, DOI 10.1016/0003-9861(75)90094-6; Gumbart JC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003475; Ha R, 2016, J BIOL CHEM, V291, P22686, DOI 10.1074/jbc.M116.746404; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; Kim HS, 2015, J BIOL CHEM, V290, P25103, DOI 10.1074/jbc.M115.658781; Kim SJ, 2015, BBA-BIOMEMBRANES, V1848, P350, DOI 10.1016/j.bbamem.2014.05.031; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lecoq L, 2012, STRUCTURE, V20, P850, DOI 10.1016/j.str.2012.03.015; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Liu YJ, 2016, ACS CHEM BIOL, V11, P981, DOI 10.1021/acschembio.5b01039; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Magnet S, 2007, J BIOL CHEM, V282, P13151, DOI 10.1074/jbc.M610911200; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Maya-Martine R, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03223; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Mesnage S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5269; Min K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13934-4; Moore JE, 2006, MICROBES INFECT, V8, P1955, DOI 10.1016/j.micinf.2005.12.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Rocaboy M, 2013, MOL MICROBIOL, V90, P267, DOI 10.1111/mmi.12361; Schanda P, 2014, J AM CHEM SOC, V136, P17852, DOI 10.1021/ja5105987; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Soni AS, 2019, CHEMBIOCHEM, V20, P1591, DOI 10.1002/cbic.201900011; Stahl M, 2016, INFECT IMMUN, V84, P3399, DOI 10.1128/IAI.00751-16; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Taylor JA, 2020, ELIFE, V9, DOI 10.7554/eLife.52482; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolgemuth CW, 2005, PHYS BIOL, V2, P189, DOI 10.1088/1478-3975/2/3/006; Yang DC, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00724-18; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	65	3	3	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100528	10.1016/j.jbc.2021.100528	http://dx.doi.org/10.1016/j.jbc.2021.100528			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33711341	Green Published, gold			2022-12-28	WOS:000672866400502
J	Muller, M; Calvert, M; Hottmann, I; Kluj, RM; Teufel, T; Balbuchta, K; Engelbrecht, A; Selim, KA; Xu, QP; Borisova, M; Titz, A; Mayer, C				Mueller, Maraike; Calvert, Matthew; Hottmann, Isabel; Kluj, Robert Maria; Teufel, Tim; Balbuchta, Katja; Engelbrecht, Alicia; Selim, Khaled A.; Xu, Qingping; Borisova, Marina; Titz, Alexander; Mayer, Christoph			The exo-beta-N-acetylmuramidase NamZ from Bacillus subtilis is the founding member of a family of exo-lytic peptidoglycan hexosaminidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC-ANALYSIS; ACETYLGLUCOSAMINIDASE; HYDROLYSIS; MECHANISM; HYDROLASE; ENZYMES; TRANSGLYCOSYLASES; IDENTIFICATION; PURIFICATION; SUBSTRATE	Endo-beta-N-acetylmuramidases, commonly known as lysozymes, are well-characterized antimicrobial enzymes that catalyze an endo-lytic cleavage of peptidoglycan; i.e., they hydrolyze the beta-1,4-glycosidic bonds connecting N-acetylmuramic acid (MurNAc) and N-acetylglucosamine (GlcNAc). In contrast, little is known about exo-beta-N-acetylmuramidases, which catalyze an exo-lytic cleavage of beta-1,4-MurNAc entities from the non-reducing ends of peptidoglycan chains. Such an enzyme was identified earlier in the bacterium Bacillus subtilis, but the corresponding gene has remained unknown so far. We now report that ybbC of B. subtilis, renamed namZ, encodes the reported exo-beta-N-acetylmuramidase. A Delta namZ mutant accumulated specific cell wall fragments and showed growth defects under starvation conditions, indicating a role of NamZ in cell wall turnover and recycling. Recombinant NamZ protein specifically hydrolyzed the artificial substrate para-nitrophenyl beta-MurNAc and the peptidoglycan-derived disaccharide MurNAc-beta-1,4-GlcNAc. Together with the exo-beta-N-acetylglucosaminidase NagZ and the exo-muramoyl-L-alanine amidase AmiE, NamZ degraded intact peptidoglycan by sequential hydrolysis from the non-reducing ends. A structure model of NamZ, built on the basis of two crystal structures of putative orthologs from Bacteroides fragilis, revealed a two-domain structure including a Rossmann-fold-like domain that constitutes a unique glycosidase fold. Thus, NamZ, a member of the DUF1343 protein family of unknown function, is now classified as the founding member of a new family of glycosidases (CAZy GH171; www.cazy.org/GH171.html). NamZ-like peptidoglycan hexosaminidases are mainly present in the phylum Bacteroidetes and less frequently found in individual genomes within Firmicutes (Bacilli, Clostridia), Actinobacteria, and gamma-proteobacteria.	[Mueller, Maraike; Hottmann, Isabel; Kluj, Robert Maria; Teufel, Tim; Balbuchta, Katja; Engelbrecht, Alicia; Selim, Khaled A.; Borisova, Marina; Mayer, Christoph] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Calvert, Matthew; Titz, Alexander] Helmholtz Ctr Infect Res HZI, Helmholtz Inst Pharmaceut Res Saarland HIPS, Chem Biol Carbohydrates, Saarbrucken, Germany; [Calvert, Matthew; Titz, Alexander] Deutsch Zentrum Infekt Forsch DZIF, Standort Hannover Brauns, Germany; [Calvert, Matthew; Titz, Alexander] Saarland Univ, Dept Chem, Saarbrucken, Germany; [Selim, Khaled A.] Natl Res Ctr, Chem Nat & Microbial Prod Dept, Pharmaceut & Drug Ind Res Div, Giza, Egypt; [Xu, Qingping] Argonne Natl Lab, GM CA APS, Lemont, IL USA; [Calvert, Matthew] Univ Auckland, Dept Chem, Auckland, New Zealand	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; Saarland University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); United States Department of Energy (DOE); Argonne National Laboratory; University of Auckland	Mayer, C (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.	christoph.mayer@uni-tuebingen.de	Titz, Alexander/E-6701-2010; Mayer, Christoph/S-8666-2017; Selim, Khaled/AAC-9733-2021	Titz, Alexander/0000-0001-7408-5084; Mayer, Christoph/0000-0003-4731-4851; Selim, Khaled/0000-0002-2974-9483	Ministry of Science, Research and Art of the state Baden-Wurttemberg (programme glycobiology/glycobiotechnology); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [SFB766, 398967434-TRR 261, 174858087-GRK1708]	Ministry of Science, Research and Art of the state Baden-Wurttemberg (programme glycobiology/glycobiotechnology); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	C. M. acknowledges funding by the Ministry of Science, Research and Art of the state Baden-Wurttemberg (programme glycobiology/glycobiotechnology) and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), grants SFB766, Project-ID 398967434-TRR 261, and Project-ID 174858087-GRK1708.	Acebron I, 2017, J AM CHEM SOC, V139, P6795, DOI 10.1021/jacs.7b01626; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; BERKELEY RC, 1973, BIOCHIM BIOPHYS ACTA, V309, P157, DOI 10.1016/0005-2744(73)90327-6; Borisova M, 2016, MBIO, V7, DOI 10.1128/mBio.00923-16; Dahl U, 2004, J BACTERIOL, V186, P2385, DOI 10.1128/JB.186.8.2385-2392.2004; DELRIO LA, 1975, ANAL BIOCHEM, V66, P405, DOI 10.1016/0003-2697(75)90608-9; DELRIO LA, 1976, EUR J BIOCHEM, V65, P3; DELRIO LA, 1973, FEBS LETT, V37, P7, DOI 10.1016/0014-5793(73)80414-4; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Fumeaux C, 2017, MBIO, V8, DOI 10.1128/mBio.00102-17; Gisin J, 2013, NAT CHEM BIOL, V9, P491, DOI 10.1038/nchembio.1289; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Horsburgh GJ, 2003, BIOCHEMISTRY-US, V42, P257, DOI 10.1021/bi020498c; Itoh T, 2019, ADV EXP MED BIOL, V1142, P131, DOI 10.1007/978-981-13-7318-3_7; Jaeger T, 2005, J BIOL CHEM, V280, P30100, DOI 10.1074/jbc.M502208200; Jaeger T, 2008, J BACTERIOL, V190, P6598, DOI 10.1128/JB.00642-08; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; JEANLOZ RW, 1968, CARBOHYD RES, V6, P184, DOI 10.1016/S0008-6215(00)81509-8; Kluj RM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02725; Koo BM, 2017, CELL SYST, V4, P291, DOI 10.1016/j.cels.2016.12.013; Laurino P, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002396; Lee M, 2013, J AM CHEM SOC, V135, P3311, DOI 10.1021/ja309036q; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Litzinger S, 2010, J BACTERIOL, V192, P3132, DOI 10.1128/JB.01256-09; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Mayer, 2019, EXTRACELLULAR SUGAR, P237, DOI DOI 10.1007/978-3-030-12919-4_6; Mayer C, 2019, INT J MED MICROBIOL, V309, DOI 10.1016/j.ijmm.2019.06.006; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; Miller J. H., 1972, ASSAY BETA GALACTOSI, V1972, P352; MSADEK T, 1990, J BACTERIOL, V172, P824, DOI 10.1128/jb.172.2.824-834.1990; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; ORTIZ JM, 1972, BIOCHIM BIOPHYS ACTA, V289, P174, DOI 10.1016/0005-2744(72)90120-9; Ragland SA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006512; Rajan SS, 2004, STRUCTURE, V12, P1619, DOI 10.1016/j.str.2004.06.020; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; Schaub RE, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2438; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Selim KA, 2020, FEBS J, V287, P465, DOI 10.1111/febs.14989; Strynadka N C, 1996, EXS, V75, P185; Sudiarta IP, 2010, BIOCHEM BIOPH RES CO, V398, P606, DOI 10.1016/j.bbrc.2010.07.001; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; Walter A, 2021, MICROB PHYSIOL, V31, P178, DOI 10.1159/000515178; Wang JP, 2013, LANGMUIR, V29, P14997, DOI 10.1021/la403401c; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183; Wheeler R, 2015, MBIO, V6, DOI 10.1128/mBio.00660-15; Yip VLY, 2007, BIOCHEMISTRY-US, V46, P9840, DOI 10.1021/bi700536p; Yip VLY, 2004, J AM CHEM SOC, V126, P8354, DOI 10.1021/ja047632w	50	4	4	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100519	10.1016/j.jbc.2021.100519	http://dx.doi.org/10.1016/j.jbc.2021.100519			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33684445	Green Submitted, gold, Green Published			2022-12-28	WOS:000672866400493
J	Neidle, S				Neidle, Stephen			Beyond the double helix: DNA structural diversity and the PDB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OCCURRING DINUCLEOSIDE PHOSPHATE; CRYSTAL-STRUCTURE; G-QUADRUPLEX; B-DNA; MOLECULAR-STRUCTURE; TELOMERIC DNA; ATOMIC-RESOLUTION; FORCE-FIELD; K+ SOLUTION; SEQUENCE	The determination of the double helical structure of DNA in 1953 remains the landmark event in the development of modern biological and biomedical science. This structure has also been the starting point for the determination of some 2000 DNA crystal structures in the subsequent 68 years. Their structural diversity has extended to the demonstration of sequence-dependent local structure in duplex DNA, to DNA bending in short and long sequences and in the DNA wound round the nucleosome, and to left-handed duplex DNAs. Beyond the double helix itself, in circumstances where DNA sequences are or can be induced to unwind from being duplex, a wide variety of topologies and forms can exist. Quadruplex structures, based on four-stranded cores of stacked G-quartets, are prevalent though not randomly distributed in the human and other genomes and can play roles in transcription, translation, and replication. Yet more complex folds can result in DNAs with extended tertiary structures and enzymatic/catalytic activity. The Protein Data Bank is the depository of all these structures, and the resource where structures can be critically examined and validated, as well as compared one with another to facilitate analysis of conformational and base morphology features. This review will briefly survey the major structural classes of DNAs and illustrate their significance, together with some examples of how the use of the Protein Data Bank by for example, data mining, has illuminated DNA structural concepts.	[Neidle, Stephen] UCL, Sch Pharm, London, England	University of London; University College London; University of London School of Pharmacy	Neidle, S (corresponding author), UCL, Sch Pharm, London, England.	s.neidle@ucl.ac.uk		Neidle, Stephen/0000-0003-0622-6548				Acosta-Reyes FJ, 2021, BIOPOLYMERS, V112, DOI 10.1002/bip.23397; ARNOTT S, 1972, BIOCHEM BIOPH RES CO, V48, P1392, DOI 10.1016/0006-291X(72)90867-4; ARNOTT S, 1980, NATURE, V283, P743, DOI 10.1038/283743a0; Arnott S, 1970, Prog Biophys Mol Biol, V21, P265, DOI 10.1016/0079-6107(70)90027-1; ARNOTT S, 1966, NATURE, V211, P227, DOI 10.1038/211227a0; ARNOTT S, 1974, BIOCHEM J, V141, P537, DOI 10.1042/bj1410537; Azad RN, 2018, NUCLEIC ACIDS RES, V46, P2636, DOI 10.1093/nar/gky033; Bang I, 1910, BIOCHEM Z, V26, P293; Bates PJ, 2017, BBA-GEN SUBJECTS, V1861, P1414, DOI 10.1016/j.bbagen.2016.12.015; Battistini F, 2019, J MOL BIOL, V431, P3845, DOI 10.1016/j.jmb.2019.07.021; Bishop EP, 2011, ACS CHEM BIOL, V6, P1314, DOI 10.1021/cb200155t; Blanchet C, 2011, NUCLEIC ACIDS RES, V39, pW68, DOI 10.1093/nar/gkr316; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; CALLADINE CR, 1986, J MOL BIOL, V192, P907, DOI 10.1016/0022-2836(86)90036-7; Cerny J, 2020, ACTA CRYSTALLOGR D, V76, P805, DOI 10.1107/S2059798320009389; Chandrasekaran R, 1996, J BIOMOL STRUCT DYN, V13, P1015, DOI 10.1080/07391102.1996.10508916; Chung WJ, 2015, P NATL ACAD SCI USA, V112, P2729, DOI 10.1073/pnas.1418718112; CRAWFORD JL, 1980, P NATL ACAD SCI-BIOL, V77, P4016, DOI 10.1073/pnas.77.7.4016; Silva MW, 2007, CHEM-EUR J, V13, P9738, DOI 10.1002/chem.200701255; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P4927, DOI 10.1093/nar/gkm522; Dans PD, 2019, NUCLEIC ACIDS RES, V47, P11090, DOI 10.1093/nar/gkz905; Dans PD, 2017, NUCLEIC ACIDS RES, V45, P4217, DOI 10.1093/nar/gkw1355; DAY RO, 1973, P NATL ACAD SCI USA, V70, P849, DOI 10.1073/pnas.70.3.849; DICKERSON RE, 1994, P NATL ACAD SCI USA, V91, P3579, DOI 10.1073/pnas.91.9.3579; DICKERSON RE, 1981, J MOL BIOL, V149, P761, DOI 10.1016/0022-2836(81)90357-0; DIGABRIELE AD, 1989, P NATL ACAD SCI USA, V86, P1816, DOI 10.1073/pnas.86.6.1816; DiMaio F, 2015, SCIENCE, V348, P914, DOI 10.1126/science.aaa4181; DREW H, 1980, NATURE, V286, P567, DOI 10.1038/286567a0; DREW HR, 1981, J MOL BIOL, V151, P535, DOI 10.1016/0022-2836(81)90009-7; FRANKLIN RE, 1953, NATURE, V171, P740, DOI 10.1038/171740a0; Galindo-Murillo R, 2016, J CHEM THEORY COMPUT, V12, P4114, DOI 10.1021/acs.jctc.6b00186; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Geng YY, 2019, NUCLEIC ACIDS RES, V47, P5395, DOI 10.1093/nar/gkz221; Golub E, 2011, ANGEW CHEM INT EDIT, V50, P11710, DOI 10.1002/anie.201103853; Haider S, 2002, J MOL BIOL, V320, P189, DOI 10.1016/S0022-2836(02)00428-X; Haider S, 2018, J AM CHEM SOC, V140, P15366, DOI 10.1021/jacs.8b08699; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752; Hardwick JS, 2017, NAT STRUCT MOL BIOL, V24, P544, DOI 10.1038/nsmb.3411; Hays FA, 2005, P NATL ACAD SCI USA, V102, P7157, DOI 10.1073/pnas.0409455102; Heddi B, 2011, J AM CHEM SOC, V133, P9824, DOI 10.1021/ja200786q; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; Hizver J, 2001, P NATL ACAD SCI USA, V98, P8490, DOI 10.1073/pnas.151247298; Holliday R, 2011, DNA REPAIR, V10, P993, DOI 10.1016/j.dnarep.2011.04.005; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; Hoshika S, 2018, J AM CHEM SOC, V140, P11655, DOI 10.1021/jacs.8b05042; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Ivani I, 2016, NAT METHODS, V13, P55, DOI [10.1038/nmeth.3658, 10.1038/NMETH.3658]; KANG C, 1992, NATURE, V356, P126, DOI 10.1038/356126a0; Kesavardhana S, 2020, J BIOL CHEM, V295, P8325, DOI 10.1074/jbc.RA120.013752; Lercher L, 2014, CHEM COMMUN, V50, P1794, DOI 10.1039/c3cc48151d; Li K, 2021, NUCLEIC ACIDS RES, V49, P519, DOI 10.1093/nar/gkaa1177; Li SX, 2019, NUCLEIC ACIDS RES, V47, pW26, DOI 10.1093/nar/gkz394; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Luo ZP, 2014, ACTA CRYSTALLOGR D, V70, P1790, DOI 10.1107/S1399004714004684; Ma LZ, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2019.100815; Marathe A, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-24; McKinney JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13878-9; Minhas V, 2020, J PHYS CHEM B, V124, P38, DOI 10.1021/acs.jpcb.9b09106; Neidle S, 2008, PRINCIPLES OF NUCLEIC ACID STRUCTURE, P1; Do NQ, 2017, NUCLEIC ACIDS RES, V45, P7487, DOI 10.1093/nar/gkx274; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; Ortiz-Lombardia M, 1999, NAT STRUCT BIOL, V6, P913; Ou A, 2020, NUCLEIC ACIDS RES, V48, P5766, DOI 10.1093/nar/gkaa262; Parkinson G, 1996, ACTA CRYSTALLOGR D, V52, P57, DOI 10.1107/S0907444995011115; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Ponce-Salvatierra A, 2021, NUCLEIC ACIDS RES, V49, pD76, DOI 10.1093/nar/gkaa867; Ponce-Salvatierra A, 2016, NATURE, V529, P231, DOI 10.1038/nature16471; Privalov PL, 2018, PROG BIOPHYS MOL BIO, V135, P30, DOI 10.1016/j.pbiomolbio.2018.01.007; Ravichandran Subramaniyam, 2019, Biophys Rev, V11, P383, DOI 10.1007/s12551-019-00534-1; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; ROSENBERG JM, 1973, NATURE, V243, P150, DOI 10.1038/243150a0; ROSENBERG JM, 1976, J MOL BIOL, V104, P145, DOI 10.1016/0022-2836(76)90006-1; Rossetti G, 2015, NUCLEIC ACIDS RES, V43, P4309, DOI 10.1093/nar/gkv254; RUBIN J, 1971, SCIENCE, V174, P1020, DOI 10.1126/science.174.4013.1020; Ruggiero E, 2020, ANNU REP MED CHEM, V54, P101, DOI 10.1016/bs.armc.2020.04.001; Schneider B, 1997, BIOPOLYMERS, V42, P113, DOI 10.1002/(SICI)1097-0282(199707)42:1<113::AID-BIP10>3.0.CO;2-O; Schultze P, 1999, NUCLEIC ACIDS RES, V27, P3018, DOI 10.1093/nar/27.15.3018; SEEMAN NC, 1976, J MOL BIOL, V104, P109, DOI 10.1016/0022-2836(76)90005-X; SEEMAN NC, 1971, NATURE-NEW BIOL, V233, P90, DOI 10.1038/newbio233090a0; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SKELLY JV, 1993, P NATL ACAD SCI USA, V90, P804, DOI 10.1073/pnas.90.3.804; Soman A, 2020, NUCLEIC ACIDS RES, V48, P5383, DOI 10.1093/nar/gkaa289; Spiegel J, 2020, TRENDS CHEM, V2, P123, DOI 10.1016/j.trechm.2019.07.002; Stump S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205584; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; SUSSMAN JL, 1972, J MOL BIOL, V66, P403, DOI 10.1016/0022-2836(72)90423-8; Svozil D, 2008, NUCLEIC ACIDS RES, V36, P3690, DOI 10.1093/nar/gkn260; Tereshko V, 1999, J AM CHEM SOC, V121, P470, DOI 10.1021/ja9832919; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Travascio P, 1998, CHEM BIOL, V5, P505, DOI 10.1016/S1074-5521(98)90006-0; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WEBSTER GD, 1990, P NATL ACAD SCI USA, V87, P6693, DOI 10.1073/pnas.87.17.6693; Wei DG, 2013, J AM CHEM SOC, V135, P19319, DOI 10.1021/ja4101358; Wei DG, 2012, NUCLEIC ACIDS RES, V40, P4691, DOI 10.1093/nar/gks023; WILKINS MHF, 1953, NATURE, V171, P738, DOI 10.1038/171738a0; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0; Winnerdy FR, 2020, ANNU REP MED CHEM, V54, P45, DOI 10.1016/bs.armc.2020.06.005; Winnerdy FR, 2019, NUCLEIC ACIDS RES, V47, P8272, DOI 10.1093/nar/gkz349; Yum JH, 2019, ORG BIOMOL CHEM, V17, P9547, DOI 10.1039/c9ob01876j; ZIMMERMAN SB, 1975, J MOL BIOL, V92, P181, DOI 10.1016/0022-2836(75)90222-3; Zyner KG, 2019, ELIFE, V8, DOI 10.7554/eLife.46793	107	7	7	6	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100553	10.1016/j.jbc.2021.100553	http://dx.doi.org/10.1016/j.jbc.2021.100553			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744292	gold, Green Published			2022-12-28	WOS:000672866400526
J	Quintero-Barceinas, RS; Gehringer, F; Ducker, C; Saxton, J; Shaw, PE				Quintero-Barceinas, Reyna Sara; Gehringer, Franziska; Ducker, Charles; Saxton, Janice; Shaw, Peter E.			ELK-1 ubiquitination status and transcriptional activity are modulated independently of F-Box protein FBXO25	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERK PHOSPHORYLATION; ACTIVATION; SRF; EXPRESSION; PROMOTES; USP17	The mitogen-responsive, ETS-domain transcription factor ELK-1 stimulates the expression of immediate early genes at the onset of the cell cycle and participates in early developmental programming. ELK-1 is subject to multiple levels of posttranslational control, including phosphorylation, SUMOylation, and ubiquitination. Recently, removal of monoubiquitin from the ELK-1 ETS domain by the Ubiquitin Specific Protease USP17 was shown to augment ELK-1 transcriptional activity and promote cell proliferation. Here we have used coimmunoprecipitation experiments, protein turnover and ubiquitination assays, RNA-interference and gene expression analyses to examine the possibility that USP17 acts antagonistically with the F-box protein FBXO25, an E3 ubiquitin ligase previously shown to promote ELK-1 ubiquitination and degradation. Our data confirm that FBXO25 and ELK-1 interact in HEK293T cells and that FBXO25 is active toward Hand1 and HAX1, two of its other candidate substrates. However, our data indicate that FBXO25 neither promotes ubiquitination of ELK-1 nor impacts on its transcriptional activity and suggest that an E3 ubiquitin ligase other than FBXO25 regulates ELK-1 ubiquitination and function.	[Quintero-Barceinas, Reyna Sara; Gehringer, Franziska; Ducker, Charles; Saxton, Janice; Shaw, Peter E.] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Transcript & Signal Transduct Lab, Nottingham, England; [Gehringer, Franziska] Univ Ulm, Ulm, Germany	University of Nottingham; Ulm University	Shaw, PE (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Life Sci, Transcript & Signal Transduct Lab, Nottingham, England.	peter.shaw1@nottingham.ac.uk		Ducker, Charles/0000-0003-0323-5983	Conacyt fellowship; Erasmus fellowship; BBSRC-DTP studentship [BB/D526602/1]	Conacyt fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Erasmus fellowship; BBSRC-DTP studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	D This work was supported by a Conacyt fellowship to R. Q. B., an Erasmus fellowship to F. G., and a BBSRC-DTP studentship to C. D. (grant number BB/D526602/1).	Baumann U, 2014, NAT MED, V20, P1401, DOI 10.1038/nm.3740; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Ducker C, 2021, INT J BIOCHEM CELL B, V130, DOI 10.1016/j.biocel.2020.105886; Ducker C, 2019, NUCLEIC ACIDS RES, V47, P4495, DOI 10.1093/nar/gkz166; Esnault C, 2017, MOL CELL, V65, P1081, DOI 10.1016/j.molcel.2017.02.005; Evans EL, 2011, NUCLEIC ACIDS RES, V39, P6390, DOI 10.1093/nar/gkr266; Galbraith MD, 2013, NUCLEIC ACIDS RES, V41, P10241, DOI 10.1093/nar/gkt837; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Gualdrini F, 2016, MOL CELL, V64, P1048, DOI 10.1016/j.molcel.2016.10.016; Hagens O, 2006, BBA-GEN SUBJECTS, V1760, P110, DOI 10.1016/j.bbagen.2005.09.018; Jang JW, 2011, BIOCHEM BIOPH RES CO, V410, P183, DOI 10.1016/j.bbrc.2011.05.011; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Maragno ALGC, 2006, BBA-GEN SUBJECTS, V1760, P966, DOI 10.1016/j.bbagen.2006.03.020; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; McFarlane C, 2010, CANCER RES, V70, P3329, DOI 10.1158/0008-5472.CAN-09-4152; Nentwich O, 2009, DEV BIOL, V336, P313, DOI 10.1016/j.ydbio.2009.09.039; Rizzo F, 2016, DEV BIOL, V416, P173, DOI 10.1016/j.ydbio.2016.05.026; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Teixeira FR, 2013, J BIOL CHEM, V288, P28152, DOI 10.1074/jbc.M113.504308; Teixeira FR, 2010, PROTEOMICS, V10, P2746, DOI 10.1002/pmic.200900419; van der Laan S, 2013, MOL CELL, V52, P366, DOI 10.1016/j.molcel.2013.10.003; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005	26	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100214	10.1074/jbc.RA120.014616	http://dx.doi.org/10.1074/jbc.RA120.014616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428929	Green Published, gold			2022-12-28	WOS:000672866400192
J	Usuelli, M; Meyer, T; Mezzenga, R; Mitsi, M				Usuelli, Mattia; Meyer, Timmy; Mezzenga, Raffaele; Mitsi, Maria			VEGF and VEGFR2 bind to similar pH-sensitive sites on fibronectin, exposed by heparin-mediated conformational changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXTRACELLULAR-MATRIX; ISOFORMS; ANGIOGENESIS; ACTIVATION; CELL; RECEPTORS; MECHANISM; TRANSPORT; RESPONSES	Physical interactions between vascular endothelial growth factor (VEGF), a central player in blood endothelial cell biology, and fibronectin, a major fibrillar protein of the extracellular matrix, are important determinants of angiogenic activity in health and disease. Conditions signaling the need for new blood vessel growth, such as hypoxia and low extracellular pH, increase VEGF-fibronectin interactions. These interactions can be further fine-tuned through changes in the availability of the VEGF-binding sites on fibronectin, regulated by conformational changes induced by heparin and heparan sulfate chains within the extracellular matrix. These interactions may alter VEGF bioavailability, generate gradients, or alter the way VEGF is recognized by and activates its cell-surface receptors. Here, using equilibrium and kinetic studies, we discovered that fibronectin can also interact with the extracellular domain of the VEGF receptor 2 (VEGFR2). The VEGFR2-binding sites on fibronectin show great similarity to the VEGF-binding sites, as they were also exposed upon heparin-induced conformational changes in fibronectin, and the interaction was enhanced at acidic pH. Kinetic parameters and affinities for VEGF and VEGFR2 binding to fibronectin were determined by surface plasmon resonance measurements, revealing two populations of fibronectin-binding sites for each molecule. Our data also suggest that a VEGF/VEGFR2/fibronectin triple complex may be formed by VEGF or VEGFR2 first binding to fibronectin and subsequently recruiting the third binding partner. The formation of such a complex may lead to the activation of distinct angiogenic signaling pathways, offering new possibilities for clinical applications that target angiogenesis.	[Usuelli, Mattia; Meyer, Timmy; Mezzenga, Raffaele; Mitsi, Maria] Swiss Fed Inst Technol, Lab Food & Soft Mat, Dept Hlth Sci & Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Mezzenga, R; Mitsi, M (corresponding author), Swiss Fed Inst Technol, Lab Food & Soft Mat, Dept Hlth Sci & Technol, Zurich, Switzerland.	raffaele.mezzenga@hest.ethz.ch; maria.mitsi@alumni.ethz.ch	Mitsi, Maria/S-2519-2017	Mitsi, Maria/0000-0001-8983-1983; Usuelli, Mattia/0000-0003-1459-7250	SNF [200021_172767]	SNF	This study was funded by SNF grant (200021_172767) to R.M. in Switzerland.	Airley RE, 2007, CHEMOTHERAPY, V53, P233, DOI 10.1159/000104457; Akerman S, 2013, INT J CANCER, V133, P2563, DOI 10.1002/ijc.28281; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Buczek-Thomas JA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205065; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Charafeddine RA, 2019, J BIOL CHEM, V294, P8779, DOI 10.1074/jbc.RA118.007004; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Childs S, 2002, DEVELOPMENT, V129, P973; Chiu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043040; Derricks KE, 2015, INTEGR BIOL-UK, V7, P1011, DOI 10.1039/c5ib00140d; Di Russo NV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002761; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Finley SD, 2012, AAPS J, V14, P500, DOI 10.1208/s12248-012-9363-4; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Goerges AL, 2004, J BIOL CHEM, V279, P2307, DOI 10.1074/jbc.M308482200; Gopalakrishnan M, 2005, EUR BIOPHYS J BIOPHY, V34, P943, DOI 10.1007/s00249-005-0471-2; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Lagerholm BC, 1998, BIOPHYS J, V74, P1215, DOI 10.1016/S0006-3495(98)77836-1; Lupo G, 2017, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00519; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Maydeu-Olivares A., 2010, INT ENCY ED, V7, P190, DOI [10.1016/B978-0-08-044894-7.01333-6, DOI 10.1016/B978-0-08-044894-7.01333-6]; Mezzenga R, 2019, BIOMACROMOLECULES, V20, P55, DOI 10.1021/acs.biomac.8b01258; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p; Mitsi M, 2008, J BIOL CHEM, V283, P34796, DOI 10.1074/jbc.M806692200; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Onell A, 2005, J MOL RECOGNIT, V18, P307, DOI 10.1002/jmr.745; Pahari S, 2019, BIOPHYS J, V116, p166A, DOI 10.1016/j.bpj.2018.11.924; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Peng YH, 2017, PROTEINS, V85, P282, DOI 10.1002/prot.25221; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sack KD, 2016, J CELL PHYSIOL, V231, P2026, DOI 10.1002/jcp.25312; Saint-Geniez M, 2009, INVEST OPHTH VIS SCI, V50, P311, DOI 10.1167/iovs.08-2461; SCHWARZBAUER JE, 1991, BIOESSAYS, V13, P527, DOI 10.1002/bies.950131006; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Small AR, 2008, J THEOR BIOL, V252, P593, DOI 10.1016/j.jtbi.2008.02.009; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; Stuttfeld E, 2009, IUBMB LIFE, V61, P915, DOI 10.1002/iub.234; Teleanu RI, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010084; Wang L, 2016, BIOINFORMATICS, V32, P614, DOI 10.1093/bioinformatics/btv607; Watanabe H, 2019, ACS CHEM BIOL, V14, P2729, DOI 10.1021/acschembio.9b00652; Watanabe H, 2009, J BIOL CHEM, V284, P12373, DOI 10.1074/jbc.M809236200; Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; WILLIAMS EC, 1982, J BIOL CHEM, V257, P4973	53	3	3	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100584	10.1016/j.jbc.2021.100584	http://dx.doi.org/10.1016/j.jbc.2021.100584			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33771558	gold, Green Published			2022-12-28	WOS:000672866400556
J	Bauer, NC; Yang, AL; Wang, X; Zhou, YL; Klibanski, A; Soberman, RJ				Bauer, Nicholas C.; Yang, Anli; Wang, Xin; Zhou, Yunli; Klibanski, Anne; Soberman, Roy J.			A cross-nearest neighbor/Monte Carlo algorithm for single-molecule localization microscopy defines interactions between p53, Mdm2, and MEG3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG NONCODING RNA; PROLYL ISOMERASE PIN1; GENE-EXPRESSION; EXPLOITING NANOBODIES; HYPERMETHYLATION; IDENTIFICATION; ACTIVATION; LOCUS; SUPPRESSOR; PATHWAY	The functions of long noncoding (lnc)RNAs, such as MEG3, are defined by their interactions with other RNAs and proteins. These interactions, in turn, are shaped by their subcellular localization and temporal context. Therefore, it is important to be able to analyze the relationships of lncRNAs while preserving cellular architecture. The ability of MEG3 to suppress cell proliferation led to its recognition as a tumor suppressor. MEG3 has been proposed to activate p53 by disrupting the interaction of p53 with mouse double minute 2 homolog (Mdm2). To test this mechanism in the native cellular context, we employed two-color direct stochastic optical reconstruction microscopy, a single-molecule localization microscopy technique, to detect and quantify the localizations of p53, Mdm2, and MEG3 in U2OS cells. We developed a new cross-nearest neighbor/Monte Carlo algorithm to quantify the association of these molecules. Proof of concept for our method was obtained by examining the association between FKBP1A and mTOR, MEG3 and p53, and Mdm2 and p53. In contrast to previous models, our data support a model in which MEG3 modulates p53 independently of the interaction with Mdm2.	[Bauer, Nicholas C.; Soberman, Roy J.] Massachusetts Gen Hosp, Div Nephrol, Dept Med, Charlestown, MA 02129 USA; [Bauer, Nicholas C.; Soberman, Roy J.] Harvard Med Sch, Charlestown, MA 02129 USA; [Yang, Anli; Wang, Xin; Zhou, Yunli; Klibanski, Anne] Massachusetts Gen Hosp, Dept Med, Neuroendocrine Unit, Boston, MA 02114 USA; [Yang, Anli; Wang, Xin; Zhou, Yunli; Klibanski, Anne] Harvard Med Sch, Boston, MA 02115 USA; [Yang, Anli] Sun Yat Sen Univ Canc Ctr, Dept Breast Oncol, Guangzhou, Guangdong, Peoples R China; [Wang, Xin] Guangdong Pharmaceut Univ, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China; [Klibanski, Anne] Mass Gen Brigham, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Sun Yat Sen University; Guangdong Pharmaceutical University	Soberman, RJ (corresponding author), Massachusetts Gen Hosp, Div Nephrol, Dept Med, Charlestown, MA 02129 USA.; Soberman, RJ (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	soberman@helix.mgh.harvard.edu		Bauer, Nicholas/0000-0002-8513-4467; Zhou, Yunli/0000-0003-4831-209X	Jarislowsky Foundation [R01CA193520, R01DK062472, S10RR027931, T32DK007540]	Jarislowsky Foundation	R. J. S. obtained grants R01CA193520, R01DK062472, S10RR027931; N. C. B.: T32DK007540; A. K. and Y. Z. obtained grants R01CA193520 and from the Jarislowsky Foundation. Stochastic optical reconstruction microscopy experiments were conducted at the MGH Molecular Imaging Core. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Bauer NC, 2015, TRAFFIC, V16, P1039, DOI 10.1111/tra.12310; Bezanson J, 2017, SIAM REV, V59, P65, DOI 10.1137/141000671; Carrington G, 2019, MOL BIOL CELL, V30, P2737, DOI 10.1091/mbc.E18-11-0694; Chen XZ, 2018, CELL RES, V28, P518, DOI 10.1038/s41422-018-0029-3; Cheunsuchon P, 2011, AM J PATHOL, V179, P2120, DOI 10.1016/j.ajpath.2011.07.002; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; Das PP, 2015, CELL REP, V12, P1456, DOI 10.1016/j.celrep.2015.07.053; Eliscovich C, 2017, P NATL ACAD SCI USA, V114, pE1875, DOI 10.1073/pnas.1621440114; Feher K, 2019, CURR OPIN CHEM BIOL, V51, P130, DOI 10.1016/j.cbpa.2019.05.019; Gejman R, 2008, J CLIN ENDOCR METAB, V93, P4119, DOI 10.1210/jc.2007-2633; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Herce HD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3660; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Ingram JR, 2018, ANNU REV IMMUNOL, V36, P695, DOI 10.1146/annurev-immunol-042617-053327; Jia LF, 2014, INT J CANCER, V135, P2282, DOI 10.1002/ijc.28667; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Landre V, 2017, CELL DEATH DIFFER, V24, P903, DOI 10.1038/cdd.2017.42; Levet F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10007-4; Li LL, 2010, CLIN CANCER RES, V16, P2949, DOI 10.1158/1078-0432.CCR-09-3178; Li RP, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao2387; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Lu KH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-461; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Pageon SV, 2016, MOL BIOL CELL, V27, P3627, DOI 10.1091/mbc.E16-07-0478; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Qu CS, 2013, GENE EXPR PATTERNS, V13, P51, DOI 10.1016/j.gep.2012.11.003; Riley KJL, 2007, RNA, V13, P1825, DOI 10.1261/rna.673407; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Savchenko A, 2009, MOL BIOTECHNOL, V41, P270, DOI 10.1007/s12033-008-9116-x; Schmider AB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211943; Sheng XJ, 2014, ONCOL REP, V32, P277, DOI 10.3892/or.2014.3208; Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049; Sograte-Idrissi S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010048; Sun M, 2014, TUMOR BIOL, V35, P1065, DOI 10.1007/s13277-013-1142-z; Swoboda M, 2012, ACS NANO, V6, P6364, DOI 10.1021/nn301895c; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Uroda T, 2019, MOL CELL, V75, P982, DOI 10.1016/j.molcel.2019.07.025; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Yan HL, 2016, NEUROSCIENCE, V337, P191, DOI 10.1016/j.neuroscience.2016.09.017; Young RM, 2019, METHODS MOL BIOL, V1956, P363, DOI 10.1007/978-1-4939-9151-8_18; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zhu JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139790	56	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100540	10.1016/j.jbc.2021.100540	http://dx.doi.org/10.1016/j.jbc.2021.100540			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33722609	gold, Green Published			2022-12-28	WOS:000672866400513
J	Kimber, MS				Kimber, Matthew S.			How to extend your (polylactosamine) antennae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							GLYCOSYLTRANSFERASES	The elongated antennae decorating eukaryotic glycans are built from polylactosamine repeats. Polylactosamine forms a lectin recognition site and also acts as a platform for presenting diverse additional modifications (e.g., terminal cell-surface antigens); it therefore plays important roles in cell adherence, development, and immunity. Two new papers present a detailed structural and mechanistic investigation of beta 1-3-N-acetylgucosaminyltransferase 2, a key enzyme in antennae synthesis. The resulting insights will also help decipher other members of GT31, the single largest human glycosyltransferase family.	[Kimber, Matthew S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada	University of Guelph	Kimber, MS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.	mkimber@uoguelph.ca		Kimber, Matthew/0000-0001-9454-5586	Natural Sciences and Engineering Research Council of Canada [2020-07113]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Work in the author's laboratory is supported by a Natural Sciences and Engineering Research Council of Canada Discovery grant (2020-07113).	Arthur CM, 2015, METHODS MOL BIOL, V1207, P1, DOI 10.1007/978-1-4939-1396-1_1; Hao Y., 2021, J BIOL CHEM, V296; Kadirvelraj R., 2021, J BIOL CHEM, V296; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Petit D., 2020, GLYCOBIOLOGY, V25, P3389; Seko A, 2005, GLYCOBIOLOGY, V15, P943, DOI 10.1093/glycob/cwi082; Togayachi A, 2001, J BIOL CHEM, V276, P22032, DOI 10.1074/jbc.M011369200; Varki A., 2017, ESSENTIALS GLYCOBIOL	9	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100212	10.1016/j.jbc.2020.100212	http://dx.doi.org/10.1016/j.jbc.2020.100212			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33453284	gold, Green Published			2022-12-28	WOS:000672866400190
J	Parker, ET; Lollar, P				Parker, Ernest T.; Lollar, Pete			Conformation of the von Willebrand factor/factor VIII complex in quasi-static flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION COEFFICIENT DISTRIBUTIONS; ANALYTICAL ULTRACENTRIFUGATION; SELF-ASSOCIATION; FACTOR MULTIMERS; HYDRODYNAMIC PROPERTIES; VONWILLEBRAND-FACTOR; ELECTRON-MICROSCOPY; SIZE-DISTRIBUTION; DILUTE-SOLUTION; A1 DOMAIN	Von Willebrand factor (VWF) is a plasma glycoprotein that circulates noncovalently bound to blood coagulation factor VIII (fVIII). VWF is a population of multimers composed of a variable number of similar to 280 kDa monomers that is activated in shear flow to bind collagen and platelet glycoprotein Ib alpha. Electron microscopy, atomic force microscopy, small-angle neutron scattering, and theoretical studies have produced a model in which the conformation of VWF under static conditions is a compact, globular "ball-of-yarn," implying strong, attractive forces between monomers. We performed sedimentation velocity (SV) analytical ultracentrifugation measurements on unfractionated VWF/fVIII complexes. There was a 20% per mg/ml decrease in the weight-average sedimentation coefficient, s(w), in contrast to the similar to 1% per mg/ml decrease observed for compact globular proteins. SV and dynamic light scattering measurements were performed on VWF/fVIII complexes fractionated by size-exclusion chromatography to obtain s(w) values and z-average diffusion coefficients, D-z. Molecular weights estimated using these values in the Svedberg equation ranged from 1.7 to 4.1 MDa. Frictional ratios calculated from D-z and molecular weights ranged from 2.9 to 3.4, in contrast to values of 1.1-1.3 observed for globular proteins. The Mark-Houwink-Kuhn-Sakurada scaling relationships between s(w), D-z and molecular weight, s = k' M-alpha s and D = k '' M-alpha D, yielded estimates of 0.51 and -0.49 for alpha(s) and alpha(D), respectively, consistent with a random coil, in contrast to the alpha(s) value of 0.65 observed for globular proteins. These results indicate that interactions between monomers are weak or nonexistent and that activation of VWF is intramonomeric.	[Lollar, Pete] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30307 USA; Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	Children's Healthcare of Atlanta (CHOA); Emory University	Lollar, P (corresponding author), Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30307 USA.	jlollar@emory.edu			National Institutes of Health/National Heart, Lung and Blood Institute [U54HL141981]	National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health/National Heart, Lung and Blood Institute (award number U54HL141981 to P. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amoros D, 2011, MACROMOLECULES, V44, P5788, DOI 10.1021/ma102697q; Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; BATCHELOR GK, 1972, J FLUID MECH, V52, P245, DOI 10.1017/S0022112072001399; Bienkowska J, 1997, J BIOL CHEM, V272, P25162, DOI 10.1074/jbc.272.40.25162; Brautigam CA, 2019, BIOMOLECULAR AND BIOANALYTICAL TECHNIQUES: THEORY, METHODOLOGY AND APPLICATIONS, P255; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Budde U, 2006, SEMIN THROMB HEMOST, V32, P514, DOI 10.1055/s-2006-947866; Cantor C. R., 1980, ULTRACENTRIFUGATION, P591; Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P539; Chaturvedi SK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06902-x; CHOPEK MW, 1986, BIOCHEMISTRY-US, V25, P3146, DOI 10.1021/bi00359a012; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; CROTHERS DM, 1965, J MOL BIOL, V12, P525, DOI 10.1016/S0022-2836(65)80310-2; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Dam J, 2004, METHOD ENZYMOL, V384, P185; Deng W, 2018, J THROMB HAEMOST, V16, P2097, DOI 10.1111/jth.14251; Deng W, 2017, J THROMB HAEMOST, V15, P1867, DOI 10.1111/jth.13775; Doering CB, 2004, J BIOL CHEM, V279, P6546, DOI 10.1074/jbc.M312451200; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Dong XC, 2019, BLOOD, V133, P1523, DOI 10.1182/blood-2018-10-876300; Einstein A, 1926, INVESTIGATIONS THEOR, DOI DOI 10.2307/2298685; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Federici AB, 2010, HAEMOPHILIA, V16, P101, DOI 10.1111/j.1365-2516.2009.02088.x; Flory PJ., 1953, PRINCIPLES POLYM CHE, V672; FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129; Fu HX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00230-2; FUJII M, 1973, BIOPOLYMERS, V12, P1177, DOI 10.1002/bip.1973.360120520; de la Torre JG, 2020, J MOL BIOL, V432, P2930, DOI 10.1016/j.jmb.2019.12.027; Garland C. W., 2009, EXPT PHYS CHEM, V8th; Ghirlando R, 2014, ANAL BIOCHEM, V458, P37, DOI 10.1016/j.ab.2014.04.029; Gillis RB, 2014, BIOTECHNOL GENET ENG, V30, P142, DOI 10.1080/02648725.2014.994870; Harding SE, 2005, ADV POLYM SCI, V186, P211, DOI 10.1007/b136821; Javitt G, 2020, CELL, V183, P717, DOI 10.1016/j.cell.2020.09.021; Johnsen J., 2016, WILLIAMS HEMATOLOGY, V9th, P2163; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Lippok S, 2013, BIOPHYS J, V105, P1208, DOI 10.1016/j.bpj.2013.07.037; Lodge T. P., 2007, POLYM CHEM-UK; LOSCALZO J, 1985, BIOCHEMISTRY-US, V24, P4468, DOI 10.1021/bi00337a031; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Morris GA, 2008, CARBOHYD POLYM, V71, P101, DOI 10.1016/j.carbpol.2007.05.029; Muller JP, 2016, P NATL ACAD SCI USA, V113, P1208, DOI 10.1073/pnas.1516214113; NISHIHARA T, 1958, P NATL ACAD SCI USA, V44, P411, DOI 10.1073/pnas.44.5.411; OHMORI K, 1982, J CELL BIOL, V95, P632, DOI 10.1083/jcb.95.2.632; Oncley J. L., 1941, ANN NY ACAD SCI, V41, P121; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Patel TR, 2018, EUR BIOPHYS J BIOPHY, V47, P291, DOI 10.1007/s00249-017-1259-x; Pavlov G, 2003, EUR BIOPHYS J BIOPHY, V32, P437, DOI 10.1007/s00249-003-0316-9; Prakash JR, 2019, CURR OPIN COLLOID IN, V43, P63, DOI 10.1016/j.cocis.2019.03.001; ROTBLAT F, 1985, BIOCHEMISTRY-US, V24, P4294, DOI 10.1021/bi00337a007; ROWE AJ, 1977, BIOPOLYMERS, V16, P2595, DOI 10.1002/bip.1977.360161202; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 2002, P NATL ACAD SCI USA, V99, P425, DOI 10.1073/pnas.012459599; Schachman H.K., 1959, ULTRACENTRIFUGATION; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2001, J BIOL CHEM, V276, P9679, DOI 10.1074/jbc.M009398200; Schuck P., 2017, SEDIMENTATION VELOCI; Schuck P, 2016, BASIC PRINCIPLES ANA; SHOGREN RL, 1986, BIOPOLYMERS, V25, P1505, DOI 10.1002/bip.360250809; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Sing CE, 2010, BIOPHYS J, V98, pL35, DOI 10.1016/j.bpj.2010.01.032; Singh I, 2006, J BIOL CHEM, V281, P38266, DOI 10.1074/jbc.M607123200; SLAYTER H, 1985, J BIOL CHEM, V260, P8559; Springer TA, 2011, J THROMB HAEMOST, V9, P130, DOI 10.1111/j.1538-7836.2011.04320.x; Stetefeld Jorg, 2016, Biophys Rev, V8, P409, DOI 10.1007/s12551-016-0218-6; Stockschlaeder M, 2014, BLOOD COAGUL FIBRIN, V25, P206, DOI 10.1097/MBC.0000000000000065; TANFORD C, 1967, J AM CHEM SOC, V89, P729, DOI 10.1021/ja00980a001; Tanford C., 1961, PHYS CHEM MACROMOLEC; Teller D C, 1979, Methods Enzymol, V61, P103; THORELL L, 1984, THROMB RES, V35, P431, DOI 10.1016/0049-3848(84)90235-4; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; YAMAKAWA H, 1973, MACROMOLECULES, V6, P407, DOI 10.1021/ma60033a018; YANAKI T, 1980, MACROMOLECULES, V13, P1462, DOI 10.1021/ma60078a019; Zaccai N. R., 2017, HYDRODYNAMICS METHOD, V2nd, P159; Zhang CJ, 2019, BLOOD ADV, V3, P957, DOI 10.1182/bloodadvances.2018030122; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhao HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126420; Zhao Huaying, 2013, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2012s71; Zhou YF, 2011, EMBO J, V30, P4098, DOI 10.1038/emboj.2011.297; Zimm B H, 1974, Biophys Chem, V1, P279, DOI 10.1016/0301-4622(74)80014-1	86	6	6	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100420	10.1016/j.jbc.2021.100420	http://dx.doi.org/10.1016/j.jbc.2021.100420			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600794	Green Published, gold			2022-12-28	WOS:000672866400394
J	Parthasarathy, A; Borrego, EJ; Savka, MA; Dobson, RCJ; Hudson, AO				Parthasarathy, Anutthaman; Borrego, Eli J.; Savka, Michael A.; Dobson, Renwick C. J.; Hudson, Andre O.			Amino acid-derived defense metabolites from plants: A potential source to facilitate novel antimicrobial development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEPATITIS-C VIRUS; EMERGING INFECTIOUS-DISEASES; HELICAL HAIRPIN STRUCTURE; CYSTINE KNOT MOTIF; CRUSGALLI L. SEEDS; IN-VITRO; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; TRYPSIN-INHIBITOR; NATURAL-PRODUCTS	For millennia, humanity has relied on plants for its medicines, and modern pharmacology continues to reexamine and mine plant metabolites for novel compounds and to guide improvements in biological activity, bioavailability, and chemical stability. The critical problem of antibiotic resistance and increasing exposure to viral and parasitic diseases has spurred renewed interest into drug treatments for infectious diseases. In this context, an urgent revival of natural product discovery is globally underway with special attention directed toward the numerous and chemically diverse plant defensive compounds such as phytoalexins and phytoanticipins that combat herbivores, microbial pathogens, or competing plants. Moreover, advancements in "omics," chemistry, and heterologous expression systems have facilitated the purification and characterization of plant metabolites and the identification of possible therapeutic targets. In this review, we describe several important amino acid-derived classes of plant defensive compounds, including antimicrobial peptides (e.g., defensins, thionins, and knottins), alkaloids, nonproteogenic amino acids, and phenylpropanoids as potential drug leads, examining their mechanisms of action, therapeutic targets, and structure-function relationships. Given their potent antibacterial, antifungal, antiparasitic, and antiviral properties, which can be superior to existing drugs, phytoalexins and phytoanticipins are an excellent resource to facilitate the rational design and development of antimicrobial drugs.	[Parthasarathy, Anutthaman; Borrego, Eli J.; Savka, Michael A.; Hudson, Andre O.] Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA; [Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Christchurch, New Zealand; [Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Dobson, Renwick C. J.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic, Australia	Rochester Institute of Technology; University of Canterbury; University of Canterbury; University of Melbourne	Hudson, AO (corresponding author), Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA.	aohsbi@rit.edu	Dobson, Renwick/AAZ-7020-2021; Borrego, Eli/G-9867-2011	Dobson, Renwick/0000-0002-5506-4939; Borrego, Eli/0000-0002-3538-3203; Hudson, Andre/0000-0001-5690-4322; Parthasarathy, Anutthaman/0000-0003-1830-5948	National Institutes of Health (NIH) [R15GM120653]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Institutes of Health (NIH) award (R15GM120653) to A. O. H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abreu AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03716-7; Abreu AC, 2014, DIAGN MICR INFEC DIS, V79, P125, DOI 10.1016/j.diagmicrobio.2014.03.002; ADAMS R, 1945, J AM CHEM SOC, V67, P89, DOI 10.1021/ja01217a032; Aerts AM, 2007, J MOL MICROB BIOTECH, V13, P243, DOI 10.1159/000104753; Aerts AM, 2009, FEBS LETT, V583, P2513, DOI 10.1016/j.febslet.2009.07.004; Aguirre AA, 2008, ANN NY ACAD SCI, V1149, P1, DOI 10.1196/annals.1428.052; Ahmed N, 2018, CHEM BIOL DRUG DES, V91, P647, DOI 10.1111/cbdd.13115; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Akagawa K, 2018, J ORG CHEM, V83, P4279, DOI 10.1021/acs.joc.8b00497; Akagawa K, 2017, CHEM COMMUN, V53, P8645, DOI 10.1039/c7cc04033d; Akiyama R, 2019, PLANT BIOTECHNOL-NAR, V36, P253, DOI 10.5511/plantbiotechnology.19.1030a; Albert M, 2013, J EXP BOT, V64, P5269, DOI 10.1093/jxb/ert275; Aldholmi M, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12040182; Allard PM, 2011, J NAT PROD, V74, P2446, DOI 10.1021/np200715v; Almeida MS, 2000, ARCH BIOCHEM BIOPHYS, V378, P278, DOI 10.1006/abbi.2000.1824; Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252; Althaus JB, 2014, MOLECULES, V19, P6184, DOI 10.3390/molecules19056184; Amirkia V., 2014, PHYTOCHEMISTRY LETT, V10; Anitha R, 2005, PHYTOTHER RES, V19, P992, DOI 10.1002/ptr.1761; Aparna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101840; Arguello-Garcia R, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00353; Astafieva AA, 2012, PEPTIDES, V36, P266, DOI 10.1016/j.peptides.2012.05.009; Baell JB, 2018, ACS CHEM BIOL, V13, P36, DOI 10.1021/acschembio.7b00903; Bailly C, 2019, PHYTOMEDICINE, V62, DOI 10.1016/j.phymed.2019.152956; Barbosa H, 2020, BIOORG CHEM, V101, DOI 10.1016/j.bioorg.2020.103978; Battenberg OA, 2013, MOL BIOSYST, V9, P343, DOI 10.1039/c2mb25446h; Bedard KM, 2012, J VIROL, V86, P7334, DOI 10.1128/JVI.06867-11; Bell EA, 2003, J AGR FOOD CHEM, V51, P2854, DOI 10.1021/jf020880w; Belofsky G, 2013, J NAT PROD, V76, P915, DOI 10.1021/np4000763; Benko-Iseppon AM, 2010, CURR PROTEIN PEPT SC, V11, P181, DOI 10.2174/138920310791112075; Berrocal-Lobo M, 2002, PLANT PHYSIOL, V128, P951, DOI 10.1104/pp.010685; Bertin C, 2007, P NATL ACAD SCI USA, V104, P16964, DOI 10.1073/pnas.0707198104; Beutler John A, 2009, Curr Protoc Pharmacol, VChapter 9, DOI 10.1002/0471141755.ph0911s46; Biala W, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01610; BICKEL AF, 1946, RECL TRAV CHIM PAY B, V65, P65; Billard-Pomares T, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00635-19; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P3873, DOI 10.1099/mic.0.27955-0; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Freijo MB, 2018, EUR J MED CHEM, V143, P1312, DOI 10.1016/j.ejmech.2017.10.032; Bloom DE, 2017, P NATL ACAD SCI USA, V114, P4055, DOI 10.1073/pnas.1701410114; Bologa CG, 2013, CURR OPIN PHARMACOL, V13, P678, DOI 10.1016/j.coph.2013.07.002; Bondaryk M, 2017, J FUNGI, V3, DOI 10.3390/jof3030046; Bonjean K, 1998, BIOCHEMISTRY-US, V37, P5136, DOI 10.1021/bi972927q; Borges A, 2015, CURR MED CHEM, V22, P2590, DOI 10.2174/0929867322666150530210522; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; Bringmann G, 2013, CHEM-EUR J, V19, P916, DOI 10.1002/chem.201202755; Brown S, 2015, P NATL ACAD SCI USA, V112, P3205, DOI 10.1073/pnas.1423555112; Burman R, 2010, BIOPOLYMERS, V94, P626, DOI 10.1002/bip.21408; Camarero JA, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7020031; CAMMUE BPA, 1992, J BIOL CHEM, V267, P2228; Cardenas PD, 2015, PHYTOCHEMISTRY, V113, P24, DOI 10.1016/j.phytochem.2014.12.010; Carrasco MP, 2014, EUR J MED CHEM, V80, P523, DOI 10.1016/j.ejmech.2014.04.076; Casadevall A, 2019, MBIO, V10, DOI 10.1128/mBio.01397-19; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1950, DOI 10.1021/ja01239a048; Cedron JC, 2010, BIOORGAN MED CHEM, V18, P4694, DOI 10.1016/j.bmc.2010.05.023; Centers for Disease Control, 2019, BIGG THREATS DAT 201; CHAGOLLALOPEZ A, 1994, J BIOL CHEM, V269, P23675; Chan BCL, 2011, J ETHNOPHARMACOL, V137, P767, DOI 10.1016/j.jep.2011.06.039; Chan H, 2017, INFECT DRUG RESIST, V10, P521, DOI 10.2147/IDR.S148444; Chassagne F, 2019, PHYTOCHEM REV, V18, P601, DOI 10.1007/s11101-019-09606-2; Chen HN, 2020, VIROLOGY, V546, P88, DOI 10.1016/j.virol.2020.04.009; Chen KX, 2005, J MED CHEM, V48, P6229, DOI 10.1021/jm050323b; Chen RB, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100879; Chen Y, 2010, PHARM BIOL, V48, P1018, DOI 10.3109/13880200903440211; Chierrito TPC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-142; Choi JA, 2018, INNATE IMMUN-LONDON, V24, P79, DOI 10.1177/1753425917747975; Chopra G, 2016, CURR PHARM DESIGN, V22, P3109, DOI 10.2174/1381612822666160325121943; Choudhury D, 2016, COMB CHEM HIGH T SCR, V19, P705, DOI 10.2174/1386207319666160720101502; Chowdhury SR, 2017, BIOCHEM PHARMACOL, V138, P19, DOI 10.1016/j.bcp.2017.05.002; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Confalonieri UEC, 2014, ACTA TROP, V129, P33, DOI 10.1016/j.actatropica.2013.09.013; Conners R, 2007, J BIOL CHEM, V282, P27760, DOI 10.1074/jbc.M703871200; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Cragg GM, 2014, J NAT PROD, V77, P703, DOI 10.1021/np5000796; Craik DJ, 2018, BIOORGAN MED CHEM, V26, P2727, DOI 10.1016/j.bmc.2017.08.005; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Cravens A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09848-w; Da X, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38916-w; Dahmer J, 2019, J ETHNOPHARMACOL, V239, DOI 10.1016/j.jep.2018.12.009; Dai JP, 2013, ANTIMICROB AGENTS CH, V57, P4433, DOI 10.1128/AAC.00759-13; Daneshmand F, 2013, NAT PROD RES, V27, P2292, DOI 10.1080/14786419.2013.827192; Dang Z, 2014, ACS MED CHEM LETT, V5, P942, DOI 10.1021/ml500236n; Davis-Searles PR, 2005, CANCER RES, V65, P4448, DOI 10.1158/0008-5472.CAN-04-4662; Davison EK, 2019, CURR OPIN CHEM BIOL, V52, P1, DOI [10.1016/j.cbpa.2018.12.007, 10.1016/j.cbpa.2018.12.07]; De Rosa M, 2015, MOLECULES, V20, P22044, DOI 10.3390/molecules201219828; de Veer SJ, 2019, CHEM REV, V119, P12375, DOI 10.1021/acs.chemrev.9b00402; DebRoy S, 2016, J VIRAL HEPATITIS, V23, P708, DOI 10.1111/jvh.12551; Dey P, 2020, RECENT ADVANCES IN NATURAL PRODUCTS ANALYSIS, P505, DOI 10.1016/B978-0-12-816455-6.00015-9; Djeussi DE, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-164; Dong WJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07237; Dorsaz S, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00829-17, 10.1128/aac.00829-17]; Duncan B, 2015, ACS NANO, V9, P7775, DOI 10.1021/acsnano.5b01696; DUVICK JP, 1992, J BIOL CHEM, V267, P18814; Eagleson M, 1994, CONCISE ENCY CHEM; Eguchi R, 2017, J COMPUT AIDED CHEM, V18, P58, DOI 10.2751/jcac.18.58; Endo M, 2019, NAT PLANTS, V5, P14, DOI 10.1038/s41477-018-0321-8; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Exner M, 2017, GMS HYG INFECT CONTR, V12, DOI 10.3205/dgkh000290; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767; FAVEL A, 1989, INT J PEPT PROT RES, V33, P202; Fedorova VA, 2021, NAT PROD RES, V35, P4256, DOI 10.1080/14786419.2019.1696791; Fellenberg C, 2015, TRENDS PLANT SCI, V20, P212, DOI 10.1016/j.tplants.2015.01.011; Fensterseifer ICM, 2015, PEPTIDES, V63, P38, DOI 10.1016/j.peptides.2014.10.019; FEWELL AM, 1993, PHYTOCHEMISTRY, V33, P323, DOI 10.1016/0031-9422(93)85511-O; FOWDEN L, 1956, BIOCHEM J, V64, P323, DOI 10.1042/bj0640323; Francklyn CS, 2019, J BIOL CHEM, V294, P5365, DOI 10.1074/jbc.REV118.002956; Freeman BC., 2008, OVERVIEW PLANT DEFEN, DOI [10.1094/PHI-I-2008-0226-01, 10.1094/PHI-I-2008-0226-01%20, DOI 10.1094/PHI-I-2008-0226-01]; Gao GH, 2001, BIOCHEMISTRY-US, V40, P10973, DOI 10.1021/bi010167k; Gerlach Samantha L, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6010033; Gertsch J, 2016, PLANTA MED, V82, P920, DOI 10.1055/s-0042-108340; Gournelis DC, 1997, NAT PROD REP, V14, P75, DOI 10.1039/np9971400075; Gowd KH, 2010, BIOCHEMISTRY-US, V49, P2741, DOI 10.1021/bi902137c; Guantai EM, 2011, J MED CHEM, V54, P3637, DOI 10.1021/jm200149e; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Gutierrez D, 2013, EXP PARASITOL, V135, P456, DOI 10.1016/j.exppara.2013.08.008; Hahn F, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02388-2; Hall A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070159; Hamid HA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00096; Hammerschmidt R., 1999, NOVARTIS FDN S, V223, P188; Hannich JT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004762; Haridas V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002005; Hartrampf N, 2020, SCIENCE, V368, P980, DOI 10.1126/science.abb2491; Haudecoeur R, 2011, J MED CHEM, V54, P5395, DOI 10.1021/jm200242p; Hay SI, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1073-z; Hayashi K, 2010, BIOL PHARM BULL, V33, P1199, DOI 10.1248/bpb.33.1199; Heitz A, 2001, BIOCHEMISTRY-US, V40, P7973, DOI 10.1021/bi0106639; Henriques ST, 2017, BIOCHEMISTRY-US, V56, P669, DOI 10.1021/acs.biochem.6b01212; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Herbel V, 2016, PEERJ, V4, DOI 10.7717/peerj.1987; Herbel V, 2015, MOLECULES, V20, P14889, DOI 10.3390/molecules200814889; HERZOG M, 1995, PLANT MOL BIOL, V27, P743, DOI 10.1007/BF00020227; Hocking G., 1997, DICT NATURAL PRODUCT, V1; Hu Z, 2018, PLANT SIGNAL BEHAV, V13, DOI 10.1080/15592324.2018.1475175; Huang MH, 2019, ACTA PHARMACOL SIN B, V9, P769, DOI 10.1016/j.apsb.2019.01.013; Huang RH, 2002, FEBS LETT, V521, P87, DOI 10.1016/S0014-5793(02)02829-6; Almasia NI, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0401-2; Jakobsen TH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09886-8; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Jeandet P, 2015, MOLECULES, V20, P2770, DOI 10.3390/molecules20022770; Jeandet P, 2014, MOLECULES, V19, P18033, DOI 10.3390/molecules191118033; Jing XS, 2020, MED RES REV, V40, P753, DOI 10.1002/med.21639; Johari SA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8032865; Johari SA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/823829; Joo SH, 2012, BIOMOL THER, V20, P19, DOI 10.4062/biomolther.2012.20.1.019; Joullie MM, 2004, CHEM COMMUN, P2011, DOI 10.1039/b400334a; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kannan S, 2018, J BIOMOL STRUCT DYN, V36, P4255, DOI 10.1080/07391102.2017.1413422; Kedes DH, 1997, J CLIN INVEST, V99, P2082, DOI 10.1172/JCI119380; Kedzierski L, 2007, PARASITOL RES, V102, P91, DOI 10.1007/s00436-007-0729-y; Keri RS, 2010, ARCH PHARM, V343, P237, DOI 10.1002/ardp.200900188; Keshavan ND, 2005, J BACTERIOL, V187, P8427, DOI 10.1128/JB.187.24.8427-8436.2005; Khadem S, 2012, MOLECULES, V17, P191, DOI 10.3390/molecules17010191; Kintzing JR, 2016, CURR OPIN CHEM BIOL, V34, P143, DOI 10.1016/j.cbpa.2016.08.022; Klein AP, 2017, P NATL ACAD SCI USA, V114, P1910, DOI 10.1073/pnas.1615625114; Klint JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063865; Komericki P, 2011, SEX TRANSM DIS, V38, P216, DOI 10.1097/OLQ.0b013e3181f68ebb; Koo HB, 2019, PEPTIDE SCI, V111, DOI 10.1002/pep2.24122; Kotilainen M, 1999, PLANT CELL, V11, P1093, DOI 10.1105/tpc.11.6.1093; Kovalskaya N, 2009, PROTEIN EXPRES PURIF, V63, P12, DOI 10.1016/j.pep.2008.08.013; Kowalska J, 2007, PHYTOCHEMISTRY, V68, P1487, DOI 10.1016/j.phytochem.2007.03.012; Kregiel D., 2016, SAPONIN BASED BIOL A; Kuddus MR, 2016, PROTEIN EXPRES PURIF, V122, P15, DOI 10.1016/j.pep.2016.02.002; Kumar N, 2016, CURR OPIN HIV AIDS, V11, P432, DOI 10.1097/COH.0000000000000290; Landis RF, 2018, J AM CHEM SOC, V140, P6176, DOI 10.1021/jacs.8b03575; Lani R, 2016, ANTIVIR RES, V133, P50, DOI 10.1016/j.antiviral.2016.07.009; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; LEE H, 1991, J BIOL CHEM, V266, P15944; Li F, 2003, PEPTIDES, V24, P799, DOI 10.1016/S0196-9781(03)00173-6; Li HB, 2005, J CHROMATOGR A, V1074, P107, DOI 10.1016/j.chroma.2005.03.088; Li H, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01438; Li L, 2008, J AM CHEM SOC, V130, P1918, DOI 10.1021/ja0760877; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; Li X, 2016, CURR HIV RES, V14, P484, DOI 10.2174/1570162X14666161003152458; Lillehoj H, 2018, VET RES, V49, DOI 10.1186/s13567-018-0562-6; Lin Liang-Tzung, 2014, J Tradit Complement Med, V4, P24, DOI 10.4103/2225-4110.124335; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu CH, 2019, MOLECULES, V24, DOI 10.3390/molecules24081552; Liu GT, 2009, MED CHEM, V5, P29, DOI 10.2174/157340609787049316; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103442; Loo SN, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02162; Madhavan A, 2019, BBA-PROTEINS PROTEOM, V1867, DOI 10.1016/j.bbapap.2019.140262; Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x; Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11; Majewski J, 2010, EUR BIOPHYS J BIOPHY, V39, P1155, DOI 10.1007/s00249-009-0568-0; Majik MS, 2013, BIOORG MED CHEM LETT, V23, P2353, DOI 10.1016/j.bmcl.2013.02.051; Manske R. H. F., 2014, ALKALOIDS CHEM PHYSL; Mao ZC, 2011, PHYTOPARASITICA, V39, P151, DOI 10.1007/s12600-011-0149-5; Matkhalikova S. F., 1969, CHEM NAT COMPOUNDS, V5, P530; Mattio LM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55975-1; Meguellati A, 2014, EUR J MED CHEM, V80, P579, DOI 10.1016/j.ejmech.2014.04.005; Meng DM, 2019, PROTEIN EXPRES PURIF, V160, P19, DOI 10.1016/j.pep.2019.03.007; Mitchell G, 2011, ANTIMICROB AGENTS CH, V55, P1937, DOI 10.1128/AAC.01468-10; Moldrup ME, 2013, PLANT CELL, V25, P360, DOI 10.1105/tpc.112.104745; Monte J, 2014, PATHOGENS, V3, P473, DOI 10.3390/pathogens3020473; Moore SJ, 2012, METHOD ENZYMOL, V503, P223, DOI 10.1016/B978-0-12-396962-0.00009-4; Moradi MT, 2018, TOXIN REV, V37, P11, DOI 10.1080/15569543.2017.1323338; Morita H, 2019, J BIOL CHEM, V294, P15121, DOI 10.1074/jbc.REV119.006129; Moses T, 2014, CRIT REV BIOCHEM MOL, V49, P439, DOI 10.3109/10409238.2014.953628; Mucha S, 2019, PLANT CELL, V31, P2697, DOI 10.1105/tpc.19.00403; Muller A, 2016, J BIOL CHEM, V291, P11477, DOI 10.1074/jbc.M115.702308; Munde T, 2013, PHYTOCHEMISTRY, V91, P165, DOI 10.1016/j.phytochem.2012.02.020; Nakabayashi R, 2013, ANAL BIOANAL CHEM, V405, P5005, DOI 10.1007/s00216-013-6869-2; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Nawrot R, 2014, FOLIA MICROBIOL, V59, P181, DOI 10.1007/s12223-013-0280-4; Newman DJ, 2020, J NAT PROD, V83, P770, DOI 10.1021/acs.jnatprod.9b01285; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Ng YM, 2011, J STRUCT BIOL, V174, P164, DOI 10.1016/j.jsb.2010.12.007; Ng YP, 2015, NEUROCHEM INT, V89, P260, DOI 10.1016/j.neuint.2015.07.018; Nguyen PQT, 2014, FEBS J, V281, P4351, DOI 10.1111/febs.12939; Nielsen KK, 1997, PLANT PHYSIOL, V113, P83, DOI 10.1104/pp.113.1.83; Nolde SB, 2011, J BIOL CHEM, V286, P25145, DOI 10.1074/jbc.M110.200378; Norman EO, 2019, NAT PROD REP, V36, P753, DOI 10.1039/c8np00067k; Nowakowska Z, 2007, EUR J MED CHEM, V42, P125, DOI 10.1016/j.ejmech.2006.09.019; Nworu CS, 2017, AFR HEALTH SCI, V17, P827, DOI 10.4314/ahs.v17i3.26; O'Connell KMG, 2013, ANGEW CHEM INT EDIT, V52, P10706, DOI 10.1002/anie.201209979; Ochiai A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29715-w; Odintsova TI, 2009, FEBS J, V276, P4266, DOI 10.1111/j.1742-4658.2009.07135.x; Ogungbe IV, 2014, J MOL GRAPH MODEL, V48, P105, DOI 10.1016/j.jmgm.2013.12.010; Ohyama K, 2014, BIOORG MED CHEM LETT, V24, P3556, DOI 10.1016/j.bmcl.2014.05.048; Oparin PB, 2012, BIOCHEM J, V446, P69, DOI 10.1042/BJ20120548; Opitz S, 2002, J NAT PROD, V65, P1122, DOI 10.1021/np020083s; Oros G, 2019, BIOACTIVE MOLECULES IN PLANT DEFENSE: SIGNALING IN GROWTH AND STRESS, P179, DOI 10.1007/978-3-030-27165-7_11; Otten A, 2020, MICROB RISK ANAL, V14, DOI 10.1016/j.mran.2019.100089; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Panseeta P, 2011, PHYTOCHEMISTRY, V72, P909, DOI 10.1016/j.phytochem.2011.03.003; Parsley NC, 2018, PHYTOCHEMISTRY, V152, P61, DOI 10.1016/j.phytochem.2018.04.014; Parthasarathy A, 2019, CURR MED CHEM, V26, P2330, DOI 10.2174/0929867324666171012103559; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Pedras MSC, 2013, BIOORGAN MED CHEM, V21, P4541, DOI 10.1016/j.bmc.2013.05.026; Pedras MSC, 2012, MOL PLANT PATHOL, V13, P483, DOI 10.1111/j.1364-3703.2011.00765.x; Pedras MSC, 2011, NAT PROD REP, V28, P1381, DOI 10.1039/c1np00020a; Persson T, 2005, ORG BIOMOL CHEM, V3, P253, DOI 10.1039/b415761c; Nguyen QT, 2015, J BIOL CHEM, V290, P31138, DOI 10.1074/jbc.M115.654855; Pieper P, 2020, TETRAHEDRON, V76, DOI 10.1016/j.tet.2019.130814; Pingaew R, 2014, EUR J MED CHEM, V85, P65, DOI 10.1016/j.ejmech.2014.07.087; Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923; Poon IKH, 2014, ELIFE, V3, DOI 10.7554/eLife.01808; Poth AG, 2013, BIOPOLYMERS, V100, P480, DOI 10.1002/bip.22284; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P1964, DOI 10.1093/jac/dkq220; Pronin SV, 2012, NAT CHEM, V4, P915, DOI [10.1038/nchem.1458, 10.1038/NCHEM.1458]; Qamar MTU, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38450-1; Qurrat-Ul-Ain, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00292; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Ranjbar-Omid M, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv049; Rao R., 1942, J SCI IND RES, V5, P31; Rehm FBH, 2019, P NATL ACAD SCI USA, V116, P7831, DOI 10.1073/pnas.1901807116; Reiter J, 2017, MOLECULES, V22, DOI 10.3390/molecules22101711; Renz J, 1936, H-S Z PHYSIOL CHEM, V244, P153, DOI 10.1515/bchm2.1936.244.3-4.153; Antinarelli LMR, 2019, J PHARM PHARMACOL, V71, P1854, DOI 10.1111/jphp.13177; Caldas GFR, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/856168; Rodriguez-Decuadro S, 2018, AMINO ACIDS, V50, P1245, DOI 10.1007/s00726-018-2598-3; Rogosnitzky M, 2020, PHARMACOL REP, V72, P1509, DOI 10.1007/s43440-020-00132-z; Rogosnitzky M, 2011, PHARMACOL REP, V63, P337, DOI 10.1016/S1734-1140(11)70500-X; Rogozhin E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113449; Rollin-Pinheiro R, 2016, FUTURE MED CHEM, V8, P1469, DOI 10.4155/fmc-2016-0053; Rosales PF, 2020, FITOTERAPIA, V143, DOI 10.1016/j.fitote.2020.104558; Roussaki M, 2012, INT J MED CHEM, V2012, DOI 10.1155/2012/196921; Rouzaud C, 2016, J FUNGI, V2, DOI 10.3390/jof2010004; Rozmer Z, 2016, PHYTOCHEM REV, V15, P87, DOI 10.1007/s11101-014-9387-8; Rubenstein E, 2006, PHYTOCHEMISTRY, V67, P898, DOI 10.1016/j.phytochem.2006.01.028; Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213; Saavedra MJ, 2010, MED CHEM, V6, P174, DOI 10.2174/1573406411006030174; Sahoo Maheswata, 2016, Genomics & Informatics, V14, P96, DOI 10.5808/GI.2016.14.3.96; Saslis-Lagoudakis CH, 2012, P NATL ACAD SCI USA, V109, P15835, DOI 10.1073/pnas.1202242109; SCHENK SU, 1991, BIOL FERT SOILS, V11, P203, DOI 10.1007/BF00335768; SCHENK SU, 1991, PHYTOCHEMISTRY, V30, P467, DOI 10.1016/0031-9422(91)83706-Q; Scossa F, 2018, PLANTA MED, V84, P855, DOI 10.1055/a-0630-1899; Segura A, 1999, MOL PLANT MICROBE IN, V12, P16, DOI 10.1094/MPMI.1999.12.1.16; Sharifi-Rad J, 2014, ANN MED HEALTH SCI R, V4, P863, DOI 10.4103/2141-9248.144883; Sharma Sunayana, 2014, Int J Pept, V2014, P156060, DOI 10.1155/2014/156060; SHI LF, 1992, PLANT J, V2, P153; Shin J., 2018, MICROB PATHOGENESIS, V116, P209, DOI DOI 10.1016/j.micpath.2018.01.043; Short Erica E, 2017, Infect Dis (Auckl), V10, p1178633617732296, DOI 10.1177/1178633617732296; Silva S., 2017, J FUNGI BASEL, P3; Slavokhotova AA, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1659, DOI 10.1134/S0006297917130065; Slavokhotova AA, 2014, PLANT MOL BIOL, V84, P189, DOI 10.1007/s11103-013-0127-z; Slazak B, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01296; Smyth AR, 2010, PEDIATR PULM, V45, P356, DOI 10.1002/ppul.21193; Solaymani-Mohammadi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000682; Soledade M, 2017, RSC ADV, V7, P23633, DOI 10.1039/c7ra01574g; Song Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02201-z; Srinivasan P, 2020, NATURE, V585, P614, DOI 10.1038/s41586-020-2650-9; Stec B, 2006, CELL MOL LIFE SCI, V63, P1370, DOI 10.1007/s00018-005-5574-5; Stromstedt AA, 2017, BBA-BIOMEMBRANES, V1859, P1986, DOI 10.1016/j.bbamem.2017.06.018; Struyfs C, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183255; Svensson B, 2004, BBA-PROTEINS PROTEOM, V1696, P145, DOI 10.1016/j.bbapap.2003.07.004; Swaminathan K, 2014, ANAL CHIM ACTA, V828, P61, DOI 10.1016/j.aca.2014.04.021; Swaminathan K, 2013, ANAL BIOANAL CHEM, V405, P6563, DOI 10.1007/s00216-013-7068-x; Szeliga M, 2019, GENE, V712, DOI 10.1016/j.gene.2019.143962; Tam JP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33894-x; Tam JP, 2015, PHARMACEUTICALS-BASE, V8, P711, DOI 10.3390/ph8040711; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; Tantak MP, 2015, BIOORG MED CHEM LETT, V25, P4225, DOI 10.1016/j.bmcl.2015.07.105; Tardugno R, 2018, NAT PROD RES, V32, P544, DOI 10.1080/14786419.2017.1329730; Tavares PM, 2008, ANTIMICROB AGENTS CH, V52, P4522, DOI 10.1128/AAC.00448-08; Taveira GB, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180119; Taveira GB, 2017, BIOPOLYMERS, V108, DOI 10.1002/bip.23008; Taveira GB, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0626-6; Taveira GB, 2014, BIOPOLYMERS, V102, P30, DOI 10.1002/bip.22351; Tavormina P, 2015, PLANT CELL, V27, P2095, DOI 10.1105/tpc.15.00440; Tegos GP, 2011, CURR PHARM DESIGN, V17, P1291; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Thevissen K, 2007, DRUG DISCOV TODAY, V12, P966, DOI 10.1016/j.drudis.2007.07.016; Thevissen K, 2012, MOL MICROBIOL, V84, P166, DOI 10.1111/j.1365-2958.2012.08017.x; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Thornsberry C, 2002, CLIN INFECT DIS, V34, pS4, DOI 10.1086/324525; Tomassoli I, 2016, CURR TOP MED CHEM, V16, P1314, DOI 10.2174/1568026615666150915111434; Nguyen TD, 2012, METHOD ENZYMOL, V517, P261, DOI 10.1016/B978-0-12-404634-4.00013-9; Troost B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63397-7; Tuenter E., 2016, PLANTA MED, V82; Tuenter E, 2017, PHYTOCHEM REV, V16, P623, DOI 10.1007/s11101-016-9484-y; Tuenter E, 2017, MOLECULES, V22, DOI 10.3390/molecules22020224; Van Den Bergh K. P. B., 2002, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V67, P327; Van den Bergh KPB, 2002, FEBS LETT, V530, P181, DOI 10.1016/S0014-5793(02)03474-9; van der Weerden NL, 2010, J BIOL CHEM, V285, P37513, DOI 10.1074/jbc.M110.134882; VANPARIJS J, 1991, PLANTA, V183, P258, DOI 10.1007/BF00197797; Varghese FS, 2016, J VIROL, V90, P9743, DOI 10.1128/JVI.01382-16; Vasilchenko AS, 2016, SCANNING, V38, P591, DOI 10.1002/sca.21305; Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314; Ventola C Lee, 2015, P T, V40, P277; Vo DD, 2016, ADV SYNTH CATAL, V358, P4085, DOI 10.1002/adsc.201601089; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Vozzolo L, 2010, J BIOL CHEM, V285, P39314, DOI 10.1074/jbc.M110.155275; Vranova V, 2011, PLANT SOIL, V342, P31, DOI 10.1007/s11104-010-0673-y; Vriens K, 2016, PEPTIDES, V75, P71, DOI 10.1016/j.peptides.2015.11.001; Walewska A, 2009, ANGEW CHEM INT EDIT, V48, P2221, DOI 10.1002/anie.200806085; Walsh C., 2003, ANTIBIOTICS ACTIONS; Wang CK, 2009, BIOPHYS J, V97, P1471, DOI 10.1016/j.bpj.2009.06.032; Wang RF, 2020, CURR OPIN BIOTECH, V62, P65, DOI 10.1016/j.copbio.2019.09.004; Warrilow AGS, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00333-17; Wei WY, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00961; Whitesell L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08248-w; Wink M, 2010, ANNU PLANT REV, V40, P1, DOI 10.1002/9781444320503.ch1; Wink M, 2012, MOLECULES, V17, P12771, DOI 10.3390/molecules171112771; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Wong JH, 2005, INT J BIOCHEM CELL B, V37, P1626, DOI 10.1016/j.biocel.2005.02.022; Wong KH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01639; WRIGHT CW, 1991, PLANTA MED, V57, P337, DOI 10.1055/s-2006-960112; Xie YR, 2020, INFECT MICROBE DIS, V2, P30, DOI 10.1097/IM9.0000000000000016; Xu SH, 2020, J IND MICROBIOL BIOT, V47, P829, DOI 10.1007/s10295-020-02291-7; Xu ZM, 2019, CAN J MICROBIOL, V65, P563, DOI 10.1139/cjm-2019-0055; Ye N, 2016, ACS INFECT DIS, V2, P382, DOI 10.1021/acsinfecdis.6b00041; Ynigez-Gutierrez AE, 2019, J MED CHEM, V62, P8412, DOI 10.1021/acs.jmedchem.9b00246; Yu HF, 2018, ORG LETT, V20, P4116, DOI 10.1021/acs.orglett.8b01675; Zaurov D., 2012, MED PLANTS CENTRAL A, P74; Zetterstrom CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081969; Zhai WJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020340; Zhang L, 2014, TETRAHEDRON LETT, V55, P1815, DOI 10.1016/j.tetlet.2014.01.122; Zhang X, 2020, SCIENCE, V369, P799, DOI 10.1126/science.abb8271; Zheng K, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00032; Zhuang CL, 2017, CHEM REV, V117, P7762, DOI 10.1021/acs.chemrev.7b00020; Zou B, 2015, ACS MED CHEM LETT, V6, P344, DOI 10.1021/ml500521r; Zou G, 2009, VIROLOGY, V384, P242, DOI 10.1016/j.virol.2008.11.003	361	12	12	4	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100438	10.1016/j.jbc.2021.100438	http://dx.doi.org/10.1016/j.jbc.2021.100438			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610552	Green Published, gold			2022-12-28	WOS:000672866400412
J	Stuckey, JI; Cantone, NR; Cote, A; Arora, S; Vivat, V; Ramakrishnan, A; Mertz, JA; Khanna, A; Brenneman, J; Gehling, VS; Moine, L; Sims, RJ; Audia, JE; Trojer, P; Levell, JR; Cummings, RT				Stuckey, Jacob, I; Cantone, Nico R.; Cote, Alexandre; Arora, Shilpi; Vivat, Valerie; Ramakrishnan, Ashwin; Mertz, Jennifer A.; Khanna, Avinash; Brenneman, Jehrod; Gehling, Victor S.; Moine, Ludivine; Sims, Robert J.; Audia, James E.; Trojer, Patrick; Levell, Julian R.; Cummings, Richard T.			Identification and characterization of second-generation EZH2 inhibitors with extended residence times and improved biological activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE EZH2; CARBOXYPEPTIDASE-A; BINDING; NONCOVALENT; AFFINITIES; COMPLEXES; CHROMATIN; MUTATION; ENHANCER; OPINION	The histone methyltransferase EZH2 has been the target of numerous small-molecule inhibitor discovery efforts over the last 10+ years. Emerging clinical data have provided early evidence for single agent activity with acceptable safety profiles for first-generation inhibitors. We have developed kinetic methodologies for studying EZH2-inhibitor-binding kinetics that have allowed us to identify a unique structural modification that results in significant increases in the drug-target residence times of all EZH2 inhibitor scaffolds we have studied. The unexpected residence time enhancement bestowed by this modification has enabled us to create a series of second-generation EZH2 inhibitors with sub-pM binding affinities. We provide both biophysical evidence validating this sub-pM potency and biological evidence demonstrating the utility and relevance of such high-affinity interactions with EZH2.	[Stuckey, Jacob, I; Cantone, Nico R.; Cote, Alexandre; Arora, Shilpi; Vivat, Valerie; Ramakrishnan, Ashwin; Mertz, Jennifer A.; Khanna, Avinash; Brenneman, Jehrod; Gehling, Victor S.; Moine, Ludivine; Sims, Robert J.; Audia, James E.; Trojer, Patrick; Levell, Julian R.; Cummings, Richard T.] Constellat Pharmaceut, Cambridge, MA 02142 USA		Cummings, RT (corresponding author), Constellat Pharmaceut, Cambridge, MA 02142 USA.	richard.cummings@constellationpharma.com	Ramakrishnan, Ashwin/AAF-8638-2021	Ramakrishnan, Ashwin/0000-0003-1569-6664				Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Beno BR, 2015, J MED CHEM, V58, P4383, DOI 10.1021/jm501853m; Benson S. W., 1960, FDN CHEM KINETICS; BOEKER EA, 1984, EXPERIENTIA, V40, P453, DOI 10.1007/BF01952382; Bratkowski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27175-w; Brooun A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11384; Bull HG, 1996, J AM CHEM SOC, V118, P2359, DOI 10.1021/ja953069t; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Copeland RA, 2016, NAT REV DRUG DISCOV, V15, P87, DOI 10.1038/nrd.2015.18; Copeland RA, 2011, ANAL BIOCHEM, V416, P206, DOI 10.1016/j.ab.2011.05.029; Danishuddin, 2019, DRUG DISCOV TODAY, V24, P179, DOI 10.1016/j.drudis.2018.07.002; Gan L, 2018, BIOMARK RES, V6, DOI 10.1186/s40364-018-0122-2; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; Gonzalez M, 1997, J BIOL CHEM, V272, P11288; Gulati N, 2018, LEUKEMIA LYMPHOMA, V59, P1574, DOI 10.1080/10428194.2018.1430795; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; He YP, 2017, NAT CHEM BIOL, V13, P389, DOI 10.1038/nchembio.2306; Honma D, 2017, CANCER SCI, V108, P2069, DOI 10.1111/cas.13326; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KAPLAN AP, 1991, BIOCHEMISTRY-US, V30, P8165, DOI 10.1021/bi00247a011; Khanna A, 2020, ACS MED CHEM LETT, V11, P1205, DOI 10.1021/acsmedchemlett.0c00045; KIM HD, 1991, BIOCHEMISTRY-US, V30, P8171, DOI 10.1021/bi00247a012; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]; Koschmann C, 2017, CANCER RES, V77, P227, DOI 10.1158/0008-5472.CAN-16-2301; Kung PP, 2018, J MED CHEM, V61, P650, DOI 10.1021/acs.jmedchem.7b01375; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Majer CR, 2012, FEBS LETT, V586, P3448, DOI 10.1016/j.febslet.2012.07.066; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; MCPHERSON RA, 1975, ANAL BIOCHEM, V64, P501, DOI 10.1016/0003-2697(75)90460-1; MOTULSKY HJ, 1984, MOL PHARMACOL, V25, P1; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Qi W, 2017, NAT CHEM BIOL, V13, P381, DOI 10.1038/nchembio.2304; Quinn JG, 2018, J MED CHEM, V61, P5154, DOI 10.1021/acs.jmedchem.7b01829; SCHLOSS JV, 1988, J BIOL CHEM, V263, P4145; Smith AJT, 2009, J MED CHEM, V52, P225, DOI 10.1021/jm800498e; Stazi G, 2017, EXPERT OPIN THER PAT, V27, P797, DOI 10.1080/13543776.2017.1316976; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanaka M, 2015, PHARM PAT ANAL, V4, P261, DOI [10.4155/ppa.15.16, 10.4155/PPA.15.16]; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Van Aller GS, 2014, ACS CHEM BIOL, V9, P622, DOI 10.1021/cb4008748; Vaswani RG, 2016, J MED CHEM, V59, P9928, DOI 10.1021/acs.jmedchem.6b01315; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zhao L, 2018, CURR TOP MED CHEM, V18, P2395, DOI 10.2174/1568026619666181224095449	48	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100349	10.1016/j.jbc.2021.100349	http://dx.doi.org/10.1016/j.jbc.2021.100349			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524394	Green Published, gold			2022-12-28	WOS:000672866400323
J	Taylor, A; Grapentine, S; Ichhpuniani, J; Bakovic, M				Taylor, Adrian; Grapentine, Sophie; Ichhpuniani, Jasmine; Bakovic, Marica			Choline transporter-like proteins 1 and 2 are newly identified plasma membrane and mitochondrial ethanolamine transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOETHANOLAMINE CYTIDYLYLTRANSFERASE GENE; FUNCTIONAL-CHARACTERIZATION; CTP; PHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; DEFICIENCY; TARGET; CANCER; CELLS	The membrane phospholipids phosphatidylcholine and phosphatidylethanolamine (PE) are synthesized de novo by the CDP-choline and CDP-ethanolamine (Kennedy) pathway, in which the extracellular substrates choline and ethanolamine are transported into the cell, phosphorylated, and coupled with diacylglycerol to form the final phospholipid product. Although multiple transport systems have been established for choline, ethanolamine transport is poorly characterized and there is no single protein assigned a transport function for ethanolamine. The solute carriers 44A (SLC44A) known as choline transporter-like proteins-1 and -2 (CTL1 and CTL2) are choline transporter at the plasma membrane and mitochondria. We report a novel function of CTL1 and CTL2 in ethanolamine transport. Using the lack or the gain of gene function in combination with specific antibodies and transport inhibitors we established two distinct ethanolamine transport systems of a high affinity, mediated by CTL1, and of a low affinity, mediated by CTL2. Both transporters are Na+-independent ethanolamine/H+ antiporters. Primary human fibroblasts with separate frameshift mutations in the CTL1 gene (M1 = SLC44A1(Delta Asp517) and M2 = SLC44A1(Delta Ser126)) are devoid of CTL1 ethanolamine transport but maintain unaffected CTL2 transport. The lack of CTL1 in M2 cells reduced the ethanolamine transport, the flux through the CDP-ethanolamine Kennedy pathway, and PE synthesis. In contrast, overexpression of CTL1 in M2 cells improved ethanolamine transport and PE synthesis. These data firmly establish that CTL1 and CTL2 are the first identified ethanolamine transporters in whole cells and mitochondria, with intrinsic roles in de novo PE synthesis by the Kennedy pathway and intracellular redistribution of ethanolamine.	[Taylor, Adrian; Grapentine, Sophie; Ichhpuniani, Jasmine; Bakovic, Marica] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada	University of Guelph	Bakovic, M (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada.	mbakovic@uoguelph.ca		Bakovic, Marica/0000-0001-9081-3539	University of Guelph Scholarship; Canadian Institutes of Health Research Grant [CIHR-450137]; National Sciences and Engineering Research Council of Canada [NSERC-400482]	University of Guelph Scholarship; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the University of Guelph Scholarship (to A. T. and S. G.), the Canadian Institutes of Health Research Grant #CIHR-450137, and the National Sciences and Engineering Research Council of Canada Discovery Grant #NSERC-400482 (to M. B.).	Ball WB, 2018, J BIOL CHEM, V293, P10870, DOI 10.1074/jbc.RA118.004014; Bennett JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17254-w; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chang WG, 2019, J CELL MOL MED, V23, P702, DOI 10.1111/jcmm.13984; Constantinescu-Bercu A, 2020, J THROMB HAEMOST, V18, P1556, DOI 10.1111/jth.14834; Constantinescu-Bercu A, 2020, ELIFE, V9, DOI 10.7554/eLife.53353; Fagerberg CR, 2020, BRAIN, V143, P94, DOI 10.1093/brain/awz376; Flesch BK, 2018, TRANSFUS MED HEMOTH, V45, P300, DOI 10.1159/000491031; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Girardi JP, 2011, MED HYPOTHESES, V77, P1083, DOI 10.1016/j.mehy.2011.09.008; Heden TD, 2016, TRENDS ENDOCRIN MET, V27, P553, DOI 10.1016/j.tem.2016.05.007; Hedtke V, 2019, EXP BIOL MED, V244, P655, DOI 10.1177/1535370219830997; Ikon N, 2017, BBA-BIOMEMBRANES, V1859, P1156, DOI 10.1016/j.bbamem.2017.03.013; Iwao B, 2016, NEUROCHEM INT, V93, P40, DOI 10.1016/j.neuint.2015.12.011; Jennings W, 2020, CHEM PHYS LIPIDS, V230, DOI 10.1016/j.chemphyslip.2020.104914; Kouji H, 2009, ARCH BIOCHEM BIOPHYS, V483, P90, DOI 10.1016/j.abb.2008.12.008; Kwiatek JM, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.03.006; Leonardi R, 2009, J BIOL CHEM, V284, P27077, DOI 10.1074/jbc.M109.031336; LIPTON BA, 1988, J CELL PHYSIOL, V137, P571, DOI 10.1002/jcp.1041370325; Martensson CU, 2017, BBA-MOL CELL BIOL L, V1862, P102, DOI 10.1016/j.bbalip.2016.06.015; MASSARELLI AC, 1986, NEUROCHEM RES, V11, P29, DOI 10.1007/BF00965162; Michel V, 2006, EXP BIOL MED, V231, P490; Michel V, 2009, FASEB J, V23, P2749, DOI 10.1096/fj.08-121491; Nagashima F, 2018, BIOMOL THER, V26, P399, DOI 10.4062/biomolther.2017.113; Nair T. S., GENOMICS, V108, P201; Nishiyama R, 2016, J PHARMACOL SCI, V131, P101, DOI 10.1016/j.jphs.2016.04.022; Patel D, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/4829180; Pavlovic Z, 2014, J BIOL CHEM, V289, P9053, DOI 10.1074/jbc.M113.544932; Pavlovic Z, 2013, INT J MOL SCI, V14, P2529, DOI 10.3390/ijms14022529; Schenkel LC, 2015, J NUTR BIOCHEM, V26, P1221, DOI 10.1016/j.jnutbio.2015.05.014; Schenkel LC, 2015, FASEB J, V29, P1663, DOI 10.1096/fj.14-258566; Schenkel LC, 2014, LIPIDS, V49, P731, DOI 10.1007/s11745-014-3925-4; Selathurai A, 2015, CELL METAB, V21, P718, DOI 10.1016/j.cmet.2015.04.001; Sivanesan S, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00061; Taguchi C, 2014, BIOCHEM PHARMACOL, V88, P303, DOI 10.1016/j.bcp.2014.01.033; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Tie A, 2007, J LIPID RES, V48, P2172, DOI 10.1194/jlr.M600536-JLR200; Tilburg J, 2020, J THROMB HAEMOST, V18, P1714, DOI 10.1111/jth.14835; Tilburg J, 2018, THROMB RES, V171, P155, DOI 10.1016/j.thromres.2018.09.057; Trotta F, 2020, MOL CANCER THER, V19, P1909, DOI 10.1158/1535-7163.MCT-19-1063; Yang HS, 2016, IN VITRO CELL DEV-AN, V52, P562, DOI 10.1007/s11626-016-0002-8; YOREK MA, 1986, J LIPID RES, V27, P1205; ZELINSKI TA, 1984, BIOCHIM BIOPHYS ACTA, V794, P326, DOI 10.1016/0005-2760(84)90163-2; ZHA XL, 1992, BIOCHEM CELL BIOL, V70, P1319, DOI 10.1139/o92-179; Zhu L, 2008, J LIPID RES, V49, P2197, DOI 10.1194/jlr.M800259-JLR200	45	8	8	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100604	10.1016/j.jbc.2021.100604	http://dx.doi.org/10.1016/j.jbc.2021.100604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33789160	Green Published, gold			2022-12-28	WOS:000672866400576
J	Zheng, WW; Chu, Q; Xu, TJ				Zheng, Weiwei; Chu, Qing; Xu, Tianjun			Long noncoding RNA IRL regulates NF-kappa B-mediated immune responses through suppression of miR-27c-3p-dependent IRAK4 downregulation in teleost fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; GENE; INTERLEUKIN-1; MECHANISM; MYD88; NLRS	Growing pieces of evidence show that the long noncoding RNAs (lncRNAs) as new regulators participate in the regulation of various physiological and pathological processes. The study of lncRNA in lower invertebrates is still unclear compared with that in mammals. Here, we identified a novel lncRNA, termed IRAK4-related lncRNA (IRL), as a key regulator for innate immunity in teleost fish. We find that miR-27c-3p inhibits IRAK4 expression and thus weakens the NF-kappa B-mediated signaling pathway. Furthermore, the Gram-negative bacterium Vibrio anguillarum and lipopolysaccharide significantly upregulated host lncRNA IRL expression. Results indicate that IRL functions as a competing endogenous RNA for miR-27c-3p to regulate protein abundance of IRAK4; thus, invading microorganisms are eliminated and immune responses are promoted. Our study also demonstrates the regulation mechanism that lncRNA IRL can competitively adsorb miRNA to regulate the miR-27c-3p/IRAK4 axis that is widespread in teleost fish.	[Zheng, Weiwei; Chu, Qing; Xu, Tianjun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China; [Zheng, Weiwei; Chu, Qing; Xu, Tianjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China	Shanghai Ocean University; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Shanghai Ocean University	Xu, TJ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China.	tianjunxu@163.com			National Natural Science Foundation of China [31822057]; National Key Research and Development Project [2018YFD0900503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project	This study was supported by National Natural Science Foundation of China (31822057) and National Key Research and Development Project (2018YFD0900503).	Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chu Q, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008670; Chu Q, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01623; Chu Q, 2017, J IMMUNOL, V198, P3274, DOI 10.4049/jimmunol.1602064; Chu Q, 2017, J BIOL CHEM, V292, P5282, DOI [10.1074/jbc.M117.777078, 10.1074/jbc.m117.777078]; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Fu T, 2021, GASTRIC CANCER, V24, P45, DOI 10.1007/s10120-020-01096-y; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hjorton K, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1702-0; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Huang MG, 2016, ONCOTARGET, V7, P47186, DOI 10.18632/oncotarget.9706; Hynes J, 2014, ANNU REP MED CHEM, V49, P117, DOI 10.1016/B978-0-12-800167-7.00009-2; Jing ZT, 2018, J IMMUNOL, V201, P2303, DOI 10.4049/jimmunol.1800732; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Li XX, 2008, EUR J IMMUNOL, V38, P614, DOI 10.1002/eji.200838161; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Paraskevopoulou MD, 2016, METHODS MOL BIOL, V1402, P271, DOI 10.1007/978-1-4939-3378-5_21; Patop IL, 2019, EMBO J, V38, DOI 10.15252/embj.2018100836; Pattabiraman G, 2018, J LEUKOCYTE BIOL, V104, P811, DOI 10.1002/JLB.2A1117-449R; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Umar S, 2021, CELL MOL IMMUNOL, V18, P2199, DOI 10.1038/s41423-020-0433-8; Vollmer S, 2017, BIOCHEM J, V474, P2027, DOI 10.1042/BCJ20170097; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Xu TJ, 2018, J IMMUNOL, V201, P982, DOI 10.4049/jimmunol.1800377; Xu TJ, 2018, J BIOL CHEM, V293, P1386, DOI [10.1074/jbc.RA117.000158, 10.1074/jbc.ra117.000158]; Xu Y, 2014, FEBS LETT, V588, P1692, DOI 10.1016/j.febslet.2014.03.013; Yan BA, 2015, CIRC RES, V116, P1143, DOI 10.1161/CIRCRESAHA.116.305510; Yang XZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0874-1; Ye F, 2020, CANCER MANAG RES, V12, P2339, DOI 10.2147/CMAR.S246332; Zhang L, 2020, J IMMUNOL, V205, P1620, DOI 10.4049/jimmunol.2000341; Zhou M, 2016, ONCOTARGET, V7, P56383, DOI 10.18632/oncotarget.10891; Zhou M, 2016, ONCOTARGET, V7, P12598, DOI 10.18632/oncotarget.7181; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212	50	22	23	11	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100304	10.1016/j.jbc.2021.100304	http://dx.doi.org/10.1016/j.jbc.2021.100304			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465375	gold, Green Published			2022-12-28	WOS:000672866400278
J	Chan, SC; Hajarnis, SS; Vrba, SM; Patel, V; Igarashi, P				Chan, Siu Chiu; Hajarnis, Sachin S.; Vrba, Sophia M.; Patel, Vishal; Igarashi, Peter			Hepatocyte nuclear factor 1 beta suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HNF-1&#946; &#946; -catenin; LEF1; kidney; histone methylation; tissue-specific transcription factor; Wnt pathway; beta-catenin (B-catenin); transcription repressor; T-cell factor (TCF); cystic kidney disease	WNT/BETA-CATENIN; KIDNEY DEVELOPMENT; GENE-EXPRESSION; RENAL CYSTS; FACTOR-I; HNF-1-BETA; ACTIVATION; DISEASE; MECHANISMS; COMPONENTS	Hepatocyte nuclear factor-1 beta (HNF-1 beta) is a tissue-specific transcription factor that is required for normal kidney development and renal epithelial differentiation. Mutations of HNF-1 beta produce congenital kidney abnormalities and inherited renal tubulopathies. Here, we show that ablation of HNF-1 beta in mIMCD3 renal epithelial cells results in activation of beta-catenin and increased expression of lymphoid enhancer-binding factor 1 (LEF1), a downstream effector in the canonical Wnt signaling pathway. Increased expression and nuclear localization of LEF1 are also observed in cystic kidneys from Hnf1b mutant mice. Expression of dominant-negative mutant HNF-1 beta in mIMCD3 cells produces hyperresponsiveness to exogenous Wnt ligands, which is inhibited by siRNA-mediated knockdown of Lef1. WT HNF-1 beta binds to two evolutionarily conserved sites located 94 and 30 kb from the mouse Lef1 promoter. Ablation of HNF-1 beta decreases H3K27 trimethylation repressive marks and increases beta-catenin occupancy at a site 4 kb upstream to Lef1. Mechanistically, WT HNF-1 beta recruits the polycomb-repressive complex 2 that catalyzes H3K27 trimethylation. Deletion of the beta-catenin-binding domain of LEF1 in HNF-1 beta-deficient cells abolishes the increase in Lef1 transcription and decreases the expression of downstream Wnt target genes. The canonical Wnt target gene, Axin2, is also a direct transcriptional target of HNF-1 beta through binding to negative regulatory elements in the gene promoter. These findings demonstrate that HNF-1 beta regulates canonical Wnt target genes through long-range effects on histone methylation at Wnt enhancers and reveal a new mode of active transcriptional repression by HNF-1 beta.	[Chan, Siu Chiu; Vrba, Sophia M.; Igarashi, Peter] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Hajarnis, Sachin S.; Patel, Vishal; Igarashi, Peter] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Hajarnis, Sachin S.] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA; [Vrba, Sophia M.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Southwestern Medical Center Dallas; Otsuka Pharmaceutical; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Igarashi, P (corresponding author), Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.; Igarashi, P (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	igarashi@umn.edu	Patel, Vishal/GMW-7076-2022	Patel, Vishal/0000-0003-2875-4659; Igarashi, Peter/0000-0001-8698-1185; Vrba, Sophia/0000-0003-1679-8240	NIDDK, National Institutes of Health [R37DK042921]	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIDDK, National Institutes of Health Grant R37DK042921 (to P. I.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aboudehen K, 2017, J AM SOC NEPHROL, V28, P2887, DOI 10.1681/ASN.2016101095; Aboudehen K, 2016, J AM SOC NEPHROL, V27, P2408, DOI 10.1681/ASN.2015060607; Bai Y, 2002, AM J PHYSIOL-RENAL, V283, pF839, DOI 10.1152/ajprenal.00128.2002; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chan SC, 2019, P NATL ACAD SCI USA, V116, P24133, DOI 10.1073/pnas.1909452116; Chan SC, 2018, J AM SOC NEPHROL, V29, P2493, DOI 10.1681/ASN.2018040437; Chan SC, 2015, NUCLEIC ACIDS RES, V43, P5880, DOI 10.1093/nar/gkv262; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Chi YI, 2002, MOL CELL, V10, P1129, DOI 10.1016/S1097-2765(02)00704-9; Choi YH, 2013, AM J PHYSIOL-RENAL, V305, pF100, DOI 10.1152/ajprenal.00582.2012; Choi YH, 2011, P NATL ACAD SCI USA, V108, P10679, DOI 10.1073/pnas.1016214108; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Fang S, 2019, ONCOGENE, V38, P4061, DOI 10.1038/s41388-019-0704-y; Feder K, 2020, LEUKEMIA, V34, P1027, DOI 10.1038/s41375-019-0635-1; Ferre S, 2019, PEDIATR NEPHROL, V34, P1325, DOI 10.1007/s00467-018-3990-7; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gammons M, 2018, CURR OPIN CELL BIOL, V51, P42, DOI 10.1016/j.ceb.2017.10.008; Gong YM, 2009, J AM SOC NEPHROL, V20, P41, DOI 10.1681/ASN.2008020238; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hajarnis SS, 2015, J BIOL CHEM, V290, P24793, DOI 10.1074/jbc.M115.670646; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Hiesberger T, 2005, J BIOL CHEM, V280, P10578, DOI 10.1074/jbc.M414121200; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Huffstater T, 2020, SEMIN NEPHROL, V40, P126, DOI 10.1016/j.semnephrol.2020.01.004; Igarashi P, 2005, KIDNEY INT, V68, P1944, DOI 10.1111/j.1523-1755.2005.00625.x; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kim K, 2017, CURR BIOL, V27, P2357, DOI 10.1016/j.cub.2017.06.037; Laugesen A, 2019, MOL CELL, V74, P8, DOI 10.1016/j.molcel.2019.03.011; Ma ZD, 2007, P NATL ACAD SCI USA, V104, P20386, DOI 10.1073/pnas.0705957104; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Shao A, 2020, CELL SIGNAL, V71, DOI 10.1016/j.cellsig.2020.109568; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; Verhave JC, 2016, J AM SOC NEPHROL, V27, P345, DOI 10.1681/ASN.2015050544; Wang YP, 2018, PROG MOL BIOL TRANSL, V153, P181, DOI 10.1016/bs.pmbts.2017.11.019; Yu DD, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0049-3; Zhou D, 2016, LAB INVEST, V96, P156, DOI 10.1038/labinvest.2015.153	44	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17560	17572		10.1074/jbc.RA120.015592	http://dx.doi.org/10.1074/jbc.RA120.015592			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453998	Green Published, hybrid			2022-12-28	WOS:000603272300014
J	Barros, GC; Requiao, RD; Carneiro, RL; Masuda, CA; Moreira, MH; Rossetto, S; Domitrovic, T; Palhano, FL				Barros, Gessica C.; Requiao, Rodrigo D.; Carneiro, Rodolfo L.; Masuda, Claudio A.; Moreira, Mariana H.; Rossetto, Silvana; Domitrovic, Tatiana; Palhano, Fernando L.			Rqc1 and other yeast proteins containing highly positively charged sequences are not targets of the RQC complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA SURVEILLANCE; E3 UBIQUITIN LIGASE; QUALITY-CONTROL; RIBOSOME COLLISIONS; TRANSLATION ARREST; DEGRADATION; TERMINATION; CODON; INITIATION; LISTERIN	Previous work has suggested that highly positively charged protein segments coded by rare codons or poly (A) stretches induce ribosome stalling and translational arrest through electrostatic interactions with the negatively charged ribosome exit tunnel, leading to inefficient elongation. This arrest leads to the activation of the Ribosome Quality Control (RQC) pathway and results in low expression of these reporter proteins. However, the only endogenous yeast proteins known to activate the RQC are Rqc1, a protein essential for RQC function, and Sdd1, a protein with unknown function, both of which contain polybasic sequences. To explore the generality of this phenomenon, we investigated whether the RQC complex controls the expression of other proteins with polybasic sequences. We showed by ribosome profiling data analysis and western blot that proteins containing polybasic sequences similar to, or even more positively charged than those of Rqc1 and Sdd1, were not targeted by the RQC complex. We also observed that the previously reported Ltn1-dependent regulation of Rqc1 is posttranslational, independent of the RQC activity. Taken together, our results suggest that RQC should not be regarded as a general regulatory pathway for the expression of highly positively charged proteins in yeast.	[Barros, Gessica C.; Requiao, Rodrigo D.; Carneiro, Rodolfo L.; Moreira, Mariana H.; Palhano, Fernando L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Estrutural, Rio De Janeiro, RJ, Brazil; [Masuda, Claudio A.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Mol & Biotecnol, Rio De Janeiro, RJ, Brazil; [Rossetto, Silvana] Univ Fed Rio de Janeiro, Dept Ciencia Comp, Rio De Janeiro, RJ, Brazil; [Domitrovic, Tatiana] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Palhano, FL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Estrutural, Rio De Janeiro, RJ, Brazil.; Domitrovic, T (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, RJ, Brazil.	domitrovic@micro.ufrj.br; palhano@bioqmed.ufrj.br	Palhano, Fernando/C-2586-2008; Masuda, Claudio Akio/F-7214-2014	Palhano, Fernando/0000-0001-5336-632X; C Barros, Gessica/0000-0003-4611-8883; Hoyer Moreira, Mariana/0000-0002-7138-7279; Masuda, Claudio Akio/0000-0002-0310-7108; Carneiro, Rodolfo/0000-0002-1141-2735	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil.	Archer SK, 2016, NATURE, V535, P570, DOI 10.1038/nature18647; Arthur LL, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1486; Arthur LL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500154; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Carneiro RL, 2019, NUCLEIC ACIDS RES, V47, P2216, DOI 10.1093/nar/gkz033; Chandrasekaran V, 2019, NAT STRUCT MOL BIOL, V26, P1132, DOI 10.1038/s41594-019-0331-x; Chiabudini M, 2014, MOL CELL BIOL, V34, P4062, DOI 10.1128/MCB.00799-14; Chiabudini M, 2012, MOL CELL BIOL, V32, P4769, DOI 10.1128/MCB.00809-12; Choe YJ, 2016, NATURE, V531, P191, DOI 10.1038/nature16973; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Crowder JJ, 2015, J BIOL CHEM, V290, P18454, DOI 10.1074/jbc.M115.663559; Cuperus JT, 2017, GENOME RES, V27, P2015, DOI 10.1101/gr.224964.117; D'Orazio KN, 2019, ELIFE, V8, DOI 10.7554/eLife.49117; Dean KM, 2012, RNA, V18, P2335, DOI 10.1261/rna.035907.112; Defenouillere Q, 2016, J BIOL CHEM, V291, P12245, DOI 10.1074/jbc.M116.722264; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Doamekpor SK, 2016, P NATL ACAD SCI USA, V113, pE4151, DOI 10.1073/pnas.1605951113; Fedyukina DV, 2011, ANNU REV BIOPHYS, V40, P337, DOI 10.1146/annurev-biophys-042910-155338; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gamble CE, 2016, CELL, V166, P679, DOI 10.1016/j.cell.2016.05.070; Gamerdinger M, 2016, ESSAYS BIOCHEM, V60, P203, DOI 10.1042/EBC20160011; Ghoneim DH, 2019, NUCLEIC ACIDS RES, V47, P1164, DOI 10.1093/nar/gky1262; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldman DH, 2021, MOL CELL, V81, P1830, DOI 10.1016/j.molcel.2021.01.029; Habich M, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.45; Heyer EE, 2016, CELL, V164, P757, DOI 10.1016/j.cell.2016.01.003; Hickey KL, 2020, MOL CELL, V79, P950, DOI 10.1016/j.molcel.2020.07.007; Ikeuchi K, 2019, EMBO J, V38, DOI 10.15252/embj.2018100276; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Inada T, 2020, NUCLEIC ACIDS RES, V48, P1084, DOI 10.1093/nar/gkz1201; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Joazeiro CAP, 2019, NAT REV MOL CELL BIO, V20, P368, DOI 10.1038/s41580-019-0118-2; Joazeiro CAP, 2017, ANNU REV CELL DEV BI, V33, P343, DOI 10.1146/annurev-cellbio-111315-125249; Juszkiewicz S, 2020, ELIFE, V9, DOI 10.7554/eLife.60038; Juszkiewicz S, 2018, MOL CELL, V72, P469, DOI 10.1016/j.molcel.2018.08.037; Juszkiewicz S, 2017, MOL CELL, V65, P743, DOI 10.1016/j.molcel.2016.11.039; Karamyshev AL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00431; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kiniry SJ, 2019, NUCLEIC ACIDS RES, V47, pD847, DOI 10.1093/nar/gky842; Kostova KK, 2017, SCIENCE, V357, P414, DOI 10.1126/science.aam7787; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Koutmou KS, 2015, ELIFE, V4, DOI 10.7554/eLife.05534; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Letzring DP, 2013, RNA, V19, P1208, DOI 10.1261/rna.039446.113; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Lu JL, 2007, J MOL BIOL, V371, P1378, DOI 10.1016/j.jmb.2007.06.038; Matsuda R, 2014, GENES CELLS, V19, P1, DOI 10.1111/gtc.12106; Matsuo Y, 2020, NAT STRUCT MOL BIOL, V27, P323, DOI 10.1038/s41594-020-0393-9; Matsuo Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00188-1; Maurer MJ, 2016, G3-GENES GENOM GENET, V6, P1853, DOI 10.1534/g3.116.027953; Meydan S, 2020, MOL CELL, V79, P588, DOI 10.1016/j.molcel.2020.06.010; Nissley DA, 2020, J AM CHEM SOC, V142, P6103, DOI 10.1021/jacs.9b12264; Park H, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000396; Phillips B, 2020, J CELL SCI, V133, DOI 10.1242/jcs.251983; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Requiao RD, 2020, BIOCHEM J, V477, P2921, DOI 10.1042/BCJ20200303; Requiao RD, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005549; Requiao RD, 2016, RNA BIOL, V13, P561, DOI 10.1080/15476286.2016.1172755; Saito K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005197; Shah AA, 2002, BIOINFORMATICS, V18, P1046, DOI 10.1093/bioinformatics/18.8.1046; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Simms CL, 2019, CELL REP, V28, P1679, DOI 10.1016/j.celrep.2019.07.046; Simms CL, 2017, MOL CELL, V68, P361, DOI 10.1016/j.molcel.2017.08.019; Sitron CS, 2019, NAT STRUCT MOL BIOL, V26, P450, DOI 10.1038/s41594-019-0230-1; Sitron CS, 2017, RNA, V23, P798, DOI 10.1261/rna.060897.117; Siwiak M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000865; Tesina P, 2020, EMBO J, V39, DOI 10.15252/embj.2019103365; Thompson MK, 2016, ELIFE, V5, DOI 10.7554/eLife.11154; Tuller T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r110; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang JY, 2018, ELIFE, V7, DOI 10.7554/eLife.39637; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Wolf AS, 2015, RNA, V21, P935, DOI 10.1261/rna.049080.114; Wu CCC, 2019, MOL CELL, V73, P959, DOI 10.1016/j.molcel.2018.12.009; Xiao W., 2005, METHODS MOL BIOL, V313, P047; Yonashiro R, 2016, ELIFE, V5, DOI 10.7554/eLife.11794; Zhao T, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-020-02256-0; Zuzow N, 2018, MOL BIOL CELL, V29, P1258, DOI 10.1091/mbc.E17-12-0714	88	2	2	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100586	10.1016/j.jbc.2021.100586	http://dx.doi.org/10.1016/j.jbc.2021.100586			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33774050	gold, Green Published, Green Submitted			2022-12-28	WOS:000672866400558
J	Beg, M; Zhang, W; McCourt, AC; Enerback, S				Beg, Muheeb; Zhang, Wei; McCourt, Andrew C.; Enerback, Sven			ATGL activity regulates GLUT1-mediated glucose uptake and lactate production via TXNIP stability in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING MECHANISMS; INSULIN; GLUT4; INVOLVEMENT; METABOLISM; LIPOLYSIS; PATHWAY	Traditionally, lipolysis has been regarded as an enzymatic activity that liberates fatty acids as metabolic fuel. However, recent work has shown that novel substrates, including a variety of lipid compounds such as fatty acids and their derivatives, release lipolysis products that act as signaling molecules and transcriptional modulators. While these studies have expanded the role of lipolysis, the mechanisms underpinning lipolysis signaling are not fully defined. Here, we uncover a new mechanism regulating glucose uptake, whereby activation of lipolysis, in response to elevated cAMP, leads to the stimulation of thioredoxin-interacting protein (TXNIP) degradation. This, in turn, selectively induces glucose transporter 1 surface localization and glucose uptake in 3T3-L1 adipocytes and increases lactate production. Interestingly, cAMP-induced glucose uptake via degradation of TXNIP is largely dependent upon adipose triglyceride lipase (ATGL) and not hormone-sensitive lipase or monoacylglycerol lipase. Pharmacological inhibition or knockdown of ATGL alone prevents cAMP-dependent TXNIP degradation and thus significantly decreases glucose uptake and lactate secretion. Conversely, overexpression of ATGL amplifies the cAMP response, yielding increased glucose uptake and lactate production. Similarly, knockdown of TXNIP elicits enhanced basal glucose uptake and lactate secretion, and increased cAMP further amplifies this phenotype. Overexpression of TXNIP reduces basal and cAMP-stimulated glucose uptake and lactate secretion. As a proof of concept, we replicated these findings in human primary adipocytes and observed TXNIP degradation and increased glucose uptake and lactate secretion upon elevated cAMP signaling. Taken together, our results suggest a crosstalk between ATGL-mediated lipolysis and glucose uptake.	[Beg, Muheeb; Zhang, Wei; McCourt, Andrew C.; Enerback, Sven] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden	University of Gothenburg	Enerback, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	sven.enerback@medgen.gu.se		Enerback, Sven/0000-0003-2911-9710	Swedish Research Council [2019-00773, 2018-02537]; Knut and Alice Wallenberg Foundation; Sahlgrenska's University Hospital; Novo Nordisk; Novo Nordisk Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sahlgrenska's University Hospital; Novo Nordisk(Novo Nordisk); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	S. E. is supported by the Swedish Research Council (2019-00773 and 2018-02537), The Knut and Alice Wallenberg Foundation, Sahlgrenska's University Hospital (under the LUA-ALF agreement), Novo Nordisk, and Novo Nordisk Foundation.	Alhawiti NM, 2017, CURR DRUG TARGETS, V18, P1095, DOI 10.2174/1389450118666170130145514; AMRI EZ, 1994, J LIPID RES, V35, P930; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Czech MP, 2013, DIABETOLOGIA, V56, P949, DOI 10.1007/s00125-013-2869-1; Dube JJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE879, DOI 10.1152/ajpendo.00530.2014; Eichmann TO, 2015, CELL MOL LIFE SCI, V72, P3931, DOI 10.1007/s00018-015-1982-3; EZAKI O, 1990, DIABETES, V39, P1543, DOI 10.2337/diabetes.39.12.1543; Haber EP, 2003, FEBS LETT, V544, P185, DOI 10.1016/S0014-5793(03)00503-9; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hauner H, 1998, INT J OBESITY, V22, P448, DOI 10.1038/sj.ijo.0800606; Kalinovich A, 2020, DIABETOLOGIA, V63, P1603, DOI 10.1007/s00125-020-05171-y; Klip A, 2019, J BIOL CHEM, V294, P11369, DOI 10.1074/jbc.REV119.008351; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; Nugent C, 2001, J BIOL CHEM, V276, P9149, DOI 10.1074/jbc.M009817200; Rabinowitz JD, 2020, NAT METAB, V2, P566, DOI 10.1038/s42255-020-0243-4; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sato M, 2014, DIABETES, V63, P4115, DOI 10.2337/db13-1860; Schoiswohl G, 2015, ENDOCRINOLOGY, V156, P3610, DOI 10.1210/en.2015-1322; Schreiber R, 2019, BBA-MOL CELL BIOL L, V1864, P880, DOI 10.1016/j.bbalip.2018.10.008; Schweiger M, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14859, 10.1038/ncomms15490]; Sokolowska E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00577; Sukonina V, 2019, NATURE, V566, P279, DOI 10.1038/s41586-019-0900-5; VOGT B, 1991, BIOCHEM J, V275, P597, DOI 10.1042/bj2750597; Waldhart AN, 2017, CELL REP, V19, P2005, DOI 10.1016/j.celrep.2017.05.041; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	29	6	7	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100332	10.1016/j.jbc.2021.100332	http://dx.doi.org/10.1016/j.jbc.2021.100332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33508319	gold, Green Published			2022-12-28	WOS:000672866400306
J	Chakraborty, MP; Bhattacharyya, S; Roy, S; Bhattacharya, I; Das, R; Mukherjee, A				Chakraborty, Manas Pratim; Bhattacharyya, Sudipta; Roy, Souryadip; Bhattacharya, Indira; Das, Rahul; Mukherjee, Arindam			Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; INHIBITION; PROTEIN; ACTIVATION; BINDING; ABL; CONFORMATION; MOLECULES	Hck, a Src family nonreceptor tyrosine kinase (SFK), has recently been established as an attractive pharmacological target to improve pulmonary function in COVID-19 patients. Hck inhibitors are also well known for their regulatory role in various malignancies and autoimmune diseases. Curcumin has been previously identified as an excellent DYRK-2 inhibitor, but curcumin's fate is tainted by its instability in the cellular environment. Besides, small molecules targeting the inactive states of a kinase are desirable to reduce promiscuity. Here, we show that functionalization of the 4-arylidene position of the fluorescent curcumin scaffold with an aryl nitrogen mustard provides a stable Hck inhibitor (K-d = 50 +/- 10 nM). The mustard curcumin derivative preferentially interacts with the inactive conformation of Hck, similar to type-II kinase inhibitors that are less promiscuous. Moreover, the lead compound showed no inhibitory effect on three other kinases (DYRK2, Src, and Abl). We demonstrate that the cytotoxicity may be mediated via inhibition of the SFK signaling pathway in triple-negative breast cancer and murine macrophage cells. Our data suggest that curcumin is a modifiable fluorescent scaffold to develop selective kinase inhibitors by remodeling its target affinity and cellular stability.	[Chakraborty, Manas Pratim; Bhattacharya, Indira; Das, Rahul] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur Campus, Mohanpur, India; [Bhattacharyya, Sudipta; Roy, Souryadip; Mukherjee, Arindam] Indian Inst Sci Educ & Res Kolkata, Dept Chem Sci, Mohanpur Campus, Mohanpur, India; [Das, Rahul; Mukherjee, Arindam] Indian Inst Sci Educ & Res Kolkata, Ctr Adv Funct Mat, Mohanpur Campus, Mohanpur, India	Indian Institute of Science Education & Research (IISER) - Kolkata; Indian Institute of Science Education & Research (IISER) - Kolkata; Indian Institute of Science Education & Research (IISER) - Kolkata	Das, R (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur Campus, Mohanpur, India.; Mukherjee, A (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Chem Sci, Mohanpur Campus, Mohanpur, India.; Das, R; Mukherjee, A (corresponding author), Indian Inst Sci Educ & Res Kolkata, Ctr Adv Funct Mat, Mohanpur Campus, Mohanpur, India.	rahul.das@iiserkol.ac.in; a.mukherjee@iiserkol.ac.in	Mukherjee, Arindam/ACI-4201-2022; Bhattacharyya, Sudipta/A-2714-2014	Mukherjee, Arindam/0000-0001-9545-8628; Roy, Souryadip/0000-0001-8291-0291; Das, Rahul/0000-0001-7841-8229; Bhattacharyya, Sudipta/0000-0002-8469-7866	Science and Engineering Research Board (SERB), Government of India [EMR/2107/002324, ECR/2015/000142]; DBT (Department of Biotechnology) Ramalingaswami Fellowship [BT/RFF/Re-entry/14/2014]; DBT Wellcome Trust; CSIR (Council of Scientific and Industrial Research); INSPIRE; IISER-K	Science and Engineering Research Board (SERB), Government of India; DBT (Department of Biotechnology) Ramalingaswami Fellowship; DBT Wellcome Trust(Wellcome Trust DBT India Alliance); CSIR (Council of Scientific and Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India); INSPIRE; IISER-K	The work presented in this article is extramurally funded by Science and Engineering Research Board (SERB), Government of India vide project no. EMR/2107/002324, ECR/2015/000142 and DBT (Department of Biotechnology) Ramalingaswami Fellowship (BT/RFF/Re-entry/14/2014) to R. D. We thank Dr Arnab Gupta for helping us with the confocal microscopy, a facility funded by DBT Wellcome Trust to A. G. Authors S. B. and M. P. C. thank CSIR (Council of Scientific and Industrial Research) and S. R. thanks INSPIRE for their respective research fellowships. We are thankful to IISER-K for the financial support.	Agafonov RV, 2014, NAT STRUCT MOL BIOL, V21, P848, DOI 10.1038/nsmb.2891; AGUILAR MA, 1989, CHEM PHYS, V129, P439, DOI 10.1016/0301-0104(89)85013-X; Albanese SK, 2018, BIOCHEMISTRY-US, V57, P4675, DOI 10.1021/acs.biochem.7b01081; Aleem SU, 2016, CELL CHEM BIOL, V23, P1103, DOI 10.1016/j.chembiol.2016.07.017; Armarego W.L.F., 1997, PURIFICATION LAB CHE; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Banerjee S, 2018, P NATL ACAD SCI USA, V115, P8155, DOI 10.1073/pnas.1806797115; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Chandrasekar T, 2016, J MOL STRUCT, V1116, P146, DOI 10.1016/j.molstruc.2016.02.102; Chandrasekar T, 2015, J MOL STRUCT, V1081, P477, DOI 10.1016/j.molstruc.2014.10.073; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Ernst M, 2002, J EXP MED, V196, P589, DOI 10.1084/jem.20020873; Foda ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6939; Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051; Golubovskaya VM, 2003, MOL CANCER RES, V1, P755; Gordon ON, 2012, TRENDS MOL MED, V18, P361, DOI 10.1016/j.molmed.2012.04.011; Guimaraes CRW, 2011, J CHEM INF MODEL, V51, P1199, DOI 10.1021/ci200153c; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Hari SB, 2013, ACS CHEM BIOL, V8, P2734, DOI 10.1021/cb400663k; Hartig Sean M, 2013, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1415s102; HARTLEY JA, 1991, ANAL BIOCHEM, V193, P131, DOI 10.1016/0003-2697(91)90052-U; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kaszuba M, 2008, J NANOPART RES, V10, P823, DOI 10.1007/s11051-007-9317-4; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kwarcinski FE, 2012, ACS CHEM BIOL, V7, P1910, DOI 10.1021/cb300337u; Lamontanara AJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6470; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li YX, 2018, ANGEW CHEM INT EDIT, V57, P17084, DOI 10.1002/anie.201810087; Lin L, 2006, J MED CHEM, V49, P3963, DOI 10.1021/jm051043z; Lovera S, 2012, J AM CHEM SOC, V134, P2496, DOI 10.1021/ja210751t; Miranda MB, 2007, LEUKEMIA, V21, P1363, DOI 10.1038/sj.leu.2404690; Nagar B, 2002, CANCER RES, V62, P4236; Nelson KM, 2017, J MED CHEM, V60, P1620, DOI 10.1021/acs.jmedchem.6b00975; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; OSUSKY M, 1995, J BIOL CHEM, V270, P25729, DOI 10.1074/jbc.270.43.25729; Plotnikov A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7685; Poh AR, 2017, CANCER CELL, V31, P563, DOI 10.1016/j.ccell.2017.03.006; Poh AR, 2015, ONCOTARGET, V6, P15752, DOI 10.18632/oncotarget.4199; Qiu X, 2010, J MED CHEM, V53, P8260, DOI 10.1021/jm1004545; RASHIN AA, 1987, J PHYS CHEM-US, V91, P6003, DOI 10.1021/j100307a038; Revelo NH, 2014, J CELL BIOL, V205, P591, DOI 10.1083/jcb.201402066; Rooswinkel RW, 2014, BLOOD, V123, P2806, DOI 10.1182/blood-2013-08-519470; Saito Y, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004387; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schneider C, 2015, J AGR FOOD CHEM, V63, P7606, DOI 10.1021/acs.jafc.5b00244; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; STEFANOVICH EV, 1995, CHEM PHYS LETT, V244, P65, DOI 10.1016/0009-2614(95)00898-E; Suen PW, 1999, J CELL SCI, V112, P4067; Tamura Y, 2004, FEBS LETT, V569, P249, DOI 10.1016/j.febslet.2004.06.003; Tang ZN, 2011, ONCOL REP, V26, P1243, DOI 10.3892/or.2011.1368; Teijido O, 2010, FEBS LETT, V584, P3305, DOI 10.1016/j.febslet.2010.07.002; Treon SP, 2020, BLOOD, V135, P1912, DOI 10.1182/blood.2020006288; Tsai PC, 2013, TOXICON, V74, P56, DOI 10.1016/j.toxicon.2013.07.021; Wolczyk D, 2016, CELL ONCOL, V39, P353, DOI 10.1007/s13402-016-0280-x; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yue X, 2017, BIOCHEM PHARMACOL, V137, P29, DOI 10.1016/j.bcp.2017.04.032; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhou JM, 2009, J MED CHEM, V52, P5546, DOI 10.1021/jm801218k	66	2	2	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100449	10.1016/j.jbc.2021.100449	http://dx.doi.org/10.1016/j.jbc.2021.100449			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33617879	gold, Green Published			2022-12-28	WOS:000672866400423
J	Chen, Y; Hu, WQ; Li, Q; Zhao, SW; Zhao, D; Zhang, S; Wei, Z; Yang, XX; Chen, YL; Li, XJ; Liao, CZ; Han, JH; Miao, QR; Duan, YJ				Chen, Yi; Hu, Wenquan; Li, Qi; Zhao, Shiwei; Zhao, Dan; Zhang, Shuang; Wei, Zhuo; Yang, Xiaoxiao; Chen, Yuanli; Li, Xiaoju; Liao, Chenzhong; Han, Jihong; Miao, Qing Robert; Duan, Yajun			NGBR is required to ameliorate type 2 diabetes in mice by enhancing insulin sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOGO-B RECEPTOR; BETA-CELL MASS; ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; FATTY-ACIDS; IN-VIVO; RESISTANCE; MECHANISMS; COMPLICATIONS; DYSFUNCTION	The reduction of insulin resistance or improvement of insulin sensitivity is the most effective treatment for type 2 diabetes (T2D). We previously reported that Nogo-B receptor (NGBR), encoded by the NUS1 gene, is required for attenuating hepatic lipogenesis by blocking nuclear translocation of liver X receptor alpha, suggesting its important role in regulating hepatic lipid metabolism. Herein, we demonstrate that NGBR expression was decreased in the liver of obesity-associated T2D patients and db/db mice. NGBR knockout in mouse hepatocytes resulted in increased blood glucose, insulin resistance, and beta-cell loss. High-fat diet (HFD)/streptozotocin (STZ)-treated mice presented the T2D phenotype by showing increased nonesterified fatty acid (NEFA) and triglyceride (TG) in the liver and plasma and increased insulin resistance and beta-cell loss. AAV-mediated NGBR overexpression in the liver reduced NEFA and TG in the liver and circulation and improved liver functions. Consequently, HFD/STZ-treated mice with hepatic NGBR overexpression had increased insulin sensitivity and reduced beta-cell loss. Mechanistically, NGBR overexpression restored insulin signaling of AMPK alpha 1-dependent phosphorylation of AKT and GSK3 beta. NGBR overexpression also reduced expression of endoplasmic reticulum stress-associated genes in the liver and skeletal muscle to improve insulin sensitivity. Together, our results reveal that NGBR is required to ameliorate T2D in mice, providing new insight into the role of hepatic NGBR in insulin sensitivity and T2D treatment.	[Chen, Yi; Li, Qi; Zhao, Shiwei; Zhao, Dan; Wei, Zhuo; Li, Xiaoju; Han, Jihong] Nankai Univ, Coll Life Sci, Minist Educ, State Key Lab Med Chem Biol,Key Lab Bioact Mat, Tianjin, Peoples R China; [Chen, Yi; Zhang, Shuang; Yang, Xiaoxiao; Chen, Yuanli; Liao, Chenzhong; Han, Jihong; Duan, Yajun] Hefei Univ Technol, Coll Food & Biol Engn, Anhui Dept Educ, Key Lab Major Metab Dis & Nutr Regulat, Hefei, Peoples R China; [Hu, Wenquan; Miao, Qing Robert] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Hu, Wenquan; Miao, Qing Robert] NYU, Long Isl Sch Med, Diabet & Obes Res Ctr, Mineola, NY 11501 USA	Nankai University; Hefei University of Technology; Medical College of Wisconsin; New York University	Duan, YJ (corresponding author), Hefei Univ Technol, Coll Food & Biol Engn, Anhui Dept Educ, Key Lab Major Metab Dis & Nutr Regulat, Hefei, Peoples R China.; Miao, QR (corresponding author), Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA.; Miao, QR (corresponding author), NYU, Long Isl Sch Med, Diabet & Obes Res Ctr, Mineola, NY 11501 USA.	Qing.Miao@nyulangone.org; yduan@hfut.edu.cn		Liao, Chenzhong/0000-0001-7080-1768; Chen, Yi/0000-0002-7474-6230	International Science & Technology Cooperation Programs of China [2017YFE0110100]; China NSFC [81722046, 81773727, 81973316, 31770863, 81803517]; Fundamental Research Funds for the Central Universities of China	International Science & Technology Cooperation Programs of China; China NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was funded by the International Science & Technology Cooperation Programs of China 2017YFE0110100 to J. H., Y. D., Y. C., and X. Y.; the China NSFC grants 81722046 to Y. D.; 81773727 and 81973316 to J. H., 31770863 to Y. C., and 81803517 to X. Y.; the Fundamental Research Funds for the Central Universities of China to Y. D., X. Y., and Y. C.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Boteon YL, 2019, LIVER TRANSPLANT, V25, P1007, DOI 10.1002/lt.25439; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen YL, 2015, ARTERIOSCL THROM VAS, V35, P948, DOI 10.1161/ATVBAHA.114.305116; Chen YL, 2012, J BIOL CHEM, V287, P43340, DOI 10.1074/jbc.M112.403394; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Chopra I, 2012, DIABETOLOGIA, V55, P783, DOI 10.1007/s00125-011-2407-y; Cote CD, 2015, NAT MED, V21, P498, DOI 10.1038/nm.3821; Dong CY, 2016, ONCOTARGET, V7, P8850, DOI 10.18632/oncotarget.7091; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Franko A, 2014, J HEPATOL, V60, P816, DOI 10.1016/j.jhep.2013.11.020; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Hood DA, 2016, BIOCHEM J, V473, P2295, DOI 10.1042/BCJ20160009; Hu WQ, 2016, HEPATOLOGY, V64, P1559, DOI 10.1002/hep.28747; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Lee JM, 2017, DIABETES METAB J, V41, P10, DOI 10.4093/dmj.2017.41.1.10; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Liu Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05309-y; Ma CR, 2018, BRIT J PHARMACOL, V175, P1486, DOI 10.1111/bph.14156; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mann JI, 2002, LANCET, V360, P783, DOI 10.1016/S0140-6736(02)09901-4; Marselli L, 2014, DIABETOLOGIA, V57, P362, DOI 10.1007/s00125-013-3098-3; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Moore JA, 2016, CELL SIGNAL, V28, P384, DOI 10.1016/j.cellsig.2016.01.017; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Oh YS, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00384; Petrie JR, 2011, BIOCHEM PHARMACOL, V81, P471, DOI 10.1016/j.bcp.2010.11.010; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rachek LI, 2014, PROG MOL BIOL TRANSL, V121, P267, DOI 10.1016/B978-0-12-800101-1.00008-9; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSSETTI L, 1995, J CLIN INVEST, V96, P132, DOI 10.1172/JCI118013; Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Sakai K, 2003, ENDOCRINOLOGY, V144, P2388, DOI 10.1210/en.2002-221133; Sun T, 2020, SEMIN CELL DEV BIOL, V103, P76, DOI 10.1016/j.semcdb.2019.12.002; Targher G, 2018, NAT REV ENDOCRINOL, V14, P99, DOI 10.1038/nrendo.2017.173; Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Wallis MG, 2005, DIABETOLOGIA, V48, P2131, DOI 10.1007/s00125-005-1887-z; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yao XG, 2015, J ENDOCRINOL, V224, P327, DOI 10.1530/JOE-14-0721; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang S, 2020, J HEPATOL, V73, P1482, DOI 10.1016/j.jhep.2020.07.034; Zhang WW, 2018, BBA-MOL CELL BIOL L, V1863, P177, DOI 10.1016/j.bbalip.2017.12.002; Zhao B, 2017, ONCOGENE, V36, P3406, DOI 10.1038/onc.2016.484; Zhao BF, 2010, BLOOD, V116, P5423, DOI 10.1182/blood-2010-02-271577; Zhou TT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.119	63	4	5	3	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100624	10.1016/j.jbc.2021.100624	http://dx.doi.org/10.1016/j.jbc.2021.100624			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33812996	gold, Green Published			2022-12-28	WOS:000672866400595
J	Crooke, ST; Liang, XH; Baker, BF; Crooke, RM				Crooke, Stanley T.; Liang, Xue-Hai; Baker, Brenda F.; Crooke, Rosanne M.			Antisense technology: A review	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HUMAN RNASE H1; DUCHENNE MUSCULAR-DYSTROPHY; RESISTANT PROSTATE-CANCER; I DOSE-ESCALATION; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; MESSENGER-RNA; DOUBLE-BLIND; PHASE-I; TARGETING APOLIPOPROTEIN(A); HETERODUPLEX SUBSTRATE	Antisense technology is beginning to deliver on the broad promise of the technology. Ten RNA-targeted drugs including eight single-strand antisense drugs (ASOs) and two double-strand ASOs (siRNAs) have now been approved for commercial use, and the ASOs in phase 2/3 trials are innovative, delivered by multiple routes of administration and focused on both rare and common diseases. In fact, two ASOs are used in cardiovascular outcome studies and several others in very large trials. Interest in the technology continues to grow, and the field has been subject to a significant number of reviews. In this review, we focus on the molecular events that result in the effects observed and use recent clinical results involving several different ASOs to exemplify specific molecular mechanisms and specific issues. We conclude with the prospective on the technology.	[Crooke, Stanley T.; Liang, Xue-Hai] Ionis Pharmaceut Inc, Core Antisense Res, Carlsbad, CA 92008 USA; [Baker, Brenda F.] Ionis Pharmaceut Inc, Dev Commun, Carlsbad, CA USA; [Crooke, Rosanne M.] Ionis Pharmaceut Inc, Antisense Drug Discovery, Carlsbad, CA USA	Ionis Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.	Crooke, ST (corresponding author), Ionis Pharmaceut Inc, Core Antisense Res, Carlsbad, CA 92008 USA.	scrooke@ionisph.com		Liang, Xuehai/0000-0001-9333-8622; Baker, Brenda/0000-0001-8586-768X	Ionis Pharmaceuticals	Ionis Pharmaceuticals	We wish to thank Kim Butler for excellent assistance in manuscript preparation, and Tracy Reigle for help in figure preparation. This work is supported by an internal funding from Ionis Pharmaceuticals.	AbdulManan N, 1996, NUCLEIC ACIDS RES, V24, P4063, DOI 10.1093/nar/24.20.4063; Abou-Gharbia M, 2009, J MED CHEM, V52, P2, DOI 10.1021/jm8012823; Akcea Therapeutics Ionis Pharmaceuticals., 2020, AKC ION REP POS TOPL; Alexander VJ, 2019, EUR HEART J, V40, P2785, DOI 10.1093/eurheartj/ehz209; Alfano LN, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015858; Ammala C, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat3386; Anguela XM, 2019, ANNU REV MED, V70, P273, DOI 10.1146/annurev-med-012017-043332; Bailey JK, 2017, NUCLEIC ACIDS RES, V45, P10649, DOI 10.1093/nar/gkx709; BARANIAK J, 1988, J AM CHEM SOC, V110, P4059, DOI 10.1021/ja00220a067; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Bennett C. F., 2008, ANTISENSE DRUG TECHN, P273; Bennett CF, 2019, ANNU REV NEUROSCI, V42, P385, DOI 10.1146/annurev-neuro-070918-050501; Bennett CF, 2019, ANNU REV MED, V70, P307, DOI 10.1146/annurev-med-041217-010829; Benson MD, 2018, NEW ENGL J MED, V379, P22, DOI 10.1056/NEJMoa1716793; Bethune C., 2019, USDIA OL BAS THER C; Bhanot S, 2013, DIABETOLOGIA, V56, pS282; Bianchini D, 2013, BRIT J CANCER, V109, P2579, DOI 10.1038/bjc.2013.619; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Buller HR, 2015, NEW ENGL J MED, V372, P1672, DOI 10.1056/NEJMc1503223; Burel SA, 2016, NUCLEIC ACIDS RES, V44, P2093, DOI 10.1093/nar/gkv1210; Capaldi D.C., 2008, ANTISENSE DRUG TECHN, P401; Castanotto D, 2015, NUCLEIC ACIDS RES, V43, P9350, DOI 10.1093/nar/gkv964; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; Chernikov IV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00444; Chi KN, 2016, ANN ONCOL, V27, P1116, DOI 10.1093/annonc/mdw068; Chowdhury S, 2016, EUR J CANCER, V69, pS145, DOI 10.1016/S0959-8049(16)33031-3; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Cohn DM, 2020, NEW ENGL J MED, V383, P1242, DOI 10.1056/NEJMoa1915035; Crooke S.T, 2008, ANTISENSE DRUG TECHN, P3; Crooke S.T, 2008, ANTISENSE DRUG TECHN, V2nd, P47; Crooke S.T, 2008, ANTISENSE DRUG TECHN, V2nd, P665; Crooke S.T, 2008, ANTISENSE DRUG TECHN, V2nd, P437; Crooke S.T, 2008, ANTISENSE DRUG TECHN, V2nd, P75; Crooke S.T, 2008, ANTISENSE DRUG TECHN, V2nd, P183; Crooke S.T, 2008, ANTISENSE DRUG TECHN, P565; Crooke S.T., 2008, ANTISENSE DRUG TECHN, P327; Crooke ST, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P1; Crooke ST, 2021, NAT REV DRUG DISCOV, V20, P427, DOI 10.1038/s41573-021-00162-z; Crooke ST, 2021, BIOCHEM PHARMACOL, V189, DOI 10.1016/j.bcp.2020.114196; Crooke ST, 2020, J AM CHEM SOC, V142, P14754, DOI 10.1021/jacs.0c04928; Crooke ST, 2020, NUCLEIC ACIDS RES, V48, P5235, DOI 10.1093/nar/gkaa299; Crooke ST, 2018, NUCLEIC ACID THER, V28, P10, DOI 10.1089/nat.2017.0693; Crooke ST, 2019, CELL METAB, V29, P501, DOI 10.1016/j.cmet.2019.01.001; Crooke ST, 2019, NUCLEIC ACID THER, V29, P16, DOI 10.1089/nat.2018.0753; Crooke ST, 2018, CELL METAB, V27, P714, DOI 10.1016/j.cmet.2018.03.004; Crooke ST, 2017, NUCLEIC ACID THER, V27, P121, DOI 10.1089/nat.2016.0650; Crooke ST, 2017, NUCLEIC ACID THER, V27, P70, DOI 10.1089/nat.2016.0656; Crooke ST, 2017, NAT BIOTECHNOL, V35, P230, DOI 10.1038/nbt.3779; Crooke ST, 2016, MOL THER, V24, P1771, DOI 10.1038/mt.2016.136; De Vivo DC, 2019, NEUROMUSCULAR DISORD, V29, P842, DOI 10.1016/j.nmd.2019.09.007; Debacker AJ, 2020, MOL THER, V28, P1759, DOI 10.1016/j.ymthe.2020.06.015; Digenio A, 2018, DIABETES CARE, V41, P807, DOI 10.2337/dc17-2132; Eckstein F, 2000, ANTISENSE NUCLEIC A, V10, P117, DOI 10.1089/oli.1.2000.10.117; Ferrone JD, 2019, NUCLEIC ACID THER, V29, P82, DOI 10.1089/nat.2018.0754; Fey RA, 2014, INHAL TOXICOL, V26, P452, DOI 10.3109/08958378.2014.907587; FIELD AK, 1971, P SOC EXP BIOL MED, V136, P1180, DOI 10.3181/00379727-136-35454; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Finkel RS, 2016, LANCET, V388, P3017, DOI 10.1016/S0140-6736(16)31408-8; Finlay DB, 2020, BRIT J PHARMACOL, V177, P1472, DOI 10.1111/bph.14988; Flaim JD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000560; Fougerolles A. R. D., 2008, ANTISENSE DRUG TECHN, P465; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Frank DE, 2020, NEUROLOGY, V94, pE2270, DOI 10.1212/WNL.0000000000009233; Freier S. M., 2008, ANTISENSE DRUG TECHN, P117; Gale JD, 2018, PRS-GLOB OPEN, V6, DOI 10.1097/GOX.0000000000001861; Gaudet D, 2020, EUR HEART J, V41, P3936, DOI 10.1093/eurheartj/ehaa689; Gaus HJ, 2019, NUCLEIC ACIDS RES, V47, P1110, DOI 10.1093/nar/gky1260; Geary R. S., 2008, ANTISENSE DRUG TECHN, P305; Geary RS, 2015, ADV DRUG DELIVER REV, V87, P46, DOI 10.1016/j.addr.2015.01.008; Giljohann D, 2019, 15 ANN M OL THER SOC; Goding J. W., 1996, MONOCLONAL ANTIBODIE, P116; Goemans NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161955; Graham MJ, 2017, NEW ENGL J MED, V377, P222, DOI 10.1056/NEJMoa1701329; Graham MJ, 2016, J LIPID RES, V57, P340, DOI 10.1194/jlr.R052258; Greuter T, 2017, IMMUNOTHERAPY-UK, V9, P1143, DOI 10.2217/imt-2017-0085; Grillone LR, 2001, DRUG TODAY, V37, P245, DOI 10.1358/dot.2001.37.4.620590; Grossman TR, 2017, MOL VIS, V23, P561; Hagedorn PH, 2018, DRUG DISCOV TODAY, V23, P101, DOI 10.1016/j.drudis.2017.09.018; Hardee G. E., 2008, ANTISENSE DRUG TECHN, P217; HODGE D, 1995, MOL PHARMACOL, V48, P905; Hong D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5272; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Huang JG, 2015, SCI REP-UK, V5, DOI 10.1038/srep08789; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson N, 2018, J ANTIMICROB CHEMOTH, V73, P1452, DOI 10.1093/jac/dky019; Jahns H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7317; Jairath V, 2017, EXPERT OPIN INV DRUG, V26, P991, DOI 10.1080/13543784.2017.1349753; Janas MM, 2019, NUCLEIC ACIDS RES, V47, P3306, DOI 10.1093/nar/gkz140; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Judge DP, 2020, CARDIOVASC DRUG THER, V34, P357, DOI 10.1007/s10557-019-06919-4; Kandimalla ER, 2013, NUCLEIC ACIDS RES, V41, P3947, DOI 10.1093/nar/gkt078; Karras JG, 2007, AM J RESP CELL MOL, V36, P276, DOI 10.1165/rcmb.2005-0456OC; Khan N, 2019, J NEUROMUSCULAR DIS, V6, P213, DOI 10.3233/JND-180351; Koch T., 2008, ANTISENSE DRUG DISCO, P519; Kolb SJ, 2015, NEUROL CLIN, V33, P831, DOI 10.1016/j.ncl.2015.07.004; Kotula JW, 2012, NUCLEIC ACID THER, V22, P187, DOI 10.1089/nat.2012.0347; Koziolkiewicz M, 1997, ANTISENSE NUCLEIC A, V7, P43, DOI 10.1089/oli.1.1997.7.43; Koziolkiewicz M, 1995, NUCLEIC ACIDS RES, V23, P5000, DOI 10.1093/nar/23.24.5000; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liang XH, 2020, NUCLEIC ACIDS RES, V48, P9840, DOI 10.1093/nar/gkaa715; Liang XH, 2020, NUCLEIC ACIDS RES, V48, P1372, DOI 10.1093/nar/gkz1171; Liang XH, 2019, NUCLEIC ACIDS RES, V47, P6900, DOI 10.1093/nar/gkz500; Liang XH, 2018, NUCLEIC ACIDS RES, V46, P10225, DOI 10.1093/nar/gky841; Liang XH, 2018, NUCLEIC ACIDS RES, V46, P293, DOI 10.1093/nar/gkx1174; Liang XH, 2017, NUCLEIC ACIDS RES, V45, P9528, DOI 10.1093/nar/gkx632; Liang XH, 2017, MOL THER, V25, P2075, DOI 10.1016/j.ymthe.2017.06.002; Liang XH, 2016, NAT BIOTECHNOL, V34, P875, DOI 10.1038/nbt.3589; Liang XH, 2016, NUCLEIC ACIDS RES, V44, P3892, DOI 10.1093/nar/gkw144; Liang XH, 2015, NUCLEIC ACIDS RES, V43, P2927, DOI 10.1093/nar/gkv143; Liang XH, 2014, NUCLEIC ACIDS RES, V42, P7819, DOI 10.1093/nar/gku484; Liang XH, 2013, BBA-GENE REGUL MECH, V1829, P455, DOI 10.1016/j.bbagrm.2013.01.011; Liang XH, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1121; Lima WF, 2007, MOL PHARMACOL, V71, P83, DOI 10.1124/mol.106.025015; Lima WF, 2007, MOL PHARMACOL, V71, P73, DOI 10.1124/mol.106.025429; Lima WF, 2016, NUCLEIC ACIDS RES, V44, P5299, DOI 10.1093/nar/gkw350; Lima WF, 2016, NUCLEIC ACIDS RES, V44, P3351, DOI 10.1093/nar/gkw065; Lima WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101752; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Lima WF, 2004, J BIOL CHEM, V279, P36317, DOI 10.1074/jbc.M405035200; Lima WF, 2003, J BIOL CHEM, V278, P49860, DOI 10.1074/jbc.M306543200; Limmroth V, 2014, NEUROLOGY, V83, P1780, DOI 10.1212/WNL.0000000000000926; Loomba R, 2020, LANCET GASTROENTEROL, V5, P829, DOI 10.1016/S2468-1253(20)30186-2; MacLeod AR, 2017, J CLIN PHARMACOL, V57, pS43, DOI 10.1002/jcph.957; Maehle AH, 2004, MED HIST, V48, P153, DOI 10.1017/S0025727300000090; Maehle AH, 2002, NAT REV DRUG DISCOV, V1, P637, DOI 10.1038/nrd875; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; Manoharan M, 2011, ANGEW CHEM INT EDIT, V50, P2284, DOI 10.1002/anie.201006519; McCarty T., 2016, BIOMARIN ANNOUNCES W; McCombie WR, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a036798; McGowan MP, 2014, CLIN LIPIDOL, V9, P487, DOI 10.2217/CLP.14.43; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; Mercuri E, 2018, NEW ENGL J MED, V378, P625, DOI 10.1056/NEJMoa1710504; Migawa MT, 2019, NUCLEIC ACIDS RES, V47, P5465, DOI 10.1093/nar/gkz247; Mignon L, 2016, NEUROLOGY, V86; Miller CM, 2016, NUCLEIC ACIDS RES, V44, P2782, DOI 10.1093/nar/gkw112; Miller T, 2020, NEW ENGL J MED, V383, P109, DOI 10.1056/NEJMoa2003715; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Miner P, 2004, ALIMENT PHARM THER, V19, P281, DOI 10.1111/j.1365-2036.2004.01863.x; Miner PB, 2006, ALIMENT PHARM THER, V23, P1403, DOI 10.1111/j.1365-2036.2006.02837.x; Miraglia L, 2000, ANTISENSE NUCLEIC A, V10, P453, DOI 10.1089/oli.1.2000.10.453; Monia BP, 1996, NAT MED, V2, P668, DOI 10.1038/nm0696-668; Monteleone G, 2015, NEW ENGL J MED, V372, P2461, DOI 10.1056/NEJMc1504845; Morgan ES, 2019, DIABETES CARE, V42, P585, DOI 10.2337/dc18-1343; Nair JK, 2017, NUCLEIC ACIDS RES, V45, P10969, DOI 10.1093/nar/gkx818; Narayanan P, 2020, NUCLEIC ACID THER, V30, P94, DOI 10.1089/nat.2019.0829; Ng WL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12550-w; Oka N, 2003, J AM CHEM SOC, V125, P8307, DOI 10.1021/ja034502z; OncoGenex Pharmaceuticals Inc, 2016, ONCOGENEX ANN RES PH; Ostergaard ME, 2020, NUCLEIC ACIDS RES, V48, P1691, DOI 10.1093/nar/gkaa031; Ostergaard ME, 2019, NUCLEIC ACIDS RES, V47, P6045, DOI 10.1093/nar/gkz360; Ostergaard ME, 2013, NUCLEIC ACIDS RES, V41, P9634, DOI 10.1093/nar/gkt725; Panzara M, 2019, SELECTIVE TARGETING; Paz S, 2017, NUCLEIC ACID THER, V27, P272, DOI 10.1089/nat.2017.0668; Pfeiffer N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188899; Plumridge A, 2017, NUCLEIC ACIDS RES, V45, P3932, DOI 10.1093/nar/gkx140; Pollak AJ, 2020, NUCLEIC ACID THER, V30, P312, DOI 10.1089/nat.2020.0864; Prakash TP, 2019, NUCLEIC ACIDS RES, V47, P6029, DOI 10.1093/nar/gkz354; Prakash TP, 2014, NUCLEIC ACIDS RES, V42, P8796, DOI 10.1093/nar/gku531; ProQR Therapeutics, 2020, PROQR ANN POS FIND I; Querfeld C, 2017, BLOOD, V130; Regulus Therapeutics, 2017, REG ANN PIP UPD ADV; Reilley MJ, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0436-5; Saad F, 2011, CLIN CANCER RES, V17, P5765, DOI 10.1158/1078-0432.CCR-11-0859; Sands BE, 2020, AM J GASTROENTEROL, V115, P738, DOI 10.14309/ajg.0000000000000493; Sazani P., 2008, ANTISENSE DRUG TECHN, P89; Senn JJ, 2005, J PHARMACOL EXP THER, V314, P972, DOI 10.1124/jpet.105.084004; Setten RL, 2019, NAT REV DRUG DISCOV, V18, P421, DOI 10.1038/s41573-019-0017-4; Sewell KL, 2002, J PHARMACOL EXP THER, V303, P1334, DOI 10.1124/jpet.102.036749; Shen W, 2019, NAT BIOTECHNOL, V37, P640, DOI 10.1038/s41587-019-0106-2; Shen W, 2018, NUCLEIC ACIDS RES, V46, P2204, DOI 10.1093/nar/gky060; Shen W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173494; Shen W, 2015, NUCLEIC ACIDS RES, V43, P4569, DOI 10.1093/nar/gkv298; Shen W, 2014, NUCLEIC ACIDS RES, V42, P8648, DOI 10.1093/nar/gku579; Steinke CA, 1997, J BIOMOL STRUCT DYN, V14, P509, DOI 10.1080/07391102.1997.10508149; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; Swayze EE., 2008, ANTISENSE DRUG TECHN, P143; Swayze EE, 2007, NUCLEIC ACIDS RES, V35, P687, DOI 10.1093/nar/gkl1071; Swinnen B, 2020, EMBO J, V39, DOI 10.15252/embj.2018101112; Tabrizi SJ, 2019, NEW ENGL J MED, V380, P2307, DOI 10.1056/NEJMoa1900907; Tang XJ, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01208; Tanowitz M, 2017, NUCLEIC ACIDS RES, V45, P12388, DOI 10.1093/nar/gkx960; Therapeutics Sarepta., 2019, SAR THER ANN POS EXP; Tillman LG, 2008, J PHARM SCI-US, V97, P225, DOI 10.1002/jps.21084; Trainer PJ, 2018, EUR J ENDOCRINOL, V179, P97, DOI 10.1530/EJE-18-0138; Tsimikas S, 2020, NEW ENGL J MED, V382, P244, DOI 10.1056/NEJMoa1905239; Tsimikas S, 2015, LANCET, V386, P1472, DOI 10.1016/S0140-6736(15)61252-1; van der Ree MH, 2014, ANTIVIR RES, V111, P53, DOI 10.1016/j.antiviral.2014.08.015; van Meer L, 2016, J PHARMACOL EXP THER, V359, P280, DOI 10.1124/jpet.116.233809; Vecchio I, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00613; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Vickers TA, 2001, NUCLEIC ACIDS RES, V29, P1293, DOI 10.1093/nar/29.6.1293; Vickers TA, 2020, J AM CHEM SOC, V142, P9661, DOI 10.1021/jacs.0c01808; Vickers TA, 2019, NUCLEIC ACIDS RES, V47, P10865, DOI 10.1093/nar/gkz771; Vickers TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161930; Vickers TA, 2015, NUCLEIC ACIDS RES, V43, P8955, DOI 10.1093/nar/gkv920; Vickers TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110615; Vickers TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108625; Vickers TA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr150; Vickers TA, 2009, NUCLEIC ACIDS RES, V37, P6927, DOI 10.1093/nar/gkp735; Viney NJ, 2019, J CARD FAIL, V25, pS80, DOI 10.1016/j.cardfail.2019.07.228; Viney NJ, 2016, LANCET, V388, P2239, DOI 10.1016/S0140-6736(16)31009-1; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Wagner K, 2019, NEUROMUSCULAR DISORD, V29, pS124, DOI 10.1016/j.nmd.2019.06.311; Wan WB, 2014, NUCLEIC ACIDS RES, V42, P13456, DOI 10.1093/nar/gku1115; Wang SY, 2019, NUCLEIC ACID THER, V29, P245, DOI 10.1089/nat.2019.0794; Wang SY, 2018, MOL THER-NUCL ACIDS, V13, P686, DOI 10.1016/j.omtn.2018.10.011; Wang SY, 2018, NUCLEIC ACIDS RES, V46, P3579, DOI 10.1093/nar/gky145; Wang SY, 2016, NUCLEIC ACIDS RES, V44, P7314, DOI 10.1093/nar/gkw595; Wang Y, 2019, NUCLEIC ACID THER, V29, P343, DOI 10.1089/nat.2019.0806; Wave Life Sciences, 2019, WAV LIF SCI ANN TOPL; WEIDNER DA, 1995, FEBS LETT, V366, P146, DOI 10.1016/0014-5793(95)00517-D; Werten S, 2006, NAT STRUCT MOL BIOL, V13, P181, DOI 10.1038/nsmb1044; Werten S, 1998, J MOL BIOL, V276, P367, DOI 10.1006/jmbi.1997.1534; White AP, 1996, NUCLEIC ACIDS RES, V24, P3261, DOI 10.1093/nar/24.16.3261; Witztum JL, 2019, NEW ENGL J MED, V381, P531, DOI 10.1056/NEJMoa1715944; Wu HJ, 1999, J BIOL CHEM, V274, P28270, DOI 10.1074/jbc.274.40.28270; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200; Wu HJ, 2001, J BIOL CHEM, V276, P23547, DOI 10.1074/jbc.M009676200; Wu HJ, 1998, ANTISENSE NUCLEIC A, V8, P53, DOI 10.1089/oli.1.1998.8.53; Wu XX, 2017, HUM MOL GENET, V26, P2768, DOI 10.1093/hmg/ddx166; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Yu R. Z., 2019, DIA FDA OL BAS THER; Yuen M., 2019, RESULTS 12 WEEKS TRE; Yuen M. F., 2019, HEPATOLOGY, V70; ZAMECNIK PC, 1978, P NATL ACAD SCI USA, V75, P280, DOI 10.1073/pnas.75.1.280; Zanardi TA, 2012, J PHARMACOL EXP THER, V343, P489, DOI 10.1124/jpet.112.197426; Zhang H, 2010, BLOOD, V116, P4684, DOI 10.1182/blood-2010-04-277798; Zhao CG, 2019, J CYST FIBROS, V18, P334, DOI 10.1016/j.jcf.2018.07.006	230	54	54	13	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100416	10.1016/j.jbc.2021.100416	http://dx.doi.org/10.1016/j.jbc.2021.100416			39	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600796	gold, Green Published			2022-12-28	WOS:000672866400390
J	Desai, AA; Smith, MD; Zhang, YL; Makowski, EK; Gerson, JE; Ionescu, E; Starr, CG; Zupancic, JM; Moore, SJ; Sutter, AB; Ivanova, MI; Murphy, GG; Paulson, HL; Tessier, PM				Desai, Alec A.; Smith, Matthew D.; Zhang, Yulei; Makowski, Emily K.; Gerson, Julia E.; Ionescu, Edward; Starr, Charles G.; Zupancic, Jennifer M.; Moore, Shannon J.; Sutter, Alexandra B.; Ivanova, Magdalena I.; Murphy, Geoffrey G.; Paulson, Henry L.; Tessier, Peter M.			Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; PROTEIN-A CHROMATOGRAPHY; ALZHEIMERS-DISEASE; MONOCLONAL-ANTIBODIES; IN-VITRO; IMAGING ABNORMALITIES; TRANSFERRIN RECEPTOR; NONSPECIFIC-BINDING; IMMUNOGLOBULIN-G; CELLULAR UPTAKE	The aggregation of amyloidogenic polypeptides is strongly linked to several neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. Conformational antibodies that selectively recognize protein aggregates are leading therapeutic agents for selectively neutralizing toxic aggregates, diagnostic and imaging agents for detecting disease, and biomedical reagents for elucidating disease mechanisms. Despite their importance, it is challenging to generate high-quality conformational antibodies in a systematic and site-specific manner due to the properties of protein aggregates (hydrophobic, multivalent, and heterogeneous) and limitations of immunization (uncontrolled antigen presentation and immunodominant epitopes). Toward addressing these challenges, we have developed a systematic directed evolution procedure for affinity maturing antibodies against Alzheimer's A beta fibrils and selecting variants with strict conformational and sequence specificity. We first designed a library based on a lead conformational antibody by sampling combinations of amino acids in the antigen-binding site predicted to mediate high antibody specificity. Next, we displayed this library on the surface of yeast, sorted it against A beta 42 aggregates, and identified promising clones using deep sequencing. The resulting antibodies displayed similar or higher affinities than clinical-stage A beta antibodies (aducanumab and crenezumab). Moreover, the affinity-matured antibodies retained high conformational specificity for A beta aggregates, as observed for aducanumab and unlike crenezumab. Notably, the affinity-maturated antibodies displayed extremely low levels of nonspecific interactions, as observed for crenezumab and unlike aducanumab. We expect that our systematic methods for generating antibodies with unique combinations of desirable properties will improve the generation of high-quality conformational antibodies specific for diverse types of aggregated conformers.	[Desai, Alec A.; Smith, Matthew D.; Zhang, Yulei; Ionescu, Edward; Starr, Charles G.; Zupancic, Jennifer M.; Tessier, Peter M.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Desai, Alec A.; Smith, Matthew D.; Zhang, Yulei; Makowski, Emily K.; Ionescu, Edward; Starr, Charles G.; Zupancic, Jennifer M.; Tessier, Peter M.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Makowski, Emily K.; Starr, Charles G.; Tessier, Peter M.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Gerson, Julia E.; Sutter, Alexandra B.; Ivanova, Magdalena I.; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Moore, Shannon J.; Murphy, Geoffrey G.; Paulson, Henry L.; Tessier, Peter M.] Univ Michigan, Prot Folding Dis Initiat, Ann Arbor, MI 48109 USA; [Moore, Shannon J.; Murphy, Geoffrey G.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Sutter, Alexandra B.; Ivanova, Magdalena I.] Univ Michigan, Biophys Program, Ann Arbor, MI USA; [Paulson, Henry L.] Univ Michigan, Michigan Alzheimers Dis Ctr, Ann Arbor, MI USA; [Tessier, Peter M.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Starr, Charles G.] Sanofi Genzyme, Biol Res, Framingham, MA 01701 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Sanofi-Aventis; Genzyme Corporation	Tessier, PM (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Prot Folding Dis Initiat, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	ptessier@umich.edu	Tessier, Peter/GPP-3396-2022	Ionescu, Edward/0000-0001-7187-7094	National Institutes of Health [R01GM104130, RF1AG059723, R01AG050598, R35GM136300]; National Science Foundation [CBET 1159943, 1605266, 1813963]; Albert M. Mattocks Chair; American Parkinson Disease Association (APDA); Babcox; University of Michigan M-cubed	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Albert M. Mattocks Chair; American Parkinson Disease Association (APDA); Babcox; University of Michigan M-cubed(University of Michigan System)	This work was supported by the National Institutes of Health [R01GM104130, RF1AG059723, R01AG050598, and R35GM136300 to P. M. T.], National Science Foundation [CBET 1159943, 1605266, and 1813963 to P. M. T., Graduate Research Fellowship to M. D. S.], the Albert M. Mattocks Chair (to P. M. T.), American Parkinson Disease Association (APDA; to M. I. I.), Babcox (to M. I. I.) and University of Michigan M-cubed (to M. I. I.).	Alam ME, 2020, J PHARM SCI-US, V109, P656, DOI 10.1016/j.xphs.2019.10.051; Aprile FA, 2020, P NATL ACAD SCI USA, V117, P13509, DOI 10.1073/pnas.1919464117; Arndt JW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24501-0; Barkhof F, 2013, AM J NEURORADIOL, V34, P1550, DOI 10.3174/ajnr.A3475; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Bodani RU, 2015, ACS CHEM NEUROSCI, V6, P1981, DOI 10.1021/acschemneuro.5b00231; Bonito-Oliva A, 2019, J CELL MOL MED, V23, P2103, DOI 10.1111/jcmm.14119; Boswell CA, 2010, BIOCONJUGATE CHEM, V21, P2153, DOI 10.1021/bc100261d; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Bushnell B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185056; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Chung S, 2019, MABS-AUSTIN, V11, P942, DOI 10.1080/19420862.2019.1605270; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Combs B, 2016, NEUROBIOL DIS, V94, P18, DOI 10.1016/j.nbd.2016.05.016; Covell DJ, 2017, NEUROPATH APPL NEURO, V43, P604, DOI 10.1111/nan.12402; Cromwell MEM, 2006, AAPS J, V8, pE572, DOI 10.1208/aapsj080366; Datta-Mannan A, 2015, MABS-AUSTIN, V7, P1084, DOI 10.1080/19420862.2015.1075109; Datta-Mannan A, 2015, MABS-AUSTIN, V7, P483, DOI 10.1080/19420862.2015.1016696; Droste P, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0146-8; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Gibbons GS, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0687-5; Gibbons GS, 2018, J NEUROPATH EXP NEUR, V77, P216, DOI 10.1093/jnen/nly010; Gibbs E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46306-5; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u; Hatami A, 2014, J BIOL CHEM, V289, P32131, DOI 10.1074/jbc.M114.594846; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Hong GY, 2000, J DRUG TARGET, V8, P67, DOI 10.3109/10611860008996853; Jain T, 2017, P NATL ACAD SCI USA, V114, P944, DOI 10.1073/pnas.1616408114; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Julian MC, 2019, J BIOL CHEM, V294, P8438, DOI 10.1074/jbc.RA118.004731; Julian MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45259; Julian MC, 2015, PROTEIN ENG DES SEL, V28, P339, DOI 10.1093/protein/gzv050; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kelly RL, 2015, MABS-AUSTIN, V7, P770, DOI 10.1080/19420862.2015.1043503; Kulenkampff K, 2020, BIOPHYS J, V118, p370A; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lee CC, 2016, J BIOL CHEM, V291, P2858, DOI 10.1074/jbc.M115.682336; Munke A, 2017, P NATL ACAD SCI USA, V114, P6444, DOI 10.1073/pnas.1700407114; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Nilvebrant J, 2016, CURR PHARM DESIGN, V22, P6527, DOI 10.2174/1381612822666160921143011; Pardridge WM, 2017, BIODRUGS, V31, P503, DOI 10.1007/s40259-017-0248-z; Pardridge WM, 2016, EXPERT OPIN BIOL TH, V16, P1455, DOI 10.1080/14712598.2016.1230195; Pardridge WM, 2015, EXPERT OPIN DRUG DEL, V12, P207, DOI 10.1517/17425247.2014.952627; PARDRIDGE WM, 1994, IMMUNOL LETT, V42, P191, DOI 10.1016/0165-2478(94)90085-X; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Rabia LA, 2018, PROTEIN ENG DES SEL, V31, P409, DOI 10.1093/protein/gzz002; Rabia LA, 2018, BIOCHEM ENG J, V137, P365, DOI 10.1016/j.bej.2018.06.003; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sebollela A, 2017, J NEUROCHEM, V142, P934, DOI 10.1111/jnc.14118; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shukla AA, 2007, J CHROMATOGR A, V1171, P22, DOI 10.1016/j.chroma.2007.09.040; Silverman JM, 2018, ACS CHEM NEUROSCI, V9, P1591, DOI 10.1021/acschemneuro.7b00469; Spencer S, 2012, MABS-AUSTIN, V4, P319, DOI 10.4161/mabs.19869; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Starr CG, 2019, CURR OPIN BIOTECH, V60, P119, DOI 10.1016/j.copbio.2019.01.008; Stimple SD, 2019, BIOTECHNOL BIOENG, V116, P1868, DOI 10.1002/bit.26994; Sumbria RK, 2013, MOL PHARMACEUT, V10, P3507, DOI 10.1021/mp400348n; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Tiller KE, 2017, J BIOL CHEM, V292, P16638, DOI 10.1074/jbc.M117.783837; Tiller KE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00986; TRIGUERO D, 1989, P NATL ACAD SCI USA, V86, P4761, DOI 10.1073/pnas.86.12.4761; Vaikath NN, 2015, NEUROBIOL DIS, V79, P81, DOI 10.1016/j.nbd.2015.04.009; van Dyck CH, 2018, BIOL PSYCHIAT, V83, P311, DOI 10.1016/j.biopsych.2017.08.010; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weihofen A, 2019, NEUROBIOL DIS, V124, P276, DOI 10.1016/j.nbd.2018.10.016; Xu YD, 2013, PROTEIN ENG DES SEL, V26, P663, DOI 10.1093/protein/gzt047; Zago Wagner, 2013, Alzheimers Dement, V9, pS105, DOI 10.1016/j.jalz.2012.11.010; Zhang YL, 2020, MOL PHARMACEUT, V17, P2555, DOI 10.1021/acs.molpharmaceut.0c00257; Zuchero YJY, 2016, NEURON, V89, P70, DOI 10.1016/j.neuron.2015.11.024	80	3	3	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100508	10.1016/j.jbc.2021.100508	http://dx.doi.org/10.1016/j.jbc.2021.100508			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675750	gold, Green Published			2022-12-28	WOS:000672866400482
J	Duarte, M; Viegas, A; Alves, VD; Prates, JAM; Ferreira, LMA; Najmudin, S; Cabrita, EJ; Carvalho, AL; Fontes, CMGA; Bule, P				Duarte, Marlene; Viegas, Aldino; Alves, Victor D.; Prates, Jose A. M.; Ferreira, Luis M. A.; Najmudin, Shabir; Cabrita, Eurico J.; Carvalho, Ana Luisa; Fontes, Carlos M. G. A.; Bule, Pedro			A dual cohesin-dockerin complex binding mode in Bacteroides cellulosolvens contributes to the size and complexity of its cellulosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE ATTACHMENT; X-RAY CHARACTERIZATION; CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; SCAFFOLDIN; SPECIFICITIES; MODULE; CRYSTALLIZATION; OVEREXPRESSION; CALCIUM	The Cellulosome is an intricate macromolecular protein complex that centralizes the cellulolytic efforts of many anaerobic microorganisms through the promotion of enzyme synergy and protein stability. The assembly of numerous carbohydrate processing enzymes into a macromolecular multiprotein structure results from the interaction of enzyme-borne dockerin modules with repeated cohesin modules present in noncatalytic scaffold proteins, termed scaffoldins. Cohesin-dockerin (Coh-Doc) modules are typically classified into different types, depending on structural conformation and cellulosome role. Thus, type I Coh-Doc complexes are usually responsible for enzyme integration into the cellulosome, while type II Coh-Doc complexes tether the cellulosome to the bacterial wall. In contrast to other known cellulosomes, cohesin types from Bacteroides cellulosolvens, a cellulosome-producing bacterium capable of utilizing cellulose and cellobiose as carbon sources, are reversed for all scaffoldins, i.e., the type II cohesins are located on the enzyme-integrating primary scaffoldin, whereas the type I cohesins are located on the anchoring scaffoldins. It has been previously shown that type I B. cellulosolvens interactions possess a dual-binding mode that adds flexibility to scaffoldin assembly. Herein, we report the structural mechanism of enzyme recruitment into B. cellulosolvens cellulosome and the identification of the molecular determinants of its type II cohesin-dockerin interactions. The results indicate that, unlike other type II complexes, these possess a dual-binding mode of interaction, akin to type I complexes. Therefore, the plasticity of dual-binding mode interactions seems to play a pivotal role in the assembly of B. cellulosolvens cellulosome, which is consistent with its unmatched complexity and size.	[Duarte, Marlene; Alves, Victor D.; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Bule, Pedro] Univ Lisbon, Polo Univ Alto da Ajuda, Fac Vet Med, CIISA Ctr Interdisciplinary Res Anim Hlth, Ave Univ Tecn, Lisbon, Portugal; [Viegas, Aldino; Cabrita, Eurico J.; Carvalho, Ana Luisa] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, UCIBIO, Caparica, Portugal; [Najmudin, Shabir] Kings Coll London, Randall Ctr Cell & Mol Biophys, London, England; [Fontes, Carlos M. G. A.] NZYTech Genes & Enzymes, Res & Dev, Lisbon, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa; University of London; King's College London	Bule, P (corresponding author), Univ Lisbon, Polo Univ Alto da Ajuda, Fac Vet Med, CIISA Ctr Interdisciplinary Res Anim Hlth, Ave Univ Tecn, Lisbon, Portugal.; Carvalho, AL (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, UCIBIO, Caparica, Portugal.	almc@fct.unl.pt; pedrobule@fmv.ulisboa.pt	Prates, José A M/K-9934-2013; Viegas, Aldino/A-1889-2011; Bule, Pedro/W-6838-2019; Cabrita, Eurico/E-8053-2011; Carvalho, Ana Luisa/G-5638-2011	Prates, José A M/0000-0003-1032-5987; Viegas, Aldino/0000-0003-1733-136X; Bule, Pedro/0000-0003-2531-9926; Cabrita, Eurico/0000-0002-0720-2751; Alves, Victor Diogo/0000-0002-8430-4380; Fontes, Carlos/0000-0002-1219-9753; Najmudin, Shabir/0000-0002-0429-5454; Duarte Santos, Marlene/0000-0001-5634-699X; Carvalho, Ana Luisa/0000-0002-3824-0240	Portuguese Foundation for Science and Technology (FCT-MCTES) through the Centro de Investigacao Interdisciplinar em Sanidade Animal (CIISA) [UIDB/00276/2020]; Portuguese Foundation for Science and Technology (FCT-MCTES) through Applied Molecular Biosciences Unit (UCIBIO) [UIDB/04378/2020]; FCT-MCTES [SFRH/BD/35992/2007, SFRH/BD/146965/2019]; Portuguese Foundation for Science and Technology (FCT-MCTES) [RECI/BBB-BEP/0124/2012]; Fundação para a Ciência e a Tecnologia [UIDB/04378/2020, SFRH/BD/35992/2007, SFRH/BD/146965/2019, RECI/BBB-BEP/0124/2012] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT-MCTES) through the Centro de Investigacao Interdisciplinar em Sanidade Animal (CIISA); Portuguese Foundation for Science and Technology (FCT-MCTES) through Applied Molecular Biosciences Unit (UCIBIO); FCT-MCTES(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Foundation for Science and Technology (FCT-MCTES)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was supported by the Portuguese Foundation for Science and Technology (FCT-MCTES) through the Centro de Investigacao Interdisciplinar em Sanidade Animal (CIISA) grant UIDB/00276/2020, the Applied Molecular Biosciences Unit (UCIBIO) grant UIDB/04378/2020, and through the National Project grant RECI/BBB-BEP/0124/2012. M. D. is supported by a PhD studentship (SFRH/BD/146965/2019) from FCT-MCTES. A. V. was supported by a PhD studentship (SFRH/BD/35992/2007) FCT-MCTES.	Adams JJ, 2006, P NATL ACAD SCI USA, V103, P305, DOI 10.1073/pnas.0507109103; Adams JJ, 2005, BIOCHEMISTRY-US, V44, P2173, DOI 10.1021/bi048039u; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bras JLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38292; Bule P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25171-8; Bule P, 2018, J BIOL CHEM, V293, P4201, DOI 10.1074/jbc.RA117.001241; Bule P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00919-w; Bule P, 2016, J BIOL CHEM, V291, P26658, DOI 10.1074/jbc.M116.761643; Bule P, 2014, ACTA CRYSTALLOGR F, V70, P1065, DOI 10.1107/S2053230X14013181; Bule P, 2014, ACTA CRYSTALLOGR F, V70, P1061, DOI 10.1107/S2053230X14012667; Cameron K, 2015, J BIOL CHEM, V290, P13578, DOI 10.1074/jbc.M114.633339; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2011, ACTA CRYSTALLOGR D, V67, P233, DOI 10.1107/S0907444911007578; Dassa B, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01022-15; Ding S.-Y., 2000, SCAFFOLDIN BACTEROID; Ding SY, 2000, J BACTERIOL, V182, P4915, DOI 10.1128/JB.182.17.4915-4925.2000; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; GIULIANO C, 1984, APPL ENVIRON MICROB, V48, P446, DOI 10.1128/AEM.48.2.446-448.1984; GIULIANO C, 1985, BIOTECHNOL BIOENG, V27, P980, DOI 10.1002/bit.260270708; Haimovitz R, 2008, PROTEOMICS, V8, P968, DOI 10.1002/pmic.200700486; Israeli-Ruimy V, 2017, SCI REP-UK, V7, DOI 10.1038/srep42355; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noach I, 2005, J MOL BIOL, V348, P1, DOI 10.1016/j.jmb.2005.02.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Vera AM, 2021, STRUCTURE, V29, P587, DOI 10.1016/j.str.2021.01.006; Yaniv O, 2011, ACTA CRYSTALLOGR D, V67, P506, DOI 10.1107/S0907444911011322; Yao XZ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd7182; Zhao GS, 2006, BIOSCI BIOTECH BIOCH, V70, P1636, DOI 10.1271/bbb.50699; Zhivin O, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0898-6	38	2	3	5	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100552	10.1016/j.jbc.2021.100552	http://dx.doi.org/10.1016/j.jbc.2021.100552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744293	Green Published, gold			2022-12-28	WOS:000672866400525
J	Fan, JJ; Xiao, Y; Quick, M; Yang, YW; Sun, ZY; Javitch, JA; Zhou, XM				Fan, Jianjun; Xiao, Yang; Quick, Matthias; Yang, Yuwei; Sun, Ziyi; Javitch, Jonathan A.; Zhou, Xiaoming			Crystal structures of LeuT reveal conformational dynamics in the outward-facing states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER-SODIUM SYMPORTER; BINDING-SITE; SUBSTRATE; MECHANISM; NA+; PROTEINS	The neurotransmitter:sodium symporter (NSS) homolog LeuT from Aquifex aeolicus has proven to be a valuable model for studying the transport mechanism of the NSS family. Crystal structures have captured LeuT in key conformations visited during the transport cycle, allowing for the construction of a nearly complete model of transport, with much of the conformational dynamics studied by computational simulations. Here, we report crystal structures of LeuT representing new intermediate conformations between the outward-facing open and occluded states. These structures, combined with binding and accessibility studies, reveal details of conformational dynamics that can follow substrate binding at the central substrate binding site (S1) of LeuT in outward-facing states, suggesting a potential competition for direction between the outward-open and outward-occluded states at this stage during substrate transport. Our structures further support an intimate interplay between the protonation state of Glu290 and binding of Na1 that may ultimately regulate the outward-open-to-occluded transition.	[Fan, Jianjun; Xiao, Yang; Yang, Yuwei; Sun, Ziyi; Zhou, Xiaoming] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Integrated Tradit Chinese & Western Med,Rare, Chengdu, Sichuan, Peoples R China; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, New York State Psychiat Inst, Div Mol Therapeut, New York, NY 10027 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA; [Javitch, Jonathan A.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA	Sichuan University; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University	Sun, ZY; Zhou, XM (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Integrated Tradit Chinese & Western Med,Rare, Chengdu, Sichuan, Peoples R China.; Javitch, JA (corresponding author), Columbia Univ, New York State Psychiat Inst, Div Mol Therapeut, New York, NY 10027 USA.; Javitch, JA (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA.; Javitch, JA (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA.	ziyi.sun@scu.edu.cn; jonathan.javitch@nyspi.columbia.edu; x.zhou@scu.edu.cn		Javitch, Jonathan/0000-0001-7395-2967; Quick, Matthias/0000-0002-8620-827X; Xiao, Yang/0000-0001-6513-0533; Sun, Ziyi/0000-0002-3345-1065; Zhou, Xiaoming/0000-0001-8866-7245; Fan, Jianjun/0000-0002-2086-0839	National Natural Science Foundation of China [31770783]; National Institutes of Health [R01 DA041510, R01 GM119396]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Natural Science Foundation of China grant No. 31770783 to X. Z., National Institutes of Health grant R01 DA041510 to JAJ, and R01 GM119396 to M. Q. The content is solely the responsibility of the authors and does not necessarily represent the official views of National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; Conley BE, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.01253-20; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gotfryd K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14735-w; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Kaback HR, 2015, P NATL ACAD SCI USA, V112, P1259, DOI 10.1073/pnas.1419325112; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Khelashvili G, 2016, J BIOL CHEM, V291, P19786, DOI 10.1074/jbc.M116.731455; Kracke F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00575; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Malinauskaite L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11673; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; PARTIS MD, 1983, J PROTEIN CHEM, V2, P263, DOI 10.1007/BF01025358; Pravda L, 2018, NUCLEIC ACIDS RES, V46, pW368, DOI 10.1093/nar/gky309; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Tavoulari S, 2016, J BIOL CHEM, V291, P1456, DOI 10.1074/jbc.M115.692012; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang WZ, 2019, NUCL SCI TECH, V30, DOI 10.1007/s41365-019-0683-2; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou XM, 2014, NATURE, V505, P569, DOI 10.1038/nature12811; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133; Zomot E, 2015, J BIOL CHEM, V290, P544, DOI 10.1074/jbc.M114.617555	34	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100609	10.1016/j.jbc.2021.100609	http://dx.doi.org/10.1016/j.jbc.2021.100609			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811858	gold, Green Published			2022-12-28	WOS:000672866400581
J	Klyuyeva, AV; Belyaeva, OV; Goggans, KR; Krezel, W; Popov, KM; Kedishvili, NY				Klyuyeva, Alla, V; Belyaeva, Olga, V; Goggans, Kelli R.; Krezel, Wojciech; Popov, Kirill M.; Kedishvili, Natalia Y.			Changes in retinoid metabolism and signaling associated with metabolic remodeling during fasting and in type I diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A; PHOSPHOENOLPYRUVATE CARBOXYKINASE; ACID BIOSYNTHESIS; DEHYDROGENASE 10; CYP26A1; EXPRESSION; ENZYME; RDH10; GENE; HOMEOSTASIS	Liver is the central metabolic hub that coordinates carbohydrate and lipid metabolism. The bioactive derivative of vitamin A, retinoic acid (RA), was shown to regulate major metabolic genes including phosphoenolpyruvate carboxykinase, fatty acid synthase, carnitine palmitoyltransferase 1, and glucokinase among others. Expression levels of these genes undergo profound changes during adaptation to fasting or in metabolic diseases such as type 1 diabetes (T1D). However, it is unknown whether the levels of hepatic RA change during metabolic remodeling. This study investigated the dynamics of hepatic retinoid metabolism and signaling in the fed state, in fasting, and in T1D. Our results show that fed-to-fasted transition is associated with significant decrease in hepatic retinol dehydrogenase (RDH) activity, the rate-limiting step in RA biosynthesis, and downregulation of RA signaling. The decrease in RDH activity correlates with the decreased abundance and altered subcellular distribution of RDH10 while Rdh10 transcript levels remain unchanged. In contrast to fasting, untreated T1D is associated with upregulation of RA signaling and an increase in hepatic RDH activity, which correlates with the increased abundance of RDH10 in microsomal membranes. The dynamic changes in RDH10 protein levels in the absence of changes in its transcript levels imply the existence of posttranscriptional regulation of RDH10 protein. Together, these data suggest that the downregulation of hepatic RA biosynthesis, in part via the decrease in RDH10, is an integral component of adaptation to fasting. In contrast, the upregulation of hepatic RA biosynthesis and signaling in T1D might contribute to metabolic inflexibility associated with this disease.	[Klyuyeva, Alla, V; Belyaeva, Olga, V; Goggans, Kelli R.; Popov, Kirill M.; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Krezel, Wojciech] Univ Strasbourg, INSERM, Inst Genet & Mol & Cellular Biol IGBMC, Strasbourg, France	University of Alabama System; University of Alabama Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Popov, KM; Kedishvili, NY (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	kpopov@uab.edu; nkedishvili@uab.edu	Goggans, Kelli/HHS-2351-2022; Krezel, Wojciech/H-9080-2017	Krezel, Wojciech/0000-0003-1605-3185; Goggans, Kelli/0000-0002-7008-7506; Beliaeva, Olga/0000-0003-2512-925X	National Institutes of Health [R01AR076924, R01GM051262]; University of Alabama at Birmingham School of Medicine AMC21 Research Support	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham School of Medicine AMC21 Research Support	The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was supported by grants from the National Institutes of Health R01AR076924 (N. Y. K.), R01GM051262 (K. M. P.), and the University of Alabama at Birmingham School of Medicine AMC21 Research Support (N. Y. K.).	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Amengual J, 2010, CELL PHYSIOL BIOCHEM, V25, P657, DOI 10.1159/000315085; Ashique AM, 2012, GENESIS, V50, P415, DOI 10.1002/dvg.22002; Ashton A, 2018, MOL NEUROBIOL, V55, P8219, DOI 10.1007/s12035-018-0964-5; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bar-El Dadon S, 2017, CRIT REV FOOD SCI, V57, P2404, DOI 10.1080/10408398.2015.1060940; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; Belyaeva OV, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010005; Belyaeva OV, 2018, J BIOL CHEM, V293, P6996, DOI 10.1074/jbc.RA117.001646; Belyaeva OV, 2017, J BIOL CHEM, V292, P5884, DOI 10.1074/jbc.M117.776914; Billings SE, 2013, FASEB J, V27, P4877, DOI 10.1096/fj.13-227967; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Chen W, 2014, J CLIN MED, V3, P453, DOI 10.3390/jcm3020453; Drager U C, 2001, Prog Brain Res, V131, P579; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Hebert SL, 2010, CLIN NUTR, V29, P13, DOI 10.1016/j.clnu.2009.09.001; Henne WM, 2018, EMBO J, V37, DOI 10.15252/embj.201898947; Hogarth CA, 2011, TRENDS ENDOCRIN MET, V22, P136, DOI 10.1016/j.tem.2011.01.001; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kasus-Jacobi A, 2003, J BIOL CHEM, V278, P32380, DOI 10.1074/jbc.M304969200; Kim CH, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e1; Kramer DA, 2018, J PROTEOMICS, V181, P213, DOI 10.1016/j.jprot.2018.04.024; Kuang HQ, 2019, BIOCHEM CELL BIOL, V97, P545, DOI 10.1139/bcb-2018-0284; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Li Y, 2018, AM J PATHOL, V188, P1833, DOI 10.1016/j.ajpath.2018.04.015; LUCAS PC, 1991, P NATL ACAD SCI USA, V88, P2184, DOI 10.1073/pnas.88.6.2184; Ma YL, 2021, HEPATOLOGY, V73, P1701, DOI 10.1002/hep.31517; Ma YL, 2019, HEPATOLOGY, V69, P1504, DOI 10.1002/hep.30350; Metzler MA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120812; Moore T, 1937, BIOCHEM J, V31, P155, DOI 10.1042/bj0310155; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; NAPOLI JL, 1986, J BIOL CHEM, V261, P3592; Napoli JL, 1998, METH MOL B, V89, P29; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Obrochta KM, 2015, J BIOL CHEM, V290, P7259, DOI 10.1074/jbc.M114.609313; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ozpolat B, 2005, LEUKEMIA LYMPHOMA, V46, P1497, DOI 10.1080/10428190500174737; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Ransom J, 2014, J NEUROCHEM, V129, P366, DOI 10.1111/jnc.12620; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Ross AC, 2012, AM J CLIN NUTR, V96, p1166S, DOI 10.3945/ajcn.112.034637; Ross AC, 2004, J NUTR, V134, p269S, DOI 10.1093/jn/134.1.269S; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Shannon SR, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.264; Shin DJ, 1997, J NUTR, V127, P1274, DOI 10.1093/jn/127.7.1274; Sztalryd C, 2017, BBA-MOL CELL BIOL L, V1862, P1221, DOI 10.1016/j.bbalip.2017.07.009; Topletz AR, 2015, MOL PHARMACOL, V87, P430, DOI 10.1124/mol.114.096784; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Trasino Steven E, 2015, Diabetes Manag (Lond), V5, P359; Urvalek A, 2014, SUBCELL BIOCHEM, V70, P129, DOI 10.1007/978-94-017-9050-5_7; Wei LN, 2012, BBA-MOL CELL BIOL L, V1821, P206, DOI 10.1016/j.bbalip.2011.03.003; WOLF G, 1958, Prog Nucl Energy 6 Biol Sci, V2, P457; Yang D, 2018, DIABETES, V67, P662, DOI 10.2337/db17-0946; Yang X, 2007, COLD SPRING HARB SYM, V72, P387, DOI 10.1101/sqb.2007.72.058; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang Y, 2010, GENE, V464, P32, DOI 10.1016/j.gene.2010.05.004; Zhong G, 2019, J BIOL CHEM, V294, P11166, DOI 10.1074/jbc.RA119.009023	63	5	5	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100323	10.1016/j.jbc.2021.100323	http://dx.doi.org/10.1016/j.jbc.2021.100323			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33485967	Green Published, gold			2022-12-28	WOS:000672866400297
J	Lardone, RD; Garay, YC; Parodi, P; de la Fuente, S; Angeloni, G; Bravo, EO; Schmider, AK; Irazoqui, FJ				Lardone, Ricardo D.; Garay, Yohana C.; Parodi, Pedro; de la Fuente, Sofia; Angeloni, Genaro; Bravo, Eduardo O.; Schmider, Anneke K.; Irazoqui, Fernando J.			How glycobiology can help us treat and beat the COVID-19 pandemic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MANNOSE-BINDING LECTIN; BLOOD-GROUP; NATURAL ANTIBODY; INFLUENZA-VIRUS; CORONAVIRUS; INNATE; SUSCEPTIBILITY; POLYMORPHISMS; RECOGNITION; ASSOCIATION	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged during the last months of 2019, spreading throughout the world as a highly transmissible infectious illness designated as COVID-19. Vaccines have now appeared, but the challenges in producing sufficient material and distributing them around the world means that effective treatments to limit infection and improve recovery are still urgently needed. This review focuses on the relevance of different glycobiological molecules that could potentially serve as or inspire therapeutic tools during SARS-CoV-2 infection. As such, we highlight the glycobiology of the SARS-CoV-2 infection process, where glycans on viral proteins and on host glycosaminoglycans have critical roles in efficient infection. We also take notice of the glycan-binding proteins involved in the infective capacity of virus and in human defense. In addition, we critically evaluate the glycobiological contribution of candidate drugs for COVID-19 therapy such as glycans for vaccines, anti-glycan antibodies, recombinant lectins, lectin inhibitors, glycosidase inhibitors, polysaccharides, and numerous glycosides, emphasizing some opportunities to repurpose FDA-approved drugs. For the next-generation drugs suggested here, biotechnological engineering of new probes to block the SARS-CoV-2 infection might be based on the essential glycobiological insight on glycosyltransferases, glycans, glycan-binding proteins, and glycosidases related to this pathology.	[Lardone, Ricardo D.; Garay, Yohana C.; Parodi, Pedro; de la Fuente, Sofia; Angeloni, Genaro; Irazoqui, Fernando J.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, CONICET, Ciudad Univ, Cordoba, Argentina; [Lardone, Ricardo D.; Garay, Yohana C.; Parodi, Pedro; de la Fuente, Sofia; Angeloni, Genaro; Irazoqui, Fernando J.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Ciudad Univ, Cordoba, Argentina; [Bravo, Eduardo O.] Nuevo Hosp San Roque, Minist Salud Prov Cordoba, Med Interna, Cordoba, Argentina; [Schmider, Anneke K.] Psychiat Klin Luneburg, Klin Kinder & Jugendpsychiat & Psychotherapie, Luneburg, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Irazoqui, FJ (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, CONICET, Ciudad Univ, Cordoba, Argentina.; Irazoqui, FJ (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Ciudad Univ, Cordoba, Argentina.	fernando.irazoqui@unc.edu.ar	Lardone, Ricardo/J-1197-2019	Lardone, Ricardo/0000-0003-3569-8755	ANPCyT, FONCyT [PICT 2018-03228, PICT-0223-2017]; CONICET [PIP 11220150100226]; SeCyT, UNC, Argentina; Mizutani Foundation for Glycoscience, Japan [200062]; CONICET; EVC-CIN; INC (Argentina)	ANPCyT, FONCyT(ANPCyTFONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); SeCyT, UNC, Argentina(Secretaria de Ciencia y Tecnologia (SECYT)); Mizutani Foundation for Glycoscience, Japan; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); EVC-CIN; INC (Argentina)	This study was supported by funding to F. J. I. from ANPCyT, FONCyT (PICT 2018-03228); CONICET (PIP 11220150100226); and SeCyT, UNC, Argentina; and Mizutani Foundation for Glycoscience (No. 200062), Japan; as well as by funding to R. D. L. from ANPCyT, FONCyT (PICT-02232017). Y. C. G. and P. P. have PhD fellowship support from CONICET. S. F. and G. A. have student fellowship assistances from EVC-CIN and INC (Argentina), respectively. R. D. L. and F. J. I. are career investigators of CONICET.	Amraei R, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071652; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Arya R, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2020.11.024; Benton DJ, 2020, NATURE, V588, DOI 10.1038/s41586-020-2772-0; Blanchard H, 2014, EXPERT OPIN THER PAT, V24, DOI 10.1517/13543776.2014.947961; Bratteby K, 2020, J MED CHEM, V63, P747, DOI 10.1021/acs.jmedchem.9b01692; Brockhausen I., 2017, ESSENTIALS GLYCOBIOL, P113; Cagno V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070596; Caly L, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104787; Casalino L, 2020, ACS CENTRAL SCI, V6, P1722, DOI 10.1021/acscentsci.0c01056; Chalichem NSS, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109984; Cherrak SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240653; Cho Junhyung, 2020, Sci Rep, V10, P16200, DOI 10.1038/s41598-020-72879-7; Clarke EC, 2021, GLYCOBIOLOGY, V31, P378, DOI 10.1093/glycob/cwaa091; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; da Silva FMA, 2020, MEM I OSWALDO CRUZ, V115, DOI 10.1590/0074-02760200207; Das P, 2021, J BIOMOL STRUCT DYN, V39, P6265, DOI 10.1080/07391102.2020.1796799; Das S, 2021, J BIOMOL STRUCT DYN, V39, P3347, DOI 10.1080/07391102.2020.1763201; Denneny E, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1120; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Dong L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13838-7; Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6; Gan R, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110024; Gao Chao, 2020, bioRxiv, DOI 10.1101/2020.07.29.227462; Guillon P, 2008, GLYCOBIOLOGY, V18, P1085, DOI 10.1093/glycob/cwn093; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; Hoiland RL, 2020, BLOOD ADV, V4, P4981, DOI 10.1182/bloodadvances.2020002623; Idda ML, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00497; Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Johnson Bryan A, 2020, bioRxiv, DOI 10.1101/2020.08.26.268854; Kalathiya U, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051473; Kalhor H, 2022, J BIOMOL STRUCT DYN, V40, P1299, DOI 10.1080/07391102.2020.1824816; Kandeel M, 2021, J BIOMOL STRUCT DYN, V39, P5129, DOI 10.1080/07391102.2020.1784291; Koehler M, 2020, ANNU REV VIROL, V7, P143, DOI 10.1146/annurev-virology-122019-070025; Lang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023710; Letko M., 2020, NAT MICROBIOL, V5, P562, DOI [DOI 10.1038/s41564-020-0688-y, 10.1038/s41564-020-0688-y]; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Li N, 2021, J CELL PHYSIOL, V236, P2959, DOI 10.1002/jcp.30055; Lin L, 2020, EMERG MICROBES INFEC, V9, P727, DOI 10.1080/22221751.2020.1746199; Liu J, 2020, RES PRACT THROMB HAE, V4, P518, DOI 10.1002/rth2.12353; Mason CP, 2015, MOLECULES, V20, P2229, DOI 10.3390/molecules20022229; Matricardi PM, 2020, PEDIAT ALLERG IMM-UK, V31, P454, DOI 10.1111/pai.13271; Mehdipour AR., 2020, DUAL NATURE HUMAN AC, V2020, DOI DOI 10.1101/2020.07.09.193680; Mellet J, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010039; Milewska A, 2020, BIORXIV, DOI DOI 10.1101/2020.03.29.014183; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Morse JS, 2020, CHEMBIOCHEM, V21, P730, DOI 10.1002/cbic.202000047; Muthana SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19509; Muthana SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119298; New JS, 2016, IMMUNOL REV, V270, P32, DOI 10.1111/imr.12397; Nicholls JM, 2013, INFECT CHEMOTHER, V45, P11, DOI 10.3947/ic.2013.45.1.11; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Palma J, 2018, CENT EUR J IMMUNOL, V43, P466, DOI 10.5114/ceji.2018.81354; Pedersen AML, 2019, J DENT, V80, pS3, DOI 10.1016/j.jdent.2018.08.010; Poddighe Dimitri, 2020, Antiviral Chemistry & Chemotherapy, V28, DOI 10.1177/2040206620961712; Prajapat M, 2020, J MOL GRAPH MODEL, V101, DOI 10.1016/j.jmgm.2020.107716; Raza S, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8030409; Rizza S, 2011, J CLIN ENDOCR METAB, V96, pE782, DOI 10.1210/jc.2010-2879; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Rodriguez-Zhurbenko N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00483; Saito S, 2019, J THORAC DIS, V11, pS1740, DOI 10.21037/jtd.2019.04.62; Senel S, 2020, DRUG DELIV TRANSL RE, V10, P1644, DOI 10.1007/s13346-020-00806-4; Shajahan A., 2020, Glycobiology, V31, P410, DOI 10.1093/glycob/cwaa101; Shajahan Asif, 2020, Glycobiology, V30, P981, DOI 10.1093/glycob/cwaa042; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236; SPRINGER GF, 1969, J CLIN INVEST, V48, P1280, DOI 10.1172/JCI106094; Stawiski E.W., 2020, BIORXIV, DOI [10.1101/2020.04.07.024752, DOI 10.1101/2020.04.07.024752]; Stegmayr J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38497-8; Stroh LJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186781; Taguchi YH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238907; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Tandon R, 2021, J VIROL, V95, DOI [10.1128/JVI.01987-20, 10.1101/2020.06.08.140236]; Tannock GA, 2020, J MED VIROL, V92, P129, DOI 10.1002/jmv.25593; Taylor M. E., 2011, INTRO GLYCOBIOLOGY; TERAI I, 1993, BIOCHEM MED METAB B, V50, P111, DOI 10.1006/bmmb.1993.1052; Terali K, 2020, J MOL GRAPH MODEL, V100, DOI 10.1016/j.jmgm.2020.107697; Tu XY, 2015, J INFECTION, V71, P101, DOI 10.1016/j.jinf.2015.03.006; Valverde P, 2020, CHEMBIOCHEM, V21, P2999, DOI 10.1002/cbic.202000238; van Vliet SJ, 2008, IMMUNOL CELL BIOL, V86, P580, DOI 10.1038/icb.2008.55; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Venkataraman N, 2009, PLOS BIOL, V7, P720, DOI 10.1371/journal.pbio.1000095; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Wang Denong, 2020, Curr Trends Immunol, V21, P17; Watanabe Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16567-0; Watanabe Y, 2019, BBA-GEN SUBJECTS, V1863, P1480, DOI 10.1016/j.bbagen.2019.05.012; Watanabe Y, 2018, P NATL ACAD SCI USA, V115, P7320, DOI 10.1073/pnas.1803990115; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Wei TZ, 2020, CHIN J INTEGR MED, V26, P663, DOI 10.1007/s11655-020-3427-6; Whayne TF, 2018, AM J CARDIOVASC DRUG, V18, P427, DOI 10.1007/s40256-018-0292-1; Williams SJ, 2020, BIOCHEM SOC T, V48, P1287, DOI 10.1042/BST20200505; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yang TJ, 2020, P NATL ACAD SCI USA, V117, P1438, DOI 10.1073/pnas.1908898117; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang HX, 2005, J INFECT DIS, V192, P1355, DOI 10.1086/491479; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9; Zhao P, 2020, CELL HOST MICROBE, V28, P586, DOI [10.1101/2020.06.25.172403, 10.1016/j.chom.2020.08.004]; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zlocowski N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44601-9	107	14	14	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100375	10.1016/j.jbc.2021.100375	http://dx.doi.org/10.1016/j.jbc.2021.100375			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548227	Green Published, gold			2022-12-28	WOS:000672866400349
J	Min, KB; Hwang, W; Lee, KM; Kim, JB; Yoon, SS				Min, Kyung Bae; Hwang, Wontae; Lee, Kang-Mu; Kim, June Beom; Yoon, Sang Sun			Chemical inhibitors of the conserved bacterial transcriptional regulator DksA1 suppressed quorum sensing-mediated virulence of Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA PROMOTERS; PPGPP; POLYMERASE; MODULATION; MECHANISMS; EXPRESSION; INITIATION; INSIGHTS; ROLES	Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen whose virulence is dependent on quorum sensing (QS). DksA1, an RNA polymerase-binding transcriptional regulator, plays a role in determining a number of phenotypes, including QS-mediated virulence. We therefore envisioned that DksA1 inhibitors may help to control P. aeruginosa infection. Here, we screened a library of 6970 chemical compounds and identified two compounds (henceforth termed Dkstatins) that specifically suppressed DksA1 activity. Treatment with these two compounds also substantially decreased the production of elastase and pyocyanin, dominant virulence determinants of P. aeruginosa, and protected murine hosts from lethal infection from a prototype strain of P. aeruginosa, PAO1. The Dkstatins also suppressed production of homoserine lactone (HSL)-based autoinducers that activate P. aeruginosa QS. The level of 3-oxo-C12-HSL produced by Dkstatin-treated wildtype PAO1 closely resembled that of the Delta dksA1 mutant. RNA-Seq analysis showed that transcription levels of QS- and virulence-associated genes were markedly reduced in Dkstatin-treated PAO1 cells, indicating that Dkstatin-mediated suppression occurs at the transcriptional level. Importantly, Dkstatins increased the antibiotic susceptibilities of PAO1, particularly to protein synthesis inhibitors, such as tobramycin and tetracycline. Co-immunoprecipitation assays demonstrated that these Dkstatins interfered with DksA1 binding to the beta subunit of RNA polymerase, pointing to a potential mechanism of action. Collectively, our results illustrate that inhibition of P. aeruginosa QS may be achieved via DksA1 inhibitors and that Dkstatins may serve as potential lead compounds to control infection.	[Min, Kyung Bae; Hwang, Wontae; Lee, Kang-Mu; Kim, June Beom; Yoon, Sang Sun] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; [Min, Kyung Bae; Hwang, Wontae; Kim, June Beom; Yoon, Sang Sun] Yonsei Univ, Coll Med, Brain Korea 21 Plus Project Med Sci, Seoul, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea.; Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Brain Korea 21 Plus Project Med Sci, Seoul, South Korea.; Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea.; Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.	sangsun_yoon@yuhs.ac		LEE, Kang-Mu/0000-0001-7414-5921; Yoon, Sang Sun/0000-0003-2979-365X	National Research Foundation (NRF) of Korea [2017M3A9F3041233, 2019R1A6A1A03032869]; Korea Health Technology R&D Project - Ministry of Health Welfare, Korea [HI14C1324]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [918003041SB010]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Korea Health Technology R&D Project - Ministry of Health Welfare, Korea; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) - Ministry of Agriculture, Food and Rural Affairs (MAFRA)(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of KoreaInstitute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea)	This work was supported by grants from the National Research Foundation (NRF) of Korea, (2017M3A9F3041233, 2019R1A6A1A03032869). This research was also supported by a grant from the Korea Health Technology R&D Project, funded by the Ministry of Health & Welfare, Korea (HI14C1324). This work was also supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Agricultural Microbiome R&D Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (918003041SB010).	Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Azriel S, 2016, INFECT IMMUN, V84, P375, DOI 10.1128/IAI.01135-15; Berger R, 2011, CHEM SOC REV, V40, P3496, DOI 10.1039/c0cs00221f; Bernardo LMD, 2006, MOL MICROBIOL, V60, P749, DOI 10.1111/j.1365-2958.2006.05129.x; Blaby-Haas CE, 2011, MOL MICROBIOL, V79, P700, DOI 10.1111/j.1365-2958.2010.07475.x; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cloutier JF, 2001, J MOL BIOL, V313, P539, DOI 10.1006/jmbi.2001.4997; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Doniselli N, 2015, NUCLEIC ACIDS RES, V43, P5249, DOI 10.1093/nar/gkv391; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; Fan XJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01950; Filloux A, 2014, METHODS MOL BIOL, V1149, pV; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geske GD, 2007, J AM CHEM SOC, V129, P13613, DOI 10.1021/ja074135h; Gourse RL, 2018, ANNU REV MICROBIOL, V72, P163, DOI 10.1146/annurev-micro-090817-062444; Gray MJ, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00664-18; Guendouze A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00227; Henard CA, 2010, J BIOL CHEM, V285, P36785, DOI 10.1074/jbc.M110.160960; Hirai T, 2016, P NATL ACAD SCI USA, V113, P12815, DOI 10.1073/pnas.1613308113; Ikeda H, 2006, CHEM PHARM BULL, V54, P731, DOI 10.1248/cpb.54.731; Jiang Q, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2015978; Kim HY, 2018, J BIOL CHEM, V293, P5679, DOI [10.1074/jbc.RA117.000383, 10.1074/jbc.ra117.000383]; Kim JS, 2018, P NATL ACAD SCI USA, V115, pE11780, DOI 10.1073/pnas.1813572115; Klockgether Jens, 2017, F1000Res, V6, P1261, DOI 10.12688/f1000research.10506.1; Kolmsee T, 2011, MICROBIOL-SGM, V157, P2871, DOI 10.1099/mic.0.052357-0; Lee J, 2015, PROTEIN CELL, V6, P26, DOI 10.1007/s13238-014-0100-x; Lee KM, 2011, INFECT IMMUN, V79, P2792, DOI 10.1128/IAI.01361-10; Lee K, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw104; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Min KB, 2020, J BIOL CHEM, V295, P3851, DOI 10.1074/jbc.RA119.011692; Nathwani D, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-32; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Paczkowski JE, 2017, J BIOL CHEM, V292, P4064, DOI 10.1074/jbc.M116.770552; Pal RR, 2012, J BACTERIOL, V194, P5638, DOI 10.1128/JB.00518-12; Parshin A, 2015, P NATL ACAD SCI USA, V112, pE6862, DOI 10.1073/pnas.1521365112; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; Ross W, 2016, MOL CELL, V62, P811, DOI 10.1016/j.molcel.2016.04.029; Scoffone VC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081838; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Stockert JC, 2018, ACTA HISTOCHEM, V120, P159, DOI 10.1016/j.acthis.2018.02.005; Valentini M, 2018, CURR OPIN MICROBIOL, V41, P15, DOI 10.1016/j.mib.2017.11.006; Yang YX, 2012, J MICROBIOL, V50, P987, DOI 10.1007/s12275-012-2149-7; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	48	3	3	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100576	10.1016/j.jbc.2021.100576	http://dx.doi.org/10.1016/j.jbc.2021.100576			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33757766	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400549
J	Porter, KJ; Cao, LY; Chen, YD; TerBush, AD; Chen, C; Erickson, HP; Osteryoung, KW				Porter, Katie J.; Cao, Lingyan; Chen, Yaodong; TerBush, Allan D.; Chen, Cheng; Erickson, Harold P.; Osteryoung, Katherine W.			The Arabidopsis thaliana chloroplast division protein FtsZ1 counterbalances FtsZ2 filament stability in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION; PLASTID DIVISION; ESCHERICHIA-COLI; CHLOROPHYLL FLUORESCENCE; BACTERIAL CYTOKINESIS; GTPASE ACTIVITY; RING STRUCTURE; GENE FAMILIES; EXPRESSION; INSIGHTS	Bacterial cell and chloroplast division are driven by a contractile "Z ring" composed of the tubulin-like cytoskeletal GTPase FtsZ. Unlike bacterial Z rings, which consist of a single FtsZ, the chloroplast Z ring in plants is composed of two FtsZ proteins, FtsZ1 and FtsZ2. Both are required for chloroplast division in vivo, but their biochemical relationship is poorly understood. We used GTPase assays, light scattering, transmission electron microscopy, and sedimentation assays to investigate the assembly behavior of purified Arabidopsis thaliana (At) FtsZ1 and AtFtsZ2 both individually and together. Both proteins exhibited GTPase activity. AtFtsZ2 assembled relatively quickly, forming protofilament bundles that were exceptionally stable, as indicated by their sustained assembly and slow disassembly. AtFtsZ1 did not form detectable protofilaments on its own. When mixed with AtFtsZ2, AtFtsZ1 reduced the extent and rate of AtFtsZ2 assembly, consistent with its previously demonstrated ability to promote protofilament subunit turnover in living cells. Mixing the two FtsZ proteins did not increase the overall GTPase activity, indicating that the effect of AtFtsZ1 on AtFtsZ2 assembly was not due to a stimulation of GTPase activity. However, the GTPase activity of AtFtsZ1 was required to reduce AtFtsZ2 assembly. Truncated forms of AtFtsZ1 and AtFtsZ2 consisting of only their conserved core regions largely recapitulated the behaviors of the full-length proteins. Our in vitro findings provide evidence that FtsZ1 counterbalances the stability of FtsZ2 filaments in the regulation of chloroplast Z-ring dynamics and suggest that restraining FtsZ2 self-assembly is a critical function of FtsZ1 in chloroplasts.	[Porter, Katie J.; Cao, Lingyan; TerBush, Allan D.; Chen, Cheng; Osteryoung, Katherine W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Chen, Yaodong; Erickson, Harold P.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC USA; [Chen, Yaodong] Northwest Univ, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China; [Chen, Cheng] Shanghai Jiao Tong Univ, Joint Ctr Single Cell Biol, Sch Agr & Biol, Dept Plant Sci, Shanghai 200240, Peoples R China	Michigan State University; Duke University; Northwest University Xi'an; Shanghai Jiao Tong University	Osteryoung, KW (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	osteryou@msu.edu		Porter, Katie/0000-0002-3995-0244; Erickson, Harold/0000-0002-9104-8987; Chen, Cheng/0000-0002-1423-118X; Chen, Yaodong/0000-0002-3751-0923	National Science Foundation [1121943, 1719376]; National Institute of General Medical Sciences [R01GM066014]	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant 1719376 (to K. W. O.), National Science Foundation grant 1121943 (to K. W. O. and H. P. E.), and National Institute of General Medical Sciences grant R01GM066014 (to H. P. E.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arjes HA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0544-z; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bisson AW, 2017, SCIENCE, V355, P739, DOI 10.1126/science.aak9973; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Chen C, 2018, PLANT PHYSIOL, V176, P138, DOI 10.1104/pp.17.01272; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2017, J BIOL CHEM, V292, P5207, DOI 10.1074/jbc.M116.767715; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Corbin LC, 2020, BIOPHYS J, V119, P792, DOI 10.1016/j.bpj.2020.05.041; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Du SS, 2019, TRENDS MICROBIOL, V27, P781, DOI 10.1016/j.tim.2019.04.011; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; Dutta S, 2017, J EXP BOT, V68, P3541, DOI 10.1093/jxb/erx203; Dutta S, 2015, PLANT J, V84, P428, DOI 10.1111/tpj.13009; Ei-Kafafi E, 2005, BIOCHEM J, V387, p669 676; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Eun YJ, 2015, J BIOL CHEM, V290, P17181, DOI 10.1074/jbc.R115.637876; Fujiwara M, 2001, BIOCHEM BIOPH RES CO, V287, P462, DOI 10.1006/bbrc.2001.5588; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Jeong KJ, 2003, APPL ENVIRON MICROB, V69, P1295, DOI 10.1128/AEM.69.2.1295-1298.2003; Johnson CB, 2015, MICROSC MICROANAL, V21, P313, DOI 10.1017/S1431927615000082; Lohse S, 2006, PLANT CELL PHYSIOL, V47, P1124, DOI 10.1093/pcp/pcj083; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Matsui T, 2014, J BIOL CHEM, V289, P3501, DOI 10.1074/jbc.M113.514901; Matsui T, 2012, ACTA CRYSTALLOGR D, V68, P1175, DOI 10.1107/S0907444912022640; McAndrew RS, 2008, BIOCHEM J, V412, P367, DOI 10.1042/BJ20071354; McAndrew RS, 2001, PLANT PHYSIOL, V127, P1656, DOI 10.1104/pp.010542; McQuillen R, 2020, ANNU REV BIOPHYS, V49, P309, DOI 10.1146/annurev-biophys-121219-081703; Miyagishima S, 2011, INT REV CEL MOL BIO, V291, P115, DOI 10.1016/B978-0-12-386035-4.00004-5; Miyagishima SY, 2004, J MOL EVOL, V58, P291, DOI 10.1007/s00239-003-2551-1; Miyagishima SY, 2001, PLANT CELL, V13, P2257, DOI 10.1105/tpc.010185; Monahan LG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00019; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Mulrooney SB, 2000, PROTEIN EXPRES PURIF, V19, P173, DOI 10.1006/prep.2000.1228; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Olson BJSC, 2010, J BIOL CHEM, V285, P20634, DOI 10.1074/jbc.M110.122614; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2011, MOL MICROBIOL, V81, P571, DOI 10.1111/j.1365-2958.2011.07716.x; Osteryoung KW, 2014, ANNU REV PLANT BIOL, V65, P443, DOI 10.1146/annurev-arplant-050213-035748; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Osteryoung KW, 2001, ANNU REV PLANT PHYS, V52, P315, DOI 10.1146/annurev.arplant.52.1.315; Pacheco-Gomez R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019369; Ramirez-Diaz DA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004845; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Rowlett VW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00478; Scheffers DJ, 2002, BIOCHEMISTRY-US, V41, P521, DOI 10.1021/bi011370i; Schmitz AJ, 2009, MOL PLANT, V2, P1211, DOI 10.1093/mp/ssp077; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaik RS, 2018, BIOCHEM J, V475, P99, DOI 10.1042/BCJ20170697; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Smith AG, 2010, FEBS LETT, V584, P166, DOI 10.1016/j.febslet.2009.11.044; Srinivasan R, 2008, GENE DEV, V22, P1741, DOI 10.1101/gad.1660908; Stokes KD, 2003, GENE, V320, P97, DOI 10.1016/S0378-1119(03)00814-X; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Szwedziak P, 2014, ELIFE, V3, DOI 10.7554/eLife.04601; TerBush AD, 2018, PLANT PHYSIOL, V176, P295, DOI 10.1104/pp.17.00558; TerBush AD, 2016, MICROSC MICROANAL, V22, P275, DOI 10.1017/S1431927616000143; TerBush AD, 2013, CURR OPIN CELL BIOL, V25, P461, DOI 10.1016/j.ceb.2013.04.006; TerBush AD, 2012, J CELL BIOL, V199, P623, DOI 10.1083/jcb.201205114; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Wang N, 2019, J BIOL CHEM, V294, P16309, DOI 10.1074/jbc.RA119.009621; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000; Yang XX, 2017, SCIENCE, V355, P744, DOI 10.1126/science.aak9995; Yoder DW, 2007, PLANT CELL PHYSIOL, V48, P775, DOI 10.1093/pcp/pcm049; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yoshida Y, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.95, 10.1038/nplants.2016.95]; Zhang M, 2016, PLANT PHYSIOL, V170, P250, DOI 10.1104/pp.15.01460; Zhang M, 2013, PLANT CELL, V25, P1787, DOI 10.1105/tpc.113.111047	88	1	1	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100627	10.1016/j.jbc.2021.100627	http://dx.doi.org/10.1016/j.jbc.2021.100627			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33812992	gold, Green Published			2022-12-28	WOS:000672866400598
J	Rahman, MM; Mohiuddin, M; Keka, IS; Yamada, K; Tsuda, M; Sasanuma, H; Andreani, J; Guerois, R; Borde, V; Charbonnier, JB; Takeda, S				Rahman, Md Maminur; Mohiuddin, Mohiuddin; Keka, Islam Shamima; Yamada, Kousei; Tsuda, Masataka; Sasanuma, Hiroyuki; Andreani, Jessica; Guerois, Raphael; Borde, Valerie; Charbonnier, Jean-Baptiste; Takeda, Shunichi			Genetic evidence for the involvement of mismatch repair proteins, PMS2 and MLH3, in a late step of homologous recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						homologous recombination; PMS2; MLH3; MLH1; MUS81; GEN1; resolvase; joint molecules; mutL homolog 1 (MLH1); mutL homolog 3 (MLH3); Holliday junction; endonuclease	STRAND-BREAK REPAIR; HOLLIDAY JUNCTION RESOLUTION; MUTL-ALPHA; DNA-REPAIR; ESSENTIAL ROLES; HUMAN-CELLS; MUS81; ENDONUCLEASE; MAINTENANCE; PATHWAYS	Homologous recombination (HR) repairs DNA double-strand breaks using intact homologous sequences as template DNA. Broken DNA and intact homologous sequences form joint molecules (JMs), including Holliday junctions (HJs), as HR intermediates. HJs are resolved to form crossover and noncrossover products. A mismatch repair factor, MLH3 endonuclease, produces the majority of crossovers during meiotic HR, but it remains elusive whether mismatch repair factors promote HR in nonmeiotic cells. We disrupted genes encoding the MLH3 and PMS2 endonucleases in the human B cell line, TK6, generating null MLH3(-/-) and PMS2(-/-) mutant cells. We also inserted point mutations into the endonuclease motif of MLH3 and PMS2 genes, generating endonuclease death MLH3(DN/DN) and PMS2(EK/EK) cells. MLH3(-/-) and MLH3(DN/DN) cells showed a very similar phenotype, a 2.5-fold decrease in the frequency of heteroallelic HR-dependent repair of restriction enzyme-induced double-strand breaks. PMS2(-/-) and PMS2(EK/EK) cells showed a phenotype very similar to that of the MLH3 mutants. These data indicate that MLH3 and PMS2 promote HR as an endonuclease. The MLH3(DN/DN) and PMS2(EK/EK) mutations had an additive effect on the heteroallelic HR. MLH3(DN/DN)/PMS2(EK/EK) cells showed normal kinetics of gamma-irradiation-induced Rad51 foci but a significant delay in the resolution of Rad51 foci and a 3-fold decrease in the number of cisplatin-induced sister chromatid exchanges. The ectopic expression of the Gen1 HJ re-solvase partially reversed the defective heteroallelic HR of MLH3(DN/DN)/PMS2(EK/EK) cells. Taken together, we propose that MLH3 and PMS2 promote HR as endonucleases, most likely by processing JMs in mammalian somatic cells.	[Rahman, Md Maminur; Mohiuddin, Mohiuddin; Keka, Islam Shamima; Yamada, Kousei; Tsuda, Masataka; Sasanuma, Hiroyuki; Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Yoshida Konoe Cho, Kyoto, Japan; [Andreani, Jessica; Guerois, Raphael; Charbonnier, Jean-Baptiste] Univ Paris Saclay, CNRS, Commissariat Energie Atom CEA, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Borde, Valerie] PSL Res Univ, UMR3244, CNRS, Inst Curie, Paris, France; [Mohiuddin, Mohiuddin; Keka, Islam Shamima] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada; [Tsuda, Masataka] Hiroshima Univ, Grad Sch Integrated Sci Life, Program Math & Life Sci, Higashihiroshima, Japan	Kyoto University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Hiroshima University	Takeda, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Yoshida Konoe Cho, Kyoto, Japan.	stakeda@rg.med.kyoto-u.ac.jp	Charbonnier, Jean-Baptiste/A-3868-2009; Mohiuddin, Mohiuddin/AAD-5338-2022	Charbonnier, Jean-Baptiste/0000-0002-5219-1983; Mohiuddin, Mohiuddin/0000-0003-1899-6734; Keka, Shamima Islam/0000-0002-7826-2508; Tsuda, Masataka/0000-0002-1267-3777; Andreani, Jessica/0000-0003-4435-9093	Ministry of Education, Science, Sport, and Culture [KAKENHI 25650006, 23221005, 19K22561, 16H06306, KAKENHI 16H02953, 18H04900, 19H04267]; Agence Nationale de la Recherche (ANR) Grant [ANR-15-CE11-0011]; French Infrastructure for Integrated Structural Biology (FRISBI) Grant [ANR-10-INBS-05]; Japan Society for the Promotion of Science Core-to-Core Program, Advanced Research Networks	Ministry of Education, Science, Sport, and Culture; Agence Nationale de la Recherche (ANR) Grant(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI) Grant; Japan Society for the Promotion of Science Core-to-Core Program, Advanced Research Networks(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was directly supported by grants-in-aid from the Ministry of Education, Science, Sport, and Culture (KAKENHI 25650006, 23221005, 19K22561, and 16H06306 (to S. T.) and KAKENHI 16H02953, 18H04900, and 19H04267 (to H. S.)), Agence Nationale de la Recherche (ANR) Grant ANR-15-CE11-0011 (to V. B. and J.-B. C.), and by French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INBS-05 (to J.-B. C.). This work was also supported by the Japan Society for the Promotion of Science Core-to-Core Program, Advanced Research Networks (to S. T.). This study was conducted through the Joint Research Program of the Radiation Biology Center, Kyoto.	Abraham J, 2003, EMBO J, V22, P6137, DOI 10.1093/emboj/cdg580; Al-Sweel N, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006974; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Bannister LA, 2004, DNA REPAIR, V3, P465, DOI 10.1016/j.dnarep.2004.01.001; Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007; Cannavo E, 2020, NATURE, V586, P618, DOI 10.1038/s41586-020-2592-2; Castor D, 2013, MOL CELL, V52, P221, DOI 10.1016/j.molcel.2013.08.036; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chan YW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5844; Chen PC, 2005, CANCER RES, V65, P8662, DOI 10.1158/0008-5472.CAN-05-0742; Deschenes SM, 2007, CANCER LETT, V249, P148, DOI 10.1016/j.canlet.2006.08.008; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Elliott B, 2001, MOL CELL BIOL, V21, P2671, DOI 10.1128/MCB.21.8.2671-2682.2001; Fischer JM, 2016, DNA REPAIR, V39, P46, DOI 10.1016/j.dnarep.2015.12.011; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Fowler P, 2010, MUTAT RES-GEN TOX EN, V702, P171, DOI 10.1016/j.mrgentox.2010.02.016; Fujita M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060043; Garner E, 2013, CELL REP, V5, P207, DOI 10.1016/j.celrep.2013.08.041; Goellner EM, 2015, DNA REPAIR, V32, P24, DOI 10.1016/j.dnarep.2015.04.010; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hodskinson MRG, 2014, MOL CELL, V54, P472, DOI 10.1016/j.molcel.2014.03.014; Hoffmann ER, 2004, CYTOGENET GENOME RES, V107, P232, DOI 10.1159/000080601; Honma M, 2003, ENVIRON MOL MUTAGEN, V42, P288, DOI 10.1002/em.10201; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrova LY, 2020, P NATL ACAD SCI USA, V117, P3535, DOI 10.1073/pnas.1914718117; Kaur H, 2015, MOL CELL, V57, P583, DOI 10.1016/j.molcel.2015.01.020; Keka IS, 2015, NUCLEIC ACIDS RES, V43, P6359, DOI 10.1093/nar/gkv621; Kikuchi K, 2013, CANCER RES, V73, P4362, DOI 10.1158/0008-5472.CAN-12-3154; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kulkarni DS, 2020, NATURE, V586, P623, DOI 10.1038/s41586-020-2645-6; Kunkel TA, 2015, ANNU REV GENET, V49, P291, DOI 10.1146/annurev-genet-112414-054722; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Lorenz A, 2010, NUCLEIC ACIDS RES, V38, P1866, DOI 10.1093/nar/gkp1179; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Matton N, 2000, J BIOL CHEM, V275, P17808, DOI 10.1074/jbc.M909794199; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mohiuddin, 2016, DNA REPAIR, V40, P67, DOI 10.1016/j.dnarep.2016.02.002; Mohiuddin, 2014, ARCH TOXICOL, V88, P145, DOI 10.1007/s00204-013-1084-7; Mohiuddin M, 2019, NUCLEIC ACIDS RES, V47, P2966, DOI 10.1093/nar/gkz009; Mohiuddin M, 2018, P NATL ACAD SCI USA, V115, P12793, DOI 10.1073/pnas.1716349115; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Neuwirth EAH, 2007, MOL CELL BIOL, V27, P5261, DOI 10.1128/MCB.01852-06; Hoa NN, 2015, GENES CELLS, V20, P1059, DOI 10.1111/gtc.12310; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Pamidi A, 2007, CANCER RES, V67, P8527, DOI 10.1158/0008-5472.CAN-07-1161; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sanchez A., 2020, 16876623 BIORXIV, DOI [10.1101/2019.12.16.876623, DOI 10.1101/2019.12.16.876623]; Sarbajna S, 2014, GENE DEV, V28, P1124, DOI 10.1101/gad.238303.114; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Shcherbakova PV, 2001, MOL CELL BIOL, V21, P940, DOI 10.1128/MCB.21.3.940-951.2001; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shimizu N, 2020, GENOME INSTABILITY D, V1, P184, DOI [10.1007/s42764-020-00015-w, DOI 10.1007/S42764-020-00015-W]; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Srivatsan A, 2014, J BIOL CHEM, V289, P9352, DOI 10.1074/jbc.M114.552190; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Suzuki T, 2016, MOL CELL BIOL, V36, P2877, DOI 10.1128/MCB.00443-16; Svetlanov A, 2008, GENETICS, V178, P1937, DOI 10.1534/genetics.107.084798; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Tang SM, 2015, MOL CELL, V57, P607, DOI 10.1016/j.molcel.2015.01.021; Toledo M, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008177; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Wang XW, 2016, DNA CELL BIOL, V35, P585, DOI 10.1089/dna.2015.3022; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; West SC, 2017, COLD SH Q B, V82, P207, DOI 10.1101/sqb.2017.82.034256; West SC, 2015, COLD SH Q B, V80, P103, DOI 10.1101/sqb.2015.80.027649; Wyatt HDM, 2017, MOL CELL, V65, P848, DOI 10.1016/j.molcel.2017.01.031; Wyatt HDM, 2013, MOL CELL, V52, P234, DOI 10.1016/j.molcel.2013.08.035; Yoshimoto K, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00186; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zeng M, 2000, CANCER RES, V60, P4889; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	88	8	9	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17460	17475		10.1074/jbc.RA120.013521	http://dx.doi.org/10.1074/jbc.RA120.013521			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453991	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000603272300007
J	Berman, HM; Gierasch, LM				Berman, Helen M.; Gierasch, Lila M.			How the Protein Data Bank changed biology: An introduction to the JBC Reviews thematic series, part 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPACT; PDB	This collection of articles celebrates the 50th anniversary of the Protein Data Bank (PDB), the single global digital archive of biological macromolecular structures. The impact of the PDB is immense; we have invited a number of top researchers in structural biology to illustrate its influence on an array of scientific fields. What emerges is a compelling picture of the synergism between the PDB and the explosive progress witnessed in many scientific areas. Availability of reliable, openly accessible, well-archived structural information has arguably had more impact on cell and molecular biology than even some of the enabling technologies such as PCR. We have seen the science move from a time when structural biologists contributed the lion's share of the structures to the PDB and for discussion within their community to a time when any effort to achieve in-depth understanding of a biochemical or cell biological question demands an interdisciplinary approach built atop structural underpinnings.	[Berman, Helen M.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Berman, Helen M.] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90007 USA; [Berman, Helen M.] Univ Southern Calif, Bridge Inst, Los Angeles, CA 90007 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Rutgers State University New Brunswick; University of Southern California; University of Southern California; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Berman, HM (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.; Berman, HM (corresponding author), Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90007 USA.; Berman, HM (corresponding author), Univ Southern Calif, Bridge Inst, Los Angeles, CA 90007 USA.; Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.; Gierasch, LM (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.	berman@rcsb.rutgers.edu; gierasch@biochem.umass.edu		Gierasch, Lila/0000-0002-5706-115X	NIH [R35 GM118161]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH Grant R35 GM118161 to L. M. G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bank P. D., 1971, NATURE-NEW BIOL, V233, P223, DOI [10.1038/newbio233223a0, DOI 10.1038/NEWBIO233223A0, DOI 10.1038/NEWBIO233223B0]; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Burley S. K, 2021, J BIOL CHEM, V296; Chiu W., 2021, J BIOL CHEM, V296; International Union of Crystallography, 1989, ACTA CRYSTALLOGR A 9, VA45, P658, DOI 10.1107/S0108767389007695; Johnson J. E., 2021, J BIOL CHEM, V296; Johnson JE, 2013, MICROSCOPY-JPN, V62, P69, DOI 10.1093/jmicro/dfs097; Li F, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100557; Moore P. B, 2021, J BIOL CHEM, V296; Murray D., 2021, J BIOL CHEM, V296; Neidle S, 2021, J BIOL CHEM, V296; Pan X., 2021, J BIOL CHEM, V296; Prestegard J. H, 2021, J BIOL CHEM, V296; Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7; The Editors, 1989, J BIOL CHEM, V264, P663; Westhof E., 2021, J BIOL CHEM, V296	16	5	5	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100608	10.1016/j.jbc.2021.100608	http://dx.doi.org/10.1016/j.jbc.2021.100608			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33785358	Green Published, gold			2022-12-28	WOS:000672866400580
J	Iorga, A; Donovan, K; Shojaie, L; Johnson, H; Kwok, J; Suda, J; Lee, BT; Aghajan, M; Shao, L; Liu, ZX; Dara, L				Iorga, Andrea; Donovan, Katherine; Shojaie, Layla; Johnson, Heather; Kwok, Janet; Suda, Jo; Lee, Brian T.; Aghajan, Mariam; Shao, Ling; Liu, Zhang-Xu; Dara, Lily			Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-INJURY; CELL-DEATH; NECROPTOSIS; NECROSIS; APOPTOSIS; UBIQUITINATION; HEPATOTOXICITY; HEPATOCYTES; INHIBITION; KINASES	Acetaminophen (APAP)-induced liver necrosis is a form of regulated cell death (RCD) in which APAP activates the mitogen-activated protein kinases (MAPKs) and specifically the c-Jun-N-terminal kinase (JNK) pathway, leading to necrotic cell death. Previously, we have shown that receptor interacting protein kinase-1 (RIPK1) knockdown is also protective against APAP RCD upstream of JNK. However, whether the kinase or platform function of RIPK1 is involved in APAP RCD is not known. To answer this question, we used genetic mouse models of targeted hepatocyte RIPK1 knockout (RIPK1(HepCKO)) or kinase dead knock-in (RIPK1(D138N)) and adult hepatocyte specific knockout of the cytoprotective protein A20 (A20(HepCKO)), known to interact with RIPK1, to study its potential involvement in MAPK signaling. We observed no difference in injury between WT and RIPK1D138N mice post APAP. However, RIPK1(HepCKO) was protective. We found that RIPK1(HepCKO) mice had attenuated pJNK activation, while A20 was simultaneously upregulated. Conversely, A20(HepCKO) markedly worsened liver injury from APAP. Mechanistically, we observed a significant upregulation of apoptosis signal-regulating kinase 1 (ASK1) and increased JNK activation in A20(HepCKO) mice compared with littermate controls. We also demonstrated that A20 coimmunoprecipitated (co-IP) with both RIPK1 and ASK1, and that in the presence of RIPK1, there was less A20-ASK1 association than in its absence. We conclude that the kinase-independent platform function of RIPK1 is involved in APAP toxicity. Adult RIPK1(HepCKO) mice are protected against APAP by upregulating A20 and attenuating JNK signaling through ASK1, conversely, A20(HepCKO) worsens injury from APAP.	[Iorga, Andrea; Johnson, Heather; Kwok, Janet; Lee, Brian T.; Shao, Ling; Liu, Zhang-Xu; Dara, Lily] Univ Southern Calif, Div Gastrointestinal & Liver Dis, Dept Med, Keck Sch Med, Los Angeles, CA 90007 USA; [Iorga, Andrea; Donovan, Katherine; Shojaie, Layla; Johnson, Heather; Suda, Jo; Shao, Ling; Liu, Zhang-Xu; Dara, Lily] Univ Southern Calif, Keck Sch Med, USC Res Ctr Liver Dis, Los Angeles, CA 90007 USA; [Suda, Jo] Cedar Sinai Med Ctr, Los Angeles, CA USA; [Aghajan, Mariam] IONIS Pharmaceut, Carlsbad, CA USA	University of Southern California; University of Southern California; Cedars Sinai Medical Center; Ionis Pharmaceuticals, Inc.	Dara, L (corresponding author), Univ Southern Calif, Div Gastrointestinal & Liver Dis, Dept Med, Keck Sch Med, Los Angeles, CA 90007 USA.; Dara, L (corresponding author), Univ Southern Calif, Keck Sch Med, USC Res Ctr Liver Dis, Los Angeles, CA 90007 USA.	lily.dara@usc.edu	Donovan, Katherine/GSJ-2005-2022; Lee, Brian T/AAX-3191-2021; Iorga, Andrea/AAU-8447-2021	Lee, Brian T/0000-0002-0621-4304; Iorga, Andrea/0000-0001-7809-9184; Donovan, Katherine/0000-0002-8757-4415	USC Research Center for Liver Diseases, National Institutes of Health [P30 DK048522, K08DK109141]	USC Research Center for Liver Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Analytical-Metabolomics-Instrumentation, Cell and Tissue Imaging, and Liver Histology Cores of the USC Research Center for Liver Diseases, National Institutes of Health P30 DK048522 and K08DK109141 (L. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An JF, 2013, J HEPATOL, V58, P297, DOI 10.1016/j.jhep.2012.10.002; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Catrysse L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.154; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chen DS, 2019, HEPATOLOGY, V69, P2164, DOI 10.1002/hep.30422; Dara L, 2020, LIVER: BIOLOGY AND PATHOBIOLOGY, 6TH EDITION, 6 EDITION, P701; Dara L, 2017, CELL DEATH BIOL DIS, P1, DOI 10.1007/978-3-319-53774-0_1; Dara L, 2018, SEMIN LIVER DIS, V38, P73, DOI 10.1055/s-0038-1629924; Dara L, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.89; Dara L, 2015, HEPATOLOGY, V62, P1847, DOI 10.1002/hep.27939; Deutsch M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.126; Dorronsoro A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.494; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Gunther C, 2016, J CLIN INVEST, V126, P4346, DOI 10.1172/JCI87545; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Iorga A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051018; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Jaeschke H, 2019, ARCH TOXICOL, V93, P3491, DOI 10.1007/s00204-019-02597-1; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lee WM, 2017, J HEPATOL, V67, P1324, DOI 10.1016/j.jhep.2017.07.005; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Newton K, 2015, TRENDS CELL BIOL, V25, P347, DOI 10.1016/j.tcb.2015.01.001; Pinna F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00610; Priem D, 2020, TRENDS IMMUNOL, V41, P421, DOI 10.1016/j.it.2020.03.001; Ramachandran A, 2013, HEPATOLOGY, V58, P2099, DOI 10.1002/hep.26547; Schneider AT, 2016, HEPATOLOGY, V64, P306, DOI 10.1002/hep.28225; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Simpson DS, 2021, SEMIN CELL DEV BIOL, V109, P76, DOI 10.1016/j.semcdb.2020.08.008; Suda J, 2016, J IMMUNOL, V197, P3120, DOI 10.4049/jimmunol.1600690; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Takemoto K, 2014, FEBS OPEN BIO, V4, P777, DOI 10.1016/j.fob.2014.08.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Win S, 2018, HEPATOLOGY, V67, P2013, DOI 10.1002/hep.29689; Win S, 2011, J BIOL CHEM, V286, P35071, DOI 10.1074/jbc.M111.276089; Won M, 2010, CELL DEATH DIFFER, V17, P1830, DOI 10.1038/cdd.2010.47; Zhang J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.295; Zhang P, 2018, NAT MED, V24, P84, DOI 10.1038/nm.4453; Zhang YF, 2014, TOXICOL LETT, V225, P445, DOI 10.1016/j.toxlet.2014.01.005	41	7	7	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100300	10.1016/j.jbc.2021.100300	http://dx.doi.org/10.1016/j.jbc.2021.100300			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460648	Green Published, gold			2022-12-28	WOS:000672866400274
J	Kitano, M; Kizuka, Y; Sobajima, T; Nakano, M; Nakajima, K; Misaki, R; Itoyama, S; Harada, Y; Harada, A; Miyoshi, E; Taniguchi, N				Kitano, Masato; Kizuka, Yasuhiko; Sobajima, Tomoaki; Nakano, Miyako; Nakajima, Kazuki; Misaki, Ryo; Itoyama, Saki; Harada, Yoichiro; Harada, Akihiro; Miyoshi, Eiji; Taniguchi, Naoyuki			Rab11-mediated post-Golgi transport of the sialyltransferase ST3GAL4 suggests a new mechanism for regulating glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCANS; FUNCTIONAL ASSOCIATION; NUCLEOTIDE SUGARS; PROTEIN; RAB11; LOCALIZATION; COMPLEX; DOMAIN; EXPRESSION; PLATFORM	Glycosylation, the most common posttranslational modification of proteins, is a stepwise process that relies on tight regulation of subcellular glycosyltransferase location to control the addition of each monosaccharide. Glycosyltransferases primarily reside and function in the endoplasmic reticulum (ER) and the Golgi apparatus; whether and how they traffic beyond the Golgi, how this trafficking is controlled, and how it impacts glycosylation remain unclear. Our previous work identified a connection between N-glycosylation and Rab11, a key player in the post-Golgi transport that connects recycling endosomes and other compartments. To learn more about the specific role of Rab11, we knocked down Rab11 in HeLa cells. Our findings indicate that Rab11 knockdown results in a dramatic enhancement in the sialylation of N-glycans. Structural analyses of glycans using lectins and LC-MS revealed that alpha 2,3-sialylation is selectively enhanced, suggesting that an alpha 2,3-sialyltransferase that catalyzes the sialyation of glycoproteins is activated or upregulated as the result of Rab11 knockdown. ST3GAL4 is the major alpha 2,3-sialyltransferase that acts on N-glycans; we demonstrated that the localization of ST3GAL4, but not the levels of its mRNA, protein, or donor substrate, was altered by Rab11 depletion. In knockdown cells, ST3GAL4 is densely distributed in the trans-Golgi network, compared with the wider distribution in the Golgi and in other peripheral puncta in control cells, whereas the alpha 2,6-sialyltransferase ST6GAL1 is predominantly localized to the Golgi regardless of Rab11 knockdown. This indicates that Rab11 may negatively regulate alpha 2,3-sialylation by transporting ST3GAL4 to post-Golgi compartments (PGCs), which is a novel mechanism of glycosyltransferase regulation.	[Kitano, Masato; Kizuka, Yasuhiko; Harada, Yoichiro; Taniguchi, Naoyuki] Osaka Int Canc Inst, Dept Glycooncol & Med Biochem, Chuo Ku, Osaka, Japan; [Kitano, Masato; Sobajima, Tomoaki; Itoyama, Saki; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Osaka, Japan; [Kizuka, Yasuhiko] Gifu Univ, Ctr Highly Adv Integrat Nano & Life Sci G CHAIN, Gifu, Japan; [Kizuka, Yasuhiko] Gifu Univ, Inst Glycocore Res iGCORE, Gifu, Japan; [Nakano, Miyako] Hiroshima Univ, Grad Sch Integrated Sci Life, Hiroshima, Japan; [Nakajima, Kazuki] Fujita Hlth Univ, Toyoake, Aichi, Japan; [Misaki, Ryo] Osaka Univ, Int Ctr Biotechnol, Osaka, Japan; [Harada, Akihiro] Osaka Univ, Grad Sch Med, Dept Cell Biol, Osaka, Japan; [Sobajima, Tomoaki] Univ Oxford, Dept Biochem, Oxford, England	Osaka University; Gifu University; Gifu University; Hiroshima University; Fujita Health University; Osaka University; Osaka University; University of Oxford	Taniguchi, N (corresponding author), Osaka Int Canc Inst, Dept Glycooncol & Med Biochem, Chuo Ku, Osaka, Japan.; Miyoshi, E (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Osaka, Japan.	emiyoshi@sahs.med.osaka-u.ac.jp; glycotani@mc.pref.osaka.jp	; Taniguchi, Naoyuki/I-4182-2014	Kizuka, Yasuhiko/0000-0002-3181-9743; Taniguchi, Naoyuki/0000-0001-5889-5968; Sobajima, Tomoaki/0000-0002-0753-5361	Japan Society for the Promotion of Science (JSPS) [18K06914, 19K06546, 17K07356, 20H03207, 19H03562]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [16811705]; CREST grant from JST [18070267]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST grant from JST	This work was partially supported by a Grant-in-Aid for Scientific Research (C) to N. T. (18K06914), Y. H. (19K06546), and Y. K. (17K07356), a Grant-in-Aid for Scientific Research (B) to Y. K. (20H03207) and E. M. (19H03562) from the Japan Society for the Promotion of Science (JSPS), a Leading Initiative for Excellent Young Researchers (LEADER) project to Y. K. (16811705) from Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a CREST grant ([18070267] to Y. K.) from JST.	Agrawal P, 2017, CANCER CELL, V31, P804, DOI 10.1016/j.ccell.2017.05.007; Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Bhuin T, 2015, INT J MOL CELL MED, V4, P1; Campa Carlo Cosimo, 2017, Advances in Biological Regulation, V63, P132, DOI 10.1016/j.jbior.2016.09.002; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Fisher P, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00015; Gomes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066737; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Harada Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236074; Hathaway HJ, 2003, J CELL SCI, V116, P4319, DOI 10.1242/jcs.00720; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Ito J, 2014, ANAL BIOCHEM, V448, P14, DOI 10.1016/j.ab.2013.11.026; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kizuka Y, 2016, PROTEOMICS, V16, P2854, DOI 10.1002/pmic.201600053; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Kizuka Y, 2009, J BIOL CHEM, V284, P9247, DOI 10.1074/jbc.M807517200; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Koyota S, 2001, J BIOL CHEM, V276, P32867, DOI 10.1074/jbc.M102371200; Laughlin ST, 2006, METHOD ENZYMOL, V415, P230, DOI 10.1016/S0076-6879(06)15015-6; Li PT, 2012, FERTIL STERIL, V97, P1206, DOI 10.1016/j.fertnstert.2012.02.019; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Maccioni HJF, 2011, J NEUROCHEM, V117, P589, DOI 10.1111/j.1471-4159.2011.07232.x; Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Mondal N, 2015, BLOOD, V125, P687, DOI 10.1182/blood-2014-07-588590; Moremen KW, 2019, NAT CHEM BIOL, V15, P853, DOI 10.1038/s41589-019-0350-2; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nagae M., 2020, INT J MOL SCI, V21, P1; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Nakano M, 2019, MOL CELL PROTEOMICS, V18, P2044, DOI 10.1074/mcp.RA119.001534; Nakano M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009001; Nguyen K, 2018, MOL CANCER THER, V17, P2689, DOI 10.1158/1535-7163.MCT-18-0399; Nozaki S, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00660-18; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Parmar HB, 2016, MOL BIOL CELL, V27, P1320, DOI 10.1091/mbc.E15-12-0845; Petrosyan A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.C112.403006; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Puri C, 2018, DEV CELL, V45, P114, DOI 10.1016/j.devcel.2018.03.008; Qi F, 2020, FASEB J, V34, P881, DOI 10.1096/fj.201901793R; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Seko A, 2005, GLYCOBIOLOGY, V15, P943, DOI 10.1093/glycob/cwi082; Shen X, 2007, P NATL ACAD SCI USA, V104, P1230, DOI 10.1073/pnas.0610535104; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; Sobajima T, 2018, J CELL BIOL, V217, P1777, DOI 10.1083/jcb.201709123; Sobajima T, 2015, BIOL OPEN, V4, P86, DOI 10.1242/bio.20148532; Stanley P., 2017, ESSENTIALS GLYCOBIOL; Takahashi M, 2016, MOL ASPECTS MED, V51, P56, DOI 10.1016/j.mam.2016.04.008; Tomida S, 2020, J BIOL CHEM, V295, P7992, DOI 10.1074/jbc.RA120.013079; Tran DT, 2012, J BIOL CHEM, V287, P20967, DOI 10.1074/jbc.M112.370387; Udayar V, 2013, CELL REP, V5, P1536, DOI 10.1016/j.celrep.2013.12.005; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Vilcaes AA, 2011, J BIOL CHEM, V286, P31437, DOI 10.1074/jbc.M111.257196; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Yamane J, 2007, EXP CELL RES, V313, P3472, DOI 10.1016/j.yexcr.2007.07.010; Yu SY, 2014, J BIOL CHEM, V289, P32030, DOI 10.1074/jbc.M113.538223; Zhao W, 2006, J BIOL CHEM, V281, P31106, DOI 10.1074/jbc.M605564200	67	7	7	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100354	10.1016/j.jbc.2021.100354	http://dx.doi.org/10.1016/j.jbc.2021.100354			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524390	Green Published, gold			2022-12-28	WOS:000672866400328
J	Mai, QN; Shenoy, P; Quach, T; Retamal, JS; Gondin, AB; Yeatman, HR; Aurelio, L; Conner, JW; Poole, DP; Canals, M; Nowell, CJ; Graham, B; Davis, TP; Briddon, SJ; Hill, SJ; Porter, CJH; Bunnett, NW; Halls, ML; Veldhuis, NA				Mai, Quynh N.; Shenoy, Priyank; Quach, Tim; Retamal, Jeffri S.; Gondin, Arisbel B.; Yeatman, Holly R.; Aurelio, Luigi; Conner, Joshua W.; Poole, Daniel P.; Canals, Meritxell; Nowell, Cameron J.; Graham, Bim; Davis, Thomas P.; Briddon, Stephen J.; Hill, Stephen J.; Porter, Christopher J. H.; Bunnett, Nigel W.; Halls, Michelle L.; Veldhuis, Nicholas A.			A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CONVERTING ENZYME 1; SUBSTANCE-P; ADENYLYL-CYCLASE; BETA-ARRESTINS; ASSOCIATION; BINDING; INTERNALIZATION; LOCALIZATION; TACHYKININS	G-protein-coupled receptors (GPCRs) are traditionally known for signaling at the plasma membrane, but they can also signal from endosomes after internalization to control important pathophysiological processes. In spinal neurons, sustained endosomal signaling of the neurokinin 1 receptor (NK1R) mediates nociception, as demonstrated in models of acute and neuropathic pain. An NK1R antagonist, Spantide I (Span), conjugated to cholestanol (Span-Chol), accumulates in endosomes, inhibits endosomal NK1R signaling, and causes prolonged antinociception. However, the extent to which the Chol-anchor influences long-term location and activity is poorly understood. Herein, we used fluorescent correlation spectroscopy and targeted biosensors to characterize Span-Chol over time. The Chol-anchor increased local concentration of probe at the plasma membrane. Over time we observed an increase in NK1R-binding affinity and more potent inhibition of NK1R-mediated calcium signaling. Span-Chol, but not Span, caused a persistent decrease in NK1R recruitment of beta-arrestin and receptor internalization to early endosomes. Using targeted biosensors, we mapped the relative inhibition of NK1R signaling as the receptor moved into the cell. Span selectively inhibited cell surface signaling, whereas Span-Chol partitioned into endosomal membranes and blocked endosomal signaling. In a preclinical model of pain, Span-Chol caused prolonged antinociception (>9 h), which is attributable to a three-pronged mechanism of action: increased local concentration at membranes, a prolonged decrease in NK1R endocytosis, and persistent inhibition of signaling from endosomes. Identifying the mechanisms that contribute to the increased preclinical efficacy of lipid-anchored NK1R antagonists is an important step toward understanding how we can effectively target intracellular GPCRs in disease	[Mai, Quynh N.; Shenoy, Priyank; Gondin, Arisbel B.; Yeatman, Holly R.; Aurelio, Luigi; Poole, Daniel P.; Nowell, Cameron J.; Bunnett, Nigel W.; Halls, Michelle L.; Veldhuis, Nicholas A.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic, Australia; [Mai, Quynh N.; Quach, Tim; Retamal, Jeffri S.; Davis, Thomas P.; Porter, Christopher J. H.; Veldhuis, Nicholas A.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam Theme, Parkville, Vic, Australia; [Mai, Quynh N.; Shenoy, Priyank; Retamal, Jeffri S.; Gondin, Arisbel B.; Conner, Joshua W.; Poole, Daniel P.; Davis, Thomas P.; Porter, Christopher J. H.; Bunnett, Nigel W.; Veldhuis, Nicholas A.] Monash Univ, Monash Inst Pharmaceut Sci, Australian Res Council Ctr Excellence Convergent, Parkville, Vic, Australia; [Mai, Quynh N.; Aurelio, Luigi; Conner, Joshua W.; Graham, Bim] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem Theme, Parkville, Vic, Australia; [Canals, Meritxell; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Sch Life Sci, Div Physiol Pharmacol & Neurosci, Med Sch, Nottingham, England; [Canals, Meritxell; Briddon, Stephen J.; Hill, Stephen J.] Univ Birmingham, Ctr Membrane Prot & Receptors, Birmingham, W Midlands, England; [Canals, Meritxell; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Ctr Membrane Prot & Receptors, Nottingham, England; [Davis, Thomas P.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic, Australia; [Bunnett, Nigel W.] NYU, Dept Mol Pathobiol, Coll Dent, New York, NY 10003 USA; [Mai, Quynh N.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Monash University; Monash University; Monash University; Monash University; University of Nottingham; University of Birmingham; University of Nottingham; University of Queensland; University of Melbourne; New York University; University of California System; University of California San Francisco	Bunnett, NW; Halls, ML; Veldhuis, NA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic, Australia.; Veldhuis, NA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam Theme, Parkville, Vic, Australia.; Bunnett, NW; Veldhuis, NA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Australian Res Council Ctr Excellence Convergent, Parkville, Vic, Australia.; Bunnett, NW (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic, Australia.; Bunnett, NW (corresponding author), NYU, Dept Mol Pathobiol, Coll Dent, New York, NY 10003 USA.	nwb2@nyu.edu; michelle.halls@monash.edu; nicholas.veldhuis@monash.edu	Davis, Thomas/B-6395-2008; Poole, Daniel/AET-6645-2022; Porter, Christopher JH/C-6333-2011; Hill, Stephen/N-6753-2013	Davis, Thomas/0000-0003-2581-4986; Poole, Daniel/0000-0002-6168-8422; Porter, Christopher JH/0000-0003-3474-7551; Hill, Stephen/0000-0002-4424-239X; Canals, Meritxell/0000-0002-7942-5006; Batista Gondin, Arisbel/0000-0002-1751-4062; Mai, Quynh/0000-0002-6199-2096; Veldhuis, Nicholas/0000-0002-8902-9365; Retamal, Jeffri S./0000-0003-4984-4530; Bunnett, Nigel W./0000-0003-3367-0644	National Institutes of Health [NS102722, DE026806, DE029951, DK118971]; Department of Defence [W81XWH1810431]; National Health and Medical Research Council [63303, 1049682, 1031886, 1083054]; ARC Centre of Excellence in Convergent BioNano Science and Technology [CE14100036]; Medical Research Council [MR/N020081/1]; NHMRC [1061687]; Joint Award Doctoral Training Centre in Molecular Pharmacology and Drug Discovery at Monash University (Australia) and the University of Nottingham (UK); MRC [MR/N020081/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defence; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Centre of Excellence in Convergent BioNano Science and Technology(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Joint Award Doctoral Training Centre in Molecular Pharmacology and Drug Discovery at Monash University (Australia) and the University of Nottingham (UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the National Institutes of Health (NS102722, DE026806, DE029951, DK118971 to N. W. B), Department of Defence (W81XWH1810431 to N. W. B.), National Health and Medical Research Council (63303 to N. W. B., 1049682 to N. W. B. and B. G., 1031886 to N. W. B. and D. P. P, 1083054 to N. W. B., M. L. H., M. C., C. J. P., and T. P. D.), ARC Centre of Excellence in Convergent BioNano Science and Technology (CE14100036 to N. W. B., T. P. D., C. J. P., N. A. V.), and Medical Research Council (MR/N020081/1 to S. J. B., S. J. H.). M. L. H. was an NHMRC RD Wright Fellow (1061687). Q. N. M. was part of the Joint Award Doctoral Training Centre in Molecular Pharmacology and Drug Discovery at Monash University (Australia) and the University of Nottingham (UK).	Alemi F, 2013, J CLIN INVEST, V123, P1513, DOI 10.1172/JCI64551; Arshavsky Vadim Y, 2014, Cell Logist, V4, pe29390; Ayling LJ, 2012, J CELL SCI, V125, P869, DOI 10.1242/jcs.091090; Briddon SJ, 2007, TRENDS PHARMACOL SCI, V28, P637, DOI 10.1016/j.tips.2007.09.008; Caberlotto L, 2003, EUR J NEUROSCI, V17, P1736, DOI 10.1046/j.1460-9568.2003.02600.x; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cattaruzza F, 2009, BRIT J PHARMACOL, V156, P730, DOI 10.1111/j.1476-5381.2008.00039.x; Civciristov S, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan1188; Collazos A, 2006, MOL CELL BIOL, V26, P2247, DOI 10.1128/MCB.26.6.2247-2261.2006; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Diener HC, 2003, CEPHALALGIA, V23, P183, DOI 10.1046/j.1468-2982.2003.00496.x; Dionne RA, 1998, CLIN PHARMACOL THER, V64, P562, DOI 10.1016/S0009-9236(98)90140-0; Eichel K, 2018, NATURE, V557, P381, DOI 10.1038/s41586-018-0079-1; Gherbi K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21100-x; Goldstein DJ, 1997, CEPHALALGIA, V17, P785, DOI 10.1046/j.1468-2982.1997.1707785.x; GREENO EW, 1993, J EXP MED, V177, P1269, DOI 10.1084/jem.177.5.1269; Halls Michelle L, 2015, Methods Mol Biol, V1335, P131, DOI 10.1007/978-1-4939-2914-6_10; Hargreaves R, 2002, J CLIN PSYCHIAT, V63, P18; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Huang WJ, 2020, NATURE, V579, P303, DOI 10.1038/s41586-020-1953-1; Irannejad R, 2017, NAT CHEM BIOL, V13, P799, DOI 10.1038/nchembio.2389; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jarcho JM, 2013, PAIN, V154, P987, DOI 10.1016/j.pain.2013.02.026; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Jensen DD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3447; Jensen DD, 2014, J BIOL CHEM, V289, P20283, DOI 10.1074/jbc.M114.578179; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Jimenez-Vargas NN, 2020, P NATL ACAD SCI USA, V117, P15281, DOI 10.1073/pnas.2000500117; Johannessen L, 2011, CHEMBIOCHEM, V12, P914, DOI 10.1002/cbic.201000563; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Latorraca NR, 2017, CHEM REV, V117, P139, DOI 10.1021/acs.chemrev.6b00177; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Liang YL, 2020, ACS PHARMACOL TRANSL, V3, P263, DOI 10.1021/acsptsci.9b00080; Linning P, 2012, ORG BIOMOL CHEM, V10, P8216, DOI 10.1039/c2ob26103k; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Merriam LA, 2013, J NEUROSCI, V33, P4614, DOI 10.1523/JNEUROSCI.4999-12.2013; Mukherjee A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00045; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nowell C. J., 2020, FRET ANAL STACK CREA; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Pinto FM, 2004, EUR J PHARMACOL, V494, P233, DOI 10.1016/j.ejphar.2004.05.016; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Ramirez-Garcia PD, 2019, NAT NANOTECHNOL, V14, P1150, DOI 10.1038/s41565-019-0568-x; Renzi D, 2000, AM J PATHOL, V157, P1511, DOI 10.1016/S0002-9440(10)64789-X; Rose RH, 2012, BRIT J PHARMACOL, V165, P1789, DOI 10.1111/j.1476-5381.2011.01640.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Stoddart LA, 2015, NEUROPHARMACOLOGY, V98, P68, DOI 10.1016/j.neuropharm.2015.04.013; Stoddart LA, 2012, CHEM BIOL, V19, P1105, DOI 10.1016/j.chembiol.2012.07.014; Sykes DA, 2014, MOL PHARMACOL, V85, P608, DOI 10.1124/mol.113.090209; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vauquelin G, 2010, BRIT J PHARMACOL, V161, P488, DOI 10.1111/j.1476-5381.2010.00936.x; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Wu FJ, 2020, J BIOL CHEM, V295, P7404, DOI 10.1074/jbc.RA120.012842; Yarwood RE, 2017, P NATL ACAD SCI USA, V114, P12309, DOI 10.1073/pnas.1706656114; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	64	4	4	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100345	10.1016/j.jbc.2021.100345	http://dx.doi.org/10.1016/j.jbc.2021.100345			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33515548	Green Published, gold			2022-12-28	WOS:000672866400319
J	Medina, MS; Bretzing, KO; Aviles, RA; Chong, KM; Espinoza, A; Garcia, CNG; Katz, BB; Kharwa, RN; Hernandez, A; Lee, JL; Lee, TM; Lo Verde, C; Strul, MW; Wong, EY; Owens, CP				Medina, Michael S.; Bretzing, Kevin O.; Aviles, Richard A.; Chong, Kiersten M.; Espinoza, Alejandro; Garcia, Chloe Nicole G.; Katz, Benjamin B.; Kharwa, Ruchita N.; Hernandez, Andrea; Lee, Justin L.; Lee, Terrence M.; Lo Verde, Christine; Strul, Max W.; Wong, Emily Y.; Owens, Cedric P.			CowN sustains nitrogenase turnover in the presence of the inhibitor carbon monoxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; GLUCONACETOBACTER-DIAZOTROPHICUS; GENE-EXPRESSION; FEMO-COFACTOR; BINDING; PROTEIN; FIXATION; PROTECTION; MECHANISM; IDENTIFICATION	Nitrogenase is the only enzyme capable of catalyzing nitrogen fixation, the reduction of dinitrogen gas (N-2) to ammonia (NH3). Nitrogenase is tightly inhibited by the environmental gas carbon monoxide (CO). Nitrogen-fixing bacteria rely on the protein CowN to grow in the presence of CO. However, the mechanism by which CowN operates is unknown. Here, we present the biochemical characterization of CowN and examine how CowN protects nitrogenase from CO. We determine that CowN interacts directly with nitrogenase and that CowN protection observes hyperbolic kinetics with respect to CowN concentration. At a CO concentration of 0.001 atm, CowN restores nearly full nitrogenase activity. Our results further indicate that CowN's protection mechanism involves decreasing the binding affinity of CO to nitrogenase's active site approximately tenfold without interrupting substrate turnover. Taken together, our work suggests CowN is an important auxiliary protein in nitrogen fixation that engenders CO tolerance to nitrogenase.	[Medina, Michael S.; Bretzing, Kevin O.; Aviles, Richard A.; Chong, Kiersten M.; Espinoza, Alejandro; Garcia, Chloe Nicole G.; Kharwa, Ruchita N.; Hernandez, Andrea; Lee, Terrence M.; Lo Verde, Christine; Strul, Max W.; Wong, Emily Y.; Owens, Cedric P.] Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA; [Katz, Benjamin B.; Lee, Justin L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA	Chapman University System; Chapman University; University of California System; University of California Irvine	Owens, CP (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA.	cpowens@chapman.edu		Lee, Justin/0000-0001-8207-1272	USDA-NIFA [2015-67012-26563]; NSF-CLP grant [1905399]; Research Corporation for Science Advancement Cottrell Scholar Award; Chapman University Faculty Opportunity Fund grant; Chapman Center for Undergraduate Excellence grants; Schmid College's Capstone funds	USDA-NIFA(United States Department of Agriculture (USDA)); NSF-CLP grant; Research Corporation for Science Advancement Cottrell Scholar Award; Chapman University Faculty Opportunity Fund grant; Chapman Center for Undergraduate Excellence grants; Schmid College's Capstone funds	This work was supported by USDA-NIFA grant 2015-67012-26563, NSF-CLP grant 1905399, a Research Corporation for Science Advancement Cottrell Scholar Award, and a Chapman University Faculty Opportunity Fund grant to C. P. O, through Chapman Center for Undergraduate Excellence grants to K. O. B., K. M. C., C. N. G. G., T. M. L., and C. L. V., and Schmid College's Capstone funds.	Buscagan TM, 2021, ANGEW CHEM INT EDIT, V60, P5704, DOI 10.1002/anie.202015751; Christiansen J, 2000, J BIOL CHEM, V275, P36104, DOI 10.1074/jbc.M004889200; CONRAD R, 1982, GEOPHYS RES LETT, V9, P1353, DOI 10.1029/GL009i012p01353; Danyal K, 2011, METHODS MOL BIOL, V766, P191, DOI 10.1007/978-1-61779-194-9_13; DAVIS LC, 1979, BIOCHEMISTRY-US, V18, P4860, DOI 10.1021/bi00589a014; DAVIS LC, 1980, J BACTERIOL, V141, P1230, DOI 10.1128/JB.141.3.1230-1238.1980; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Fisher K, 2005, BBA-PROTEINS PROTEOM, V1750, P154, DOI 10.1016/j.bbapap.2005.04.010; Flores-Encarnacion M, 1999, J BACTERIOL, V181, P6987; Galisa PS, 2012, J MICROBIOL METH, V91, P1, DOI 10.1016/j.mimet.2012.07.005; Gee LB, 2015, BIOCHEMISTRY-US, V54, P3314, DOI 10.1021/acs.biochem.5b00216; George SJ, 1997, J AM CHEM SOC, V119, P6450, DOI 10.1021/ja971088s; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guo K, 2008, J EXP BOT, V59, P3443, DOI 10.1093/jxb/ern194; Hoffmann MC, 2014, J BACTERIOL, V196, P3494, DOI 10.1128/JB.01754-14; Howard JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072751; Hsu YY, 2013, J PLANT PHYSIOL, V170, P1075, DOI 10.1016/j.jplph.2013.03.004; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Jasniewski AJ, 2020, CHEM REV, V120, P5107, DOI 10.1021/acs.chemrev.9b00704; Katz FEH, 2017, ANAL BIOCHEM, V520, P62, DOI 10.1016/j.ab.2016.12.012; Katz FEH, 2016, ISR J CHEM, V56, P682, DOI 10.1002/ijch.201600020; Kerby RL, 2011, J BACTERIOL, V193, P774, DOI 10.1128/JB.00794-10; King GM, 2002, APPL ENVIRON MICROB, V68, P4480, DOI 10.1128/AEM.68.9.4480-4485.2002; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lee CC, 2018, CHEMBIOCHEM, V19, P649, DOI 10.1002/cbic.201800035; Lee CC, 2010, SCIENCE, V329, P642, DOI 10.1126/science.1191455; Lee CC, 2009, P NATL ACAD SCI USA, V106, P9209, DOI 10.1073/pnas.0904408106; Lee HI, 2005, J AM CHEM SOC, V127, P15880, DOI 10.1021/ja054078x; Lee HI, 1997, J AM CHEM SOC, V119, P10121, DOI 10.1021/ja9715096; LOWE DJ, 1990, BIOCHEM J, V272, P621, DOI 10.1042/bj2720621; Masepohl B, 2002, J MOL MICROB BIOTECH, V4, P243; Milligan P, 2000, FEMS MICROBIOL ECOL, V34, P157, DOI 10.1111/j.1574-6941.2000.tb00765.x; MORETT E, 1988, P NATL ACAD SCI USA, V85, P9401, DOI 10.1073/pnas.85.24.9401; Morrison CN, 2015, BIOCHEMISTRY-US, V54, P2052, DOI 10.1021/bi501313k; Owens CP, 2018, METHOD ENZYMOL, V599, P355, DOI 10.1016/bs.mie.2017.09.007; Owens CP, 2016, J AM CHEM SOC, V138, P10124, DOI 10.1021/jacs.6b06783; Owens CP, 2015, J AM CHEM SOC, V137, P12704, DOI 10.1021/jacs.5b08310; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Rebelein JG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13641; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Rich JJ, 1999, FEMS MICROBIOL ECOL, V28, P215; RIVERAORTIZ JM, 1975, J BACTERIOL, V123, P537, DOI 10.1128/JB.123.2.537-545.1975; Rutledge HL, 2020, CHEM REV, V120, P5158, DOI 10.1021/acs.chemrev.9b00663; Schlesier J, 2016, J AM CHEM SOC, V138, P239, DOI 10.1021/jacs.5b10341; Scott AD, 2014, J AM CHEM SOC, V136, P15942, DOI 10.1021/ja505720m; Seefeldt LC, 2013, BBA-BIOENERGETICS, V1827, P1102, DOI 10.1016/j.bbabio.2013.04.003; Segal HM, 2017, PROTEIN SCI, V26, P1984, DOI 10.1002/pro.3236; Sippel D, 2018, SCIENCE, V359, P1484, DOI 10.1126/science.aar2765; Sippel D, 2017, NAT CHEM BIOL, V13, P956, DOI [10.1038/nchembio.2428, 10.1038/NCHEMBIO.2428]; Souza ALF, 2010, J MICROBIOL, V48, P77, DOI 10.1007/s12275-009-0077-y; Spatzal T, 2014, SCIENCE, V345, P1620, DOI 10.1126/science.1256679; Sun P, 2011, METHODS MOL BIOL, V705, P259, DOI 10.1007/978-1-61737-967-3_16; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; Urbauer JL, 2015, PROTEINS, V83, P1137, DOI 10.1002/prot.24811; Ureta A, 2002, J BACTERIOL, V184, P5805, DOI 10.1128/JB.184.20.5805-5809.2002; Walsh I, 2012, BIOINFORMATICS, V28, P2189, DOI 10.1093/bioinformatics/bts343; Wareham LK, 2016, ANTIOXID REDOX SIGN, V24, P1013, DOI 10.1089/ars.2015.6501; Xuan W, 2008, PLANT SIGNAL BEHAV, V3, P381, DOI 10.4161/psb.3.6.5374; Yan LF, 2011, EUR J INORG CHEM, P2064, DOI 10.1002/ejic.201100029; Yang ZY, 2011, J BIOL CHEM, V286, P19417, DOI 10.1074/jbc.M111.229344; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	61	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100501	10.1016/j.jbc.2021.100501	http://dx.doi.org/10.1016/j.jbc.2021.100501			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667548	Green Published, gold			2022-12-28	WOS:000672866400475
J	Patt, J; Alenfelder, J; Pfeil, EM; Voss, JH; Merten, N; Eryilmaz, F; Heycke, N; Rick, U; Inoue, A; Kehraus, S; Deupi, X; Muller, CE; Konig, GM; Crusemann, M; Kostenis, E				Patt, Julian; Alenfelder, Judith; Pfeil, Eva Marie; Voss, Jan Hendrik; Merten, Nicole; Eryilmaz, Funda; Heycke, Nina; Rick, Uli; Inoue, Asuka; Kehraus, Stefan; Deupi, Xavier; Mueller, Christa E.; Koenig, Gabriele M.; Cruesemann, Max; Kostenis, Evi			An experimental strategy to probe Gq contribution to signal transduction in living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; G-BETA-GAMMA; HETEROTRIMERIC G-PROTEINS; PHOSPHOLIPASE-C-BETA; ADENYLYL CYCLASES; G-ALPHA(Q) INHIBITOR; EGF RECEPTOR; G-ALPHA; ACTIVATION; CALCIUM	Heterotrimeric G protein subunits G alpha q and G alpha 11 are inhibited by two cyclic depsipeptides, FR900359 (FR) and YM-254890 (YM), both of which are being used widely to implicate Gq/11 proteins in the regulation of diverse biological processes. An emerging major research question therefore is whether the cellular effects of both inhibitors are on-target, that is, mediated via specific inhibition of Gq/11 proteins, or off-target, that is, the result of nonspecific interactions with other proteins. Here we introduce a versatile experimental strategy to discriminate between these possibilities. We developed a G alpha q variant with preserved catalytic activity, but refractory to FR/YM inhibition. A minimum of two amino acid changes were required and sufficient to achieve complete inhibitor resistance. We characterized the novel mutant in HEK293 cells depleted by CRISPR-Cas9 of endogenous G alpha q and G alpha 11 to ensure precise control over the G alpha-dependent cellular signaling route. Using a battery of cellular outcomes with known and concealed Gq contribution, we found that FR/YM specifically inhibited cellular signals after G alpha q introduction via transient transfection. Conversely, both inhibitors were inert across all assays in cells expressing the drug-resistant variant. These findings eliminate the possibility that inhibition of non-Gq proteins contributes to the cellular effects of the two depsipeptides. We conclude that combined application of FR or YM along with the drug-resistant G alpha q variant is a powerful in vitro strategy to discern on-target Gq against off-target non-Gq action. Consequently, it should be of high value for uncovering Gq input to complex biological processes with high accuracy and the requisite specificity.	[Patt, Julian; Alenfelder, Judith; Pfeil, Eva Marie; Merten, Nicole; Eryilmaz, Funda; Heycke, Nina; Rick, Uli; Kostenis, Evi] Univ Bonn, Mol Cellular & Pharmacobiol Sect, Inst Pharmaceut Biol, Bonn, Germany; [Voss, Jan Hendrik; Mueller, Christa E.] Univ Bonn, PharmaCtr Bonn, Pharmaceut Inst, Pharmaceut & Med Chem, Bonn, Germany; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Kehraus, Stefan; Koenig, Gabriele M.; Cruesemann, Max] Univ Bonn, Inst Pharmaceut Biol, Bonn, Germany; [Deupi, Xavier] Paul Scherrer Inst, Lab Biomol Res & Condensed Matter Theory Grp, Villigen, Switzerland	University of Bonn; University of Bonn; Tohoku University; University of Bonn; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Kostenis, E (corresponding author), Univ Bonn, Mol Cellular & Pharmacobiol Sect, Inst Pharmaceut Biol, Bonn, Germany.	kostenis@uni-bonn.de	Deupi, Xavier/B-2424-2009	Deupi, Xavier/0000-0003-4572-9316; Pfeil, Eva Marie/0000-0001-7909-0042; Crusemann, Max/0000-0001-6660-2715; Patt, Julian/0000-0001-5736-0283	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) [KO 1582/10-1, KO 1582/10-2, KO 902/17-1, KO 902/17-2, CR 464/7-1]; Japan Agency for Medical Research and Development; Japan Society for the Promotion of Science (JSPS) [20H03206];  [PRIME JP17gm5910013];  [LEAP JP17gm0010004]	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	This work was funded by the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) with the Grants KO 1582/10-1 and KO 1582/10-2 (to E. K.), KO 902/17-1 and KO 902/17-2 (to G. M. K.), and CR 464/7-1 (to M. C.) and the Japan Agency for Medical Research and Development with partial support by PRIME JP17gm5910013 and LEAP JP17gm0010004, and by the Japan Society for the Promotion of Science (JSPS) with the KAKENHI Grant No.20H03206 (to A. I.).	Ando K, 2010, J PHARMACOL EXP THER, V334, P809, DOI 10.1124/jpet.110.167528; Annala S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau5948; Ayoub MA, 2018, EUR J PHARMACOL, V826, P169, DOI 10.1016/j.ejphar.2018.03.003; Ayoub MA, 2009, J BIOL CHEM, V284, P29136, DOI 10.1074/jbc.M109.042333; Badolia R, 2017, J BIOL CHEM, V292, P14516, DOI 10.1074/jbc.M117.791012; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bird SD, 2018, CELL CALCIUM, V72, P116, DOI 10.1016/j.ceca.2018.02.002; Bockaert J, 1998, CR ACAD SCI III-VIE, V321, P529, DOI 10.1016/S0764-4469(98)80455-1; Boesgaard MW, 2020, J BIOL CHEM, V295, P13850, DOI 10.1074/jbc.RA120.013002; Bolognini D, 2016, J BIOL CHEM, V291, P18915, DOI 10.1074/jbc.M116.736157; BOYER JL, 1992, J BIOL CHEM, V267, P25451; Campbell AP, 2018, NAT REV DRUG DISCOV, V17, P789, DOI 10.1038/nrd.2018.135; Carr R, 2016, MOL PHARMACOL, V89, P94, DOI 10.1124/mol.115.100339; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; Chambers C, 2003, COMB CHEM HIGH T SCR, V6, P355; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Charpentier TH, 2014, J BIOL CHEM, V289, P29545, DOI 10.1074/jbc.M114.586784; Cheng YG, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061437; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Coombs C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13107-3; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Crisman TJ, 2007, J CHEM INF MODEL, V47, P1319, DOI 10.1021/ci6005504; Croce M, 2019, CANCERS, V11, DOI 10.3390/cancers11060846; Crusemann M, 2018, ANGEW CHEM INT EDIT, V57, P836, DOI 10.1002/anie.201707996; Cervantes-Villagrana RD, 2019, J BIOL CHEM, V294, P531, DOI 10.1074/jbc.RA118.006254; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; Dohlman HG, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003013; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Ebner JK, 2019, BONE, V127, P592, DOI 10.1016/j.bone.2019.07.031; Fang Y, 2005, FEBS LETT, V579, P4175, DOI 10.1016/j.febslet.2005.06.050; Fisher IJ, 2020, MOL CELL, V80, P933, DOI 10.1016/j.molcel.2020.11.038; FUJIOKA M, 1988, J ORG CHEM, V53, P2820, DOI 10.1021/jo00247a030; Gaffal E, 2020, J DTSCH DERMATOL GES, V18, P1245, DOI 10.1111/ddg.14288; Gao ZG, 2018, BIOCHEM PHARMACOL, V151, P201, DOI 10.1016/j.bcp.2017.12.003; Gao ZG, 2016, BIOCHEM PHARMACOL, V107, P59, DOI 10.1016/j.bcp.2016.03.003; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Grundmann M, 2015, METHODS MOL BIOL, V1272, P199, DOI 10.1007/978-1-4939-2336-6_14; Guillou JL, 1999, J BIOL CHEM, V274, P35539, DOI 10.1074/jbc.274.50.35539; Gupte TM, 2017, P NATL ACAD SCI USA, V114, P3756, DOI 10.1073/pnas.1617232114; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Halls ML, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004143; Hennen S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004350; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Inamdar V, 2015, PLATELETS, V26, P771, DOI 10.3109/09537104.2014.998993; Iyengar R, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00112; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Karpinsky-Semper D, 2014, MOL PHARMACOL, V85, P758, DOI 10.1124/mol.114.091843; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Kawasaki T, 2003, THROMB HAEMOSTASIS, V90, P406, DOI 10.1160/TH03-02-0115; Kawasaki Tomihisa, 2006, Folia Pharmacologica Japonica, V128, P23, DOI 10.1254/fpj.128.23; Kienitz MC, 2019, J MOL CELL CARDIOL, V130, P107, DOI 10.1016/j.yjmcc.2019.03.022; Kim SH, 2016, MOL CELL ENDOCRINOL, V420, P11, DOI 10.1016/j.mce.2015.11.012; Klein RR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191783; Kostenis E, 2020, J BIOL CHEM, V295, P5206, DOI 10.1074/jbc.REV119.007061; Krebs KM, 2018, ACS OMEGA, V3, P14814, DOI 10.1021/acsomega.8b02254; Kuschak M, 2020, BRIT J PHARMACOL, V177, P1898, DOI 10.1111/bph.14960; Lapadula D, 2019, MOL CANCER RES, V17, P963, DOI 10.1158/1541-7786.MCR-18-0574; LEE SB, 1993, J BIOL CHEM, V268, P25952; Li YY, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835920965852; Lian XM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01234; Liao Y, 2016, J BIOL CHEM, V291, P7505, DOI 10.1074/jbc.M115.704122; Lorenzen E, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6152; Lowes VL, 2002, NEUROSIGNALS, V11, P5, DOI 10.1159/000057317; Lyon AM, 2014, STRUCTURE, V22, P1844, DOI 10.1016/j.str.2014.10.008; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; MacMillan D, 2010, BRIT J PHARMACOL, V160, P1295, DOI 10.1111/j.1476-5381.2010.00771.x; Malfacini D, 2019, J BIOL CHEM, V294, P5747, DOI 10.1074/jbc.RA118.007250; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Matthey M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2288; Meleka M., 2018, FASEB J, V31; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Mons N, 1998, LIFE SCI, V62, P1647, DOI 10.1016/S0024-3205(98)00122-2; Moujaber O, 2020, TRENDS BIOCHEM SCI, V45, P96, DOI 10.1016/j.tibs.2019.11.003; Murga C, 1999, TRENDS ENDOCRIN MET, V10, P122, DOI 10.1016/S1043-2760(98)00131-3; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Natarajan Kanchana, 2006, V332, P51; Nesterov A, 2010, J BIOMOL SCREEN, V15, P518, DOI 10.1177/1087057110369702; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Olianas MC, 2016, BRIT J PHARMACOL, V173, P2910, DOI 10.1111/bph.13570; Oligny-Longpre G, 2012, P NATL ACAD SCI USA, V109, pE1028, DOI 10.1073/pnas.1112422109; Onken MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6852; Patel TB, 2004, PHARMACOL REV, V56, P371, DOI 10.1124/pr.56.3.4; Peng QM, 2021, EUR J PHARMACOL, V891, DOI 10.1016/j.ejphar.2020.173706; Pfeil EM, 2020, MOL CELL, V80, P940, DOI 10.1016/j.molcel.2020.10.027; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rebres RA, 2011, J BIOL CHEM, V286, P942, DOI 10.1074/jbc.M110.198200; Roszko KL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91079; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmitz AL, 2014, CHEM BIOL, V21, P890, DOI 10.1016/j.chembiol.2014.06.003; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Schroder R, 2009, J BIOL CHEM, V284, P1324, DOI 10.1074/jbc.M806867200; Shah BH, 2004, TRENDS NEUROSCI, V27, P48, DOI 10.1016/j.tins.2003.11.003; Shukla A. K., 2016, G PROTEIN COUPLED RE; Smrcka AV, 2013, TRENDS PHARMACOL SCI, V34, P290, DOI 10.1016/j.tips.2013.02.006; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Sokalingam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040410; Steiner D, 2006, CELL SIGNAL, V18, P62, DOI 10.1016/j.cellsig.2005.03.014; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Taniguchi M, 2003, J ANTIBIOT, V56, P358, DOI 10.7164/antibiotics.56.358; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; Trinquet E, 2011, EXPERT OPIN DRUG DIS, V6, P981, DOI 10.1517/17460441.2011.608658; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Uemura T, 2006, EUR J PHARMACOL, V536, P154, DOI 10.1016/j.ejphar.2006.02.048; Uemura T, 2006, BRIT J PHARMACOL, V148, P61, DOI 10.1038/sj.bjp.0706711; Vazquez-Victorio G, 2016, METHOD CELL BIOL, V132, P165, DOI 10.1016/bs.mcb.2015.10.003; Wauson EM, 2015, MOL ENDOCRINOL, V29, P1114, DOI 10.1210/ME.2014-1181; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wettschureck N, 2004, PHARMACOL THERAPEUT, V101, P75, DOI 10.1016/j.pharmthera.2003.10.005; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Wong MPM, 2000, BRIT J PHARMACOL, V130, P1021, DOI 10.1038/sj.bjp.0703411; Wu V, 2019, J BIOL CHEM, V294, P11062, DOI 10.1074/jbc.REV119.005601; YAMANE HK, 1993, ANNU REV PHARMACOL, V33, P201, DOI 10.1146/annurev.pharmtox.33.1.201; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Zhang YX, 2003, J BIOMOL SCREEN, V8, P571, DOI 10.1177/1087057103257240	135	7	7	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100472	10.1016/j.jbc.2021.100472	http://dx.doi.org/10.1016/j.jbc.2021.100472			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639168	Green Published, gold			2022-12-28	WOS:000672866400446
J	Perry, M; Biegert, M; Kollala, SS; Mallard, H; Su, G; Kodavati, M; Kreiling, N; Holbrook, A; Ghosal, G				Perry, Megan; Biegert, Meghan; Kollala, Sai Sundeep; Mallard, Halle; Su, Grace; Kodavati, Manohar; Kreiling, Natasha; Holbrook, Alexander; Ghosal, Gargi			USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HOMOLOGOUS RECOMBINATION; DVC1 C1ORF124; REGULATOR; SPARTAN/C1ORF124; UBIQUITYLATION; DEFICIENCY; MECHANISM; ENZYME	DNA-protein cross-links (DPCs) are toxic DNA lesions that interfere with DNA metabolic processes such as replication, transcription, and recombination. USP11 deubiquitinase participates in DNA repair, but the role of USP11 in DPC repair is not known. SPRTN is a replication-coupled DNA-dependent metalloprotease that cleaves proteins cross-linked to DNA to promote DPC repair. SPRTN function is tightly regulated by a monoubiquitin switch that controls SPRTN auto-proteolysis and chromatin accessibility during DPC repair. Previously, VCPIP1 and USP7 deubiquitinases have been shown to regulate SPRTN. Here, we identify USP11 as an SPRTN deubiquitinase. USP11 interacts with SPRTN and cleaves monoubiquitinated SPRTN in cells and in vitro. USP11 depletion impairs SPRTN deubiquitination and promotes SPRTN auto-proteolysis in response to formaldehyde-induced DPCs. Loss of USP11 causes an accumulation of unrepaired DPCs and cellular hypersensitivity to treatment with DPC-inducing agents. Our findings show that USP11 regulates SPRTN auto-proteolysis and SPRTN-mediated DPC repair to maintain genome stability.	[Perry, Megan; Biegert, Meghan; Kollala, Sai Sundeep; Mallard, Halle; Kreiling, Natasha; Holbrook, Alexander; Ghosal, Gargi] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Su, Grace] Doane Univ, Dept Biol, Crete, NE USA; [Kodavati, Manohar] Houston Methodist Res Inst, Dept Radiat Oncol, Houston, TX USA; [Ghosal, Gargi] Fred & Pamela Buffett Canc Ctr, Omaha, NE 68105 USA	University of Nebraska System; University of Nebraska Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston	Ghosal, G (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.; Ghosal, G (corresponding author), Fred & Pamela Buffett Canc Ctr, Omaha, NE 68105 USA.	gargi.ghosal@unmc.edu	kodavati, manohar/V-5200-2019	kodavati, manohar/0000-0003-3939-7351; Ghosal, Gargi/0000-0001-8399-5354	National Institutes of Health grants, USA: NIGMS COBRE [P20GM121316]; NCI K22 Career Development Award [K22CA188181]	National Institutes of Health grants, USA: NIGMS COBRE; NCI K22 Career Development Award	This work was supported by National Institutes of Health grants, USA: NIGMS COBRE (P20GM121316; G. G. as project leader) and NCI K22 Career Development Award (K22CA188181) to G. G.	Alvarez-Quilon A, 2020, MOL CELL, V78, P1152, DOI 10.1016/j.molcel.2020.05.021; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007; Deng TG, 2018, P NATL ACAD SCI USA, V115, P4678, DOI 10.1073/pnas.1714938115; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fielden J, 2018, DNA REPAIR, V71, P198, DOI 10.1016/j.dnarep.2018.08.025; Georges A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34197-x; Ghosal G, 2012, J BIOL CHEM, V287, P34225, DOI 10.1074/jbc.M112.400135; Halder S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11095-y; He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu QH, 2020, CELL REP, V30, P1235, DOI 10.1016/j.celrep.2019.12.067; Huang JZ, 2020, MOL CELL, V79, P824, DOI 10.1016/j.molcel.2020.06.027; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Ide H, 2018, DNA REPAIR, V71, P190, DOI 10.1016/j.dnarep.2018.08.024; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Jacko AM, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.371; Juhasz S, 2012, NUCLEIC ACIDS RES, V40, P10795, DOI 10.1093/nar/gks850; Kiianitsa K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt171; Kim MS, 2013, NUCLEIC ACIDS RES, V41, P1661, DOI 10.1093/nar/gks1267; Larsen NB, 2019, MOL CELL, V73, P574, DOI 10.1016/j.molcel.2018.11.024; Lessel D, 2014, NAT GENET, V46, P1239, DOI 10.1038/ng.3103; Li FX, 2019, CELL REP, V26, P3336, DOI 10.1016/j.celrep.2019.02.082; Li FY, 2019, NAT STRUCT MOL BIOL, V26, P155, DOI 10.1038/s41594-019-0186-1; Lin CH, 2008, J BIOL CHEM, V283, P15681, DOI 10.1074/jbc.M708278200; Lopez-Mosqueda J, 2016, ELIFE, V5, DOI 10.7554/eLife.21491; Luo QY, 2020, CELL REP, V30, P98, DOI 10.1016/j.celrep.2019.12.017; Machida Y, 2012, CELL CYCLE, V11, P3395, DOI 10.4161/cc.21694; Maertens GN, 2010, EMBO J, V29, P2553, DOI 10.1038/emboj.2010.129; Maskey RS, 2017, NUCLEIC ACIDS RES, V45, P4564, DOI 10.1093/nar/gkx107; Maskey RS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6744; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Serbyn N, 2020, MOL CELL, V77, P1066, DOI 10.1016/j.molcel.2019.12.007; Shah P, 2017, ONCOTARGET, V8, P96522, DOI 10.18632/oncotarget.22105; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stingele J, 2017, NAT REV MOL CELL BIO, V18, P563, DOI 10.1038/nrm.2017.56; Stingele J, 2016, MOL CELL, V64, P688, DOI 10.1016/j.molcel.2016.09.031; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; Stockum A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190513; Sun WJ, 2010, CELL SIGNAL, V22, P386, DOI 10.1016/j.cellsig.2009.10.008; Ting X, 2019, NUCLEIC ACIDS RES, V47, P9721, DOI 10.1093/nar/gkz726; Tretyakova NY, 2015, ACCOUNTS CHEM RES, V48, P1631, DOI 10.1021/acs.accounts.5b00056; Vaz B, 2016, MOL CELL, V64, P704, DOI 10.1016/j.molcel.2016.09.032; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Yu M, 2016, J BIOL CHEM, V291, P959, DOI 10.1074/jbc.M114.624478; Zhao SB, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1224	58	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100396	10.1016/j.jbc.2021.100396	http://dx.doi.org/10.1016/j.jbc.2021.100396			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33567341	gold, Green Published			2022-12-28	WOS:000672866400370
J	Ramirez, J; Morales, M; Osinalde, N; Martinez-Padron, I; Mayor, U; Ferrus, A				Ramirez, Juanma; Morales, Miguel; Osinalde, Nerea; Martinez-Padron, Imanol; Mayor, Ugo; Ferrus, Alberto			The ubiquitin ligase Ariadne-1 regulates neurotransmitter release via ubiquitination of NSF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; PROTEIN; GENE; TRAFFICKING; MUTATIONS; RECEPTOR; PARKIN; LRRK2; BRAIN; QUANTIFICATION	Ariadne-1 (Ari-1) is an E3 ubiquitin-ligase essential for neuronal development, but whose neuronal substrates are yet to be identified. To search for putative Ari-1 substrates, we used an in vivo ubiquitin biotinylation strategy coupled to quantitative proteomics of Drosophila heads. We identified 16 candidates that met the established criteria: a significant change of at least twofold increase on ubiquitination, with at least two unique peptides identified. Among those candidates, we identified Comatose (Comt), the homologue of the N-ethylmaleimide sensitive factor (NSF), which is involved in neurotransmitter release. Using a pull-down approach that relies on the over-expression and stringent isolation of a GFP-fused construct, we validate Comt/NSF to be an ubiquitination substrate of Ari-1 in fly neurons, resulting in the preferential monoubiquitination of Comt/NSF. We tested the possible functional relevance of this modification using Ari-1 loss-of-function mutants, which displayed a lower rate of spontaneous neurotransmitter release due to failures at the presynaptic side. By contrast, evoked release in Ari-1 mutants was enhanced compared with controls in a Ca2+-dependent manner without modifications in the number of active zones, indicating that the probability of release per synapse is increased in these mutants. This phenotype distinction between spontaneous and evoked release suggests that NSF activity may discriminate between these two types of vesicle fusion. Our results thus provide a mechanism to regulate NSF activity in the synapse through Ari-1-dependent ubiquitination.	[Ramirez, Juanma; Mayor, Ugo] Univ Basque Country, Dept Biochem & Mol Biol, Fac Sci & Technol, Leioa, Bizkaia, Spain; [Morales, Miguel; Martinez-Padron, Imanol; Ferrus, Alberto] CSIC, Cajal Inst, Madrid, Spain; [Osinalde, Nerea] Univ Basque Country, Dept Biochem & Mol Biol, Fac Pharm, Vitoria, Araba, Spain; [Mayor, Ugo] Basque Fdn Sci, Ikerbasque, Bilbao, Bizkaia, Spain	University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); University of Basque Country; Basque Foundation for Science	Mayor, U (corresponding author), Univ Basque Country, Dept Biochem & Mol Biol, Fac Sci & Technol, Leioa, Bizkaia, Spain.; Ferrus, A (corresponding author), CSIC, Cajal Inst, Madrid, Spain.; Mayor, U (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Bizkaia, Spain.	ugo.mayor@ehu.eus; aferrus@cajal.csic.es	Ramírez, Juanma/AAZ-8953-2021	Osinalde, Nerea/0000-0001-8850-7794; Ramirez, Juanma/0000-0002-8500-7521; Ferrus, Alberto/0000-0002-0346-0489	Spanish Ministry of Economy [BFU2015-65685, PGC2018-094630-B-100, SAF2016-76898-P]; FEDER funds; University of the Basque Country (UPV/EHU)	Spanish Ministry of Economy(Spanish Government); FEDER funds(European Commission); University of the Basque Country (UPV/EHU)	This research was funded by grants BFU2015-65685 and PGC2018-094630-B-100 from the Spanish Ministry of Economy to A. F. and grant SAF2016-76898-P from the Spanish Ministry of Economy cofinanced with FEDER funds to U. M. J. R. was supported with a postdoctoral research fellowship from the University of the Basque Country (UPV/EHU).	Aguilera M, 2000, GENETICS, V155, P1231; Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Babcock DT, 2015, GENETICS, V199, P511, DOI 10.1534/genetics.114.172403; Bar S, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036954; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Belluzzi E, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-015-0066-z; Berger Z, 2010, BIOCHEMISTRY-US, V49, P5511, DOI 10.1021/bi100157u; Blard O, 2007, HUM MOL GENET, V16, P555, DOI 10.1093/hmg/ddm011; Bridi JC, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00080; Brunger AT, 2019, CURR OPIN STRUC BIOL, V54, P179, DOI 10.1016/j.sbi.2019.03.007; BUCHNER E, 1988, CELL TISSUE RES, V253, P357, DOI 10.1007/BF00222292; Burre J, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024091; CHANDLER CS, 1985, BIOCHEM J, V232, P385, DOI 10.1042/bj2320385; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curry RJ, 2018, J NEUROSCI, V38, P8187, DOI 10.1523/JNEUROSCI.0603-18.2018; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Elu N, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00534; Franco M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002188; Garcia-Barcena C, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00039; Goda Y, 1998, P NATL ACAD SCI USA, V95, P1283, DOI 10.1073/pnas.95.3.1283; Gradilla AC, 2011, GENETICS, V189, P871, DOI 10.1534/genetics.111.132191; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hallengren J, 2013, CELL BIOCHEM BIOPHYS, V67, P67, DOI 10.1007/s12013-013-9634-4; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Kawasaki F, 1998, J NEUROSCI, V18, P10241; Lee SY, 2014, CELL MOL LIFE SCI, V71, P2747, DOI 10.1007/s00018-013-1526-7; Li XQ, 2012, DEV COMP IMMUNOL, V36, P648, DOI 10.1016/j.dci.2011.11.005; Littleton JT, 2000, J CELL BIOL, V150, pF77, DOI 10.1083/jcb.150.2.F77; Littleton JT, 2001, P NATL ACAD SCI USA, V98, P12233, DOI 10.1073/pnas.221450198; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Liu Y, 2019, J NEUROSCI, V39, P6049, DOI 10.1523/JNEUROSCI.0403-19.2019; MALLART A, 1993, J PHYSIOLOGY-PARIS, V87, P83, DOI 10.1016/0928-4257(93)90002-B; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Martinez A, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0170-3; MartinezPadron M, 1997, J NEUROSCI, V17, P3412; Melom JE, 2013, J NEUROSCI, V33, P17253, DOI 10.1523/JNEUROSCI.3334-13.2013; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Oja SS, 2000, NEUROCHEM INT, V37, P299, DOI 10.1016/S0197-0186(00)00031-0; ORDWAY RW, 1994, P NATL ACAD SCI USA, V91, P5715, DOI 10.1073/pnas.91.12.5715; Osinalde N, 2015, DATA BRIEF, V5, P53, DOI 10.1016/j.dib.2015.08.007; Parelkar SS, 2012, J MOL NEUROSCI, V46, P109, DOI 10.1007/s12031-011-9535-1; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Ramirez J, 2018, HUM MOL GENET, V27, P1955, DOI 10.1093/hmg/ddy103; Ramirez J, 2017, NEUROMETHODS, V127, P179, DOI 10.1007/978-1-4939-7119-0_11; Ramirez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139083; Rinetti GV, 2010, J NEUROSCI, V30, P3157, DOI 10.1523/JNEUROSCI.3712-09.2010; Rudenko I, 2014, NEUROTHERAPEUTICS, V11, P738, DOI 10.1007/s13311-014-0284-z; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Selvaraj S, 2019, GENES DIS, V6, P120, DOI 10.1016/j.gendis.2019.01.004; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tan KL, 2018, DEV CELL, V45, P226, DOI 10.1016/j.devcel.2018.03.020; Tan NGS, 2003, FEBS LETT, V554, P501, DOI 10.1016/S0014-5793(03)01235-3; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wang C, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120258; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yu WH, 2011, MOL CELL NEUROSCI, V47, P19, DOI 10.1016/j.mcn.2011.02.002; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	75	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100408	10.1016/j.jbc.2021.100408	http://dx.doi.org/10.1016/j.jbc.2021.100408			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581113	Green Published, gold			2022-12-28	WOS:000672866400382
J	Ren, SQ; Breuillaud, L; Yao, W; Yin, T; Norris, KA; Zehntner, SP; D'Adamio, L				Ren, Siqiang; Breuillaud, Lionel; Yao, Wen; Yin, Tao; Norris, Kelly A.; Zehntner, Simone P.; D'Adamio, Luciano			TNF-alpha-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2(R47H) rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; NECROSIS-FACTOR-ALPHA; MOUSE MODEL; SYNAPTIC PLASTICITY; INTERFERON-GAMMA; MEMORY DEFICITS; MYELOID CELLS-2; BETA; RECEPTOR; EXPRESSION	Alzheimer's disease (AD) is a neurodegenerative dementia associated with deposition of amyloid plaques and neurofibrillary tangles, formed by amyloid beta (A beta) peptides and phosphor-tau, respectively, in the central nervous system. Approximately 2% of AD cases are due to familial AD (FAD); similar to 98% of cases are sporadic AD (SAD). Animal models with FAD are commonly used to study SAD pathogenesis. Because mechanisms leading to FAD and SAD may be distinct, to study SAD pathogenesis, we generated Trem2(R47H) knock-in rats, which carry the SAD risk factor p.R47H variant of the microglia gene triggering receptor expressed on myeloid cells 2 (TREM2). Trem2(R47H) rats produce human-A beta from a humanized-App rat allele because human-A beta is more toxic than rodent-A beta and the pathogenic role of the p.R47H TREM2 variant has been linked to human-A beta-clearing deficits. Using periadolescent Trem2(R47H) rats, we previously demonstrated that supraphysiological tumor necrosis factor-alpha (TNF-alpha) boosts glutamatergic transmission, which is excitatory, and suppresses long-term potentiation, a surrogate of learning and memory. Here, we tested the effect of the p.R47H variant on the inhibitory neurotransmitter gamma-aminobutyric acid. We report that GABAergic transmission is decreased in Trem2(R47H/R47H) rats. This decrease is due to acute and reversible action of TNF-alpha and is not associated with increased human-A beta levels and AD pathology. Thus, the p.R47H variant changes the excitatory/inhibitory balance, favoring excitation. This imbalance could potentiate glutamate excitotoxicity and contribute to neuronal dysfunction, enhanced neuronal death, and neurodegeneration. Future studies will determine whether this imbalance represents an early, A beta-independent pathway leading to dementia and may reveal the AD-modifying therapeutic potential of TNF-alpha inhibition in the central nervous system.	[Ren, Siqiang; Yao, Wen; Yin, Tao; Norris, Kelly A.; D'Adamio, Luciano] Rutgers State Univ, Jacqueline Krieger Klein Ctr Alzheimers Dis & Neu, Physiol & Neurosci New Jersey Med Sch, Brain Hlth Inst,Dept Pharmacol, Newark, NJ 07102 USA; [Breuillaud, Lionel; Zehntner, Simone P.] Biospect Inc, Montreal, PQ, Canada	Rutgers State University Newark; Rutgers State University New Brunswick	D'Adamio, L (corresponding author), Rutgers State Univ, Jacqueline Krieger Klein Ctr Alzheimers Dis & Neu, Physiol & Neurosci New Jersey Med Sch, Brain Hlth Inst,Dept Pharmacol, Newark, NJ 07102 USA.	luciano.dadamio@rutgers.edu			NIH/NIA [R01AG052286, RF1AG064821-01, 1R01AG033007-01A109]	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	L.D. was funded by the NIH/NIA R01AG052286, RF1AG064821-01, and 1R01AG033007-01A109. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Cheng X, 2014, DRUG DISCOV TODAY, V19, P1822, DOI 10.1016/j.drudis.2014.06.029; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Del Prete D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108576; Eyre MD, 2012, J NEUROSCI, V32, P5853, DOI 10.1523/JNEUROSCI.6495-11.2012; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim DH, 2016, BEHAV BRAIN RES, V311, P384, DOI 10.1016/j.bbr.2016.06.001; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lundgren JL, 2015, J NEUROCHEM, V135, P606, DOI 10.1111/jnc.13287; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2011, NEUROBIOL AGING, V32, P1400, DOI 10.1016/j.neurobiolaging.2009.08.005; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; Medeiros R, 2007, J NEUROSCI, V27, P5394, DOI 10.1523/JNEUROSCI.5047-06.2007; Montgomery SL, 2011, AM J PATHOL, V179, P2053, DOI 10.1016/j.ajpath.2011.07.001; Norstrom EM, 2010, J NEUROSCI, V30, P15677, DOI 10.1523/JNEUROSCI.4464-10.2010; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; Perry RT, 2001, NEUROBIOL AGING, V22, P873, DOI 10.1016/S0197-4580(01)00291-3; Perry RT, 2001, AM J MED GENET, V105, P332, DOI 10.1002/ajmg.1371; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Ren SQ, 2020, ELIFE, V9, DOI 10.7554/eLife.57513; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shi JQ, 2011, J AM GERIATR SOC, V59, P1142, DOI 10.1111/j.1532-5415.2011.03445.x; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Sly LM, 2001, BRAIN RES BULL, V56, P581, DOI 10.1016/S0361-9230(01)00730-4; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2010, J NEUROSCI, V30, P14915, DOI 10.1523/JNEUROSCI.3917-10.2010; Tambini MD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60800-1; Tambini MD, 2019, AGING CELL, V18, DOI 10.1111/acel.13033; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; Tarkowski E, 2003, DEMENT GERIATR COGN, V15, P207, DOI 10.1159/000068780; Tobinick Edward, 2006, MedGenMed, V8, P25; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Wu B, 2013, P NATL ACAD SCI USA, V110, P15091, DOI 10.1073/pnas.1304171110; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xia D, 2015, NEURON, V85, P967, DOI 10.1016/j.neuron.2015.02.010; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yao W, 2019, J NEUROSCI, V39, P6992, DOI 10.1523/JNEUROSCI.0207-19.2019; Yao W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41340-9; Zehntner SP, 2008, J HISTOCHEM CYTOCHEM, V56, P873, DOI 10.1369/jhc.2008.950345; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zhou SL, 2019, J ALZHEIMERS DIS, V68, P1171, DOI 10.3233/JAD-181038; Zhou YY, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00202	59	11	11	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100089	10.1074/jbc.RA120.016395	http://dx.doi.org/10.1074/jbc.RA120.016395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33434745	gold, Green Published			2022-12-28	WOS:000672866400070
J	Szabo, A; Toldi, V; Gazda, LD; Demcsak, A; Tozser, J; Sahin-Toth, M				Szabo, Andras; Toldi, Vanda; Gazda, Livia Diana; Demcsak, Alexandra; Tozser, Jozsef; Sahin-Toth, Miklos			Defective binding of SPINK1 variants is an uncommon mechanism for impaired trypsin inhibition in chronic pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE INHIBITOR; HUMAN CATIONIC TRYPSINOGEN; HUMAN ANIONIC TRYPSINOGEN; FUNCTIONAL-ANALYSIS; MISSENSE MUTATIONS; INTRONIC VARIANTS; HUMAN MESOTRYPSIN; ACINAR-CELLS; KAZAL TYPE-1; GENE	The serine protease inhibitor Kazal type 1 (SPINK1) protects the pancreas from intrapancreatic trypsin activation that can lead to pancreatitis. Loss-of-function genetic variants of SPINK1 increase the risk for chronic pancreatitis, often by diminishing inhibitor expression or secretion. Variants that are secreted normally have been presumed to be pathogenic because of defective trypsin inhibition, but evidence has been lacking. Here, we report quantitative studies on the inhibition of human trypsins by wildtype SPINK1 and seven secreted missense variants. We found that tyrosine sulfation of human trypsins weakens binding of SPINK1 because of altered interactions with Tyr43 in the SPINK1 reactive loop. Using authentic sulfated human trypsins, we provide conclusive evidence that SPINK1 variants N34S, N37S, R65Q, and Q68R have unimpaired inhibitory activity, whereas variant P55S exhibits a small and clinically insignificant binding defect. In contrast, rare variants K41N and I42M that affect the reactive-site peptide bond of SPINK1 decrease inhibitor binding by 20,000- to 30,000-fold and three- to sevenfold, respectively. Taken together, the observations indicate that defective trypsin inhibition by SPINK1 variants is an uncommon mechanism in chronic pancreatitis. The results also strengthen the notion that a decline in inhibitor levels explains pancreatitis risk associated with the large majority of SPINK1 variants.	[Szabo, Andras; Toldi, Vanda; Gazda, Livia Diana; Tozser, Jozsef] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Debrecen, Hungary; [Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Ctr Exocrine Disorders, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA; [Toldi, Vanda; Gazda, Livia Diana] Univ Debrecen, Doctoral Sch Mol Cell & Immune Biol, Debrecen, Hungary; [Demcsak, Alexandra; Sahin-Toth, Miklos] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA	University of Debrecen; Boston University; University of Debrecen; University of California System; University of California Los Angeles	Szabo, A (corresponding author), Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Debrecen, Hungary.; Szabo, A; Sahin-Toth, M (corresponding author), Boston Univ, Ctr Exocrine Disorders, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA.; Sahin-Toth, M (corresponding author), Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA.	andrasszabo@med.unideb.hu; msahintoth@mednet.ucla.edu		Demcsak, Alexandra/0000-0002-5391-6931; Szabo, Andras/0000-0001-8687-470X; Sahin-Toth, Miklos/0000-0003-4513-9922; Toldi, Vanda/0000-0002-0446-027X	National Institutes of Health [R01 DK117809, R01 DK058088]; National Research Development and Innovation Office of Hungary [PD120960, FK127942]; University of Debrecen OTKA Bridging Fund; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences grant [BO/00514/19/5]; New National Excellence Program of the Ministry for Innovation and Technology of Hungary from the source of the National Research, Development and Innovation Fund [UNKP-20-5]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Development and Innovation Office of Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary); University of Debrecen OTKA Bridging Fund; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences grant; New National Excellence Program of the Ministry for Innovation and Technology of Hungary from the source of the National Research, Development and Innovation Fund	This work was supported by the National Institutes of Health grants R01 DK117809 and R01 DK058088 (to M. S.-T.), the National Research Development and Innovation Office of Hungary grants PD120960 and FK127942, the University of Debrecen OTKA Bridging Fund, the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences grant (BO/00514/19/5), and the UNKP-20-5 New National Excellence Program of the Ministry for Innovation and Technology of Hungary from the source of the National Research, Development and Innovation Fund (to A. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beer S, 2014, GUT, V63, P860, DOI 10.1136/gutjnl-2013-305981; Boulling A., 2012, WEBMEDCENTRAL GENE, V3; Boulling A, 2007, EUR J HUM GENET, V15, P936, DOI 10.1038/sj.ejhg.5201873; Boulling A, 2017, HUM MUTAT, V38, P1014, DOI 10.1002/humu.23269; Boulling A, 2012, PANCREAS, V41, P329, DOI 10.1097/MPA.0b013e3182277b83; Chandak GR, 2002, J MED GENET, V39, P347, DOI 10.1136/jmg.39.5.347; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen JM, 2009, GUT, V58, P478, DOI 10.1136/gut.2008.170191; COLLINS J, 1990, BIOL CHEM H-S, V371, P29; Drenth JPH, 2002, GUT, V50, P687, DOI 10.1136/gut.50.5.687; Gaboriaud C, 1996, J MOL BIOL, V259, P995, DOI 10.1006/jmbi.1996.0376; Hamoir C, 2013, DIGESTION, V87, P229, DOI 10.1159/000348439; HECHT HJ, 1991, J MOL BIOL, V220, P711, DOI 10.1016/0022-2836(91)90112-J; Hegyi E, 2017, DIGEST DIS SCI, V62, P1692, DOI 10.1007/s10620-017-4601-3; Hirota Masahiko, 2003, JOP, V4, P83; Kereszturi E, 2009, GUT, V58, P545, DOI 10.1136/gut.2008.164947; Kereszturi E, 2017, PANCREAS, V46, pE54, DOI 10.1097/MPA.0000000000000817; KIKUCHI N, 1989, J BIOCHEM-TOKYO, V106, P1059, DOI 10.1093/oxfordjournals.jbchem.a122964; Kiraly O, 2007, GUT, V56, P1433, DOI 10.1136/gut.2006.115725; Kiraly O, 2007, HUM MUTAT, V28, P469, DOI 10.1002/humu.20471; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Kukor Z, 2003, EUR J BIOCHEM, V270, P2047, DOI 10.1046/j.1432-1033.2003.03581.x; Kume K, 2006, GUT, V55, P1214, DOI 10.1136/gut.2006.095752; Kuwata K, 2002, J GASTROENTEROL, V37, P928, DOI 10.1007/s005350200156; Lasher D, 2019, AM J GASTROENTEROL, V114, P974, DOI 10.14309/ajg.0000000000000051; LASKOWSKI M, 1953, J BIOL CHEM, V204, P797; Le Marechal C, 2004, Hum Mutat, V23, P205, DOI 10.1002/humu.9212; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Masamune A, 2007, PANCREAS, V34, P423, DOI 10.1097/mpa.0b013e3180335fd0; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; Ohmuraya M, 2006, PANCREAS, V33, P104, DOI 10.1097/01.mpa.0000226889.86322.9b; Pfutzer RH, 2000, GASTROENTEROLOGY, V119, P615, DOI 10.1053/gast.2000.18017; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Ronai Z, 2009, BIOCHEM J, V418, P155, DOI 10.1042/BJ20081848; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2006, FEBS J, V273, P5044, DOI 10.1111/j.1742-4658.2006.05501.x; Sahin-Toth Miklos, 2017, Hum Mutat, V38, P1619, DOI 10.1002/humu.23352; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; SCHNEIDE.SL, 1974, J BIOL CHEM, V249, P2009; SCHNEIDER SL, 1973, J BIOL CHEM, V248, P7207; Szabo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102063; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szepessy E, 2006, FEBS J, V273, P2942, DOI 10.1111/j.1742-4658.2006.05305.x; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Terlizzi V, 2013, MINERVA PEDIATR, V65, P669; Toldi V, 2020, J BIOL CHEM, V295, P3447, DOI 10.1074/jbc.RA120.012526; Venet T, 2017, HUM MUTAT, V38, P1660, DOI 10.1002/humu.23343; Werlin S, 2015, J PEDIATR GASTR NUTR, V60, P675, DOI 10.1097/MPG.0000000000000623; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Wu H, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100263; Wu H, 2017, GUT, V66, P2195, DOI 10.1136/gutjnl-2017-313948; Zou WB, 2016, GUT, V65, P884, DOI 10.1136/gutjnl-2015-311168	55	11	11	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100343	10.1016/j.jbc.2021.100343	http://dx.doi.org/10.1016/j.jbc.2021.100343			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33515547	Green Accepted, Green Published, gold			2022-12-28	WOS:000672866400317
J	Westhof, E; Leontis, NB				Westhof, Eric; Leontis, Neocles B.			An RNA-centric historical narrative around the Protein Data Bank	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PHENYLALANINE TRANSFER-RNA; LARGE RIBOSOMAL-SUBUNIT; NUCLEIC-ACID DATABASE; DOUBLE-HELICAL DNA; 90S PRE-RIBOSOME; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; STRUCTURE PREDICTION; HAMMERHEAD RIBOZYME; RIBONUCLEASE-P	Some of the amazing contributions brought to the scientific community by the Protein Data Bank (PDB) are described. The focus is on nucleic acid structures with a bias toward RNA. The evolution and key roles in science of the PDB and other structural databases for nucleic acids illustrate how small initial ideas can become huge and indispensable resources with the unflinching willingness of scientists to cooperate globally. The progress in the understanding of the molecular interactions driving RNA architectures followed the rapid increase in RNA structures in the PDB. That increase was consecutive to improvements in chemical synthesis and purification of RNA molecules, as well as in biophysical methods for structure determination and computer technology. The RNA modeling efforts from the early beginnings are also described together with their links to the state of structural knowledge and technological development. Structures of RNA and of its assemblies are physical objects, which, together with genomic data, allow us to integrate present-day biological functions and the historical evolution in all living species on earth.	[Westhof, Eric] Univ Strasbourg, Inst Biol Mol & Cellulaire CNRS Architecture & Re, Strasbourg, France; [Leontis, Neocles B.] Bowling Green State Univ, Dept Chem, Bowling Green, OH 43403 USA	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University System of Ohio; Bowling Green State University	Westhof, E (corresponding author), Univ Strasbourg, Inst Biol Mol & Cellulaire CNRS Architecture & Re, Strasbourg, France.	E.Westhof@ibmc-cnrs.unistra.fr	; Leontis, Neocles/E-8866-2011	Westhof, Eric/0000-0002-6172-5422; Leontis, Neocles/0000-0003-3521-5119				Adams PL, 2004, RNA, V10, P1867, DOI 10.1261/rna.7140504; Allain FHT, 1997, J MOL BIOL, V267, P338, DOI 10.1006/jmbi.1996.0855; ALTONA C, 1972, J AM CHEM SOC, V94, P8205, DOI 10.1021/ja00778a043; Ameismeier M, 2020, NATURE, V587, P683, DOI 10.1038/s41586-020-2929-x; Anderson AC, 1996, RNA, V2, P110; Anderson WP, 2017, NATURE, V543, P179, DOI 10.1038/543179a; Auffinger P, 2001, RNA, V7, P334, DOI 10.1017/S1355838201002382; Bai R, 2017, CELL, V171, P1589, DOI 10.1016/j.cell.2017.10.038; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bank P. D., 1971, NATURE-NEW BIOL, V233, P223, DOI [10.1038/newbio233223a0, DOI 10.1038/NEWBIO233223A0, DOI 10.1038/NEWBIO233223B0]; Baugh C, 2000, J MOL BIOL, V301, P117, DOI 10.1006/jmbi.2000.3951; BEAUDRY AA, 1992, SCIENCE, V257, P635, DOI 10.1126/science.1496376; Bekker Gert-Jan, 2020, Biophys Rev, V12, P371, DOI 10.1007/s12551-020-00632-5; BELRHALI H, 1994, SCIENCE, V263, P1432, DOI 10.1126/science.8128224; Berman HM, 2019, STRUCTURE, V27, P1745, DOI 10.1016/j.str.2019.11.002; BERMAN HM, 1992, BIOPHYS J, V63, P751, DOI 10.1016/S0006-3495(92)81649-1; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Boniecki MJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1479; Bourne PE, 2015, NATURE, V527, pS16, DOI 10.1038/527S16a; BRANDEN CI, 1990, NATURE, V343, P687, DOI 10.1038/343687a0; Breaker RR, 2020, ACS CHEM BIOL, V15, P2020, DOI 10.1021/acschembio.0c00214; BUGG CE, 1971, BIOPOLYMERS, V10, P175, DOI 10.1002/bip.360100113; Callaway E, 2020, NATURE, V588, P203, DOI 10.1038/d41586-020-03348-4; Caruthers MH, 2013, J BIOL CHEM, V288, P1420, DOI 10.1074/jbc.X112.442855; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Cech TR, 2000, SCIENCE, V289, P878, DOI 10.1126/science.289.5481.878; CECH TR, 1981, CELL, V27, P487, DOI 10.1016/0092-8674(81)90390-1; CHEN ZG, 1989, SCIENCE, V245, P154, DOI 10.1126/science.2749253; Cheng JD, 2020, SCIENCE, V369, P1470, DOI 10.1126/science.abb4119; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; CHEONG CJ, 1992, BIOCHEMISTRY-US, V31, P8406, DOI 10.1021/bi00151a003; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]; CLARK BFC, 1968, NATURE, V219, P1222, DOI 10.1038/2191222a0; CLERICI L, 1979, NUCLEIC ACIDS RES, V6, P247, DOI 10.1093/nar/6.1.247; Colussi TM, 2014, NATURE, V511, P366, DOI 10.1038/nature13378; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; COSTA M, 1995, EMBO J, V14, P1276, DOI 10.1002/j.1460-2075.1995.tb07111.x; Costa M, 2016, SCIENCE, V354, DOI 10.1126/science.aaf9258; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Cruz JA, 2012, RNA, V18, P610, DOI 10.1261/rna.031054.111; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Daubner GM, 2013, CURR OPIN STRUC BIOL, V23, P100, DOI 10.1016/j.sbi.2012.11.006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DellaVigna S, 2019, SCIENCE, V366, P428, DOI 10.1126/science.aaz1704; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dethoff EA, 2012, NATURE, V491, P724, DOI 10.1038/nature11498; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Dibrov SM, 2011, P NATL ACAD SCI USA, V108, P6405, DOI 10.1073/pnas.1017999108; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; DOCKBREGEON AC, 1988, NATURE, V335, P375, DOI 10.1038/335375a0; DOCKBREGEON AC, 1989, J MOL BIOL, V209, P459, DOI 10.1016/0022-2836(89)90010-7; Dominguez C, 2006, NUCLEIC ACIDS RES, V34, P3634, DOI 10.1093/nar/gkl488; Doudna JA, 2005, NAT STRUCT MOL BIOL, V12, P395, DOI 10.1038/nsmb932; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; DUMAS P, 1987, J BIOMOL STRUCT DYN, V4, P707, DOI 10.1080/07391102.1987.10507674; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FELDMANN RJ, 1976, ANNU REV BIOPHYS BIO, V5, P477, DOI 10.1146/annurev.bb.05.060176.002401; Ferre-D'Amare AR, 2010, METHODS, V52, P159, DOI 10.1016/j.ymeth.2010.06.008; Ferre-D'Amare AR, 1998, J MOL BIOL, V279, P621, DOI 10.1006/jmbi.1998.1789; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; FerreDAmare AR, 1996, NUCLEIC ACIDS RES, V24, P977, DOI 10.1093/nar/24.5.977; FERRIN TE, 1991, J MOL GRAPHICS, V9, P27, DOI 10.1016/0263-7855(91)80030-4; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Fica SM, 2017, NATURE, V542, P377, DOI 10.1038/nature21078; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; FULLER W, 1967, NATURE, V215, P817, DOI 10.1038/215817a0; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; GANGLOFF J, 1971, NATURE-NEW BIOL, V230, P125, DOI 10.1038/newbio230125a0; Gao WH, 2020, PATTERNS, V1, DOI 10.1016/j.patter.2020.100142; Garst AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003533; GEWIRTH DT, 1987, BIOCHEMISTRY-US, V26, P5213, DOI 10.1021/bi00390a047; GIEGE R, 1994, ACTA CRYSTALLOGR D, V50, P339, DOI 10.1107/S0907444994001344; Giege R, 2017, IUCRJ, V4, P340, DOI 10.1107/S2052252517006595; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; Goodsell DS, 2020, BIOCHEM MOL BIOL EDU, V48, P350, DOI 10.1002/bmb.21360; Gore S, 2017, STRUCTURE, V25, P1916, DOI 10.1016/j.str.2017.10.009; GREENHOUGH TJ, 1983, PROG BIOPHYS MOL BIO, V41, P67, DOI 10.1016/0079-6107(83)90026-3; Grigg JC, 2013, STRUCTURE, V21, P2025, DOI 10.1016/j.str.2013.09.001; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hainzl T, 2007, P NATL ACAD SCI USA, V104, P14911, DOI 10.1073/pnas.0702467104; HAMPEL A, 1968, SCIENCE, V162, P1384, DOI 10.1126/science.162.3860.1384; HAYES JA, 1985, TETRAHEDRON LETT, V26, P2407, DOI 10.1016/S0040-4039(00)94839-1; Helliwell J. R., 2020, IUCR NEWSL, V28, P6; Hendrickson W. A., 1981, BIOMOLECULAR STRUCTU, V1, P43; HEUS HA, 1991, SCIENCE, V253, P191, DOI 10.1126/science.1712983; Hiller DA, 2011, NATURE, V476, P236, DOI 10.1038/nature10248; HINGERTY B, 1978, J MOL BIOL, V124, P523, DOI 10.1016/0022-2836(78)90185-7; HOLLEY RW, 1965, SCIENCE, V147, P1462, DOI 10.1126/science.147.3664.1462; HOPE H, 1989, ACTA CRYSTALLOGR B, V45, P190, DOI 10.1107/S0108768188013710; HUTCHINS CJ, 1986, NUCLEIC ACIDS RES, V14, P3627, DOI 10.1093/nar/14.9.3627; ITAKURA K, 1975, J AM CHEM SOC, V97, P7327, DOI 10.1021/ja00858a020; JAMES BD, 1988, CELL, V52, P19, DOI 10.1016/0092-8674(88)90527-2; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson JE, 2012, NATURE, V492, P133, DOI 10.1038/nature11607; Jomaa A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15470; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Jossinet F, 2005, BIOINFORMATICS, V21, P3320, DOI 10.1093/bioinformatics/bti504; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Kappel K, 2020, NAT METHODS, V17, P698, DOI 10.1038/s41592-020-0878-9; Kastner B, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032417; KATZ L, 1972, ANNU REV BIOPHYS BIO, V1, P465, DOI 10.1146/annurev.bb.01.060172.002341; KENNARD O, 1977, PURE APPL CHEM, V49, P1807, DOI 10.1351/pac197749121807; KENNARD O, 1967, ACTA CRYSTALLOGR, V22, P445, DOI 10.1107/S0365110X67000945; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kim S H, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P279; KIM SH, 1987, P NATL ACAD SCI USA, V84, P8788, DOI 10.1073/pnas.84.24.8788; KIM SH, 1972, P NATL ACAD SCI USA, V69, P3746, DOI 10.1073/pnas.69.12.3746; KIM SH, 1968, SCIENCE, V162, P1381, DOI 10.1126/science.162.3860.1381; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; Kimsey IJ, 2015, NATURE, V519, P315, DOI 10.1038/nature14227; KOLTUN WL, 1965, BIOPOLYMERS, V3, P665, DOI 10.1002/bip.360030606; KONNERT JH, 1980, ACTA CRYSTALLOGR A, V36, P344, DOI 10.1107/S0567739480000794; KROL A, 1990, NUCLEIC ACIDS RES, V18, P3803, DOI 10.1093/nar/18.13.3803; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Kurata S, 2008, J BIOL CHEM, V283, P18801, DOI 10.1074/jbc.M800233200; LAKE JA, 1968, J MOL BIOL, V31, P115, DOI 10.1016/0022-2836(68)90059-4; LANGRIDGE R, 1974, FED PROC, V33, P2332; LANGRIDGE R, 1960, J MOL BIOL, V2, P38, DOI 10.1016/S0022-2836(60)80005-8; LANGRIDGE R, 1981, SCIENCE, V211, P661, DOI 10.1126/science.7455704; Lau B, 2021, MOL CELL, V81, P293, DOI 10.1016/j.molcel.2020.11.009; Lawson CL, 2020, STRUCT DYNAM-US, V7, DOI 10.1063/1.5138589; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; LEONTIS NB, 1986, BIOCHEMISTRY-US, V25, P5736, DOI 10.1021/bi00367a058; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; LEVITT M, 1969, NATURE, V224, P759, DOI 10.1038/224759a0; Li B, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.574485; Li S, 2019, NAT STRUCT MOL BIOL, V26, P1094, DOI 10.1038/s41594-019-0326-7; Lilley D. M. J., 2019, CLASSIFICATION NUCL; Lilley DMJ, 2011, BIOCHEM SOC T, V39, P641, DOI 10.1042/BST0390641; Liu SH, 2017, SCIENCE, V358, P1278, DOI 10.1126/science.aar3462; MADISON JT, 1966, SCIENCE, V153, P531, DOI 10.1126/science.153.3735.531; Magnus M, 2020, NUCLEIC ACIDS RES, V48, P576, DOI 10.1093/nar/gkz1108; MAJOR F, 1991, SCIENCE, V253, P1255, DOI 10.1126/science.1716375; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Marcia M, 2012, CELL, V151, P497, DOI 10.1016/j.cell.2012.09.033; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Massire C, 1998, J MOL GRAPH MODEL, V16, P197, DOI 10.1016/S1093-3263(98)80004-1; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; McCown PJ, 2017, RNA, V23, P995, DOI 10.1261/rna.061234.117; Meyer M, 2014, METHODS MOL BIOL, V1086, P21, DOI 10.1007/978-1-62703-667-2_2; Miao ZC, 2020, RNA, V26, P982, DOI 10.1261/rna.075341.120; Miao ZC, 2017, ANNU REV BIOPHYS, V46, P483, DOI 10.1146/annurev-biophys-070816-034125; Miao Z, 2017, RNA, V23, P655, DOI 10.1261/rna.060368.116; Miao ZC, 2015, RNA, V21, P1066, DOI 10.1261/rna.049502.114; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Michel F, 2000, METHOD ENZYMOL, V317, P491; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Moore PB, 2021, RNA, V27, pVII, DOI 10.1261/rna.078673.121; MORAS D, 1980, NATURE, V288, P669, DOI 10.1038/288669a0; Moult J, 1996, CURR OPIN BIOTECH, V7, P422, DOI 10.1016/S0958-1669(96)80118-2; Nakane T, 2020, NATURE, V587, P152, DOI 10.1038/s41586-020-2829-0; NAMBA K, 1989, J MOL BIOL, V208, P307, DOI 10.1016/0022-2836(89)90391-4; Narayanan BC, 2014, NUCLEIC ACIDS RES, V42, pD114, DOI 10.1093/nar/gkt980; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; NOLLER HF, 1981, SCIENCE, V212, P403, DOI 10.1126/science.6163215; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; OLSON WK, 1972, BIOPOLYMERS, V11, P57, DOI 10.1002/bip.1972.360110104; OLSON WK, 1972, BIOPOLYMERS, V11, P25, DOI 10.1002/bip.1972.360110103; OLSON WK, 1972, BIOPOLYMERS, V11, P1, DOI 10.1002/bip.1972.360110102; OUBRIDGE C, 1995, J MOL BIOL, V249, P409, DOI 10.1006/jmbi.1995.0306; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Peselis A, 2012, NAT STRUCT MOL BIOL, V19, P1182, DOI 10.1038/nsmb.2405; Petrov AI, 2013, RNA, V19, P1327, DOI 10.1261/rna.039438.113; Petrov AI, 2011, NUCLEIC ACIDS RES, V39, pW50, DOI 10.1093/nar/gkr249; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PLEIJ CWA, 1985, NUCLEIC ACIDS RES, V13, P1717, DOI 10.1093/nar/13.5.1717; PLEY HW, 1994, NATURE, V372, P111, DOI 10.1038/372111a0; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Rangan P, 2004, J MOL BIOL, V339, P41, DOI 10.1016/j.jmb.2004.03.059; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Reining A, 2013, NATURE, V499, P355, DOI 10.1038/nature12378; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Ren AM, 2012, NATURE, V486, P85, DOI 10.1038/nature11152; Richardson JS, 2020, NAT METHODS, V17, P663, DOI 10.1038/s41592-020-0888-7; Rinnenthal J, 2011, ACCOUNTS CHEM RES, V44, P1292, DOI 10.1021/ar200137d; ROBERTSON M, 1980, NATURE, V285, P358, DOI 10.1038/285358a0; Rother M, 2011, NUCLEIC ACIDS RES, V39, P4007, DOI 10.1093/nar/gkq1320; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Rozov A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10457; RUBIN J, 1971, SCIENCE, V174, P1020, DOI 10.1126/science.174.4013.1020; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Saenger W., 1984, PRINCIPLES NUCL ACID; Salvail H, 2020, BIOCHEMISTRY-US, V59, P4654, DOI 10.1021/acs.biochem.0c00793; Scaringe SA, 2000, METHOD ENZYMOL, V317, P3; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; SEEMAN NC, 1971, NATURE-NEW BIOL, V233, P90, DOI 10.1038/newbio233090a0; Seith DD, 2018, ACS CATAL, V8, P314, DOI 10.1021/acscatal.7b02976; Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov AA, 1996, RNA, V2, P1124; Strobel SA, 2007, CURR OPIN CHEM BIOL, V11, P636, DOI 10.1016/j.cbpa.2007.09.010; STURCHLER C, 1993, NUCLEIC ACIDS RES, V21, P1073, DOI 10.1093/nar/21.5.1073; Subramaniam S, 2016, CURR OPIN STRUC BIOL, V41, P194, DOI 10.1016/j.sbi.2016.07.009; Sun AA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13600-9; SUNDARAL.M, 1965, J MOL BIOL, V13, P914, DOI 10.1016/S0022-2836(65)80154-1; SUNDARAL.M, 1969, BIOPOLYMERS, V7, P821, DOI 10.1002/bip.1969.360070602; Sussman D, 2000, NAT STRUCT BIOL, V7, P53, DOI 10.1038/71253; SUSSMAN JL, 1978, J MOL BIOL, V123, P607, DOI 10.1016/0022-2836(78)90209-7; SWAMINATHAN V, 1979, CRC CR REV BIOCH MOL, V6, P245, DOI 10.3109/10409237909102565; Sweeney BA, 2021, NUCLEIC ACIDS RES, V49, pD212, DOI 10.1093/nar/gkaa921; TANNER NK, 1994, CURR BIOL, V4, P488, DOI 10.1016/S0960-9822(00)00109-3; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Trachman RJ, 2019, NAT CHEM BIOL, V15, P472, DOI 10.1038/s41589-019-0267-9; Trachman RJ, 2018, BIOCHEMISTRY-US, V57, P3544, DOI 10.1021/acs.biochem.8b00399; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Turk M, 2020, FEBS LETT, V594, P3243, DOI 10.1002/1873-3468.13948; TUSCHL T, 1994, SCIENCE, V266, P785, DOI 10.1126/science.7973630; Uhlenbeck OC, 2003, RNA, V9, P1415, DOI 10.1261/rna.5155903; van den Worm SHE, 1998, NUCLEIC ACIDS RES, V26, P1345, DOI 10.1093/nar/26.5.1345; Vasudevan SS, 2001, J BIOMOL STRUCT DYN, V18, P824, DOI 10.1080/07391102.2001.10506710; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; WAINWRIGHT SA, 1988, AM ZOOL, V28, P671; Wan RX, 2019, CURR OPIN STRUC BIOL, V59, P124, DOI 10.1016/j.sbi.2019.07.010; Wan RX, 2019, CELL, V177, P339, DOI 10.1016/j.cell.2019.02.006; Wan RX, 2016, SCIENCE, V353, P895, DOI 10.1126/science.aag2235; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; WANG AHJ, 1981, SCIENCE, V211, P171, DOI 10.1126/science.7444458; Wang YQ, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032383; Warner KD, 2014, NAT STRUCT MOL BIOL, V21, P658, DOI 10.1038/nsmb.2865; Watson ZL, 2020, ELIFE, V9, DOI 10.7554/eLife.60482; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P498, DOI 10.1038/nsmb1242; WESTHOF E, 1992, NATURE, V358, P459, DOI 10.1038/358459b0; WESTHOF E, 1985, J MOL BIOL, V184, P119, DOI 10.1016/0022-2836(85)90048-8; WESTHOF E, 1989, J MOL BIOL, V207, P417, DOI 10.1016/0022-2836(89)90264-7; Westhof E, 2007, J MOL RECOGNIT, V20, P1, DOI 10.1002/jmr.806; Westhof E, 2019, J MOL RECOGNIT, V32, DOI 10.1002/jmr.2782; Wilkinson ME, 2020, ANNU REV BIOCHEM, V89, P359, DOI 10.1146/annurev-biochem-091719-064225; Wilkinson ME, 2017, SCIENCE, V358, P1283, DOI 10.1126/science.aar3729; Wilson TJ, 2019, J AM CHEM SOC, V141, P7865, DOI 10.1021/jacs.9b02141; Wilson TJ, 2016, J AM CHEM SOC, V138, P6151, DOI 10.1021/jacs.5b11791; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wu HH, 2005, METHOD ENZYMOL, V394, P525, DOI 10.1016/S0076-6879(05)94022-6; Wu J, 2020, NUCLEIC ACIDS RES, V48, P3134, DOI 10.1093/nar/gkaa100; Wuthrich K., 1991, NMR PROTEINS NUCL AC; Xu XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107504; Yan CY, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032409; Yan CY, 2017, SCIENCE, V355, P149, DOI 10.1126/science.aak9979; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; YATHINDRA N, 1976, NUCLEIC ACIDS RES, V3, P729, DOI 10.1093/nar/3.3.729; Young JY, 2017, STRUCTURE, V25, P536, DOI 10.1016/j.str.2017.01.004; Zhang Q, 2011, P NATL ACAD SCI USA, V108, P20325, DOI 10.1073/pnas.1100279108; Zhao YJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00734; Zhou LJ, 2014, NATURE, V506, P116, DOI 10.1038/nature12803; Zirbel CL, 2009, NUCLEIC ACIDS RES, V37, P4898, DOI 10.1093/nar/gkp468; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	268	4	4	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100555	10.1016/j.jbc.2021.100555	http://dx.doi.org/10.1016/j.jbc.2021.100555			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744291	Green Published, gold			2022-12-28	WOS:000672866400528
J	Liu, HB; Sun, ST; Liu, B				Liu, Haibin; Sun, Shengtao; Liu, Bing			Smurf2 exerts neuroprotective effects on cerebral ischemic injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-EDGED-SWORD; OXIDATIVE STRESS; APOPTOSIS; DEGRADATION; HIF-1-ALPHA; EXPRESSION; AUTOPHAGY; RECOVERY; NEURON; ROLES	The present study aimed to explore specific mechanisms involved in mediating the neuroprotective effects of Smad ubiquitination regulatory factor 2 (Smurf2) in cerebral ischemic injury. A middle cerebral artery occlusion (MCAO) mouse model and an oxygen-glucose deprivation (OGD)-treated neuron model were developed. The expression of Smurf2, Yin Yang 1 (YY1), hypoxia-inducible factor-1 alpha (HIF1 alpha), and DNA damage-inducible transcript 4 gene (DDIT4) was analyzed. Thereafter, the expression of Smurf2, YY1, HIF1 alpha, and DDIT4 was altered in the MCAO mice and OGD-treated neurons. Apoptosis in tissues and cerebral infarction were assessed. In neurons, the expression of apoptosis-related proteins, viability, and apoptosis were assessed, followed by evaluation of lactate dehydrogenase leakage rate. The interaction between Smurf2 and YY1 was analyzed by coimmunoprecipitation assay and that between YY1 ubiquitination by in vivo ubiquitination experiment. The results showed downregulation of Smurf2 and upregulation of YY1, HIF1 alpha, and DDIT4 in both MCAO mice and OGD-treated neurons. Smurf2 elevated YY1 ubiquitination and degradation, and YY1 increased HIF1 alpha expression to promote DDIT4 in neurons. Overexpressed Smurf2 or down-regulated YY1, HIF1 alpha, or DDIT4 reduced the volume of cerebral infarction and apoptosis in MCAO mice, while enhancing cell viability and reducing apoptosis and lactate dehydrogenase leakage in OGD-treated neurons. In summary, our findings elucidated a neuroprotective role of Smurf2 in cerebral ischemic injury via inactivation of the YY1/HIF1 alpha/DDIT4 axis.	[Liu, Haibin; Sun, Shengtao; Liu, Bing] Linyi Peoples Hosp, Dept Paediat, Linyi, Shandong, Peoples R China		Liu, B (corresponding author), Linyi Peoples Hosp, Dept Paediat, Linyi, Shandong, Peoples R China.	13562955239@163.com						Chae DK, 2019, MOL ONCOL, V13, P2663, DOI 10.1002/1878-0261.12581; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Chen SH, 2020, BRAIN RES, V1748, DOI 10.1016/j.brainres.2020.147075; Chen WQ, 2014, NEURAL REGEN RES, V9, P1210, DOI 10.4103/1673-5374.135329; Dong S, 2019, AM J PHYSIOL-CELL PH, V316, pC632, DOI 10.1152/ajpcell.00443.2018; Fu L, 2020, SEMIN CANCER BIOL, V67, P102, DOI 10.1016/j.semcancer.2019.12.023; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; He JT, 2012, MOLECULES, V17, P315, DOI 10.3390/molecules17010315; Jeong HM, 2014, BBA-MOL CELL RES, V1843, P2005, DOI 10.1016/j.bbamcr.2014.04.023; Jo DH, 2014, J MOL MED, V92, P1083, DOI 10.1007/s00109-014-1168-8; Koganti P, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00295; Koizumi S, 2018, NEUROCHEM INT, V119, P107, DOI 10.1016/j.neuint.2018.01.007; Liu W, 2018, BIOMED PHARMACOTHER, V108, P698, DOI 10.1016/j.biopha.2018.09.082; Lou Z, 2018, CELL PHYSIOL BIOCHEM, V46, P2103, DOI 10.1159/000489450; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Park KM, 2016, AM J PHYSIOL-HEART C, V311, pH371, DOI 10.1152/ajpheart.00807.2015; Radak D, 2017, CURR VASC PHARMACOL, V15, P115, DOI 10.2174/1570161115666161104095522; Ramkumar C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3598; Sarvagalla S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01230; Singh N, 2012, CELL MOL NEUROBIOL, V32, P491, DOI 10.1007/s10571-012-9803-9; Su JY, 2019, NEUROCHEM INT, V128, P14, DOI 10.1016/j.neuint.2019.03.019; Sun JG, 2019, J CELL BIOCHEM, V120, P14771, DOI 10.1002/jcb.28737; Wang J, 2018, CELL PHYSIOL BIOCHEM, V51, P692, DOI 10.1159/000495327; Wang XW, 2016, EXP BIOL MED, V241, P177, DOI 10.1177/1535370215600548; Wei K, 2012, CNS NEUROSCI THER, V18, P879, DOI 10.1111/cns.12005; Wu SR, 2013, CANCER RES, V73, P1787, DOI 10.1158/0008-5472.CAN-12-0366; Yang XS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06088-0; Yao MH, 2010, J NEUROSCI, V30, P4062, DOI 10.1523/JNEUROSCI.2964-09.2010; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Zhang JB, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.144; Zhang XC, 2019, NEUROPHARMACOLOGY, V158, DOI 10.1016/j.neuropharm.2019.107682; Zong YH, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0235-6	32	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100537	10.1016/j.jbc.2021.100537	http://dx.doi.org/10.1016/j.jbc.2021.100537			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	33722608	gold, Green Published			2022-12-28	WOS:000690873500010
J	Ard, R; Maillet, JC; Daher, E; Phan, M; Zinoviev, R; Parks, RJ; Gee, SH				Ard, Ryan; Maillet, Jean-Christian; Daher, Elias; Phan, Michael; Zinoviev, Radoslav; Parks, Robin J.; Gee, Stephen H.			PKC alpha-mediated phosphorylation of the diacylglycerol kinase zeta MARCKS domain switches cell migration modes by regulating interactions with Rac1 and RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION; C-ALPHA; GTPASES; DISSOCIATION; ACTIVATION; PROTEINS; DYNAMICS; ADHESION; FAMILY; RHOGDI	Cells can switch between Rac1 (lamellipodia-based) and RhoA (blebbing-based) migration modes, but the molecular mechanisms regulating this shift are not fully understood. Diacylglycerol kinase zeta (DGK zeta), which phosphorylates diacylglycerol to yield phosphatidic acid, forms independent complexes with Rac1 and RhoA, selectively dissociating each from their common inhibitor RhoGDI. DGK zeta catalytic activity is required for Rac1 dissociation but is dispensable for RhoA dissociation; instead, DGK zeta stimulates RhoA release via a kinase-independent scaffolding mechanism. The molecular determinants that mediate the selective targeting of DGK zeta to Rac1 or RhoA signaling complexes are unknown. Here, we show that protein kinase C alpha (PKC alpha)-mediated phosphorylation of the DGK zeta MARCKS domain increased DGK. association with RhoA and decreased its interaction with Rac1. The same modification also enhanced DGK zeta interaction with the scaffold protein syntrophin. Expression of a phosphomimetic DGK zeta mutant stimulated membrane blebbing in mouse embryonic fibroblasts and C2C12 myoblasts, which was augmented by inhibition of endogenous Rac1. DGK zeta expression in differentiated C2 myotubes, which have low endogenous Rac1 levels, also induced substantial membrane blebbing via the RhoA-ROCK pathway. These events were independent of DGK zeta catalytic activity, but dependent upon a functional C-terminal PDZ-binding motif. Rescue of RhoA activity in DGK zeta-null cells also required the PDZ-binding motif, suggesting that syntrophin interaction is necessary for optimal RhoA activation. Collectively, our results define a switch-like mechanism whereby DGK zeta phosphorylation by PKC alpha plays a role in the interconversion between Rac1 and RhoA signaling pathways that underlie different cellular migration modes.	[Ard, Ryan; Maillet, Jean-Christian; Daher, Elias; Phan, Michael; Zinoviev, Radoslav; Gee, Stephen H.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Ard, Ryan; Maillet, Jean-Christian; Daher, Elias; Phan, Michael; Zinoviev, Radoslav; Parks, Robin J.; Gee, Stephen H.] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Parks, Robin J.] Ottawa Hlth Res Inst, Mol Med Program, Ottawa, ON, Canada; [Parks, Robin J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Ard, Ryan] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC V1V 1V7, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of British Columbia; University of British Columbia Okanagan	Gee, SH (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.; Gee, SH (corresponding author), Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada.	stevegee@uottawa.ca			Cancer Research Society [20457]	Cancer Research Society	This work was made possible by grant #20457 from the Cancer Research Society to S. G.	Abramovici H, 2003, MOL BIOL CELL, V14, P4499, DOI 10.1091/mbc.E03-03-0190; Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Antonyak Marc A, 2012, Small GTPases, V3, P219, DOI 10.4161/sgtp.20755; Ard R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144942; Ard R, 2012, MOL BIOL CELL, V23, P4008, DOI 10.1091/mbc.E12-01-0026; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Byrne KM, 2016, CELL SYST, V2, P38, DOI 10.1016/j.cels.2016.01.003; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dovas A, 2010, J BIOL CHEM, V285, P23294, DOI 10.1074/jbc.M109.098129; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Froehner SC, 1997, SOC GEN PHY, V52, P197; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Heller H, 2001, J BIOL CHEM, V276, P37307, DOI 10.1074/jbc.M103195200; Hogan A, 2001, J BIOL CHEM, V276, P26526, DOI 10.1074/jbc.M104156200; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Myat MM, 1997, CURR BIOL, V7, P611, DOI 10.1016/S0960-9822(06)00262-4; Nguyen Lan K, 2018, Small GTPases, V9, P316, DOI 10.1080/21541248.2016.1224399; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Santos T, 2002, J BIOL CHEM, V277, P30300, DOI 10.1074/jbc.M200999200; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Street M, 2006, J CELL SCI, V119, P1528, DOI 10.1242/jcs.02872; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Torgerson RR, 1998, J CELL SCI, V111, P2911; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Yakubchyk Y, 2005, MOL CELL BIOL, V25, P7289, DOI 10.1128/MCB.25.16.7289-7302.2005	35	1	2	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100516	10.1016/j.jbc.2021.100516	http://dx.doi.org/10.1016/j.jbc.2021.100516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676892	Green Published, gold			2022-12-28	WOS:000672866400490
J	Black, MH; Osinski, A; Park, GJ; Gradowski, M; Servage, KA; Pawlowski, K; Tagliabracci, VS				Black, Miles H.; Osinski, Adam; Park, Gina J.; Gradowski, Marcin; Servage, Kelly A.; Pawlowski, Krzysztof; Tagliabracci, Vincent S.			A Legionella effector ADP-ribosyltransferase inactivates glutamate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR GROWTH; PNEUMOPHILA; UBIQUITINATION; RIBOSYLATION; METABOLISM; SEQUENCE; ENZYMES; AUTOPHAGOSOMES; PURIFICATION; CATALYZES	ADP-ribosyltransferases (ARTs) are a widespread superfamily of enzymes frequently employed in pathogenic strategies of bacteria. Legionella pneumophila, the causative agent of a severe form of pneumonia known as Legionnaire's disease, has acquired over 330 translocated effectors that showcase remarkable biochemical and structural diversity. However, the ART effectors that influence L. pneumophila have not been well defined. Here, we took a bioinformatic approach to search the Legionella effector repertoire for additional divergent members of the ART superfamily and identified an ART domain in Legionella pneumophila gene0181, which we hereafter refer to as Legionella ADP-Ribosyltransferase 1 (Lart1) (Legionella ART 1). We show that L. pneumophila Lart1 targets a specific class of 120-kDa NAD+-dependent glutamate dehydrogenase (GDH) enzymes found in fungi and protists, including many natural hosts of Legionella. Lart1 targets a conserved arginine residue in the NAD+-binding pocket of GDH, thereby blocking oxidative deamination of glutamate. Therefore, Lart1 could be the first example of a Legionella effector which directly targets a host metabolic enzyme during infection.	[Black, Miles H.; Osinski, Adam; Park, Gina J.; Servage, Kelly A.; Pawlowski, Krzysztof; Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Gradowski, Marcin; Pawlowski, Krzysztof] Warsaw Univ Life Sci, Inst Biol, Warsaw, Poland; [Servage, Kelly A.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Warsaw University of Life Sciences; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.; Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.	vincent.tagliabracci@utsouthwestern.edu	Gradowski, Marcin/AHC-8195-2022; Pawlowski, Krzysztof/C-2949-2013	Gradowski, Marcin/0000-0001-7695-5434; Osinski, Adam Krzysztof/0000-0003-0010-0733; Black, Miles/0000-0002-2864-1710; Park, Gina/0000-0002-2513-8917; Pawlowski, Krzysztof/0000-0002-5367-0935; Tagliabracci, Vincent/0000-0002-9735-4678	National Institutes of Health [DP2GM137419, F30HL143859-02]; Welch Foundation [I1911]; Polish National Agency for Scientific Exchange Scholarship [PPN/BEK/2018/1/00431]; Polish National Science Centre grant [2019/33/B/NZ2/01409]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Polish National Agency for Scientific Exchange Scholarship; Polish National Science Centre grant	This work was supported by National Institutes of Health Grants DP2GM137419 (to V. S. T.), and F30HL143859-02 (to M. H. B.), Welch Foundation Grants I1911 (to V. S. T.), the Polish National Agency for Scientific Exchange Scholarship PPN/BEK/2018/1/00431 (to K. P.) and Polish National Science Centre grant 2019/33/B/NZ2/01409 (to K. P.). V. S. T. is the Michael L. Rosenberg Scholar in Medical Research, a Cancer Prevention Research Institute of Texas Scholar (RR150033), and a Searle Scholar. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Akturk A, 2018, NATURE, V557, P729, DOI 10.1038/s41586-018-0147-6; Andersson JO, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-14; Aravind L, 2015, CURR TOP MICROBIOL, V384, P3, DOI 10.1007/82_2014_414; Avendano A, 1997, J BACTERIOL, V179, P5594, DOI 10.1128/jb.179.17.5594-5597.1997; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Best A, 2019, TRENDS MICROBIOL, V27, P550, DOI 10.1016/j.tim.2018.12.012; Bhogaraju S, 2019, NATURE, V572, P382, DOI 10.1038/s41586-019-1440-8; Bhogaraju S, 2016, CELL, V167, P1636, DOI 10.1016/j.cell.2016.11.019; Black MH, 2019, SCIENCE, V364, P787, DOI 10.1126/science.aaw7446; Bock FJ, 2015, MOL CELL, V58, P911, DOI 10.1016/j.molcel.2015.06.012; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Chen Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003382; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Choi MM, 2005, FEBS LETT, V579, P4125, DOI 10.1016/j.febslet.2005.06.041; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Domenighini M, 1996, MOL MICROBIOL, V21, P667, DOI 10.1046/j.1365-2958.1996.321396.x; Dong YA, 2018, NATURE, V557, P674, DOI 10.1038/s41586-018-0146-7; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Fey P, 2009, NUCLEIC ACIDS RES, V37, pD515, DOI 10.1093/nar/gkn844; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gan NH, 2019, NATURE, V572, P387, DOI 10.1038/s41586-019-1439-1; Goetz M, 2001, P NATL ACAD SCI USA, V98, P12221, DOI 10.1073/pnas.211106398; Gomez-Valero L, 2019, P NATL ACAD SCI USA, V116, P2265, DOI 10.1073/pnas.1808016116; Gutierrez MG, 2005, AUTOPHAGY, V1, P179, DOI 10.4161/auto.1.3.2063; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; HELLEBUST JA, 1988, J PROTOZOOL, V35, P498, DOI 10.1111/j.1550-7408.1988.tb04136.x; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Kalayil S, 2018, NATURE, V557, P734, DOI 10.1038/s41586-018-0145-8; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kent U M, 1999, Methods Mol Biol, V115, P11; Kim L, 2018, J MOL BIOL, V430, P2843, DOI 10.1016/j.jmb.2018.05.043; Kotewicz KM, 2017, CELL HOST MICROBE, V21, P169, DOI 10.1016/j.chom.2016.12.007; Krska D, 2015, J BIOL CHEM, V290, P1639, DOI 10.1074/jbc.M114.589846; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; LANGRIDGE WHR, 1977, ARCH BIOCHEM BIOPHYS, V178, P581, DOI 10.1016/0003-9861(77)90229-6; Lyons B, 2016, J BIOL CHEM, V291, P11198, DOI 10.1074/jbc.M115.707653; Merriam JJ, 1997, INFECT IMMUN, V65, P2497, DOI 10.1128/IAI.65.6.2497-2501.1997; MILLER SM, 1990, J BACTERIOL, V172, P4927, DOI 10.1128/jb.172.9.4927-4935.1990; Minambres B, 2000, J BIOL CHEM, V275, P39529, DOI 10.1074/jbc.M005136200; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; Neunuebel MR, 2011, SCIENCE, V333, P453, DOI 10.1126/science.1207193; Niu H, 2012, P NATL ACAD SCI USA, V109, P20800, DOI 10.1073/pnas.1218674109; Park JM, 2020, NAT MICROBIOL, V5, P599, DOI 10.1038/s41564-019-0663-7; POULIN R, 1987, J EXP ZOOL, V243, P365, DOI 10.1002/jez.1402430303; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; Qiu JZ, 2016, NATURE, V533, P120, DOI 10.1038/nature17657; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Schaap P, 2018, MICROBIOL-SGM, V164, P727, DOI 10.1099/mic.0.000653; Sexton JA, 2004, J BACTERIOL, V186, P1658, DOI 10.1128/JB.186.6.1658-1666.2004; Smith HQ, 2019, NEUROCHEM RES, V44, P117, DOI 10.1007/s11064-017-2428-0; Sreelatha A, 2020, J BIOL CHEM, V295, P6214, DOI 10.1074/jbc.RA120.013067; Sreelatha A, 2018, CELL, V175, P809, DOI 10.1016/j.cell.2018.08.046; Sulpizio A, 2019, ELIFE, V8, DOI 10.7554/eLife.51162; Sun JJ, 2004, NAT STRUCT MOL BIOL, V11, P868, DOI 10.1038/nsmb818; UNO I, 1984, J BIOL CHEM, V259, P1288; Wang Y, 2018, CELL, V173, P1231, DOI 10.1016/j.cell.2018.04.023; WEEKERS PHH, 1993, J EUKARYOT MICROBIOL, V40, P251, DOI 10.1111/j.1550-7408.1993.tb04912.x; Xu D, 2014, BIOINFORMATICS, V30, P660, DOI 10.1093/bioinformatics/btt578; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	70	5	6	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100301	10.1016/j.jbc.2021.100301	http://dx.doi.org/10.1016/j.jbc.2021.100301			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33476647	Green Published, gold			2022-12-28	WOS:000672866400275
J	Brown, NP; Vergara, AM; Whelan, AB; Guerra, P; Bolger, TA				Brown, Nicolette P.; Vergara, Ashley M.; Whelan, Alisha B.; Guerra, Paolo; Bolger, Timothy A.			Medulloblastoma-associated mutations in the DEAD-box RNA helicase DDX3X/DED1 cause specific defects in translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE; INTELLECTUAL DISABILITY; MESSENGER-RNA; COMMON-CAUSE; PROTEIN; DDX3; DED1P; INITIATION; RESOLUTION	Medulloblastoma is the most common pediatric brain cancer, and sequencing studies identified frequent mutations in DDX3X, a DEAD-box RNA helicase primarily implicated in translation. Forty-two different sites were identified, suggesting that the functional effects of the mutations are complex. To investigate how these mutations are affecting DDX3X cellular function, we constructed a full set of equivalent mutant alleles in DED1, the Saccharomyces cerevisiae ortholog of DDX3X, and characterized their effects in vivo and in vitro. Most of the medulloblastoma-associated mutants in DDX3X/DED1 (ded1-mam) showed substantial growth defects, indicating that functional effects are conserved in yeast. Further, while translation was affected in some mutants, translation defects affecting bulk mRNA were neither consistent nor correlated with the growth phenotypes. Likewise, increased formation of stress granules in ded1-mam mutants was common but did not correspond to the severity of the mutants' growth defects. In contrast, defects in translating mRNAs containing secondary structure in their 5' untranslated regions (UTRs) were found in almost all ded1-mam mutants and correlated well with growth phenotypes. We thus conclude that these specific translation defects, rather than generalized effects on translation, are responsible for the observed cellular phenotypes and likely contribute to DDX3X-mutant medulloblastoma. Examination of ATPase activity and RNA binding of recombinant mutant proteins also did not reveal a consistent defect, indicating that the translation defects are derived from multiple enzymatic deficiencies. This work suggests that future studies into medulloblastoma pathology should focus on this specific translation defect, while taking into account the wide spectrum of DDX3X mutations.	[Brown, Nicolette P.; Vergara, Ashley M.; Whelan, Alisha B.; Guerra, Paolo; Bolger, Timothy A.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Whelan, Alisha B.] Virginia Commonwealth Univ, Dept Forens Sci, Richmond, VA USA	University of Arizona; Virginia Commonwealth University	Bolger, TA (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	tbolger@arizona.edu		Bolger, Timothy/0000-0001-9526-4110	American Cancer Society [RSG-1326301-RMC]; National Institutes of Health [1R01-GM136827]; Arizona Biomedical Research Commission [ADHS14-082993]	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Biomedical Research Commission	This work was supported by the American Cancer Society (RSG-1326301-RMC), the National Institutes of Health (1R01-GM136827), and the Arizona Biomedical Research Commission (ADHS14-082993). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funding organizations.	Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Aryanpur PP, 2019, MOL BIOL CELL, V30, P2171, DOI 10.1091/mbc.E18-11-0702; Aryanpur PP, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00139-17; Aylett CHS, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0186; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; Blessing Melissa M, 2020, Surg Pathol Clin, V13, P235, DOI 10.1016/j.path.2020.01.003; Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004; Bolger TA, 2011, J BIOL CHEM, V286, P39750, DOI 10.1074/jbc.M111.299321; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Epling LB, 2015, J MOL BIOL, V427, P1779, DOI 10.1016/j.jmb.2015.02.015; Floor SN, 2016, J BIOL CHEM, V291, P2412, DOI 10.1074/jbc.M115.700625; Gao XM, 2019, BRIT J PHARMACOL, V176, P4421, DOI 10.1111/bph.14790; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Guenther UP, 2018, NATURE, V559, P130, DOI 10.1038/s41586-018-0258-0; Gulay S, 2020, ELIFE, V9, DOI 10.7554/eLife.58243; Gupta N, 2018, ELIFE, V7, DOI 10.7554/eLife.38892; Hanzlik E, 2015, CHILD NERV SYST, V31, P1869, DOI 10.1007/s00381-015-2867-3; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Hondele M, 2019, NATURE, V573, P144, DOI 10.1038/s41586-019-1502-y; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Iserman C, 2020, CELL, V181, P818, DOI 10.1016/j.cell.2020.04.009; Jiang L, 2015, NAT GENET, V47, P1061, DOI 10.1038/ng.3358; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Lennox AL, 2020, NEURON, V106, P404, DOI 10.1016/j.neuron.2020.01.042; Li Qian, 2018, Oncotarget, V9, P30189, DOI 10.18632/oncotarget.23773; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Mabbott DJ, 2008, NEUROPSYCHOLOGY, V22, P159, DOI 10.1037/0894-4105.22.2.159; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Oh S, 2016, ONCOTARGET, V7, P28169, DOI 10.18632/oncotarget.8612; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Ris MD, 2001, J CLIN ONCOL, V19, P3470, DOI 10.1200/JCO.2001.19.15.3470; Robichaud N, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032896; Robichaud N, 2017, CURR OPIN CELL BIOL, V45, P102, DOI 10.1016/j.ceb.2017.05.007; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sen ND, 2015, GENOME RES, V25, P1196, DOI 10.1101/gr.191601.115; Sharma D, 2017, J MOL BIOL, V429, P3730, DOI 10.1016/j.jmb.2017.10.008; Sharma D, 2014, CRIT REV BIOCHEM MOL, V49, P343, DOI 10.3109/10409238.2014.931339; Shen L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124402; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Valentin-Vega YA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25996; Wang X, 2018, ANN CLIN TRANSL NEUR, V5, P1277, DOI 10.1002/acn3.622	55	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100296	10.1016/j.jbc.2021.100296	http://dx.doi.org/10.1016/j.jbc.2021.100296			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460649	Green Published, gold			2022-12-28	WOS:000672866400270
J	Jiang, FF; Takagi, Y; Shams, A; Heissler, SM; Friedman, TB; Sellers, JR; Bird, JE				Jiang, Fangfang; Takagi, Yasuharu; Shams, Arik; Heissler, Sarah M.; Friedman, Thomas B.; Sellers, James R.; Bird, Jonathan E.			The ATPase mechanism of myosin 15, the molecular motor mutated in DFNB3 human deafness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOAD-DEPENDENT KINETICS; HAIR CELL STEREOCILIA; UNCONVENTIONAL MYOSIN; HEAVY-MEROMYOSIN; INORGANIC-PHOSPHATE; FLUORESCENT-PROBE; SMOOTH-MUSCLE; ACTIN; BINDING; DOMAIN	Cochlear hair cells each possess an exquisite bundle of actin-based stereocilia that detect sound. Unconventional myosin 15 (MYO15) traffics and delivers critical molecules required for stereocilia development and thus is essential for building the mechanosensory hair bundle. Mutations in the human MYO15A gene interfere with stereocilia trafficking and cause hereditary hearing loss, DFNB3, but the impact of these mutations is not known, as MYO15 itself is poorly characterized. To learn more, we performed a kinetic study of the ATPase motor domain to characterize its mechanochemical cycle. Using the baculovirus-Sf9 system, we purified a recombinant minimal motor domain (S1) by coexpressing the mouse MYO15 ATPase, essential and regulatory light chains that bind its IQ domains, and UNC45 and HSP90A chaperones required for correct folding of the ATPase. MYO15 purified with either UNC45A or UNC45B coexpression had similar ATPase activities (k(cat) = similar to 6 s(-1) at 20 degrees C). Using stopped-flow and quenched-flow transient kinetic analyses, we measured the major rate constants describing the ATPase cycle, including ATP, ADP, and actin binding; hydrolysis; and phosphate release. Actin-attached ADP release was the slowest measured transition (similar to 12 s(-1) at 20 degrees C), although this did not rate-limit the ATPase cycle. The kinetic analysis shows the MYO15 motor domain has a moderate duty ratio (similar to 0.5) and weak thermodynamic coupling between ADP and actin binding. These findings are consistent with MYO15 being kinetically adapted for processive motility when oligomerized. Our kinetic characterization enables future studies into how deafness-causing mutations affect MYO15 and disrupt stereocilia trafficking necessary for hearing.	[Jiang, Fangfang; Bird, Jonathan E.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Jiang, Fangfang; Bird, Jonathan E.] Univ Florida, Coll Med, Myol Inst, Gainesville, FL 32610 USA; [Takagi, Yasuharu; Sellers, James R.] NHLBI, Lab Mol Physiol, Cell & Dev Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Shams, Arik; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Lab Mol Genet, NIH, Bethesda, MD USA; [Heissler, Sarah M.] Ohio State Univ, Wexner Med Ctr, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University System of Ohio; Ohio State University	Bird, JE (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA.; Bird, JE (corresponding author), Univ Florida, Coll Med, Myol Inst, Gainesville, FL 32610 USA.	j.bird@ufl.edu		Bird, Jonathan/0000-0001-5531-8794; , fangfangjiang/0000-0003-4659-9322; Shams, Arik/0000-0002-0151-0593; Heissler, Sarah/0000-0002-6972-7940; Friedman, Thomas/0000-0003-4614-6630	National Institutes of Health Intramural Research Program of the NHLBI [HL006049]; NIDCD [DC000048]; NIDCD of the National Institutes of Health [R01 DC018827]	National Institutes of Health Intramural Research Program of the NHLBI; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported (in part) by the National Institutes of Health Intramural Research Program of the NHLBI to J. R. S. (HL006049), NIDCD to T. B. F. (DC000048), and by the NIDCD of the National Institutes of Health under award number R01 DC018827 to J. E. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DW, 2000, HUM MOL GENET, V9, P1729, DOI 10.1093/hmg/9.12.1729; Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; Baboolal TG, 2016, J BIOL CHEM, V291, P22373, DOI 10.1074/jbc.M116.730689; Barr-Gillespie PG, 2015, MOL BIOL CELL, V26, P2727, DOI 10.1091/mbc.E14-04-0940; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Bird JE, 2014, P NATL ACAD SCI USA, V111, P12390, DOI 10.1073/pnas.1409459111; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Bookwalter CS, 2014, J BIOL CHEM, V289, P30832, DOI 10.1074/jbc.M114.572453; BRETSCHER A, 1981, P NATL ACAD SCI-BIOL, V78, P6849, DOI 10.1073/pnas.78.11.6849; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Carinhas N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026444; Clark R, 2005, J BIOL CHEM, V280, P30935, DOI 10.1074/jbc.M504698200; Comyn SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048861; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Dose AC, 2008, BIOCHEMISTRY-US, V47, P2485, DOI 10.1021/bi7021574; Drummond MC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7873; Ebrahim S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10833; Esteve C, 2018, AM J HUM GENET, V102, P364, DOI 10.1016/j.ajhg.2018.01.009; Etard C, 2008, J CELL BIOL, V180, P1163, DOI 10.1083/jcb.200709128; Fang Q, 2015, ELIFE, V4, DOI 10.7554/eLife.08627; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Giese APJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00061-1; Greenberg MJ, 2015, P NATL ACAD SCI USA, V112, pE3337, DOI 10.1073/pnas.1506633112; Haithcock J, 2011, J BIOL CHEM, V286, P8819, DOI 10.1074/jbc.M110.163592; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; Heissler SM, 2016, TRAFFIC, V17, P839, DOI 10.1111/tra.12388; Hellerschmied D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12667-8; Homma K, 2005, J BIOL CHEM, V280, P29381, DOI 10.1074/jbc.M504779200; Hopkins RF, 2009, BIOTECHNIQUES, V47, P785, DOI 10.2144/000113238; Houdusse A, 2016, TRENDS BIOCHEM SCI, V41, P989, DOI 10.1016/j.tibs.2016.09.006; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Hwang P, 2015, CELL REP, V13, P1287, DOI 10.1016/j.celrep.2015.10.003; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; KATZ LA, 1989, AM J PHYSIOL, V256, pH265, DOI 10.1152/ajpheart.1989.256.1.H265; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Lee CF, 2014, INT REV CEL MOL BIO, V313, P103, DOI 10.1016/B978-0-12-800177-6.00004-9; Lelli A, 2016, J CELL BIOL, V212, P231, DOI 10.1083/jcb.201509017; Lewis JH, 2006, BIOCHEMISTRY-US, V45, P11589, DOI 10.1021/bi0611917; Liang Y, 1999, GENOMICS, V61, P243, DOI 10.1006/geno.1999.5976; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046; Mauriac SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14907; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mentes A, 2018, P NATL ACAD SCI USA, V115, P1292, DOI 10.1073/pnas.1718316115; MORITA F, 1967, J BIOL CHEM, V242, P4501; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Narayanan P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7855; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Pan BF, 2018, NEURON, V99, P736, DOI 10.1016/j.neuron.2018.07.033; Pato MD, 1996, J BIOL CHEM, V271, P2689, DOI 10.1074/jbc.271.5.2689; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Pylypenko O, 2011, J BIOL CHEM, V286, P11716, DOI 10.1074/jbc.M110.200626; Rehman AU, 2016, HUM MUTAT, V37, P991, DOI 10.1002/humu.23042; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Ricca BL, 2010, BIOPHYS J, V99, P1818, DOI 10.1016/j.bpj.2010.06.066; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; Ropars V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12456; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Shuman H, 2014, P NATL ACAD SCI USA, V111, P2116, DOI 10.1073/pnas.1321022111; SLEEP JA, 1980, BIOCHEMISTRY-US, V19, P1276, DOI 10.1021/bi00548a002; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Tadenev ALD, 2019, CURR BIOL, V29, P921, DOI 10.1016/j.cub.2019.01.051; Tarchini B, 2016, DEVELOPMENT, V143, P3926, DOI 10.1242/dev.139089; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Usaj M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11984-6; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Walsh VL, 2011, MAMM GENOME, V22, P170, DOI 10.1007/s00335-010-9310-6; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WERBER MM, 1972, BIOCHEMISTRY-US, V11, P2872, DOI 10.1021/bi00765a021; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Zampini V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001048; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	104	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100243	10.1074/jbc.RA120.014903	http://dx.doi.org/10.1074/jbc.RA120.014903			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33372036	Green Submitted, Green Published, gold			2022-12-28	WOS:000672866400221
J	Kim, D; Castano, M; Lujan, LK; Woo, JA; Liggett, SB				Kim, Donghwa; Castano, Maria; Lujan, Lauren K.; Woo, Jung A.; Liggett, Stephen B.			The short third intracellular loop and cytoplasmic tail of bitter taste receptors provide functionally relevant GRK phosphorylation sites in TAS2R14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-PROMOTED DESENSITIZATION; KINASE-MEDIATED PHOSPHORYLATION; BETA-2-ADRENERGIC RECEPTOR; PROTEIN; SALMETEROL; IDENTIFICATION; ASTHMA; INTERNALIZATION; BRONCHODILATORS; SUBSENSITIVITY	For most G protein-coupled receptors, the third intracellular loop (IL3) and carboxy-terminal tail (CT) are sites for G protein-coupled receptor kinase (GRK)-mediated phosphorylation, leading to beta-arrestin binding and agonist-specific desensitization. These regions of bitter taste receptors (TAS2Rs) are extremely short compared with the superfamily, and their function in desensitization is unknown. TAS2R14 expressed on human airway smooth muscle cells relax the cell, suggesting a novel target for bronchodilators. To assess IL3 and CT in agonist-promoted TAS2R14 desensitization (tachyphylaxis), we generated fusion proteins of both the WT sequence and Ala substituted for Ser/Thr in the IL3 and CT sequences. In vitro, activated GRK2 phosphorylated WT IL3 and WT CT proteins but not Ala-substituted forms. TAS2R14s with mutations in IL3 (IL-5A), CT (CT-5A), and in both regions (IL/CT-10A) were expressed in human embryonic kidney 293T cells. IL/CT-10A and CT-5A failed to undergo desensitization of the intracellular calcium response compared with WT, indicating that functional desensitization by GRK phosphorylation is at residues in the CT. Desensitization of TAS2R14 was blocked by GRK2 knockdown in human airway smooth muscle cells. Receptor:beta-arrestin binding was absent in IL/CT-10A and CT-5A and reduced in IL-5A, indicating a role for IL3 phosphorylation in the beta-arrestin interaction for this function. Agonist-promoted internalization of IL-5A and CT-5A receptors was impaired, and they failed to colocalize with early endosomes. Thus, agonist-promoted functional desensitization of TAS2R14 occurs by GRK phosphorylation of CT residues and beta-arrestin binding. However, beta-arrestin function in the internalization and trafficking of the receptor also requires GRK phosphorylation of IL3 residues.	[Kim, Donghwa; Castano, Maria; Lujan, Lauren K.] Univ S Florida, Morsani Coll Med, Dept Med, Tampa, FL 33620 USA; [Woo, Jung A.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Liggett, Stephen B.] Univ S Florida, Morsani Coll Med, Dept Med & Mol Pharmacol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Liggett, SB (corresponding author), Univ S Florida, Morsani Coll Med, Dept Med & Mol Pharmacol, Tampa, FL 33620 USA.	sliggett@usf.edu	Kim, Donghwa/AAJ-8148-2021	Kim, Donghwa/0000-0002-8994-8513; Lujan, Lauren/0000-0002-5342-7126; Liggett, Stephen B./0000-0002-0128-3669; Woo, Jung A/0000-0002-9194-1361	National Institutes of Health [HL114471, HL155532]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant HL114471 and HL155532 to S. B. L. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; An SS, 2017, CELL SIGNAL, V41, P82, DOI 10.1016/j.cellsig.2017.02.002; BHAGAT R, 1995, CHEST, V108, P1235, DOI 10.1378/chest.108.5.1235; Booth H, 1996, THORAX, V51, P1100, DOI 10.1136/thx.51.11.1100; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Cazzola M, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0095-2019; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chen YJ, 2013, J NEUROCHEM, V124, P189, DOI 10.1111/jnc.12071; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Deshpande DA, 2011, NAT MED, V17, P776, DOI 10.1038/nm0711-776b; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; EASON MG, 1995, J BIOL CHEM, V270, P4681, DOI 10.1074/jbc.270.9.4681; EASON MG, 1992, J BIOL CHEM, V267, P25473; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Gagnon L, 2019, J BIOL CHEM, V294, P17409, DOI 10.1074/jbc.RA119.010324; GREEN SA, 1994, J BIOL CHEM, V269, P26215; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Huang WJ, 2020, NATURE, V579, P303, DOI 10.1038/s41586-020-1953-1; Jewell-Motz EA, 2000, J BIOL CHEM, V275, P28989, DOI 10.1074/jbc.M005381200; JewellMotz EA, 1996, J BIOL CHEM, V271, P18082, DOI 10.1074/jbc.271.30.18082; Kim D, 2019, AM J RESP CELL MOL, V60, P532, DOI 10.1165/rcmb.2018-0189OC; Kim DW, 2017, AM J RESP CELL MOL, V56, P762, DOI 10.1165/rcmb.2016-0373OC; Kim D, 2016, J BIOL CHEM, V291, P17616, DOI 10.1074/jbc.M116.722736; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; Lee H, 2007, MOL CELL BIOL, V27, P2103, DOI 10.1128/MCB.00572-06; Liang M, 1998, MOL PHARMACOL, V54, P44, DOI 10.1124/mol.54.1.44; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; LIGGETT SB, 1993, P NATL ACAD SCI USA, V90, P3665, DOI 10.1073/pnas.90.8.3665; Maestri-El Kouhen O, 2000, J BIOL CHEM, V275, P36659, DOI 10.1074/jbc.M006788200; Mafi A, 2020, P NATL ACAD SCI USA, V117, P16346, DOI 10.1073/pnas.1918264117; Matera MG, 2011, TRENDS PHARMACOL SCI, V32, P495, DOI 10.1016/j.tips.2011.04.003; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; NEWNHAM DM, 1995, THORAX, V50, P497, DOI 10.1136/thx.50.5.497; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Palmer TM, 2000, MOL PHARMACOL, V57, P539, DOI 10.1124/mol.57.3.539; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Robinett KS, 2014, AM J RESP CELL MOL, V50, P678, DOI 10.1165/rcmb.2013-0439RC; Robinett KS, 2011, AM J RESP CELL MOL, V45, P1069, DOI 10.1165/rcmb.2011-0061OC; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Salpeter SR, 2010, AM J MED, V123, P322, DOI 10.1016/j.amjmed.2009.07.035; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Staus DP, 2020, NATURE, V579, P297, DOI 10.1038/s41586-020-1954-0; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Wang WCH, 2009, P NATL ACAD SCI USA, V106, P15007, DOI 10.1073/pnas.0906034106; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Woo JA, 2019, FASEB J, V33, P12213, DOI 10.1096/fj.201802627RR; Woo JAA, 2020, P NATL ACAD SCI USA, V117, P5006, DOI 10.1073/pnas.1917194117	56	1	1	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100216	10.1074/jbc.RA120.016056	http://dx.doi.org/10.1074/jbc.RA120.016056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465377	gold, Green Published			2022-12-28	WOS:000672866400194
J	Lin, KF; Fry, MY; Saladi, SM; Clemons, WM				Lin, Ku-Feng; Fry, Michelle Y.; Saladi, Shyam M.; Clemons, William M., Jr.			Molecular basis of tail-anchored integral membrane protein recognition by the cochaperone Sgt2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; RICH TETRATRICOPEPTIDE REPEAT; CYTOSOLIC QUALITY-CONTROL; UBIQUITIN-LIKE DOMAIN; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; PROSTATE-CANCER; COMPLEX; INSERTION; CHAPERONE	The targeting and insertion of tail-anchored (TA) integral membrane proteins (IMPs) into the correct membrane is critical for cellular homeostasis. The fungal protein Sgt2, and its human homolog SGTA, is the entry point for clients to the guided entry of tail-anchored protein (GET) pathway, which targets endoplasmic reticulum-bound TA IMPs. Consisting of three structurally independent domains, the C terminus of Sgt2 binds to the hydrophobic transmembrane domain (TMD) of clients. However, the exact binding interface within Sgt2 and molecular details that underlie its binding mechanism and client preference are not known. Here, we reveal the mechanism of Sgt2 binding to hydrophobic clients, including TA IMPs. Through sequence analysis, biophysical characterization, and a series of capture assays, we establish that the Sgt2 C-terminal domain is flexible but conserved and sufficient for client binding. A molecular model for this domain reveals a helical hand forming a hydrophobic groove approximately 15 A long that is consistent with our observed higher affinity for client TMDs with a hydrophobic face and a minimal length of 11 residues. This work places Sgt2 into a broader family of TPR-containing cochaperone proteins, demonstrating structural and sequence-based similarities to the DP domains in the yeast Hsp90 and Hsp70 coordinating protein, Sti1.	[Lin, Ku-Feng; Fry, Michelle Y.; Saladi, Shyam M.; Clemons, William M., Jr.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Clemons, WM (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	clemons@caltech.edu	Clemons, William M/D-1026-2009	Clemons, William M/0000-0002-0021-889X; Fry, Michelle/0000-0002-3209-5492	National Institutes of Health [GM105385, GM097572]; NIH/National Research Service Award Training Grant [GM07616]; National Science Foundation [1144469]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Research Service Award Training Grant; National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health grants GM105385 and GM097572 (to W. M. C.), NIH/National Research Service Award Training Grant GM07616 (to S. M. S. and M. Y. F.), and a National Science Foundation Graduate Research fellowship Grant 1144469 (to S. M. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anishchenko I., 2019, IMPROVED PROTEIN STR, V13; Aviram N, 2017, J CELL SCI, V130, P4079, DOI 10.1242/jcs.204396; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Buchanan G, 2007, CANCER RES, V67, P10087, DOI 10.1158/0008-5472.CAN-07-1646; Callahan MA, 1998, J VIROL, V72, P5189, DOI 10.1128/JVI.72.6.5189-5197.1998; Chartron JW, 2012, CELL REP, V2, P1620, DOI 10.1016/j.celrep.2012.10.010; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Chio US, 2019, CELL REP, V26, P37, DOI 10.1016/j.celrep.2018.12.035; Chio US, 2017, ANNU REV CELL DEV BI, V33, P417, DOI 10.1146/annurev-cellbio-100616-060839; Cho HJ, 2018, EMBO J, V37, DOI 10.15252/embj.201899264; Chu R, 2002, J MOL BIOL, V323, P253, DOI 10.1016/S0022-2836(02)00884-7; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Clemons WM, 1999, J MOL BIOL, V292, P697, DOI 10.1006/jmbi.1999.3090; Coto ALS, 2018, INT J BIOL MACROMOL, V118, P693, DOI 10.1016/j.ijbiomac.2018.06.123; Cziepluch C, 1998, J VIROL, V72, P4149, DOI 10.1128/JVI.72.5.4149-4156.1998; Darby JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113281; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dupzyk A, 2017, J VIROL, V91, DOI 10.1128/JVI.00232-17; Dutta S, 2008, BIOCHEMISTRY-US, V47, P10123, DOI 10.1021/bi800758a; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; FERNANDEZPATRON C, 1995, ANAL BIOCHEM, V224, P263, DOI 10.1006/abio.1995.1039; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gristick HB, 2014, NAT STRUCT MOL BIOL, V21, P437, DOI 10.1038/nsmb.2813; Guna A, 2018, CURR BIOL, V28, pR498, DOI 10.1016/j.cub.2018.02.004; Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Leznicki P, 2015, J CELL SCI, V128, P3187, DOI 10.1242/jcs.165209; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li Z, 2013, NAT STRUCT MOL BIOL, V20, P929, DOI 10.1038/nsmb.2608; Liou ST, 2005, ARCH BIOCHEM BIOPHYS, V435, P253, DOI 10.1016/j.abb.2004.12.020; Long P, 2012, EUR J NEUROSCI, V36, P2733, DOI 10.1111/j.1460-9568.2012.08189.x; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Martinez-Lumbreras S, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0542-3; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mock JY, 2015, P NATL ACAD SCI USA, V112, P106, DOI 10.1073/pnas.1402745112; Nelson GM, 2003, CELL STRESS CHAPERON, V8, P125, DOI 10.1379/1466-1268(2003)008<0125:COTCDR>2.0.CO;2; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pieper U, 2013, NAT STRUCT MOL BIOL, V20, P135, DOI 10.1038/nsmb.2508; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Rao M, 2016, ELIFE, V5, DOI 10.7554/eLife.21301; Reisser S, 2014, BIOPHYS J, V106, P2385, DOI 10.1016/j.bpj.2014.04.020; Rodrigo-Brenni MC, 2014, MOL CELL, V55, P227, DOI 10.1016/j.molcel.2014.05.025; Rohl A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7655; Rome ME, 2014, P NATL ACAD SCI USA, V111, pE4929, DOI 10.1073/pnas.1411284111; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shao SC, 2017, SCIENCE, V355, P298, DOI 10.1126/science.aah6130; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Simon AC, 2013, P NATL ACAD SCI USA, V110, P1327, DOI 10.1073/pnas.1207518110; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suloway CJM, 2012, EMBO J, V31, P707, DOI 10.1038/emboj.2011.433; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Trotta AP, 2013, INT J CANCER, V133, P2812, DOI 10.1002/ijc.28310; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Voorhees RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07975; Waheed A. A., 2016, SCI REP-UK, V6, P1; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang HX, 2003, BIOCHEM BIOPH RES CO, V311, P877, DOI 10.1016/j.bbrc.2003.10.080; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Webb B., 2002, COMP PROTEIN STRUCTU, V235; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Wunderley L, 2014, J CELL SCI, V127, P4728, DOI 10.1242/jcs.155648; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu Y, 2013, J BIOL CHEM, V288, P18068, DOI 10.1074/jbc.M112.449199; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	87	10	10	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100441	10.1016/j.jbc.2021.100441	http://dx.doi.org/10.1016/j.jbc.2021.100441			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610544	Green Published, gold, Green Accepted			2022-12-28	WOS:000672866400415
J	Mohd-Kipli, F; Claridge, JK; Habjanic, J; Jiang, A; Schnell, JR				Mohd-Kipli, Faiz; Claridge, Jolyon K.; Habjanic, Jelena; Jiang, Alex; Schnell, Jason R.			Conformational triggers associated with influenza matrix protein 1 polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS M1 PROTEIN; SEASONAL INFLUENZA; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; WATER ACTIVITY; MEMBRANE; BINDING; IDENTIFICATION; LOCALIZATION; RESIDUES	A central role for the influenza matrix protein 1 (M1) is to form a polymeric coat on the inner leaflet of the host membrane that ultimately provides shape and stability to the virion. M1 polymerizes upon binding membranes, but triggers for conversion of M1 from a water-soluble component of the nucleus and cytosol into an oligomer at the membrane surface are unknown. While full-length M1 is required for virus viability, the N-terminal domain (M1NT) retains membrane binding and pH-dependent oligomerization. We studied the structural plasticity and oligomerization of M1NT in solution using NMR spectroscopy. We show that the isolated domain can be induced by sterol-containing compounds to undergo a conformational change and self-associate in a pH-dependent manner consistent with the stacked dimer oligomeric interface. Surface-exposed residues at one of the stacked dimer interfaces are most sensitive to sterols. Several perturbed residues are at the interface between the N-terminal subdomains and are also perturbed by changes in pH. The effects of sterols appear to be indirect and most likely mediated by reduction in water activity. The local changes are centered on strictly conserved residues and consistent with a priming of the N-terminal domain for polymerization. We hypothesize that M1NT is sensitive to changes in the aqueous environment and that this sensitivity is part of a mechanism for restricting polymerization to the membrane surface. Structural models combined with information from chemical shift perturbations indicate mechanisms by which conformational changes can be transmitted from one polymerization interface to the other.	[Mohd-Kipli, Faiz; Claridge, Jolyon K.; Habjanic, Jelena; Jiang, Alex; Schnell, Jason R.] Univ Oxford, Dept Biochem, Oxford, England; [Mohd-Kipli, Faiz] Univ Brunei Darussalam, Fac Sci, Gadong, Brunei	University of Oxford; University Brunei Darussalam	Schnell, JR (corresponding author), Univ Oxford, Dept Biochem, Oxford, England.	Jason.Schnell@bioch.ox.ac.uk		Jiang, Alex/0000-0002-2928-7530	Chancellor's Scholarship; UK Medical Research Council [L018578]; MRC [MR/L018578/1] Funding Source: UKRI	Chancellor's Scholarship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Chancellor's Scholarship to FMK and a grant from the UK Medical Research Council (L018578).	Arzt S, 2001, VIROLOGY, V279, P439, DOI 10.1006/viro.2000.0727; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Chiang MJ, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.96; COMPANS RW, 1970, VIROLOGY, V42, P880, DOI 10.1016/0042-6822(70)90337-5; Damodaran Srinivasan, 2015, Subcell Biochem, V71, P233, DOI 10.1007/978-3-319-19060-0_10; Darapaneni V., 2015, AM J CURR MICROBIOL, V3, P1; Das SC, 2012, J VIROL, V86, P1522, DOI 10.1128/JVI.06230-11; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Halder UC, 2013, J BIOL CHEM, V288, P14554, DOI 10.1074/jbc.M112.447086; Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119; Hass MAS, 2015, ANNU REV BIOPHYS, V44, P53, DOI 10.1146/annurev-biophys-083012-130351; Hilsch M, 2014, BIOPHYS J, V107, P912, DOI 10.1016/j.bpj.2014.06.042; Hofer CT, 2019, BBA-BIOMEMBRANES, V1861, P1123, DOI 10.1016/j.bbamem.2019.03.013; Hom N, 2019, J VIROL, V93, DOI 10.1128/JVI.00161-19; Hutchinson EC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002993; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Keller R., 2004, THESIS SWISS FEDERAL; Kerviel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165421; Kordyukova LV, 2019, J BIOMOL STRUCT DYN, V37, P671, DOI 10.1080/07391102.2018.1436089; Lai YT, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501855; Li S, 2014, BIOPHYS J, V106, P1447, DOI 10.1016/j.bpj.2014.02.018; Marcolli C, 2005, ATMOS CHEM PHYS, V5, P1545, DOI 10.5194/acp-5-1545-2005; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; PARSEGIAN VA, 1984, J CELL BIOL, V99, pS196, DOI 10.1083/jcb.99.1.196s; Peukes J, 2020, NATURE, V587, P495, DOI 10.1038/s41586-020-2696-8; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Reinhardt J, 2000, VET MICROBIOL, V74, P87, DOI 10.1016/S0378-1135(00)00169-3; Rolfes MA, 2018, INFLUENZA OTHER RESP, V12, P132, DOI 10.1111/irv.12486; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Scianimanico S, 2000, EMBO J, V19, P6732, DOI 10.1093/emboj/19.24.6732; Selzer L, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000827; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shilova LA, 2017, BIOCHEM MOSC SUPPL S, V11, P225, DOI 10.1134/S1990747817030072; Shishkov AV, 1999, P NATL ACAD SCI USA, V96, P7827, DOI 10.1073/pnas.96.14.7827; Shtykova EV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16986-y; Vemula SV, 2017, EXPERT REV VACCINES, V16, P1141, DOI 10.1080/14760584.2017.1379396; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WHITTAKER G, 1995, J VIROL, V69, P439, DOI 10.1128/JVI.69.1.439-445.1995; Xie H, 2013, J VIROL, V87, P345, DOI 10.1128/JVI.02024-12; Xiong J., 2020, BIORXIV; Zhang K, 2015, CELL MICROBIOL, V17, P1583, DOI 10.1111/cmi.12457; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037786; Zhang WT, 2017, P NATL ACAD SCI USA, V114, P8550, DOI 10.1073/pnas.1701747114; Zhu HJ, 1996, INT J PHARM, V135, P151, DOI 10.1016/0378-5173(95)04466-3	53	1	1	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100316	10.1016/j.jbc.2021.100316	http://dx.doi.org/10.1016/j.jbc.2021.100316			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33516724	Green Published, gold			2022-12-28	WOS:000672866400290
J	Omata, Y; Yamauchi, T; Tsuruta, A; Matsunaga, N; Koyanagi, S; Ohdo, S				Omata, Yuji; Yamauchi, Tomoaki; Tsuruta, Akito; Matsunaga, Naoya; Koyanagi, Satoru; Ohdo, Shigehiro			RNA editing enzyme ADAR1 governs the circadian expression of P-glycoprotein in human renal cells by regulating alternative splicing of the ABCB1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-4; MULTIDRUG-RESISTANCE; INTESTINAL EXPRESSION; MEMBRANE TRANSPORTERS; 24-HOUR RHYTHM; CANCER; TIME; PHARMACOKINETICS; MRP2	The expression and function of some xenobiotic transporters vary according to the time of the day, causing the dosing time-dependent changes in drug disposition and toxicity. P-glycoprotein (P-gp), encoded by the ABCB1 gene, is highly expressed in the kidneys and functions in the renal elimination of various drugs. The elimination of several P-gp substrates was demonstrated to vary depending on administration time, but the underlying mechanism remains unclear. We found that adenosine deaminase acting on RNA (ADAR1) was involved in the circadian regulation of P-gp expression in human renal proximal tubular epithelial cells (RPTECs). After synchronization of the cellular circadian clock by dexamethasone treatment, the expression of P-gp exhibited a significant 24-h oscillation in RPTECs, but this oscillation was disrupted by the downregulation of ADAR1. Although ADAR1 catalyzes adenosine-to-inosine (A-to-I) RNA editing in double-stranded RNA substrates, no significant ADAR1-regulated editing sites were detected in the human ABCB1 transcripts in RPTECs. On the other hand, downregulation of ADAR1 induced alternative splicing in intron 27 of the human ABCB1 gene, resulting in the production of retained intron transcripts. The aberrant spliced transcript was sensitive to nonsense-mediated mRNA decay, leading to the decreased stability of ABCB1 mRNA and prevention of the 24-h oscillation of P-gp expression. These findings support the notion that ADAR1-mediated regulation of alternative splicing of the ABCB1 gene is a key mechanism of circadian expression of P-gp in RPTECs, and the regulatory mechanism may underlie the dosing time-dependent variations in the renal elimination of P-gp substrates.	[Omata, Yuji; Yamauchi, Tomoaki; Tsuruta, Akito; Matsunaga, Naoya; Koyanagi, Satoru; Ohdo, Shigehiro] Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Fukuoka, Japan; [Matsunaga, Naoya; Koyanagi, Satoru] Kyushu Univ, Fac Pharmaceut Sci, Dept Glocal Healthcare Sci, Fukuoka, Japan	Kyushu University; Kyushu University	Koyanagi, S; Ohdo, S (corresponding author), Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Fukuoka, Japan.; Koyanagi, S (corresponding author), Kyushu Univ, Fac Pharmaceut Sci, Dept Glocal Healthcare Sci, Fukuoka, Japan.	koyanagi@phar.kyushu-u.ac.jp; ohdo@phar.kyushu-u.ac.jp		Koyanagi, Satoru/0000-0003-4849-2377; matsunaga2, naoya2/0000-0001-6226-8473	Naito Foundation; Platform Project for Supporting Drug Discovery, and Life Science Research [Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)] from AMED [JP20am0101091];  [18H04019]	Naito Foundation(Naito Memorial Foundation); Platform Project for Supporting Drug Discovery, and Life Science Research [Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)] from AMED; 	This study was supported in part by a Grant-in-Aid for Scientific Research A (18H04019 to S. K.), the Naito Foundation (S. K.), and the Platform Project for Supporting Drug Discovery, and Life Science Research [Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)] from AMED (Grant Number JP20am0101091).	Agranat L, 2010, RNA BIOL, V7, P253, DOI 10.4161/rna.7.2.11568; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bao LL, 2012, AM J PATHOL, V180, P2490, DOI 10.1016/j.ajpath.2012.02.024; Choi JS, 1999, RES COMMUN MOL PATH, V103, P109; Dallmann R, 2016, TRENDS MOL MED, V22, P430, DOI 10.1016/j.molmed.2016.03.004; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feng DD, 2011, J CELL MOL MED, V15, P2164, DOI 10.1111/j.1582-4934.2010.01213.x; FERRAZZINI G, 1991, EUR J CLIN PHARMACOL, V41, P425, DOI 10.1007/BF00626363; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hamdan AM, 2012, J BIOL CHEM, V287, P17224, DOI 10.1074/jbc.M111.333377; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hsiao YHE, 2018, GENOME RES, V28, P812, DOI 10.1101/gr.231209.117; Iwasaki M, 2015, MOL PHARMACOL, V88, P29, DOI 10.1124/mol.114.096735; Jones BR, 2005, MOL PHARMACOL, V68, P701, DOI 10.1124/mol.105.013144; Kato M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70321-6; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Martin L, 2014, CANCER RES, V74, P3104, DOI 10.1158/0008-5472.CAN-13-2235; Matsunaga N, 2008, HEPATOLOGY, V48, P240, DOI 10.1002/hep.22304; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Nakano M, 2018, PHARMACOL THERAPEUT, V181, P13, DOI 10.1016/j.pharmthera.2017.07.003; Nakano M, 2016, J BIOL CHEM, V291, P894, DOI 10.1074/jbc.M115.699363; NISHIKURA K, 1991, EMBO J, V10, P3523, DOI 10.1002/j.1460-2075.1991.tb04916.x; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ohdo S, 2019, PHARMACOL THERAPEUT, V202, P72, DOI 10.1016/j.pharmthera.2019.05.018; Ohdo S, 2011, J PHARM SCI-US, V100, P3560, DOI 10.1002/jps.22656; Okazaki H, 2014, CANCER RES, V74, P543, DOI 10.1158/0008-5472.CAN-12-3241; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Picardi E, 2017, NUCLEIC ACIDS RES, V45, pD750, DOI 10.1093/nar/gkw767; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Sakurai M, 2017, NAT STRUCT MOL BIOL, V24, P534, DOI 10.1038/nsmb.3403; Shang Y, 2014, ONCOGENE, V33, P3267, DOI 10.1038/onc.2013.297; Shitara Y, 2006, EUR J PHARM SCI, V27, P425, DOI 10.1016/j.ejps.2005.12.003; Sissung TM, 2014, METHODS MOL BIOL, V1175, P91, DOI 10.1007/978-1-4939-0956-8_6; Tang SJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14621-5; Terajima H, 2017, NAT GENET, V49, P146, DOI 10.1038/ng.3731; Tsurudome Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27280-w; Ushijima K, 2012, MOL PHARMACOL, V82, P264, DOI 10.1124/mol.112.079079; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wong JJL, 2016, BIOESSAYS, V38, P41, DOI 10.1002/bies.201500117; Yu FJ, 2019, THERANOSTICS, V9, P2754, DOI 10.7150/thno.33395	49	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100601	10.1016/j.jbc.2021.100601	http://dx.doi.org/10.1016/j.jbc.2021.100601			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781748	gold, Green Published			2022-12-28	WOS:000672866400573
J	Pedersen, MH; Pham, J; Mancebo, H; Inoue, A; Asher, WB; Javitch, JA				Pedersen, Maria Hauge; Pham, Jennifer; Mancebo, Helena; Inoue, Asuka; Asher, Wesley B.; Javitch, Jonathan A.			A novel luminescence-based beta-arrestin recruitment assay for unmodified receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; BETA-ARRESTIN2; REPORTER	G protein-coupled receptors (GPCRs) signal through activation of G proteins and subsequent modulation of downstream effectors. More recently, signaling mediated by beta-arrestin has also been implicated in important physiological functions. This has led to great interest in the identification of biased ligands that favor either G protein or beta-arrestin-signaling pathways. However, nearly all screening techniques for measuring beta-arrestin recruitment have required C-terminal receptor modifications that can in principle alter protein interactions and thus signaling. Here, we have developed a novel luminescence-based assay to measure beta-arrestin recruitment to the membrane or early endosomes by unmodified receptors. Our strategy uses NanoLuc, an engineered luciferase from Oplophorus gracilirostris (deep-sea shrimp) that is smaller and brighter than other well-established luciferases. Recently, several publications have explored functional NanoLuc split sites for use in complementation assays. We have identified a unique split site within NanoLuc and fused the corresponding N-terminal fragment to either a plasma membrane or early endosome tether and the C-terminal fragment to beta-arrestins, which form the basis for the MeNArC and EeNArC assays, respectively. Upon receptor activation, beta-arrestin is recruited to the membrane and subsequently internalized in an agonist concentration-dependent manner. This recruitment promotes complementation of the two NanoLuc fragments, thereby reconstituting functional NanoLuc, allowing for quantification of beta-arrestin recruitment with a single luminescence signal. Our assay avoids potential artifacts related to C-terminal receptor modification and has promise as a new generic assay for measuring beta-arrestin recruitment to diverse GPCR types in heterologous or native cells.	[Pedersen, Maria Hauge; Asher, Wesley B.; Javitch, Jonathan A.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA; [Pedersen, Maria Hauge; Asher, Wesley B.; Javitch, Jonathan A.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Mol Pharmacol & Therapeut, New York, NY 10027 USA; [Pedersen, Maria Hauge; Asher, Wesley B.; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Pedersen, Maria Hauge] Univ Copenhagen, Fac Hlth & Med Sci, NNF Ctr Basic Metab Res, Sect Metab Receptol, Copenhagen, Denmark; [Pham, Jennifer; Mancebo, Helena] Multispan Inc, Hayward, CA USA; [Inoue, Asuka] Tohoku Univ, Dept Pharmacol Sci, Sendai, Miyagi, Japan	Columbia University; Columbia University; New York State Psychiatry Institute; University of Copenhagen; Tohoku University	Javitch, JA (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA.; Javitch, JA (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Mol Pharmacol & Therapeut, New York, NY 10027 USA.; Javitch, JA (corresponding author), New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA.	javitch@nyspi.columbia.edu		Hauge Pedersen, Maria/0000-0003-0034-5837	National Institutes of Health [MH54137]; Novo Nordisk Foundation [NNF17OC0024830]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Supported by National Institutes of Health grant MH54137 (J. A. J) and Novo Nordisk Foundation grant NNF17OC0024830 (M. H. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2002, J NEUROSCI, V22, P10494; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; DeLano W. L, 2002, CCP4 NEWSLETTER PROT, V40, P44; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Donthamsetti P, 2020, MOL PSYCHIATR, V25, P2086, DOI 10.1038/s41380-018-0212-4; Donthamsetti Prashant, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0214s70; Ehrlich AT, 2019, ISCIENCE, V14, P47, DOI 10.1016/j.isci.2019.03.011; Eishingdrelo Haifeng, 2011, Curr Chem Genomics, V5, P122, DOI 10.2174/1875397301105010122; Grunberg R, 2013, NAT METHODS, V10, P1021, DOI [10.1038/nmeth.2625, 10.1038/NMETH.2625]; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Klewe IV, 2008, NEUROPHARMACOLOGY, V54, P1215, DOI 10.1016/j.neuropharm.2008.03.015; Kliewer A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08162-1; Kliewer A, 2020, BRIT J PHARMACOL, V177, P2923, DOI 10.1111/bph.15004; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Laschet C, 2019, J BIOL CHEM, V294, P4079, DOI 10.1074/jbc.RA118.006231; Lohse Martin J, 2014, Handb Exp Pharmacol, V219, P15, DOI 10.1007/978-3-642-41199-1_2; Miess E, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aas9609; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Oakley RH, 2002, ASSAY DRUG DEV TECHN, V1, P21, DOI 10.1089/154065802761001275; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Reyes-Alcaraz A, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0134-3; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Thompson GL, 2016, BIOCHEM PHARMACOL, V113, P70, DOI 10.1016/j.bcp.2016.05.014; Tomabechi Y, 2016, BIOCHEM BIOPH RES CO, V470, P88, DOI 10.1016/j.bbrc.2015.12.123; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yano H, 2018, BIOTECHNIQUES, V65, P9, DOI 10.2144/btn-2018-0039; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao XN, 2008, J BIOMOL SCREEN, V13, P737, DOI 10.1177/1087057108321531	35	4	4	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100503	10.1016/j.jbc.2021.100503	http://dx.doi.org/10.1016/j.jbc.2021.100503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33684444	Green Published, gold			2022-12-28	WOS:000672866400477
J	Prestegard, JH				Prestegard, James H.			A perspective on the PDB's impact on the field of glycobiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN GLYCOSYLATION; HUMAN ERYTHROPOIETIN; GLYCOPROTEIN; COMPLEX; TRANSFERASE; DISTORTION; GLYCANS; SYSTEM; DOMAIN	Structures deposited in the Protein Data Bank (PDB) facilitate our understanding of many biological processes including those that fall under the general category of glycobiology. However, structure-based studies of how glycans affect protein structure, how they are synthesized, and how they regulate other biological processes remain challenging. Despite the abundant presence of glycans on proteins and the dense layers of glycans that surround most of our cells, structures containing glycans are underrepresented in the PDB. There are sound reasons for this, including difficulties in producing proteins with well-defined glycosylation and the tendency of mobile and heterogeneous glycans to inhibit crystallization. Nevertheless, the structures we do find in the PDB, even some of the earliest deposited structures, have had an impact on our understanding of function. I highlight a few examples in this review and point to some promises for the future. Promises include new structures from methodologies, such as cryo-EM, that are less affected by the presence of glycans and experiment-aided computational methods that build on existing structures to provide insight into the many ways glycans affect biological function.	[Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Prestegard, JH (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	jpresteg@ccrc.uga.edu		Prestegard, James/0000-0002-1602-4790	NIH [R01-GM033225, R01-GM134335]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The author thanks the following members of my group for assistance in preparing figures and editing the final version of the manuscript: L. Morris, M. Rogals, and R. Williams. This work was supported by grants from the NIH (R01-GM033225 and R01-GM134335). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso J, 2014, J BIOL CHEM, V289, P34433, DOI 10.1074/jbc.R114.609198; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Barb AW, 2011, NAT CHEM BIOL, V7, P147, DOI 10.1038/NCHEMBIO.511; Bonnardel F, 2019, NUCLEIC ACIDS RES, V47, pD1236, DOI 10.1093/nar/gky832; Braunger K, 2018, SCIENCE, V360, P215, DOI 10.1126/science.aar7899; Casalino L, 2020, ACS CENTRAL SCI, V6, P1722, DOI 10.1021/acscentsci.0c01056; Chakraborty A, 2020, BIOCHEM SOC T, V48, P1089, DOI 10.1042/BST20191084; Chalmers GR, 2019, J MOL BIOL, V431, P2369, DOI 10.1016/j.jmb.2019.04.029; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Cheetham JC, 1998, NAT STRUCT BIOL, V5, P861, DOI 10.1038/2302; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Cobb BA, 2020, GLYCOBIOLOGY, V30, P202, DOI 10.1093/glycob/cwz065; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Cummings RD, 2014, CHEM BIOL, V21, P1, DOI 10.1016/j.chembiol.2013.12.010; Danev R, 2019, TRENDS BIOCHEM SCI, V44, P837, DOI 10.1016/j.tibs.2019.04.008; Dashti H, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0547-y; Davies GJ, 2009, AUST J CHEM, V62, P528, DOI 10.1071/CH09038; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Everett JK, 2016, PROTEIN SCI, V25, P30, DOI 10.1002/pro.2774; Frank M, 2014, J MOL BIOL, V426, P1799, DOI 10.1016/j.jmb.2014.01.011; Fulcher YG, 2017, STRUCTURE, V25, P1100, DOI 10.1016/j.str.2017.05.019; Gao Q, 2018, BIOCHEMISTRY-US, V57, P2189, DOI 10.1021/acs.biochem.8b00241; Grant OC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71748-7; Hart GW, 2019, J BIOL CHEM, V294, P2211, DOI 10.1074/jbc.AW119.003226; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irvine EB, 2020, GLYCOBIOLOGY, V30, P241, DOI 10.1093/glycob/cwaa018; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KELLY JA, 1979, NATURE, V282, P875, DOI 10.1038/282875a0; Koukos PI, 2020, J MOL BIOL, V432, P2861, DOI 10.1016/j.jmb.2019.11.009; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; LEMIEUX RU, 1994, ADV CARBOHYD CHEM BI, V50, P1, DOI 10.1016/S0065-2318(08)60149-3; Levine ZG, 2016, ANNU REV BIOCHEM, V85, P631, DOI 10.1146/annurev-biochem-060713-035344; Li BB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00865-1; Limb MAL, 2019, CHEM-EUR J, V25, P764, DOI 10.1002/chem.201805250; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Moremen KW, 2018, NAT CHEM BIOL, V14, P156, DOI [10.1038/NCHEMBIO.2539, 10.1038/nchembio.2539]; Murin CD, 2019, NAT MICROBIOL, V4, P734, DOI 10.1038/s41564-019-0392-y; Neelamegham S, 2019, GLYCOBIOLOGY, V29, P620, DOI 10.1093/glycob/cwz045; NOSE M, 1983, P NATL ACAD SCI-BIOL, V80, P6632, DOI 10.1073/pnas.80.21.6632; Ognjenovic J, 2019, ANNU REV BIOMED ENG, V21, P395, DOI 10.1146/annurev-bioeng-060418-052453; Ohtake Y, 2015, BRAIN RES, V1619, P22, DOI 10.1016/j.brainres.2014.08.064; Okerblom J, 2017, CHEMBIOCHEM, V18, P1155, DOI 10.1002/cbic.201700077; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramirez AS, 2019, SCIENCE, V366, P1372, DOI 10.1126/science.aaz3505; Roth C, 2017, NAT CHEM BIOL, V13, P610, DOI 10.1038/nchembio.2358; Shukla R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16600-2; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Thieker DF, 2016, GLYCOBIOLOGY, V26, P786, DOI 10.1093/glycob/cww076; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Uversky VN, 2017, MOL BIOSYST, V13, P56, DOI 10.1039/c6mb00657d; Valverde P, 2019, MEDCHEMCOMM, V10, P1678, DOI 10.1039/c9md00292h; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Varki A., ESSENTIALS GLYCOBIOL, V3rd, P387; Wang P, 2013, SCIENCE, V342, P1357, DOI 10.1126/science.1245095; Wang YX, 2020, CHEMBIOCHEM, V21, P3301, DOI 10.1002/cbic.202000347; Williams CL, 2016, BIOENERG RES, V9, P1, DOI 10.1007/s12155-015-9694-y; WITHKA JM, 1993, STRUCTURE, V1, P69, DOI 10.1016/0969-2126(93)90009-6; Woods R. J., 2020, 2005 2020 GLYCAM WEB; Woods RJ, 2018, CHEM REV, V118, P8005, DOI 10.1021/acs.chemrev.8b00032; Yamaguchi Y, 2020, GLYCOBIOLOGY, V30, P214, DOI 10.1093/glycob/cwz068; Yanaka S, 2018, J BIOMOL NMR, V71, P193, DOI 10.1007/s10858-018-0169-2; Yang Q, 2017, ACS CHEM BIOL, V12, P1665, DOI 10.1021/acschembio.7b00282	68	8	8	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100556	10.1016/j.jbc.2021.100556	http://dx.doi.org/10.1016/j.jbc.2021.100556			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744289	gold, Green Published			2022-12-28	WOS:000672866400529
J	Rehling, D; Zhang, SM; Jemth, AS; Koolmeister, T; Throup, A; Wallner, O; Scaletti, E; Moriyama, T; Nishii, R; Davies, J; Desroses, M; Rudd, SG; Scobie, M; Homan, E; Berglund, UW; Yang, JJ; Helleday, T; Stenmark, P				Rehling, Daniel; Zhang, Si Min; Jemth, Ann-Sofie; Koolmeister, Tobias; Throup, Adam; Wallner, Olov; Scaletti, Emma; Moriyama, Takaya; Nishii, Rina; Davies, Jonathan; Desroses, Matthieu; Rudd, Sean G.; Scobie, Martin; Homan, Evert; Berglund, Ulrika Warpman; Yang, Jun J.; Helleday, Thomas; Stenmark, Pal			Crystal structures of NUDT15 variants enabled by a potent inhibitor reveal the structural basis for thiopurine sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH REPAIR; METHYLTRANSFERASE; 6-MERCAPTOPURINE; THERAPY; 6-THIOGUANINE; AZATHIOPRINE; INTOLERANCE	The enzyme NUDT15 efficiently hydrolyzes the active metabolites of thiopurine drugs, which are routinely used for treating cancer and inflammatory diseases. Loss-of-function variants in NUDT15 are strongly associated with thiopurine intolerance, such as leukopenia, and preemptive NUDT15 genotyping has been clinically implemented to personalize thiopurine dosing. However, understanding the molecular consequences of these variants has been difficult, as no structural information was available for NUDT15 proteins encoded by clinically actionable pharmacogenetic variants because of their inherent instability. Recently, the small molecule NUDT15 inhibitor TH1760 has been shown to sensitize cells to thiopurines, through enhanced accumulation of 6-thio-guanine in DNA. Building upon this, we herein report the development of the potent and specific NUDT15 inhibitor, TH7755. TH7755 demonstrates a greatly improved cellular target engagement and 6-thioguanine potentiation compared with TH1760, while showing no cytotoxicity on its own. This potent inhibitor also stabilized NUDT15, enabling analysis by X-ray crystallography. We have determined high-resolution structures of the clinically relevant NUDT15 variants Arg139Cys, Arg139His, Val18Ile, and V18_V19insGlyVal. These structures provide clear insights into the structural basis for the thiopurine intolerance phenotype observed in patients carrying these pharmacogenetic variants. These findings will aid in predicting the effects of new NUDT15 sequence variations yet to be discovered in the clinic.	[Rehling, Daniel; Scaletti, Emma; Davies, Jonathan; Stenmark, Pal] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden; [Zhang, Si Min; Jemth, Ann-Sofie; Koolmeister, Tobias; Throup, Adam; Wallner, Olov; Desroses, Matthieu; Rudd, Sean G.; Scobie, Martin; Homan, Evert; Berglund, Ulrika Warpman; Helleday, Thomas] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden; [Scaletti, Emma; Davies, Jonathan; Stenmark, Pal] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Moriyama, Takaya; Nishii, Rina; Yang, Jun J.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Helleday, Thomas] Univ Sheffield, Weston Pk Canc Ctr, Dept Oncol & Metab, Sheffield, S Yorkshire, England	Stockholm University; Karolinska Institutet; Lund University; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Sheffield	Stenmark, P (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden.; Helleday, T (corresponding author), Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden.; Stenmark, P (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.; Helleday, T (corresponding author), Univ Sheffield, Weston Pk Canc Ctr, Dept Oncol & Metab, Sheffield, S Yorkshire, England.	thomas.helleday@scilifelab.se; stenmark@dbb.su.se	Rudd, Sean/AAC-3150-2019; Nishii, Rina/AAC-4177-2022	Rudd, Sean/0000-0002-4368-3855; Scaletti, Emma Rose/0000-0002-8741-8981; Rehling, Daniel/0000-0002-8627-3469; Jemth, Ann-Sofie/0000-0002-7550-1833; Davies, Jonathan/0000-0002-4986-8594; Homan, Evert/0000-0002-9057-1848; Zhang, Si Min/0000-0001-7763-603X	Swedish Research Council [2018-03406, 2018-02114, 2015-00162]; European Research Council [TAROX-695376]; Swedish Cancer Society [201287 PjF, CAN2018/0658, 19-0056-JI]; Knut and Alice Wallenberg Foundation [KAW2014.0273]; Swedish Children's Cancer Foundation [PR2018-0095, PR2019-0014]; Swedish Pain Relief Foundation [SSF/01-05]; Crafoord Foundation; Torsten and Ragnar Soderberg Foundation; Felix Mindus contribution to Leukemia Research [2019-02004, 2020-02573]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Children's Cancer Foundation; Swedish Pain Relief Foundation; Crafoord Foundation; Torsten and Ragnar Soderberg Foundation; Felix Mindus contribution to Leukemia Research	This project was supported by the Swedish Research Council (P. S. 2018-03406, T. H. 2015-00162, S. G. R. 2018-02114), the European Research Council (TAROX-695376, T. H.), Swedish Cancer Society (201287 PjF, P. S.; CAN2018/0658, T. H.; 19-0056-JI, S. G. R). The Knut and Alice Wallenberg Foundation (KAW2014.0273, T. H.; P. S.), the Swedish Children's Cancer Foundation (PR2018-0095, T. H.; PR2019-0014, S. G. R.), the Swedish Pain Relief Foundation (SSF/01-05, T. H.), the Crafoord Foundation (P. S.), the Torsten and Ragnar Soderberg Foundation (T. H.), and the Felix Mindus contribution to Leukemia Research (2019-02004 and 2020-02573, S. M. Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Beilsten-Edmands J, 2020, ACTA CRYSTALLOGR D, V76, P385, DOI 10.1107/S2059798320003198; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bradford K, 2011, WORLD J GASTROENTERO, V17, P4166, DOI 10.3748/wjg.v17.i37.4166; Carter M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8871; Chojnacki S, 2017, NUCLEIC ACIDS RES, V45, pW550, DOI 10.1093/nar/gkx273; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fotoohi AK, 2010, BIOCHEM PHARMACOL, V79, P1211, DOI 10.1016/j.bcp.2010.01.006; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Gardiner SJ, 2008, CLIN GASTROENTEROL H, V6, P654, DOI 10.1016/j.cgh.2008.02.032; Kovalevskiy O, 2018, ACTA CRYSTALLOGR D, V74, P215, DOI 10.1107/S2059798318000979; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; Li GM, 1999, ONCOL RES, V11, P393; LING YH, 1991, MOL PHARMACOL, V40, P508; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Moriyama T, 2016, NAT GENET, V48, P367, DOI 10.1038/ng.3508; NELSON JA, 1975, CANCER RES, V35, P2872; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Regueiro M, 2002, J CLIN GASTROENTEROL, V35, P240, DOI 10.1097/00004836-200209000-00008; Relling MV, 2019, CLIN PHARMACOL THER, V105, P1095, DOI 10.1002/cpt.1304; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Schmiegelow K, 2014, J PEDIAT HEMATOL ONC, V36, P503, DOI 10.1097/MPH.0000000000000206; Suiter CC, 2020, P NATL ACAD SCI USA, V117, P5394, DOI 10.1073/pnas.1915680117; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Valerie NCK, 2016, CANCER RES, V76, P5501, DOI 10.1158/0008-5472.CAN-16-0584; WARREN DJ, 1995, CANCER RES, V55, P1670; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang JJ, 2015, J CLIN ONCOL, V33, P1235, DOI 10.1200/JCO.2014.59.4671; Yang SK, 2014, NAT GENET, V46, P1017, DOI 10.1038/ng.3060; Zhang RS, 2019, DRUG DELIV, V26, P328, DOI 10.1080/10717544.2019.1582730; Zhang SM, 2020, NAT CHEM BIOL, V16, P1120, DOI 10.1038/s41589-020-0592-z	35	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100568	10.1016/j.jbc.2021.100568	http://dx.doi.org/10.1016/j.jbc.2021.100568			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753169	Green Accepted, gold, Green Published			2022-12-28	WOS:000672866400541
J	Sharif, AS; Gerstner, CD; Cady, MA; Arshavsky, VY; Mitchell, C; Ying, GX; Frederick, JM; Baehr, W				Sharif, Ali S.; Gerstner, Cecilia D.; Cady, Martha A.; Arshavsky, Vadim Y.; Mitchell, Christina; Ying, Guoxin; Frederick, Jeanne M.; Baehr, Wolfgang			Deletion of the phosphatase INPP5E in the murine retina impairs photoreceptor axoneme formation and prevents disc morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL POLYPHOSPHATE 5-PHOSPHATASES; JOUBERT SYNDROME; INTRAFLAGELLAR TRANSPORT; PROTEIN TRAFFICKING; TRANSITION ZONE; OUTER SEGMENTS; PHOSPHOINOSITIDES; CILIA; CILIOGENESIS; TRANSDUCIN	INPP5E, also known as pharbin, is a ubiquitously expressed phosphatidylinositol polyphosphate 5-phosphatase that is typically located in the primary cilia and modulates the phosphoinositide composition of membranes. Mutations to or loss of INPP5E is associated with ciliary dysfunction. INPP5E missense mutations of the phosphatase catalytic domain cause Joubert syndrome in humans-a syndromic ciliopathy affecting multiple tissues including the brain, liver, kidney, and retina. In contrast to other primary cilia, photoreceptor INPP5E is prominently expressed in the inner segment and connecting cilium and absent in the outer segment, which is a modified primary cilium dedicated to phototransduction. To investigate how loss of INPP5e causes retina degeneration, we generated mice with a retina-specific KO (Inpp5e(F/F);Six3Cre, abbreviated as (ret)Inpp5e(-/-)). These mice exhibit a rapidly progressing rod-cone degeneration resembling Leber congenital amaurosis that is nearly completed by postnatal day 21 (P21) in the central retina. Mutant cone outer segments contain vesicles instead of discs as early as P8. Although P10 mutant outer segments contain structural and phototransduction proteins, axonemal structure and disc membranes fail to form. Connecting cilia of (ret)Inpp5e(-/-) rods display accumulation of intraflagellar transport particles A and B at their distal ends, suggesting disrupted intraflagellar transport. Although INPP5E ablation may not prevent delivery of outer segment-specific proteins by means of the photoreceptor secretory pathway, its absence prevents the assembly of axonemal and disc components. Herein, we suggest a model for INPP5E-Leber congenital amaurosis, proposing how deletion of INPP5E may interrupt axoneme extension and disc membrane elaboration.	[Sharif, Ali S.; Gerstner, Cecilia D.; Ying, Guoxin; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; [Cady, Martha A.; Arshavsky, Vadim Y.] Duke Univ, Dept Ophthalmol, Durham, NC USA; [Mitchell, Christina] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Baehr, Wolfgang] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Duke University; Monash University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.; Baehr, W (corresponding author), Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.; Baehr, W (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	wbaehr@hsc.utah.edu			NIH [EY08123, EY019298, EY012859, EY005722, EY014800-039003, 5T32 EY024234]; Research to Prevent Blindness (RPB; New York); Retina Research Foundation, Houston; RPB Senior Investigator award; RPB Nelson Trust award; NEI training grant	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB; New York)(Research to Prevent Blindness (RPB)); Retina Research Foundation, Houston; RPB Senior Investigator award; RPB Nelson Trust award; NEI training grant	This work was supported by NIH Grants EY08123, EY019298 (to W. B.); EY012859 (to V. Y. A.); EY005722 (to V. Y. A.); EY014800-039003 (NEI core grant); 5T32 EY024234 (NEI training grant) by unrestricted grants to the University of Utah Department of Ophthalmology from Research to Prevent Blindness (RPB; New York) and by a grant from the Retina Research Foundation, Houston (Alice McPherson, MD). W. B. and V. Y. A. are recipients of the RPB Senior Investigator award and the RPB Nelson Trust award. A. S. S. is a fellow on the NEI training grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Badgandi HB, 2017, J CELL BIOL, V216, P743, DOI 10.1083/jcb.201607095; Baehr W, 2014, INVEST OPHTH VIS SCI, V55, P8653, DOI 10.1167/iovs.14-16066; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Boldt K, 2011, J CLIN INVEST, V121, P2169, DOI 10.1172/JCI45627; CHAITIN MH, 1991, EXP EYE RES, V53, P107, DOI 10.1016/0014-4835(91)90152-5; Chavez M, 2015, DEV CELL, V34, P338, DOI 10.1016/j.devcel.2015.06.016; Conduit SE, 2012, FEBS LETT, V586, P2846, DOI 10.1016/j.febslet.2012.07.037; Dyson JM, 2017, J CELL BIOL, V216, P247, DOI 10.1083/jcb.201511055; Fansa EK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11366; Fei YJ, 2003, MOL VIS, V9, P31; Finkelstein S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061417; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Garcia-Gonzalo FR, 2015, DEV CELL, V34, P400, DOI 10.1016/j.devcel.2015.08.001; Hagstrom SA, 2012, ADV EXP MED BIOL, V723, P783, DOI 10.1007/978-1-4614-0631-0_100; Hakim S, 2016, HUM MOL GENET, V25, P2295, DOI 10.1093/hmg/ddw097; Hanke-Gogokhia C, 2017, J BIOL CHEM, V292, P21442, DOI 10.1074/jbc.RA117.000141; Hanke-Gogokhia C, 2016, J BIOL CHEM, V291, P7142, DOI 10.1074/jbc.M115.710954; Hardee I, 2017, AM J MED GENET A, V173, P3231, DOI 10.1002/ajmg.a.38376; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; Kosling SK, 2018, BIOL CHEM, V399, P277, DOI 10.1515/hsz-2017-0226; Kong AM, 2000, J BIOL CHEM, V275, P24052, DOI 10.1074/jbc.M000874200; Krock BL, 2009, INVEST OPHTH VIS SCI, V50, P5463, DOI 10.1167/iovs.09-3828; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Nachury MV, 2019, NAT REV MOL CELL BIO, V20, P389, DOI 10.1038/s41580-019-0116-4; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Nozaki S, 2017, J CELL SCI, V130, P563, DOI 10.1242/jcs.197004; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Plotnikova OV, 2015, J CELL SCI, V128, P364, DOI 10.1242/jcs.161323; Rao KN, 2016, HUM MOL GENET, V25, P4533, DOI 10.1093/hmg/ddw281; Roberson EC, 2015, J CELL BIOL, V209, P129, DOI 10.1083/jcb.201411087; Ronquillo CC, 2016, FASEB J, V30, P3400, DOI 10.1096/fj.201600511R; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Scholey JM, 2012, VISION RES, V75, P44, DOI 10.1016/j.visres.2012.06.015; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Spencer WJ, 2020, TRENDS CELL BIOL, V30, P904, DOI 10.1016/j.tcb.2020.08.005; Spencer WJ, 2019, P NATL ACAD SCI USA, V116, P13087, DOI 10.1073/pnas.1906421116; Thomas S, 2014, HUM MUTAT, V35, P137, DOI 10.1002/humu.22470; Travaglini L, 2013, EUR J HUM GENET, V21, P1074, DOI 10.1038/ejhg.2012.305; Vig A, 2020, GENET MED, V22, P2041, DOI 10.1038/s41436-020-0915-1; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Wensel TG, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040866; Xi QS, 2005, INVEST OPHTH VIS SCI, V46, P4754, DOI 10.1167/iovs.05-0693; Xu WY, 2017, J AM SOC NEPHROL, V28, P118, DOI 10.1681/ASN.2015080906; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915; Zhang HB, 2012, VISION RES, V75, P19, DOI 10.1016/j.visres.2012.08.013	64	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100529	10.1016/j.jbc.2021.100529	http://dx.doi.org/10.1016/j.jbc.2021.100529			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33711342	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400503
J	Smith, AD; Garcia-Santamarina, S; Ralle, M; Loiselle, DR; Haystead, TA; Thiele, DJ				Smith, Aaron D.; Garcia-Santamarina, Sarela; Ralle, Martina; Loiselle, David R.; Haystead, Timothy A.; Thiele, Dennis J.			Transcription factor-driven alternative localization of Cryptococcus neoformans superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE ACTIVATION; TERMINAL ACETYLATION; BRITISH-COLUMBIA; IRON TRANSPORT; CODON CONTEXT; COPPER; METAL; YEAST; MITOCHONDRIA; RESISTANCE	Cryptococcus neoformans is an opportunistic fungal pathogen whose pathogenic lifestyle is linked to its ability to cope with fluctuating levels of copper (Cu), an essential metal involved in multiple virulence mechanisms, within distinct host niches. During lethal cryptococcal meningitis in the brain, C. neoformans senses a Cu-deficient environment and is highly dependent on its ability to scavenge trace levels of Cu from its host and adapt to Cu scarcity to successfully colonize this niche. In this study, we demonstrate for this critical adaptation, the Cu-sensing transcription factor Cuf1 differentially regulates the expression of the SOD1 and SOD2 superoxide dismutases in novel ways. Genetic and transcriptional analysis reveals Cuf1 specifies 5'-truncations of the SOD1 and SOD2 mRNAs through specific binding to Cu responsive elements within their respective promoter regions. This results in Cuf1-dependent repression of the highly abundant SOD1 and simultaneously induces expression of two isoforms of SOD2, the canonical mitochondrial targeted isoform and a novel alternative cytosolic isoform, from a single alternative transcript produced specifically under Cu limitation. The generation of cytosolic Sod2 during Cu limitation is required to maintain cellular antioxidant defense against superoxide stress both in vitro and in vivo. Further, decoupling Cuf1 regulation of Sod2 localization compromises the ability of C. neoformans to colonize organs in murine models of cryptococcosis. Our results provide a link between transcription factor-mediated alteration of protein localization and cell proliferation under stress, which could impact tissue colonization by a fungal pathogen.	[Smith, Aaron D.; Garcia-Santamarina, Sarela; Loiselle, David R.; Haystead, Timothy A.; Thiele, Dennis J.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Ralle, Martina] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Thiele, Dennis J.] Duke Univ, Dept Biochem, Durham, NC 27708 USA; [Thiele, Dennis J.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Smith, Aaron D.] George Mason Univ, Coll Sci, Fairfax, VA 22030 USA; [Garcia-Santamarina, Sarela] European Mol Biol Lab, Heidelberg, Germany; [Thiele, Dennis J.] Sisu Pharma Inc, Chapel Hill, NC 27514 USA	Duke University; Oregon Health & Science University; Duke University; Duke University; George Mason University; European Molecular Biology Laboratory (EMBL)	Thiele, DJ (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Thiele, DJ (corresponding author), Duke Univ, Dept Biochem, Durham, NC 27708 USA.; Thiele, DJ (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.; Thiele, DJ (corresponding author), Sisu Pharma Inc, Chapel Hill, NC 27514 USA.	dthiele@sisupharma.com	Garcia Santamarina, Sarela/O-4477-2017	Garcia Santamarina, Sarela/0000-0002-0611-7918; Smith, Aaron/0000-0001-8864-1934	United States National Institutes of Health (NIH) [GM041840-30, DK074192]; NIH Molecular Mycology and Pathogenesis Training Program [5T32AI052080]; NIH [S10RR025512]	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Molecular Mycology and Pathogenesis Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by funds from the United States National Institutes of Health (NIH) (GM041840-30 to D. J. T.) and (DK074192 to M. R.), and the NIH Molecular Mycology and Pathogenesis Training Program (5T32AI052080 to A. D. S.). ICPMS measurements were performed in the OHSU Elemental Analysis Core with partial support from NIH (S10RR025512). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Akulich KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep37905; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barton CH, 1999, J LEUKOCYTE BIOL, V66, P757, DOI 10.1002/jlb.66.5.757; Besold AN, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00779-17; Besold AN, 2016, J BIOL INORG CHEM, V21, P137, DOI 10.1007/s00775-016-1335-1; Blaby-Haas CE, 2013, CURR OPIN MICROBIOL, V16, P677, DOI 10.1016/j.mib.2013.07.019; Brancaccio D, 2017, J AM CHEM SOC, V139, P719, DOI 10.1021/jacs.6b09567; Brown DE, 2013, VET PATHOL, V50, P867, DOI 10.1177/0300985813478213; Broxton CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168400; Byrnes EJ, 2011, MICROBES INFECT, V13, P895, DOI 10.1016/j.micinf.2011.05.009; Chang CP, 2012, NUCLEIC ACIDS RES, V40, P314, DOI 10.1093/nar/gkr724; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chen Y, 2014, MBIO, V5, DOI 10.1128/mBio.01087-13; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Culbertson EM, 2020, MOL MICROBIOL, V114, P1006, DOI 10.1111/mmi.14591; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Dickinson EK, 2000, J BIOL CHEM, V275, P26780; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Ding C, 2011, MOL MICROBIOL, V81, P1560, DOI 10.1111/j.1365-2958.2011.07794.x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; EILERS M, 1988, CELL, V52, P481, DOI 10.1016/0092-8674(88)90458-8; Festa RA, 2014, CHEM BIOL, V21, P977, DOI 10.1016/j.chembiol.2014.06.009; Festa RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002887; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; Gaddy JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004450; Garcia-Santamarina S, 2018, MOL MICROBIOL, V108, P473, DOI 10.1111/mmi.13960; Garcia-Santamarina S, 2017, MBIO, V8, DOI [10.1128/mBio.01742-17, 10.1128/mbio.01742-17]; Garcia-Santamarina S, 2015, J BIOL CHEM, V290, P18945, DOI 10.1074/jbc.R115.649129; Geslain R, 2000, RNA, V6, P434, DOI 10.1017/S1355838200992331; Giles SS, 2005, EUKARYOT CELL, V4, P46, DOI 10.1128/EC.4.1.46-54.2005; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Hawkins CL, 2001, BBA-BIOENERGETICS, V1504, P196, DOI 10.1016/S0005-2728(00)00252-8; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hylander BL, 2019, J IMMUNOL, V202, P631, DOI 10.4049/jimmunol.1800621; Hyre AN, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.01041-16; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Jung WH, 2009, EUKARYOT CELL, V8, P1511, DOI 10.1128/EC.00166-09; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kropat J, 2015, P NATL ACAD SCI USA, V112, P2644, DOI 10.1073/pnas.1422492112; Kuhn DE, 1999, J LEUKOCYTE BIOL, V66, P113, DOI 10.1002/jlb.66.1.113; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Ladomersky E, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00351-17; Ladomersky E, 2015, METALLOMICS, V7, P957, DOI 10.1039/c4mt00327f; Li CX, 2015, P NATL ACAD SCI USA, V112, pE5336, DOI 10.1073/pnas.1513447112; Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200; Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Merchant SS, 2012, ADV MICROB PHYSIOL, V60, P91, DOI 10.1016/B978-0-12-398264-3.00002-4; Montefusco S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079455; Mourad A, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170391; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/S1473-3099(17)30243-8, 10.1016/s1473-3099(17)30243-8]; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shen Q, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007444; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Smith AD, 2017, ANNU REV MICROBIOL, V71, P597, DOI 10.1146/annurev-micro-030117-020444; Stafford SL, 2013, BIOSCIENCE REP, V33, P541, DOI 10.1042/BSR20130014; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Subashchandrabose S, 2014, P NATL ACAD SCI USA, V111, P18327, DOI 10.1073/pnas.1415959112; Sun TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6550; Tan GQ, 2014, MOL MICROBIOL, V93, P629, DOI 10.1111/mmi.12676; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Torres AS, 2001, J BIOL CHEM, V276, P38410, DOI 10.1074/jbc.M104790200; Wallace EWJ, 2020, NUCLEIC ACIDS RES, V48, P2312, DOI 10.1093/nar/gkaa060; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Waterman SR, 2012, MBIO, V3, DOI 10.1128/mBio.00285-12; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; WISPE JR, 1989, BIOCHIM BIOPHYS ACTA, V994, P30, DOI 10.1016/0167-4838(89)90058-7; Woodacre A, 2008, MICROBIOL-SGM, V154, P1502, DOI 10.1099/mic.0.2007/013441-0; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; Zwilling BS, 1999, INFECT IMMUN, V67, P1386, DOI 10.1128/IAI.67.3.1386-1392.1999	84	3	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100391	10.1016/j.jbc.2021.100391	http://dx.doi.org/10.1016/j.jbc.2021.100391			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33567338	gold, Green Published			2022-12-28	WOS:000672866400365
J	Sutton, EC; DeRose, VJ				Sutton, Emily C.; DeRose, Victoria J.			Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE I; DNA-DAMAGE; TRANSCRIPTION; ACTIVATION; REDISTRIBUTION; COMPONENTS; ADDUCTS; CX-5461; CYCLE; P53	Recent reports provide evidence that the platinum chemotherapeutic oxaliplatin causes cell death via ribosome biogenesis stress, while cisplatin causes cell death via the DNA damage response (DDR). Underlying differences in mechanisms that might initiate disparate routes to cell death by these two broadly used platinum compounds have not yet been carefully explored. Additionally, prior studies had demonstrated that cisplatin can also inhibit ribosome biogenesis. Therefore, we sought to directly compare the initial influences of oxaliplatin and cisplatin on nucleolar processes and on the DDR. Using pulse-chase experiments, we found that at equivalent doses, oxaliplatin but not cisplatin significantly inhibited ribosomal RNA (rRNA) synthesis by Pol I, but neither compound affected rRNA processing. Inhibition of rRNA synthesis occurred as early as 90 min after oxaliplatin treatment in A549 cells, concurrent with the initial redistribution of the nucleolar protein nucleophosmin (NPM1). We observed that the nucleolar protein fibrillarin began to redistribute by 6 h after oxaliplatin treatment and formed canonical nucleolar caps by 24 h. In cisplatin-treated cells, DNA damage, as measured by gamma H2AX immunofluorescence, was more extensive, whereas nucleolar organization was unaffected. Taken together, our results demonstrate that oxaliplatin causes early nucleolar disruption via inhibition of rRNA synthesis accompanied by NPM1 relocalization and subsequently causes extensive nucleolar reorganization, while cisplatin causes early DNA damage without significant nucleolar disruption. These data support a model in which, at clinically relevant doses, cisplatin kills cells via the canonical DDR, and oxaliplatin kills cells via ribosome biogenesis stress, specifically via rapid inhibition of rRNA synthesis.	[Sutton, Emily C.] Univ Oregon, Dept Biol, Eugene, OR 97403 USA; [Sutton, Emily C.; DeRose, Victoria J.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [DeRose, Victoria J.] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA	University of Oregon; University of Oregon; University of Oregon	DeRose, VJ (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.; DeRose, VJ (corresponding author), Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA.	derose@uoregon.edu		Sutton, Emily/0000-0002-9607-3890	National Science Foundation [CHE1710721, CHE1531189]; National Institutes of Health [T32 GM007759-29]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation [CHE1710721 to V. J. D. and CHE1531189 for microscopy] and the National Institutes of Health [T32 GM007759-29 to E. C. S.].	Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brodska B, 2016, J CELL BIOCHEM, V117, P1319, DOI 10.1002/jcb.25420; Bruno PM, 2020, P NATL ACAD SCI USA, V117, P4053, DOI 10.1073/pnas.1921649117; Bruno PM, 2017, NAT MED, V23, P461, DOI 10.1038/nm.4291; Burger K, 2013, RNA BIOL, V10, P1623, DOI 10.4161/rna.26214; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Bursac S, 2014, BBA-MOL BASIS DIS, V1842, P817, DOI 10.1016/j.bbadis.2013.08.014; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Gilder AS, 2011, MOL BIOL CELL, V22, P1070, DOI 10.1091/mbc.E10-08-0731; Haddach M, 2012, ACS MED CHEM LETT, V3, P602, DOI 10.1021/ml300110s; Hamdane N, 2015, ONCOTARGET, V6, P27519, DOI 10.18632/oncotarget.4823; Horky M, 2001, J CELL SCI, V114, P663; Jordan P, 1998, NUCLEIC ACIDS RES, V26, P2831, DOI 10.1093/nar/26.12.2831; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Korsholm LM, 2020, NUCLEIC ACIDS RES, V48, P9449, DOI 10.1093/nar/gkaa713; Kruhlak M, 2007, NATURE, V447, P730, DOI 10.1038/nature05842; Larsen DH, 2014, NAT CELL BIOL, V16, P792, DOI 10.1038/ncb3007; Lee C, 2005, CANCER RES, V65, P9834, DOI 10.1158/0008-5472.CAN-05-1759; McDevitt CE, 2019, J BIOL INORG CHEM, V24, P899, DOI 10.1007/s00775-019-01707-9; McKeage MJ, 2001, BRIT J CANCER, V85, P1219, DOI 10.1054/bjoc.2001.2024; Nicolas E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11390; Ozdian T, 2017, J PROTEOMICS, V162, P73, DOI 10.1016/j.jprot.2017.05.005; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Peltonen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012996; Pickard AJ, 2013, CHEMMEDCHEM, V8, P1441, DOI 10.1002/cmdc.201300262; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Scott DD, 2016, BIOCHEM CELL BIOL, V94, P419, DOI 10.1139/bcb-2016-0068; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sutton EC, 2019, J AM CHEM SOC, V141, P18411, DOI 10.1021/jacs.9b10319; Terenzi A, 2016, J INORG BIOCHEM, V165, P71, DOI 10.1016/j.jinorgbio.2016.06.021; TREIBER DK, 1994, P NATL ACAD SCI USA, V91, P5672, DOI 10.1073/pnas.91.12.5672; Tsai RYL, 2014, FASEB J, V28, P3290, DOI 10.1096/fj.14-254680; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; van Sluis M, 2017, CURR OPIN CELL BIOL, V46, P81, DOI 10.1016/j.ceb.2017.03.004; van Sluis M, 2015, GENE DEV, V29, P1151, DOI 10.1101/gad.260703.115; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wei M, 2001, J BIOL CHEM, V276, P38774, DOI 10.1074/jbc.M106374200; Wei T, 2018, CELL REP, V23, P404, DOI 10.1016/j.celrep.2018.03.066; Woods SJ, 2015, BBA-GENE REGUL MECH, V1849, P821, DOI 10.1016/j.bbagrm.2014.10.007; Woynarowski JM, 2000, MOL PHARMACOL, V58, P920, DOI 10.1124/mol.58.5.920; Woynarowski JM, 1998, MOL PHARMACOL, V54, P770, DOI 10.1124/mol.54.5.770; Yang K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13599; Zhai XQ, 1998, BIOCHEMISTRY-US, V37, P16307, DOI 10.1021/bi981708h	50	7	7	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100633	10.1016/j.jbc.2021.100633	http://dx.doi.org/10.1016/j.jbc.2021.100633			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33819479	Green Published, gold			2022-12-28	WOS:000672866400604
J	Tamura, K; Dejean, G; Van Petegem, F; Brumer, H				Tamura, Kazune; Dejean, Guillaume; Van Petegem, Filip; Brumer, Harry			Distinct protein architectures mediate species-specific beta-glucan binding and metabolism in the human gut microbiota	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; LIGAND-BINDING; DENSITY MODIFICATION; MIXED-LINKAGE; RECOGNITION; MODULE; BACTERIA; REVEALS; REFINEMENT; MECHANISM	Complex glycans that evade our digestive system are major nutrients that feed the human gut microbiota (HGM). The prevalence of Bacteroidetes in the HGM of populations worldwide is engendered by the evolution of polysaccharide utilization loci (PULs), which encode concerted protein systems to utilize the myriad complex glycans in our diets. Despite their crucial roles in glycan recognition and transport, cell-surface glycan-binding proteins (SGBPs) remained understudied cogs in the PUL machinery. Here, we report the structural and biochemical characterization of a suite of SGBP-A and SGBP-B structures from three syntenic beta(1,3)-glucan utilization loci (1,3GULs) from Bacteroides thetaiotaomicron (Bt), Bacteroides uniformis (Bu), and B. fluxus (Bf), which have varying specificities for distinct beta-glucans. Ligand complexes provide definitive insight into beta(1,3)-glucan selectivity in the HGM, including structural features enabling dual beta(1,3)-glucan/mixed-linkage beta(1,3)/beta(1,4)-glucan-binding capability in some orthologs. The tertiary structural conservation of SusD-like SGBPs-A is juxtaposed with the diverse architectures and binding modes of the SGBPs-B. Specifically, the structures of the trimodular BtSGBP-B and BuSGBP-B revealed a tandem repeat of carbohydrate-binding module-like domains connected by long linkers. In contrast, BfSGBP-B comprises a bimodular architecture with a distinct beta-barrel domain at the C terminus that bears a shallow binding canyon. The molecular insights obtained here contribute to our fundamental understanding of HGM function, which in turn may inform tailored microbial intervention therapies.	[Tamura, Kazune; Dejean, Guillaume; Brumer, Harry] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Tamura, Kazune; Van Petegem, Filip; Brumer, Harry] Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Inst, Vancouver, BC, Canada; [Brumer, Harry] Univ British Columbia, Dept Chem, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Brumer, H (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada.; Brumer, H (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Inst, Vancouver, BC, Canada.; Brumer, H (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC, Canada.	brumer@msl.ubc.ca	Dejean, Guillaume/AAU-8207-2021; Van petegem, Filip/M-6061-2016	Tamura, Kazune/0000-0003-4393-5554; Dejean, Guillaume/0000-0003-1950-5693; Van petegem, Filip/0000-0003-2728-8537; Brumer, Harry/0000-0002-0101-862X	Canadian Institutes of Health Research [MOP-119404, MOP-137134, MOP-142472]; Canadian Foundation for Innovation [30663]; British Columbia Knowledge Development Fund; University of British Columbia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; University of British Columbia	Work in the Brumer Lab was supported by operating grants from the Canadian Institutes of Health Research (MOP-137134 and MOP-142472) and infrastructure support from the Canadian Foundation for Innovation (Project #30663) and the British Columbia Knowledge Development Fund. Work in the Van Petegem Lab was supported by the Canadian Institutes of Health Research (MOP-119404). K. T. was partially supported by a 4-year doctoral fellowship from the University of British Columbia.	Abbott W, 2018, GLYCOBIOLOGY, V28, P3, DOI 10.1093/glycob/cwx089; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Bacic A, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P1; Bolam DN, 2012, CURR OPIN STRUC BIOL, V22, P563, DOI 10.1016/j.sbi.2012.06.006; Boraston AB, 2003, J MOL BIOL, V327, P659, DOI 10.1016/S0022-2836(03)00152-9; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P14679, DOI 10.1021/bi015760g; Briliute J, 2019, NAT MICROBIOL, V4, P1571, DOI 10.1038/s41564-019-0466-x; Cameron EA, 2014, MBIO, V5, DOI 10.1128/mBio.01441-14; Cameron EA, 2012, J BIOL CHEM, V287, P34614, DOI 10.1074/jbc.M112.397380; Cartmell A, 2018, NAT MICROBIOL, V3, P1314, DOI 10.1038/s41564-018-0258-8; Cartmell A, 2017, P NATL ACAD SCI USA, V114, P7037, DOI 10.1073/pnas.1704367114; Cockburn D, 2017, METHODS MOL BIOL, V1588, P119, DOI 10.1007/978-1-4939-6899-2_9; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Davies G. J., 2008, BIOCHEMIST, V30, P26, DOI DOI 10.1042/BJ20080382; Dejean G, 2020, MBIO, V11, DOI 10.1128/mBio.00095-20; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; El Khoury D, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/851362; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ficko-Blean E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01832-6; Foley MH, 2018, MOL MICROBIOL, V108, P551, DOI 10.1111/mmi.13949; Fujimura KE, 2015, CELL HOST MICROBE, V17, P592, DOI 10.1016/j.chom.2015.04.007; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Glenwright AJ, 2017, NATURE, V541, P407, DOI 10.1038/nature20828; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Gunness P, 2016, FASEB J, V30, P4227, DOI 10.1096/fj.201600465R; Hehemann JH, 2012, P NATL ACAD SCI USA, V109, P19786, DOI 10.1073/pnas.1211002109; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hemsworth GR, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160142; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Hettle AG, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0721-y; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karunatilaka K, 2013, BIOPHYS J, V104, p526A, DOI 10.1016/j.bpj.2012.11.2909; Kolodziejczyk AA, 2019, NAT REV MICROBIOL, V17, P742, DOI 10.1038/s41579-019-0256-8; Koropatkin N, 2009, BIOCHEMISTRY-US, V48, P1532, DOI 10.1021/bi801942a; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lazaridou A, 2004, FOOD HYDROCOLLOID, V18, P837, DOI 10.1016/j.foodhyd.2004.01.002; Legentil L, 2015, MOLECULES, V20, P9745, DOI 10.3390/molecules20069745; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luis AS, 2018, NAT MICROBIOL, V3, P210, DOI 10.1038/s41564-017-0079-1; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Mystkowska AA, 2018, FEBS J, V285, P4465, DOI 10.1111/febs.14674; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Nilsson U, 2008, EUR J CLIN NUTR, V62, P978, DOI 10.1038/sj.ejcn.1602816; Pires VMR, 2004, J BIOL CHEM, V279, P21560, DOI 10.1074/jbc.M401599200; Pluvinage B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03366-x; Porter NT, 2017, ANNU REV MICROBIOL, V71, P349, DOI 10.1146/annurev-micro-102215-095316; Potterton L, 2018, ACTA CRYSTALLOGR D, V74, P68, DOI 10.1107/S2059798317016035; Ribeiro DO, 2020, FEBS J, V287, P2723, DOI 10.1111/febs.15162; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Tamura K, 2021, CURR OPIN STRUC BIOL, V68, P26, DOI 10.1016/j.sbi.2020.11.001; Tamura K, 2019, CELL MOL LIFE SCI, V76, P4319, DOI 10.1007/s00018-019-03115-3; Tamura K, 2017, CELL REP, V21, P417, DOI 10.1016/j.celrep.2017.09.049; Tauzin AS, 2016, MBIO, V7, DOI 10.1128/mBio.02134-15; Taylor ME, 2014, CURR OPIN STRUC BIOL, V28, P14, DOI 10.1016/j.sbi.2014.07.003; Temple MJ, 2017, J BIOL CHEM, V292, P10639, DOI 10.1074/jbc.M117.787606; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tuson HH, 2018, BIOPHYS J, V115, P242, DOI 10.1016/j.bpj.2017.12.015; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Yaoi K, 2004, STRUCTURE, V12, P1209, DOI 10.1016/j.str.2004.04.020; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zmora N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1815; Zmora N, 2019, NAT REV GASTRO HEPAT, V16, P35, DOI 10.1038/s41575-018-0061-2	90	5	5	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100415	10.1016/j.jbc.2021.100415	http://dx.doi.org/10.1016/j.jbc.2021.100415			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33587952	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400389
J	Whillock, AL; Ybarra, TK; Bishop, GA				Whillock, Amy L.; Ybarra, Tiffany K.; Bishop, Gail A.			TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; TYROSINE KINASE; CUTTING EDGE; IN-VIVO; LYMPHOMA; LYMPHOCYTES; TRAF3; CD40; ACTIVATION; CBL	TRAF3 has diverse signaling functions, which vary by cell type. Uniquely in B lymphocytes, TRAF3 inhibits homeostatic survival. Highlighting the role of TRAF3 as a tumor suppressor, loss-of-function TRAF3 mutations are associated with human B-cell malignancies, while B-cell-specific deletion of TRAF3 in mice leads to autoimmunity and lymphoma development. The role of TRAF3 in inhibiting noncanonical NF-kappa B activation, CD40 and BAFF-R signaling to B cells is well documented. In contrast, TRAF3 enhances many T-cell effector functions, through associating with and enhancing signaling by the T-cell receptor (TCR)-CD28 complex. The present study was designed to determine the role of TRAF3 in signaling via the B-cell antigen receptor (BCR). The BCR is crucial for antigen recognition, survival, proliferation, and antibody production, and defects in BCR signaling can promote abnormal survival of malignant B cells. Here, we show that TRAF3 is associated with both CD79B and the BCR-activated kinases Syk and Btk following BCR stimulation. BCR-induced phosphorylation of Syk and additional downstream kinases was increased in TRAF3(-/-) B cells, with regulation observed in both follicular and marginal zone B-cell subsets. BCR stimulation of TRAF3(-/-) B cells resulted in increased surface expression of MHC-II, CD80, and CD86 molecules. Interestingly, increased survival of TRAF3(-/-) primary B cells was resistant to inhibition of Btk, while TRAF3-deficient malignant B-cell lines showed enhanced sensitivity. TRAF3 serves to restrain normal and malignant BCR signaling, with important implications for its role in normal B-cell biology and abnormal survival of malignant B cells.	[Whillock, Amy L.; Ybarra, Tiffany K.; Bishop, Gail A.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Whillock, Amy L.; Ybarra, Tiffany K.; Bishop, Gail A.] Univ Iowa, Immunol Grad Program, Iowa City, IA 52242 USA; [Whillock, Amy L.; Bishop, Gail A.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA; [Whillock, Amy L.; Bishop, Gail A.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Bishop, Gail A.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bishop, Gail A.] VA Med Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bishop, GA (corresponding author), Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.; Bishop, GA (corresponding author), Univ Iowa, Immunol Grad Program, Iowa City, IA 52242 USA.; Bishop, GA (corresponding author), Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA.; Bishop, GA (corresponding author), Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.; Bishop, GA (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.; Bishop, GA (corresponding author), VA Med Ctr, Iowa City, IA 52246 USA.	gail-bishop@uiowa.edu		Bishop, Gail/0000-0002-1291-5078	National Cancer Institute [P30CA086862]; NIH [T32 AI07485, CA97274, AG065532]; VA Merit Review [I01 BX001702]; Department of Veterans Affairs; Department of Defense Congressionally Directed Medical Research Program Horizon Award [W81XWH-19-1-0442]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; Holden Comprehensive Cancer Center at The University of Iowa;  [GM007337];  [AI007485];  [AI007533]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); Department of Defense Congressionally Directed Medical Research Program Horizon Award(United States Department of Defense); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Holden Comprehensive Cancer Center at The University of Iowa; ; ; 	This work was supported by the Holden Comprehensive Cancer Center at The University of Iowa and its National Cancer Institute Award P30CA086862, NIH P50 grant CA97274, NIH R21 grant AG065532, VA Merit Review I01 BX001702, and a Senior Research Career Scientist award from the Department of Veterans Affairs to G. A. B. A. L. W. received support from T32 awards GM007337, AI007485, and AI007533 and Department of Defense Congressionally Directed Medical Research Program Horizon Award W81XWH-19-1-0442. T. K. Y. was supported by NIH T32 AI07485. This material is based upon work supported in part by facilities and equipment provided by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development.	Aguilar SV, 2020, NAT IMMUNOL, V21, P700, DOI 10.1038/s41590-020-0687-4; Arkee T, 2020, J LEUKOCYTE BIOL, V107, P907, DOI 10.1002/JLB.2MR1119-397R; Bangalore-Prakash P, 2017, BLOOD ADV, V1, P2712, DOI 10.1182/bloodadvances.2017009670; Berry CT, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.038; BISHOP GA, 1986, P NATL ACAD SCI USA, V83, P7410, DOI 10.1073/pnas.83.19.7410; Bishop GA, 2001, IMMUNOL RES, V24, P97, DOI 10.1385/IR:24:2:097; Bishop GA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02161; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Burger JA, 2018, NAT REV CANCER, V18, P148, DOI 10.1038/nrc.2017.121; Bushell KR, 2015, BLOOD, V125, P999, DOI 10.1182/blood-2014-10-602714; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Chen XJ, 2008, ARCH IMMUNOL THER EX, V56, P77, DOI 10.1007/s00005-008-0014-5; Chen ZG, 2020, J IMMUNOL, V205, P830, DOI 10.4049/jimmunol.2000322; Choi NM, 2011, CURR OPIN IMMUNOL, V23, P81, DOI 10.1016/j.coi.2010.09.007; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; de Claro RA, 2015, CLIN CANCER RES, V21, P3586, DOI 10.1158/1078-0432.CCR-14-2225; Denlinger NM, 2018, CANCER MANAG RES, V10, P615, DOI 10.2147/CMAR.S133291; Dunleavy K, 2018, CANCER TREAT REV, V65, P41, DOI 10.1016/j.ctrv.2018.01.002; DYER MJS, 1990, BLOOD, V75, P709; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; George AA, 2006, EMBO J, V25, P811, DOI 10.1038/sj.emboj.7600966; George B, 2020, CANCERS, V12, DOI 10.3390/cancers12051328; Hampel F, 2011, BLOOD, V118, P6321, DOI 10.1182/blood-2010-12-325944; Haxhinasto SA, 2002, J IMMUNOL, V169, P1145, DOI 10.4049/jimmunol.169.3.1145; Haxhinasto SA, 2004, J BIOL CHEM, V279, P2575, DOI 10.1074/jbc.M310628200; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hostager BS, 1999, J IMMUNOL, V162, P6307; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Hou KL, 2020, CRIT REV ONCOL HEMAT, V152, DOI 10.1016/j.critrevonc.2020.103010; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Katkere B, 2012, J BIOL CHEM, V287, P16636, DOI 10.1074/jbc.M112.357640; Ke JY, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-132; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; KLEIN E, 1968, CANCER RES, V28, P1300; KLEIN G, 1974, P NATL ACAD SCI USA, V71, P3283, DOI 10.1073/pnas.71.8.3283; Klintman J., 2020, BLOOD; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kumar M, 2020, NUCLEIC ACIDS RES, V48, pD296, DOI 10.1093/nar/gkz1030; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Kurosaki T, 2011, MOL IMMUNOL, V48, P1287, DOI 10.1016/j.molimm.2010.12.007; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Li JF, 1999, J IMMUNOL, V163, P6386; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Mambetsariev N, 2016, P NATL ACAD SCI USA, V113, P1032, DOI 10.1073/pnas.1514586113; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; MENEZES J, 1975, BIOMEDICINE, V22, P276; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moore CR, 2012, LEUKEMIA, V26, P1122, DOI 10.1038/leu.2011.309; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oliver AM, 1999, J IMMUNOL, V162, P7198; Ondrisova L, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.591577; Pagliarini R, 2015, EMBO REP, V16, P280, DOI 10.15252/embr.201439949; Paiva C, 2017, HAEMATOLOGICA, V102, P1890, DOI 10.3324/haematol.2017.170571; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Papanota AM, 2019, J BLOOD MED, V10, P291, DOI 10.2147/JBM.S183997; San Miguel JF, 2015, BLOOD, V125, P3039, DOI 10.1182/blood-2015-01-613596; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Suljagic M, 2010, BLOOD, V116, P4894, DOI 10.1182/blood-2010-03-275180; Tompkins VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076889; TWEEDDALE ME, 1987, BLOOD, V69, P1307; Wallis AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02280-4; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Whillock AL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49390-9; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012; Xie P, 2011, J LEUKOCYTE BIOL, V90, P1149, DOI 10.1189/jlb.0111044; Xie P, 2011, J IMMUNOL, V186, P143, DOI 10.4049/jimmunol.1000290; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Zhang BC, 2015, CELL REP, V11, P715, DOI 10.1016/j.celrep.2015.03.059; Zhu SN, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02111	75	11	11	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100465	10.1016/j.jbc.2021.100465	http://dx.doi.org/10.1016/j.jbc.2021.100465			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639170	gold, Green Published			2022-12-28	WOS:000672866400439
J	Wu, Q; Huang, YP; Gu, LY; Chang, ZJ; Li, GM				Wu, Qiong; Huang, Yaping; Gu, Liya; Chang, Zhijie; Li, Guo-Min			OTUB1 stabilizes mismatch repair protein MSH2 by blocking ubiquitinationy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA; CANCER; OVEREXPRESSION; MECHANISMS; HOMOLOG; TUMORS; HMLH1; O-6-METHYLGUANINE; RECOGNITION; MODULATION	DNA mismatch repair (MMR) maintains genome stability primarily by correcting replication errors. MMR deficiency can lead to cancer development and bolsters cancer cell resistance to chemotherapy. However, recent studies have shown that checkpoint blockade therapy is effective in MMR-deficient cancers, thus the ability to identify cancer etiology would greatly benefit cancer treatment. MutS homolog 2 (MSH2) is an obligate subunit of mismatch recognition proteins MutSa (MSH2-MSH6) and MutS beta (MSH2-MSH3). Precise regulation of MSH2 is critical, as either over- or underexpression of MSH2 results in an increased mutation frequency. The mechanism by which cells maintain MSH2 proteostasis is unknown. Using functional ubiquitination and deubiquitination assays, we show that the ovarian tumor (OTU) family deubiquitinase ubiquitin aldehyde binding 1 (OTUB1) inhibits MSH2 ubiquitination by blocking the E2 ligase ubiquitin transfer activity. Depleting OTUB1 in cells promotes the ubiquitination and subsequent degradation of MSH2, leading to greater mutation frequency and cellular resistance to genotoxic agents, including the common chemotherapy agents N-methyl-N'-nitro-N-nitrosoguanidine and cisplatin. Taken together, our data identify OTUB1 as an important regulator of MSH2 stability and provide evidence that OTUB1 is a potential biomarker for cancer etiology and therapy.	[Wu, Qiong; Chang, Zhijie] Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing, Peoples R China; [Huang, Yaping; Gu, Liya; Li, Guo-Min] Univ Texas Dallas, Southwestern Med Ctr, Dept Radiat Oncol, Dallas, TX 75080 USA	Tsinghua University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chang, ZJ (corresponding author), Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing, Peoples R China.; Li, GM (corresponding author), Univ Texas Dallas, Southwestern Med Ctr, Dept Radiat Oncol, Dallas, TX 75080 USA.	zhijiec@mail.tsinghua.edu.cn; guo-min.li@utsouthwestern.edu	wu, qiong/GRY-4672-2022	Chang, Zhijie/0000-0003-1567-3227; Li, Guo-Min/0000-0002-9842-4578	National Natural Science Foundation of China [31570814, 81630077]; Cancer Prevention and Research Institute of Texas (CPRIT) [RR160101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cancer Prevention and Research Institute of Texas (CPRIT)	This work was supported in part by the National Natural Science Foundation of China grants 31570814 and 81630077 (to Z. C.) and the Cancer Prevention and Research Institute of Texas (CPRIT) grant RR160101 (to G. -M. L.). G. -M. L. is a CPRIT Scholar in Cancer Research and the holder of the Reece A. Overcash, Jr. Distinguished Chair for Research on Colon Cancer.	Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Castri P, 2014, BBA-MOL CELL RES, V1843, P640, DOI 10.1016/j.bbamcr.2013.12.005; Chang DK, 2000, J BIOL CHEM, V275, P29178; Chen Z, 2016, MOL CELL PROTEOMICS, V15, P1299, DOI [10.1074/mcp.M115.056093, 10.1074/mcp.M115.056093 ]; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Fink D, 1998, CLIN CANCER RES, V4, P1; Goldstein M, 2015, ANNU REV MED, V66, P129, DOI 10.1146/annurev-med-081313-121208; Herhaus L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0441; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hernandez-Pigeon H, 2004, FEBS LETT, V562, P40, DOI 10.1016/S0014-5793(04)00181-4; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kane MF, 1997, CANCER RES, V57, P808; Karran P, 2001, CARCINOGENESIS, V22, P1931, DOI 10.1093/carcin/22.12.1931; Karunarathna U, 2016, ONCOGENE, V35, P1433, DOI 10.1038/onc.2015.208; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li GM, 1999, ONCOL RES, V11, P393; Li GM, 1996, J BIOL CHEM, V271, P24084, DOI 10.1074/jbc.271.39.24084; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li GM, 2013, CANCER RES, V73, P6379, DOI 10.1158/0008-5472.CAN-13-1870; Liu JP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00206-2; Mao GG, 2012, CELL RES, V22, P973, DOI 10.1038/cr.2012.18; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Morgan MA, 2015, CLIN CANCER RES, V21, P2898, DOI 10.1158/1078-0432.CCR-13-3229; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Ortega J, 2015, P NATL ACAD SCI USA, V112, P5667, DOI 10.1073/pnas.1417711112; Saldana M, 2019, ENDOCR-RELAT CANCER, V26, pR1, DOI 10.1530/ERC-18-0264; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Valeri N, 2010, P NATL ACAD SCI USA, V107, P6982, DOI 10.1073/pnas.1002472107; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Wu JX, 1999, MOL CELL BIOL, V19, P8292; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200; Zhang H, 1999, CANCER RES, V59, P3021; Zhang M, 2016, J BIOL CHEM, V291, P10783, DOI 10.1074/jbc.M115.700047; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhao LL, 2018, J BIOL CHEM, V293, P4883, DOI 10.1074/jbc.M117.809533	47	7	7	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100466	10.1016/j.jbc.2021.100466	http://dx.doi.org/10.1016/j.jbc.2021.100466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33640455	gold, Green Published			2022-12-28	WOS:000672866400440
J	Yeo, CT; Stancill, JS; Oleson, BJ; Schnuck, JK; Stafford, JD; Naatz, A; Hansen, PA; Corbett, JA				Yeo, Chay Teng; Stancill, Jennifer S.; Oleson, Bryndon J.; Schnuck, Jamie K.; Stafford, Joshua D.; Naatz, Aaron; Hansen, Polly A.; Corbett, John A.			Regulation of ATR-dependent DNA damage response by nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; HISTONE H2AX PHOSPHORYLATION; RIBONUCLEOTIDE REDUCTASE; METABOLIC REQUIREMENTS; OXIDATIVE-METABOLISM; INSULIN-SECRETION; ENERGY-METABOLISM; ISLET DESTRUCTION; EMCV REPLICATION; POTENTIAL ROLE	We have shown that nitric oxide limits ataxia-telangiectasia mutated signaling by inhibiting mitochondrial oxidative metabolism in a beta-cell selective manner. In this study, we examined the actions of nitric oxide on a second DNA damage response transducer kinase, ataxia-telangiectasia and Rad3-related protein (ATR). In beta-cells and non-beta-cells, nitric oxide activates ATR signaling by inhibiting ribonucleotide reductase; however, when produced at inducible nitric oxide synthase-derived (low micromolar) levels, nitric oxide impairs ATR signaling in a beta-cell selective manner. The inhibitory actions of nitric oxide are associated with impaired mitochondrial oxidative metabolism and lack of glycolytic compensation that result in a decrease in beta-cell ATP. Like nitric oxide, inhibitors of mitochondrial respiration reduce ATP levels and limit ATR signaling in a beta-cell selective manner. When non-beta-cells are forced to utilize mitochondrial oxidative metabolism for ATP generation, their response is more like beta-cells, as nitric oxide and inhibitors of mitochondrial respiration attenuate ATR signaling. These studies support a dual role for nitric oxide in regulating ATR signaling. Nitric oxide activates ATR in all cell types examined by inhibiting ribonucleotide reductase, and in a beta-cell selective manner, inducible nitric oxide synthase-derived levels of nitric oxide limit ATR signaling by attenuating mitochondrial oxidative metabolism and depleting ATP.	[Yeo, Chay Teng; Stancill, Jennifer S.; Oleson, Bryndon J.; Schnuck, Jamie K.; Stafford, Joshua D.; Naatz, Aaron; Hansen, Polly A.; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu			National Institutes of Health [DK-052194, AI-44458]; Juvenile Diabetes Research Foundation [2-SRA-2019-829-S-B]; American Heart Association [17PRE32530001]; National Heart, Lung, and Blood Institute [T32 HL134643]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants (DK-052194 and AI-44458), Juvenile Diabetes Research Foundation grant 2-SRA-2019-829-S-B, and a gift from the Forest County Potawatomi Foundation (to J. A. C). J. D. S was funded by an American Heart Association Fellowship 17PRE32530001 (to J. D. S), and J. S. S. was supported by the National Heart, Lung, and Blood Institute grant (T32 HL134643). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnush M, 1998, J IMMUNOL, V160, P2684; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Broniowska KA, 2013, J BIOL CHEM, V288, P36567, DOI 10.1074/jbc.M113.522243; Broniowska KA, 2013, BIOCHEMISTRY-US, V52, P4364, DOI 10.1021/bi400342t; Brown GC, 2007, FRONT BIOSCI-LANDMRK, V12, P1024, DOI 10.2741/2122; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; DELANEY CA, 1993, FEBS LETT, V333, P291, DOI 10.1016/0014-5793(93)80673-I; ELFORD HL, 1968, BIOCHEM BIOPH RES CO, V33, P129, DOI 10.1016/0006-291X(68)90266-0; ERECINSKA M, 1992, BIOCHIM BIOPHYS ACTA, V1101, P273, DOI 10.1016/0167-4838(92)90555-R; FEHSEL K, 1993, DIABETES, V42, P496, DOI 10.2337/diabetes.42.3.496; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hughes KJ, 2011, J BIOL CHEM, V286, P8338, DOI 10.1074/jbc.M110.204768; Hughes KJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1187, DOI 10.1152/ajpendo.00214.2009; Hughes KJ, 2009, J BIOL CHEM, V284, P27402, DOI 10.1074/jbc.M109.046912; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Khan P, 2014, APPL BIOCHEM BIOTECH, V173, P333, DOI 10.1007/s12010-014-0850-1; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Kulkarni A, 2008, AM J PHYSIOL-LUNG C, V294, pL998, DOI 10.1152/ajplung.00004.2008; KWON NS, 1991, J EXP MED, V174, P761, DOI 10.1084/jem.174.4.761; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LACY PE, 1994, MT SINAI J MED, V61, P170; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Liu QH, 2000, GENE DEV, V14, P1448; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; MANDRUPPOULSEN T, 1985, ALLERGY, V40, P424, DOI 10.1111/j.1398-9995.1985.tb02681.x; MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P182; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Meares GP, 2011, MOL CELL BIOL, V31, P4286, DOI 10.1128/MCB.05668-11; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Oleson BJ, 2020, BIOCHEM PHARMACOL, V176, DOI 10.1016/j.bcp.2020.113907; Oleson BJ, 2018, ANTIOXID REDOX SIGN, V29, P1432, DOI 10.1089/ars.2017.7351; Oleson BJ, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00153-19; Oleson BJ, 2018, DIABETES, V67, P898, DOI 10.2337/db17-1062; Oleson BJ, 2016, MOL CELL BIOL, V36, P2067, DOI 10.1128/MCB.00262-16; Oleson BJ, 2014, J BIOL CHEM, V289, P11454, DOI 10.1074/jbc.M113.531228; Olson KA, 2016, TRENDS BIOCHEM SCI, V41, P219, DOI 10.1016/j.tibs.2016.01.002; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; PANTEN U, 1975, DIABETOLOGIA, V11, P569, DOI 10.1007/BF01222108; PETERSSON L, 1980, J BIOL CHEM, V255, P6706; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Puri S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02939-0; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; ROY B, 1995, BIOCHEMISTRY-US, V34, P5411, DOI 10.1021/bi00016a012; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Shaheen ZR, 2020, J BIOL CHEM, V295, P2385, DOI 10.1074/jbc.RA119.010267; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Stafford JD, 2020, J BIOL CHEM, V295, P18189, DOI 10.1074/jbc.RA120.015893; Stafford JD, 2020, J BIOL CHEM, V295, P16655, DOI 10.1074/jbc.RA120.014851; Stancill JS, 2019, AM J PHYSIOL-ENDOC M, V316, pE196, DOI 10.1152/ajpendo.00229.2018; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; STOCCHI V, 1987, ANAL BIOCHEM, V167, P181, DOI 10.1016/0003-2697(87)90150-3; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; Willis J, 2013, P NATL ACAD SCI USA, V110, P10592, DOI 10.1073/pnas.1301445110; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	81	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100388	10.1016/j.jbc.2021.100388	http://dx.doi.org/10.1016/j.jbc.2021.100388			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33567339	gold, Green Published			2022-12-28	WOS:000672866400362
J	van Dierendonck, XAMH; Sancerni, T; Alves-Guerra, MC; Stienstra, R				van Dierendonck, Xanthe A. M. H.; Sancerni, Tiphaine; Alves-Guerra, Marie-Clotilde; Stienstra, Rinke			The role of uncoupling protein 2 in macrophages and its impact on obesity-induced adipose tissue inflammation and insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						uncoupling protein 2; immunometabolism; adipose tissue inflammation; obesity; insulin resistance; diabetes; macrophage; metabolism; inflammation	OXIDATIVE STRESS; LIPID-METABOLISM; UCP2; IMMUNOMETABOLISM; ACTIVATION; RISK; GENE; CELL; PROLIFERATION; POLYMORPHISM	The development of a chronic, low-grade inflammation originating from adipose tissue in obese subjects is widely recognized to induce insulin resistance, leading to the development of type 2 diabetes. The adipose tissue microenvironment drives specific metabolic reprogramming of adipose tissue macrophages, contributing to the induction of tissue inflammation. Uncoupling protein 2 (UCP2), a mitochondrial anion carrier, is thought to separately modulate inflammatory and metabolic processes in macrophages and is up-regulated in macrophages in the context of obesity and diabetes. Here, we investigate the role of UCP2 in macrophage activation in the context of obesity-induced adipose tissue inflammation and insulin resistance. Using a myeloid-specific knockout of UCP2 (Ucp2(Delta LysM)), we found that UCP2 deficiency significantly increases glycolysis and oxidative respiration, both unstimulated and after inflammatory conditions. Strikingly, fatty acid loading abolished the metabolic differences between Ucp2(Delta LysM) macrophages and their floxed controls. Furthermore, Ucp2(Delta LysM) macrophages show attenuated pro-inflammatory responses toward Toll-like receptor-2 and -4 stimulation. To test the relevance of macrophage-specific Ucp2 deletion in vivo, Ucp2(Delta LysM) and Ucp2(fl/fl) mice were rendered obese and insulin resistant through high-fat feeding. Although no differences in adipose tissue inflammation or insulin resistance was found between the two genotypes, adipose tissue macrophages isolated from diet-induced obese Ucp2(Delta LysM) mice showed decreased TNF alpha secretion after ex vivo lipopolysaccharide stimulation compared with their Ucp2(fl/fl) littermates. Together, these results demonstrate that although UCP2 regulates both metabolism and the inflammatory response of macrophages, its activity is not crucial in shaping macrophage activation in the adipose tissue during obesity-induced insulin resistance.	[van Dierendonck, Xanthe A. M. H.; Stienstra, Rinke] Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Wageningen, Netherlands; [van Dierendonck, Xanthe A. M. H.; Stienstra, Rinke] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands; [Sancerni, Tiphaine; Alves-Guerra, Marie-Clotilde] Univ Paris, Inst Cochin, INSERM, CNRS, F-75014 Paris, France	Wageningen University & Research; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Stienstra, R (corresponding author), Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Wageningen, Netherlands.; Stienstra, R (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands.	rinke.stienstra@wur.nl	Alves-Guerra, Marie-Clotilde/P-4356-2017	Alves-Guerra, Marie-Clotilde/0000-0002-7918-1216; van Dierendonck, Xanthe/0000-0002-9855-8701	Vidi Grant from the NWO; Dutch Diabetes Foundation [2015.82.1824]	Vidi Grant from the NWO; Dutch Diabetes Foundation	This work was supported by Vidi Grant from the NWO and by Dutch Diabetes Foundation senior fellowship 2015.82.1824 (to R. S.).	Aguilar E, 2019, CELL REP, V28, P2306, DOI 10.1016/j.celrep.2019.07.097; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Andersen G, 2013, INT J OBESITY, V37, P175, DOI 10.1038/ijo.2012.22; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bouillaud F, 2016, BBA-MOL CELL RES, V1863, P2443, DOI 10.1016/j.bbamcr.2016.04.013; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Boutens L, 2018, DIABETOLOGIA, V61, P942, DOI 10.1007/s00125-017-4526-6; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Emre Y, 2010, FEBS LETT, V584, P1437, DOI 10.1016/j.febslet.2010.03.014; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; Esteves P, 2014, CANCER RES, V74, P3971, DOI 10.1158/0008-5472.CAN-13-3383; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Hurtaud C, 2006, CELL MOL LIFE SCI, V63, P1780, DOI 10.1007/s00018-006-6129-0; Kim JD, 2019, CELL METAB, V30, P952, DOI 10.1016/j.cmet.2019.08.010; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lachmandas E, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.246; Li N, 2017, REDOX BIOL, V13, P541, DOI 10.1016/j.redox.2017.07.012; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Martinez-Hervas S, 2012, EUR J CLIN INVEST, V42, P171, DOI 10.1111/j.1365-2362.2011.02570.x; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Meyer TE, 2010, CANCER EPIDEM BIOMAR, V19, P558, DOI 10.1158/1055-9965.EPI-09-0902; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Nubel T, 2008, BBA-BIOENERGETICS, V1777, P48, DOI 10.1016/j.bbabio.2007.11.002; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Oktavianthi S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-41; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Salopuro T, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-94; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HL, 2015, MOL CELL BIOL, V35, P1055, DOI 10.1128/MCB.01122-14; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001	43	7	7	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17535	17548		10.1074/jbc.RA120.014868	http://dx.doi.org/10.1074/jbc.RA120.014868			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453996	Green Published, hybrid			2022-12-28	WOS:000603272300012
J	Basu, R; Nahar, K; Kulkarni, P; Kerekes, O; Sattler, M; Hall, Z; Neggers, S; Holub, JM; Kopchick, JJ				Basu, Reetobrata; Nahar, Khairun; Kulkarni, Prateek; Kerekes, Olivia; Sattler, Maya; Hall, Zachary; Neggers, Sebastian; Holub, Justin M.; Kopchick, John J.			A novel peptide antagonist of the human growth hormone receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR DOMAIN; HGH RECEPTOR; ALPHA-HELIX; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; 22-KDA HGH; IN-VITRO; GENE; BINDING; MOUSE	Excess circulating human growth hormone (hGH) in vivo is linked to metabolic and growth disorders such as cancer, diabetes, and acromegaly. Consequently, there is considerable interest in developing antagonists of hGH action. Here, we present the design, synthesis, and characterization of a 16-residue peptide (site 1-binding helix [S1H]) that inhibits hGH-mediated STAT5 phosphorylation in cultured cells. S1H was designed as a direct sequence mimetic of the site 1 minihelix (residues 36-51) of wild-type hGH and acts by inhibiting the interaction of hGH with the human growth hormone receptor (hGHR). In vitro studies indicated that S1H is stable in human serum and can adopt an alpha-helix in solution. Our results also show that S1H mitigates phosphorylation of STAT5 in cells co-treated with hGH, reducing intracellular STAT5 phosphorylation levels to those observed in untreated controls. Furthermore, S1H was found to attenuate the activity of the hGHR and the human prolactin receptor, suggesting that this peptide acts as an antagonist of both lactogenic and somatotrophic hGH actions. Finally, we used alanine scanning to determine how discrete amino acids within the S1H sequence contribute to its structural organization and biological activity. We observed a strong correlation between helical propensity and inhibitory effect, indicating that S1H-mediated antagonism of the hGHR is largely dependent on the ability for S1H to adopt an a-helix. Taken together, these results show that S1H not only acts as a novel peptide-based antagonist of the hGHR but can also be applied as a chemical tool to study the molecular nature of hGH-hGHR interactions.	[Basu, Reetobrata; Kopchick, John J.] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Basu, Reetobrata; Kulkarni, Prateek; Holub, Justin M.; Kopchick, John J.] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA; [Nahar, Khairun; Kerekes, Olivia; Sattler, Maya; Hall, Zachary; Holub, Justin M.] Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA; [Kulkarni, Prateek; Holub, Justin M.; Kopchick, John J.] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA; [Sattler, Maya] Ohio Univ, Honors Tutorial Coll, Athens, OH 45701 USA; [Neggers, Sebastian] Erasmus MC, Dept Med, Endocrinol Sect, Rotterdam, Netherlands	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; Erasmus University Rotterdam; Erasmus MC	Kopchick, JJ (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA.; Holub, JM; Kopchick, JJ (corresponding author), Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA.; Holub, JM (corresponding author), Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA.; Holub, JM; Kopchick, JJ (corresponding author), Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA.	holub@ohio.edu; kopchick@ohio.edu	Basu, Reetobrata/I-8828-2019; Holub, Justin M/G-6537-2015	Hall, Zachary/0000-0001-6463-8570; Basu, Reetobrata/0000-0001-8415-1356	State of Ohio's Eminent Scholar Program; Edison Biotechnology Institute at Ohio University, Athens, OH; Department of Chemistry and Biochemistry	State of Ohio's Eminent Scholar Program; Edison Biotechnology Institute at Ohio University, Athens, OH; Department of Chemistry and Biochemistry	This work was supported in part by the State of Ohio's Eminent Scholar Program to J. J. K. that includes a gift from Milton and Lawrence Goll and by the Edison Biotechnology Institute at Ohio University, Athens, OH. J. M. H. was supported by the Department of Chemistry and Biochemistry and the Edison Biotechnology Institute at Ohio University, Athens, OH.	ABDELMEGUID SS, 1987, P NATL ACAD SCI USA, V84, P6434, DOI 10.1073/pnas.84.18.6434; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; ALBERT JS, 1995, BIOCHEMISTRY-US, V34, P984, DOI 10.1021/bi00003a033; Arachchige D, 2017, J PEPT SCI, V23, P367, DOI 10.1002/psc.2999; Baik M, 2011, ANN NY ACAD SCI, V1229, P29, DOI 10.1111/j.1749-6632.2011.06100.x; Basu R, 2018, EUR J ENDOCRINOL, V178, pR155, DOI 10.1530/EJE-18-0018; Basu R, 2017, ONCOTARGET, V8, P21579, DOI 10.18632/oncotarget.15375; Berryman DE, 2006, ENDOCRINOLOGY, V147, P2801, DOI 10.1210/en.2006-0086; Berryman DE, 2010, J GERONTOL A-BIOL, V65, P31, DOI 10.1093/gerona/glp175; Boatman PD, 1999, J MED CHEM, V42, P1367, DOI 10.1021/jm980354p; Bottger R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178943; Bonkowski MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004567; BREMS DN, 1988, P NATL ACAD SCI USA, V85, P3367, DOI 10.1073/pnas.85.10.3367; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Carter-Su Christin, 1996, Endocrine Journal, V43, pS65, DOI 10.1507/endocrj.43.Suppl_S65; Carter-Su C, 2016, GROWTH HORM IGF RES, V28, P11, DOI 10.1016/j.ghir.2015.09.002; CHEN WY, 1994, J BIOL CHEM, V269, P15892; CHEN WY, 1991, J BIOL CHEM, V266, P2252; CHEN WY, 1991, MOL ENDOCRINOL, V5, P1845, DOI 10.1210/mend-5-12-1845; CHEN WY, 1990, P NATL ACAD SCI USA, V87, P5061, DOI 10.1073/pnas.87.13.5061; CHEN WY, 1991, ENDOCRINOLOGY, V129, P1402, DOI 10.1210/endo-129-3-1402; Chesnokova V, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125762; Chien CH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2898-5; Colao A, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0071-6; COOKE NE, 1988, J CLIN INVEST, V82, P270, DOI 10.1172/JCI113582; CUNNINGHAM BC, 1991, P NATL ACAD SCI USA, V88, P3407, DOI 10.1073/pnas.88.8.3407; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Dehkhoda F, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00035; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Dominici FP, 2000, J ENDOCRINOL, V166, P579, DOI 10.1677/joe.0.1660579; Feldt-Rasmussen U., 2000, ADULT GROWTH HORMONE; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Frank SJ, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110999; Freda PU, 2015, ENDOCR PRACT, V21, P264, DOI 10.4158/EP14330.OR; Gadelha MR, 2019, ENDOCR REV, V40, P268, DOI 10.1210/er.2018-00115; Garner J, 2007, ORG BIOMOL CHEM, V5, P3577, DOI 10.1039/b710425a; Gesing A, 2017, J GERONTOL A-BIOL, V72, P1054, DOI 10.1093/gerona/glw193; Gross A, 2016, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00211; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Harvey S, 2000, CAN J PHYSIOL PHARM, V78, P1013, DOI 10.1139/cjpp-78-12-1013; Harvey S, 2010, ENDOCRINE, V38, P335, DOI 10.1007/s12020-010-9403-8; Healy ML, 2003, J CLIN ENDOCR METAB, V88, P5221, DOI 10.1210/jc.2002-021872; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Holub JM, 2017, DRUG DEVELOP RES, V78, P268, DOI 10.1002/ddr.21408; HOUSSAY BA, 1953, ENDOCRINOLOGY, V53, P114, DOI 10.1210/endo-53-1-114; HSIEH KUANG-MEI, 1952, ENDOCRINOLOGY, V51, P298; Ikeno Y, 2009, J GERONTOL A-BIOL, V64, P522, DOI 10.1093/gerona/glp017; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Jochim AL, 2009, MOL BIOSYST, V5, P924, DOI 10.1039/b903202a; Johnstone SA, 2001, BBA-BIOMEMBRANES, V1513, P25, DOI 10.1016/S0005-2736(01)00292-9; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Kooijman R, 1997, ENDOCRINOLOGY, V138, P3949, DOI 10.1210/en.138.9.3949; Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022; Kopchick JJ, 2014, MOL CELL ENDOCRINOL, V386, P34, DOI 10.1016/j.mce.2013.09.004; Kossiakoff AA, 2004, ADV PROTEIN CHEM, V68, P147; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Laron Z, 2011, LARON SYNDROME - FROM MAN TO MOUSE: LESSONS FROM CLINICAL AND EXPERIEMENTAL EXPERIENCE, P1, DOI 10.1007/978-3-642-11183-9; Laron Z, 2004, J CLIN ENDOCR METAB, V89, P1031, DOI 10.1210/jc.2003-031033; Laron Z, 2015, ENDOCR PRACT, V21, P1395, DOI 10.4158/EP15939.RA; List EO, 2020, MOL CELL ENDOCRINOL, V515, DOI 10.1016/j.mce.2020.110919; List EO, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa097; List EO, 2011, ENDOCR REV, V32, P356, DOI 10.1210/er.2010-0009; Liu JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE405, DOI 10.1152/ajpendo.00423.2003; Lu M, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0036-y; Mabonga Lloyd, 2019, Biophys Rev, V11, P559, DOI 10.1007/s12551-019-00570-x; Madsen M, 2014, CLIN ENDOCRINOL, V80, P92, DOI 10.1111/cen.12239; Melmed S, 2009, J CLIN INVEST, V119, P3189, DOI 10.1172/JCI39375; Miles JA, 2016, CHEM SCI, V7, P3694, DOI 10.1039/c5sc04048e; MILLER WL, 1980, J BIOL CHEM, V255, P7521; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Moon H, 2015, CURR OPIN CHEM BIOL, V24, P38, DOI 10.1016/j.cbpa.2014.10.023; MURPHY LJ, 1984, ENDOCRINOLOGY, V115, P1625, DOI 10.1210/endo-115-4-1625; Palasek SA, 2007, J PEPT SCI, V13, P143, DOI 10.1002/psc.804; Parkinson C, 2003, ADV DRUG DELIVER REV, V55, P1303, DOI 10.1016/S0169-409X(03)00111-X; Peterson FC, 2004, PROTEIN ENG DES SEL, V17, P417, DOI 10.1093/protein/gzh051; Pradhananga S, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290011; Puche JE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-224; RABINOWI.D, 1965, J CLIN INVEST, V44, P51, DOI 10.1172/JCI105126; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; Ranke MB, 2018, NAT REV ENDOCRINOL, V14, P285, DOI 10.1038/nrendo.2018.22; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Robinson JA, 2008, ACCOUNTS CHEM RES, V41, P1278, DOI 10.1021/ar700259k; Ross NT, 2010, PHILOS T R SOC A, V368, P989, DOI 10.1098/rsta.2009.0210; Ross RJM, 2001, J CLIN ENDOCR METAB, V86, P1716, DOI 10.1210/jc.86.4.1716; Ross RJM, 1997, MOL ENDOCRINOL, V11, P265, DOI 10.1210/me.11.3.265; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Roy S, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6040118; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHOLTZ JM, 1992, ANNU REV BIOPH BIOM, V21, P95, DOI 10.1146/annurev.bb.21.060192.000523; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Sundstrom M, 1996, J BIOL CHEM, V271, P32197, DOI 10.1074/jbc.271.50.32197; Tsunekawa B, 1999, ENDOCRINOLOGY, V140, P3909, DOI 10.1210/en.140.9.3909; Uchida H, 1999, J MOL ENDOCRINOL, V23, P347, DOI 10.1677/jme.0.0230347; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; Verhoef JJF, 2013, DRUG DELIV TRANSL RE, V3, P499, DOI 10.1007/s13346-013-0176-5; Wada M, 1997, MOL CELL ENDOCRINOL, V133, P99, DOI 10.1016/S0303-7207(97)00151-2; Wada M, 1998, MOL ENDOCRINOL, V12, P146, DOI 10.1210/mend.12.1.0054; Wang J, 2004, J ENDOCRINOL, V180, P247, DOI 10.1677/joe.0.1800247; Wang XZ, 1996, MOL ENDOCRINOL, V10, P1249, DOI 10.1210/me.10.10.1249; Waters MJ, 2011, HORM RES PAEDIAT, V76, P12, DOI 10.1159/000329138; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Wingfield Paul T, 2015, Curr Protoc Protein Sci, V80, DOI 10.1002/0471140864.ps0601s80; Yi JZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134427; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215; Zhu T, 2001, CELL SIGNAL, V13, P599, DOI 10.1016/S0898-6568(01)00186-3	111	2	2	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100588	10.1016/j.jbc.2021.100588	http://dx.doi.org/10.1016/j.jbc.2021.100588			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33774052	Green Published, gold			2022-12-28	WOS:000672866400560
J	Cochrane, VA; Yang, ZY; Dell'Acqua, ML; Shyng, SL				Cochrane, Veronica A.; Yang, Zhongying; Dell'Acqua, Mark L.; Shyng, Show-Ling			AKAP79/150 coordinates leptin-induced PKA signaling to regulate K-ATP channel trafficking in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; INSULIN-SECRETION; ANCHORING PROTEIN; MEDIATED PHOSPHORYLATION; CAMP SYNTHESIS; CA2+ CHANNEL; RAT; EXOCYTOSIS; RECEPTORS; COMPLEXES	The adipocyte hormone leptin regulates glucose homeostasis both centrally and peripherally. A key peripheral target is the pancreatic beta-cell, which secretes insulin upon glucose stimulation. Leptin is known to suppress glucose-stimulated insulin secretion by promoting trafficking of K-ATP channels to the beta-cell surface, which increases K+ conductance and causes beta-cell hyperpolarization. We have previously shown that leptin-induced K-ATP channel trafficking requires protein kinase A (PKA)-dependent actin remodeling. However, whether PKA is a downstream effector of leptin signaling or PKA plays a permissive role is unknown. Using FRET-based reporters of PKA activity, we show that leptin increases PKA activity at the cell membrane and that this effect is dependent on N-methyl-D-aspartate receptors, CaMKK beta, and AMPK, which are known to be involved in the leptin signaling pathway. Genetic knockdown and rescue experiments reveal that the increased PKA activity upon leptin stimulation requires the membrane-targeted PKA-anchoring protein AKAP79/150, indicating that PKA activated by leptin is anchored to AKAP79/150. Interestingly, disrupting protein phosphatase 2B (PP2B) anchoring to AKAP79/150, known to elevate basal PKA signaling, leads to increased surface K-ATP channels even in the absence of leptin stimulation. Our findings uncover a novel role of AKAP79/150 in coordinating leptin and PKA signaling to regulate K-ATP channel trafficking in beta-cells, hence insulin secretion. The study further advances our knowledge of the downstream signaling events that may be targeted to restore insulin secretion regulation in beta-cells defective in leptin signaling, such as those from obese individuals with type 2 diabetes.	[Cochrane, Veronica A.; Yang, Zhongying; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97239 USA; [Dell'Acqua, Mark L.] Univ Colorado, Dept Pharmacol, Sch Med, Anschutz Med Campus, Aurora, CO USA	Oregon Health & Science University; University of Colorado System; University of Colorado Anschutz Medical Campus	Cochrane, VA; Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97239 USA.	cochranv@ohsu.edu; shyngs@ohsu.edu			National Institutes of Health [R01DK057699, 3R01DK057699-14S1]; NIH [NS040701]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant R01DK057699 and 3R01DK057699-14S1 (to S.-L. S.). Dr M. L. D. acknowledges the support of NIH grant NS040701. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AUNIS D, 1988, J EXP BIOL, V139, P253; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Brandao KE, 2012, J COMP NEUROL, V520, P81, DOI 10.1002/cne.22692; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chen PC, 2013, J BIOL CHEM, V288, P34098, DOI 10.1074/jbc.M113.516880; Cochrane VA, 2020, J BIOL CHEM, V295, P17281, DOI 10.1074/jbc.RA120.015489; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Depry C, 2011, MOL BIOSYST, V7, P52, DOI 10.1039/c0mb00079e; Dittmer PJ, 2014, CELL REP, V7, P1410, DOI 10.1016/j.celrep.2014.04.039; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Emilsson V, 1997, DIABETES, V46, P313, DOI 10.2337/diabetes.46.2.313; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Gromada J, 1998, DIABETES, V47, P57, DOI 10.2337/diabetes.47.1.57; HANSEN WA, 1989, DIABETES RES CLIN EX, V10, P53; Haushalter KJ, 2018, J BIOL CHEM, V293, P4411, DOI 10.1074/jbc.M117.809988; Hinke SA, 2012, EMBO J, V31, P3991, DOI 10.1038/emboj.2012.244; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Johanns M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10856; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Johnstone TB, 2018, MOL PHARMACOL, V93, P270, DOI 10.1124/mol.117.110825; Josefsen K, 2010, FEBS LETT, V584, P81, DOI 10.1016/j.febslet.2009.10.086; Kaihara KA, 2013, DIABETES, V62, P1527, DOI 10.2337/db12-1013; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim KY, 2009, CANCER RES, V69, P4018, DOI 10.1158/0008-5472.CAN-08-2641; Kobashigawa LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104888; Kudo N, 1996, BBA-LIPID LIPID MET, V1301, P67, DOI 10.1016/0005-2760(96)00013-6; Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818; Lee J, 2012, BIOCHEM BIOPH RES CO, V424, P358, DOI 10.1016/j.bbrc.2012.07.008; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Lester LB, 2001, ENDOCRINOLOGY, V142, P1218, DOI 10.1210/en.142.3.1218; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Lim A, 2009, DIABETES, V58, P2813, DOI 10.2337/db09-0600; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Logue JS, 2011, J BIOL CHEM, V286, P39269, DOI 10.1074/jbc.M111.277756; Mason MJ, 2005, BIOPHYS J, V88, P739, DOI 10.1529/biophysj.104.049866; Mehebik N, 2005, AM J PHYSIOL-CELL PH, V289, pC379, DOI 10.1152/ajpcell.00320.2004; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Murphy JG, 2014, CELL REP, V7, P1577, DOI 10.1016/j.celrep.2014.04.027; Nauert JB, 2003, J CELL BIOCHEM, V90, P97, DOI 10.1002/jcb.10604; Nystoriak MA, 2014, CIRC RES, V114, P607, DOI 10.1161/CIRCRESAHA.114.302168; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Ookuma M, 1998, DIABETES, V47, P219, DOI 10.2337/diabetes.47.2.219; Orie NN, 2009, BRIT J PHARMACOL, V157, P554, DOI 10.1111/j.1476-5381.2009.00221.x; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; Prada MP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18947-y; Purkey AM, 2018, CELL REP, V25, P974, DOI 10.1016/j.celrep.2018.09.085; Radeva MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106733; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Seufert J, 1999, J CLIN ENDOCR METAB, V84, P670, DOI 10.1210/jc.84.2.670; Smelt MJ, 2008, EXP DIABETES RES, DOI 10.1155/2008/165360; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Stone JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00409; Suga S, 1997, DIABETES, V46, P1755, DOI 10.2337/diabetes.46.11.1755; Surdo NC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15031; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Tenner B, 2020, ELIFE, V9, DOI 10.7554/eLife.55013; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; VANDEWINKEL M, 1983, BIOCHEM BIOPH RES CO, V114, P835, DOI 10.1016/0006-291X(83)90857-4; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725; Wilson AJ, 2000, CIRC RES, V87, P1019, DOI 10.1161/01.RES.87.11.1019; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu Y, 2017, J BIOL CHEM, V292, P15512, DOI 10.1074/jbc.M117.802249; Wu Y, 2015, J BIOL CHEM, V290, P29676, DOI 10.1074/jbc.M115.670877; Yang SN, 2007, CELL METAB, V6, P217, DOI 10.1016/j.cmet.2007.08.002; Yuan DW, 2020, P NATL ACAD SCI USA, V117, P9292, DOI 10.1073/pnas.2000963117; Zhang J, 2011, J NEUROSCI, V31, P7199, DOI 10.1523/JNEUROSCI.4446-10.2011; Zhang MX, 2013, J BIOL CHEM, V288, P17918, DOI 10.1074/jbc.M112.449462; Zheng SQ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.166876	79	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100442	10.1016/j.jbc.2021.100442	http://dx.doi.org/10.1016/j.jbc.2021.100442			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33617875	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400416
J	Eastep, GN; Ghanam, RH; Green, TJ; Saad, JS				Eastep, Gunnar N.; Ghanam, Ruba H.; Green, Todd J.; Saad, Jamil S.			Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PLASMA-MEMBRANE ASSOCIATION; SIZE-DISTRIBUTION ANALYSIS; GP41 CYTOPLASMIC TAIL; ANALYTICAL ULTRACENTRIFUGATION; MOLECULAR DETERMINANTS; TRIMERIZATION DOMAIN; MYRISTATE EXPOSURE; ENV INCORPORATION; GAG	During the late phase of HIV-1 infection, viral Gag polyproteins are targeted to the plasma membrane (PM) for assembly. Gag localization at the PM is a prerequisite for the incorporation of the envelope protein (Env) into budding particles. Gag assembly and Env incorporation are mediated by the N-terminal myristoylated matrix (MA) domain of Gag. Nonconservative mutations in the trimer interface of MA (A45E, T70R, and L75G) were found to impair Env incorporation and infectivity, leading to the hypothesis that MA trimerization is an obligatory step for Env incorporation. Conversely, Env incorporation can be rescued by a compensatory mutation in the MA trimer interface (Q63R). The impact of these MA mutations on the structure and trimerization properties of MA is not known. In this study, we employed NMR spectroscopy, X-ray crystallography, and sedimentation techniques to characterize the structure and trimerization properties of HIV-1 MA A45E, Q63R, T70R, and L75G mutant proteins. NMR data revealed that these point mutations did not alter the overall structure and folding of MA but caused minor structural perturbations in the trimer interface. Analytical ultracentrifugation data indicated that mutations had a minimal effect on the MA monomer-trimer equilibrium. The high-resolution X-ray structure of the unmyristoylated MA Q63R protein revealed hydrogen bonding between the side chains of adjacent Arg-63 and Ser-67 on neighboring MA molecules, providing the first structural evidence for an additional intermolecular interaction in the trimer interface. These findings advance our knowledge of the interplay of MA trimerization and Env incorporation into HIV-1 particles.	[Eastep, Gunnar N.; Ghanam, Ruba H.; Green, Todd J.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Saad, JS (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484; Green, Todd/0000-0003-1158-4710; Eastep, Gunnar/0000-0003-3567-8500	NIH [5R01GM117837, 9R01AI150901, 1S10RR026478]; O'Neal comprehensive cancer center (NIH) [P30 CA013148]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); O'Neal comprehensive cancer center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants 5R01GM117837 and 9R01AI150901 from the NIH to J. S. S. The High-Field NMR facility at the University of Alabama at Birmingham was established through the NIH (1S10RR026478) and is currently supported by the O'Neal comprehensive cancer center (NIH grant P30 CA013148). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akari H, 2000, J VIROL, V74, P4891, DOI 10.1128/JVI.74.10.4891-4893.2000; Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Alfadhli A, 2019, J VIROL, V93, DOI 10.1128/JVI.01079-19; Alfadhli A, 2016, J VIROL, V90, P5657, DOI 10.1128/JVI.00509-16; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; Anraku K, 2010, BIOCHEMISTRY-US, V49, P5109, DOI 10.1021/bi9019274; Barros M, 2016, J VIROL, V90, P4544, DOI 10.1128/JVI.02820-15; Brown LA, 2015, VIRUSES-BASEL, V7, P2210, DOI 10.3390/v7052210; Chan J, 2011, J VIROL, V85, P10851, DOI 10.1128/JVI.00760-11; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen B, 2019, TRENDS MICROBIOL, V27, P878, DOI 10.1016/j.tim.2019.06.002; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2013, J VIROL, V87, P7155, DOI 10.1128/JVI.00075-13; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; Dalton AK, 2007, J VIROL, V81, P6434, DOI 10.1128/JVI.02757-06; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dick RA, 2018, NATURE, V560, P509, DOI 10.1038/s41586-018-0396-4; Dick RA, 2012, P NATL ACAD SCI USA, V109, P18761, DOI 10.1073/pnas.1209408109; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes F, 2011, TRAFFIC, V12, P438, DOI 10.1111/j.1600-0854.2010.01153.x; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; Hamard-Peron E, 2010, J VIROL, V84, P503, DOI 10.1128/JVI.01134-09; Hendrix J, 2015, J CELL BIOL, V210, P629, DOI 10.1083/jcb.201504006; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Massiah MA, 1996, PROTEIN SCI, V5, P2391, DOI 10.1002/pro.5560051202; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079; Mercredi PY, 2016, J MOL BIOL, V428, P1637, DOI 10.1016/j.jmb.2016.03.005; Mucksch F, 2017, ELIFE, V6, DOI 10.7554/eLife.25287; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Murphy RE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050548; Murphy RE, 2019, J BIOL CHEM, V294, P18600, DOI 10.1074/jbc.RA119.010997; Murphy RE, 2017, STRUCTURE, V25, P1708, DOI 10.1016/j.str.2017.09.010; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 1997, J VIROL, V71, P4409, DOI 10.1128/JVI.71.6.4409-4418.1997; Ono A, 2010, VACCINE, V28, pB55, DOI 10.1016/j.vaccine.2009.10.021; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paillart JC, 1999, J VIROL, V73, P2604, DOI 10.1128/JVI.73.4.2604-2612.1999; Pak AJ, 2017, P NATL ACAD SCI USA, V114, pE10056, DOI 10.1073/pnas.1706600114; Pezeshkian N, 2019, P NATL ACAD SCI USA, V116, P25269, DOI 10.1073/pnas.1910008116; Piai A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16165-0; Prchal J, 2012, J MOL BIOL, V423, P427, DOI 10.1016/j.jmb.2012.07.021; Purohit P, 2001, RNA, V7, P576, DOI 10.1017/S1355838201002023; Racine J, 2006, J APPL ECONOMET, V21, P133, DOI 10.1002/jae.885; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Stansell E, 2007, J VIROL, V81, P8977, DOI 10.1128/JVI.00657-07; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tedbury PR, 2020, J VIROL, V94, DOI 10.1128/JVI.01526-19; Tedbury PR, 2016, P NATL ACAD SCI USA, V113, pE182, DOI 10.1073/pnas.1516618113; Tedbury PR, 2015, J MOL BIOL, V427, P1413, DOI 10.1016/j.jmb.2015.01.018; Tedbury PR, 2015, PROG MOL BIOL TRANSL, V129, P253, DOI 10.1016/bs.pmbts.2014.10.009; Tedbury PR, 2014, TRENDS MICROBIOL, V22, P372, DOI 10.1016/j.tim.2014.04.012; Tedbury PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003739; Vlach J, 2018, J BIOL CHEM, V293, P18828, DOI 10.1074/jbc.RA118.003944; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Wang Q, 2020, TRENDS MICROBIOL, V28, P655, DOI 10.1016/j.tim.2020.03.007; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992	87	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100321	10.1016/j.jbc.2021.100321	http://dx.doi.org/10.1016/j.jbc.2021.100321			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33485964	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400295
J	Gorski, JP; Franz, NT; Pernoud, D; Keightley, A; Eyre, DR; Oxford, JT				Gorski, Jeff P.; Franz, Nichole T.; Pernoud, Daniel; Keightley, Andrew; Eyre, David R.; Oxford, Julia Thom			A repeated triple lysine motif anchors complexes containing bone sialoprotein and the type XI collagen A1 chain involved in bone mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCOLLAGENOUS MATRIX PROTEINS; ACIDIC GLYCOPROTEIN-75; IN-VITRO; PHOSPHOPROTEIN COMPLEXES; BINDING DOMAIN; V COLLAGEN; HYDROXYAPATITE; NUCLEATION; EXPRESSION; COL11A1	While details remain unclear, initiation of woven bone mineralization is believed to be mediated by collagen and potentially nucleated by bone sialoprotein (BSP). Interestingly, our recent publication showed that BSP and type XI collagen form complexes in mineralizing osteoblastic cultures. To learn more, we examined the protein composition of extracellular sites of de novo hydroxyapatite deposition which were enriched in BSP and Col11a1 containing an alternatively spliced "6b" exonal sequence. An alternate splice variant "6a" sequence was not similarly co-localized. BSP and Col11a1 co-purify upon ion-exchange chromatography or immunoprecipitation. Binding of the Col11a1 "6b" exonal sequence to bone sialoprotein was demonstrated with overlapping peptides. Peptide 3, containing three unique lysine-triplet sequences, displayed the greatest binding to osteoblastic cultures; peptides containing fewer lysine triplet motifs or derived from the "6a" exon yielded dramatically lower binding. Similar results were obtained with 6-carboxyfluorescein (FAM)-conjugated peptides and western blots containing extracts from osteoblastic cultures. Mass spectroscopic mapping demonstrated that FAM-peptide 3 bound to 90 kDa BSP and its 18 to 60 kDa fragments, as well as to 110 kDa nucleolin. In osteoblastic cultures, FAM-peptide 3 localized to biomineralization foci (site of BSP) and to nucleoli (site of nucleolin). In bone sections, biotin-labeled peptide 3 bound to sites of new bone formation which were co-labeled with anti-BSP antibodies. These results establish the fluorescent peptide 3 conjugate as the first nonantibody-based method to identify BSP on western blots and in/on cells. Further examination of the "6b" splice variant interactions will likely reveal new insights into bone mineralization during development.	[Gorski, Jeff P.; Franz, Nichole T.] Univ Missouri, Sch Dent, Ctr Excellence Mineralized Tissue Res, Kansas City, MO 64110 USA; [Gorski, Jeff P.; Franz, Nichole T.; Pernoud, Daniel] Univ Missouri, Dept Oral & Craniofacial Sci, Sch Dent, Kansas City, MO 64110 USA; [Keightley, Andrew] Univ Missouri, Sch Med, Dept Ophthalmol & Prote Core Facil, Kansas City, MO 64110 USA; [Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Oxford, Julia Thom] Boise State Univ, Ctr Biomed Res Excellence Matrix Biol, Dept Biol Sci, Boise, ID 83725 USA; [Gorski, Jeff P.] Univ Missouri, Dept Oral & Craniofacial Sci, Ctr Excellence Mineralized Tissue Res, Sch Dent, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Washington; University of Washington Seattle; Idaho; Boise State University; University of Missouri System; University of Missouri Kansas City	Gorski, JP (corresponding author), Univ Missouri, Sch Dent, Ctr Excellence Mineralized Tissue Res, Kansas City, MO 64110 USA.; Gorski, JP (corresponding author), Univ Missouri, Dept Oral & Craniofacial Sci, Sch Dent, Kansas City, MO 64110 USA.; Gorski, JP (corresponding author), Univ Missouri, Dept Oral & Craniofacial Sci, Ctr Excellence Mineralized Tissue Res, Sch Dent, Kansas City, MO 64110 USA.	gorskij@umsytem.edu		Oxford, Julia/0000-0002-4850-3569	NIH [R21 DE14619, R01 AR052775, P20GM109095, P20GM103408]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support for this project was begun with funding from NIH (R21 DE14619; R01 AR052775) and finished with ancillary funds and personal contributions (J. P. G.). J. T. O. was supported by NIH P20GM109095 and P20GM103408. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aghajanian P, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0021-z; ARSENAULT AL, 1984, J CELL BIOL, V98, P911, DOI 10.1083/jcb.98.3.911; Baht GS, 2010, BIOCHEM J, V428, P385, DOI 10.1042/BJ20091864; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; Bilezikian J., 2019, PRINCIPLES BONE BIOL; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; BIRK DE, 1990, J CELL SCI, V95, P649; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Booth KT, 2019, GENET MED, V21, P948, DOI 10.1038/s41436-018-0285-0; BOSKEY AL, 1989, CONNECT TISSUE RES, V21, P501; Bouleftour W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095144; Brown RJ, 2011, PROTEOMICS, V11, P4660, DOI 10.1002/pmic.201100058; CARMICHAEL DJ, 1971, CALC TISS RES, V7, P331, DOI 10.1007/BF02062622; CHEN J, 1994, HISTOCHEM J, V26, P67; CHEN Y, 1992, J BIOL CHEM, V267, P24871; Davies GBM, 1998, DEV DYNAM, V213, P12, DOI 10.1002/(SICI)1097-0177(199809)213:1<12::AID-AJA2>3.0.CO;2-0; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Fallahi A, 2005, PROTEIN SCI, V14, P1526, DOI 10.1110/ps.051363105; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; Fujiwara Y, 2011, J BIOL CHEM, V286, P21732, DOI 10.1074/jbc.M110.174680; GLIMCHER MJ, 1990, BIOMATERIALS, V11, P7; GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205; Goldberg HA, 1996, CONNECT TISSUE RES, V35, P385, DOI 10.3109/03008209609029216; Gorski JP, 2011, J BIOL CHEM, V286, P1836, DOI 10.1074/jbc.M110.151647; Gorski JP, 2011, FRONT BIOSCI-LANDMRK, V16, P2598, DOI 10.2741/3875; GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767; Gorski JP, 2004, J BIOL CHEM, V279, P25455, DOI 10.1074/jbc.M312408200; GORSKI JP, 1990, J BIOL CHEM, V265, P14956; Gorski JP, 1998, CRIT REV ORAL BIOL M, V9, P201, DOI 10.1177/10454411980090020401; Griffith AJ, 1998, AM J HUM GENET, V62, P816, DOI 10.1086/301789; Hafez A, 2015, J DEV BIOL, V3, P158, DOI 10.3390/jdb3040158; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200; Holm E, 2015, BONE, V71, P145, DOI 10.1016/j.bone.2014.10.007; Huffman NT, 2007, J BIOL CHEM, V282, P26002, DOI 10.1074/jbc.M701332200; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Jiang CY, 2018, CONNECT TISSUE RES, V59, P274, DOI 10.1080/03008207.2017.1379514; Kahler RA, 2008, MATRIX BIOL, V27, P330, DOI 10.1016/j.matbio.2008.01.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDIS WJ, 1991, CONNECT TISSUE RES, V25, P181, DOI 10.3109/03008209109029155; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Magnuson SK, 1997, J BONE MINER RES, V12, P200, DOI 10.1359/jbmr.1997.12.2.200; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Medeck RJ, 2003, BIOCHEM J, V376, P361, DOI 10.1042/BJ20030894; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; Millan JL, 2016, CALCIFIED TISSUE INT, V98, P398, DOI 10.1007/s00223-015-0079-1; Moradi-Ameli M, 1998, MATRIX BIOL, V17, P393, DOI 10.1016/S0945-053X(98)90091-9; Morris NP, 2000, J HISTOCHEM CYTOCHEM, V48, P725, DOI 10.1177/002215540004800601; Nisole S, 2002, J BIOL CHEM, V277, P20877, DOI 10.1074/jbc.M110024200; OXFORD JT, 1995, J BIOL CHEM, V270, P9478, DOI 10.1074/jbc.270.16.9478; Riminucci M, 1998, J BONE MINER RES, V13, P1852, DOI 10.1359/jbmr.1998.13.12.1852; Rousseau JC, 1996, J BIOL CHEM, V271, P23743, DOI 10.1074/jbc.271.39.23743; SEEGMILLER R, 1971, J CELL BIOL, V48, P580, DOI 10.1083/jcb.48.3.580; Sirko-Osadsa D, 1998, J PEDIATR-US, V132, P368, DOI 10.1016/S0022-3476(98)70466-4; Smith SM, 2012, EXP EYE RES, V98, P105, DOI 10.1016/j.exer.2010.08.003; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Tompson SW, 2010, AM J HUM GENET, V87, P708, DOI 10.1016/j.ajhg.2010.10.009; Tye CE, 2003, J BIOL CHEM, V278, P7949, DOI 10.1074/jbc.M211915200; Tye CE, 2005, J BIOL CHEM, V280, P13487, DOI 10.1074/jbc.M408923200; Vaughan-Thomas A, 2001, J BIOL CHEM, V276, P5303, DOI 10.1074/jbc.M008764200; Wang CY, 2009, J BIOL CHEM, V284, P7100, DOI 10.1074/jbc.M805898200; Warner LR, 2007, PROTEIN EXPRES PURIF, V52, P403, DOI 10.1016/j.pep.2006.10.016; Wenstrup RJ, 2011, J BIOL CHEM, V286, P20455, DOI 10.1074/jbc.M111.223693; Whyte MP, 2016, J CLIN ENDOCR METAB, V101, P333, DOI 10.1210/jc.2015-3462; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173	66	4	4	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100436	10.1016/j.jbc.2021.100436	http://dx.doi.org/10.1016/j.jbc.2021.100436			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610546	Green Published, gold			2022-12-28	WOS:000672866400410
J	Hong, SJ; Huh, WK				Hong, Sujin; Huh, Won-Ki			Loss of Smi1, a protein involved in cell wall synthesis, extends replicative life span by enhancing rDNA stability in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; NUCLEAR-LOCALIZATION; INTEGRITY PATHWAY; SIGNALING PATHWAY; RIBOSOMAL DNA; KNR4 PROTEIN; YEAST-CELLS; STRESS; SIR2; GENE	In Saccharomyces cerevisiae, replicative life span (RLS) is primarily affected by the stability of ribosomal DNA (rDNA). The stability of the highly repetitive rDNA array is maintained through transcriptional silencing by the NAD(+)-dependent histone deacetylase Sir2. Recently, the loss of Smi1, a protein of unknown molecular function that has been proposed to be involved in cell wall synthesis, has been demonstrated to extend RLS in S. cerevisiae, but the mechanism by which Smi1 regulates RLS has not been elucidated. In this study, we determined that the loss of Smi1 extends RLS in a Sir2-dependent manner. We observed that the smi1 Delta mutation enhances transcriptional silencing at the rDNA locus and promotes rDNA stability. In the absence of Smi1, the stress-responsive transcription factor Msn2 translocates from the cytoplasm to the nucleus, and nuclear-accumulated Msn2 stimulates the expression of nicotinamidase Pnc1, which serves as an activator of Sir2. In addition, we observed that the MAP kinase Hog1 is activated in smi1 Delta. cells and that the activation of Hog1 induces the translocation of Msn2 into the nucleus. Taken together, our findings suggest that the loss of Smi1 leads to the nuclear accumulation of Msn2 and stimulates the expression of Pnc1, thereby enhancing Sir2-mediated rDNA stability and extending RLS in S. cerevisiae.	[Hong, Sujin; Huh, Won-Ki] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Huh, Won-Ki] Seoul Natl Univ, Inst Microbiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Huh, WK (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.; Huh, WK (corresponding author), Seoul Natl Univ, Inst Microbiol, Seoul, South Korea.	wkh@snu.ac.kr		Hong, Sujin/0000-0002-8827-2232; Huh, Won-Ki/0000-0002-9091-6594	National Research Foundation of Korea [2018R1A2B2009169, 2020R1A5A1018081]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (2018R1A2B2009169, 2020R1A5A1018081).	Basmaji F, 2006, MOL GENET GENOMICS, V275, P217, DOI 10.1007/s00438-005-0082-8; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bicknell AA, 2010, J BIOL CHEM, V285, P17545, DOI 10.1074/jbc.M109.084681; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dagkessamanskaia A, 2001, FEMS MICROBIOL LETT, V200, P53, DOI 10.1016/S0378-1097(01)00203-8; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; FISHEL BR, 1993, P NATL ACAD SCI USA, V90, P5623, DOI 10.1073/pnas.90.12.5623; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Garcia-Marques S, 2015, FEBS LETT, V589, P2163, DOI 10.1016/j.febslet.2015.06.021; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; Ha CW, 2014, NUCLEIC ACIDS RES, V42, P8486, DOI 10.1093/nar/gku570; Ha CW, 2011, NUCLEIC ACIDS RES, V39, P1336, DOI 10.1093/nar/gkq895; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; HONG Z, 1994, MOL CELL BIOL, V14, P1017, DOI 10.1128/MCB.14.2.1017; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.17; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Jacquet Michel, 2003, ScientificWorldJournal, V3, P609; Johnston M, 1997, NATURE, V387, P87, DOI 10.1038/387s087; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Koch MR, 2009, P NATL ACAD SCI USA, V106, P11224, DOI 10.1073/pnas.0900809106; KOPECKA M, 1992, ARCH MICROBIOL, V158, P115, DOI 10.1007/BF00245214; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Markovich S, 2004, ANTIMICROB AGENTS CH, V48, P3871, DOI 10.1128/AAC.48.10.3871-3876.2004; Martin H, 1999, MICROBIOL-SGM, V145, P249, DOI 10.1099/13500872-145-1-249; Martin-Yken H, 2003, MOL MICROBIOL, V49, P23, DOI 10.1046/j.1365-2958.2003.03541.x; Martin-Yken H, 2002, CURR GENET, V41, P323, DOI 10.1007/s00294-002-0299-6; Martin-Yken H, 2001, YEAST, V18, pS187; Martin-Yken H, 2016, CELL MICROBIOL, V18, P1217, DOI 10.1111/cmi.12618; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Mollapour M, 2006, FEMS YEAST RES, V6, P1274, DOI 10.1111/j.1567-1364.2006.00118.x; Molon M, 2018, BIOGERONTOLOGY, V19, P67, DOI 10.1007/s10522-017-9740-6; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Panadero J, 2006, J BIOL CHEM, V281, P4638, DOI 10.1074/jbc.M512736200; Paredes S, 2018, J BIOL CHEM, V293, P11242, DOI 10.1074/jbc.AC118.003325; Park PU, 2002, METHOD ENZYMOL, V351, P468; PETES TD, 1977, P NATL ACAD SCI USA, V74, P5091, DOI 10.1073/pnas.74.11.5091; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; Ray A, 2003, NAT GENET, V33, P522, DOI 10.1038/ng1132; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Sadeh A, 2011, MOL BIOL CELL, V22, P3127, DOI 10.1091/mbc.E10-12-1007; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Srivastava R, 2016, MICROBIOL MOL BIOL R, V80, P545, DOI 10.1128/MMBR.00005-16; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Torres-Quiroz F, 2010, J BIOL CHEM, V285, P20088, DOI 10.1074/jbc.M109.063578; Turchini A, 2000, J BACTERIOL, V182, P1167, DOI 10.1128/JB.182.4.1167-1171.2000; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; Yi DG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198619	75	3	3	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100258	10.1016/j.jbc.2021.100258	http://dx.doi.org/10.1016/j.jbc.2021.100258			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837734	gold, Green Published			2022-12-28	WOS:000672866400234
J	Kambe, T; Taylor, KM; Fu, D				Kambe, Taiho; Taylor, Kathryn M.; Fu, Dax			Zinc transporters and their functional integration in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GENOME-WIDE ASSOCIATION; PANCREATIC BETA-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; UNFOLDED PROTEIN RESPONSE; METAL-ION-TRANSPORT; SECRETORY PATHWAY; INSULIN-SECRETION; STRUCTURAL BASIS; LIV-1 SUBFAMILY; ALKALINE-PHOSPHATASES	Zinc is a ubiquitous biological metal in all living organisms. The spatiotemporal zinc dynamics in cells provide crucial cellular signaling opportunities, but also challenges for intracellular zinc homeostasis with broad disease implications. Zinc transporters play a central role in regulating cellular zinc balance and subcellular zinc distributions. The discoveries of two complementary families of mammalian zinc transporters (ZnTs and ZIPs) in the mid-1990s spurred much speculation on their metal selectivity and cellular functions. After two decades of research, we have arrived at a biochemical description of zinc transport. However, in vitro functions are fundamentally different from those in living cells, where mammalian zinc transporters are directed to specific subcellular locations, engaged in dedicated macromolecular machineries, and connected with diverse cellular processes. Hence, the molecular functions of individual zinc transporters are reshaped and deeply integrated in cells to promote the utilization of zinc chemistry to perform enzymatic reactions, tune cellular responsiveness to pathophysiologic signals, and safeguard cellular homeostasis. At present, the underlying mechanisms driving the functional integration of mammalian zinc transporters are largely unknown. This knowledge gap has motivated a shift of the research focus from in vitro studies of purified zinc transporters to in cell studies of mammalian zinc transporters in the context of their subcellular locations and protein interactions. In this review, we will outline how knowledge of zinc transporters has been accumulated from in-test-tube to in-cell studies, highlighting new insights and paradigm shifts in our understanding of the molecular and cellular basis of mammalian zinc transporter functions.	[Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Japan; [Taylor, Kathryn M.] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, Wales; [Fu, Dax] Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Kyoto University; Cardiff University; Johns Hopkins University; Johns Hopkins Medicine	Fu, D (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	dfu3@jhmi.edu	; Taylor, Kathryn/O-3401-2014	Fu, Dax/0000-0002-2663-1316; Kambe, Taiho/0000-0001-9757-063X; Taylor, Kathryn/0000-0002-9576-9490	Ministry of Education, Culture, Sports, Science and Technology, Japan [19H05768]; Florence Schute Millennium Foundation; National Institutes of Health [R56 DK123435, R01 DK125746]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Florence Schute Millennium Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas "Biometal" KAKENHI Grant 19H05768 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T. K.); Florence Schute Millennium Foundation grant to (K. M. T.). K. M. T. is a member of the European COST action ZINC-NET; National Institutes of Health R56 DK123435 and R01 DK125746 (to D. F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Adulcikas J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020408; Ahern ME, 2019, BIOCHEMISTRY-US, V58, P1705, DOI 10.1021/acs.biochem.9b00131; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Antala S, 2015, J BIOL CHEM, V290, P17796, DOI 10.1074/jbc.M114.617613; Antala S, 2012, BIOCHEMISTRY-US, V51, P963, DOI 10.1021/bi201553p; Anzilotti C, 2019, NAT IMMUNOL, V20, P350, DOI 10.1038/s41590-018-0295-8; Arnold GL, 2004, SCIENCE, V304, P87, DOI 10.1126/science.1091785; Atay O, 2017, J CELL BIOL, V216, P317, DOI 10.1083/jcb.201609124; Bafaro EM, 2015, METALLOMICS, V7, P1319, DOI 10.1039/c5mt00066a; Baird TT, 1997, BIOCHEMISTRY-US, V36, P2669, DOI 10.1021/bi962663s; BAKSH S, 1995, FEBS LETT, V376, P53, DOI 10.1016/0014-5793(95)01246-4; Balachandran RC, 2020, J BIOL CHEM, V295, P6312, DOI 10.1074/jbc.REV119.009453; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Bancila V, 2005, J BIOL CHEM, V280, P8793, DOI 10.1074/jbc.M413426200; Barber-Zucker S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16777-5; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Bellomo EA, 2011, J BIOL CHEM, V286, P25778, DOI 10.1074/jbc.M111.246082; Bin BH, 2017, J INVEST DERMATOL, V137, P1682, DOI 10.1016/j.jid.2017.03.031; Bin BH, 2011, J BIOL CHEM, V286, P40255, DOI 10.1074/jbc.M111.256784; Bird AJ, 2020, CURR OPIN CHEM BIOL, V55, P145, DOI 10.1016/j.cbpa.2020.01.011; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonnefond A, 2015, CELL METAB, V21, P357, DOI 10.1016/j.cmet.2014.12.020; Bowers K, 2018, TRAFFIC, V19, P813, DOI 10.1111/tra.12602; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Brethour D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40313; Cao MF, 2019, CANCER BIOL MED, V16, P595, DOI 10.20892/j.issn.2095-3941.2018.0277; Chabosseau P, 2014, ACS CHEM BIOL, V9, P2111, DOI 10.1021/cb5004064; Chantalat L, 1999, EMBO J, V18, P2930, DOI 10.1093/emboj/18.11.2930; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Choi S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007262; Chowanadisai W, 2013, P NATL ACAD SCI USA, V110, P9903, DOI 10.1073/pnas.1222142110; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Chun HR, 2019, J BIOL CHEM, V294, P2815, DOI 10.1074/jbc.RA118.005203; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Davidson HW, 2014, TRENDS ENDOCRIN MET, V25, P415, DOI 10.1016/j.tem.2014.03.008; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Dwivedi OP, 2019, NAT GENET, V51, P1596, DOI 10.1038/s41588-019-0513-9; Ehsani S, 2012, PRION, V6, P317, DOI 10.4161/pri.20196; Ehsani S, 2012, J MOL BIOL, V422, P556, DOI 10.1016/j.jmb.2012.06.003; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; FALCHUK KH, 1975, J CELL SCI, V17, P57; FALCHUK KH, 1977, CANCER RES, V37, P2050; FALCHUK KH, 1975, BIOCHEMISTRY-US, V14, P3439, DOI 10.1021/bi00686a023; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Fauster A, 2019, CELL DEATH DIFFER, V26, P1138, DOI 10.1038/s41418-018-0192-6; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Flannick J, 2019, NATURE, V570, P71, DOI 10.1038/s41586-019-1231-2; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Franz MC, 2018, BIOCHEMISTRY-US, V57, P3976, DOI 10.1021/acs.biochem.8b00511; Fred RG, 2015, MOL CELL ENDOCRINOL, V414, P53, DOI 10.1016/j.mce.2015.07.015; Fujimoto S, 2016, BIOCHEM J, V473, P2611, DOI 10.1042/BCJ20160324; Fujiwara T, 2015, FEBS J, V282, P1965, DOI 10.1111/febs.13252; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Giunta C, 2008, AM J HUM GENET, V82, P1290, DOI 10.1016/j.ajhg.2008.05.001; Golan Y, 2015, J BIOL CHEM, V290, P9050, DOI 10.1074/jbc.M114.617332; Gore A, 2004, J BIOL CHEM, V279, P11106, DOI 10.1074/jbc.M400005200; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Grass G, 2001, J BACTERIOL, V183, P4664, DOI 10.1128/JB.183.15.4664-4667.2001; Gupta S, 2019, J BIOL CHEM, V294, P13327, DOI 10.1074/jbc.RA119.009239; Gupta S, 2014, NATURE, V512, P101, DOI 10.1038/nature13382; Gyimesi G, 2019, J BIOL CHEM, V294, P8046, DOI 10.1074/jbc.RA118.006113; Haller G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06705-0; Hara K, 2016, EXPERT OPIN THER TAR, V20, P255, DOI 10.1517/14728222.2016.1098618; Hara T, 2017, J PHYSIOL SCI, V67, P283, DOI 10.1007/s12576-017-0521-4; Hashimoto A, 2016, AM J PHYSIOL-REG I, V310, pR459, DOI 10.1152/ajpregu.00439.2015; Hennigar SR, 2015, J CELL PHYSIOL, V230, P2345, DOI 10.1002/jcp.24992; Henshall SM, 2003, ONCOGENE, V22, P6005, DOI 10.1038/sj.onc.1206797; Herbert TP, 2016, DIABETES, V65, P1472, DOI 10.2337/db15-1633; Hershfinkel M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020439; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Hogstrand C, 2013, BIOCHEM J, V455, P229, DOI 10.1042/BJ20130483; Hojyo S, 2014, P NATL ACAD SCI USA, V111, P11786, DOI 10.1073/pnas.1323557111; Holst B, 2009, ENDOCRINOLOGY, V150, P2577, DOI 10.1210/en.2008-1250; Homma K, 2013, MOL CELL, V52, P75, DOI 10.1016/j.molcel.2013.08.038; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Hu J, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010004; Huang LP, 2007, FEBS J, V274, P3986, DOI 10.1111/j.1742-4658.2007.05933.x; Huang LP, 2014, VITAM HORM, V95, P365, DOI 10.1016/B978-0-12-800174-5.00014-4; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Huang Q, 2017, J BIOL CHEM, V292, P4034, DOI 10.1074/jbc.M116.772152; HUBBARD SR, 1991, SCIENCE, V254, P1776; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Ilouz R, 2002, BIOCHEM BIOPH RES CO, V295, P102, DOI 10.1016/S0006-291X(02)00636-8; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Jiang DK, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06842-0; Jirakulaporn T, 2004, J BIOL CHEM, V279, P27807, DOI 10.1074/jbc.M401210200; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kagara N, 2007, CANCER SCI, V98, P692, DOI 10.1111/j.1349-7006.2007.00446.x; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2019, ZINC SIGNALING, 2ND EDITION, P23, DOI 10.1007/978-981-15-0557-7_3; Kambe T, 2020, BIOCHEMISTRY-US, V59, P74, DOI 10.1021/acs.biochem.9b00924; Kambe T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102179; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kaneko M, 2015, J NEUROSCI RES, V93, P370, DOI 10.1002/jnr.23491; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.000232; Kim BE, 2004, J BIOL CHEM, V279, P4523, DOI 10.1074/jbc.M310799200; Kim BJ, 2000, DIABETES, V49, P367, DOI 10.2337/diabetes.49.3.367; Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007; Kim MH, 2017, P NATL ACAD SCI USA, V114, pE5805, DOI 10.1073/pnas.1704012114; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Komatsu M, 2013, J DIABETES INVEST, V4, P511, DOI 10.1111/jdi.12094; Kukic I, 2013, BIOCHEM J, V451, P155, DOI 10.1042/BJ20121506; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Laitaoja M, 2013, INORG CHEM, V52, P10983, DOI 10.1021/ic401072d; Langmuir I, 1921, SCIENCE, V54, P59, DOI 10.1126/science.54.1386.59; Lasry I, 2014, J BIOL CHEM, V289, P7275, DOI 10.1074/jbc.M113.533786; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Lee S, 2017, J BIOL CHEM, V292, P21598, DOI 10.1074/jbc.M117.794461; Lee S, 2015, J BIOL CHEM, V290, P13064, DOI 10.1074/jbc.M115.637439; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lengyel I, 2000, J NEUROCHEM, V75, P594, DOI 10.1046/j.1471-4159.2000.0750594.x; Leung KW, 2012, J MOL NEUROSCI, V46, P122, DOI 10.1007/s12031-011-9536-0; Levy S, 2009, J BIOL CHEM, V284, P32434, DOI 10.1074/jbc.M109.058842; Li DL, 2016, GASTROENTEROLOGY, V151, P724, DOI 10.1053/j.gastro.2016.06.051; Li M, 2007, P NATL ACAD SCI USA, V104, P18636, DOI 10.1073/pnas.0709307104; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Little EB, 2001, P NATL ACAD SCI USA, V98, P2238, DOI 10.1073/pnas.041597098; Liu L., 2020, BIOSCIENCE REP, V40; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu MY, 2020, GASTROENTEROLOGY, V158, P679, DOI 10.1053/j.gastro.2019.10.038; Liu Y, 2015, J BIOL CHEM, V290, P18757, DOI 10.1074/jbc.M115.640524; Lopez-Redondo ML, 2018, P NATL ACAD SCI USA, V115, P3042, DOI 10.1073/pnas.1715051115; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Luck K, 2020, NATURE, V580, P402, DOI 10.1038/s41586-020-2188-x; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; McCormick NH, 2012, AM J PHYSIOL-CELL PH, V303, pC291, DOI 10.1152/ajpcell.00443.2011; Melia JMP, 2019, BIOCHEM BIOPH RES CO, V515, P325, DOI 10.1016/j.bbrc.2019.05.137; Merriman C, 2019, J BIOL CHEM, V294, P16992, DOI 10.1074/jbc.RA119.010937; Merriman C, 2018, J BIOL CHEM, V293, P579, DOI 10.1074/jbc.RA117.000195; Merriman C, 2016, J BIOL CHEM, V291, P26950, DOI 10.1074/jbc.M116.764605; Miyai T, 2014, P NATL ACAD SCI USA, V111, P11780, DOI 10.1073/pnas.1323549111; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Nimmanon T, 2017, METALLOMICS, V9, P471, DOI 10.1039/c6mt00286b; Nimmanon T, 2019, ZINC SIGNALING, 2ND EDITION, P319, DOI 10.1007/978-981-15-0557-7_16; Nimmanon T, 2021, CELL MOL LIFE SCI, V78, P1781, DOI 10.1007/s00018-020-03616-6; Nishito Y, 2019, J BIOL CHEM, V294, P15686, DOI 10.1074/jbc.RA119.010227; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Ohashi W, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006349; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Park JA, 1999, J NEUROCHEM, V73, P450, DOI 10.1046/j.1471-4159.1999.0730450.x; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Pocanschi CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072446; Podany AB, 2016, CELL MOL GASTROENTER, V2, P369, DOI 10.1016/j.jcmgh.2015.12.006; Popovics P, 2011, CELL MOL LIFE SCI, V68, P85, DOI 10.1007/s00018-010-0517-1; Pound LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040972; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; QUEST AFG, 1992, J BIOL CHEM, V267, P10193; Raimunda D, 2014, BBA-BIOMEMBRANES, V1838, P3203, DOI 10.1016/j.bbamem.2014.09.005; RAMOS S, 1976, P NATL ACAD SCI USA, V73, P1892, DOI 10.1073/pnas.73.6.1892; Rauniyar N, 2014, J PROTEOME RES, V13, P5293, DOI 10.1021/pr500880b; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Roux B, 2011, J GEN PHYSIOL, V137, P415, DOI 10.1085/jgp.201010577; Salazar G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005896; Sato S, 2016, MOL PHARMACOL, V90, P726, DOI 10.1124/mol.116.106112; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Seo YA, 2014, J BIOL CHEM, V289, P23653, DOI 10.1074/jbc.M113.531145; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Slepchenko KG, 2012, EXP DIABETES RES, DOI 10.1155/2012/190309; Sousa SF, 2007, J AM CHEM SOC, V129, P1378, DOI 10.1021/ja067103n; Sun HX, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-319; Suzuki E, 2020, J BIOL CHEM, V295, P5669, DOI 10.1074/jbc.RA120.012610; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Takamoto K, 2006, ANNU REV BIOPH BIOM, V35, P251, DOI 10.1146/annurev.biophys.35.040405.102050; Takeda T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0118-3; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Taylor KM, 2016, BIOCHEM J, V473, P2531, DOI 10.1042/BCJ20160388; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; ten Have S, 2011, PROTEOMICS, V11, P1153, DOI 10.1002/pmic.201000548; Toth K, 2011, ANNU REV NUTR, V31, P139, DOI 10.1146/annurev-nutr-072610-145218; Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790; Tremblay F, 2009, ENDOCRINOLOGY, V150, P2586, DOI 10.1210/en.2008-1251; Tsuji T, 2017, J BIOL CHEM, V292, P2159, DOI 10.1074/jbc.M116.763946; Tuncay E, 2017, DIABETES, V66, P1346, DOI 10.2337/db16-1099; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Vahrenkamp H, 2007, DALTON T, P4751, DOI 10.1039/b712138e; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Wang XX, 2010, IUBMB LIFE, V62, P176, DOI 10.1002/iub.291; Wang YR, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00269j; Watanabe S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08429-1; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Weaver BP, 2007, BIOL CHEM, V388, P1301, DOI 10.1515/BC.2007.149; Weaver Benjamin P, 2010, PLoS One, V5, DOI 10.1371/journal.pone.0013158; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Wilson M, 2012, J BIOL CHEM, V287, P9322, DOI 10.1074/jbc.C111.320796; Woodruff G, 2018, MOL PHARMACOL, V94, P1092, DOI 10.1124/mol.118.112557; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Xue J, 2020, ELIFE, V9, DOI 10.7554/eLife.58823; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yang TY, 2008, J AM CHEM SOC, V130, P3844, DOI 10.1021/ja076277h; Zhang C, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107582; Zhang T, 2020, FASEB J, V34, P237, DOI 10.1096/fj.201902043R; Zhang T, 2019, BIOCHEM J, V476, P1791, DOI 10.1042/BCJ20190108; Zhang T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700344; Zhang T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11979; Zhang Y., 2020, BIOSCIENCE REP, V40; Zhao L, 2007, BIOCHEM BIOPH RES CO, V363, P82, DOI 10.1016/j.bbrc.2007.08.127; Zhao NN, 2014, P NATL ACAD SCI USA, V111, P9175, DOI 10.1073/pnas.1405355111; Zhao YT, 2016, TRAFFIC, V17, P267, DOI 10.1111/tra.12371; Ziliotto S., 2018, MET IONS LIFE SCI, V18; Ziliotto S, 2019, METALLOMICS, V11, P1579, DOI 10.1039/c9mt00136k; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	270	34	34	4	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100320	10.1016/j.jbc.2021.100320	http://dx.doi.org/10.1016/j.jbc.2021.100320			27	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33485965	Green Published, Green Accepted, gold			2022-12-28	WOS:000672866400294
J	Li, YL; Yao, YX; Zhao, YM; Di, YQ; Zhao, XF				Li, Yan-Li; Yao, You-Xiang; Zhao, Yu-Meng; Di, Yu-Qin; Zhao, Xiao-Fan			The steroid hormone 20-hydroxyecdysone counteracts insulin signaling via insulin receptor dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; WING IMAGINAL DISKS; DOUBLE-STRANDED-RNA; PROTHORACIC GLAND; TOBACCO HORNWORM; MANDUCA-SEXTA; DROSOPHILA; GROWTH; SIZE; CELL	The insulin receptor (INSR) binds insulin to promote body growth and maintain normal blood glucose levels. While it is known that steroid hormones such as estrogen and 20-hydroxyecdysone counteract insulin function, the molecular mechanisms responsible for this attenuation remain unclear. In the present study, using the agricultural pest lepidopteran Helicoverpa armigera as a model, we proposed that the steroid hormone 20-hydroxyecdysone (20E) induces dephosphorylation of INSR to counteract insulin function. We observed high expression and phosphorylation of INSR during larval feeding stages that decreased during metamorphosis. Insulin upregulated INSR expression and phosphorylation, whereas 20E repressed INSR expression and induced INSR dephosphorylation in vivo. Protein tyrosine phosphatase 1B (PTP1B, encoded by Ptpn1) dephosphorylated INSR in vivo. PTEN (phosphatase and tensin homolog deleted on chromosome 10) was critical for 20E-induced INSR dephosphorylation by maintaining the transcription factor Forkhead box O (FoxO) in the nucleus, where FoxO promoted Ptpn1 expression and repressed Insr expression. Knockdown of Ptpn1 using RNA interference maintained INSR phosphorylation, increased 20E production, and accelerated pupation. RNA interference of Insr in larvae repressed larval growth, decreased 20E production, delayed pupation, and accumulated hemolymph glucose levels. Taken together, these results suggest that a high 20E titer counteracts the insulin pathway by dephosphorylating INSR to stop larval growth and accumulate glucose in the hemolymph.	[Li, Yan-Li; Yao, You-Xiang; Zhao, Yu-Meng; Di, Yu-Qin; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Qingdao, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Qingdao, Peoples R China.	xfzhao@sdu.edu.cn	Zhao, Xiao-Fan/AGW-9886-2022	Li, Yan-Li/0000-0003-2919-7647	National Natural Science Foundation of China [31730083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31730083).	Alvarez-Rendon JP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1417528; [Anonymous], 2011, DIABETES RES CLIN PR, V93, P299, DOI 10.1016/j.diabres.2011.03.012; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bass J, 2000, P NATL ACAD SCI USA, V97, P11905, DOI 10.1073/pnas.97.22.11905; Brown MR, 1998, J BIOL CHEM, V273, P3967, DOI 10.1074/jbc.273.7.3967; Cai MJ, 2016, DEVELOPMENT, V143, P1005, DOI 10.1242/dev.128694; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; COMPTON SJ, 1985, ANAL BIOCHEM, V151, P369, DOI 10.1016/0003-2697(85)90190-3; CZECH M P, 1985, Diabetes Metabolism Reviews, V1, P33; Das D, 2017, MOL REPROD DEV, V84, P444, DOI 10.1002/mrd.22806; De Franca IR, 2018, INTERV MED APPL SCI, V10, P226, DOI 10.1556/1646.10.2018.44; Di YQ, 2021, AUTOPHAGY, V17, P1170, DOI 10.1080/15548627.2020.1752497; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Elena C, 2018, CURR PHARM BIOTECHNO, V19, P1210, DOI 10.2174/1389201020666190102145305; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gabbouj S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00629; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; GIORGINO F, 1993, J CLIN INVEST, V91, P2020, DOI 10.1172/JCI116424; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Herrera NA, 2020, FREE RADICAL BIO MED, V152, P689, DOI 10.1016/j.freeradbiomed.2020.01.012; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Hwang JL, 2014, DIABETES-METAB RES, V30, P96, DOI 10.1002/dmrr.2486; Hyun S, 2013, CELL MOL LIFE SCI, V70, P2351, DOI 10.1007/s00018-013-1313-5; Jamaspishvili T, 2018, NAT REV UROL, V15, P222, DOI 10.1038/nrurol.2018.9; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kang XL, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008331; Kannan K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00288; Koyama T, 2004, MOL CELL ENDOCRINOL, V213, P155, DOI 10.1016/j.mce.2003.10.063; Kumar D, 2008, EUR J ENTOMOL, V105, P591, DOI 10.14411/eje.2008.079; Langelan RE, 2000, DEV BIOL, V227, P481, DOI 10.1006/dbio.2000.9895; Li YB, 2016, INSECT BIOCHEM MOLEC, V79, P73, DOI 10.1016/j.ibmb.2016.10.004; Lin F, 2017, AUST J CHEM, V70, P208, DOI [10.1071/ch16626, 10.1071/CH16626]; Lin XY, 2019, PEPTIDES, V122, DOI 10.1016/j.peptides.2018.02.001; Liu CY, 2015, CELL CYCLE, V14, P3045, DOI 10.1080/15384101.2015.1053664; Liu CY, 2013, APOPTOSIS, V18, P171, DOI 10.1007/s10495-012-0784-4; Liu ML, 2011, BIOTECHNOL PROGR, V27, P1407, DOI 10.1002/btpr.666; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mohammadiarani H, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00068; Nassel DR, 2016, CELL MOL LIFE SCI, V73, P271, DOI 10.1007/s00018-015-2063-3; Nijhout HF, 2007, DEV BIOL, V302, P569, DOI 10.1016/j.ydbio.2006.10.023; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; NIJHOUT HF, 1975, BIOL BULL, V149, P214, DOI 10.2307/1540491; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; Nussey S, 2001, ENDOCRINOLOGY INTEGR; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Pan J, 2018, J BIOL CHEM, V293, P18613, DOI [10.1074/jbc.RA118.004891, 10.1074/jbc.ra118.004891]; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Rewitz KF, 2006, MOL CELL ENDOCRINOL, V247, P166, DOI 10.1016/j.mce.2005.12.053; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Schultz H, 2018, NEURO-ONCOL PRACT, V5, P170, DOI 10.1093/nop/npx027; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Smith WA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00019; Tatulian SA, 2015, BIOCHEMISTRY-US, V54, P5523, DOI 10.1021/acs.biochem.5b00805; Tawfik AI, 1997, J INSECT PHYSIOL, V43, P485, DOI 10.1016/S0022-1910(96)00116-3; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Wang D, 2016, CELL CALCIUM, V60, P1, DOI 10.1016/j.ceca.2016.05.003; Wang JL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-76; Xu J, 2016, GENES-BASEL, V7, DOI 10.3390/genes7100088; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang XQ, 2015, CELL SIGNAL, V27, P878, DOI 10.1016/j.cellsig.2015.01.016; Zhao WL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29205; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0; Zhao XF, 2020, J INTEGR AGR, V19, P1417, DOI 10.1016/S2095-3119(19)62860-1; Zhou XF, 2004, J EXP BIOL, V207, P1151, DOI 10.1242/jeb.00855	68	5	5	2	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100318	10.1016/j.jbc.2021.100318	http://dx.doi.org/10.1016/j.jbc.2021.100318			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33484713	gold, Green Published			2022-12-28	WOS:000672866400292
J	Murray, D; Petrey, D; Honig, B				Murray, Diana; Petrey, Donald; Honig, Barry			Integrating 3D structural information into systems biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-PROTEIN INTERACTION; STRUCTURE-BASED PREDICTION; CANCER; NETWORKS; DISCOVERY; ALIGNMENT; MIMICRY; MAP; IDENTIFICATION; SPECIFICITY	Systems biology is a data-heavy field that focuses on systems-wide depictions of biological phenomena necessarily sacrificing a detailed characterization of individual components. As an example, genome-wide protein interaction networks are widely used in systems biology and continuously extended and refined as new sources of evidence become available. Despite the vast amount of information about individual protein structures and protein complexes that has accumulated in the past 50 years in the Protein Data Bank, the data, computational tools, and language of structural biology are not an integral part of systems biology. However, increasing effort has been devoted to this integration, and the related literature is reviewed here. Relationships between proteins that are detected via structural similarity offer a rich source of information not available from sequence similarity, and homology modeling can be used to leverage Protein Data Bank structures to produce 3D models for a significant fraction of many proteomes. A number of structure-informed genomic and cross-species (i.e., virus-host) interactomes will be described, and the unique information they provide will be illustrated with a number of examples. Tissue- and tumor-specific interactomes have also been developed through computational strategies that exploit patient information and through genetic interactions available from increasingly sensitive screens. Strategies to integrate structural information with these alternate data sources will be described. Finally, efforts to link protein structure space with chemical compound space offer novel sources of information in drug design, off-target identification, and the identification of targets for compounds found to be effective in phenotypic screens.	[Murray, Diana; Petrey, Donald] Columbia Univ, Dept Syst Biol, Zuckerman Mind Brain & Behav Inst, New York, NY USA; [Honig, Barry] Columbia Univ, Dept Syst Biol, Dept Biochem & Mol Biophys, Dept Med,Zuckerman Mind Brain & Behav Inst, New York, NY 10027 USA	Columbia University; Columbia University	Honig, B (corresponding author), Columbia Univ, Dept Syst Biol, Dept Biochem & Mol Biophys, Dept Med,Zuckerman Mind Brain & Behav Inst, New York, NY 10027 USA.	bh6@columbia.edu		Honig, Barry/0000-0002-1835-1031	National Institutes of Health [R01-GM030518, R35GM139585, U54-CA209997]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants R01-GM030518, R35GM139585 and U54-CA209997 (B. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adedeji AO, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00235-16; Alonso-Lopez D, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Alvarez MJ, 2018, NAT GENET, V50, P979, DOI 10.1038/s41588-018-0138-4; Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bajorath J, 2017, METHODS MOL BIOL, V1526, P231, DOI 10.1007/978-1-4939-6613-4_13; Barradas-Bautista D, 2018, ADV PROTEIN CHEM STR, V110, P203, DOI 10.1016/bs.apcsb.2017.06.003; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boyle EA, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188594; Broyde J, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-0652-7; Califano A, 2017, NAT REV CANCER, V17, P116, DOI 10.1038/nrc.2016.124; Carter H, 2013, CURR OPIN GENET DEV, V23, P611, DOI 10.1016/j.gde.2013.10.003; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Cong Q, 2019, SCIENCE, V365, P185, DOI 10.1126/science.aaw6718; Corsello SM, 2017, NAT MED, V23, P405, DOI 10.1038/nm.4306; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Dey F, 2013, PROTEIN SCI, V22, P359, DOI 10.1002/pro.2225; Doxey AC, 2013, VIRULENCE, V4, P453, DOI 10.4161/viru.25180; Dugger SA, 2018, NAT REV DRUG DISCOV, V17, P183, DOI 10.1038/nrd.2017.226; Filipp FV, 2017, CANCER METAST REV, V36, P91, DOI 10.1007/s10555-017-9662-4; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Franzosa EA, 2011, P NATL ACAD SCI USA, V108, P10538, DOI 10.1073/pnas.1101440108; Fratev F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53133-1; Gao JJ, 2017, GENOME MED, V9, DOI 10.1186/s13073-016-0393-x; Garzon JI, 2016, ELIFE, V5, DOI 10.7554/eLife.18715; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Gilson MK, 2016, NUCLEIC ACIDS RES, V44, pD1045, DOI 10.1093/nar/gkv1072; Giorgi FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109569; Greene CS, 2015, NAT GENET, V47, P569, DOI 10.1038/ng.3259; Guven-Maiorov E, 2019, METHODS MOL BIOL, V1851, P317, DOI 10.1007/978-1-4939-8736-8_18; Hill SM, 2017, CELL SYST, V4, P73, DOI 10.1016/j.cels.2016.11.013; Honig B, 2020, CELL, V181, P520, DOI 10.1016/j.cell.2020.04.010; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Huang JK, 2018, CELL SYST, V6, P484, DOI 10.1016/j.cels.2018.03.001; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hutter C, 2018, CELL, V173, P283, DOI 10.1016/j.cell.2018.03.042; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Hwang H, 2017, P NATL ACAD SCI USA, V114, P13685, DOI 10.1073/pnas.1705381114; Hwang H, 2016, PROTEIN SCI, V25, P159, DOI 10.1002/pro.2744; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033; Krogan NJ, 2015, MOL CELL, V58, P690, DOI 10.1016/j.molcel.2015.05.008; Lasso G, 2021, CELL SYST, V12, P82, DOI 10.1016/j.cels.2020.09.006; Lasso G, 2019, CELL, V178, P1526, DOI 10.1016/j.cell.2019.08.005; Lim H, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006619; Lo YC, 2018, DRUG DISCOV TODAY, V23, P1538, DOI 10.1016/j.drudis.2018.05.010; Luck K, 2020, NATURE, V580, P402, DOI 10.1038/s41586-020-2188-x; Ludin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017546; Lundberg E, 2019, NAT REV MOL CELL BIO, V20, P285, DOI 10.1038/s41580-018-0094-y; Maggiora G, 2014, J MED CHEM, V57, P3186, DOI 10.1021/jm401411z; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Martinez-Jimenez F, 2020, NAT REV CANCER, V20, P555, DOI 10.1038/s41568-020-0290-x; McDermott U, 2019, CURR OPIN GENET DEV, V54, P12, DOI 10.1016/j.gde.2019.02.002; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Mendez D, 2019, NUCLEIC ACIDS RES, V47, pD930, DOI 10.1093/nar/gky1075; Meyer MJ, 2018, NAT METHODS, V15, P107, DOI 10.1038/nmeth.4540; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Pagadala Nataraj S, 2017, Biophys Rev, V9, P91, DOI 10.1007/s12551-016-0247-1; Pan J, 2018, CELL SYST, V6, P555, DOI 10.1016/j.cels.2018.04.011; Petrey D, 2015, CURR OPIN STRUC BIOL, V32, P33, DOI 10.1016/j.sbi.2015.01.007; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; Porta-Pardo E, 2020, FEBS LETT, V594, P4233, DOI 10.1002/1873-3468.13781; Porta-Pardo E, 2017, NAT METHODS, V14, P782, DOI [10.1038/NMETH.4364, 10.1038/nmeth.4364]; Porta-Pardo E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004518; Porta-Pardo E, 2014, BIOINFORMATICS, V30, P3109, DOI 10.1093/bioinformatics/btu499; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Ragoza M, 2017, J CHEM INF MODEL, V57, P942, DOI 10.1021/acs.jcim.6b00740; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Sahni N, 2013, CURR OPIN GENET DEV, V23, P649, DOI 10.1016/j.gde.2013.11.002; Stathias V, 2020, NUCLEIC ACIDS RES, V48, pD431, DOI 10.1093/nar/gkz1023; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Szklarczyk D, 2015, METHODS MOL BIOL, V1278, P39, DOI 10.1007/978-1-4939-2425-7_3; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Vakser IA, 2014, BIOPHYS J, V107, P1785, DOI 10.1016/j.bpj.2014.08.033; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang L, 2012, P NATL ACAD SCI USA, V109, P1937, DOI 10.1073/pnas.1114017109; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Will T, 2016, BIOINFORMATICS, V32, P571, DOI 10.1093/bioinformatics/btv620; Willett P, 2011, METHODS MOL BIOL, V672, P133, DOI 10.1007/978-1-60761-839-3_5; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xie L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003554; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhang QC, 2011, NUCLEIC ACIDS RES, V39, pW283, DOI 10.1093/nar/gkr311; Zhou HY, 2018, J CHEM INF MODEL, V58, P2343, DOI 10.1021/acs.jcim.8b00309	102	4	4	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100562	10.1016/j.jbc.2021.100562	http://dx.doi.org/10.1016/j.jbc.2021.100562			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744294	Green Published, gold			2022-12-28	WOS:000672866400535
J	Ohgami, N; Iizuka, A; Hirai, H; Yajima, I; Iida, M; Shimada, A; Tsuzuki, T; Jijiwa, M; Asai, N; Takahashi, M; Kato, M				Ohgami, Nobutaka; Iizuka, Akira; Hirai, Hirokazu; Yajima, Ichiro; Iida, Machiko; Shimada, Atsuyoshi; Tsuzuki, Toyonori; Jijiwa, Mayumi; Asai, Naoya; Takahashi, Masahide; Kato, Masashi			Loss-of-function mutation of c-Ret causes cerebellar hypoplasia in mice with Hirschsprung disease and Down's syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY-THYROID CARCINOMA; ENDOTHELIN RECEPTOR B; SONIC HEDGEHOG; TYROSINE KINASE; GENE; PROLIFERATION; MECHANISMS; NEURONS; SYSTEM; FAMILY	The c-RET proto-oncogene encodes a receptor-tyrosine kinase. Loss-of-function mutations of RET have been shown to be associated with Hirschsprung disease and Down's syndrome (HSCR-DS) in humans. DS is known to involve cerebellar hypoplasia, which is characterized by reduced cerebellar size. Despite the fact that c-Ret has been shown to be associated with HSCR-DS in humans and to be expressed in Purkinje cells (PCs) in experimental animals, there is limited information about the role of activity of c-Ret/c-RET kinase in cerebellar hypoplasia. We found that a loss-of-function mutation of c-Ret Y1062 in PCs causes cerebellar hypoplasia in c-Ret mutant mice. Wild-type mice had increased phosphorylation of c-Ret in PCs during postnatal development, while c-Ret mutant mice had postnatal hypoplasia of the cerebellum with immature neurite outgrowth in PCs and granule cells (GCs). c-Ret mutant mice also showed decreased numbers of glial fibers and mitogenic sonic hedgehog (Shh)-positive vesicles in the external germinal layer of PCs. c-Ret-mediated cerebellar hypoplasia was rescued by subcutaneous injection of a smoothened agonist (SAG) as well as by reduced expression of Patched1, a negative regulator for Shh. Our results suggest that the loss-of-function mutation of c-Ret Y1062 results in the development of cerebellar hypoplasia via impairment of the Shh-mediated development of GCs and glial fibers in mice with HSCR-DS.	[Ohgami, Nobutaka; Yajima, Ichiro; Iida, Machiko; Kato, Masashi] Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Nagoya, Aichi, Japan; [Ohgami, Nobutaka; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi, Japan; [Iizuka, Akira; Hirai, Hirokazu] Gunma Univ, Dept Neurophysiol & Neural Repair, Grad Sch Med, Maebashi, Gumma, Japan; [Shimada, Atsuyoshi] Kyorin Univ, Fac Hlth Sci, Pathol Res Team, Mitaka, Tokyo, Japan; [Tsuzuki, Toyonori] Aichi Med Univ Hosp, Dept Surg Pathol, Nagakute, Aichi, Japan; [Jijiwa, Mayumi; Takahashi, Masahide] Nagoya Univ, Dept Pathol, Grad Sch Med, Nagoya, Aichi, Japan; [Asai, Naoya] Fujita Hlth Univ, Dept Pathol, Toyoake, Aichi, Japan; [Takahashi, Masahide] Fujita Hlth Univ, Int Ctr Cell & Gene Therapy, Toyoake, Aichi, Japan	Nagoya University; Chubu University; Gunma University; Kyorin University; Aichi Medical University; Nagoya University; Fujita Health University; Fujita Health University	Kato, M (corresponding author), Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Nagoya, Aichi, Japan.; Kato, M (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi, Japan.	katomasa@med.nagoya-u.ac.jp	Kato, Masashi/AAG-3755-2021; Hirai, Hirokazu/ABP-1143-2022; KATO, Masashi/I-7250-2014; Tsuzuki, Toyonori/GRJ-7409-2022	Kato, Masashi/0000-0002-8951-3640; Tsuzuki, Toyonori/0000-0002-4855-4366; Iida, Machiko/0000-0002-2286-9167; Hirai, Hirokazu/0000-0002-0721-4293	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [15H01743, 15H02588, 19H01147, 17KT0033, 20H03929, 20K21708]; AEON Environmental Foundation; Mirai-Program Small Start Type from the Japan Science and Technology Agency (JST); Grant Program of Innovation for Future Society; Kobayashi International Scholarship Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AEON Environmental Foundation; Mirai-Program Small Start Type from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grant Program of Innovation for Future Society; Kobayashi International Scholarship Foundation	We thank Drs Matthew P. Scott and Masashi Yanagisawa for providing Patched1-KO mice and Ednrb-KO mice, respectively. This study was supported in part by Grants-in-Aid for Scientific Research (A) (15H01743, 15H02588, and 19H01147) and (B) (17KT0033 and 20H03929) and challenging Exploratory Research (20K21708) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), AEON Environmental Foundation, Mirai-Program Small Start Type from the Japan Science and Technology Agency (JST), Grant Program of Innovation for Future Society and Kobayashi International Scholarship Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the article.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Beug ST, 2011, MOL CELL NEUROSCI, V46, P583, DOI 10.1016/j.mcn.2010.12.009; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Campbell C, 2016, J CELL SCI, V129, P3832, DOI 10.1242/jcs.183541; Cheng FY, 2018, DEV BIOL, V440, P152, DOI 10.1016/j.ydbio.2018.05.015; Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013; ColucciDAmato GL, 1996, CELL GROWTH DIFFER, V7, P1081; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; Currier DG, 2012, PROG BRAIN RES, V197, P223, DOI 10.1016/B978-0-444-54299-1.00011-X; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Drosten M, 2006, NAT CLIN PRACT ONCOL, V3, P564, DOI 10.1038/ncponc0610; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; Gustin JA, 2007, J NEUROCHEM, V102, P1184, DOI 10.1111/j.1471-4159.2007.04624.x; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Huang XF, 2010, J BONE MINER RES, V25, P1167, DOI 10.1359/jbmr.091103; Ida-Eto M, 2011, J BIOL CHEM, V286, P29621, DOI 10.1074/jbc.M111.236802; Iida M, 2020, AGING CELL, V19, DOI 10.1111/acel.13273; Iizuka A, 2016, BRAIN STRUCT FUNCT, V221, P2879, DOI 10.1007/s00429-015-1077-9; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004; Johanson V, 2007, ENDOCR-RELAT CANCER, V14, P433, DOI 10.1677/ERC-06-0033; Ju B, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.10; Kato M, 2002, CANCER RES, V62, P2414; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Moore S W, 1998, Semin Pediatr Surg, V7, P156; Moore SW, 2012, J PEDIATR SURG, V47, P299, DOI 10.1016/j.jpedsurg.2011.11.018; Moore SW, 2006, PEDIATR SURG INT, V22, P305, DOI 10.1007/s00383-006-1655-2; Negishi-Oshino R, 2019, ARCH TOXICOL, V93, P3219, DOI 10.1007/s00204-019-02587-3; Ohgami N, 2010, P NATL ACAD SCI USA, V107, P13051, DOI 10.1073/pnas.1004520107; Petralia Ronald S, 2011, Commun Integr Biol, V4, P775; Roper RJ, 2006, P NATL ACAD SCI USA, V103, P1452, DOI 10.1073/pnas.0510750103; Sergaki MC, 2017, CELL REP, V19, P1977, DOI 10.1016/j.celrep.2017.05.030; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; Vaillant C, 2009, CEREBELLUM, V8, P291, DOI 10.1007/s12311-009-0094-8; Vidovic M, 2008, CELL MOL NEUROBIOL, V28, P1129, DOI 10.1007/s10571-008-9292-z; Vohra BPS, 2006, DEV BIOL, V298, P259, DOI 10.1016/j.ydbio.2006.06.033; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang W, 2004, J BIOL CHEM, V279, P53491, DOI 10.1074/jbc.M410370200; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Yajima I, 2017, ARCH TOXICOL, V91, P3507, DOI 10.1007/s00204-017-1975-0; Zaahl MG, 2003, MOL CELL PROBE, V17, P49, DOI 10.1016/S0890-8508(03)00003-3	48	3	3	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100389	10.1016/j.jbc.2021.100389	http://dx.doi.org/10.1016/j.jbc.2021.100389			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33561442	Green Published, gold			2022-12-28	WOS:000672866400363
J	Szymczak-Kulus, K; Weidler, S; Bereznicka, A; Mikolajczyk, K; Kaczmarek, R; Bednarz, B; Zhang, T; Urbaniak, A; Olczak, M; Park, EY; Majorczyk, E; Kapczynska, K; Lukasiewicz, J; Wuhrer, M; Unverzagt, C; Czerwinski, M				Szymczak-Kulus, Katarzyna; Weidler, Sascha; Bereznicka, Anna; Mikolajczyk, Krzysztof; Kaczmarek, Radoslaw; Bednarz, Bartosz; Zhang, Tao; Urbaniak, Anna; Olczak, Mariusz; Park, Enoch Y.; Majorczyk, Edyta; Kapczynska, Katarzyna; Lukasiewicz, Jolanta; Wuhrer, Manfred; Unverzagt, Carlo; Czerwinski, Marcin			Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; AMINO-ACID; UDP-GALACTOSE; GLYCOPROTEINS; EXPRESSION; GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPIDS; SPECIFICITY; TISSUE; TRISACCHARIDE	The humanGb3/CD77 synthase, encoded by theA4GALT gene, is an unusually promiscuous glycosyltransferase. It synthesizes the Gala1 -> 4Gal linkage on two different glycosphingolipids (GSLs), producing globotriaosylceramide (Gb3, CD77, P-k) and the P1 antigen. Gb3 is themajor receptor for Shiga toxins (Stxs) produced by enterohemorrhagic Escherichia coli. A single amino acid sub-stitution (p.Q211E) ramps up the enzyme's promiscuity, rendering it able to attach Gal both to another Gal residue and to GalNAc, giving rise toNOR1 andNOR2GSLs. HumanGb3/CD77 synthase was long believed to transfer Gal only to GSL acceptors, therefore its GSL products were, by default, considered the only human Stx receptors. Here, using soluble, recombinant human Gb3/CD77 synthase and p.Q211E mutein, we demonstrate that both enzymes can synthesize the P1 glycotope (terminal Gal-alpha 1 -> 4Gal beta 1 -> 4GlcNAc-R) on a complex type N-glycan and a syntheticN-glycoprotein (saposinD). Moreover, by transfection of CHO-Lec2 cells with vectors encoding human Gb3/CD77 synthase and its p.Q211E mutein, we demonstrate that both enzymes produce P1 glycotopes on N-glycoproteins, with the mutein exhibiting elevated activity. These P1-terminatedN-glycoproteins are recognized by Stx1 but not Stx2 B subunits. Finally, cytotoxicity assays showthat Stx1 can useP1N-glycoproteins produced in CHO-Lec2 cells as functional receptors. We conclude that Stx1 can recognize and use P1 N-glycoproteins in addition to its canonicalGSL receptors to enter and kill the cells, while Stx2 can use GSLs only. Collectively, these results may have important implications for our understanding of the Shiga toxin pathology.	[Szymczak-Kulus, Katarzyna; Bereznicka, Anna; Mikolajczyk, Krzysztof; Kaczmarek, Radoslaw; Czerwinski, Marcin] Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol, Wroclaw, Poland; [Weidler, Sascha; Unverzagt, Carlo] Univ Bayreuth, Dept Bioorgan Chem, Bayreuth, Germany; [Bednarz, Bartosz] Hirszfeld Inst Immunol & Expt Therapy, Lab Mol Biol Microorganisms, Wroclaw, Poland; [Zhang, Tao; Wuhrer, Manfred] Leiden Univ, Ctr Prote & Metabol, Med Ctr, Leiden, Netherlands; [Urbaniak, Anna] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Biochem & Mol Biol, Wroclaw, Poland; [Olczak, Mariusz] Univ Wroclaw, Fac Biotechnol, Dept Biochem, Wroclaw, Poland; [Park, Enoch Y.] Shizuoka Univ, Lab Biotechnol, Shizuoka, Japan; [Majorczyk, Edyta] Opole Univ Technol, Fac Phys Educ & Physiotherapy, Opole, Poland; [Kapczynska, Katarzyna] Hirszfeld Inst Immunol & Expt Therapy, Lab Med Microbiol, Wroclaw, Poland; [Lukasiewicz, Jolanta] Hirszfeld Inst Immunol & Expt Therapy, Lab Microbial Immunochem & Vaccines, Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; University of Bayreuth; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wroclaw University of Environmental & Life Sciences; University of Wroclaw; Shizuoka University; Opole University of Technology; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Czerwinski, M (corresponding author), Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol, Wroclaw, Poland.	marcin.czerwinski@hirszfeld.pl	Wuhrer, Manfred/ABE-9168-2020	Wuhrer, Manfred/0000-0002-0814-4995; Mikolajczyk, Krzysztof/0000-0003-1879-2205; Bereznicka, Anna/0000-0002-7228-0772; Szymczak-Kulus, Katarzyna/0000-0003-2660-3662; Lukasiewicz, Jolanta/0000-0001-8081-7261; Czerwinski, Marcin/0000-0003-2859-3699; Kaczmarek, Radoslaw/0000-0001-8084-1958; Urbaniak, Anna/0000-0002-2803-0952; Majorczyk, Edyta/0000-0001-7248-9544; Kapczynska, Katarzyna/0000-0003-2722-9596; Bednarz, Bartosz/0000-0003-3983-5868; Olczak, Mariusz/0000-0001-8629-6364; Park, Enoch Y./0000-0002-7840-1424	National Science Centre of Poland Opus Project [2014/13/B/NZ6/00227]	National Science Centre of Poland Opus Project	This work was funded by National Science Centre of Poland Opus Project 2014/13/B/NZ6/00227 (M. C.). The study was approved by the Wroclaw Medical University Bioethics Committee, Consent 641/2014, December 14, 2014.	Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Anugraham M, 2015, RAPID COMMUN MASS SP, V29, P545, DOI 10.1002/rcm.7130; Arvidsson I, 2015, J IMMUNOL, V194, P2309, DOI 10.4049/jimmunol.1402470; BITZAN M, 1994, INFECT IMMUN, V62, P3337, DOI 10.1128/IAI.62.8.3337-3347.1994; Brigotti M, 2008, J LEUKOCYTE BIOL, V84, P1019, DOI 10.1189/jlb.0308157; Brigotti M, 2018, INT J MED MICROBIOL, V308, P940, DOI 10.1016/j.ijmm.2018.06.013; Bruyand M, 2018, MED MALADIES INFECT, V48, P167, DOI 10.1016/j.medmal.2017.09.012; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cherian RM, 2014, GLYCOBIOLOGY, V24, P26, DOI 10.1093/glycob/cwt086; Cid E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37515-5; Cody EM, 2019, PEDIATR CLIN N AM, V66, P235, DOI 10.1016/j.pcl.2018.09.011; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Cooling LLW, 2005, BLOOD, V105, P3356, DOI 10.1182/blood-2004-08-3080; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Daniels G., 2013, HUMAN BLOOD GROUPS; DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520; Devenish J, 1998, CAN J MICROBIOL, V44, P28, DOI 10.1139/cjm-44-1-28; Duk M, 2005, GLYCOBIOLOGY, V15, P109, DOI 10.1093/oxfordjournals.glycob.a034964; Ferrando ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175639; Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368; Geyer PE, 2016, MOL CANCER THER, V15, P1008, DOI 10.1158/1535-7163.MCT-15-0633; Graf CGF, 2017, ANGEW CHEM INT EDIT, V56, P5252, DOI 10.1002/anie.201701362; Harvey DJ, 2020, MASS SPECTROM REV, V39, P586, DOI 10.1002/mas.21622; HASELBERGER CG, 1982, FEBS LETT, V149, P126, DOI 10.1016/0014-5793(82)81086-7; Hellberg A., 2020, ISBT SCI SER, V15, P40; Henion TR, 2001, J BIOL CHEM, V276, P30261, DOI 10.1074/jbc.M102979200; Jacob F, 2014, BRIT J CANCER, V111, P1634, DOI 10.1038/bjc.2014.455; Jacob F, 2018, CANCER RES, V78, P2952, DOI 10.1158/0008-5472.CAN-17-2223; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kaczmarek R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196627; Kaczmarek R, 2016, GLYCOCONJUGATE J, V33, P963, DOI 10.1007/s10719-016-9716-9; Kaczmarek R, 2016, BIOCHEM BIOPH RES CO, V470, P168, DOI 10.1016/j.bbrc.2016.01.017; Kaczmarek R, 2014, TRANSFUS MED REV, V28, P126, DOI 10.1016/j.tmrv.2014.04.007; Karlsson NG, 2004, RAPID COMMUN MASS SP, V18, P2282, DOI 10.1002/rcm.1626; Karlsson NG, 2004, J AM SOC MASS SPECTR, V15, P659, DOI 10.1016/j.jasms.2004.01.002; Karpman D, 2006, SEMIN THROMB HEMOST, V32, P128, DOI 10.1055/s-2006-939769; Karve SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101173; Kato T, 2015, J BIOTECHNOL, V209, P50, DOI 10.1016/j.jbiotec.2015.06.403; Kavaliauskiene S, 2017, TOXINS, V9, DOI 10.3390/toxins9020044; Kellokumpu S, 2016, CELL MOL LIFE SCI, V73, P305, DOI 10.1007/s00018-015-2066-0; Khoder-Agha F, 2019, J BIOL CHEM, V294, P14383, DOI 10.1074/jbc.RA119.009539; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Lai Y.-J., 2014, TRANSFUSION, V126, P3668; Lee MS, 2019, TOXINS, V11, DOI 10.3390/toxins11040212; Lee YC, 1999, J BIOL CHEM, V274, P11958, DOI 10.1074/jbc.274.17.11958; LEE YC, 1994, J BIOL CHEM, V269, P10028; Liu YY, 2013, ADV CANCER RES, V117, P59, DOI 10.1016/B978-0-12-394274-6.00003-0; Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704; MARCUS DM, 1971, TRANSFUSION, V11, P16, DOI 10.1111/j.1537-2995.1971.tb04368.x; Maszczak-Seneczko D, 2011, FEBS LETT, V585, P3090, DOI 10.1016/j.febslet.2011.08.038; Mikolajczyk K., 2021, BIORXIV; Miller JJ, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.129437; Miyake M, 2000, ANAL BIOCHEM, V281, P202, DOI 10.1006/abio.2000.4559; Mondal N, 2018, J BIOL CHEM, V293, P7300, DOI 10.1074/jbc.RA117.000775; Morimoto K, 2020, J BIOL CHEM, V295, P9490, DOI 10.1074/jbc.RA120.013926; Muthing J, 2012, GLYCOBIOLOGY, V22, P849, DOI 10.1093/glycob/cws009; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Owczarek TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084191; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Pezeshkian W, 2016, SOFT MATTER, V12, P5164, DOI 10.1039/c6sm00464d; Roche N, 2007, MICROBES INFECT, V9, P605, DOI 10.1016/j.micinf.2007.01.023; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; STANLEY P, 1983, METHOD ENZYMOL, V96, P157; Stenfelt L, 2019, TRANSFUSION, V59, P1108, DOI 10.1111/trf.15115; Suchanowska A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408286; Suzuki N, 2006, BBA-GEN SUBJECTS, V1760, P538, DOI 10.1016/j.bbagen.2005.10.005; Takahashi N, 2001, J BIOL CHEM, V276, P23230, DOI 10.1074/jbc.M101380200; Taniguchi N., 2014, HDB GLYCOSYLTRANSFER; Teintenier-Lelievre M, 2005, BIOCHEM J, V392, P665, DOI 10.1042/BJ20051120; Thuresson B, 2011, BLOOD, V117, P678, DOI 10.1182/blood-2010-08-301333; Tsuchida A, 2005, J BIOCHEM, V138, P237, DOI 10.1093/jb/mvi124; Ullmann V, 2012, ANGEW CHEM INT EDIT, V51, P11566, DOI 10.1002/anie.201204272; UNVERZAGT C, 1990, J AM CHEM SOC, V112, P9308, DOI 10.1021/ja00181a037; van Die I, 1999, FEBS LETT, V450, P52, DOI 10.1016/S0014-5793(99)00462-7; Villysson A, 2017, TOXINS, V9, DOI 10.3390/toxins9110376; Volynsky P, 2017, MOL IMMUNOL, V90, P87, DOI 10.1016/j.molimm.2017.06.247; WATKINS WM, 1988, BIOCHIMIE, V70, P1597, DOI 10.1016/0300-9084(88)90295-7; Weissgerber TL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002128; YANG ZT, 1994, J BIOL CHEM, V269, P14620; Zhang T, 2020, MOL OMICS, V16, P355, DOI 10.1039/c9mo00180h; Zhou DP, 1999, EUR J BIOCHEM, V263, P571, DOI 10.1046/j.1432-1327.1999.00541.x; Zhou DP, 2000, J BIOL CHEM, V275, P22631, DOI 10.1074/jbc.C000263200; Zumbrun SD, 2010, INFECT IMMUN, V78, P4488, DOI 10.1128/IAI.00620-10	84	7	7	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100299	10.1016/j.jbc.2021.100299	http://dx.doi.org/10.1016/j.jbc.2021.100299			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460651	Green Published, gold			2022-12-28	WOS:000672866400273
J	Wang, XJ; Wu, HJ; Zhao, LL; Liu, ZY; Qi, MZ; Jin, YP; Liu, W				Wang, Xiaojuan; Wu, Hanjie; Zhao, Lingling; Liu, Zeyao; Qi, Maozhen; Jin, Yaping; Liu, Wei			FLCN regulates transferrin receptor 1 transport and iron homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIRT-HOGG-DUBE; TUMOR-SUPPRESSOR; MTOR ACTIVATION; DOWN-REGULATION; MESSENGER-RNA; FOLLICULIN; GENE; PROTEIN; KIDNEY; METABOLISM	Birt-Hogg-Dube (BHD) syndrome is a multiorgan disorder caused by inactivation of the folliculin (FLCN) protein. Previously, we identified FLCN as a binding protein of Rab11A, a key regulator of the endocytic recycling pathway. This finding implies that the abnormal localization of specific proteins whose transport requires the FLCN-Rab11A complex may contribute to BHD. Here, we used human kidney-derived HEK293 cells as a model, and we report that FLCN promotes the binding of Rab11A with transferrin receptor 1 (TfR1), which is required for iron uptake through continuous trafficking between the cell surface and the cytoplasm. Loss of FLCN attenuated the Rab11A-TfR1 interaction, resulting in delayed recycling transport of TfR1. This delay caused an iron deficiency condition that induced hypoxia-inducible factor (HIF) activity, which was reversed by iron supplementation. In a Drosophila model of BHD syndrome, we further demonstrated that the phenotype of BHD mutant larvae was substantially rescued by an iron-rich diet. These findings reveal a conserved function of FLCN in iron metabolism and may help to elucidate the mechanisms driving BHD syndrome.	[Wang, Xiaojuan; Wu, Hanjie; Zhao, Lingling; Liu, Zeyao; Qi, Maozhen; Jin, Yaping; Liu, Wei] Northwest A&F Univ, Coll Vet Med, Yangling, Shanxi, Peoples R China; [Wang, Xiaojuan] Pulike Biol Engn Inc, Natl Res Ctr Vet Med, Luoyang 471000, Henan, Peoples R China; [Zhao, Lingling] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou 325035, Zhejiang, Peoples R China	Northwest A&F University - China; Wenzhou Medical University	Jin, YP; Liu, W (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shanxi, Peoples R China.	yapingjin@163.com; wliu20cn@nwafu.edu.cn	qi, maozhen/HIA-0257-2022	Zhao, Lingling/0000-0002-8907-6495	National Natural Science Foundation of China [31372256]; Program of Shaanxi Province Science and Technology Innovation Team [2019TD-036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shaanxi Province Science and Technology Innovation Team	This work was supported by the National Natural Science Foundation of China (31372256) to W. L. and was partly supported by Program of Shaanxi Province Science and Technology Innovation Team (2019TD-036).	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Baba M, 2016, STEM CELLS, V34, P1068, DOI 10.1002/stem.2293; Baba M, 2012, BLOOD, V120, P1254, DOI 10.1182/blood-2012-02-410407; Barbeito AG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-50; Bianchi L, 1999, NUCLEIC ACIDS RES, V27, P4223, DOI 10.1093/nar/27.21.4223; Chaston TB, 2003, AM J HEMATOL, V73, P200, DOI 10.1002/ajh.10348; Chen CY, 2013, CELL METAB, V17, P343, DOI 10.1016/j.cmet.2013.01.013; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Cui C, 2019, CANCER MANAG RES, V11, P6323, DOI 10.2147/CMAR.S198911; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Ghio AJ, 2009, BBA-GEN SUBJECTS, V1790, P731, DOI 10.1016/j.bbagen.2008.11.004; Gijezen LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099071; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Greene CJ, 2017, ONCOTARGET, V8, P107052, DOI 10.18632/oncotarget.22323; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hasumi H, 2015, P NATL ACAD SCI USA, V112, pE1624, DOI 10.1073/pnas.1419502112; Hasumi H, 2012, JNCI-J NATL CANCER I, V104, P1750, DOI 10.1093/jnci/djs418; Hasumi Y, 2014, HUM MOL GENET, V23, P5706, DOI 10.1093/hmg/ddu286; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; Kawabata H, 2019, FREE RADICAL BIO MED, V133, P46, DOI 10.1016/j.freeradbiomed.2018.06.037; Kennedy JC, 2019, HUM MOL GENET, V28, P3270, DOI 10.1093/hmg/ddz158; Klomp JA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-59; Kuhn LC, 2015, METALLOMICS, V7, P232, DOI [10.1039/c4mt00164h, 10.1039/C4MT00164H]; Laviolette LA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15866; Li S, 2010, CELL RES, V20, P1148, DOI 10.1038/cr.2010.102; Lim JE, 2005, NAT GENET, V37, P1270, DOI 10.1038/ng1659; Liu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065869; Mathieu J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08020-0; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Nookala RK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120071; OWEN D, 1987, EMBO J, V6, P1287, DOI 10.1002/j.1460-2075.1987.tb02366.x; Pacitto A, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150174; Peli-Gulli MP, 2015, CELL REP, V13, P1, DOI 10.1016/j.celrep.2015.08.059; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Possik E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004273; Preston RS, 2011, ONCOGENE, V30, P1159, DOI 10.1038/onc.2010.497; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Riedelberger M, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3552; Roberg KJ, 1997, GENETICS, V147, P1569; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Starling GP, 2016, EMBO REP, V17, P823, DOI 10.15252/embr.201541382; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Tong XJ, 2002, BRIT J HAEMATOL, V116, P458, DOI 10.1046/j.0007-1048.2001.03289.x; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; van Swelm RPL, 2020, NAT REV NEPHROL, V16, P77, DOI 10.1038/s41581-019-0197-5; Wada S, 2016, GENE DEV, V30, P2551, DOI 10.1101/gad.287953.116; Wang D, 2010, IUBMB LIFE, V62, P629, DOI 10.1002/iub.363; WANG GL, 1993, BLOOD, V82, P3610; Wright JA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00156; Wu MS, 2015, ONCOTARGET, V6, P32761, DOI 10.18632/oncotarget.5018; Wu XC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157100; Yan M, 2016, GENE DEV, V30, P1034, DOI 10.1101/gad.281410.116; Yan M, 2014, J CLIN INVEST, V124, P2640, DOI 10.1172/JCI71749; Yu SY, 2014, J BIOL CHEM, V289, P32030, DOI 10.1074/jbc.M113.538223; Zhao LL, 2018, J CELL SCI, V131, DOI 10.1242/jcs.218792; Zheng JC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00688	65	0	0	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100426	10.1016/j.jbc.2021.100426	http://dx.doi.org/10.1016/j.jbc.2021.100426			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33609526	Green Published, gold			2022-12-28	WOS:000672866400400
J	Zheng, SM; Matthews, AJ; Rahman, N; Herrick-Reynolds, K; Sible, E; Choi, JE; Wishnie, A; Ng, YK; Rhodes, D; Elledge, SJ; Vuong, BQ				Zheng, Simin; Matthews, Allysia J.; Rahman, Numa; Herrick-Reynolds, Kayleigh; Sible, Emily; Choi, Jee Eun; Wishnie, Alec; Ng, Yan Kee; Rhodes, Daniela; Elledge, Stephen J.; Vuong, Bao Q.			The uncharacterized SANT and BTB domain-containing protein SANBR inhibits class switch recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCES; TARGETED DNA DEAMINATION; SOMATIC HYPERMUTATION; TERMINAL SEQUENCES; CODING SEQUENCES; MOUSE HOMOLOGS; KIAA GENE; C-MYC; AID; TRANSCRIPTION	Class switch recombination (CSR) is the process by which B cells switch production from IgM/IgD to other immunoglobulin isotypes, enabling them to mount an effective immune response against pathogens. Timely resolution of CSR prevents damage due to an uncontrolled and prolonged immune response. While many positive regulators of CSR have been described, negative regulators of CSR are relatively unknown. Using an shRNA library screen targeting more than 28,000 genes in a mouse B cell line, we have identified a novel, uncharacterized protein of 82kD (KIAA1841, NM_027860), which we have named SANBR (SANT and BTB domain regulator of CSR), as a negative regulator of CSR. The purified, recombinant BTB domain of SANBR exhibited characteristic properties such as homodimerization and interaction with corepressor proteins, including HDAC and SMRT. Overexpression of SANBR inhibited CSR in primary mouse splenic B cells, and inhibition of CSR is dependent on the BTB domain while the SANT domain is largely dispensable. Thus, we have identified a new member of the BTB family that serves as a negative regulator of CSR. Future investigations to identify transcriptional targets of SANBR in B cells will reveal further insights into the specific mechanisms by which SANBR regulates CSR as well as fundamental gene regulatory activities of this protein.	[Zheng, Simin] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Zheng, Simin; Ng, Yan Kee; Rhodes, Daniela] Nanyang Technol Univ, NTU Inst Struct Biol, Singapore, Singapore; [Matthews, Allysia J.] Yale Univ, Yale Sch Med, New Haven, CT USA; [Matthews, Allysia J.; Sible, Emily; Choi, Jee Eun; Wishnie, Alec; Vuong, Bao Q.] Grad Ctr, Dept Biol, New York, NY 10016 USA; [Matthews, Allysia J.; Sible, Emily; Choi, Jee Eun; Wishnie, Alec; Vuong, Bao Q.] CUNY City Coll, New York, NY 10031 USA; [Rahman, Numa; Herrick-Reynolds, Kayleigh] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Elledge, Stephen J.] Harvard Med Sch, Howard Hughes Med Inst, Dept Genet, Program Virol, Boston, MA 02115 USA; [Elledge, Stephen J.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Yale University; City University of New York (CUNY) System; City College of New York (CUNY); Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Vuong, BQ (corresponding author), Grad Ctr, Dept Biol, New York, NY 10016 USA.; Vuong, BQ (corresponding author), CUNY City Coll, New York, NY 10031 USA.	bvuong@ccny.cuny.edu		Zheng, Simin/0000-0002-3442-1255; Vuong, Bao/0000-0001-5416-9635; Wishnie, Alec/0000-0002-7148-9785	Lee Kuan Yew Postdoctoral Fellowship; American Association of Immunologists Careers in Immunology Fellowship; American Association of Immunologists Early Career Faculty Travel Grant; PSC-CUNY Enhanced Research Award	Lee Kuan Yew Postdoctoral Fellowship; American Association of Immunologists Careers in Immunology Fellowship; American Association of Immunologists Early Career Faculty Travel Grant; PSC-CUNY Enhanced Research Award	S. Z. was supported by the Lee Kuan Yew Postdoctoral Fellowship. A. J. M. was supported by The American Association of Immunologists Careers in Immunology Fellowship. B. Q. V. was supported by The American Association of Immunologists Early Career Faculty Travel Grant and the PSC-CUNY Enhanced Research Award.	Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Chaharbakhshi E, 2016, GENESIS, V54, P505, DOI 10.1002/dvg.22964; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chi XY, 2020, IMMUNOLOGY, V160, P233, DOI 10.1111/imm.13176; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Feng YQ, 2020, TRENDS IMMUNOL, V41, P586, DOI 10.1016/j.it.2020.04.009; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Huang CX, 2015, SCI CHINA LIFE SCI, V58, P1226, DOI 10.1007/s11427-015-4919-z; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Lee-Theilen M, 2011, NAT STRUCT MOL BIOL, V18, P75, DOI 10.1038/nsmb.1942; Li GD, 2013, CELL REP, V5, P702, DOI 10.1016/j.celrep.2013.09.031; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Matthews AJ, 2014, J IMMUNOL, V193, P252, DOI 10.4049/jimmunol.1400433; Matthews AJ, 2014, ADV IMMUNOL, V122, P1, DOI 10.1016/B978-0-12-800267-4.00001-8; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Mena EL, 2018, SCIENCE, V362, P198, DOI 10.1126/science.aap8236; Methot SP, 2017, ADV IMMUNOL, V133, P37, DOI 10.1016/bs.ai.2016.11.002; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Nance JP, 2015, J IMMUNOL, V194, P5599, DOI 10.4049/jimmunol.1500200; Nicolas Laura, 2018, F1000Res, V7, P458, DOI 10.12688/f1000research.13247.1; Nowak U, 2011, NAT IMMUNOL, V12, P160, DOI 10.1038/ni.1977; Okazaki N, 2003, DNA RES, V10, P167, DOI 10.1093/dnares/10.4.167; Okazaki N, 2003, DNA RES, V10, P35, DOI 10.1093/dnares/10.1.35; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Qi H, 2014, CURR OPIN IMMUNOL, V28, P34, DOI 10.1016/j.coi.2014.01.016; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Robert I, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005240; Sadler AJ, 2015, P NATL ACAD SCI USA, V112, P1535, DOI 10.1073/pnas.1409728112; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Schwab KR, 2011, MOL CELL BIOL, V31, P1503, DOI 10.1128/MCB.00990-10; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stead MA, 2014, ACTA CRYSTALLOGR F, V70, P1591, DOI 10.1107/S2053230X14023449; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127; Vaidyanathan B, 2017, J EXP MED, V214, P197, DOI 10.1084/jem.20160789; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Yang JA, 2015, J IMMUNOL, V194, P5604, DOI 10.4049/jimmunol.1500201; Yeap LS, 2019, ADV IMMUNOL, V141, P51, DOI 10.1016/bs.ai.2019.01.002; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zheng S, 2019, FEBS LETT, V593, P80, DOI 10.1002/1873-3468.13290; Zheng SM, 2015, CELL, V161, P762, DOI 10.1016/j.cell.2015.03.020	54	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100625	10.1016/j.jbc.2021.100625	http://dx.doi.org/10.1016/j.jbc.2021.100625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33831416	gold, Green Published			2022-12-28	WOS:000672866400596
J	Flynn, CM; Kespohl, B; Daunke, T; Garbers, Y; Dusterhoft, S; Rose-John, S; Haybaeck, J; Lokau, J; Aparicio-Siegmund, S; Garbers, C				Flynn, Charlotte M.; Kespohl, Birte; Daunke, Tina; Garbers, Yvonne; Dusterhoft, Stefan; Rose-John, Stefan; Haybaeck, Johannes; Lokau, Juliane; Aparicio-Siegmund, Samadhi; Garbers, Christoph			Interleukin-6 controls recycling and degradation, but not internalization of its receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-INDUCED ENDOCYTOSIS; TRANSDUCER GP130 IMPORTANT; CYTOPLASMIC DOMAIN; DOWN-REGULATION; SIGNAL; CLATHRIN; IL-6; CYTOKINE; ASSOCIATION; PROTEIN	Interleukin-6 (IL-6) is a cytokine implicated in proinflammatory as well as regenerative processes and acts via receptor complexes consisting of the ubiquitously expressed, signal-transducing receptor gp130 and the IL-6 receptor (IL-6R). The IL-6R is expressed only on hepatocytes and subsets of leukocytes, where it mediates specificity of the receptor complex to IL-6 as the subunit gp130 is shared with all other members of the IL-6 cytokine family such as IL-11 or IL-27. The amount of IL-6R at the cell surface thus determines the responsiveness of the cell to the cytokine and might therefore be decisive in the development of inflammatory disorders. However, how the expression levels of IL-6R and gp130 at the cell surface are controlled is largely unknown. Here, we show that IL-6R and gp130 are constitutively internalized independent of IL-6. This process depends on dynamin and clathrin and is temporally controlled by motifs within the intracellular region of gp130 and IL-6R. IL-6 binding and internalization of the receptors is a prerequisite for activation of the Jak/STAT signaling cascade. Targeting of gp130, but not of the IL-6R, to the lysosome for degradation depends on stimulation with IL-6. Furthermore, we show that after internalization and activation of signaling, both the IL-6R and gp130 are recycled back to the cell surface, a process that is enhanced by IL-6. These data reveal an important function of IL-6 beyond the pure activation of signaling.	[Flynn, Charlotte M.; Daunke, Tina; Rose-John, Stefan; Aparicio-Siegmund, Samadhi] Univ Kiel, Inst Biochem, Kiel, Germany; [Kespohl, Birte; Lokau, Juliane; Garbers, Christoph] Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany; [Garbers, Yvonne] Univ Kiel, Inst Psychol, Kiel, Germany; [Dusterhoft, Stefan] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Aachen, Germany; [Haybaeck, Johannes] Med Univ Innsbruck, Dept Pathol Neuropathol & Mol Pathol, Innsbruck, Austria; [Haybaeck, Johannes] Med Univ Graz, Diagnost & Res Ctr Mol Biomed, Inst Pathol, Graz, Austria	University of Kiel; Otto von Guericke University; University of Kiel; RWTH Aachen University; Medical University of Innsbruck; Medical University of Graz	Garbers, C (corresponding author), Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany.	christoph.garbers@med.ovgu.de	Garbers, Christoph/D-9932-2015	Garbers, Christoph/0000-0003-4939-6950; Dusterhoft, Stefan/0000-0002-6926-136X	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [125440785-SFB 877]; Bundesministerium fur Bildung und Forschung (BMBF)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors thank Alyn Gerneth and Christian Bretscher for excellent technical assistance. This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Projektnummer 125440785-SFB 877 (project A14) and by the Bundesministerium fur Bildung und Forschung (BMBF grant "InTraSig", project B). The expression plasmid encoding DN-AP180_BFP2 was kindly provided by Harvey McMahoon (MRC Laboratory of Molecular Biology, Cambridge), and the expression plasmids encoding the different endophilin constructs were kindly provided by Emmanuel Boucrot (MRC Laboratory of Molecular Biology, Cambridge).	Basagiannis D, 2016, J BIOL CHEM, V291, P16892, DOI 10.1074/jbc.M116.730309; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Cendrowski J, 2016, CYTOKINE GROWTH F R, V32, P63, DOI 10.1016/j.cytogfr.2016.07.002; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; DITTRICH E, 1994, J BIOL CHEM, V269, P19014; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; Dittrich E, 1995, ANN NY ACAD SCI, V762, P410; Doumanov JA, 2006, CELL SIGNAL, V18, P1140, DOI 10.1016/j.cellsig.2005.09.006; Fujimoto K, 2015, MOL PHARMACOL, V88, P660, DOI 10.1124/mol.115.099184; Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; GERHARTZ C, 1994, EUR J BIOCHEM, V223, P265, DOI 10.1111/j.1432-1033.1994.tb18991.x; Hermanns HM, 2016, BIOL CHEM, V397, P695, DOI 10.1515/hsz-2015-0277; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Martens AS, 2000, J CELL SCI, V113, P3593; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Monhasery N, 2016, CELL REP, V16, P1067, DOI 10.1016/j.celrep.2016.06.062; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; Riethmueller S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000080; Riethmueller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25550; Rinis N, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-14; Schmidt-Arras D, 2014, J CELL SCI, V127, P341, DOI 10.1242/jcs.130294; Schumacher N, 2015, J BIOL CHEM, V290, P26059, DOI 10.1074/jbc.M115.649509; Sommer J, 2012, J BIOL CHEM, V287, P13743, DOI 10.1074/jbc.M111.349167; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Stautz D, 2012, TRAFFIC, V13, P1532, DOI 10.1111/j.1600-0854.2012.01405.x; Suthaus J, 2010, MOL BIOL CELL, V21, P2797, DOI 10.1091/mbc.E10-03-0240; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Thiel S, 2000, FEBS LETT, V470, P15, DOI 10.1016/S0014-5793(00)01276-X; Thiel S, 1998, FEBS LETT, V441, P231, DOI 10.1016/S0014-5793(98)01559-2; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wilkinson AN, 2018, J IMMUNOL, V200, P3547, DOI 10.4049/jimmunol.1701191; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Zhao XH, 2001, J CELL SCI, V114, P353; ZOHLNHOFER D, 1992, FEBS LETT, V306, P219, DOI 10.1016/0014-5793(92)81004-6	42	8	9	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100434	10.1016/j.jbc.2021.100434	http://dx.doi.org/10.1016/j.jbc.2021.100434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610555	Green Published, gold			2022-12-28	WOS:000672866400408
J	Fujimoto, BA; Young, M; Nakamura, N; Ha, H; Carter, L; Pitts, MW; Torres, D; Noh, HL; Suk, S; Kim, JK; Polgar, N				Fujimoto, Brent A.; Young, Madison; Nakamura, Nicole; Ha, Herena; Carter, Lamar; Pitts, Matthew W.; Torres, Daniel; Noh, Hye-Lim; Suk, Sujin; Kim, Jason K.; Polgar, Noemi			Disrupted glucose homeostasis and skeletal-muscle-specific glucose uptake in an exocyst knockout mouse model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUT4 TRAFFICKING; INSULIN-RESISTANCE; PLASMA-MEMBRANE; ACTIVATION; COMPLEX	Skeletal muscle is responsible for the majority of glucose disposal following meals, and this is achieved by insulin-mediated trafficking of glucose transporter type 4 (GLUT4) to the cell membrane. The eight-protein exocyst trafficking complex facilitates targeted docking of membrane-bound vesicles, a process underlying the regulated delivery of fuel transporters. We previously demonstrated the role of exocyst subunit EXOC5 in insulin-stimulated GLUT4 exocytosis and glucose uptake in cultured rat skeletal myoblasts. However, the in vivo role of EXOC5 in skeletal muscle remains unclear. Using mice with inducible, skeletal-muscle-specific knockout of exocyst subunit EXOC5 (Exoc5-SMKO), we examined how muscle-specific disruption of the exocyst would affect glucose homeostasis in vivo. We found that both male and female Exoc5-SMKO mice displayed elevated fasting glucose levels. Additionally, male Exoc5-SMKO mice had impaired glucose tolerance and lower serum insulin levels. Using indirect calorimetry, we observed that male Exoc5-SMKO mice have a reduced respiratory exchange ratio during the light period and lower energy expenditure. Using the hyperinsulinemic-euglycemic clamp method, we further showed that insulin-stimulated skeletal muscle glucose uptake is reduced in Exoc5-SMKO males compared with wildtype controls. Overall, our findings indicate that EXOC5 and the exocyst are necessary for insulin-stimulated glucose uptake in skeletal muscle and regulate glucose homeostasis in vivo.	[Fujimoto, Brent A.; Young, Madison; Nakamura, Nicole; Ha, Herena; Carter, Lamar; Polgar, Noemi] Univ Hawaii, John A Burns Sch Med, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA; [Pitts, Matthew W.; Torres, Daniel] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Noh, Hye-Lim; Suk, Sujin; Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Program Mol Med, Worcester, MA USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA USA	University of Hawaii System; University of Hawaii System; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Polgar, N (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA.	polgar@hawaii.edu		Torres, Daniel/0000-0002-4451-712X; Fujimoto, Brent/0000-0002-8341-1571; Pitts, Matthew/0000-0002-0994-7466	NIH [5U2C-DK093000, P20GM113134, 3T32HL115505-05S2]; National Institute on Minority Health and Health Disparities [U54MD007601]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by NIH funding (P20GM113134 to Dr. Mariana Gerschenson/N. P., B. A. F. was supported by 3T32HL115505-05S2 awarded to R Shohet). The University of Hawaii Behavior & Metabolic Core was supported by grant number #U54MD007601 from the National Institute on Minority Health and Health Disparities. Part of this study was performed at the National Mouse Metabolic Phenotyping Center (MMPC) at UMass Medical School supported by an NIH grant 5U2C-DK093000 to J. K. K. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; Alquier T, 2018, DIABETOLOGIA, V61, P526, DOI 10.1007/s00125-017-4495-9; BARNARD RJ, 1992, FASEB J, V6, P3238, DOI 10.1096/fasebj.6.14.1426762; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Byrns CN, 2014, J BIOL CHEM, V289, P9662, DOI 10.1074/jbc.M113.540682; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2011, CELL CYCLE, V10, P2299, DOI 10.4161/cc.10.14.16524; Choi Hye-Min, 2015, Lab Anim Res, V31, P1, DOI 10.5625/lar.2015.31.1.1; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; Fogelgren B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129346; Fujimoto BA, 2019, AM J PHYSIOL-ENDOC M, V317, pE957, DOI 10.1152/ajpendo.00109.2019; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; Hartig Sean M, 2013, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1415s102; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jaldin-Fincati JR, 2017, TRENDS ENDOCRIN MET, V28, P597, DOI 10.1016/j.tem.2017.05.002; Jensen J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00112; Johnson TL, 2010, J DAIRY RES, V77, P199, DOI 10.1017/S0022029910000087; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Lepore DM, 2018, TRENDS BIOCHEM SCI, V43, P714, DOI 10.1016/j.tibs.2018.06.012; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lurick A, 2018, CURR BIOL, V28, pR417, DOI 10.1016/j.cub.2017.12.012; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mauvais-Jarvis F, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0033-y; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; Sano H, 2015, BIOCHEM BIOPH RES CO, V465, P601, DOI 10.1016/j.bbrc.2015.08.069; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Tunduguru R, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00329; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	40	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100482	10.1016/j.jbc.2021.100482	http://dx.doi.org/10.1016/j.jbc.2021.100482			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33647317	gold, Green Published			2022-12-28	WOS:000672866400456
J	Kim, D; Kim, V; McCarty, KD; Guengerich, FP				Kim, Donghak; Kim, Vitchan; McCarty, Kevin D.; Guengerich, F. Peter			Tight binding of cytochrome b(5) to cytochrome P450 17A1 is a critical feature of stimulation of C21 steroid lyase activity and androgen synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED 17,20-LYASE DEFICIENCY; PROSTATE-CANCER; ABIRATERONE ACETATE; ESCHERICHIA-COLI; CATIONIC CHARGES; P450C17; CYP17; CASTRATION; BIOSYNTHESIS; PHOSPHORYLATION	It has been recognized for >50 years that cytochrome b(5) (b(5)) stimulates some cytochrome P450 (P450)-catalyzed oxidations, but the basis of this function is still not understood well. The strongest stimulation of catalytic activity by b(5) is in the P450 17A1 lyase reaction, an essential step in androgen synthesis from 21-carbon (C21) steroids, making this an excellent model system to interrogate b(5) function. One of the issues in studying b(5)-P450 interactions has been the limited solution assay methods. We constructed a fluorescently labeled variant of human b5 that can be used in titrations. The labeled b(5) bound to WT P450 17A1 with a K-d of 2.5 nM and rapid kinetics, on the order of 1 s(-1). Only weak binding was observed with the clinical P450 17A1 variants E305G, R347H, and R358Q; these mutants are deficient in lyase activity, which has been hypothesized to be due to attenuated b5 binding. K-d values were not affected by the presence of P450 17A1 substrates. A peptide containing the P450 17A1 Arg-347/Arg-358 region attenuated Alexa 488-T70C-b(5) fluorescence at higher concentrations. The addition of NADPH-P450 reductase (POR) to an Alexa 488-T70C-b(5):P450 17A1 complex resulted in a concentration-dependent partial restoration of b(5) fluorescence, indicative of a ternary P450:b(5):POR complex, which was also supported by gel filtration experiments. Overall, these results are interpreted in the context of a dynamic and tight P450 17A1:b5 complex that also binds POR to form a catalytically competent ternary complex, and variants that disrupt this interaction have low catalytic activity.	[Kim, Donghak; McCarty, Kevin D.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Kim, Donghak; Kim, Vitchan] Konkuk Univ, Dept Biol Sci, Seoul, South Korea	Vanderbilt University; Konkuk University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R01 GM118122]; Konkuk University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Konkuk University	This study was supported by the National Institutes of Health grant R01 GM118122 (F. P. G.). This work constitutes part of a Konkuk University research support program for its faculty on sabbatical leave in 2020 (D. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albertolle ME, 2019, CHEM RES TOXICOL, V32, P484, DOI 10.1021/acs.chemrestox.8b00353; Auchus R. J., 2015, CYTOCHROME P450 STRU, P851; Auchus RJ, 2017, J STEROID BIOCHEM, V165, P71, DOI 10.1016/j.jsbmb.2016.02.002; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Bhatt MR, 2017, J STEROID BIOCHEM, V170, P2, DOI 10.1016/j.jsbmb.2016.02.033; Brock BJ, 1999, BIOCHEMISTRY-US, V38, P1598, DOI 10.1021/bi9821059; Burris-Hiday SD, 2021, MOL CELL ENDOCRINOL, V528, DOI 10.1016/j.mce.2021.111261; Child SA, 2020, ARCH BIOCHEM BIOPHYS, V694, DOI 10.1016/j.abb.2020.108596; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Duggal R, 2018, FEBS LETT, V592, P2282, DOI 10.1002/1873-3468.13153; Duggal R, 2016, BIOCHEM BIOPH RES CO, V477, P202, DOI 10.1016/j.bbrc.2016.06.043; Ershov PV, 2019, J STEROID BIOCHEM, V187, P124, DOI 10.1016/j.jsbmb.2018.11.009; Estrada DF, 2016, J BIOL CHEM, V291, P3990, DOI 10.1074/jbc.M115.677294; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Gonzalez E, 2018, J BIOL CHEM, V293, P541, DOI 10.1074/jbc.RA117.000504; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; Guengerich FP, 2019, J BIOL CHEM, V294, P10028, DOI 10.1074/jbc.RA119.008860; Guengerich FP, 2018, CHEM REV, V118, P6573, DOI 10.1021/acs.chemrev.8b00031; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; GUO ZY, 1994, ARCH BIOCHEM BIOPHYS, V312, P436, DOI 10.1006/abbi.1994.1330; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Holien JK, 2017, CURR PROTEIN PEPT SC, V18, P515, DOI 10.2174/1389203717666161220142957; Huggins C, 1940, J UROLOGY, V43, P705, DOI 10.1016/S0022-5347(17)71453-X; Idkowiak J, 2012, J CLIN ENDOCR METAB, V97, pE465, DOI 10.1210/jc.2011-2413; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; Johnson K. A., 2019, KINETIC ANAL NEW ENZ, V1st; Johnson KA, 2019, BEILSTEIN J ORG CHEM, V15, P16, DOI 10.3762/bjoc.15.2; KATAGIRI M, 1982, BIOCHEM BIOPH RES CO, V108, P379, DOI 10.1016/0006-291X(82)91877-0; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Kim D, 2007, ARCH BIOCHEM BIOPHYS, V464, P213, DOI 10.1016/j.abb.2007.02.032; Kok RC, 2010, J CLIN ENDOCR METAB, V95, P994, DOI 10.1210/jc.2008-1745; Krug SJ, 2013, J STEROID BIOCHEM, V134, P75, DOI 10.1016/j.jsbmb.2012.10.019; Lee-Robichaud P, 2004, J STEROID BIOCHEM, V92, P119, DOI 10.1016/j.jsbmb.2004.07.005; Lee-Robichaud P, 1999, BIOCHEM J, V342, P309, DOI 10.1042/0264-6021:3420309; Lee-Robichaud P, 1998, BIOCHEM J, V332, P293, DOI 10.1042/bj3320293; Lim YR, 2017, BIOMOL THER, V25, P171, DOI 10.4062/biomolther.2016.182; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; Mak PJ, 2015, P NATL ACAD SCI USA, V112, P15856, DOI 10.1073/pnas.1519376113; Mendieta MAEPB, 2008, J MED CHEM, V51, P5009, DOI 10.1021/jm800355c; OMURA T, 1964, J BIOL CHEM, V239, P2370; ONODA M, 1982, BIOCHEM BIOPH RES CO, V108, P454, DOI 10.1016/0006-291X(82)90850-6; Pallan PS, 2015, J BIOL CHEM, V290, P3248, DOI 10.1074/jbc.M114.627265; Pandey AV, 2005, J BIOL CHEM, V280, P13265, DOI 10.1074/jbc.M414673200; Park HG, 2017, J MICROBIOL BIOTECHN, V27, P983, DOI 10.4014/jmb.1701.01028; Peng HM, 2016, BIOCHEMISTRY-US, V55, P4356, DOI 10.1021/acs.biochem.6b00532; Peng HM, 2014, J BIOL CHEM, V289, P33838, DOI 10.1074/jbc.M114.608919; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Saad F, 2015, LANCET ONCOL, V16, P338, DOI 10.1016/S1470-2045(15)70027-6; SANDHU P, 1993, ARCH BIOCHEM BIOPHYS, V306, P443, DOI 10.1006/abbi.1993.1536; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Scott LJ, 2017, DRUGS, V77, P1565, DOI 10.1007/s40265-017-0799-9; Sherbet DP, 2003, J BIOL CHEM, V278, P48563, DOI 10.1074/jbc.M307586200; Simonov AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141252; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; STAYTON PS, 1989, BIOCHEMISTRY-US, V28, P8201, DOI 10.1021/bi00446a035; STAYTON PS, 1988, J BIOL CHEM, V263, P13544; Stein MN, 2012, CLIN CANCER RES, V18, P1848, DOI 10.1158/1078-0432.CCR-11-1805; Storbeck KH, 2012, J STEROID BIOCHEM, V132, P311, DOI 10.1016/j.jsbmb.2012.07.006; Tee MK, 2008, ENDOCRINOLOGY, V149, P2667, DOI 10.1210/en.2007-1527; Tee MK, 2013, J BIOL CHEM, V288, P23903, DOI 10.1074/jbc.M113.460048; Wang CX, 2017, J BIOL CHEM, V292, P10767, DOI 10.1074/jbc.M117.792465; Wang YH, 2010, ENDOCRINOLOGY, V151, P1677, DOI 10.1210/en.2009-1247; Wrobel TM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144868; Wu ZL, 2006, MOL PHARMACOL, V69, P2007, DOI 10.1124/mol.106.023648; Yang LPH, 2011, DRUGS, V71, P2067, DOI 10.2165/11208080-000000000-00000; Yang WH, 2005, J BIOL CHEM, V280, P10196, DOI 10.1074/jbc.M411886200; Yin LN, 2014, NAT REV UROL, V11, P32, DOI 10.1038/nrurol.2013.274; Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r; Zhou LY, 2007, ENDOCRINOLOGY, V148, P4282, DOI 10.1210/en.2007-0487	76	7	7	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100571	10.1016/j.jbc.2021.100571	http://dx.doi.org/10.1016/j.jbc.2021.100571			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753170	gold, Green Published			2022-12-28	WOS:000672866400544
J	Linehan, MP; Thoden, JB; Holden, HM				Linehan, Michael P.; Thoden, James B.; Holden, Hazel M.			Characterization of two enzymes from Psychrobacter cryohalolentis that are required for the biosynthesis of an unusual diacetamido-D-sugar	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLTRANSFERASE; MOLECULAR ARCHITECTURE; CATALYTIC MECHANISM; SP-NOV	Psychrobacter cryohalolentis strain K5(T) is a Gram-negative organism first isolated in 2006. It has a complex O-antigen that contains, in addition to L-rhamnose and D-galactose, two diacetamido- and a triacetamido-sugar. The biochemical pathways for the production of these unusual sugars are presently unknown. Utilizing the published genome sequence of the organism, we hypothesized that the genes 0612, 0638, and 0637 encode for a 4,6-dehydratase, an aminotransferase, and an N-acetyltransferase, respectively, which would be required for the biosynthesis of one of the diacetamido-sugars, 2,4-diacetamido-2,4,6-trideoxy-D-glucose, starting from UDP-N-acetylglucosamine. Here we present functional and structural data on the proteins encoded by the 0638 and 0637 genes. The kinetic properties of these enzymes were investigated by a discontinuous HPLC assay. An X-ray crystallographic structure of 0638, determined in its external aldimine form to 1.3 angstrom resolution, demonstrated the manner in which the UDP ligand is positioned into the active site. It is strikingly different from that previously observed for PglE from Campylobacter jejuni, which functions on the same substrate. Four X-ray crystallographic structures were also determined for 0637 in various complexed states at resolutions between 1.3 and 1.55 angstrom. Remarkably, a tetrahedral intermediate mimicking the presumed transition state was trapped in one of the complexes. The data presented herein confirm the hypothesized functions of these enzymes and provide new insight into an unusual sugar biosynthetic pathway in Gram-negative bacteria. We also describe an efficient method for acetyl-CoA synthesis that allowed us to overcome its prohibitive cost for this analysis.	[Linehan, Michael P.; Thoden, James B.; Holden, Hazel M.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Holden, HM (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	Hazel_Holden@biochem.wisc.edu			NIH [R35 GM134643]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH R35 GM134643. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bakermans C, 2006, INT J SYST EVOL MICR, V56, P1285, DOI 10.1099/ijs.0.64043-0; Bonwitt J, 2018, EMERG INFECT DIS, V24, P1942, DOI 10.3201/eid2410.171821; Burgie ES, 2007, BIOCHEMISTRY-US, V46, P8999, DOI 10.1021/bi700751d; Caspar Y, 2013, EMERG INFECT DIS, V19, P1118, DOI 10.3201/eid1907.121599; Chantigian DP, 2013, BIOCHEMISTRY-US, V52, P8374, DOI 10.1021/bi401170t; Chen Y, 2011, CHEM COMMUN, V47, P10815, DOI 10.1039/c1cc14034e; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gonzalez CJ, 2000, J FOOD PROTECT, V63, P315, DOI 10.4315/0362-028X-63.3.315; JUNI E, 1986, INT J SYST BACTERIOL, V36, P388, DOI 10.1099/00207713-36-3-388; Kondakova AN, 2012, J NAT PROD, V75, P2236, DOI 10.1021/np300484m; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrison MJ, 2013, J BIOL CHEM, V288, P32248, DOI 10.1074/jbc.M113.510560; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odeyemi OA, 2020, COMPR REV FOOD SCI F, V19, P311, DOI 10.1111/1541-4337.12526; Olivier NB, 2008, J BIOL CHEM, V283, P27937, DOI 10.1074/jbc.M801207200; Olivier NB, 2006, BIOCHEMISTRY-US, V45, P13659, DOI 10.1021/bi061456h; Rangarajan ES, 2008, BIOCHEMISTRY-US, V47, P1827, DOI 10.1021/bi702032r; Riegert AS, 2017, BIOCHEMISTRY-US, V56, P6030, DOI 10.1021/acs.biochem.7b00910; Riegert AS, 2015, PROTEIN SCI, V24, P1609, DOI 10.1002/pro.2745; Thoden JB, 2012, BIOCHEMISTRY-US, V51, P3433, DOI 10.1021/bi300197h; Thoden JB, 2010, BIOCHEMISTRY-US, V49, P4644, DOI 10.1021/bi1005738; Thoden JB, 2009, BIOCHEMISTRY-US, V48, P2699, DOI 10.1021/bi802313n; Thoden JB, 2009, BIOCHEMISTRY-US, V48, P1553, DOI 10.1021/bi8022015; Thoden JB, 2005, J BIOL CHEM, V280, P32784, DOI 10.1074/jbc.M505730200	27	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100463	10.1016/j.jbc.2021.100463	http://dx.doi.org/10.1016/j.jbc.2021.100463			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639157	Green Published, gold			2022-12-28	WOS:000672866400437
J	Radka, CD; Batte, JL; Frank, MW; Young, BM; Rock, CO				Radka, Christopher D.; Batte, Justin L.; Frank, Matthew W.; Young, Brandon M.; Rock, Charles O.			Structure and mechanism of Staphylococcus aureus oleate hydratase (OhyA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNSATURATED FATTY-ACIDS; DOUBLE-BOND HYDRATASE; ANTIBACTERIAL ACTIVITY; CRYSTAL-STRUCTURE; DIFFRACTION DATA; LINOLEIC-ACID; OLEIC-ACID; PROTEIN; BINDING; FAD	Flavin adenine dinucleotide (FAD)-dependent bacterial oleate hydratases (OhyAs) catalyze the addition of water to isolated fatty acid carbon-carbon double bonds. Staphylococcus aureus uses OhyA to counteract the host innate immune response by inactivating antimicrobial unsaturated fatty acids. Mechanistic information explaining how OhyAs catalyze regiospecific and stereospecific hydration is required to understand their biological functions and the potential for engineering new products. In this study, we deduced the catalytic mechanism of OhyA from multiple structures of S. aureus OhyA in binary and ternary complexes with combinations of ligands along with biochemical analyses of relevant mutants. The substrate-free state shows Arg81 is the gatekeeper that controls fatty acid entrance to the active site. FAD binding engages the catalytic loop to simultaneously rotate Glu82 into its active conformation and Arg81 out of the hydrophobic substrate tunnel, allowing the fatty acid to rotate into the active site. FAD binding also dehydrates the active site, leaving a single water molecule connected to Glu82. This active site water is a hydronium ion based on the analysis of its hydrogen bond network in the OhyA center dot PEG400 center dot FAD complex. We conclude that OhyA accelerates acid-catalyzed alkene hydration by positioning the fatty acid double bond to attack the active site hydronium ion, followed by the addition of water to the transient carbocation intermediate. Structural transitions within S. aureus OhyA channel oleate to the active site, curl oleate around the substrate water, and stabilize the hydroxylated product to inactivate antimicrobial fatty acids.	[Radka, Christopher D.; Batte, Justin L.; Frank, Matthew W.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Young, Brandon M.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA; [Batte, Justin L.] Thermo Fisher Sci, 13859 Progress Blvd, Alachua, FL 32615 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Thermo Fisher Scientific	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles.rock@stjude.org	Radka, Christopher D./AGX-1090-2022; Rock, Charles/N-2256-2018	Radka, Christopher D./0000-0002-6037-7710; Young, Brandon/0000-0003-2973-2072; Rock, Charles/0000-0001-8648-4189; Frank, Matthew/0000-0002-4914-1440	National Institutes of Health [GM034496, S10_RR25528, S10_RR028976]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31, 109-Eng-38]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by National Institutes of Health grant GM034496 (C.O.R.), Cancer Center Support Grant CA21765, and the American Lebanese Syrian Associated Charities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory is supported by its member institutions (see www.ser-cat.org/members.html), and equipment grants (S10_RR25528 and S10_RR028976) from the National Institutes of Health. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31 to 109-Eng-38. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Beller M, 2004, ANGEW CHEM INT EDIT, V43, P3368, DOI 10.1002/anie.200300616; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen BS, 2015, BIOTECHNOL ADV, V33, P526, DOI 10.1016/j.biotechadv.2015.01.007; Chen YY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01561; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; DAVIS EN, 1969, LIPIDS, V4, P356, DOI 10.1007/BF02531006; DeLano W.L, PYMOL MOL GRAPHICS S; Demming RM, 2018, CURR OPIN CHEM BIOL, V43, P43, DOI 10.1016/j.cbpa.2017.10.030; Demming RM, 2017, CHEMCATCHEM, V9, P758, DOI 10.1002/cctc.201601329; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engleder M, 2019, ANGEW CHEM INT EDIT, V58, P7480, DOI 10.1002/anie.201901462; Engleder M, 2018, APPL MICROBIOL BIOT, V102, P5841, DOI 10.1007/s00253-018-9065-7; Engleder M, 2015, CHEMBIOCHEM, V16, P1730, DOI 10.1002/cbic.201500269; Eser BE, 2020, CHEMBIOCHEM, V21, P550, DOI 10.1002/cbic.201900389; Fu ZQ, 2005, ACTA CRYSTALLOGR D, V61, P1643, DOI 10.1107/S0907444905033494; GALBRAITH H, 1971, J APPL BACTERIOL, V34, P803, DOI 10.1111/j.1365-2672.1971.tb01019.x; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233, DOI 10.1099/00221287-115-1-233; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Hou CT, 2000, ADV APPL MICROBIOL, V47, P201, DOI 10.1016/S0065-2164(00)47005-X; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Kumar K, 2018, CHEM SCI, V9, P2655, DOI 10.1039/c7sc04905f; Lorenzen J, 2018, CHEMCATCHEM, V10, P407, DOI 10.1002/cctc.201701350; Macheroux Peter, 2005, BMC Biochem, V6, P26, DOI 10.1186/1471-2091-6-26; Malachowa N, 2011, INFECT IMMUN, V79, P342, DOI 10.1128/IAI.00736-10; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miyamoto J, 2015, J BIOL CHEM, V290, P2902, DOI 10.1074/jbc.M114.610733; MOLLER W, 1985, FEBS LETT, V186, P1, DOI 10.1016/0014-5793(85)81326-0; NIEHAUS WG, 1970, J BIOL CHEM, V245, P3790; O'Flaherty SJ, 2010, MICROBIOL-SGM, V156, P3360, DOI 10.1099/mic.0.043158-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park AK, 2018, BIOCHEM BIOPH RES CO, V499, P772, DOI 10.1016/j.bbrc.2018.03.220; Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12; Radka CD, 2017, ACTA CRYSTALLOGR D, V73, P921, DOI 10.1107/S2059798317015236; RAYCHOWDHURY MK, 1985, J APPL BACTERIOL, V59, P183, DOI 10.1111/j.1365-2672.1985.tb03319.x; Saika A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00036; Schmid J., 2016, J MOL CATAL B-ENZYM, V133, pS243; SCHROEPFER GJ, 1966, J BIOL CHEM, V241, P5441; Subramanian C, 2019, J BIOL CHEM, V294, P9285, DOI 10.1074/jbc.RA119.008439; Tchoupa AK, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00804-20; Volkov A, 2013, ACTA CRYSTALLOGR D, V69, P648, DOI 10.1107/S0907444913000991; Volkov A, 2010, J BIOL CHEM, V285, P10353, DOI 10.1074/jbc.M109.081851; WALLEN LL, 1962, ARCH BIOCHEM BIOPHYS, V99, P249, DOI 10.1016/0003-9861(62)90006-1; WIERENGA RK, 1983, J MOL BIOL, V167, P725, DOI 10.1016/S0022-2836(83)80106-5; Zhang Y, 2020, CHINESE J CHEM ENG, V28, P2051, DOI 10.1016/j.cjche.2020.02.008; Zheng CJ, 2005, FEBS LETT, V579, P5157, DOI 10.1016/j.febslet.2005.08.028	49	6	6	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100252	10.1074/jbc.RA120.016818	http://dx.doi.org/10.1074/jbc.RA120.016818			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33376139	Green Published, gold			2022-12-28	WOS:000672866400228
J	Ren, J; Yao, HW; Hu, WH; Perrett, S; Gong, WB; Feng, YG				Ren, Jie; Yao, Hongwei; Hu, Wanhui; Perrett, Sarah; Gong, Weibin; Feng, Yingang			Structural basis for the DNA-binding activity of human ARID4B Tudor domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEB SERVER; PROTEINS; IDENTIFICATION; RECOGNITION; PROGRAM; METHYLATION; SYSTEM	Human ARID4A and ARID4B are homologous proteins that are important in controlling gene expression and epigenetic regulation but have distinct functions. Previous studies have shown that the N-terminal domain of ARID4A is an unusual interdigitated double Tudor domain with DNA-binding activity. However, how the Tudor domain of ARID4B differs from that of ARID4A remains unknown. Here, we found that the ARID4B Tudor domain has significantly weaker DNA affinity than the ARID4A Tudor domain despite sharing more than 80% sequence identity. Structure determination and DNA titration analysis indicated that the ARID4B Tudor domain is also an interdigitated double Tudor domain with a DNA-binding surface similar to ARID4A. We identified a residue close to the DNA-binding site of the Tudor domain that differs between ARID4A and ARID4B. The Leu50 in ARID4A is Glu50 in ARID4B, and the latter forms salt bridges with two lysine residues at the DNA-binding surface. This causes a decrease in the strength of positive charge, thus reducing DNA-binding affinity while significantly increasing protein stability. We also found that a C-terminal extension region enhances the DNA-binding affinity of the ARID4B Tudor domain. This C-terminal extension is disordered and contains a positively charged RGR motif, providing an additional DNA-binding site. Finally, sequence and phylogenetic analyses indicated that the residue differences and the presence of the RGR extension region are conserved. These results provide new insight into the functional differences between ARID4A and ARID4B proteins, as well as elucidating the function of the disordered regions in these proteins.	[Ren, Jie; Hu, Wanhui; Perrett, Sarah; Gong, Weibin] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Ren, Jie; Hu, Wanhui; Perrett, Sarah; Feng, Yingang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yao, Hongwei] Soochow Univ, Sch Biol & Basic Med Sci, Inst Mol Enzymol, Suzhou, Peoples R China; [Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, Qingdao, Peoples R China; [Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Synthet Biol, Qingdao, Peoples R China; [Hu, Wanhui] Shanghai Henlius Biotech Inc, Bldg C,1289 Yishan Rd, Shanghai 200233, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Soochow University - China; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Gong, WB (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China.; Feng, YG (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Feng, YG (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, Qingdao, Peoples R China.; Feng, YG (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Synthet Biol, Qingdao, Peoples R China.	gongweibin@ibp.ac.cn; fengyg@qibebt.ac.cn	Feng, Yingang/B-6304-2008	Feng, Yingang/0000-0002-0879-1316; Gong, Weibin/0000-0001-7130-4093	National Key R&D Program of China [2017YFA0504000]; National Natural Science Foundation of China [31470747, 32070125, 31870735]; Beijing Natural Science Foundation [5172026]; CAS Center for Excellence in Biomacromolecules; Director Innovation Foundation of Qingdao Institute of Bioenergy and Bioprocess Technology, CAS; QIBEBT; Dalian National Laboratory for Clean Energy [QIBEBT I201804]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); CAS Center for Excellence in Biomacromolecules; Director Innovation Foundation of Qingdao Institute of Bioenergy and Bioprocess Technology, CAS; QIBEBT; Dalian National Laboratory for Clean Energy	This work was supported by National Key R&D Program of China [grant number 2017YFA0504000 to S. P.]; National Natural Science Foundation of China [grant numbers 31470747 to W. G., 32070125 to Y. F., 31870735 to H. Y.]; Beijing Natural Science Foundation [grant number 5172026 to W. G.]; the CAS Center for Excellence in Biomacromolecules; the Director Innovation Foundation of Qingdao Institute of Bioenergy and Bioprocess Technology, CAS [to Y. F.]; and QIBEBT and Dalian National Laboratory for Clean Energy [grant number QIBEBT I201804 to Y. F.].	Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cajuso T, 2014, INT J CANCER, V135, P611, DOI 10.1002/ijc.28705; Crane-Robinson C, 2006, TRENDS BIOCHEM SCI, V31, P547, DOI 10.1016/j.tibs.2006.08.006; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Gong WB, 2018, J BIOL CHEM, V293, P17663, DOI 10.1074/jbc.RA118.002691; Gong WB, 2014, J BIOL CHEM, V289, P4882, DOI 10.1074/jbc.M113.501940; Gong WB, 2012, J BIOL CHEM, V287, P8531, DOI 10.1074/jbc.M111.299149; Gordon BRG, 2011, P NATL ACAD SCI USA, V108, P10690, DOI 10.1073/pnas.1102544108; Hafsa NE, 2015, NUCLEIC ACIDS RES, V43, pW370, DOI 10.1093/nar/gkv494; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Hurst DR, 2008, J BIOL CHEM, V283, P7438, DOI 10.1074/jbc.M709446200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li SX, 2019, NUCLEIC ACIDS RES, V47, pW26, DOI 10.1093/nar/gkz394; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Pek JW, 2012, DEVELOPMENT, V139, P2255, DOI 10.1242/dev.073304; Shen Y, 2015, METHODS MOL BIOL, V1260, P17, DOI 10.1007/978-1-4939-2239-0_2; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; Wu MY, 2006, GENE DEV, V20, P2859, DOI 10.1101/gad.1452206; Wu RC, 2017, STEM CELLS, V35, P1554, DOI 10.1002/stem.2597; Wu RC, 2015, MOL ENDOCRINOL, V29, P1334, DOI 10.1210/me.2015-1089; Wu RC, 2013, P NATL ACAD SCI USA, V110, P4616, DOI 10.1073/pnas.1218318110; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	36	5	5	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100506	10.1016/j.jbc.2021.100506	http://dx.doi.org/10.1016/j.jbc.2021.100506			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675746	Green Published, gold			2022-12-28	WOS:000672866400480
J	Sabusap, CM; Joshi, D; Simhaev, L; Oliver, KE; Senderowitz, H; van Willigen, M; Braakman, I; Rab, A; Sorscher, EJ; Hong, JS				Sabusap, Carleen Mae; Joshi, Disha; Simhaev, Luba; Oliver, Kathryn E.; Senderowitz, Hanoch; van Willigen, Marcel; Braakman, Ineke; Rab, Andras; Sorscher, Eric J.; Hong, Jeong S.			The CFTR P67L variant reveals a key role for N-terminal lasso helices in channel folding, maturation, and pharmacologic rescue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM; MOLECULAR-DYNAMICS; CONFORMATIONAL MATURATION; CORRECTOR VX-809; R-DOMAIN; PROTEIN; MODEL; MECHANISM	Patients with cystic fibrosis (CF) harboring the P67L variant in the cystic fibrosis transmembrane conductance regulator (CFTR) often exhibit a typical CF phenotype, including severe respiratory compromise. This rare mutation (reported in <300 patients worldwide) responds robustly to CFTR correctors, such as lumacaftor and tezacaftor, with rescue in model systems that far exceed what can be achieved for the archetypical CFTR mutant F508del. However, the specific molecular consequences of the P67L mutation are poorly characterized. In this study, we conducted biochemical measurements following low-temperature growth and/or intragenic suppression, which suggest a mechanism underlying P67L that (1) shares key pathogenic features with F508del, including off-pathway (non-native) folding intermediates, (2) is linked to folding stability of nucleotide-binding domains 1 and 2, and (3) demonstrates pharmacologic rescue that requires domains in the carboxyl half of the protein. We also investigated the "lasso" helices 1 and 2, which occur immediately upstream of P67. Based on limited proteolysis, pulse chase, and molecular dynamics analysis of full-length CFTR and a series of deletion constructs, we argue that P67L and other maturational processing (class 2) defects impair the integrity of the lasso motif and confer misfolding of downstream domains. Thus, amino-terminal missense variants elicit a conformational change throughout CFTR that abrogates maturation while providing a robust substrate for pharmacologic repair.	[Sabusap, Carleen Mae] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Joshi, Disha; Oliver, Kathryn E.; Rab, Andras; Sorscher, Eric J.; Hong, Jeong S.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Simhaev, Luba; Senderowitz, Hanoch] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel; [van Willigen, Marcel; Braakman, Ineke] Univ Utrecht, Dept Cellular Prot Chem, Utrecht, Netherlands; [Sabusap, Carleen Mae] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, 1161 21st Avenuke South,T-1218 MCN, Nashville, TN 37232 USA	University of Alabama System; University of Alabama Birmingham; Emory University; Bar Ilan University; Utrecht University; Vanderbilt University	Sorscher, EJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	esorscher@emory.edu		Oliver, Kathryn/0000-0002-7781-7006; Braakman, Ineke/0000-0003-1592-4364	Cystic Fibrosis Foundation Therapeutics [SORSCH13XX0, BRAAKM14XX0, SENDERO9XX0]; National Institutes of Health [P30 DK072482, R01HL136414, RO1HL139876]; National Center for Advancing Translational Sciences of National Institutes of Health [UL1TR000454]; Netherlands Organization for Health Research and Development (ZonMw TOP) [40-00812-98-14103]; Netherlands Cystic Fibrosis Foundation (HIT-CF grant)	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of National Institutes of Health; Netherlands Organization for Health Research and Development (ZonMw TOP)(Netherlands Organization for Health Research and Development); Netherlands Cystic Fibrosis Foundation (HIT-CF grant)	This work was supported by grants from Cystic Fibrosis Foundation Therapeutics (SORSCH13XX0, BRAAKM14XX0, and SENDERO9XX0), National Institutes of Health (P30 DK072482, R01HL136414, and RO1HL139876), the National Center for Advancing Translational Sciences of National Institutes of Health (under UL1TR000454), the Netherlands Organization for Health Research and Development (ZonMw TOP grant 40-00812-98-14103), and the Netherlands Cystic Fibrosis Foundation (HIT-CF grant). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Corradi V, 2018, BIOPHYS J, V114, P1751, DOI 10.1016/j.bpj.2018.03.003; Corradi V, 2015, J BIOL CHEM, V290, P22891, DOI 10.1074/jbc.M115.665125; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DULHANTY AM, 1994, FEBS LETT, V343, P109, DOI 10.1016/0014-5793(94)80300-5; Durmowicz AG, 2018, ANN AM THORAC SOC, V15, P1, DOI 10.1513/AnnalsATS.201708-668PS; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Farinha Carlos M, 2004, J Cyst Fibros, V3 Suppl 2, P73, DOI 10.1016/j.jcf.2004.05.017; Farinha CM, 2017, CELL MOL LIFE SCI, V74, P39, DOI 10.1007/s00018-016-2387-7; Farinha CM, 2013, CHEM BIOL, V20, P943, DOI 10.1016/j.chembiol.2013.06.004; Fu J, 2001, J PHYSIOL-LONDON, V536, P459, DOI 10.1111/j.1469-7793.2001.0459c.xd; Gene GG, 2008, HUM MUTAT, V29, P738, DOI 10.1002/humu.20721; Han ST, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121159; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Hoffmann B, 2018, CELL MOL LIFE SCI, V75, P3829, DOI 10.1007/s00018-018-2835-7; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Hudson R, 2016, PEDIATR PULM, V51, P213; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jurkuvenaite A, 2006, J BIOL CHEM, V281, P3329, DOI 10.1074/jbc.M508131200; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; King SA, 2000, BIOCHEMISTRY-US, V39, P9868, DOI 10.1021/bi992807d; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Laselva O, 2018, MOL PHARMACOL, V93, P612, DOI 10.1124/mol.118.111799; Law EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157553; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Loo TW, 2017, BIOCHEM PHARMACOL, V136, P24, DOI 10.1016/j.bcp.2017.03.020; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Manfredi C, 2019, SCIENCE, V365, P220, DOI 10.1126/science.aaw0553; McCague AF, 2019, AM J RESP CRIT CARE, V199, P1116, DOI 10.1164/rccm.201901-0145OC; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Molinski SV, 2018, PROTEINS, V86, P833, DOI 10.1002/prot.25496; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2015, CELL MOL LIFE SCI, V72, P1377, DOI 10.1007/s00018-014-1749-2; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Niemyska W, 2016, SCI REP-UK, V6, DOI 10.1038/srep36895; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Oliver KE, 2019, J CLIN INVEST, V129, P5236, DOI 10.1172/JCI124282; Ostedgaard LS, 2001, J BIOL CHEM, V276, P7689, DOI 10.1074/jbc.R100001200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pintani E., 2020, J CYST FIBROS, V19, pS34; Phuan PW, 2014, MOL PHARMACOL, V86, P42, DOI 10.1124/mol.114.092478; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rahman KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074574; Raraigh KS, 2018, AM J HUM GENET, V102, P1062, DOI 10.1016/j.ajhg.2018.04.003; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sabusap CM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86581; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Schuck RN, 2018, CLIN PHARMACOL THER, V104, P282, DOI 10.1002/cpt.1041; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Shelar A, 2016, BBA-BIOMEMBRANES, V1858, P2804, DOI 10.1016/j.bbamem.2016.08.003; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Tordai H, 2017, BIOCHEM BIOPH RES CO, V491, P986, DOI 10.1016/j.bbrc.2017.07.165; van der Kamp MW, 2010, STRUCTURE, V18, P423, DOI 10.1016/j.str.2010.01.012; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; van Meegen MA, 2013, J CYST FIBROS, V12, P487, DOI 10.1016/j.jcf.2012.12.005; van Willigen M, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800172; Vergani P, 2005, BIOCHEM SOC T, V33, P1003, DOI 10.1042/BST0331003; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Xu Z, 2014, J PHYSIOL-LONDON, V592, P1931, DOI 10.1113/jphysiol.2014.271817; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Yousef S, 2015, CHEST, V147, pE79, DOI 10.1378/chest.14-1198; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zhenin M, 2015, J CHEM INF MODEL, V55, P2349, DOI 10.1021/acs.jcim.5b00312	81	9	9	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100598	10.1016/j.jbc.2021.100598	http://dx.doi.org/10.1016/j.jbc.2021.100598			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781744	Green Published, gold			2022-12-28	WOS:000672866400570
J	Sayedyahossein, S; Huang, K; Li, ZG; Zhang, C; Kozlov, AM; Johnston, D; Nouri-Nejad, D; Dagnino, L; Betts, DH; Sacks, DB; Penuela, S				Sayedyahossein, Samar; Huang, Kenneth; Li, Zhigang; Zhang, Christopher; Kozlov, Alexandra M.; Johnston, Danielle; Nouri-Nejad, Daniel; Dagnino, Lina; Betts, Dean H.; Sacks, David B.; Penuela, Silvia			Pannexin 1 binds beta-catenin to modulate melanoma cell growth and metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNELS; WNT; PROLIFERATION; EXPRESSION; PATHWAY; TARGET; MITF; INFLAMMASOME; PROGRESSION; CALMODULIN	Melanoma is the most aggressive skin malignancy with increasing incidence worldwide. Pannexin1 (PANX1), a member of the pannexin family of channel-forming glycoproteins, regulates cellular processes in melanoma cells including proliferation, migration, and invasion/metastasis. However, the mechanisms responsible for coordinating and regulating PANX1 function remain unclear. Here, we demonstrated a direct interaction between the C-terminal region of PANX1 and the N-terminal portion of beta-catenin, a key transcription factor in the Wnt pathway. At the protein level, beta-catenin was significantly decreased when PANX1 was either knocked down or inhibited by two PANX1 blockers, Probenecid and Spironolactone. Immunofluorescence imaging showed a disrupted pattern of beta-catenin localization at the cell membrane in PANX1-deficient cells, and transcription of several Wnt target genes, including MITF, was suppressed. In addition, a mitochondrial stress test revealed that the metabolism of PANX1-deficient cells was impaired, indicating a role for PANX1 in the regulation of the melanoma cell metabolic profile. Taken together, our data show that PANX1 directly interacts with beta-catenin to modulate growth and metabolism in melanoma cells. These findings provide mechanistic insight into PANX1-mediated melanoma progression and may be applicable to other contexts where PANX1 and beta-catenin interact as a potential new component of the Wnt signaling pathway.	[Sayedyahossein, Samar; Huang, Kenneth; Zhang, Christopher; Johnston, Danielle; Nouri-Nejad, Daniel; Penuela, Silvia] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada; [Li, Zhigang; Sacks, David B.] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA; [Kozlov, Alexandra M.; Betts, Dean H.] Univ Western Ontario, Fac Sci, Dept Biol, London, ON, Canada; [Dagnino, Lina; Betts, Dean H.] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dentristry, London, ON, Canada; [Dagnino, Lina; Penuela, Silvia] Univ Western Ontario, Dept Oncol, Schulich Sch Med & Dentristry, Div Expt Oncol, London, ON, Canada	Western University (University of Western Ontario); National Institutes of Health (NIH) - USA; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Penuela, S (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada.; Penuela, S (corresponding author), Univ Western Ontario, Dept Oncol, Schulich Sch Med & Dentristry, Div Expt Oncol, London, ON, Canada.	spenuela@uwo.ca	Penuela, Silvia/A-6961-2010; Betts, Dean H/B-7414-2015	Penuela, Silvia/0000-0003-4829-5517; Betts, Dean H/0000-0002-5528-9142; Sacks, David/0000-0003-3100-0735; Sayedyahossein, Samar/0000-0003-1773-4740	Canadian Institutes of Health Research Project Grant [FRN 153112]; Intramural Research Program of the National Institutes of Health; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2015-03878]; Western's Interdisciplinary Development Initiative (IDI) in stem cells and regenerative medicine	Canadian Institutes of Health Research Project Grant(Canadian Institutes of Health Research (CIHR)); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Western's Interdisciplinary Development Initiative (IDI) in stem cells and regenerative medicine	Funding for S. P. and L. D. was provided from a Canadian Institutes of Health Research Project Grant (FRN 153112), and for Z. L. and D. B. S. by the Intramural Research Program of the National Institutes of Health. Funding for D. H. B. was provided by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-2015-03878. S. S. is funded by a postdoctoral training from Western's Interdisciplinary Development Initiative (IDI) in stem cells and regenerative medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bellei B, 2011, PIGM CELL MELANOMA R, V24, P309, DOI 10.1111/j.1755-148X.2010.00800.x; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Bhalla-Gehi R, 2010, J BIOL CHEM, V285, P9147, DOI 10.1074/jbc.M109.082008; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Brown K, 2017, ONCOGENE, V36, P3119, DOI 10.1038/onc.2016.450; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chen YY, 2011, BIOCHEM J, V435, P711, DOI 10.1042/BJ20101726; D'hondt C, 2011, CELL SIGNAL, V23, P305, DOI 10.1016/j.cellsig.2010.07.018; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Dar MS, 2017, MUTAT RES-REV MUTAT, V773, P122, DOI 10.1016/j.mrrev.2017.06.001; Demunter A, 2002, MODERN PATHOL, V15, P454, DOI 10.1038/modpathol.3880546; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Eichhoff OM, 2011, PIGM CELL MELANOMA R, V24, P631, DOI 10.1111/j.1755-148X.2011.00871.x; Fan GB, 2017, ONCOTARGET, V8, P106026, DOI 10.18632/oncotarget.22523; Freeman TJ, 2019, CANCERS, V11, DOI 10.3390/cancers11010102; Furlow PW, 2015, NAT CELL BIOL, V17, P943, DOI 10.1038/ncb3194; Godoy JA, 2014, J BIOL CHEM, V289, P36179, DOI 10.1074/jbc.M114.557009; Good ME, 2018, CIRC RES, V122, P606, DOI 10.1161/CIRCRESAHA.117.312380; Goodall J, 2004, MOL CELL BIOL, V24, P2915, DOI 10.1128/MCB.24.7.2915-2922.2004; Graham SV, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061645; Grossmann AH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003398; Hartman ML, 2015, CELL MOL LIFE SCI, V72, P1249, DOI 10.1007/s00018-014-1791-0; Hugo W, 2015, CELL, V162, P1271, DOI 10.1016/j.cell.2015.07.061; Jalaleddine N, 2019, CANCERS, V11, DOI 10.3390/cancers11121967; Jiang JX, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0094-8; Kaur A, 2016, BRIT J CANCER, V115, P1273, DOI 10.1038/bjc.2016.332; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Leclerc J, 2017, ONCOGENE, V36, P6659, DOI 10.1038/onc.2017.292; Lin YX, 2018, EXP THER MED, V16, P2032, DOI 10.3892/etm.2018.6413; Louphrasitthiphol P, 2020, PIGM CELL MELANOMA R, V33, P112, DOI 10.1111/pcmr.12830; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Omholt K, 2001, INT J CANCER, V92, P839, DOI 10.1002/ijc.1270; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2014, BIOCHEM J, V461, P371, DOI 10.1042/BJ20140447; Penuela S, 2012, J BIOL CHEM, V287, P29184, DOI 10.1074/jbc.M112.377176; Planutiene M, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-28; Reifenberger J, 2002, INT J CANCER, V100, P549, DOI 10.1002/ijc.10512; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Schaefer KN, 2019, DEV CELL, V48, P429, DOI 10.1016/j.devcel.2019.01.025; Serrat R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067773; Shah KV, 2008, J INVEST DERMATOL, V128, P2870, DOI 10.1038/jid.2008.170; Shang S, 2017, ONCOTARGET, V8, P33972, DOI 10.18632/oncotarget.15687; Shao Q, 2016, J BIOL CHEM, V291, P12432, DOI 10.1074/jbc.M116.717934; Sherwood V, 2015, MOL CELL BIOL, V35, P2, DOI 10.1128/MCB.00992-14; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Siu RCE, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00120; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Tucci M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01148; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Vanden Abeele F, 2006, J CELL BIOL, V174, P535, DOI 10.1083/jcb.200601115; Vincent KM, 2017, ONCOTARGET, V8, P10498, DOI 10.18632/oncotarget.14443; Wang HB, 2013, PROTEIN CELL, V4, P259, DOI 10.1007/s13238-013-2114-1; White CD, 2011, J BIOL CHEM, V286, P29734, DOI 10.1074/jbc.M111.220939; Wicki-Stordeur LE, 2013, CELL COMMUN ADHES, V20, P73, DOI 10.3109/15419061.2013.791681; Wohrle S, 2007, MOL CELL BIOL, V27, P8164, DOI 10.1128/MCB.00555-07; Xu XX, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00124; Xue GD, 2016, CANCER TREAT REV, V49, P1, DOI 10.1016/j.ctrv.2016.06.009; Zou J, 2014, FEBS LETT, V588, P1430, DOI 10.1016/j.febslet.2014.01.003	67	6	6	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100478	10.1016/j.jbc.2021.100478	http://dx.doi.org/10.1016/j.jbc.2021.100478			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33647315	Green Published, gold			2022-12-28	WOS:000672866400452
J	Tian, XY; Zhou, B				Tian, Xueying; Zhou, Bin			Strategies for site-specific recombination with high efficiency and precise spatiotemporal resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRE RECOMBINASE; DNA RECOMBINATION; GENE-EXPRESSION; PROTEIN INTERACTIONS; OPTOGENETIC CONTROL; ESTROGEN-RECEPTOR; TEMPORAL CONTROL; IN-VIVO; TAMOXIFEN; SYSTEM	Site-specific recombinases (SSRs) are invaluable genome engineering tools that have enormously boosted our understanding of gene functions and cell lineage relationships in developmental biology, stem cell biology, regenerative medicine, and multiple diseases. However, the ever-increasing complexity of biomedical research requires the development of novel site-specific genetic recombination technologies that can manipulate genomic DNA with high efficiency and fine spatiotemporal control. Here, we review the latest innovative strategies of the commonly used Cre-loxP recombination system and its combinatorial strategies with other site-specific recombinase systems. We also highlight recent progress with a focus on the new generation of chemical- and light-inducible genetic systems and discuss the merits and limitations of each new and established system. Finally, we provide the future perspectives of combining various recombination systems or improving well-established site-specific genetic tools to achieve more efficient and precise spatiotemporal genetic manipulation.	[Tian, Xueying] Jinan Univ, Coll Life Sci & Technol, Key Lab Regenerat Med, Minist Educ, Guangzhou, Peoples R China; [Zhou, Bin] Chinese Acad Sci, Univ Chinese Acad Sci, Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Shanghai Inst Biochem & C, Shanghai, Peoples R China; [Zhou, Bin] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Zhou, Bin] Univ Chinese Acad Sci, Sch Life Sci, Hangzhou Inst Adv Study, Hangzhou, Peoples R China	Jinan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tian, XY (corresponding author), Jinan Univ, Coll Life Sci & Technol, Key Lab Regenerat Med, Minist Educ, Guangzhou, Peoples R China.; Zhou, B (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Shanghai Inst Biochem & C, Shanghai, Peoples R China.; Zhou, B (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Zhou, B (corresponding author), Univ Chinese Acad Sci, Sch Life Sci, Hangzhou Inst Adv Study, Hangzhou, Peoples R China.	xytian@jnu.edu.cn; zhoubin@sibs.ac.cn		Zhou, Bin/0000-0001-5278-5522	National Science Foundation of China [81872132, 31730112, 91849202, 31625019]; National Key Research and Development Program of China [2018YFA0107900, 2016YFC1300600, 2019YFA011040, 2019YFA080200]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000, XDA16010507]; Ten Thousand Talent Program for Young Top-notch Talent; Royal Society-Newton Advanced Fellowship	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ten Thousand Talent Program for Young Top-notch Talent; Royal Society-Newton Advanced Fellowship	This work was supported by the National Science Foundation of China (81872132 to X. T.; 31730112, 91849202, and 31625019 to B. Z.), National Key Research and Development Program of China (2018YFA0107900 and 2016YFC1300600 to X. T.; 2019YFA011040 and 2019YFA080200 to B. Z.), Strategic Priority Research Program of the Chinese Academy of Sciences (XDB19000000 and XDA16010507 to B. Z.), Ten Thousand Talent Program for Young Top-notch Talent to X. T., Royal Society-Newton Advanced Fellowship to B. Z.	ANDREWS BJ, 1985, CELL, V40, P795, DOI 10.1016/0092-8674(85)90339-3; Beckervordersandforth R, 2014, STEM CELL REP, V2, P153, DOI 10.1016/j.stemcr.2014.01.004; Boulina M, 2013, DEVELOPMENT, V140, P1605, DOI 10.1242/dev.088930; Brocard J, 1998, NUCLEIC ACIDS RES, V26, P4086, DOI 10.1093/nar/26.17.4086; Brown KA, 2015, CHEM COMMUN, V51, P5702, DOI 10.1039/c4cc09442e; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cambridge SB, 1997, SCIENCE, V277, P825, DOI 10.1126/science.277.5327.825; Cambridge SB, 2009, NAT METHODS, V6, P527, DOI 10.1038/nmeth.1340; Chen D, 2013, J CELL BIOL, V201, P631, DOI 10.1083/jcb.201210119; Crefcoeur RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2800; Duan LT, 2015, CHEM BIOL, V22, P671, DOI 10.1016/j.chembiol.2015.04.014; Duo C, 2002, PHARMACOL BIOCHEM BE, V71, P269, DOI 10.1016/S0091-3057(01)00656-6; Edwards WF, 2009, ACS CHEM BIOL, V4, P441, DOI 10.1021/cb900041s; Faal T, 2015, MOL BIOSYST, V11, P783, DOI 10.1039/c4mb00581c; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Fernandez-Chacon M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10239-4; Garcia-Otin AL, 2006, FRONT BIOSCI-LANDMRK, V11, P1108, DOI 10.2741/1867; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gomelsky M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan3936; Gorka AP, 2014, J AM CHEM SOC, V136, P14153, DOI 10.1021/ja5065203; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Han X., 2021, CELL STEM CELL; He LJ, 2021, SCIENCE, V371, P905, DOI 10.1126/science.abc4346; He LJ, 2017, NAT MED, V23, P1488, DOI 10.1038/nm.4437; He M, 2016, NEURON, V91, P1228, DOI 10.1016/j.neuron.2016.08.021; Hermann M, 2014, NUCLEIC ACIDS RES, V42, P3894, DOI 10.1093/nar/gkt1361; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008354; Hsu YC, 2015, STEM CELLS, V33, P3197, DOI 10.1002/stem.2123; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Inlay MA, 2013, CHEM COMMUN, V49, P4971, DOI 10.1039/c3cc42179a; Inoue S, 2010, GENESIS, V48, P207, DOI 10.1002/dvg.20603; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Jullien N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001355; Kaberniuk AA, 2016, NAT METHODS, V13, P591, DOI [10.1038/NMETH.3864, 10.1038/nmeth.3864]; Kaczmarczyk SJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng087; Kakumoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070861; Karimova M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30130; Karimova M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1037; Kawano F, 2016, NAT CHEM BIOL, V12, P1059, DOI [10.1038/NCHEMBIO.2205, 10.1038/nchembio.2205]; Kawano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7256; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; KUHSTOSS S, 1991, J MOL BIOL, V222, P897, DOI 10.1016/0022-2836(91)90584-S; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li F, 2019, CELL RES, V29, P862, DOI 10.1038/s41422-019-0209-9; Li Y, 2020, DEV CELL, V54, P593, DOI 10.1016/j.devcel.2020.06.021; Li Y, 2018, CIRCULATION, V138, P793, DOI 10.1161/CIRCULATIONAHA.118.034250; Lindeberg J, 2002, J NEUROSCI RES, V68, P248, DOI 10.1002/jnr.10213; Link KH, 2005, J AM CHEM SOC, V127, P13088, DOI 10.1021/ja0531226; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu K, 2020, J BIOL CHEM, V295, P6413, DOI 10.1074/jbc.REV120.011631; Liu K, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167775; Lu X, 2012, BIOCONJUGATE CHEM, V23, P1945, DOI 10.1021/bc300319c; Luo J, 2016, CHEM COMMUN, V52, P8529, DOI 10.1039/c6cc03934k; Maiuri P, 2015, CELL, V161, P374, DOI 10.1016/j.cell.2015.01.056; Meador K, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz585; Meinke G, 2016, CHEM REV, V116, P12785, DOI 10.1021/acs.chemrev.6b00077; METZGER D, 1995, J BIOL CHEM, V270, P9535, DOI 10.1074/jbc.270.16.9535; Morikawa K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16030-0; Motta-Mena LB, 2014, NAT CHEM BIOL, V10, P196, DOI [10.1038/NCHEMBIO.1430, 10.1038/nchembio.1430]; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt340; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt002; Murray SA, 2012, MAMM GENOME, V23, P587, DOI 10.1007/s00335-012-9430-2; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nagy Andras, 2009, V530, P365, DOI 10.1007/978-1-59745-471-1_19; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Noiman T, 2018, CRISPR J, V1, P278, DOI 10.1089/crispr.2018.0010; Olorunniji FJ, 2016, BIOCHEM J, V473, P673, DOI 10.1042/BJ20151112; Pan XC, 2013, GENESIS, V51, P430, DOI 10.1002/dvg.22381; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Pu WJ, 2018, CIRC RES, V123, P86, DOI 10.1161/CIRCRESAHA.118.312981; Reid DA, 2017, NUCLEIC ACIDS RES, V45, P1872, DOI 10.1093/nar/gkw1221; Reid DA, 2015, P NATL ACAD SCI USA, V112, pE2575, DOI 10.1073/pnas.1420115112; Roshangar L, 2010, J OBSTET GYNAECOL RE, V36, P224, DOI 10.1111/j.1447-0756.2009.01129.x; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Sadek S, 1996, BRIT J OBSTET GYNAEC, V103, P630, DOI 10.1111/j.1471-0528.1996.tb09830.x; Sajgo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091435; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schindler SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13627; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Smedley D, 2011, METHODS, V53, P411, DOI 10.1016/j.ymeth.2010.12.027; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; StOnge L, 1996, NUCLEIC ACIDS RES, V24, P3875, DOI 10.1093/nar/24.19.3875; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Suzuki E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1280; Taslimi A, 2016, NAT CHEM BIOL, V12, P425, DOI [10.1038/nchembio.2063, 10.1038/NCHEMBIO.2063]; Thakur VS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240256; Tian XY, 2020, EMBO J, V39, DOI 10.15252/embj.2019102675; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Tronche F, 2002, FEBS LETT, V529, P116, DOI 10.1016/S0014-5793(02)03266-0; Utomo ARH, 1999, NAT BIOTECHNOL, V17, P1091, DOI 10.1038/15073; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Ved N, 2019, LAB ANIM-UK, V53, P630, DOI 10.1177/0023677219856918; WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P679, DOI 10.1111/j.1751-1097.1981.tb09424.x; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00497; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Wu BR, 2010, GENESIS, V48, P63, DOI 10.1002/dvg.20573; Wu JL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17530-9; Yao SQ, 2020, NAT METHODS, V17, P422, DOI 10.1038/s41592-020-0774-3; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Zhao H, 2019, CURR OPIN CELL BIOL, V61, P101, DOI 10.1016/j.ceb.2019.07.004; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	113	13	15	4	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100509	10.1016/j.jbc.2021.100509	http://dx.doi.org/10.1016/j.jbc.2021.100509			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676891	gold, Green Published			2022-12-28	WOS:000672866400483
J	Truman, AW				Truman, Andrew W.			Dealing with difficult clients via personalized chaperone inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT P53	The importance of molecular chaperones in cancer is well established, yet several chaperone inhibitors have failed in clinical trials due to toxicity. Recent efforts have focused on targeting chaperone function in cancer by either manipulating the "chaperone code" or inhibiting helper cochaperones, such as DNAJA1. Tong et al. identify a novel inhibitor that specifically disrupts DNAJA1's interaction with p53, promoting p53 degradation. This finding highlights specific DNAJA1 interactions with the potential for less toxicity compared to traditional chaperone inhibitors.	[Truman, Andrew W.] Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Truman, AW (corresponding author), Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA.	atruman1@uncc.edu		Truman, Andrew/0000-0002-6409-3723	National Institutes of Health [R15GM139059, R01GM139885]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (http://www.nih.gov) grant R15GM139059 and R01GM139885. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Moses MA, 2018, CANCER RES, V78, P4022, DOI 10.1158/0008-5472.CAN-17-3728; Nitika, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70764-x; Nitika, 2020, J BIOL CHEM, V295, P10689, DOI 10.1074/jbc.REV120.011666; Parrales A, 2016, NAT CELL BIOL, V18, P1233, DOI 10.1038/ncb3427; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; Sluder IT, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007462; Tong X., 2021, J BIOL CHEM, V296; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Xu DD, 2019, MOL CARCINOGEN, V58, P2052, DOI 10.1002/mc.23097	10	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100211	10.1016/j.jbc.2020.100211	http://dx.doi.org/10.1016/j.jbc.2020.100211			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837724	gold, Green Published			2022-12-28	WOS:000672866400189
J	Vaneyck, J; Segers-Nolten, I; Broersen, K; Claessens, MMAE				Vaneyck, Jonathan; Segers-Nolten, Ine; Broersen, Kerensa; Claessens, Mireille M. A. E.			Cross-seeding of alpha-synuclein aggregation by amyloid fibrils of food proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; ALZHEIMERS; PATHOLOGIES; NUCLEATION; IMPACT; BRAIN; TAU	The aggregation of the protein alpha-synuclein (aSyn) into amyloid fibrils in the human brain is associated with the development of several neurodegenerative diseases, including Parkinson's disease. The previously observed prion-like spreading of aSyn aggregation throughout the brain and the finding that heterologous cross-seeding of amyloid aggregation occurs in vitro for some proteins suggest that exposure to amyloids in general may pose a risk for disease development. To elucidate which protein fibril characteristics determine if and how heterologous amyloid seeding can occur, we investigated the potential of amyloid fibrils formed from proteins found in food, hen egg white lysozyme, and bovine milk beta-lactoglobulin to cross-seed aSyn aggregation in the test tube. We observed that amyloid fibrils from lysozyme, but not beta-lactoglobulin, potently cross-seeded the aggregation of aSyn as indicated by a significantly shorter lag phase of aSyn aggregation in the presence of lysozyme fibrils. The cross-seeding effect of lysozyme was found to be primarily driven by a surface-mediated nucleation mechanism. The differential seeding effect of lysozyme and beta-lactoglobulin on aSyn aggregation could be explained on the basis of binding affinity, binding site, and electrostatic interactions. Our results indicate that heterologous seeding of proteins may occur depending on the physicochemical characteristics of the seed protein fibril. Our findings suggest that heterologous seeding has the potential to determine the pathogenesis of neurodegenerative amyloid diseases.	[Vaneyck, Jonathan; Segers-Nolten, Ine; Claessens, Mireille M. A. E.] Univ Twente, MESA Inst Nanotechnol, Nanobiophys, Enschede, Netherlands; [Broersen, Kerensa] Univ Twente, Tech Med Ctr, Appl Stem Cell Technol, Enschede, Netherlands	University of Twente; University of Twente	Vaneyck, J (corresponding author), Univ Twente, MESA Inst Nanotechnol, Nanobiophys, Enschede, Netherlands.	j.vaneyck@utwente.nl		Vaneyck, Jonathan/0000-0003-3095-7420	Netherlands Organization for Scientific Research, Biotechnology and Safety Research Programme [15784]	Netherlands Organization for Scientific Research, Biotechnology and Safety Research Programme	We thank the Netherlands Organization for Scientific Research, Biotechnology and Safety Research Programme, project 15784, for funding.	Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Arnaudov LN, 2005, BIOPHYS J, V88, P515, DOI 10.1529/biophysj.104.048819; Arnaudov LN, 2006, BIOMACROMOLECULES, V7, P3490, DOI 10.1021/bm060584i; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brunnstrom H, 2009, AM J GERIAT PSYCHIAT, V17, P664, DOI 10.1097/JGP.0b013e3181a6516e; Challis C, 2020, NAT NEUROSCI, V23, P327, DOI 10.1038/s41593-020-0589-7; Chaudhuri P, 2019, AGEING RES REV, V56, DOI 10.1016/j.arr.2019.100937; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Echavarri C, 2012, J ALZHEIMERS DIS, V30, P909, DOI 10.3233/JAD-2012-111400; EDWARDS LL, 1991, MOVEMENT DISORD, V6, P151, DOI 10.1002/mds.870060211; Faas FGA, 2009, BIOPHYS J, V97, P1148, DOI 10.1016/j.bpj.2009.06.015; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Hamada D, 2009, J MOL BIOL, V386, P878, DOI 10.1016/j.jmb.2008.12.038; Hashimoto M, 2000, AM J PATHOL, V156, P734, DOI 10.1016/S0002-9440(10)64777-3; Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hung C, 2013, MBIO, V4, DOI 10.1128/mBio.00645-13; Jansens KJA, 2019, COMPR REV FOOD SCI F, V18, P84, DOI 10.1111/1541-4337.12404; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jimenez-Saiz R, 2014, MOL NUTR FOOD RES, V58, P614, DOI 10.1002/mnfr.201300442; Katorcha E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006563; Kim S, 2019, NEURON, V103, P627, DOI 10.1016/j.neuron.2019.05.035; Knowles TPJ, 2016, ADV MATER, V28, P6546, DOI 10.1002/adma.201505961; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Kroes-Nijboer A, 2012, FARADAY DISCUSS, V158, P125, DOI 10.1039/c2fd20031g; McCann H, 2016, MOVEMENT DISORD, V31, P152, DOI 10.1002/mds.26421; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Nicolai T, 2013, CURR OPIN COLLOID IN, V18, P249, DOI 10.1016/j.cocis.2013.03.001; Ono K, 2012, J NEUROCHEM, V122, P883, DOI 10.1111/j.1471-4159.2012.07847.x; Oskarsson ME, 2015, AM J PATHOL, V185, P834, DOI 10.1016/j.ajpath.2014.11.016; Pearce FG, 2007, J AGR FOOD CHEM, V55, P318, DOI 10.1021/jf062154p; Peelaerts W, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13595; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Ren BP, 2019, J MATER CHEM B, V7, P7267, DOI 10.1039/c9tb01871a; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Sidhu A, 2017, ACS CHEM NEUROSCI, V8, P538, DOI 10.1021/acschemneuro.6b00287; Sidhu A, 2016, ACS CHEM NEUROSCI, V7, P719, DOI 10.1021/acschemneuro.5b00322; Sidhu A, 2014, BBA-PROTEINS PROTEOM, V1844, P2127, DOI 10.1016/j.bbapap.2014.09.007; Singhrao SK, 1998, EXP NEUROL, V150, P213, DOI 10.1006/exnr.1998.6778; Tiiman A, 2015, AIP ADV, V5, DOI 10.1063/1.4921071; Tornquist M, 2018, CHEM COMMUN, V54, P8667, DOI 10.1039/c8cc02204f; Uemura N, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0257-5; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; White AP, 2001, J MOL BIOL, V311, P735, DOI 10.1006/jmbi.2001.4876; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509	48	12	13	3	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100358	10.1016/j.jbc.2021.100358	http://dx.doi.org/10.1016/j.jbc.2021.100358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539920	Green Published, gold			2022-12-28	WOS:000672866400332
J	Zhang, HL; Li, YM; Sun, J; Zhang, YY; Wang, TY; Sun, MX; Wang, MH; Yang, YL; Hu, XL; Tang, YD; Zhao, JC; Cai, XH				Zhang, Hong-Liang; Li, Yu-Ming; Sun, Jing; Zhang, Yu-Yuan; Wang, Tong-Yun; Sun, Ming-Xia; Wang, Meng-Hang; Yang, Yue-Lin; Hu, Xiao-Liang; Tang, Yan-Dong; Zhao, Jincun; Cai, Xuehui			Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-LIKE CORONAVIRUS; FUNCTIONAL RECEPTOR; CELL ENTRY; INSIGHT; USAGE; ACE2	The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic represents a global threat, and the interaction between the virus and angiotensin-converting enzyme 2 (ACE2), the primary entry receptor for SARS-CoV-2, is a key determinant of the range of hosts that can be infected by the virus. However, the mechanisms underpinning ACE2-mediated viral entry across species remains unclear. Using infection assay, we evaluated SARS-CoV-2 entry mediated by ACE2 of 11 different animal species. We discovered that ACE2 of Rhinolophus sinicus (Chinese rufous horseshoe bat), Felis catus (domestic cat), Canis lupus familiaris (dog), Sus scrofa (wild pig), Capra hircus (goat), and Manis javanica(Malayan pangolin) facilitated SARS-CoV-2 entry into nonsusceptible cells. Moreover, ACE2 of the pangolin also mediated SARS-CoV-2 entry, adding credence to the hypothesis that SARS-CoV-2 may have originated from pangolins. However, the ACE2 proteins of Rhinolophus ferrumequinum (greater horseshoe bat), Gallus gallus (red junglefowl), Notechis scutatus (mainland tiger snake), or Mus musculus (house mouse) did not facilitate SARS-CoV-2 entry. In addition, a natural isoform of the ACE2 protein of Macaca mulatta (rhesus monkey) with the Y217N mutation was resistant to SARS-CoV-2 infection, highlighting the possible impact of this ACE2 mutation on SARS-CoV-2 studies in rhesus monkeys. We further demonstrated that the Y217 residue of ACE2 is a critical determinant for the ability of ACE2 to mediate SARS-CoV-2 entry. Overall, these results clarify that SARS-CoV-2 can use the ACE2 receptors of multiple animal species and show that tracking the natural reservoirs and intermediate hosts of SARS-CoV-2 is complex.	[Zhang, Hong-Liang; Zhang, Yu-Yuan; Wang, Tong-Yun; Sun, Ming-Xia; Wang, Meng-Hang; Yang, Yue-Lin; Tang, Yan-Dong; Cai, Xuehui] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Peoples R China; [Li, Yu-Ming; Sun, Jing; Zhao, Jincun] Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Hu, Xiao-Liang] Yibin Univ, Sch Life Sci & Food Engn, Yibin Key Lab Zool Divers & Ecol Conservat, Yibin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Yibin University	Tang, YD; Cai, XH (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Peoples R China.; Zhao, JC (corresponding author), Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	tangyandong@caas.cn; zhaojincun@gird.cn; caixuehui139@163.com	Tang, Yan-Dong/ABE-7678-2021; sun, jing/GWQ-6926-2022; Zhao, Jincun/ABD-8679-2021; zhang, hongliang/HDM-5116-2022	Tang, Yan-Dong/0000-0002-5690-2690; Zhao, Jincun/0000-0003-2515-5589; 	National Key Research and Development Program of China [2018YFC1200100, 2018ZX10301403]; emergency grants for prevention and control of SARS-CoV-2 of Ministry of Science and Technology [2020YFC0841400]; Guangdong Province [2020B111108001, 2018B020207013]	National Key Research and Development Program of China; emergency grants for prevention and control of SARS-CoV-2 of Ministry of Science and Technology; Guangdong Province	This study was funded by grants from The National Key Research and Development Program of China (2018YFC1200100, 2018ZX10301403), the emergency grants for prevention and control of SARS-CoV-2 of Ministry of Science and Technology (2020YFC0841400) and Guangdong Province (2020B111108001, 2018B020207013).	Chen YX, 2008, VIROLOGY, V381, P89, DOI 10.1016/j.virol.2008.08.016; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hou YX, 2010, ARCH VIROL, V155, P1563, DOI 10.1007/s00705-010-0729-6; Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682; Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lau SKP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0208-9; Li F, 2008, J VIROL, V82, P6984, DOI 10.1128/JVI.00442-08; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Liu YH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025373118; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lu S, 2020, COMP SARS COV 2 INFE, DOI 10.1101/2020.04.08.031807; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu KL, 2012, J BIOL CHEM, V287, P8904, DOI 10.1074/jbc.M111.325803; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111; Yang YL, 2020, EMERG MICROBES INFEC, V9, P457, DOI 10.1080/22221751.2020.1730245; Zhai XF, 2020, J VIROL, V94, DOI 10.1128/JVI.00831-20; Zhang C, 2018, ONCOTARGET, V9, P2175, DOI [10.18632/oncotarget.23299, 10.18632/oncotarget.25667]; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022; Zhao XS, 2020, J VIROL, V94, DOI 10.1128/JVI.00940-20; Zheng Y, 2018, J VIROL, V92, DOI 10.1128/JVI.01504-18; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	31	15	15	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100435	10.1016/j.jbc.2021.100435	http://dx.doi.org/10.1016/j.jbc.2021.100435			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610551	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400409
J	Zheng, WW; Chu, Q; Xu, TJ				Zheng, Weiwei; Chu, Qing; Xu, Tianjun			The long noncoding RNA NARL regulates immune responses via microRNA-mediated NOD1 downregulation in teleost fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B PATHWAY; RAPID EVOLUTION; PEPTIDOGLYCAN; CONSERVATION; EXPRESSION	Increasing evidence shows that the long noncoding RNA (lncRNA) is a major regulator and participates in the regulation of various physiological and pathological processes, such as cell proliferation, differentiation, metastasis, and apoptosis. Unlike mammals, however, the study of lncRNA in lower invertebrates is just beginning and the extent of lncRNA-mediate regulation remains unclear. Here, we for the first time identify an lncRNA, termed nucleotide oligomerization domain 1 (NOD1) anti-bacterial and antiviral-related lncRNA (NARL), as a key regulator for innate immunity in teleost fish. We found that NOD1 plays an important role in the antibacterial and antiviral process in fish and that the microRNA miR-217-5p inhibits NOD1 expression and thus weakens the NF-kappa B and the IRF3-driven signaling pathway. Furthermore, our results indicated that NARL functions as a competing endogenous RNA (ceRNA) for miR-217-5p to regulate protein abundance of NOD1; thus, invading microorganisms are eliminated and immune responses are promoted. Our study also demonstrates the regulation mechanism that lncRNA NARL can competitive adsorption miR-217-5p to regulate the miR-217-5p/NOD1 axis is widespread in teleost fish. Taken together, our results reveal that NARL in fish is a critical positive regulator of innate immune responses to viral and bacterial infection by suppressing a feedback to NOD1-NF-kappa B/IRF3-mediated signaling.	[Zheng, Weiwei; Chu, Qing; Xu, Tianjun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China; [Zheng, Weiwei; Chu, Qing; Xu, Tianjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China	Shanghai Ocean University; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Shanghai Ocean University	Xu, TJ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China.	tianjunxu@163.com			National Natural Science Foundation of China [31822057]; National Key Research and Development Project [2018YFD0900503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project	This study was supported by National Natural Science Foundation of China (31822057) and National Key Research and Development Project (2018YFD0900503).	Bi DK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01413; Bi DK, 2017, DEV COMP IMMUNOL, V76, P238, DOI 10.1016/j.dci.2017.06.012; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chu Q, 2021, SCI CHINA LIFE SCI, V64, P803, DOI 10.1007/s11427-020-1777-y; Chu Q, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008670; Chu Q, 2017, J IMMUNOL, V198, P3274, DOI 10.4049/jimmunol.1602064; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fritz T, 2011, GUT, V60, P1580, DOI 10.1136/gut.2009.206466; Fu T, 2021, GASTRIC CANCER, V24, P45, DOI 10.1007/s10120-020-01096-y; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Hahn JS, 2005, FEBS LETT, V579, P4513, DOI 10.1016/j.febslet.2005.07.024; Hoang M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115428; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Jing ZT, 2018, J IMMUNOL, V201, P2303, DOI 10.4049/jimmunol.1800732; Kang H, 2017, BIOCHEM BIOPH RES CO, V482, P28, DOI 10.1016/j.bbrc.2016.11.032; Li CL, 2021, J CELL PHYSIOL, V236, P653, DOI 10.1002/jcp.29892; Li JR, 2015, FISH SHELLFISH IMMUN, V46, P387, DOI 10.1016/j.fsi.2015.06.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luis AIS, 2020, ACS OMEGA, V5, P15557, DOI 10.1021/acsomega.0c01716; Marques AC, 2014, CURR OPIN GENET DEV, V27, P48, DOI 10.1016/j.gde.2014.03.009; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Nie W, 2016, CANCER LETT, V371, P99, DOI 10.1016/j.canlet.2015.11.024; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Park SB, 2012, DEV COMP IMMUNOL, V36, P680, DOI 10.1016/j.dci.2011.11.007; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Swain B, 2013, J BIOSCIENCES, V38, P533, DOI 10.1007/s12038-013-9330-y; Wu XM, 2020, J IMMUNOL, V204, P2216, DOI 10.4049/jimmunol.1900667; Xu TJ, 2018, J IMMUNOL, V201, P982, DOI 10.4049/jimmunol.1800377; Xu TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21902; Yamamoto-Furusho JK, 2006, J BIOL CHEM, V281, P36060, DOI 10.1074/jbc.M602383200; Yang XZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0874-1; Zhang L, 2020, J IMMUNOL, V205, P1620, DOI 10.4049/jimmunol.2000341; Zhang R, 2014, CELL PHYSIOL BIOCHEM, V33, P1954, DOI 10.1159/000362972; Zhu SM, 2020, INFLAMMATION, V43, P2256, DOI 10.1007/s10753-020-01293-y; Zhu XH, 2016, EUR REV MED PHARMACO, V20, P3653	43	21	23	11	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100414	10.1016/j.jbc.2021.100414	http://dx.doi.org/10.1016/j.jbc.2021.100414			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581111	Green Published, gold			2022-12-28	WOS:000672866400388
J	Zhu, XB; Jin, CM; Pan, QR; Hu, X				Zhu, Xiaobing; Jin, Chengmeng; Pan, Qiangrong; Hu, Xun			Determining the quantitative relationship between glycolysis and GAPDH in cancer cells exhibiting the Warburg effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-KINASE M2; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MOLECULAR-MECHANISM; GLUCOSE-METABOLISM; INHIBITION; THERMODYNAMICS; INACTIVATION; IODOACETATE; GLUTATHIONE; RESISTANCE	Previous studies have identified GAPDH as a promising target for treating cancer and modulating immunity because its inhibition reduces glycolysis in cells (cancer cells and immune cells) with the Warburg effect, a modified form of cellular metabolism found in cancer cells. However, the quantitative relationship between GAPDH and the aerobic glycolysis remains unknown. Here, using siRNA-mediated knockdown of GAPDH expression and iodoacetate-dependent inhibition of enzyme activity, we examined the quantitative relationship between GAPDH activity and glycolysis rate. We found that glycolytic rates were unaffected by the reduction of GAPDH activity down to 19% +/- 4.8% relative to untreated controls. However, further reduction of GAPDH activity below this level caused proportional reductions in the glycolysis rate. GAPDH knockdown or inhibition also simultaneously increased the concentration of glyceraldehyde 3-phosphate (GA3P, the substrate of GAPDH). This increased GA3P concentration countered the effect of GAPDH knockdown or inhibition and stabilized the glycolysis rate by promoting GAPDH activity. Mechanistically, the intracellular GA3P concentration is controlled by the Gibbs free energy of the reactions upstream of GAPDH. The thermodynamic state of the reactions along the glycolysis pathway was only affected when GAPDH activity was reduced below 19% +/- 4.8%. Doing so moved the reactions catalyzed by GAPDH + PGK1 (phosphoglycerate kinase 1, the enzyme immediate downstream of GAPDH) away from the near-equilibrium state, revealing an important biochemical basis to interpret the rate control of glycolysis by GAPDH. Collectively, we resolved the numerical relationship between GAPDH and glycolysis in cancer cells with the Warburg effect and interpreted the underlying mechanism.	[Zhu, Xiaobing; Jin, Chengmeng; Pan, Qiangrong; Hu, Xun] Zhejiang Univ, Canc Inst,Sch Med, China Natl Minist Educ,Zhejiang Prov Key Lab Mol, Key Lab Canc Intervent & Prevent,Affiliated Hosp, Hangzhou, Peoples R China	Zhejiang University	Hu, X (corresponding author), Zhejiang Univ, Canc Inst,Sch Med, China Natl Minist Educ,Zhejiang Prov Key Lab Mol, Key Lab Canc Intervent & Prevent,Affiliated Hosp, Hangzhou, Peoples R China.	huxun@zju.edu.cn			China National 973 project [2013CB911303]; China Natural Science Foundation [81470126, 82073038]; Zhejiang Provincial Department of Sciences and Technologies [2018C03009]; Fundamental Research Funds for the Central Universities [2017XZZX001-01, 2019FZJD009]; National Ministry of Education, China	China National 973 project(National Basic Research Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Department of Sciences and Technologies; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Ministry of Education, China(Ministry of Education, China)	This work has been supported in part by the China National 973 project (2013CB911303), China Natural Science Foundation projects (81470126, 82073038), a key project (2018C03009) funded by Zhejiang Provincial Department of Sciences and Technologies, the Fundamental Research Funds for the Central Universities (2017XZZX001-01, 2019FZJD009), and the National Ministry of Education, China, to X. H.	Alberty Robert A, 2006, Methods Biochem Anal, V48, P1; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Ardehali H, 1996, J BIOL CHEM, V271, P1849, DOI 10.1074/jbc.271.4.1849; Arias-Salvatierra D, 2011, CELL SIGNAL, V23, P425, DOI 10.1016/j.cellsig.2010.10.017; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; CAMPBELLBURK SL, 1987, BIOCHEMISTRY-US, V26, P7483, DOI 10.1021/bi00397a043; Carneiro AS, 2011, CHEM PHYS LETT, V514, P336, DOI 10.1016/j.cplett.2011.08.051; Cascone T, 2018, CELL METAB, V27, P977, DOI 10.1016/j.cmet.2018.02.024; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Dai ZW, 2018, J BIOL CHEM, V293, P19725, DOI 10.1074/jbc.RA118.004372; DONNOVAN L, 1975, THERMOCHIM ACTA, V11, P151, DOI 10.1016/0040-6031(75)80018-9; Giachelli CM, 2003, J AM SOC NEPHROL, V14, pS300, DOI 10.1097/01.ASN.0000081663.52165.66; Gibon Y, 1997, ANAL BIOCHEM, V251, P153, DOI 10.1006/abio.1997.2283; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Jin CM, 2020, J BIOL CHEM, V295, P6425, DOI 10.1074/jbc.RA119.012312; KELETI T, 1972, BIOCHIM BIOPHYS ACTA, V268, P285, DOI 10.1016/0005-2744(72)90323-3; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; LAMBEIR AM, 1991, EUR J BIOCHEM, V198, P429, DOI 10.1111/j.1432-1033.1991.tb16032.x; Li X., 2011, DATABASE, V2011; Liao S., 2019, NAT COMMUN, V10; Liberti MV, 2020, J BIOL CHEM, V295, P111, DOI 10.1074/jbc.RA119.010903; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Locasale Jason W, 2018, Curr Opin Syst Biol, V8, P32, DOI 10.1016/j.coisb.2017.11.005; Martyniuk CJ, 2011, CHEM RES TOXICOL, V24, P2302, DOI 10.1021/tx200437y; Mendez E, 2008, BIOCHEM MOL BIOL EDU, V36, P116, DOI 10.1002/bmb.20157; Mountassif D, 2009, ACTA BIOCH BIOPH SIN, V41, P399, DOI 10.1093/abbs/gmp026; Nakazawa MS, 2016, NAT REV CANCER, V16, P663, DOI 10.1038/nrc.2016.84; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Passonneau J.V., 1993, ENZYMATIC ANAL PRACT; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; POLGAR L, 1975, EUR J BIOCHEM, V51, P63, DOI 10.1111/j.1432-1033.1975.tb03907.x; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; REKHARSKY MV, 1981, THERMOCHIM ACTA, V46, P89, DOI 10.1016/0040-6031(81)80234-1; SABRI MI, 1971, J NEUROCHEM, V18, P1509, DOI 10.1111/j.1471-4159.1971.tb00013.x; SAKAI K, 1990, EUR J BIOCHEM, V193, P195, DOI 10.1111/j.1432-1033.1990.tb19323.x; SAKAI K, 1988, BIOCHIM BIOPHYS ACTA, V952, P297, DOI 10.1016/0167-4838(88)90130-6; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shi YH, 2005, J BIOL CHEM, V280, P41805, DOI 10.1074/jbc.M505181200; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P897, DOI 10.1042/bj1920897; Varga A, 2009, FEBS LETT, V583, P3660, DOI 10.1016/j.febslet.2009.10.048; WILLIAMSON JR, 1967, J BIOL CHEM, V242, P4476; Xie JS, 2016, J BIOL CHEM, V291, P8987, DOI 10.1074/jbc.M115.704825; Xie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04927; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Ying MF, 2019, J BIOL CHEM, V294, P9615, DOI 10.1074/jbc.RA119.007841; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zhang W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08277-3; Zhong XY, 2018, CELL REP, V24, P3207, DOI 10.1016/j.celrep.2018.08.066	54	4	4	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100369	10.1016/j.jbc.2021.100369	http://dx.doi.org/10.1016/j.jbc.2021.100369			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33545174	Green Published, gold			2022-12-28	WOS:000672866400343
J	Bayati, A; Kumar, R; Francis, V; McPherson, PS				Bayati, Armin; Kumar, Rahul; Francis, Vincent; McPherson, Peter S.			SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS CORONAVIRUS; VIRUS ENTRY; RECEPTOR; PNEUMONIA; ACE2; COVID-19; BINDING; PROTEIN; SPIKE	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19, so understanding its biology and infection mechanisms is critical to facing this major medical challenge. SARS-CoV-2 is known to use its spike glycoprotein to interact with the cell surface as a first step in the infection process. As for other coronaviruses, it is likely that SARS-CoV-2 next undergoes endocytosis, but whether or not this is required for infectivity and the precise endocytic mechanism used are unknown. Using purified spike glycoprotein and lentivirus pseudotyped with spike glycoprotein, a common model of SARS-CoV-2 infectivity, we now demonstrate that after engagement with the plasma membrane, SARS-CoV-2 undergoes rapid, clathrin-mediated endocytosis. This suggests that transfer of viral RNA to the cell cytosol occurs from the lumen of the endosomal system. Importantly, we further demonstrate that knockdown of clathrin heavy chain, which blocks clathrin-mediated endocytosis, reduces viral infectivity. These discoveries reveal that SARS-CoV-2 uses clathrin-mediated endocytosis to gain access into cells and suggests that this process is a key aspect of virus infectivity.	[Bayati, Armin; Kumar, Rahul; Francis, Vincent; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University	McPherson, PS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	peter.mcpherson@mcgill.ca		Kumar, Rahul/0000-0002-7762-807X; Bayati, Armin/0000-0002-5960-0479	Natural Sciences and Engineering Research Council; Parkinson Society of Canada; ALS Canada; Fonds de recherche du Quebec-Sante	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Parkinson Society of Canada; ALS Canada; Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Natural Sciences and Engineering Research Council to P. S. M. A. B. is supported by a studentship from the Parkinson Society of Canada. R. K. is supported by a studentship from ALS Canada. V. F. was supported by a fellowship from the Fonds de recherche du Quebec-Sante. P. S. M. is a James McGill Professor and a Fellow of the Royal Society of Canada.	Burkard C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004502; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; Davies J, 2020, MOL MED REP, V22, P4221, DOI 10.3892/mmr.2020.11510; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Ghosh S, 2020, CELL, V183, P1520, DOI 10.1016/j.cell.2020.10.039; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hikmet F, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209610; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Hu TY, 2020, NAT NANOTECHNOL, V15, P247, DOI 10.1038/s41565-020-0674-9; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hulswit RJG, 2019, P NATL ACAD SCI USA, V116, P2681, DOI 10.1073/pnas.1809667116; Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07; Kang Yuan-Lin, 2020, Proc Natl Acad Sci U S A, V117, P20803, DOI [10.1101/2020.04.21.053058, 10.1073/pnas.2007837117]; Kiesslich S, 2020, J BIOTECHNOL, V310, P32, DOI 10.1016/j.jbiotec.2020.01.015; Kim ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017158; Lemmon SK, 2012, TRAFFIC, V13, P511, DOI 10.1111/j.1600-0854.2011.01321.x; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Li HS, 2005, TRAFFIC, V6, P324, DOI 10.1111/j.1600-0854.2005.00274.x; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Milewska A, 2018, J VIROL, V92, DOI 10.1128/JVI.01933-17; Miller SE, 2015, DEV CELL, V33, P163, DOI 10.1016/j.devcel.2015.03.002; Nature, 2021, NATURE; Nomura R, 2004, J VIROL, V78, P8701, DOI 10.1128/JVI.78.16.8701-8708.2004; Owczarek K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25640-0; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Plaze M, 2020, ENCEPHALE, V46, P169, DOI 10.1016/j.encep.2020.05.006; Stoorvogel W, 1991, Targeted Diagn Ther, V4, P267; Sun H, 2020, P NATL ACAD SCI USA, V117, P17204, DOI [10.1073/pnas.1921186117, DOI 10.1073/pnas.1921186117]; Tang T, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104792; Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weston S, 2020, J VIROL, V94, DOI 10.1128/JVI.01218-20; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Yamauchi Y, 2013, J CELL SCI, V126, P1289, DOI 10.1242/jcs.119685; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	49	143	143	14	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100306	10.1016/j.jbc.2021.100306	http://dx.doi.org/10.1016/j.jbc.2021.100306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33476648	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400280
J	Cardenas, RA; Gonzalez, R; Sanchez, E; Ramos, MA; Cardenas, EI; Rodarte, AI; Alcazar-Felix, RJ; Isaza, A; Burns, AR; Heidelberger, R; Adachi, R				Cardenas, Rodolfo A.; Gonzalez, Ricardo; Sanchez, Elizabeth; Ramos, Marco A.; Cardenas, Eduardo, I; Rodarte, Alejandro, I; Alcazar-Felix, Roberto J.; Isaza, Alejandro; Burns, Alan R.; Heidelberger, Ruth; Adachi, Roberto			SNAP23 is essential for platelet and mast cell development and required in connective tissue mast cells for anaphylaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITANCE MEASUREMENTS; DIFFERENTIAL EXPRESSION; REGULATED EXOCYTOSIS; W/WV MICE; MOUSE; SNARE; SNAP-23; GENE; DEFICIENT; SECRETION	Degranulation, a fundamental effector response from mast cells (MCs) and platelets, is an example of regulated exocytosis. This process is mediated by SNARE proteins and their regulators. We have previously shown that several of these proteins are essential for exocytosis in MCs and platelets. Here, we assessed the role of the SNARE protein SNAP23 using conditional knockout mice, in which SNAP23 was selectively deleted from either the megakaryocyte/platelet or connective tissue MC lineages. We found that removal of SNAP23 in platelets results in severe defects in degranulation of all three platelet secretory granule types, i.e., alpha, dense, and lysosomal granules. The mutation also induces thrombocytopenia, abnormal platelet morphology and activation, and reduction in the number of alpha granules. Therefore, the degranulation defect might not be secondary to an intrinsic failure of the machinery mediating regulated exocytosis in platelets. When we removed SNAP23 expression in MCs, there was a complete developmental failure in vitro and in vivo. The developmental defects in platelets and MCs and the abnormal translocation of membrane proteins to the surface of platelets indicate that SNAP23 is also involved in constitutive exocytosis in these cells. The MC conditional deletant animals lacked connective tissue MCs, but their mucosal MCs were normal and expanded in response to an antigenic stimulus. We used this mouse to show that connective tissue MCs are required and mucosal MCs are not sufficient for an anaphylactic response.	[Cardenas, Rodolfo A.; Sanchez, Elizabeth; Ramos, Marco A.; Cardenas, Eduardo, I; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Cardenas, Rodolfo A.; Rodarte, Alejandro, I; Alcazar-Felix, Roberto J.; Isaza, Alejandro] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Nuevo Leon, Mexico; [Gonzalez, Ricardo; Cardenas, Eduardo, I] Tecnol Monterrey, Escuela Ingn & Ciencias, Monterrey, Nuevo Leon, Mexico; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX USA; [Heidelberger, Ruth] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; Tecnologico de Monterrey; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston	Adachi, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.	radachi@mdanderson.org		Alcazar-Felix, Roberto/0000-0003-1214-5576; Cardenas, Eduardo/0000-0001-5973-5675	National Institutes of Health [AI093533, AI137319, CA016672, EY007551]; Vale-Asche Foundation via the Frederic B. Asche Endowment	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vale-Asche Foundation via the Frederic B. Asche Endowment	This project was supported by the National Institutes of Health AI093533, AI137319, CA016672, and EY007551 and the Vale-Asche Foundation via the Frederic B. Asche Endowment. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi R, 2012, J BIOL CHEM, V287, P20047, DOI 10.1074/jbc.M112.360388; Agarwal V, 2019, BBA-MOL CELL RES, V1866, P1618, DOI 10.1016/j.bbamcr.2019.06.015; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Boschert U, 1996, J COMP NEUROL, V367, P177, DOI 10.1002/(SICI)1096-9861(19960401)367:2<177::AID-CNE2>3.0.CO;2-2; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Cardenas EI, 2019, J BIOL CHEM, V294, P4784, DOI 10.1074/jbc.RA118.006922; Cardenas EI, 2018, HAEMATOLOGICA, V103, P1235, DOI 10.3324/haematol.2017.185637; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; Feng DR, 2018, J CLIN INVEST, V128, P3941, DOI 10.1172/JCI99217; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; French SL, 2018, PLATELETS, V29, P196, DOI 10.1080/09537104.2017.1349310; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Gutierrez BA, 2018, J BIOL CHEM, V293, P7148, DOI 10.1074/jbc.RA118.002455; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Kadkova A, 2019, NEUROSCIENCE, V420, P50, DOI 10.1016/j.neuroscience.2018.09.020; Kerris EWJ, 2020, J INVEST MED, V68, P813, DOI 10.1136/jim-2019-001195; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; KITAMURA Y, 1978, BLOOD, V52, P447; Kitamura Y, 2007, P JPN ACAD B-PHYS, V83, P164, DOI 10.2183/pjab.83.164; Krystel-Whittemore M, 2016, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00620; Kuster A, 2015, J BIOL CHEM, V290, P28056, DOI 10.1074/jbc.M115.666362; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu ZQ, 2016, AM J TRANSL RES, V8, P2317; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; Mehlmann LM, 2019, BIOL REPROD, V101, P338, DOI 10.1093/biolre/ioz106; Melicoff E, 2009, J BIOL CHEM, V284, P19445, DOI 10.1074/jbc.M109.002550; Morgan A, 1995, ESSAYS BIOCHEM, V30, P77; Mouton PR, 2011, UNBIASED STEREOLOGY; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Naskar P, 2017, BIOL OPEN, V6, P1257, DOI 10.1242/bio.025791; OTSU K, 1987, J EXP MED, V165, P615, DOI 10.1084/jem.165.3.615; Peschke K, 2015, METHODS MOL BIOL, V1220, P403, DOI 10.1007/978-1-4939-1568-2_25; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Reber LL, 2013, J ALLERGY CLIN IMMUN, V132, P881, DOI 10.1016/j.jaci.2013.06.008; Ren BH, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150004; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; Rizo J, 2018, PROTEIN SCI, V27, P1364, DOI 10.1002/pro.3445; Rodarte EM, 2018, J BIOL CHEM, V293, P345, DOI 10.1074/jbc.M117.816884; ROTH D, 1994, FEBS LETT, V351, P207, DOI 10.1016/0014-5793(94)00833-7; SAGE SO, 1987, J BIOL CHEM, V262, P16364; Sanchez E, 2019, J BIOL CHEM, V294, P3012, DOI 10.1074/jbc.RA118.005532; SCHAEFFER J, 1989, CELL CALCIUM, V10, P101, DOI 10.1016/0143-4160(89)90050-X; Schneider JP, 2012, METHOD CELL BIOL, V113, P257, DOI 10.1016/B978-0-12-407239-8.00012-4; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; SORENSEN FB, 1989, AM J DERMATOPATH, V11, P517, DOI 10.1097/00000372-198912000-00002; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; WARREN BA, 1971, BRIT J EXP PATHOL, V52, P378; Williams CM, 2018, BLOOD ADV, V2, P3627, DOI 10.1182/bloodadvances.2018023291; Wong PPC, 1997, BIOCHEM BIOPH RES CO, V230, P64, DOI 10.1006/bbrc.1996.5884; Xing W, 2011, P NATL ACAD SCI USA, V108, P14210, DOI 10.1073/pnas.1111048108	72	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100268	10.1016/j.jbc.2021.100268	http://dx.doi.org/10.1016/j.jbc.2021.100268			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837726	gold, Green Published			2022-12-28	WOS:000672866400244
J	Choi, M; Park, S; Yi, JK; Kwon, W; Jang, S; Kim, SY; Yu, W; Kim, MO; Ryoo, ZY; Choi, SK				Choi, Minjee; Park, Song; Yi, Jun Koo; Kwon, Wookbong; Jang, Soyoung; Kim, Si-Yong; Yu, Wookyung; Kim, Myoung Ok; Ryoo, Zae Young; Choi, Seong-Kyoon			Overexpression of hepatic serum amyloid A1 in mice increases IL-17-producing innate immune cells and decreases bone density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; RECEPTOR; NEUTROPHILIA; DISEASE; WNT	Serum amyloid A (SAA) is an acute-phase protein produced primarily in the liver that plays a key role in both the initiation and maintenance of inflammation. Rapidly secreted SAA induces neutrophilia at inflammatory sites, initiating inflammation and inducing the secretion of various cytokines, including TNF-a, IL-6, and IL-17. IL-17 is expressed in several inflammatory cells, including innate immune cells such as.dT cells, ILC3 cells, and neutrophils. Increased IL-17 levels exacerbate various inflammatory diseases. Among other roles, IL-17 induces bone loss by increasing receptor activator of nuclear factor-.B ligand (RANKL) secretion, which stimulates osteoclast differentiation. Several studies have demonstrated that chronic inflammation induces bone loss, suggesting a role for SAA in bone health. To test this possibility, we observed an increase in IL-17-producing innate immune cells, neutrophils, and.dT cells in these mice. In 6-month-old animals, we detected increased osteoclast-related gene expression and IL17 expression in bone lysates. We also observed an increase in neutrophils that secreted RANKL in the bone marrow of TG mice. Finally, we demonstrated decreased bone mineral density in these transgenic (TG) mice. Our results revealed that the TG mice have increased populations of IL-17-producing innate immune cells,.dT cells, and neutrophils in TG mice. We additionally detected increased RANKL and IL-17 expression in the bone marrow of 6-month-old TG mice. Furthermore, we confirmed significant increases in RANKL-expressing neutrophils in TG mice and decreased bone mineral density. Our results provide evidence that chronic inflammation induced by SAA1 causes bone loss via IL-17-secreting innate immune cells.	[Choi, Minjee; Park, Song; Choi, Seong-Kyoon] DGIST, Core Prot Resources Ctr, Daegu, South Korea; [Park, Song; Yu, Wookyung] DGIST, Dept Brain & Cognit Sci, Daegu, South Korea; [Yi, Jun Koo] Gyeongsangbukdo Livestock Res Inst, Yeongju Si, South Korea; [Kwon, Wookbong; Choi, Seong-Kyoon] DGIST, Div Biotechnol, Daegu, South Korea; [Jang, Soyoung; Kim, Si-Yong; Ryoo, Zae Young] Kyungpook Natl Univ, Sch Life Sci, BK21 KNU Creat Biores Grp 4, Daegu, South Korea; [Kim, Myoung Ok] Kyungpook Natl Univ, Sch Anim Sci Biotechnol, Sangju Si, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Kyungpook National University; Kyungpook National University	Choi, SK (corresponding author), DGIST, Core Prot Resources Ctr, Daegu, South Korea.; Choi, SK (corresponding author), DGIST, Div Biotechnol, Daegu, South Korea.; Ryoo, ZY (corresponding author), Kyungpook Natl Univ, Sch Life Sci, BK21 KNU Creat Biores Grp 4, Daegu, South Korea.	jaewoong64@hanmail.net; cskbest@dgist.ac.kr		Jang, Soyoung/0000-0003-2673-4259; Kim, Si-Yong/0000-0002-9583-8193; Kwon, Wookbong/0000-0002-0655-6531; Yi, JunKoo/0000-0003-2593-6529	DGIST R&D Program of the Ministry of Science and ICT [2020010096]; pCoE program of DGIST [DGIST 20-CoE-BT-01]; National Research Foundation of Korea (NRF) - Ministry of Education [2020R1I1A2075315]	DGIST R&D Program of the Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea); pCoE program of DGIST; National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea)	This work was supported by the DGIST R&D Program of the Ministry of Science and ICT (2020010096), the pCoE program of DGIST (DGIST 20-CoE-BT-01), and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2020R1I1A2075315).	Anthony D, 2013, AM J RESP CRIT CARE, V188, P179, DOI 10.1164/rccm.201211-2139OC; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Chakravarti A, 2009, BLOOD, V114, P1633, DOI 10.1182/blood-2008-09-178301; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Chen X, 2018, CONNECT TISSUE RES, V59, P99, DOI 10.1080/03008207.2017.1290085; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Choi M, 2019, SCAND J IMMUNOL, V89, DOI 10.1111/sji.12764; Connolly M, 2012, ARTHRITIS RHEUM-US, V64, P1035, DOI 10.1002/art.33455; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Edwards SW, 1997, IMMUNOL TODAY, V18, P320, DOI 10.1016/S0167-5699(97)01087-6; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Gravallese EM, 2018, NAT REV RHEUMATOL, V14, P631, DOI 10.1038/s41584-018-0091-8; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Jang WY, 2016, APPL PHYSIOL NUTR ME, V41, P640, DOI 10.1139/apnm-2015-0369; Ji YR, 2015, J BIOL CHEM, V290, P12804, DOI 10.1074/jbc.M114.635763; Kim AR, 2020, J PERIODONTAL RES, V55, P868, DOI 10.1111/jre.12779; Kim J, 2016, J LEUKOCYTE BIOL, V99, P595, DOI 10.1189/jlb.3A0415-173R; Kirkham G, 2007, TOP TISSUE ENG, P1; Li JY, 2019, J BONE MINER RES, V34, P349, DOI 10.1002/jbmr.3600; Milanova V, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/643406; Morizane S, 2017, J INVEST DERMATOL, V137, P757, DOI 10.1016/j.jid.2016.10.016; Oh E, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.83; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Shabgah AG, 2014, POSTEP DERM ALERGOL, V31, P256, DOI 10.5114/pdia.2014.40954; Srivastava RK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00657; Uluckan O, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8996; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; Yu N, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12320; Zhao QX, 2007, FRONT BIOSCI-LANDMRK, V12, P2519, DOI 10.2741/2252	31	4	5	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100595	10.1016/j.jbc.2021.100595	http://dx.doi.org/10.1016/j.jbc.2021.100595			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781747	Green Published, gold			2022-12-28	WOS:000672866400567
J	Kang, TZE; Zhu, LN; Yang, D; Ding, DB; Zhu, XX; Wan, YCE; Liu, JX; Ramakrishnan, S; Chan, LL; Chan, SY; Wang, X; Gan, HY; Han, JH; Ishibashi, T; Li, Q; Chan, KM				Kang, Tze Zhen Evangeline; Zhu, Lina; Yang, Du; Ding, Dongbo; Zhu, Xiaoxuan; Wan, Yi Ching Esther; Liu, Jiaxian; Ramakrishnan, Saravanan; Chan, Landon Long; Chan, Siu Yuen; Wang, Xin; Gan, Haiyun; Han, Junhong; Ishibashi, Toyotaka; Li, Qing; Chan, Kui Ming			The elevated transcription of ADAM19 by the oncohistone H2BE76K contributes to oncogenic properties in breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							R/BIOCONDUCTOR PACKAGE; DRIVER MUTATIONS; READ ALIGNMENT; GENES; CHROMATIN; METHYLATION; REPROGRAMS; PROTEINS; TUMOR; H2B	The recent discovery of the cancer-associated E76K mutation in histone H2B (H2BE76-to-K) in several types of cancers revealed a new class of oncohistone. H2BE76K weakens the stability of histone octamers, alters gene expression, and promotes colony formation. However, the mechanism linking the H2BE76K mutation to cancer development remains largely unknown. In this study, we knock in the H2BE76K mutation in MDA-MB-231 breast cancer cells using CRISPR/Cas9 and show that the E76K mutant histone H2B preferentially localizes to genic regions. Interestingly, genes upregulated in the H2BE76K mutant cells are enriched for the E76K mutant H2B and are involved in cell adhesion and proliferation pathways. We focused on one H2BE76K target gene, ADAM19 (a disintegrin and metalloproteinase-domain-containing protein 19), a gene highly expressed in various human cancers including breast invasive carcinoma, and demonstrate that H2BE76K directly promotes ADAM19 transcription by facilitating efficient transcription along the gene body. ADAM19 depletion reduced the colony formation ability of the H2BE76K mutant cells, whereas wild-type MDA-MB-231 cells overexpressing ADAM19 mimics the colony formation phenotype of the H2BE76K mutant cells. Collectively, our data demonstrate the mechanism by which H2BE76K deregulates the expression of genes that control oncogenic properties through a combined effect of its specific genomic localization and nucleosome destabilization effect.	[Kang, Tze Zhen Evangeline; Zhu, Lina; Zhu, Xiaoxuan; Wan, Yi Ching Esther; Liu, Jiaxian; Ramakrishnan, Saravanan; Wang, Xin; Chan, Kui Ming] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China; [Kang, Tze Zhen Evangeline; Zhu, Lina; Zhu, Xiaoxuan; Wan, Yi Ching Esther; Liu, Jiaxian; Ramakrishnan, Saravanan; Wang, Xin; Chan, Kui Ming] City Univ Hong Kong, Key Lab Biochip Technol, Biotech & Hlth Ctr, Shenzhen Res Inst, Shenzhen, Peoples R China; [Yang, Du; Li, Qing] Peking Univ, State Key Lab Prot & Plant Gene Res, Sch Life Sci, Beijing, Peoples R China; [Yang, Du; Li, Qing] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Ding, Dongbo; Ishibashi, Toyotaka] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China; [Chan, Landon Long] Princess Margaret Hosp, Dept Oncol, Hong Kong, Peoples R China; [Chan, Siu Yuen] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China; [Gan, Haiyun] Chinese Acad Sci, Guangdong Prov Key Lab Synthet Genom, CAS Key Lab Quantitat Engn Biol, Shenzhen Inst Synthet Biol,Shenzhen Inst Adv Tech, Shenzhen, Peoples R China; [Gan, Haiyun] Chinese Acad Sci, Shenzhen Key Lab Synthet Genom, Shenzhen Inst Synthet Biol, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Han, Junhong] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, West China Med Sch, Chengdu, Sichuan, Peoples R China; [Han, Junhong] Sichuan Univ, Canc Ctr, West China Hosp, West China Med Sch, Chengdu, Sichuan, Peoples R China	City University of Hong Kong; City University of Hong Kong; Peking University; Peking University; Hong Kong University of Science & Technology; University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Sichuan University; Sichuan University	Chan, KM (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China.; Chan, KM (corresponding author), City Univ Hong Kong, Key Lab Biochip Technol, Biotech & Hlth Ctr, Shenzhen Res Inst, Shenzhen, Peoples R China.	Ming.chan@cityu.edu.hk		ZHU, Lina/0000-0002-8558-2120; ZHU, Xiaoxuan/0000-0002-1664-8034; WAN, Yi Ching Esther/0000-0002-5916-3336	Research Grants Council Hong Kong [17101814, 21100615, 11102118, 11101919, 11102317, C7007-17GF]; Shenzhen Science and Technology Fund Program [JCYJ20170818104203065, JCYJ20180307124019360, JCYJ20170307091256048]; National Natural Science Foundation of China [81802384]; Hong Kong Epigenomics Project of the EpiHK	Research Grants Council Hong Kong(Hong Kong Research Grants Council); Shenzhen Science and Technology Fund Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Epigenomics Project of the EpiHK	This work was supported by grants from Research Grants Council Hong Kong [Project No. 17101814, 21100615, 11102118, 11101919 (K. M. C.), 11102317 (X. W.), and C7007-17GF (K. M. C.], the Shenzhen Science and Technology Fund Program Project No. JCYJ20170818104203065, JCYJ20180307124019360 (K. M. C.), JCYJ20170307091256048 (X. W.), and National Natural Science Foundation of China [Project No. 81802384 (X. W.)]. This work was also supported by the Hong Kong Epigenomics Project of the EpiHK (K. M. C.).	Ai LB, 2014, CANCER RES, V74, P4875, DOI 10.1158/0008-5472.CAN-13-3579; Aktary Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078388; Arimura Y, 2018, NUCLEIC ACIDS RES, V46, P10007, DOI 10.1093/nar/gky661; Audia JE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019521; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Bennett RL, 2019, CANCER DISCOV, V9, P1438, DOI 10.1158/2159-8290.CD-19-0393; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; De P, 2016, ONCOTARGET, V7, P43124, DOI 10.18632/oncotarget.8988; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fang D, 2016, SCIENCE, V352, P1344, DOI 10.1126/science.aae0065; Gao F., 2017, ISMB ECCB 2017; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Holen I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3201; Huang H, 2014, CELL, V159, P458, DOI 10.1016/j.cell.2014.09.037; Huang P, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0304-4; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Kurohara K, 2004, DEV BIOL, V267, P14, DOI 10.1016/j.ydbio.2003.10.021; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2016, TRENDS GENET, V32, P42, DOI 10.1016/j.tig.2015.10.007; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu J, 2012, AM J PATHOL, V180, P839, DOI 10.1016/j.ajpath.2011.10.020; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meers MP, 2019, ELIFE, V8, DOI 10.7554/eLife.46314; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Nacev BA, 2019, NATURE, V567, P473, DOI 10.1038/s41586-019-1038-1; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schlondorff J, 1999, J CELL SCI, V112, P3603; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Wan YCE, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0131-0; Wan Yi Ching Esther, 2018, Curr Pharmacol Rep, V4, P292, DOI 10.1007/s40495-018-0141-6; Wang Y., 2018, ONCOIMMUNOLOGY, V7, P1; Witwicki RM, 2018, CELL REP, V25, P1255, DOI 10.1016/j.celrep.2018.10.023; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004	53	4	4	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100374	10.1016/j.jbc.2021.100374	http://dx.doi.org/10.1016/j.jbc.2021.100374			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548228	gold, Green Published			2022-12-28	WOS:000672866400348
J	Kim, W; Watanabe, H; Lomoio, S; Tesco, G				Kim, WonHee; Watanabe, Hiroto; Lomoio, Selene; Tesco, Giuseppina			Spatiotemporal processing of neural cell adhesion molecules 1 and 2 by BACE1 in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS BETA-SECRETASE; POLYSIALIC ACID SYNTHESIS; LONG-TERM POTENTIATION; GATED SODIUM-CHANNELS; CLEAVING ENZYME BACE1; MICE DEFICIENT; CLOSE HOMOLOG; MOSSY FIBER; PSA-NCAM	Neural cell adhesion molecules 1 (NCAM1) and 2 (NCAM2) belong to the cell adhesion molecules of the immunoglobulin superfamily and have been shown to regulate formation, maturation, and maintenance of synapses. NCAM1 and NCAM2 undergo proteolysis, but the identity of all the proteases involved and how proteolysis is used to regulate their functions are not known. We report here that NCAM1 and NCAM2 are BACE1 substrates in vivo. NCAM1 and NCAM2 overexpressed in HEK cells were both cleaved by metalloproteinases or BACE1, and NCAM2 was also processed by gamma-secretase. We identified the BACE1 cleavage site of NCAM1 (at Glu 671) and NCAM2 (at Glu 663) using mass spectrometry and site-directed mutagenesis. Next, we assessed BACE1-mediated processing of NCAM1 and NCAM2 in the mouse brain during aging. NCAM1 and NCAM2 were cleaved in the olfactory bulb of BACE1+/+ but not BACE1-/- mice at postnatal day 10 (P10), 4 and 12 months of age. In the hippocampus, a BACE1-specific soluble fragment of NCAM1 (sNCAM1 beta) was only detected at P10. However, we observed an accumulation of full-length NCAM1 in hippocampal synaptosomes in 4-mont-hold BACE1-/- mice. We also found that polysialylated NCAM1 (PSA-NCAM1) levels were increased in BACE1-/- mice at P10 and demonstrated that BACE1 cleaves both NCAM1 and PSA-NCAM1 in vitro. In contrast, we did not find evidence for BACE1-dependent NCAM2 processing in the hippocampus at any age analyzed. In summary, our data demonstrate that BACE1 differentially processes NCAM1 and NCAM2 depending on the region of brain, subcellular localization, and age in vivo.	[Kim, WonHee; Watanabe, Hiroto; Lomoio, Selene; Tesco, Giuseppina] Tufts Univ, Sch Med, Dept Neurosci, Alzheimers Dis Res Lab, Boston, MA 02111 USA	Tufts University	Tesco, G (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Alzheimers Dis Res Lab, Boston, MA 02111 USA.	Giuseppina.Tesco@Tufts.edu		Kim, WonHee/0000-0001-5530-7606	BrightFocus Foundation [A201902F]; National Institutes of Health and Alzheimer's Disease Research fellowship [R01NS092497]	BrightFocus Foundation(BrightFocus Foundation); National Institutes of Health and Alzheimer's Disease Research fellowship	This work was supported by Award Number R01NS092497 (to G. T.) from National Institutes of Health and Alzheimer's Disease Research fellowship (A201902F) from BrightFocus Foundation (to W. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aisa B, 2010, J ALZHEIMERS DIS, V20, P659, DOI 10.3233/JAD-2010-1398; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brennaman LH, 2014, J NEUROCHEM, V128, P267, DOI 10.1111/jnc.12468; Brennaman LH, 2008, MOL CELL NEUROSCI, V37, P781, DOI 10.1016/j.mcn.2008.01.006; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cao LX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00231; Coppieters N, 2019, BRAIN RES, V1710, P199, DOI 10.1016/j.brainres.2018.12.035; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dislich B, 2015, MOL CELL PROTEOMICS, V14, P2550, DOI 10.1074/mcp.M114.041533; Dityatev A, 2008, NEURON GLIA BIOL, V4, P197, DOI 10.1017/S1740925X09990111; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Egan MF, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0520-1; Egan MF, 2019, NEW ENGL J MED, V380, P1408, DOI 10.1056/NEJMoa1812840; Egan MF, 2018, NEW ENGL J MED, V378, P1691, DOI 10.1056/NEJMoa1706441; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Evans Gareth J O, 2015, Cold Spring Harb Protoc, V2015, P462, DOI 10.1101/pdb.prot083469; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Finan GM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.170217; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Gunnersen JM, 2007, NEURON, V56, P621, DOI 10.1016/j.neuron.2007.09.018; He WX, 2014, J BIOL CHEM, V289, P20630, DOI 10.1074/jbc.M114.579862; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Henley D, 2019, NEW ENGL J MED, V380, P1483, DOI 10.1056/NEJMc1813435; Heyden A, 2008, NEUROSCIENCE, V155, P221, DOI 10.1016/j.neuroscience.2008.04.080; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Hu XY, 2018, J EXP MED, V215, P927, DOI 10.1084/jem.20171831; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kasper C, 2000, NAT STRUCT BIOL, V7, P389; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim W, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0239-7; Kimura A, 2016, J BIOL CHEM, V291, P24041, DOI 10.1074/jbc.M116.744722; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kitazume S, 2006, GLYCOCONJUGATE J, V23, P437, DOI 10.1007/s10719-006-6671-x; Krebs J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00106, 10.3389/fnins.2011.00107]; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Leshchyns'ka I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9836; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Lombardo S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56329-7; Lundgren JL, 2015, J NEUROCHEM, V135, P606, DOI 10.1111/jnc.13287; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Nacher J, 2002, BRAIN RES, V927, P111, DOI 10.1016/S0006-8993(01)03241-3; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Ou-Yang MH, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao5620; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pigoni M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0134-z; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; Pollock N, 2018, MICROBES INFECT, V20, P228, DOI 10.1016/j.micinf.2017.12.011; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Rasmussen KK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27089-7; Njavro JR, 2020, FASEB J, V34, P2465, DOI 10.1096/fj.201902347R; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00061; Schauenburg L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19530-8; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Seki T, 1998, J NEUROSCI, V18, P3757; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Shen HM, 1999, ANAT RECORD, V256, P448, DOI 10.1002/(SICI)1097-0185(19991201)256:4<448::AID-AR11>3.0.CO;2-8; Shetty A, 2013, J NEUROSCI, V33, P16828, DOI 10.1523/JNEUROSCI.2192-13.2013; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shichi K, 2011, J PHARMACOL EXP THER, V338, P701, DOI 10.1124/jpet.110.178079; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Stutzer I, 2013, J BIOL CHEM, V288, P10536, DOI 10.1074/jbc.M112.444703; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Tenreiro P, 2017, ANAL BIOCHEM, V517, P1, DOI 10.1016/j.ab.2016.10.015; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Turner RT, 2001, BIOCHEMISTRY-US, V40, P10001, DOI 10.1021/bi015546s; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Wang H, 2008, J NEUROSCI, V28, P8677, DOI 10.1523/JNEUROSCI.2440-08.2008; Wennstrom M, 2012, DEGENER NEUROL NEURO, V2, P65, DOI 10.2147/DNND.S19829; Wessels AM, 2020, ALZHEIMERS DEMENT, V16, P1483, DOI 10.1002/alz.12164; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yan XX, 2012, EXP NEUROL, V235, P228, DOI 10.1016/j.expneurol.2012.01.003; YANG PF, 1994, J BIOL CHEM, V269, P23039; Yoo SJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.349; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465; Zhu KC, 2018, BIOL PSYCHIAT, V83, P428, DOI 10.1016/j.biopsych.2016.12.023	112	8	8	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100372	10.1016/j.jbc.2021.100372	http://dx.doi.org/10.1016/j.jbc.2021.100372			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548223	gold, Green Published			2022-12-28	WOS:000672866400346
J	Liu, XY; Wang, YW; Chen, DS; Ji, SY; Yang, LT; Huang, QM; Guan, X; Chang, KX; Li, D; Yuan, RY; Ouyang, CY; Hu, TY; Liu, ZQ; Sun, BQ; Xu, GR; Liu, ZG; Yang, PC				Liu, Xiaoyu; Wang, Yuwei; Chen, Desheng; Ji, Shuyu; Yang, Li-Teng; Huang, Qinmiao; Guan, Lvxin; Chang, Kexin; Li, Dan; Yuan, Ruyi; Ouyang, Chunyan; Hu, Tian-Yong; Liu, Zhi-Qiang; Sun, Baoqing; Xu, Guorong; Liu, Zhi-Gang; Yang, Ping-Chang			Dust-mite-derived protein disulfide isomerase suppresses airway allergy by inducing tolerogenic dendritic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS	House dust mites (HDMs) are a potent allergen source that are commonly found in human living environments. While HDMs are known to induce allergic diseases in humans, such as asthma, its other biological activities related to human health are less understood. Our laboratory recently purified the HDM protein PDI (protein disulfide isomerase). In this study, we assess the role of PDI in contributing to immune regulation. Using mass spectrometry, we analyzed the complexes of DEC205 and HDM extracts, and the role of PDI in the induction of tolerogenic dendritic cells (DCs) was assessed in human cell culture experiments and verified in a murine model. We found that more than 20 HDM-derived proteins, including PDI, bound to DCs by forming complexes with DEC205. Additionally, DEC205-mediated the endocytosis of PDI. HDM-derived PDI (HDM-PDI) promoted Foxp3 expression in DCs. HDM-PDI-primed DCs also showed tolerogenic properties that induced regulatory T cell development, indicating that the primed DCs were tolerogenic DCs. Our results suggested that the PDI/DEC205/TIEG1/Foxp3 signal pathway activation was involved in the HDM-PDI-induced Foxp3 expression in DCs. Finally, we found that HDM-PDI competitively counteracted the Th2 cytokines to restore DC's tolerogenicity, and administration of HDM-PDI could suppress experimental asthma. In conclusion, our data suggest that HDM-PDI contributes to immune regulation by inducing tolerogenic DC development. Administration of HDM-PDI can alleviate experimental asthma. These findings demonstrate that HDM-PDI has translational potential to be used in the treatment of immune disorders such as asthma.	[Liu, Xiaoyu; Wang, Yuwei; Chen, Desheng; Ji, Shuyu; Huang, Qinmiao; Guan, Lvxin; Chang, Kexin; Li, Dan; Yuan, Ruyi; Ouyang, Chunyan; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, State Key Lab Resp Dis Allergy, Shenzhen, Peoples R China; [Liu, Xiaoyu; Wang, Yuwei; Chen, Desheng; Ji, Shuyu; Huang, Qinmiao; Guan, Lvxin; Chang, Kexin; Li, Dan; Yuan, Ruyi; Ouyang, Chunyan; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, Sch Med, Shenzhen, Peoples R China; [Yang, Li-Teng] Shenzhen Univ, Affiliated Hosp 3, Dept Respirol, Shenzhen, Peoples R China; [Hu, Tian-Yong; Liu, Zhi-Qiang] Longgnag ENT Hosp, Dept Allergy, Shenzhen, Peoples R China; [Sun, Baoqing] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis,Natl Clin Ctr Resp Dis, Guangzhou, Peoples R China; [Xu, Guorong] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Yang, Ping-Chang] Guangdong Prov Key Lab Reg Immun & Dis, Shenzhen, Peoples R China	Shenzhen University; State Key Laboratory of Respiratory Disease; Shenzhen University; Shenzhen University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Chinese University of Hong Kong	Liu, ZG; Yang, PC (corresponding author), Shenzhen Univ, State Key Lab Resp Dis Allergy, Shenzhen, Peoples R China.; Liu, ZG; Yang, PC (corresponding author), Shenzhen Univ, Sch Med, Shenzhen, Peoples R China.; Sun, BQ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis,Natl Clin Ctr Resp Dis, Guangzhou, Peoples R China.; Yang, PC (corresponding author), Guangdong Prov Key Lab Reg Immun & Dis, Shenzhen, Peoples R China.	lzg@szu.edu.cn; pc2356@163.com	Yang, Liteng/AAK-1611-2021	Hu, TianYong/0000-0002-4416-6948; Wang, Yuwei/0000-0003-4996-6458	National Nature and Science Foundation of China [32090052, 31570932, U1801286, 82071807, 82004046]; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases [2019B030301009]; Medical and Health Technology Project of Guangzhou [20171A010042]; Shenzhen Nanshan District Oversea Research Personnel Initiative Group Fund [LHTD20180007]; Shenzhen science, technology and innovation committee [KQTD20170331145453160, GJHZ20180418190535757, KQJSCX20180328095619081]; Shenzhen Key Medical Discipline Construction Fund [SZXK039]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Key Laboratory of Regional Immunity and Diseases; Medical and Health Technology Project of Guangzhou; Shenzhen Nanshan District Oversea Research Personnel Initiative Group Fund; Shenzhen science, technology and innovation committee; Shenzhen Key Medical Discipline Construction Fund	This study was supported by grants of the National Nature and Science Foundation of China (32090052, 31570932, U1801286, 82071807, 82004046), Guangdong Provincial Key Laboratory of Regional Immunity and Diseases (2019B030301009), The Funding of Medical and Health Technology Project of Guangzhou (20171A010042), Shenzhen Nanshan District Oversea Research Personnel Initiative Group Fund (LHTD20180007), and Shenzhen science, technology and innovation committee (KQTD20170331145453160, GJHZ20180418190535757, KQJSCX20180328095619081) and Shenzhen Key Medical Discipline Construction Fund (No.SZXK039).	Abediankenari S, 2009, IRAN J ALLERGY ASTHM, V8, P25, DOI 08.01/ijaai.2530; Alroqi FJ, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0606-9; Chan TF, 2015, J ALLERGY CLIN IMMUN, V135, P539, DOI 10.1016/j.jaci.2014.09.031; Cho J, 2013, J THROMB HAEMOST, V11, P2084, DOI 10.1111/jth.12413; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cui YB, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0200-4; Esebanmen GE, 2017, IMMUNOL RES, V65, P987, DOI 10.1007/s12026-017-8944-9; Hoffman SM, 2016, J ALLERGY CLIN IMMUN, V137, P822, DOI 10.1016/j.jaci.2015.08.018; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kanamori M, 2016, TRENDS IMMUNOL, V37, P803, DOI 10.1016/j.it.2016.08.012; Koch S, 2017, SEMIN IMMUNOPATHOL, V39, P55, DOI 10.1007/s00281-016-0601-1; Lee E, 2017, BMB REP, V50, P401, DOI 10.5483/BMBRep.2017.50.8.107; Lin JL, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.02375-2019; Peng DJ, 2011, J IMMUNOL, V186, P5638, DOI 10.4049/jimmunol.1003801; Sanjabi S, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022236; Spiering R, 2015, J IMMUNOL, V194, P4804, DOI 10.4049/jimmunol.1400986; Stopa JD, 2018, THROMB RES, V164, pS130, DOI 10.1016/j.thromres.2018.01.005; Volpi C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2874; Wang H, 2017, SCI REP-UK, V7, DOI 10.1038/srep43322; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wilson JM, 2018, J ALLER CL IMM-PRACT, V6, P1, DOI 10.1016/j.jaip.2017.10.003; Zhang HP, 2020, ALLERGY, V75, P1205, DOI 10.1111/all.14157	22	0	0	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100585	10.1016/j.jbc.2021.100585	http://dx.doi.org/10.1016/j.jbc.2021.100585			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33771560	Green Published, gold			2022-12-28	WOS:000672866400557
J	Lu, JQ; Hu, ZH; Deng, YJ; Wu, QZ; Wu, M; Song, H				Lu, Jinqiu; Hu, Zonghao; Deng, Yujie; Wu, Qingzhe; Wu, Ming; Song, Hai			MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; AMPK-MEDIATED REGULATION; TOLL-LIKE-RECEPTOR; N-TERMINAL KINASE; KAPPA-B; CONTACT INHIBITION; TISSUE-GROWTH; SIZE-CONTROL; YAP; PHOSPHORYLATION	The Hippo pathway is an evolutionarily conserved signaling pathway that controls organ size in animals via the regulation of cell proliferation and apoptosis. It consists of a kinase cascade, in which MST1/2 and MAP4Ks phosphorylate and activate LATS1/2, which in turn phosphorylate and inhibit YAP/TAZ activity. A variety of signals can modulate LATS1/2 kinase activity to regulate Hippo pathway. However, the full mechanistic details of kinase-mediated regulation of Hippo pathway signaling remain elusive. Here, we report that TNF activates LATS1/2 and inhibits YAP/TAZ activity through MEKK2/3. Furthermore, MEKK2/3 act in parallel to MST1/2 and MAP4Ks to regulate LATS1/2 and YAP/TAZ in response to various signals, such as serum and actin dynamics. Mechanistically, we show that MEKK2/3 interact with LATS1/2 and YAP/TAZ and phosphorylate them. In addition, Striatin-interacting phosphatase and kinase (STRIPAK) complex associates with MEKK3 via CCM2 and CCM3 to inactivate MEKK3 kinase activity. Upstream signals of Hippo pathway trigger the dissociation of MEKK3 from STRIPAK complex to release MEKK3 activity. Our work has uncovered a previous unrecognized regulation of Hippo pathway via MEKK2/3 and provides new insights into molecular mechanisms for the interplay between Hippo-YAP and NF-kappa B signaling and the pathogenesis of cerebral cavernous malformations.	[Lu, Jinqiu; Hu, Zonghao; Deng, Yujie; Wu, Qingzhe; Song, Hai] Zhejiang Univ, MOE Key Lab Biosyst Homeostasis & Protect, Zhejiang Prov Key Lab Canc Mol Cell Biol, Affiliated Hosp 2,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Lu, Jinqiu; Hu, Zonghao; Deng, Yujie; Wu, Qingzhe; Song, Hai] Zhejiang Univ, Sch Med, Innovat Ctr Cell Signaling Network, Life Sci Inst,Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Wu, Ming; Song, Hai] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Song, H (corresponding author), Zhejiang Univ, MOE Key Lab Biosyst Homeostasis & Protect, Zhejiang Prov Key Lab Canc Mol Cell Biol, Affiliated Hosp 2,Sch Med, Hangzhou, Zhejiang, Peoples R China.; Song, H (corresponding author), Zhejiang Univ, Sch Med, Innovat Ctr Cell Signaling Network, Life Sci Inst,Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China.; Song, H (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China.	haisong@zju.edu.cn	Lu, Jinqiu/HIR-7408-2022	DNEG, Yujie/0000-0002-8842-4267	National Key Research and Development Program of China [2019YFA0802003]; National Natural Science Foundation of China [31970727, 81700002]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program of China (No. 2019YFA0802003 to H. S.) and the National Natural Science Foundation of China (No. 31970727 to H. S., No. 81700002 to Y. D.).	Bae SJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30278.001, 10.7554/eLife.30278]; Bae SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7314; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen R, 2019, NAT CELL BIOL, V21, P1565, DOI 10.1038/s41556-019-0426-y; Chen TH, 2017, FASEB J, V31, P2963, DOI 10.1096/fj.201601090R; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Deng YJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07022-2; Deran M, 2014, CELL REP, V9, P495, DOI 10.1016/j.celrep.2014.09.036; Dey A, 2020, NAT REV DRUG DISCOV, V19, P480, DOI 10.1038/s41573-020-0070-z; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gill MK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05939-2; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hong AW, 2017, EMBO REP, V18, P72, DOI 10.15252/embr.201642681; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; LaCanna R, 2019, J CLIN INVEST, V129, P2107, DOI 10.1172/JCI125014; Lee IY, 2019, MOL CELL, V73, P1138, DOI 10.1016/j.molcel.2019.01.022; Li W, 2014, CANCER CELL, V26, P48, DOI 10.1016/j.ccr.2014.05.001; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Lu JQ, 2018, ONCOGENE, V37, P3864, DOI 10.1038/s41388-018-0249-5; Lv Y, 2018, CIRC RES, V123, P43, DOI 10.1161/CIRCRESAHA.118.313143; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Plummer Nicholas W, 2005, Curr Neurol Neurosci Rep, V5, P391, DOI 10.1007/s11910-005-0063-7; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Si Y, 2017, CANCER RES, V77, P4868, DOI 10.1158/0008-5472.CAN-17-0391; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00323; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan WC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07394-5; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2017, CELL REP, V21, P3612, DOI 10.1016/j.celrep.2017.11.076; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014; Zhong J, 2004, MOL CELL BIOL, V24, P9165, DOI 10.1128/MCB.24.20.9165-9175.2004; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178	55	4	4	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100400	10.1016/j.jbc.2021.100400	http://dx.doi.org/10.1016/j.jbc.2021.100400			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571521	Green Published, gold			2022-12-28	WOS:000672866400374
J	Massari, M; Nicoll, CR; Mattevi, A				Massari, Marta; Nicoll, Callum R.; Mattevi, Andrea			A lonely electron blocks incoming pairs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							TRANSFERRING FLAVOPROTEIN	Electron bifurcation exploits high energetic states to drive unfavorable single electron reactions and determining the overall mechanism governing these electron transfers represents an arduous task. Using extensive stopped-flow spectroscopy and kinetic simulations, Sucharitakul et al. now explore the bifurcation mechanism of the electron transfer flavoprotein EtfAB from the anaerobic gut bacterium Acidaminococcus fermentans. Strikingly, they illustrated that catalysis is orchestrated by a negatively charged radical, alpha-FAD, that inhibits further reductions and features an atypical inverted kinetic isotope effect. These results provide additional insight behind electron transfers that are prevalent within multienzyme governed reactions.	[Massari, Marta; Nicoll, Callum R.; Mattevi, Andrea] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Pavia, Italy	University of Pavia	Mattevi, A (corresponding author), Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Pavia, Italy.	andrea.mattevi@unipv.it	; Mattevi, Andrea/K-5464-2012	Massari, Marta/0000-0002-7731-7626; Nicoll, Callum/0000-0002-2122-9387; Mattevi, Andrea/0000-0002-9523-7128				Buckel W, 2018, CHEM REV, V118, P3862, DOI 10.1021/acs.chemrev.7b00707; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Demmer JK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01746-3; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; Peters JW, 2016, CURR OPIN CHEM BIOL, V31, P146, DOI 10.1016/j.cbpa.2016.03.007; Sucharitakul J., 2021, J BIOL CHEM, V296	8	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100294	10.1016/j.jbc.2021.100294	http://dx.doi.org/10.1016/j.jbc.2021.100294			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33755021	gold, Green Published			2022-12-28	WOS:000672866400268
J	Noor, SI; Hoffmann, M; Rinis, N; Bartels, MF; Winterhalter, PR; Hoelscher, C; Hennig, R; Himmelreich, N; Thiel, C; Ruppert, T; Rapp, E; Strahl, S				Noor, Sina Ibne; Hoffmann, Marcus; Rinis, Natalie; Bartels, Markus F.; Winterhalter, Patrick R.; Hoelscher, Christina; Hennig, Rene; Himmelreich, Nastassja; Thiel, Christian; Ruppert, Thomas; Rapp, Erdmann; Strahl, Sabine			Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN O-MANNOSYLATION; GLYCOSYLATION PATHWAY; BASEMENT-MEMBRANE; DYSTROGLYCAN; EXPRESSION; MIGRATION; LAMININ; MUSCLE; CONTRIBUTES	Defects in protein O-mannosylation lead to severe congenital muscular dystrophies collectively known as alpha-dystroglycanopathy. A hallmark of these diseases is the loss of the O-mannose-bound matriglycan on alpha-dystroglycan, which reduces cell adhesion to the extracellular matrix. Mutations in protein O-mannose beta 1,2-N-acetylglucosaminyltransferase 1 (POMGNT1), which is crucial for the elongation of O-mannosyl glycans, have mainly been associated with muscle-eye-brain (MEB) disease. In addition to defects in cell-extracellular matrix adhesion, aberrant cell-cell adhesion has occasionally been observed in response to defects in POMGNT1. However, specific molecular consequences of POMGNT1 deficiency on cell-cell adhesion are largely unknown. We used POMGNT1 knockout HEK293T cells and fibroblasts from an MEB patient to gain deeper insight into the molecular changes in POMGNT1 deficiency. Biochemical and molecular biological techniques combined with proteomics, glycoproteomics, and glycomics revealed that a lack of POMGNT1 activity strengthens cell-cell adhesion. We demonstrate that the altered intrinsic adhesion properties are due to an increased abundance of N-cadherin (N-Cdh). In addition, site-specific changes in the N-glycan structures in the extracellular domain of N-Cdh were detected, which positively impact on homotypic interactions. Moreover, in POMGNT1-deficient cells, ERK1/2 and p38 signaling pathways are activated and transcriptional changes that are comparable with the epithelial-mesenchymal transition (EMT) are triggered, defining a possible molecular mechanism underlying the observed phenotype. Our study indicates that changes in cadherin-mediated cell-cell adhesion and other EMT-related processes may contribute to the complex clinical symptoms of MEB or alpha-dystroglycanopathy in general and suggests that the impact of changes in O-mannosylation on N-glycosylation has been underestimated.	[Noor, Sina Ibne; Rinis, Natalie; Bartels, Markus F.; Winterhalter, Patrick R.; Hoelscher, Christina; Strahl, Sabine] Heidelberg Univ, Ctr Organismal Studies COS, Glycobiol, Heidelberg, Germany; [Hoffmann, Marcus; Hennig, Rene; Rapp, Erdmann] Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn, Magdeburg, Germany; [Hennig, Rene; Rapp, Erdmann] GlyXera GmbH, Magdeburg, Germany; [Himmelreich, Nastassja; Thiel, Christian] Heidelberg Univ, Ctr Child & Adolescent Med, Dept Pediat 1, Heidelberg, Germany; [Ruppert, Thomas] Ctr Mol Biol Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Heidelberg, Germany; [Winterhalter, Patrick R.] Martin Luther Univ Halle Wittenberg, Clin Heart Surg, Halle, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Martin Luther University Halle Wittenberg	Strahl, S (corresponding author), Heidelberg Univ, Ctr Organismal Studies COS, Glycobiol, Heidelberg, Germany.	sabine.strahl@cos.uni-heidelberg.de		Himmelreich, Nastassja/0000-0002-1895-625X; Thiel, Christian/0000-0001-6419-8747	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [STR 443/6-1, RA2992/1-1, RU 747/1-1, TH1461/7-1]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Project-ID STR 443/6-1 (to S. S.), RA2992/1-1 (to E. R.), RU 747/1-1 (to T. R.), TH1461/7-1 (to C. T.)-Forschungsgruppe FOR 2509. P. R. W. is currently founded by the GRK 2155 ProMoAge.	Abbott KL, 2006, EXP CELL RES, V312, P2837, DOI 10.1016/j.yexcr.2006.05.022; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Aikawa R, 2002, HYPERTENSION, V39, P233, DOI 10.1161/hy0202.102699; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Bozzi M, 2015, MATRIX BIOL, V44-46, P130, DOI 10.1016/j.matbio.2015.02.005; Carvalho S, 2016, ONCOTARGET, V7, P65231, DOI 10.18632/oncotarget.11245; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Corfield AP, 2015, TRENDS BIOCHEM SCI, V40, P351, DOI 10.1016/j.tibs.2015.04.004; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Day BW, 2019, ACTA NEUROPATHOL, V138, P1033, DOI 10.1007/s00401-019-02069-x; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Emond MR, 2014, JOVE-J VIS EXP, DOI 10.3791/51762; Endo T, 2019, P JPN ACAD B-PHYS, V95, P39, DOI 10.2183/pjab.95.004; Endo T, 2015, J BIOCHEM, V157, P1, DOI 10.1093/jb/mvu066; Ferletta M, 2003, MOL BIOL CELL, V14, P2088, DOI 10.1091/mbc.E03-01-0852; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Graham JB, 2020, MOL BIOL CELL, V31, P167, DOI 10.1091/mbc.E19-07-0408; Gui Ting, 2012, J Signal Transduct, V2012, P289243, DOI 10.1155/2012/289243; Guo HB, 2009, J BIOL CHEM, V284, P34986, DOI 10.1074/jbc.M109.060806; Haensel D, 2018, DEV DYNAM, V247, P473, DOI 10.1002/dvdy.24561; Hennig R, 2016, BBA-GEN SUBJECTS, V1860, P1728, DOI 10.1016/j.bbagen.2016.03.035; Hoffmann M, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800282; Hu HY, 2007, J COMP NEUROL, V501, P168, DOI 10.1002/cne.21238; Huang Q, 2015, CANCER BIOL THER, V16, P125, DOI 10.4161/15384047.2014.987078; Ivaska Johanna, 2011, Small GTPases, V2, P51; Khoder-Agha F, 2019, J BIOL CHEM, V294, P14383, DOI 10.1074/jbc.RA119.009539; Konze SA, 2017, CHEMBIOCHEM, V18, P1317, DOI 10.1002/cbic.201700100; Kuwabara N, 2016, P NATL ACAD SCI USA, V113, P9280, DOI 10.1073/pnas.1525545113; Kwon Munjin, 2013, Methods Mol Biol, V1018, P107, DOI 10.1007/978-1-62703-444-9_10; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lan J, 2015, NEURO-ONCOLOGY, V17, P211, DOI 10.1093/neuonc/nou151; Langer MD, 2012, J CELL SCI, V125, P2478, DOI 10.1242/jcs.101147; Larsen ISB, 2017, P NATL ACAD SCI USA, V114, P11163, DOI 10.1073/pnas.1708319114; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; LeBert DC, 2015, DEVELOPMENT, V142, P2136, DOI 10.1242/dev.121160; Li X, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00033; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Liu Q, 2017, ONCOL REP, V38, P2911, DOI 10.3892/or.2017.5964; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Nakaya Y, 2011, CELLS TISSUES ORGANS, V193, P64, DOI 10.1159/000320165; Narimatsu Y, 2019, MOL CELL PROTEOMICS, V18, P1396, DOI 10.1074/mcp.RA118.001121; Neubert P, 2016, CURR OPIN CELL BIOL, V41, P100, DOI 10.1016/j.ceb.2016.04.010; Olea-Flores M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122885; Pereira MS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02754; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Pioch M, 2018, ANAL CHEM, V90, P11908, DOI 10.1021/acs.analchem.8b02087; Qi F, 2020, FASEB J, V34, P881, DOI 10.1096/fj.201901793R; Ruhaak LR, 2010, J PROTEOME RES, V9, P6655, DOI 10.1021/pr100802f; Schaeffer D, 2014, MOL CELL BIOL, V34, P3486, DOI 10.1128/MCB.00694-14; Shay G, 2015, MATRIX BIOL, V44-46, P200, DOI 10.1016/j.matbio.2015.01.019; Smorodinsky-Atias K, 2016, MOL BIOL CELL, V27, P1026, DOI 10.1091/mbc.E15-07-0521; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Theodore M, 2011, CURR OPIN PEDIATR, V23, P581, DOI 10.1097/MOP.0b013e32834cd693; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thoeni C, 2019, CAN J GASTROENTEROL, V2019, DOI 10.1155/2019/1085717; VANHOOF J, 1986, DIFFERENTIATION, V32, P120, DOI 10.1111/j.1432-0436.1986.tb00563.x; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Winterhalter PR, 2013, FEBS LETT, V587, P3715, DOI 10.1016/j.febslet.2013.09.041; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	75	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100433	10.1016/j.jbc.2021.100433	http://dx.doi.org/10.1016/j.jbc.2021.100433			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610554	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400407
J	Stuehr, DJ; Misra, S; Dai, Y; Ghosh, A				Stuehr, Dennis J.; Misra, Saurav; Dai, Yue; Ghosh, Arnab			Maturation, inactivation, and recovery mechanisms of soluble guanylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEAT-SHOCK-PROTEIN; ASSISTED S-NITROSATION; NITRIC-OXIDE RECEPTOR; H-NOX; ENDOTHELIAL DYSFUNCTION; INDUCED ACTIVATION; OXIDATIVE STRESS; THIOL OXIDATION; DOWN-REGULATION; HEME INSERTION	Soluble guanylate cyclase (sGC) is a heme-containing heterodimeric enzyme that generates many molecules of cGMP in response to its ligand nitric oxide (NO); sGC thereby acts as an amplifier in NO-driven biological signaling cascades. Because sGC helps regulate the cardiovascular, neuronal, and gastrointestinal systems through its cGMP production, boosting sGC activity and preventing or reversing sGC inactivation are important therapeutic and pharmacologic goals. Work over the last two decades is uncovering the processes by which sGC matures to become functional, how sGC is inactivated, and how sGC is rescued from damage. A diverse group of small molecules and proteins have been implicated in these processes, including NO itself, reactive oxygen species, cellular heme, cell chaperone Hsp90, and various redox enzymes as well as pharmacologic sGC agonists. This review highlights their participation and provides an update on the processes that enable sGC maturation, drive its inactivation, or assist in its recovery in various settings within the cell, in hopes of reaching a better understanding of how sGC function is regulated in health and disease.	[Stuehr, Dennis J.; Dai, Yue; Ghosh, Arnab] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44106 USA; [Misra, Saurav] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Cleveland Clinic Foundation; Kansas State University	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44106 USA.	stuehrd@ccf.org			National Institutes of Health [RO1GM130624, P01HL081064, P01HL103453, R56HL139564, R01HL150049]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants RO1GM130624 (D. J. S.), P01HL081064 (D. J. S. and A. G.), P01HL103453 (D. J. S.), R56HL139564 (A. G.), and R01HL150049 (A. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alapa M, 2021, FREE RADICAL BIO MED, V162, P450, DOI 10.1016/j.freeradbiomed.2020.11.001; Alexandre EC, 2014, J PHARMACOL EXP THER, V349, P2, DOI 10.1124/jpet.113.211029; Allerston CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057644; Bacon B, 2017, ADV MICROB PHYSIOL, V70, P1, DOI 10.1016/bs.ampbs.2017.01.004; BAEK KJ, 1993, J BIOL CHEM, V268, P21120; Ben Aissa M, 2016, CURR MED CHEM, V23, P2770, DOI 10.2174/0929867323666160812145454; Beuve A, 2017, ANTIOXID REDOX SIGN, V26, P137, DOI 10.1089/ars.2015.6591; Beuve A, 2016, J PROTEOMICS, V138, P40, DOI 10.1016/j.jprot.2016.02.009; BISSELL DM, 1977, BIOCHEM J, V166, P301, DOI 10.1042/bj1660301; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Buys E, 2014, CURR OPIN NEPHROL HY, V23, P135, DOI 10.1097/01.mnh.0000441048.91041.3a; Cabilla JP, 2009, AM J PHYSIOL-ENDOC M, V296, pE731, DOI 10.1152/ajpendo.90795.2008; Chakravarti R, 2015, FREE RADICAL BIO MED, V82, P105, DOI 10.1016/j.freeradbiomed.2015.01.030; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Cheng D, 2019, ARTERIOSCL THROM VAS, V39, P1448, DOI 10.1161/ATVBAHA.119.312725; Childers KC, 2019, J BIOL CHEM, V294, P18451, DOI 10.1074/jbc.RA119.011010; Choi H, 2011, J CARDIOVASC PHARM, V58, P522, DOI 10.1097/FJC.0b013e31822d80a5; Crassous PA, 2012, AM J PHYSIOL-HEART C, V303, pH597, DOI 10.1152/ajpheart.00138.2012; CRAVEN PA, 1983, BIOCHIM BIOPHYS ACTA, V745, P310, DOI 10.1016/0167-4838(83)90063-8; CRAVEN PA, 1978, J BIOL CHEM, V253, P8433; Dai Y, 2020, J BIOL CHEM, V295, P8145, DOI 10.1074/jbc.RA120.013802; Dai Y, 2019, J BIOL CHEM, V294, P12880, DOI 10.1074/jbc.RA119.009016; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; DeZwaan DC, 2008, CELL CYCLE, V7, P1006, DOI 10.4161/cc.7.8.5723; Ding JD, 2006, J COMP NEUROL, V495, P668, DOI 10.1002/cne.20901; EDWARDS JC, 1981, BIOCHEM PHARMACOL, V30, P2531, DOI 10.1016/0006-2952(81)90579-7; Fernhoff NB, 2012, J BIOL CHEM, V287, P43053, DOI 10.1074/jbc.M112.393892; Fernhoff NB, 2009, P NATL ACAD SCI USA, V106, P21602, DOI 10.1073/pnas.0911083106; Foerster J, 1996, EUR J BIOCHEM, V240, P380, DOI 10.1111/j.1432-1033.1996.0380h.x; Follmann M, 2013, ANGEW CHEM INT EDIT, V52, P9442, DOI 10.1002/anie.201302588; Friebe A, 1997, BIOCHEMISTRY-US, V36, P1194, DOI 10.1021/bi962047w; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Friebe A, 2022, BRIT J PHARMACOL, V179, P2328, DOI 10.1111/bph.15345; Friebe A, 2020, N-S ARCH PHARMACOL, V393, P287, DOI 10.1007/s00210-019-01779-z; Fritz BG, 2011, BIOCHEMISTRY-US, V50, P5813, DOI 10.1021/bi200794c; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Garthwaite J, 2010, MOL CELL BIOCHEM, V334, P221, DOI 10.1007/s11010-009-0318-8; Ghosh A, 2021, REDOX BIOL, V39, DOI 10.1016/j.redox.2020.101832; Ghosh A, 2019, FASEB J, V33, P9885, DOI 10.1096/fj.201802793RR; Ghosh A, 2018, P NATL ACAD SCI USA, V115, pE1117, DOI 10.1073/pnas.1717993115; Ghosh A, 2017, ANTIOXID REDOX SIGN, V26, P182, DOI 10.1089/ars.2016.6690; Ghosh A, 2016, P NATL ACAD SCI USA, V113, pE2355, DOI 10.1073/pnas.1524398113; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Groneberg D, 2010, CIRCULATION, V121, P401, DOI 10.1161/CIRCULATIONAHA.109.890962; Guo YR, 2019, CHEMBIOCHEM, V20, P7, DOI 10.1002/cbic.201800478; Haase N, 2010, J NEUROCHEM, V112, P542, DOI 10.1111/j.1471-4159.2009.06484.x; Heckler EJ, 2013, BIOCHEM J, V452, P161, DOI 10.1042/BJ20130298; Heid SE, 2000, MOL PHARMACOL, V57, P82; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Horst BG, 2019, ELIFE, V8, DOI 10.7554/eLife.50634; Huang C, 2017, J BIOL CHEM, V292, P14362, DOI 10.1074/jbc.M117.787390; Itoh H, 1998, ENDOCRINOLOGY, V139, P3329, DOI 10.1210/en.139.7.3329; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; Kang YL, 2019, NATURE, V574, P206, DOI 10.1038/s41586-019-1584-6; Karow DS, 2005, BIOCHEMISTRY-US, V44, P16266, DOI 10.1021/bi051601b; Kloss S, 2000, HYPERTENSION, V35, P43; Kollau A, 2018, MOL PHARMACOL, V93, P73, DOI 10.1124/mol.117.109918; Korkmaz S, 2013, J CARDIOVASC PHARM T, V18, P70, DOI 10.1177/1074248412455696; Kraehling JR, 2017, CIRC RES, V120, P1174, DOI 10.1161/CIRCRESAHA.117.303776; Kumar V, 2013, BIOCHEMISTRY-US, V52, P3601, DOI 10.1021/bi301657w; Maron BA, 2009, J BIOL CHEM, V284, P7665, DOI 10.1074/jbc.M809460200; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; Martin E, 2014, AM J PHYSIOL-HEART C, V307, pH1565, DOI 10.1152/ajpheart.00222.2014; Mayer B, 2009, MOL PHARMACOL, V75, P886, DOI 10.1124/mol.108.052142; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Mingone CJ, 2008, AM J PHYSIOL-HEART C, V294, pH1244, DOI 10.1152/ajpheart.00846.2007; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Montfort WR, 2017, ANTIOXID REDOX SIGN, V26, P107, DOI 10.1089/ars.2016.6693; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Nedvetsky PI, 2008, FEBS LETT, V582, P327, DOI 10.1016/j.febslet.2007.12.025; Nelp MT, 2018, P NATL ACAD SCI USA, V115, P3249, DOI 10.1073/pnas.1719190115; Ott IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042623; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Papapetropoulos A, 2005, MOL PHARMACOL, V68, P1133, DOI 10.1124/mol.105.012682; PAPAPETROPOULOS A, 1995, HYPERTENSION, V26, P696, DOI 10.1161/01.HYP.26.4.696; Park M, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0212-8; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Pedraza CE, 2003, J NEUROIMMUNOL, V144, P80, DOI 10.1016/j.jneuroim.2003.08.034; Perdew GH, 1996, BIOCHEM MOL BIOL INT, V39, P589; Pifarre P, 2009, INT J BIOCHEM CELL B, V41, P1719, DOI 10.1016/j.biocel.2009.02.022; Priviero FBM, 2009, AM J HYPERTENS, V22, P493, DOI 10.1038/ajh.2009.18; Pyriochou A, 2005, CELL SIGNAL, V17, P407, DOI 10.1016/j.cellsig.2004.09.008; Rahaman MM, 2017, CIRC RES, V121, P137, DOI 10.1161/CIRCRESAHA.117.310705; Rekowski MV, 2013, J MED CHEM, V56, P8948, DOI 10.1021/jm400539d; Rogers NM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00134; Ronchetti SA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51420-5; Roy B, 2008, BRIT J PHARMACOL, V153, P1495, DOI 10.1038/sj.bjp.0707687; Russo I, 2008, ENDOCRINOLOGY, V149, P1480, DOI 10.1210/en.2007-0920; Russwurm M, 1998, BIOCHEM J, V335, P125, DOI 10.1042/bj3350125; Sandner P, 2021, HANDB EXP PHARMACOL, V264, P355, DOI 10.1007/164_2018_197; Sardon T, 2004, TOXICOL LETT, V149, P75, DOI 10.1016/j.toxlet.2003.12.021; Sarkar A, 2015, J BIOL CHEM, V290, P21615, DOI 10.1074/jbc.M115.645515; Sayed N, 2008, CIRC RES, V103, P606, DOI 10.1161/CIRCRESAHA.108.175133; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Schmidt P, 2003, PROTEIN EXPRES PURIF, V31, P42, DOI 10.1016/S1046-5928(03)00142-6; Seeger F, 2014, BIOCHEMISTRY-US, V53, P2153, DOI 10.1021/bi500129k; Shah RC, 2018, NITRIC OXIDE-BIOL CH, V76, P97, DOI 10.1016/j.niox.2018.03.013; Sharina IG, 2008, J BIOL CHEM, V283, P15104, DOI 10.1074/jbc.M710269200; Sharina IG, 2011, NITRIC OXIDE-BIOL CH, V25, P265, DOI 10.1016/j.niox.2011.08.001; Shi FX, 2004, BIOL REPROD, V70, P1552, DOI 10.1095/biolreprod.103.025510; SHIMOUCHI A, 1993, AM J PHYSIOL, V265, pL456, DOI 10.1152/ajplung.1993.265.5.L456; Smith BC, 2012, CURR OPIN CHEM BIOL, V16, P498, DOI 10.1016/j.cbpa.2012.10.016; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2015, CURR OPIN PHARMACOL, V21, P95, DOI 10.1016/j.coph.2014.12.014; Stasch JP, 2013, HANDB EXP PHARMACOL, V218, P279, DOI 10.1007/978-3-642-38664-0_12; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Surmeli NB, 2012, CHEMBIOCHEM, V13, P977, DOI 10.1002/cbic.201100809; Sweeny EA, 2018, J BIOL CHEM, V293, P14557, DOI 10.1074/jbc.RA118.004169; Tawa M, 2014, J VASC RES, V51, P439, DOI 10.1159/000371491; Theilig F, 2001, J AM SOC NEPHROL, V12, P2209, DOI 10.1681/ASN.V12112209; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Tsai AL, 2012, ANTIOXID REDOX SIGN, V17, P1246, DOI 10.1089/ars.2012.4564; Tsai EJ, 2012, CIRC RES, V110, P295, DOI 10.1161/CIRCRESAHA.111.259242; Tsai EJ, 2009, PHARMACOL THERAPEUT, V122, P216, DOI 10.1016/j.pharmthera.2009.02.009; Tsuji N, 2014, FEBS OPEN BIO, V4, P796, DOI 10.1016/j.fob.2014.09.003; Vaughan CK, 2010, NAT STRUCT MOL BIOL, V17, P1400, DOI 10.1038/nsmb1210-1400; Venema RC, 2003, AM J PHYSIOL-HEART C, V285, pH669, DOI 10.1152/ajpheart.01025.2002; Dao VTV, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66639-w; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Weichsel A, 2005, P NATL ACAD SCI USA, V102, P594, DOI 10.1073/pnas.0406549102; Wolhuter K, 2018, MOL CELL, V69, P438, DOI 10.1016/j.molcel.2017.12.019; Wood KC, 2019, BLOOD ADV, V3, P4104, DOI 10.1182/bloodadvances.2019000621; Xu XJ, 2012, J CELL SCI, V125, P6117, DOI 10.1242/jcs.113381; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Zabel U, 1999, J BIOL CHEM, V274, P18149, DOI 10.1074/jbc.274.26.18149; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296	132	15	15	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100336	10.1016/j.jbc.2021.100336	http://dx.doi.org/10.1016/j.jbc.2021.100336			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33508317	Green Published, gold			2022-12-28	WOS:000672866400310
J	Thompson, AP; Bitsina, C; Gray, JL; von Delft, F; Brennan, PE				Thompson, Andrew P.; Bitsina, Christina; Gray, Janine L.; von Delft, Frank; Brennan, Paul E.			RHO to the DOCK for GDP disembarking: Structural insights into the DOCK GTPase nucleotide exchange factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMYLOID PRECURSOR PROTEIN; CELL-MIGRATION; EPILEPTIC ENCEPHALOPATHY; SIGNAL-TRANSDUCTION; AXONAL OUTGROWTH; FAMILY PROTEINS; RAS SUPERFAMILY; GAMMA-SECRETASE; CDC42; ACTIVATION	The human dedicator of cytokinesis (DOCK) family consists of 11 structurally conserved proteins that serve as atypical RHO guanine nucleotide exchange factors (RHO GEFs). These regulatory proteins act as mediators in numerous cellular cascades that promote cytoskeletal remodeling, playing roles in various crucial processes such as differentiation, migration, polarization, and axon growth in neurons. At the molecular level, DOCK DHR2 domains facilitate nucleotide dissociation from small GTPases, a process that is otherwise too slow for rapid spatiotemporal control of cellular signaling. Here, we provide an overview of the biological and structural characteristics for the various DOCK proteins and describe how they differ from other RHO GEFs and between DOCK subfamilies. The expression of the family varies depending on cell or tissue type, and they are consequently implicated in a broad range of disease phenotypes, particularly in the brain. A growing body of available structural information reveals the mechanism by which the catalytic DHR2 domain elicits nucleotide dissociation and also indicates strategies for the discovery and design of high-affinity small-molecule inhibitors. Such compounds could serve as chemical probes to interrogate the cellular function and provide starting points for drug discovery of this important class of enzymes.	[Thompson, Andrew P.; Bitsina, Christina; Gray, Janine L.; von Delft, Frank; Brennan, Paul E.] Univ Oxford, Nuffield Dept Med, Alzheimers Res UK Oxford Drug Discovery Inst, Oxford, England; [Thompson, Andrew P.; Bitsina, Christina; Gray, Janine L.; Brennan, Paul E.] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford, England; [Thompson, Andrew P.; Bitsina, Christina; Gray, Janine L.; von Delft, Frank; Brennan, Paul E.] Univ Oxford, Nuffield Dept Med, Ctr Med Discovery, Oxford, England; [von Delft, Frank] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot, Oxon, England; [von Delft, Frank] Univ Johannesburg, Dept Biochem, Auckland Pk, South Africa	University of Oxford; University of Oxford; University of Oxford; Diamond Light Source; University of Johannesburg	Brennan, PE (corresponding author), Univ Oxford, Nuffield Dept Med, Alzheimers Res UK Oxford Drug Discovery Inst, Oxford, England.; Brennan, PE (corresponding author), Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford, England.; Brennan, PE (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Med Discovery, Oxford, England.	paul.brennan@cmd.ox.ac.uk		Thompson, Andrew/0000-0002-3910-2317				Alzahem T, 2020, OPHTHALMIC GENET, V41, P377, DOI 10.1080/13816810.2020.1776339; Ayana R, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00266; Bai B, 2019, CHINESE MED J-PEKING, V132, P600, DOI 10.1097/CM9.0000000000000100; Biggs CM, 2017, CLIN IMMUNOL, V181, P75, DOI 10.1016/j.clim.2017.06.003; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Boo JH, 2008, BIOCHEM BIOPH RES CO, V372, P913, DOI 10.1016/j.bbrc.2008.05.153; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chang LF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17271-9; Chen Q, 2002, J CELL BIOL, V158, P79, DOI 10.1083/jcb.200110151; Chen YY, 2018, EUR J IMMUNOL, V48, P915, DOI 10.1002/eji.201747157; Chen YN, 2021, J LEUKOCYTE BIOL, V109, P383, DOI 10.1002/JLB.1MR0520-221RR; Chi HC, 2020, ONCOGENE, V39, P5933, DOI 10.1038/s41388-020-01390-0; Chiang SK, 2019, CANCERS, V11, DOI 10.3390/cancers11111762; Cimino PJ, 2013, EXP MOL PATHOL, V94, P366, DOI 10.1016/j.yexmp.2013.01.002; Cimino PJ, 2009, AM J PATHOL, V175, P1622, DOI 10.2353/ajpath.2009.090443; Clayton NS, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00222; Collins PM, 2018, METHOD ENZYMOL, V610, P251, DOI 10.1016/bs.mie.2018.09.027; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Cunningham RL, 2018, NEURAL DEV, V13, DOI 10.1186/s13064-018-0114-9; Dai WC, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02827-w; Davies B, 2017, HUM MOL GENET, V26, P3869, DOI 10.1093/hmg/ddx270; DeGeer J, 2013, EXP CELL RES, V319, P2384, DOI 10.1016/j.yexcr.2013.06.016; Dobbs K, 2015, NEW ENGL J MED, V372, P2409, DOI 10.1056/NEJMoa1413462; Dudoignon B, 2020, AM J MED GENET A, V182, P29, DOI 10.1002/ajmg.a.61364; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Ferrandez Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13619-2; Gadea G, 2014, EUR J CELL BIOL, V93, P466, DOI 10.1016/j.ejcb.2014.06.003; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gray JL, 2020, ANGEW CHEM INT EDIT, V59, P6342, DOI 10.1002/anie.201900585; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Guo DJ, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040835; Haga Raquel B, 2016, Small GTPases, V7, P207; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanawa-Suetsugu K, 2012, P NATL ACAD SCI USA, V109, P3305, DOI 10.1073/pnas.1113512109; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Hemonnot AL, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00233; Hillig RC, 2019, P NATL ACAD SCI USA, V116, P2551, DOI 10.1073/pnas.1812963116; Hofmann MH, 2021, CANCER DISCOV, V11, P142, DOI 10.1158/2159-8290.CD-20-0142; Hoon JL, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020017; Huang LZ, 2019, NATURE, V569, P565, DOI 10.1038/s41586-019-1140-4; Huang MQ, 2020, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00577; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Kang MG, 2012, J BIOL CHEM, V287, P28632, DOI 10.1074/jbc.M111.336644; Kashiwa A, 2000, J NEUROCHEM, V75, P109, DOI 10.1046/j.1471-4159.2000.0750109.x; Kearney CJ, 2017, J IMMUNOL, V199, P2118, DOI 10.4049/jimmunol.1700751; Kearney CJ, 2017, CELL MOL IMMUNOL, V14, P406, DOI 10.1038/cmi.2017.9; Kelleher RJ, 2017, P NATL ACAD SCI USA, V114, P629, DOI 10.1073/pnas.1619574114; Kikuchi T, 2008, BIOCHEM BIOPH RES CO, V367, P90, DOI 10.1016/j.bbrc.2007.12.093; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; Konietzny A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00147; Krojer T., 2019, HUMAN KALIRIN RAC1 G; Kukimoto-Niino M, 2019, STRUCTURE, V27, P741, DOI 10.1016/j.str.2019.02.001; Kulkarni K, 2011, J BIOL CHEM, V286, P25341, DOI 10.1074/jbc.M111.236455; Kunimura K, 2020, INT IMMUNOL, V32, P5, DOI 10.1093/intimm/dxz067; Lai YR, 2020, EMBO REP, V21, DOI 10.15252/embr.201949473; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Lefort R, 2015, NEUROTHERAPEUTICS, V12, P19, DOI 10.1007/s13311-014-0328-4; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Liang S, 2014, J ZHEJIANG UNIV-SC B, V15, P264, DOI 10.1631/jzus.B1300133; Liang YY, 2018, ONCOL LETT, V16, P3481, DOI 10.3892/ol.2018.9077; Liu XR, 2013, PROTEINS, V81, P906, DOI 10.1002/prot.24236; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34; Maldonado MD, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00201; McNally L, 2020, P NATL ACAD SCI USA, V117, P15852, DOI 10.1073/pnas.1920776117; Miyamoto Y, 2007, EXP CELL RES, V313, P791, DOI 10.1016/j.yexcr.2006.11.017; Miyamoto Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003661; Moura MM, 2015, ENDOCR-RELAT CANCER, V22, pR235, DOI 10.1530/ERC-15-0070; Murray DW, 2014, BRIT J CANCER, V110, P1307, DOI 10.1038/bjc.2014.39; Nakamuta S, 2017, J CELL BIOL, V216, P4313, DOI 10.1083/jcb.201704157; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Namekata K, 2020, J BIOL CHEM, V295, P6710, DOI 10.1074/jbc.RA119.010438; Namekata K, 2019, J BIOL CHEM, V294, P13421, DOI 10.1074/jbc.RA119.007645; Namekata K, 2014, PROG RETIN EYE RES, V43, P1, DOI 10.1016/j.preteyeres.2014.06.005; Namekata K, 2012, GENES CELLS, V17, P688, DOI 10.1111/j.1365-2443.2012.01616.x; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Nayak RC, 2013, IMMUNOL REV, V256, P255, DOI 10.1111/imr.12119; Nishikimi A, 2005, FEBS LETT, V579, P1039, DOI 10.1016/j.febslet.2005.01.006; Nishikimi A, 2013, EXP CELL RES, V319, P2343, DOI 10.1016/j.yexcr.2013.07.024; Ostrem JML, 2016, NAT REV DRUG DISCOV, V15, P771, DOI 10.1038/nrd.2016.139; Oxford G, 2003, J UROLOGY, V170, P1987, DOI 10.1097/01.ju.0000088670.02905.78; Pakes Nicholl K, 2013, Small GTPases, V4, P22, DOI 10.4161/sgtp.22087; Pankratz N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020988; Parrado A, 2020, ANTIBODIES, V9, DOI 10.3390/antib9030027; Perrault I, 2014, AM J HUM GENET, V94, P891, DOI 10.1016/j.ajhg.2014.04.012; Pinheiro EM, 2006, NEURON, V51, P674, DOI 10.1016/j.neuron.2006.08.020; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; RIDLEY AJ, 1994, BIOESSAYS, V16, P321, DOI 10.1002/bies.950160506; Rudolph MG, 1999, PROTEIN SCI, V8, P778; Ruiz-Lafuente N, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01391; Ruiz-Lafuente N, 2018, BIOCHEM BIOPHYS REP, V14, P178, DOI 10.1016/j.bbrep.2018.05.004; Ruiz-Lafuente N, 2015, BIOL OPEN, V4, P627, DOI 10.1242/bio.20149050; Sakabe I, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-2; Sakamoto Akihiko, 2020, Immunohorizons, V4, P520, DOI 10.4049/immunohorizons.2000048; Sakamoto A, 2017, INT IMMUNOL, V29, P431, DOI 10.1093/intimm/dxx054; Schneider C, 2020, NAT IMMUNOL, V21, P1528, DOI 10.1038/s41590-020-0795-1; Shi Lei, 2013, Commun Integr Biol, V6, pe26839, DOI 10.4161/cib.26839; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Sukalo M, 2015, HUM MUTAT, V36, P593, DOI 10.1002/humu.22795; Tachi N, 2012, BIOCHEM J, V442, P413, DOI 10.1042/BJ20100993; Tam JHK, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0054-1; Tate B., 2012, INT J ALZHEIMERS DIS, V2012; Thomas SE, 2019, PHILOS T R SOC A, V377, DOI 10.1098/rsta.2018.0422; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tomino T, 2018, BIOCHEM BIOPH RES CO, V497, P298, DOI 10.1016/j.bbrc.2018.02.073; Turkdogan D, 2019, SEIZURE-EUR J EPILEP, V66, P12, DOI 10.1016/j.seizure.2019.01.010; Ueda S, 2008, J NEUROSCI RES, V86, P3052, DOI 10.1002/jnr.21763; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Umehara H, 2021, J HUM GENET, V66, P243, DOI 10.1038/s10038-020-00840-7; Ushijima M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00243; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; Wang CS, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.4_suppl.68; Wang ZK, 2019, GENE, V700, P65, DOI 10.1016/j.gene.2019.03.023; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Westbrook JA, 2019, J PATHOL, V247, P381, DOI 10.1002/path.5197; Wiltrout K, 2019, EUR J HUM GENET, V27, P1225, DOI 10.1038/s41431-019-0397-2; Wolfe MS, 2012, ADV PHARMACOL, V64, P127, DOI 10.1016/B978-0-12-394816-8.00004-0; Wu M, 2019, BLOOD, V134, DOI 10.1182/blood-2019-129157; Xiao YG, 2013, J BIOL CHEM, V288, P20034, DOI 10.1074/jbc.M113.458612; Xu XY, 2017, J EXP MED, V214, P209, DOI 10.1084/jem.20160068; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yamauchi J, 2011, J NEUROSCI, V31, P12579, DOI 10.1523/JNEUROSCI.2738-11.2011; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Yang YT, 2012, NAT NEUROSCI, V15, P1201, DOI 10.1038/nn.3171; Yelo E, 2008, MOL IMMUNOL, V45, P3411, DOI 10.1016/j.molimm.2008.04.003; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	138	7	7	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100521	10.1016/j.jbc.2021.100521	http://dx.doi.org/10.1016/j.jbc.2021.100521			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33684443	gold, Green Published			2022-12-28	WOS:000672866400495
J	Vistrup-Parry, M; Sneddon, WB; Bach, S; Stromgaard, K; Friedman, PA; Mamonova, T				Vistrup-Parry, Maria; Sneddon, W. Bruce; Bach, Sofie; Stromgaard, Kristian; Friedman, Peter A.; Mamonova, Tatyana			Multisite NHERF1 phosphorylation controls GRK6A regulation of hormone-sensitive phosphate transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I NHERF-1; PDZ DOMAINS; STRUCTURAL BASIS; PROTEIN; CFTR; BINDING; MECHANISM; REQUIRES; GROWTH; AUTOINHIBITION	The type II sodium-dependent phosphate cotransporter (NPT2A) mediates renal phosphate uptake. The NPT2A is regulated by parathyroid hormone (PTH) and fibroblast growth factor 23, which requires Na+/H+ exchange regulatory factor-1 (NHERF1), a multidomain PDZ-containing phosphoprotein. Phosphocycling controls the association between NHERF1 and the NPT2A. Here, we characterize the critical involvement of G protein-coupled receptor kinase 6A (GRK6A) in mediating PTH-sensitive phosphate transport by targeted phosphorylation coupled with NHERF1 conformational rearrangement, which in turn allows phosphorylation at a secondary site. GRK6A, through its carboxy-terminal PDZ recognition motif, binds NHERF1 PDZ1 with greater affinity than PDZ2. However, the association between NHERF1 PDZ2 and GRK6A is necessary for PTH action. Ser(162), a PKC alpha phosphorylation site in PDZ2, regulates the binding affinity between PDZ2 and GRK6A. Substitution of Ser(162) with alanine (S(162)A) blocks the PTH action but does not disrupt the interaction between NHERF1 and the NPT2A. Replacement of Ser(162) with aspartic acid ((SD)-D-162) abrogates the interaction between NHERF1 and the NPT2A and concurrently PTH action. We used amber codon suppression to generate a phosphorylated Ser(162)(pSer(162))-PDZ2 variant. K-D values determined by fluorescence anisotropy indicate that incorporation of pSer(162) increased the binding affinity to the carboxy terminus of GRK6A 2-fold compared with WT PDZ2. Molecular dynamics simulations predict formation of an electrostatic network between pSer(162) and Asp(183) of PDZ2 and Arg at position -1 of the GRK6A PDZ-binding motif. Our results suggest that PDZ2 plays a regulatory role in PTH-sensitive NPT2A-mediated phosphate transport and phosphorylation of Ser(162) in PDZ2 modulates the interaction with GRK6A.	[Vistrup-Parry, Maria; Bach, Sofie; Stromgaard, Kristian] Univ Copenhagen, Ctr Biopharmaceut, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Sneddon, W. Bruce; Friedman, Peter A.; Mamonova, Tatyana] Univ Pittsburgh, Lab GPCR Biol, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15260 USA	University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mamonova, T (corresponding author), Univ Pittsburgh, Lab GPCR Biol, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15260 USA.	tbm7@pitt.edu		Bach, Sofie/0000-0002-3056-8532; Stromgaard, Kristian/0000-0003-2206-4737; Vistrup-Parry, Maria/0000-0003-2176-2541	National Institutes of Health [R01DK105811]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Dr Qiangmin Zhang for preparing NHERF1 constructs used here. Dr Dale F. Mierke kindly provided pET16-N1P1 encoding PDZ1 (1-140) and pET16-N1P2 encoding PDZ2 (133-300 aa) of NHERF1. This work was supported by National Institutes of Health grant R01DK105811. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alshafie W, 2014, AM J PHYSIOL-CELL PH, V307, pC107, DOI 10.1152/ajpcell.00296.2013; Amacher JF, 2014, STRUCTURE, V22, P82, DOI 10.1016/j.str.2013.09.019; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Awadia S, 2019, J CELL BIOL, V218, P2699, DOI 10.1083/jcb.201811114; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; BIBER J, 1990, METHOD ENZYMOL, V191, P494; Case D. A., 2016, AMBER 2016; Clairfeuille T, 2016, NAT STRUCT MOL BIOL, V23, P921, DOI 10.1038/nsmb.3290; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Ernst A, 2014, J MOL BIOL, V426, P3509, DOI 10.1016/j.jmb.2014.08.012; Gordon RJ, 2020, J CLIN ENDOCR METAB, V105, P2392, DOI 10.1210/clinem/dgaa217; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang SJ, 2019, ANN PEDIATR ENDOCRIN, V24, P64, DOI 10.6065/apem.2019.24.1.64; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Khundmiri SJ, 2005, J AM SOC NEPHROL, V16, P2598, DOI 10.1681/ASN.2004121049; Laursen L, 2020, P NATL ACAD SCI USA, V117, P24294, DOI 10.1073/pnas.2007201117; Laursen L, 2020, J BIOL CHEM, V295, P1992, DOI 10.1074/jbc.RA119.011050; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Mahon MJ, 2009, MOL ENDOCRINOL, V23, P1691, DOI 10.1210/me.2009-0164; Mamonova T, 2017, BIOCHEMISTRY-US, V56, P2584, DOI 10.1021/acs.biochem.7b00078; Mamonova T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129554; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Martin ER, 2020, J BIOL CHEM, V295, P4464, DOI 10.1074/jbc.RA119.012015; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Pedersen SW, 2017, ACS CHEM BIOL, V12, P2313, DOI 10.1021/acschembio.7b00361; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Rogerson DT, 2015, NAT CHEM BIOL, V11, P496, DOI [10.1038/NCHEMBIO.1823, 10.1038/nchembio.1823]; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Salyer S, 2011, AM J PHYSIOL-CELL PH, V300, pC425, DOI 10.1152/ajpcell.00357.2010; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Toto A, 2017, PROTEIN ENG DES SEL, V30, P1, DOI 10.1093/protein/gzw055; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Weinman EJ, 2011, J BIOL CHEM, V286, P37216, DOI 10.1074/jbc.M111.288357; Weinman EJ, 2011, AM J PHYSIOL-RENAL, V300, pF231, DOI 10.1152/ajprenal.00532.2010; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; Zhang QM, 2019, J BIOL CHEM, V294, P4546, DOI 10.1074/jbc.RA119.007421	52	2	2	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100473	10.1016/j.jbc.2021.100473	http://dx.doi.org/10.1016/j.jbc.2021.100473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639163	gold, Green Published			2022-12-28	WOS:000672866400447
J	Wang, X; Ma, QJ				Wang, Xin; Ma, Qingjun			Wzb of Vibrio vulnificus represents a new group of low-molecular-weight protein tyrosine phosphatases with a unique insertion in the W-loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PHOSPHOTYROSYL PHOSPHATASE; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; PHOSPHORYLATION; REFINEMENT; INSIGHTS; KINASES; MPTPA	Protein tyrosine phosphorylation regulates the production of capsular polysaccharide, an essential virulence factor of the deadly pathogen Vibrio vulnificus. The process requires the protein tyrosine kinase Wzc and its cognate phosphatase Wzb, both of which are largely uncharacterized. Herein, we report the structures of Wzb of V. vulnificus (VvWzb) in free and ligand-bound forms. VvWzb belongs to the low-molecular-weight protein tyrosine phosphatase (LMWPTP) family. Interestingly, it contains an extra four-residue insertion in the W-loop, distinct from all known LMWPTPs. The W-loop of VvWzb protrudes from the protein body in the free structure, but undergoes significant conformational changes to fold toward the active site upon ligand binding. Deleting the four-residue insertion from the W-loop severely impaired the enzymatic activity of VvWzb, indicating its importance for optimal catalysis. However, mutating individual residues or even substituting the whole insertion with four alanine residues only modestly decreased the enzymatic activity, suggesting that the contribution of the insertion to catalysis is not determined by the sequence specificity. Furthermore, inserting the four residues into Escherichia coli Wzb at the corresponding position enhanced its activity as well, indicating that the four-residue insertion in the W-loop can act as a general activity enhancing element for other LMWPTPs. The novel W-loop type and phylogenetic analysis suggested that VvWzb and its homologs should be classified into a new group of LMWPTPs. Our study sheds new insight into the catalytic mechanism and structural diversity of the LMWPTP family and promotes the understanding of the protein tyrosine phosphorylation system in prokaryotes.	[Wang, Xin; Ma, Qingjun] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wang, Xin; Ma, Qingjun] Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Wang, Xin; Ma, Qingjun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ma, Qingjun] Chinese Acad Sci, Ctr Ocean Megasci, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Ma, QJ (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.; Ma, QJ (corresponding author), Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Ma, QJ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Ma, QJ (corresponding author), Chinese Acad Sci, Ctr Ocean Megasci, Qingdao, Peoples R China.	qma@qdio.ac.cn			Qingdao Innovation Leadership Program [18-1-2-12-zhc]; "Aoshan Talents Program" of the Pilot National Laboratory for Marine Science and Technology [2015ASTP]	Qingdao Innovation Leadership Program; "Aoshan Talents Program" of the Pilot National Laboratory for Marine Science and Technology	This work was supported by "Qingdao Innovation Leadership Program" (No. 18-1-2-12-zhc) and "Aoshan Talents Program" of the Pilot National Laboratory for Marine Science and Technology (No. 2015ASTP) to Q. M.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Baker-Austin C, 2018, ENVIRON MICROBIOL, V20, P423, DOI 10.1111/1462-2920.13955; Bechet E, 2009, AMINO ACIDS, V37, P499, DOI 10.1007/s00726-009-0237-8; Caselli A, 2016, BBA-PROTEINS PROTEOM, V1864, P1339, DOI 10.1016/j.bbapap.2016.07.001; Chao JD, 2014, J BIOL CHEM, V289, P9463, DOI 10.1074/jbc.R113.520015; Chatterjee S, 2019, BBA-PROTEINS PROTEOM, V1867, P114, DOI 10.1016/j.bbapap.2018.11.003; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esser D, 2012, J PROTEOME RES, V11, P4823, DOI 10.1021/pr300190k; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fanzani L, 2015, CURR MED CHEM, V22, P3110, DOI 10.2174/0929867322666150812150036; Fouz B, 2006, J FISH DIS, V29, P285, DOI 10.1111/j.1365-2761.2006.00719.x; Getz LJ, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00205-19; Grangeasse C, 1997, GENE, V204, P259, DOI 10.1016/S0378-1119(97)00554-4; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Hagelueken G, 2009, J MOL BIOL, V392, P678, DOI 10.1016/j.jmb.2009.07.026; Hansen AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003403; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hunter T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020644; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-24; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ku B, 2016, BIOCHEM BIOPH RES CO, V478, P1217, DOI 10.1016/j.bbrc.2016.08.097; Kumagai T, 2009, BIOCHEM BIOPH RES CO, V385, P534, DOI 10.1016/j.bbrc.2009.05.091; Lescop E, 2006, J BIOL CHEM, V281, P19570, DOI 10.1074/jbc.M601263200; Lori G, 2018, CANCER MED-US, V7, P1933, DOI 10.1002/cam4.1435; Madhurantakam C, 2005, J BACTERIOL, V187, P2175, DOI 10.1128/JB.187.6.2175-2181.2005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nadler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037984; Nath S, 2014, BIOCHEM BIOPH RES CO, V450, P390, DOI 10.1016/j.bbrc.2014.05.129; Petrova OE, 2012, P NATL ACAD SCI USA, V109, P16690, DOI 10.1073/pnas.1207832109; Pettis GS, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093259; Phippen BL, 2015, INFECT IMMUN, V83, P551, DOI 10.1128/IAI.02559-14; Raugei G, 2002, CELL MOL LIFE SCI, V59, P941, DOI 10.1007/s00018-002-8481-z; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sachdeva S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00070; Salomone-Stagni M, 2016, ACTA CRYSTALLOGR F, V72, P903, DOI 10.1107/S2053230X16018781; Sanchez-Rodriguez R, 2020, ARCH BIOCHEM BIOPHYS, V681, DOI 10.1016/j.abb.2020.108277; Schwechheimer C, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008745; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Stanford SM, 2017, NAT CHEM BIOL, V13, P624, DOI 10.1038/nchembio.2344; Stehle T, 2012, J BIOL CHEM, V287, P34569, DOI 10.1074/jbc.M112.399261; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Studer RA, 2013, BIOCHEM J, V449, P581, DOI 10.1042/BJ20121221; SU XD, 1994, NATURE, V370, P575, DOI 10.1038/370575a0; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wan Y, 2019, J BIOL CHEM, V294, P11391, DOI 10.1074/jbc.RA119.008280; Wang SS, 2000, BIOCHEMISTRY-US, V39, P1903, DOI 10.1021/bi991348d; Wang ZJ, 2016, J SYNCHROTRON RADIAT, V23, P1323, DOI 10.1107/S160057751601451X; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Whitmore SE, 2012, INT J ORAL SCI, V4, P1, DOI 10.1038/ijos.2012.6; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright AC, 2001, INFECT IMMUN, V69, P6893, DOI 10.1128/IAI.69.11.6893-6901.2001; Zabell APR, 2006, J BIOL CHEM, V281, P6520, DOI 10.1074/jbc.M506285200; Zang K, 2018, J BIOL CHEM, V293, P1088, DOI [10.1074/jbc.M117.815266, 10.1074/jbc.m117.815266]; ZHANG M, 1994, BIOCHEMISTRY-US, V33, P11097, DOI 10.1021/bi00203a006; Zhang M, 1998, J BIOL CHEM, V273, P21714, DOI 10.1074/jbc.273.34.21714; Zhang M, 1997, BIOCHEMISTRY-US, V36, P15, DOI 10.1021/bi961804n; Zhang WZ, 2019, NUCL SCI TECH, V30, DOI 10.1007/s41365-019-0683-2	64	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100280	10.1016/j.jbc.2021.100280	http://dx.doi.org/10.1016/j.jbc.2021.100280			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450227	gold, Green Published			2022-12-28	WOS:000672866400256
J	Wilson, T; Mourino, S; Wilks, A				Wilson, Tyree; Mourino, Susana; Wilks, Angela			The heme-binding protein PhuS transcriptionally regulates the Pseudomonas aeruginosa tandem sRNA prrF1,F2 locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON HOMEOSTASIS; FUR REGULATOR; OXYGENASE; ALGR; SYSTEM; RYHB; PHOSPHORYLATION; TRAFFICKING; HOMOLOGS; REVEALS	Pseudomonas aeruginosa is an opportunistic pathogen requiring iron for its survival and virulence. P. aeruginosa can acquire iron from heme via the nonredundant heme assimilation system and Pseudomonas heme uptake (Phu) systems. Heme transported by either the heme assimilation system or Phu system is sequestered by the cytoplasmic protein PhuS. Furthermore, PhuS has been shown to specifically transfer heme to the iron-regulated heme oxygenase HemO. As the PhuS homolog ShuS from Shigella dysenteriae was observed to bind DNA as a function of its heme status, we sought to further determine if PhuS, in addition to its role in regulating heme flux through HemO, functions as a DNA-binding protein. Herein, through a combination of chromatin immunoprecipitation-PCR, EMSA, and fluorescence anisotropy, we show that apo-PhuS but not holo-PhuS binds upstream of the tandem iron-responsive sRNAs prrF1,F2. Previous studies have shown the PrrF sRNAs are required for sparing iron for essential proteins during iron starvation. Furthermore, under certain conditions, a heme-dependent read through of the prrF1 terminator yields the longer PrrH transcript. Quantitative PCR analysis of P. aeruginosa WT and Delta phuS strains shows that loss of PhuS abrogates the heme-dependent regulation of PrrF and PrrH levels. Taken together, our data show that PhuS, in addition to its role in extracellular heme metabolism, also functions as a transcriptional regulator by modulating PrrF and PrrH levels in response to heme. This dual function of PhuS is central to integrating extracellular heme utilization into the PrrF/PrrH sRNA regulatory network that is critical for P. aeruginosa adaptation and virulence within the host.	[Wilson, Tyree; Mourino, Susana; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wilks, A (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu		MOURINO, SUSANA/0000-0003-3707-1139	National Institutes of Health [R01 AI134886]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant R01 AI134886 (to A. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agriesti F, 2014, NUCLEIC ACIDS RES, V42, P3138, DOI 10.1093/nar/gkt1258; Barker KD, 2012, J BIOL CHEM, V287, P18342, DOI 10.1074/jbc.M112.359265; Carpenter BM, 2010, J BACTERIOL, V192, P5037, DOI 10.1128/JB.00198-10; Cody WL, 2009, J BACTERIOL, V191, P2993, DOI 10.1128/JB.01156-08; Contreras H, 2014, CURR OPIN CHEM BIOL, V19, P34, DOI 10.1016/j.cbpa.2013.12.014; Cournac A, 2013, J BACTERIOL, V195, P1109, DOI 10.1128/JB.02038-12; Dent AT, 2020, J BIOL CHEM, V295, P10456, DOI 10.1074/jbc.RA120.014081; Dent AT, 2019, J BIOL CHEM, V294, P2771, DOI 10.1074/jbc.RA118.006185; Deredge DJ, 2017, P NATL ACAD SCI USA, V114, P3421, DOI 10.1073/pnas.1606931114; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Jacques JF, 2006, MOL MICROBIOL, V62, P1181, DOI 10.1111/j.1365-2958.2006.05439.x; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; Kaur AP, 2007, BIOCHEMISTRY-US, V46, P2994, DOI 10.1021/bi061722r; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Kong WN, 2015, NUCLEIC ACIDS RES, V43, P8268, DOI 10.1093/nar/gkv747; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Leclerc JM, 2013, MICROBIOL-SGM, V159, P591, DOI 10.1099/mic.0.064329-0; Letoffe S, 2004, J BACTERIOL, V186, P4067, DOI 10.1128/JB.186.13.4067-4074.2004; Little AS, 2018, MBIO, V9, DOI 10.1128/mBio.02318-17; Marvig RL, 2014, MBIO, V5, DOI 10.1128/mBio.00966-14; Mascher T, 2013, CURR OPIN MICROBIOL, V16, P148, DOI 10.1016/j.mib.2013.02.001; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; MOHR CD, 1994, MOL GEN GENET, V242, P177, DOI 10.1007/BF00391011; Morici LA, 2007, J BACTERIOL, V189, P7752, DOI 10.1128/JB.01797-06; Mourino S, 2016, J BIOL CHEM, V291, P20503, DOI 10.1074/jbc.M116.728527; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; Nguyen AT, 2014, J BACTERIOL, V196, P2265, DOI 10.1128/JB.01491-14; O'Neill MJ, 2013, ACS CHEM BIOL, V8, P1794, DOI 10.1021/cb400165b; O'Neill MJ, 2012, P NATL ACAD SCI USA, V109, P5639, DOI 10.1073/pnas.1121549109; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Oglesby-Sherrouse AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009930; Okkotsu Y, 2013, J BACTERIOL, V195, P5499, DOI 10.1128/JB.00726-13; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Reinhart AA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00764-16; Reinhart AA, 2015, INFECT IMMUN, V83, P863, DOI 10.1128/IAI.02707-14; Roncarati D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12593; Smith AD, 2015, J BIOL CHEM, V290, P7756, DOI 10.1074/jbc.M114.633495; Whitchurch CB, 2002, J BACTERIOL, V184, P4544, DOI 10.1128/JB.184.16.4544-4554.2002; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101	45	5	5	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100275	10.1016/j.jbc.2021.100275	http://dx.doi.org/10.1016/j.jbc.2021.100275			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428928	gold, Green Published			2022-12-28	WOS:000672866400251
J	Yu, ML; Wu, H; Wang, JH; Chen, XY; Pan, JQ; Liu, PH; Zhang, J; Chen, YS; Zhu, W; Tang, CX; Jin, Q; Li, CX; Lu, C; Zeng, H; Yu, CH; Sun, J				Yu, Mengli; Wu, Hao; Wang, Jinhai; Chen, Xueyang; Pan, Jiaqi; Liu, Peihao; Zhang, Jie; Chen, Yishu; Zhu, Wei; Tang, Chenxi; Jin, Qi; Li, Chunxiao; Lu, Chao; Zeng, Hang; Yu, Chaohui; Sun, Jing			Vitamin D receptor inhibits EMT via regulation of the epithelial mitochondrial function in intestinal fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; MESENCHYMAL TRANSITION; CELL; MECHANISMS; COLITIS; INDUCTION; PROMOTES; PATHWAY; FUSION	We previously showed that the vitamin D receptor (VDR) plays a crucial role in acute inflammatory bowel disease and that intestinal fibrosis is a common complication of Crohn's disease (CD). Epithelial-mesenchymal transition (EMT) is an important hallmark of fibrogenesis through which epithelial cells lose their epithelial phenotype and transform into mesenchymal cells. It is known that the VDR plays an essential role in epithelial integrity and mitochondrial function, but its role in intestinal fibrosis remains unknown. Here, we investigated whether the VDR is involved in epithelial mitochondrial dysfunction that results in EMT in intestinal fibrosis. Using human CD samples, intestine-specific VDR-KO mice, and fibroblast cellular models, we showed that the expression of the VDR was significantly lower in intestinal stenotic areas than in nonstenotic areas in patients with chronic CD. Genetic deletion of the VDR in the intestinal epithelium exacerbated intestinal fibrosis in mice administered with dextran sulfate sodium or 2,4,6-trinitrobenzene sulfonic acid, two experimental colitis inducers. In addition, we found that vitamin D dietary intervention regulated intestinal fibrosis by modulating the intestinal expression of the VDR. Mechanistically, knocking down the VDR in both CCD-18Co cells and human primary colonic fibroblasts promoted fibroblast activation, whereas VDR overexpression or VDR agonist administration inhibited fibroblast activation. Further analysis illustrated that the VDR inhibited EMT in the HT29 cell model and that mitochondrial dysfunction mediated epithelial integrity and barrier function in VDR-deficient epithelial cells. Together, our data for the first time demonstrate that VDR activation alleviates intestinal fibrosis by inhibiting fibroblast activation and epithelial mitochondria-mediated EMT.	[Yu, Mengli; Chen, Xueyang; Pan, Jiaqi; Liu, Peihao; Zhang, Jie; Chen, Yishu; Zhu, Wei; Tang, Chenxi; Jin, Qi; Lu, Chao; Zeng, Hang; Yu, Chaohui] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Hangzhou, Peoples R China; [Wu, Hao] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, Shanghai, Peoples R China; [Wang, Jinhai] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Colorectal Surg, Hangzhou, Peoples R China; [Li, Chunxiao] Ningbo First Hosp, Dept Gastroenterol, Ningbo, Peoples R China; [Sun, Jing] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gastroenterol, Sch Med, Shanghai, Peoples R China	Zhejiang University; Fudan University; Zhejiang University; Shanghai Jiao Tong University	Yu, CH (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Hangzhou, Peoples R China.; Sun, J (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gastroenterol, Sch Med, Shanghai, Peoples R China.	zyyyych@zju.edu.cn; sunjinrj@shsmu.edu.cn		Tang, Chenxi/0000-0003-3448-8748	Natural Science Foundation of Zhejiang Province [LY20H030005]; National Natural Science Foundation of China [81770547]; Foundation of Shanghai Municipal Population and Family Planning Commission [20174Y0151]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Shanghai Municipal Population and Family Planning Commission	This work was supported and approved by Natural Science Foundation of Zhejiang Province (No. LY20H030005) and the National Natural Science Foundation of China (No. 81770547) and the Foundation of Shanghai Municipal Population and Family Planning Commission (No. 20174Y0151).	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Amodeo GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103879; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Bikle DD, 2015, J STEROID BIOCHEM, V148, P47, DOI 10.1016/j.jsbmb.2014.10.017; Breynaert C, 2016, J CROHNS COLITIS, V10, P1336, DOI 10.1093/ecco-jcc/jjw101; Camara AKS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00460; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang E, 2019, MOLECULES, V24, DOI 10.3390/molecules24213903; Chen C, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109170; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Consiglio M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115816; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Duran A, 2016, CANCER CELL, V30, P595, DOI 10.1016/j.ccell.2016.09.004; Gisbert-Ferrandiz L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040973; Glorevski N, 2016, NATURE, V539, P560, DOI 10.1038/nature20168; Gordon IO, 2014, INFLAMM BOWEL DIS, V20, P2198, DOI 10.1097/MIB.0000000000000080; Gracz A D, 2012, Methods Mol Biol, V879, P89, DOI 10.1007/978-1-61779-815-3_6; He L, 2018, ENDOCRINOLOGY, V159, P967, DOI 10.1210/en.2017-00748; Holvoet T, 2017, GASTROENTEROLOGY, V153, P1054, DOI 10.1053/j.gastro.2017.06.013; Honzawa Y, 2014, GUT, V63, P1902, DOI 10.1136/gutjnl-2013-305632; Huang H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.419; Jiang H, 2018, MUCOSAL IMMUNOL, V11, P294, DOI 10.1038/mi.2017.107; Johnson LA, 2013, INFLAMM BOWEL DIS, V19, P891, DOI 10.1097/MIB.0b013e3182813297; Kemmis CM, 2008, J CELL BIOCHEM, V105, P980, DOI 10.1002/jcb.21896; Lee CT, 2019, J STEROID BIOCHEM, V185, P200, DOI 10.1016/j.jsbmb.2018.09.002; Lenti MV, 2019, MOL ASPECTS MED, V65, P100, DOI 10.1016/j.mam.2018.10.003; Li CX, 2020, J CROHNS COLITIS, V14, P1103, DOI 10.1093/ecco-jcc/jjaa016; Lisse TS, 2014, MOL ENDOCRINOL, V28, P1698, DOI 10.1210/me.2014-1043; Liu D, 2019, BIOMATERIALS, V211, P57, DOI 10.1016/j.biomaterials.2019.04.034; Liu WC, 2013, J CLIN INVEST, V123, P3983, DOI 10.1172/JCI65842; Lu XW, 2019, EXP EYE RES, V187, DOI 10.1016/j.exer.2019.107776; Marchi S, 2014, J PHYSIOL-LONDON, V592, P829, DOI 10.1113/jphysiol.2013.268235; Margolis RN, 2010, ANN NY ACAD SCI, V1192, P208, DOI 10.1111/j.1749-6632.2009.05227.x; Garcia IM, 2012, AM J PHYSIOL-RENAL, V302, pF1595, DOI 10.1152/ajprenal.00617.2011; Nanki K, 2020, NATURE, V577, P254, DOI 10.1038/s41586-019-1844-5; Ortiz-Masia D, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051104; Ortiz-Masia D, 2020, J CROHNS COLITIS, V14, P230, DOI 10.1093/ecco-jcc/jjz134; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Ricca C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061672; Rieder F, 2013, GUT, V62, P1072, DOI 10.1136/gutjnl-2012-304353; Rieder F, 2012, J CROHNS COLITIS, V6, P373, DOI 10.1016/j.crohns.2011.11.009; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Ryan ZC, 2016, J BIOL CHEM, V291, P1514, DOI 10.1074/jbc.M115.684399; Scharl M, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0046-5; Scheibe K, 2019, GASTROENTEROLOGY, V156, P1082, DOI 10.1053/j.gastro.2018.11.029; Scheibe K, 2017, GUT, V66, P823, DOI 10.1136/gutjnl-2015-310374; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Shi YY, 2020, FASEB J, V34, P13494, DOI 10.1096/fj.202000143RRR; Speca S, 2016, INFLAMM BOWEL DIS, V22, P279, DOI 10.1097/MIB.0000000000000618; Speca S, 2012, WORLD J GASTROENTERO, V18, P3635, DOI 10.3748/wjg.v18.i28.3635; Tao QS, 2015, DIGEST DIS SCI, V60, P868, DOI 10.1007/s10620-014-3398-6; Thia KT, 2010, GASTROENTEROLOGY, V139, P1147, DOI 10.1053/j.gastro.2010.06.070; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Wang ZT, 2014, WORLD J GASTROENTERO, V20, P2397, DOI 10.3748/wjg.v20.i9.2397; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Yang L, 2017, MOL MED REP, V15, P2273, DOI 10.3892/mmr.2017.6276; Zhang H, 2020, J BIOL CHEM, V295, P3891, DOI 10.1074/jbc.RA119.011487; Zhang J, 2020, J BIOL CHEM, V295, P4237, DOI 10.1074/jbc.RA119.010143	60	11	11	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100531	10.1016/j.jbc.2021.100531	http://dx.doi.org/10.1016/j.jbc.2021.100531			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713706	gold, Green Published			2022-12-28	WOS:000672866400505
J	Devkota, S; Williams, TD; Wolfe, MS				Devkota, Sujan; Williams, Todd D.; Wolfe, Michael S.			Familial Alzheimer's disease mutations in amyloid protein precursor alter proteolysis by gamma-secretase to increase amyloid beta-peptides of >= 45 residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE CLEAVAGE; TERMINAL FRAGMENT; A-BETA; PRESENILIN-1; MECHANISM; A-BETA-40; DRIVEN; DOMAIN	Production of amyloid beta-protein (A beta) is carried out by the membrane-embedded gamma-secretase complex. Mutations in the transmembrane domain of amyloid beta-protein precursor (APP) associated with early-onset familial Alzheimer's disease (FAD) can alter the ratio of aggregation-prone 42-residue A beta (A beta 42) to 40-residue A beta (A beta 40). However, APP substrate is proteolyzed processively by gamma-secretase along two pathways: A beta 49 -> A beta 46 -> A beta 43 -> A beta 40 and A beta 48 -> A beta 45 -> A beta 42 -> A beta 38. Effects of FAD mutations on each proteolytic step are unknown, largely due to difficulties in detecting and quantifying longer A beta peptides. To address this, we carried out systematic and quantitative analyses of all tri- and tetrapeptide coproducts from proteolysis of wild-type and 14 FAD-mutant APP substrates by purified gamma-secretase. These small peptides, including FAD-mutant forms, were detected by tandem mass spectrometry and quantified by establishing concentration curves for each of 32 standards. APP intracellular domain (AICD) coproducts were quantified by immunoblot, and the ratio of AICD products corresponding to A beta 48 and A beta 49 was determined by mass spectrometry. Levels of individual A beta peptides were determined by subtracting levels of peptide coproducts associated with degradation from those associated with production. This method was validated for A beta 40 and A beta 42 by specific ELISAs and production of equimolar levels of A beta and AICD. Not all mutant substrates led to increased A beta 42/40. However, all 14 disease-causing mutations led to inefficient processing of longer forms of A beta >= 45 residues. In addition, the effects of certain mutations provided insight into the mechanism of processive proteolysis: intermediate A beta peptides apparently remain bound for subsequent trimming and are not released and reassociated.	[Devkota, Sujan; Wolfe, Michael S.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Williams, Todd D.] Univ Kansas, Mass Spectrometry Lab, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Wolfe, MS (corresponding author), Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA.	mswolfe@ku.edu		Wolfe, Michael/0000-0002-5721-9092	U.S. National Institutes of Health [GM122894, AG66986]	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was support by grants GM122894 and AG66986 from the U.S. National Institutes of Health to M. S. W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Bolduc DM, 2017, METHOD ENZYMOL, V584, P295, DOI 10.1016/bs.mie.2016.10.026; Bolduc DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17578; Bolduc DM, 2016, P NATL ACAD SCI USA, V113, pE509, DOI 10.1073/pnas.1512952113; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; Fernandez MA, 2016, BIOCHEMISTRY-US, V55, P5675, DOI 10.1021/acs.biochem.6b00718; Fernandez MA, 2014, J BIOL CHEM, V289, P31043, DOI 10.1074/jbc.M114.581165; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Kretner B, 2016, EMBO MOL MED, V8, P458, DOI 10.15252/emmm.201505952; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tanzi RE, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006296; Veugelen S, 2016, NEURON, V90, P410, DOI 10.1016/j.neuron.2016.03.010; Wolfe MS, 2019, BIOCHEMISTRY-US, V58, P2953, DOI 10.1021/acs.biochem.9b00401; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200	28	16	16	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100281	10.1016/j.jbc.2021.100281	http://dx.doi.org/10.1016/j.jbc.2021.100281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450230	gold, Green Published			2022-12-28	WOS:000672866400257
J	Goto, H; Miyamoto, M; Kihara, A				Goto, Hirotaka; Miyamoto, Masatoshi; Kihara, Akio			Direct uptake of sphingosine-1-phosphate independent of phospholipid phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; TRANSPORTER SPNS2; IDENTIFICATION; DEGRADATION; RECEPTOR; PLASMA; PHOSPHOHYDROLASE; SPHINGOLIPIDS	Sphingosine-1-phosphate (S1P) is a lipid mediator that is relatively abundant in plasma and plays an important role in the vascular and immune systems. To date, the only known mechanism for removing S1P from plasma has been dephosphorylation by phospholipid phosphatases (PLPPs) on the surface of cells in contact with the plasma. However, there remains a possibility that PLPP-independent dephosphorylation or direct S1P uptake into cells could occur. To examine these possibilities, here we generated triple KO (TKO) HAP1 cells that lacked all PLPPs (PLPP1-3) present in mammals. In the TKO cells, the intracellular metabolism of externally added deuterium-labeled S1P to ceramide was reduced to 17% compared with the WT cells, indicating that most extracellular S1P is dephosphorylated by PLPPs and then taken up into cells. However, this result also reveals the existence of a PLPP-independent S1P uptake pathway. Tracer experiments using [P-32]S1P showed the existence of a direct S1P uptake pathway that functions without prior dephosphorylation. Overexpression of sphingolipid transporter 2 (SPNS2) or of major facilitator superfamily domain containing 2B (MFSD2B), both known S1P efflux transporters, in TKO cells increased the direct uptake of S1P, whereas KO of MFSD2B in TKO cells reduced this uptake. These results suggest that these are channel-type transporters and capable of not only exporting but also importing S1P. Furthermore, we observed that erythroid cells expressing MFSD2B, exhibited high S1P uptake activity. Our findings describing direct S1P uptake may contribute to the elucidation of the molecular mechanisms that regulate plasma S1P concentration.	[Goto, Hirotaka; Miyamoto, Masatoshi; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan	Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan.	kihara@pharm.hokudai.ac.jp	; KIHARA, AKIO/A-3802-2012	Miyamoto, Masatoshi/0000-0002-7785-7438; KIHARA, AKIO/0000-0001-5889-0788	Japan Society for the Promotion of Science KAKENHI [JP18H03976]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI grant number JP18H03976 (to A. K.).	Bigaud M, 2014, BBA-MOL CELL BIOL L, V1841, P745, DOI 10.1016/j.bbalip.2013.11.001; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Caligan TB, 2000, ANAL BIOCHEM, V281, P36, DOI 10.1006/abio.2000.4555; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Fukuda Y, 2003, BIOCHEM BIOPH RES CO, V309, P155, DOI 10.1016/S0006-291X(03)01551-1; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hiroyama T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001544; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hla T, 2005, SCIENCE, V309, P1682, DOI 10.1126/science.1118340; Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Jojima K, 2020, FASEB J, V34, P3318, DOI 10.1096/fj.201902645R; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Kobayashi N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23300-x; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Narita T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25469; Obinata H, 2019, J LIPID RES, V60, P1912, DOI 10.1194/jlr.RA119000277; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Ohkuni A, 2013, BIOCHEM BIOPH RES CO, V442, P195, DOI 10.1016/j.bbrc.2013.11.036; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Rees SE, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.011; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; STOFFEL W, 1967, H-S Z PHYSIOL CHEM, V348, P1345, DOI 10.1515/bchm2.1967.348.1.1345; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Tang XY, 2015, J LIPID RES, V56, P2048, DOI 10.1194/jlr.R058362; Tukijan F, 2018, BRIT J PHARMACOL, V175, P3741, DOI 10.1111/bph.14451; Vance DE, 2008, N COMP BIOC, P1; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vu TM, 2017, NATURE, V550, P524, DOI 10.1038/nature24053; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; Yamanaka M, 2008, BIOCHEM BIOPH RES CO, V375, P675, DOI 10.1016/j.bbrc.2008.07.165; Yatomi Y, 1997, J BIOCHEM, V121, P969; Yatomi Y, 1997, J BIOL CHEM, V272, P5291, DOI 10.1074/jbc.272.8.5291; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	52	7	7	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100605	10.1016/j.jbc.2021.100605	http://dx.doi.org/10.1016/j.jbc.2021.100605			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33785361	Green Published, gold			2022-12-28	WOS:000672866400577
J	Hamano, F; Kuribayashi, H; Iwagawa, T; Tsuhako, A; Nagata, K; Sagara, H; Shimizu, T; Shindou, H; Watanabe, S				Hamano, Fumie; Kuribayashi, Hiroshi; Iwagawa, Toshiro; Tsuhako, Asano; Nagata, Katsuyuki; Sagara, Hiroshi; Shimizu, Takao; Shindou, Hideo; Watanabe, Sumiko			Mapping membrane lipids in the developing and adult mouse retina under physiological and pathological conditions using mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; ELOVL4; NRL; PHOSPHATIDYLCHOLINE; HOMEOSTASIS; METABOLISM; DISEASE; HEALTH; AGE	Membrane phospholipids play pivotal roles in various cellular processes, and their levels are tightly regulated. In the retina, phospholipids had been scrutinized because of their distinct composition and requirement in visual transduction. However, how lipid composition changes during retinal development remains unclear. Here, we used liquid chromatography-mass spectrometry (LC-MS) to assess the dynamic changes in the levels of two main glycerophospholipids, phosphatidylcholine (PC) and phosphatidyl-ethanolamine (PE), in the developing mouse retina under physiological and pathological conditions. The total levels of PC and PE increased during retinal development, and individual lipid species exhibited distinct level changes. The amount of very-long-chain PC and PE increased dramatically in the late stages of retinal development. The mRNA levels of Elovl2 and Elovl4, genes encoding enzymes essential for the synthesis of very-long-chain polyunsaturated fatty acids, increased in developing photoreceptors. Cell sorting based on CD73 expression followed by LC-MS revealed distinct changes in PC and PE levels in CD73-positive rod photoreceptors and CD73-negative retinal cells. Finally, using the NaIO3-induced photoreceptor degeneration model, we identified photoreceptor-specific changes in PC and PE levels from 1 day after NaIO3 administration, before the outer segment of photoreceptors displayed morphological impairment. In conclusion, our findings provide insight into the dynamic changes in PC and PE levels in the developing and adult mouse retina under physiological and pathological conditions. Furthermore, we provide evidence that cell sorting followed by LC-MS is a promising approach for investigating the relevance of lipid homeostasis in the function of different retinal cell types.	[Hamano, Fumie; Nagata, Katsuyuki; Shimizu, Takao; Shindou, Hideo] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, Tokyo, Japan; [Hamano, Fumie] Univ Tokyo, Grad Sch Med, Life Sci Core Facil, Bunkyo Ku, Tokyo, Japan; [Kuribayashi, Hiroshi; Iwagawa, Toshiro; Tsuhako, Asano; Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Minato Ku, Tokyo, Japan; [Sagara, Hiroshi] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Bunkyo Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Watanabe, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Minato Ku, Tokyo, Japan.	sumiko@ims.u-tokyo.ac.jp	Sagara, Hiroshi/GRX-7740-2022	Sagara, Hiroshi/0000-0001-8456-8362; Watanabe, Sumiko/0000-0003-4497-5750	Joint Research Project of the Institute of Medical Science, University of Tokyo; Agency for Medical Research and Development (AMED)-Core Research for Evolutional Science and Technology [19gm0910011]; Takeda Science Foundation	Joint Research Project of the Institute of Medical Science, University of Tokyo; Agency for Medical Research and Development (AMED)-Core Research for Evolutional Science and Technology(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work is supported by the grants from the Joint Research Project of the Institute of Medical Science, University of Tokyo (S. W., H. Sagara, H. Shindou) and Agency for Medical Research and Development (AMED)-Core Research for Evolutional Science and Technology 19gm0910011 (S. W., H. Sagara, H. Shindou); the Takeda Science Foundation.	Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; AVELDANO MI, 1987, J BIOL CHEM, V262, P1172; Barragan I, 2005, INT J MOL MED, V16, P1163; Brooks MJ, 2019, STEM CELL REP, V13, P891, DOI 10.1016/j.stemcr.2019.09.009; Carter JM, 2008, J BIOL CHEM, V283, P202, DOI 10.1074/jbc.M706531200; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Deak F, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00428; Enzmann V, 2006, EXP EYE RES, V82, P441, DOI 10.1016/j.exer.2005.08.002; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Harayama T, 2020, J LIPID RES, V61, P1150, DOI 10.1194/jlr.R120000800; Hopiavuori BR, 2017, J LIPID RES, V58, P668, DOI 10.1194/jlr.M070714; Iida A, 2011, INVEST OPHTH VIS SCI, V52, P3008, DOI 10.1167/iovs.10-6428; Iwagawa T, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.3.7; Iwagawa T, 2019, NEUROSCI RES, V138, P43, DOI 10.1016/j.neures.2018.09.010; Kim JW, 2016, CELL REP, V17, P2460, DOI 10.1016/j.celrep.2016.10.074; Koso H, 2009, INVEST OPHTH VIS SCI, V50, P5411, DOI 10.1167/iovs.08-3246; LAVAIL MM, 1973, J CELL BIOL, V58, P650, DOI 10.1083/jcb.58.3.650; Lenis TL, 2018, P NATL ACAD SCI USA, V115, pE11120, DOI 10.1073/pnas.1802519115; Mandal MNA, 2004, GENOMICS, V83, P626, DOI 10.1016/j.ygeno.2003.09.020; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; MARTIN RE, 1992, J NEUROCHEM, V59, P318, DOI 10.1111/j.1471-4159.1992.tb08906.x; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505; Pauter AM, 2014, J LIPID RES, V55, P718, DOI 10.1194/jlr.M046151; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; SCOTT BL, 1987, EXP EYE RES, V44, P101, DOI 10.1016/S0014-4835(87)80029-5; SCOTT BL, 1988, J NEUROSCI RES, V20, P202, DOI 10.1002/jnr.490200209; Shindou H, 2017, J BIOL CHEM, V292, P12054, DOI [10.1074/jbc.M117.790568, 10.1074/jbc.m117.790568]; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tanna P, 2017, BRIT J OPHTHALMOL, V101, P25, DOI 10.1136/bjophthalmol-2016-308823; Ueno K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29264; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; Wu J, 2017, OPHTHALMOLOGY, V124, P634, DOI 10.1016/j.ophtha.2016.12.033; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	37	6	6	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100303	10.1016/j.jbc.2021.100303	http://dx.doi.org/10.1016/j.jbc.2021.100303			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465374	Green Published, gold			2022-12-28	WOS:000672866400277
J	Hart, JE; Gardner, KH				Hart, Jaynee E.; Gardner, Kevin H.			Lighting the way: Recent insights into the structure and regulation of phototropin blue light receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INDUCED CONFORMATIONAL-CHANGES; LOV2 DOMAIN; ARABIDOPSIS NPH1; KINASE DOMAIN; CRYO-EM; FUNCTIONAL-CHARACTERIZATION; PHOTORECEPTOR PHOTOTROPIN; CHLAMYDOMONAS-REINHARDTII; MUTATIONAL ANALYSIS; BINDING DOMAINS	The phototropins (phots) are light-activated kinases that are critical for plant physiology and the many diverse optogenetic tools that they have inspired. Phototropins combine two bluelight-sensing Light-Oxygen-Voltage (LOV) domains (LOV1 and LOV2) and a C-terminal serine/threonine kinase domain, using the LOV domains to control the catalytic activity of the kinase. While much is known about the structure and photochemistry of the light-perceiving LOV domains, particularly in how activation of the LOV2 domain triggers the unfolding of alpha helices that communicate the light signal to the kinase domain, many questions about phot structure and mechanism remain. Recent studies have made progress addressing these questions by utilizing small-angle X-ray scattering (SAXS) and other biophysical approaches to study multidomain phots from Chlamydomonas and Arabidopsis, leading to models where the domains have an extended linear arrangement, with the regulatory LOV2 domain contacting the kinase domain N-lobe. We discuss this and other advances that have improved structural and mechanistic understanding of phot regulation in this review, along with the challenges that will have to be overcome to obtain high-resolution structural information on these exciting photoreceptors. Such information will be essential to advancing fundamental understanding of plant physiology while enabling engineering efforts at both the whole plant and molecular levels.	[Hart, Jaynee E.; Gardner, Kevin H.] CUNY, Struct Biol Initiat, Adv Sci Res Ctr, New York, NY 10021 USA; [Gardner, Kevin H.] CUNY City Coll, Dept Chem & Biochem, New York, NY 10031 USA; [Gardner, Kevin H.] CUNY, Grad Ctr, PhD Programs Biochem Chem & Biol, New York, NY 10010 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Gardner, KH (corresponding author), CUNY, Struct Biol Initiat, Adv Sci Res Ctr, New York, NY 10021 USA.; Gardner, KH (corresponding author), CUNY City Coll, Dept Chem & Biochem, New York, NY 10031 USA.; Gardner, KH (corresponding author), CUNY, Grad Ctr, PhD Programs Biochem Chem & Biol, New York, NY 10010 USA.	kgardner@gc.cuny.edu	Gardner, Kevin H./K-7802-2012	Gardner, Kevin H./0000-0002-8671-2556	NIH [R01 GM106239]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work in the Gardner laboratory on photosensing is supported by NIH R01 GM106239 to K. H. G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Banerjee A, 2016, STRUCTURE, V24, P171, DOI 10.1016/j.str.2015.10.022; Blake-Hodek KA, 2012, MOL CELL BIOL, V32, P1337, DOI 10.1128/MCB.06525-11; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Breitenlechner CB, 2005, J MED CHEM, V48, P163, DOI 10.1021/jm049701n; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Dagliyan O, 2016, SCIENCE, V354, P1441, DOI 10.1126/science.aah3404; Dikiy I, 2019, P NATL ACAD SCI USA, V116, P4963, DOI 10.1073/pnas.1813586116; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Gil AA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17836-8; Glantz ST, 2016, P NATL ACAD SCI USA, V113, pE1442, DOI 10.1073/pnas.1509428113; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Halavaty AS, 2013, ACTA CRYSTALLOGR F, V69, P1316, DOI 10.1107/S1744309113029199; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hart JE, 2019, P NATL ACAD SCI USA, V116, P12550, DOI 10.1073/pnas.1902915116; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Henry L, 2020, BIOCHEMISTRY-US, V59, P3206, DOI 10.1021/acs.biochem.0c00324; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Huang KY, 2003, P NATL ACAD SCI USA, V100, P6269, DOI 10.1073/pnas.0931459100; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Inoue S, 2011, PLANT PHYSIOL, V156, P117, DOI 10.1104/pp.111.175943; Iuliano JN, 2020, ACS CHEM BIOL, V15, P2752, DOI 10.1021/acschembio.0c00543; Jentzsch K, 2009, BIOCHEMISTRY-US, V48, P10321, DOI 10.1021/bi901115z; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kashojiya S, 2016, FEBS LETT, V590, P139, DOI 10.1002/1873-3468.12028; Katsura H, 2009, FEBS LETT, V583, P526, DOI 10.1016/j.febslet.2009.01.019; Kawano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7256; Kawano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082693; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kolar K, 2018, ACS SYNTH BIOL, V7, P1825, DOI 10.1021/acssynbio.8b00120; Lee CH, 2018, SCIENCE, V360, P508, DOI 10.1126/science.aas9466; Leroux AE, 2018, SEMIN CANCER BIOL, V48, P1, DOI 10.1016/j.semcancer.2017.05.011; Li FW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00637; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Losi A, 2018, CHEM REV, V118, P10659, DOI 10.1021/acs.chemrev.8b00163; Loveland AB, 2017, NATURE, V546, P113, DOI 10.1038/nature22397; Modi V, 2019, P NATL ACAD SCI USA, V116, P6818, DOI 10.1073/pnas.1814279116; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Nakasako M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186638; Nakasone Y, 2019, J PHYS CHEM B, V123, P10939, DOI 10.1021/acs.jpcb.9b09685; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Ocasio CA, 2016, ONCOTARGET, V7, P71182, DOI 10.18632/oncotarget.11511; Oide M, 2018, J BIOL CHEM, V293, P963, DOI [10.1074/jbc.RA117.000324, 10.1074/jbc.ra117.000324]; Oide M, 2016, J BIOL CHEM, V291, P19975, DOI 10.1074/jbc.M116.735787; Okajima K, 2014, J BIOL CHEM, V289, P413, DOI 10.1074/jbc.M113.515403; Onodera A, 2005, PLANT CELL PHYSIOL, V46, P367, DOI 10.1093/pcp/pci037; Peter E, 2014, PROTEINS, V82, P2018, DOI 10.1002/prot.24556; Petersen J, 2017, J BIOL CHEM, V292, P13843, DOI 10.1074/jbc.M117.799643; Petroutsos D, 2016, NATURE, V537, P563, DOI 10.1038/nature19358; Pfeifer A, 2010, BIOCHEMISTRY-US, V49, P1024, DOI 10.1021/bi9016044; Rademacher EH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00250; Rivera-Cancel G, 2014, P NATL ACAD SCI USA, V111, P17839, DOI 10.1073/pnas.1413983111; Rutter J, 2001, P NATL ACAD SCI USA, V98, P8991, DOI 10.1073/pnas.161284798; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2004, FEBS LETT, V572, P8, DOI 10.1016/j.febslet.2004.06.081; Schnabel J, 2018, J BIOL CHEM, V293, P5613, DOI 10.1074/jbc.RA118.001834; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; Sullivan S, 2008, MOL PLANT, V1, P178, DOI 10.1093/mp/ssm017; Sullivan S, 2016, NEW PHYTOL, V209, P612, DOI 10.1111/nph.13640; Takakado A, 2017, J PHYS CHEM B, V121, P4414, DOI 10.1021/acs.jpcb.7b01552; Takaki T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16013; Tokutomi S, 2008, BBA-PROTEINS PROTEOM, V1784, P133, DOI 10.1016/j.bbapap.2007.09.010; Trabjerg E, 2018, TRAC-TREND ANAL CHEM, V106, P125, DOI 10.1016/j.trac.2018.06.008; Trippens J, 2012, PLANT CELL, V24, P4687, DOI 10.1105/tpc.112.103523; Valon L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14396; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Xiong S, 2018, STRUCTURE, V26, P1101, DOI 10.1016/j.str.2018.05.014; Xue YQ, 2018, MOL PLANT, V11, P846, DOI 10.1016/j.molp.2018.04.003; Yao XL, 2008, NAT CHEM BIOL, V4, P491, DOI 10.1038/nchembio.99; Zayner JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087074; Zayner JP, 2012, J MOL BIOL, V419, P61, DOI 10.1016/j.jmb.2012.02.037; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	91	6	6	4	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100594	10.1016/j.jbc.2021.100594	http://dx.doi.org/10.1016/j.jbc.2021.100594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781746	gold, Green Published			2022-12-28	WOS:000672866400566
J	Konig, AS; Rosener, NS; Gremer, L; Tusche, M; Flender, D; Reinartz, E; Hoyer, W; Neudecker, P; Willbold, D; Heise, H				Koenig, Anna S.; Roesener, Nadine S.; Gremer, Lothar; Tusche, Markus; Flender, Daniel; Reinartz, Elke; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter; Heise, Henrike			Structural details of amyloid beta oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-RESOLUTION STRUCTURE; NUCLEAR-MAGNETIC-RESONANCE; GLUTAMATE-RECEPTOR 5; ALZHEIMERS A-BETA; CELLULAR PRION; SYNAPTIC PLASTICITY; CROSS-POLARIZATION; CHEMICAL-SHIFTS; DISEASE; C-13	Human PrP (huPrP) is a high-affinity receptor for oligomeric amyloid beta (A beta) protein aggregates. Binding of A beta oligomers to membrane-anchored huPrP has been suggested to trigger neurotoxic cell signaling in Alzheimer's disease, while an N-terminal soluble fragment of huPrP can sequester A beta oligomers and reduce their toxicity. Synthetic oligomeric A beta species are known to be heterogeneous, dynamic, and transient, rendering their structural investigation particularly challenging. Here, using huPrP to preserve A beta oligomers by coprecipitating them into large heteroassemblies, we investigated the conformations of A beta(1-42) oligomers and huPrP in the complex by solid-state MAS NMR spectroscopy. The disordered N-terminal region of huPrP becomes immobilized in the complex and therefore visible in dipolar spectra without adopting chemical shifts characteristic of a regular secondary structure. Most of the well-defined C-terminal part of huPrP is part of the rigid complex, and solid-state NMR spectra suggest a loss in regular secondary structure in the two C-terminal a-helices. For A beta(1-42) oligomers in complex with huPrP, secondary chemical shifts reveal substantial beta-strand content. Importantly, not all A beta(1-42) molecules within the complex have identical conformations. Comparison with the chemical shifts of synthetic A beta fibrils suggests that the A beta oligomer preparation represents a heterogeneous mixture of beta-strand-rich assemblies, of which some have the potential to evolve and elongate into different fibril polymorphs, reflecting a general propensity of A beta to adopt variable beta-strand-rich conformers. Taken together, our results reveal structural changes in huPrP upon binding to A beta oligomers that suggest a role of the C terminus of huPrP in cell signaling. Trapping A beta(1-42) oligomers by binding to huPrP has proved to be a useful tool for studying the structure of these highly heterogeneous beta-strand-rich assemblies.	[Koenig, Anna S.; Roesener, Nadine S.; Gremer, Lothar; Tusche, Markus; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter; Heise, Henrike] Forschungszentrum Julich, Inst Biol Informat Proc 181 7 Struct Biochem & Ju, Julich Ctr Struct Biol, Julich, Germany; [Koenig, Anna S.; Roesener, Nadine S.; Gremer, Lothar; Flender, Daniel; Reinartz, Elke; Hoyer, Wolfgang; Neudecker, Philipp; Willbold, Dieter; Heise, Henrike] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Gremer, Lothar; Willbold, Dieter] Moscow Inst Phys & Technol, Res Ctr Mol Mech Aging & Age Related Dis, Dolgoprudnyi, Russia; [Flender, Daniel] Univ Greifswald, Inst Mikrobiol, Greifswald, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Moscow Institute of Physics & Technology; Ernst Moritz Arndt Universitat Greifswald	Willbold, D; Heise, H (corresponding author), Forschungszentrum Julich, Inst Biol Informat Proc 181 7 Struct Biochem & Ju, Julich Ctr Struct Biol, Julich, Germany.; Willbold, D; Heise, H (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany.; Willbold, D (corresponding author), Moscow Inst Phys & Technol, Res Ctr Mol Mech Aging & Age Related Dis, Dolgoprudnyi, Russia.	d.willbold@fz-juelich.de; h.heise@fz-juelich.de	Heise, Henrike/A-7703-2010; Neudecker, Philipp/AAP-9005-2020; Gremer, Lothar/H-9128-2013; Hoyer, Wolfgang/H-6193-2013; Neudecker, Philipp/G-5265-2013; Willbold, Dieter/A-6280-2013	Heise, Henrike/0000-0002-9081-3894; Neudecker, Philipp/0000-0002-0557-966X; Gremer, Lothar/0000-0001-7065-5027; Hoyer, Wolfgang/0000-0003-4301-5416; Neudecker, Philipp/0000-0002-0557-966X; Willbold, Dieter/0000-0002-0065-7366; Rosener, Nadine/0000-0002-9481-6347	European Research Council (ERC) Consolidator Grant [726368]	European Research Council (ERC) Consolidator Grant(European Research Council (ERC))	information-Support from a European Research Council (ERC) Consolidator Grant (grant agreement no. 726368) to W. H. is acknowledged.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Alzheimer's Assoc, 2018, ALZHEIMERS DEMENT, V14, P367, DOI 10.1016/j.jalz.2018.02.001; Amin L., 2019, ABETA RECEPTORS SPEC, DOI [10.1101/822361, DOI 10.1101/822361]; Andronesi OC, 2005, J AM CHEM SOC, V127, P12965, DOI 10.1021/ja0530164; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bove-Fenderson E, 2017, J BIOL CHEM, V292, P16858, DOI 10.1074/jbc.M117.789990; Brener O, 2015, SCI REP-UK, V5, DOI 10.1038/srep13222; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Calzolai L, 2003, J BIOL CHEM, V278, P35592, DOI 10.1074/jbc.M303005200; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Ciudad S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16566-1; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; Colvin MT, 2015, J AM CHEM SOC, V137, P7509, DOI 10.1021/jacs.5b03997; Corbett GT, 2020, ACTA NEUROPATHOL, V139, P503, DOI 10.1007/s00401-019-02114-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Ferreira DG, 2017, NAT NEUROSCI, V20, P1569, DOI 10.1038/nn.4648; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gao Y, 2020, J MOL BIOL, V432, P4388, DOI 10.1016/j.jmb.2020.05.018; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Glynn C, 2020, NAT STRUCT MOL BIOL, V27, P417, DOI 10.1038/s41594-020-0403-y; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Haas LT, 2016, BRAIN, V139, P526, DOI 10.1093/brain/awv356; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Heise H, 2001, J MAGN RESON, V150, P198, DOI 10.1006/jmre.2001.2343; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Jaroniec CP, 2019, J MAGN RESON, V306, P42, DOI 10.1016/j.jmr.2019.07.015; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.63; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kostylev MA, 2018, MOL CELL, V72, P426, DOI 10.1016/j.molcel.2018.10.009; Kostylev MA, 2015, J BIOL CHEM, V290, P17415, DOI 10.1074/jbc.M115.643577; Kovacs H, 2014, J BIOMOL NMR, V58, P101, DOI 10.1007/s10858-013-9808-9; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; Li D, 2020, BIOCHEMISTRY-US, V59, P639, DOI 10.1021/acs.biochem.9b01069; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Madhu P, 2020, ACS CHEM NEUROSCI, V11, P86, DOI 10.1021/acschemneuro.9b00646; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; Mengel D, 2019, BRAIN RES, V1710, P125, DOI 10.1016/j.brainres.2018.12.038; Mohammadi B, 2020, MOL NEUROBIOL, V57, P2812, DOI 10.1007/s12035-020-01917-2; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; Pagano K, 2019, MOL NEUROBIOL, V56, P1957, DOI 10.1007/s12035-018-1202-x; Parthasarathy S, 2015, J AM CHEM SOC, V137, P6480, DOI 10.1021/jacs.5b03373; Peters C, 2015, NEUROBIOL AGING, V36, P1369, DOI 10.1016/j.neurobiolaging.2014.11.019; Potapov A, 2015, J AM CHEM SOC, V137, P8294, DOI 10.1021/jacs.5b04843; Ravotti F, 2016, BIOMOL NMR ASSIGN, V10, P269, DOI 10.1007/s12104-016-9682-y; Rosener NS, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1085-z; Rosener NS, 2018, J BIOL CHEM, V293, P15748, DOI 10.1074/jbc.RA118.003116; Sahoo BR, 2020, CHEM COMMUN, V56, P4627, DOI 10.1039/d0cc01551b; Sarell C. J., 2017, OPEN BIOL, V7, DOI DOI 10.6084/m9; Scheidt HA, 2020, PHYS CHEM CHEM PHYS, V22, P16887, DOI 10.1039/d0cp02307h; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; SCHLEUCHER J, 1993, ANGEW CHEM INT EDIT, V32, P1489, DOI 10.1002/anie.199314891; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Silvers R, 2017, BIOCHEMISTRY-US, V56, P4850, DOI 10.1021/acs.biochem.7b00729; Skinner SP, 2016, J BIOMOL NMR, V66, P111, DOI 10.1007/s10858-016-0060-y; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Tay WM, 2013, J MOL BIOL, V425, P2494, DOI 10.1016/j.jmb.2013.04.003; Theint T, 2017, BIOMOL NMR ASSIGN, V11, P75, DOI 10.1007/s12104-016-9723-6; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wang LQ, 2020, NAT STRUCT MOL BIOL, V27, P598, DOI 10.1038/s41594-020-0441-5; Williams TL, 2015, ACS CHEM NEUROSCI, V6, P1972, DOI 10.1021/acschemneuro.5b00229; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xiao YL, 2020, J BIOL CHEM, V295, P458, DOI 10.1074/jbc.RA119.008522; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Younan ND, 2013, FASEB J, V27, P1847, DOI 10.1096/fj.12-222588; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	99	9	9	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100499	10.1016/j.jbc.2021.100499	http://dx.doi.org/10.1016/j.jbc.2021.100499			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667547	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400473
J	Lei, HW; DenDekker, AD; Li, GB; Zhang, ZG; Sha, L; Schaller, MA; Kunkel, SL; Rui, LY; Tao, KX; Dou, YL				Lei, Hongwei; DenDekker, Aaron D.; Li, Guobing; Zhang, Zhiguo; Sha, Liang; Schaller, Matthew A.; Kunkel, Steven L.; Rui, Liangyou; Tao, Kaixiong; Dou, Yali			Dysregulation of intercellular signaling by MOF deletion leads to liver injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE MOF; LYSINE 16; DISEASE; ACETYLATION; CELL; TRANSCRIPTION; MITOCHONDRIA; ACTIVATION; MECHANISMS; IMPACT	Epigenetic mechanisms that alter heritable gene expression and chromatin structure play an essential role in many biological processes, including liver function. Human MOF (males absent on the first) is a histone acetyltransferase that is globally downregulated in human steatohepatitis. However, the function of MOF in the liver remains unclear. Here, we report that MOF plays an essential role in adult liver. Genetic deletion of Mof by Mx1-Cre in the liver leads to acute liver injury, with increase of lipid deposition and fibrosis akin to human steatohepatitis. Surprisingly, hepatocyte-specific Mof deletion had no overt liver abnormality. Using the in vitro coculturing experiment, we show that Mof deletion-induced liver injury requires coordinated changes and reciprocal signaling between hepatocytes and Kupffer cells, which enables feedforward regulation to augment inflammation and apoptotic responses. At the molecular level, Mof deletion induced characteristic changes in metabolic gene programs, which bore noticeable similarity to the molecular signature of human steatohepatitis. Simultaneous deletion of Mof in both hepatocytes and macrophages results in enhanced expression of inflammatory genes and NO signaling in vitro. These changes, in turn, lead to apoptosis of hepatocytes and lipotoxicity. Our work highlights the importance of histone acetyltransferase MOF in maintaining metabolic liver homeostasis and sheds light on the epigenetic dysregulation in liver pathogenesis.	[Lei, Hongwei; Tao, Kaixiong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China; [Lei, Hongwei; Li, Guobing; Sha, Liang; Dou, Yali] Univ Southern Calif, Dept Med, Los Angeles, CA 90007 USA; [DenDekker, Aaron D.; Kunkel, Steven L.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Zhang, Zhiguo; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Schaller, Matthew A.] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA	Huazhong University of Science & Technology; University of Southern California; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida	Tao, KX (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China.; Dou, YL (corresponding author), Univ Southern Calif, Dept Med, Los Angeles, CA 90007 USA.	kaixiongtao@hust.edu.cn; yalidou@usc.edu		Dou, Yali/0000-0002-4040-1429; denDekker, Aaron/0000-0001-9604-0557; Li, Guobing/0000-0002-5077-6101; ZHANG, ZHIGUO/0000-0002-0331-7682; Sha, Liang/0000-0003-0748-9630	Ruth L. Kirschstein T32 training grant [5T32HL007517-33]; NIH [GM082856, P30CA014089]; NIH	Ruth L. Kirschstein T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by a Ruth L. Kirschstein T32 training grant (5T32HL007517-33) to A. D., NIH grants (GM082856 and P30CA014089) to Y. D., and NIH grants to L. R. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baell JB, 2018, NATURE, V560, P253, DOI 10.1038/s41586-018-0387-5; Bocsan IC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4297206; Carrer A, 2017, J BIOL CHEM, V292, P3312, DOI 10.1074/jbc.M116.750620; Chatterjee A, 2016, CELL, V167, P722, DOI 10.1016/j.cell.2016.09.052; Chelmicki T, 2014, ELIFE, V3, DOI 10.7554/eLife.02024; de Conti A, 2017, MOL CANCER RES, V15, P1163, DOI 10.1158/1541-7786.MCR-17-0109; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Florentino RM, 2020, HEPATOL COMMUN, V4, P859, DOI 10.1002/hep4.1505; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Gaggini M, 2018, HEPATOLOGY, V67, P145, DOI 10.1002/hep.29465; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Holohan C, 2008, J CELL MOL MED, V12, P591, DOI 10.1111/j.1582-4934.2007.00191.x; Huai WW, 2019, J EXP MED, V216, P772, DOI 10.1084/jem.20181773; Ibrahim SH, 2018, GUT, V67, P963, DOI 10.1136/gutjnl-2017-315691; Jemail L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24825-x; Jiang YM, 2019, HEPATOLOGY, V69, P343, DOI 10.1002/hep.30131; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Kim D, 2017, CLIN GASTROENTEROL H, V15, P474, DOI 10.1016/j.cgh.2016.08.028; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Khoa LTP, 2020, CELL STEM CELL, V27, P441, DOI 10.1016/j.stem.2020.06.005; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Li XZ, 2012, CELL STEM CELL, V11, P163, DOI 10.1016/j.stem.2012.04.023; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059; Liu Y, 2014, FEBS J, V281, P3315, DOI 10.1111/febs.12863; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mariani S, 2015, ENDOCRINE, V49, P711, DOI 10.1007/s12020-014-0465-x; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Shi YJ, 2011, AM J PATHOL, V179, P1138, DOI 10.1016/j.ajpath.2011.05.029; Shin S, 2016, HEPATOLOGY, V64, P1163, DOI 10.1002/hep.28602; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; Sunny NE, 2015, AM J PHYSIOL-ENDOC M, V309, pE311, DOI 10.1152/ajpendo.00161.2015; Suppli MP, 2019, AM J PHYSIOL-GASTR L, V316, pG462, DOI 10.1152/ajpgi.00358.2018; Tian Y, 2013, SEMIN CANCER BIOL, V23, P471, DOI 10.1016/j.semcancer.2013.08.010; Trouplin V, 2013, JOVE-J VIS EXP, DOI 10.3791/50966; Urdinguio RG, 2019, NUCLEIC ACIDS RES, V47, P5016, DOI 10.1093/nar/gkz195; Valerio DG, 2017, BLOOD, V129, P48, DOI 10.1182/blood-2016-05-714568; Verma S, 2013, LIVER INT, V33, P1398, DOI 10.1111/liv.12226; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhang J, 2014, BIOCHEM BIOPH RES CO, V452, P575, DOI 10.1016/j.bbrc.2014.08.122; Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069	50	2	2	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100235	10.1074/jbc.RA120.016079	http://dx.doi.org/10.1074/jbc.RA120.016079			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33376138	Green Published, gold			2022-12-28	WOS:000672866400213
J	Lippert, LG; Ma, N; Ritt, M; Jain, A; Vaidehi, N; Sivaramakrishnan, S				Lippert, Lisa G.; Ma, Ning; Ritt, Michael; Jain, Abhinandan; Vaidehi, Nagarajan; Sivaramakrishnan, Sivaraj			Kinase inhibitors allosterically disrupt a regulatory interaction to enhance PKC alpha membrane translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; SUBSTRATE AFFINITY; ACCURATE DOCKING; PROTEIN; GLIDE; AUTOINHIBITION; ACTIVATION; MECHANISMS; DOMAINS; GROMACS	The eukaryotic kinase domain has multiple intrinsically disordered regions whose conformation dictates kinase activity. Small molecule kinase inhibitors (SMKIs) rely on disrupting the active conformations of these disordered regions to inactivate the kinase. While SMKIs are selected for their ability to cause this disruption, the allosteric effects of conformational changes in disordered regions is limited by a lack of dynamic information provided by traditional structural techniques. In this study, we integrated multiscale molecular dynamics simulations with FRET sensors to characterize a novel allosteric mechanism that is selectively triggered by SMKI binding to the protein kinase C alpha domain. The indole maleimide inhibitors BimI and sotrastaurin were found to displace the Gly-rich loop (G-loop) that normally shields the ATP-binding site. Displacement of the G-loop interferes with a newly identified, structurally conserved binding pocket for the C1a domain on the N lobe of the kinase domain. This binding pocket, in conjunction with the N-terminal regulatory sequence, masks a diacylglycerol (DAG) binding site on the C1a domain. SMK-Imediated displacement of the G-loop released C1a and exposed the DAG binding site, enhancing protein kinase C alpha translocation both to synthetic lipid bilayers and to live cell membranes in the presence of DAG. Inhibitor chemotype determined the extent of the observed allosteric effects on the kinase domain and correlated with the extent of membrane recruitment. Our findings demonstrate the allosteric effects of SMKIs beyond the confines of kinase catalytic conformation and provide an integrated computational-experimental paradigm to investigate parallel mechanisms in other kinases.	[Lippert, Lisa G.; Ritt, Michael; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Ma, Ning; Vaidehi, Nagarajan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Computat & Quantitat Med, Duarte, CA 91010 USA; [Jain, Abhinandan] CALTECH, Jet Prop Lab, Pasadena, CA USA	University of Minnesota System; University of Minnesota Twin Cities; City of Hope; Beckman Research Institute of City of Hope; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Sivaramakrishnan, S (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.; Vaidehi, N (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Computat & Quantitat Med, Duarte, CA 91010 USA.	Nvaidehi@coh.org; Sivaraj@umn.edu		Sivaramakrishnan, Sivaraj/0000-0002-9541-6994	NIH [R01GM117923, R35GM126940]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research in this publication is supported by NIH-R35GM126940 (to S. S.) and NIH-R01GM117923 (to N. V. and S. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125; Antal CE, 2015, CELL REP, V12, P1252, DOI 10.1016/j.celrep.2015.07.039; Bazzoli A, 2017, PROTEINS, V85, P1994, DOI 10.1002/prot.25353; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; Bonny M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36028; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Fabbro D, 2015, MOL PHARMACOL, V87, P766, DOI 10.1124/mol.114.095489; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Komander D, 2004, STRUCTURE, V12, P215, DOI 10.1016/j.str.2004.01.005; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Larsen AB, 2014, J CHEM INF MODEL, V54, P508, DOI [10.1021/ci4004841, 10.1021/ci400484c]; Lee S, 2017, J BIOL CHEM, V292, P16300, DOI 10.1074/jbc.M117.804781; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Li H, 2014, J CHEM INF MODEL, V54, P1391, DOI [10.1021/ci400750x, 10.1021/ci40750x1]; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Lucic I, 2016, J MOL BIOL, V428, P121, DOI 10.1016/j.jmb.2015.11.001; Ma N, 2018, BIOCHEMISTRY-US, V57, P6387, DOI 10.1021/acs.biochem.8b00729; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Roffey J, 2009, CURR OPIN CELL BIOL, V21, P268, DOI 10.1016/j.ceb.2009.01.019; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Sommese RF, 2017, J BIOL CHEM, V292, P2873, DOI 10.1074/jbc.M116.768457; Sommese RF, 2016, J BIOL CHEM, V291, P21963, DOI 10.1074/jbc.M116.737601; Soriano EV, 2016, DEV CELL, V38, P384, DOI 10.1016/j.devcel.2016.07.018; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Swanson CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162331; Swanson CJ, 2014, J BIOL CHEM, V289, P17812, DOI 10.1074/jbc.M113.534750; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Uberall F, 1997, J BIOL CHEM, V272, P4072, DOI 10.1074/jbc.272.7.4072; Vaidehi N, 2015, J PHYS CHEM B, V119, P1233, DOI 10.1021/jp509136y; VARTANIAN T, 1989, GLIA, V2, P370, DOI 10.1002/glia.440020509; Wagner JR, 2013, J COMPUT CHEM, V34, P904, DOI 10.1002/jcc.23200; Wang CH, 2012, STRUCTURE, V20, P791, DOI 10.1016/j.str.2012.02.022	46	0	0	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100339	10.1016/j.jbc.2021.100339	http://dx.doi.org/10.1016/j.jbc.2021.100339			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33508318	Green Published, gold			2022-12-28	WOS:000672866400313
J	Rai, A; Vang, D; Ritt, M; Sivaramakrishnan, S				Rai, Ashim; Vang, Duha; Ritt, Michael; Sivaramakrishnan, Sivaraj			Dynamic multimerization of Dab2-Myosin VI complexes regulates cargo processivity while minimizing cortical actin reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-VI; MOTOR; BINDING; ENDOCYTOSIS; TRANSPORT; KINESIN; DAB2; ORGANIZATION; DIMERIZATION; MECHANISM	Myosin VI ensembles on endocytic cargo facilitate directed transport through a dense cortical actin network. Myosin VI is recruited to clathrin-coated endosomes via the cargo adaptor Dab2. Canonically, it has been assumed that the interactions between a motor and its cargo adaptor are stable. However, it has been demonstrated that the force generated by multiple stably attached motors disrupts local cytoskeletal architecture, potentially compromising transport. In this study, we demonstrate that dynamic multimerization of myosin VI-Dab2 complexes facilitates cargo processivity without significant reorganization of cortical actin networks. Specifically, we find that Dab2 myosin interacting region (MIR) binds myosin VI with a moderate affinity (184 nM) and single-molecule kinetic measurements demonstrate a high rate of turnover (1 s(-1)) of the Dab2 MIR-myosin VI interaction. Single-molecule motility shows that saturating Dab2-MIR concentration (2 mu M) promotes myosin VI homodimerization and processivity with run lengths comparable with constitutive myosin VI dimers. Cargo-mimetic DNA origami scaffolds patterned with Dab2 MIR-myosin VI complexes are weakly processive, displaying sparse motility on single actin filaments and "stop-and-go" motion on a cellular actin network. On a minimal actin cortex assembled on lipid bilayers, unregulated processive movement by either constitutive myosin V or VI dimers results in actin remodeling and foci formation. In contrast, Dab2 MIR-myosin VI interactions preserve the integrity of a minimal cortical actin network. Taken together, our study demonstrates the importance of dynamic motor-cargo association in enabling cargo transportation without disrupting cytoskeletal organization.	[Rai, Ashim; Vang, Duha; Ritt, Michael; Sivaramakrishnan, Sivaraj] Univ Minnesota Twin Cities, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Sivaramakrishnan, S (corresponding author), Univ Minnesota Twin Cities, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	sivaraj@umn.edu		Sivaramakrishnan, Sivaraj/0000-0002-9541-6994; Vang, Duha/0000-0002-8990-8968	National Institute of General Medical Sciences (NIGMS) R35 grant [R35GM126940-01]	National Institute of General Medical Sciences (NIGMS) R35 grant	This work was supported by National Institute of General Medical Sciences (NIGMS) R35 grant R35GM126940-01 awarded to S.S.	Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Batters C, 2016, P NATL ACAD SCI USA, V113, pE1162, DOI 10.1073/pnas.1519435113; Biancospino M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12855-6; Bond LM, 2012, J BIOL CHEM, V287, P38637, DOI 10.1074/jbc.M112.373969; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; DeSantis ME, 2017, CELL, V170, P1197, DOI 10.1016/j.cell.2017.08.037; Fili N, 2020, J BIOL CHEM, V295, P337, DOI 10.1074/jbc.RA119.010142; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hariadi RF, 2015, NAT NANOTECHNOL, V10, P696, DOI [10.1038/NNANO.2015.132, 10.1038/nnano.2015.132]; Hariadi RF, 2015, ELIFE, V4, DOI 10.7554/eLife.05472; Hariadi RF, 2014, P NATL ACAD SCI USA, V111, P4091, DOI 10.1073/pnas.1315923111; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Heissler SM, 2012, FEBS LETT, V586, P3208, DOI 10.1016/j.febslet.2012.07.014; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Inoue A, 2002, BIOCHEM BIOPH RES CO, V292, P300, DOI 10.1006/bbrc.2002.6636; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Koster DV, 2016, P NATL ACAD SCI USA, V113, pE1645, DOI 10.1073/pnas.1514030113; Koral K, 2014, AM J PHYSIOL-RENAL, V307, pF1380, DOI 10.1152/ajprenal.00454.2014; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Kumar M, 2019, J CELL BIOL, V218, P3697, DOI 10.1083/jcb.201903102; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Nagai J, 2005, AM J PHYSIOL-RENAL, V289, pF569, DOI 10.1152/ajprenal.00292.2004; O'Loughlin T, 2018, EMBO REP, V19, DOI 10.15252/embr.201744884; Olenick MA, 2016, J BIOL CHEM, V291, P18239, DOI 10.1074/jbc.M116.738211; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Pyrpassopoulos S., 2016, SCI REP-UK, V6, P1; Rai A, 2016, CELL, V164, P722, DOI 10.1016/j.cell.2015.12.054; Reck-Peterson SL, 2018, NAT REV MOL CELL BIO, V19, P382, DOI 10.1038/s41580-018-0004-3; Reymann AC, 2012, SCIENCE, V336, P1310, DOI 10.1126/science.1221708; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sckolnick M, 2013, J BIOL CHEM, V288, P29313, DOI 10.1074/jbc.M113.476929; Shang GJ, 2017, ELIFE, V6, P1, DOI 10.7554/eLife.27322; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; Sladewski TE, 2018, ELIFE, V7, DOI 10.7554/eLife.36306; Sonal, 2019, J CELL SCI, V132, DOI 10.1242/jcs.219899; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tumbarello DA, 2013, J CELL SCI, V126, P2561, DOI 10.1242/jcs.095554; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vogel SK, 2013, CYTOSKELETON, V70, P706, DOI 10.1002/cm.21136; Vogel SK, 2013, ELIFE, V2, DOI 10.7554/eLife.00116; Yao LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10874; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	60	4	4	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100232	10.1074/jbc.RA120.012703	http://dx.doi.org/10.1074/jbc.RA120.012703			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33372034	Green Published, gold			2022-12-28	WOS:000672866400210
J	Uchida, Y; Yamamoto, Y; Sakisaka, T				Uchida, Yasunori; Yamamoto, Yasunori; Sakisaka, Toshiaki			Trans-2-enoyl-CoA reductase limits Ca2+ accumulation in the endoplasmic reticulum by inhibiting the Ca2+ pump SERCA2b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID ELONGATION; SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; TRANSCRIPTION FACTOR; MENTAL-RETARDATION; CRYSTAL-STRUCTURES; MOLECULAR-CLONING; GENE; RECEPTOR; NFAT	The endoplasmic reticulum (ER) contains various enzymes that metabolize fatty acids (FAs). Given that FAs are the components of membranes, FA metabolic enzymes might be associated with regulation of ER membrane functions. However, it remains unclear whether there is the interplay between FA metabolic enzymes and ER membrane proteins. Trans-2-enoyl-CoA reductase (TER) is an FA reductase present in the ER membrane and catalyzes the last step in the FA elongation cycle and sphingosine degradation pathway. Here we identify sarco(endo)plasmic reticulum Ca2+-ATPase 2b (SERCA2b), an ER Ca2+ pump responsible for Ca2+ accumulation in the ER, as a TER-binding protein by affinity purification from HEK293 cell lysates. We show that TER directly binds to SERCA2b by in vitro assays using recombinant proteins. Thapsigargin, a specific SERCA inhibitor, inhibits this binding. TER binds to SERCA2b through its conserved C-terminal region. TER overexpression suppresses SERCA2b ATPase activity in microsomal membranes of HEK293 cells. Depletion of TER increases Ca2+ storage in the ER and accelerates SERCA2b-dependent Ca2+ uptake to the ER after ligand-induced Ca2+ release. Moreover, depletion of TER reduces the Ca2+-dependent nuclear translocation of nuclear factor of activated T cells 4. These results demonstrate that TER is a negative regulator of SERCA2b, implying the direct linkage of FA metabolism and Ca2+ accumulation in the ER.	[Uchida, Yasunori; Yamamoto, Yasunori; Sakisaka, Toshiaki] Kobe Univ, Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo, Japan	Kobe University	Sakisaka, T (corresponding author), Kobe Univ, Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo, Japan.	sakisaka@med.kobe-u.ac.jp			Japan Society for the Promotion of Sciences [18K14698, 18K06112, 16K15218]; GSK Japan Research Grant 2017; Setsuro Fujii Memorial, The Osaka Foundation for Promotion of Fundamental Medical Research	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); GSK Japan Research Grant 2017; Setsuro Fujii Memorial, The Osaka Foundation for Promotion of Fundamental Medical Research	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Sciences (18K14698, 18K06112, 16K15218) and also by GSK Japan Research Grant 2017 and the Setsuro Fujii Memorial, The Osaka Foundation for Promotion of Fundamental Medical Research.	Abe K, 2013, J BIOL CHEM, V288, P36741, DOI 10.1074/jbc.M113.493221; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; Cartier A, 2019, SCIENCE, V366, P323, DOI 10.1126/science.aar5551; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Devalla HD, 2016, EMBO MOL MED, V8, P1390, DOI 10.15252/emmm.201505719; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fujii Y, 2014, PROTEIN EXPRES PURIF, V95, P240, DOI 10.1016/j.pep.2014.01.009; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hatano N, 2008, J PROTEOME RES, V7, P809, DOI 10.1021/pr700566d; Inoue M, 2019, CELL REP, V27, P1221, DOI 10.1016/j.celrep.2019.03.106; INUI M, 1987, J BIOL CHEM, V262, P1740; JOHNSTON IG, 1992, J NEUROSCI RES, V32, P159, DOI 10.1002/jnr.490320205; JORGENSEN AO, 1988, CELL MOTIL CYTOSKEL, V9, P164, DOI 10.1002/cm.970090208; Kar P, 2015, MOL CELL, V58, P232, DOI 10.1016/j.molcel.2015.02.027; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Koshiba M., 2007, SOLUTION STRUCTURE N; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lee J, 2007, MOL CELL PROTEOMICS, V6, P669, DOI 10.1074/mcp.M600218-MCP200; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Moscu-Gregor A, 2020, J CARDIOVASC ELECTR, V31, P1527, DOI 10.1111/jce.14446; MOVSESIAN MA, 1994, CIRCULATION, V90, P653, DOI 10.1161/01.CIR.90.2.653; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Olivera A, 1999, FASEB J, V13, P1593, DOI 10.1096/fasebj.13.12.1593; Paul S, 2007, J BIOL CHEM, V282, P19237, DOI 10.1074/jbc.M701774200; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Stepanovska B, 2020, PHARMACOL RES, V154, DOI 10.1016/j.phrs.2019.02.009; Su WC, 2019, J CELL BIOL, V218, P3663, DOI 10.1083/jcb.201902072; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Ushioda R, 2016, P NATL ACAD SCI USA, V113, pE6055, DOI 10.1073/pnas.1605818113; Vandecaetsbeek I, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004184; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; WU KD, 1995, AM J PHYSIOL-CELL PH, V269, pC775, DOI 10.1152/ajpcell.1995.269.3.C775; Xie LJ, 2019, EUR J MED GENET, V62, DOI 10.1016/j.ejmg.2019.01.018; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; Zhang XX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09593-0; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993; Zimmermann H, 2016, PURINERG SIGNAL, V12, P25, DOI 10.1007/s11302-015-9483-2	68	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100310	10.1016/j.jbc.2021.100310	http://dx.doi.org/10.1016/j.jbc.2021.100310			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482198	Green Published, gold			2022-12-28	WOS:000672866400284
J	Wargnies, M; Plazolles, N; Schenk, R; Villafraz, O; Dupuy, JW; Biran, M; Bachmaier, S; Baudouin, H; Clayton, C; Boshart, M; Bringaud, F				Wargnies, Marion; Plazolles, Nicolas; Schenk, Robin; Villafraz, Oriana; Dupuy, Jean-William; Biran, Marc; Bachmaier, Sabine; Baudouin, Helene; Clayton, Christine; Boshart, Michael; Bringaud, Frederic			Metabolic selection of a homologous recombination-mediated gene loss protects Trypanosoma brucei from ROS production by glycosomal fumarate reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ASPARTATE OXIDASE; DEHYDROGENASE GENE; ESCHERICHIA-COLI; LINEAR AMPLICONS; ENZYME; AMPLIFICATION; EXPRESSION; IDENTIFICATION; SUPEROXIDE; GENERATION	The genome of trypanosomatids rearranges by using repeated sequences as platforms for amplification or deletion of genomic segments. These stochastic recombination events have a direct impact on gene dosage and foster the selection of adaptive traits in response to environmental pressure. We provide here such an example by showing that the phosphoenolpyruvate carboxykinase (PEPCK) gene knockout (Delta pepck) leads to the selection of a deletion event between two tandemly arranged fumarate reductase (FRDg and FRDm2) genes to produce a chimeric FRDg-m2 gene in the Delta pepck* cell line. FRDg is expressed in peroxisome-related organelles, named glycosomes, expression of FRDm2 has not been detected to date, and FRDg-m2 is nonfunctional and cytosolic. Reexpression of FRDg significantly impaired growth of the Delta pepck* cells, but FRD enzyme activity was not required for this negative effect. Instead, glycosomal localization as well as the covalent flavinylation motif of FRD is required to confer growth retardation and intracellular accumulation of reactive oxygen species (ROS). The data suggest that FRDg, similar to Escherichia coli FRD, can generate ROS in a flavin-dependent process by transfer of electrons from NADH to molecular oxygen instead of fumarate when the latter is unavailable, as in the Delta pepck background. Hence, growth retardation is interpreted as a consequence of increased production of ROS, and rearrangement of the FRD locus liberates Delta pepck* cells from this obstacle. Interestingly, intracellular production of ROS has been shown to be required to complete the parasitic cycle in the insect vector, suggesting that FRDg may play a role in this process.	[Wargnies, Marion; Plazolles, Nicolas; Villafraz, Oriana; Baudouin, Helene; Bringaud, Frederic] Univ Bordeaux, UMR 5234, Microbiol Fondamentale & Pathogenicite MFP, CNRS, Bordeaux, France; [Wargnies, Marion; Biran, Marc; Baudouin, Helene; Bringaud, Frederic] Univ Bordeaux, CNRS, Ctr Resonance Magnet Syst Biol CRMSB, UMR 5536, Bordeaux, France; [Schenk, Robin; Bachmaier, Sabine; Boshart, Michael] Ludwig Maximilians Univ Munchen, Genet, Fak Biol, Martinsried, Germany; [Dupuy, Jean-William] Univ Bordeaux, Plateforme Proteome, Bordeaux, France; [Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, Univ Heidelberg ZBMH, Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Munich; UDICE-French Research Universities; Universite de Bordeaux; Ruprecht Karls University Heidelberg	Bringaud, F (corresponding author), Univ Bordeaux, UMR 5234, Microbiol Fondamentale & Pathogenicite MFP, CNRS, Bordeaux, France.; Bringaud, F (corresponding author), Univ Bordeaux, CNRS, Ctr Resonance Magnet Syst Biol CRMSB, UMR 5536, Bordeaux, France.; Boshart, M (corresponding author), Ludwig Maximilians Univ Munchen, Genet, Fak Biol, Martinsried, Germany.	boshart@lmu.de; frederic.bringaud@u-bordeaux.fr	Dupuy, Jean-William JWD/F-5335-2012; Boshart, Michael/A-2700-2011	Dupuy, Jean-William JWD/0000-0002-2448-4797; Boshart, Michael/0000-0002-5070-2663; PLAZOLLES, Nicolas/0000-0002-7186-3765; Bachmaier, Sabine/0000-0001-7416-8613; VILLAFRAZ, Oriana/0000-0001-6927-7276; Baudouin, Helene/0000-0002-3480-0685; Clayton, Christine/0000-0002-6384-0731	Faculty of Biology of LMU	Faculty of Biology of LMU	Work in the Munich lab was supported by a student research fellowship and the BioNa junior career award of the Faculty of Biology of LMU to R. S. and S. B., respectively.	Allmann S, 2013, J BIOL CHEM, V288, P18494, DOI 10.1074/jbc.M113.462978; Bassarak B, 2011, CELL PHYSIOL BIOCHEM, V27, P411, DOI 10.1159/000327968; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; Bringaud F, 2015, MOL MICROBIOL, V96, P917, DOI 10.1111/mmi.12990; BRUN R, 1979, ACTA TROP, V36, P289; Chiasson D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46171-2; Clayton CE, 2016, CURR OPIN MICROBIOL, V32, P46, DOI 10.1016/j.mib.2016.04.018; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Denise H, 1999, EUR J BIOCHEM, V259, P339, DOI 10.1046/j.1432-1327.1999.00048.x; Deramchia K, 2014, J BIOL CHEM, V289, P17365, DOI 10.1074/jbc.M114.567230; Deutsch EW, 2020, NUCLEIC ACIDS RES, V48, pD1145, DOI 10.1093/nar/gkz984; Dolezelova E, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000741; Dubessay P, 2001, NUCLEIC ACIDS RES, V29, P3231, DOI 10.1093/nar/29.15.3231; Ebikeme C, 2010, J BIOL CHEM, V285, P32312, DOI 10.1074/jbc.M110.124917; Elahian F, 2014, CRIT REV BIOTECHNOL, V34, P134, DOI 10.3109/07388551.2012.732031; GARVEY EP, 1986, SCIENCE, V233, P535, DOI 10.1126/science.3726545; Graf FE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002475; GRONDIN K, 1993, NUCLEIC ACIDS RES, V21, P1895, DOI 10.1093/nar/21.8.1895; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Harlow E., 1988, ANTIBODIES LAB MANUA; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kramer S, 2007, MOL BIOCHEM PARASIT, V151, P129, DOI 10.1016/j.molbiopara.2006.10.004; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Mantilla BS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006158; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Meehan BM, 2012, MICROBIOL-SGM, V158, P539, DOI 10.1099/mic.0.054403-0; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Mulindwa J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006280; Munday JC, 2014, J ANTIMICROB CHEMOTH, V69, P651, DOI 10.1093/jac/dkt442; NASU S, 1982, J BIOL CHEM, V257, P626; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; OLMO A, 1995, NUCLEIC ACIDS RES, V23, P2856, DOI 10.1093/nar/23.15.2856; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P21, DOI 10.1111/j.1432-1033.1977.tb11566.x; PAPADOPOULOU B, 1993, NUCLEIC ACIDS RES, V21, P4305, DOI 10.1093/nar/21.18.4305; PATNAIK PK, 1994, MOL BIOCHEM PARASIT, V66, P153, DOI 10.1016/0166-6851(94)90047-7; Ponte-Sucre A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006052; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schenk R, 2021, FEBS J, V288, P5430, DOI 10.1111/febs.15812; Serebryakova MV, 2018, BIOCHIMIE, V149, P34, DOI 10.1016/j.biochi.2018.03.013; Song J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005436; Stevens JR, 2001, ADV PARASIT, V48, P1, DOI 10.1016/S0065-308X(01)48003-1; Tedeschi G, 1996, EUR J BIOCHEM, V239, P427, DOI 10.1111/j.1432-1033.1996.0427u.x; TURRENS JF, 1987, MOL BIOCHEM PARASIT, V25, P55, DOI 10.1016/0166-6851(87)90018-1; Ubeda JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001868; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; van der Reest J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04003-3; Wargnies M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007502; WILSON K, 1994, J BIOL CHEM, V269, P28979; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	57	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100548	10.1016/j.jbc.2021.100548	http://dx.doi.org/10.1016/j.jbc.2021.100548			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33741344	Green Submitted, Green Published, gold			2022-12-28	WOS:000672866400521
J	Wong, SJ; Ringel, AE; Yuan, W; Paulo, JA; Yoon, H; Currie, MA; Haigis, MC				Wong, Samantha J.; Ringel, Alison E.; Yuan, William; Paulo, Joao A.; Yoon, Haejin; Currie, Mark A.; Haigis, Marcia C.			Development of a colorimetric alpha-ketoglutarate detection assay for prolyl hydroxylase domain (PHD) proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR INHIBITING HIF; INDUCIBLE FACTOR HIF; GLUTAMATE-DEHYDROGENASE; BIOCHEMICAL-CHARACTERIZATION; ASCORBATE; 4-HYDROXYLASE; FAMILY; IDENTIFICATION; PURIFICATION; METABOLISM	Since the discovery of the prolyl hydroxylases domain (PHD) proteins and their canonical hypoxia-inducible factor (HIF) substrate two decades ago, a number of in vitro hydroxylation (IVH) assays for PHD activity have been developed to measure the PHD-HIF interaction. However, most of these assays either require complex proteomics mass spectrometry methods that rely on the specific PHD-HIF interaction or require the handling of radioactive material, as seen in the most commonly used assay measuring [C-14]O-2 release from labeled [C-14]alpha-ketoglutarate. Here, we report an alternative rapid, cost-effective assay in which the consumption of a-ketoglutarate is monitored by its derivatization with 2,4-dinitrophenylhydrazine (2,4-DNPH) followed by treatment with concentrated base. We extensively optimized this 2,4-DNPH alpha-ketoglutarate assay to maximize the signal-to-noise ratio and demonstrated that it is robust enough to obtain kinetic parameters of the well-characterized PHD2 isoform comparable with those in published literature. We further showed that it is also sensitive enough to detect and measure the IC50 values of pan-PHD inhibitors and several PHD2 inhibitors in clinical trials for chronic kidney disease (CKD)induced anemia. Given the efficiency of this assay coupled with its multiwell format, the 2,4-DNPH alpha-KG assay may be adaptable to explore non-HIF substrates of PHDs and potentially to high-throughput assays.	[Wong, Samantha J.; Ringel, Alison E.; Paulo, Joao A.; Yoon, Haejin; Currie, Mark A.; Haigis, Marcia C.] Harvard Med Sch, Blavatn Inst, Dept Cell Biol, Boston, MA 02115 USA; [Yuan, William] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Currie, Mark A.] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada; [Currie, Mark A.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Toronto; University Toronto Mississauga; University of Toronto	Haigis, MC (corresponding author), Harvard Med Sch, Blavatn Inst, Dept Cell Biol, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu	Yoon, Haejin/ABA-5821-2021	Yoon, Haejin/0000-0002-7139-0419	Agency for Science, Technology and Research, Singapore; American Cancer Society [PF-17-13201-CCG]; National Institutes of Health (NIH)/National Institute of General Medical Sciences [R01GM132129]; American Diabetes Association Fellowship [1-17-PDF-109]; NIH [R01CA213062]; Glenn Foundation for Medical Research	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); American Cancer Society(American Cancer Society); National Institutes of Health (NIH)/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Diabetes Association Fellowship(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research	S. J. W. is supported by the National Science Scholarship from the Agency for Science, Technology and Research, Singapore. A. E. R. is supported by a postdoctoral fellowship from the American Cancer Society (PF-17-13201-CCG). J. A. P is funded in part by National Institutes of Health (NIH)/National Institute of General Medical Sciences grant R01GM132129. H. Y. is funded by the American Diabetes Association Fellowship (1-17-PDF-109), and M. C. H. is funded by NIH grant R01CA213062 and the Glenn Foundation for Medical Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adusumilli R, 2017, METHODS MOL BIOL, V1550, P339, DOI 10.1007/978-1-4939-6747-6_23; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Briggs KJ, 2016, CELL, V166, P126, DOI 10.1016/j.cell.2016.05.042; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cao J, 2012, ORG BIOMOL CHEM, V10, P3913, DOI 10.1039/c2ob07076f; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Cho H, 2005, BIOCHEM BIOPH RES CO, V337, P275, DOI 10.1016/j.bbrc.2005.09.041; Choudhury R, 2007, FEBS LETT, V581, P2733, DOI 10.1016/j.febslet.2007.05.032; Chowdhury R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12673; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Cockmann ME, 2019, ELIFE, V8, DOI 10.7554/eLife.46490; CONSALVI V, 1994, COMP BIOCHEM PHYS B, V109, P691, DOI 10.1016/0305-0491(94)90132-5; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dao JH, 2009, ANAL BIOCHEM, V384, P213, DOI 10.1016/j.ab.2008.09.052; DEJONG L, 1982, BIOCHIM BIOPHYS ACTA, V704, P326, DOI 10.1016/0167-4838(82)90162-5; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fedulova N, 2007, PROTEIN EXPRES PURIF, V54, P1, DOI 10.1016/j.pep.2007.02.018; Flashman E, 2008, J BIOL CHEM, V283, P3808, DOI 10.1074/jbc.M707411200; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; German NJ, 2016, MOL CELL, V63, P1006, DOI 10.1016/j.molcel.2016.08.014; Goda S, 2005, BIOCHEMISTRY-US, V44, P15304, DOI 10.1021/bi050478l; Gorres KL, 2009, ANAL BIOCHEM, V386, P181, DOI 10.1016/j.ab.2008.11.046; Hewitson KS, 2007, METHOD ENZYMOL, V435, P25, DOI 10.1016/S0076-6879(07)35002-7; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Johansson C, 2014, EPIGENOMICS-UK, V6, P89, DOI 10.2217/epi.13.79; Joharapurkar AA, 2018, J MED CHEM, V61, P6964, DOI 10.1021/acs.jmedchem.7b01686; JONES LA, 1956, ANAL CHEM, V28, P191, DOI 10.1021/ac60110a013; Kanelakis KC, 2009, J BIOMOL SCREEN, V14, P627, DOI 10.1177/1087057109333976; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koivunen P, 2018, METHODS MOL BIOL, V1742, P15, DOI 10.1007/978-1-4939-7665-2_2; Koontz L, 2014, METHOD ENZYMOL, V541, P3, DOI 10.1016/B978-0-12-420119-4.00001-X; Li JM, 2020, NAT METHODS, V17, P399, DOI 10.1038/s41592-020-0781-4; Li M, 2011, NEUROCHEM INT, V59, P445, DOI 10.1016/j.neuint.2010.10.017; Li M, 2009, J BIOL CHEM, V284, P22988, DOI 10.1074/jbc.M109.020222; Liu Y, 2010, BIOCHEM BIOPH RES CO, V401, P231, DOI 10.1016/j.bbrc.2010.09.037; Luo WB, 2014, MOL BIOL CELL, V25, P2788, DOI 10.1091/mbc.E14-02-0775; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; McMahon GM, 2019, CURR OPIN NEPHROL HY, V28, P600, DOI 10.1097/MNH.0000000000000554; McNeill LA, 2005, ANAL BIOCHEM, V336, P125, DOI 10.1016/j.ab.2004.09.019; Mesquita CS, 2014, ANAL BIOCHEM, V458, P69, DOI 10.1016/j.ab.2014.04.034; Munawar N, 2012, EXTREMOPHILES, V16, P463, DOI 10.1007/s00792-012-0446-z; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; NIETFELD JJ, 1981, BIOCHIM BIOPHYS ACTA, V657, P159, DOI 10.1016/0005-2744(81)90139-X; Nytko KJ, 2011, BLOOD, V117, P5485, DOI 10.1182/blood-2010-09-307637; Oehme F, 2004, ANAL BIOCHEM, V330, P74, DOI 10.1016/j.ab.2004.03.066; Pappalardi MB, 2011, BIOCHEM J, V436, P363, DOI 10.1042/BJ20101201; PIJOAN M, 1946, SCIENCE, V103, P202, DOI 10.1126/science.103.2668.202; Rabinowitz MH, 2013, J MED CHEM, V56, P9369, DOI 10.1021/jm400386j; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Sim JW, 2018, CELL METAB, V27, P898, DOI 10.1016/j.cmet.2018.02.020; Smirnova NA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1108, DOI 10.1134/S0006297912100033; Strowitzki MJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050384; Tarhonskaya H, 2015, J BIOL CHEM, V290, P19726, DOI 10.1074/jbc.M115.653014; Tennant DA, 2009, ONCOGENE, V28, P4009, DOI 10.1038/onc.2009.250; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wakamatsu T, 2013, EXTREMOPHILES, V17, P379, DOI 10.1007/s00792-013-0527-7; Xie L, 2012, J CLIN INVEST, V122, P2827, DOI 10.1172/JCI62374; Yeh TL, 2017, CHEM SCI, V8, P7651, DOI 10.1039/c7sc02103h; Yu Z, 2020, CHEM BIOL DRUG DES, V95, P270, DOI 10.1111/cbdd.13640	68	4	4	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100397	10.1016/j.jbc.2021.100397	http://dx.doi.org/10.1016/j.jbc.2021.100397			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571527	Green Published, gold			2022-12-28	WOS:000672866400371
J	Wu, J; Chen, X; Sehgal, P; Zhang, TW; Jackson-Weaver, O; Gou, YC; Bautch, V; Frenkel, B; Sun, HC; Xu, J				Wu, Jian; Chen, Xi; Sehgal, Prerna; Zhang, Tingwei; Jackson-Weaver, Olan; Gou, Yongchao; Bautch, Victoria; Frenkel, Baruch; Sun, Hongchen; Xu, Jian			Arginine methylation of R81 in Smad6 confines BMP-induced Smad1 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION; TRANSCRIPTION; HOMEOSTASIS; MUTATIONS; GROWTH; CANCER; RUNX2	Bone morphogenetic proteins (BMPs) secreted by a variety of cell types are known to play essential roles in cell differentiation and matrix formation in the bone, cartilage, muscle, blood vessel, and neuronal tissue. BMPs activate intracellular effectors via C-terminal phosphorylation of Smad1, Smad5, and Smad9, which relay the signaling by forming a complex with Smad4 and translocate to the nucleus for transcriptional activation. Smad6 inhibits BMP signaling through diverse mechanisms operative at the membrane, cytosolic, and nuclear levels. However, the mechanistic underpinnings of Smad6 functional diversity remain unclear. Here, using a biochemical approach and cell differentiation systems, we report a cytosolic mechanism of action for Smad6 that requires arginine methylation at arginine 81 (R81) and functions through association with Smad1 and interference with the formation of Smad1-Smad4 complexes. By mutating the methylated arginine residue, R81, and by silencing the expression of protein arginine methyltransferase 1, we show that protein arginine methyltransferase 1 catalyzes R81 methylation of Smad6 upon BMP treatment, R81 methylation subsequently facilitates Smad6 interaction with the phosphorylated active Smad1, and R81 methylation facilitates Smad6-mediated interruption of Smad1-Smad4 complex formation and nuclear translocation. Furthermore, Smad6 WT but not the methylation-deficient R81A mutant inhibited BMP-responsive transcription, attenuated BMP-mediated osteogenic differentiation, and antagonized BMP-mediated inhibition of cell invasion. Taken together, our results suggest that R81 methylation plays an essential role in Smad6-mediated inhibition of BMP responses.	[Wu, Jian; Chen, Xi; Sehgal, Prerna; Zhang, Tingwei; Jackson-Weaver, Olan; Gou, Yongchao; Xu, Jian] Univ Southern Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90007 USA; [Chen, Xi; Sun, Hongchen] China Med Univ, Coll Stomatol, Shenyang, Peoples R China; [Zhang, Tingwei; Gou, Yongchao] Chongqing Med Univ, Coll Stomatol, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China; [Bautch, Victoria] Univ Northern Carolina, Dept Biol, Chapel Hill, NC USA; [Bautch, Victoria] Univ Northern Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Frenkel, Baruch; Xu, Jian] Univ Southern Calif, Dept Biochem & Mol Med, Keck Sch Med, Los Angeles, CA 90007 USA; [Xu, Jian] Univ Southern Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90007 USA; [Wu, Jian] Louisiana State Univ, Cardiovasc Ctr Excellence, New Orleans, LA USA; [Jackson-Weaver, Olan] Tulane Univ, Tulane Sch Med, Trauma & Crit Care Educ Div, New Orleans, LA 70118 USA	University of Southern California; China Medical University; Chongqing Medical University; University of Southern California; University of Southern California; Louisiana State University System; Tulane University	Xu, J (corresponding author), Univ Southern Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90007 USA.; Sun, HC (corresponding author), China Med Univ, Coll Stomatol, Shenyang, Peoples R China.; Xu, J (corresponding author), Univ Southern Calif, Dept Biochem & Mol Med, Keck Sch Med, Los Angeles, CA 90007 USA.; Xu, J (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90007 USA.	sunhongchen@cmu.edu.cn; xujian@usc.edu		Xu, Jian/0000-0002-8162-889X; Gou, Yongchao/0000-0001-8725-3702; Jackson-Weaver, Olan/0000-0002-0545-0647; Zhang, Tingwei/0000-0003-2173-4663; Sehgal, Prerna/0000-0003-4913-896X	NIDCR, National Institutes of Health [RO1DE02468]; American Heart Association [16BGIA26540000, 11SDG5220002]; American Heart Association postdoctoral fellowship [15POST25710243]; National Natural Science Foundation of China [81800985]; Herman Ostrow School of Dentistry; University of Southern California	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Heart Association(American Heart Association); American Heart Association postdoctoral fellowship(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Herman Ostrow School of Dentistry; University of Southern California	This research was supported by grants including the NIDCR, National Institutes of Health (RO1DE02468, to J. X.), American Heart Association (16BGIA26540000 and 11SDG5220002, to J. X.), American Heart Association postdoctoral fellowship (15POST25710243, to J. W.), National Natural Science Foundation of China (81800985, to T. Z.), Seed grant from the Herman Ostrow School of Dentistry (to J. X.), and start-up fund from the Provost at the University of Southern California (to J. X.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Chaikuad A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022111; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; de Boeck M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24968; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Goumans MJ, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a031989; Grgurevic L, 2016, CYTOKINE GROWTH F R, V27, P105, DOI 10.1016/j.cytogfr.2015.12.009; Guccione E, 2019, NAT REV MOL CELL BIO, V20, P642, DOI 10.1038/s41580-019-0155-x; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inamitsu M, 2006, FEBS LETT, V580, P6603, DOI 10.1016/j.febslet.2006.11.008; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Jiao JT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04936-9; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Koromila T, 2014, J CELL BIOCHEM, V115, P27, DOI 10.1002/jcb.24646; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lin X, 2003, MOL CELL BIOL, V23, P9081, DOI 10.1128/MCB.23.24.9081-9093.2003; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Morimoto E, 2017, J CELL PHYSIOL, V232, P145, DOI 10.1002/jcp.25399; Mouillesseaux KP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13247; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Timberlake AT, 2018, HUM GENOME VAR, V5, DOI 10.1038/s41439-018-0014-x; Timberlake AT, 2017, P NATL ACAD SCI USA, V114, pE7341, DOI 10.1073/pnas.1709255114; Timberlake AT, 2016, ELIFE, V5, DOI 10.7554/eLife.20125; Wang Y, 2016, ONCOTARGET, V7, P24383, DOI 10.18632/oncotarget.8328; Wyliea LA, 2018, DEV BIOL, V442, P199, DOI 10.1016/j.ydbio.2018.07.027; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhang T, 2018, J DENT RES, V97, P810, DOI 10.1177/0022034518755688	37	2	2	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100496	10.1016/j.jbc.2021.100496	http://dx.doi.org/10.1016/j.jbc.2021.100496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667543	Green Published, gold			2022-12-28	WOS:000672866400470
J	Yu, BB; Liu, YA; Luo, HG; Fu, JY; Li, Y; Shao, C				Yu, Bingbing; Liu, Yanan; Luo, Haoge; Fu, Jiaying; Li, Yang; Shao, Chen			Androgen receptor splicing variant 7 (ARV7) inhibits docetaxel sensitivity by inactivating the spindle assembly checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; MITOTIC CHECKPOINT; RESISTANCE; SLIPPAGE; MECHANISMS; AR-V7	The clinical efficacy of docetaxel (DTX) in prostate cancer treatment is barely satisfactory due to diverse responses of the patients, including the development of resistance. Recently, aberrant androgen receptor (AR) signaling, including expression of the constitutively active ARV7, was reported to contribute to DTX resistance. However, the underlying molecular mechanism remains largely unknown. Of note, previous studies have highlighted that ARV7, unlike its parental AR, potentially favors the expression of some genes involved in cell cycle progression. Since DTX mainly targets microtubule dynamics and mitosis, we wanted to test whether ARV7 plays a specific role in mitotic regulation and whether this activity is involved in DTX resistance. In the present study, we found that ARV7 mediates DTX sensitivity through inactivating the spindle assembly checkpoint (SAC) and promoting mitotic slippage. By shifting the balance to the slippage pathway, ARV7-expressing cells are more likely to escape from mitotic death induced by acute DTX treatment. Furthermore, we also identified E2 enzyme UBE2C as the primary downstream effector of ARV7 in promoting the SAC inactivation and premature degradation of cyclin B1. Moreover, we showed that combination treatment of DTX and an inhibitor of mitotic exit can exert synergistic effect in high ARV7-expressing prostate cancer cells. In sum, our work identified a novel role of ARV7 in promoting DTX resistance and offering a potential path to combat DTX resistance related to abnormal activation of the AR signaling and mitotic dysregulation.	[Yu, Bingbing; Liu, Yanan; Luo, Haoge; Fu, Jiaying; Li, Yang; Shao, Chen] Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, Changchun, Peoples R China	Jilin University	Shao, C (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, Changchun, Peoples R China.	shaochen@jlu.edu.cn		, Chen/0000-0001-5008-6912	National Natural Science Foundation of China [81802579]; Jilin University Bethune Plan B Projects [2018B30]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin University Bethune Plan B Projects	This work was supported by the National Natural Science Foundation of China (81802579) and the Jilin University Bethune Plan B Projects (2018B30).	Antonarakis ES, 2015, JAMA ONCOL, V1, P582, DOI 10.1001/jamaoncol.2015.1341; Bastos DA, 2018, EXPERT REV MOL DIAGN, V18, P155, DOI 10.1080/14737159.2018.1427068; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Cao B, 2014, ONCOTARGET, V5, P1646, DOI 10.18632/oncotarget.1802; Cheng B, 2017, ENDOCR-RELAT CANCER, V24, pT97, DOI 10.1530/ERC-17-0147; Ciccarese C, 2016, CANCER TREAT REV, V43, P27, DOI 10.1016/j.ctrv.2015.12.003; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Dai C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a030452; Fu YF, 2007, GYNECOL ONCOL, V105, P66, DOI 10.1016/j.ygyno.2006.10.061; Han JS, 2013, MOL CELL, V51, P92, DOI 10.1016/j.molcel.2013.05.019; Hao ZL, 2012, TUMOR BIOL, V33, P723, DOI 10.1007/s13277-011-0291-1; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Haschka M, 2018, EMBO REP, V19, DOI 10.15252/embr.201745440; He YD, 2018, NUCLEIC ACIDS RES, V46, P1895, DOI 10.1093/nar/gkx1306; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Komura K, 2016, P NATL ACAD SCI USA, V113, P6259, DOI 10.1073/pnas.1600420113; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lu J, 2015, J UROLOGY, V193, P690, DOI 10.1016/j.juro.2014.08.043; Ma HT, 2012, J BIOL CHEM, V287, P21561, DOI 10.1074/jbc.M112.364356; Nakazawa M, 2014, HORM CANCER-US, V5, P265, DOI 10.1007/s12672-014-0190-1; Pienta KJ, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.26892; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Shao C, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116768; Sharp A, 2019, J CLIN INVEST, V129, P192, DOI 10.1172/JCI122819; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sloss O, 2016, ONCOTARGET, V7, P5176, DOI 10.18632/oncotarget.6894; Tagawa ST, 2019, CLIN CANCER RES, V25, P1880, DOI 10.1158/1078-0432.CCR-18-0320; Thadani-Mulero M, 2014, CANCER RES, V74, P2270, DOI 10.1158/0008-5472.CAN-13-2876; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; Wadosky KM, 2017, ONCOTARGET, V8, P18550, DOI 10.18632/oncotarget.14537; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Xie CL, 2014, INT J BIOCHEM CELL B, V47, P113, DOI 10.1016/j.biocel.2013.11.023; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhan Y, 2017, MOL CANCER RES, V15, P59, DOI 10.1158/1541-7786.MCR-16-0236; Zhang GY, 2015, ONCOTARGET, V6, P23358, DOI 10.18632/oncotarget.4396	41	6	6	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100276	10.1016/j.jbc.2021.100276	http://dx.doi.org/10.1016/j.jbc.2021.100276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428943	Green Published, gold			2022-12-28	WOS:000672866400252
J	Glasgow, EM; Kemna, EI; Bingman, CA; Ing, NL; Deng, K; Bianchetti, CM; Takasuka, TE; Northen, TR; Fox, BG				Glasgow, Evan M.; Kemna, Elias, I; Bingman, Craig A.; Ing, Nicole L.; Deng, Kai; Bianchetti, Christopher M.; Takasuka, Taichi E.; Northen, Trent R.; Fox, Brian G.			A structural and kinetic survey of GH5_4 endoglucanases reveals determinants of broad substrate specificity and opportunities for biomass hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; substrate specificity; polysaccharide; cellulase; bioenergy; endoglucanase; GH5; xyloglucanase	BIOCHEMICAL-CHARACTERIZATION; RUMINOCOCCUS-FLAVEFACIENS; GLYCOSYL HYDROLASES; TRICHODERMA-REESEI; GENOME SEQUENCE; XYLOGLUCAN; BINDING; RECOGNITION; CELLULASE; IDENTIFICATION	Broad-specificity glycoside hydrolases (GHs) contribute to plant biomass hydrolysis by degrading a diverse range of polysaccharides, making them useful catalysts for renewable energy and biocommodity production. Discovery of new GHs with improved kinetic parameters or more tolerant substrate-binding sites could increase the efficiency of renewable bioenergy production even further. GH5 has over 50 subfamilies exhibiting selectivities for reaction with beta-(1,4)-linked oligo- and polysaccharides. Among these, subfamily 4 (GH5_4) contains numerous broad-selectivity endoglucanases that hydrolyze cellulose, xyloglucan, and mixed-linkage glucans. We previously surveyed the whole subfamily and found over 100 new broad-specificity endoglucanases, although the structural origins of broad specificity remained unclear. A mechanistic understanding of GH5_4 substrate specificity would help inform the best protein design strategies and the most appropriate industrial application of broad-specificity endoglucanases. Here we report structures of 10 new GH5_4 enzymes from cellulolytic microbes and characterize their substrate selectivity using normalized reducing sugar assays and MS. We found that GH5_4 enzymes have the highest catalytic efficiency for hydrolysis of xyloglucan, glucomannan, and soluble beta-glucans, with opportunistic secondary reactions on cellulose, mannan, and xylan. The positions of key aromatic residues determine the overall reaction rate and breadth of substrate tolerance, and they contribute to differences in oligosaccharide cleavage patterns. Our new composite model identifies several critical structural features that confer broad specificity and may be readily engineered into existing industrial enzymes. We demonstrate that GH5_4 endoglucanases can have broad specificity without sacrificing high activity, making them a valuable addition to the biomass deconstruction toolset.	[Glasgow, Evan M.; Kemna, Elias, I; Bingman, Craig A.; Bianchetti, Christopher M.; Fox, Brian G.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Glasgow, Evan M.; Bingman, Craig A.; Bianchetti, Christopher M.; Fox, Brian G.] Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA; [Ing, Nicole L.; Deng, Kai; Northen, Trent R.] Joint BioEnergy Inst, Emeryville, CA USA; [Ing, Nicole L.; Deng, Kai] Sandia Natl Labs, Livermore, CA USA; [Takasuka, Taichi E.] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Northen, Trent R.] Lawrence Berkeley Natl Lab, Berkeley, CA USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Sandia National Laboratories; Hokkaido University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Fox, BG (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.; Fox, BG (corresponding author), Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA.	bgfox@biochem.wisc.edu	Takasuka, Taichi/AAF-9441-2020; Bingman, Craig/F-1711-2019	Takasuka, Taichi/0000-0002-4413-2924; Glasgow, Evan/0000-0002-6542-781X; Kemna, Elias/0000-0002-9527-7189; Ing, Nicole/0000-0003-4264-9679; Bingman, Craig/0000-0002-3073-5089	United States Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-SC0018409, DE-FC02-07ER64494, DE-AC02-05CH11231]; National Institutes of Health [5 T32 GM008349]	United States Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the United States Department of Energy, Office of Science, Office of Biological and Environmental Research under Awards DE-SC0018409, DE-FC02-07ER64494, and DE-AC02-05CH11231. E. M. G. was supported by National Institutes of Health Grant 5 T32 GM008349 (UW-Madison Biotechnology Training Program). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Andric P, 2010, BIOTECHNOL ADV, V28, P308, DOI 10.1016/j.biotechadv.2010.01.003; Annamalai N, 2016, BIOFUEL BIOREFIN TEC, V3, P37, DOI 10.1007/978-3-319-43679-1_3; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Attia MA, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1039-6; Badieyan S, 2012, BIOTECHNOL BIOENG, V109, P31, DOI 10.1002/bit.23280; Bianchetti CM, 2013, J MOL BIOL, V425, P4267, DOI 10.1016/j.jmb.2013.05.030; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Chandel AK, 2018, BIORESOURCE TECHNOL, V264, P370, DOI 10.1016/j.biortech.2018.06.004; Chassard C, 2012, INT J SYST EVOL MICR, V62, P138, DOI 10.1099/ijs.0.027375-0; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; Couturier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079800; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Deng K, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00165; Deng K, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00153; Deng K, 2014, ACS CHEM BIOL, V9, P1470, DOI 10.1021/cb5000289; Desvaux M, 2005, FEMS MICROBIOL REV, V29, P741, DOI 10.1016/j.femsre.2004.11.003; Diederichs K, 2003, ACTA CRYSTALLOGR D, V59, P903, DOI 10.1107/S0907444903006516; Dorival J, 2018, BIOCHEM J, V475, P3609, DOI 10.1042/BCJ20180486; dos Santos CR, 2015, BIOCHEMISTRY-US, V54, P1930, DOI 10.1021/acs.biochem.5b00011; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FIEROBE HP, 1991, J BACTERIOL, V173, P7956, DOI 10.1128/jb.173.24.7956-7962.1991; Findley SD, 2011, APPL ENVIRON MICROB, V77, P8106, DOI 10.1128/AEM.05925-11; Fort S, 2001, CHEMBIOCHEM, V2, P319; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; FREIER D, 1988, APPL ENVIRON MICROB, V54, P204, DOI 10.1128/AEM.54.1.204-211.1988; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; Glasgow EM, 2019, J MOL BIOL, V431, P1217, DOI 10.1016/j.jmb.2019.01.024; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Goldman AD, 2016, J MOL EVOL, V82, P17, DOI 10.1007/s00239-015-9722-8; Gorrec F, 2016, DRUG DISCOV TODAY, V21, P819, DOI 10.1016/j.drudis.2016.03.008; Harjunpaa V, 1996, EUR J BIOCHEM, V240, P584, DOI 10.1111/j.1432-1033.1996.0584h.x; Himmel ME, 1999, CURR OPIN BIOTECH, V10, P358, DOI 10.1016/S0958-1669(99)80065-2; Hudson KL, 2015, J AM CHEM SOC, V137, P15152, DOI 10.1021/jacs.5b08424; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Julliand V, 1999, APPL ENVIRON MICROB, V65, P3738; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Lan PTN, 2006, INT J SYST EVOL MICR, V56, P2853, DOI 10.1099/ijs.0.64517-0; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Liberato MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep36428; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lo Leggio L, 2002, FEBS LETT, V523, P103, DOI 10.1016/S0014-5793(02)02954-X; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Matsuzawa T, 2016, TRENDS GLYCOSCI GLYC, V28, pE63, DOI 10.4052/tigg.1510.1E; McGregor N, 2016, J BIOL CHEM, V291, P1175, DOI 10.1074/jbc.M115.691659; Meng DD, 2017, BIOCHEM J, V474, P3373, DOI 10.1042/BCJ20170328; Naas AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11666; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Oke MA, 2016, BIOENERG RES, V9, P1189, DOI 10.1007/s12155-016-9765-8; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page R, 2003, ACTA CRYSTALLOGR D, V59, P1028, DOI 10.1107/S0907444903007790; Peng XW, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0509-y; Rahikainen JL, 2013, ENZYME MICROB TECH, V53, P315, DOI 10.1016/j.enzmictec.2013.07.003; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Srivastava N, 2018, RENEW SUST ENERG REV, V82, P2379, DOI 10.1016/j.rser.2017.08.074; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Tamaru Y, 2010, J BACTERIOL, V192, P901, DOI 10.1128/JB.01450-09; Tatko C, 2008, NAT CHEM BIOL, V4, P586, DOI 10.1038/nchembio1008-586; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Tseng CW, 2011, ACTA CRYSTALLOGR F, V67, P1189, DOI 10.1107/S1744309111032428; VAREL VH, 1989, ARCH MICROBIOL, V152, P209, DOI 10.1007/BF00409652; Venditto I, 2016, P NATL ACAD SCI USA, V113, P7136, DOI 10.1073/pnas.1601558113; Venditto I, 2015, J BIOL CHEM, V290, P10572, DOI 10.1074/jbc.M115.637827; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wong DDWS, 2010, APPL MICROBIOL BIOT, V86, P1463, DOI 10.1007/s00253-009-2364-2; Wu TH, 2011, BBA-PROTEINS PROTEOM, V1814, P1832, DOI 10.1016/j.bbapap.2011.07.020; Xue SS, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0378-9; Yuan SF, 2015, J BIOL CHEM, V290, P5739, DOI 10.1074/jbc.M114.604454	81	6	6	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17752	17769		10.1074/jbc.RA120.015328	http://dx.doi.org/10.1074/jbc.RA120.015328			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454012	Green Published, hybrid			2022-12-28	WOS:000603272300028
J	Schafer, CT; Shumate, A; Farrens, DL				Schafer, Christopher T.; Shumate, Anthony; Farrens, David L.			Novel fluorescent GPCR biosensor detects retinal equilibrium binding to opsin and active G protein and arrestin signaling conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); G protein; arrestin; biosensor; fluorescence; conformational change; rhodopsin; drug discovery; protein engineering	ROD OUTER SEGMENTS; CRYSTAL-STRUCTURE; TRANSMEMBRANE HELICES; METARHODOPSIN-II; RHODOPSIN; SITE; ACTIVATION; INSIGHTS; DYNAMICS; SPECTROSCOPY	Rhodopsin is a canonical class A photosensitive G protein-coupled receptor (GPCR), yet relatively few pharmaceutical agents targeting this visual receptor have been identified, in part due to the unique characteristics of its light-sensitive, covalently bound retinal ligands. Rhodopsin becomes activated when light isomerizes 11-cis-retinal into an agonist, all-trans-retinal (ATR), which enables the receptor to activate its G protein. We have previously demonstrated that, despite being covalently bound, ATR can display properties of equilibrium binding, yet how this is accomplished is unknown. Here, we describe a new approach for both identifying compounds that can activate and attenuate rhodopsin and testing the hypothesis that opsin binds retinal in equilibrium. Our method uses opsin-based fluorescent sensors, which directly report the formation of active receptor conformations by detecting the binding of G protein or arrestin fragments that have been fused onto the receptor's C terminus. We show that these biosensors can be used to monitor equilibrium binding of the agonist, ATR, as well as the noncovalent binding of beta-ionone, an antagonist for G protein activation. Finally, we use these novel biosensors to observe ATR release from an activated, unlabeled receptor and its subsequent transfer to the sensor in real time. Taken together, these data support the retinal equilibrium binding hypothesis. The approach we describe should prove directly translatable to other GPCRs, providing a new tool for ligand discovery and mutant characterization.	[Schafer, Christopher T.; Shumate, Anthony; Farrens, David L.] Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA	Oregon Health & Science University	Farrens, DL (corresponding author), Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA.	farrensd@ohsu.edu		Schafer, Christopher/0000-0001-9907-295X	National Institutes of Health [R01EY029343, R21EY027959, R21DA043001, F31DA049438, T32 EY023211, T32 GM071338]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY029343, R21EY027959, and R21DA043001 (to D. L. F.); F31DA049438 (to A. D. S.), and T32 EY023211 and T32 GM071338 (to C. T. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya S, 1997, J BIOL CHEM, V272, P6519, DOI 10.1074/jbc.272.10.6519; Alexiev U, 2014, BBA-BIOENERGETICS, V1837, P694, DOI 10.1016/j.bbabio.2013.10.008; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brunette AMJ, 2014, BIOCHEMISTRY-US, V53, P6290, DOI 10.1021/bi500493r; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; Chen CH, 2017, J BIOL CHEM, V292, P19356, DOI 10.1074/jbc.M117.795187; DAEMEN FJM, 1978, NATURE, V276, P847, DOI 10.1038/276847a0; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; Eichel K, 2016, NAT CELL BIOL, V18, P303, DOI 10.1038/ncb3307; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fay JF, 2015, P NATL ACAD SCI USA, V112, P8469, DOI 10.1073/pnas.1500895112; Garcia-Nafria J, 2019, MOL CELL ENDOCRINOL, V488, P1, DOI 10.1016/j.mce.2019.02.006; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Han M, 1997, P NATL ACAD SCI USA, V94, P13442, DOI 10.1073/pnas.94.25.13442; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Huang WJ, 2020, NATURE, V579, P303, DOI 10.1038/s41586-020-1953-1; Isayama T, 2006, VISUAL NEUROSCI, V23, P899, DOI 10.1017/S0952523806230256; Isayama T, 2009, VISUAL NEUROSCI, V26, P267, DOI 10.1017/S0952523809090105; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Janz JM, 2003, VISION RES, V43, P2991, DOI 10.1016/j.visres.2003.08.010; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kefalov VJ, 1999, J GEN PHYSIOL, V113, P491, DOI 10.1085/jgp.113.3.491; Kobayashi H, 2019, NAT PROTOC, V14, P1084, DOI 10.1038/s41596-019-0129-7; Kono M, 2008, BIOCHEMISTRY-US, V47, P7567, DOI 10.1021/bi800357b; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maeda R, 2018, J PHYS CHEM B, V122, P4838, DOI 10.1021/acs.jpcb.8b02819; Mansoor SE, 2006, P NATL ACAD SCI USA, V103, P3060, DOI 10.1073/pnas.0511010103; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; MATSUMOTO H, 1975, NATURE, V258, P523, DOI 10.1038/258523a0; Nguyen AH, 2019, NAT STRUCT MOL BIOL, V26, P1123, DOI 10.1038/s41594-019-0330-y; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; RESEK JF, 1993, BIOCHEMISTRY-US, V32, P12025, DOI 10.1021/bi00096a012; Sato S, 2019, J NEUROSCI, V39, P212, DOI 10.1523/JNEUROSCI.1980-18.2018; Schafer CT, 2016, P NATL ACAD SCI USA, V113, P11961, DOI 10.1073/pnas.1606347113; Schafer CT, 2015, J BIOL CHEM, V290, P4304, DOI 10.1074/jbc.M114.603134; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Seifert R, 1999, TRENDS PHARMACOL SCI, V20, P383, DOI 10.1016/S0165-6147(99)01368-1; Shukla AK, 2014, TRENDS BIOCHEM SCI, V39, P594, DOI 10.1016/j.tibs.2014.10.001; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Sinha A, 2014, BIOCHEMISTRY-US, V53, P3294, DOI 10.1021/bi401534y; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Staus DP, 2020, NATURE, V579, P297, DOI 10.1038/s41586-020-1954-0; Steen A, 2013, J BIOL CHEM, V288, P12511, DOI 10.1074/jbc.M112.449587; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Tesmer JJG, 2016, NAT REV MOL CELL BIO, V17, P439, DOI 10.1038/nrm.2016.36; Tian H, 2017, BIOPHYS J, V112, P153, DOI 10.1016/j.bpj.2016.12.005; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Van Eps N, 2010, BIOCHEMISTRY-US, V49, P6877, DOI 10.1021/bi100846c; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Wingler LM, 2019, CELL, V176, P468, DOI 10.1016/j.cell.2018.12.005; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Yin WC, 2019, CELL RES, V29, P971, DOI 10.1038/s41422-019-0256-2; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002	68	0	0	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17486	17496		10.1074/jbc.RA120.014631	http://dx.doi.org/10.1074/jbc.RA120.014631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453993	Green Published, hybrid			2022-12-28	WOS:000603272300009
J	Canalis, E; Zanotti, S; Schilling, L; Eller, T; Yu, J				Canalis, Ernesto; Zanotti, Stefano; Schilling, Lauren; Eller, Tabitha; Yu, Jungeun			Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; PROTEOLYTIC ACTIVATION; PROGENITOR CELLS; TRABECULAR BONE; GROWTH-FACTOR; BETA-CATENIN; EXPRESSION; OSTEOCLASTOGENESIS; OSTEOCYTE; MICE	Notch receptors maintain skeletal homeostasis. NOTCH1 and 2 have been studied for their effects on bone remodeling. Although NOTCH3 plays a significant role in vascular physiology, knowledge about its function in other cellular environments, including bone, is limited. The present study was conducted to establish the function of NOTCH3 in skeletal cells using models of Notch3 misexpression. Microcomputed tomography demonstrated that Notch3 null mice did not have appreciable bone phenotypes. To study the effects of the NOTCH3 activation in the osteoblast lineage, BGLAP-Cre or Dmp1-Cre transgenics were crossed with Rosa(Notch3) mice, where the NOTCH3 intracellular domain is expressed following the removal of a loxP-flanked STOP cassette. Microcomputed tomography demonstrated that BGLAP-Cre;Rosa(Notch3) and Dmp1-Cre;Rosa(Notch3) mice of both sexes exhibited an increase in trabecular bone and in connectivity, with a decrease in cortical bone and increased cortical porosity. Histological analysis revealed a decrease in osteoclast number and bone resorption in trabecular bone and an increase in osteoclast number and void or pore area in cortical bone of Rosa(Notch3) mice. Bone formation was either decreased or could not be determined in Cre;Rosa(Notch3) mice. NOTCH3 activation in osteoblasts inhibited Alpl (alkaline phosphatase) and Bglap (osteocalcin) and induced Tnfsf11 (RANKL) and Tnfrsf11b (osteoprotegerin) mRNA, possibly explaining the trabecular bone phenotype. However, NOTCH3 induced Tnfsf11 and suppressed Tnfrsf11b in osteocytes, possibly explaining the cortical porosity. In conclusion, basal NOTCH3 is dispensable for skeletal homeostasis, whereas activation of NOTCH3 in osteoblasts/osteocytes inhibits osteoclastogenesis and bone resorption in cancellous bone but increases intracortical remodeling and causes cortical porosity.	[Canalis, Ernesto; Zanotti, Stefano; Yu, Jungeun] UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA; [Canalis, Ernesto] UConn Hlth, Dept Med, Farmington, CT 06030 USA; [Canalis, Ernesto; Zanotti, Stefano; Schilling, Lauren; Eller, Tabitha; Yu, Jungeun] UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA; [Zanotti, Stefano] Dyne Therapeut, Waltham, MA 02451 USA		Canalis, E (corresponding author), UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, Dept Med, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA.	canalis@uchc.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR072987, AR076747]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases AR072987 (E. C.) and AR076747 (E. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Bagi CM, 2006, BONE, V38, P136, DOI 10.1016/j.bone.2005.07.028; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Birling MC, 2012, GENESIS, V50, P482, DOI 10.1002/dvg.20826; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cadet ER, 2003, J BONE JOINT SURG AM, V85A, P1739, DOI 10.2106/00004623-200309000-00013; Canalis E, 2018, OSTEOPOROSIS INT, V29, P2611, DOI 10.1007/s00198-018-4694-3; Canalis E, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.620334; Canalis E, 2018, J BIOL CHEM, V293, P14165, DOI 10.1074/jbc.RA118.004242; Canalis E, 2017, J CELL PHYSIOL, V232, P363, DOI 10.1002/jcp.25433; Canalis E, 2016, J BIOL CHEM, V191, P1538, DOI 10.1074/jbc.M115.685453; Canalis E, 2014, BONE, V64, P273, DOI 10.1016/j.bone.2014.04.028; Canalis E, 2013, NAT REV ENDOCRINOL, V9, P575, DOI 10.1038/nrendo.2013.154; Canalis E, 2013, J BIOL CHEM, V288, P25614, DOI 10.1074/jbc.M113.470492; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Cho DC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00920-x; Choy L, 2017, CANCER RES, V77, P1439, DOI 10.1158/0008-5472.CAN-16-1022; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Duggan SP, 2016, CELL SIGNAL, V28, P1, DOI 10.1016/j.cellsig.2015.10.006; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Gripp KW, 2015, AM J MED GENET A, V167, P271, DOI 10.1002/ajmg.a.36863; Halleux C, 2012, METHODS MOL BIOL, V816, P55, DOI 10.1007/978-1-61779-415-5_5; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Ke HZ, 2012, ENDOCR REV, V33, P747, DOI 10.1210/er.2011-1060; Kobayashi T, 2014, CURR TOP DEV BIOL, V110, P263, DOI 10.1016/B978-0-12-405943-6.00007-5; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Krebs LT, 2000, GENE DEV, V14, P1343; Lafkas D, 2013, J CELL BIOL, V203, P47, DOI 10.1083/jcb.201307046; Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; McCright B, 2001, DEVELOPMENT, V128, P491; Moon YJ, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0119-9; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Neutzsky-Wulff AV, 2010, DEV BIOL, V344, P1001, DOI 10.1016/j.ydbio.2010.06.018; NYE JS, 1994, DEVELOPMENT, V120, P2421; Otero K, 2012, J IMMUNOL, V188, P2612, DOI 10.4049/jimmunol.1102836; Ryeom SW, 2011, J CLIN INVEST, V121, P508, DOI 10.1172/JCI45976; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Shirayoshi Y, 1997, GENES CELLS, V2, P213, DOI 10.1046/j.1365-2443.1997.d01-310.x; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Walker EC, 2020, ELIFE, V9, DOI 10.7554/eLife.56666; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xiong JH, 2012, J BONE MINER RES, V27, P499, DOI 10.1002/jbmr.1547; Yorgan T, 2016, BONE, V87, P136, DOI 10.1016/j.bone.2016.04.012; Yu J, 2019, J BIOL CHEM, V294, P14203, DOI 10.1074/jbc.RA119.009824; Yu JG, 2020, J CELL PHYSIOL, V235, P210, DOI 10.1002/jcp.28960; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2017, BONE, V103, P159, DOI 10.1016/j.bone.2017.06.027; Zanotti S, 2017, J BIOL CHEM, V292, P12232, DOI 10.1074/jbc.M117.786129; Zanotti S, 2016, ENDOCR REV, V37, P223, DOI 10.1210/er.2016-1002; Zanotti S, 2014, BONE, V62, P22, DOI 10.1016/j.bone.2014.01.023; Zanotti S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086757; Zanotti S, 2013, J BIOL CHEM, V288, P624, DOI 10.1074/jbc.M112.340455; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	81	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100583	10.1016/j.jbc.2021.100583	http://dx.doi.org/10.1016/j.jbc.2021.100583			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33774049	Green Published, gold			2022-12-28	WOS:000672866400555
J	Chen, YC; Hsieh, HH; Chang, HC; Wang, HC; Lin, WJ; Lin, JJ				Chen, Ying-Chieh; Hsieh, Hsi-Hsien; Chang, Hsi-Chi; Wang, Hsin-Chiao; Lin, Wey-Jinq; Lin, Jing-Jer			CDC25B induces cellular senescence and correlates with tumor suppression in a p53-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 STABILIZATION; CANCER-CELLS; PHOSPHORYLATION; PHOSPHATASE; KINASE; ACCUMULATION; CYCLE; OVEREXPRESSION; DEGRADATION; CHECKPOINT	The phosphatase cell division cycle 25B (Cdc25B) regulates cell cycle progression. Increased Cdc25B levels are often detected in cancer cell lines and human cancers and have been implicated in contributing to tumor growth, potentially by providing cancer cells with the ability to bypass checkpoint controls. However, the specific mechanism by which increased Cdc25B impacts tumor progression is not clear. Here we analyzed The Cancer Genome Atlas (TCGA) database and found that patients with high CDC25B expression had the expected poor survival. However, we also found that high CDC25B expression had a p53-dependent tumor suppressive effect in lung cancer and possibly several other cancer types. Looking in more detail at the tumor suppressive function of Cdc25B, we found that increased Cdc25B expression caused inhibition of cell growth in human normal fibroblasts. This effect was not due to alteration of specific cell cycle stage or inhibition of apoptosis, nor by induction of the DNA damage response. Instead, increased CDC25B expression led cells into senescence. We also found that p53 was required to induce senescence, which might explain the p53-dependent tumor suppressive function of Cdc25B. Mechanistically, we found that the Cdc25B phosphatase activity was required to induce senescence. Further analysis also found that Cdc25B stabilized p53 through binding and dephosphorylating p53. Together, this study identified a tumor-suppressive function of Cdc25B that is mediated through a p53-dependent senescence pathway.	[Chen, Ying-Chieh; Hsieh, Hsi-Hsien; Chang, Hsi-Chi; Lin, Wey-Jinq; Lin, Jing-Jer] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan; [Wang, Hsin-Chiao; Lin, Jing-Jer] Natl Taiwan Univ, Inst Biochem & Mol Biol, Coll Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University	Lin, WJ; Lin, JJ (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan.; Lin, JJ (corresponding author), Natl Taiwan Univ, Inst Biochem & Mol Biol, Coll Med, Taipei, Taiwan.	wjlin@ym.edu.tw; jingjerlin@ntu.edu.tw		LIN, JING-JER/0000-0001-8250-7398; Hsieh, Hsi-Hsien/0000-0002-1734-6417	National Taiwan University [Aim for Top University Project] [104R8955-2, 108L9014]; Ministry of Science and Technology [MOST104-2311-B-002-028-MY3, MOST1042321-B-002-036]	National Taiwan University [Aim for Top University Project]; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Taiwan University [Aim for Top University Project under grants 104R8955-2 and 108L9014]; the Ministry of Science and Technology [MOST104-2311-B-002-028-MY3 and MOST1042321-B-002-036].	Al-Matouq J, 2019, MOL CARCINOGEN, V58, P1691, DOI 10.1002/mc.23075; Baldin V, 1997, J BIOL CHEM, V272, P32731, DOI 10.1074/jbc.272.52.32731; Bansal P, 2007, CANCER RES, V67, P3356, DOI 10.1158/0008-5472.CAN-06-3685; Bean LJH, 2002, J BIOL CHEM, V277, P1864, DOI 10.1074/jbc.M108881200; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, CANCER RES, V67, P11557, DOI 10.1158/0008-5472.CAN-07-2415; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Boutros R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067822; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Cai X, 2008, P NATL ACAD SCI USA, V105, P16958, DOI 10.1073/pnas.0804608105; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; De Souza CPC, 2000, EXP CELL RES, V257, P11, DOI 10.1006/excr.2000.4872; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dumaz N, 1999, FEBS LETT, V463, P312, DOI 10.1016/S0014-5793(99)01647-6; Escarpe P, 2003, MOL THER, V8, P332, DOI 10.1016/S1525-0016(03)00167-9; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Gatti A, 2000, BIOCHEMISTRY-US, V39, P9837, DOI 10.1021/bi992454i; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Hsu YH, 2010, J BIOL CHEM, V285, P22630, DOI 10.1074/jbc.M109.096255; Huang YF, 2009, MOL CELL BIOL, V29, P2935, DOI 10.1128/MCB.01837-08; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Ma ZQ, 1999, ONCOGENE, V18, P4564, DOI 10.1038/sj.onc.1202809; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Miyata H, 2001, CANCER RES, V61, P3188; Mullee LI, 2016, CHROMOSOME RES, V24, P35, DOI 10.1007/s10577-015-9503-7; NAGATA A, 1991, NEW BIOL, V3, P959; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Scian MJ, 2008, ONCOGENE, V27, P2583, DOI 10.1038/sj.onc.1210898; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Sohn R, 2005, BIOCHEMISTRY-US, V44, P16563, DOI 10.1021/bi0516879; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665; Yao Y, 1999, ONCOGENE, V18, P5159, DOI 10.1038/sj.onc.1202908; Yeh PY, 2001, BIOCHEM BIOPH RES CO, V284, P880, DOI 10.1006/bbrc.2001.5043	49	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100564	10.1016/j.jbc.2021.100564	http://dx.doi.org/10.1016/j.jbc.2021.100564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33745968	gold, Green Published			2022-12-28	WOS:000672866400537
J	Deshpande, S; Altermann, E; Sarojini, V; Lott, JS; Lee, TV				Deshpande, Sandesh; Altermann, Eric; Sarojini, Vijayalekshmi; Lott, J. Shaun; Lee, T. Verne			Structural characterization of a PCP-R didomain from an archaeal nonribosomal peptide synthetase reveals novel interdomain interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY CRYSTALLOGRAPHY; REDUCTASE DOMAINS; PROTEIN-STRUCTURE; ADENYLATION; CYCLIZATION; ALIGNMENT; MODULE; ACID; TOOL	Nonribosomal peptide synthetases (NRPSs) are multi-modular enzymes that produce a wide range of bioactive peptides, such as siderophores, toxins, and antibacterial and insecticidal agents. NRPSs are dynamic proteins characterized by extensive interdomain communications as a consequence of their assembly-line mode of synthesis. Hence, crystal structures of multidomain fragments of NRPSs have aided in elucidating crucial interdomain interactions that occur during different steps of the NRPS catalytic cycle. One crucial yet unexplored interaction is that between the reductase (R) domain and the peptide carrier protein (PCP) domain. R domains are members of the short-chain dehydrogenase/reductase family and function as termination domains that catalyze the reductive release of the final peptide product from the terminal PCP domain of the NRPS. Here, we report the crystal structure of an archaeal NRPS PCP-R didomain construct. This is the first NRPS R domain structure to be determined together with the upstream PCP domain and is also the first structure of an archaeal NRPS to be reported. The structure reveals that a novel helix-turn-helix motif, found in NRPS R domains but not in other short-chain dehydrogenase/reductase family members, plays a major role in the interface between the PCP and R domains. The information derived from the described PCP-R interface will aid in gaining further mechanistic insights into the peptide termination reaction catalyzed by the R domain and may have implications in engineering NRPSs to synthesize novel peptide products.	[Deshpande, Sandesh; Lott, J. Shaun; Lee, T. Verne] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Altermann, Eric] AgResearch Ltd, Food Syst Integr, Palmerston North, New Zealand; [Altermann, Eric] Massey Univ, Riddet Inst, Palmerston North, New Zealand; [Sarojini, Vijayalekshmi] Univ Auckland, Sch Chem Sci, Auckland, New Zealand	University of Auckland; AgResearch - New Zealand; Massey University; University of Auckland	Lee, TV (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	t.lee@auckland.ac.nz	Lee, Verne/M-6283-2014	Lee, Verne/0000-0002-5768-2781; Lott, Shaun/0000-0003-3660-452X	New Zealand Ministry for Business, Innovation and Employment [UOAX1506]	New Zealand Ministry for Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This research was supported by the New Zealand Ministry for Business, Innovation and Employment on contract UOAX1506.	Alphey MS, 2005, J BIOL CHEM, V280, P3068, DOI 10.1074/jbc.M411069200; Barajas JF, 2015, CHEM BIOL, V22, P1018, DOI 10.1016/j.chembiol.2015.06.022; Bozhuyuk KAJ, 2019, NAT CHEM, V11, P653, DOI 10.1038/s41557-019-0276-z; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Chakravarty D, 2015, IUCRJ, V2, P643, DOI 10.1107/S2052252515015250; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Drake EJ, 2016, NATURE, V529, P235, DOI 10.1038/nature16163; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fonin AV, 2019, CELL MOL LIFE SCI, V76, P4461, DOI 10.1007/s00018-019-03276-1; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Gahloth D, 2017, NAT CHEM BIOL, V13, P975, DOI [10.1038/nchembio.2434, 10.1038/NCHEMBIO.2434]; Hague AS, 2014, J STRUCT BIOL, V187, P207, DOI 10.1016/j.jsb.2014.07.008; Hur GH, 2012, NAT PROD REP, V29, P1074, DOI 10.1039/c2np20025b; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kallberg Y, 2010, FEBS J, V277, P2375, DOI 10.1111/j.1742-4658.2010.07656.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Keating TA, 2002, NAT STRUCT BIOL, V9, P522, DOI 10.1038/nsb810; Kinatukara P, 2016, J STRUCT BIOL, V194, P368, DOI 10.1016/j.jsb.2016.03.014; Koropatkin NM, 2005, ACTA CRYSTALLOGR D, V61, P365, DOI 10.1107/S0907444904033876; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Lee TV, 2010, J BIOL CHEM, V285, P2415, DOI 10.1074/jbc.M109.071324; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Liu Y, 2011, CHEM BIOL, V18, P1482, DOI 10.1016/j.chembiol.2011.09.018; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Miller BR, 2014, PROTEINS, V82, P2691, DOI 10.1002/prot.24635; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mullowney MW, 2018, NAT PROD REP, V35, P847, DOI 10.1039/c8np00013a; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Owen JG, 2016, CELL CHEM BIOL, V23, P1395, DOI 10.1016/j.chembiol.2016.09.014; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; Pluskal T., 2018, BIOSYNTHETIC ORIGIN, DOI [10.1101/294439, DOI 10.1101/294439]; Reimer JM, 2019, SCIENCE, V366, P706, DOI 10.1126/science.aaw4388; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sussmuth RD, 2017, ANGEW CHEM INT EDIT, V56, P3770, DOI 10.1002/anie.201609079; Sundlov JA, 2012, CHEM BIOL, V19, P188, DOI 10.1016/j.chembiol.2011.11.013; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Tarry MJ, 2017, STRUCTURE, V25, P783, DOI 10.1016/j.str.2017.03.014; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Wang H, 2014, P NATL ACAD SCI USA, V111, P9259, DOI 10.1073/pnas.1401734111; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; Weng JW, 2020, CURR OPIN STRUC BIOL, V62, P9, DOI 10.1016/j.sbi.2019.11.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wyatt MA, 2012, CHEMBIOCHEM, V13, P2408, DOI 10.1002/cbic.201200340	55	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100432	10.1016/j.jbc.2021.100432	http://dx.doi.org/10.1016/j.jbc.2021.100432			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610550	gold, Green Published			2022-12-28	WOS:000672866400406
J	Ho, K; Bradshaw, N				Ho, Kristin; Bradshaw, Niels			A conserved allosteric element controls specificity and activity of functionally divergent PP2C phosphatases from Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASES; STRESS; ACTIVATION; GROWTH; TRANSCRIPTION; MECHANISM; TRANSPORT; KINASES; SYSTEM; SPOIIE	Reversible phosphorylation relies on highly regulated kinases and phosphatases that target specific substrates to control diverse cellular processes. Here, we address how protein phosphatase activity is directed to the correct substrates under the correct conditions. The serine/threonine phosphatase SpoIIE from Bacillus subtilis, a member of the widespread protein phosphatase 2C (PP2C) family of phosphatases, is activated by movement of a conserved alpha-helical element in the phosphatase domain to create the binding site for the metal cofactor. We hypothesized that this conformational switch could provide a general mechanism for control of diverse members of the PP2C family of phosphatases. The B. subtilis phosphatase RsbU responds to different signals, acts on a different substrates, and produces a more graded response than SpoIIE. Using an unbiased genetic screen, we isolated mutants in the alpha-helical switch region of RsbU that are constitutively active, indicating conservation of the switch mechanism. Using phosphatase activity assays with phosphoprotein substrates, we found that both phosphatases integrate substrate recognition with activating signals to control metal-cofactor binding and substrate dephosphorylation. This integrated control provides a mechanism for PP2C family of phosphatases to produce specific responses by acting on the correct substrates, under the appropriate conditions.	[Ho, Kristin; Bradshaw, Niels] Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA	Brandeis University	Bradshaw, N (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA.	niels@brandeis.edu		Bradshaw, Niels/0000-0002-6845-4717	Brandeis University; NIH [GM18568]	Brandeis University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was from start-up funds from Brandeis University to N. B. and NIH Grant GM18568 to Richard Losick. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bradshaw N, 2017, ELIFE, V6, DOI 10.7554/eLife.26111; Bradshaw N, 2015, ELIFE, V4, DOI 10.7554/eLife.08145; Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6; Cabeen MT, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006901; Carniol K, 2004, J BACTERIOL, V186, P4390, DOI 10.1128/JB.186.13.4390-4394.2004; Carniol K, 2004, J BIOL CHEM, V279, P14860, DOI 10.1074/jbc.M314274200; Carrara M, 2017, NAT STRUCT MOL BIOL, V24, P708, DOI 10.1038/nsmb.3443; Delumeau O, 2004, J BIOL CHEM, V279, P40927, DOI 10.1074/jbc.M405464200; Dorich V, 2019, GENE DEV, V33, P718, DOI 10.1101/gad.320168.118; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; EISENSTADT E, 1973, J BACTERIOL, V113, P1363, DOI 10.1128/JB.113.3.1363-1372.1973; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/nchembio.1427, 10.1038/NCHEMBIO.1427]; Gottesman S, 2019, J BIOL CHEM, V294, P11685, DOI 10.1074/jbc.REV119.005593; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hilbert DW, 2003, J BACTERIOL, V185, P1590, DOI 10.1128/JB.185.5.1590-1598.2003; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kerk D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132863; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Levchenko I., 2009, STRUCTURE ORTHORHOMB, DOI [10.2210/pdb3F7A/pdb, DOI 10.2210/PDB3F7A/PDB]; Levdikov VM, 2012, J MOL BIOL, V415, P343, DOI 10.1016/j.jmb.2011.11.017; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Mazur SJ, 2017, BIOCHEMISTRY-US, V56, P2676, DOI 10.1021/acs.biochem.6b01220; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Morita K, 2020, CELL, V181, P702, DOI 10.1016/j.cell.2020.03.051; Padua RAP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06814-w; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poh WH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241019; Rothstein DM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00212-17; SCRIBNER H, 1974, J BACTERIOL, V117, P1224, DOI 10.1128/JB.117.3.1224-1230.1974; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Tagad HD, 2018, CHEMMEDCHEM, V13, P894, DOI 10.1002/cmdc.201700779; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002; Vintonyak VV, 2011, BIOORGAN MED CHEM, V19, P2145, DOI 10.1016/j.bmc.2011.02.047; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1; Zhang Y, 2013, J BIOL CHEM, V288, P22058, DOI 10.1074/jbc.M113.464339	41	1	1	6	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100518	10.1016/j.jbc.2021.100518	http://dx.doi.org/10.1016/j.jbc.2021.100518			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33684446	Green Published, gold			2022-12-28	WOS:000672866400492
J	Huang, YZ; Yang, YT; Wang, JL; Yao, SS; Yao, T; Xu, YN; Chen, ZZ; Yuan, PT; Gao, J; Shen, SY; Ma, JJ				Huang, Yizhen; Yang, Yute; Wang, Jianle; Yao, Shasha; Yao, Teng; Xu, Yining; Chen, Zizheng; Yuan, Putao; Gao, Jun; Shen, Shuying; Ma, Jianjun			miR-21-5p targets SKP2 to reduce osteoclastogenesis in a mouse model of osteoporosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RANKL-INDUCED OSTEOCLAST; DIFFERENTIATION; ESTROGEN	Osteoporosis results from an imbalance between bone formation and bone resorption. Traditional drugs for treating osteoporosis are associated with serious side effects, and thus, new treatment methods are required. This study investigated the role of differentially expressed microRNAs during osteoclast differentiation and osteoclast activity during osteoarthritis as well as the associated underlying mechanisms. We used a microarray to screen microRNAs that decreased in the process of osteoclast differentiation and verified miR-21-5p to decrease significantly using RT-qPCR. In follow-up experiments, we found that miR-21-5p targets SKP2 to regulate osteoclast differentiation. In vivo, ovariectomized mice were used to simulate perimenopausal osteoporosis induced by estrogen deficiency, and miR-21-5p treatment inhibited bone resorption and maintained bone cortex and trabecular structure. These results suggest that miR-21-5p is a new therapeutic target for osteoporosis.	[Huang, Yizhen; Yang, Yute; Wang, Jianle; Yao, Shasha; Yao, Teng; Chen, Zizheng; Yuan, Putao; Gao, Jun; Shen, Shuying; Ma, Jianjun] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Orthopaed Surg, Sch Med, Hangzhou, Peoples R China; [Huang, Yizhen; Yang, Yute; Wang, Jianle; Yao, Shasha; Yao, Teng; Chen, Zizheng; Yuan, Putao; Gao, Jun; Shen, Shuying; Ma, Jianjun] Key Lab Musculoskeletal Syst Degenerat & Regenera, Hangzhou, Peoples R China; [Xu, Yining] Shaoxing Univ, Sch Med, Shaoxing, Peoples R China	Zhejiang University; Shaoxing University	Shen, SY; Ma, JJ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Orthopaed Surg, Sch Med, Hangzhou, Peoples R China.; Shen, SY; Ma, JJ (corresponding author), Key Lab Musculoskeletal Syst Degenerat & Regenera, Hangzhou, Peoples R China.	11207057@zju.edu.cn; sealteam@zju.edu.cn			Medical Healthy Scientific Technology Project of Zhejiang Province [2020388803, 2020RC070, WKJ-ZJ-1906]; National Natural Science Foundation of China [81972504, 81802680, 81972089, 81871797, 81874015, 81871796, 81802147]; Zhejiang Provincial Natural Science Foundation of China [LY19H160058, Z20H060003, Q20H160293, Q20H160237]; National Key R&D Program of China [2018YFC1105202, 2019YFC110055]; Key research and development plan in Zhejiang province [2018C03060, 2020C03041]	Medical Healthy Scientific Technology Project of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Key R&D Program of China; Key research and development plan in Zhejiang province	This work was supported by Medical Healthy Scientific Technology Project of Zhejiang Province (2020388803, 2020RC070, WKJ-ZJ-1906), National Natural Science Foundation of China (81972504, 81802680, 81972089, 81972504, 81871797, 81874015, 81871796, 81802147), Zhejiang Provincial Natural Science Foundation of China (LY19H160058, Z20H060003, Q20H160293, Q20H160237), National Key R&D Program of China (No. 2018YFC1105202, 2019YFC110055), the Key research and development plan in Zhejiang province (No. 2018C03060, 2020C03041).	Armas LAG, 2012, ENDOCRIN METAB CLIN, V41, P475, DOI 10.1016/j.ecl.2012.04.006; Cai Z, 2020, SEMIN CANCER BIOL, V67, P16, DOI 10.1016/j.semcancer.2020.01.013; Chen X, 2019, RNA BIOL, V16, P1249, DOI 10.1080/15476286.2019.1624470; Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868; Gan K, 2016, INT IMMUNOPHARMACOL, V35, P294, DOI 10.1016/j.intimp.2016.03.038; Kabekkodu SP, 2018, BIOL REV, V93, P1955, DOI 10.1111/brv.12428; Li C, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1069-3; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Li JY, 2019, EUR REV MED PHARMACO, V23, P6394, DOI 10.26355/eurrev_201908_18519; Li J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2159-z; Li LY, 2018, ADV EXP MED BIOL, V1086, P199, DOI 10.1007/978-981-13-1117-8_13; Lian WS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1942-1; Mohr AM, 2015, SEMIN LIVER DIS, V35, P3, DOI 10.1055/s-0034-1397344; Munoz-Torres Manuel, 2004, Treat Endocrinol, V3, P117; Song CC, 2019, J CELL PHYSIOL, V234, P11969, DOI 10.1002/jcp.27852; Sun L, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0146-0; Thacker G, 2016, BBA-MOL CELL RES, V1863, P510, DOI 10.1016/j.bbamcr.2016.01.010; Vaananen HK, 1996, MATURITAS, V23, pS65; Wang L, 2021, CELL BIOL INT, V45, P612, DOI 10.1002/cbin.11544; Wang SS, 2021, DNA CELL BIOL, V40, P147, DOI 10.1089/dna.2020.6151; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P367, DOI 10.1007/s00198-015-3386-5; Xiao Y, 2018, MOL MED REP, V17, P7789, DOI 10.3892/mmr.2018.8845; Xie Z, 2018, J BONE MINER RES, V33, P667, DOI 10.1002/jbmr.3334; Yan S, 2019, CELL BIOCHEM FUNCT, V37, P598, DOI 10.1002/cbf.3436; Yin ZQ, 2019, EUR J PHARMACOL, V859, DOI 10.1016/j.ejphar.2019.172550; Yuan F, 2019, INT J SURG, V66, P1, DOI 10.1016/j.ijsu.2019.03.004; Zhang YD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32428-9; Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015; Zhao HY, 2017, MOL CELLS, V40, P211, DOI 10.14348/molcells.2017.2303	29	10	10	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100617	10.1016/j.jbc.2021.100617	http://dx.doi.org/10.1016/j.jbc.2021.100617			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811860	Green Published, gold			2022-12-28	WOS:000672866400588
J	Kerth, CM; Hautvast, P; Korner, J; Lampert, A; Meents, JE				Kerth, Clara M.; Hautvast, Petra; Koerner, Jannis; Lampert, Angelika; Meents, Jannis E.			Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA(V)1.7; GENES; SCN9A	Mutations in voltage-gated sodium channels (Navs) can cause alterations in pain sensation, such as chronic pain diseases like inherited erythromelalgia. The mutation causing inherited erythromelalgia, Nav1.7 p.I848T, is known to induce a hyperpolarized shift in the voltage dependence of activation in Nav1.7. So far, however, the mechanism to explain this increase in voltage sensitivity remains unknown. In the present study, we show that phosphorylation of the newly introduced Thr residue explains the functional change. We expressed wildtype human Nav1.7, the I848T mutant, or other mutations in HEK293T cells and performed whole-cell patch-clamp electrophysiology. As the insertion of a Thr residue potentially creates a novel phosphorylation site for Ser/Thr kinases and because Nav1.7 had been shown in Xenopus oocytes to be affected by protein kinases C and A, we used different nonselective and selective kinase inhibitors and activators to test the effect of phosphorylation on Nav1.7 in a human system. We identify protein kinase C, but not protein kinase A, to be responsible for the phosphorylation of T848 and thereby for the shift in voltage sensitivity. Introducing a negatively charged amino acid instead of the putative phosphorylation site mimics the effect on voltage gating to a lesser extent. 3D modeling using the published cryo-EM structure of human Nav1.7 showed that introduction of this negatively charged site seems to alter the interaction of this residue with the surrounding amino acids and thus to influence channel function. These results could provide new opportunities for the development of novel treatment options for patients with chronic pain.	[Kerth, Clara M.; Hautvast, Petra; Koerner, Jannis; Lampert, Angelika; Meents, Jannis E.] Rhein Westfal TH Aachen, Inst Physiol, Uniklin, Aachen, Germany; [Koerner, Jannis] Rhein Westfal TH Aachen, Dept Anesthesiol, Uniklin, Aachen, Germany; [Meents, Jannis E.] Multi Channel Syst, Reutlingen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Meents, JE (corresponding author), Rhein Westfal TH Aachen, Inst Physiol, Uniklin, Aachen, Germany.; Meents, JE (corresponding author), Multi Channel Syst, Reutlingen, Germany.	jmeents@multichannelsystems.com	Lampert, Angelika/F-7198-2010	Lampert, Angelika/0000-0001-6319-6272	DFG [LA 2740/3-1, 363055819/GRK2415, 368482240/GRK2416]; Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University [IZKF TN1-1/IA 532001]	DFG(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University	This work was supported in part by the DFG LA 2740/3-1 and the DFG-funded research training groups 363055819/GRK2415 and 368482240/GRK2416 (to A. L.). Supported by a grant from the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University (IZKF TN1-1/IA 532001).	Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; Ahn HS, 2010, EUR J PAIN, V14, P944, DOI 10.1016/j.ejpain.2010.03.007; Anjana R, 2012, BIOINFORMATION, V8, P1220, DOI 10.6026/97320630081220; Brouwer BA, 2014, J PERIPHER NERV SYST, V19, P53, DOI 10.1111/jns5.12071; Burel S, 2017, J BIOL CHEM, V292, P17431, DOI 10.1074/jbc.M117.787788; Cao LS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7653; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chatelier A, 2008, J NEUROPHYSIOL, V99, P2241, DOI 10.1152/jn.01350.2007; Cheng XY, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-24; Cheng XY, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-1; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Davis Mark D P, 2006, Curr Treat Options Cardiovasc Med, V8, P153, DOI 10.1007/s11936-006-0008-8; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Dib-Hajj SD, 2017, PAIN, V158, pS97, DOI 10.1097/j.pain.0000000000000854; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dickson VK, 2014, NATURE, V516, P213, DOI 10.1038/nature13913; Drenth JPH, 2005, J INVEST DERMATOL, V124, P1333, DOI 10.1111/j.0022-202X.2005.23737.x; Eberhardt M, 2014, J BIOL CHEM, V289, P1971, DOI 10.1074/jbc.M113.502211; Han CY, 2009, BRAIN, V132, P1711, DOI 10.1093/brain/awp078; Hoeijmakers JGJ, 2012, BRAIN, V135, P345, DOI 10.1093/brain/awr349; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Korner J., 2020, SENSES COMPREHENSIVE, P120, DOI DOI 10.1016/B978-0-12-809324-5.24208-9; Laedermann CJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00263; Laedermann CJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00137; Lampert A, 2008, J BIOL CHEM, V283, P24118, DOI 10.1074/jbc.M802900200; Lampert A, 2006, J BIOL CHEM, V281, P36029, DOI 10.1074/jbc.M607637200; Lenaeus MJ, 2017, P NATL ACAD SCI USA, V114, pE3051, DOI 10.1073/pnas.1700761114; Lorenzini M., 2020, PROTEOMIC FUNCTIONAL; Meents JE, 2019, PAIN, V160, P1327, DOI 10.1097/j.pain.0000000000001511; Meents JE, 2016, NEUROMETHODS, V113, P37, DOI 10.1007/978-1-4939-3411-9_3; Neel AJ, 2017, NATURE, V543, P637, DOI 10.1038/nature21701; Novella SP, 2007, NAT CLIN PRACT NEURO, V3, P229, DOI 10.1038/ncpneuro0425; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Scheuer T, 2011, SEMIN CELL DEV BIOL, V22, P160, DOI 10.1016/j.semcdb.2010.10.002; Schwarz N, 2016, J NEUROL, V263, P334, DOI 10.1007/s00415-015-7984-0; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; Tang ZL, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0347-1; Vijayaragavan K, 2004, J NEUROPHYSIOL, V91, P1556, DOI 10.1152/jn.00676.2003; Wang J, 2017, CHANNELS, V11, P534, DOI 10.1080/19336950.2017.1380758; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waxman SG, 2014, LANCET NEUROL, V13, P1152, DOI 10.1016/S1474-4422(14)70150-4; Wisedchaisri G, 2019, CELL, V178, P993, DOI 10.1016/j.cell.2019.06.031; Wu MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055212; Zhang LL, 2007, BRIT J DERMATOL, V156, P767, DOI 10.1111/j.1365-2133.2006.07727.x	47	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100227	10.1074/jbc.RA120.014288	http://dx.doi.org/10.1074/jbc.RA120.014288			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361158	Green Published, gold			2022-12-28	WOS:000672866400205
J	Li, J; Ma, XL; Banerjee, S; Baruah, S; Schnicker, NJ; Roh, E; Ma, WY; Liu, KD; Bode, AM; Dong, ZG				Li, Jian; Ma, Xinli; Banerjee, Surajit; Baruah, Sankar; Schnicker, Nicholas J.; Roh, Eunmiri; Ma, Weiya; Liu, Kangdong; Bode, Ann M.; Dong, Zigang			Structural basis for multifunctional roles of human Ints3 C-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEINS; DOUBLE-STRAND BREAKS; DNA-DAMAGE; MODULAR RECOGNITION; CRYSTAL-STRUCTURE; COMPLEX; HSSB1; INTEGRATOR; REPAIR; PARTICIPATE	Proper repair of damaged DNA is critical for the maintenance of genome stability. A complex composed of Integrator subunit 3 (Ints3), single-stranded DNA-binding protein 1 (SSB1), and SSB-interacting protein 1 (SSBIP1) is required for efficient homologous recombination-dependent repair of double-strand breaks (DSBs) and ataxia-telangiectasia mutated (ATM)-dependent signaling pathways. It is known that in this complex the Ints3 N-terminal domain scaffolds SSB1 and SSBIP1. However, the molecular basis for the function of the Ints3 C-terminal domain remains unclear. Here, we present the crystal structure of the Ints3 C-terminal domain, uncovering a HEAT-repeat superhelical fold. Using structure and mutation analysis, we show that the C-terminal domain exists as a stable dimer. A basic groove and a cluster of conserved residues on two opposite sides of the dimer bind single-stranded RNA/DNA (ssRNA/ssDNA) and Integrator complex subunit 6 (Ints6), respectively. Dimerization is required for nucleic acid binding, but not for Ints6 binding. Additionally, in vitro experiments using HEK 293T cells demonstrate that Ints6 interaction is critical for maintaining SSB1 protein level. Taken together, our findings establish the structural basis of a multifunctional Ints3 C-terminal module, allowing us to propose a novel mode of nucleic acid recognition by helical repeat protein and paving the way for future mechanistic studies.	[Li, Jian; Ma, Xinli; Roh, Eunmiri; Ma, Weiya; Bode, Ann M.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Li, Jian; Ma, Xinli; Liu, Kangdong; Dong, Zigang] China US Henan Hormel Canc Inst, Zhengzhou, Henan, Peoples R China; [Banerjee, Surajit] Cornell Univ, Northeastern Collaborat Access Team, Adv Photon Source, Lemont, IL USA; [Baruah, Sankar; Schnicker, Nicholas J.] Univ Iowa, Carver Coll Med, Prot & Crystallog Facil, Iowa City, IA USA; [Roh, Eunmiri] Kwangju Womens Univ, Dept Cosmet Sci, Gwangju, South Korea; [Liu, Kangdong; Dong, Zigang] Zhengzhou Univ, Coll Med, Zhengzhou, Henan, Peoples R China	University of Minnesota System; United States Department of Energy (DOE); Argonne National Laboratory; University of Iowa; Zhengzhou University	Dong, ZG (corresponding author), China US Henan Hormel Canc Inst, Zhengzhou, Henan, Peoples R China.; Dong, ZG (corresponding author), Zhengzhou Univ, Coll Med, Zhengzhou, Henan, Peoples R China.	dongzg@zzu.edu.cn		Li, Jian/0000-0002-7532-1728; Dong, Zigang/0000-0002-4174-4028; Liu, Kangdong/0000-0002-4425-5625	National Institute of General Medical Sciences from the National Institutes of Health [P30 GM124165]; NIH-ORIP HEI grant [S10 RR029205]; Hormel Foundation	National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; Hormel Foundation	This work is supported by The Hormel Foundation and is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P30 GM124165). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht TR, 2018, NUCLEIC ACIDS RES, V46, P4241, DOI 10.1093/nar/gky100; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ashton NW, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-9; Bader AS, 2020, BRIT J CANCER, V122, P613, DOI 10.1038/s41416-019-0624-1; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Ben-Shaul A, 2015, BIOPHYS J, V108, P14, DOI 10.1016/j.bpj.2014.11.010; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Chatterjee N, 2017, ENVIRON MOL MUTAGEN, V58, P235, DOI 10.1002/em.22087; Chen JD, 2012, RNA, V18, P2148, DOI 10.1261/rna.035725.112; Corley M, 2020, MOL CELL, V78, P9, DOI 10.1016/j.molcel.2020.03.011; Dickey TH, 2013, STRUCTURE, V21, P1074, DOI 10.1016/j.str.2013.05.013; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ezzeddine N, 2011, MOL CELL BIOL, V31, P328, DOI 10.1128/MCB.00943-10; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li YJ, 2009, J BIOL CHEM, V284, P23525, DOI 10.1074/jbc.C109.039586; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu Q, 2011, ACTA CRYSTALLOGR D, V67, P45, DOI 10.1107/S0907444910046573; Liu YF, 2001, P NATL ACAD SCI USA, V98, P6877, DOI 10.1073/pnas.121013398; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ni ZY, 2014, NAT STRUCT MOL BIOL, V21, P686, DOI 10.1038/nsmb.2853; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Ren WD, 2014, CELL REP, V6, P982, DOI 10.1016/j.celrep.2014.02.020; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Richard DJ, 2011, NUCLEIC ACIDS RES, V39, P3643, DOI 10.1093/nar/gkq1340; Richard DJ, 2011, NUCLEIC ACIDS RES, V39, P1692, DOI 10.1093/nar/gkq1098; Rubinson EH, 2012, CURR OPIN STRUC BIOL, V22, P101, DOI 10.1016/j.sbi.2011.11.005; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Skaar JR, 2009, J CELL BIOL, V187, P25, DOI 10.1083/jcb.200907026; Syed A, 2018, ANNU REV BIOCHEM, V87, P263, DOI 10.1146/annurev-biochem-062917-012415; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vidhyasagar V, 2018, BIOCHEM J, V475, P45, DOI 10.1042/BCJ20170351; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wernimont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005094; Williams RM, 2020, CURR OPIN STRUC BIOL, V61, P98, DOI 10.1016/j.sbi.2019.12.010; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang SH, 2013, EMBO J, V32, P126, DOI 10.1038/emboj.2012.314; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Yoshimura SH, 2016, J CELL SCI, V129, P3963, DOI 10.1242/jcs.185710; Zhang F, 2013, J CELL SCI, V126, P4850, DOI 10.1242/jcs.132514; Zhang F, 2009, J BIOL CHEM, V284, P30408, DOI 10.1074/jbc.M109.039404	55	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100112	10.1074/jbc.RA120.016393	http://dx.doi.org/10.1074/jbc.RA120.016393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33434574	Green Published, gold			2022-12-28	WOS:000672866400092
J	Pan, XJ; Kortemme, T				Pan, Xingjie; Kortemme, Tanja			Recent advances in de novo protein design: Principles, methods, and applications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COMPUTATIONAL DESIGN; STRUCTURE PREDICTION; MACROMOLECULAR ENERGY; RATIONAL DESIGN; ACCURATE DESIGN; END ELIMINATION; SIMPLE-MODEL; FORCE-FIELD; AMINO-ACIDS; BINDING	The computational de novo protein design is increasingly applied to address a number of key challenges in biomedicine and biological engineering. Successes in expanding applications are driven by advances in design principles and methods over several decades. Here, we review recent innovations in major aspects of the de novo protein design and include how these advances were informed by principles of protein architecture and interactions derived from the wealth of structures in the Protein Data Bank. We describe developments in de novo generation of designable backbone structures, optimization of sequences, design scoring functions, and the design of the function. The advances not only highlight design goals reachable now but also point to the challenges and opportunities for the future of the field.	[Pan, Xingjie; Kortemme, Tanja] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Pan, Xingjie; Kortemme, Tanja] Univ Calif San Francisco, UC Berkeley UCSF Grad Program Bioengn, San Francisco, CA 94143 USA; [Kortemme, Tanja] Univ Calif San Francisco, Quantitat Biosci Inst QBI, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pan, XJ; Kortemme, T (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Pan, XJ; Kortemme, T (corresponding author), Univ Calif San Francisco, UC Berkeley UCSF Grad Program Bioengn, San Francisco, CA 94143 USA.; Kortemme, T (corresponding author), Univ Calif San Francisco, Quantitat Biosci Inst QBI, San Francisco, CA 94143 USA.	xingjiepan@gmail.com; tanjakortemme@gmail.com		Pan, XingJie/0000-0002-0060-4352	National Institutes of Health [R01-GM110089]; National Science Foundation (NSF) [DBI-1564692]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	Our work is supported by grants from the National Institutes of Health (R01-GM110089) and the National Science Foundation (NSF) (DBI-1564692) to T. K. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. X. P. is a UCSF Discovery Fellow. T. K. is a Chan Zuckerberg Biohub Investigator.	Alford RF, 2020, BIOPHYS J, V118, P2042, DOI 10.1016/j.bpj.2020.03.006; Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125; Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; Allen BD, 2010, J COMPUT CHEM, V31, P904, DOI 10.1002/jcc.21375; Alley EC, 2019, NAT METHODS, V16, P1315, DOI 10.1038/s41592-019-0598-1; Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; Anand N., 2019, 7 INT C LEARN REPR I; Anand N., 2022, PROTEIN SEQUENCE DES, V13, P1, DOI [DOI 10.1101/2020.01.06.895466, 10.1101/2020.01.06.895466]; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Baker D, 2019, PROTEIN SCI, V28, P678, DOI 10.1002/pro.3588; Basanta B, 2020, P NATL ACAD SCI USA, V117, P22135, DOI 10.1073/pnas.2005412117; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bhardwaj G, 2016, NATURE, V538, P329, DOI 10.1038/nature19791; Bick MJ, 2017, ELIFE, V6, DOI 10.7554/eLife.28909; Bonet J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006623; Bowers PM, 2000, J BIOMOL NMR, V18, P311, DOI 10.1023/A:1026744431105; Boyken SE, 2019, SCIENCE, V364, P658, DOI 10.1126/science.aav7897; Boyken SE, 2016, SCIENCE, V352, P680, DOI 10.1126/science.aad8865; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunette TJ, 2020, P NATL ACAD SCI USA, V117, P8870, DOI 10.1073/pnas.1908768117; Brunette TJ, 2015, NATURE, V528, P580, DOI 10.1038/nature16162; Callaway E, 2020, NATURE, V588, P203, DOI 10.1038/d41586-020-03348-4; Cao LX, 2020, SCIENCE, V370, P426, DOI 10.1126/science.abd9909; CHANDRASEKARAN R, 1970, INT J PROT RES, V2, P223; Chen ZB, 2020, SCIENCE, V368, P78, DOI 10.1126/science.aay2790; Chen ZB, 2019, J AM CHEM SOC, V141, P8891, DOI 10.1021/jacs.9b01978; Chen ZB, 2019, NATURE, V565, P106, DOI 10.1038/s41586-018-0802-y; Chevalier A, 2017, NATURE, V550, P74, DOI 10.1038/nature23912; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Coutsias EA, 2004, J COMPUT CHEM, V25, P510, DOI 10.1002/jcc.10416; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Dang BB, 2017, P NATL ACAD SCI USA, V114, P10852, DOI 10.1073/pnas.1710695114; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Davey JA, 2017, NAT CHEM BIOL, V13, P1280, DOI [10.1038/nchembio.2503, 10.1038/NCHEMBIO.2503]; Davey JA, 2014, PROTEINS, V82, P771, DOI 10.1002/prot.24457; Davidsen K, 2019, ELIFE, V8, DOI 10.7554/eLife.46935; Davis IW, 2006, STRUCTURE, V14, P265, DOI 10.1016/j.str.2005.10.007; Dawson NL, 2017, NUCLEIC ACIDS RES, V45, pD289, DOI 10.1093/nar/gkw1098; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; Dou JY, 2018, NATURE, V561, P485, DOI 10.1038/s41586-018-0509-0; Dou JY, 2017, PROTEIN SCI, V26, P2426, DOI 10.1002/pro.3317; Doyle L, 2015, NATURE, V528, P585, DOI 10.1038/nature16191; Eguchi R. R., 2020, IG VAE GENERATIVE MO, DOI [10.1101/2020.08.07, DOI 10.1101/2020.08.07]; Fallas JA, 2017, NAT CHEM, V9, P353, DOI [10.1038/nchem.2673, 10.1038/NCHEM.2673]; Feng J, 2015, ELIFE, V4, DOI 10.7554/eLife.10606; Frappier V, 2019, STRUCTURE, V27, P606, DOI 10.1016/j.str.2019.01.008; Friedland GD, 2008, J MOL BIOL, V380, P757, DOI 10.1016/j.jmb.2008.05.006; Friedland GD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000393; Georgiev I, 2008, BIOINFORMATICS, V24, pI196, DOI 10.1093/bioinformatics/btn169; Georgiev I, 2007, BIOINFORMATICS, V23, pI185, DOI 10.1093/bioinformatics/btm197; Glasgow AA, 2019, SCIENCE, V366, P1024, DOI 10.1126/science.aax8780; Gonen S, 2015, SCIENCE, V348, P1365, DOI 10.1126/science.aaa9897; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Hawkins-Hooker A., 2019, GENERATING FUNCTIONA, DOI 10.1101/2020.04.07.029264; Helling R, 2001, J MOL GRAPH MODEL, V19, P157, DOI 10.1016/S1093-3263(00)00137-6; HELLINGA HW, 1991, J MOL BIOL, V222, P763, DOI 10.1016/0022-2836(91)90510-D; Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h; HO SP, 1987, J AM CHEM SOC, V109, P6751, DOI 10.1021/ja00256a032; Hosseinzadeh P, 2017, SCIENCE, V358, P1461, DOI 10.1126/science.aap7577; Hsia Y, 2016, NATURE, V535, P136, DOI 10.1038/nature18010; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Huang PS, 2016, NAT CHEM BIOL, V12, P29, DOI [10.1038/NCHEMBIO.1966, 10.1038/nchembio.1966]; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Ingraham J., 2019, INT C LEARN REPR; Jacobs TM, 2016, SCIENCE, V352, P687, DOI 10.1126/science.aad8036; Jacobson MP, 2002, J PHYS CHEM B, V106, P11673, DOI 10.1021/jp021564n; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Joh NH, 2014, SCIENCE, V346, P1520, DOI 10.1126/science.1261172; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Karimi M, 2020, J CHEM INF MODEL, V60, P5667, DOI 10.1021/acs.jcim.0c00593; Keedy DA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002629; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; Koepnick B, 2019, NATURE, V570, P390, DOI 10.1038/s41586-019-1274-4; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Korendovych IV, 2020, Q REV BIOPHYS, V53, DOI 10.1017/S0033583519000131; Korendovych IV, 2010, J AM CHEM SOC, V132, P15516, DOI 10.1021/ja107487b; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuhlman B, 2019, NAT REV MOL CELL BIO, V20, P681, DOI 10.1038/s41580-019-0163-x; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Labonte JW, 2017, J COMPUT CHEM, V38, P276, DOI 10.1002/jcc.24679; Lajoie MJ, 2020, SCIENCE, V369, P1637, DOI 10.1126/science.aba6527; Langan RA, 2019, NATURE, V572, P205, DOI 10.1038/s41586-019-1432-8; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; LEE C, 1991, J MOL BIOL, V217, P373, DOI 10.1016/0022-2836(91)90550-P; Leman JK, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1541-z; LEVITT M, 1969, J MOL BIOL, V46, P269, DOI 10.1016/0022-2836(69)90421-5; Li H, 1996, SCIENCE, V273, P666, DOI 10.1126/science.273.5275.666; Lin YR, 2015, P NATL ACAD SCI USA, V112, pE5478, DOI 10.1073/pnas.1509508112; Lipsh-Sokolik R, 2021, PROTEIN SCI, V30, P151, DOI 10.1002/pro.3970; Loshbaugh AL, 2020, PROTEINS, V88, P206, DOI 10.1002/prot.25790; Lu PL, 2018, SCIENCE, V359, P1042, DOI 10.1126/science.aaq1739; Lucas JE, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008178; Mackenzie CO, 2016, P NATL ACAD SCI USA, V113, pE7438, DOI 10.1073/pnas.1607178113; Maguire JB, 2018, J CHEM THEORY COMPUT, V14, P2751, DOI 10.1021/acs.jctc.8b00033; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Marcos E, 2018, NAT STRUCT MOL BIOL, V25, P1028, DOI 10.1038/s41594-018-0141-6; Marcos E, 2017, SCIENCE, V355, P201, DOI 10.1126/science.aah7389; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mohan K, 2019, SCIENCE, V364, P750, DOI 10.1126/science.aav7532; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; Mravic M, 2019, SCIENCE, V363, P1418, DOI 10.1126/science.aav7541; Norn C., 2020, PROTEIN SEQUENCE DES, DOI [10.1101/2020.07.23.218917, DOI 10.1101/2020.07.23.218917]; O'Meara MJ, 2015, J CHEM THEORY COMPUT, V11, P609, DOI 10.1021/ct500864r; Ollikainen N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004335; Ollikainen N, 2013, METHOD ENZYMOL, V523, P61, DOI 10.1016/B978-0-12-394292-0.00004-7; Pan XJ, 2020, SCIENCE, V369, P1132, DOI 10.1126/science.abc0881; Park H., 2020, LEARNING FORCE FIELD, DOI [10.1101/2020.09.06.285239, DOI 10.1101/2020.09.06.285239]; Park H, 2016, J CHEM THEORY COMPUT, V12, P6201, DOI 10.1021/acs.jctc.6b00819; Park K, 2015, NAT STRUCT MOL BIOL, V22, P167, DOI 10.1038/nsmb.2938; Polizzi NF, 2020, SCIENCE, V369, P1227, DOI 10.1126/science.abb8330; Polizzi NF, 2017, NAT CHEM, V9, P1157, DOI 10.1038/NCHEM.2846; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rocklin GJ, 2017, SCIENCE, V357, P168, DOI 10.1126/science.aan0693; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Sheffler W, 2009, PROTEIN SCI, V18, P229, DOI 10.1002/pro.8; Shen H, 2018, SCIENCE, V362, P705, DOI 10.1126/science.aau3775; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Smith CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020451; Smith CA, 2010, J MOL BIOL, V402, P460, DOI 10.1016/j.jmb.2010.07.032; Strokach A, 2020, CELL SYST, V11, P402, DOI 10.1016/j.cels.2020.08.016; TANAKA S, 1976, MACROMOLECULES, V9, P945, DOI 10.1021/ma60054a013; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Votteler J, 2016, NATURE, V540, P292, DOI 10.1038/nature20607; Wang JX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24760-x; Wei KY, 2020, P NATL ACAD SCI USA, V117, P7208, DOI 10.1073/pnas.1914808117; WHITLEY P, 1994, NAT STRUCT BIOL, V1, P858, DOI 10.1038/nsb1294-858; Woolfson DN, 2017, SUBCELL BIOCHEM, V82, P35, DOI 10.1007/978-3-319-49674-0_2; Xu CF, 2020, NATURE, V585, P129, DOI 10.1038/s41586-020-2646-5; Xu JB, 2019, P NATL ACAD SCI USA, V116, P16856, DOI 10.1073/pnas.1821309116; Yang C, 2021, NAT CHEM BIOL, V17, P492, DOI 10.1038/s41589-020-00699-x; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Yang KK, 2019, NAT METHODS, V16, P687, DOI 10.1038/s41592-019-0496-6; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yeh A., 2020, NOVO DESIGN MODULAR, DOI [10.1101/2020.07.18.206946, DOI 10.1101/2020.07.18.206946]; Zhang SQ, 2018, NAT CHEM BIOL, V14, P870, DOI 10.1038/s41589-018-0105-5; Zheng F, 2015, STRUCTURE, V23, P961, DOI 10.1016/j.str.2015.03.015	156	31	32	19	61	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100558	10.1016/j.jbc.2021.100558	http://dx.doi.org/10.1016/j.jbc.2021.100558			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744284	Green Published, gold			2022-12-28	WOS:000672866400531
J	Park, T; Large, N; Curran, T				Park, Taeju; Large, Neka; Curran, Tom			Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN CRK; EPITHELIAL-MESENCHYMAL TRANSITION; GASTRIC-CANCER; INTRATUMORAL HETEROGENEITY; MALIGNANT FEATURE; POOR-PROGNOSIS; TGF-BETA; EXPRESSION; PROLIFERATION; INVASION	The expression levels of CT10 regulator of kinase (Crk) and Crk-like (CrkL) are elevated in many human cancers, including glioblastoma (GBM), and are believed to contribute to poor prognosis. Although Crk and CrkL have been proposed as therapeutic targets in these tumors, the lack of a reliable, quantitative assay to measure Crk and CrkL activity has hindered development of inhibitors. Here, we knocked down Crk, CrkL, or both using siRNAs in a human GBM cell line, U-118MG, to determine the respective, quantitative contributions of Crk and CrkL to cellular phenotypes. The combined use of specific and potent Crk and CrkL siRNAs induced effective knockdown of CrkII, CrkI, and CrkL. Whereas Crk knockdown did not affect cell morphology, proliferation, adhesion, or invasion, CrkL knockdown caused shrinkage of cells and inhibition of cell proliferation, adhesion, and invasion. Crk/CrkL double knockdown resulted in more pronounced morphological alterations and more robust inhibition of proliferation, adhesion, and invasion. Furthermore, Crk/CrkL double knockdown completely blocked cell migration, and this effect was rescued by transient overexpression of CrkL but not of Crk. Quantification of protein levels indicated that CrkL is expressed more abundantly than CrkII and CrkI in U-118MG cells. These results demonstrate both the predominant role of CrkL and the essential overlapping functions of Crk and CrkL in U-118MG cells. Furthermore, our study indicates that migration of U-118MG cells depends entirely on Crk and CrkL. Thus, impedance-based, real-time measurement of tumor cell migration represents a robust assay for monitoring Crk and CrkL activities.	[Park, Taeju; Large, Neka; Curran, Tom] Childrens Mercy Kansas City, Childrens Mercy Res Inst, Kansas City, MO 64108 USA; [Park, Taeju; Curran, Tom] Univ Missouri, Sch Med, Dept Pediat, Kansas City, MO 64108 USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City	Park, T (corresponding author), Childrens Mercy Kansas City, Childrens Mercy Res Inst, Kansas City, MO 64108 USA.; Park, T (corresponding author), Univ Missouri, Sch Med, Dept Pediat, Kansas City, MO 64108 USA.	tjpark@cmh.edu	Curran, Tom/C-1164-2008	Curran, Tom/0000-0003-1444-7551; Park, Taeju/0000-0003-3897-3994	Tom Keaveny Endowed Fund for Pediatric Cancer Research; MCA Partners Advisory Board grant from Children's Mercy Hospital; University of Kansas Cancer Center (KUCC)	Tom Keaveny Endowed Fund for Pediatric Cancer Research; MCA Partners Advisory Board grant from Children's Mercy Hospital; University of Kansas Cancer Center (KUCC)	This work was supported by Tom Keaveny Endowed Fund for Pediatric Cancer Research (to T. P.) and by a MCA Partners Advisory Board grant from Children's Mercy Hospital (CMH) and the University of Kansas Cancer Center (KUCC) (to T. P.).	Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cai L, 2017, ONCOL LETT, V13, P51, DOI 10.3892/ol.2016.5394; Cheng SM, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0494-1; Cheng SM, 2015, TUMOR BIOL, V36, P915, DOI 10.1007/s13277-014-2724-0; Collins TN, 2018, ELIFE, V7, DOI 10.7554/eLife.32586; Dai YQ, 2011, CELL BIOCHEM FUNCT, V29, P625, DOI 10.1002/cbf.1797; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dhupkar Pooja, 2016, Biochem Biophys Rep, V8, P382, DOI 10.1016/j.bbrep.2016.10.009; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Elmansuri AZ, 2016, ONCOTARGET, V7, P27094, DOI 10.18632/oncotarget.8314; Fathers KE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3183; Feng RH, 2018, CANCER BIOMARK, V21, P335, DOI 10.3233/CBM-170472; Franke FC, 2020, INT J CANCER, V147, P1715, DOI 10.1002/ijc.32955; Franke FC, 2019, CELL MOL GASTROENTER, V7, P33, DOI 10.1016/j.jcmgh.2018.08.007; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Huang YP, 2015, J CLIN INVEST, V125, P1019, DOI 10.1172/JCI77278; Itakura M, 2013, BRIT J CANCER, V109, P1100, DOI 10.1038/bjc.2013.440; Ji H, 2016, ONCOL LETT, V12, P3811, DOI 10.3892/ol.2016.5160; Klank RL, 2017, CELL REP, V19, P668, DOI 10.1016/j.celrep.2017.03.074; Kumar S, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1376155; Kumar S, 2018, MOL CANCER RES, V16, P173, DOI 10.1158/1541-7786.MCR-17-0242; Kumar S, 2015, ONCOTARGET, V6, P37792, DOI 10.18632/oncotarget.6096; Lefranc F, 2018, CANCER TREAT REV, V68, P145, DOI 10.1016/j.ctrv.2018.06.017; Li X, 2014, EUR REV MED PHARMACO, V18, P2031; Linghu H, 2006, ONCOGENE, V25, P3547, DOI 10.1038/sj.onc.1209398; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lv SZ, 2013, J MOL NEUROSCI, V51, P1046, DOI 10.1007/s12031-013-0096-3; Matsumoto R, 2015, CANCER SCI, V106, P709, DOI 10.1111/cas.12662; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Mudduluru G, 2020, JOVE-J VIS EXP, DOI 10.3791/60997; Nabekura T, 2018, J IMMUNOL, V200, P3420, DOI 10.4049/jimmunol.1701639; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; Park TJ, 2014, ONCOGENE, V33, P5121, DOI 10.1038/onc.2013.453; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Park T, 2016, J BIOL CHEM, V291, P26273, DOI 10.1074/jbc.M116.764613; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Ren YL, 2017, J BIOL CHEM, V292, P17939, DOI 10.1074/jbc.M116.773978; Rodrigues SP, 2005, MOL CANCER RES, V3, P183; Shi X, 2018, ONCOL RES, V26, P987, DOI 10.3727/096504017X15140534417184; Smith CL, 2016, CELL REP, V15, P2616, DOI 10.1016/j.celrep.2016.05.042; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Song QL, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5671-8; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Takino T, 2003, CANCER RES, V63, P2335; Velasquez C, 2019, J ONCOL, V2019, DOI 10.1155/2019/1740763; Wang J, 2011, MOL CARCINOGEN, V50, P506, DOI 10.1002/mc.20745; Wang JQ, 2013, CHEM-BIOL INTERACT, V206, P230, DOI 10.1016/j.cbi.2013.09.003; Wang L, 2007, BIOCHEM BIOPH RES CO, V362, P976, DOI 10.1016/j.bbrc.2007.08.106; Wang LL, 2017, DIAGN PATHOL, V12, DOI 10.1186/s13000-017-0633-4; Wang Y, 2013, MOL CARCINOGEN, V52, P890, DOI 10.1002/mc.21935; Watanabe T, 2009, MOL CANCER RES, V7, P1582, DOI 10.1158/1541-7786.MCR-09-0064; Yamada S, 2011, CANCER LETT, V303, P84, DOI 10.1016/j.canlet.2011.01.004; Yanagi H, 2012, BIOCHEM BIOPH RES CO, V418, P104, DOI 10.1016/j.bbrc.2011.12.142; Yang XS, 2014, TUMOR BIOL, V35, P12435, DOI 10.1007/s13277-014-2561-1; Yeung CL, 2013, ONCOGENE, V32, P5429, DOI 10.1038/onc.2012.590; Yue S, 2016, ONCOTARGETS THER, V9, P6127, DOI 10.2147/OTT.S87778; Zhao TT, 2013, TUMOR BIOL, V34, P2891, DOI 10.1007/s13277-013-0851-7	59	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100390	10.1016/j.jbc.2021.100390	http://dx.doi.org/10.1016/j.jbc.2021.100390			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33561443	gold, Green Published			2022-12-28	WOS:000672866400364
J	Sancar, A				Sancar, Aziz			My 100th JBC paper	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item							COLI DNA PHOTOLYASE; ACTION MECHANISM		[Sancar, Aziz] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Sancar, A (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu						JORNS MS, 1987, J BIOL CHEM, V262, P486; SANCAR A, 1984, J BIOL CHEM, V259, P6028; SANCAR GB, 1987, J BIOL CHEM, V262, P492; SANCAR GB, 1984, J BIOL CHEM, V259, P6033; SANCAR GB, 1987, J BIOL CHEM, V262, P478; Selby CP, 2020, J BIOL CHEM, V295, P17374, DOI 10.1074/jbc.AC120.016325	6	0	0	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100061	10.1016/j.jbc.2020.100061	http://dx.doi.org/10.1016/j.jbc.2020.100061			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33410410	gold, Green Published			2022-12-28	WOS:000672866400043
J	Squires, KE; Gerber, KJ; Tillman, MC; Lustberg, DJ; Montanez-Miranda, C; Zhao, M; Ramineni, S; Scharer, CD; Saha, RN; Shu, FJ; Schroeder, JP; Ortlund, EA; Weinshenker, D; Dudek, SM; Hepler, JR				Squires, Katherine E.; Gerber, Kyle J.; Tillman, Matthew C.; Lustberg, Daniel J.; Montanez-Miranda, Carolina; Zhao, Meilan; Ramineni, Suneela; Scharer, Christopher D.; Saha, Ramendra N.; Shu, Feng-Jue; Schroeder, Jason P.; Ortlund, Eric A.; Weinshenker, David; Dudek, Serena M.; Hepler, John R.			Human genetic variants disrupt RGS14 nuclear shuttling and regulation of LTP in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SIGNALING PROTEINS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; MOLECULAR-CHANGES; EXPRESSION; ALPHA; RNA; ACTIVATION; TRANSPORT; EVOLUTION	The human genome contains vast genetic diversity as naturally occurring coding variants, yet the impact of these variants on protein function and physiology is poorly understood. RGS14 is a multifunctional signaling protein that suppresses synaptic plasticity in dendritic spines of hippocampal neurons. RGS14 also is a nucleocytoplasmic shuttling protein, suggesting that balanced nuclear import/export and dendritic spine localization are essential for RGS14 functions. We identified genetic variants L505R (LR) and R507Q (RQ) located within the nuclear export sequence (NES) of human RGS14. Here we report that RGS14 encoding LR or RQ profoundly impacts protein functions in hippocampal neurons. RGS14 membrane localization is regulated by binding Gai-GDP, whereas RGS14 nuclear export is regulated by Exportin 1 (XPO1). Remarkably, LR and RQ variants disrupt RGS14 binding to G alpha i1-GDP and XPO1, nucleocytoplasmic equilibrium, and capacity to inhibit long-term potentiation (LTP). Variant LR accumulates irreversibly in the nucleus, preventing RGS14 binding to G alpha i1, localization to dendritic spines, and inhibitory actions on LTP induction, while variant RQ exhibits a mixed phenotype. When introduced into mice by CRISPR/Cas9, RGS14-LR protein expression was detected predominantly in the nuclei of neurons within hippocampus, central amygdala, piriform cortex, and striatum, brain regions associated with learning and synaptic plasticity. Whereas mice completely lacking RGS14 exhibit enhanced spatial learning, mice carrying variant LR exhibit normal spatial learning, suggesting that RGS14 may have distinct functions in the nucleus independent from those in dendrites and spines. These findings show that naturally occurring genetic variants can profoundly alter normal protein function, impacting physiology in unexpected ways.	[Squires, Katherine E.; Gerber, Kyle J.; Montanez-Miranda, Carolina; Ramineni, Suneela; Shu, Feng-Jue; Hepler, John R.] Emory Univ, Dept Pharmacol & Chem Biol, Atlanta, GA 30322 USA; [Tillman, Matthew C.; Ortlund, Eric A.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Lustberg, Daniel J.; Schroeder, Jason P.; Weinshenker, David] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Scharer, Christopher D.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Zhao, Meilan; Dudek, Serena M.] NIEHS, POB 12233, Res Triangle Pk, NC 27709 USA; [Saha, Ramendra N.] Univ Calif Merced, Dept Mol & Cell Biol, Merced, CA USA	Emory University; Emory University; Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of California System; University of California Merced	Hepler, JR (corresponding author), Emory Univ, Dept Pharmacol & Chem Biol, Atlanta, GA 30322 USA.	jhepler@emory.edu			National Institutes of Health [2R21NS102652, R01NS037112]; Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health [ES 100221]; Neuropathology/Histochemistry Core of the Emory NINDS Neurosciences Core Facility [P30 NS055077]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health; Neuropathology/Histochemistry Core of the Emory NINDS Neurosciences Core Facility	This research was supported by funding from the National Institutes of Health awards 2R21NS102652 (to J. R. H.) and R01NS037112 (to J. R. H.), the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health (ES 100221 to S. D.), and the Neuropathology/Histochemistry Core of the Emory NINDS Neurosciences Core Facility (P30 NS055077). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham WC, 2019, NPJ SCI LEARN, V4, DOI 10.1038/s41539-019-0048-y; Adams JP, 2005, NAT REV NEUROSCI, V6, P737, DOI 10.1038/nrn1749; Alexander GM, 2019, NEUROBIOL LEARN MEM, V163, DOI 10.1016/j.nlm.2019.107044; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Antonarakis S E, 2001, Dialogues Clin Neurosci, V3, P7; Aoyagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116280; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Barwick BG, 2016, NAT IMMUNOL, V17, P1216, DOI 10.1038/ni.3519; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Betke KM, 2012, PROG NEUROBIOL, V96, P304, DOI 10.1016/j.pneurobio.2012.01.009; Bomba L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1212-4; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Branch MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184497; Brown NE, 2015, METHODS MOL BIOL, V1278, P457, DOI 10.1007/978-1-4939-2425-7_30; Brown NE, 2015, J BIOL CHEM, V290, P9037, DOI 10.1074/jbc.M114.634329; Burgon PG, 2001, J BIOL CHEM, V276, P32828, DOI 10.1074/jbc.M100960200; Chatterjee TK, 2002, MOL CELL BIOL, V22, P4334, DOI 10.1128/MCB.22.12.4334-4345.2002; Cho HS, 2005, J BIOL CHEM, V280, P805, DOI 10.1074/jbc.M408163200; DiGiacomo V, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax8620; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Dudek SM, 1999, NEUROSCIENTIST, V5, P275, DOI 10.1177/107385849900500512; Evans PR, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0353-17.2018; Evans PR, 2018, J PROTEOME RES, V17, P1700, DOI 10.1021/acs.jproteome.8b00027; Evans PR, 2014, J COMP NEUROL, V522, P186, DOI 10.1002/cne.23395; Ferretti V, 2010, P NATL ACAD SCI USA, V107, P7945, DOI 10.1073/pnas.0911757107; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Fung HYJ, 2017, ELIFE, V6, DOI 10.7554/eLife.23961; Fung HYJ, 2015, ELIFE, V4, DOI 10.7554/eLife.10034; Gerber KJ, 2019, J PROTEOME RES, V18, P2571, DOI 10.1021/acs.jproteome.9b00103; Gerber KJ, 2018, J BIOL CHEM, V293, P14616, DOI 10.1074/jbc.RA118.002816; Gerber KJ, 2016, MOL PHARMACOL, V89, P273, DOI 10.1124/mol.115.102210; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Gong B, 2012, EMBO J, V31, P783, DOI 10.1038/emboj.2012.3; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Hu YN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10448; Huang J, 2009, PROG MOL BIOL TRANSL, V86, P115, DOI 10.1016/S1877-1173(09)86005-5; Jagatheesan G, 1999, J CELL SCI, V112, P4651; Jay JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160519; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee JK, 2008, J NEUROSCI, V28, P8517, DOI 10.1523/JNEUROSCI.1806-08.2008; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lo Bello M, 2017, NEURODEGENER DIS, V17, P292, DOI 10.1159/000480085; de Maturana RL, 2010, CNS NEUROL DISORD-DR, V9, P601, DOI 10.2174/187152710793361531; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Maas C, 2009, P NATL ACAD SCI USA, V106, P8731, DOI 10.1073/pnas.0812391106; Martin-McCaffrey L, 2005, CELL CYCLE, V4, P953, DOI 10.4161/cc.4.7.1787; Merriam EB, 2013, J NEUROSCI, V33, P16471, DOI 10.1523/JNEUROSCI.0661-13.2013; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; Muralikrishna B, 2001, J CELL SCI, V114, P4001; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Nicoll RA, 2017, NEURON, V93, P281, DOI 10.1016/j.neuron.2016.12.015; Ogden KK, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006536; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Qiao HF, 2014, J NEUROSCI, V34, P4801, DOI 10.1523/JNEUROSCI.4393-13.2014; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Ressler RL, 2019, CURR OPIN NEUROBIOL, V54, P54, DOI 10.1016/j.conb.2018.08.012; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenblum K, 2002, J NEUROSCI, V22, P5432; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rossetti T, 2017, NEURON, V96, P207, DOI 10.1016/j.neuron.2017.09.010; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Sethakorn N, 2010, CELL SIGNAL, V22, P1274, DOI 10.1016/j.cellsig.2010.03.016; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Sjogren B, 2017, BRIT J PHARMACOL, V174, P427, DOI 10.1111/bph.13716; Squires KE, 2018, PHARMACOL REV, V70, P446, DOI 10.1124/pr.117.015354; Squires KE, 2018, BRAIN STRUCT FUNCT, V223, P233, DOI 10.1007/s00429-017-1487-y; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Taubenfeld SM, 2002, J NEUROCHEM, V81, P1348, DOI 10.1046/j.1471-4159.2002.00936.x; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Vellano CP, 2011, TRENDS PHARMACOL SCI, V32, P666, DOI 10.1016/j.tips.2011.07.005; Wang SH, 2010, P NATL ACAD SCI USA, V107, P19537, DOI 10.1073/pnas.1008638107; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Xie ZH, 2016, AAPS J, V18, P294, DOI 10.1208/s12248-015-9847-0; Yuan HJ, 2015, MOL PHARMACOL, V88, P203, DOI 10.1124/mol.115.097998; Zhao M, 2007, J NEUROSCI, V27, P12025, DOI 10.1523/JNEUROSCI.4094-07.2007	94	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100024	10.1074/jbc.RA120.016009	http://dx.doi.org/10.1074/jbc.RA120.016009			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33410399	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400009
J	Thada, V; Cortez, D				Thada, Vaughn; Cortez, David			ATR activation is regulated by dimerization of ATR activating proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; KINASE; COMPLEX; STRESS; OLIGOMERIZATION; MEC1/ATR; DISTINCT; DAMAGE; ETAA1	The checkpoint kinase ATR regulates DNA repair, cell cycle progression, and other DNA damage and replication stress responses. ATR signaling is stimulated by an ATR activating protein, and in metazoan cells, there are at least two ATR activators: TOPBP1 and ETAA1. Current evidence indicates TOPBP1 and ETAA1 activate ATR via the same biochemical mechanism, but several aspects of this mechanism remain undefined. For example, ATR and its obligate binding partner ATR interacting protein (ATRIP) form a tetrameric complex consisting of two ATR and two ATRIP molecules, but whether TOPBP1 or ETAA1 dimerization is similarly required for ATR function is unclear. Here, we show that fusion of the TOPBP1 and ETAA1 ATR activation domains (AADs) to dimeric tags makes them more potent activators of ATR in vitro. Furthermore, induced dimerization of both AADs using chemical dimerization of a modified FKBP tag enhances ATR kinase activation and signaling in cells. ETAA1 forms oligomeric complexes mediated by regions of the protein that are predicted to be intrinsically disordered. Induced dimerization of a "mini-ETAA1" protein that contains the AAD and Replication Protein A (RPA) interaction motifs enhances ATR signaling, rescues cellular hypersensitivity to DNA damaging agents, and suppresses micronuclei formation in ETAA1-deficient cells. Together, our results indicate that TOPBP1 and ETAA1 dimerization is important for optimal ATR signaling and genome stability.	[Thada, Vaughn; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	david.cortez@vanderbilt.edu		Cortez, David/0000-0003-0154-140X	National Institutes of Health [R01CA239161]; National Institutes of Health, United States [P50CA098131]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by National Institutes of Health grant R01CA239161 to D. C. Additional funding is provided by National Institutes of Health, United States grant P50CA098131. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achuthankutty D, 2019, J CELL BIOL, V218, P3943, DOI 10.1083/jcb.201905064; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bass TE, 2019, J CELL BIOL, V218, P1235, DOI 10.1083/jcb.201810058; Bass TE, 2016, NAT CELL BIOL, V18, P1185, DOI 10.1038/ncb3415; Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2019, MOL CELL, V74, P866, DOI 10.1016/j.molcel.2019.04.027; Frattini C, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.12.049; Haahr P, 2016, NAT CELL BIOL, V18, P1196, DOI 10.1038/ncb3422; Kabeche L, 2018, SCIENCE, V359, P108, DOI 10.1126/science.aan6490; Kim A, 2020, DNA REPAIR, V96, DOI 10.1016/j.dnarep.2020.102973; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee JH, 2013, J BIOL CHEM, V288, P12840, DOI 10.1074/jbc.M113.460378; Lee YC, 2016, CURR BIOL, V26, P3257, DOI 10.1016/j.cub.2016.10.030; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu K, 2013, MOL CELL BIOL, V33, P4685, DOI 10.1128/MCB.00373-13; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Rao QH, 2018, CELL RES, V28, P143, DOI 10.1038/cr.2017.158; Saldivar JC, 2018, SCIENCE, V361, P806, DOI 10.1126/science.aap9346; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Sawicka M, 2016, J BIOL CHEM, V291, P13436, DOI 10.1074/jbc.M115.708263; Syed A, 2018, ANNU REV BIOCHEM, V87, P263, DOI 10.1146/annurev-biochem-062917-012415; Tannous EA, 2021, NAT STRUCT MOL BIOL, V28, DOI 10.1038/s41594-020-00522-0; Thada V, 2019, J BIOL CHEM, V294, P8395, DOI 10.1074/jbc.RA119.008154; Wang XJ, 2017, SCIENCE, V358, P1206, DOI 10.1126/science.aan8414; Wang XS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10464; Zhou ZW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003702; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	37	7	7	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100455	10.1016/j.jbc.2021.100455	http://dx.doi.org/10.1016/j.jbc.2021.100455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33636182	Green Published, gold			2022-12-28	WOS:000672866400429
J	Wang, J; Yan, X; Feng, W; Wang, QT; Shi, WH; Chai, LM; Zhang, QQ; Chen, YQ; Liu, J; Qu, Z; Xie, XM; Li, MX				Wang, Jian; Yan, Xin; Feng, Wei; Wang, Qingting; Shi, Wenhua; Chai, Limin; Zhang, Qianqian; Chen, Yuqian; Liu, Jin; Qu, Zhan; Xie, Xinming; Li, Manxiang			S1P induces proliferation of pulmonary artery smooth muscle cells by promoting YAP-induced Notch3 expression and activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERSISTENT STAT3 ACTIVATION; SPHINGOSINE-1-PHOSPHATE; PATHWAY; CANCER; METABOLISM; MIGRATION; LIGASES	Sphingosine-1-phosphate (S1P), a natural multifunctional phospholipid, is highly increased in plasma from patients with pulmonary arterial hypertension and mediates proliferation of pulmonary artery smooth muscle cells (PASMCs) by activating the Notch3 signaling pathway. However, the mechanisms underpinning S1P-mediated induction of PASMCs proliferation remain unclear. In this study, using biochemical and molecular biology approaches, RNA interference and gene expression analyses, 5'-ethynyl-2'-deoxyuridine incorporation assay, and 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay, we demonstrated that S1P promoted the activation of signal transducers and activators of transcription 3 (STAT3) through sphingosine-1-phosphate receptor 2 (S1PR2), and subsequently upregulated the expression of the microRNA miR-135b, which further reduced the expression of E3 ubiquitin ligase beta-transduction repeat-containing protein and led to a reduction in yes-associated protein (YAP) ubiquitinated degradation in PASMCs. YAP is the core effector of the Hippo pathway and mediates the expression of particular genes. The accumulation of YAP further increased the expression and activation of Notch3 and ultimately promoted the proliferation of PASMCs. In addition, we showed that preblocking S1PR2, prior silencing of STAT3, miR-135b, or YAP, and prior inhibition of Notch3 all attenuated S1P-induced PASMCs proliferation. Taken together, our study indicates that S1P stimulates PASMCs proliferation by activation of the S1PR2/STAT3/miR-135b/beta-transduction repeat-containing protein/YAP/Notch3 pathway, and our data suggest that targeting this cascade might have potential value in ameliorating PASMCs hyperproliferation and benefit pulmonary arterial hypertension.	[Wang, Jian; Yan, Xin; Feng, Wei; Wang, Qingting; Shi, Wenhua; Chai, Limin; Zhang, Qianqian; Chen, Yuqian; Liu, Jin; Qu, Zhan; Xie, Xinming; Li, Manxiang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Li, MX (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Xian, Shaanxi, Peoples R China.	manxiangli@hotmail.com	SHI, wen/GPW-9531-2022	Wang, Jian/0000-0001-5066-1526	National Natural Science Foundation of China [81670051, 81970050, 81800052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81670051 and No. 81970050 to M. L. and No. 81800052 to X. X.).	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Banerjee K, 2016, INT J CANCER, V138, P2570, DOI 10.1002/ijc.29923; Bao YH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102109; Chen JW, 2014, AM J RESP CRIT CARE, V190, P1032, DOI 10.1164/rccm.201401-0121OC; de Lima JE, 2016, ELIFE, V5, DOI 10.7554/eLife.15593; Dieffenbach PB, 2017, AM J PHYSIOL-LUNG C, V313, pL628, DOI 10.1152/ajplung.00173.2017; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gairhe S, 2016, PULM CIRC, V6, P369, DOI 10.1086/687766; Galoczova M, 2018, CELL MOL BIOL LETT, V23, DOI 10.1186/s11658-018-0078-0; Hemnes AR, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0093-2017; Hirata N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5806; Huang XW, 2019, LIFE SCI, V220, P76, DOI 10.1016/j.lfs.2019.01.041; Jeffery TK, 2001, PHARMACOL THERAPEUT, V92, P1, DOI 10.1016/S0163-7258(01)00157-7; Ji C, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2510-4; Khatri R, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00268; Kim Y, 2018, BMB REP, V51, P143, DOI 10.5483/BMBRep.2018.51.3.017; Kudryashova TV, 2016, AM J RESP CRIT CARE, V194, P866, DOI 10.1164/rccm.201510-2003OC; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Leong WI, 2010, BIOCHIMIE, V92, P716, DOI 10.1016/j.biochi.2010.02.014; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu J, 2020, ADV EXP MED BIOL, V1217, P123, DOI 10.1007/978-981-15-1025-0_9; Liu L, 2018, AM J PHYSIOL-LUNG C, V315, pL609, DOI 10.1152/ajplung.00554.2017; Loh KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037218; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Manderfield LJ, 2015, DEVELOPMENT, V142, P2962, DOI 10.1242/dev.125807; Matsuyama H, 2011, BLOOD, V118, P6881, DOI 10.1182/blood-2011-05-354654; Misra JR, 2018, ANNU REV GENET, V52, P65, DOI 10.1146/annurev-genet-120417-031621; Oskouian B, 2007, CELL CYCLE, V6, P522, DOI 10.4161/cc.6.5.3903; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Qian ZJ, 2018, AM J PHYSIOL-LUNG C, V315, pL965, DOI 10.1152/ajplung.00224.2018; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Shi WW, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00694; Song Y, 2015, FEBS OPEN BIO, V5, P656, DOI 10.1016/j.fob.2015.08.007; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Wang J, 2018, PULM CIRC, V9, DOI 10.1177/2045894018816977; Wang SS, 2018, MED SCI MONITOR, V24, P1912, DOI 10.12659/MSM.905833; Wang YB, 2018, CIRCULATION, V138, P48, DOI 10.1161/CIRCULATIONAHA.117.032398; Wu YY, 2014, EXP LUNG RES, V40, P251, DOI 10.3109/01902148.2014.913092; Yan X, 2019, BIOCHEM BIOPH RES CO, V516, P921, DOI 10.1016/j.bbrc.2019.06.160; Yin J, 2018, J CELL MOL MED, V22, P1507, DOI 10.1111/jcmm.13416; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang Yanbing, 2015, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V31, P1316; Zhang YH, 2015, EXP LUNG RES, V41, P435, DOI 10.3109/01902148.2015.1060545; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhu YT, 2018, EXP CELL RES, V371, P379, DOI 10.1016/j.yexcr.2018.08.032	51	6	6	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100599	10.1016/j.jbc.2021.100599	http://dx.doi.org/10.1016/j.jbc.2021.100599			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781742	gold, Green Published			2022-12-28	WOS:000672866400571
J	Schut, GJ; Mohamed-Raseek, N; Tokmina-Lukaszewska, M; Mulder, DW; Nguyen, DMN; Lipscomb, GL; Hoben, JP; Patterson, A; Lubner, CE; King, PW; Peters, JW; Bothner, B; Miller, AF; Adams, MWW				Schut, Gerrit J.; Mohamed-Raseek, Nishya; Tokmina-Lukaszewska, Monika; Mulder, David W.; Nguyen, Diep M. N.; Lipscomb, Gina L.; Hoben, John P.; Patterson, Angela; Lubner, Carolyn E.; King, Paul W.; Peters, John W.; Bothner, Brian; Miller, Anne-Frances; Adams, Michael W. W.			The catalytic mechanism of electron-bifurcating electron transfer flavoproteins (ETFs) involves an intermediary complex with NAD(+)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; flavin; flavoprotein; radical; electron paramagnetic resonance (EPR); archaea; extreme thermophile; electron transport; bifurcation; charge transfer; semiquinone; EtfABCX; anaerobic physiology	NUCLEAR DOUBLE-RESONANCE; ENERGY-CONSERVATION; MASS-SPECTROMETRY; AZOTOBACTER-VINELANDII; PROTEIN COMPLEX; CROSS-LINKING; FERREDOXIN; REDUCTION; OXIDATION; NADH	Electron bifurcation plays a key role in anaerobic energy metabolism, but it is a relatively new discovery, and only limited mechanistic information is available on the diverse enzymes that employ it. Herein, we focused on the bifurcating electron transfer flavoprotein (ETF) from the hyperthermophilic archaeon Pyrobaculum aerophilum. The EtfABCX enzyme complex couples NADH oxidation to the endergonic reduction of ferredoxin and exergonic reduction of menaquinone. We developed a model for the enzyme structure by using nondenaturing MS, cross-linking, and homology modeling in which EtfA, -B, and -C each contained FAD, whereas EtfX contained two [4Fe-4S] clusters. On the basis of analyses using transient absorption, EPR, and optical titrations with NADH or inorganic reductants with and without NAD(+), we propose a catalytic cycle involving formation of an intermediary NAD(+)-bound complex. A charge transfer signal revealed an intriguing interplay of flavin semiquinones and a protein conformational change that gated electron transfer between the low- and high-potential pathways. We found that despite a common bifurcating flavin site, the proposed EtfABCX catalytic cycle is distinct from that of the genetically unrelated bifurcating NADH-dependent ferredoxin NADP(+) oxidoreductase (NfnI). The two enzymes particularly differed in the role of NAD(+), the resting and bifurcating-ready states of the enzymes, how electron flow is gated, and the two two-electron cycles constituting the overall four-electron reaction. We conclude that P. aerophilum EtfABCX provides a model catalytic mechanism that builds on and extends previous studies of related bifurcating ETFs and can be applied to the large bifurcating ETF family.	[Schut, Gerrit J.; Nguyen, Diep M. N.; Lipscomb, Gina L.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Mohamed-Raseek, Nishya; Hoben, John P.; Miller, Anne-Frances] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Tokmina-Lukaszewska, Monika; Patterson, Angela; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Mulder, David W.; Lubner, Carolyn E.; King, Paul W.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	University System of Georgia; University of Georgia; University of Kentucky; Montana State University System; Montana State University Bozeman; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Washington State University	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adamsm@uga.edu	King, Paul W./D-9979-2011; Mulder, David/AHC-0138-2022	King, Paul W./0000-0001-5039-654X; Mulder, David/0000-0003-0559-0145	Murdock Charitable Trust; National Institutes of Health IDEA Program [P20GM103474]	Murdock Charitable Trust; National Institutes of Health IDEA Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Mass Spectrometry Facility at Montana State University is supported in part by the Murdock Charitable Trust and National Institutes of Health IDEA Program Grant P20GM103474. We thank the Microfabrication Facility of Montana State University for help in preparation of gold-coated borosilica capillaries for noncovalent MS and Zachary Wood (University of Georgia) for use of the upcycled Agilent HP 8453.	BATIE CJ, 1986, J BIOL CHEM, V261, P1214; Baud A, 2016, BIOCHEM J, V473, P1805, DOI 10.1042/BCJ20160225; Bergdoll L, 2016, BBA-BIOENERGETICS, V1857, P1569, DOI 10.1016/j.bbabio.2016.06.006; Berry L, 2018, BBA-GEN SUBJECTS, V1862, P9, DOI 10.1016/j.bbagen.2017.10.002; Bertsch J, 2013, J BIOL CHEM, V288, P11304, DOI 10.1074/jbc.M112.444919; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brandt U, 1996, FEBS LETT, V387, P1, DOI 10.1016/0014-5793(96)00436-X; BROCKMAN HL, 1975, J BACTERIOL, V124, P1454, DOI 10.1128/JB.124.3.1454-1461.1975; Buckel W, 2018, CHEM REV, V118, P3862, DOI 10.1021/acs.chemrev.7b00707; Buckel W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00401; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Chowdhury NP, 2015, FEBS J, V282, P3149, DOI 10.1111/febs.13308; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Costas AMG, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00440-17; DEISTUNG J, 1986, BIOCHEM J, V239, P69, DOI 10.1042/bj2390069; Demmer JK, 2018, FEBS LETT, V592, P332, DOI 10.1002/1873-3468.12971; Demmer JK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01746-3; DeRose VJ, 1996, BIOCHEMISTRY-US, V35, P11085, DOI 10.1021/bi960749f; Duan HD, 2018, J BIOL CHEM, V293, P4688, DOI 10.1074/jbc.RA117.000707; Edgren T, 2004, J BACTERIOL, V186, P2052, DOI 10.1128/JB.186.7.2052-2060.2004; Efimov I, 2014, FEBS LETT, V588, P701, DOI 10.1016/j.febslet.2013.12.030; Elling FJ, 2016, ENVIRON MICROBIOL, V18, P692, DOI 10.1111/1462-2920.13086; Fernandez-Martinez J, 2016, CELL, V167, P1215, DOI 10.1016/j.cell.2016.10.028; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; Hagedoorn PL, 2005, J BIOL INORG CHEM, V10, P259, DOI 10.1007/s00775-005-0637-5; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; IYANAGI T, 1977, BIOCHEMISTRY-US, V16, P2725, DOI 10.1021/bi00631a021; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Ledbetter RN, 2017, BIOCHEMISTRY-US, V56, P4177, DOI 10.1021/acs.biochem.7b00389; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Lin TY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.374918; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Liu WH, 2016, ELIFE, V5, DOI 10.7554/eLife.18023; Lubner CE, 2017, NAT CHEM BIOL, V13, P655, DOI 10.1038/nchembio.2348; Luo ML, 2016, NUCLEIC ACIDS RES, V44, P7385, DOI 10.1093/nar/gkw421; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; MEDINA M, 1995, EUR J BIOCHEM, V227, P529, DOI 10.1111/j.1432-1033.1995.tb20420.x; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Metcalf WW, 2016, J BACTERIOL, V198, P1358, DOI 10.1128/JB.00185-16; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Mummadisetti MP, 2014, P NATL ACAD SCI USA, V111, P16178, DOI 10.1073/pnas.1415165111; Nguyen DMN, 2017, J BIOL CHEM, V292, P14603, DOI 10.1074/jbc.M117.794172; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Peters JW, 2018, CURR OPIN CHEM BIOL, V47, P32, DOI 10.1016/j.cbpa.2018.07.026; Peters JW, 2018, CHEM COMMUN, V54, P4091, DOI 10.1039/c8cc01530a; Peters JW, 2016, CURR OPIN CHEM BIOL, V31, P146, DOI 10.1016/j.cbpa.2016.03.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poudel S, 2016, BBA-GEN SUBJECTS, V1860, P1910, DOI 10.1016/j.bbagen.2016.05.034; Peregrina JR, 2010, BBA-BIOENERGETICS, V1797, P1638, DOI 10.1016/j.bbabio.2010.05.006; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 2013, J BIOCHEM, V153, P565, DOI 10.1093/jb/mvt026; Schmidt C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2985; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Sena FV, 2018, REDOX BIOL, V16, P209, DOI 10.1016/j.redox.2018.02.004; Song Y, 2015, ACS CENTRAL SCI, V1, P477, DOI 10.1021/acscentsci.5b00251; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Trimmer EE, 2005, BIOCHEMISTRY-US, V44, P6809, DOI 10.1021/bi0477236; TSAI MH, 1995, RES MICROBIOL, V146, P397, DOI 10.1016/0923-2508(96)80285-3; Verhagen MFJM, 2001, METHOD ENZYMOL, V330, P25; VOLKL P, 1993, APPL ENVIRON MICROB, V59, P2918; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Weghoff MC, 2015, ENVIRON MICROBIOL, V17, P670, DOI 10.1111/1462-2920.12493; Yang ZY, 2016, BIOCHEMISTRY-US, V55, P3625, DOI 10.1021/acs.biochem.6b00421; Zanphorlin LM, 2016, J BIOL CHEM, V291, P18620, DOI 10.1074/jbc.M115.710137; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008; Zhang H, 2012, INT J MASS SPECTROM, V312, P78, DOI 10.1016/j.ijms.2011.07.015; Zhang P, 2017, ACCOUNTS CHEM RES, V50, P2410, DOI 10.1021/acs.accounts.7b00327	68	24	24	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3271	3283		10.1074/jbc.RA118.005653	http://dx.doi.org/10.1074/jbc.RA118.005653			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	33743959	Green Published, hybrid			2022-12-28	WOS:000464980100024
J	Ando, T; Jongruja, N; Okumura, N; Morikawa, K; Kanaya, S; Takao, T				Ando, Tomoshige; Jongruja, Nujarin; Okumura, Nobuaki; Morikawa, Kosuke; Kanaya, Shigenori; Takao, Toshifumi			Identification of the ternary complex of ribonuclease HI:RNA/DNA hybrid:metal ions by ESI mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RNASE HI; HIV-1 REVERSE-TRANSCRIPTASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SUPEROXIDE-DISMUTASE; CATALYTIC MECHANISM; RNA/DNA HYBRID; RESOLUTION; BINDING; ENZYME	Ribonuclease HI, an endoribonuclease, catalyzes the hydrolysis of the RNA strand of an RNA/DNA hybrid and requires divalent metal ions for its enzymatic activity. However, the mechanistic details of the activity of ribonuclease HI and its interaction with divalent metal ions remain unclear. In this study, we performed real-time monitoring of the enzymesubstrate complex in the presence of divalent metal ions (Mn2+ or Zn2+) using electrospray ionization-mass spectrometry (ESI-MS). The findings provide clear evidence that the enzymatic activity of the ternary complex requires the binding of two divalent metal ions. The Zn2+ ions bind to both the enzyme itself and the enzyme:substrate complex more strongly than Mn2+ ions, and gives, in part, the ternary complex, [RNase HI:nicked RNA/DNA hybrid:2Zn(2+)], suggesting that the ternary complex is retained, even after the hydrolysis of the substrate. The collective results presented herein shed new light on the essential role of divalent metal ions in the activity of ribonuclease HI and demonstrate how Zn2+ ions confer inhibitory properties on the activity of this enzyme by forming a highly stable complex with the substrate.	[Ando, Tomoshige; Okumura, Nobuaki; Takao, Toshifumi] Osaka Univ, Inst Prot Res, Osaka, Japan; [Jongruja, Nujarin; Kanaya, Shigenori] Osaka Univ, Grad Sch Engn, Osaka, Japan; [Morikawa, Kosuke] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Kyoto, Japan	Osaka University; Osaka University; Kyoto University	Takao, T (corresponding author), Osaka Univ, Inst Prot Res, Osaka, Japan.	tak@protein.osaka-u.ac.jp		Okumura, Nobuaki/0000-0001-9587-5085; takao, toshifumi/0000-0002-4941-922X				Andersen KR, 2009, RNA, V15, P850, DOI 10.1261/rna.1489409; Banos-Mateos S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00886-w; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; Fenstermacher KJ, 2011, J BIOL CHEM, V286, P40433, DOI 10.1074/jbc.M111.289850; Fernandez-de-Cossio J, 2004, NUCLEIC ACIDS RES, V32, pW674, DOI 10.1093/nar/gkh423; Goedken ER, 2001, J BIOL CHEM, V276, P7266, DOI 10.1074/jbc.M009626200; HAUSEN P, 1970, EUR J BIOCHEM, V14, P278, DOI 10.1111/j.1432-1033.1970.tb00287.x; Hostomsky Z., 1993, NUCLEASES, V2nd, P341; ITAYA M, 1991, MOL GEN GENET, V227, P424, DOI 10.1007/BF00273933; KANAYA S, 1993, J BIOTECHNOL, V28, P117, DOI 10.1016/0168-1656(93)90129-B; KANAYA S, 1991, J BIOL CHEM, V266, P11621; Kashiwagi T, 1996, PROTEIN ENG, V9, P857, DOI 10.1093/protein/9.10.857; KATAYANAGI K, 1993, PROTEINS, V17, P337, DOI 10.1002/prot.340170402; KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0; Lockhart A, 2019, CELL REP, V29, P2890, DOI 10.1016/j.celrep.2019.10.108; Loo JA, 1997, MASS SPECTROM REV, V16, P1; MILLER HI, 1973, J BIOL CHEM, V248, P2621; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; NAKAMURA H, 1991, P NATL ACAD SCI USA, V88, P11535, DOI 10.1073/pnas.88.24.11535; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pinkse MWH, 2004, J AM SOC MASS SPECTR, V15, P1392, DOI 10.1016/j.jasms.2004.06.015; ROBINSON CV, 1994, NATURE, V372, P646, DOI 10.1038/372646a0; Rosta E, 2011, J AM CHEM SOC, V133, P8934, DOI 10.1021/ja200173a; Samara NL, 2018, NAT STRUCT MOL BIOL, V25, P715, DOI 10.1038/s41594-018-0099-4; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; STEIN H, 1969, SCIENCE, V166, P393, DOI 10.1126/science.166.3903.393; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; SUGIMOTO K, 1968, P NATL ACAD SCI USA, V60, P1356, DOI 10.1073/pnas.60.4.1356; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x; Tsunaka Y, 2005, J MOL BIOL, V345, P1171, DOI 10.1016/j.jmb.2004.11.007; Tsutakawa SE, 1999, CELL, V99, P615, DOI 10.1016/S0092-8674(00)81550-0; Van Berkel WJH, 2000, PROTEIN SCI, V9, P435; White HD, 2007, BIOPHYS J, V93, P914, DOI [10.1529/biophysj.106.101618, 10.1529/biophysj.l06.101618]; Yamazaki Y, 2008, ANAL CHEM, V80, P8246, DOI 10.1021/ac801324b; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; Zhao HC, 2018, EMBO REP, V19, DOI 10.15252/embr.201745335; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	41	3	3	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100462	10.1016/j.jbc.2021.100462	http://dx.doi.org/10.1016/j.jbc.2021.100462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639158	Green Published, gold			2022-12-28	WOS:000672866400436
J	Cooke, SL; Soares, BL; Muller, CA; Nieduszynski, CA; de Oliveira, FMB; de Bruin, RAM				Cooke, Sophie L.; Soares, Barbara L.; Muller, Carolin A.; Nieduszynski, Conrad A.; Bastos de Oliveira, Francisco M.; de Bruin, Robertus A. M.			Tos4 mediates gene expression homeostasis through interaction with HDAC complexes independently of H3K56 acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; DAMAGE CHECKPOINT; CELL; TRANSCRIPTION; RPD3; REVEALS; SPECIFICITY; HISTONE-H3; PATHWAYS; DYNAMICS	Saccharomyces cerevisiae exhibits gene expression homeostasis, which is defined as the buffering of transcription levels against changes in DNA copy number during the S phase of the cell cycle. It has been suggested that S. cerevisiae employs an active mechanism to maintain gene expression homeostasis through Rtt109-Asf1-dependent acetylation of histone H3 on lysine 56 (H3K56). Here, we show that gene expression homeostasis can be achieved independently of H3K56 acetylation by Tos4 (Target of Swi6-4). Using Nanostring technology, we establish that Tos4-dependent gene expression homeostasis depends on its forkhead-associated (FHA) domain, which is a phosphopeptide recognition domain required to bind histone deacetylases (HDACs). We demonstrate that the mechanism of Tos4-dependent gene expression homeostasis requires its interaction with the Rpd3L HDAC complex. However, this is independent of Rpd3's well-established roles in both histone deacetylation and controlling the DNA replication timing program, as established by deep sequencing of Fluorescence-Activated Cell Sorted (FACS) S and G2 phase populations. Overall, our data reveals that Tos4 mediates gene expression homeostasis through its FHA domain-dependent interaction with the Rpd3L complex, which is independent of H3K56ac.	[Cooke, Sophie L.; de Bruin, Robertus A. M.] UCL, MRC Lab Mol Cell Biol, London, England; [Soares, Barbara L.; Bastos de Oliveira, Francisco M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Muller, Carolin A.; Nieduszynski, Conrad A.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Nieduszynski, Conrad A.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [de Bruin, Robertus A. M.] UCL, UCL Canc Inst, London, England	MRC Laboratory Molecular Biology; University of London; University College London; Universidade Federal do Rio de Janeiro; University of Oxford; University of Sussex; University of London; University College London	de Bruin, RAM (corresponding author), UCL, MRC Lab Mol Cell Biol, London, England.; de Bruin, RAM (corresponding author), UCL, UCL Canc Inst, London, England.	r.debruin@ucl.ac.uk	de Oliveira, Francisco Bastos/I-3540-2013	de Oliveira, Francisco Bastos/0000-0003-3314-3940; Soares, Barbara Luisa/0000-0002-7513-3399; De Bruin, Robertus/0000-0001-9957-1409; Cooke, Sophie/0000-0001-8169-8735	R. A. M. d. B.'s Cancer Research UK Programme Foundation Award; FAPERJ [E-26/010.002425/2019, E-26/26/010.002187/2019]; CAPES/PRINT [41/2017];  [MC_EX_G0800785]	R. A. M. d. B.'s Cancer Research UK Programme Foundation Award; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES/PRINT; 	This work was supported by core funding to the MRC-UCL University Unit (Ref. MC_EX_G0800785) and funded by R. A. M. d. B.'s Cancer Research UK Programme Foundation Award, F. M. B. d. O. is funded by FAPERJ E-26/010.002425/2019, E-26/26/010.002187/2019 and B. L. S. is supported by a scholarship from CAPES/PRINT 41/2017.	Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Batrakou DG, 2020, NAT PROTOC, V15, P1255, DOI 10.1038/s41596-019-0287-7; Chen Y, 2019, GENOME RES, V29, P1929, DOI 10.1101/gr.254342.119; Claude K. -L., 2020, TRANSCRIPTION COORDI, DOI [10.1101/2020.08.28.272492, DOI 10.1101/2020.08.28.272492]; Clemente-Ruiz M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002376; de Oliveira FMB, 2012, EMBO J, V31, P1798, DOI 10.1038/emboj.2012.27; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Geisberg JV, 2014, CELL, V156, P812, DOI 10.1016/j.cell.2013.12.026; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gomez-Gonzalez B, 2019, GENETICS, V211, P503, DOI 10.1534/genetics.118.301817; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kishkevich A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47170-z; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Koivomagi M, 2011, MOL CELL, V42, P610, DOI 10.1016/j.molcel.2011.05.016; Landry BD, 2014, EMBO J, V33, P1044, DOI 10.1002/embj.201386877; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Muller CA, 2012, GENOME RES, V22, P1953, DOI 10.1101/gr.139477.112; Muller CA, 2017, J CELL BIOL, V216, P1907, DOI 10.1083/jcb.201701061; Natsume T, 2013, MOL CELL, V50, P661, DOI 10.1016/j.molcel.2013.05.011; Ostapenko D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045895; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Santos A, 2015, NUCLEIC ACIDS RES, V43, pD1140, DOI 10.1093/nar/gku1092; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Serra-Cardona A, 2018, TRENDS BIOCHEM SCI, V43, P136, DOI 10.1016/j.tibs.2017.12.003; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Slager J, 2016, TRENDS MICROBIOL, V24, P788, DOI 10.1016/j.tim.2016.06.003; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sundin BA, 2004, YEAST, V21, P793, DOI 10.1002/yea.1133; Tao R, 2013, MOL CELL BIOL, V33, P4212, DOI 10.1128/MCB.00618-13; Topal S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12400-5; Vargas-Garcia Cesar A, 2018, Curr Opin Syst Biol, V8, P109, DOI 10.1016/j.coisb.2018.01.002; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Voichek Y, 2018, MOL CELL, V70, P1121, DOI 10.1016/j.molcel.2018.05.015; Voichek Y, 2016, SCIENCE, V351, P1087, DOI 10.1126/science.aad1162; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x; Yeheskely-Hayon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085088; Yoshida K, 2014, MOL CELL, V54, P691, DOI 10.1016/j.molcel.2014.04.032; Yunger S, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800086; Zhu J, 2018, DEV CELL, V44, P420, DOI 10.1016/j.devcel.2018.02.002; Ziane R., MECH DNA REPLICATION, DOI [10.1101/553669, DOI 10.1101/553669]	52	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100533	10.1016/j.jbc.2021.100533	http://dx.doi.org/10.1016/j.jbc.2021.100533			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713703	Green Accepted, gold, Green Published			2022-12-28	WOS:000672866400507
J	Eiyama, A; Aaltonen, MJ; Nolte, H; Tatsuta, T; Langer, T				Eiyama, Akinori; Aaltonen, Mari J.; Nolte, Hendrik; Tatsuta, Takashi; Langer, Thomas			Disturbed intramitochondrial phosphatidic acid transport impairs cellular stress signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN-RESPONSE; ENDOPLASMIC-RETICULUM STRESS; TRANSMEMBRANE PROTEIN; PHOSPHOLIPID TRANSFER; MITOCHONDRIAL FUSION; TRANSCRIPTION FACTOR; SENSOR IRE1; CARDIOLIPIN; YEAST; SCH9	Lipid transfer proteins of the Ups1/PRELID1 family facilitate the transport of phospholipids across the intermembrane space of mitochondria in a lipid-specific manner. Heterodimeric complexes of yeast Ups1/Mdm35 or human PRELID1/TRIAP1 shuttle phosphatidic acid (PA) mainly synthesized in the endoplasmic reticulum (ER) to the inner membrane, where it is converted to cardiolipin (CL), the signature phospholipid of mitochondria. Loss of Ups1/PRELID1 proteins impairs the accumulation of CL and broadly affects mitochondrial structure and function. Unexpectedly and unlike yeast cells lacking the CL synthase Crd1, Ups1-deficient yeast cells exhibit glycolytic growth defects, pointing to functions of Ups1-mediated PA transfer beyond CL synthesis. Here, we show that the disturbed intramitochondrial transport of PA in ups1. cells leads to altered unfolded protein response (UPR) and mTORC1 signaling, independent of disturbances in CL synthesis. The impaired flux of PA into mitochondria is associated with the increased synthesis of phosphatidylcholine and a reduced phosphatidylethanolamine/phosphatidylcholine ratio in the ER of ups1. cells which suppresses the UPR. Moreover, we observed inhibition of target of rapamycin complex 1 (TORC1) signaling in these cells. Activation of either UPR by ER protein stress or of TORC1 signaling by disruption of its negative regulator, the Seh1-associated complex inhibiting TORC1 complex, increased cytosolic protein synthesis, and restored glycolytic growth of ups1. cells. These results demonstrate that PA influx into mitochondria is required to preserve ER membrane homeostasis and that its disturbance is associated with impaired glycolytic growth and cellular stress signaling.	[Eiyama, Akinori; Nolte, Hendrik; Tatsuta, Takashi; Langer, Thomas] Max Planck Inst Biol Ageing, Cologne, Germany; [Aaltonen, Mari J.; Langer, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Aaltonen, Mari J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	Max Planck Society; University of Cologne; McGill University	Langer, T (corresponding author), Max Planck Inst Biol Ageing, Cologne, Germany.; Langer, T (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.	TLanger@age.mpg.de		Aaltonen, Mari J./0000-0002-7333-9334	JSPS Overseas Research Fellowships; Deutsche Forschungsgemeinschaft [TA1132/2-1, LA918/14-1]	JSPS Overseas Research Fellowships; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by JSPS Overseas Research Fellowships to A. E. and by grants of the Deutsche Forschungsgemeinschaft to T. T. (TA1132/2-1) and T. L. (LA918/14-1).	Aaltonen MJ, 2016, J CELL BIOL, V213, P525, DOI 10.1083/jcb.201602007; Ahmed K, 2019, FEBS LETT, V593, P1957, DOI 10.1002/1873-3468.13463; Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123; Bertero E, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165803; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Bruderer R, 2015, MOL CELL PROTEOMICS, V14, P1400, DOI 10.1074/mcp.M114.044305; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dokudovskaya S, 2015, J CELL SCI, V128, P2219, DOI 10.1242/jcs.168922; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; GAIGG B, 1995, BBA-BIOMEMBRANES, V1234, P214, DOI 10.1016/0005-2736(94)00287-Y; Gao X, 2015, BBA-MOL BASIS DIS, V1852, P2689, DOI 10.1016/j.bbadis.2015.09.006; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Halbleib K, 2017, MOL CELL, V67, P673, DOI 10.1016/j.molcel.2017.06.012; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Ho N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.199307; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Ikon N, 2017, BBA-BIOMEMBRANES, V1859, P1156, DOI 10.1016/j.bbamem.2017.03.013; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011; Kannan M, 2017, J LIPID RES, V58, P553, DOI 10.1194/jlr.M072959; Kawai S, 2011, EUKARYOT CELL, V10, P1367, DOI 10.1128/EC.05157-11; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lev S, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013300; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; MacVicar T, 2019, NATURE, V575, P361, DOI 10.1038/s41586-019-1738-6; Metge F., 2018, AGEPY PYTHON PACKAGE, DOI [10.1101/450890, DOI 10.1101/450890]; Miliara X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09089-x; Miliara X, 2015, EMBO REP, V16, P824, DOI 10.15252/embr.201540229; Miyata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16661-2; Miyata N, 2016, J CELL BIOL, V214, P77, DOI 10.1083/jcb.201601082; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Musatov A, 2017, BIOCHIMIE, V142, P102, DOI 10.1016/j.biochi.2017.08.013; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Peng KY, 2018, J LIPID RES, V59, P1977, DOI 10.1194/jlr.M085613; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pincus D, 2014, P NATL ACAD SCI USA, V111, P14800, DOI 10.1073/pnas.1409588111; Pizzuto M, 2020, TRENDS CELL BIOL, V30, P892, DOI 10.1016/j.tcb.2020.09.004; Pollard AK, 2017, AGING-US, V9, P986, DOI 10.18632/aging.101204; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Powis K, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2015.49; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Saita S, 2018, EMBO J, V37, DOI 10.15252/embj.201797909; Samluk L, 2018, CURR OPIN PHYSIOL, V3, P41, DOI 10.1016/j.cophys.2018.02.010; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Tamura Y, 2020, BIOL CHEM, V401, P821, DOI 10.1515/hsz-2020-0121; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tatsuta T, 2017, METHODS MOL BIOL, V1567, P79, DOI 10.1007/978-1-4939-6824-4_7; Tatsuta T, 2017, BBA-MOL CELL BIOL L, V1862, P81, DOI 10.1016/j.bbalip.2016.08.006; Thibault G, 2012, MOL CELL, V48, P16, DOI 10.1016/j.molcel.2012.08.016; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Watanabe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8922; Weidberg H, 2018, SCIENCE, V360, DOI 10.1126/science.aan4146; Yu F, 2015, EMBO REP, V16, P813, DOI 10.15252/embr.201540137	77	2	2	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100335	10.1016/j.jbc.2021.100335	http://dx.doi.org/10.1016/j.jbc.2021.100335			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33497623	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400309
J	Ferousi, C; Schmitz, RA; Maalcke, WJ; Lindhoud, S; Versantvoort, W; Jetten, MSM; Reimann, J; Kartal, B				Ferousi, Christina; Schmitz, Rob A.; Maalcke, Wouter J.; Lindhoud, Simon; Versantvoort, Wouter; Jetten, Mike S. M.; Reimann, Joachim; Kartal, Boran			Characterization of a nitrite-reducing octaheme hydroxylamine oxidoreductase that lacks the tyrosine cross-link	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROSOMONAS-EUROPAEA; ELECTRON-TRANSFER; REDUCTASE-ACTIVITY; CRYSTAL-STRUCTURE; CYTOCHROME; HEME; OXIDE; AMMONIA; PROTEIN; BACTERIUM	The hydroxylamine oxidoreductase (HAO) family consists of octaheme proteins that harbor seven bis-His ligated electron-transferring hemes and one 5-coordinate catalytic heme with His axial ligation. Oxidative HAOs have a homotrimeric configuration with the monomers covalently attached to each other via a unique double cross-link between a Tyr residue and the catalytic heme moiety of an adjacent subunit. This cross-linked active site heme, termed the P460 cofactor, has been hypothesized to modulate enzyme reactivity toward oxidative catalysis. Conversely, the absence of this cross-link is predicted to favor reductive catalysis. However, this prediction has not been directly tested. In this study, an HAO homolog that lacks the heme-Tyr cross-link (HAOr) was purified to homogeneity from the nitrite-dependent anaerobic ammonium-oxidizing (anammox) bacterium Kuenenia stuttgartiensis, and its catalytic and spectroscopic properties were assessed. We show that HAOr reduced nitrite to nitric oxide and also reduced nitric oxide and hydroxylamine as nonphysiological substrates. In contrast, HAOr was not able to oxidize hydroxylamine or hydrazine supporting the notion that cross-link-deficient HAO enzymes are reductases. Compared with oxidative HAOs, we found that HAOr harbors an active site heme with a higher (at least 80 mV) midpoint potential and a much lower degree of porphyrin ruffling. Based on the physiology of anammox bacteria and our results, we propose that HAOr reduces nitrite to nitric oxide in vivo, providing anammox bacteria with NO, which they use to activate ammonium in the absence of oxygen.	[Ferousi, Christina; Schmitz, Rob A.; Maalcke, Wouter J.; Lindhoud, Simon; Versantvoort, Wouter; Jetten, Mike S. M.; Reimann, Joachim] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Microbiol, Nijmegen, Netherlands; [Kartal, Boran] Max Planck Inst Marine Microbiol, Microbial Physiol Grp, Bremen, Germany; [Ferousi, Christina] Natl Tech Univ Athens, Sch Chem Engn, Biotechnol Lab, Ind Biotechnol & Biocatalysis Grp, 5 Iroon Polytech Str,Zografou Campus, Athens 15780, Greece; [Lindhoud, Simon] Wageningen Univ, Lab Biochem, NL-6708 WE Wageningen, Netherlands; [Versantvoort, Wouter] Synthon BV, Microweg 22, NL-6545 CM Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; National Technical University of Athens; Wageningen University & Research	Kartal, B (corresponding author), Max Planck Inst Marine Microbiol, Microbial Physiol Grp, Bremen, Germany.	bkartal@mpi-bremen.de	Kartal, Boran/ABD-5400-2021; Jetten, Mike/B-8834-2011	Jetten, Mike/0000-0002-4691-7039; Schmitz, Rob/0000-0001-5145-991X; Kartal, Boran/0000-0003-4199-952X; Ferousi, Christina/0000-0001-6400-7373; Versantvoort, Wouter/0000-0001-5418-2741; Maalcke, Wouter/0000-0002-3736-7282	Spinoza Prize - Netherlands Organization for Scientific Research [NWO 62001581, NWO 824.15.011]; NWO [VI.Vidi.192.001]; European Research Council [ERC 640422, ERC 339880];  [ERC 232937];  [NWO 024002002]	Spinoza Prize - Netherlands Organization for Scientific Research; NWO(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); ; 	C. F. and M. S. M. J. were supported by a Spinoza Prize awarded to M. S. M. J. by the Netherlands Organization for Scientific Research [NWO 62001581, 2012], S. L. and W. V. by [NWO 824.15.011, 2015 awarded to B. K.], W. V. by NWO VI.Vidi.192.001 grant (awarded to Laura van Niftrik) B. K. by the European Research Council [ERC 640422, 2014], and J. R. by [ERC 339880, 2014]. M. S. M. J. was further supported by [ERC 232937, 2009], [ERC 339880, 2014], and [NWO 024002002, 2014].	Akram M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4310; Andersen JF, 2000, BIOCHEMISTRY-US, V39, P10118, DOI 10.1021/bi000766b; ANDERSSON KK, 1984, J BIOL CHEM, V259, P6833; ARCIERO DM, 1991, BIOCHEMISTRY-US, V30, P11459, DOI 10.1021/bi00112a013; Atkinson SJ, 2007, FEBS LETT, V581, P3805, DOI 10.1016/j.febslet.2007.07.005; Atwood J.L., 1996, COMPREHENSIVE SUPRAM, DOI DOI 10.1021/jacs.6b12949; BAYMANN F, 1991, ANAL BIOCHEM, V199, P269, DOI 10.1016/0003-2697(91)90100-8; Baymann F, 2007, P NATL ACAD SCI USA, V104, P519, DOI 10.1073/pnas.0606369104; Bergmann DJ, 2005, APPL ENVIRON MICROB, V71, P5371, DOI 10.1128/AEM.71.9.5371-5382.2005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bykov D, 2015, INORG CHEM, V54, P9303, DOI 10.1021/acs.inorgchem.5b01506; Caranto JD, 2017, P NATL ACAD SCI USA, V114, P8217, DOI 10.1073/pnas.1704504114; Caranto JD, 2016, P NATL ACAD SCI USA, V113, P14704, DOI 10.1073/pnas.1611051113; Cedervall PE, 2009, ACTA CRYSTALLOGR F, V65, P1296, DOI 10.1107/S1744309109046119; Clarke TA, 2008, METHOD ENZYMOL, V437, P63, DOI 10.1016/S0076-6879(07)37004-3; COLLINS MJ, 1993, J BIOL CHEM, V268, P14655; de Almeida NM, 2015, J BACTERIOL, V197, P2432, DOI 10.1128/JB.00186-15; Dietl A, 2019, ACTA CRYSTALLOGR D, V75, P333, DOI 10.1107/S2059798318017473; Dietl A, 2015, NATURE, V527, P404, DOI 10.1038/nature15517; Ding XD, 1999, J AM CHEM SOC, V121, P128, DOI 10.1021/ja982979i; Edwards MJ, 2020, CELL, V181, P665, DOI 10.1016/j.cell.2020.03.032; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Farhoud MH, 2005, MOL CELL PROTEOMICS, V4, P1653, DOI 10.1074/mcp.M500171-MCP200; Ferousi C, 2019, J BIOL CHEM, V294, P16953, DOI 10.1074/jbc.RA119.010568; Ford PC, 2005, CHEM REV, V105, P2439, DOI 10.1021/cr0307289; Fourmond V, 2016, ANAL CHEM, V88, P5050, DOI 10.1021/acs.analchem.6b00224; Graves AB, 2016, J PHYS CHEM B, V120, P3844, DOI 10.1021/acs.jpcb.6b01497; Guo ML, 2004, P NATL ACAD SCI USA, V101, P5940, DOI 10.1073/pnas.0306708101; Haase D, 2017, MOL MICROBIOL, V105, P127, DOI 10.1111/mmi.13690; HOOPER AB, 1965, J BIOL CHEM, V240, P4044; Hu Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09268-w; Igarashi N, 1997, NAT STRUCT BIOL, V4, P276, DOI 10.1038/nsb0497-276; Jentzen W, 1997, J PHYS CHEM B, V101, P1684, DOI 10.1021/jp963142h; Judd ET, 2014, BIOCHEMISTRY-US, V53, P5638, DOI 10.1021/bi500854p; Kartal B, 2006, J BIOTECHNOL, V126, P546, DOI 10.1016/j.jbiotec.2006.05.012; Kartal B, 2013, FEMS MICROBIOL REV, V37, P428, DOI 10.1111/1574-6976.12014; Kartal B, 2012, ADV MICROB PHYSIOL, V60, P211, DOI 10.1016/B978-0-12-398264-3.00003-6; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kleingardner JG, 2015, ACCOUNTS CHEM RES, V48, P1845, DOI 10.1021/acs.accounts.5b00106; Klotz MG, 2008, ENVIRON MICROBIOL, V10, P3150, DOI 10.1111/j.1462-2920.2008.01733.x; Kostera J, 2008, J BIOL INORG CHEM, V13, P1073, DOI 10.1007/s00775-008-0393-4; Kostera J, 2010, BIOCHEMISTRY-US, V49, P8546, DOI 10.1021/bi1006783; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawton TJ, 2013, J BIOL CHEM, V288, P25575, DOI 10.1074/jbc.M113.484543; Liptak MD, 2010, J AM CHEM SOC, V132, P9753, DOI 10.1021/ja102098p; Lukat P, 2008, BIOCHEMISTRY-US, V47, P2080, DOI 10.1021/bi7021415; Maalcke WJ, 2016, J BIOL CHEM, V291, P17077, DOI 10.1074/jbc.M116.735530; Maalcke WJ, 2014, J BIOL CHEM, V289, P1228, DOI 10.1074/jbc.M113.525147; Moffet DA, 2003, BIOPHYS CHEM, V105, P231, DOI 10.1016/S0301-4622(03)00072-3; Mowat CG, 2004, NAT STRUCT MOL BIOL, V11, P1023, DOI 10.1038/nsmb827; Neumann S, 2014, MOL MICROBIOL, V94, P794, DOI 10.1111/mmi.12816; Polyakov KM, 2009, J MOL BIOL, V389, P846, DOI 10.1016/j.jmb.2009.04.037; Radoul M, 2011, J AM CHEM SOC, V133, P3043, DOI 10.1021/ja109688w; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Rinaldo S, 2007, J BIOL CHEM, V282, P14761, DOI 10.1074/jbc.M700933200; Schmitz RA, 2020, ISME J, V14, P1223, DOI 10.1038/s41396-020-0609-3; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; Simon J, 2011, BIOCHEM SOC T, V39, P1864, DOI 10.1042/BST20110713; Sun YH, 2014, P NATL ACAD SCI USA, V111, P6570, DOI 10.1073/pnas.1322274111; Suschek C. V., 2016, SKIN STRESS RESPONSE, P127; TAYLOR S, 1974, ANAL BIOCHEM, V60, P153, DOI 10.1016/0003-2697(74)90140-7; Tikhonova TV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1129, DOI 10.1134/S0006297912100057; van Niftrik L, 2008, J STRUCT BIOL, V161, P401, DOI 10.1016/j.jsb.2007.05.005; van Wonderen JH, 2008, J BIOL CHEM, V283, P9587, DOI 10.1074/jbc.M709090200	64	7	8	11	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100476	10.1016/j.jbc.2021.100476	http://dx.doi.org/10.1016/j.jbc.2021.100476			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33652023	gold, Green Published			2022-12-28	WOS:000672866400450
J	Haindrich, AC; Ernst, V; Naguleswaran, A; Oliveres, QF; Roditi, I; Rentsch, D				Haindrich, Alexander C.; Ernst, Viona; Naguleswaran, Arunasalam; Oliveres, Quentin-Florian; Roditi, Isabel; Rentsch, Doris			Nutrient availability regulates proline/alanine transporters in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; AMINO-ACID PERMEASE; HIGH-AFFINITY; GLOSSINA-MORSITANS; PROLINE METABOLISM; ACTIVE-TRANSPORT; PROCYCLIC FORMS; TSETSE-FLIES; LEISHMANIA; PROTEIN	Trypanosoma brucei is a species of unicellular parasite that can cause severe diseases in livestock and humans, including African trypanosomiasis and Chagas disease. Adaptation to diverse environments and changes in nutritional conditions is essential for T. brucei to establish an infection when changing hosts or during invasion of different host tissues. One such adaptation is the ability of T. brucei to rapidly switch its energy metabolism from glucose metabolism in the mammalian blood to proline catabolism in the insect stages and vice versa. However, the mechanisms that support the parasite's response to nutrient availability remain unclear. Using RNAseq and qRT-PCR, we investigated the response of T. brucei to amino acid or glucose starvation and found increased mRNA levels of several amino acid transporters, including all genes of the amino acid transporter AAT7-B subgroup. Functional characterization revealed that AAT7-B members are plasma membrane-localized in T. brucei and when expressed in Saccharomyces cerevisiae supported the uptake of proline, alanine, and cysteine, while other amino acids were poorly recognized. All AAT7-B members showed a preference for proline, which is transported with high or low affinity. RNAi-mediated AAT7-B downregulation resulted in a reduction of intracellular proline concentrations and growth arrest under low proline availability in cultured procyclic form parasites. Taken together, these results suggest a role of AAT7-B transporters in the response of T. brucei to proline starvation and proline catabolism.	[Haindrich, Alexander C.; Ernst, Viona; Oliveres, Quentin-Florian; Rentsch, Doris] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Naguleswaran, Arunasalam; Roditi, Isabel] Univ Bern, Inst Cell Biol, Bern, Switzerland	University of Bern; University of Bern	Rentsch, D (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	doris.rentsch@ips.unibe.ch		Haindrich, Alexander C./0000-0001-6484-2846; Roditi, Isabel/0000-0003-2812-6513; Rentsch, Doris/0000-0003-4313-7683; Naguleswaran, Arunasalam/0000-0002-9509-485X	Swiss National Science Foundation [CRSII3_141913, 31003A_182426]; University of Bern	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Bern	This work was supported by the Swiss National Science Foundation CRSII3_141913 and 31003A_182426 (DR) and the University of Bern.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Aoki JI, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006025; Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Armenteros JJA, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900429; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; BALOGUN RA, 1974, COMP BIOCHEM PHYSIOL, V49, P215, DOI 10.1016/0300-9629(74)90110-8; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Bridges DJ, 2008, PROTEOMICS, V8, P83, DOI 10.1002/pmic.200700607; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; BROWN R C, 1973, International Journal for Parasitology, V3, P691, DOI 10.1016/0020-7519(73)90095-7; BRUN R, 1979, ACTA TROP, V36, P289; BRUN R, 1981, Z PARASITENKD, V66, P17, DOI 10.1007/BF00941941; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; BURSELL E, 1963, J INSECT PHYSIOL, V9, P439, DOI 10.1016/0022-1910(63)90054-4; BURSELL E, 1966, COMP BIOCHEM PHYSIOL, V19, P809, DOI 10.1016/0010-406X(66)90437-3; Capewell P, 2016, ELIFE, V5, DOI 10.7554/eLife.17716; CHAPPELL LH, 1972, PARASITOLOGY, V64, P379, DOI 10.1017/S0031182000045455; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; CUNNINGHAM I, 1974, Acta Tropica, V31, P83; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Dejung M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005439; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Ebikeme CE, 2008, PARASITOLOGY, V135, P585, DOI 10.1017/S0031182008004241; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Ghaddar K, 2014, MOL CELL BIOL, V34, P4447, DOI 10.1128/MCB.00699-14; Girard RMBM, 2018, MSPHERE, V3, DOI 10.1128/mSphereDirect.00338-18; Goldman-Pinkovich A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005494; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Haanstra JR, 2011, MOL MICROBIOL, V79, P94, DOI 10.1111/j.1365-2958.2010.07435.x; HARGROVE JW, 1976, J INSECT PHYSIOL, V22, P309, DOI 10.1016/0022-1910(76)90040-8; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Inbar E, 2013, BIOCHEM J, V449, P555, DOI 10.1042/BJ20121262; ISOUN TT, 1978, ACTA TROP, V35, P287; Jackson AP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-26; Jackson AP, 2016, CURR BIOL, V26, P161, DOI 10.1016/j.cub.2015.11.055; Jackson AP, 2015, PARASITOLOGY, V142, pS40, DOI 10.1017/S0031182014000894; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; JAUNIAUX JC, 1987, EUR J BIOCHEM, V164, P601, DOI 10.1111/j.1432-1033.1987.tb11169.x; Jensen BC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-911; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Kaur J, 2007, GENETICS, V176, P877, DOI 10.1534/genetics.107.070342; Kim DH, 2015, METABOLOMICS, V11, P1721, DOI 10.1007/s11306-015-0827-2; KWART M, 1993, PLANT J, V4, P993, DOI 10.1046/j.1365-313X.1993.04060993.x; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LHOSTIS C, 1993, BIOCHEM J, V291, P297, DOI 10.1042/bj2910297; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Macedo JP, 2017, FASEB J, V31, P4649, DOI 10.1096/fj.201700311R; Mani J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7646; Mantilla BS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006158; Marchese L, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020036; Marciano D, 2009, MOL BIOCHEM PARASIT, V166, P172, DOI 10.1016/j.molbiopara.2009.04.001; Mathieu C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168775; Mathieu C, 2014, BIOCHEM J, V463, P9, DOI 10.1042/BJ20140719; Mazareb S, 1999, EXP PARASITOL, V91, P341, DOI 10.1006/expr.1998.4391; Mazet M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002587; Meyer A, 2006, J BIOL CHEM, V281, P7197, DOI 10.1074/jbc.M510766200; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Mogk S, 2017, BIOL REV, V92, P1675, DOI 10.1111/brv.12301; Muller LSM, 2018, NATURE, V563, P121, DOI 10.1038/s41586-018-0619-8; Naguleswaran A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4600-6; NEWPORT GR, 1977, J PARASITOL, V63, P15, DOI 10.2307/3280098; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; PATEL NY, 1981, INSECT SCI APPL, V1, P383, DOI 10.1017/S1742758400000722; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Qiu YJ, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00366-18, 10.1128/msphere.00366-18]; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; Rico E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26303-w; Rico E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00078; Roditi I, 2008, CURR OPIN MICROBIOL, V11, P345, DOI 10.1016/j.mib.2008.06.006; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rolin S, 1998, MOL BIOCHEM PARASIT, V93, P251, DOI 10.1016/S0166-6851(98)00046-2; Royle SJ, 2003, BIOESSAYS, V25, P39, DOI 10.1002/bies.10200; Savage AF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168877; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Sbicego S, 1999, MOL BIOCHEM PARASIT, V104, P311, DOI 10.1016/S0166-6851(99)00157-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlisselberg D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16289; Shaked-Mishan P, 2006, MOL MICROBIOL, V60, P30, DOI 10.1111/j.1365-2958.2006.05060.x; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Silber AM, 2002, J EUKARYOT MICROBIOL, V49, P441, DOI 10.1111/j.1550-7408.2002.tb00225.x; SIMON MW, 1983, MOL BIOCHEM PARASIT, V9, P47, DOI 10.1016/0166-6851(83)90056-7; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Smith Terry K, 2017, F1000Res, V6, DOI 10.12688/f1000research.10342.2; Spitznagel D, 2009, FEBS J, V276, P7187, DOI 10.1111/j.1742-4658.2009.07432.x; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Szoor B, 2020, TRENDS PARASITOL, V36, P266, DOI 10.1016/j.pt.2019.12.011; t'Kindt R, 2010, ANAL BIOANAL CHEM, V398, P2059, DOI 10.1007/s00216-010-4139-0; TANAKA J, 1985, GENE, V38, P205, DOI 10.1016/0378-1119(85)90219-7; Tanowitz HB, 2017, TRENDS PARASITOL, V33, P276, DOI 10.1016/j.pt.2016.11.008; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Van Den Abbeele J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000926; van Grinsven KWA, 2009, EUKARYOT CELL, V8, P1307, DOI 10.1128/EC.00091-09; Vasquez JJ, 2014, NUCLEIC ACIDS RES, V42, P3623, DOI 10.1093/nar/gkt1386; Vieira LL, 1996, BIOCHEM J, V319, P691, DOI 10.1042/bj3190691; Vigneron A, 2020, P NATL ACAD SCI USA, V117, P2613, DOI 10.1073/pnas.1914423117; Vincent IM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001204; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; WILLIAMSON J, 1956, Ann Trop Med Parasitol, V50, P334; WILLIAMSON J, 1961, EXP PARASITOL, V11, P161, DOI 10.1016/0014-4894(61)90023-6; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zikova A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006679; Zoltner M, 2020, J BIOL CHEM, V295, P8331, DOI 10.1074/jbc.RA120.012355	124	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100566	10.1016/j.jbc.2021.100566	http://dx.doi.org/10.1016/j.jbc.2021.100566			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33745971	Green Published, gold			2022-12-28	WOS:000672866400539
J	Hameedi, MA; Grba, DN; Richardson, KH; Jones, AJY; Song, W; Roessler, MM; Wright, JJ; Hirst, J				Hameedi, Mikhail A.; Grba, Daniel N.; Richardson, Katherine H.; Jones, Andrew J. Y.; Song, Wei; Roessler, Maxie M.; Wright, John J.; Hirst, Judy			A conserved arginine residue is critical for stabilizing the N2 FeS cluster in mitochondrial complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BEAM-INDUCED MOTION; CRYSTAL-STRUCTURE; QUINONE BINDING; 49-KDA SUBUNIT; SITE; VALIDATION; RESOLUTION; REDUCTION; FEATURES	Respiratory complex I (NADH:ubiquinone oxidoreductase), the first enzyme of the electron-transport chain, captures the free energy released by NADH oxidation and ubiquinone reduction to translocate protons across an energy-transducing membrane and drive ATP synthesis during oxidative phosphorylation. The cofactor that transfers the electrons directly to ubiquinone is an iron-sulfur cluster (N2) located in the NDUFS2/NUCM subunit. A nearby arginine residue (R121), which forms part of the second coordination sphere of the N2 cluster, is known to be posttranslationally dimethylated but its functional and structural significance are not known. Here, we show that mutations of this arginine residue (R121M/K) abolish the quinone-reductase activity, concomitant with disappearance of the N2 signature from the electron paramagnetic resonance (EPR) spectrum. Analysis of the cryo-EM structure of NDUFS2-R121M complex I at 3.7 angstrom resolution identified the absence of the cubane N2 cluster as the cause of the dysfunction, within an otherwise intact enzyme. The mutation further induced localized disorder in nearby elements of the quinone-binding site, consistent with the close connections between the cluster and substrate-binding regions. Our results demonstrate that R121 is required for the formation and/or stability of the N2 cluster and highlight the importance of structural analyses for mechanistic interpretation of biochemical and spectroscopic data on complex I variants.	[Hameedi, Mikhail A.; Grba, Daniel N.; Jones, Andrew J. Y.; Wright, John J.; Hirst, Judy] Univ Cambridge, Med Res Council Mitochondrial Biol Unit, Cambridge, England; [Richardson, Katherine H.; Song, Wei; Roessler, Maxie M.; Wright, John J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Richardson, Katherine H.; Roessler, Maxie M.] Imperial Coll London, Mol Sci Res Hub, Dept Chem, White City Campus, London, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of London; Queen Mary University London; Imperial College London	Wright, JJ; Hirst, J (corresponding author), Univ Cambridge, Med Res Council Mitochondrial Biol Unit, Cambridge, England.; Roessler, MM; Wright, JJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.; Roessler, MM (corresponding author), Imperial Coll London, Mol Sci Res Hub, Dept Chem, White City Campus, London, England.	m.roessler@imperial.ac.uk; jjw86@mrc-mbu.cam.ac.uk; jh@mrc-mbu.cam.ac.uk	; Hirst, Judy/F-4803-2011	Grba, Daniel/0000-0003-2915-951X; Wright, John/0000-0001-8987-4449; Hirst, Judy/0000-0001-8667-6797; Richardson, Katherine/0000-0002-5166-0100	Medical Research Council [MC_U105663141, MC_UU_00015/2]; Chinese Scholarship Council; EPSRC [EP/M024393/1, EP/T031425/1]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chinese Scholarship Council(China Scholarship Council); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Medical Research Council (MC_U105663141 and MC_UU_00015/2 to J. H.), a studentship from Chinese Scholarship Council (to W. S.) and the EPSRC (EP/M024393/1 and EP/T031425/1 to M. M. R.).	Abdrakhmanova A, 2004, BBA-BIOENERGETICS, V1658, P148, DOI 10.1016/j.bbabio.2004.04.019; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Agip ANA, 2019, ANNU REV BIOPHYS, V48, P165, DOI 10.1146/annurev-biophys-052118-115704; Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; ALBRACHT SPJ, 1993, BIOCHIM BIOPHYS ACTA, V1144, P221, DOI 10.1016/0005-2728(93)90176-G; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359; Bak DW, 2014, CURR OPIN CHEM BIOL, V19, P50, DOI 10.1016/j.cbpa.2013.12.015; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Belevich G, 2007, BIOCHEMISTRY-US, V46, P526, DOI 10.1021/bi062062t; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Birrell JA, 2013, BIOCHEM J, V456, P139, DOI 10.1042/BJ20130606; Blaza JN, 2018, STRUCTURE, V26, P312, DOI 10.1016/j.str.2017.12.014; Cabrera-Orefice A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06955-y; Carilla-Latorre S, 2010, J CELL SCI, V123, P1674, DOI 10.1242/jcs.066076; Carroll J, 2013, J BIOL CHEM, V288, P24799, DOI 10.1074/jbc.M113.488106; D'Imprima E, 2016, BBA-BIOENERGETICS, V1857, P1935, DOI 10.1016/j.bbabio.2016.09.014; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; Djafarzadeh R, 2000, BBA-BIOENERGETICS, V1459, P230, DOI 10.1016/S0005-2728(00)00154-7; Duarte M, 2002, BIOCHEM J, V364, P833, DOI 10.1042/BJ20011750; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evich M, 2016, PROTEIN SCI, V25, P479, DOI 10.1002/pro.2838; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; Fendel U, 2008, BBA-BIOENERGETICS, V1777, P660, DOI 10.1016/j.bbabio.2008.04.033; Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006; Flemming D, 2003, J BIOL CHEM, V278, P47602, DOI 10.1074/jbc.M308967200; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Grba DN, 2020, NAT STRUCT MOL BIOL, V27, P892, DOI 10.1038/s41594-020-0473-x; Grgic L, 2004, J BIOL CHEM, V279, P21193, DOI 10.1074/jbc.M313180200; Gupta C, 2020, J AM CHEM SOC, V142, P9220, DOI 10.1021/jacs.9b13450; Haapanen O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07930-1; Hameed UFS, 2018, CELL REP, V24, P1996, DOI 10.1016/j.celrep.2018.07.075; Hinchliffe P, 2006, BIOCHEMISTRY-US, V45, P4413, DOI 10.1021/bi0600998; Hirst J, 2016, BBA-BIOENERGETICS, V1857, P872, DOI 10.1016/j.bbabio.2015.12.009; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; INGLEDEW WJ, 1980, BIOCHEM J, V186, P111, DOI 10.1042/bj1860111; Kaila VRI, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0916; Kampjut D, 2020, SCIENCE, V370, P547, DOI 10.1126/science.abc4209; Kashani-Poor N, 2001, BBA-BIOENERGETICS, V1504, P363, DOI 10.1016/S0005-2728(00)00266-8; Kashani-Poor N, 2001, J BIOL CHEM, V276, P24082, DOI 10.1074/jbc.M102296200; Kerscher S, 2002, BBA-BIOENERGETICS, V1555, P83, DOI 10.1016/S0005-2728(02)00259-1; Le Breton N, 2017, J AM CHEM SOC, V139, P16319, DOI 10.1021/jacs.7b09261; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Letts JA, 2019, MOL CELL, V75, P1131, DOI 10.1016/j.molcel.2019.07.022; Vilas JL, 2018, STRUCTURE, V26, P337, DOI 10.1016/j.str.2017.12.018; MEINHARDT SW, 1990, J BIOL CHEM, V265, P1360; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Parey K, 2020, CURR OPIN STRUC BIOL, V63, P1, DOI 10.1016/j.sbi.2020.01.004; Parey K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9484; Parey K, 2018, ELIFE, V7, DOI 10.7554/eLife.39213; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramirez-Aportela E, 2020, BIOINFORMATICS, V36, P765, DOI 10.1093/bioinformatics/btz671; Rendon OZ, 2014, HUM MOL GENET, V23, P5159, DOI 10.1093/hmg/ddu239; Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tocilescu M. A., 2009, THESIS GOETHE U FRAN; Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200; Tocilescu MA, 2010, BBA-BIOENERGETICS, V1797, P1883, DOI 10.1016/j.bbabio.2010.05.009; Tuppen HAL, 2010, BRAIN, V133, P2952, DOI 10.1093/brain/awq232; Varghese F, 2015, HUM MOL GENET, V24, P6350, DOI 10.1093/hmg/ddv344; Vinogradov AD, 2016, BBA-BIOENERGETICS, V1857, P863, DOI 10.1016/j.bbabio.2015.11.004; Wang JH, 2011, J MICROBIOL, V49, P469, DOI 10.1007/s12275-011-0433-6; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wright JJ, 2016, J INORG BIOCHEM, V162, P201, DOI 10.1016/j.jinorgbio.2016.04.025; Yoga EG, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2020.148153; Yoga EG, 2019, BBA-BIOENERGETICS, V1860, P573, DOI 10.1016/j.bbabio.2019.06.006; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166; Zwicker K, 2006, J BIOL CHEM, V281, P23013, DOI 10.1074/jbc.M603442200	75	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100474	10.1016/j.jbc.2021.100474	http://dx.doi.org/10.1016/j.jbc.2021.100474			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33640456	gold, Green Published			2022-12-28	WOS:000672866400448
J	Landor, SKJ; Santio, NM; Eccleshall, WB; Paramonov, VM; Gagliani, EK; Hall, D; Jin, SB; Dahlstrom, KM; Salminen, TA; Rivero-Muller, A; Lendahl, U; Kovall, RA; Koskinen, PJ; Sahlgren, C				Landor, Sebastian K. J.; Santio, Niina M.; Eccleshall, William B.; Paramonov, Valeriy M.; Gagliani, Ellen K.; Hall, Daniel; Jin, Shao-Bo; Dahlstrom, Kathe M.; Salminen, Tiina A.; Rivero-Muller, Adolfo; Lendahl, Urban; Kovall, Rhett A.; Koskinen, Paivi J.; Sahlgren, Cecilia			PIM-induced phosphorylation of Notch3 promotes breast cancer tumorigenicity in a CSL-independent fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOONCOGENE PIM-1; RECEPTOR; KINASES; REFINEMENT; SWITCH	Dysregulation of the developmentally important Notch signaling pathway is implicated in several types of cancer, including breast cancer. However, the specific roles and regulation of the four different Notch receptors have remained elusive. We have previously reported that the oncogenic PIM kinases phosphorylate Notch1 and Notch3. Phosphorylation of Notch1 within the second nuclear localization sequence of its intracellular domain (ICD) enhances its transcriptional activity and tumorigenicity. In this study, we analyzed Notch3 phosphorylation and its functional impact. Unexpectedly, we observed that the PIM target sites are not conserved between Notch1 and Notch3. Notch3 ICD (N3ICD) is phosphorylated within a domain, which is essential for formation of a transcriptionally active complex with the DNA-binding protein CSL. Through molecular modeling, X-ray crystallography, and isothermal titration calorimetry, we demonstrate that phosphorylation of N3ICD sterically hinders its interaction with CSL and thereby inhibits its CSL-dependent transcriptional activity. Surprisingly however, phosphorylated N3ICD still maintains tumorigenic potential in breast cancer cells under estrogenic conditions, which support PIM expression. Taken together, our data indicate that PIM kinases modulate the signaling output of different Notch paralogs by targeting distinct protein domains and thereby promote breast cancer tumorigenesis via both CSL-dependent and CSL-independent mechanisms.	[Landor, Sebastian K. J.; Eccleshall, William B.; Paramonov, Valeriy M.; Rivero-Muller, Adolfo; Sahlgren, Cecilia] Abo Akad Univ, Fac Sci & Engn Cell Biol, Turku, Finland; [Landor, Sebastian K. J.; Eccleshall, William B.; Paramonov, Valeriy M.; Sahlgren, Cecilia] Univ Turku, Turku Biosci, Turku, Finland; [Landor, Sebastian K. J.; Eccleshall, William B.; Paramonov, Valeriy M.; Sahlgren, Cecilia] Abo Akad Univ, Turku, Finland; [Santio, Niina M.; Eccleshall, William B.; Rivero-Muller, Adolfo; Koskinen, Paivi J.] Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Dept Biol, Turku, Finland; [Paramonov, Valeriy M.] Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Turku, Finland; [Gagliani, Ellen K.; Hall, Daniel; Kovall, Rhett A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA; [Jin, Shao-Bo; Lendahl, Urban] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Dahlstrom, Kathe M.; Salminen, Tiina A.] Abo Akad Univ, Fac Sci & Engn, Biochem, Struct Bioinformat Lab, Turku, Finland; [Sahlgren, Cecilia] Eindhoven Univ Technol, Dept Biomed Engn, Inst Complex Mol Syst, Eindhoven, Netherlands; [Rivero-Muller, Adolfo] Med Univ Lublin, Dept Biochem & Mol Biol, Lublin, Poland	Abo Akademi University; University of Turku; Abo Akademi University; University of Turku; University of Turku; University System of Ohio; University of Cincinnati; Karolinska Institutet; Abo Akademi University; Eindhoven University of Technology; Medical University of Lublin	Sahlgren, C (corresponding author), Abo Akad Univ, Fac Sci & Engn Cell Biol, Turku, Finland.; Sahlgren, C (corresponding author), Univ Turku, Turku Biosci, Turku, Finland.; Sahlgren, C (corresponding author), Abo Akad Univ, Turku, Finland.; Koskinen, PJ (corresponding author), Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Dept Biol, Turku, Finland.; Sahlgren, C (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Inst Complex Mol Syst, Eindhoven, Netherlands.	paivi.koskinen@utu.fi; csahlgre@abo.fi	Salminen, Tiina A/G-7492-2019; Rivero-Muller, Adolfo/A-5120-2008; Salminen, Tiina A./AAM-5443-2021	Salminen, Tiina A/0000-0002-4135-8020; Rivero-Muller, Adolfo/0000-0002-9794-802X; Salminen, Tiina A./0000-0002-4135-8020; Eccleshall, William/0000-0003-1841-8897; Kolb Gagliani, Ellen/0000-0001-7270-6254; Sahlgren, Cecilia/0000-0003-3350-4937; Dahlstrom, Kathe M./0000-0002-4880-8135	Academy of Finland [309373, 287040]; Jane and Aatos Erkko Foundation; Drug Research Doctoral Programme; Turku Doctoral Programme of Molecular Medicine; Swedish Cultural Foundation of Finland; Emil Aaltonen Foundation; Maud Kuistila Memorial Foundation; K. Albin Johansson Foundation; European Community Mobility Programme EMA2; Turku University Foundation; Instrumentarium Science Foundation; Sigrid Juselius Foundation; Tor, Joe, and Pentti Borg's Foundation; Swedish Cancer Society; National Institutes of Health [CA178974]; Finnish-Norwegian Medical Foundation; Ida Montin Foundation	Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation; Drug Research Doctoral Programme; Turku Doctoral Programme of Molecular Medicine; Swedish Cultural Foundation of Finland; Emil Aaltonen Foundation; Maud Kuistila Memorial Foundation; K. Albin Johansson Foundation; European Community Mobility Programme EMA2; Turku University Foundation; Instrumentarium Science Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tor, Joe, and Pentti Borg's Foundation; Swedish Cancer Society(Swedish Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish-Norwegian Medical Foundation; Ida Montin Foundation	99 This study was financially supported by Academy of Finland (grants 309373 to C. S. and 287040 to P. J. K.), Jane and Aatos Erkko Foundation (to C. S.), Drug Research Doctoral Programme (to N. M. S. and W. B. E.), Turku Doctoral Programme of Molecular Medicine (to V. M. P.), Swedish Cultural Foundation of Finland and Finnish-Norwegian Medical Foundation (to S. K. J. L.), Emil Aaltonen Foundation (to N. M. S.), Maud Kuistila Memorial Foundation (W. B. E.), K. Albin Johansson Foundation (to S. K. J. L. and V. M. P.), European Community Mobility Programme EMA2, Ida Montin Foundation, Turku University Foundation and Instrumentarium Science Foundation (to V. M. P.), Sigrid Juselius Foundation (K. M. D. and T. A. S.) and Tor, Joe, and Pentti Borg's Foundation (T. A. S.), the Swedish Cancer Society (to U. L.), and the National Institutes of Health (CA178974 to R. K.). The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Akue-Gedu R, 2009, J MED CHEM, V52, P6369, DOI 10.1021/jm901018f; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Antfolk D, 2019, BBA-MOL CELL RES, V1866, DOI 10.1016/j.bbamcr.2019.07.002; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bhat V, 2016, STEM CELLS DEV, V25, P522, DOI 10.1089/scd.2015.0315; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Braso-Maristany F, 2016, NAT MED, V22, P1303, DOI 10.1038/nm.4198; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Choi SH, 2012, STRUCTURE, V20, P340, DOI 10.1016/j.str.2011.12.011; Cui H, 2013, CANCER RES, V73, P3451, DOI 10.1158/0008-5472.CAN-12-3902; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Diluvio G, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0051-9; Dou XW, 2017, THERANOSTICS, V7, P4041, DOI 10.7150/thno.19989; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRIEDMANN M, 1992, ARCH BIOCHEM BIOPHYS, V298, P594, DOI 10.1016/0003-9861(92)90454-5; Herrmann JL, 1996, EMBO J, V15, P3547, DOI 10.1002/j.1460-2075.1996.tb00724.x; Horiuchi D, 2016, NAT MED, V22, P1321, DOI 10.1038/nm.4213; Inder S, 2017, CANCER TREAT REV, V60, P69, DOI 10.1016/j.ctrv.2017.08.011; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Kato H, 1997, DEVELOPMENT, V124, P4133; Kiriazis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055409; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Lee HJ, 2015, BMB REP, V48, P431, DOI 10.5483/BMBRep.2015.48.8.107; Leontovich AA, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1020-0; Lin HY, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0069-z; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Malinen M, 2013, MOL CELL ENDOCRINOL, V365, P270, DOI 10.1016/j.mce.2012.10.028; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Nowell CS, 2017, NAT REV CANCER, V17, P145, DOI 10.1038/nrc.2016.145; Palaty CK, 1997, BIOCHEM CELL BIOL, V75, P153, DOI 10.1139/bcb-75-2-153; Peng C, 2007, J BIOCHEM, V141, P353, DOI 10.1093/jb/mvm040; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Santio NM, 2017, INT J BIOCHEM CELL B, V93, P74, DOI 10.1016/j.biocel.2017.10.016; Santio NM, 2016, ONCOTARGET, V7, P43220, DOI 10.18632/oncotarget.9215; Santio NM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-279; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Steinbuck MP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01230	48	5	5	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100593	10.1016/j.jbc.2021.100593	http://dx.doi.org/10.1016/j.jbc.2021.100593			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33775697	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400565
J	Li, F; Egea, PF; Vecchio, AJ; Asial, I; Gupta, M; Paulino, J; Bajaj, R; Dickinson, MS; Ferguson-Miller, S; Monk, BC; Stroud, RM				Li, Fei; Egea, Pascal F.; Vecchio, Alex J.; Asial, Ignacio; Gupta, Meghna; Paulino, Joana; Bajaj, Ruchika; Dickinson, Miles Sasha; Ferguson-Miller, Shelagh; Monk, Brian C.; Stroud, Robert M.			Highlighting membrane protein structure and function: A celebration of the Protein Data Bank	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							X-RAY-STRUCTURE; CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; BLOOD-BRAIN-BARRIER; INFLUENZA-A VIRUS; MAJOR FACILITATOR SUPERFAMILY; CYTOCHROME-C-OXIDASE; CYSTIC-FIBROSIS GENE; NICOTINIC ACETYLCHOLINE-RECEPTOR; SIGNAL RECOGNITION PARTICLE; ALKYL GLYCOSIDE DETERGENTS	Biological membranes define the boundaries of cells and compartmentalize the chemical and physical processes required for life. Many biological processes are carried out by proteins embedded in or associated with such membranes. Determination of membrane protein (MP) structures at atomic or near-atomic resolution plays a vital role in elucidating their structural and functional impact in biology. This endeavor has determined 1198 unique MP structures as of early 2021. The value of these structures is expanded greatly by deposition of their three-dimensional (3D) coordinates into the Protein Data Bank (PDB) after the first atomic MP structure was elucidated in 1985. Since then, free access to MP structures facilitates broader and deeper understanding of MPs, which provides crucial new insights into their biological functions. Here we highlight the structural and functional biology of representative MPs and landmarks in the evolution of new technologies, with insights into key developments influenced by the PDB in magnifying their impact.	[Li, Fei; Gupta, Meghna; Paulino, Joana; Dickinson, Miles Sasha; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Li, Fei] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Egea, Pascal F.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA; [Vecchio, Alex J.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Asial, Ignacio] DotBio Pte Ltd, Singapore, Singapore; [Bajaj, Ruchika] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Ferguson-Miller, Shelagh] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Monk, Brian C.] Univ Otago, Sir John Walsh Res Inst, Dunedin, New Zealand; [Monk, Brian C.] Univ Otago, Dept Oral Sci, Dunedin, New Zealand; [Dickinson, Miles Sasha] Univ Texas Austin, Sauer Lab Struct Biol CryoEM, Austin, TX 78712 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California San Francisco; Michigan State University; University of Otago; University of Otago; University of Texas System; University of Texas Austin	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	stroud@msg.ucsf.edu	Gupta, Meghna/AGY-3073-2022; Gupta, Meghna/AAZ-4389-2021	Gupta, Meghna/0000-0002-7432-3211; EGEA, Pascal F./0000-0003-4432-8625; Ferguson-Miller, Shelagh/0000-0003-4694-8289; Dickinson, Miles/0000-0002-8016-1570; Vecchio, Alex/0000-0002-4222-7874; Asial, Ignacio/0000-0002-5270-2448; Paulino, Joana/0000-0001-8846-822X	National Institutes of Health [NIH R21AG057951, K99MH119591, R21AI125983, R01GM120173, R35GM138368]; NIGMS [GM24485]; American Heart Association [19POST3437010]; Health Research Council of New Zealand [19/397];  [P50 AI50476]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); Health Research Council of New Zealand(Health Research Council of New Zealand); 	F. L. is supported by National Institutes of Health Grant K99MH119591. P. F. E. is supported by National Institutes of Health Grants R21AI125983 and R01GM120173. A. J. V. is supported by National Institutes of Health Grant R35GM138368. R. M. S., M. G., M. S. D., are supported by NIGMS GM24485 to R. M. S. R. M. S. and J. P. are supported by P50 AI50476 (Krogan). R. B. is supported by American Heart Association Fellowship Award 19POST3437010. B. C. M. is supported by Health Research Council of New Zealand grant 19/397 and S. F. -M. is supported by National Institutes of Health Grant NIH R21AG057951.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; AGARD DA, 1982, BIOPHYS J, V37, P589; AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804; AGRE P, 1993, AM J PHYSIOL, V265, pF463; AhYoung AP, 2015, PROTEIN SCI, V24, P1508, DOI 10.1002/pro.2739; Alam A, 2019, SCIENCE, V363, P753, DOI 10.1126/science.aav7102; Alam A, 2018, P NATL ACAD SCI USA, V115, pE1973, DOI 10.1073/pnas.1717044115; Alberini G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184190; Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Andreas LB, 2013, BIOCHEMISTRY-US, V52, P2774, DOI 10.1021/bi400150x; Andreas LB, 2012, J AM CHEM SOC, V134, P7215, DOI 10.1021/ja3003606; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Anghel SA, 2017, CELL REP, V21, P3708, DOI 10.1016/j.celrep.2017.12.006; Anne C, 2014, CURR TOP MEMBR, V73, P149, DOI 10.1016/B978-0-12-800223-0.00003-7; AQVIST J, 1989, BIOPHYS J, V56, P171, DOI 10.1016/S0006-3495(89)82662-1; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Bai L, 2020, NATURE, V584, P475, DOI 10.1038/s41586-020-2389-3; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Bajaj R, 2018, BIOCHEMISTRY-US, V57, P3003, DOI 10.1021/acs.biochem.8b00266; Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; Baniulis D, 2011, METHODS MOL BIOL, V684, P65, DOI [10.1007/978.1.60761.925.3_7, 10.1007/978-1-60761-925-3_7]; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Benga G, 1996, ELECTROPHORESIS, V17, P715, DOI 10.1002/elps.1150170416; Benga G, 1995, COMP BIOCHEM PHYS B, V112, P653, DOI 10.1016/0305-0491(95)00116-6; BENGA G, 1986, BIOCHEMISTRY-US, V25, P1535, DOI 10.1021/bi00355a011; BENGA G, 1986, EUR J CELL BIOL, V41, P252; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Bezanilla F, 2018, J GEN PHYSIOL, V150, P911, DOI 10.1085/jgp.201812090; Bhaduri S, 2019, J BIOL CHEM, V294, P17758, DOI 10.1074/jbc.RA119.009331; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Bischoff L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5103; BLAUROCK AE, 1975, J MOL BIOL, V93, P139, DOI 10.1016/0022-2836(75)90124-2; BLAUROCK AE, 1971, NATURE-NEW BIOL, V233, P152, DOI 10.1038/newbio233152a0; Blobel G., 1971, BIOMEMBRANE, P193; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bracken C. J., 2020, BIPARATOPIC MULTIVAL; Braun-Sand S, 2005, J PHYS CHEM B, V109, P583, DOI 10.1021/jp0465783; Braunger K, 2018, SCIENCE, V360, P215, DOI 10.1126/science.aar7899; BRISSON A, 1985, NATURE, V315, P474, DOI 10.1038/315474a0; BRISSON A, 1984, J CELL BIOL, V99, P1202, DOI 10.1083/jcb.99.4.1202; Bucker R, 2010, CURR TOP MEMBR, V65, P195, DOI 10.1016/S1063-5823(10)65009-0; Burykin A, 2003, BIOPHYS J, V85, P3696, DOI 10.1016/S0006-3495(03)74786-9; Burykin A, 2004, FEBS LETT, V570, P41, DOI 10.1016/j.febslet.2004.06.020; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Caffrey M, 2000, CURR OPIN STRUC BIOL, V10, P486, DOI 10.1016/S0959-440X(00)00119-6; Caffrey M, 2015, ACTA CRYSTALLOGR F, V71, P3, DOI 10.1107/S2053230X14026843; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Carbrey Jennifer M, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79885-9_1; Castano-Rodriguez C, 2018, MBIO, V9, DOI 10.1128/mBio.02325-17; CATTERALL WA, 1984, SCIENCE, V223, P653, DOI 10.1126/science.6320365; CATTERALL WA, 1982, TOXICON, V20, P27, DOI 10.1016/0041-0101(82)90140-4; Catterall WA, 2017, NAT CHEM BIOL, V13, P455, DOI [10.1038/NCHEMBIO.2353, 10.1038/nchembio.2353]; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chakrabarti N, 2004, STRUCTURE, V12, P65, DOI 10.1016/j.str.2003.11.017; Chakrabarti N, 2004, J MOL BIOL, V343, P493, DOI 10.1016/j.jmb.2004.08.036; Chan R, 2020, RSC ADV, V10, P21283, DOI 10.1039/d0ra03456h; Chasiotis H, 2012, RESP PHYSIOL NEUROBI, V184, P269, DOI 10.1016/j.resp.2012.05.020; Chen J, 2013, CURR OPIN STRUC BIOL, V23, P492, DOI 10.1016/j.sbi.2013.03.011; Chen XY, 2020, CELL MOL IMMUNOL, V17, P647, DOI 10.1038/s41423-020-0426-7; Chen YY, 2017, STRUCTURE, V25, P1403, DOI 10.1016/j.str.2017.07.008; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Chitwood PJ, 2019, TRENDS CELL BIOL, V29, P371, DOI 10.1016/j.tcb.2019.01.007; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Clairfeuille T, 2017, CURR OPIN STRUC BIOL, V45, P74, DOI 10.1016/j.sbi.2016.11.022; Claxton DP, 2015, METHOD ENZYMOL, V564, P349, DOI 10.1016/bs.mie.2015.07.026; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Cook GA, 2011, BBA-BIOMEMBRANES, V1808, P554, DOI 10.1016/j.bbamem.2010.08.005; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Csanady L, 2019, PHYSIOL REV, V99, P707, DOI 10.1152/physrev.00007.2018; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Dai GC, 2019, NAT STRUCT MOL BIOL, V26, P686, DOI 10.1038/s41594-019-0259-1; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; De Benedetto A, 2008, J ALLERGY CLIN IMMUN, V121, pS32, DOI 10.1016/j.jaci.2007.12.130; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; De Diego ML, 2014, VIRUS RES, V194, P124, DOI 10.1016/j.virusres.2014.07.024; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0; de Grotthuss CJT, 2006, BBA-BIOENERGETICS, V1757, P871, DOI 10.1016/j.bbabio.2006.07.004; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; DEAN DA, 1992, MOL MICROBIOL, V6, P2033, DOI 10.1111/j.1365-2958.1992.tb01376.x; DEISENHOFER J, 1984, J MOL BIOL, V180, P385, DOI 10.1016/S0022-2836(84)80011-X; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; DEVILLERSTHIERY A, 1979, FEBS LETT, V104, P99, DOI 10.1016/0014-5793(79)81092-3; DEVILLERSTHIERY A, 1983, P NATL ACAD SCI-BIOL, V80, P2067, DOI 10.1073/pnas.80.7.2067; Di Pardo A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41316; Dickerson R. E, 2002, NEWSLETTER, V13, P3; Dickinson MS, 2020, P NATL ACAD SCI USA, V117, P1988, DOI 10.1073/pnas.1915144117; Diederichs KA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17144-1; Dorr JM, 2016, EUR BIOPHYS J BIOPHY, V45, P3, DOI 10.1007/s00249-015-1093-y; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drew D, 2016, ANNU REV BIOCHEM, V85, P543, DOI 10.1146/annurev-biochem-060815-014520; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Dube M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-114; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Edelblum KL, 2009, CURR OPIN PHARMACOL, V9, P715, DOI 10.1016/j.coph.2009.06.022; Egea PF, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8060865; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Ehrmann M, 1998, MOL MICROBIOL, V29, P685, DOI 10.1046/j.1365-2958.1998.00915.x; ELLORY JC, 1988, PARASITOLOGY, V96, pS5, DOI 10.1017/S0031182000085942; Engel A, 2008, CURR OPIN STRUC BIOL, V18, P229, DOI 10.1016/j.sbi.2007.11.003; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Eriksson UK, 2013, SCIENCE, V340, P1346, DOI 10.1126/science.1234306; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Faust TB, 2017, ANNU REV VIROL, V4, P241, DOI 10.1146/annurev-virology-101416-041654; FERGUSONMILLER S, 1986, BIOCHEM SOC T, V14, P822, DOI 10.1042/bst0140822; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Freedman JC, 2016, TOXINS, V8, DOI 10.3390/toxins8030073; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Garbuzova-Davis S, 2012, BRAIN RES, V1469, P114, DOI 10.1016/j.brainres.2012.05.056; GECK P, 1989, KIDNEY INT, V36, P334, DOI 10.1038/ki.1989.201; Gemmer M, 2020, J CELL SCI, V133, DOI 10.1242/jcs.231340; GENNIS R, 1995, SCIENCE, V269, P1063, DOI 10.1126/science.7652553; Ghezzi C, 2018, DIABETOLOGIA, V61, P2087, DOI 10.1007/s00125-018-4656-5; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gilson PR, 2017, INT J PARASITOL, V47, P119, DOI 10.1016/j.ijpara.2016.06.001; Goldberg DE, 2020, TRENDS PARASITOL, V36, P138, DOI 10.1016/j.pt.2019.11.006; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Gonzalez ME, 2005, PROTEIN REV, V1, P79; Goodsell DS, 2020, BIOCHEM MOL BIOL EDU, V48, P350, DOI 10.1002/bmb.21360; Gouaux E, 1998, STRUCTURE, V6, P5, DOI 10.1016/S0969-2126(98)00002-1; Gow A, 2004, J NEUROSCI, V24, P7051, DOI 10.1523/JNEUROSCI.1640-04.2004; GRIGORIEFF N, 1995, J MOL BIOL, V254, P404, DOI 10.1006/jmbi.1995.0627; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Grote M, 2008, BIOPHYS J, V95, P2924, DOI 10.1529/biophysj.108.132456; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Gruber R, 2015, AM J PATHOL, V185, P2777, DOI 10.1016/j.ajpath.2015.06.021; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Grytsyk N, 2019, P NATL ACAD SCI USA, V116, P4934, DOI 10.1073/pnas.1820744116; Grytsyk N, 2017, P NATL ACAD SCI USA, V114, P1530, DOI 10.1073/pnas.1621431114; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Hainzl T, 2011, NAT STRUCT MOL BIOL, V18, P389, DOI 10.1038/nsmb.1994; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; HARTSHORNE RP, 1981, P NATL ACAD SCI-BIOL, V78, P4620, DOI 10.1073/pnas.78.7.4620; HARTSHORNE RP, 1982, J BIOL CHEM, V257, P3888; Hashimoto Y, 2017, PFLUG ARCH EUR J PHY, V469, P45, DOI 10.1007/s00424-016-1878-6; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; HAYWARD SB, 1978, P NATL ACAD SCI USA, V75, P4320, DOI 10.1073/pnas.75.9.4320; HAYWARD SB, 1981, J MOL BIOL, V151, P491, DOI 10.1016/0022-2836(81)90007-3; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hempel C, 2020, J MOL BIOL, V432, P2405, DOI 10.1016/j.jmb.2020.02.034; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Herrero L, 2013, BIOCHEMISTRY-US, V52, P171, DOI 10.1021/bi3011175; Hill MS, 2010, VIROLOGY, V397, P104, DOI 10.1016/j.virol.2009.10.048; Hille B, 1975, Membranes, V3, P255; HILLE B, 1973, J GEN PHYSIOL, V61, P669, DOI 10.1085/jgp.61.6.669; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Hirst J, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0577-5; Hite RK, 2015, NATURE, V527, P198, DOI 10.1038/nature14958; Ho CM, 2018, NATURE, V561, P70, DOI 10.1038/s41586-018-0469-4; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; HODGKIN AL, 1952, COLD SPRING HARB SYM, V17, P43, DOI 10.1101/SQB.1952.017.01.007; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P473, DOI 10.1113/jphysiol.1952.sp004718; Hohr AIC, 2015, BBA-MOL CELL RES, V1853, P74, DOI 10.1016/j.bbamcr.2014.10.006; Hofmann S, 2019, NATURE, V571, P580, DOI 10.1038/s41586-019-1391-0; Holland IB, 2019, RES MICROBIOL, V170, P304, DOI 10.1016/j.resmic.2019.08.004; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Holyoake J, 2007, STRUCTURE, V15, P873, DOI 10.1016/j.str.2007.06.004; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hu YM, 2018, ACS MED CHEM LETT, V9, P1111, DOI 10.1021/acsmedchemlett.8b00336; Hub Jochen S, 2009, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-540-79885-9_3; Hudson N, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130273; HUNKAPILLER MW, 1979, BIOCHEM BIOPH RES CO, V91, P164, DOI 10.1016/0006-291X(79)90598-9; Ikeda M, 2002, J BIOL CHEM, V277, P39873, DOI 10.1074/jbc.M207008200; Irudayanathan FJ, 2018, J PHYS CHEM B, V122, P7463, DOI 10.1021/acs.jpcb.8b03842; Irudayanathan FJ, 2017, ANN NY ACAD SCI, V1405, P131, DOI 10.1111/nyas.13378; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jackson SM, 2018, NAT STRUCT MOL BIOL, V25, P333, DOI 10.1038/s41594-018-0049-1; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; JAP BK, 1983, BIOPHYS J, V43, P81, DOI 10.1016/S0006-3495(83)84326-4; JAP BK, 1995, J MOL BIOL, V251, P413, DOI 10.1006/jmbi.1995.0444; Jia XF, 2014, ELIFE, V3, DOI 10.7554/eLife.02362; Jiang XX, 2016, BIOCHEMISTRY-US, V55, P4326, DOI 10.1021/acs.biochem.6b00666; Jiang X, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0082-1; Jiang X, 2016, P NATL ACAD SCI USA, V113, P12420, DOI 10.1073/pnas.1615414113; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Johnson ZL, 2018, CELL, V172, P81, DOI 10.1016/j.cell.2017.12.005; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Jomaa A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10471; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Kaback HR, 2019, J GEN PHYSIOL, V151, P878, DOI 10.1085/jgp.201912377; Kaller MR, 2012, ACS MED CHEM LETT, V3, P886, DOI 10.1021/ml3000148; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Kapoor K, 2016, P NATL ACAD SCI USA, V113, P4711, DOI 10.1073/pnas.1603735113; Kato M, 2006, PROTEINS, V64, P829, DOI 10.1002/prot.21012; Keaney J, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500472; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; KHORANA HG, 1979, P NATL ACAD SCI USA, V76, P5046, DOI 10.1073/pnas.76.10.5046; Kim DM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a029231; Kim JM, 2015, NATURE, V517, P396, DOI 10.1038/nature13872; Kintzer AF, 2018, P NATL ACAD SCI USA, V115, pE9095, DOI 10.1073/pnas.1805651115; KISTLER J, 1981, P NATL ACAD SCI-BIOL, V78, P3678, DOI 10.1073/pnas.78.6.3678; KISTLER J, 1982, BIOPHYS J, V37, P371, DOI 10.1016/S0006-3495(82)84685-7; Klare JP, 2015, METHOD ENZYMOL, V564, P315, DOI 10.1016/bs.mie.2015.05.025; Kobe B, 2015, ACTA CRYSTALLOGR F, V71, P861, DOI 10.1107/S2053230X15011061; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Kolocouris A, 2014, J MED CHEM, V57, P4629, DOI 10.1021/jm500598u; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Kuhlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903; Kumar H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232846; Kumar H, 2018, P NATL ACAD SCI USA, V115, P8769, DOI 10.1073/pnas.1801774115; Kumar H, 2015, P NATL ACAD SCI USA, V112, P9004, DOI 10.1073/pnas.1509854112; Kumar H, 2014, P NATL ACAD SCI USA, V111, P1784, DOI 10.1073/pnas.1324141111; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Lamb RA, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a038505; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lee H, 2014, FRONT BIOSCI-LANDMRK, V19, P272, DOI 10.2741/4206; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Lewis A. J. O, 2020, UNIFIED EVOLUTIONARY, DOI [10.1101/2020.12.20, DOI 10.1101/2020.12.20]; Li F, 2016, ACS INFECT DIS, V2, P726, DOI 10.1021/acsinfecdis.6b00130; Li F, 2020, SCIENCE, V368, P893, DOI 10.1126/science.aba9202; Li F, 2015, SCIENCE, V347, P555, DOI 10.1126/science.1260590; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; Li H, 2011, J MOL BIOL, V407, P607, DOI 10.1016/j.jmb.2011.01.036; Li JH, 2011, PEDIATR NEPHROL, V26, P2133, DOI 10.1007/s00467-011-1824-y; Li L, 2016, NATURE, V531, P395, DOI 10.1038/nature17163; Li Y, 2014, J BIOL CHEM, V289, P12535, DOI 10.1074/jbc.M114.560094; Liao ZB, 2016, NEUROSCIENCE, V327, P53, DOI 10.1016/j.neuroscience.2016.04.013; Lin L, 2015, NAT REV DRUG DISCOV, V14, P543, DOI 10.1038/nrd4626; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Loh YH, 2004, GENOME RES, V14, P1248, DOI 10.1101/gr.2400004; Lu JX, 2010, PROTEIN SCI, V19, P1877, DOI 10.1002/pro.474; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Lyons JA, 2012, NATURE, V487, P514, DOI 10.1038/nature11182; MacKinnon R, 2004, ANGEW CHEM INT EDIT, V43, P4265, DOI 10.1002/anie.200400662; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; Madej M. G, 2014, ADV BIOL, V2014, P1, DOI DOI 10.1155/2014/523591; Madej MG, 2012, P NATL ACAD SCI USA, V109, pE2970, DOI 10.1073/pnas.1211183109; Machtel R, 2019, RES MICROBIOL, V170, P321, DOI 10.1016/j.resmic.2019.09.004; Maeda T, 2012, PROSTATE, V72, P351, DOI 10.1002/pros.21436; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Magni F, 2006, PROTEOMICS, V6, P5637, DOI 10.1002/pmic.200600212; Mandala VS, 2020, NAT STRUCT MOL BIOL, V27, P160, DOI 10.1038/s41594-019-0371-2; Manolaridis I, 2018, NATURE, V563, P426, DOI 10.1038/s41586-018-0680-3; Marco S, 2006, NEUROSCI LETT, V401, P219, DOI 10.1016/j.neulet.2006.03.047; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Marino J, 2016, FEBS LETT, V590, P655, DOI 10.1002/1873-3468.12098; Martin RE, 2020, BIOL REV, V95, P305, DOI 10.1111/brv.12565; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Mateja A, 2018, CURR OPIN STRUC BIOL, V51, P195, DOI 10.1016/j.sbi.2018.07.009; Mateja A, 2015, SCIENCE, V347, P1152, DOI 10.1126/science.1261671; Matz JM, 2020, NAT REV MICROBIOL, V18, P379, DOI 10.1038/s41579-019-0321-3; McCafferty CL, 2020, J CHEM INF MODEL, V60, P2424, DOI 10.1021/acs.jcim.9b01164; McGilvray PT, 2020, ELIFE, V9, DOI 10.7554/eLife.56889; Miao YM, 2015, STRUCTURE, V23, P2300, DOI 10.1016/j.str.2015.09.011; MICHEL H, 1980, BIOCHEMISTRY-US, V19, P4615, DOI 10.1021/bi00561a012; MICHEL H, 1980, P NATL ACAD SCI-BIOL, V77, P1283, DOI 10.1073/pnas.77.3.1283; MICHEL H, 1982, EMBO J, V1, P1267, DOI 10.1002/j.1460-2075.1982.tb00023.x; MICHEL H, 1980, P NATL ACAD SCI-BIOL, V77, P338, DOI 10.1073/pnas.77.1.338; MILDER SJ, 1991, BIOCHEMISTRY-US, V30, P1751, DOI 10.1021/bi00221a004; Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009; Miller-Vedam LE, 2020, ELIFE, V9, DOI 10.7554/eLife.62611; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; MITRA AK, 1989, J CELL BIOL, V109, P755, DOI 10.1083/jcb.109.2.755; Monenschein H, 2012, BIOORG MED CHEM LETT, V22, P3607, DOI 10.1016/j.bmcl.2012.04.060; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Musharrafieh R, 2020, EUR J PHARM SCI, V141, DOI 10.1016/j.ejps.2019.105124; Naeem M, 2011, AM J NEPHROL, V34, P241, DOI 10.1159/000330854; Nakamura S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08760-7; Nakano Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000610; Neuhaus W, 2018, BIOMATERIALS, V161, P129, DOI 10.1016/j.biomaterials.2018.01.028; Neverisky DL, 2016, CRIT REV BIOCHEM MOL, V51, P257, DOI 10.3109/10409238.2016.1172553; Newport TD, 2019, NUCLEIC ACIDS RES, V47, pD390, DOI 10.1093/nar/gky1047; Newstead S, 2008, PROTEIN SCI, V17, P466, DOI 10.1110/ps.073263108; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Nielsen H, 2019, PROTEIN J, V38, P200, DOI 10.1007/s10930-019-09838-3; NIELSEN S, 1995, KIDNEY INT, V48, P1057, DOI 10.1038/ki.1995.389; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Noll A, 2017, P NATL ACAD SCI USA, V114, pE438, DOI 10.1073/pnas.1620009114; Noinaj N, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.191; Nollert P, 2001, FEBS LETT, V504, P112, DOI 10.1016/S0014-5793(01)02710-7; Nosol K, 2020, P NATL ACAD SCI USA, V117, P26245, DOI 10.1073/pnas.2010264117; O'Donnell JP, 2020, ELIFE, V9, DOI 10.7554/eLife.57887; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2013, P NATL ACAD SCI USA, V110, P18132, DOI 10.1073/pnas.1311407110; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oliveira SS, 2007, CELL MOL LIFE SCI, V64, P17, DOI 10.1007/s00018-006-6314-1; Ooi AT, 2015, CLIN CANCER RES, V21, P2440, DOI 10.1158/1078-0432.CCR-14-1209; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Orlando BJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16155-2; Ortiz de Montellano PR, 2015, CYTOCHROME P450 STRU; OVCHINNIKOV YA, 1977, FEBS LETT, V84, P1, DOI 10.1016/0014-5793(77)81046-6; OVCHINNIKOV YA, 1979, FEBS LETT, V100, P219, DOI 10.1016/0014-5793(79)80338-5; Padhi S, 2020, VITAM HORM, V112, P47, DOI 10.1016/bs.vh.2019.10.001; Pahle J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3123-x; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Park SH, 2003, J MOL BIOL, V333, P409, DOI 10.1016/j.jmb.2003.08.048; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Paulino J, 2019, BIOPHYS J, V116, P1075, DOI 10.1016/j.bpj.2019.01.042; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Peng M, 2015, BIOCHEM BIOPH RES CO, V456, P403, DOI 10.1016/j.bbrc.2014.11.096; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Pleiner T, 2020, SCIENCE, V369, P433, DOI 10.1126/science.abb5008; Polishchuk AL, 2010, BIOCHEMISTRY-US, V49, P10061, DOI 10.1021/bi101229m; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Popot JL, 2016, BIOCHEMISTRY-US, V55, P5, DOI 10.1021/acs.biochem.5b01134; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; Qin L, 2008, BIOCHEMISTRY-US, V47, P9931, DOI 10.1021/bi8013483; Qin L, 2007, CURR OPIN STRUC BIOL, V17, P444, DOI 10.1016/j.sbi.2007.07.001; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Quistgaard EM, 2016, NAT REV MOL CELL BIO, V17, P123, DOI 10.1038/nrm.2015.25; RACKER E, 1974, J BIOL CHEM, V249, P662; RAFTERY M A, 1974, Journal of Supramolecular Structure, V2, P582, DOI 10.1002/jss.400020506; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; Ramzan R, 2019, MITOCHONDRION, V49, P149, DOI 10.1016/j.mito.2019.08.002; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rice AJ, 2014, CRIT REV BIOCHEM MOL, V49, P426, DOI 10.3109/10409238.2014.953626; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; ROSEVEAR P, 1980, BIOCHEMISTRY-US, V19, P4108, DOI 10.1021/bi00558a032; ROSS MJ, 1977, J MOL BIOL, V116, P635, DOI 10.1016/0022-2836(77)90264-9; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Ruiz A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00476; Sagnella DE, 1996, BIOPHYS J, V70, P2043, DOI 10.1016/S0006-3495(96)79773-4; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Salom D, 2000, BIOCHEMISTRY-US, V39, P14160, DOI 10.1021/bi001799u; Samanta P, 2018, J GEN PHYSIOL, V150, P949, DOI 10.1085/jgp.201711868; SANDERS CR, 1995, BIOCHEMISTRY-US, V34, P4030, DOI 10.1021/bi00012a022; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Schafer E, 2007, BIOCHEMISTRY-US, V46, P12579, DOI 10.1021/bi700983h; SCHMIDT J, 1973, BIOCHEMISTRY-US, V12, P852, DOI 10.1021/bi00729a011; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Seissler T, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110322; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Shen K, 2012, NATURE, V492, P271, DOI 10.1038/nature11726; Shi Q, 2006, J PHYS CHEM B, V110, P15045, DOI 10.1021/jp062700h; Shilton BH, 2015, BIOCHEM J, V467, P193, DOI 10.1042/BJ20140675; Shinoda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33632; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Shinzawa-Itoh K, 2019, P NATL ACAD SCI USA, V116, P19945, DOI 10.1073/pnas.1907183116; Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018; Sidorenko Y, 2004, BIOTECHNOL BIOENG, V88, P1, DOI 10.1002/bit.20096; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Smirnova IN, 2003, BIOCHEMISTRY-US, V42, P3025, DOI 10.1021/bi027329c; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Smirnova I, 2015, P NATL ACAD SCI USA, V112, P13839, DOI 10.1073/pnas.1519485112; Smirnova IN, 2008, P NATL ACAD SCI USA, V105, P8896, DOI 10.1073/pnas.0803577105; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Smith DE, 2013, MOL ASPECTS MED, V34, P323, DOI 10.1016/j.mam.2012.11.003; SOLOMON AK, 1968, J GEN PHYSIOL, V51, pS335; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; Soper A, 2017, EXP BIOL MED, V242, P850, DOI 10.1177/1535370217697384; Srivastava AP, 2018, SCIENCE, V360, DOI 10.1126/science.aas9699; Stefkova J, 2004, PHYSIOL RES, V53, P235; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Steinmann E, 2007, HEPATOLOGY, V46, P330, DOI 10.1002/hep.21686; StGelais C, 2009, J VIROL, V83, P7970, DOI 10.1128/JVI.00521-09; Stroud RM, 2003, ADV PROTEIN CHEM, V63, P291; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Sun C, 2018, NATURE, V557, P123, DOI 10.1038/s41586-018-0061-y; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Suzuki H, 2015, J MOL BIOL, V427, P291, DOI 10.1016/j.jmb.2014.10.020; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Suzuki H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2731; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tabaries S, 2017, ONCOGENE, V36, P1176, DOI 10.1038/onc.2016.289; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Takeda H, 2021, NATURE, V590, P163, DOI 10.1038/s41586-020-03113-7; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Tepass U, 2003, NAT CELL BIOL, V5, P595, DOI 10.1038/ncb0703-595; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139; Thomas C, 2020, ANNU REV BIOCHEM, V89, P605, DOI 10.1146/annurev-biochem-011520-105201; Thomaston JL, 2016, PROTEIN SCI, V25, P1551, DOI 10.1002/pro.2937; Tomasek D, 2020, NATURE, V583, P473, DOI 10.1038/s41586-020-2370-1; TREPTOW NA, 1985, J BACTERIOL, V163, P654, DOI 10.1128/JB.163.2.654-660.1985; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2019, PROTEIN J, V38, P249, DOI 10.1007/s10930-019-09830-x; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Unwin N, 2013, Q REV BIOPHYS, V46, P283, DOI 10.1017/S0033583513000061; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Van Itallie CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25247; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; VANAKEN T, 1986, METHOD ENZYMOL, V125, P27; VANHOEK AN, 1992, J BIOL CHEM, V267, P18267; Varanasi L, 2006, BIOCHEMISTRY-US, V45, P14896, DOI 10.1021/bi061390q; Vecchio AJ, 2019, P NATL ACAD SCI USA, V116, P17817, DOI 10.1073/pnas.1908929116; Verdia-Baguena C, 2013, BBA-BIOMEMBRANES, V1828, P2026, DOI 10.1016/j.bbamem.2013.05.008; Verdia-Baguena C, 2012, VIROLOGY, V432, P485, DOI 10.1016/j.virol.2012.07.005; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Veshnyakova A, 2012, J BIOL CHEM, V287, P1698, DOI 10.1074/jbc.M111.312165; Veshnyakova A, 2010, TOXINS, V2, P1336, DOI 10.3390/toxins2061336; Voorhees RM, 2016, SCIENCE, V351, P88, DOI 10.1126/science.aad4992; Wang F, 2014, NATURE, V512, P441, DOI 10.1038/nature13471; Wang JZ, 2013, J MED CHEM, V56, P2804, DOI 10.1021/jm301538e; Wang J, 2013, P NATL ACAD SCI USA, V110, P1315, DOI 10.1073/pnas.1216526110; Wang L, 2020, ELIFE, V9, DOI 10.7554/eLife.56451; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Watson REB, 2007, J PATHOL, V212, P450, DOI 10.1002/path.2200; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623; Wisedchaisri G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5521; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Wright EM, 2020, PFLUG ARCH EUR J PHY, V472, P1407, DOI 10.1007/s00424-020-02448-4; Wu YB, 2014, J AM CHEM SOC, V136, P17987, DOI 10.1021/ja508461m; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xiong XL, 2020, NAT STRUCT MOL BIOL, V27, P934, DOI 10.1038/s41594-020-0478-5; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yamazaki Y, 2008, BIOCHEMISTRY-US, V47, P5378, DOI 10.1021/bi8002567; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Yu ASL, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1301852; Zalisko BE, 2017, CELL REP, V20, P2287, DOI 10.1016/j.celrep.2017.08.035; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zhang JY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209862; Zhang X, 2013, CELL RES, V23, P444, DOI 10.1038/cr.2012.158; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zhao J, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00137; Zhao J, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0051-5; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Arnold FH, 2019, ANGEW CHEM INT EDIT, V58, P14420, DOI 10.1002/anie.201907729; Artigas Francesc, 2002, Psychopharmacol Bull, V36 Suppl 2, P123; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Blakely RD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005595; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bracken CJ, 2021, NAT CHEM BIOL, V17, P113, DOI 10.1038/s41589-020-00679-1; Bregman H, 2017, J MED CHEM, V60, P1105, DOI 10.1021/acs.jmedchem.6b01496; Callaway E, 2020, NATURE, V588, P203, DOI 10.1038/d41586-020-03348-4; Caramalho R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16123-9; Chapman HN, 2019, ANNU REV BIOCHEM, V88, P35, DOI 10.1146/annurev-biochem-013118-110744; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Coleman JA, 2019, NATURE, V569, P141, DOI 10.1038/s41586-019-1135-1; Coleman JA, 2018, NAT STRUCT MOL BIOL, V25, P170, DOI 10.1038/s41594-018-0026-8; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; Deisseroth K, 2017, SCIENCE, V357, DOI 10.1126/science.aan5544; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Denisov IG, 2012, J INORG BIOCHEM, V108, P150, DOI 10.1016/j.jinorgbio.2011.11.026; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Fan L., 2020, NAT COMMUN, V11; Focke PJ, 2013, STRUCTURE, V21, P694, DOI 10.1016/j.str.2013.03.002; Gentzsch M, 2018, CHEST, V154, P383, DOI 10.1016/j.chest.2018.04.036; Gharpure A, 2019, NEURON, V104, P501, DOI 10.1016/j.neuron.2019.07.030; Glasgow A, 2020, P NATL ACAD SCI USA, V117, P28046, DOI 10.1073/pnas.2016093117; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gordon DE, 2020, SCIENCE, V370, P1181, DOI 10.1126/science.abe9403; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hadida S, 2014, J MED CHEM, V57, P9776, DOI 10.1021/jm5012808; Hargrove TY, 2020, J BIOL CHEM, V295, P9998, DOI 10.1074/jbc.RA120.014064; Hargrove TY, 2018, J BIOL CHEM, V293, P19344, DOI 10.1074/jbc.RA118.005850; Hargrove TY, 2016, J LIPID RES, V57, P1552, DOI 10.1194/jlr.M069229; Hargrove TY, 2011, J BIOL CHEM, V286, P26838, DOI 10.1074/jbc.M111.237099; HELLWIG B, 1991, MOL PHARMACOL, V40, P383; Huang X, 2017, STRUCTURE, V25, P945, DOI 10.1016/j.str.2017.04.007; Huang X, 2017, NAT STRUCT MOL BIOL, V24, P108, DOI 10.1038/nsmb.3329; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Jiang X, 2020, CELL, V183, P258, DOI 10.1016/j.cell.2020.08.015; Josts I, 2021, STRUCTURAL INSIGHTS, DOI [10.1101/2021.01.28.428567, DOI 10.1101/2021.01.28.428567]; Kato Hideaki E, 2013, Biophysics (Nagoya-shi), V9, P57, DOI 10.2142/biophysics.9.57; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Keating D, 2018, NEW ENGL J MED, V379, P1612, DOI 10.1056/NEJMoa1807120; Keniya MV, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.01134-18, 10.1128/aac.01134-18]; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Klepper J, 1999, PEDIATR RES, V46, P677, DOI 10.1203/00006450-199912000-00006; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Liu FY, 2019, SCIENCE, V364, P1184, DOI 10.1126/science.aaw7611; Liu SX, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abe3717; Lynagh T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00160; MacKenzie T, 2014, ANN INTERN MED, V161, P233, DOI 10.7326/M13-0636; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P113, DOI 10.1038/nrclinonc.2017.1; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Masiulis S, 2019, NATURE, V565, P454, DOI 10.1038/s41586-018-0832-5; Medina RA, 2002, BIOL RES, V35, P9, DOI 10.4067/S0716-97602002000100004; Meriney SD, 2019, SYNAPTIC TRANSMISSION, P245, DOI 10.1016/B978-0-12-815320-8.00012-0; Meriney SD, 2019, SYNAPTIC TRANSMISSION, P215, DOI 10.1016/B978-0-12-815320-8.00011-9; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mishra RK, 2015, J BIOL CHEM, V290, P14441, DOI 10.1074/jbc.M114.628826; Mo CQ, 2005, BBA-MOL CELL BIOL L, V1737, P152, DOI 10.1016/j.bbalip.2005.11.002; Monk BC, 2020, BBA-PROTEINS PROTEOM, V1868, DOI 10.1016/j.bbapap.2019.02.008; Monk BC, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02114-18; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Murphy KC, 2018, MBIO, V9, DOI 10.1128/mBio.01467-18; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Patriarchi T, 2018, SCIENCE, V360, P1420, DOI 10.1126/science.aat4422; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; Qureshi AA, 2020, NATURE, V578, P321, DOI 10.1038/s41586-020-1963-z; Rafeeq MM, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1193-9; Rahman MM, 2020, NEURON, V106, P952, DOI 10.1016/j.neuron.2020.03.012; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sagatova AA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02242-17; Sagatova AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26213; Sagatova AA, 2015, ANTIMICROB AGENTS CH, V59, P4982, DOI 10.1128/AAC.00925-15; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Schoof M, 2020, SCIENCE, V370, P1473, DOI 10.1126/science.abe3255; Siebeneicher H, 2016, CHEMMEDCHEM, V11, P2261, DOI 10.1002/cmdc.201600276; Sun FM, 2018, CELL, V174, P481, DOI 10.1016/j.cell.2018.06.042; Thompson AMG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12804; Tyndall JDA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167485; Ung PMU, 2016, ACS CHEM BIOL, V11, P1908, DOI 10.1021/acschembio.6b00304; Van der Plas SE, 2018, J MED CHEM, V61, P1425, DOI 10.1021/acs.jmedchem.7b01288; Walsh RM, 2018, NATURE, V557, P261, DOI 10.1038/s41586-018-0081-7; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Wang S, 2017, SCIENCE, V358, P381, DOI 10.1126/science.aan5468; Watson A., 2020, BIORXIV, V85, P833, DOI [DOI 10.1101/2020.08.06.238915, 10.1101/2020.08.06.238915]; Watson RT, 2001, RECENT PROG HORM RES, V56, P175, DOI 10.1210/rp.56.1.175; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang Z, 2018, P NATL ACAD SCI USA, V115, P12757, DOI 10.1073/pnas.1815287115; Zhu ST, 2018, NATURE, V559, P67, DOI 10.1038/s41586-018-0255-3	616	20	20	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100557	10.1016/j.jbc.2021.100557	http://dx.doi.org/10.1016/j.jbc.2021.100557			50	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744283	gold, Green Published			2022-12-28	WOS:000672866400530
J	Nakahara, K; Hamada, K; Tsuchida, T; Takasugi, N; Abiko, Y; Shien, K; Toyooka, S; Kumagai, Y; Uehara, T				Nakahara, Kengo; Hamada, Kyohei; Tsuchida, Tomoki; Takasugi, Nobumasa; Abiko, Yumi; Shien, Kazuhiko; Toyooka, Shinichi; Kumagai, Yoshito; Uehara, Takashi			Covalent N-arylation by the pollutant 1,2-naphthoquinone activates the EGF receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; POLYCYCLIC AROMATIC-HYDROCARBONS; TYROSINE-PHOSPHATASE 1B; LUNG-CANCER CELLS; ATMOSPHERIC ELECTROPHILE; QUINONES; PROTEIN; INHIBITION; PATHWAY; A549	The epidermal growth factor receptor (EGFR) is the most intensively investigated receptor tyrosine kinase. Several EGFR mutations and modifications have been shown to lead to abnormal self-activation, which plays a critical role in carcinogenesis. Environmental air pollutants, which are associated with cancer and respiratory diseases, can also activate EGFR. Specifically, the environmental electrophile 1,2-naphthoquinone (1,2-NQ), a component of diesel exhaust particles and particulate matter more generally, has previously been shown to impact EGFR signaling. However, the detailed mechanism of 1,2-NQ function is unknown. Here, we demonstrate that 1,2-NQ is a novel chemical activator of EGFR but not other EGFR family proteins. We found that 1,2-NQ forms a covalent bond, in a reaction referred to as N-arylation, with Lys80, which is in the ligand-binding domain. This modification activates the EGFR-Akt signaling pathway, which inhibits serum deprivation-induced cell death in a human lung adenocarcinoma cell line. Our study reveals a novel mode of EGFR pathway activation and suggests a link between abnormal EGFR activation and environmental pollutant-associated diseases such as cancer.	[Nakahara, Kengo; Hamada, Kyohei; Tsuchida, Tomoki; Takasugi, Nobumasa; Uehara, Takashi] Okayama Univ, Dept Med Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Abiko, Yumi; Kumagai, Yoshito] Univ Tsukuba, Fac Med, Environm Biol Lab, Tsukuba, Ibaraki, Japan; [Shien, Kazuhiko; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Breast & Endocrinol Surg, Okayama, Japan	Okayama University; University of Tsukuba; Okayama University	Uehara, T (corresponding author), Okayama Univ, Dept Med Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	uehara-t@okayama-u.ac.jp	; Shien, Kazuhiko/B-8560-2012	TAKASUGI, NOBUMASA/0000-0002-6059-2082; Nakahara, Kengo/0000-0003-0765-4931; Shien, Kazuhiko/0000-0002-4959-4220	Ministry of Education, Culture, Sports and Technology (MEXT) of Japan [18H02579, 19K22498, 18H05293]; Smoking Research Foundation	Ministry of Education, Culture, Sports and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation	This work was supported in part by Grants-in-Aid for Scientific Research (B) (18H02579), Challenging Exploratory Research (19K22498) (to T. U.), and Scientific Research (S) (18H05293) (to Y. K.) from the Ministry of Education, Culture, Sports and Technology (MEXT) of Japan and by the Smoking Research Foundation (to T. U.).	Abiko Y, 2017, FREE RADICAL BIO MED, V104, P118, DOI 10.1016/j.freeradbiomed.2016.12.047; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Beei C, 2013, J TOXICOL SCI, V38, P793; Cho AK, 2004, AEROSOL SCI TECH, V38, P68, DOI 10.1080/02786820390229471; Chung MY, 2006, ENVIRON SCI TECHNOL, V40, P4880, DOI 10.1021/es0515957; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Delgado-Saborit JM, 2013, ATMOS ENVIRON, V77, P974, DOI 10.1016/j.atmosenv.2013.05.080; Dienstmann R, 2014, MOL CANCER THER, V13, P1021, DOI 10.1158/1535-7163.MCT-13-0639; Eiguren-Fernandez A, 2008, AEROSOL SCI TECH, V42, P854, DOI 10.1080/02786820802339546; Endo A, 2007, BIOCHEM BIOPH RES CO, V361, P243, DOI 10.1016/j.bbrc.2007.07.024; Fraser MP, 1998, ENVIRON SCI TECHNOL, V32, P1760, DOI 10.1021/es970349v; GOLDMAN R, 1990, BIOCHEMISTRY-US, V29, P11024, DOI 10.1021/bi00502a002; Hecht SS, 2002, LANCET ONCOL, V3, P461, DOI 10.1016/S1470-2045(02)00815-X; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Huang LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11541-1; Huang Y, 1997, APOPTOSIS, V2, P199, DOI 10.1023/A:1026420616484; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Izuishi K, 2000, CANCER RES, V60, P6201; Jakober CA, 2007, ENVIRON SCI TECHNOL, V41, P4548, DOI 10.1021/es062967u; Jin YF, 2017, ENVIRON TOXICOL, V32, P1121, DOI 10.1002/tox.22308; Kautzman KE, 2010, J PHYS CHEM A, V114, P913, DOI 10.1021/jp908530s; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Kumagai Yoshito, 2016, J Toxicol Sci, V41, pSP37, DOI 10.2131/jts.41.SP37; Kumagai Y, 2012, ANNU REV PHARMACOL, V52, P221, DOI 10.1146/annurev-pharmtox-010611-134517; Kuzman JA, 2005, J MOL CELL CARDIOL, V39, P841, DOI 10.1016/j.yjmcc.2005.07.019; Laux I, 2006, BRIT J CANCER, V94, P85, DOI 10.1038/sj.bjc.6602875; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Matsui T, 2019, CHEM RES TOXICOL, V32, P1760, DOI 10.1021/acs.chemrestox.9b00088; Misaki K, 2016, MUTAGENESIS, V31, P205, DOI 10.1093/mutage/gev076; Miura T, 2011, CHEM RES TOXICOL, V24, P1836, DOI 10.1021/tx200025y; Nair S., 2020, PLOS ONE, V15, P1; Nakahara K, 2019, BIOL PHARM BULL, V42, P1044, DOI 10.1248/bpb.b19-00025; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Pan M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006624; Parsa N, 2012, IRAN J PUBLIC HEALTH, V41, P1; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Purba ER, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020013; Sakaguchi M, 2014, MOL BIOTECHNOL, V56, P621, DOI 10.1007/s12033-014-9738-0; Sakai K, 2007, CANCER SCI, V98, P1498, DOI 10.1111/j.1349-7006.2007.00553.x; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Sasaki T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/546318; Shinkai Y, 2015, CHEM RES TOXICOL, V28, P838, DOI 10.1021/tx500416y; Sigismund S, 2018, MOL ONCOL, V12, P3, DOI 10.1002/1878-0261.12155; Sumi D, 2010, J TOXICOL SCI, V35, P891, DOI 10.2131/jts.35.891; Sun Y, 2006, ARCH TOXICOL, V80, P280, DOI 10.1007/s00204-005-0043-3; Takayama N, 2011, J TOXICOL SCI, V36, P817, DOI 10.2131/jts.36.817; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Toyama T, 2014, CHEM-BIOL INTERACT, V214, P41, DOI 10.1016/j.cbi.2014.02.008; Walgraeve C, 2010, ATMOS ENVIRON, V44, P1831, DOI 10.1016/j.atmosenv.2009.12.004; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Zhou P, 2018, ONCOL LETT, V15, P5201, DOI 10.3892/ol.2018.7961	55	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100524	10.1016/j.jbc.2021.100524	http://dx.doi.org/10.1016/j.jbc.2021.100524			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33705793	Green Published, gold			2022-12-28	WOS:000672866400498
J	Ng, CY; Whitelock, JM; Williams, H; Kim, HN; Medbury, HJ; Lord, MS				Ng, Chun-yi; Whitelock, John M.; Williams, Helen; Kim, Ha Na; Medbury, Heather J.; Lord, Megan S.			Macrophages bind LDL using heparan sulfate and the perlecan protein core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; SMOOTH-MUSCLE-CELLS; ARTERIAL PROTEOGLYCANS; APOLIPOPROTEIN-B; GROWTH-FACTOR; ATHEROSCLEROSIS; GLYCOSAMINOGLYCANS; RETENTION; ACCUMULATION; IDENTIFICATION	The retention of low-density lipoprotein (LDL) is a key process in the pathogenesis of atherosclerosis and largely mediated via smooth-muscle cell-derived extracellular proteoglycans including the glycosaminoglycan chains. Macrophages can also internalize lipids via complexes with proteoglycans. However, the role of polarized macrophage-derived proteoglycans in binding LDL is unknown and important to advance our understanding of the pathogenesis of atherosclerosis. We therefore examined the identity of proteoglycans, including the pendent glycosaminoglycans, produced by polarized macrophages to gain insight into the molecular basis for LDL binding. Using the quartz crystal microbalance with dissipation monitoring technique, we established that classically activated macrophage (M1)- and alternatively activated macrophage (M2)-derived proteoglycans bind LDL via both the protein core and heparan sulfate (HS) in vitro. Among the proteoglycans secreted by macrophages, we found perlecan was the major protein core that bound LDL. In addition, we identified perlecan in the necrotic core as well as the fibrous cap of advanced human atherosclerotic lesions in the same regions as HS and colocalized with M2 macrophages, suggesting a functional role in lipid retention in vivo. These findings suggest that macrophages may contribute to LDL retention in the plaque by the production of proteoglycans; however, their contribution likely depends on both their phenotype within the plaque and the presence of enzymes, such as heparanase, that alter the secreted protein structure.	[Ng, Chun-yi; Whitelock, John M.; Kim, Ha Na; Lord, Megan S.] UNSW Sydney, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Ng, Chun-yi; Williams, Helen; Medbury, Heather J.] Westmead Hosp, Vasc Biol Res Ctr, Dept Surg, Westmead, NSW, Australia; [Ng, Chun-yi; Williams, Helen; Medbury, Heather J.] Univ Sydney, Westmead Clin Sch, Westmead, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney	Lord, MS (corresponding author), UNSW Sydney, Grad Sch Biomed Engn, Sydney, NSW, Australia.; Medbury, HJ (corresponding author), Westmead Hosp, Vasc Biol Res Ctr, Dept Surg, Westmead, NSW, Australia.; Medbury, HJ (corresponding author), Univ Sydney, Westmead Clin Sch, Westmead, NSW, Australia.	heather.medbury@sydney.edu.au; m.lord@unsw.edu.au	Williams, Helen/AAW-9632-2021; Lord, Megan/D-4673-2013	Williams, Helen/0000-0001-8221-5766; Lord, Megan/0000-0002-0506-9811	Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	C. Y. N. was supported by an Australian Government Research Training Program Scholarship.	Adhikara IM, 2019, BIOCHEM BIOPH RES CO, V509, P89, DOI 10.1016/j.bbrc.2018.12.068; Asplund A, 2011, ATHEROSCLEROSIS, V215, P77, DOI 10.1016/j.atherosclerosis.2010.12.017; Asplund A, 2010, GLYCOBIOLOGY, V20, P33, DOI 10.1093/glycob/cwp139; Asplund A, 2009, J LEUKOCYTE BIOL, V86, P381, DOI 10.1189/jlb.0908536; Baker AB, 2010, ATHEROSCLEROSIS, V213, P436, DOI 10.1016/j.atherosclerosis.2010.09.003; Ballinger ML, 2009, ATHEROSCLEROSIS, V205, P451, DOI 10.1016/j.atherosclerosis.2009.01.024; Barthwal MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058054; Bi Y, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/6724903; Boren J, 1998, J CLIN INVEST, V101, P2658, DOI 10.1172/JCI2265; Boren J, 2016, CURR OPIN LIPIDOL, V27, P473, DOI 10.1097/MOL.0000000000000330; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; CAMEJO G, 1993, J BIOL CHEM, V268, P14131; CAMEJO G, 1980, ATHEROSCLEROSIS, V35, P307, DOI 10.1016/0021-9150(80)90129-X; CAMEJO G, 1988, ARTERIOSCLEROSIS, V8, P368, DOI 10.1161/01.ATV.8.4.368; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Chang MY, 2014, MATRIX BIOL, V34, P1, DOI 10.1016/j.matbio.2014.01.011; Chang MY, 1998, J BIOL CHEM, V273, P15985, DOI 10.1074/jbc.273.26.15985; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; CHRISTNER JE, 1988, ARTERIOSCLEROSIS, V8, P535, DOI 10.1161/01.ATV.8.5.535; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; DALFERES ER, 1987, EXP MOL PATHOL, V47, P363, DOI 10.1016/0014-4800(87)90019-0; Davies NP, 2008, J AGR FOOD CHEM, V56, P343, DOI 10.1021/jf072624v; Evanko SP, 1998, AM J PATHOL, V152, P533; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hakamata H, 1998, J Atheroscler Thromb, V5, P66; Halvorsen B, 1998, BIOCHEM J, V331, P743, DOI 10.1042/bj3310743; Hamilton TA, 1999, PATHOBIOLOGY, V67, P241, DOI 10.1159/000028101; HOLLMANN J, 1989, ARTERIOSCLEROSIS, V9, P154, DOI 10.1161/01.ATV.9.2.154; HURT E, 1990, J LIPID RES, V31, P443; HurtCamejo E, 1997, ARTERIOSCL THROM VAS, V17, P1011, DOI 10.1161/01.ATV.17.6.1011; HURTCAMEJO E, 1992, ARTERIOSCLER THROMB, V12, P569, DOI 10.1161/01.ATV.12.5.569; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; IVERIUS PH, 1972, J BIOL CHEM, V247, P2607; Kang H., 2019, MED NOVEL TECHNOLOGY, V3, P100016; Kaplan M, 2000, ATHEROSCLEROSIS, V149, P5, DOI 10.1016/S0021-9150(99)00287-7; Kaplan M, 1997, BIOCHEM BIOPH RES CO, V237, P271, DOI 10.1006/bbrc.1997.7130; Kovanen PT, 1999, TRENDS CARDIOVAS MED, V9, P86, DOI 10.1016/S1050-1738(99)00013-4; Krisko A, 2006, BIOPHYS CHEM, V119, P234, DOI 10.1016/j.bpc.2005.09.011; Kunjathoor VV, 2002, ARTERIOSCL THROM VAS, V22, P462, DOI 10.1161/hq0302.105378; Li Yu-Zhen, 2007, Shengli Xuebao, V59, P221; Little PJ, 2008, CURR OPIN LIPIDOL, V19, P448, DOI 10.1097/MOL.0b013e32830dd7c4; Little PJ, 2002, ARTERIOSCL THROM VAS, V22, P55, DOI 10.1161/hq0102.101100; Lord MS, 2016, METAB ENG, V38, P105, DOI 10.1016/j.ymben.2016.07.006; Lord MS, 2014, MATRIX BIOL, V35, P112, DOI 10.1016/j.matbio.2014.01.016; Lord MS, 2013, J BIOL CHEM, V288, P22930, DOI 10.1074/jbc.M112.404186; MAHLEY RW, 1979, BIOCHIM BIOPHYS ACTA, V575, P81, DOI 10.1016/0005-2760(79)90133-4; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Medbury HJ, 2013, INT ANGIOL, V32, P74; Mikita T, 2001, J BIOL CHEM, V276, P45729, DOI 10.1074/jbc.M106114200; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Olsson U, 2001, GLYCOCONJUGATE J, V18, P789, DOI 10.1023/A:1021155518464; Osman N, 2013, CARDIOVASC PATHOL, V22, P146, DOI 10.1016/j.carpath.2012.07.002; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; OWENS RT, 1991, ATHEROSCLEROSIS, V91, P229, DOI 10.1016/0021-9150(91)90170-8; PAN YT, 1978, ARCH BIOCHEM BIOPHYS, V189, P231, DOI 10.1016/0003-9861(78)90208-4; Pillarisetti S, 1997, J CLIN INVEST, V100, P867, DOI 10.1172/JCI119602; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; SRINIVASAN SR, 1995, BBA-MOL BASIS DIS, V1272, P61, DOI 10.1016/0925-4439(95)00068-F; STEVENS RL, 1976, J CLIN INVEST, V58, P470, DOI 10.1172/JCI108491; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Swart M, 2019, J HISTOCHEM CYTOCHEM, V67, P9, DOI 10.1369/0022155418798770; Tedesco S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00071; Tran PK, 2007, ATHEROSCLEROSIS, V190, P264, DOI 10.1016/j.atherosclerosis.2006.03.010; Tran-Lundmark K, 2008, CIRC RES, V103, P43, DOI 10.1161/CIRCRESAHA.108.172833; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Vijayagopal P, 2005, ATHEROSCLEROSIS, V178, P75, DOI 10.1016/j.atherosclerosis.2004.08.028; Vikramadithyan RK, 2004, J LIPID RES, V45, P1806, DOI 10.1194/jlr.M400019-JLR200; VOLKER W, 1990, EUR HEART J, V11, P29, DOI 10.1093/eurheartj/11.suppl_E.29; WASTY F, 1993, DIABETOLOGIA, V36, P316, DOI 10.1007/BF00400234; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Xu YX, 2015, J LIPID RES, V56, P266, DOI 10.1194/jlr.M053017; Zhang X, 2018, J CELL MOL MED, V22, P409, DOI 10.1111/jcmm.13329	75	9	9	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100520	10.1016/j.jbc.2021.100520	http://dx.doi.org/10.1016/j.jbc.2021.100520			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33684447	gold, Green Published			2022-12-28	WOS:000672866400494
J	Nosyreva, ED; Thompson, D; Syeda, R				Nosyreva, Elena D.; Thompson, David; Syeda, Ruhma			Identification and functional characterization of the Piezo1 channel pore domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM; MODULE; CELL	Mechanotransduction is the process by which cells convert physical forces into electrochemical responses. On a molecular scale, these forces are detected by mechanically activated ion channels, which constitute the basis for hearing, touch, pain, cold, and heat sensation, among other physiological processes. Exciting high-resolution structural details of these channels are currently emerging that will eventually allow us to delineate the molecular determinants of gating and ion permeation. However, our structural-functional understanding across the family remains limited. Piezo1 is one of the largest and least understood of these channels, with various structurally identified features within its trimeric assembly. This study seeks to determine the modularity and function of Piezo1 channels by constructing deletion proteins guided by cryo EM structural knowledge. Our comprehensive functional study identified, for the first time, the minimal amino acid sequence of the full-length Piezo1 that can fold and function as the channel's pore domain between E2172 and the last residue E2547. While the addition of an anchor region has no effect on permeation properties. The Piezo1 pore domain is not pressure-sensitive and the appending of Piezo Repeat-A did not restore pressure-dependent gating, hence the sensing module must exist between residues 1 to 1952. Our efforts delineating the permeation and gating regions within this complex ion channel have implications in identifying small molecules that exclusively regulate the activity of the channel's pore module to influence mechanotransduction and downstream processes.	[Nosyreva, Elena D.; Thompson, David; Syeda, Ruhma] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Syeda, R (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	Ruhma.syeda@utsouthwestern.edu		Nosyreva, Elena D/0000-0002-6624-7415	UT Southwestern Medical Center Endowed Scholar Program; Welch Foundation [I-1965-20180324]; American Heart Association scientist development grant [17SDG33410184]	UT Southwestern Medical Center Endowed Scholar Program; Welch Foundation(The Welch Foundation); American Heart Association scientist development grant(American Heart Association)	This study was supported by the UT Southwestern Medical Center Endowed Scholar Program, Welch Foundation Award (I-1965-20180324), and American Heart Association scientist development grant (17SDG33410184) to R.S.	Alper SL, 2017, CURR TOP MEMBR, V79, P97, DOI 10.1016/bs.ctm.2017.01.001; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Coste B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8223; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Erdogmus S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13722-0; Geng J, 2020, NEURON, V106, P438, DOI 10.1016/j.neuron.2020.02.010; Gottlieb PA, 2017, CURR TOP MEMBR, V79, P1, DOI 10.1016/bs.ctm.2016.11.007; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Guo YSR, 2017, ELIFE, V6, DOI 10.7554/eLife.33660; Hyman AJ, 2017, CURR TOP MEMBR, V79, P37, DOI 10.1016/bs.ctm.2016.11.001; Kovacsova G, 2015, PROTEIN EXPRES PURIF, V111, P42, DOI 10.1016/j.pep.2015.03.002; Lewis AH, 2020, CELL REP, V30, P870, DOI 10.1016/j.celrep.2019.12.040; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Maneshi MM, 2017, CURR TOP MEMBR, V79, P309, DOI 10.1016/bs.ctm.2016.11.005; McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015; MONTAL M, 1990, FASEB J, V4, P2623, DOI 10.1096/fasebj.4.9.1693348; Moroni M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03502-7; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Patten CD, 1999, FEBS LETT, V463, P375, DOI 10.1016/S0014-5793(99)01659-2; Penny CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38426; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Saotome K, 2018, NATURE, V554, P481, DOI 10.1038/nature25453; Shaya D, 2014, J MOL BIOL, V426, P467, DOI 10.1016/j.jmb.2013.10.010; Spasic Milos, 2017, Semin Cell Dev Biol, V71, P42, DOI 10.1016/j.semcdb.2017.08.036; Suchyna TM, 2017, PROG BIOPHYS MOL BIO, V130, P244, DOI 10.1016/j.pbiomolbio.2017.07.011; Syeda R, 2016, CELL REP, V17, P1739, DOI 10.1016/j.celrep.2016.10.033; Syeda R, 2016, J BIOL CHEM, V291, P2931, DOI 10.1074/jbc.M115.683185; Syeda R, 2012, P NATL ACAD SCI USA, V109, P16917, DOI 10.1073/pnas.1205592109; Szczot M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat9892; Volkers L, 2015, PFLUG ARCH EUR J PHY, V467, P95, DOI 10.1007/s00424-014-1578-z; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Xu J, 2018, CELL, V173, P762, DOI 10.1016/j.cell.2018.03.076; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253; Zeng WZ, 2018, SCIENCE, V362, P464, DOI 10.1126/science.aau6324; Zeng Y, 2018, ADV EXP MED BIOL, V1097, P1, DOI 10.1007/978-3-319-96445-4_1; Zhao J, 2016, ELIFE, V5, DOI 10.7554/eLife.18130; Zhao QC, 2018, NATURE, V554, P487, DOI 10.1038/nature25743; Zhao QC, 2016, NEURON, V89, P1248, DOI 10.1016/j.neuron.2016.01.046; Zheng W, 2019, ELIFE, V8, DOI 10.7554/eLife.44003	44	7	8	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100225	10.1074/jbc.RA120.015905	http://dx.doi.org/10.1074/jbc.RA120.015905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361157	gold, Green Published			2022-12-28	WOS:000672866400203
J	Petrillo, T; Ayombil, F; Van't Veer, C; Camire, RM				Petrillo, Teodolinda; Ayombil, Francis; Van't Veer, Cornelis; Camire, Rodney M.			Regulation of factor V and factor V-short by TFPI alpha: Relationship between B-domain proteolysis and binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR PATHWAY INHIBITOR; THROMBIN-CATALYZED ACTIVATION; MACROMOLECULAR SUBSTRATE RECOGNITION; FACTOR-XA; BLEEDING DISORDER; COFACTOR FUNCTION; C-TERMINUS; PROTEIN-S; PROTHROMBINASE; COAGULATION	Coagulation factor V (FV) plays an anticoagulant role but serves as a procoagulant cofactor in the prothrombinase complex once activated to FVa. At the heart of these opposing effects is the proteolytic removal of its central B-domain, including conserved functional landmarks (basic region, BR; 963-1008 and acidic region 2, AR2; 1493-1537) that enforce the inactive FV procofactor state. Tissue factor pathway inhibitor alpha (TFPI alpha) has been associated with FV as well as FV-short, a physiologically relevant isoform with a shortened B-domain missing the BR. However, it is unclear which forms of FV are physiologic ligands for TFPI alpha. Here, we characterize the binding and regulation of FV and FV-short by TFPI alpha via its positively charged C-terminus (TFPI alpha-BR) and examine how bond cleavage in the B-domain influences these interactions. We show that FV-short is constitutively active and functions in prothrombinase like FVa. Unlike FVa, FV-short binds with high affinity (K-d similar to 1 nM) to TFPI alpha-BR, which blocks procoagulant function unless FV-short is cleaved at Arg(1545), removing AR2. Importantly, we do not observe FV binding (mu M detection limit) to TFPI alpha. However, cleavage at Arg(709) and Arg(1018) displaces the FV BR, exposing AR2 and allowing TFPI alpha to bind via its BR. We conclude that for full-length FV, the detachment of FV BR from AR2 is necessary and sufficient for TFPI alpha binding and regulation. Our findings pinpoint key forms of FV, including FV-short, that act as physiologic ligands for TFPI alpha and establish a mechanistic framework for assessing the functional connection between these proteins.	[Petrillo, Teodolinda; Ayombil, Francis; Camire, Rodney M.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Petrillo, Teodolinda; Ayombil, Francis; Camire, Rodney M.] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Van't Veer, Cornelis] Univ Amsterdam, Amsterdam UMC, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Camire, Rodney M.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Amsterdam; University of Pennsylvania; Pennsylvania Medicine	Camire, RM (corresponding author), Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA.; Camire, RM (corresponding author), Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA.; Camire, RM (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	rcamire@pennmedicine.upenn.edu	Ayombil, Francis/AAE-2889-2020	Ayombil, Francis/0000-0001-6011-1931; Camire, Rodney/0000-0002-0585-4537	US National Institutes of Health [P01 HL139420, T32 HL007971]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US National Institutes of Health grant P01 HL139420, Project 2 (RM Camire) and T32 HL007971 (F Ayombil). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; Bradford HN, 2019, J BIOL CHEM, V294, P2422, DOI 10.1074/jbc.RA118.006510; Bradford HN, 2013, J BIOL CHEM, V288, P27789, DOI 10.1074/jbc.M113.502005; Broze GJ, 2012, FRONT BIOSCI-LANDMRK, V17, P262, DOI 10.2741/3926; Buddai SK, 2010, J BIOL CHEM, V285, P5212, DOI 10.1074/jbc.M109.049833; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Bunce MW, 2013, J BIOL CHEM, V288, P30151, DOI 10.1074/jbc.M113.506840; Bunce MW, 2011, BLOOD, V117, P290, DOI 10.1182/blood-2010-08-300756; Camire RM, 2016, HAEMOPHILIA, V22, P3, DOI 10.1111/hae.13004; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Camire RM, 1998, BIOCHEMISTRY-US, V37, P11896, DOI 10.1021/bi980520v; Camire RM, 2011, CURR OPIN HEMATOL, V18, P338, DOI 10.1097/MOH.0b013e3283497ebc; Chowdary P, 2020, INT J HEMATOL, V111, P42, DOI 10.1007/s12185-018-2548-6; Cunha MLR, 2015, BLOOD, V125, P1822, DOI 10.1182/blood-2014-08-592733; Dahlback B, 2017, J THROMB HAEMOST, V15, P1241, DOI 10.1111/jth.13665; Dahlback B, 2019, J THROMB HAEMOST, V17, P585, DOI 10.1111/jth.14405; Dahlback B, 2018, RES PRACT THROMB HAE, V2, P114, DOI 10.1002/rth2.12057; Dahlback B, 2016, INT J LAB HEMATOL, V38, P4, DOI 10.1111/ijlh.12508; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Eaton SL, 2014, JOVE-J VIS EXP, DOI 10.3791/52099; ESMON CT, 1979, J BIOL CHEM, V254, P964; HACKENG TM, 1993, J BIOL CHEM, V268, P3993; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; HUANG ZF, 1993, J BIOL CHEM, V268, P26950; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; KALAFATIS M, 1993, METHOD ENZYMOL, V222, P224; KANE WH, 1990, BIOCHEMISTRY-US, V29, P6762, DOI 10.1021/bi00481a003; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KELLER FG, 1995, BIOCHEMISTRY-US, V34, P4118, DOI 10.1021/bi00012a030; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; Kuang SQ, 2001, BLOOD, V97, P1549, DOI 10.1182/blood.V97.6.1549; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; MANN KG, 1990, BLOOD, V76, P1; Maroney SA, 2015, J THROMB HAEMOST, V13, pS200, DOI 10.1111/jth.12897; Maroney SA, 2012, THROMB RES, V129, pS21, DOI 10.1016/j.thromres.2012.02.023; Mast AE, 1996, BLOOD, V87, P1845; Mast Alan E, 2011, Front Biosci (Schol Ed), V3, P1457; MONKOVIC DD, 1990, J BIOL CHEM, V265, P17132; Ndonwi M, 2012, J THROMB HAEMOST, V10, P1944, DOI 10.1111/j.1538-7836.2012.04834.x; NESHEIM ME, 1979, J BIOL CHEM, V254, P1326; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; NOVOTNY WF, 1988, BLOOD, V72, P2020; Peraramelli S, 2016, THROMB HAEMOSTASIS, V115, P580, DOI 10.1160/TH15-04-0354; Santamaria S, 2017, J BIOL CHEM, V292, P9335, DOI 10.1074/jbc.M116.769570; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; Thalji N, 2013, SEMIN THROMB HEMOST, V39, P607, DOI 10.1055/s-0033-1349224; Thorelli E, 1997, EUR J BIOCHEM, V247, P12, DOI 10.1111/j.1432-1033.1997.00012.x; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; TRACY PB, 1982, BLOOD, V60, P59; van Doorn P, 2017, J THROMB HAEMOST, V15, P140, DOI 10.1111/jth.13559; Vincent LM, 2013, J CLIN INVEST, V123, P3777, DOI 10.1172/JCI69091; Wood JP, 2017, BLOOD ADV, V1, P2692, DOI 10.1182/bloodadvances.2017011098; Wood JP, 2014, BLOOD, V123, P2934, DOI 10.1182/blood-2013-11-512764; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110; Zhou HX, 2006, BIOPHYS J, V91, P3170, DOI 10.1529/biophysj.106.090258; Zhu H, 2007, J BIOL CHEM, V282, P15033, DOI 10.1074/jbc.M701315200; Zimowski KL, 2017, BLOOD, V130	65	9	9	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100234	10.1074/jbc.RA120.016341	http://dx.doi.org/10.1074/jbc.RA120.016341			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33376137	gold, Green Published			2022-12-28	WOS:000672866400212
J	Tange, H; Ishibashi, D; Nakagaki, T; Taguchi, Y; Kamatari, YO; Ozawa, H; Nishida, N				Tange, Hiroya; Ishibashi, Daisuke; Nakagaki, Takehiro; Taguchi, Yuzuru; Kamatari, Yuji O.; Ozawa, Hiroki; Nishida, Noriyuki			Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE-ASSOCIATED FORM; CELL-SURFACE; AMYLOID FORMATION; PRPSC; AGGREGATION; BINDING; PROPAGATION; RECOMBINANT; INTERACT; KINETICS	Prion diseases are characterized by the accumulation of amyloid fibrils. The causative agent is an infectious amyloid that comprises solely misfolded prion protein (PrPSc). Prions can convert normal cellular prion protein (PrPC) to protease K-resistance prion protein fragment (PrP-res) in vitro; however, the intermediate steps involved in this spontaneous conversion still remain unknown. We investigated whether recombinant prion protein (rPrP) can directly convert into PrP-res via liquid-liquid phase separation (LLPS) in the absence of PrPSc. We found that rPrP underwent LLPS at the interface of the aqueous two-phase system of polyethylene glycol and dextran, whereas single-phase conditions were not inducible. Fluorescence recovery assay after photobleaching revealed that the liquid-solid phase transition occurred within a short time. The aged rPrP-gel acquired a proteinase-resistant amyloid accompanied by beta-sheet conversion, as confirmed by Western blotting, Fourier transform infrared spectroscopy, and Congo red staining. The reactions required both the N-terminal region of rPrP (amino acids 23-89) and kosmotropic salts, suggesting that the kosmotropic anions may interact with the N-terminal region of rPrP to promote LLPS. Thus, structural conversion via LLPS and liquid-solid phase transition could be the intermediate steps in the conversion of prions.	[Tange, Hiroya; Ishibashi, Daisuke; Nakagaki, Takehiro; Taguchi, Yuzuru; Nishida, Noriyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki, Japan; [Tange, Hiroya; Ozawa, Hiroki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neuropsychiat, Nagasaki, Japan; [Kamatari, Yuji O.] Gifu Univ, Life Sci Res Ctr, Gifu, Japan	Nagasaki University; Nagasaki University; Gifu University	Tange, H (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki, Japan.; Tange, H (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Neuropsychiat, Nagasaki, Japan.	bb55416003@ms.nagasaki-u.ac.jp		Nakagaki, Takehiro/0000-0003-1960-8326; Tange, Hiorya/0000-0002-0871-0133	JSPS KAKENHI [JP19K22600]; Japan Science Society [29-420]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science Society	This research was supported by JSPS KAKENHI JP19K22600 and Sasakawa Scientific Research Grant from The Japan Science Society 29-420.	Alsiary RA, 2020, NEUROL SCI, V41, P2389, DOI 10.1007/s10072-020-04321-9; Asenjo JA, 2011, J CHROMATOGR A, V1218, P8826, DOI 10.1016/j.chroma.2011.06.051; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Benavides J, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 2: ENGINEERING FUNDAMENTALS OF BIOTECHNOLOGY, 2ND EDITION, P697; Beutel O, 2019, CELL, V179, P923, DOI 10.1016/j.cell.2019.10.011; Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; CARLSON A, 1988, SEPAR SCI TECHNOL, V23, P785, DOI 10.1080/01496398808063140; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Deas E, 2016, ANTIOXID REDOX SIGN, V24, P376, DOI 10.1089/ars.2015.6343; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Diaz-Espinoza R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031678; Dorosz J, 2009, LANGMUIR, V25, P12501, DOI 10.1021/la901750v; Ellett LJ, 2015, GLYCOBIOLOGY, V25, P745, DOI 10.1093/glycob/cwv014; Evans EGB, 2016, STRUCTURE, V24, P1057, DOI 10.1016/j.str.2016.04.017; Exley C, 2010, J INORG BIOCHEM, V104, P1125, DOI 10.1016/j.jinorgbio.2010.05.012; Feng Z, 2019, J BIOL CHEM, V294, P14823, DOI 10.1074/jbc.REV119.007895; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gabryelczyk B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13469-8; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Godsave SF, 2013, NEUROBIOL AGING, V34, P1621, DOI 10.1016/j.neurobiolaging.2012.12.015; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Hackl EV, 2015, EUR BIOPHYS J BIOPHY, V44, P249, DOI 10.1007/s00249-015-1019-8; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Hodak M, 2009, P NATL ACAD SCI USA, V106, P11576, DOI 10.1073/pnas.0903807106; Hofmeister F, 1888, ARCH EXP PATHOL PHAR, V25, P1, DOI [10.1007/BF01918191, DOI 10.1007/BF01918191]; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Iqbal M, 2016, BIOL PROCED ONLINE, V18, DOI 10.1186/s12575-016-0048-8; Ishibashi D, 2019, BRAIN, V142, P1035, DOI 10.1093/brain/awz016; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kostylev MA, 2018, MOL CELL, V72, P426, DOI 10.1016/j.molcel.2018.10.009; Li HR, 2018, J BIOL CHEM, V293, P6090, DOI 10.1074/jbc.AC117.001037; Lu AX, 2017, CHEM SCI, V8, P6893, DOI 10.1039/c7sc01335c; Matos CO, 2020, FASEB J, V34, P365, DOI 10.1096/fj.201901897R; Metrick MA, 2019, P NATL ACAD SCI USA, V116, P23029, DOI 10.1073/pnas.1909322116; Miyazaki Y, 2019, MOL NEUROBIOL, V56, P367, DOI 10.1007/s12035-018-1088-7; Moore RA, 2007, BIOCHEMISTRY-US, V46, P7079, DOI 10.1021/bi700247y; Murthy AC, 2019, NAT STRUCT MOL BIOL, V26, P637, DOI 10.1038/s41594-019-0250-x; Nakatani N, 2018, CHEMBIOCHEM, V19, P1370, DOI 10.1002/cbic.201800066; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roucou X, 2004, J NEUROSCI RES, V75, P153, DOI 10.1002/jnr.10864; Rouvinski A, 2014, J CELL BIOL, V204, P423, DOI 10.1083/jcb.201308028; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Sankaranarayanan K, 2012, J PHYS CHEM B, V116, P895, DOI 10.1021/jp2100733; Shibata C, 2019, PROTEIN EXPRES PURIF, V161, P57, DOI 10.1016/j.pep.2019.05.002; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Spagnolli G, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007864; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Vernon RM, 2018, ELIFE, V7, DOI 10.7554/eLife.31486; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Wik L, 2012, PRION, V6, DOI 10.4161/pri.22588; Xiong LW, 2001, J NEUROCHEM, V79, P669, DOI 10.1046/j.1471-4159.2001.00606.x; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281; Yen CF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600014; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	82	21	21	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100367	10.1016/j.jbc.2021.100367	http://dx.doi.org/10.1016/j.jbc.2021.100367			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33545172	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400341
J	Teo, AKK; Nguyen, L; Gupta, MK; Lau, HH; Loo, LSW; Jackson, N; Lim, CS; Mallard, W; Gritsenko, MA; Rinn, JL; Smith, RD; Qian, WJ; Kulkarni, RN				Teo, Adrian Kee Keong; Linh Nguyen; Gupta, Manoj K.; Lau, Hwee Hui; Loo, Larry Sai Weng; Jackson, Nicholas; Lim, Chang Siang; Mallard, William; Gritsenko, Marina A.; Rinn, John L.; Smith, Richard D.; Qian, Wei-Jun; Kulkarni, Rohit N.			Defective insulin receptor signaling in hPSCs skews pluripotency and negatively perturbs neural differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; EXTRACELLULAR-MATRIX; NETWORK; FGF; NEUROECTODERM; PROLIFERATION; MAINTENANCE; STABILITY; PATHWAYS	Human embryonic stem cells are a type of pluripotent stem cells (hPSCs) that are used to investigate their differentiation into diverse mature cell types for molecular studies. The mechanisms underlying insulin receptor (IR)-mediated signaling in the maintenance of human pluripotent stem cell (hPSC) identity and cell fate specification are not fully understood. Here, we used two independent shRNAs to stably knock down IRs in two hPSC lines that represent pluripotent stem cells and explored the consequences on expression of key proteins in pathways linked to proliferation and differentiation. We consistently observed lowered pAKT in contrast to increased pERK1/2 and a concordant elevation in pluripotency gene expression. ERK2 chromatin immunoprecipitation, luciferase assays, and ERK1/2 inhibitors established direct causality between ERK1/2 and OCT4 expression. Of importance, RNA sequencing analyses indicated a dysregulation of genes involved in cell differentiation and organismal development. Mass spectrometry-based proteomic analyses further confirmed a global downregulation of extracellular matrix proteins. Subsequent differentiation toward the neural lineage reflected alterations in SOX1(+)PAX6(+) neuroectoderm and FOXG1(+) cortical neuron marker expression and protein localization. Collectively, our data underscore the role of IR-mediated signaling in maintaining pluripotency, the extracellular matrix necessary for the stem cell niche, and regulating cell fate specification including the neural lineage.	[Teo, Adrian Kee Keong; Gupta, Manoj K.; Jackson, Nicholas; Kulkarni, Rohit N.] Harvard Med Sch, Brigham & Womens Hosp, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol,Dept Med, Boston, MA 02115 USA; [Teo, Adrian Kee Keong; Gupta, Manoj K.; Jackson, Nicholas; Kulkarni, Rohit N.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Teo, Adrian Kee Keong; Linh Nguyen; Lau, Hwee Hui; Loo, Larry Sai Weng; Lim, Chang Siang] Proteos, Stem Cells & Diabet Lab, Inst Mol & Cell Biol, Singapore, Singapore; [Teo, Adrian Kee Keong; Linh Nguyen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Teo, Adrian Kee Keong; Linh Nguyen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Lau, Hwee Hui; Loo, Larry Sai Weng] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Mallard, William; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mallard, William; Rinn, John L.] Broad Inst MIT, Cambridge, MA USA; [Gritsenko, Marina A.; Smith, Richard D.; Qian, Wei-Jun] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA 99352 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Teo, AKK; Kulkarni, RN (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol,Dept Med, Boston, MA 02115 USA.; Teo, AKK; Kulkarni, RN (corresponding author), Harvard Stem Cell Inst, Boston, MA 02115 USA.; Teo, AKK (corresponding author), Proteos, Stem Cells & Diabet Lab, Inst Mol & Cell Biol, Singapore, Singapore.; Teo, AKK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.; Teo, AKK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.	ateo@imcb.a-star.edu.sg; rohit.kulkarni@joslin.harvard.edu	; Teo, Adrian/A-4009-2013	Jackson, Nicholas/0000-0003-4837-6624; Rinn, John/0000-0002-7231-7539; Loo, Larry Sai Weng/0000-0003-1671-2232; Nguyen, Linh/0000-0001-9850-1302; Teo, Adrian/0000-0001-5901-7075	Institute of Molecular and Cell Biology (IMCB); JCO Career Development Award (CDA) [15302FG148]; NMRC OFYIRG [OFYIRG16may014]; MRC; A*STAR ETPL Gap Funding [ETPL/18-GAP005-R20H]; Skin Innovation Grant [SIG18011]; NMRC OF-LCG/DYNAMO; Lee Foundation [SHTX/LFG/002/2018]; Precision Medicine and Personalised Therapeutics Joint Research Grant 2019; FY2019 SingHealth Duke-NUS Surgery Academic Clinical Programme Research Support Programme Grant; SingHealth Duke-NUS Transplant Centre -MultiVisceral Transplant Fund Award; Industry Alignment Fund-Industry Collaboration Project (IAF-ICP); NIH [P41 GM103493, R01 DK 67536, R01 DK103215, UC4 DK 116278]; HSCI; DOE [DE-AC05-76RLO-1830]; A*STAR	Institute of Molecular and Cell Biology (IMCB); JCO Career Development Award (CDA); NMRC OFYIRG; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); A*STAR ETPL Gap Funding(Agency for Science Technology & Research (A*STAR)); Skin Innovation Grant; NMRC OF-LCG/DYNAMO(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lee Foundation; Precision Medicine and Personalised Therapeutics Joint Research Grant 2019; FY2019 SingHealth Duke-NUS Surgery Academic Clinical Programme Research Support Programme Grant; SingHealth Duke-NUS Transplant Centre -MultiVisceral Transplant Fund Award; Industry Alignment Fund-Industry Collaboration Project (IAF-ICP); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HSCI; DOE(United States Department of Energy (DOE)); A*STAR(Agency for Science Technology & Research (A*STAR))	A. K. K. T. is supported by the Institute of Molecular and Cell Biology (IMCB), A*STAR, the JCO Career Development Award (CDA) 15302FG148, NMRC OFYIRG OFYIRG16may014, MRC Research Grant, A*STAR ETPL Gap Funding ETPL/18-GAP005-R20H, Skin Innovation Grant SIG18011, NMRC OF-LCG/DYNAMO, Lee Foundation Grant SHTX/LFG/002/2018, Precision Medicine and Personalised Therapeutics Joint Research Grant 2019, FY2019 SingHealth Duke-NUS Surgery Academic Clinical Programme Research Support Programme Grant, SingHealth Duke-NUS Transplant Centre -MultiVisceral Transplant Fund Award and the Industry Alignment FundIndustry Collaboration Project (IAF-ICP). R. D. S. is supported by NIH grant P41 GM103493. R. N. K. is supported by the HSCI and, NIH grants R01 DK 67536, R01 DK103215, and UC4 DK 116278. Pacific Northwest National Laboratory is under DOE contract DEAC05-76RLO-1830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Chen HX, 2015, P NATL ACAD SCI USA, V112, pE5936, DOI 10.1073/pnas.1516319112; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Dalton S, 2013, CURR OPIN CELL BIOL, V25, P241, DOI 10.1016/j.ceb.2012.09.005; Dastidar SG, 2011, J NEUROSCI, V31, P402, DOI 10.1523/JNEUROSCI.2897-10.2011; Ding V, 2006, BIOTECHNOL LETT, V28, P491, DOI 10.1007/s10529-006-0005-8; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Gupta MK, 2018, MOL METAB, V18, P153, DOI 10.1016/j.molmet.2018.09.003; Gupta MK, 2015, STEM CELL TRANSL MED, V4, P1101, DOI 10.5966/sctm.2014-0217; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Jerabek S, 2014, BBA-GENE REGUL MECH, V1839, P138, DOI 10.1016/j.bbagrm.2013.10.001; Kim SH, 2014, STEM CELL RES, V13, P1, DOI 10.1016/j.scr.2014.04.001; Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112; Kumamoto T, 2017, DEV GROWTH DIFFER, V59, P258, DOI 10.1111/dgd.12367; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Liu J, 2014, DIABETES OBES METAB, V16, P16, DOI 10.1111/dom.12337; Liu ZZ, 1997, P NATL ACAD SCI USA, V94, P6758, DOI 10.1073/pnas.94.13.6758; Ludwig T., 2007, CURR PROTOC STEM CEL; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Mitter D, 2018, GENET MED, V20, P98, DOI 10.1038/gim.2017.75; Na J, 2010, STEM CELL RES, V5, P157, DOI 10.1016/j.scr.2010.06.002; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teo AKK, 2013, J BIOL CHEM, V288, P5353, DOI 10.1074/jbc.C112.428979; Teo AKK, 2010, BIOCHEM J, V428, P11, DOI 10.1042/BJ20100102; Teo AKK, 2015, STEM CELL REP, V4, P578, DOI 10.1016/j.stemcr.2015.02.015; Teo AKK, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.007; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744	42	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100495	10.1016/j.jbc.2021.100495	http://dx.doi.org/10.1016/j.jbc.2021.100495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667549	gold, Green Published			2022-12-28	WOS:000672866400469
J	Thabault, L; Liberelle, M; Koruza, K; Yildiz, E; Joudiou, N; Messens, J; Brisson, L; Wouters, J; Sonveaux, P; Frederick, R				Thabault, Leopold; Liberelle, Maxime; Koruza, Katarina; Yildiz, Esra; Joudiou, Nicolas; Messens, Joris; Brisson, Lucie; Wouters, Johan; Sonveaux, Pierre; Frederick, Raphael			Discovery of a novel lactate dehydrogenase tetramerization domain using epitope mapping and peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; LUNG-CANCER; INHIBITORS; IDENTIFICATION; TUMORS; VULNERABILITY; DISSOCIATION; METABOLISM; INTERFACE; POTENT	Despite being initially regarded as a metabolic waste product, lactate is now considered to serve as a primary fuel for the tricarboxylic acid cycle in cancer cells. At the core of lactate metabolism, lactate dehydrogenases (LDHs) catalyze the interconversion of lactate to pyruvate and as such represent promising targets in cancer therapy. However, direct inhibition of the LDH active site is challenging from physicochemical and selectivity standpoints. However, LDHs are obligate tetramers. Thus, targeting the LDH tetrameric interface has emerged as an appealing strategy. In this work, we examine a dimeric construct of truncated human LDH to search for new druggable sites. We report the identification and characterization of a new cluster of interactions in the LDH tetrameric interface. Using nanoscale differential scanning fluorimetry, chemical denaturation, and mass photometry, we identified several residues (E62, D65, L71, and F72) essential for LDH tetrameric stability. Moreover, we report a family of peptide ligands based on this cluster of interactions. We next demonstrated these ligands to destabilize tetrameric LDHs through binding to this new tetrameric interface using nanoscale differential scanning fluorimetry, NMR water-ligand observed via gradient spectroscopy, and microscale thermophoresis. Altogether, this work provides new insights on the LDH tetrameric interface as well as valuable pharmacological tools for the development of LDH tetramer disruptors.	[Thabault, Leopold; Liberelle, Maxime; Yildiz, Esra; Frederick, Raphael] Univ Catholique Louvain UCLouvain, Louvain Drug Res Inst LDRI, Brussels, Belgium; [Thabault, Leopold; Sonveaux, Pierre] Univ Catholique Louvain UCLouvain, Inst Rech Expt & Clin IREC, Pole Pharmacol & Therapeut, Brussels, Belgium; [Koruza, Katarina; Messens, Joris] VIB VUB Ctr Struct Biol, Brussels, Belgium; [Koruza, Katarina; Messens, Joris] Brussels Ctr Redox Biol, Redox Signaling Lab, Brussels, Belgium; [Koruza, Katarina; Messens, Joris] Vrije Univ Brussel, Struct Biol Brussels, Brussels, Belgium; [Joudiou, Nicolas] Univ Catholique Louvain UCLouvain, Louvain Drug Res Inst LDRI, Nucl & Electron Spin Technol, Brussels, Belgium; [Brisson, Lucie] Univ Tours, Nutr Growth & Canc, INSERM, UMR1069, Tours, France; [Wouters, Johan] Univ Namur, Dept Chem, UNamur, NARILIS, Namur, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Namur	Frederick, R (corresponding author), Univ Catholique Louvain UCLouvain, Louvain Drug Res Inst LDRI, Brussels, Belgium.; Sonveaux, P (corresponding author), Univ Catholique Louvain UCLouvain, Inst Rech Expt & Clin IREC, Pole Pharmacol & Therapeut, Brussels, Belgium.	pierre.sonveaux@uclouvain.be; raphael.frederick@uclouvain.be	Liberelle, Maxime/AAB-5341-2022; Liberelle, Maxime/ADZ-6254-2022; Brisson, Lucie/R-1179-2016; Liberelle, Maxime/GQH-8403-2022; Messens, Joris/K-5856-2016	Brisson, Lucie/0000-0001-7811-1382; Liberelle, Maxime/0000-0002-8620-9256; Messens, Joris/0000-0002-2128-8264; Koruza, Katarina/0000-0002-7855-9184; Thabault, Leopold/0000-0001-9501-6563; Wouters, Johan/0000-0002-4920-6857	European Research Council [243188]; Belgian Science Policy Office (Belspo) [P7/03]; French Community of Belgium [ARC 14/19-58]; Belgian Fonds National de la Recherche Scientifique (FRS-FNRS) [3.4575.11, 2.5025.12, 31288018]; Belgian Fondation contre le Cancer [FAF-F/2018/1282]; VIB grant; Research Foundation-Flanders-Fonds de la Recherche Scientifique Excellence of Science project [30829584]; Belgian Televie [7.4611.11, 7.4548.13, 7.4507.14, 7.4647.20, 7.8504.18]	European Research Council(European Research Council (ERC)European Commission); Belgian Science Policy Office (Belspo)(Belgian Federal Science Policy Office); French Community of Belgium; Belgian Fonds National de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian Fondation contre le Cancer; VIB grant; Research Foundation-Flanders-Fonds de la Recherche Scientifique Excellence of Science project; Belgian Televie	This work was supported by European Research Council independent researcher starting grant 243188 (TUMETABO), the Belgian Science Policy Office (Belspo; Interuniversity Attraction Pole Grant P7/03), the French Community of Belgium (ARC 14/19-58), the Belgian Fonds National de la Recherche Scientifique (FRS-FNRS; grants 3.4575.11, 2.5025.12, and 31288018), the Belgian Fondation contre le Cancer (Fundamental Research Grant FAF-F/2018/1282), a VIB grant (to J. M.), the Research Foundation-Flanders-Fonds de la Recherche Scientifique Excellence of Science project (30829584 to J. M.), and the Belgian Televie (grants 7.4611.11, 7.4548.13, 7.4507.14, 7.4647.20, and 7.8504.18). P. S. is a research director of the FRS-FNRS. L. T. was a PhD fellow of the FRS-FNRS and is currently a postdoctoral researcher of the Belgian Fondation contre le Cancer.	Altamimi AMS, 2017, J ENZYM INHIB MED CH, V33, P147, DOI 10.1080/14756366.2017.1404593; APPELLA E, 1961, BIOCHEM BIOPH RES CO, V6, P171, DOI 10.1016/0006-291X(61)90123-1; Beckert S, 2006, WOUND REPAIR REGEN, V14, P321, DOI 10.1111/j.1743-6109.2006.00127.x; Billiard J, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-19; Boudreau A, 2016, NAT CHEM BIOL, V12, P779, DOI 10.1038/nchembio.2143; Brisson L, 2016, CANCER CELL, V30, P418, DOI 10.1016/j.ccell.2016.08.005; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Chung TW, 2019, CANCERS, V11, DOI 10.3390/cancers11070963; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Colen CB, 2011, NEOPLASIA, V13, P620, DOI 10.1593/neo.11134; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Dragovich PS, 2014, BIOORG MED CHEM LETT, V24, P3764, DOI 10.1016/j.bmcl.2014.06.076; Dragovich PS, 2013, BIOORG MED CHEM LETT, V23, P3186, DOI 10.1016/j.bmcl.2013.04.001; Friberg A, 2020, ACS OMEGA, V5, P13034, DOI 10.1021/acsomega.0c00715; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Gunderwala AY, 2019, ACS CHEM BIOL, V14, P1471, DOI 10.1021/acschembio.9b00191; Izumi H, 2011, CANCER SCI, V102, P1007, DOI 10.1111/j.1349-7006.2011.01908.x; JAENICKE R, 1981, EUR J BIOCHEM, V114, P525, DOI 10.1111/j.1432-1033.1981.tb05176.x; Jafary F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38854-7; Kohlmann A, 2013, J MED CHEM, V56, P1023, DOI 10.1021/jm3014844; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oshima N, 2020, CELL REP, V30, P1798, DOI 10.1016/j.celrep.2020.01.039; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Payen VL, 2020, MOL METAB, V33, P48, DOI 10.1016/j.molmet.2019.07.006; Qi J, 2016, CANCER RES, V76, P453, DOI 10.1158/0008-5472.CAN-15-1874; Rai G, 2017, J MED CHEM, V60, P9184, DOI 10.1021/acs.jmedchem.7b00941; Rani R, 2016, J MED CHEM, V59, P487, DOI 10.1021/acs.jmedchem.5b00168; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; Rupiani S, 2015, EUR J MED CHEM, V101, P63, DOI 10.1016/j.ejmech.2015.06.028; San-Millan I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127; Schmidt RK, 1999, J MOL MODEL, V5, P153, DOI 10.1007/s008940050115; Seetoh WG, 2016, J AM CHEM SOC, V138, P14303, DOI 10.1021/jacs.6b07440; Smith B, 2016, CELL REP, V17, P821, DOI 10.1016/j.celrep.2016.09.045; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Thabault L, 2021, DRUG DISCOV TODAY, V26, P1148, DOI 10.1016/j.drudis.2021.01.028; Thabault L, 2020, J MED CHEM, V63, P4628, DOI 10.1021/acs.jmedchem.9b01955; Vander Jagt DL, 2000, CURR MED CHEM, V7, P479, DOI 10.2174/0929867003375119; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward RA, 2012, J MED CHEM, V55, P3285, DOI 10.1021/jm201734r; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P1772, DOI 10.4161/cc.10.11.15659; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Young G, 2018, SCIENCE, V360, P423, DOI 10.1126/science.aar5839; Zdralevic Masa, 2018, Advances in Biological Regulation, V68, P55, DOI 10.1016/j.jbior.2017.12.002	48	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100422	10.1016/j.jbc.2021.100422	http://dx.doi.org/10.1016/j.jbc.2021.100422			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33607109	Green Published, gold			2022-12-28	WOS:000672866400396
J	Wang, C; Xiao, QJ; Duan, HC; Li, JH; Zhang, JY; Wang, QS; Guo, L; Hu, JP; Sun, B; Deng, D				Wang, Chen; Xiao, Qingjie; Duan, Huaichuan; Li, Jinhong; Zhang, Jiying; Wang, Qisheng; Guo, Li; Hu, Jianping; Sun, Bo; Deng, Dong			Molecular basis for substrate recognition by the bacterial nucleoside transporter NupG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; LACTOSE PERMEASE; STRUCTURAL BASIS; BIOLOGY; SPECIFICITY; MECHANISM; SEQUENCE; BINDING	Nucleoside homeostasis, which is mediated by transporters and channels, is essential for all life on Earth. In Escherichia coli, NupG mediates the transport of nucleosides and was deemed to be the prototype of the nucleoside proton symporter (NHS) family and the major facilitator superfamily. To date, the substrate recognition and transport mechanisms of NHS transporters are still elusive. Here, we report two crystal structures of NupG (WT and D323A NupG) resolved at 3.0 angstrom. Both structures reveal an identical inward-open conformation. Together with molecular docking and molecular dynamics simulations and in vitro uridine-binding assays, we found that the uridine binding site, which locates in the central cavity between N and C domains of NupG, is constituted by R136, T140, F143, Q225, N228, Q261, E264, Y318, and F322. Moreover, we found that D323 is very important for substrate binding via in vitro uridine-binding assays using D323 mutations, although it does not have a direct contact with uridine. Our structural and biochemical data therefore provide an important framework for the mechanistic understanding of nucleoside transporters of the NHS family.	[Wang, Chen; Xiao, Qingjie; Li, Jinhong; Zhang, Jiying; Guo, Li; Deng, Dong] Sichuan Univ, West China Second Hosp, Key Lab Birth Defects & Related Dis Women & Child, Dept Obstet,State Key Lab Biotherapy, Chengdu, Peoples R China; [Duan, Huaichuan; Hu, Jianping] Chengdu Univ, Sch Pharm, Sichuan Ind Inst Antibiot, Chengdu, Peoples R China; [Wang, Qisheng; Sun, Bo] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai Synchrotron Radiat Facil, Shanghai, Peoples R China	Sichuan University; Chengdu University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS	Deng, D (corresponding author), Sichuan Univ, West China Second Hosp, Key Lab Birth Defects & Related Dis Women & Child, Dept Obstet,State Key Lab Biotherapy, Chengdu, Peoples R China.; Hu, JP (corresponding author), Chengdu Univ, Sch Pharm, Sichuan Ind Inst Antibiot, Chengdu, Peoples R China.; Sun, B (corresponding author), Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai Synchrotron Radiat Facil, Shanghai, Peoples R China.	hjpcdu@163.com; sunb@sari.ac.cn; dengd@scu.edu.cn		Wang, Chen/0000-0002-3777-5454; Li, Jinhong/0000-0003-2448-1067; Deng, Dong/0000-0002-8590-9525	National Natural Science Foundation of China [31971132]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the staff at Shanghai Synchrotron Radiation Facility (SSRF) beamline BL18U1. This work was supported by fund from the National Natural Science Foundation of China (31971132).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed HEA, 2018, BIOORG CHEM, V76, P332, DOI 10.1016/j.bioorg.2017.11.019; Cabrita MA, 2002, BIOCHEM CELL BIOL, V80, P623, DOI 10.1139/O02-153; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Case I. Y. B.-S. D. A., 2018, AMBER; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Frisch M. J, GAUSSIAN 09 REVISION; Grytsyk N, 2017, P NATL ACAD SCI USA, V114, P1530, DOI 10.1073/pnas.1621431114; HANSEN SEW, 1987, EUR J BIOCHEM, V168, P385, DOI 10.1111/j.1432-1033.1987.tb13431.x; Hirschi M, 2017, NATURE, V545, P66, DOI 10.1038/nature22057; Jiang X, 2020, CELL, V183, P258, DOI 10.1016/j.cell.2020.08.015; Johnson ZL, 2014, ELIFE, V3, DOI 10.7554/eLife.03604; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kumar H, 2014, P NATL ACAD SCI USA, V111, P1784, DOI 10.1073/pnas.1324141111; Ma P, 2017, NAT PROTOC, V12, P1745, DOI 10.1038/nprot.2017.057; Madej MG, 2014, SPRINGER SER BIOPHYS, V17, P121, DOI 10.1007/978-3-642-53839-1_6; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; MUNCHPETERSEN A, 1976, J CELL PHYSIOL, V89, P551, DOI 10.1002/jcp.1040890410; MUNCHPETERSEN A, 1979, J BIOL CHEM, V254, P3730; Nieweg A, 1997, MICROBIOL-SGM, V143, P603, DOI 10.1099/00221287-143-2-603; Norholm MHH, 2001, J BACTERIOL, V183, P4900, DOI 10.1128/JB.183.16.4900-4904.2001; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; Patching SG, 2005, ORG BIOMOL CHEM, V3, P462, DOI 10.1039/b414739a; Quistgaard EM, 2016, NAT REV MOL CELL BIO, V17, P123, DOI 10.1038/nrm.2015.25; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Qureshi AA, 2020, NATURE, V578, P321, DOI 10.1038/s41586-020-1963-z; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sahin-Toth M, 1999, BIOCHEMISTRY-US, V38, P813, DOI 10.1021/bi982200h; SEEGER C, 1995, J BACTERIOL, V177, P5506, DOI 10.1128/jb.177.19.5506-5516.1995; Serpi M, 2016, J MED CHEM, V59, P10343, DOI 10.1021/acs.jmedchem.6b00325; Smirnova I, 2009, BIOCHEMISTRY-US, V48, P8852, DOI 10.1021/bi9011918; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Vaziri H, 2013, MOL MEMBR BIOL, V30, P114, DOI 10.3109/09687688.2012.748939; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisedchaisri G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5521; Xie H, 2004, MOL MEMBR BIOL, V21, P323, DOI 10.1080/09687860400003941; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Ye JQ, 2004, EMBO J, V23, P3187, DOI 10.1038/sj.emboj.7600330; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007; Zhou YX, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000790	50	0	0	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100479	10.1016/j.jbc.2021.100479	http://dx.doi.org/10.1016/j.jbc.2021.100479			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33640454	Green Published, gold			2022-12-28	WOS:000672866400453
J	Molstad, DHH; Mattson, AM; Begun, DL; Westendorf, JJ; Bradley, EW				Molstad, David H. H.; Mattson, Anna M.; Begun, Dana L.; Westendorf, Jennifer J.; Bradley, Elizabeth W.			Hdac3 regulates bone modeling by suppressing osteoclast responsiveness to RANKL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NF-&#954; B; acetylation; Sphk1; sphingosine-1-phosphate; bone resorption; sphingosine-1-phosphate (S1P); sphingosine kinase (SphK); bone; NF-kB transcription factor	HISTONE DEACETYLASE 3; ESTROGEN-RECEPTOR; DELETION; ACTIVATION; EXPRESSION; RESORPTION; PERIOSTEUM; PROMOTION; MASS; AGE	Hdac3 is a lysine deacetylase that removes acetyl groups from histones and additional proteins. Although Hdac3 functions within mesenchymal lineage skeletal cells are defined, little is known about Hdac3 activities in bone-resorbing osteoclasts. In this study we conditionally deleted Hdac3 within Ctsk-expressing cells and examined the effects on bone modeling and osteoclast differentiation in mice. Hdac3 deficiency reduced femur and tibia periosteal circumference and increased cortical periosteal osteoclast number. Trabecular bone was likewise reduced and was accompanied by increased osteoclast number per trabecular bone surface. We previously showed that Hdac3 deacetylates the p65 subunit of the NF-kappa B transcriptional complex to decrease DNA-binding and transcriptional activity. Hdac3-deficient osteoclasts demonstrate increased K310 NF-kappa B acetylation and NF-kappa B transcriptional activity. Hdac3-deficient osteoclast lineage cells were hyper-responsive to RANKL and showed elevated ex vivo osteoclast number and size and enhanced bone resorption in pit formation assays. Osteoclast-directed Hdac3 deficiency decreased cortical and trabecular bone mass parameters, suggesting that Hdac3 regulates coupling of bone resorption and bone formation. We surveyed a panel of osteoclast-derived coupling factors and found that Hdac3 suppression diminished sphingosine-1-phosphate production. Osteoclast-derived sphingosine-1-phosphate acts in paracrine to promote bone mineralization. Mineralization of WT bone marrow stromal cells cultured with conditioned medium from Hdac3-deficient osteoclasts was markedly reduced. Expression of alkaline phosphatase, type 1a1 collagen, and osteocalcin was also suppressed, but no change in Runx2 expression was observed. Our results demonstrate that Hdac3 controls bone modeling by suppressing osteoclast lineage cell responsiveness to RANKL and coupling to bone formation.	[Molstad, David H. H.; Bradley, Elizabeth W.] Univ Minnesota, Dept Orthoped, Minneapolis, MN 55455 USA; [Bradley, Elizabeth W.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Mattson, Anna M.; Begun, Dana L.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic	Bradley, EW (corresponding author), Univ Minnesota, Dept Orthoped, Minneapolis, MN 55455 USA.; Bradley, EW (corresponding author), Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA.	ebradle1@umn.edu		Bradley, Elizabeth/0000-0002-8814-5524; Westendorf, Jennifer J/0000-0002-4464-6108	National Institutes of Health [AR065397, AR072634]; Mayo Clinic Center for Biomedical Discovery; Mayo Clinic Foundation; University of Minnesota Board of Regents	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Biomedical Discovery; Mayo Clinic Foundation; University of Minnesota Board of Regents	This work was supported by National Institutes of Health Grants AR065397 and AR072634 and by funds from the Mayo Clinic Center for Biomedical Discovery, the Mayo Clinic Foundation, and the University of Minnesota Board of Regents. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen MR, 2004, BONE, V35, P1003, DOI 10.1016/j.bone.2004.07.014; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Bradley EW, 2008, J CELL PHYSIOL, V217, P752, DOI 10.1002/jcp.21550; Bradley EW, 2008, J CELL BIOCHEM, V104, P1439, DOI 10.1002/jcb.21719; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Carpio LR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf3273; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; Debnath S, 2018, NATURE, V562, P133, DOI 10.1038/s41586-018-0554-8; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Feigenson M, 2017, J BONE MINER RES, V32, P2453, DOI 10.1002/jbmr.3236; Greene Warner C, 2004, Novartis Found Symp, V259, P208; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jepsen KJ, 2010, J BONE MINER RES, V25, P1581, DOI 10.1002/jbmr.41; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Keller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6215; Khosla S, 2013, J GERONTOL A-BIOL, V68, P1226, DOI 10.1093/gerona/gls163; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Liu P, 2008, CANCER RES, V68, P10290, DOI 10.1158/0008-5472.CAN-08-2038; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; McGee-Lawrence ME, 2011, BONE, V48, P1117, DOI 10.1016/j.bone.2011.01.007; MILGROM C, 1989, J BIOMECH, V22, P1243, DOI 10.1016/0021-9290(89)90226-1; Miyazaki Y, 2016, J NEUROIMMUNOL, V298, P24, DOI 10.1016/j.jneuroim.2016.06.007; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Orwoll ES, 2003, J BONE MINER RES, V18, P949, DOI 10.1359/jbmr.2003.18.6.949; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Quint P, 2013, J BIOL CHEM, V288, P5398, DOI 10.1074/jbc.M112.413583; Rantalainen T, 2016, BONE, V93, P71, DOI 10.1016/j.bone.2016.09.015; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Riggs BL, 2004, J BONE MINER RES, V19, P1945, DOI 10.1359/JBMR.040916; Ruiz P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36201; Schoenbuchner SM, 2017, J BONE MINER RES, V32, P2355, DOI 10.1002/jbmr.3279; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Smith LM, 2014, BONE, V67, P130, DOI 10.1016/j.bone.2014.06.035; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396	46	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17713	17723		10.1074/jbc.RA120.013573	http://dx.doi.org/10.1074/jbc.RA120.013573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454009	hybrid, Green Published			2022-12-28	WOS:000603272300025
J	Ziegler, N; Bader, E; Epanchintsev, A; Margerie, D; Kannt, A; Schmoll, D				Ziegler, Nicole; Bader, Erik; Epanchintsev, Alexey; Margerie, Daniel; Kannt, Aimo; Schmoll, Dieter			AMPK beta 1 and AMPK beta 2 define an isoform-specific gene signature in human pluripotent stem cells, differentially mediating cardiac lineage specification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMPK; isoforms; stem cells; gene expression; differentiation; mesoderm; lineage decision; cardiomyocyte; AMP-activated kinase; energy metabolism; cardiac development; cell differentiation; induced pluripotent stem cell; iPSC	ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; IN-VITRO; TRANSCRIPTION; SUBUNIT; PHOSPHORYLATION; CARDIOMYOCYTES; EXPRESSION; STRESS; LOCALIZATION	AMP-activated protein kinase (AMPK) is a key regulator of energy metabolism that phosphorylates a wide range of proteins to maintain cellular homeostasis. AMPK consists of three subunits: alpha, beta, and gamma. AMPK alpha and beta are encoded by two genes, the gamma subunit by three genes, all of which are expressed in a tissue-specific manner. It is not fully understood, whether individual isoforms have different functions. Using RNA-Seq technology, we provide evidence that the loss of AMPK beta 1 and AMPK beta 2 lead to different gene expression profiles in human induced pluripotent stem cells (hiPSCs), indicating isoform-specific function. The knockout of AMPK beta 2 was associated with a higher number of differentially regulated genes than the deletion of AMPK beta 1, suggesting that AMPK beta 2 has a more comprehensive impact on the transcriptome. Bioinformatics analysis identified cell differentiation as one biological function being specifically associated with AMPK beta 2. Correspondingly, the two isoforms differentially affected lineage decision toward a cardiac cell fate. Although the lack of PRKAB1 impacted differentiation into cardiomyocytes only at late stages of cardiac maturation, the availability of PRKAB2 was indispensable for mesoderm specification as shown by gene expression analysis and histochemical staining for cardiac lineage markers such as cTnT, GATA4, and NKX2.5. Ultimately, the lack of AMPK beta 1 impairs, whereas deficiency of AMPK beta 2 abrogates differentiation into cardiomyocytes. Finally, we demonstrate that AMPK affects cellular physiology by engaging in the regulation of hiPSC transcription in an isoform-specific manner, providing the basis for further investigations elucidating the role of dedicated AMPK subunits in the modulation of gene expression.	[Ziegler, Nicole; Epanchintsev, Alexey; Kannt, Aimo; Schmoll, Dieter] Sanofi Aventis Deutschland GmbH, Res & Dev, Frankfurt, Germany; [Bader, Erik] Sanofi Aventis Deutschland GmbH, Integrated Drug Discovery, Frankfurt, Germany; [Margerie, Daniel] Sanofi Aventis Deutschland GmbH, Digital Data Sci, Res & Dev, Frankfurt, Germany	Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis	Ziegler, N; Schmoll, D (corresponding author), Sanofi Aventis Deutschland GmbH, Res & Dev, Frankfurt, Germany.	Nicole.Ziegler@unimedizin-mainz.de; Dieter.Schmoll@sanofi.com		Kannt, Aimo/0000-0002-5197-2286				Alfar EA, 2018, CARDIOVASC RES, V114, P779, DOI 10.1093/cvr/cvy065; Anderson DJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03714-x; Andre E, 2019, STEM CELLS DEV, V28, P1498, DOI 10.1089/scd.2019.0129; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Birket MJ, 2013, STEM CELL REP, V1, P560, DOI 10.1016/j.stemcr.2013.11.008; Breckwoldt K, 2017, NAT PROTOC, V12, P1177, DOI 10.1038/nprot.2017.033; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Carvajal K, 2007, AM J PHYSIOL-HEART C, V292, pH3136, DOI 10.1152/ajpheart.00683.2006; Chen S, 2014, LIFE SCI, V98, P75, DOI 10.1016/j.lfs.2014.01.006; Chiu WT, 2014, DEVELOPMENT, V141, P4537, DOI 10.1242/dev.107227; Churko JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07333-4; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Dasgupta B, 2012, MOL CELL BIOL, V32, P2837, DOI 10.1128/MCB.05853-11; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Dubois-Deruy E, 2015, CARDIOVASC RES, V107, P56, DOI 10.1093/cvr/cvv136; Dzeja PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019300; Estaras C, 2017, GENE DEV, V31, P2250, DOI 10.1101/gad.307512.117; Fu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027417; Fuerstenau-Sharp M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126596; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gelinas R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02795-4; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Holmes BF, 2005, AM J PHYSIOL-ENDOC M, V289, pE1071, DOI 10.1152/ajpendo.00606.2004; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Hsu HT, 2018, STEM CELL REP, V11, P1357, DOI 10.1016/j.stemcr.2018.10.013; Hu DJ, 2018, CIRC RES, V123, P1066, DOI 10.1161/CIRCRESAHA.118.313249; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kay M, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1249-2; Keil S, 2010, J MED CHEM, V53, P8679, DOI 10.1021/jm101179e; Kim EK, 2012, J CELL PHYSIOL, V227, P1680, DOI 10.1002/jcp.22892; Kim M, 2012, J MOL CELL CARDIOL, V52, P1066, DOI 10.1016/j.yjmcc.2012.01.016; Koay A, 2010, FEBS LETT, V584, P3499, DOI 10.1016/j.febslet.2010.07.015; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kuppusamy KT, 2015, P NATL ACAD SCI USA, V112, pE2785, DOI 10.1073/pnas.1424042112; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Ling X, 2017, ONCOTARGET, V8, P84403, DOI 10.18632/oncotarget.21218; Malizia AP, 2011, WIRES SYST BIOL MED, V3, P183, DOI 10.1002/wsbm.111; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926; Mills RJ, 2017, P NATL ACAD SCI USA, V114, pE8372, DOI 10.1073/pnas.1707316114; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Olivier S, 2018, BIOCHEM PHARMACOL, V153, P147, DOI 10.1016/j.bcp.2018.01.049; Peng CM, 2017, MOL CELL, V68, P591, DOI 10.1016/j.molcel.2017.10.010; Poon E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077784; Ross FA, 2016, FEBS J, V283, P2987, DOI 10.1111/febs.13698; Rubio T, 2013, MOL BIOL CELL, V24, P1801, DOI 10.1091/mbc.E12-11-0806; Salminen A, 2016, CELL SIGNAL, V28, P887, DOI 10.1016/j.cellsig.2016.03.009; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Salt IP, 2017, CIRC RES, V120, P1825, DOI 10.1161/CIRCRESAHA.117.309633; Sarikhani M, 2020, STEM CELL REP, V15, P498, DOI 10.1016/j.stemcr.2020.06.012; Shen XP, 2016, P NATL ACAD SCI USA, V113, P9551, DOI 10.1073/pnas.1608256113; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Song CC, 2019, STEM CELL REP, V13, P338, DOI 10.1016/j.stemcr.2019.06.003; Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Sung MM, 2015, CARDIOVASC RES, V107, P235, DOI 10.1093/cvr/cvv166; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Wang Q, 2016, TOXICOL SCI, V149, P346, DOI 10.1093/toxsci/kfv246; Wang YG, 2016, SCI REP-UK, V6, DOI 10.1038/srep32771; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Wilson KD, 2010, CIRC-CARDIOVASC GENE, V3, P426, DOI 10.1161/CIRCGENETICS.109.934281; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Young NP, 2016, GENE DEV, V30, P535, DOI 10.1101/gad.274142.115; Zhu WZ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011260	73	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17659	17671		10.1074/jbc.RA120.013990	http://dx.doi.org/10.1074/jbc.RA120.013990			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454005	hybrid, Green Published			2022-12-28	WOS:000603272300021
J	Mund, JA; Park, S; Smith, AE; He, YZ; Jiang, L; Hawley, E; Roberson, MJ; Mitchell, DK; Abu-Sultanah, M; Yuan, J; Bessler, WK; Sandusky, G; Chen, S; Zhang, C; Rhodes, SD; Clapp, DW				Mund, Julie A.; Park, SuJung; Smith, Abbi E.; He, Yongzheng; Jiang, Li; Hawley, Eric; Roberson, Michelle J.; Mitchell, Dana K.; Abu-Sultanah, Mohannad; Yuan, Jin; Bessler, Waylan K.; Sandusky, George; Chen, Shi; Zhang, Chi; Rhodes, Steven D.; Clapp, D. Wade			Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; tumor cell biology; short hairpin RNA (shRNA); Ras-related C3 botulinum toxin substrate 1 (Rac1); Schwann cells; neurofibromatosis type 1; GTPase-activating protein (GAP); tumor suppressor; kinase signaling	BREAST-CANCER; RHO GTPASES; NF1; SCHWANN; EXPRESSION; GROWTH; TUMORS; CELLS; IDENTIFICATION; PATHWAYS	Neurofibromatosis type 1 (NF1) is a common cancer predisposition syndrome caused by mutations in theNF1tumor suppressor gene.NF1encodes neurofibromin, a GTPase-activating protein for RAS proto-oncogene GTPase (RAS). Plexiform neurofibromas are a hallmark of NF1 and result from loss of heterozygosity ofNF1in Schwann cells, leading to constitutively activated p21RAS. Given the inability to target p21RAS directly, here we performed an shRNA library screen of all human kinases and Rho-GTPases in a patient-derivedNF1(?/?)Schwann cell line to identify novel therapeutic targets to disrupt PN formation and progression. Rho family members, including Rac family small GTPase 1 (RAC1), were identified as candidates. Corroborating these findings, we observed that shRNA-mediated knockdown of RAC1 reduces cell proliferation and phosphorylation of extracellular signal?regulated kinase (ERK) inNF1(?/?)Schwann cells. Genetically engineeredNf1(flox/flox);PostnCre(+)mice, which develop multiple PNs, also exhibited increased RAC1-GTP and phospho-ERK levels compared withNf1(flox/flox);PostnCre(?)littermates. Notably, mice in which bothNf1andRac1loci were disrupted (Nf1(flox/flox)Rac1(flox/flox);PostnCre(+)) were completely free of tumors and had normal phospho-ERK activity compared withNf1(flox/flox);PostnCre(+)mice. We conclude that the RAC1-GTPase is a key downstream node of RAS and that genetic disruption of theRac1allele completely prevents PN tumor formationin vivoin mice.	[Mund, Julie A.; Park, SuJung; Smith, Abbi E.; He, Yongzheng; Jiang, Li; Hawley, Eric; Roberson, Michelle J.; Mitchell, Dana K.; Abu-Sultanah, Mohannad; Yuan, Jin; Bessler, Waylan K.; Chen, Shi; Rhodes, Steven D.; Clapp, D. Wade] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Mund, Julie A.; Hawley, Eric; Clapp, D. Wade] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Zhang, Chi; Clapp, D. Wade] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Sandusky, George] Indiana Univ Sch Med, Div Pediat Hematol Oncol, Indianapolis, IN 46202 USA; [Rhodes, Steven D.] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Clapp, DW (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA.; Clapp, DW (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.; Clapp, DW (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	dclapp@iu.edu		Mitchell, Dana/0000-0002-1022-1072; Smith, Abbi/0000-0002-4402-8959	Developmental and Hyperactive Ras Tumor SPORE through NCI, National Institutes of Health [U54-CA19651904]; NCI/NINDS, National Institutes of Health [R01NS104489-02]; Institutional National Research Service Award T32 [5T32DK007519-34]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K12HD000850-35]	Developmental and Hyperactive Ras Tumor SPORE through NCI, National Institutes of Health; NCI/NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional National Research Service Award T32(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a Developmental and Hyperactive Ras Tumor SPORE funded through NCI, National Institutes of Health Grant U54-CA19651904 and NCI/NINDS, National Institutes of Health Grant R01NS104489-02. Julie Mund is a predoctoral fellow supported by Institutional National Research Service Award T32 through Award 5T32DK007519-34. Steven Rhodes is a fellow in the Pediatric Scientist Development Program supported by Award K12HD000850-35 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez Diego E, 2014, Small GTPases, V5, pe29038, DOI 10.4161/sgtp.29038; Birnbaum RA, 2000, MOL CELL, V5, P189, DOI 10.1016/S1097-2765(00)80415-3; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Brosseau JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07452-y; Canavese F, 2011, J PEDIATR ORTHOPED, V31, P303, DOI 10.1097/BPO.0b013e31820cad77; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Chen ZG, 2014, CANCER CELL, V26, P695, DOI 10.1016/j.ccell.2014.09.009; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dai Zhiyin, 2014, F1000Res, V3, P95, DOI 10.12688/f1000research.3928.2; DeClue JE, 2000, J CLIN INVEST, V105, P1233, DOI 10.1172/JCI7610; Dombi E, 2016, NEW ENGL J MED, V375, P2550, DOI 10.1056/NEJMoa1605943; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ferguson MJ, 2016, PEDIATR BLOOD CANCER, V63, P206, DOI 10.1002/pbc.25763; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Guo L, 2012, J NEUROSCI, V32, P17251, DOI 10.1523/JNEUROSCI.2461-12.2012; Gutmann DH, 2013, EXPERT OPIN INV DRUG, V22, P443, DOI 10.1517/13543784.2013.772979; Haga Raquel B, 2016, Small GTPases, V7, P207; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hein AL, 2016, ONCOGENE, V35, P6319, DOI 10.1038/onc.2016.163; Hiatt KK, 2001, J BIOL CHEM, V276, P7240, DOI 10.1074/jbc.M009202200; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Li H, 2016, LAB INVEST, V96, P1105, DOI 10.1038/labinvest.2016.88; Liao CP, 2018, J CLIN INVEST, V128, P2848, DOI 10.1172/JCI99424; Lin Y, 2015, EXPERT OPIN DRUG DIS, V10, P991, DOI 10.1517/17460441.2015.1058775; Lindsley A, 2007, DEV BIOL, V307, P340, DOI 10.1016/j.ydbio.2007.04.041; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mayes DA, 2011, CANCER RES, V71, P4675, DOI 10.1158/0008-5472.CAN-10-4558; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Rhodes SD, 2019, HUM MOL GENET, V28, P2752, DOI 10.1093/hmg/ddz095; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Robertson KA, 2012, LANCET ONCOL, V13, P1218, DOI 10.1016/S1470-2045(12)70414-X; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Staser K, 2012, ANNU REV PATHOL-MECH, V7, P469, DOI 10.1146/annurev-pathol-011811-132441; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Watson AL, 2014, ONCOTARGET, V5, P1502, DOI 10.18632/oncotarget.1609; Watson IR, 2014, CANCER RES, V74, P4845, DOI 10.1158/0008-5472.CAN-14-1232-T; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	51	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9948	9958		10.1074/jbc.RA119.010981	http://dx.doi.org/10.1074/jbc.RA119.010981			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	33685622	Green Published, hybrid			2022-12-28	WOS:000553333300014
J	Dudas, EF; Huynen, MA; Lesk, AM; Pastore, A				Dudas, Erika F.; Huynen, Martijn A.; Lesk, Arthur M.; Pastore, Annalisa			Invisible leashes: The tethering VAPs from infectious diseases to neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LIPID-TRANSFER PROTEINS; C VIRUS-REPLICATION; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; IMMUNOGLOBULIN SUPERFAMILY; REVERSE-TRANSCRIPTASE; BINDING PROTEIN; CONTACT SITES; FFAT MOTIF; MITOCHONDRIA	Intracellular organelles do not, as thought for a long time, act in isolation but are dynamically tethered together by entire machines responsible for interorganelle trafficking and positioning. Among the proteins responsible for tethering is the family of VAMP-associated proteins (VAPs) that appear in all eukaryotes and are localized primarily in the endoplasmic reticulum. The major functional role of VAPs is to tether the endoplasmic reticulum with different organelles and regulate lipid metabolism and transport. VAPs have gained increasing attention because of their role in human pathology where they contribute to infections by viruses and bacteria and participate in neurodegeneration. In this review, we discuss the structure, evolution, and functions of VAPs, focusing more specifically on VAP-B for its relationship with amyotrophic lateral sclerosis and other neurodegenerative diseases.	[Dudas, Erika F.; Pastore, Annalisa] Kings Coll London, Maurice Wohl Inst, UK Dementia Res Inst, London, England; [Huynen, Martijn A.] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat CMBI, Med Ctr, Ga Nijmegen, Netherlands; [Lesk, Arthur M.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of London; King's College London; Radboud University Nijmegen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pastore, A (corresponding author), Kings Coll London, Maurice Wohl Inst, UK Dementia Res Inst, London, England.	annalisa.pastore@crick.ac.uk		Foldesne Dudas, Erika/0000-0003-1574-2763	UK Dementia Research Institute - Medical Research Council [RE1 3556]; Alzheimer's Society; Alzheimer's Research UK [ARUK-PG2019B-020]	UK Dementia Research Institute - Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Society; Alzheimer's Research UK(Alzheimer's Research UK (ARUK))	The research was supported by UK Dementia Research Institute (RE1 3556), which is funded by the Medical Research Council, Alzheimer's Society, and Alzheimer's Research UK, and by Alzheimer's Research UK (grant ARUK-PG2019B-020).	Agaisse H, 2014, INFECT IMMUN, V82, P2037, DOI 10.1128/IAI.01530-14; Alfahad T, 2013, ANTIVIR RES, V99, P180, DOI 10.1016/j.antiviral.2013.05.006; Barajas D, 2014, VIROLOGY, V471, P72, DOI 10.1016/j.virol.2014.10.005; Baron Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-39; Bastos AF, 2011, NEUROL INT, V3, P12, DOI 10.4081/ni.2011.e4; Bohnert M, 2020, DEV CELL, V54, P212, DOI 10.1016/j.devcel.2020.06.026; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Borsom EM, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110814; Brown EG, 2020, NEUROTHERAPEUTICS, V17, P1406, DOI 10.1007/s13311-020-00942-2; Cabukusta B, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108475; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; De Matteis MA, 2007, BBA-MOL CELL BIOL L, V1771, P761, DOI 10.1016/j.bbalip.2007.04.004; De Vos KJ, 2012, HUM MOL GENET, V21, P1299, DOI 10.1093/hmg/ddr559; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170; Di Mattia T, 2018, EMBO REP, V19, DOI 10.15252/embr.201745453; Douville R, 2011, ANN NEUROL, V69, P141, DOI 10.1002/ana.22149; Eisenberg-Bord M, 2016, DEV CELL, V39, P395, DOI 10.1016/j.devcel.2016.10.022; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Farhadian S, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0606-5; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Giau VV, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111765; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Gomez-Suaga P, 2017, CURR BIOL, V27, P371, DOI 10.1016/j.cub.2016.12.038; Gupta G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147278; Gupta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039261; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Han SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003738; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Henne WM, 2016, J STRUCT BIOL, V196, P15, DOI 10.1016/j.jsb.2016.05.003; JAMIESON GA, 1991, J MED VIROL, V33, P224, DOI 10.1002/jmv.1890330403; Jia HQ, 2022, CANCER BIOTHER RADIO, V37, P650, DOI 10.1089/cbr.2020.3675; Kabashi E, 2013, HUM MOL GENET, V22, P2350, DOI 10.1093/hmg/ddt080; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Krols M, 2016, ACTA NEUROPATHOL, V131, P505, DOI 10.1007/s00401-015-1528-7; Kuijpers M, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-24; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Liu Y., 2017, TRANSL NEURODEGENER, V6, P1; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Lua SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027072; Lyons J, 2011, SEMIN NEUROL, V31, P254, DOI 10.1055/s-0031-1287653; Ma ZG, 2010, DEVELOPMENT, V137, P3775, DOI 10.1242/dev.049312; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; McCormick AL, 2008, NEUROLOGY, V70, P278, DOI 10.1212/01.wnl.0000297552.13219.b4; McCune BT, 2017, MBIO, V8, DOI 10.1128/mBio.00668-17; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Moulignier A, 2001, NEUROLOGY, V57, P995, DOI 10.1212/WNL.57.6.995; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Paillusson S, 2017, ACTA NEUROPATHOL, V134, P129, DOI 10.1007/s00401-017-1704-z; Paillusson S, 2016, TRENDS NEUROSCI, V39, P146, DOI 10.1016/j.tins.2016.01.008; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Ramage HR, 2015, MOL CELL, V57, P329, DOI 10.1016/j.molcel.2014.12.028; Roberts TM, 2000, J CELL BIOL, V149, P7, DOI 10.1083/jcb.149.1.7; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Roulin PS, 2018, J VIROL, V92, DOI 10.1128/JVI.01462-18; Roulin PS, 2014, CELL HOST MICROBE, V16, P677, DOI 10.1016/j.chom.2014.10.003; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Steele AJ, 2005, NEUROLOGY, V64, P454, DOI 10.1212/01.WNL.0000150899.76130.71; Stoica R, 2016, EMBO REP, V17, P1326, DOI 10.15252/embr.201541726; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Suzuki H, 2011, J NEUROCHEM, V119, P1099, DOI 10.1111/j.1471-4159.2011.07491.x; Thaler R, 2011, J CELL PHYSIOL, V226, P2505, DOI 10.1002/jcp.22595; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; van Blitterswijk M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.004; Verma A, 2006, J NEUROL SCI, V240, P59, DOI 10.1016/j.jns.2005.09.005; Wang PW, 2016, NEW PHYTOL, V210, P1311, DOI 10.1111/nph.13857; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Zimmer S, 2000, J BIOL CHEM, V275, P25672, DOI 10.1074/jbc.M000851200; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	88	5	5	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100421	10.1016/j.jbc.2021.100421	http://dx.doi.org/10.1016/j.jbc.2021.100421			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33609524	Green Published, gold			2022-12-28	WOS:000672866400395
J	Duster, R; Kaltheuner, IH; Schmitz, M; Geyer, M				Duester, Robert; Kaltheuner, Ines H.; Schmitz, Maximilian; Geyer, Matthias			1,6-Hexanediol, commonly used to dissolve liquid-liquid phase separated condensates, directly impairs kinase and phosphatase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL DOMAIN; INHIBITION; PERMEABILITY; METHYLATION; TRANSITION; COMPLEXES; DYNAMICS; BINDING	The concept of liquid-liquid phase separation (LLPS) has emerged as an intriguing mechanism for the organization of membraneless compartments in cells. The alcohol 1,6-hexanediol is widely used as a control to dissolve LLPS assemblies in phase separation studies in diverse fields. However, little is known about potential side effects of 1,6-hexanediol, which could compromise data interpretation and mislead the scientific debate. To examine this issue, we analyzed the effect of 1,6-hexanediol on the activities of various enzymes in vitro. Already at 1% volume concentration, 1,6-hexanediol strongly impaired kinases and phosphatases and partly blocked DNA polymerases, while it had no effect on DNase activity. At concentrations that are usually used to dissolve LLPS droplets (5-10%), both kinases and phosphatases were virtually inactive. Given the widespread function of protein phosphorylation in cells, our data argue for a careful review of 1,6-hexanediol in phase separation studies.	[Duester, Robert; Kaltheuner, Ines H.; Schmitz, Maximilian; Geyer, Matthias] Univ Bonn, Inst Struct Biol, Bonn, Germany	University of Bonn	Geyer, M (corresponding author), Univ Bonn, Inst Struct Biol, Bonn, Germany.	matthias.geyer@uni-bonn.de	Kaltheuner, Ines H/AEP-0385-2022	Kaltheuner, Ines H/0000-0001-8450-4959; Geyer, Matthias/0000-0002-7718-5002; Duster, Robert/0000-0003-4954-6883	Deutsche Forschungsgemeinschaft (DFG) [GE 976/9-2]; DFG under Germany's Excellence Strategy [EXC2151-390873048]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG under Germany's Excellence Strategy(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG) to M. G. (GE 976/9-2). M. G. is funded by the DFG under Germany's Excellence Strategy-EXC2151-390873048.	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Boehning M, 2018, NAT STRUCT MOL BIOL, V25, P833, DOI 10.1038/s41594-018-0112-y; Bosken CA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4505; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Davis D, 2019, J VIROL, V93, DOI 10.1128/JVI.01014-19; Dechene M, 2009, PROTEINS, V76, P861, DOI 10.1002/prot.22393; Ding DQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13609-0; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Elbaum-Garfinkle S, 2019, J BIOL CHEM, V294, P7160, DOI 10.1074/jbc.REV118.001188; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fuller GG, 2020, ELIFE, V9, DOI 10.7554/eLife.48480; Guo YE, 2019, NATURE, V572, P543, DOI 10.1038/s41586-019-1464-0; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Hofweber M, 2019, J BIOL CHEM, V294, P7137, DOI 10.1074/jbc.TM118.001189; Klein IA, 2020, SCIENCE, V368, P1386, DOI 10.1126/science.aaz4427; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; Lu HS, 2018, NATURE, V558, P318, DOI 10.1038/s41586-018-0174-3; Maharana S., 2017, MATTERS, DOI [10.19185/matters.201702000010, DOI 10.19185/MATTERS.201702000010]; Martin EW, 2018, BIOCHEMISTRY-US, V57, P2478, DOI 10.1021/acs.biochem.8b00008; McSwiggen DT, 2019, GENE DEV, V33, P1619, DOI 10.1101/gad.331520.119; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Olson CM, 2019, CELL CHEM BIOL, V26, P792, DOI 10.1016/j.chembiol.2019.02.012; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Peng Q, 2020, J VIROL, V94, DOI 10.1128/JVI.01771-19; Pessina F, 2019, NAT CELL BIOL, V21, P1286, DOI 10.1038/s41556-019-0392-4; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Rai AK, 2018, NATURE, V559, P211, DOI 10.1038/s41586-018-0279-8; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Schonichen A, 2013, J CELL SCI, V126, P1891, DOI 10.1242/jcs.126706; SHAMBERGER RJ, 1987, CLIN CHEM, V33, P589; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Soundararajan M, 2013, STRUCTURE, V21, P986, DOI 10.1016/j.str.2013.03.012; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; TANISHIMA K, 1987, J CLIN CHEM CLIN BIO, V25, P729; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033	57	22	22	5	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100260	10.1016/j.jbc.2021.100260	http://dx.doi.org/10.1016/j.jbc.2021.100260			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33814344	Green Published, gold			2022-12-28	WOS:000672866400236
J	Ear, J; Abd El-Hafeez, AA; Roy, S; Ngo, T; Rajapakse, N; Choi, JL; Khandelwal, S; Ghassemian, M; McCaffrey, L; Kufareva, I; Sahoo, D; Ghosh, P				Ear, Jason; Abd El-Hafeez, Amer Ali; Roy, Suchismita; Ngo, Tony; Rajapakse, Navin; Choi, Julie; Khandelwal, Soni; Ghassemian, Majid; McCaffrey, Luke; Kufareva, Irina; Sahoo, Debashis; Ghosh, Pradipta			A long isoform of GIV/Girdin contains a PDZ-binding module that regulates localization and G-protein binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUILDING-BLOCKS; MET-DB; GIRDIN; ACTIN; IDENTIFICATION; ORGANIZATION; ACTIVATION; PROGNOSIS; RECEPTOR; DEPENDS	PDZ domains are one of the most abundant protein domains in eukaryotes and are frequently found on junction-localized scaffold proteins. Various signaling molecules bind to PDZ proteins via PDZ-binding motifs (PBM) and fine-tune cellular signaling. However, how such interaction affects protein function is difficult to predict and must be solved empirically. Here we describe a long isoform of the guanine nucleotide exchange factor GIV/Girdin (CCDC88A) that we named GIV-L, which is conserved throughout evolution, from invertebrates to vertebrates, and contains a PBM. Unlike GIV, which lacks PBM and is cytosolic, GIV-L localizes onto cell junctions and has a PDZ interactome (as shown through annotating Human Cell Map and BioID-proximity labeling studies), which impacts GIV-L's ability to bind and activate trimeric G-protein, G alpha i, through its guanine-nucleotide exchange modulator (GEM) module. This GEM module is found exclusively in vertebrates. We propose that the two functional modules in GIV may have evolved sequentially: the ability to bind PDZ proteins via the PBM evolved earlier in invertebrates, whereas G-protein binding and activation may have evolved later only among vertebrates. Phenotypic studies in Caco-2 cells revealed that GIV and GIV-L may have antagonistic effects on cell growth, proliferation (cell cycle), and survival. Immunohistochemical analysis in human colon tissues showed that GIV expression increases with a concomitant decrease in GIV-L during cancer initiation. Taken together, these findings reveal how regulation in GIV/CCDC88A transcript helps to achieve protein modularity, which allows the protein to play opposing roles either as a tumor suppressor (GIV-L) or as an oncogene (GIV).	[Ear, Jason; Abd El-Hafeez, Amer Ali; Rajapakse, Navin; Choi, Julie; Ghosh, Pradipta] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ear, Jason] Calif State Polytech Univ Pomona, Biol Sci Dept, Pomona, CA 91768 USA; [Abd El-Hafeez, Amer Ali] Cairo Univ, Natl Canc Inst, Canc Biol Dept, Pharmacol & Expt Oncol Unit, Cairo, Egypt; [Roy, Suchismita; Ngo, Tony; Kufareva, Irina] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Khandelwal, Soni; Sahoo, Debashis] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [McCaffrey, Luke] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [McCaffrey, Luke] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada; [Ghosh, Pradipta] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ghosh, Pradipta] Univ Calif San Diego, Rebecca & John Moore Comprehens Canc Ctr, La Jolla, CA 92093 USA; [Ghosh, Pradipta] Vet Affairs Med Ctr, La Jolla, CA 92037 USA	University of California System; University of California San Diego; California State University System; California State Polytechnic University Pomona; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; McGill University; McGill University; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ear, J; Ghosh, P (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Ear, J (corresponding author), Calif State Polytech Univ Pomona, Biol Sci Dept, Pomona, CA 91768 USA.; Ghosh, P (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Ghosh, P (corresponding author), Univ Calif San Diego, Rebecca & John Moore Comprehens Canc Ctr, La Jolla, CA 92093 USA.; Ghosh, P (corresponding author), Vet Affairs Med Ctr, La Jolla, CA 92037 USA.	jear@cpp.edu; prghosh@ucsd.edu	Roy, Suchismita/ADM-8755-2022	Ngo, Tony/0000-0002-6779-2546	NIH [CA238042, AI141630, CA100768, CA160911, UG3TR002968]; NCI/NIH [T32 CA067754, T32CA121938]; American Cancer Society [PF-18-101-01-CSM];  [R01GM138385]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); 	This paper was supported by NIH CA238042, AI141630, CA100768, and CA160911 as well as UG3TR002968 (to P. G.). J. E. was supported by an NCI/NIH-funded Cancer Biology, Informatics & Omics (CBIO) Training Program (T32 CA067754) and a Postdoctoral Fellowship from the American Cancer Society (PF-18-101-01-CSM). D. S. is supported by R01GM138385. This paper was also supported by NCI/NIHfunded CT2 Training Grant T32CA121938 (to A. A. A. E.-H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amacher JF, 2020, J STRUCT BIOL-X, V4, DOI 10.1016/j.yjsbx.2020.100022; Aznar N, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao4220; Aznar N, 2016, ELIFE, V5, DOI 10.7554/eLife.20795; Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Biehler C, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008674; Boldt K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11491; Breton B, 2010, BIOPHYS J, V99, P4037, DOI 10.1016/j.bpj.2010.10.025; Brown NE, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.249; Choi JS, 2017, PATHOLOGY, V49, P618, DOI 10.1016/j.pathol.2017.05.010; Coleman BD, 2016, MOL BIOL EVOL, V33, P820, DOI 10.1093/molbev/msv336; Ear J, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100859; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Ezan J, 2013, NAT CELL BIOL, V15, P1107, DOI 10.1038/ncb2819; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Ghosh P, 2015, AGING-US, V7, P469, DOI 10.18632/aging.100781; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Go C. D., 2019, PROXIMITY BIOTINYLAT, DOI [10.1101/796391v1, 10.1101/796391, DOI 10.1101/796391]; Ha A, 2015, GENETICS, V200, P1149, DOI 10.1534/genetics.115.178954; Houssin E, 2015, DEVELOPMENT, V142, P1777, DOI 10.1242/dev.122002; de Opakua AI, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15163; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jowett T, 1999, METHOD CELL BIOL, V59, P63; Kalogriopoulos NA, 2019, P NATL ACAD SCI USA, V116, P16394, DOI 10.1073/pnas.1906658116; Kannan N, 2015, J CELL BIOL, V211, P407, DOI 10.1083/jcb.201412003; Karaman R, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028753; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Liu H, 2018, NUCLEIC ACIDS RES, V46, pD281, DOI 10.1093/nar/gkx1080; Liu H, 2015, NUCLEIC ACIDS RES, V43, pD197, DOI 10.1093/nar/gku1024; Manjunath GP, 2018, J BIOSCIENCES, V43, P155, DOI 10.1007/s12038-017-9727-0; Marivin A, 2019, MOL BIOL CELL, V30, P1900, DOI 10.1091/mbc.E19-02-0091; McHenry MJ, 2007, J EXP BIOL, V210, P4244, DOI 10.1242/jeb.009290; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; Mykytyn K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028183; Nachury MV, 2019, NAT REV MOL CELL BIO, V20, P389, DOI 10.1038/s41580-019-0116-4; Nechipurenko IV, 2016, DEV CELL, V38, P493, DOI 10.1016/j.devcel.2016.07.013; Ohara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036681; Oshita A, 2003, GENES CELLS, V8, P1005, DOI 10.1111/j.1365-2443.2003.00692.x; Pan CQ, 2012, CELL SIGNAL, V24, P2143, DOI 10.1016/j.cellsig.2012.06.002; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rausch V, 2020, TRENDS CELL BIOL, V30, P32, DOI 10.1016/j.tcb.2019.10.005; Rouaud F, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183399; Sasaki K, 2015, J CELL SCI, V128, P2244, DOI 10.1242/jcs.160879; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siletti K, 2017, P NATL ACAD SCI USA, V114, pE11170, DOI 10.1073/pnas.1716522115; Subbaiah VK, 2011, BIOCHEM J, V439, P195, DOI 10.1042/BJ20110903; Tang VW, 2013, J CELL BIOL, V203, P815, DOI 10.1083/jcb.201304143; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; VERMEULEN SJ, 1995, CANCER RES, V55, P4722; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wang S, 2018, ONCOL REP, V40, P599, DOI 10.3892/or.2018.6469; Wang WL, 2020, ONCOL REP, V44, P637, DOI 10.3892/or.2020.7615; Wang YF, 2010, J NEUROPHYSIOL, V104, P3551, DOI 10.1152/jn.00656.2010; Wong V, 1997, AM J PHYSIOL-CELL PH, V273, pC1859, DOI 10.1152/ajpcell.1997.273.6.C1859; Yang ZY, 2018, EXP THER MED, V15, P2837, DOI 10.3892/etm.2018.5773; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhu LY, 2018, AM J CANCER RES, V8, P2346	62	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100493	10.1016/j.jbc.2021.100493	http://dx.doi.org/10.1016/j.jbc.2021.100493			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675748	Green Published, gold			2022-12-28	WOS:000672866400467
J	Essawy, A; Jo, S; Beetch, M; Lockridge, A; Gustafson, E; Alejandro, EU				Essawy, Ahmad; Jo, Seokwon; Beetch, Megan; Lockridge, Amber; Gustafson, Eric; Alejandro, Emilyn U.			O-linked N-acetylglucosamine transferase (OGT) regulates pancreatic alpha-cell function in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; GLCNAC TRANSFERASE; NEURONS; GLYCOSYLATION; PROGLUCAGON; ANTIBODIES; ISLETS; FOXA1; MASS	The nutrient sensor O-GlcNAc transferase (OGT) catalyzes posttranslational addition of O-GlcNAc onto target proteins, influencing signaling pathways in response to cellular nutrient levels. OGT is highly expressed in pancreatic glucagon-secreting cells (alpha-cells), which secrete glucagon in response to hypoglycemia. The objective of this study was to determine whether OGT is necessary for the regulation of alpha-cell mass and function in vivo. We utilized genetic manipulation to produce two alpha-cell specific OGT-knockout models: a constitutive glucagon-Cre (alpha OGT(KO)) and an inducible glucagon-Cre (i-alpha OGT(KO)), which effectively delete OGT in alpha-cells. Using approaches including immunoblotting, immunofluorescent imaging, and metabolic phenotyping in vivo, we provide the first insight on the role of O-GlcNAcylation in alpha-cell mass and function. alpha OGT(KO) mice demonstrated normal glucose tolerance and insulin sensitivity but displayed significantly lower glucagon levels during both fed and fasted states. alpha OGT(KO) mice exhibited significantly lower alpha-cell glucagon content and alpha-cell mass at 6 months of age. In fasting, alpha OGT(KO) mice showed impaired pyruvate stimulated gluconeogenesis in vivo and reduced glucagon secretion in vitro. i-alpha OGT(KO) mice showed similarly reduced blood glucagon levels, defective in vitro glucagon secretion, and normal alpha-cell mass. Interestingly, both alpha OGT(KO) and i-alpha OGT(KO) mice had no deficiency in maintaining blood glucose homeostasis under fed or fasting conditions, despite impairment in alpha-cell mass and function, and glucagon content. In conclusion, these studies provide a first look at the role of OGT signaling in the alpha-cell, its effect on alpha-cell mass, and its importance in regulating glucagon secretion in hypoglycemic conditions.	[Essawy, Ahmad; Jo, Seokwon; Beetch, Megan; Lockridge, Amber; Gustafson, Eric; Alejandro, Emilyn U.] Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Alejandro, EU (corresponding author), Univ Minnesota, Med Sch, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	ealejand@umn.edu		Jo, Seokwon/0000-0002-8989-4893; Alejandro, Emilyn/0000-0002-7941-8439; Lockridge, Amber/0000-0003-1122-6286	National Institutes of Health Grant NIDDK [R21DK112144, R01DK115720, T32 DK007203]; National Institutes of Health Grant NIDDK (IBP start-up funds)	National Institutes of Health Grant NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health Grant NIDDK (IBP start-up funds)	This work was supported by National Institutes of Health Grant NIDDK (R21DK112144, R01DK115720, and IBP start-up funds to E.U. A. and T32 DK007203 for M. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akimoto Y, 1999, DIABETES, V48, P2407, DOI 10.2337/diabetes.48.12.2407; Albrechtsen NJW, 2016, BIOMARK MED, V10, P1141, DOI 10.2217/bmm-2016-0090; Alejandro EU, 2015, CELL REP, V13, P2527, DOI 10.1016/j.celrep.2015.11.020; Alejandro EU, 2014, J CLIN INVEST, V124, P4395, DOI 10.1172/JCI74237; Baumann D, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.186643; Bozadjieva N, 2017, J CLIN INVEST, V127, P4379, DOI 10.1172/JCI90004; Cork SC, 2015, MOL METAB, V4, P718, DOI 10.1016/j.molmet.2015.07.008; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; DRUCKER DJ, 1988, J BIOL CHEM, V263, P13475; Folli F, 2018, DIABETES OBES METAB, V20, P137, DOI 10.1111/dom.13380; Forma E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198351; Gloster TM, 2010, CURR SIGNAL TRANSD T, V5, P74, DOI 10.2174/157436210790226537; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Ida S, 2017, DIABETOLOGIA, V60, P1761, DOI 10.1007/s00125-017-4327-y; Jo S, 2019, J BIOL CHEM, V294, P13040, DOI 10.1074/jbc.RA119.008670; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Liu YB, 2017, BIOCHEM BIOPH RES CO, V487, P755, DOI 10.1016/j.bbrc.2017.04.135; Llewellyn-Smith IJ, 2011, NEUROSCIENCE, V180, P111, DOI 10.1016/j.neuroscience.2011.02.023; Lockridge A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107609; Lockridge AD, 2016, ISLETS, V8, P195, DOI 10.1080/19382014.2016.1260797; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Lund A, 2012, CURR DIABETES REP, V14, P555, DOI 10.1007/s11892-014-0555-4; Masson MH, 2014, ENDOCRINOLOGY, V155, P3781, DOI 10.1210/en.2013-1843; McGirr R, 2013, J ENDOCRINOL, V217, P229, DOI 10.1530/JOE-12-0468; Ong QX, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00599; POITOUT V, 1995, DIABETES, V44, P306, DOI 10.2337/diabetes.44.3.306; POWERS AC, 1990, DIABETES, V39, P406, DOI 10.2337/diabetes.39.4.406; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Shiota C, 2017, DIABETOLOGIA, V60, P2399, DOI 10.1007/s00125-017-4425-x; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Tashima Y, 2014, J BIOL CHEM, V289, P11132, DOI 10.1074/jbc.M113.492512; Thorel F, 2011, DIABETES, V60, P2872, DOI 10.2337/db11-0876; Vasconcelos-dos-Santos A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00138; Wang AC, 2016, P NATL ACAD SCI USA, V113, P15120, DOI 10.1073/pnas.1606899113; Xavier GD, 2018, J CLIN MED, V7, DOI 10.3390/jcm7030054; Zachara N.E., 2022, ESSENTIALS GLYCOBIOL, DOI [10.1101/9781621824213, DOI 10.1101/9781621824213]; Zhao M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708736	43	7	7	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100297	10.1016/j.jbc.2021.100297	http://dx.doi.org/10.1016/j.jbc.2021.100297			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460647	Green Published, gold			2022-12-28	WOS:000672866400271
J	Foley, KP; Chen, Y; Barra, NG; Heal, M; Kwok, K; Tamrakar, AK; Chi, W; Duggan, BM; Henriksbo, BD; Liu, Y; Schertzer, JD				Foley, Kevin P.; Chen, Yong; Barra, Nicole G.; Heal, Mark; Kwok, Kieran; Tamrakar, Akhilesh K.; Chi, Wendy; Duggan, Brittany M.; Henriksbo, Brandyn D.; Liu, Yong; Schertzer, Jonathan D.			Inflammation promotes adipocyte lipolysis via IRE1 kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NECROSIS-FACTOR-ALPHA; SIGNAL-RELATED KINASE; INSULIN-RESISTANCE; ER STRESS; STIMULATES LIPOLYSIS; NOD1 ACTIVATORS; LINKS OBESITY; CONTRIBUTE; IMMUNITY	Obesity associates with inflammation, insulin resistance, and higher blood lipids. It is unclear if immune responses facilitate lipid breakdown and release from adipocytes via lipolysis in a separate way from hormones or adrenergic signals. We found that an ancient component of ER stress, inositol-requiring protein 1 (IRE1), discriminates inflammation-induced adipocyte lipolysis versus lipolysis from adrenergic or hormonal stimuli. Our data show that inhibiting IRE1 kinase activity was sufficient to block adipocyte-autonomous lipolysis from multiple inflammatory ligands, including bacterial components, certain cytokines, and thapsigargin-induced ER stress. IRE1-mediated lipolysis was specific for inflammatory triggers since IRE1 kinase activity was dispensable for isoproterenol and cAMP-induced lipolysis in adipocytes and mouse adipose tissue. IRE1 RNase activity was not associated with inflammation-induced adipocyte lipolysis. Inhibiting IRE1 kinase activity blocked NF-kappa B activation, interleukin-6 secretion, and adipocyte-autonomous lipolysis from inflammatory ligands. Inflammation-induced lipolysis mediated by IRE1 occurred independently from changes in insulin signaling in adipocytes, suggesting that inflammation can promote IRE1-mediated lipolysis independent of adipocyte insulin resistance. We found no role for canonical unfolded protein responses or ABL kinases in linking ER stress to IRE1-mediated lipolysis. Adiponectin-Cre-mediated IRE1 knockout in mice showed that adipocyte IRE1 was required for inflammatory ligand-induced lipolysis in adipose tissue explants and that adipocyte IRE1 was required for approximately half of the increase in blood triglycerides after a bacterial endotoxin-mediated inflammatory stimulus in vivo. Together, our results show that IRE1 propagates an inflammation-specific lipolytic program independent from hormonal or adrenergic regulation. Targeting IRE1 kinase activity may benefit metabolic syndrome and inflammatory lipid disorders.	[Foley, Kevin P.; Barra, Nicole G.; Heal, Mark; Kwok, Kieran; Tamrakar, Akhilesh K.; Chi, Wendy; Duggan, Brittany M.; Henriksbo, Brandyn D.; Schertzer, Jonathan D.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Foley, Kevin P.; Barra, Nicole G.; Heal, Mark; Kwok, Kieran; Tamrakar, Akhilesh K.; Chi, Wendy; Duggan, Brittany M.; Henriksbo, Brandyn D.; Schertzer, Jonathan D.] McMaster Univ, Ctr Metab Obes & Diabet Res, Hamilton, ON, Canada; [Chen, Yong; Liu, Yong] Wuhan Univ, Coll Life Sci, Inst Adv Studies, Hubei Key Lab Cell Homeostasis, Wuhan, Peoples R China; [Tamrakar, Akhilesh K.] CSIR Cent Drug Res Inst, Div Biochem, Lucknow, Uttar Pradesh, India	McMaster University; McMaster University; Wuhan University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Schertzer, JD (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.; Schertzer, JD (corresponding author), McMaster Univ, Ctr Metab Obes & Diabet Res, Hamilton, ON, Canada.	schertze@mcmaster.ca	Barra, Nicole/ABG-2670-2021; Schertzer, Jonathan/P-3395-2017	Barra, Nicole/0000-0002-2605-0845; Tamrakar, Akhilesh/0000-0003-0554-3779; Chen, Yong/0000-0002-0723-8105; Schertzer, Jonathan/0000-0002-1547-5856; LIU, YONG/0000-0001-7771-4181	Canadian Institutes of Health Research [FDN-154295]; National Natural Science Foundation of China [31690102]; Indian Council of Medical Research, Govt. of India	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Indian Council of Medical Research, Govt. of India(Indian Council of Medical Research (ICMR))	This work was supported by grants to J. D. S. from the Canadian Institutes of Health Research (FDN-154295) and to Y. L. from the National Natural Science Foundation of China (No. 31690102). A. K. T. was supported by ICMR International Fellowship from the Indian Council of Medical Research, Govt. of India. J. D. S. holds a Canada Research Chair in Metabolic Inflammation.	Anhe FF, 2020, NAT METAB, V2, P233, DOI 10.1038/s42255-020-0178-9; Barra NG, 2020, BIOCHEM J, V477, P1089, DOI 10.1042/BCJ20190472; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cavallari JF, 2020, AM J PHYSIOL-ENDOC M, V318, pE579, DOI 10.1152/ajpendo.00033.2020; Cavallari JF, 2017, CELL METAB, V25, P1063, DOI 10.1016/j.cmet.2017.03.021; Chan KL, 2017, CELL REP, V18, P2415, DOI 10.1016/j.celrep.2017.02.027; Chi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097675; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115; Denou E, 2015, EMBO MOL MED, V7, P259, DOI 10.15252/emmm.201404169; Duggan BM, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa086; Duggan BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01822-0; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Green A, 2004, DIABETES, V53, P74, DOI 10.2337/diabetes.53.1.74; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Harnoss JM, 2019, P NATL ACAD SCI USA, V116, P16420, DOI 10.1073/pnas.1906999116; Herrema H, 2016, J BIOL CHEM, V291, P17394, DOI 10.1074/jbc.M116.728949; Hong S, 2018, MOL METAB, V12, P25, DOI 10.1016/j.molmet.2018.03.012; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang SJ, 2019, J BIOL CHEM, V294, P18726, DOI 10.1074/jbc.REV119.007036; Jo H, 2009, CELL METAB, V9, P440, DOI 10.1016/j.cmet.2009.04.004; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; McPhee JB, 2015, CLIN SCI, V129, P1083, DOI 10.1042/CS20150431; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Morita S, 2017, CELL METAB, V25, P883, DOI 10.1016/j.cmet.2017.03.018; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Olefsky JM, 2008, CELL, V134, P914, DOI 10.1016/j.cell.2008.09.001; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Sharma A, 2021, FREE RADICAL BIO MED, V162, P118, DOI 10.1016/j.freeradbiomed.2020.11.036; Sharma A, 2019, BBA-MOL BASIS DIS, V1865, P136, DOI 10.1016/j.bbadis.2018.10.036; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Su AR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9090235; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Yan RQ, 2017, PROTEIN CELL, V8, P55, DOI 10.1007/s13238-016-0326-x; Yang L, 2015, SCIENCE, V349, P500, DOI 10.1126/science.aaa0079; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhang ZF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010031; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	51	8	9	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100440	10.1016/j.jbc.2021.100440	http://dx.doi.org/10.1016/j.jbc.2021.100440			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610548	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400414
J	Granados, JC; Nigam, AK; Bush, KT; Jamshidi, N; Nigam, SK				Granados, Jeffry C.; Nigam, Anisha K.; Bush, Kevin T.; Jamshidi, Neema; Nigam, Sanjay K.			A key role for the transporter OAT1 in systemic lipid metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTERS; POTENTIAL ENDOGENOUS BIOMARKERS; GENOME-WIDE ASSOCIATION; DRUG TRANSPORTERS; ACID TRANSPORTERS; RENAL TRANSPORT; FATTY-ACIDS; FAMILY; RECEPTORS; PATHWAYS	Organic anion transporter 1 (OAT1/SLC22A6) is a drug transporter with numerous xenobiotic and endogenous substrates. The Remote Sensing and Signaling Theory suggests that drug transporters with compatible ligand preferences can play a role in "organ crosstalk," mediating overall organismal communication. Other drug transporters are well known to transport lipids, but surprisingly little is known about the role of OAT1 in lipid metabolism. To explore this subject, we constructed a genome-scale metabolic model using omics data from the Oat1 knockout mouse. The model implicated OAT1 in the regulation of many classes of lipids, including fatty acids, bile acids, and prostaglandins. Accordingly, serum metabolomics of Oat1 knockout mice revealed increased polyunsaturated fatty acids, diacylglycerols, and long-chain fatty acids and decreased ceramides and bile acids when compared with wildtype controls. Some aged knockout mice also displayed increased lipid droplets in the liver when compared with wildtype mice. Chemoinformatics and machine learning analyses of these altered lipids defined molecular properties that form the structural basis for lipid-transporter interactions, including the number of rings, positive charge/volume, and complexity of the lipids. Finally, we obtained targeted serum metabolomics data after short-term treatment of rodents with the OAT-inhibiting drug probenecid to identify potential drug-metabolite interactions. The treatment resulted in alterations in eicosanoids and fatty acids, further supporting our metabolic reconstruction predictions. Consistent with the Remote Sensing and Signaling Theory, the data support a role of OAT1 in systemic lipid metabolism.	[Granados, Jeffry C.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Nigam, Anisha K.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Jamshidi, Neema] Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Nigam, SK (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Nigam, SK (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	snigam@health.ucsd.edu		Granados, Jeffry/0000-0003-0393-7141; Bush, Kevin/0000-0001-5889-2847	National Institutes of Health (NIH) Grants from National Institute of General Medical Sciences (NIGMS) [R01GM132938]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [T32EB009380]	National Institutes of Health (NIH) Grants from National Institute of General Medical Sciences (NIGMS); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by National Institutes of Health (NIH) Grants from National Institute of General Medical Sciences (NIGMS) R01GM132938 (to S. K. N.), and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) T32EB009380 (to J. C. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn SY, 2011, J BIOL CHEM, V286, P31522, DOI 10.1074/jbc.M111.272534; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Basit A, 2019, DRUG METAB DISPOS, V47, P802, DOI 10.1124/dmd.119.086579; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; Brunk E, 2018, NAT BIOTECHNOL, V36, P272, DOI 10.1038/nbt.4072; Burckhardt G, 2012, PHARMACOL THERAPEUT, V136, P106, DOI 10.1016/j.pharmthera.2012.07.010; Bush KT, 2017, J BIOL CHEM, V292, P15789, DOI 10.1074/jbc.M117.796516; Cattan N, 2000, EUR CYTOKINE NETW, V11, P293; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Chiappini F, 2016, SCI REP-UK, V6, DOI 10.1038/srep31587; Demsar J, 2007, J BIOMED INFORM, V40, P661, DOI 10.1016/j.jbi.2007.03.010; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; DUNN M, 1987, DRUGS, V33, P56, DOI 10.2165/00003495-198700331-00009; Engelhart DC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062002; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Gu CD, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1730-3; Hagos Y, 2010, TOXINS, V2, P2055, DOI 10.3390/toxins2082055; Hara T, 2013, REV PHYSIOL BIOCH P, V164, P77, DOI 10.1007/112_2013_13; Herink M., 2000, MED INDUCED CHANGES; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Jung KY, 2001, LIFE SCI, V69, P2123, DOI 10.1016/S0024-3205(01)01296-6; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; Kimura H, 2002, J PHARMACOL EXP THER, V301, P293, DOI 10.1124/jpet.301.1.293; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Lepist EI, 2017, EXPERT OPIN DRUG MET, V13, P1075, DOI 10.1080/17425255.2017.1372425; Liu HC, 2016, J BIOL CHEM, V291, P19474, DOI 10.1074/jbc.M116.745216; Loomba R, 2015, J LIPID RES, V56, P185, DOI 10.1194/jlr.P055640; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Miyamoto J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040450; Nigam AK, 2020, J BIOL CHEM, V295, P1829, DOI 10.1074/jbc.RA119.010729; Nigam SK, 2019, NAT REV NEPHROL, V15, P301, DOI 10.1038/s41581-019-0111-1; Nigam SK, 2018, CURR OPIN NEPHROL HY, V27, P305, DOI 10.1097/MNH.0000000000000427; Nigam SK, 2018, ANNU REV PHARMACOL, V58, P663, DOI 10.1146/annurev-pharmtox-010617-052713; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Otani N, 2017, ANAT SCI INT, V92, P200, DOI 10.1007/s12565-016-0369-3; Papackova Z, 2015, INT J MOL SCI, V16, P3831, DOI 10.3390/ijms16023831; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rosenthal SB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47798-x; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Sauvant C, 2006, J AM SOC NEPHROL, V17, P46, DOI 10.1681/ASN.2005070727; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schwenk RW, 2010, PROSTAG LEUKOTR ESS, V82, P149, DOI 10.1016/j.plefa.2010.02.029; Ulven T, 2015, ANNU REV NUTR, V35, P239, DOI 10.1146/annurev-nutr-071714-034410; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wofford Marion R, 2006, J Clin Hypertens (Greenwich), V8, P114, DOI 10.1111/j.1524-6175.2006.04751.x; Wu W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04949-2; Wu W, 2013, DRUG METAB DISPOS, V41, P1825, DOI 10.1124/dmd.113.052647; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Yee S, 2017, CLIN PHARMACOL THER, V101, pS96; Yee SW, 2016, CLIN PHARMACOL THER, V100, P524, DOI 10.1002/cpt.434; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140569	61	8	8	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100603	10.1016/j.jbc.2021.100603	http://dx.doi.org/10.1016/j.jbc.2021.100603			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33785360	gold, Green Published			2022-12-28	WOS:000672866400575
J	Gunn, KH; Gutgsell, AR; Xu, YM; Johnson, CV; Liu, J; Neher, SB				Gunn, Kathryn H.; Gutgsell, Aspen R.; Xu, Yongmei; Johnson, Caitlin, V; Liu, Jian; Neher, Saskia B.			Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPROTEIN-LIPASE ACTIVITY; SMALL-ANGLE SCATTERING; ADIPOSE-TISSUE; ANGPTL4; INHIBITION; PLASMA; RISK; SAXS; IDENTIFICATION; CONFORMATIONS	Elevated plasma triglycerides are a risk factor for coronary artery disease, which is the leading cause of death worldwide. Lipoprotein lipase (LPL) reduces triglycerides in the blood by hydrolyzing them from triglyceride-rich lipoproteins to release free fatty acids. LPL activity is regulated in a nutritionally responsive manner by macromolecular inhibitors including angiopoietin-like proteins 3 and 4 (ANGPTL3 and ANGPTL4). However, the mechanism by which ANGPTL3 inhibits LPL is unclear, in part due to challenges in obtaining pure protein for study. We used a new purification protocol for the N-terminal domain of ANGPTL3, removing a DNA contaminant, and found DNA-free ANGPTL3 showed enhanced inhibition of LPL. Structural analysis showed that ANGPTL3 formed elongated, flexible trimers and hexamers that did not interconvert. ANGPTL4 formed only elongated flexible trimers. We compared the inhibition of ANGPTL3 and ANGPTL4 using human very-low-density lipoproteins as a substrate and found both were noncompetitive inhibitors. The inhibition constants for the trimeric ANGPTL3 (7.5 +/- 0.7 nM) and ANGPTL4 (3.6 +/- 1.0 nM) were only 2-fold different. Heparin has previously been reported to interfere with ANGPTL3 binding to LPL, so we questioned if the negatively charged heparin was acting in a similar fashion to the DNA contaminant. We found that ANGPTL3 inhibition is abolished by binding to low-molecular-weight heparin, whereas ANGPTL4 inhibition is not. Our data show new similarities and differences in how ANGPTL3 and ANGPTL4 regulate LPL and opens new avenues of investigating the effect of heparin on LPL inhibition by ANGPTL3.	[Gunn, Kathryn H.; Gutgsell, Aspen R.; Neher, Saskia B.] Univ N Carolina, Eshelman Sch Pharm, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Xu, Yongmei; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA; [Johnson, Caitlin, V] Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Neher, SB (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	neher@email.unc.edu		Gunn, Kathryn/0000-0003-2078-6947; Johnson, Caitlin/0000-0003-3474-8204	National Institutes of Health [R01-HL12565, R01-HL094463, R01HL144970, 1R42GM128484]; American Heart Association [20POST35210031, 19PRE34370070]; National Cancer Institute of the National Institutes of Health [P30CA016086]; National Institute of General Medical Sciences project ALS-ENABLE [P30 GM124169]; DOE Office of Science by Argonne National Laboratory [DEAC02-06CH11357]; National Institute of General Medical Sciences of the National Institutes of Health [9 P41 GM103622]; National Institute of General Medical Sciences [1S10OD018090-01]; High-End Instrumentation Grant [S10OD018483]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences project ALS-ENABLE; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); High-End Instrumentation Grant	The authors acknowledge support from the National Institutes of Health (Grant No. R01-HL12565 to S. B. N., Grant Nos. R01-HL094463 and R01HL144970 to J. L., and Grant No. 1R42GM128484 to Y. X.) and the American Heart Association (Grant No. 20POST35210031 to K. H. G. and 19PRE34370070 to A. R. G.). The authors acknowledge help from the UNC Macromolecular Interactions Facility, which is supported by the National Cancer Institute of the National Institutes of Health under award number P30CA016086. SAXS data were collected at the Advanced Light Source (ALS), SIBYLS beamline on behalf of US DOE-BER, through the Integrated Diffraction Analysis Technologies (IDAT) program. Additional support comes from the National Institute of General Medical Sciences project ALS-ENABLE (P30 GM124169) and a High-End Instrumentation Grant S10OD018483. This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DEAC02-06CH11357. "This project was supported by grant 9 P41 GM103622 from the National Institute of General Medical Sciences of the National Institutes of Health." Use of the Pilatus 3 1M detector was provided by grant 1S10OD018090-01 from National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; Biterova E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25237-7; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chen YQ, 2020, J LIPID RES, V61, P1203, DOI 10.1194/jlr.RA120000781; Chi X, 2017, MOL METAB, V6, P1137, DOI 10.1016/j.molmet.2017.06.014; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Conklin D, 1999, GENOMICS, V62, P477, DOI 10.1006/geno.1999.6041; Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Dijk W, 2016, CURR OPIN LIPIDOL, V27, P249, DOI 10.1097/MOL.0000000000000290; Dominguez-Martin MA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72383-y; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Essalmani R, 2013, J BIOL CHEM, V288, P26410, DOI 10.1074/jbc.M113.501304; Fischetti R, 2004, J SYNCHROTRON RADIAT, V11, P399, DOI 10.1107/S0909049504016760; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2015, NAT METHODS, V12, P419, DOI [10.1038/NMETH.3358, 10.1038/nmeth.3358]; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; FRIED SK, 1983, J NUTR, V113, P1861, DOI 10.1093/jn/113.9.1861; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Gunn KH, 2020, P NATL ACAD SCI USA, V117, P10254, DOI 10.1073/pnas.1916555117; Gutgsell AR, 2019, J BIOL CHEM, V294, P2678, DOI 10.1074/jbc.RA118.005932; Haller JF, 2017, J LIPID RES, V58, P1166, DOI 10.1194/jlr.M075689; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Hura GL, 2013, NAT METHODS, V10, P453, DOI 10.1038/nmeth.2453; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kikhney AG, 2020, PROTEIN SCI, V29, P66, DOI 10.1002/pro.3731; Knott GJ, 2019, ELIFE, V8, DOI 10.7554/eLife.49110; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kovrov O, 2019, J LIPID RES, V60, P783, DOI 10.1194/jlr.M088807; Kristensen KK, 2020, P NATL ACAD SCI USA, V117, P4337, DOI 10.1073/pnas.1920202117; Lafferty MJ, 2013, J BIOL CHEM, V288, P28524, DOI 10.1074/jbc.M113.497602; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Leiherer A, 2020, ATHEROSCLEROSIS, V293, P62, DOI 10.1016/j.atherosclerosis.2019.11.011; Miller CM, 2018, THROMB RES, V167, P80, DOI 10.1016/j.thromres.2018.05.018; Mysling S, 2016, ELIFE, V5, DOI 10.7554/eLife.20958; Nimonkar AV, 2020, J BIOL CHEM, V295, P2900, DOI 10.1074/jbc.RA119.011079; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; QUIG DW, 1983, J NUTR, V113, P1150, DOI 10.1093/jn/113.6.1150; Reimund M, 2017, J LIPID RES, V58, P279, DOI 10.1194/jlr.D071787; Segel IH, 1975, ENZYME KINETICS BEHA; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Stitziel NO, 2017, J AM COLL CARDIOL, V69, P2054, DOI 10.1016/j.jacc.2017.02.030; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wu MJ, 2018, J LIPID RES, V59, P2456, DOI 10.1194/jlr.D086793; Xu YM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan5954; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; YOSHINO M, 1987, BIOCHEM J, V248, P815, DOI 10.1042/bj2480815; Zhang R, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150272; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	61	6	6	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100312	10.1016/j.jbc.2021.100312	http://dx.doi.org/10.1016/j.jbc.2021.100312			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482195	gold, Green Published			2022-12-28	WOS:000672866400286
J	Do, HQ; Hewetson, A; Borcik, CG; Hastert, MC; Whelly, S; Wylie, BJ; Sutton, RB; Cornwall, GA				Hoa Quynh Do; Hewetson, Aveline; Borcik, Collin G.; Hastert, Mary Catherine; Whelly, Sandra; Wylie, Benjamin J.; Sutton, Roger Bryan; Cornwall, Gail A.			Cross-seeding between the functional amyloidogenic CRES and CRES3 family members and their regulation of A beta assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATIN-C; SWISS-MODEL; PROTEIN; NMR; ALZHEIMERS; FIBRILLIZATION; PREDICTION; SEQUENCE; SUBGROUP; CLEAVAGE	Accumulating evidence shows that amyloids perform biological roles. We previously showed that an amyloid matrix composed of four members of the CRES subgroup of reproductive family 2 cystatins is a normal component of the mouse epididymal lumen. The cellular mechanisms that control the assembly of these and other functional amyloid structures, however, remain unclear. We speculated that cross-seeding between CRES members could be a mechanism to control the assembly of the endogenous functional amyloid. Herein we used thioflavin T assays and negative stain transmission electron microscopy to explore this possibility. We show that CRES3 rapidly formed large networks of beaded chains that possessed the characteristic cross-beta reflections of amyloid when examined by X-ray diffraction. The beaded amyloids accelerated the amyloidogenesis of CRES, a less amyloidogenic family member, in seeding assays during which beads transitioned into films and fibrils. Similarly, CRES seeds expedited CRES3 amyloidogenesis, although less efficiently than the CRES3 seeding of CRES. These studies suggest that CRES and CRES3 hetero-oligomerize and that CRES3 beaded amyloids may function as stable preassembled seeds. The CRES3 beaded amyloids also facilitated assembly of the unrelated amyloidogenic precursor A beta by providing a surface for polymerization though, intriguingly, CRES3 (and CRES) monomer/early oligomer profoundly inhibited A beta assembly. The cross-seeding between the CRES subgroup members is similar to that which occurs between bacterial curli proteins suggesting that it may be an evolutionarily conserved mechanism to control the assembly of some functional amyloids. Further, interactions between unrelated amyloidogenic precursors may also be a means to regulate functional amyloid assembly.	[Hoa Quynh Do; Hewetson, Aveline; Whelly, Sandra; Cornwall, Gail A.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Borcik, Collin G.; Wylie, Benjamin J.] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Hastert, Mary Catherine] Texas Tech Univ, Coll Arts & Sci Microscopy, Lubbock, TX 79409 USA; [Sutton, Roger Bryan] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Cornwall, GA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	gail.cornwall@ttuhsc.edu		Sutton, Bryan/0000-0001-8393-5239; Do, Quynh Hoa/0000-0001-7361-6066	TTUHSC, The Newby Family; National Institutes of Health (NIH) [R01 AR063634]; NIH [R35GM124979]	TTUHSC, The Newby Family; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by TTUHSC, The Newby Family (G. A. C.), National Institutes of Health (NIH) R01 AR063634 (R. B. S.), and NIH R35GM124979 (B. J. W.).	Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; CORNWALL GA, 1995, MOL REPROD DEV, V41, P37, DOI 10.1002/mrd.1080410107; Cornwall GA, 2003, MOL CELL ENDOCRINOL, V200, P1, DOI 10.1016/S0303-7207(02)00408-2; Dean DN, 2020, J BIOL CHEM, V295, P7544, DOI 10.1074/jbc.RA120.013012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Egge N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129907; Evans ML, 2015, MOL CELL, V57, P445, DOI 10.1016/j.molcel.2014.12.025; Fardilha M, 2007, ANN NY ACAD SCI, V1096, P196, DOI 10.1196/annals.1397.086; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gradmann S, 2012, J BIOMOL NMR, V54, P377, DOI 10.1007/s10858-012-9681-y; Guyonnet B, 2014, MOL CELL BIOL, V34, P2624, DOI 10.1128/MCB.00073-14; Guyonnet B, 2012, MOL CELL PROTEOMICS, V11, P758, DOI 10.1074/mcp.M112.020339; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hewetson A, 2020, P NATL ACAD SCI USA, V117, P16363, DOI 10.1073/pnas.2006887117; Do HQ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45545-w; Huang P, 2000, MOL HUM REPROD, V6, P1069, DOI 10.1093/molehr/6.12.1069; Jackson MP, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7040071; Jang H, 2011, BIOPHYS J, V100, P1775, DOI 10.1016/j.bpj.2011.01.072; KNELLER DG, 1993, J CELL BIOCHEM, P254; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Litscher ES, 2008, J CELL PHYSIOL, V214, P153, DOI 10.1002/jcp.21174; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Manu VS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44461-3; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Perlenfein TJ, 2017, J BIOL CHEM, V292, P11485, DOI 10.1074/jbc.M117.786558; Pham CLL, 2014, ESSAYS BIOCHEM, V56, P207, DOI [10.1042/bse0560207, 10.1042/BSE0560207]; PINES A, 1972, J CHEM PHYS, V56, P1776, DOI 10.1063/1.1677439; Roan NR, 2017, ELIFE, V6, DOI 10.7554/eLife.24888; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Sampson TR, 2020, ELIFE, V9, DOI 10.7554/eLife.53111; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Silva JV, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-014-0432-9; Takegoshi K, 2003, J CHEM PHYS, V118, P2325, DOI 10.1063/1.1534105; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Vasconcelos B, 2016, ACTA NEUROPATHOL, V131, P549, DOI 10.1007/s00401-015-1525-x; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; Wang X, 2008, PRION, V2, P57, DOI 10.4161/pri.2.2.6746; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Whelly S, 2016, MOL HUM REPROD, V22, P729, DOI 10.1093/molehr/gaw049; Whelly S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036394; Zhuang DZ, 2006, MOL REPROD DEV, V73, P61, DOI 10.1002/mrd.20380	59	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100250	10.1074/jbc.RA120.015307	http://dx.doi.org/10.1074/jbc.RA120.015307			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33384380	gold, Green Published			2022-12-28	WOS:000672866400226
J	Katikaridis, P; Romling, U; Mogk, A				Katikaridis, Panagiotis; Romling, Ute; Mogk, Axel			Basic mechanism of the autonomous ClpG disaggregase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA PLUS DISAGGREGASE; PROTEIN DISAGGREGATION; ESCHERICHIA-COLI; HEAT-RESISTANCE; TERMINAL DOMAIN; CHAPERONE; DNAK; BINDING; GRPE	Bacterial survival during lethal heat stress relies on the cellular ability to reactivate aggregated proteins. This activity is typically executed by the canonical 70-kDa heat shock protein (Hsp70)-ClpB bichaperone disaggregase, which is most widespread in bacteria. The ClpB disaggregase is a member of the ATPase associated with diverse cellular activities protein family and exhibits an ATP-driven threading activity. Substrate binding and stimulation of ATP hydrolysis depends on the Hsp70 partner, which initiates the disaggregation reaction. Recently elevated heat resistance in gamma-proteobacterial species was shown to be mediated by the ATPase associated with diverse cellular activities protein ClpG as an alternative disaggregase. Pseudomonas aeruginosa ClpG functions autonomously and does not cooperate with Hsp70 for substrate binding, enhanced ATPase activity, and disaggregation. With the underlying molecular basis largely unknown, the fundamental differences in ClpG- and ClpB-dependent disaggregation are reflected by the presence of sequence alterations and additional ClpG-specific domains. By analyzing the effects of mutants lacking ClpG-specific domains and harboring mutations in conserved motifs implicated in ATP hydrolysis and substrate threading, we show that the N-terminal, ClpG-specific N1 domain generally mediates protein aggregate binding as the molecular basis of autonomous disaggregation activity. Peptide substrate binding strongly stimulates ClpG ATPase activity by overriding repression by the N-terminal N1 and N2 domains. High ATPase activity requires two functional nucleotide binding domains and drives substrate threading which ultimately extracts polypeptides from the aggregate. ClpG ATPase and disaggregation activity is thereby directly controlled by substrate availability.	[Katikaridis, Panagiotis; Mogk, Axel] Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Katikaridis, Panagiotis; Mogk, Axel] German Canc Res Ctr, A250 Chaperones & Proteases, Heidelberg, Germany; [Romling, Ute] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet	Mogk, A (corresponding author), Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany.; Mogk, A (corresponding author), German Canc Res Ctr, A250 Chaperones & Proteases, Heidelberg, Germany.	a.mogk@zmbh.uni-heidelberg.de		Romling, Ute/0000-0003-3812-6621	Deutsche Forschungsgemeinschaft [MO970/4-3]; Heidelberg Biosciences International Graduate School (HBIGS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heidelberg Biosciences International Graduate School (HBIGS)	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (MO970/4-3) (to A. M.) and P. K. was supported by the Heidelberg Biosciences International Graduate School (HBIGS).	Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020; Fernandez-Higuero JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24140-5; Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200; Bojer MS, 2012, APMIS, V120, P699, DOI 10.1111/j.1600-0463.2012.02885.x; Bojer MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015467; Boll EJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00579; Boll EJ, 2016, RES MICROBIOL, V167, P345, DOI 10.1016/j.resmic.2016.02.002; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; Deville C, 2019, CELL REP, V27, P3433, DOI 10.1016/j.celrep.2019.05.075; Deville C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701726; Doring K, 2017, CELL, V170, P298, DOI 10.1016/j.cell.2017.06.038; Doyle SM, 2012, J BIOL CHEM, V287, P28470, DOI 10.1074/jbc.M112.383091; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Gates SN, 2020, PROTEIN SCI, V29, P407, DOI 10.1002/pro.3743; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Kamal SM, 2021, MOL MICROBIOL, V115, P255, DOI 10.1111/mmi.14614; Katikaridis P, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120815; Kedzierska S, 2003, BIOCHEMISTRY-US, V42, P14242, DOI 10.1021/bi035573d; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Lee C, 2018, P NATL ACAD SCI USA, V115, pE273, DOI 10.1073/pnas.1712051115; Lee C, 2016, CURR OPIN MICROBIOL, V30, P147, DOI 10.1016/j.mib.2016.02.006; Lee C, 2015, ENVIRON MICROBIOL, V17, P4511, DOI 10.1111/1462-2920.12915; Lee J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11474-9; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Li H, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00111; Li H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01763; Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589; Ma A, 2020, FOOD MICROBIOL, V88, DOI 10.1016/j.fm.2019.103400; Mahmoud SA, 2018, ANNU REV BIOCHEM, V87, P677, DOI 10.1146/annurev-biochem-062917-012848; Marti R, 2016, J DAIRY SCI, V99, P8622, DOI 10.3168/jds.2016-11076; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mercer RG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00932; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Mogk A, 2018, MOL CELL, V69, P214, DOI 10.1016/j.molcel.2018.01.004; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Puchades C, 2020, NAT REV MOL CELL BIO, V21, P43, DOI 10.1038/s41580-019-0183-6; Rizo AN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10150-y; Rosenzweig R, 2015, P NATL ACAD SCI USA, V112, pE6872, DOI 10.1073/pnas.1512783112; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Wang ZY, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.02123-19; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083	50	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100460	10.1016/j.jbc.2021.100460	http://dx.doi.org/10.1016/j.jbc.2021.100460			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639171	Green Published, gold			2022-12-28	WOS:000672866400434
J	Malcova, I; Bumba, L; Uljanic, F; Kuzmenko, D; Nedomova, J; Kamanova, J				Malcova, Ivana; Bumba, Ladislav; Uljanic, Filip; Kuzmenko, Darya; Nedomova, Jana; Kamanova, Jana			Lipid binding by the N-terminal motif mediates plasma membrane localization of Bordetella effector protein BteA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION SYSTEM; SACCHAROMYCES-CEREVISIAE; YEAST; PIP2; BRONCHISEPTICA; DOMAIN; PHOSPHOINOSITIDES; ORGANIZATION; MUTANTS	The respiratory pathogens Bordetella pertussis and Bordetella bronchiseptica employ a type III secretion system (T3SS) to inject a 69-kDa BteA effector protein into host cells. This effector is known to contain two functional domains, including an N-terminal lipid raft targeting (LRT) domain and a cytotoxic C-terminal domain that induces nonapoptotic and caspase-1-independent host cell death. However, the exact molecular mechanisms underlying the interaction of BteA with plasma membrane (PM) as well as its cytotoxic activity in the course of Bordetella infections remain poorly understood. Using a protein-lipid overlay assay and surface plasmon resonance, we show here that the recombinant LRT domain binds negatively charged membrane phospholipids. Specifically, we determined that the dissociation constants of the LRT domain-binding liposomes containing phosphatidylinositol 4,5-bisphosphate, phosphatidic acid, and phosphatidylserine were similar to 450 nM, similar to 490 nM, and similar to 1.2 mu M, respectively. Both phosphatidylserine and phosphatidylinositol 4,5-bisphosphate were required to target the LRT domain and/or full-length BteA to the PM of yeast cells. The membrane association further involved electrostatic and hydrophobic interactions of LRT and depended on a leucine residue in the L1 loop between the first two helices of the four-helix bundle. Importantly, charge-reversal substitutions within the L1 region disrupted PM localization of the BteA effector without hampering its cytotoxic activity during B. bronchiseptica infection of HeLa cells. The LRT-mediated targeting of BteA to the cytosolic leaflet of the PM of host cells is, therefore, dispensable for effector cytotoxicity.	[Malcova, Ivana; Uljanic, Filip; Kuzmenko, Darya; Nedomova, Jana; Kamanova, Jana] Czech Acad Sci, Inst Microbiol, Lab Infect Biol, Prague, Czech Republic; [Bumba, Ladislav] Czech Acad Sci, Inst Microbiol, Lab Mol Biol Bacterial Pathogens, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Kamanova, J (corresponding author), Czech Acad Sci, Inst Microbiol, Lab Infect Biol, Prague, Czech Republic.	kamanova@biomed.cas.cz	Malcova, Ivana/ABB-6413-2021; Kamanova, Jana/Q-4477-2017; Bumba, Ladislav/ABC-9943-2020	Malcova, Ivana/0000-0002-4385-3842; Kamanova, Jana/0000-0001-6574-4404; Bumba, Ladislav/0000-0001-6659-5447; Uljanic, Filip/0000-0002-9601-7266	Czech Science Foundation [18-16772Y]; Czech Academy of Sciences [LQ200202001]; Ministry of Education, Youth and Sports of the Czech Republic [LM2018133]; Institutional Research Concept of Institute of Microbiology of the Czech Academy of Sciences [RVO 61388971]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concept of Institute of Microbiology of the Czech Academy of Sciences	This work was supported by grant 18-16772Y of the Czech Science Foundation (www.gacr.cz) and Lumina Queruntur Fellowship LQ200202001 of the Czech Academy of Sciences to J. K., project LM2018133 (EATRIS-CZ, Czech National Node to the European Infrastructure for Translational Medicine) of the Ministry of Education, Youth and Sports of the Czech Republic (https://www.msmt.cz) to L. B., and by the Institutional Research Concept of Institute of Microbiology of the Czech Academy of Sciences RVO 61388971.	Aronov S, 2004, J BIOL CHEM, V279, P36962, DOI 10.1074/jbc.M402068200; Bart MJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01301-14; Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Bayer-Santos E, 2016, CELL HOST MICROBE, V20, P584, DOI 10.1016/j.chom.2016.10.007; Bayram J, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008512; Brachmann CB, 1998, YEAST, V14, P115; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Chavez CV, 2016, TOXINS, V8, DOI 10.3390/toxins8040090; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chierico L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06056; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; Craven R, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00012-15; Del Campo CM, 2014, STRUCTURE, V22, P397, DOI 10.1016/j.str.2013.12.018; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Geissler B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00075; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Grycova L, 2015, ACS CHEM NEUROSCI, V6, P386, DOI 10.1021/cn500250r; Guttman C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081557; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; Ji C, 2015, J BIOL CHEM, V290, P26978, DOI 10.1074/jbc.M115.663013; Kamanova J, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00466; Kamitani S, 2010, J BIOL CHEM, V285, P25467, DOI 10.1074/jbc.M110.102285; Kuwae A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148387; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Nicholson TL, 2014, INFECT IMMUN, V82, P1092, DOI 10.1128/IAI.01115-13; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pilione MR, 2006, INFECT IMMUN, V74, P1043, DOI 10.1128/IAI.74.2.1043-1049.2006; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skopova K, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00937-16; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Stockbauer KE, 2003, CELL MICROBIOL, V5, P123, DOI 10.1046/j.1462-5822.2003.00260.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tuller G, 1999, YEAST, V15, P1555, DOI 10.1002/(SICI)1097-0061(199910)15:14<1555::AID-YEA479>3.0.CO;2-Z; Tyson GH, 2015, J BIOL CHEM, V290, P2919, DOI 10.1074/jbc.M114.611251; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Varela-Chavez C, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13213; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Yahalom A, 2019, BBA-BIOMEMBRANES, V1861, DOI 10.1016/j.bbamem.2019.183054; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x; Zegarlinska J, 2018, ACTA BIOCHIM POL, V65, P163, DOI 10.18388/abp.2018_2592	57	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100607	10.1016/j.jbc.2021.100607	http://dx.doi.org/10.1016/j.jbc.2021.100607			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33789161	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400579
J	Todd, B; Tchesnokov, EP; Gotte, M				Todd, Brendan; Tchesnokov, Egor P.; Gotte, Matthias			The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; RIBONUCLEASE-H ACTIVITY; VIRUS POLYMERASE; RNASE-H; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; SUBUNIT; MECHANISM; CLEAVAGE; ACTIVATION	Baloxavir marboxil (BXM) is an FDA-approved antiviral prodrug for the treatment of influenza A and B infection and postexposure prophylaxis. The active form, baloxavir acid (BXA), targets the cap-snatching endonuclease (PA) of the influenza virus polymerase complex. The nuclease activity delivers the primer for transcription, and previous reports have shown that BXA blocks the nuclease activity with high potency. However, biochemical studies on the mechanism of action are lacking. Structural data have shown that BXA chelates the two divalent metal ions at the active site, like inhibitors of the human immunodeficiency virus type 1 (HIV-1) integrase or ribonuclease (RNase) H. Here we studied the mechanisms underlying the high potency of BXA and how the I38T mutation confers resistance to the drug. Enzyme kinetics with the recombinant heterotrimeric enzyme (FluB-ht) revealed characteristics of a tight binding inhibitor. The apparent inhibitor constant (K-i(app)) is 12 nM, while the I38T mutation increased K-i(app) by similar to 18-fold. Order-of-addition experiments show that a preformed complex of FluB-ht, Mg2+ ions and BXA is required to observe inhibition, which is consistent with active site binding. Conversely, a preformed complex of FluB-ht and RNA substrate prevents BXA from accessing the active site. Unlike integrase inhibitors that interact with the DNA substrate, BXA behaves like RNase H inhibitors that compete with the nucleic acid at the active site. The collective data support the conclusion that BXA is a tight binding inhibitor and the I38T mutation diminishes these properties.	[Todd, Brendan; Tchesnokov, Egor P.; Gotte, Matthias] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Gotte, Matthias] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Gotte, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.; Gotte, M (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.	gotte@ualberta.ca		Tchesnokov, Egor Petrovitch/0000-0003-1698-2961; Todd, Brendan/0000-0002-3536-6382	Canadian Institutes of Health Research (CIHR) [170343]; Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium	This study was supported by grants to M. G. from the Canadian Institutes of Health Research (CIHR, grant number 170343) and from the Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium.	Beilhartz GL, 2014, J BIOL CHEM, V289, P16270, DOI 10.1074/jbc.M114.569707; Beilhartz GL, 2010, VIRUSES-BASEL, V2, P900, DOI 10.3390/v2040900; Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Belongia EA, 2020, SCIENCE, V368, P1163, DOI 10.1126/science.abd2220; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; CIANCI C, 1995, J VIROL, V69, P3995, DOI 10.1128/JVI.69.7.3995-3999.1995; Copeland R. A, 2000, PRACTICAL INTRO STRU, V2nd, P104; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Engelman AN, 2021, FEBS J, V288, P427, DOI 10.1111/febs.15438; Engelman AN, 2019, J BIOL CHEM, V294, P15137, DOI 10.1074/jbc.REV119.006901; Ferro S, 2018, BIOORGAN MED CHEM, V26, P4544, DOI 10.1016/j.bmc.2018.07.046; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Fodor E, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a038398; Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; HAGEN M, 1994, J VIROL, V68, P1509, DOI 10.1128/JVI.68.3.1509-1515.1994; Hayden FG, 2018, NEW ENGL J MED, V379, P913, DOI 10.1056/NEJMoa1716197; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; Ikematsu H, 2020, NEW ENGL J MED, V383, P309, DOI 10.1056/NEJMoa1915341; Ilina Tatiana, 2012, Biology (Basel), V1, P521, DOI 10.3390/biology1030521; Ison MG, 2020, LANCET INFECT DIS, V20, P1204, DOI [10.1016/51473-3099(20)30004-9, 10.1016/S1473-3099(20)30004-9]; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Klumpp K, 2003, NUCLEIC ACIDS RES, V31, P6852, DOI 10.1093/nar/gkg881; Kobayashi M, 1996, ARCH VIROL, V141, P525, DOI 10.1007/BF01718315; Kumar G, 2021, NUCLEIC ACIDS RES, V49, P1609, DOI 10.1093/nar/gkaa1294; Li ML, 1998, EMBO J, V17, P5844, DOI 10.1093/emboj/17.19.5844; Noshi T, 2018, ANTIVIR RES, V160, P109, DOI 10.1016/j.antiviral.2018.10.008; Omoto S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27890-4; Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Powdrill MH, 2010, VIRUSES-BASEL, V2, P2169, DOI 10.3390/v2102169; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Shaw-Reid CA, 2003, J BIOL CHEM, V278, P2777, DOI 10.1074/jbc.C200621200; Takashita E, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03026; Tchesnokov EP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22328-3; te Velthuis AJW, 2016, NAT REV MICROBIOL, V14, P479, DOI 10.1038/nrmicro.2016.87; Thierry E, 2016, MOL CELL, V61, P125, DOI 10.1016/j.molcel.2015.11.016; Troeger CE, 2019, LANCET RESP MED, V7, P69, DOI [10.1016/S2213-2600(18)30496-X, 10.1016/s2213-2600(18)30496-x]; Uehara T, 2020, J INFECT DIS, V221, P346, DOI 10.1093/infdis/jiz244; Yoshino R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53945-1; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	44	4	4	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100486	10.1016/j.jbc.2021.100486	http://dx.doi.org/10.1016/j.jbc.2021.100486			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33647314	Green Published, gold			2022-12-28	WOS:000672866400460
J	Yakubu, UM; Morano, KA				Yakubu, Unekwu M.; Morano, Kevin A.			Suppression of aggregate and amyloid formation by a novel intrinsically disordered region in metazoan Hsp110 chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; ALZHEIMERS-DISEASE; SUBSTRATE-BINDING; DISTINCT; STRESS; DISAGGREGATION; PROTEOSTASIS; HUNTINGTIN	Molecular chaperones maintain proteostasis by ensuring the proper folding of polypeptides. Loss of proteostasis has been linked to numerous neurodegenerative disorders including Alzheimer's, Parkinson's, and Huntington's disease. Hsp110 is related to the canonical Hsp70 class of protein-folding molecular chaperones and interacts with Hsp70 as a nucleotide exchange factor (NEF). In addition to its NEF activity, Hsp110 possesses an Hsp70-like substrate-binding domain (SBD) whose biological roles remain undefined. Previous work in Drosophila melanogaster has implicated the sole Hsp110 gene (Hsc70cb) in proteinopathic neurodegeneration. We hypothesize that in addition to its role as an Hsp70 NEF, Drosophila Hsp110 may function as a protective protein "holdase," preventing the aggregation of unfolded polypeptides via the SBD-beta subdomain. We demonstrate for the first time that Drosophila Hsp110 effectively prevents aggregation of the model substrate citrate synthase. We also report the discovery of a redundant and heretofore unknown potent holdase capacity in a 138-aminoacid region of Hsp110 carboxyl terminal to both SBD-beta and SBD-alpha (henceforth called the C-terminal extension). This sequence is highly conserved in metazoan Hsp110 genes, completely absent from fungal representatives, and is computationally predicted to contain an intrinsically disordered region (IDR). We demonstrate that this IDR sequence within the human Hsp110s, Apg-1 and Hsp105 alpha, inhibits the formation of amyloid A beta-42 and alpha-synuclein fibrils in vitro but cannot mediate fibril disassembly. Together these findings establish capacity for metazoan Hsp110 chaperones to suppress both general protein aggregation and amyloidogenesis, raising the possibility of exploitation of this IDR for therapeutic benefit.	[Yakubu, Unekwu M.; Morano, Kevin A.] McGovern Med Sch UTHlth, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Yakubu, Unekwu M.] MD Anderson UTHlth Grad Sch UTHlth, Houston, TX USA		Morano, KA (corresponding author), McGovern Med Sch UTHlth, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	kevin.a.morano@uth.tmc.edu		Yakubu, Unekwu/0000-0003-2230-0066	National Institutes of Health [R01GM127287, R21AG051046]; Russell and Diana Hawkins Family Foundation Discovery Fellowship from the MD Anderson UTHealth Graduate School of Biomedical Sciences	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russell and Diana Hawkins Family Foundation Discovery Fellowship from the MD Anderson UTHealth Graduate School of Biomedical Sciences	We thank Drs. Bo Hu, Pratick Khara, and Kohei Kishida (Department of Microbiology and Molecular Genetics, McGovern Medical School) for expert assistance with transmission electron microscopy image acquisition and interpretation. We thank Dr Sheng Zhang from the McGovern Medical School Institute of Molecular Medicine for providing the Hsc70cb expression plasmid and numerous stimulating discussions. This study was supported by the National Institutes of Health (R01GM127287 and R21AG051046) and the Russell and Diana Hawkins Family Foundation Discovery Fellowship from the MD Anderson UTHealth Graduate School of Biomedical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrams JL, 2014, J BIOL CHEM, V289, P13155, DOI 10.1074/jbc.M113.530014; Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Boczek EE, 2018, J CELL BIOL, V217, P1173, DOI 10.1083/jcb.201803015; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Cox D, 2017, CELL STRESS CHAPERON, V22, P589, DOI 10.1007/s12192-017-0785-x; Davis AK, 2020, CELL MOL LIFE SCI, V77, P977, DOI 10.1007/s00018-019-03302-2; Dewji NN, 1996, MOL BRAIN RES, V35, P325, DOI 10.1016/0169-328X(95)00214-D; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Garcia VM, 2017, MOL BIOL CELL, V28, P2066, DOI 10.1091/mbc.E17-01-0070; Garcia VM, 2016, ANAL BIOCHEM, V508, P9, DOI 10.1016/j.ab.2016.05.016; Garvey M, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030067; Gestwicki JE, 2012, PROG MOL BIOL TRANSL, V107, P327, DOI 10.1016/B978-0-12-385883-2.00003-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim YE, 2016, MOL CELL, V63, P951, DOI 10.1016/j.molcel.2016.07.022; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kuo Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.351; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Malmos KG, 2017, AMYLOID, V24, P1, DOI 10.1080/13506129.2017.1304905; McGurk L, 2015, GENETICS, V201, P377, DOI 10.1534/genetics.115.179457; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nagy M, 2016, P NATL ACAD SCI USA, V113, P5424, DOI 10.1073/pnas.1604885113; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Ota H, 2017, BIOCHEM BIOPH RES CO, V494, P602, DOI 10.1016/j.bbrc.2017.10.099; Polier S, 2010, J MOL BIOL, V401, P696, DOI 10.1016/j.jmb.2010.07.004; Raju M, 2018, ADV BIOSYST, V2, DOI 10.1002/adbi.201700095; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Sang Tzu-Kang, 2005, NeuroRx, V2, P438, DOI 10.1602/neurorx.2.3.438; Scior A, 2018, EMBO J, V37, P282, DOI 10.15252/embj.201797212; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Song YY, 2013, P NATL ACAD SCI USA, V110, P5428, DOI 10.1073/pnas.1303279110; Taguchi YV, 2019, P NATL ACAD SCI USA, V116, P24310, DOI 10.1073/pnas.1903268116; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Trivedi R., 2019, SCI REP-UK, V9, P1; Tsai CJ, 2015, J BIOL CHEM, V290, P24816, DOI 10.1074/jbc.M115.678367; Uversky VN, 2019, FRONT PHYS-LAUSANNE, V7, DOI 10.3389/fphy.2019.00010; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Webster JM, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01047; Wentink AS, 2020, NATURE, V587, P483, DOI 10.1038/s41586-020-2904-6; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Yakubu UM, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200282; Zhang S, 2010, GENETICS, V184, P1165, DOI 10.1534/genetics.109.112516	63	8	8	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100567	10.1016/j.jbc.2021.100567	http://dx.doi.org/10.1016/j.jbc.2021.100567			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753171	gold, Green Published, Green Submitted			2022-12-28	WOS:000672866400540
J	Nandi, S; Razzaghi, M; Srivastava, D; Dey, M				Nandi, Suparno; Razzaghi, Mortezaali; Srivastava, Dhiraj; Dey, Mishtu			Structural basis for allosteric regulation of pyruvate kinase M2 by phosphorylation and acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pyruvate kinase muscle isoform 2; glycolysis; allosteric regulation; post-translational modification; phosphorylation; acetylation; crystal structure; enzyme kinetics; fluorescence binding; cancer metabolism; oligomerization; pyruvate kinase; protein structure; protein phosphorylation; post-translational modification (PTM); crystal structure; oligomerization; glycolysis; allosteric regulation; enzyme kinetics; acetylation	NA+/H+ EXCHANGER; PH DYNAMICS; ISOFORM M2; PKM2; CANCER; PROMOTES; MECHANISM; IDENTIFICATION; INHIBITORS; TARGETS	Pyruvate kinase muscle isoform 2 (PKM2) is a key glycolytic enzyme and transcriptional coactivator and is critical for tumor metabolism. In cancer cells, native tetrameric PKM2 is phosphorylated or acetylated, which initiates a switch to a dimeric/monomeric form that translocates into the nucleus, causing oncogene transcription. However, it is not known how these post-translational modifications (PTMs) disrupt the oligomeric state of PKM2. We explored this question via crystallographic and biophysical analyses of PKM2 mutants containing residues that mimic phosphorylation and acetylation. We find that the PTMs elicit major structural reorganization of the fructose 1,6-bisphosphate (FBP), an allosteric activator, binding site, impacting the interaction with FBP and causing a disruption in oligomerization. To gain insight into how these modifications might cause unique outcomes in cancer cells, we examined the impact of increasing the intracellular pH (pH(i)) from similar to 7.1 (in normal cells) to similar to 7.5 (in cancer cells). Biochemical studies of WT PKM2 (wtPKM2) and the two mimetic variants demonstrated that the activity decreases as the pH is increased from 7.0 to 8.0, and wtPKM2 is optimally active and amenable to FBP-mediated allosteric regulation at pH(i) 7.5. However, the PTM mimetics exist as a mixture of tetramer and dimer, indicating that physiologically dimeric fraction is important and might be necessary for the modified PKM2 to translocate into the nucleus. Thus, our findings provide insight into how PTMs and pH regulate PKM2 and offer a broader understanding of its intricate allosteric regulation mechanism by phosphorylation or acetylation.	[Nandi, Suparno; Razzaghi, Mortezaali; Srivastava, Dhiraj; Dey, Mishtu] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA	University of Iowa	Dey, M (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	mishtu-dey@uiowa.edu	Srivastava, Dhiraj/GLQ-8896-2022	Nandi, Suparno/0000-0002-3534-8002; Dey, Mishtu/0000-0003-4763-2921; Srivastava, Dhiraj/0000-0002-1460-1646	National Science Foundation [CLP 1506181]	National Science Foundation(National Science Foundation (NSF))	M. D. was supported by National Science Foundation Grant CLP 1506181 (to M. D.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfarouk Khalid O, 2014, Oncoscience, V1, P777; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bollenbach TJ, 1999, BIOCHEMISTRY-US, V38, P9137, DOI 10.1021/bi990690n; Bond CJ, 2000, BIOCHEMISTRY-US, V39, P15333, DOI 10.1021/bi001443i; Brummett AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127288; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen TJ, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0343-4; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; DOMINGO M, 1992, J HISTOCHEM CYTOCHEM, V40, P665, DOI 10.1177/40.5.1374093; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; GREGORY RB, 1983, BIOCHEM J, V209, P413, DOI 10.1042/bj2090413; Harguindey S, 2005, BBA-REV CANCER, V1756, P1, DOI 10.1016/j.bbcan.2005.06.004; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalaiarasan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120469; Keller KE, 2014, MOL CELL, V53, P700, DOI 10.1016/j.molcel.2014.02.015; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12431; Liu VM, 2020, FEBS LETT, V594, P646, DOI 10.1002/1873-3468.13648; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Macpherson JA, 2019, ELIFE, V8, DOI 10.7554/eLife.45068; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morgan HP, 2013, P NATL ACAD SCI USA, V110, P5881, DOI 10.1073/pnas.1217157110; Nandi S, 2020, J BIOL CHEM, V295, P5390, DOI 10.1074/jbc.RA120.013030; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Schnicker NJ, 2016, J BIOL CHEM, V291, P13360, DOI 10.1074/jbc.M116.725432; Spoden GA, 2008, INT J CANCER, V123, P312, DOI 10.1002/ijc.23512; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Srivastava D, 2019, BIOCHEMISTRY-US, V58, P3669, DOI 10.1021/acs.biochem.9b00349; Srivastava D, 2017, BIOCHEMISTRY-US, V56, P6517, DOI 10.1021/acs.biochem.7b01013; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Wang HZ, 2017, NATURE, V546, P426, DOI 10.1038/nature22797; Wang P, 2015, PROTEIN CELL, V6, P275, DOI 10.1007/s13238-015-0132-x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513; Wu SF, 2013, ACTA BIOCH BIOPH SIN, V45, P27, DOI 10.1093/abbs/gms106; Yamada E, 1999, BIOCHEM BIOPH RES CO, V256, P257, DOI 10.1006/bbrc.1999.0228; Yan M, 2016, BIOCHEMISTRY-US, V55, P4731, DOI 10.1021/acs.biochem.6b00658; Yang JX, 2016, J CHEM INF MODEL, V56, P1184, DOI 10.1021/acs.jcim.6b00115; Yang WW, 2015, J CELL SCI, V128, P1655, DOI 10.1242/jcs.166629; Yang WW, 2013, CELL CYCLE, V12, P3154, DOI 10.4161/cc.26182; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhang TB, 2015, INT J CLIN EXP MED, V8, P2423; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	57	8	8	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17425	17440		10.1074/jbc.RA120.015800	http://dx.doi.org/10.1074/jbc.RA120.015800			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453989	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000603272300005
J	Teng, FY; Wang, TT; Guo, HL; Xin, BG; Sun, B; Dou, SX; Xi, XG; Hou, XM				Teng, Fang-Yuan; Wang, Ting-Ting; Guo, Hai-Lei; Xin, Ben-Ge; Sun, Bo; Dou, Shuo-Xing; Xi, Xu-Guang; Hou, Xi-Miao			The HRDC domain oppositely modulates the unwinding activity of E. coli RecQ helicase on duplex DNA and G-quadruplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; E; coli; RecQ; G-quadruplex; helicase; unwinding; single-molecule	BLOOMS SYNDROME HELICASE; SINGLE-MOLECULE; CRYSTAL-STRUCTURE; REVEALS; BINDING; REPAIR; RECOMBINATION; MECHANISM; EFFICIENT; HAIRPIN	RecQ family helicases are highly conserved from bacteria to humans and have essential roles in maintaining genome stability. Mutations in three human RecQ helicases cause severe diseases with the main features of premature aging and cancer predisposition. Most RecQ helicases shared a conserved domain arrangement which comprises a helicase core, an RecQ C-terminal domain, and an auxiliary element helicase and RNaseD C-terminal (HRDC) domain, the functions of which are poorly understood. In this study, we systematically characterized the roles of the HRDC domain in E. coli RecQ in various DNA transactions by single-molecule FRET. We found that RecQ repetitively unwinds the 3 '-partial duplex and fork DNA with a moderate processivity and periodically patrols on the ssDNA in the 5 '-partial duplex by translocation. The HRDC domain significantly suppresses RecQ activities in the above transactions. In sharp contrast, the HRDC domain is essential for the deep and long-time unfolding of the G4 DNA structure by RecQ. Based on the observations that the HRDC domain dynamically switches between RecA core- and ssDNA-binding modes after RecQ association with DNA, we proposed a model to explain the modulation mechanism of the HRDC domain. Our findings not only provide new insights into the activities of RecQ on different substrates but also highlight the novel functions of the HRDC domain in DNA metabolisms.	[Teng, Fang-Yuan; Wang, Ting-Ting; Guo, Hai-Lei; Xin, Ben-Ge; Xi, Xu-Guang; Hou, Xi-Miao] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Teng, Fang-Yuan; Wang, Ting-Ting; Guo, Hai-Lei; Xin, Ben-Ge; Xi, Xu-Guang; Hou, Xi-Miao] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Teng, Fang-Yuan] Southwest Med Univ, Affiliated Hosp, Expt Med Ctr, Luzhou, Sichuan, Peoples R China; [Teng, Fang-Yuan] Southwest Med Univ, Dept Endocrinol & Metab, Luzhou, Sichuan, Peoples R China; [Teng, Fang-Yuan] Southwest Med Univ, Cardiovasc & Metab Dis Key Lab Luzhou, Luzhou, Sichuan, Peoples R China; [Teng, Fang-Yuan] Southwest Med Univ, Sichuan Clin Res Ctr Nephropathy & Academician Ex, Luzhou, Sichuan, Peoples R China; [Sun, Bo] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Dou, Shuo-Xing] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing, Peoples R China; [Dou, Shuo-Xing] Chinese Acad Sci, Lab Soft Matter Phys Inst Phys, Beijing, Peoples R China; [Xi, Xu-Guang] Ecole Normale Super Paris Saclay, LBPA, CNRS, Gif Sur Yvette, France	Northwest A&F University - China; Northwest A&F University - China; Southwest Medical University; Southwest Medical University; Southwest Medical University; Southwest Medical University; ShanghaiTech University; Chinese Academy of Sciences; Chinese Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Xi, XG; Hou, XM (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Xi, XG; Hou, XM (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Xi, XG (corresponding author), Ecole Normale Super Paris Saclay, LBPA, CNRS, Gif Sur Yvette, France.	xxi01@ens-cachan.fr; houximiao@nwsuaf.edu.cn	teng, fang-yuan/S-9833-2018	teng, fang-yuan/0000-0002-9564-0961; Dou, Shuo-Xing/0000-0002-7201-2081; Sun, Bo/0000-0002-4590-7795	National Natural Science Foundation of China [32071225, 31870788, 32071291]; Affiliated Hospital of Southwest Medical University [18102]; Luzhou-Southwest Medical University [2019LZXNYDJ06, 2018-ZRZD-003]; Chinese Universities Scientific Fund [Z109021718]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Affiliated Hospital of Southwest Medical University; Luzhou-Southwest Medical University; Chinese Universities Scientific Fund	This work was supported by the National Natural Science Foundation of China Grants 32071225, 31870788, and 32071291, the Research Startup Funding of the Affiliated Hospital of Southwest Medical University Grant 18102, Scientific Research Funding of Luzhou-Southwest Medical University Grants 2019LZXNYDJ06 and 2018-ZRZD-003, and the Chinese Universities Scientific Fund Grant Z109021718. The research was conducted within the context of the International Associated Laboratory "Helicase-mediated G-quadruplex DNA unwinding and Genome Stability."	Bagchi D, 2018, NUCLEIC ACIDS RES, V46, P8500, DOI 10.1093/nar/gky647; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Cahoon LA, 2013, J BACTERIOL, V195, P2255, DOI 10.1128/JB.02217-12; Chatterjee S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6556; Chen MC, 2018, NATURE, V558, P465, DOI 10.1038/s41586-018-0209-9; Choi S, 2019, NUCLEIC ACIDS RES, V47, P9708, DOI 10.1093/nar/gkz708; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Harami GM, 2017, P NATL ACAD SCI USA, V114, pE466, DOI 10.1073/pnas.1615439114; Harami GM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11091; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Hou XM, 2017, NUCLEIC ACIDS RES, V45, P11401, DOI 10.1093/nar/gkx766; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Kaplan OI, 2016, NUCLEIC ACIDS RES, V44, P9083, DOI 10.1093/nar/gkw769; Kim YM, 2010, NUCLEIC ACIDS RES, V38, P7764, DOI 10.1093/nar/gkq586; Kitano K, 2007, J BIOL CHEM, V282, P2717, DOI 10.1074/jbc.M610142200; Klaue D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3024; Kocsis ZS, 2014, J BIOL CHEM, V289, P5938, DOI 10.1074/jbc.M113.530741; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Lee M, 2018, NUCLEIC ACIDS RES, V46, P4689, DOI 10.1093/nar/gky272; Li N, 2010, J BIOL CHEM, V285, P6922, DOI 10.1074/jbc.M109.069286; Liu Z, 1999, STRUCTURE, V7, P1557, DOI 10.1016/S0969-2126(00)88346-X; Manthei KA, 2015, P NATL ACAD SCI USA, V112, P4292, DOI 10.1073/pnas.1416746112; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Markiewicz RP, 2012, NUCLEIC ACIDS RES, V40, P7975, DOI 10.1093/nar/gks523; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Newman JA, 2015, NUCLEIC ACIDS RES, V43, P5221, DOI 10.1093/nar/gkv373; Sato A, 2010, J BIOCHEM, V148, P517, DOI 10.1093/jb/mvq097; Swan MK, 2014, ACTA CRYSTALLOGR D, V70, P1465, DOI 10.1107/S139900471400501X; Teng FY, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.586450; Teng FY, 2017, FEBS J, V284, P4051, DOI 10.1111/febs.14290; Tippana R, 2016, P NATL ACAD SCI USA, V113, P8448, DOI 10.1073/pnas.1603724113; Vindigni A, 2010, BIOPHYS CHEM, V149, P67, DOI 10.1016/j.bpc.2010.03.012; Vindigni A, 2009, HFSP J, V3, P153, DOI 10.2976/1.3079540; Voter AF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06751-8; Wang S, 2015, NUCLEIC ACIDS RES, V43, P3736, DOI 10.1093/nar/gkv209; Wu CG, 2016, NUCLEIC ACIDS RES, V44, P8742, DOI 10.1093/nar/gkw574; Wu WQ, 2019, NEW PHYTOL, V223, P508, DOI 10.1111/nph.15928; Wu WQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43954; Wu WQ, 2015, NUCLEIC ACIDS RES, V43, P4614, DOI 10.1093/nar/gkv361; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Yodh JG, 2009, EMBO J, V28, P405, DOI 10.1038/emboj.2008.298; Zhang B, 2016, NUCLEIC ACIDS RES, V44, P8385, DOI 10.1093/nar/gkw669; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	50	6	6	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17646	17658		10.1074/jbc.RA120.015492	http://dx.doi.org/10.1074/jbc.RA120.015492			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454004	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000603272300020
J	Angbohang, A; Huang, L; Li, Y; Zhao, Y; Gong, YJ; Fu, Y; Mao, CF; Morales, J; Luo, PY; Ehteramyan, M; Gao, YT; Margariti, A; Gu, WD; Zhang, M; Smith, A; Shah, AM; Li, T; Kong, W; Zeng, LF				Angbohang, Angshumonik; Huang, Lei; Li, Yi; Zhao, Yue; Gong, Yijie; Fu, Yi; Mao, Chenfeng; Morales, Jose; Luo, Peiyi; Ehteramyan, Mazdak; Gao, Yingtang; Margariti, Andriana; Gu, Wenduo; Zhang, Min; Smith, Alberto; Shah, Ajay M.; Li, Tong; Kong, Wei; Zeng, Lingfang			X-box binding protein 1-mediated COL4A1s secretion regulates communication between vascular smooth muscle and stem/progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN TYPE-IV; XBP1 MESSENGER-RNA; ENDOTHELIAL-CELLS; NONCOLLAGENOUS DOMAINS; BIDIRECTIONAL PROMOTER; ALPHA-2(IV) CHAINS; ALPHA-1(IV); ACTIVATION; MECHANISMS; STRESS	Vascular smooth muscle cells (VSMCs) contribute to the deposition of extracellular matrix proteins (ECMs), including Type IV collagen, in the vessel wall. ECMs coordinate communication among different cell types, but mechanisms underlying this communication remain unclear. Our previous studies have demonstrated that X-box binding protein 1 (XBP1) is activated and contributes to VSMC phenotypic transition in response to vascular injury. In this study, we investigated the participation of XBP1 in the communication between VSMCs and vascular progenitor cells (VPCs). Immunofluorescence and immunohistology staining revealed that Xbp1 gene was essential for type IV collagen alpha 1 (COL4A1) expression during mouse embryonic development and vessel wall ECM deposition and stem cell antigen 1-positive (Sca1(+))VPC recruitment in response to vascular injury. The Western blot analysis elucidated an Xbp1 gene dose-dependent effect on COL4A1 expression and that the spliced XBP1 protein (XBP1s) increased protease-mediated COL4A1 degradation as revealed by Zymography. RT-PCR analysis revealed that XBP1s in VSMCs not only upregulated COL4A1/2 transcription but also induced the occurrence of a novel transcript variant, soluble type IV collagen alpha 1 (COL4A1s), in which the front part of exon 4 is joined with the rear part of exon 42. Chromatinimmunoprecipitation, DNA/protein pulldown and in vitro transcription demonstrated that XBP1s binds to exon 4 and exon 42, directing the transcription from exon 4 to exon 42. This leads to transcription complex bypassing the internal sequences, producing a shortened COL4A1s protein that increased Sca1(+)-VPC migration. Taken together, these results suggest that activated VSMCs may recruit Sca1(+)-VPCs via XBP1s-mediated COL4A1s secretion, leading to vascular injury repair or neointima formation.	[Angbohang, Angshumonik; Huang, Lei; Li, Yi; Zhao, Yue; Morales, Jose; Luo, Peiyi; Ehteramyan, Mazdak; Gu, Wenduo; Zhang, Min; Smith, Alberto; Shah, Ajay M.; Zeng, Lingfang] Kings Coll London, Kings Coll London British Heart Fdn Ctr Excellenc, Fac Life Sci & Med, Sch Cardiovasc Med & Sci, London, England; [Huang, Lei; Zhao, Yue; Li, Tong] Tianjin Third Cent Hosp, Dept Heart Ctr, Tianjin, Peoples R China; [Huang, Lei; Zhao, Yue; Gao, Yingtang; Li, Tong] Tianjin Key Lab Extracorporeal Life Support Crit, Tianjin, Peoples R China; [Gong, Yijie] Tianjin Med Univ, Cent Clin Coll 3, Tianjin, Peoples R China; [Fu, Yi; Mao, Chenfeng; Kong, Wei] Peking Univ, Key Lab Mol Cardiovasc Sci, Minist Educ, Dept Physiol & Pathophysiol,Sch Basic Med Sci, Beijing, Peoples R China; [Gao, Yingtang] Nankai Univ, Affiliated Hosp 3, Tianjin Inst Hepatobiliary Dis, Tianjin, Peoples R China; [Margariti, Andriana] Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland	University of London; King's College London; Tianjin Medical University; Peking University; Nankai University; Queens University Belfast	Zeng, LF (corresponding author), Kings Coll London, Kings Coll London British Heart Fdn Ctr Excellenc, Fac Life Sci & Med, Sch Cardiovasc Med & Sci, London, England.; Li, T (corresponding author), Tianjin Third Cent Hosp, Dept Heart Ctr, Tianjin, Peoples R China.; Li, T (corresponding author), Tianjin Key Lab Extracorporeal Life Support Crit, Tianjin, Peoples R China.; Kong, W (corresponding author), Peking Univ, Key Lab Mol Cardiovasc Sci, Minist Educ, Dept Physiol & Pathophysiol,Sch Basic Med Sci, Beijing, Peoples R China.	litong3zx@sina.com; kongw@bjmu.edu.cn; lingfang-zeng@kcl.ac.uk	Mao, Chenfeng/GYU-9882-2022; Gao, Yingtang/AGK-4112-2022; lei, huang/AFS-7785-2022; Zhang, Min/AAF-7467-2021	Zhang, Min/0000-0003-1657-1337; Zeng, Lingfang/0000-0002-0390-4561; Shah, Ajay/0000-0002-6547-0631; Gu, Wenduo/0000-0002-3859-3150	British Heart Foundation [PG16/13/32024]; Natural Science Foundation of Tianjin City [19JCYBJC26000]; Tianjin Third Central Hospital National Natural Science Foundation Incubation Project of China [2019YNR1]; Tianjin municipal health and Health Committee Science and Technology Talent Cultivation Project of China [KJ20008]; British Heart Foundation Chair [CH/1999001/11735]; Tianjin Municipal Health and Health Committee Science and Technology Self Financing Project of China [ZD20001]	British Heart Foundation(British Heart Foundation); Natural Science Foundation of Tianjin City(Natural Science Foundation of Tianjin); Tianjin Third Central Hospital National Natural Science Foundation Incubation Project of China; Tianjin municipal health and Health Committee Science and Technology Talent Cultivation Project of China; British Heart Foundation Chair(British Heart Foundation); Tianjin Municipal Health and Health Committee Science and Technology Self Financing Project of China	This study was supported by funding from British Heart Foundation project grant PG16/13/32024 (L. Z.), the Natural Science Foundation of Tianjin City No.19JCYBJC26000 (T. L.), the Tianjin Third Central Hospital National Natural Science Foundation Incubation Project of China No.2019YNR1 (L. H.), the Tianjin municipal health and Health Committee Science and Technology Talent Cultivation Project of China No.KJ20008 (L. H.), and A. M. S. is supported by a British Heart Foundation Chair (CH/1999001/11735). The Tianjin Municipal Health and Health Committee Science and Technology Self Financing Project of China (No. ZD20001).	Aikio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051044; Allahverdian S, 2018, CARDIOVASC RES, V114, P540, DOI 10.1093/cvr/cvy022; BEJARANO PA, 1988, BIOCHEM J, V256, P413, DOI 10.1042/bj2560413; Boosani CS, 2006, PROTEIN EXPRES PURIF, V49, P211, DOI 10.1016/j.pep.2006.03.007; BURBELO PD, 1988, P NATL ACAD SCI USA, V85, P9679, DOI 10.1073/pnas.85.24.9679; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; GRIFFIN CA, 1987, P NATL ACAD SCI USA, V84, P512, DOI 10.1073/pnas.84.2.512; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Kaimoto T, 2010, HYPERTENSION, V56, P247, DOI 10.1161/HYPERTENSIONAHA.110.149781; Kokkinopoulos I, 2017, STEM CELL REP, V9, P681, DOI 10.1016/j.stemcr.2017.06.011; Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346; Lee M, 1999, BIOCHEM MOL BIOL INT, V47, P427; Mak KM, 2017, ANAT REC, V300, P1371, DOI 10.1002/ar.23567; Martin D, 2014, J BIOL CHEM, V289, P30625, DOI 10.1074/jbc.M114.571984; Mauldin G N, 2003, Vet Comp Oncol, V1, P36, DOI 10.1046/j.1476-5829.2003.00004.x; Nguyen AT, 2013, CIRC RES, V112, P17, DOI 10.1161/CIRCRESAHA.112.281048; Oikawa D, 2010, NUCLEIC ACIDS RES, V38, P6265, DOI 10.1093/nar/gkq452; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; POSCHL E, 1988, EMBO J, V7, P2687, DOI 10.1002/j.1460-2075.1988.tb03122.x; Rebustini IT, 2009, DEV CELL, V17, P482, DOI 10.1016/j.devcel.2009.07.016; Reimold AM, 2000, GENE DEV, V14, P152; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sanford JR, 2004, J CELL SCI, V117, P6261, DOI 10.1242/jcs.01513; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Stanton AE, 2019, ACTA BIOMATER, V96, P310, DOI 10.1016/j.actbio.2019.06.048; Steffensen LB, 2018, AM J PHYSIOL-HEART C, V315, pH610, DOI 10.1152/ajpheart.00070.2018; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Wu Q, 1999, MOL CELL BIOL, V19, P3225; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, CELL STRUCT FUNCT, V31, P117, DOI 10.1247/csf.06016; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zeng LF, 2015, ARTERIOSCL THROM VAS, V35, P2134, DOI 10.1161/ATVBAHA.115.305420; Zeng LF, 2013, CIRCULATION, V127, P1712, DOI 10.1161/CIRCULATIONAHA.112.001337; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106	39	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100541	10.1016/j.jbc.2021.100541	http://dx.doi.org/10.1016/j.jbc.2021.100541			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33722606	Green Published, gold			2022-12-28	WOS:000672866400514
J	Batishchev, OV; Kuzmina, NV; Mozhaev, AA; Goryashchenko, AS; Mileshina, ED; Orsa, AN; Bocharov, EV; Deyev, IE; Petrenko, AG				Batishchev, Oleg, V; Kuzmina, Natalia, V; Mozhaev, Andrey A.; Goryashchenko, Alexander S.; Mileshina, Ekaterina D.; Orsa, Alexander N.; Bocharov, Eduard, V; Deyev, Igor E.; Petrenko, Alexander G.			Activity-dependent conformational transitions of the insulin receptor-related receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT MICELLES; SENSOR IRR; PROTEIN; VISUALIZATION; EXPRESSION	The insulin receptor (IR), insulin-like growth factor 1 receptor (IGF-1R), and insulin receptor-related receptor (IRR) form a mini family of predimerized receptor-like tyrosine kinases. IR and IGF-1R bind to their peptide agonists triggering metabolic and cell growth responses. In contrast, IRR, despite sharing with them a strong sequence homology, has no peptide-like agonist but can be activated by mildly alkaline media. The spatial structure and activation mechanisms of IRR have not been established yet. The present work represents the first account of a structural analysis of a predimerized receptor-like tyrosine kinase by high-resolution atomic force microscopy in their basal and activated forms. Our data suggest that in neutral media, inactive IRR has two conformations, where one is symmetrical and highly similar to the inactive Lambda/U-shape of IR and IGF-1R ectodomains, whereas the second is drop-like and asymmetrical resembling the IRR ectodomain in solution. We did not observe complexes of IRR intracellular catalytic domains of the inactive receptor forms. At pH 9.0, we detected two presumably active IRR conformations, G-shaped and T-shaped. Both of conformations demonstrated formation of the complex of their intracellular catalytic domains responsible for autophosphorylation. The existence of two active IRR forms correlates well with the previously described positive cooperativity of the IRR activation. In conclusion, our data provide structural insights into the molecular mechanisms of alkali-induced IRR activation under mild native conditions that could be valuable for interpretation of results of IR and IGF-IR structural studies.	[Batishchev, Oleg, V; Kuzmina, Natalia, V] Russian Acad Sci, AN Frumkin Inst Phys Chem & Electrochem, Moscow, Russia; [Mozhaev, Andrey A.; Goryashchenko, Alexander S.; Mileshina, Ekaterina D.; Orsa, Alexander N.; Bocharov, Eduard, V; Deyev, Igor E.; Petrenko, Alexander G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Mozhaev, Andrey A.] Russian Acad Sci, Shubnikov Inst Crystallog Fed Sci Res Ctr Crystal, Moscow, Russia; [Bocharov, Eduard, V] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia	Russian Academy of Sciences; Frumkin Institute of Physical Chemistry & Electrochemistry; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; Moscow Institute of Physics & Technology	Batishchev, OV (corresponding author), Russian Acad Sci, AN Frumkin Inst Phys Chem & Electrochem, Moscow, Russia.	olegbati@gmail.com	Mozhaev, Andrey A./C-6879-2014; Deyev, Igor E/L-5841-2016; Batishchev, Oleg V/L-1976-2013; Deyev, Igor E/CAJ-5868-2022	Mozhaev, Andrey A./0000-0001-5790-9926; Deyev, Igor E/0000-0002-2041-808X; Batishchev, Oleg V/0000-0002-9581-2233; Deyev, Igor E/0000-0002-2041-808X	Russian Foundation for Basic Research (RFBR) [17-00-00488-KOMFI, 17-00-00486KOMFI, 20-0400959-A, 18-04-01369-A]; Ministry of Science and Higher Education of the Russian Federation	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Ministry of Science and Higher Education of the Russian Federation	The work was supported in part by the Russian Foundation for Basic Research (RFBR) projects No. 17-00-00488-KOMFI (O. V. B., N. V. K.), No. 17-00-00486KOMFI (A. A. M., A. S. G., E. V. B., I. E. D., A. G. P.), No. 20-0400959-A (A. A. M., A. N. O.), and No. 18-04-01369-A (A. A. M., I. E. D., A. G. P.), and by the Ministry of Science and Higher Education of the Russian Federation.	Batishchev OV, 2016, J VIROL, V90, P575, DOI 10.1128/JVI.01539-15; Chen PH, 2015, J MOL BIOL, V427, P3921, DOI 10.1016/j.jmb.2015.10.003; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Deev I E, 2006, Dokl Biochem Biophys, V408, P184, DOI 10.1134/S1607672906030203; Delle Bovi RJ, 2017, ANAL BIOCHEM, V536, P69, DOI 10.1016/j.ab.2017.08.011; Deyev IE, 2017, BIOCHIMIE, V138, P62, DOI 10.1016/j.biochi.2017.04.002; Deyev IE, 2013, J BIOL CHEM, V288, P33884, DOI 10.1074/jbc.M113.483172; Deyev IE, 2011, CELL METAB, V13, P679, DOI 10.1016/j.cmet.2011.03.022; Deyev IE, 2010, BIOCHIMIE, V92, P418, DOI 10.1016/j.biochi.2010.01.015; Dissen GA, 2006, ENDOCRINOLOGY, V147, P155, DOI 10.1210/en.2005-0386; Ferguson KM, 2020, PROTEIN SCI, V29, P1331, DOI 10.1002/pro.3871; Goryashchenko AS, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10071060; Gutmann T, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201907210; Gutmann T, 2018, J CELL BIOL, V217, P1643, DOI 10.1083/jcb.201711047; Haruyama T, 2019, STRUCTURE, V27, P152, DOI 10.1016/j.str.2018.09.005; Kidmose RT, 2016, STRUCTURE, V24, P351, DOI 10.1016/j.str.2016.02.003; Krasnoperov V, 2009, BIOCHEMISTRY-US, V48, P3230, DOI 10.1021/bi802163p; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12564-0; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; Mi LZ, 2011, NAT STRUCT MOL BIOL, V18, P984, DOI 10.1038/nsmb.2092; Mozhaev AA, 2019, RUSS J BIOORG CHEM+, V45, P179, DOI 10.1134/S1068162019020080; Mozhaev AA, 2017, RUSS J BIOORG CHEM+, V43, P653, DOI 10.1134/S1068162017060097; Oliver RC, 2017, J PHYS CHEM LETT, V8, P5041, DOI 10.1021/acs.jpclett.7b02149; Petrenko AG, 2013, BBA-PROTEINS PROTEOM, V1834, P2170, DOI 10.1016/j.bbapap.2012.11.011; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Scapin G, 2018, NATURE, V556, P122, DOI 10.1038/nature26153; Shayahmetova DM, 2016, RUSS J BIOORG CHEM+, V42, P449, DOI 10.1134/S1068162016040166; Shtykova EV, 2019, J VIROL, V93, DOI 10.1128/JVI.01450-18; Shtykova EV, 2019, J BIOL CHEM, V294, P17790, DOI 10.1074/jbc.RA119.010390; Shtykova EV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16986-y; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Weis F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06826-6; Whited AM, 2014, BBA-BIOMEMBRANES, V1838, P56, DOI 10.1016/j.bbamem.2013.04.011; Woldin CN, 1999, J BIOL CHEM, V274, P34981, DOI 10.1074/jbc.274.49.34981; Zhang X, 2020, STRUCTURE, V28, P555, DOI 10.1016/j.str.2020.03.007; Zubkov EA, 2017, ZH VYSSH NERV DEYAT+, V67, P106, DOI 10.7868/S0044467717010130	39	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100534	10.1016/j.jbc.2021.100534	http://dx.doi.org/10.1016/j.jbc.2021.100534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713705	gold, Green Published			2022-12-28	WOS:000672866400508
J	Boughton, AJ; Zhang, DN; Singh, RK; Fushman, D				Boughton, Andrew J.; Zhang, Daoning; Singh, Rajesh K.; Fushman, David			Polyubiquitin and ubiquitin-like signals share common recognition sites on proteasomal subunit Rpn1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26S PROTEASOME; PROTEIN; BINDING; DOMAIN; CHAINS; CONFORMATION; RECEPTORS; PATHWAY; SERVE; RAD23	Proteasome-mediated substrate degradation is an essential process that relies on the coordinated actions of ubiquitin (Ub), shuttle proteins containing Ub-like (UBL) domains, and the proteasome. Proteinaceous substrates are tagged with polyUb and shuttle proteins, and these signals are then recognized by the proteasome, which subsequently degrades the substrate. To date, three proteasomal receptors have been identified, as well as multiple shuttle proteins and numerous types of polyUb chains that signal for degradation. While the components of this pathway are well-known, our understanding of their interplay is unclear-especially in the context of Rpn1, the largest proteasomal subunit. Here, using nuclear magnetic resonance (NMR) spectroscopy in combination with competition assays, we show that Rpn1 associates with UBL-containing proteins and polyUb chains, while exhibiting a preference for shuttle protein Rad23. Rpn1 appears to contain multiple Ub/UBL-binding sites, theoretically as many as one for each of its hallmark proteasome/cyclosome repeats. Remarkably, we also find that binding sites on Rpn1 can be shared among Ub and UBL species, while proteasomal receptors Rpn1 and Rpn10 can compete with each other for binding of shuttle protein Dsk2. Taken together, our results rule out the possibility of exclusive recognition sites on Rpn1 for individual Ub/UBL signals and further emphasize the complexity of the redundancy-laden proteasomal degradation pathway.	[Boughton, Andrew J.; Zhang, Daoning; Singh, Rajesh K.; Fushman, David] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Fushman, D (corresponding author), Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA.	fushman@umd.edu			NIH [GM065334, GM095755]; NSF [DBI1040158]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This research was supported by NIH grants GM065334 and GM095755 to D. F. NMR experiments were performed on instrumentation supported in part by NSF grant DBI1040158.	Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Boughton AJ, 2020, STRUCTURE, V28, P29, DOI 10.1016/j.str.2019.10.008; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chen X, 2016, STRUCTURE, V24, P1257, DOI 10.1016/j.str.2016.05.018; Chojnacki M, 2017, CELL CHEM BIOL, V24, P443, DOI 10.1016/j.chembiol.2017.02.013; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Effantin G, 2009, J MOL BIOL, V386, P1204, DOI 10.1016/j.jmb.2009.01.039; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goddard T. D., SPARKY 3; Goh Amanda M., 2008, BMC Biochemistry, V9, P4, DOI 10.1186/1471-2091-9-4; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; Haririnia A, 2007, J MOL BIOL, V368, P753, DOI 10.1016/j.jmb.2007.02.037; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kajava AV, 2002, J BIOL CHEM, V277, P49791, DOI 10.1074/jbc.M204982200; Mansour W, 2015, J BIOL CHEM, V290, P4688, DOI 10.1074/jbc.M114.568295; Martinez-Fonts K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13906-8; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Nawatha M, 2019, NAT CHEM, V11, P644, DOI 10.1038/s41557-019-0278-x; Nowicka U, 2015, STRUCTURE, V23, P542, DOI 10.1016/j.str.2015.01.010; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schweitzer A, 2016, P NATL ACAD SCI USA, V113, P7816, DOI 10.1073/pnas.1608050113; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Su XC, 2007, J BIOMOL NMR, V38, P65, DOI 10.1007/s10858-007-9147-9; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, METHOD ENZYMOL, V399, P177, DOI 10.1016/S0076-6879(05)99012-5; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012	40	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100450	10.1016/j.jbc.2021.100450	http://dx.doi.org/10.1016/j.jbc.2021.100450			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33617881	Green Published, gold			2022-12-28	WOS:000672866400424
J	Chinnarasu, S; Alogaili, F; Bove, KE; Jaeschke, A; Hui, DY				Chinnarasu, Sivaprakasam; Alogaili, Fawzi; Bove, Kevin E.; Jaeschke, Anja; Hui, David Y.			Hepatic LDL receptor-related protein-1 deficiency alters mitochondrial dynamics through phosphatidylinositol 4,5-bisphosphate reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; LRP1; CARDIOLIPIN; BIOSYNTHESIS; ADAPTER; LIPIDS	The LDL receptor-related protein 1 (LRP1) is a multifunctional transmembrane protein with endocytosis and signal transduction functions. Previous studies have shown that hepatic LRP1 deficiency exacerbates diet-induced steatohepatitis and insulin resistance via mechanisms related to increased lysosome and mitochondria permeability and dysfunction. The current study examined the impact of LRP1 deficiency on mitochondrial function in the liver. Hepatocytes isolated from liver-specific LRP1 knockout (hLrp1(-/-)) mice showed reduced oxygen consumption compared with control mouse hepatocytes. The mitochondria in hLrp1(-/-) mouse livers have an abnormal morphology and their membranes contain significantly less anionic phospholipids, including lower levels of phosphatidylethanolamine and cardiolipin that increase mitochondrial fission and impair fusion. Additional studies showed that LRP1 complexes with phosphatidylinositol 4-phosphate 5-kinase like protein-1 (PIP5KL1) and phosphatidylinositol 4-phosphate 5-kinase-1 beta (PIP5K1 beta). The absence of LRP1 reduces the levels of both PIP5KL1 and PIP5K1 beta in the plasma membrane and also lowers phosphatidylinositol(4,5) bisphosphate (PI(4,5)P-2) levels in hepatocytes. These data indicate that LRP1 recruits PIP5KL1 and PIP5K1 beta to the plasma membrane for PI(4,5)P-2 biosynthesis. The lack of LRP1 reduces lipid kinase expression, leading to lower PI(4,5)P-2 levels, thereby decreasing the availability of this lipid metabolite in the cardiolipin biosynthesis pathway to cause cardiolipin reduction and the impairment in mitochondria homeostasis. Taken together, the current study identifies another signaling mechanism by which LRP1 regulates cell functions: binding and recruitment of PIP5KL1 and PIP5K1 beta to the membrane for PI(4,5)P-2 synthesis. In addition, it highlights the importance of this mechanism for maintaining the integrity and functions of intracellular organelles.	[Chinnarasu, Sivaprakasam; Alogaili, Fawzi; Jaeschke, Anja; Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Metab Dis Res Ctr, Cincinnati, OH 45221 USA; [Bove, Kevin E.] Cincinnati Childrens Hosp Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Metab Dis Res Ctr, Cincinnati, OH 45221 USA.	huidy@ucmail.uc.edu		COJANDARAJ, Dr LOUIS/0000-0002-5264-6546	NIH [DK074932]; Higher Committee for Education Development in Iraq	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higher Committee for Education Development in Iraq	This study was supported by NIH grant DK074932 to D. Y. H. F. A. received scholarship support from the Higher Committee for Education Development in Iraq. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acoba MG, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202003131; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Alogaili F, 2020, J BIOL CHEM, V295, P4631, DOI 10.1074/jbc.RA119.012361; Au DT, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/7902841; Ban T, 2018, BBA-BIOENERGETICS, V1859, P951, DOI 10.1016/j.bbabio.2018.05.016; Basford JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082026; Basford JE, 2011, J BIOL CHEM, V286, P13079, DOI 10.1074/jbc.M111.229369; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; Blunsom NJ, 2019, BBA-MOL CELL BIOL L, V1864, P1072, DOI 10.1016/j.bbalip.2019.03.002; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Chang JD, 2004, J BIOL CHEM, V279, P11672, DOI 10.1074/jbc.M309721200; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Ding YY, 2016, EBIOMEDICINE, V7, P135, DOI 10.1016/j.ebiom.2016.04.002; Frohman MA, 2015, J MOL MED, V93, P263, DOI 10.1007/s00109-014-1237-z; Gaultier A, 2010, J PROTEOME RES, V9, P6689, DOI 10.1021/pr1008288; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hamlin AN, 2018, J BIOL CHEM, V293, P9674, DOI 10.1074/jbc.RA118.001952; Hamlin AN, 2016, J BIOL CHEM, V291, P16610, DOI 10.1074/jbc.M116.717744; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Hollie NI, 2014, BBA-MOL CELL BIOL L, V1841, P888, DOI 10.1016/j.bbalip.2013.11.013; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; HOSTETLER KY, 1971, BIOCHIM BIOPHYS ACTA, V239, P113, DOI 10.1016/0005-2760(71)90201-3; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Konaniah ES, 2017, ARTERIOSCL THROM VAS, V37, P1046, DOI 10.1161/ATVBAHA.117.309414; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Llorente-Cortes V, 2007, J LIPID RES, V48, P2133, DOI 10.1194/jlr.M700039-JLR200; Luo L, 2018, CELL REP, V24, P3033, DOI 10.1016/j.celrep.2018.08.028; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; Maxwell JT, 2018, JOVE-J VIS EXP, DOI 10.3791/57225; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rong YG, 2012, NAT CELL BIOL, V14, P924, DOI 10.1038/ncb2557; Rosivatz E, 2011, CELL SIGNAL, V23, P478, DOI 10.1016/j.cellsig.2010.10.025; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Suski JM, 2014, NAT PROTOC, V9, P312, DOI 10.1038/nprot.2014.016; Tan XJ, 2015, J CELL SCI, V128, P4047, DOI 10.1242/jcs.175208; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Valencia CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156738; Van Gool B, 2019, MOL NEUROBIOL, V56, P7234, DOI 10.1007/s12035-019-1594-2; Wang FJ, 2018, TRAFFIC, V19, P918, DOI 10.1111/tra.12613; Woldt E, 2011, J BIOL CHEM, V286, P16775, DOI 10.1074/jbc.M110.212878; Xian XD, 2017, ELIFE, V6, DOI 10.75549/eLife.29292; Xu FY, 1998, MOL CELL BIOCHEM, V188, P217, DOI 10.1023/A:1006815210718; Yancey PG, 2010, ARTERIOSCL THROM VAS, V30, P787, DOI 10.1161/ATVBAHA.109.202051; Yang LY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0772-7	48	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100370	10.1016/j.jbc.2021.100370	http://dx.doi.org/10.1016/j.jbc.2021.100370			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548224	gold, Green Published			2022-12-28	WOS:000672866400344
J	Huang, ZB; Chen, KM; Chi, YL; Jin, H; Li, L; Zhang, WQ; Xu, J; Zhang, YY				Huang, Zhibin; Chen, Kemin; Chi, Yali; Jin, Hao; Li, Li; Zhang, Wenqing; Xu, Jin; Zhang, Yiyue			Runx1 regulates zebrafish neutrophil maturation via synergistic interaction with c-Myb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; MYELOPEROXIDASE; DIFFERENTIATION; MACROPHAGES; C/EBP; AML1; LOCALIZATION; GRANULOCYTES; MUTATIONS; PEBP2/CBF	Neutrophils play an essential role in the innate immune defense system in vertebrates. During hematopoiesis, the full function of neutrophils involves maturation of granules and related enzymes. Yet, transcription regulators that promote neutrophil maturation remain largely undefined. Here, two hematopoiesis-defective zebrafish mutants, runx1(w84x) and c-myb(hkz3), were used to investigate the in vivo roles of Runx1 in cooperation with c-Myb in regulating neutrophil maturation. Loss of runx1 impairs primitive neutrophil development. Additional regulation of c-myb(+/-) and c-myb(-/-) induces a more severe phenotypes suggesting a synergistic genetic interaction between c-myb and runx1 in neutrophil maturation. Further studies revealed that the two transcription factors act cooperatively to control neutrophil maturation processes via transactivating a series of neutrophil maturation-related genes. These data reveal the in vivo roles of Runx1 in regulating primitive neutrophil maturation while also indicating a novel genetic and molecular orchestration of Runx1 and c-Myb in myeloid cell development. The study will provide new evidence on the regulation of neutrophil maturation during hematopoiesis.	[Huang, Zhibin; Chen, Kemin; Zhang, Wenqing; Xu, Jin; Zhang, Yiyue] South China Univ Technol, Sch Med, Div Cell Dev & Integrat Biol, Guangzhou, Peoples R China; [Chi, Yali] Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, Guangzhou, Peoples R China; [Jin, Hao] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Hong Kong, Peoples R China; [Li, Li] Southwest Univ, Sch Life Sci, State Key Lab Breeding Base Ecoenvironm & Bioreso, Key Lab Freshwater Fish Reprod & Dev,Minist Educ, Chongqing, Peoples R China	South China University of Technology; Southern Medical University - China; Hong Kong University of Science & Technology; Southwest University - China	Zhang, YY (corresponding author), South China Univ Technol, Sch Med, Div Cell Dev & Integrat Biol, Guangzhou, Peoples R China.	mczhangyy@scut.edu.cn	zhang, wenqing/GYA-0786-2022; Xu, Jin/N-6576-2018	Huang, Zhibin/0000-0003-4286-4002; Chen, Kemin/0000-0003-4881-8584; ZHANG, Yiyue/0000-0002-9402-3523; Xu, Jin/0000-0002-6840-1359	National Key R&D Program of China [2018YFA0800200, 2018YFA0801000]; National Natural Science Foundation of China [31922023]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Fundamental Research Funds for the Central Universities [2019ZD54]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key R&D Program of China (2018YFA0800200 and 2018YFA0801000), the National Natural Science Foundation of China (31922023), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2019), and the Fundamental Research Funds for the Central Universities (2019ZD54).	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Austin GE, 1998, LEUKEMIA RES, V22, P1037, DOI 10.1016/S0145-2126(98)00105-2; Bellissimo DC, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00111; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brightman DS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30355-3; Chi YL, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180043; Cuartero S, 2018, NAT IMMUNOL, V19, P932, DOI 10.1038/s41590-018-0184-1; De Braekeleer E, 2011, FUTURE ONCOL, V7, P77, DOI [10.2217/fon.10.158, 10.2217/FON.10.158]; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Ezoe S, 2004, CELL CYCLE, V3, P314; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Friedman AD, 1996, CURR TOP MICROBIOL, V211, P149; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Hart DO, 2007, NATURE, V450, P1082, DOI 10.1038/nature06349; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Jin H, 2016, BLOOD, V128, P415, DOI 10.1182/blood-2015-12-686147; Jin H, 2012, BLOOD, V119, P5239, DOI 10.1182/blood-2011-12-398362; Jin H, 2009, DEVELOPMENT, V136, P647, DOI 10.1242/dev.029637; Kitaguchi T, 2009, MECH DEVELOP, V126, P314, DOI 10.1016/j.mod.2009.02.007; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Mangan James K., 2011, Critical Reviews in Oncogenesis, V16, P77; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Ng KP, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.41; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Niemann CU, 2004, J LEUKOCYTE BIOL, V76, P406, DOI 10.1189/jlb.1003502; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Veldhoen M, 2015, NAT MED, V21, P709, DOI 10.1038/nm.3894; Wang K, 2015, FISH SHELLFISH IMMUN, V44, P109, DOI 10.1016/j.fsi.2015.01.038; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang YY, 2011, BLOOD, V118, P4093, DOI 10.1182/blood-2011-03-342501	43	2	2	4	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100272	10.1016/j.jbc.2021.100272	http://dx.doi.org/10.1016/j.jbc.2021.100272			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33434583	Green Published, gold			2022-12-28	WOS:000672866400248
J	Hutcherson, RJ; Gabbard, RD; Castellanos, AJ; Travers, JB; Kemp, MG				Hutcherson, Rebekah J.; Gabbard, Ryan D.; Castellanos, Amber J.; Travers, Jeffrey B.; Kemp, Michael G.			Age and insulin-like growth factor-1 impact PCNA monoubiquitination in UVB-irradiated human skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE ETA; INDUCED PYRIMIDINE DIMERS; TRANSLESION SYNTHESIS; REPAIR; REPLICATION; CARCINOMA; SURVIVAL	Nonmelanoma skin cancers occur primarily in individuals over the age of 60 and are characterized by an abundance of ultraviolet (UV) signature mutations in keratinocyte DNA. Though geriatric skin removes UV photoproducts from DNA less efficiently than young adult skin, it is not known whether the utilization of other prosurvival but potentially mutagenic DNA damage tolerance systems such as translesion synthesis (TLS) is altered in older individuals. Using monoubiquitination of the replicative DNA polymerase clamp protein PCNA (proliferating cell nuclear antigen) as a biochemical marker of TLS pathway activation, we find that UVB exposure of the skin of individuals over the age of 65 results in a higher level of PCNA monoubiquitination than in the skin of young adults. Furthermore, based on previous reports showing a role for deficient insulin-like growth factor-1 (IGF-1) signaling in altered UVB DNA damage responses in geriatric human skin, we find that both pharmacological inhibition of the IGF-1 receptor (IGF-1R) and deprivation of IGF-1 potentiate UVB-induced PCNA monoubiquitination in both human skin ex vivo and keratinocytes in vitro. Interestingly, though the TLS DNA polymerase Pol eta can accurately replicate the major photoproducts induced in DNA by UV radiation, we find that it fails to accumulate on chromatin in the absence of IGF-1R signaling and that this phenotype is correlated with increased mutagenesis in keratinocytes in vitro. Thus, altered IGF-1/IGF-1R signaling in geriatric skin may predispose epidermal keratinocytes to carry out a more mutagenic form of DNA synthesis following UVB exposure.	[Hutcherson, Rebekah J.; Gabbard, Ryan D.; Castellanos, Amber J.; Travers, Jeffrey B.; Kemp, Michael G.] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Travers, Jeffrey B.] Wright State Univ, Boonshoft Sch Med, Dept Dermatol, Dayton, OH 45435 USA; [Travers, Jeffrey B.] Dayton Vet Affairs Med Ctr, Dayton, OH USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton	Kemp, MG (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA.	mike.kemp@wright.edu		Kemp, Michael/0000-0001-8203-0745; Castellanos, Amber/0000-0002-4623-115X	Wright State University; National Institute of General Medical Sciences [GM130583]; National Institute on Aging [AG048946]; Veterans Administration (Clinical VA Merit Award) [1101CX000809]	Wright State University; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Administration (Clinical VA Merit Award)(US Department of Veterans Affairs)	This work was supported by start-up funding by Wright State University (to M. G. K.) and by grants from the National Institute of General Medical Sciences (GM130583 to M. G. K.), the National Institute on Aging (AG048946 to J. B. T.), and the Veterans Administration (Clinical VA Merit Award 1101CX000809 to J. B. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the US Veterans Administration.	Alkawar AMM, 2020, PHOTOCHEM PHOTOBIOL, V96, P1332, DOI 10.1111/php.13279; Andrade-Lima LC, 2015, J CELL SCI, V128, P150, DOI 10.1242/jcs.161596; BARRECA A, 1992, J CELL PHYSIOL, V151, P262, DOI 10.1002/jcp.1041510207; BRANCHET MC, 1990, GERONTOLOGY, V36, P28; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; CERIMELE D, 1990, BRIT J DERMATOL, V122, P13, DOI 10.1111/j.1365-2133.1990.tb16120.x; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Cordonnier AM, 1999, MUTAT RES-DNA REPAIR, V435, P111, DOI 10.1016/S0921-8777(99)00047-6; Cruet-Hennequart S, 2010, SUBCELL BIOCHEM, V50, P189, DOI 10.1007/978-90-481-3471-7_10; FENSKE NA, 1986, J AM ACAD DERMATOL, V15, P571, DOI 10.1016/S0190-9622(86)70208-9; FERBER A, 1993, J BIOL CHEM, V268, P17883; Fernandez TL, 2015, EXP DERMATOL, V24, P235, DOI 10.1111/exd.12637; FREEMAN SE, 1988, J INVEST DERMATOL, V90, P814, DOI 10.1111/1523-1747.ep12462039; Gohler T, 2011, J CELL BIOL, V192, P219, DOI 10.1083/jcb.201008076; Gupta V, 2019, CLIN DERMATOL, V37, P430, DOI 10.1016/j.clindermatol.2019.07.010; Johnson GE, 2012, METHODS MOL BIOL, V817, P55, DOI 10.1007/978-1-61779-421-6_4; Kanao R., 2017, MUTAT RES, VS0027- 5107, P30081; Kemp MG, 2019, J INVEST DERMATOL, V139, P448, DOI 10.1016/j.jid.2018.07.039; Kemp MG, 2017, J BIOL CHEM, V292, P1231, DOI 10.1074/jbc.M116.765883; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; Kuhn C, 1999, INT J CANCER, V80, P431, DOI 10.1002/(SICI)1097-0215(19990129)80:3<431::AID-IJC16>3.3.CO;2-X; Lerner LK, 2017, NUCLEIC ACIDS RES, V45, P1270, DOI 10.1093/nar/gkw1196; Lewis DA, 2010, ONCOGENE, V29, P1475, DOI 10.1038/onc.2009.440; Lewis DA, 2011, AGING-US, V3, P407, DOI 10.18632/aging.100318; Loesch MM, 2016, MOL ONCOL, V10, P1245, DOI 10.1016/j.molonc.2016.06.002; MARKS R, 1981, BRIT J DERMATOL, V104, P627, DOI 10.1111/j.1365-2133.1981.tb00748.x; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Pilzecker B, 2019, NUCLEIC ACIDS RES, V47, P7163, DOI 10.1093/nar/gkz531; Sale JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012708; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Spandau DF, 2012, J INVEST DERMATOL, V132, P1591, DOI 10.1038/jid.2012.29; Travers JB, 2013, DERMATOL SURG, V39, P967, DOI 10.1111/dsu.12138; Waraky A, 2017, J BIOL CHEM, V292, P18227, DOI 10.1074/jbc.M117.781492; Washington MT, 2001, P NATL ACAD SCI USA, V98, P8355, DOI 10.1073/pnas.121007298; Xu GG, 2000, MUTAT RES-DNA REPAIR, V459, P195, DOI 10.1016/S0921-8777(99)00069-5; Yamada M, 2006, ARCH DERMATOL RES, V297, P294, DOI 10.1007/s00403-005-0618-0; Yang C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236291	38	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100570	10.1016/j.jbc.2021.100570	http://dx.doi.org/10.1016/j.jbc.2021.100570			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753168	gold, Green Published			2022-12-28	WOS:000672866400543
J	Ilyaskin, AV; Korbmacher, C; Diakov, A				Ilyaskin, Alexandr, V; Korbmacher, Christoph; Diakov, Alexei			Inhibition of the epithelial sodium channel (ENaC) by connexin 30 involves stimulation of clathrin-mediated endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; ROMK POTASSIUM CHANNEL; PROTEIN-KINASE-C; NA+-CHANNEL; LIDDLE-SYNDROME; BETA-SUBUNIT; ELECTROPHYSIOLOGICAL CHARACTERIZATION; FEEDBACK INHIBITION; OPEN PROBABILITY; PLASMA-MEMBRANE	Mice lacking connexin 30 (Cx30) display increased epithelial sodium channel (ENaC) activity in the distal nephron and develop salt-sensitive hypertension. This indicates a functional link between Cx30 and ENaC, which remains incompletely understood. Here, we explore the effect of Cx30 on ENaC function using the Xenopus laevis oocyte expression system. Coexpression of human Cx30 with human alpha beta gamma ENaC significantly reduced ENaC-mediated whole-cell currents. The size of the inhibitory effect on ENaC depended on the expression level of Cx30 and required Cx30 ion channel activity. ENaC inhibition by Cx30 was mainly due to reduced cell surface ENaC expression resulting from enhanced ENaC retrieval without discernible effects on proteolytic channel activation and single-channel properties. ENaC retrieval from the cell surface involves the interaction of the ubiquitin ligase Nedd4-2 with PPPxY-motifs in the C-termini of ENaC. Truncating the C-termini of beta- or gamma ENaC significantly reduced the inhibitory effect of Cx30 on ENaC. In contrast, mutating the prolines belonging to the PPPxY-motif in gamma ENaC or coexpressing a dominant-negative Xenopus Nedd4 (xNedd4-CS) did not significantly alter ENaC inhibition by Cx30. Importantly, the inhibitory effect of Cx30 on ENaC was significantly reduced by Pitstop-2, an inhibitor of clathrin-mediated endocytosis, or by mutating putative clathrin adaptor protein 2 (AP-2) recognition motifs (Yxx Phi) in the C termini of beta- or gamma-ENaC. In conclusion, our findings suggest that Cx30 inhibits ENaC by promoting channel retrieval from the plasma membrane via clathrin-dependent endocytosis. Lack of this inhibition may contribute to increased ENaC activity and salt-sensitive hypertension in mice with Cx30 deficiency.	[Ilyaskin, Alexandr, V; Korbmacher, Christoph; Diakov, Alexei] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Zellulare & Mol Physiol, Erlangen, Germany	University of Erlangen Nuremberg	Korbmacher, C (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Zellulare & Mol Physiol, Erlangen, Germany.	christoph.korbmacher@fau.de		Ilyaskin, Alexandr V./0000-0002-2153-7849	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [387509280, SFB 1350]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), project number 387509280, SFB 1350 (subproject A4 to C. K.).	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Awayda MS, 2000, J GEN PHYSIOL, V115, P559, DOI 10.1085/jgp.115.5.559; Awayda MS, 1996, J GEN PHYSIOL, V108, P49, DOI 10.1085/jgp.108.1.49; Bahima L, 2006, J CELL PHYSIOL, V206, P95, DOI 10.1002/jcp.20440; Bao HF, 2014, AM J PHYSIOL-RENAL, V306, pF309, DOI 10.1152/ajprenal.00519.2013; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; Bicego M, 2006, HUM MOL GENET, V15, P2569, DOI 10.1093/hmg/ddl184; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bugaj V, 2012, J BIOL CHEM, V287, P38552, DOI 10.1074/jbc.M112.408476; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; DURIEUX ME, 1994, FEBS LETT, V337, P235, DOI 10.1016/0014-5793(94)80198-3; Ebihara L, 1996, BIOPHYS J, V71, P742, DOI 10.1016/S0006-3495(96)79273-1; EBIHARA L, 1989, SCIENCE, V243, P1194, DOI 10.1126/science.2466337; Enkvetchakul D, 2003, J PHYSIOL-LONDON, V553, P95, DOI 10.1113/jphysiol.2003.047910; Eskandari S, 2002, J MEMBRANE BIOL, V185, P93, DOI 10.1007/s00232-001-0115-0; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Fiori MC, 2012, J BIOL CHEM, V287, P40826, DOI 10.1074/jbc.M112.383281; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Frindt G, 2020, AM J PHYSIOL-RENAL, V318, pF1113, DOI 10.1152/ajprenal.00609.2019; Frindt G, 2016, J GEN PHYSIOL, V147, P217, DOI 10.1085/jgp.201511533; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Gu YC, 2008, J EXP BIOL, V211, P3167, DOI 10.1242/jeb.019646; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Hanner F, 2010, AM J PHYSIOL-REG I, V298, pR1143, DOI 10.1152/ajpregu.00808.2009; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Ilyaskin AV, 2019, J GEN PHYSIOL, V151, P820, DOI 10.1085/jgp.201812291; Ilyaskin AV, 2016, J BIOL CHEM, V291, P19835, DOI 10.1074/jbc.M116.726471; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Klemens CA, 2017, J BIOL CHEM, V292, P375, DOI 10.1074/jbc.M116.753616; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; KORBMACHER C, 1995, J MEMBRANE BIOL, V146, P29; Krueger B, 2018, PFLUG ARCH EUR J PHY, V470, P649, DOI 10.1007/s00424-018-2115-2; Kunzelmann K, 2004, FASEB J, V18, P142, DOI 10.1096/fj.04-2314fje; Kurtz A, 2012, BBA-BIOMEMBRANES, V1818, P1903, DOI 10.1016/j.bbamem.2011.05.023; Lefevre CMT, 2014, PFLUG ARCH EUR J PHY, V466, P253, DOI 10.1007/s00424-013-1310-4; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Loffing J, 2009, PFLUG ARCH EUR J PHY, V458, P111, DOI 10.1007/s00424-009-0656-0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; McCulloch F, 2005, AM J PHYSIOL-RENAL, V289, pF1304, DOI 10.1152/ajprenal.00203.2005; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Mironova E, 2011, J BIOL CHEM, V286, P1054, DOI 10.1074/jbc.M110.176552; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Nesterov V, 2016, HYPERTENSION, V67, P1256, DOI 10.1161/HYPERTENSIONAHA.115.07061; Nesterov V, 2012, AM J PHYSIOL-RENAL, V303, pF1289, DOI 10.1152/ajprenal.00247.2012; Nielsen BS, 2017, J BIOL CHEM, V292, P19999, DOI 10.1074/jbc.M117.805986; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; OGrady SM, 1996, J BIOL CHEM, V271, P29080, DOI 10.1074/jbc.271.46.29080; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Oshima A, 2011, J MOL BIOL, V405, P724, DOI 10.1016/j.jmb.2010.10.032; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; PALMER LG, 1987, AM J PHYSIOL, V253, pF333, DOI 10.1152/ajprenal.1987.253.2.F333; Patel AB, 2014, CHANNELS, V8, P444, DOI 10.4161/19336950.2014.949190; Rauh R, 2006, PFLUG ARCH EUR J PHY, V452, P290, DOI 10.1007/s00424-005-0026-5; Rauh R, 2013, AM J PHYSIOL-LUNG C, V304, pL43, DOI 10.1152/ajplung.00093.2012; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; RIBERA AB, 1987, P NATL ACAD SCI USA, V84, P6577, DOI 10.1073/pnas.84.18.6577; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Shi HK, 2002, EUR J BIOCHEM, V269, P4551, DOI 10.1046/j.1432-1033.2002.03154.x; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; SILVER RB, 1993, AM J PHYSIOL, V264, pF557, DOI 10.1152/ajprenal.1993.264.3.F557; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Staruschenko A, 2005, J BIOL CHEM, V280, P39161, DOI 10.1074/jbc.M509608200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Stoessel A, 2010, AM J PHYSIOL-RENAL, V298, pF216, DOI 10.1152/ajprenal.00295.2009; Svenningsen P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00292; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Valiunas V, 2000, PFLUG ARCH EUR J PHY, V440, P366, DOI 10.1007/s004240000294; Volk T, 2004, PFLUG ARCH EUR J PHY, V447, P884, DOI 10.1007/s00424-003-1193-x; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wagner C, 2009, PFLUG ARCH EUR J PHY, V459, P151, DOI 10.1007/s00424-009-0707-6; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; White TW, 1998, NATURE, V394, P630, DOI 10.1038/29202; Wiemuth D, 2007, BIOCHEM J, V405, P147, DOI 10.1042/BJ20060747; Willebrords J, 2017, PHARMACOL THERAPEUT, V180, P144, DOI 10.1016/j.pharmthera.2017.07.001; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Wu P, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014996; YAMAZAKI J, 1995, JPN J PHARMACOL, V68, P25, DOI 10.1254/jjp.68.25; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001; Zhang Y, 1998, J PHYSIOL-LONDON, V508, P763, DOI 10.1111/j.1469-7793.1998.763bp.x; Zhou Y, 2012, P NATL ACAD SCI USA, V109, P11413, DOI 10.1073/pnas.1204444109	112	6	6	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100404	10.1016/j.jbc.2021.100404	http://dx.doi.org/10.1016/j.jbc.2021.100404			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33577799	Green Published, gold			2022-12-28	WOS:000672866400378
J	Kontou, G; Ng, SFJ; Cardarelli, RA; Howden, JH; Choi, C; Ren, Q; Santos, MAR; Bope, CE; Dengler, JS; Kelley, MR; Davies, PA; Kittler, JT; Brandon, NJ; Moss, SJ; Smalley, JL				Kontou, Georgina; Ng, Shu Fun Josephine; Cardarelli, Ross A.; Howden, Jack H.; Choi, Catherine; Ren, Qiu; Santos, Miguel A. Rodriguez; Bope, Christopher E.; Dengler, Jake S.; Kelley, Matt R.; Davies, Paul A.; Kittler, Josef T.; Brandon, Nicholas J.; Moss, Stephen J.; Smalley, Joshua L.			KCC2 is required for the survival of mature neurons but not for their development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE COTRANSPORTER KCC2; TNF-ALPHA; ACTIVATION; HYPEREXCITABILITY; DISRUPTION; EPILEPSY; FODRIN; INJURY; GLIA	The K+/Cl- cotransporter KCC2 (SLC12A5) allows mature neurons in the CNS to maintain low intracellular Cl- levels that are critical in mediating fast hyperpolarizing synaptic inhibition via type A gamma-aminobutyric acid receptors (GABA(A)Rs). In accordance with this, compromised KCC2 activity results in seizures, but whether such deficits directly contribute to the subsequent changes in neuronal structure and viability that lead to epileptogenesis remains to be assessed. Canonical hyperpolarizing GABA(A)R currents develop postnatally, which reflect a progressive increase in KCC2 expression levels and activity. To investigate the role that KCC2 plays in regulating neuronal viability and architecture, we have conditionally ablated KCC2 expression in developing and mature neurons. Decreasing KCC2 expression in mature neurons resulted in the rapid activation of the extrinsic apoptotic pathway. Intriguingly, direct pharmacological inhibition of KCC2 in mature neurons was sufficient to rapidly induce apoptosis, an effect that was not abrogated via blockade of neuronal depolarization using tetrodotoxin (TTX). In contrast, ablating KCC2 expression in immature neurons had no discernable effects on their subsequent development, arborization, or dendritic structure. However, removing KCC2 in immature neurons was sufficient to ablate the subsequent postnatal development of hyperpolarizing GABA(A)R currents. Collectively, our results demonstrate that KCC2 plays a critical role in neuronal survival by limiting apoptosis, and mature neurons are highly sensitive to the loss of KCC2 function. In contrast, KCC2 appears to play a minimal role in mediating neuronal development or architecture.	[Kontou, Georgina; Ng, Shu Fun Josephine; Cardarelli, Ross A.; Brandon, Nicholas J.; Moss, Stephen J.] Tufts Univ, AstraZeneca, Tufts Lab Basic & Translat Neurosci, Sch Med, Boston, MA 02155 USA; [Kontou, Georgina; Ng, Shu Fun Josephine; Cardarelli, Ross A.; Choi, Catherine; Ren, Qiu; Santos, Miguel A. Rodriguez; Bope, Christopher E.; Dengler, Jake S.; Kelley, Matt R.; Davies, Paul A.; Moss, Stephen J.; Smalley, Joshua L.] Tufts Univ, Dept Neurosci, Sch Med, Boston, MA 02155 USA; [Howden, Jack H.; Kittler, Josef T.; Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Brandon, Nicholas J.] AstraZeneca, Neurosci, IMED Biotech Unit, Boston, MA USA	AstraZeneca; Tufts University; Tufts University; University of London; University College London; AstraZeneca	Moss, SJ (corresponding author), Tufts Univ, AstraZeneca, Tufts Lab Basic & Translat Neurosci, Sch Med, Boston, MA 02155 USA.; Moss, SJ (corresponding author), Tufts Univ, Dept Neurosci, Sch Med, Boston, MA 02155 USA.; Moss, SJ (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	Stephen.Moss@Tufts.edu	Ng, Shu Fun Josephine/AAH-4384-2021	Howden, Jack/0000-0001-9303-2076; Choi, Catherine/0000-0002-3215-9601; Smalley, Joshua/0000-0002-7437-6655; Ng, Shu Fun Josephine/0000-0003-4567-1409	National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke [NS051195, NS056359, NS081735, NS087662, NS108378, R21NS080064, R21NS111338, R21NS111064]; NIH, United Sates; National Institute of Mental Health [MH097446]; AstraZeneca Postdoctoral Program, United States; BBSRC [1775200] Funding Source: UKRI	National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, United Sates; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AstraZeneca Postdoctoral Program, United States(AstraZeneca); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke Grants NS051195 (S. J. M.), NS056359 (S. J. M.), NS081735 (S. J. M.), NS087662 (S. J. M.), NS108378 (S. J. M. and P. A. D.), R21NS080064 (S. J. M.), R21NS111338 (P. A. D.), R21NS111064 (P. A. D.); NIH, United Sates; National Institute of Mental Health Grant MH097446 (S. J. M. and P. A. D.). G. K. was a fellow of and funded by the AstraZeneca Postdoctoral Program, United States. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Awad PN, 2018, CEREB CORTEX, V28, P4049, DOI 10.1093/cercor/bhy198; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Benchoua A, 2001, J NEUROSCI, V21, P7127, DOI 10.1523/JNEUROSCI.21-18-07127.2001; Bengzon J, 2002, PROG BRAIN RES, V135, P111; Chen LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00196-7; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Fiumelli H, 2013, CEREB CORTEX, V23, P378, DOI 10.1093/cercor/bhs027; Friedel P, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0354; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Gulyas AI, 2001, EUR J NEUROSCI, V13, P2205, DOI 10.1046/j.0953-816x.2001.01600.x; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Kelley MR, 2018, EBIOMEDICINE, V32, P62, DOI 10.1016/j.ebiom.2018.05.029; Kelley MR, 2016, NEUROPHARMACOLOGY, V108, P103, DOI 10.1016/j.neuropharm.2016.04.029; Lee REC, 2016, SCI REP-UK, V6, DOI 10.1038/srep39519; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Mavrovic M, 2020, EMBO REP, V21, DOI 10.15252/embr.201948880; Meller R, 2006, EPILEPSY RES, V70, P3, DOI 10.1016/j.eplepsyres.2006.02.002; Melon LC, 2018, PSYCHONEUROENDOCRINO, V90, P182, DOI 10.1016/j.psyneuen.2017.12.003; Monie TP, 2015, IMMUNOL REV, V265, P181, DOI 10.1111/imr.12284; Moore YE, 2018, P NATL ACAD SCI USA, V115, P10166, DOI 10.1073/pnas.1810134115; Moore YE, 2017, TRENDS NEUROSCI, V40, P555, DOI 10.1016/j.tins.2017.06.008; Munoz A, 2007, EPILEPSIA, V48, P663, DOI 10.1111/j.1528-1167.2007.00986.x; NIXON RA, 1986, J NEUROSCI, V6, P1264; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Pisella LI, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aay0300; Puskarjov M, 2012, J NEUROSCI, V32, P11356, DOI 10.1523/JNEUROSCI.6265-11.2012; Saito T, 2017, CLIN GENET, V92, P654, DOI 10.1111/cge.13049; Saitsu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep30072; Schiavon E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201022; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sedmak G, 2016, CEREB CORTEX, V26, P4574, DOI 10.1093/cercor/bhv218; Silayeva L, 2015, P NATL ACAD SCI USA, V112, P3523, DOI 10.1073/pnas.1415126112; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Sivakumaran S, 2015, J NEUROSCI, V35, P8291, DOI 10.1523/JNEUROSCI.5205-14.2015; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Smalley JL, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.563091; Stodberg T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9038; Teocchi MA, 2016, MEDIAT INFLAMM, V2016, P1; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007	48	8	8	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100364	10.1016/j.jbc.2021.100364	http://dx.doi.org/10.1016/j.jbc.2021.100364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539918	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400338
J	Liu, K; Graves, JD; Lin, FT; Lin, WC				Liu, Kang; Graves, Joshua D.; Lin, Fang-Tsyr; Lin, Weei-Chin			Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; BINDING; P53; RECRUITMENT; MECHANISM; SITES; ETAA1	Topoisomerase II beta-binding protein 1 (TopBP1) is involved in cellular replication among other functions and is known to activate ATR/Chk1 during replicative stress. TopBP1 is also expressed at high levels in many cancers. However, the impact of TopBP1 overexpression on ATR/Chk1 activation and cancer development has not been investigated. Here we demonstrate that the degree of ATR/Chk1 activation is regulated by TopBP1 in a biphasic, concentration-dependent manner in a non-transformed MCF10A cell line and several cancer cell lines, including H1299, MDA-MB468, and U2OS. At low levels, TopBP1 activates ATR/Chk1, but once TopBP1 protein accumulates above an optimal level, it paradoxically leads to lower activation of ATR/Chk1. This is due to the perturbation of ATR-TopBP1 interaction and ATR chromatin loading by excessive TopBP1. Overexpression of TopBP1 thus hinders the ATR/Chk1 checkpoint response, leading to the impairment of genome integrity as demonstrated by the cytokinesis-block micronucleus assay. In contrast, moderate depletion of TopBP1 by shRNA in TopBP1-overexpressing cancer cells enhanced ATR/Chk1 activation and S-phase checkpoint response after replicative stress. The clinical significance of these findings is supported by an association between TopBP1 overexpression and genome instability in many types of human cancer. Taken together, our study illustrates an unexpected relationship between the levels of TopBP1 and the final functional outcome and suggests TopBP1 overexpression as a new mechanism directly contributing to genomic instability during tumorigenesis.U	[Liu, Kang; Graves, Joshua D.; Lin, Fang-Tsyr; Lin, Weei-Chin] Baylor Coll Med, Sect Hematol Oncol, Dept Med, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Lin, WC (corresponding author), Baylor Coll Med, Sect Hematol Oncol, Dept Med, Houston, TX 77030 USA.; Lin, WC (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	weeichil@bcm.edu		Lin, Weei-Chin/0000-0002-6804-3205	National Institutes of Health [R01CA100857]; Rivkin Center for Ovarian Cancer Pilot Award [R01CA203824]; Department of Defense [W81XWH-18-1-0329, W81XWH-19-1-0369]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rivkin Center for Ovarian Cancer Pilot Award; Department of Defense(United States Department of Defense)	This work was supported by National Institutes of Health Grants R01CA100857, Rivkin Center for Ovarian Cancer Pilot Award (to W.-C. L.) and R01CA203824 and Department of Defense Grants, W81XWH-18-1-0329 and W81XWH-19-1-0369 (to W.-C. L. and F.-T. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acevedo J, 2016, J BIOL CHEM, V291, P13124, DOI 10.1074/jbc.M116.729194; Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bass TE, 2016, NAT CELL BIOL, V18, P1185, DOI 10.1038/ncb3415; Chowdhury P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6476; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Haahr P, 2016, NAT CELL BIOL, V18, P1196, DOI 10.1038/ncb3422; Hintzsche H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21680-8; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Lee YC, 2016, CURR BIOL, V26, P3257, DOI 10.1016/j.cub.2016.10.030; Lewis KA, 2005, CANCER RES, V65, P7091, DOI 10.1158/0008-5472.CAN-05-1019; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu K, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00599-19; Liu K, 2017, P NATL ACAD SCI USA, V114, pE3766, DOI 10.1073/pnas.1619832114; Liu K, 2013, MOL CELL BIOL, V33, P4685, DOI 10.1128/MCB.00373-13; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Liu K, 2009, MOL CELL BIOL, V29, P2673, DOI 10.1128/MCB.01140-08; Schlomm T, 2016, EUR UROL, V69, P1157, DOI 10.1016/j.eururo.2016.02.024; Thomas P, 2011, METHODS MOL BIOL, V682, P217, DOI 10.1007/978-1-60327-409-8_16; Wardlaw CP, 2014, DNA REPAIR, V22, P165, DOI 10.1016/j.dnarep.2014.06.004; Wu DP, 2017, EUR REV MED PHARMACO, V21, P4022; Yan S, 2009, CELL CYCLE, V8, P2877, DOI 10.4161/cc.8.18.9485; Yoshida K, 2004, ONCOGENE, V23, P6250, DOI 10.1038/sj.onc.1207829	25	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100382	10.1016/j.jbc.2021.100382	http://dx.doi.org/10.1016/j.jbc.2021.100382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556369	gold, Green Published			2022-12-28	WOS:000672866400356
J	Liu, L; Lauro, BM; Wolfe, MS; Selkoe, DJ				Liu, Lei; Lauro, Bianca M.; Wolfe, Michael S.; Selkoe, Dennis J.			Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate gamma-secretase function in generating Alzheimer-causing A beta peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATORS; A-BETA-42; CLEAVAGE; MECHANISM	gamma-Secretase is responsible for the proteolysis of amyloid precursor protein (APP) into amyloid-beta (A beta) peptides, which are centrally implicated in the pathogenesis of Alzheimer's disease (AD). The biochemical mechanism of how processing by gamma-secretase is regulated, especially as regards the interaction between enzyme and substrate, remains largely unknown. Here, mutagenesis reveals that the hydrophilic loop-1 (HL-1) of presenilin-1 (PS1) is critical for both gamma-secretase step-wise cleavages (processivity) and its allosteric modulation by heterocyclic gamma-modulatory compounds. Systematic mutagenesis of HL-1, including all of its familial AD mutations and additional engineered variants, and quantification of the resultant A beta products show that HL-1 is necessary for proper sequential gamma-secretase processivity. We identify Y106, L113, and Y115 in HL-1 as key targets for heterocyclic gamma-secretase modulators (GSMs) to stimulate processing of pathogenic A beta peptides. Further, we confirm that the GxxxG domain in the APP transmembrane region functions as a critical substrate motif for gamma-secretase processivity: a G29A substitution in APP-C99 mimics the beneficial effects of GSMs. Together, these findings provide a molecular basis for the structural regulation of gamma-processivity by enzyme and substrate, facilitating the rational design of new GSMs that lower AD-initiating amyloidogenic A beta peptides.	[Liu, Lei; Lauro, Bianca M.; Selkoe, Dennis J.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Wolfe, Michael S.] Univ Kansas, Dept Med Chem, Sch Pharm, Lawrence, KS 66045 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kansas	Selkoe, DJ (corresponding author), Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA.	jselkoe@bwh.harvard.edu	Liu, Lei/R-7673-2017	Liu, Lei/0000-0002-4604-4629; Lauro, Bianca/0000-0003-2461-8481; Wolfe, Michael/0000-0002-5721-9092	NIH [R01 AG006173, P01 AG015379, R03 AG063046]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by NIH grants R01 AG006173 (D. J. S.), P01 AG015379 (M. S. W. and D. J. S.), and R03 AG063046 (L.L).	Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Bolduc DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17578; Cai T, 2019, J NEUROSCI, V39, P8600, DOI 10.1523/JNEUROSCI.0838-19.2019; Cai T, 2017, J NEUROSCI, V37, P12272, DOI 10.1523/JNEUROSCI.1628-17.2017; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Crump CJ, 2013, BIOCHEMISTRY-US, V52, P3197, DOI 10.1021/bi400377p; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Higashide H, 2017, J NEUROCHEM, V140, P955, DOI 10.1111/jnc.13942; Imai S, 2019, J BIOCHEM, V165, P37, DOI 10.1093/jb/mvy081; Johnson DS, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024067; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kretner B, 2013, J NEUROCHEM, V125, P144, DOI 10.1111/jnc.12124; Kretner B, 2011, J BIOL CHEM, V286, P15240, DOI 10.1074/jbc.M110.213587; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Liu L, 2019, J CELL BIOL, V218, P644, DOI 10.1083/jcb.201806205; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Moore BD, 2018, J EXP MED, V215, P283, DOI 10.1084/jem.20170600; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Selkoe D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011460; Struyfs H, 2015, J ALZHEIMERS DIS, V45, P813, DOI 10.3233/JAD-141986; Sun JC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07971-8; Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114; Taghian T, 2020, MOL THER, V28, P411, DOI 10.1016/j.ymthe.2019.11.012; Takagi-Niidome S, 2015, J NEUROSCI, V35, P2646, DOI 10.1523/JNEUROSCI.3164-14.2015; Takeo K, 2014, P NATL ACAD SCI USA, V111, P10544, DOI 10.1073/pnas.1402171111; Tominaga A, 2016, J NEUROSCI, V36, P1362, DOI 10.1523/JNEUROSCI.5090-14.2016; Wagner SL, 2014, BIOCHEMISTRY-US, V53, P702, DOI 10.1021/bi401537v; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Yang GH, 2021, CELL, V184, P521, DOI 10.1016/j.cell.2020.11.049; Zhou R, 2019, SCIENCE, V363, P708, DOI 10.1126/science.aaw0930	35	13	13	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100393	10.1016/j.jbc.2021.100393	http://dx.doi.org/10.1016/j.jbc.2021.100393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571524	Green Published, gold			2022-12-28	WOS:000672866400367
J	Lopusna, K; Nowialis, P; Opavska, J; Abraham, A; Riva, A; Haney, SL; Opavsky, R				Lopusna, Katarina; Nowialis, Pawel; Opavska, Jana; Abraham, Ajay; Riva, Alberto; Haney, Staci L.; Opavsky, Rene			Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; DE-NOVO METHYLATION; DNA METHYLATION; GENE; MYC; EXPRESSION; TCL1; TUMORIGENESIS; TRANSCRIPTION; INSTABILITY	DNA methylation regulates gene transcription and is involved in various physiological processes in mammals, including development and hematopoiesis. It is catalyzed by DNA methyltransferases including Dnmt1, Dnmt3a, and Dnmt3b. For Dnmt3b, its effects on transcription can result from its own DNA methylase activity, the recruitment of other Dnmts to mediate methylation, or transcription repression in a methylation-independent manner. Low-frequency mutations in human DNMT3B are found in hematologic malignancies including cutaneous T-cell lymphomas, hairy cell leukemia, and diffuse large B-cell lymphomas. Moreover, Dnmt3b is a tumor suppressor in oncogene-driven lymphoid and myeloid malignancies in mice. However, it is poorly understood how the different Dnmt3b activities contribute to these outcomes. We modulated Dnmt3b activity in vivo by generating Dnmt3b(+/-) mice expressing one wild-type allele as well as Dnmt3b(+/CI) and Dnmt3b(CI/CI) mice where one or both alleles express catalytically inactive Dnmt3b(CI). We show that 43% of Dnmt3b(+/-) mice developed T-cell lymphomas, chronic lymphocytic leukemia, and myeloproliferation over 18 months, thus resembling phenotypes previously observed in Dnmt3a(+/-) mice, possibly through regulation of shared target genes. Interestingly, Dnmt3b(+/CI) and Dnmt3b(CI/CI) mice survived postnatal development and were affected by B-cell rather than T-cell malignancies with decreased penetrance. Genome-wide hypomethylation, increased expression of oncogenes such as Jdp2, STAT1, and Trip13, and p53 downregulation were major events contributing to Dnmt3b(+/-) lymphoma development. We conclude that Dnmt3b catalytic activity is critical to prevent B-cell transformation in vivo, whereas accessory and methylation-independent repressive functions are important to prevent T-cell transformation.	[Lopusna, Katarina; Nowialis, Pawel; Opavska, Jana; Abraham, Ajay; Opavsky, Rene] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32611 USA; [Riva, Alberto] Univ Florida, ICBR Bioinformat Canc & Genet Res Complex, Gainesville, FL USA; [Haney, Staci L.] Univ Nebraska Med Ctr, Dept Internal Med, Nebraska Med Ctr 985950, Omaha, NE USA; [Abraham, Ajay] Univ Texas Austin, Dell Med Sch, Dept Oncol, 1601 Trinity St,Bldg B, Austin, TX 78712 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Nebraska System; University of Nebraska Medical Center; University of Texas System; University of Texas Austin	Opavsky, R (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32611 USA.	ropavsky@ufl.edu	Abraham, Ajay/AAK-8454-2020; Lopusna, Katarina/AAO-7437-2020	Abraham, Ajay/0000-0003-4094-2476; Lopusna, Katarina/0000-0002-9887-8422	NIH/NCI [1R01CA188561-01A1]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH/NCI grant 1R01CA188561-01A1 (R.O.).	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Barau J, 2016, SCIENCE, V354, P909, DOI 10.1126/science.aah5143; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Blanco-Betancourt CE, 2004, BLOOD, V103, P2683, DOI 10.1182/blood-2003-08-2632; Celik H, 2016, INT J HEMATOL, V103, P617, DOI 10.1007/s12185-016-1957-7; Cole CB, 2017, J CLIN INVEST, V127, P3657, DOI 10.1172/JCI93041; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duymich CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11453; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; FRANCESCHINI P, 1995, EUR J PEDIATR, V154, P840, DOI 10.1007/BF01959794; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Gao TS, 2016, BIOINFORMATICS, V32, P3543, DOI 10.1093/bioinformatics/btw495; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Haney SL, 2015, ONCOGENE, V34, P5436, DOI 10.1038/onc.2014.472; Haney SL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006334; Haney SL, 2016, CELL REP, V15, P1190, DOI 10.1016/j.celrep.2016.04.004; Herling M, 2006, LEUKEMIA, V20, P280, DOI 10.1038/sj.leu.2404017; Hlady RA, 2012, J CLIN INVEST, V122, P163, DOI 10.1172/JCI57292; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Juhling F, 2016, GENOME RES, V26, P256, DOI 10.1101/gr.196394.115; Kiel MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9470; King AD, 2016, CELL REP, V17, P289, DOI 10.1016/j.celrep.2016.08.083; Kovacic B, 2006, CANCER CELL, V10, P77, DOI 10.1016/j.ccr.2006.05.025; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Lu S, 2019, COMPUT STRUCT BIOTEC, V17, P854, DOI 10.1016/j.csbj.2019.06.005; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nowialis P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12355-7; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Palamarchuk A, 2012, P NATL ACAD SCI USA, V109, P2555, DOI 10.1073/pnas.1200003109; Peters SL, 2014, LEUKEMIA, V28, P1138, DOI 10.1038/leu.2013.364; Peters SL, 2013, MOL CELL BIOL, V33, P4321, DOI 10.1128/MCB.00776-13; Poole CJ, 2017, ONCOTARGET, V8, P76898, DOI 10.18632/oncotarget.20176; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Shah MY, 2010, CANCER RES, V70, P5840, DOI 10.1158/0008-5472.CAN-10-0847; Sterlin D, 2016, J CLIN IMMUNOL, V36, P149, DOI 10.1007/s10875-016-0240-2; Stratikopoulos E, 2008, P NATL ACAD SCI USA, V105, P19378, DOI 10.1073/pnas.0809223105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; Upchurch GM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00182; van der Weyden L, 2013, ONCOGENE, V32, P397, DOI 10.1038/onc.2012.56; Vasanthakumar A, 2013, BLOOD, V121, P2059, DOI 10.1182/blood-2012-04-421065; Wierda RJ, 2010, J CELL MOL MED, V14, P1225, DOI 10.1111/j.1582-4934.2010.01022.x; Xiao H, 2019, EPIGENETICS-US, V14, P837, DOI 10.1080/15592294.2019.1625670; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yuille MR, 2001, GENE CHROMOSOME CANC, V30, P336, DOI 10.1002/gcc.1099; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945; Zhang YY, 2018, ELIFE, V7, DOI 10.7554/eLife.40757; Zheng Y, 2016, LEUKEMIA, V30, P2373, DOI 10.1038/leu.2016.112	63	2	2	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100285	10.1016/j.jbc.2021.100285	http://dx.doi.org/10.1016/j.jbc.2021.100285			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450231	gold, Green Published			2022-12-28	WOS:000672866400261
J	Moseler, A; Dhalleine, T; Rouhier, N; Couturier, J				Moseler, Anna; Dhalleine, Tiphaine; Rouhier, Nicolas; Couturier, Jeremy			Arabidopsis thaliana 3-mercaptopyruvate sulfurtransferases interact with and are protected by reducing systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE; SULFANE SULFUR; L-CYSTEINE; H2S; THIOREDOXIN; ACID; ENCEPHALOPATHY; BIOSYNTHESIS; LOCALIZATION; FLUORESCENCE	The formation of a persulfide group (-SSH) on cysteine residues has gained attention as a reversible posttranslational modification contributing to protein regulation or protection. The widely distributed 3-mercaptopyruvate sulfurtransferases (MSTs) are implicated in the generation of persulfidated molecules and H2S biogenesis through transfer of a sulfane sulfur atom from a suitable donor to an acceptor. Arabidopsis has two MSTs, named STR1 and STR2, but they are poorly characterized. To learn more about these enzymes, we conducted a series of biochemical experiments including a variety of possible reducing systems. Our kinetic studies, which used a combination of sulfur donors and acceptors revealed that both MSTs use 3-mercaptopyruvate efficiently as a sulfur donor while thioredoxins, glutathione, and glutaredoxins all served as high-affinity sulfane sulfur acceptors. Using the redox-sensitive GFP (roGFP2) as a model acceptor protein, we showed that the persulfide-forming MSTs catalyze roGFP2 oxidation and more generally trans-persulfidation reactions. However, a preferential interaction with the thioredoxin system and glutathione was observed in case of competition between these sulfur acceptors. Moreover, we observed that MSTs are sensitive to overoxidation but are protected from an irreversible inactivation by their persulfide intermediate and subsequent reactivation by thioredoxins or glutathione. This work provides significant insights into Arabidopsis STR1 and STR2 catalytic properties and more specifically emphasizes the interaction with cellular reducing systems for the generation of H2S and glutathione persulfide and reactivation of an oxidatively modified form.	[Moseler, Anna; Dhalleine, Tiphaine; Rouhier, Nicolas; Couturier, Jeremy] Univ Lorraine, INRAE, IAM, Nancy, France	INRAE; Universite de Lorraine	Couturier, J (corresponding author), Univ Lorraine, INRAE, IAM, Nancy, France.	jeremy.couturier@univ-lorraine.fr		Couturier, Jeremy/0000-0003-3127-2669; Rouhier, Nicolas/0000-0002-2036-7884; Moseler, Anna/0000-0003-4641-8093	French National Research Agency as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE) [ANR-11-LABX-0002-01]; SULPAR GrandEst region contract [17_GE2_016]; Alexander von Humboldt Foundation;  [ANR-16-CE20-0012]	French National Research Agency as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR)); SULPAR GrandEst region contract; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); 	The salary of A. M. was funded by grants of the French National Research Agency as part of the "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE) and of the SULPAR (17_GE2_016) GrandEst region contract. A.M. is also recipient of a Feodor Lynen Research Fellowship from the Alexander von Humboldt Foundation. This work on plant sulfurtransferases was supported by grant of the ANR-16-CE20-0012 contract.	Akaike T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01311-y; Aller I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00506; Alvarez C, 2012, PLANT CELL, V24, P4621, DOI 10.1105/tpc.112.105403; Alvarez C, 2010, PLANT PHYSIOL, V152, P656, DOI 10.1104/pp.109.147975; Aroca A, 2017, J EXP BOT, V68, P4915, DOI 10.1093/jxb/erx294; Aroca A, 2015, PLANT PHYSIOL, V168, P334, DOI 10.1104/pp.15.00009; Bailey TS, 2015, FREE RADICAL BIO MED, V89, P662, DOI 10.1016/j.freeradbiomed.2015.08.017; Bauer M, 2004, PLANT PHYSIOL, V135, P916, DOI 10.1104/pp.104.040121; Behm M, 2000, PLANT PHYSIOL BIOCH, V38, P363, DOI 10.1016/S0981-9428(00)00760-9; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Burow M, 2002, BIOL CHEM, V383, P1363, DOI 10.1515/BC.2002.155; Chen J, 2011, J EXP BOT, V62, P4481, DOI 10.1093/jxb/err145; Colnaghi R, 2001, FEBS LETT, V500, P153, DOI 10.1016/S0014-5793(01)02610-2; Coughlin CR, 2015, J MED GENET, V52, P532, DOI 10.1136/jmedgenet-2015-103049; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00518; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00105; Couturier J, 2009, CELL MOL LIFE SCI, V66, P2539, DOI 10.1007/s00018-009-0054-y; Doka E, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax8358; Doka E, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500968; Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; Frasdorf B, 2014, J BIOL CHEM, V289, P34543, DOI 10.1074/jbc.M114.605733; Francoleon NE, 2011, ARCH BIOCHEM BIOPHYS, V516, P146, DOI 10.1016/j.abb.2011.09.015; Fricker MD, 2000, J MICROSC-OXFORD, V198, P162, DOI 10.1046/j.1365-2818.2000.00696.x; Fujii S, 2019, BRIT J PHARMACOL, V176, P607, DOI 10.1111/bph.14356; Gotor C, 2019, J EXP BOT, V70, P4251, DOI 10.1093/jxb/erz225; Hanaoka K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40227; Hartle MD, 2016, CHEM SOC REV, V45, P6108, DOI 10.1039/c6cs00212a; Henne M, 2015, FEBS OPEN BIO, V5, P832, DOI 10.1016/j.fob.2015.10.001; Hofler S, 2016, PHYSIOL PLANTARUM, V157, P352, DOI 10.1111/ppl.12454; Kimura Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11004-7; Kimura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14774; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Krussel L, 2014, PLANT PHYSIOL, V165, P92, DOI 10.1104/pp.114.239764; Lec JC, 2018, ACS CATAL, V8, P2049, DOI 10.1021/acscatal.7b02432; Li K, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00298; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Longen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29808; Mao GH, 2011, J BIOL CHEM, V286, P7548, DOI 10.1074/jbc.M110.182865; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; Millikin R, 2016, FREE RADICAL BIO MED, V97, P136, DOI 10.1016/j.freeradbiomed.2016.05.013; Moseler A, 2020, NEW PHYTOL, V226, P967, DOI 10.1111/nph.15870; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nakai Y, 2012, J BIOL CHEM, V287, P30874, DOI 10.1074/jbc.M112.350090; Nakamura T, 2000, EUR J BIOCHEM, V267, P5621, DOI 10.1046/j.1432-1327.2000.01633.x; Nietzel T, 2020, P NATL ACAD SCI USA, V117, P741, DOI 10.1073/pnas.1910501117; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Papenbrock J, 2000, EUR J BIOCHEM, V267, P145, DOI 10.1046/j.1432-1327.2000.00980.x; Papenbrock J, 2000, EUR J BIOCHEM, V267, P5571, DOI 10.1046/j.1432-1327.2000.01623.x; Rose P, 2017, CELL MOL LIFE SCI, V74, P1391, DOI 10.1007/s00018-016-2406-8; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Selles B, 2019, J EXP BOT, V70, P4139, DOI 10.1093/jxb/erz213; Shen J, 2020, PLANT CELL, V32, P1000, DOI 10.1105/tpc.19.00826; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Stroher E, 2016, PLANT PHYSIOL, V170, P1284, DOI 10.1104/pp.15.01308; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; Wedmann R, 2016, CHEM SCI, V7, P3414, DOI 10.1039/c5sc04818d; Yadav PK, 2020, J BIOL CHEM, V295, P6299, DOI 10.1074/jbc.RA120.012616; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yamaguchi Y, 2000, PLANT CELL PHYSIOL, V41, P465, DOI 10.1093/pcp/41.4.465; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zannini F, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7100142; Zimmermann J, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101598; Zivanovic J, 2019, CELL METAB, V30, P1152, DOI 10.1016/j.cmet.2019.10.007; Zuhra K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080828	68	8	9	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100429	10.1016/j.jbc.2021.100429	http://dx.doi.org/10.1016/j.jbc.2021.100429			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33609525	gold, Green Published			2022-12-28	WOS:000672866400403
J	Pan, Y; Iejima, D; Nakayama, M; Suga, A; Noda, T; Kaur, I; Das, T; Chakrabarti, S; Guymer, RH; DeAngelis, MM; Yamamoto, M; Baird, PN; Iwata, T				Pan, Yang; Iejima, Daisuke; Nakayama, Mao; Suga, Akiko; Noda, Toru; Kaur, Inderjeet; Das, Taraprasad; Chakrabarti, Subhabrata; Guymer, Robyn H.; DeAngelis, Margaret M.; Yamamoto, Megumi; Baird, Paul N.; Iwata, Takeshi			Binding of Gtf2i-beta/delta transcription factors to the ARMS2 gene leads to increased circulating HTRA1 in AMD patients and in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FACTOR TFII-I; MACULAR DEGENERATION; TYROSINE KINASE; TGF-BETA; VARIANT; TARGET; SUSCEPTIBILITY; IDENTIFICATION; ENDOTHELIUM	The disease-initiating molecular events for age-related macular degeneration (AMD), a multifactorial retinal disease affecting many millions of elderly individuals worldwide, are still unknown. Of the over 30 risk and protective loci so far associated with AMD through whole genome-wide association studies (GWAS), the Age-Related Maculopathy Susceptibility 2 (ARMS2) gene locus represents one of the most highly associated risk regions for AMD. A unique insertion/deletion (in/del) sequence located immediately upstream of the High Temperature Requirement A1 ( HTRA1) gene in this region confers high risk for AMD. Using electrophoretic mobility shift assay (EMSA), we identified that two Gtf2i-beta/delta transcription factor isoforms bind to the cis-element 5'- ATTAATAACC-3' contained in this in/del sequence. The binding of these transcription factors leads to enhanced upregulation of transcription of the secretory serine protease HTRA1 in transfected cells and AMD patient-derived induced pluripotent stem cells (iPSCs). Overexpression of Htra1 in mice using a CAG-promoter demonstrated increased blood concentration of Htra1 protein, caused upregulation of vascular endothelial growth factor (VEGF), and produced a choroidal neovascularization (CNV)-like phenotype. Finally, a comparison of 478 AMD patients to 481 healthy, age-matched controls from Japan, India, Australia, and the USA showed a statistically increased level of secreted HTRA1 blood concentration in AMD patients compared with age-matched controls. Taken together, these results suggest a common mechanism across ethnicities whereby increased systemic blood circulation of secreted serine protease HTRA1 leads to subsequent degradation of Bruch's membrane and eventual CNV in AMD.	[Pan, Yang; Iejima, Daisuke; Nakayama, Mao; Suga, Akiko; Yamamoto, Megumi; Iwata, Takeshi] Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo, Japan; [Noda, Toru] Natl Hosp Org Tokyo Med Ctr, Div Ophthalmol, Tokyo, Japan; [Kaur, Inderjeet; Das, Taraprasad; Chakrabarti, Subhabrata] LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Kallam Anji Reddy Mol Genet Lab, Hyderabad, India; [Guymer, Robyn H.] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia; [Guymer, Robyn H.; Baird, Paul N.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Surg, Ophthalmol, East Melbourne, Vic, Australia; [DeAngelis, Margaret M.] Univ Buffalo State Univ New York, Jacobs Sch Med & Biomed Sci, Dept Ophthalmol, Buffalo, NY USA; [DeAngelis, Margaret M.] Univ Buffalo State Univ New York, Jacobs Sch Med & Biomed Sci, Ira G Ross Eye Inst, Buffalo, NY USA; [Yamamoto, Megumi] JAC Ltd, Tokyo, Japan	L. V. Prasad Eye Institute; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Melbourne; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Iwata, T (corresponding author), Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo, Japan.	takeshi.iwata@kankakuki.go.jp	Chakrabarti, Subhabrata/F-2468-2015; Kaur, Inderjeet/ABD-1833-2021	Chakrabarti, Subhabrata/0000-0003-3717-4963; Baird, Paul/0000-0002-1305-3502; Suga, Akiko/0000-0001-6609-2647; Pan, Yang/0000-0001-7673-2599	Japan Agency for Medical Research and Development [19ek0109282h0003]; Japan Society for the Promotion of Science (JSPS) [963552]; Department of Science & Technology and Australia-India Strategic Research Fund (AISRF) through the Department of Biotechnology (DBT), Government of India; Department of Science & Technology and Australia-India Strategic Research Fund (AISRF) through the Department of Innovation, Industry, Science and Research (DIISR), Government of Australia; National Health and Medical Research Council of Australia (NHMRC) [1138585, 1103013]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Department of Science & Technology and Australia-India Strategic Research Fund (AISRF) through the Department of Biotechnology (DBT), Government of India; Department of Science & Technology and Australia-India Strategic Research Fund (AISRF) through the Department of Innovation, Industry, Science and Research (DIISR), Government of Australia; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work has been supported by research grant to T. I. by the Japan Agency for Medical Research and Development (19ek0109282h0003), T. I. by the Bilateral Program (2006-2007), Japan Society for the Promotion of Science (JSPS, 963552) with (D. B. and I. K.). Under the Bilateral Program (2006-2007), Department of Science & Technology and Australia-India Strategic Research Fund (AISRF) jointly funded through the Department of Biotechnology (DBT), Government of India (S. C. and I. K.) and the Department of Innovation, Industry, Science and Research (DIISR), Government of Australia (P. N. B. and R. H. G.). National Health and Medical Research Council of Australia (NHMRC) Research Fellowship 1138585 (P. N. B.) and 1103013 (R. H. G.). I. K. and S. C. would acknowledge the support of Retina consultants of LVPEI; Dr Nazimul Hussain, Dr Avinash Pathengay, Late Dr Annie Mathai and Dr Anjli Hussain for their help in recruitment of AMD patients and controls for this study. CERA receives Operational Infrastructure Support from the Victorian Government, Australia.	Bhisitkul RB, 2006, BRIT J OPHTHALMOL, V90, P1542, DOI 10.1136/bjo.2006.098426; Chailangkarn T, 2018, MOL CELL PROBE, V40, P45, DOI 10.1016/j.mcp.2017.12.005; Chen JG, 2005, J VIROL, V79, P4396, DOI 10.1128/JVI.79.7.4396-4406.2005; Chen LJ, 2020, ASIA-PAC J OPHTHALMO, V9, P104, DOI 10.1097/01.APO.0000656976.47696.7d; Cheriyath V, 2000, J BIOL CHEM, V275, P26300, DOI 10.1074/jbc.M002980200; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Goto Asako, 2009, J Ocul Biol Dis Infor, V2, P164; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Iejima D, 2015, J BIOL CHEM, V290, P2784, DOI 10.1074/jbc.M114.593384; Itoh F, 2012, BLOOD, V119, P5320, DOI 10.1182/blood-2011-12-395772; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Kaur I, 2013, MOL VIS, V19, P822; Kim DW, 2000, MOL CELL BIOL, V20, P1140, DOI 10.1128/MCB.20.4.1140-1148.2000; Kim DW, 2001, MOL CELL BIOL, V21, P3387, DOI 10.1128/MCB.21.10.3387-3397.2000; Ku MC, 2005, MOL CELL BIOL, V25, P7144, DOI 10.1128/MCB.25.16.7144-7157.2005; Makeyev AV, 2009, GENE, V433, P16, DOI 10.1016/j.gene.2008.11.027; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Misra UK, 2009, J CELL BIOCHEM, V106, P381, DOI 10.1002/jcb.22016; Montes T, 2009, P NATL ACAD SCI USA, V106, P4366, DOI 10.1073/pnas.0812584106; Nakayama M, 2014, INVEST OPHTH VIS SCI, V55, P6514, DOI 10.1167/iovs.14-14453; Novina CD, 1999, MOL CELL BIOL, V19, P5014; Oura Y, 2018, AM J PATHOL, V188, P2729, DOI 10.1016/j.ajpath.2018.08.012; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Pena-Hernandez R, 2015, P NATL ACAD SCI USA, V112, pE677, DOI 10.1073/pnas.1416674112; Pennington KL, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0063-5; Roy AL, 2017, TRENDS MOL MED, V23, P501, DOI 10.1016/j.molmed.2017.04.002; Sacristan C, 2009, EUR J IMMUNOL, V39, P2584, DOI 10.1002/eji.200839031; Saika S, 2001, DEV BIOL, V240, P419, DOI 10.1006/dbio.2001.0480; Seuntjens E, 2009, CYTOKINE GROWTH F R, V20, P449, DOI 10.1016/j.cytogfr.2009.10.005; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tipney HJ, 2004, EUR J HUM GENET, V12, P551, DOI 10.1038/sj.ejhg.5201174; Tosi GM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113363; Tosi GM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26442-0; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Walshe TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005149; Wang GF, 2010, HUM GENET, V127, P595, DOI 10.1007/s00439-010-0805-8; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758	50	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100456	10.1016/j.jbc.2021.100456	http://dx.doi.org/10.1016/j.jbc.2021.100456			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33636181	Green Published, gold			2022-12-28	WOS:000672866400430
J	Parthibane, V; Lin, J; Acharya, D; Abimannan, T; Srideshikan, SM; Klarmann, K; Yang, AC; Soheilian, F; Nagashima, K; Fox, SD; Andresson, T; Tessarollo, L; Keller, JR; Acharya, U; Acharya, JK				Parthibane, Velayoudame; Lin, Jing; Acharya, Diwash; Abimannan, Thiruvaimozhi; Srideshikan, Sargur Madabushi; Klarmann, Kimberly; Yang, Acong; Soheilian, Ferri; Nagashima, Kunio; Fox, Stephen D.; Andresson, Thorkell; Tessarollo, Lino; Keller, Jonathan R.; Acharya, Usha; Acharya, Jairaj K.			SSSPTA is essential for serine palmitoyltransferase function during development and hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOVO SPHINGOLIPID BIOSYNTHESIS; LONG-CHAIN-BASE; SACCHAROMYCES-CEREVISIAE; METABOLISM; IDENTIFICATION; PHYSIOLOGY; STEM; DYSFUNCTION; DEFICIENCY; PROTEINS	Serine palmitoyltransferase complex (SPT) mediates the first and rate-limiting step in the de novo sphingolipid biosynthetic pathway. The larger subunits SPTLC1 and SPTLC2/SPTLC3 together form the catalytic core while a smaller third subunit either SSSPTA or SSSPTB has been shown to increase the catalytic efficiency and provide substrate specificity for the fatty acyl-CoA substrates. The in vivo biological significance of these smaller subunits in mammals is still unknown. Here, using two null mutants, a conditional null for ssSPTa and a null mutant for ssSPTb, we show that SSSPTA is essential for embryogenesis and mediates much of the known functions of the SPT complex in mammalian hematopoiesis. The ssSPTa null mutants are embryonic lethal at E6.5 much like the Sptlc1 and Sptlc2 null alleles. Mx1-Cre induced deletion of ssSPTa leads to lethality and myelopoietic defect. Chimeric and competitive bone marrow transplantation experiments show that the defect in myelopoiesis is accompanied by an expansion of the Lin(-)Sca1(+)c-Kit(+) stem and progenitor compartment. Progenitor cells that fail to differentiate along the myeloid lineage display evidence of endoplasmic reticulum stress. On the other hand, ssSPTb null mice are homozygous viable, and analyses of the bone marrow cells show no significant difference in the proliferation and differentiation of the adult hematopoietic compartment. SPTLC1 is an obligatory subunit for the SPT function, and because Sptlc1(-/-) and ssSPTa(-/-) mice display similar defects during development and hematopoiesis, we conclude that an SPT complex that includes SSSPTA mediates much of its developmental and hematopoietic functions in a mammalian model.	[Parthibane, Velayoudame; Lin, Jing; Acharya, Diwash; Abimannan, Thiruvaimozhi; Srideshikan, Sargur Madabushi; Acharya, Usha; Acharya, Jairaj K.] NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA; [Klarmann, Kimberly; Tessarollo, Lino; Keller, Jonathan R.] NCI, Mouse Canc Genet Program, Frederick, MD USA; [Yang, Acong] NCI, RNA Biol Lab, Ctr Canc Res, Frederick, MD USA; [Soheilian, Ferri; Nagashima, Kunio] NCI, Electron Microscopy Grp, Ctr Canc Res, Frederick, MD USA; [Fox, Stephen D.; Andresson, Thorkell] NCI, Mass Spectrometry Grp, Ctr Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Acharya, U; Acharya, JK (corresponding author), NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA.	acharyaura@nih.gov; acharyaj@mail.nih.gov		Madabushi, Srideshikan/0000-0002-1087-6044; Acharya, Jairaj/0000-0001-7366-4228; Abimannan, Thiruvaimozhi/0000-0001-6210-8058	intramural division of the National Cancer Institute, National Institutes of Health (Division of Health and Human Services)	intramural division of the National Cancer Institute, National Institutes of Health (Division of Health and Human Services)	This study was funded by the intramural division of the National Cancer Institute, National Institutes of Health (Division of Health and Human Services). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Acharya U, 2005, CELL MOL LIFE SCI, V62, P128, DOI 10.1007/s00018-004-4254-1; Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P7276; Alexaki A, 2017, J BIOL CHEM, V292, P3929, DOI 10.1074/jbc.M116.756460; Bieberich E, 2018, CHEM PHYS LIPIDS, V216, P114, DOI 10.1016/j.chemphyslip.2018.08.003; Cartier A, 2019, SCIENCE, V366, P323, DOI 10.1126/science.aar5551; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Dadsena S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09654-4; Dzierzak E, 2018, CELL STEM CELL, V22, P639, DOI 10.1016/j.stem.2018.04.015; Fagundez CB, 2009, CELL BIOL INT, V33, P1196, DOI 10.1016/j.cellbi.2009.08.001; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; HAKOMORI S, 1993, BIOCHEM SOC T, V21, P583, DOI 10.1042/bst0210583; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Harmon JM, 2013, J BIOL CHEM, V288, P10144, DOI 10.1074/jbc.M113.451526; Harrison PJ, 2018, NAT PROD REP, V35, P921, DOI 10.1039/c8np00019k; Heath V, 2004, BLOOD, V104, P1639, DOI 10.1182/blood-2003-11-3963; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Kimberlin AN, 2013, PLANT CELL, V25, P4627, DOI 10.1105/tpc.113.116145; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749; Loh KC, 2011, ANTI-CANCER AGENT ME, V11, P782; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Montefusco DJ, 2018, BIOCHEM BIOPH RES CO, V504, P608, DOI 10.1016/j.bbrc.2018.05.078; Fernandes CM, 2020, EXPERT REV ANTI-INFE, V18, P1083, DOI 10.1080/14787210.2020.1792288; Mousley CJ, 2010, ADV ENZYME REGUL, V50, P339, DOI 10.1016/j.advenzreg.2009.12.004; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Oswald MCW, 2015, HUM MOL GENET, V24, P6899, DOI 10.1093/hmg/ddv390; Parthibane V, 2019, BLOOD ADV, V3, P3635, DOI 10.1182/bloodadvances.2019000729; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ross JS, 2014, CLIN LIPIDOL, V9, P553, DOI 10.2217/CLP.14.37; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608; Smith CM, 2019, NUCLEIC ACIDS RES, V47, pD774, DOI 10.1093/nar/gky922; Smith WL, 2002, J BIOL CHEM, V277, P25841, DOI 10.1074/jbc.R200011200; Tessarollo Lino, 2009, V530, P141, DOI 10.1007/978-1-59745-471-1_8; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; WELLS GB, 1983, J BIOL CHEM, V258, P200; Wigger D, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00210; Xie SZ, 2019, CELL STEM CELL, V25, P639, DOI 10.1016/j.stem.2019.09.008; Yonamine I, 2011, J CELL BIOL, V192, P557, DOI 10.1083/jcb.201004098; Zhao LH, 2015, P NATL ACAD SCI USA, V112, P12962, DOI 10.1073/pnas.1516733112	50	3	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100491	10.1016/j.jbc.2021.100491	http://dx.doi.org/10.1016/j.jbc.2021.100491			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33662400	gold, Green Published			2022-12-28	WOS:000672866400465
J	Takada, YK; Shimoda, M; Maverakis, E; Felding, BH; Cheng, RH; Takada, Y				Takada, Yoko K.; Shimoda, Michiko; Maverakis, Emanual; Felding, Brunie H.; Cheng, R. Holland; Takada, Yoshikazu			Soluble CD40L activates soluble and cell-surface integrin alpha v beta 3, alpha 5 beta 1, and alpha 4 beta 1 by binding to the allosteric ligandbinding site (site 2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELETS; EXPRESSION; LIGAND; CD154	CD40L is a member of the TNF superfamily that participates in immune cell activation. It binds to and signals through several integrins, including alpha v beta 3 and alpha 5 beta 1, which bind to the trimeric interface of CD40L. We previously showed that several integrin ligands can bind to the allosteric site (site 2), which is distinct from the classical ligand-binding site (site 1), raising the question of if CD40L activates integrins. In our explorations of this question, we determined that integrin alpha 4 beta 1, which is prevalently expressed on the same CD4+ T cells as CD40L, is another receptor for CD40L. Soluble (s)CD40L activated soluble integrins alpha v beta 3, alpha 5 beta 1, and alpha 4 beta 1 in cell-free conditions, indicating that this activation does not require inside-out signaling. Moreover, sCD40L activated cell-surface integrins in CHO cells that do not express CD40. To learn more about the mechanism of binding, we determined that sCD40L bound to a cyclic peptide from site 2. Docking simulations predicted that the residues of CD40L that bind to site 2 are located outside of the CD40L trimer interface, at a site where four HIGM1 (hyper-IgM syndrome type 1) mutations are clustered. We tested the effect of these mutations, finding that the K143T and G144E mutants were the most defective in integrin activation, providing support that this region interacts with site 2. We propose that allosteric integrin activation by CD40L also plays a role in CD40L signaling, and defective site 2 binding may be related to the impaired CD40L signaling functions of these HIGM1 mutants.	[Takada, Yoko K.; Shimoda, Michiko; Maverakis, Emanual; Takada, Yoshikazu] UC Davis Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Takada, Yoko K.; Takada, Yoshikazu] UC Davis Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Felding, Brunie H.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA; [Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; Scripps Research Institute; University of California System; University of California Davis	Takada, Y (corresponding author), UC Davis Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.; Takada, Y (corresponding author), UC Davis Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu			NCI [R01 CA208669-01A1, 3R01CA232845-02S1]; UCDCCC Pilot Funding; NIH [UG3TR002866]; NIFA [CADMCB-7399-H]; UC Davis Comprehensive Cancer Center Support Grant (CCSG) - National Cancer Institute [NCI P30CA093373]; UC Davis STAIR grant	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UCDCCC Pilot Funding; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIFA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); UC Davis Comprehensive Cancer Center Support Grant (CCSG) - National Cancer Institute; UC Davis STAIR grant	This work was supported by UC Davis STAIR grant (Y. T., M. S.), NCI R01 CA208669-01A1 (B. H. F), 3R01CA232845-02S1 (M. S.), and UCDCCC Pilot Funding (Y. T., M. S.) and NIH UG3TR002866 and NIFA CADMCB-7399-H (R. H. C.). This work is partly supported by the UC Davis Comprehensive Cancer Center Support Grant (CCSG) awarded by the National Cancer Institute (NCI P30CA093373).	Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Bunch TA, 2010, J BIOL CHEM, V285, P1841, DOI 10.1074/jbc.M109.057349; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Cha JK, 2000, J KOREAN MED SCI, V15, P273, DOI 10.3346/jkms.2000.15.3.273; Chatzigeorgiou A, 2009, BIOFACTORS, V35, P474, DOI 10.1002/biof.62; Craig DB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-346; Crow MK, 2001, CURR OPIN RHEUMATOL, V13, P361, DOI 10.1097/00002281-200109000-00004; Daub K, 2006, FASEB J, V20, P2559, DOI 10.1096/fj.06-6265fje; Delmas Y, 2005, KIDNEY INT, V68, P2068, DOI 10.1111/j.1523-1755.2005.00663.x; El Fakhry Y, 2012, J BIOL CHEM, V287, P18055, DOI 10.1074/jbc.M111.333989; Fujita M, 2018, BIOCHEM J, V475, P723, DOI 10.1042/BCJ20170867; Fujita M, 2015, J BIOL CHEM, V290, P259, DOI 10.1074/jbc.M114.579946; Fujita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096372; Fujita M, 2012, J IMMUNOL, V189, P5809, DOI 10.4049/jimmunol.1200889; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Pokharel SM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09453-x; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Takada YK, 2019, J IMMUNOL, V203, P1383, DOI 10.4049/jimmunol.1801630; Takada YK, 2017, J BIOL CHEM, V292, P20067, DOI 10.1074/jbc.M117.818302; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Yokoyama K, 1999, BIOCHEMISTRY-US, V38, P5872, DOI 10.1021/bi9827619	31	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100399	10.1016/j.jbc.2021.100399	http://dx.doi.org/10.1016/j.jbc.2021.100399			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571526	Green Published, gold			2022-12-28	WOS:000672866400373
J	Yang, Y; Kang, XJ; Hu, SQ; Chen, BZ; Xie, YJ; Song, B; Zhang, QJ; Wu, H; Ou, ZH; Xian, YX; Fan, Y; Li, XP; Lai, LX; Sun, XF				Yang, Yi; Kang, Xiangjin; Hu, Shiqi; Chen, Bangzhu; Xie, Yingjun; Song, Bing; Zhang, Quanjun; Wu, Han; Ou, Zhanhui; Xian, Yexing; Fan, Yong; Li, Xiaoping; Lai, Liangxue; Sun, Xiaofang			CRISPR/Cas9-mediated beta-globin gene knockout in rabbits recapitulates human beta-thalassemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MODEL; EXPRESSION; MUTATIONS; MICE; COMPLICATIONS; DISRUPTION; GENERATION; SPECTRIN; BLOOD	beta-thalassemia, an autosomal recessive blood disorder that reduces the production of hemoglobin, is majorly caused by the point mutation of the HBB gene resulting in reduced or absent beta-globin chains of the hemoglobin tetramer. Animal models recapitulating both the phenotype and genotype of human disease are valuable in the exploration of pathophysiology and for in vivo evaluation of novel therapeutic treatments. The docile temperament, short vital cycles, and low cost of rabbits make them an attractive animal model. However, beta-thalassemia rabbit models are currently unavailable. Here, using CRISPR/Cas9-mediated genome editing, we point mutated the rabbit beta-globin gene HBB2 with high efficiency and generated a beta-thalassemia rabbit model. Hematological and histological analyses demonstrated that the genotypic mosaic F0 displayed a mild phenotype of anemia, and the heterozygous F1 exhibited typical characteristics of beta-thalassemia. Whole-blood transcriptome analysis revealed that the gene expression was altered in HBB2-targeted when compared with WT rabbits. And the highly expressed genes in HBB2-targeted rabbits were enriched in lipid and iron metabolism, innate immunity, and hematopoietic processes. In conclusion, using CRISPR-mediated HBB2 knockout, we have created a beta-thalassemia rabbit model that accurately recapitulates the human disease phenotype. We believe this tool will be valuable in advancing the investigation of pathogenesis and novel therapeutic targets of beta-thalassemia and associated complications.	[Yang, Yi; Kang, Xiangjin; Hu, Shiqi; Chen, Bangzhu; Xie, Yingjun; Song, Bing; Ou, Zhanhui; Xian, Yexing; Fan, Yong; Sun, Xiaofang] Guangzhou Med Univ, Affiliated Hosp 3, Dept Obstet & Gynecol, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Zhang, Quanjun; Wu, Han; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China; [Li, Xiaoping] Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Zhongshan Med Sch, Key Lab Stem Cells & Tissue Engn,Minist Educ, Guangzhou, Peoples R China	Guangzhou Medical University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Sun Yat Sen University	Sun, XF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Dept Obstet & Gynecol, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China.; Lai, LX (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China.; Li, XP (corresponding author), Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Zhongshan Med Sch, Key Lab Stem Cells & Tissue Engn,Minist Educ, Guangzhou, Peoples R China.	lixiaoping@mail.sysu.edu.cn; lai_liangxue@gibh.ac.cn; xiaofangsun@gzhmu.edu		xiangjin, kang/0000-0001-7377-7169; Sun, Xiaofang/0000-0002-3308-5325	National Key Research and Development Program of China, Stem Cell and Translational Research [2019YFA0111500, 2019YFA0110804]; National Natural Science Foundation of China [31801124, 82071801, 81671121, 31872800]; Guangzhou Science and Technology Project [201803010048, 201904010024]; Guangzhou City Science and Technology Key Topics Project [201904020025]; Guangdong Basic and Applied Basic Research Foundation [2019A1515010755]; Health Science and technology project of Guangzhou [20191A011087]; Natural Science Foundation of Guangdong Province [2020A0505100062]; Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR0201002]	National Key Research and Development Program of China, Stem Cell and Translational Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Project; Guangzhou City Science and Technology Key Topics Project; Guangdong Basic and Applied Basic Research Foundation; Health Science and technology project of Guangzhou; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory	This work was supported by the National Key Research and Development Program of China, Stem Cell and Translational Research [grant numbers 2019YFA0111500, 2019YFA0110804]; the National Natural Science Foundation of China [grant numbers 31801124, 82071801, 81671121, 31872800]; the Guangzhou Science and Technology Project [grant numbers 201803010048, 201904010024]; the Guangzhou City Science and Technology Key Topics Project [201904020025]; the Guangdong Basic and Applied Basic Research Foundation [2019A1515010755]; the Health Science and technology project of Guangzhou [20191A011087]; the Natural Science Foundation of Guangdong Province [2020A0505100062]; Clinical Innovation Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR0201002].	Araki M, 2000, CYTOTECHNOLOGY, V33, P93, DOI 10.1023/A:1008115429679; Baronciani D, 2016, BONE MARROW TRANSPL, V51, P536, DOI 10.1038/bmt.2015.293; Borgna-Pignatti C, 2011, EXPERT REV HEMATOL, V4, P353, DOI [10.1586/EHM.11.29, 10.1586/ehm.11.29]; Canver M. C., 2017, INTEGRATED COMPUTATI, DOI [10.1101/125245, DOI 10.1101/125245]; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Cohen Alan R, 2004, Hematology Am Soc Hematol Educ Program, P14; Crosslin DR, 2013, HUM MOL GENET, V22, P2119, DOI 10.1093/hmg/ddt010; Danjou F, 2011, HAEMATOL-HEMATOL J, V96, P1573, DOI 10.3324/haematol.2011.055962; di Montemuros FM, 2001, BLOOD CELL MOL DIS, V27, P961, DOI 10.1006/bemd.2001.0466; Farmakis D, 2003, MED SCI MONITOR, V9, pRA19; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gallagher PG, 1998, BLOOD CELL MOL DIS, V24, P539, DOI 10.1006/bcmd.1998.0217; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Jamsai D, 2005, GENOMICS, V85, P453, DOI 10.1016/j.ygeno.2004.11.016; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magor GW, 2015, BLOOD, V125, P2405, DOI 10.1182/blood-2014-08-590968; McColl B, 2016, J BLOOD MED, V7, P263, DOI 10.2147/JBM.S87955; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; Opazo JC, 2008, P NATL ACAD SCI USA, V105, P12950, DOI 10.1073/pnas.0804392105; Peng XW, 2015, COMPARATIVE MED, V65, P499; Peng XW, 2012, COMPARATIVE MED, V62, P472; Shamshirsaz Alireza Abdollah, 2003, BMC Endocr Disord, V3, P4; SHEHEE WR, 1993, P NATL ACAD SCI USA, V90, P3177, DOI 10.1073/pnas.90.8.3177; Shiomi Masashi, 2009, P49, DOI 10.1007/978-90-481-2227-1_7; Siwaponanan P, 2017, BLOOD, V129, P3087, DOI 10.1182/blood-2016-07-730135; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Song J, 2013, CELL RES, V23, P1059, DOI 10.1038/cr.2013.85; Vichinsky E, 2014, TRANSFUSION, V54, P972, DOI 10.1111/trf.12348; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wolgast LR, 2011, AM J CLIN PATHOL, V136, P300, DOI 10.1309/AJCPSA5RNM9IGFJF; Yan Quanmei, 2014, Cell Regen, V3, P12, DOI 10.1186/2045-9769-3-12; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; Zhang X, 2014, CIRCULATION, V129, P1650, DOI 10.1161/CIRCULATIONAHA.113.005296	35	3	3	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100464	10.1016/j.jbc.2021.100464	http://dx.doi.org/10.1016/j.jbc.2021.100464			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639162	Green Published, gold			2022-12-28	WOS:000672866400438
J	Ghosh, S; Basu, M; Roy, SS				Ghosh, Sonali; Basu, Moitri; Roy, Sib Sankar			RETRACTION: ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3 (Retraction of Vol 287, Pg 15001, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Ghosh S, 2012, J BIOL CHEM, V287, P15001, DOI 10.1074/jbc.M111.284034	1	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17887	17887						1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454022	Green Published, hybrid			2022-12-28	WOS:000603272300038
J	Sasata, RJ; Reed, DW; Loewen, MC; Covello, PS				Sasata, Robert J.; Reed, Darwin W.; Loewen, Michele C.; Covello, Patrick S.			Domain swapping localizes the structural determinants of regioselectivity in membrane-bound fatty acid desaturases of Caenorhabditis elegans.(vol 279, pg 39296, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Sasata RJ, 2004, J BIOL CHEM, V279, P39296, DOI 10.1074/jbc.M405712200	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2006	281	25					17540	17540						1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	053SV	33725803	hybrid			2022-12-28	WOS:000238326300081
J	Bayarri-Olmos, R; Rosbjerg, A; Johnsen, LB; Helgstrand, C; Bak-Thomsen, T; Garred, P; Skjoedt, MO				Bayarri-Olmos, Rafael; Rosbjerg, Anne; Johnsen, Laust Bruun; Helgstrand, Charlotte; Bak-Thomsen, Theresa; Garred, Peter; Skjoedt, Mikkel-Ole			The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS CORONAVIRUS; SPIKE PROTEIN	Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 from humans to animals has been reported for many domesticated species, including farmed minks. The identification of novel spike gene mutations appearing in minks has raised major concerns about potential immune evasion and challenges for the global vaccine strategy. One genetic variant, known as "cluster five," arose among farmed minks in Denmark and resulted in a complete shutdown of the world's largest mink production. However, the functional properties of this new variant are not established. Here we present functional data on the cluster-five variant, which contains a mutation resulting in a Y453F residue change in the receptor-binding domain (RBD) of the spike protein. Using an ELISA-based angiotensin-converting enzyme-2/RBD inhibition assay, we show that the Y453F variant does not decrease established humoral immunity from previously infected individuals or affect the neutralizing antibody response in a vaccine mouse model based on the original Wuhan strain RBD or spike as antigens. However, biolayer interferometry analysis demonstrates that it binds the human angiotensin-converting enzyme-2 receptor with a 4-fold higher affinity than the original strain, suggesting an enhanced transmission capacity and a possible challenge for viral control. These results also indicate that the rise in the frequency of the cluster-five variant in mink farms might be a result of the fitness advantage conferred by the receptor adaptation rather than evading immune responses.	[Bayarri-Olmos, Rafael; Rosbjerg, Anne; Garred, Peter; Skjoedt, Mikkel-Ole] Univ Hosp Copenhagen, Dept Clin Immunol, Lab Mol Med, Copenhagen, Denmark; [Rosbjerg, Anne; Skjoedt, Mikkel-Ole] Univ Copenhagen, Inst Immunol & Microbiol, Copenhagen, Denmark; [Johnsen, Laust Bruun; Helgstrand, Charlotte; Bak-Thomsen, Theresa] Novo Nordisk AS, Malov, Denmark	University of Copenhagen; University of Copenhagen; Novo Nordisk	Skjoedt, MO (corresponding author), Univ Hosp Copenhagen, Dept Clin Immunol, Lab Mol Med, Copenhagen, Denmark.; Skjoedt, MO (corresponding author), Univ Copenhagen, Inst Immunol & Microbiol, Copenhagen, Denmark.	moskjoedt@sund.ku.dk		Skjodt, Mikkel-Ole/0000-0003-1306-6482; Garred, Peter/0000-0002-2876-8586; Rosbjerg, Anne/0000-0001-6736-3138; Johnsen, Laust/0000-0003-2953-2804	Carlsberg Foundation [CF20-0045]; Novo Nordisk Foundation [NFF205A0063505, NNF20SA0064201]	Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was financially supported by grants from the Carlsberg Foundation (CF20-0045 to M.-O.S., R. B.-O., and P. G.) and the Novo Nordisk Foundation (NFF205A0063505 and NNF20SA0064201 to M.-O. S., R. B.-O., and P. G.).	Bayarri-Olmos R., 2021, RES SQ, P1, DOI [10.21203/rs.3.rs-134388/v1, DOI 10.21203/RS.3.RS-134388/V1]; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Halfmann PJ, 2020, NEW ENGL J MED, V383, P592, DOI 10.1056/NEJMc2013400; Hansen CB, 2021, J IMMUNOL, V206, P109, DOI 10.4049/jimmunol.2000898; He YX, 2004, J IMMUNOL, V173, P4050, DOI 10.4049/jimmunol.173.6.4050; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kupferschmidt K., 2020, SCIENCE DEC, DOI [10.1126/science.abg2626, DOI 10.1126/SCIENCE.ABG2626]; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lassauniere R., 2020, PRELIMINARY REPORT, P1; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Mishra D, 2021, J MED VIROL, V93, P2406, DOI 10.1002/jmv.26744; Molenaar RJ, 2020, VET PATHOL, V57, P653, DOI 10.1177/0300985820943535; Newman A, 2020, MMWR-MORBID MORTAL W, V69, P710, DOI 10.15585/mmwr.mm6923e3; Oreshkova N, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.23.2001005; Oude Munnink B.B., 2020, BIORXIV, DOI 10.1101/2020.09.01.277152; Patterson EI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20097-0; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Sit THC, 2020, NATURE, V586, P776, DOI 10.1038/s41586-020-2334-5; Thomson E. C., 2020, CIRCULATING SARS COV, P1, DOI [10.1101/2020.11.04, DOI 10.1101/2020.11.04]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yoo HS, 2020, J VET SCI, V21, DOI 10.4142/jvs.2020.21.e51; Yurkovetskiy L, 2020, CELL, V183, P739, DOI 10.1016/j.cell.2020.09.032; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4; Zhou WY, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.697035	30	58	59	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100536	10.1016/j.jbc.2021.100536	http://dx.doi.org/10.1016/j.jbc.2021.100536			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33716040	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400510
J	Burris, A; Waite, KA; Reuter, Z; Ockerhausen, S; Roelofs, J				Burris, Alicia; Waite, Kenrick A.; Reuter, Zachary; Ockerhausen, Samuel; Roelofs, Jeroen			Proteasome activator Blm10 levels and autophagic degradation directly impact the proteasome landscape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; 26S PROTEASOME; HYBRID PROTEASOMES; INTERFERON-GAMMA; CORE PARTICLE; YEAST; PROTEIN; SUBSTRATE; SUBUNIT; NUCLEAR	The proteasome selectively degrades proteins. It consists of a core particle (CP), which contains proteolytic active sites that can associate with different regulators to form various complexes. How these different complexes are regulated and affected by changing physiological conditions, however, remains poorly understood. In this study, we focused on the activator Blm10 and the regulatory particle (RP). In yeast, increased expression of Blm10 outcompeted RP for CP binding, which suggests that controlling the cellular levels of Blm10 can affect the relative amounts of RP-bound CP. While strong overexpression of BLM10 almost eliminated the presence of RP-CP complexes, the phenotypes this should induce were not observed. Our results show this was due to the induction of Blm10-CP autophagy under prolonged growth in YPD. Similarly, under conditions of endogenous BLM10 expression, Blm10 was degraded through autophagy as well. This suggests that reducing the levels of Blm10 allows for more CP-binding surfaces and the formation of RP-CP complexes under nutrient stress. This work provides important insights into maintaining the proteasome landscape and how protein expression levels affect proteasome function.	[Burris, Alicia; Waite, Kenrick A.; Roelofs, Jeroen] Univ Kansas, Dept Biochem & Mol Biol, Med Ctr, Kansas City, KS 64106 USA; [Burris, Alicia; Reuter, Zachary; Ockerhausen, Samuel; Roelofs, Jeroen] Kansas State Univ, Mol Cellular & Dev Biol Program, Div Biol, Manhattan, KS 66506 USA	University of Kansas; University of Kansas Medical Center; Kansas State University	Roelofs, J (corresponding author), Univ Kansas, Dept Biochem & Mol Biol, Med Ctr, Kansas City, KS 64106 USA.; Roelofs, J (corresponding author), Kansas State Univ, Mol Cellular & Dev Biol Program, Div Biol, Manhattan, KS 66506 USA.	jroelofs@kumc.edu			National Institutes of Health (National Institute of General Medical Science: K-INBRE program) [P20GM103418, R01GM118660]	National Institutes of Health (National Institute of General Medical Science: K-INBRE program)	This work was supported by grants from the National Institutes of Health (National Institute of General Medical Science: K-INBRE program P20GM103418 and R01GM118660 to J. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105; Blickwedehl J, 2007, RADIAT RES, V167, P663, DOI 10.1667/RR0690.1; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Dange T, 2011, J BIOL CHEM, V286, P42830, DOI 10.1074/jbc.M111.300178; Dasgupta S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163312; De La Mota-Peynado A, 2013, J BIOL CHEM, V288, P29467, DOI 10.1074/jbc.M113.491662; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Ghaboosi N, 2007, MOL BIOL CELL, V18, P1953, DOI 10.1091/mbc.E06-10-0965; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Gu ZC, 2017, MOL BIOL CELL, V28, P2479, DOI 10.1091/mbc.E17-03-0162; Guan HX, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000654; Hendil KB, 1998, BIOCHEM J, V332, P749, DOI 10.1042/bj3320749; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kock M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7123; Kopp F, 2001, J MOL BIOL, V313, P465, DOI 10.1006/jmbi.2001.5063; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2010, MOL CELL, V38, P879, DOI 10.1016/j.molcel.2010.06.016; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Li XH, 2014, J BIOL CHEM, V289, P17392, DOI 10.1074/jbc.M114.561183; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; Mandemaker IK, 2018, EMBO REP, V19, DOI 10.15252/embr.201745566; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Marshall RS, 2018, ELIFE, V7, DOI [10.7554/eLife.34532, 10.7554/elife.34532]; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; Nemec AA, 2017, J BIOL CHEM, V292, P21466, DOI 10.1074/jbc.M117.817999; Nie J, 2010, FEBS LETT, V584, P3021, DOI 10.1016/j.febslet.2010.05.034; Olszewski MM, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0283-z; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Prein B, 2000, FEBS LETT, V485, P29, DOI 10.1016/S0014-5793(00)02179-7; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Rego AT, 2019, MOL CELL, V76, P138, DOI 10.1016/j.molcel.2019.07.014; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Roelofs J, 2018, METHODS MOL BIOL, V1844, P237, DOI 10.1007/978-1-4939-8706-1_16; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schmidt RM, 2019, ELIFE, V8, DOI 10.7554/eLife.43244; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Shirozu R, 2015, FEBS LETT, V589, P933, DOI 10.1016/j.febslet.2015.02.025; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Stadtmueller BM, 2012, J BIOL CHEM, V287, P37371, DOI 10.1074/jbc.M112.367003; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Sundin BA, 2004, YEAST, V21, P793, DOI 10.1002/yea.1133; Suzuki R, 2009, J VIROL, V83, P2389, DOI 10.1128/JVI.01690-08; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tar K, 2014, J BIOL CHEM, V289, P12145, DOI 10.1074/jbc.M114.554105; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Vigneron N, 2014, BIOMOLECULES, V4, P994, DOI 10.3390/biom4040994; Waite KA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75126-1; Waite KA, 2016, J BIOL CHEM, V291, P3239, DOI 10.1074/jbc.M115.699124; Wani PS, 2016, SCI REP-UK, V6, DOI 10.1038/srep27873; Wani PS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7384; Weberruss MH, 2013, EMBO J, V32, P2697, DOI 10.1038/emboj.2013.192; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yu HQ, 2016, J BIOL CHEM, V291, P14526, DOI 10.1074/jbc.M116.727578; Zhang ZG, 1998, P NATL ACAD SCI USA, V95, P2807, DOI 10.1073/pnas.95.6.2807	79	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100468	10.1016/j.jbc.2021.100468	http://dx.doi.org/10.1016/j.jbc.2021.100468			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639167	Green Published, gold			2022-12-28	WOS:000672866400442
J	Eesmaa, A; Yu, LY; Goos, H; Noges, K; Kovaleva, V; Hellman, M; Zimmermann, R; Jung, M; Permi, P; Varjosalo, M; Lindholm, P; Saarma, M				Eesmaa, Ave; Yu, Li-Ying; Goos, Helka; Noges, Kristofer; Kovaleva, Vera; Hellman, Maarit; Zimmermann, Richard; Jung, Martin; Permi, Perttu; Varjosalo, Markku; Lindholm, Paivi; Saarma, Mart			The cytoprotective protein MANF promotes neuronal survival independently from its role as a GRP78 cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEUROTROPHIC FACTOR MANF; ER-STRESS; COMPREHENSIVE RESOURCE; BIP; BINDING; ATF6; ATP; DISSOCIATION; IRE1-ALPHA	Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an endoplasmic reticulum (ER)-stress-regulated protein exhibiting cytoprotective properties through a poorly understood mechanism in various in vitro and in vivo models of neuronal and non-neuronal damage. Although initially characterized as a secreted neurotrophic factor for midbrain dopamine neurons, MANF has recently gained more interest for its intracellular role in regulating the ER homeostasis, including serving as a cofactor of the chaperone glucose-regulated protein 78 (GRP78). We aimed for a better understanding of the neuroprotective mechanisms of MANF. Here we show for the first time that MANF promotes the survival of ER-stressed neurons in vitro as a general unfolded protein response (UPR) regulator, affecting several UPR pathways simultaneously. Interestingly, MANF does not affect naive neurons. We hypothesize that MANF regulates UPR signaling toward a mode more compatible with neuronal survival. Screening of MANF interacting proteins from two mammalian cell lines revealed a conserved interactome of 15 proteins including several ER chaperones such as GRP78, GRP170, protein disulfide isomerase family A member 1, and protein disulfide isomerase family A member 6. Further characterization confirmed previously published finding that MANF is a cofactor of GRP78 interacting with its nucleotide binding domain. Using microscale thermophoresis and nuclear magnetic resonance spectroscopy, we discovered that MANF is an ATP binding protein and that ATP blocks the MANF-GRP78 interaction. Interestingly, functional analysis of the antiapoptotic properties of MANF mutants in cultured neurons revealed divergent roles of MANF as a GRP78 cofactor and as an antiapoptotic regulator of UPR. We conclude that the co-factor type interaction with GRP78 is dispensable for the survival-promoting activity of MANF in neurons.	[Eesmaa, Ave; Yu, Li-Ying; Goos, Helka; Noges, Kristofer; Kovaleva, Vera; Varjosalo, Markku; Lindholm, Paivi; Saarma, Mart] Univ Helsinki, Inst Biotechnol, HiLIFE, Helsinki, Finland; [Hellman, Maarit; Permi, Perttu] Univ Jyvaskyla, Nanosci Ctr, Dept Chem, Jyvaskyla, Finland; [Zimmermann, Richard; Jung, Martin] Saarland Univ, Med Biochem & Mol Biol, Homburg, Germany; [Permi, Perttu] Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm Sci, Jyvaskyla, Finland	University of Helsinki; University of Jyvaskyla; Universitatsklinikum des Saarlandes; University of Jyvaskyla	Lindholm, P; Saarma, M (corresponding author), Univ Helsinki, Inst Biotechnol, HiLIFE, Helsinki, Finland.	paivi.pulkkila@helsinki.fi; mart.saarma@helsinki.fi	Jung, Martin/AAM-4547-2021; Varjosalo, Markku/K-6424-2015	Jung, Martin/0000-0002-1482-7020; Varjosalo, Markku/0000-0002-1340-9732; Eesmaa, Ave/0000-0002-3397-3330; Goos, Helka/0000-0002-6175-4872; Kovaleva, Vera/0000-0001-7597-0480; Pulkkila, Paivi/0000-0003-3022-5035	Jane and Aatos Erkko Foundation; Academy of Finland [1310891]; European Union H2020 project "TreatER" [732386]	Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); European Union H2020 project "TreatER"	This work was funded by Jane and Aatos Erkko Foundation, Academy of Finland (grant 1310891) and European Union H2020 project "TreatER" (No 732386).	Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bai MR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03355-0; Bergmann TJ, 2018, J BIOL CHEM, V293, P5600, DOI 10.1074/jbc.RA117.001484; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bies C, 1999, BIOL CHEM, V380, P1175, DOI 10.1515/BC.1999.149; Bonora M, 2012, PURINERG SIGNAL, V8, P343, DOI 10.1007/s11302-012-9305-8; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carrara M, 2015, ELIFE, V4, DOI 10.7554/eLife.03522; Chen LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08133; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; Compostella F, 2012, CR CHIM, V15, P37, DOI 10.1016/j.crci.2011.09.011; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Danilova T, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00765; Danilova T, 2019, DIABETES, V68, P66, DOI 10.2337/db17-1149; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Gorasia DG, 2016, BBA-PROTEINS PROTEOM, V1864, P715, DOI 10.1016/j.bbapap.2016.03.002; Grinberg AV, 2004, MOL CELL BIOL, V24, P4294, DOI 10.1128/MCB.24.10.4294-4308.2004; Hakonen E, 2018, DIABETOLOGIA, V61, P2202, DOI 10.1007/s00125-018-4687-y; Hartley CL, 2013, HUM MOL GENET, V22, P5262, DOI 10.1093/hmg/ddt383; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Hellman M, 2010, BIOMOL NMR ASSIGN, V4, P215, DOI 10.1007/s12104-010-9251-8; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hong F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169260; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang JW, 2016, CELL BIOL INT, V40, P803, DOI 10.1002/cbin.10621; Ikeda J, 1997, BIOCHEM BIOPH RES CO, V230, P94, DOI 10.1006/bbrc.1996.5890; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Jung TW, 2018, J PHARMACOL EXP THER, V365, P485, DOI 10.1124/jpet.117.246686; Karagoz GE, 2017, ELIFE, V6, DOI 10.7554/eLife.30700; Kim Y, 2016, J AM SOC NEPHROL, V27, P2974, DOI 10.1681/ASN.2014100986; Klein MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06003-9; Kovaleva V., 2020, MANF REGULATES UNFOL, DOI [10.1101/2020.09.22.307744, DOI 10.1101/2020.09.22.307744]; Latge C, 2015, J BIOL CHEM, V290, P20527, DOI 10.1074/jbc.M115.662254; Latge C, 2013, BIOMOL NMR ASSIGN, V7, P101, DOI 10.1007/s12104-012-9388-8; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindahl M, 2017, NEUROBIOL DIS, V97, P90, DOI 10.1016/j.nbd.2016.07.009; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Lindstrom R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151550; Lindstrom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073928; Liu JQ, 2018, BIOCHEM BIOPH RES CO, V497, P564, DOI 10.1016/j.bbrc.2018.02.095; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Matlik K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.371; Matlik K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap8957; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; MCKAY DB, 1993, ADV PROTEIN CHEM, V44, P67, DOI 10.1016/S0065-3233(08)60564-1; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Michalak M, 2009, TRENDS CELL BIOL, V19, P253, DOI 10.1016/j.tcb.2009.03.006; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Neves J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3646; Oikawa D, 2009, EXP CELL RES, V315, P2496, DOI 10.1016/j.yexcr.2009.06.009; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pakarinen E, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0477-19.2019; Palgi M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-134; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Prins D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004069; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Silla T, 2005, J VIROL, V79, P15277, DOI 10.1128/JVI.79.24.15277-15288.2005; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Varjosalo M, 2013, CELL REP, V3, P1306, DOI 10.1016/j.celrep.2013.03.027; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Vishnu N, 2014, MOL BIOL CELL, V25, P368, DOI 10.1091/mbc.E13-07-0433; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weitzmann A, 2007, FEBS J, V274, P5175, DOI 10.1111/j.1742-4658.2007.06039.x; Wu YB, 2013, CELL PHYSIOL BIOCHEM, V32, P367, DOI 10.1159/000354444; Yagi T, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101810; Yan YH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08450-4; Yang S, 2014, NEURON, V81, P349, DOI 10.1016/j.neuron.2013.12.002; Zhao M, 2017, ONCOTARGET, V8, P77061, DOI 10.18632/oncotarget.20352	103	10	10	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100295	10.1016/j.jbc.2021.100295	http://dx.doi.org/10.1016/j.jbc.2021.100295			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460650	Green Published, gold			2022-12-28	WOS:000672866400269
J	Elrick, MJ; Pekosz, A; Duggal, P				Elrick, Matthew J.; Pekosz, Andrew; Duggal, Priya			Enterovirus D68 molecular and cellular biology and pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACUTE FLACCID MYELITIS; CENTRAL-NERVOUS-SYSTEM; UNITED-STATES; POLIOVIRUS INFECTION; RESPIRATORY ILLNESS; PROTEIN-SYNTHESIS; NUCLEOCYTOPLASMIC TRAFFICKING; PARECHOVIRUS SURVEILLANCE; TRANSLATION INITIATION; HUMAN RHINOVIRUS-87	In recent years, enterovirus D68 (EV-D68) has advanced from a rarely detected respiratory virus to a widespread pathogen responsible for increasing rates of severe respiratory illness and acute flaccid myelitis (AFM) in children worldwide. In this review, we discuss the accumulating data on the molecular features of EV-D68 and place these into the context of enterovirus biology in general. We highlight similarities and differences with other enteroviruses and genetic divergence from own historical prototype strains of EV-D68. These include changes in capsid antigens, host cell receptor usage, and viral RNA metabolism collectively leading to increased virulence. Furthermore, we discuss the impact of EV-D68 infection on the biology of its host cells, and how these changes are hypothesized to contribute to motor neuron toxicity in AFM. We highlight areas in need of further research, including the identification of its primary receptor and an understanding of the pathogenic cascade leading to motor neuron injury in AFM. Finally, we discuss the epidemiology of the EV-D68 and potential therapeutic approaches.	[Elrick, Matthew J.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Pekosz, Andrew] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Duggal, Priya] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Elrick, MJ (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	melrick1@jhmi.edu		Elrick, Matthew/0000-0001-7608-7593; Duggal, Priya/0000-0001-5809-2081	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke [5K12NS098482-03]; NIH/National Institute of Allergy and Infectious Diseases [R01AI148049]; Johns Hopkins University Catalyst Award;  [HHSN272201700024I];  [HHSN27220 1400007C]	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins University Catalyst Award; ; 	M. J. E. is supported by National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (5K12NS098482-03). A. P. is supported by HHSN272201700024I and HHSN27220 1400007C. P. D. is supported by NIH/National Institute of Allergy and Infectious Diseases (R01AI148049) and the Johns Hopkins University Catalyst Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abedi GR, 2018, MMWR-MORBID MORTAL W, V67, P515, DOI 10.15585/mmwr.mm6718a2; Abedi GR, 2015, MMWR-MORBID MORTAL W, V64, P940, DOI 10.15585/mmwr.mm6434a3; Andersen EW, 2017, EUR J NEUROL, V24, P1077, DOI 10.1111/ene.13345; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Ayers T, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-1619; Baggen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11256-z; Baggen J, 2016, P NATL ACAD SCI USA, V113, P1399, DOI 10.1073/pnas.1524498113; Barton DJ, 1999, J VIROL, V73, P10104, DOI 10.1128/JVI.73.12.10104-10112.1999; Bearden D, 2016, J ALLER CL IMM-PRACT, V4, P1059, DOI 10.1016/j.jaip.2015.12.015; Belnap DM, 2000, J VIROL, V74, P1342, DOI 10.1128/JVI.74.3.1342-1354.2000; Belov GA, 2004, J VIROL, V78, P10166, DOI 10.1128/JVI.78.18.10166-10177.2004; Belov GA, 2012, J VIROL, V86, P302, DOI 10.1128/JVI.05937-11; Bertini E, 2014, NEUROLOGY, V82, P1298, DOI 10.1212/WNL.0000000000000321; Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; Bodian D., 1948, POLIOMYELITIS; Bonderoff JM, 2008, J VIROL, V82, P9389, DOI 10.1128/JVI.00006-08; Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183; Brown DM, 2018, MBIO, V9, DOI 10.1128/mBio.01954-18; Castello A, 2009, J CELL SCI, V122, P3799, DOI 10.1242/jcs.055988; Chang LY, 2006, PEDIATR RES, V60, P466, DOI 10.1203/01.pdr.0000238247.86041.19; CHAUDHRY V, 1992, MUSCLE NERVE, V15, P687, DOI 10.1002/mus.880150610; Cheng JY, 2020, J VIROL, V94, DOI 10.1128/JVI.02041-19; Corona AK, 2018, CELL REP, V22, P3304, DOI 10.1016/j.celrep.2018.03.003; Dai WL, 2018, VACCINE, V36, P653, DOI 10.1016/j.vaccine.2017.12.057; DAS S, 1993, J VIROL, V67, P3326, DOI 10.1128/JVI.67.6.3326-3331.1993; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; Deonarain R, 2004, CIRCULATION, V110, P3540, DOI 10.1161/01.CIR.0000136824.73458.20; Dotzauer Andreas, 2012, World J Virol, V1, P91, DOI 10.5501/wjv.v1.i3.91; Drews SJ, 2015, J CLIN MICROBIOL, V53, P1042, DOI 10.1128/JCM.02982-14; Du HW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14302; Du J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144208; Dyda A, 2018, EUROSURVEILLANCE, V23, P16, DOI 10.2807/1560-7917.ES.2018.23.3.17-00310; Dyrdak R, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.46.30403; Elling U, 2017, NATURE, V550, P114, DOI 10.1038/nature24027; Elrick MJ, 2019, JAMA PEDIATR, V173, P702, DOI 10.1001/jamapediatrics.2019.1272; Elrick MJ, 2019, JAMA PEDIATR, V173, P134, DOI 10.1001/jamapediatrics.2018.4890; Ertel KJ, 2010, J VIROL, V84, P4229, DOI 10.1128/JVI.02198-09; Eshaghi A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00257; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Feng Q, 2012, CELL REP, V2, P1187, DOI 10.1016/j.celrep.2012.10.005; Fitzgerald KD, 2013, VIRUS RES, V176, P223, DOI 10.1016/j.virusres.2013.06.012; Flather D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00594; Furuse Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070626; Galan A, 2017, FEBS J, V284, P3202, DOI 10.1111/febs.14184; Gao QQ, 2015, ANTIMICROB AGENTS CH, V59, P2654, DOI 10.1128/AAC.05108-14; GELLER TJ, 1995, J NEUROL SCI, V129, P131, DOI 10.1016/0022-510X(94)00261-L; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gong YN, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004416; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; Gordon-Lipkin E, 2019, DEV MED CHILD NEUROL, V61, P366, DOI 10.1111/dmcn.14030; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; GRAHAM S, 1993, J VIROL, V67, P1627, DOI 10.1128/JVI.67.3.1627-1637.1993; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Grifoni A, 2019, HUM IMMUNOL, V80, P923, DOI 10.1016/j.humimm.2019.08.004; Gustin KE, 2003, VIRUS RES, V95, P35, DOI 10.1016/S0168-1702(03)00165-5; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Haparian V. V., 1979, DIAGNOSTIC PROCEDURE, P535; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Helfferich J, 2019, EUR J PEDIATR, V178, P1305, DOI 10.1007/s00431-019-03435-3; HERNDON CN, 1951, AM J HUM GENET, V3, P17; Herold J, 2001, MOL CELL, V7, P581, DOI 10.1016/S1097-2765(01)00205-2; Hixon AM, 2019, J VIROL, V93, DOI 10.1128/JVI.00578-19; Hixon AM, 2017, J INFECT DIS, V216, P1245, DOI 10.1093/infdis/jix468; Hixon AM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006199; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; Holm-Hansen CC, 2016, LANCET INFECT DIS, V16, pE64, DOI 10.1016/S1473-3099(15)00543-5; Hopkins SE, 2019, JAMA PEDIATR, V173, P117, DOI 10.1001/jamapediatrics.2018.4896; Hovden IAH, 2015, MUSCLE NERVE, V52, P909, DOI 10.1002/mus.24738; HOVI T, 1993, J CLIN MICROBIOL, V31, P1083, DOI 10.1128/JCM.31.5.1083-1087.1993; Hu YM, 2020, ACS INFECT DIS, V6, P1572, DOI 10.1021/acsinfecdis.0c00120; Huang WH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15223; Huang Y, 2000, J VIROL, V74, P8757, DOI 10.1128/JVI.74.18.8757-8761.2000; Huhn MH, 2010, VIROLOGY, V401, P42, DOI 10.1016/j.virol.2010.02.010; Hurst BL, 2019, VIROLOGY, V526, P146, DOI 10.1016/j.virol.2018.10.014; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Imamura T, 2014, J VIROL, V88, P2374, DOI 10.1128/JVI.03070-13; Ishiko H, 2002, INTERVIROLOGY, V45, P136, DOI 10.1159/000065866; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kanda T, 2010, J VIRAL HEPATITIS, V17, P618, DOI 10.1111/j.1365-2893.2009.01221.x; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kemball CC, 2010, FUTURE MICROBIOL, V5, P1329, DOI 10.2217/FMB.10.101; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kidd S, 2020, MMWR-MORBID MORTAL W, V69, P1031, DOI 10.15585/mmwr.mm6931e3; Kim HJ, 2017, NEURON, V96, P285, DOI 10.1016/j.neuron.2017.07.029; Kim SSY, 2019, J BIOL CHEM, V294, P6430, DOI 10.1074/jbc.RA118.005868; Kim Y, 2016, ANTIVIR RES, V125, P84, DOI 10.1016/j.antiviral.2015.11.010; Knoester M, 2019, PEDIATR INFECT DIS J, V38, P16, DOI 10.1097/INF.0000000000002188; Knoester M, 2017, EMERG INFECT DIS, V23, P140, DOI 10.3201/eid2301.161313; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Kujawski SA, 2019, MMWR-MORBID MORTAL W, V68, P277, DOI 10.15585/mmwr.mm6812a1; Kuo RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063431; Lai JKF, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070169; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; Laufman O, 2019, CELL, V178, P275, DOI 10.1016/j.cell.2019.05.030; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Limpens RWAL, 2011, MBIO, V2, DOI 10.1128/mBio.00166-11; Liu YC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004199; Liu Y, 2018, P NATL ACAD SCI USA, V115, pE12209, DOI 10.1073/pnas.1803347115; Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9865; Liu Y, 2015, SCIENCE, V347, P71, DOI 10.1126/science.1261962; Ma CL, 2019, ACS INFECT DIS, V5, P1952, DOI 10.1021/acsinfecdis.9b00284; Maloney JA, 2015, AM J NEURORADIOL, V36, P245, DOI 10.3174/ajnr.A4188; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Martin JA, 2017, NEUROLOGY, V89, P129, DOI 10.1212/WNL.0000000000004081; McLaren N, 2020, EMERG INFECT DIS, V26, P212, DOI 10.3201/eid2602.191453; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Melicosta ME, 2019, J PEDIATR REHAB MED, V12, P245, DOI 10.3233/PRM-180549; Mena I, 1999, AM J PATHOL, V155, P1205, DOI 10.1016/S0002-9440(10)65223-6; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Messacar K, 2018, MMWR-MORBID MORTAL W, V67, P1017, DOI 10.15585/mmwr.mm6736a5; Messacar K, 2018, LANCET INFECT DIS, V18, pE239, DOI 10.1016/S1473-3099(18)30094-X; Messacar K, 2016, ANN NEUROL, V80, P326, DOI 10.1002/ana.24730; Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0; Midgley S. E., 2020, EURO SURVEILL, V25; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; MINOR PD, 1993, BIOLOGICALS, V21, P357, DOI 10.1006/biol.1993.1096; Mishra N, 2019, MBIO, V10, DOI 10.1128/mBio.01903-19; Morrey JD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010033; Mueller S, 2002, J BIOL CHEM, V277, P7897, DOI 10.1074/jbc.M111937200; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Musharrafieh R, 2019, J MED CHEM, V62, P4074, DOI 10.1021/acs.jmedchem.9b00115; Mutnal MB, 2020, J MED VIROL, V92, P2130, DOI 10.1002/jmv.26010; Natera-de Benito Daniel, 2018, J Clin Neuromuscul Dis, V20, P100, DOI 10.1097/CND.0000000000000217; NATHANSON N, 1963, AM J HYG, V78, P29, DOI 10.1093/oxfordjournals.aje.a120328; NATHANSON N, 1961, B JOHNS HOPKINS HOSP, V108, P308; Nathanson N, 2010, AM J EPIDEMIOL, V172, P1213, DOI 10.1093/aje/kwq320; Nelson GR, 2016, PEDIATR NEUROL, V55, P17, DOI 10.1016/j.pediatrneurol.2015.10.007; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; NGUYEN C, 1995, AM J NEURORADIOL, V16, P265; Nguyen DKH, 2019, NEUROSCI LETT, V697, P34, DOI 10.1016/j.neulet.2018.04.006; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Ohka S, 1998, VIROLOGY, V250, P67, DOI 10.1006/viro.1998.9360; Ohka S, 2004, J VIROL, V78, P7186, DOI 10.1128/JVI.78.13.7186-7198.2004; Okumura A, 2019, BRAIN DEV-JPN, V41, P443, DOI 10.1016/j.braindev.2018.12.001; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Pallansch M., 2007, FIELDS VIROL, P839; Pallansch M. A., 2013, FIELDS VIROLOGY, V6th; Panjwani A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004294; Park N, 2008, J VIROL, V82, P1647, DOI 10.1128/JVI.01670-07; Park N, 2010, J BIOL CHEM, V285, P28796, DOI 10.1074/jbc.M110.143404; Park Sang Woo, 2021, medRxiv, DOI 10.1101/2020.07.23.20069468; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Perera R, 2007, J VIROL, V81, P8919, DOI 10.1128/JVI.01013-07; PING LH, 1992, J VIROL, V66, P2208, DOI 10.1128/JVI.66.4.2208-2216.1992; Piras A, 2018, NEURAL REGEN RES, V13, P813, DOI 10.4103/1673-5374.232473; Pons-Salort M, 2018, SCIENCE, V361, P800, DOI 10.1126/science.aat6777; Pons-Salort M, 2018, P NATL ACAD SCI USA, V115, P3078, DOI 10.1073/pnas.1721159115; Pulli T, 1998, VIROLOGY, V240, P202, DOI 10.1006/viro.1997.8908; Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015; RACANIELLO VR, 1994, ARCH VIROL, P79; Rajput C, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121882; RANISH N, 1972, J NEUROCHEM, V19, P2641, DOI 10.1111/j.1471-4159.1972.tb01323.x; REIMANN BY, 1991, J VIROL, V65, P3475, DOI 10.1128/JVI.65.7.3475-3480.1991; Reineke LC, 2015, MBIO, V6, DOI 10.1128/mBio.02486-14; Reineke LC, 2015, J VIROL, V89, P2575, DOI 10.1128/JVI.02791-14; REN RB, 1992, J INFECT DIS, V166, P747, DOI 10.1093/infdis/166.4.747; Rhoden E, 2015, ANTIMICROB AGENTS CH, V59, P7779, DOI 10.1128/AAC.00766-15; Richer MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004127; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rosenfeld AB, 2019, MBIO, V10, DOI 10.1128/mBio.02370-19; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Royston L, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006962; Rui YJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00546-17; SABIN AB, 1956, SCIENCE, V123, P1151, DOI 10.1126/science.123.3209.1151; SABIN AB, 1960, ARCH INTERN MED, V106, P57, DOI 10.1001/archinte.1960.03820010007003; SALK JE, 1953, JAMA-J AM MED ASSOC, V151, P1081, DOI 10.1001/jama.1953.13.1081; Saltzman EB, 2018, PEDIATR NEUROL, V88, P25, DOI 10.1016/j.pediatrneurol.2018.07.018; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Schubert RD, 2019, NAT MED, V25, P1748, DOI 10.1038/s41591-019-0613-1; Sejvar JJ, 2016, CLIN INFECT DIS, V63, P737, DOI 10.1093/cid/ciw372; Shen LY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42651-7; SHERRY B, 1986, J VIROL, V57, P246, DOI 10.1128/JVI.57.1.246-257.1986; Shi JY, 2013, AUTOPHAGY, V9, P1591, DOI 10.4161/auto.26059; Simmonds P, 2020, ARCH VIROL, V165, P793, DOI 10.1007/s00705-019-04520-6; SIMONS J, 1993, J VIROL, V67, P1262, DOI 10.1128/JVI.67.3.1262-1268.1993; Smee DF, 2016, ANTIVIR RES, V131, P61, DOI 10.1016/j.antiviral.2016.04.003; Smith B. D., 2020, BIORXIV, DOI [10.1101/2020.1103.1131.019380, DOI 10.1101/2020.1103.1131.019380]; Staring J, 2017, NATURE, V541, P412, DOI 10.1038/nature21032; Strauss M, 2013, J VIROL, V87, P3903, DOI 10.1128/JVI.03209-12; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Sun J, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060490; Sun L, 2015, ANTIMICROB AGENTS CH, V59, P7782, DOI 10.1128/AAC.01375-15; Sun SY, 2019, ANTIVIR RES, V161, P108, DOI 10.1016/j.antiviral.2018.11.013; Sweeney TR, 2014, EMBO J, V33, P76, DOI 10.1002/embj.201386124; Tan Y, 2016, J VIROL, V90, P1997, DOI 10.1128/JVI.02418-15; Tang Q, 2020, ANTIVIR RES, V173, DOI 10.1016/j.antiviral.2019.104650; Triantafilou K, 2005, CELL MICROBIOL, V7, P1117, DOI 10.1111/j.1462-5822.2005.00537.x; Ulferts R, 2013, ANTIMICROB AGENTS CH, V57, P1952, DOI 10.1128/AAC.02084-12; UNCAPHER CR, 1991, VIROLOGY, V180, P814, DOI 10.1016/0042-6822(91)90098-V; van der Linden L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004733; Van Haren K, 2015, JAMA-J AM MED ASSOC, V314, P2663, DOI 10.1001/jama.2015.17275; VIMTRUP B, 1956, Acta Pathol Microbiol Scand Suppl, V39, P27; Visser LJ, 2019, J VIROL, V93, DOI 10.1128/JVI.00222-19; Vogt MR, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba4902; Wahid R, 2005, J VIROL, V79, P401, DOI 10.1128/JVI.79.1.401-409.2005; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Wang GQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01349-4; Wang HB, 2015, CELL REP, V12, P42, DOI 10.1016/j.celrep.2015.05.047; Wang JP, 2010, J VIROL, V84, P254, DOI 10.1128/JVI.00631-09; Wang Y, 2014, AM J PHYSIOL-HEART C, V307, pH1438, DOI 10.1152/ajpheart.00441.2014; Wang ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00029; Wei W, 2016, CELL HOST MICROBE, V20, P631, DOI 10.1016/j.chom.2016.09.013; Wen XJ, 2019, FUTURE MICROBIOL, V14, P1147, DOI 10.2217/fmb-2019-0127; Wessely R, 2001, CIRCULATION, V103, P756; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Wyatt H V, 1975, Med Hypotheses, V1, P35, DOI 10.1016/0306-9877(75)90040-7; Xiang ZC, 2016, J VIROL, V90, P1613, DOI 10.1128/JVI.02395-15; Xiang ZC, 2014, J VIROL, V88, P6650, DOI 10.1128/JVI.03138-13; Xu N, 2020, J VIROL, V94, DOI 10.1128/JVI.00204-20; Yalamanchili P, 1997, VIROLOGY, V239, P176, DOI 10.1006/viro.1997.8862; Yalamanchili P, 1997, J VIROL, V71, P1220, DOI 10.1128/JVI.71.2.1220-1226.1997; Yang JE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64531-1; Yoo JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004012; YOSHIHARA Y, 1994, NEURON, V12, P541, DOI 10.1016/0896-6273(94)90211-9; Yu JH, 2015, CELL CYCLE, V14, P425, DOI 10.4161/15384101.2014.980631; Zhang B, 2007, BIOCHEM BIOPH RES CO, V364, P725, DOI 10.1016/j.bbrc.2007.09.133; Zhang C, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020058; Zhang C, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0005-x; Zhang YT, 2015, J CLIN VIROL, V69, P172, DOI 10.1016/j.jcv.2015.06.086; Zhang Y, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew015; Zheng HW, 2018, J IMMUNOL, V201, P2557, DOI 10.4049/jimmunol.1800655; Zheng QB, 2019, NAT MICROBIOL, V4, P124, DOI 10.1038/s41564-018-0275-7	227	7	8	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100317	10.1016/j.jbc.2021.100317	http://dx.doi.org/10.1016/j.jbc.2021.100317			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33484714	Green Published, gold			2022-12-28	WOS:000672866400291
J	Guengerich, FP; McCarty, KD; Chapman, JG				Guengerich, F. Peter; McCarty, Kevin D.; Chapman, Jesse G.			Kinetics of cytochrome P450 3A4 inhibition by heterocyclic drugs defines a general sequential multistep binding process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INACTIVATION; LIGAND-BINDING; P450 REDUCTASE; ACTIVE-SITE; METABOLISM; RITONAVIR; CYP3A4; ITRACONAZOLE; OXIDATION; ENZYMES	Cytochrome P450 (P450) 3A4 is the enzyme most involved in the metabolism of drugs and can also oxidize numerous steroids. This enzyme is also involved in one-half of pharmacokinetic drug-drug interactions, but details of the exact mechanisms of P450 3A4 inhibition are still unclear in many cases. Ketoconazole, clotrimazole, ritonavir, indinavir, and itraconazole are strong inhibitors; analysis of the kinetics of reversal of inhibition with the model substrate 7-benzoyl quinoline showed lag phases in several cases, consistent with multiple structures of P450 3A4 inhibitor complexes. Lags in the onset of inhibition were observed when inhibitors were added to P450 3A4 in 7-benzoyl quinoline O-debenzylation reactions, and similar patterns were observed for inhibition of testosterone 6 beta-hydroxylation by ritonavir and indinavir. Upon mixing with inhibitors, P450 3A4 showed rapid binding as judged by a spectral shift with at least partial high-spin iron character, followed by a slower conversion to a low-spin iron-nitrogen complex. The changes were best described by two intermediate complexes, one being a partial high-spin form and the second another intermediate, with half-lives of seconds. The kinetics could be modeled in a system involving initial loose binding of inhibitor, followed by a slow step leading to a tighter complex on a multisecond time scale. Although some more complex possibilities cannot be dismissed, these results describe a system in which conformationally distinct forms of P450 3A4 bind inhibitors rapidly and two distinct P450-inhibitor complexes exist en route to the final enzyme-inhibitor complex with full inhibitory activity.	[Guengerich, F. Peter; McCarty, Kevin D.; Chapman, Jesse G.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37235 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37235 USA.	f.guengerich@vanderbilt.edu		Chapman, Jesse G/0000-0002-3104-1310	National Institutes of Health [R01 GM118122]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health grant R01 GM118122 (F. P. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABELES RH, 1976, ACCOUNTS CHEM RES, V9, P313, DOI 10.1021/ar50105a001; Barr JT, 2020, DRUG METAB DISPOS, V48, P508, DOI 10.1124/dmd.119.089813; BRUGNARA C, 1995, J PHARMACOL EXP THER, V273, P266; Cheong EJY, 2020, J PHARMACOL EXP THER, V374, P438, DOI 10.1124/jpet.120.265868; Chiba M, 1996, DRUG METAB DISPOS, V24, P307; Child SA, 2020, J MED CHEM, V63, P6513, DOI 10.1021/acs.jmedchem.9b01849; Chuo SW, 2019, BIOCHEMISTRY-US, V58, P3903, DOI 10.1021/acs.biochem.9b00620; Chuo SW, 2019, BIOCHEMISTRY-US, V58, P2353, DOI 10.1021/acs.biochem.9b00192; Correia M. A., 2015, CYTOCHROME P450 STRU, V4th, P177, DOI [10.1007/978-3-319-12108-6_5, DOI 10.1007/978-3-319-12108-6_5]; Dabrowski MJ, 2002, J AM CHEM SOC, V124, P11866, DOI 10.1021/ja027552x; Dalvie DK, 2002, CHEM RES TOXICOL, V15, P269, DOI 10.1021/tx015574b; Daniels F., 1966, PHYS CHEM, V3rd, P330; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Ernest CS, 2005, J PHARMACOL EXP THER, V312, P583, DOI 10.1124/jpet.104.075416; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; Greenblatt DJ, 2010, XENOBIOTICA, V40, P713, DOI 10.3109/00498254.2010.506224; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; Guengerich F. P, 2006, METHODS MOL BIOL, V320, P31; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich F. P., 2020, ACS CATAL, DOI 10, 5008-5022; Guengerich F. P., 2021, ACS CATAL, V11, P639; Guengerich FP, 2019, J BIOL CHEM, V294, P10928, DOI 10.1074/jbc.RA119.009305; Guengerich FP, 2019, J BIOL CHEM, V294, P10028, DOI 10.1074/jbc.RA119.008860; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; GUENGERICH FP, 1990, CHEM RES TOXICOL, V3, P363, DOI 10.1021/tx00016a015; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; GUTHEIL WG, 1994, ANAL BIOCHEM, V223, P13, DOI 10.1006/abio.1994.1539; Hakkola J, 2020, ARCH TOXICOL, V94, P3671, DOI 10.1007/s00204-020-02936-7; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Isoherranen N, 2004, DRUG METAB DISPOS, V32, P1121, DOI 10.1124/dmd.104.000315; Johnson K. A., 2019, KINETIC ANAL NEW ENZ, V1st; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Kalgutkar AS, 2020, J MED CHEM, V63, P6276, DOI 10.1021/acs.jmedchem.9b00917; Krauser JA, 2005, J BIOL CHEM, V280, P19496, DOI 10.1074/jbc.M501854200; Kumar GN, 1996, J PHARMACOL EXP THER, V277, P423; LAVRIJSEN K, 1987, XENOBIOTICA, V17, P45, DOI 10.3109/00498258709047174; Lee YT, 2011, BIOCHEMISTRY-US, V50, P693, DOI 10.1021/bi101726d; Li F, 2011, CHEM RES TOXICOL, V24, P2109, DOI 10.1021/tx2004147; Lin HL, 2013, DRUG METAB DISPOS, V41, P1813, DOI 10.1124/dmd.113.053108; Liou SH, 2020, BIOCHEMISTRY-US, V59, P2012, DOI 10.1021/acs.biochem.0c00294; Lu P, 2001, DRUG METAB DISPOS, V29, P1473; MANSUY D, 1979, J AM CHEM SOC, V101, P3971, DOI 10.1021/ja00508a048; Mast N, 2013, J BIOL CHEM, V288, P4613, DOI 10.1074/jbc.M112.438754; MAYER RT, 1990, BIOCHEM PHARMACOL, V40, P1645, DOI 10.1016/0006-2952(90)90467-Y; Montane E, 2018, BRIT J CLIN PHARMACO, V84, P542, DOI 10.1111/bcp.13471; Murarka VC, 2020, BIOCHEMISTRY-US, V59, P2743, DOI 10.1021/acs.biochem.0c00366; Ortiz de Montellano P. R, 2015, CYTOCHROME P450 STRU, V4th; PAULSENSORMAN UB, 1984, J MED CHEM, V27, P342, DOI 10.1021/jm00369a018; Pearson JT, 2006, BIOCHEMISTRY-US, V45, P6341, DOI 10.1021/bi0600042; Peng CC, 2012, DRUG METAB DISPOS, V40, P426, DOI 10.1124/dmd.111.042739; POHL LR, 1984, MOL PHARMACOL, V25, P318; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Rock BM, 2014, MOL PHARMACOL, V86, P665, DOI 10.1124/mol.114.094862; RODRIGUES AD, 1987, BIOCHEM PHARMACOL, V36, P4277, DOI 10.1016/0006-2952(87)90670-8; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Segel I. H, 1975, 3 SIMPLE INHIBITION, P109; Sevrioukova IF, 2012, ARCH BIOCHEM BIOPHYS, V520, P108, DOI 10.1016/j.abb.2012.02.018; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Shaw PM, 1997, ARCH BIOCHEM BIOPHYS, V348, P107, DOI 10.1006/abbi.1997.0378; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; Sun G, 2020, MOL MED REP, V22, P1576, DOI 10.3892/mmr.2020.11235; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; von Moltke LL, 2000, EUR J CLIN PHARMACOL, V56, P259, DOI 10.1007/s002280000125; WALSH CT, 1979, ENZYMATIC REACTION M; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yamazaki H, 2001, J BIOL CHEM, V276, P30885, DOI 10.1074/jbc.M105011200; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yu JJ, 2018, DRUG METAB DISPOS, V46, P835, DOI 10.1124/dmd.117.078691; Zimmerlin A, 2011, DRUG METAB DISPOS, V39, P1039, DOI 10.1124/dmd.110.037911	79	4	4	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100223	10.1074/jbc.RA120.016855	http://dx.doi.org/10.1074/jbc.RA120.016855			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33449875	gold, Green Published			2022-12-28	WOS:000672866400201
J	Hierro-Yap, C; Subrtova, K; Gahura, O; Panicucci, B; Dewar, C; Chinopoulos, C; Schnaufer, A; Zikova, A				Hierro-Yap, Carolina; Subrtova, Karolina; Gahura, Ondrej; Panicucci, Brian; Dewar, Caroline; Chinopoulos, Christos; Schnaufer, Achim; Zikova, Alena			Bioenergetic consequences of FoF1-ATP synthase/ATPase deficiency in two life cycle stages of Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE EXPRESSION SYSTEM; BLOOD-STREAM FORM; ATP SYNTHASE; ALTERNATIVE OXIDASE; KINETOPLAST DNA; ENERGY-METABOLISM; GLYCOLYTIC FLUX; PROTEIN; SUBUNITS; COMPLEX	Mitochondrial ATP synthase is a reversible nanomotor synthesizing or hydrolyzing ATP depending on the potential across the membrane in which it is embedded. In the unicellular parasite Trypanosoma brucei, the direction of the complex depends on the life cycle stage of this digenetic parasite: in the midgut of the tsetse fly vector (procyclic form), the FoF1-ATP synthase generates ATP by oxidative phosphorylation, whereas in the mammalian bloodstream form, this complex hydrolyzes ATP and maintains mitochondrial membrane potential (Delta Psi m). The trypanosome FoF1-ATP synthase contains numerous lineage-specific subunits whose roles remain unknown. Here, we seek to elucidate the function of the lineage-specific protein Tb1, the largest membrane-bound subunit. In procyclic form cells, Tb1 silencing resulted in a decrease of FoF1-ATP synthase monomers and dimers, rerouting of mitochondrial electron transfer to the alternative oxidase, reduced growth rate and cellular ATP levels, and elevated Delta Psi m and total cellular reactive oxygen species levels. In bloodstream form parasites, RNAi silencing of Tb1 by similar to 90% resulted in decreased FoF1-ATPase monomers and dimers, but it had no apparent effect on growth. The same findings were obtained by silencing of the oligomycin sensitivity-conferring protein, a conserved subunit in T. brucei FoF1-ATP synthase. However, as expected, nearly complete Tb1 or oligomycin sensitivity-conferring protein suppression was lethal because of the inability to sustain Delta Psi m. The diminishment of FoF1-ATPase complexes was further accompanied by a decreased ADP/ATP ratio and reduced oxygen consumption via the alternative oxidase. Our data illuminate the often diametrically opposed bioenergetic consequences of FoF1-ATP synthase loss in insect versus mammalian forms of the parasite.	[Hierro-Yap, Carolina; Subrtova, Karolina; Gahura, Ondrej; Panicucci, Brian; Zikova, Alena] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic; [Hierro-Yap, Carolina; Zikova, Alena] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Subrtova, Karolina; Dewar, Caroline; Schnaufer, Achim] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, Budapest, Hungary; [Dewar, Caroline] Univ Bern, Dept Chem & Biochem, Bern, Switzerland	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Edinburgh; Semmelweis University; University of Bern	Zikova, A (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic.; Zikova, A (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	azikova@paru.cas.cz	Gahura, Ondřej/G-7885-2014	Gahura, Ondřej/0000-0002-2925-4763; Schnaufer, Achim/0000-0003-2132-5560; Subrtova, Karolina/0000-0001-9147-7063; Hierro-Yap, Carolina/0000-0001-9014-9551; Dewar, Caroline/0000-0002-0107-6985	Czech Science Foundation [18-17529S]; European Regional Development Fund; Ministry of Education, Youth and Sport [CZ.02.1.01/0.0/0.0/16_019/0000759]; UK Medical Research Council, United Kingdom [MR/L019701/1]; NKFIH [KH129567, K135027]; MRC [MR/L019701/1] Funding Source: UKRI	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund(European Commission); Ministry of Education, Youth and Sport(Ministry of Education, Youth & Sports - Czech Republic); UK Medical Research Council, United Kingdom; NKFIH(National Research, Development & Innovation Office (NRDIO) - Hungary); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Czech Science Foundation (18-17529S) and European Regional Development Fund and Ministry of Education, Youth and Sport (CZ.02.1.01/0.0/0.0/16_019/0000759) to A. Z., a Senior Fellowship from the UK Medical Research Council, United Kingdom (MR/L019701/1) to A. S., and by grants from NKFIH [KH129567] and [K135027] to C. C.	Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Acestor N, 2009, PROTEOMICS, V9, P5497, DOI 10.1002/pmic.200900354; Agbe A, 1995, J PARASITOL, V81, P968, DOI 10.2307/3284050; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Bakker BM, 1999, J BIOL CHEM, V274, P14551, DOI 10.1074/jbc.274.21.14551; Bakker BM, 1999, P NATL ACAD SCI USA, V96, P10098, DOI 10.1073/pnas.96.18.10098; Bauerschmitt H, 2010, MOL BIOL CELL, V21, P1937, DOI 10.1091/mbc.E10-02-0101; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Brun R, 1998, VET PARASITOL, V79, P95, DOI 10.1016/S0304-4017(98)00146-0; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Carnes J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003404; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; Chen XJ, 2000, INT REV CYTOL, V194, P197; Chinopoulos C, 2011, J NEUROSCI RES, V89, P1897, DOI 10.1002/jnr.22659; Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; Chowdhury SR, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150244; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110; El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Eze AA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004791; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Figueiredo L. M., 2017, F1000RES, V6; Flaspohler JA, 2010, EUKARYOT CELL, V9, P1702, DOI 10.1128/EC.00106-10; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; FUTAI M, 1983, MICROBIOL REV, V47, P285, DOI 10.1128/MMBR.47.3.285-312.1983; Gahura O, 2018, FEBS J, V285, P4413, DOI 10.1111/febs.14672; Gahura O, 2018, FEBS J, V285, P614, DOI 10.1111/febs.14364; Ghozlane Amine, 2012, Advances in Bioinformatics, V2012, P159423, DOI 10.1155/2012/159423; Giordani F, 2016, PARASITOLOGY, V143, P1862, DOI 10.1017/S0031182016001268; Gnipova A, 2012, MOL BIOCHEM PARASIT, V184, P90, DOI 10.1016/j.molbiopara.2012.04.013; Gould MK, 2014, ANTIMICROB AGENTS CH, V58, P2925, DOI 10.1128/AAC.00122-14; Hannaert V, 2003, EUR J BIOCHEM, V270, P3205, DOI 10.1046/j.1432-1033.2003.03692.x; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; Horvath A, 2005, MOL MICROBIOL, V58, P116, DOI 10.1111/j.1365-2958.2005.04813.x; KIAIRA JK, 1994, BIOTECHNOL APPL BIOC, V20, P347, DOI 10.1111/j.1470-8744.1994.tb00322.x; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Kuhlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Luevano-Martinez LA, 2020, FEBS LETT, V594, P2150, DOI 10.1002/1873-3468.13790; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; MILLER PGG, 1980, J GEN MICROBIOL, V116, P391; Miranda-Astudillo H, 2014, BBA-BIOENERGETICS, V1837, P1, DOI 10.1016/j.bbabio.2013.08.001; Montgomery MG, 2018, P NATL ACAD SCI USA, V115, P2102, DOI 10.1073/pnas.1720940115; Motta MCM, 2008, CURR PHARM DESIGN, V14, P847, DOI 10.2174/138161208784041051; Muhleip A, 2019, ELIFE, V8, DOI 10.7554/eLife.51179; Nina PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000418; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Panicucci B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005552; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Perez E, 2014, MITOCHONDRION, V19, P338, DOI 10.1016/j.mito.2014.02.001; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Prochazkova M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23472-6; RUYTER GJG, 1991, J BACTERIOL, V173, P6184, DOI 10.1128/jb.173.19.6184-6191.1991; Salunke R, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006128; SCHAAFF I, 1989, YEAST, V5, P285, DOI 10.1002/yea.320050408; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schnaufer A, 2010, TRENDS PARASITOL, V26, P557, DOI 10.1016/j.pt.2010.08.001; SHAPIRO TA, 1990, P NATL ACAD SCI USA, V87, P950, DOI 10.1073/pnas.87.3.950; STUART KD, 1971, J CELL BIOL, V49, P189, DOI 10.1083/jcb.49.1.189; Subrtova K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004660; van Hellemond JJ, 2005, ADV MICROB PHYSIOL, V50, P199, DOI 10.1016/S0065-2911(05)50005-5; van Lis R, 2007, PLANT PHYSIOL, V144, P1190, DOI 10.1104/pp.106.094060; Vertommen D, 2008, MOL BIOCHEM PARASIT, V158, P189, DOI 10.1016/j.molbiopara.2007.12.008; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	78	7	7	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100357	10.1016/j.jbc.2021.100357	http://dx.doi.org/10.1016/j.jbc.2021.100357			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539923	gold, Green Published			2022-12-28	WOS:000672866400331
J	Koay, TW; Osterhof, C; Orlando, IMC; Keppner, A; Andre, D; Yousefian, S; Alonso, MS; Correia, M; Markworth, R; Schodel, J; Hankeln, T; Hoogewijs, D				Koay, Teng Wei; Osterhof, Carina; Orlando, Ilaria M. C.; Keppner, Anna; Andre, Daniel; Yousefian, Schayan; Alonso, Maria Suarez; Correia, Miguel; Markworth, Robert; Schoedel, Johannes; Hankeln, Thomas; Hoogewijs, David			Androglobin gene expression patterns and FOXJ1-dependent regulation indicate its functional association with ciliogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBIN; DISTAL; CILIA; FOXJ1; INDUCTION	Androglobin (ADGB) represents the latest addition to the globin superfamily in metazoans. The chimeric protein comprises a calpain domain and a unique circularly permutated globin domain. ADGB expression levels are most abundant in mammalian testis, but its cell-type-specific expression, regulation, and function have remained unexplored. Analyzing bulk and single-cell mRNA-Seq data from mammalian tissues, we found that-in addition to the testes-ADGB is prominently expressed in the female reproductive tract, lungs, and brain, specifically being associated with cell types forming motile cilia. Correlation analysis suggested coregulation of ADGB with FOXJ1, a crucial transcription factor of ciliogenesis. Investigating the transcriptional regulation of the ADGB gene, we characterized its promoter using epigenomic datasets, exogenous promoter-dependent luciferase assays, and CRISPR/dCas9-VPR-mediated activation approaches. Reporter gene assays revealed that FOXJ1 indeed substantially enhanced luciferase activity driven by the ADGB promoter. ChIP assays confirmed binding of FOXJ1 to the endogenous ADGB promoter region. We dissected the minimal sequence required for FOXJ1-dependent regulation and fine mapped the FOXJ1 binding site to two evolutionarily conserved regions within the ADGB promoter. FOXJ1 overexpression significantly increased endogenous ADGB mRNA levels in HEK293 and MCF-7 cells. Similar results were observed upon RFX2 overexpression, another key transcription factor in ciliogenesis. The complex transcriptional regulation of the ADGB locus was illustrated by identifying a distal enhancer, responsible for synergistic regulation by RFX2 and FOXJ1. Finally, cell culture studies indicated an ADGB-dependent increase in the number of ciliated cells upon overexpression of the full-length protein, confirming a ciliogenesis-associated role of ADGB in mammals.	[Koay, Teng Wei; Orlando, Ilaria M. C.; Keppner, Anna; Alonso, Maria Suarez; Correia, Miguel; Hoogewijs, David] Univ Fribourg, Dept Endocrinol Metab & Cardiovasc Syst, Sect Med, Fribourg, Switzerland; [Osterhof, Carina; Andre, Daniel; Yousefian, Schayan; Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Fac Biol, Inst Organism & Mol Evolut, Mol Genet & Genome Anal, Mainz, Germany; [Markworth, Robert] Univ Duisburg Essen, Inst Physiol, Duisburg, Germany; [Schoedel, Johannes] Univ Klinikum Erlangen, Dept Nephrol & Hypertens, Erlangen, Germany; [Schoedel, Johannes] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephrol & Hypertens, Erlangen, Germany	University of Fribourg; Johannes Gutenberg University of Mainz; University of Duisburg Essen; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Hoogewijs, D (corresponding author), Univ Fribourg, Dept Endocrinol Metab & Cardiovasc Syst, Sect Med, Fribourg, Switzerland.	david.hoogewijs@unifr.ch		Koay, Teng Wei/0000-0002-7053-6359; Schodel, Johannes/0000-0002-3587-8839; Osterhof, Carina/0000-0002-1699-7410; Keppner, Anna/0000-0002-7880-3810	Swiss National Science Foundation [31003A_173000]; German Research Foundation [HO 5837/1-1, HA 2103/9-1, SFB 1350]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG))	This work was supported by the Swiss National Science Foundation to D. H. (grant 31003A_173000) and the German Research Foundation to D. H. (HO 5837/1-1), T. H. (HA 2103/9-1) and J. S. (Projektnummer 387509280; SFB 1350).	ACTON AB, 1966, J CELL BIOL, V29, P366, DOI 10.1083/jcb.29.2.366; Altmae S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10098-3; Barton BE, 2020, REPRODUCTION, V159, pR125, DOI 10.1530/REP-19-0189; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Bracke A, 2018, ANAL BIOCHEM, V543, P62, DOI 10.1016/j.ab.2017.11.027; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2006, FEBS J, V273, P468, DOI 10.1111/j.1742-4658.2005.05073.x; Burmester T, 2014, ACTA PHYSIOL, V211, P501, DOI 10.1111/apha.12312; Burmester T, 2018, J INSECT PHYSIOL, V106, P224, DOI 10.1016/j.jinsphys.2017.06.003; Campbell EP, 2016, DEVELOPMENT, V143, P4654, DOI 10.1242/dev.143859; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/NMETH.3312, 10.1038/nmeth.3312]; Cheneby J, 2018, NUCLEIC ACIDS RES, V46, pD267, DOI 10.1093/nar/gkx1092; Choksi SP, 2014, DEVELOPMENT, V141, P3410, DOI 10.1242/dev.108209; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Comer MT, 1998, HUM REPROD, V13, P3114, DOI 10.1093/humrep/13.11.3114; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; FERENCZY A, 1972, SCIENCE, V175, P783, DOI 10.1126/science.175.4023.783; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gleixner E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-34; Haider S, 2019, ENDOCRINOLOGY, V160, P2282, DOI 10.1210/en.2019-00314; Hoogewijs D, 2004, IUBMB LIFE, V56, P697, DOI 10.1080/15216540500037562; Hoogewijs D, 2016, HYPOXIA, V4, P91, DOI 10.2147/HP.S97681; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Hoogewijs D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-279; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huang B, 2014, INT J CLIN EXP PATHO, V7, P2179; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; JAMIESON B G M, 1991, Memoirs of the Queensland Museum, V31, P109; Keppner A, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101687; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kistler WS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005368; Kowal TJ, 2015, CELL BIOL INT, V39, P1341, DOI 10.1002/cbin.10500; Lauer V, 2020, J BIOL CHEM, V295, P4065, DOI 10.1074/jbc.RA119.009827; Lewis M, 2021, SEMIN CELL DEV BIOL, V110, P51, DOI 10.1016/j.semcdb.2020.04.007; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lukassen S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24725-0; Mirzadeh Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13759; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Mukherjee I, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00023; NELSON GA, 1982, J CELL BIOL, V92, P121, DOI 10.1083/jcb.92.1.121; Nemajerova A, 2016, GENE DEV, V30, P1300, DOI 10.1101/gad.279836.116; Orlando IMC, 2020, HAEMATOLOGICA, V105, P2774, DOI 10.3324/haematol.2019.236406; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Quigley IK, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006538; Randi EB, 2020, ANTIOXID REDOX SIGN, V32, P1155, DOI 10.1089/ars.2019.7868; Schorg A, 2015, NUCLEIC ACIDS RES, V43, P5810, DOI 10.1093/nar/gkv506; Schuster H, 2017, P NATL ACAD SCI USA, V114, pE9942, DOI 10.1073/pnas.1707658114; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Sigg MA, 2017, DEV CELL, V43, P744, DOI 10.1016/j.devcel.2017.11.014; Spassky N, 2017, NAT REV MOL CELL BIO, V18, P423, DOI 10.1038/nrm.2017.21; Stauber M, 2017, DEV BIOL, V423, P170, DOI 10.1016/j.ydbio.2016.11.019; Storti F, 2014, HAEMATOLOGICA, V99, pE45, DOI 10.3324/haematol.2013.102707; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tang ZM, 2013, NATURE, V502, P254, DOI 10.1038/nature12606; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Dam TJP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216705; Weidemann M, 2016, DEVELOPMENT, V143, P4736, DOI 10.1242/dev.139626; Whitfield M, 2019, AM J HUM GENET, V105, P198, DOI 10.1016/j.ajhg.2019.04.015; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263	65	11	11	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100291	10.1016/j.jbc.2021.100291	http://dx.doi.org/10.1016/j.jbc.2021.100291			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33453283	Green Published, gold			2022-12-28	WOS:000672866400265
J	Motizuki, M; Koinuma, D; Yokoyama, T; Itoh, Y; Omata, C; Miyazono, K; Saitoh, M; Miyazawa, K				Motizuki, Mitsuyoshi; Koinuma, Daizo; Yokoyama, Takashi; Itoh, Yuka; Omata, Chiho; Miyazono, Kohei; Saitoh, Masao; Miyazawa, Keiji			TGF-beta-induced cell motility requires downregulation of ARHGAPs to sustain Rac1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; STRUCTURAL BASIS; SMAD PROTEINS; DNA-BINDING; MH1 DOMAIN; COMPLEX; ACTIVATION; MEMBRANE; FILGAP; ROLES	Transforming growth factor-beta (TGF-beta) signaling promotes cancer progression. In particular, the epithelial-mesenchymal transition (EMT) induced by TGF-beta is considered crucial to the malignant phenotype of cancer cells. Here, we report that the EMT-associated cellular responses induced by TGF-beta are mediated by distinct signaling pathways that diverge at Smad3. By expressing chimeric Smad1/Smad3 proteins in SMAD3 knockout A549 cells, we found that the beta 4 region in the Smad3 MH1 domain is essential for TGF-beta-induced cell motility, but is not essential for other EMT-associated responses including epithelial marker downregulation. TGF-beta was previously reported to enhance cell motility by activating Rac1 via phosphoinositide 3-kinase. Intriguingly, TGF-beta-dependent signaling mediated by Smad3's beta 4 region causes the downregulation of multiple mRNAs that encode GTPase activating proteins that target Rac1 (ARHGAPs), thereby attenuating Rac1 inactivation. Therefore, two independent pathways downstream of TGF-beta type I receptor contribute cooperatively to sustained Rac1 activation, thereby leading to enhanced cell motility.	[Motizuki, Mitsuyoshi; Yokoyama, Takashi; Itoh, Yuka; Omata, Chiho; Saitoh, Masao; Miyazawa, Keiji] Univ Yamanashi, Grad Sch Med, Dept Biochem, Kofu, Yamanashi, Japan; [Koinuma, Daizo; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo, Japan; [Saitoh, Masao] Univ Yamanashi, Ctr Med Educ & Sci, Grad Sch Med, Kofu, Yamanashi, Japan	University of Yamanashi; University of Tokyo; University of Yamanashi	Miyazawa, K (corresponding author), Univ Yamanashi, Grad Sch Med, Dept Biochem, Kofu, Yamanashi, Japan.	kmiyazawa@yamanashi.ac.jp	Koinuma, Daizo/Y-8716-2018	Koinuma, Daizo/0000-0001-5611-2122	Japan Society for the Promotion of Science (JSPS) KAKENHI [16H05150, 15H05774]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI [16H05150] (K. Miyazawa) and [15H05774] (K. Miyazono).	Nieto MA, 2017, NAT CELL BIOL, V19, P416, DOI 10.1038/ncb3520; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; BabuRajendran N, 2010, NUCLEIC ACIDS RES, V38, P3477, DOI 10.1093/nar/gkq046; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Campa Carlo C, 2015, Small GTPases, V6, P71, DOI 10.4161/21541248.2014.989789; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chai JJ, 2003, J BIOL CHEM, V278, P20327, DOI 10.1074/jbc.C300134200; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Duan D, 2019, J BIOL CHEM, V294, P8490, DOI 10.1074/jbc.RA118.005763; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; Hamidi A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4186; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Hubchak SC, 2009, AM J PHYSIOL-RENAL, V297, pF1316, DOI 10.1152/ajprenal.00345.2009; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Isogaya K, 2014, CELL RES, V24, P994, DOI 10.1038/cr.2014.97; Itoh Y, 2019, J BIOL CHEM, V294, P15466, DOI 10.1074/jbc.RA119.009877; Kawasaki N, 2018, CANCER SCI, V109, P2211, DOI 10.1111/cas.13626; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kusanagi K, 2001, J BIOL CHEM, V276, P28155, DOI 10.1074/jbc.M103371200; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Liu T, 2017, ONCOGENE, V36, P362, DOI 10.1038/onc.2016.204; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Mizuide M, 2003, J BIOL CHEM, V278, P531, DOI 10.1074/jbc.C200596200; Motizuki M, 2015, J BIOCHEM, V158, P435, DOI 10.1093/jb/mvv054; Motizuki M, 2013, J BIOL CHEM, V288, P18911, DOI 10.1074/jbc.M113.480996; Muller PM, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0488-x; Nakano N, 2020, J BIOL CHEM, V295, P9033, DOI 10.1074/jbc.RA120.013596; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nguyen Lan K, 2018, Small GTPases, V9, P316, DOI 10.1080/21541248.2016.1224399; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Qin BY, 2001, MOL CELL, V8, P1303, DOI 10.1016/S1097-2765(01)00417-8; Qing J, 2000, J BIOL CHEM, V275, P38802, DOI 10.1074/jbc.M004731200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Saitoh M, 2016, ONCOGENE, V35, P1049, DOI 10.1038/onc.2015.161; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Su J, 2020, NATURE, V577, P566, DOI 10.1038/s41586-019-1897-5; Sundqvist A, 2018, NUCLEIC ACIDS RES, V46, P1180, DOI 10.1093/nar/gkx1190; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Tsubakihara Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113672; Vardouli L, 2008, FEBS J, V275, P4074, DOI 10.1111/j.1742-4658.2008.06549.x; Vervoort SJ, 2018, NUCLEIC ACIDS RES, V46, P9578, DOI 10.1093/nar/gky755; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yang J, 2020, NAT REV MOL CELL BIO, V21, P341, DOI 10.1038/s41580-020-0237-9; Yoon JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8600	55	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100545	10.1016/j.jbc.2021.100545	http://dx.doi.org/10.1016/j.jbc.2021.100545			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33741342	gold, Green Published			2022-12-28	WOS:000672866400518
J	Mukai, S; Mizokami, A; Otani, T; Sano, T; Matsuda, M; Chishaki, S; Gao, J; Kawakubo-Yasukochi, T; Tang, RH; Kanematsu, T; Takeuchi, H; Jimi, E; Hirata, M				Mukai, Satoru; Mizokami, Akiko; Otani, Takahito; Sano, Tomomi; Matsuda, Miho; Chishaki, Sakura; Gao, Jing; Kawakubo-Yasukochi, Tomoyo; Tang, Ronghao; Kanematsu, Takashi; Takeuchi, Hiroshi; Jimi, Eijiro; Hirata, Masato			Adipocyte-specific GPRC6A ablation promotes diet-induced obesity by inhibiting lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; HORMONE-SENSITIVE LIPASE; BETA-CELL; OSTEOCALCIN; EXPRESSION; INSULIN; RECEPTOR; PROTEIN; INFLAMMATION; MICE	The G protein-coupled receptor GPRC6A regulates various physiological processes in response to its interaction with multiple ligands, such as extracellular basic amino acids, divalent cations, testosterone, and the uncarboxylated form of osteocalcin (GluOC). Global ablation of GPRC6A increases the susceptibility of mice to diet-induced obesity and related metabolic disorders. However, given that GPRC6A is expressed in many tissues and responds to a variety of hormonal and nutritional signals, the cellular and molecular mechanisms underlying the development of metabolic disorders in conventional knockout mice have remained unclear. On the basis of our previous observation that long-term oral administration of GluOC markedly reduced adipocyte size and improved glucose tolerance in WT mice, we examined whether GPRC6A signaling in adipose tissue might be responsible for prevention of metabolic disorders. We thus generated adipocyte-specific GPRC6A knockout mice, and we found that these animals manifested increased adipose tissue weight, adipocyte hypertrophy, and adipose tissue inflammation when fed a high-fat and high-sucrose diet compared with control mice. These effects were associated with reduced lipolytic activity because of downregulation of lipolytic enzymes such as adipose triglyceride lipase and hormone-sensitive lipase in adipose tissue of the conditional knockout mice. Given that, among GPR6CA ligands tested, GluOC and ornithine increased the expression of adipose triglyceride lipase in cultured 3T3-L1 adipocytes in a manner dependent on GPRC6A, our results suggest that the constitutive activation of GPRC6A signaling in adipocytes by GluOC or ornithine plays a key role in adipose lipid handling and the prevention of obesity and related metabolic disorders.	[Mukai, Satoru; Mizokami, Akiko; Chishaki, Sakura; Kawakubo-Yasukochi, Tomoyo; Jimi, Eijiro] Kyushu Univ, Fac Dent Sci, OBT Res Ctr, Fukuoka, Japan; [Mukai, Satoru] Univ East Asia, Fac Allied Hlth Sci, Dept Hlth & Nutr Care, Shimonoseki, Yamaguchi, Japan; [Otani, Takahito] Fukuoka Dent Coll, Dept Morphol Biol, Div Funct Struct, Fukuoka, Japan; [Sano, Tomomi; Kanematsu, Takashi] Kyushu Univ, Fac Dent Sci, Dept Cell Biol & Pharmacol, Fukuoka, Japan; [Matsuda, Miho; Chishaki, Sakura; Gao, Jing; Tang, Ronghao; Jimi, Eijiro] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka, Japan; [Takeuchi, Hiroshi] Kyushu Dent Univ, Div Appl Pharmacol, Kitakyushu, Fukuoka, Japan; [Hirata, Masato] Fukuoka Dent Coll, Oral Med Res Ctr, Fukuoka, Japan	Kyushu University; Fukuoka Dental College (FDC); Kyushu University; Kyushu University; Kyushu Dental University; Fukuoka Dental College (FDC)	Mizokami, A (corresponding author), Kyushu Univ, Fac Dent Sci, OBT Res Ctr, Fukuoka, Japan.; Hirata, M (corresponding author), Fukuoka Dent Coll, Oral Med Res Ctr, Fukuoka, Japan.	akiko-k@dent.kyushu-u.ac.jp; hirata@college.fdcnet.ac.jp	Mizokami, Akiko/ABC-5448-2021	Mizokami, Akiko/0000-0002-7490-5190; Tang, Ronghao/0000-0002-0219-3366; Otani, Takahito/0000-0003-2103-6873	Japan Society for the Promotion of Science KAKENHI [18K09521, 17K19766, 17H01595, 20H03854]; Lotte Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Lotte Foundation	This work was supported by Japan Society for the Promotion of Science KAKENHI grants (18K09521 to A. M. and 17K19766, 17H01595, and 20H03854 to M. H.) as well as by grants from the Lotte Foundation to A. M.	Allison DB, 2008, OBESITY, V16, P1161, DOI 10.1038/oby.2008.231; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Benoit SC, 2002, J NEUROSCI, V22, P9048; Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200; Clemmensen C, 2014, BRIT J PHARMACOL, V171, P1129, DOI 10.1111/bph.12365; Clemmensen C, 2013, J ENDOCRINOL, V217, P151, DOI 10.1530/JOE-12-0550; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Hayasaka S, 2011, BRIT J NUTR, V106, P801, DOI 10.1017/S0007114511003291; Hong J, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-11; Large V, 1999, J LIPID RES, V40, P2059; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Martinelli D, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0242-9; Mizokami A, 2016, BIOSCI BIOTECH BIOCH, V80, P2176, DOI 10.1080/09168451.2016.1214530; Mizokami A, 2014, BONE, V69, P68, DOI 10.1016/j.bone.2014.09.006; Mizokami A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057375; Otani T, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1257-7; Otani T, 2015, CELL SIGNAL, V27, P532, DOI 10.1016/j.cellsig.2014.12.018; Oue K, 2016, J BIOL CHEM, V291, P4185, DOI 10.1074/jbc.M115.705723; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Oya M, 2013, J BIOL CHEM, V288, P4513, DOI 10.1074/jbc.M112.402677; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64384-8; Pi M, 2017, MOL METAB, V6, DOI 10.1016/j.molmet.2016.12.006; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Snel M, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/983814; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Wellendorph P, 2009, J MOL ENDOCRINOL, V42, P215, DOI 10.1677/JME-08-0149; Yasutake Y, 2016, AM J PHYSIOL-ENDOC M, V310, pE662, DOI 10.1152/ajpendo.00334.2015; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	39	6	7	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100274	10.1016/j.jbc.2021.100274	http://dx.doi.org/10.1016/j.jbc.2021.100274			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428938	Green Published, gold			2022-12-28	WOS:000672866400250
J	Tiffner, A; Schober, R; Hoglinger, C; Bonhenry, D; Pandey, S; Lunz, V; Sallinger, M; Frischauf, I; Fahrner, M; Lindinger, S; Maltan, L; Berlansky, S; Stadlbauer, M; Schindl, R; Ettrich, R; Romanin, C; Derler, I				Tiffner, Adela; Schober, Romana; Hoeglinger, Carmen; Bonhenry, Daniel; Pandey, Saurabh; Lunz, Victoria; Sallinger, Matthias; Frischauf, Irene; Fahrner, Marc; Lindinger, Sonja; Maltan, Lena; Berlansky, Sascha; Stadlbauer, Michael; Schindl, Rainer; Ettrich, Rudiger; Romanin, Christoph; Derler, Isabella			CRAC channel opening is determined by a series of Orai1 gating checkpoints in the transmembrane and cytosolic regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTION MOLECULE-1 STIM1; STORE-OPERATED CHANNELS; ION SELECTIVITY; CALCIUM SENSOR; SOFTWARE NEWS; FORCE-FIELD; CA2+ SENSOR; ACTIVATION; BINDING; PROTEIN	The initial activation step in the gating of ubiquitously expressed Orai1 calcium (Ca2+) ion channels represents the activation of the Ca2+-sensor protein STIM1 upon Ca2+ store depletion of the endoplasmic reticulum. Previous studies using constitutively active Orai1 mutants gave rise to, but did not directly test, the hypothesis that STIM1-mediated Orai1 pore opening is accompanied by a global conformational change of all Orai transmembrane domain (TM) helices within the channel complex. We prove that a local conformational change spreads omnidirectionally within the Orai1 complex. Our results demonstrate that these locally induced global, opening-permissive TM motions are indispensable for pore opening and require clearance of a series of Orai1 gating checkpoints. We discovered these gating checkpoints in the middle and cytosolic extended TM domain regions. Our findings are based on a library of double point mutants that contain each one loss-of-function with one gain-of-function point mutation in a series of possible combinations. We demonstrated that an array of loss-of-function mutations are dominant over most gain-of-function mutations within the same as well as of an adjacent Orai subunit. We further identified inter- and intramolecular salt-bridge interactions of Orai subunits as a core element of an opening-permissive Orai channel architecture. Collectively, clearance and synergistic action of all these gating checkpoints are required to allow STIM1 coupling and Orai1 pore opening. Our results unravel novel insights in the preconditions of the unique fingerprint of CRAC channel activation, provide a valuable source for future structural resolutions, and help to understand the molecular basis of disease-causing mutations.	[Tiffner, Adela; Schober, Romana; Hoeglinger, Carmen; Lunz, Victoria; Sallinger, Matthias; Frischauf, Irene; Fahrner, Marc; Lindinger, Sonja; Maltan, Lena; Berlansky, Sascha; Stadlbauer, Michael; Romanin, Christoph; Derler, Isabella] Johannes Kepler Univ Linz, Inst Biophys, JKU Life Sci Ctr, Linz, Austria; [Bonhenry, Daniel; Pandey, Saurabh] Czech Acad Sci, Inst Microbiol, Ctr Nanobiol & Struct Biol, Nove Hrady, Czech Republic; [Schindl, Rainer] Med Univ Graz, Gottfried Schatz Res Ctr, Graz, Austria; [Ettrich, Rudiger] Larkin Univ, Coll Biomed Sci, Miami, FL USA; [Ettrich, Rudiger] Charles Univ Prague, Fac Math & Phys, Prague, Czech Republic; [Ettrich, Rudiger] Florida Int Univ, Herbert Wertheim Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA	Johannes Kepler University Linz; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Medical University of Graz; Charles University Prague; State University System of Florida; Florida International University	Derler, I (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, JKU Life Sci Ctr, Linz, Austria.	Isabella.derler@jku.at	Ettrich, Rudi H/C-1463-2011; Pandey, Saurabh Kumar/H-8148-2014; Hoeglinger, Carmen/AAF-9364-2021; Derler, Isabella/B-7871-2019	Ettrich, Rudi H/0000-0001-8624-7706; Pandey, Saurabh Kumar/0000-0002-5923-5045; Lunz, Victoria/0000-0003-2272-9655; Derler, Isabella/0000-0002-4768-146X; Hoglinger, Carmen/0000-0002-2754-592X; Lindinger, Sonja/0000-0002-4199-0376; Fahrner, Marc/0000-0002-2689-0158; Frischauf, Irene/0000-0003-0661-2932; Tiffner, Adela/0000-0002-7529-4504	Linz Institute of Technology project [LIT-2018-05-SEE-111]; Austrian Science Fund (FWF) [P27641, P30567, P32851, P32947, P28701, P27263, P33283, P32075-B]; Czech Science Foundation [19-20728Y]; PhD program "NanoCell" [W1250]	Linz Institute of Technology project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Czech Science Foundation(Grant Agency of the Czech Republic); PhD program "NanoCell"	This work was supported in part by the Linz Institute of Technology project LIT-2018-05-SEE-111 and the Austrian Science Fund (FWF) projects P27641, P30567, and P32851 (to I. D.), P32947 (to M. F.), P32075-B (to I. F.), P28701 (to R. Schindl), P27263, P33283, and PhD program W1250 "NanoCell" (to C. R.). D. B. was supported by the Czech Science Foundation (19-20728Y).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bohm J, 2017, HUM MUTAT, V38, P426, DOI 10.1002/humu.23172; Bulla M, 2019, J PHYSIOL-LONDON, V597, P561, DOI 10.1113/JP277079; Butorac C, 2020, ADV EXP MED BIOL, V1131, P547, DOI 10.1007/978-3-030-12457-1_23; Butorac C, 2019, CELL CALCIUM, V79, P57, DOI 10.1016/j.ceca.2019.02.009; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Cai XY, 2018, J BIOL CHEM, V293, P12962, DOI 10.1074/jbc.RA118.003424; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Derler I, 2018, J BIOL CHEM, V293, P1259, DOI 10.1074/jbc.M117.812206; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; Derler I, 2013, J BIOL CHEM, V288, P29025, DOI 10.1074/jbc.M113.501510; Dong H, 2019, ISCIENCE, V16, P356, DOI 10.1016/j.isci.2019.05.041; Duboue-Dijon E, 2018, J PHYS CHEM B, V122, P3296, DOI 10.1021/acs.jpcb.7b09612; Endo Y, 2015, HUM MOL GENET, V24, P637, DOI 10.1093/hmg/ddu477; Fahrner M, 2018, J BIOL CHEM, V293, P1271, DOI 10.1074/jbc.M117.812693; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Frischauf I, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aao0358; Frischauf I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1901; Fujiwara K, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-18; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; Hoth M, 2013, CURR TOP MEMBR, V71, P237, DOI 10.1016/B978-0-12-407870-3.00010-X; Hou XW, 2020, ELIFE, V9, DOI 10.7554/eLife.62772; Hou XW, 2018, ELIFE, V7, DOI 10.7554/eLife.36758; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kann ZR, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4894500; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kohagen M, 2014, J PHYS CHEM B, V118, P7902, DOI 10.1021/jp5005693; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krizova A, 2019, EUR BIOPHYS J BIOPHY, V48, P425, DOI 10.1007/s00249-019-01355-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Leontyev I, 2011, PHYS CHEM CHEM PHYS, V13, P2613, DOI 10.1039/c0cp01971b; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Liu XF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000096; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Palty R, 2017, CELL REP, V19, P1929, DOI 10.1016/j.celrep.2017.05.025; Palty R, 2016, J BIOL CHEM, V291, P334, DOI 10.1074/jbc.M115.685289; Palty R, 2015, CELL RES, V25, P963, DOI 10.1038/cr.2015.80; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3033, DOI 10.1113/jphysiol.2008.156885; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Pluharova E, 2013, J PHYS CHEM A, V117, P11766, DOI 10.1021/jp402532e; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Sallinger M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124410; Schober R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aax3194; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Srikanth S, 2013, CURR TOP MEMBR, V71, P181, DOI 10.1016/B978-0-12-407870-3.00008-1; Srikanth S, 2011, J BIOL CHEM, V286, P35318, DOI 10.1074/jbc.M111.265884; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamashita M, 2020, J GEN PHYSIOL, V152, DOI 10.1085/jgp.201912397; Yamashita M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14512; Yen M, 2018, J GEN PHYSIOL, V150, P1373, DOI 10.1085/jgp.201711985; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeung PSW, 2018, P NATL ACAD SCI USA, V115, pE5193, DOI 10.1073/pnas.1718373115; Yeung PSW, 2020, ELIFE, V9, DOI 10.7554/eLife.60751; Yeung PSW, 2020, J PHYSIOL-LONDON, V598, P1707, DOI 10.1113/JP276550; Yeung PSW, 2018, J GEN PHYSIOL, V150, P1352, DOI 10.1085/jgp.201812172; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zhou YD, 2017, CELL CALCIUM, V63, P8, DOI 10.1016/j.ceca.2017.01.001; Zhou YD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13725; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625	89	13	13	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100224	10.1074/jbc.RA120.015548	http://dx.doi.org/10.1074/jbc.RA120.015548			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361160	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400202
J	Upadhyaya, G; Das, A; Basu, C; Agarwal, T; Basak, C; Chakraborty, C; Halder, T; Basu, G; Ray, S				Upadhyaya, Gouranga; Das, Arup; Basu, Chandradeep; Agarwal, Tanushree; Basak, Chandra; Chakraborty, Chandrima; Halder, Tanmoy; Basu, Gautam; Ray, Sudipta			Multiple copies of a novel amphipathic alpha-helix forming segment in Physcomitrella patens dehydrin play a key role in abiotic stress mitigation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; K-SEGMENTS; LACTATE-DEHYDROGENASE; WATER-STRESS; MAIZE DHN1; TOLERANCE; DEHYDRATION; MEMBRANE; FLUORESCENCE; SEQUENCES	Plants use a diverse set of proteins to mitigate various abiotic stresses. The intrinsically disordered protein dehydrin is an important member of this repertoire of proteins, characterized by a canonical amphipathic K-segment. It can also contain other stress-mitigating noncanonical segments-a likely reflection of the extremely diverse nature of abiotic stress encountered by plants. Among plants, the poikilohydric mosses have no inbuilt mechanism to prevent desiccation and therefore are likely to contain unique noncanonical stress-responsive motifs in their dehydrins. Here we report the recurring occurrence of a novel amphipathic helix-forming segment (D-segment: EG phi phi D(R/K)AKDA phi, where phi represents a hydrophobic residue) in Physcomitrella patens dehydrin (PpDHNA), a poikilohydric moss. NMR and CD spectroscopic experiments demonstrated the helix-forming tendency of the D-segment, with the shuffled D-segment as control. PpDHNA activity was shown to be size as well as D-segment dependent from in vitro, in vivo, and in planta studies using PpDHNA and various deletion mutants. Bimolecular fluorescence complementation studies showed that D-segment-mediated PpDHNA self-association is a requirement for stress abatement. The D-segment was also found to occur in two rehydrin proteins from Syntrichia ruralis, another poikilohydric plant like P. patens. Multiple occurrences of the D-segment in poikilohydric plant dehydrins/rehydrins, along with the experimental demonstration of the role of D-segment in stress abatement, implies that the D-segment mediates unique resurrection strategies, which may be employed by plant dehydrins that are capable of mitigating extreme stress.	[Upadhyaya, Gouranga; Das, Arup; Agarwal, Tanushree; Basak, Chandra; Chakraborty, Chandrima; Halder, Tanmoy; Ray, Sudipta] Univ Calcutta, Dept Bot, Plant Funct Genom Lab, Kolkata, India; [Basu, Chandradeep; Basu, Gautam] Bose Inst, Dept Biophys, Kolkata, India	University of Calcutta; Department of Science & Technology (India); Bose Institute	Ray, S (corresponding author), Univ Calcutta, Dept Bot, Plant Funct Genom Lab, Kolkata, India.	srbot@caluniv.ac.in	Upadhyaya, Gouranga/AAR-6911-2020	Upadhyaya, Gouranga/0000-0003-0816-0570	Department of Science and Technology, Government of India; University Grants Commission, Government of India; Council of Scientific and Industrial Research, Government of India; Department of Science and Technology, Government of India [SERB/SR/SO/PS-30/2010]	Department of Science and Technology, Government of India(Department of Science & Technology (India)); University Grants Commission, Government of India(University Grants Commission, India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	G. U. and C. Basu thank the Department of Science and Technology, Government of India; A.D., C.C., and C. Basak thank the University Grants Commission, Government of India; T.H. thanks the Council of Scientific and Industrial Research, Government of India, for research fellowship. Department of Science and Technology, Government of India (Sanction No. SERB/SR/SO/PS-30/2010) provided financial support.	Abraham E, 2010, METHODS MOL BIOL, V639, P317, DOI 10.1007/978-1-60761-702-0_20; Agarwal T, 2017, PLANTA, V245, P101, DOI 10.1007/s00425-016-2596-1; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Baryla A, 2000, ENVIRON POLLUT, V109, P131, DOI 10.1016/S0269-7491(99)00232-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charron AJ, 2009, MOL PLANT, V2, P478, DOI 10.1093/mp/ssp018; Clement CG, 2014, HUM PATHOL, V45, P1766, DOI 10.1016/j.humpath.2014.04.016; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuevas-Velazquez CL, 2016, J BIOL CHEM, V291, P10893, DOI 10.1074/jbc.M116.720318; Danyluk J, 1998, PLANT CELL, V10, P623, DOI 10.1105/tpc.10.4.623; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Drira M, 2015, APPL BIOCHEM BIOTECH, V175, P3310, DOI 10.1007/s12010-015-1502-9; Drira M, 2013, MOL BIOTECHNOL, V54, P643, DOI 10.1007/s12033-012-9606-8; EPAND RM, 1995, BIOPOLYMERS, V37, P319, DOI 10.1002/bip.360370504; Eriksson S, 2016, PLANT PHYSIOL, V171, P932, DOI 10.1104/pp.15.01531; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Gupta A, 2019, J BIOL CHEM, V294, P6468, DOI 10.1074/jbc.RA118.007163; Halder T, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00136; Halder T, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00918; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hara M, 2017, J PLANT PHYSIOL, V210, P18, DOI 10.1016/j.jplph.2016.12.003; Hernandez-Sanchez I. E., 2017, SCI REP-UK, V7, P1; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hossain MA, 2019, OSMOPROTECTANT-MEDIATED ABIOTIC STRESS TOLERANCE IN PLANTS: RECENT ADVANCES AND FUTURE PERSPECTIVES, pV; Hughes SL, 2013, PLANT PHYSIOL, V163, P1376, DOI 10.1104/pp.113.226803; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Li QL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01316; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lv AM, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1511-2; MANNING MC, 1991, BIOPOLYMERS, V31, P569, DOI 10.1002/bip.360310511; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Mouillon JM, 2008, PLANT PHYSIOL, V148, P1925, DOI 10.1104/pp.108.124099; Murvai N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081856; Nakayama K, 2007, PLANT PHYSIOL, V144, P513, DOI 10.1104/pp.106.094581; Rensing SA, 2020, PLANT CELL, V32, P1361, DOI 10.1105/tpc.19.00828; Reyes JL, 2008, PLANT CELL ENVIRON, V31, P1781, DOI 10.1111/j.1365-3040.2008.01879.x; Rivera-Najera LY, 2014, J BIOL CHEM, V289, P31995, DOI 10.1074/jbc.M114.583369; Rosales R, 2014, PHYTOCHEMISTRY, V108, P17, DOI 10.1016/j.phytochem.2014.10.006; Ruibal C, 2012, PLANT SCI, V190, P89, DOI 10.1016/j.plantsci.2012.03.009; Saavedra L, 2006, PLANT J, V45, P237, DOI 10.1111/j.1365-313X.2005.02603.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soulages JL, 2003, PLANT PHYSIOL, V131, P963, DOI 10.1104/pp.015891; Strimbeck GR, 2017, PLANTA, V245, P1061, DOI 10.1007/s00425-017-2679-7; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Wang XQ, 2009, PLANT PHYSIOL, V149, P1739, DOI 10.1104/pp.108.131714; Wang YJ, 2002, J AM CHEM SOC, V124, P14075, DOI 10.1021/ja026811f; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Weigel D., 2006, CSH PROTOC, V2006; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Xu KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083556; Yang WB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00406; Yokoyama T, 2020, ARCH BIOCHEM BIOPHYS, V691, DOI 10.1016/j.abb.2020.108510	63	1	1	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100596	10.1016/j.jbc.2021.100596	http://dx.doi.org/10.1016/j.jbc.2021.100596			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781743	gold, Green Published			2022-12-28	WOS:000672866400568
J	Yamaguchi, K; So, M; Aguirre, C; Ikenaka, K; Mochizuki, H; Kawata, Y; Goto, Y				Yamaguchi, Keiichi; So, Masatomo; Aguirre, Cesar; Ikenaka, Kensuke; Mochizuki, Hideki; Kawata, Yasushi; Goto, Yuji			Polyphosphates induce amyloid fibril formation of alpha-synuclein in concentration-dependent distinct manners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC POLYPHOSPHATE; SUPERSATURATION; AGGREGATION; DISEASE; WATER; SOLUBILITY; MEDIATORS; MECHANISM; PROTEINS; HEPARIN	Polyphosphates (polyPs), chains of phosphate residues found in species across nature from bacteria to mammals, were recently reported to accelerate the amyloid fibril formation of many proteins. How polyPs facilitate this process, however, remains unknown. To gain insight into their mechanisms, we used various physicochemical approaches to examine the effects of polyPs of varying chain lengths on ultrasonication-dependent alpha-synuclein (alpha-syn) amyloid formation. Although orthophosphate and diphosphate exhibited a single optimal concentration of amyloid formation, triphosphate and longer-chain phosphates exhibited two optima, with the second at a concentration lower than that of orthophosphate or diphosphate. The second optimum decreased markedly as the polyP length increased. This suggested that although the optima at lower polyP concentrations were caused by interactions between negatively charged phosphate groups and the positive charges of alpha-syn, the optima at higher polyP concentrations were caused by the Hofmeister salting-out effects of phosphate groups, where the effects do not depend on the net charge. NMR titration experiments of alpha-syn with tetraphosphate combined with principal component analysis revealed that, at low tetraphosphate concentrations, negatively charged tetra-phosphates interacted with positively charged "KTK" segments in four KTKEGV repeats located at the N-terminal region. At high concentrations, hydrated tetraphosphates affected the surface-exposed hydrophilic groups of compact alpha-syn. Taken together, our results suggest that long-chain polyPs consisting of 60 to 70 phosphates induce amyloid formation at sub-mu M concentrations, which are comparable with the concentrations of polyPs in the blood or tissues. Thus, these findings may identify a role for polyPs in the pathogenesis of amyloid-related diseases.	[Yamaguchi, Keiichi; Goto, Yuji] Osaka Univ, Grad Sch Med, Global Ctr Med Engn & Informat, Osaka, Japan; [Yamaguchi, Keiichi; So, Masatomo; Aguirre, Cesar; Goto, Yuji] Osaka Univ, Grad Sch Med, Inst Prot Res, Osaka, Japan; [Aguirre, Cesar; Ikenaka, Kensuke; Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Kawata, Yasushi] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori, Japan	Osaka University; Osaka University; Osaka University; Tottori University	Goto, Y (corresponding author), Osaka Univ, Grad Sch Med, Global Ctr Med Engn & Informat, Osaka, Japan.; Goto, Y (corresponding author), Osaka Univ, Grad Sch Med, Inst Prot Res, Osaka, Japan.	gtyj8126@protein.osaka-u.ac.jp	Kawata, Yasushi/ABA-9608-2021	Goto, Yuji/0000-0003-1221-1270; Kawata, Yasushi/0000-0002-2744-1506; So, Masatomo/0000-0002-4815-4995	Cooperative Research Program for the Institute for Protein Research, Osaka University [CR-18-02]; Japan Society for the Promotion of Science [20K06580]; Ministry of Education, Culture, Sports, Science and Technology [17H06352]; SENTAN from the Japan Agency for Medical Research and Development, AMED [16809242]	Cooperative Research Program for the Institute for Protein Research, Osaka University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SENTAN from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was performed as part of the Cooperative Research Program for the Institute for Protein Research, Osaka University (CR-18-02) and was supported by the Japan Society for the Promotion of Science (20K06580) and Core-to-Core Program A (Advance Research Networks), Ministry of Education, Culture, Sports, Science and Technology (17H06352), and SENTAN from the Japan Agency for Medical Research and Development, AMED (16809242).	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Adachi M, 2018, J BIOL CHEM, V293, P14775, DOI 10.1074/jbc.RA118.004683; Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; Cremers CM, 2016, MOL CELL, V63, P768, DOI 10.1016/j.molcel.2016.07.016; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2015, P NATL ACAD SCI USA, V112, P9596, DOI 10.1073/pnas.1505953112; Fonseca-Ornelas L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6857; Furukawa K, 2020, CURR RES STRUCT BIOL, V2, P35, DOI 10.1016/j.crstbi.2020.03.001; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Giehm L, 2010, J MOL BIOL, V401, P115, DOI 10.1016/j.jmb.2010.05.060; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAHAM JG, 1969, J NEUROL NEUROSUR PS, V32, P28, DOI 10.1136/jnnp.32.1.28; Guerrero-Ferreira R, 2018, ELIFE, V7, DOI 10.7554/eLife.36402; HSIEH PC, 1993, PROTEIN EXPRES PURIF, V4, P76, DOI 10.1006/prep.1993.1012; Iadanza MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06761-6; Ishige K, 2002, P NATL ACAD SCI USA, V99, P16684, DOI 10.1073/pnas.262655299; Ito T, 2020, J BIOL CHEM, V295, P4014, DOI 10.1074/jbc.RA119.011763; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jaumot J, 2004, ANAL BIOCHEM, V327, P1, DOI 10.1016/j.ab.2003.12.028; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAGER GA, 1973, AM MINERAL, V58, P756; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lever J, 2017, NAT METHODS, V14, P641, DOI 10.1038/nmeth.4346; Marek PJ, 2012, BIOCHEMISTRY-US, V51, P8478, DOI 10.1021/bi300574r; Melki R, 2015, J PARKINSON DIS, V5, P217, DOI 10.3233/JPD-150543; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Nihonyanagi S, 2014, J AM CHEM SOC, V136, P6155, DOI 10.1021/ja412952y; Nitani A, 2017, J BIOL CHEM, V292, P21219, DOI 10.1074/jbc.M117.813097; Noji M, 2019, J BIOL CHEM, V294, P15826, DOI 10.1074/jbc.RA119.009971; Noji M, 2018, BIOCHEMISTRY-US, V57, P5415, DOI 10.1021/acs.biochem.8b00619; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Sakurai K, 2007, P NATL ACAD SCI USA, V104, P15346, DOI 10.1073/pnas.0702112104; Sasahara K, 2019, J BIOL CHEM, V294, P15318, DOI 10.1074/jbc.RA119.008662; Sawada M, 2020, LANGMUIR, V36, P4671, DOI 10.1021/acs.langmuir.0c00426; Schweighauser M, 2020, NATURE, V585, P464, DOI 10.1038/s41586-020-2317-6; Sipe JD, 2016, AMYLOID, V23, P209, DOI 10.1080/13506129.2016.1257986; So M, 2017, PROTEIN SCI, V26, P1024, DOI 10.1002/pro.3149; So M, 2016, CURR OPIN STRUC BIOL, V36, P32, DOI 10.1016/j.sbi.2015.11.009; Strohaker T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13564-w; Terakawa MS, 2018, BBA-BIOMEMBRANES, V1860, P757, DOI 10.1016/j.bbamem.2017.12.011; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Wang X, 2020, ANGEW CHEM INT EDIT, V59, P2679, DOI 10.1002/anie.201913833; WEISEMANN R, 1993, J BIOMOL NMR, V3, P113; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Xie LH, 2019, J BIOL CHEM, V294, P2180, DOI 10.1074/jbc.REV118.002808; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yoshimura Y, 2017, J BIOL CHEM, V292, P8269, DOI 10.1074/jbc.M116.764886; Zhang CM, 2019, P NATL ACAD SCI USA, V116, P12833, DOI 10.1073/pnas.1819813116	60	1	1	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100510	10.1016/j.jbc.2021.100510	http://dx.doi.org/10.1016/j.jbc.2021.100510			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676889	gold, Green Published			2022-12-28	WOS:000672866400484
J	Yazici, AT; Gianti, E; Kasimova, MA; Lee, BH; Carnevale, V; Rohacs, T				Yazici, Aysenur Torun; Gianti, Eleonora; Kasimova, Marina A.; Lee, Bo-Hyun; Carnevale, Vincenzo; Rohacs, Tibor			Dual regulation of TRPV1 channels by phosphatidylinositol via functionally distinct binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID 1 TRPV1; ION-CHANNEL; PHOSPHOINOSITIDE REGULATION; MOLECULAR DETERMINANTS; CAPSAICIN RECEPTOR; ACTIVATION; PI(4,5)P-2; 4,5-BISPHOSPHATE; DYNAMICS; PROTEIN	Regulation of the heat- and capsaicin-activated transient receptor potential vanilloid 1 (TRPV1) channel by phosphoinositides is complex and controversial. In the most recent TRPV1 cryo-EM structure, endogenous phosphatidylinositol (PtdIns) was detected in the vanilloid binding site, and phosphoinositides were proposed to act as competitive vanilloid antagonists. This model is difficult to reconcile with phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P-2] being a well-established positive regulator of TRPV1. Here we show that in the presence of PtdIns(4,5)P-2 in excised patches, PtdIns, but not PtdIns(4)P, partially inhibited TRPV1 activity at low, but not at high capsaicin concentrations. This is consistent with PtdIns acting as a competitive vanilloid antagonist. However, in the absence of PtdIns(4,5)P-2, PtdIns partially stimulated TRPV1 activity. We computationally identified residues, which are in contact with PtdIns, but not with capsaicin in the vanilloid binding site. The I703A mutant of TRPV1 showed increased sensitivity to capsaicin, as expected when removing the effect of an endogenous competitive antagonist. I703A was not inhibited by PtdIns in the presence of PtdIns(4,5)P-2, but it was still activated by PtdIns in the absence of PtdIns(4,5)P-2 indicating that inhibition, but not activation by PtdIns proceeds via the vanilloid binding site. In molecular dynamics simulations, PtdIns was more stable than PtdIns(4,5)P-2 in this inhibitory site, whereas PtdIns(4,5)P-2 was more stable than PtdIns in a previously identified, nonoverlapping, putative activating binding site. Our data indicate that phosphoinositides regulate channel activity via functionally distinct binding sites, which may explain some of the complexities of the effects of these lipids on TRPV1.	[Yazici, Aysenur Torun; Lee, Bo-Hyun; Rohacs, Tibor] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Gianti, Eleonora; Kasimova, Marina A.; Carnevale, Vincenzo] Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA; [Kasimova, Marina A.] Novo Nordisk, Malov, Denmark	Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Rohacs, T (corresponding author), Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA.; Carnevale, V (corresponding author), Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA.	vincenzo.carnevale@temple.edu; tibor.rohacs@rutgers.edu	; Carnevale, Vincenzo/D-8015-2014	Lee, Bo Hyun/0000-0003-2652-8797; Carnevale, Vincenzo/0000-0002-1918-8280; Yazici, Aysenur/0000-0002-1715-0107; Rohacs, Tibor/0000-0003-3580-2575; Gianti, Eleonora/0000-0003-2892-2771	National Institutes of Health [NS055159]; National Science Foundation [ACI-1614804]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health Grants NS055159 (to T. R.), and National Science Foundation Grant ACI-1614804 (V.C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Beard H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082849; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chernov-Rogan T, 2019, P NATL ACAD SCI USA, V116, P26008, DOI 10.1073/pnas.1913929116; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Doerner JF, 2011, J GEN PHYSIOL, V137, P271, DOI 10.1085/jgp.200910388; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gallego-Sandin S, 2009, J BIOL CHEM, V284, P32591, DOI 10.1074/jbc.M109.019687; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hughes TET, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06753-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kasimova MA, 2018, J PHYS CHEM LETT, V9, P1260, DOI 10.1021/acs.jpclett.7b03396; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Lukacs V, 2013, J NEUROSCI, V33, P11451, DOI 10.1523/JNEUROSCI.5637-12.2013; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poblete H, 2015, J BIOL CHEM, V290, P2086, DOI 10.1074/jbc.M114.613620; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2015, PFLUG ARCH EUR J PHY, V467, P1851, DOI 10.1007/s00424-015-1695-3; Rohacs T, 2014, HANDB EXP PHARMACOL, V223, P1143, DOI 10.1007/978-3-319-05161-1_18; Rohacs Tibor, 2013, Methods Mol Biol, V998, P119, DOI 10.1007/978-1-62703-351-0_9; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Seabrook GR, 2002, J PHARMACOL EXP THER, V303, P1052, DOI 10.1124/jpet.102.040394; Senning EN, 2014, J BIOL CHEM, V289, P10999, DOI 10.1074/jbc.M114.553180; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sun XH, 2015, J BIOL CHEM, V290, P4741, DOI 10.1074/jbc.M114.611459; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Ufret-Vincenty CA, 2015, J GEN PHYSIOL, V145, P431, DOI 10.1085/jgp.201511354; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Wisnoskey BJ, 2003, BIOCHEM J, V372, P517, DOI 10.1042/BJ20021574; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046	45	5	5	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100573	10.1016/j.jbc.2021.100573	http://dx.doi.org/10.1016/j.jbc.2021.100573			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33766560	gold, Green Published			2022-12-28	WOS:000672866400546
J	Zhang, YX; Wang, L; Peng, DZ; Zhang, QF; Yang, QC; Li, JY; Li, D; Tang, DF; Chen, MZ; Liang, SP; Liu, Y; Wang, S; Liu, ZH				Zhang, Yunxiao; Wang, Li; Peng, Dezheng; Zhang, Qingfeng; Yang, Qiuchu; Li, Jiayan; Li, Dan; Tang, Dongfang; Chen, Minzhi; Liang, Songping; Liu, Yu; Wang, Sheng; Liu, Zhonghua			Engineering of highly potent and selective HNTX-III mutant against hNa(v)1.7 sodium channel for treatment of pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAIN-OF-FUNCTION; ANALGESIC TARGET; NEUROPATHIC PAIN; VENOM; MUTATION; ANTAGONIST; MODULATORS; NA(V)1.6; SCN8A; MECHANISMS	Human voltage-gated sodium channel Na(v)1.7 (hNa(v)1.7) is involved in the generation and conduction of neuropathic and nociceptive pain signals. Compelling genetic and preclinical studies have validated that hNa(v)1.7 is a therapeutic target for the treatment of pain; however, there is a dearth of currently available compounds capable of targeting hNav1.7 with high potency and specificity. Hainantoxin-III (HNTX-III) is a 33-residue polypeptide from the venom of the spider Ornithoctonus hainana. It is a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels. Here, we report the engineering of improved potency and Na-v selectivity of hNa(v)1.7 inhibition peptides derived from the HNTX-III scaffold. Alanine scanning mutagenesis showed key residues for HNTX-III interacting with hNa(v)1.7. Site-directed mutagenesis analysis indicated key residues on hNa(v)1.7 interacting with HNTX-III. Molecular docking was conducted to clarify the binding interface between HNTX-III and Nav1.7 and guide the molecular engineering process. Ultimately, we obtained H4 [K0G1-P18K-A21L-V] based on molecular docking of HNTX-III and hNa(v)1.7 with a 30-fold improved potency (IC50 0.007 +/- 0.001 mu M) and >1000-fold selectivity against Na(v)1.4 and Na(v)1.5. H4 also showed robust analgesia in the acute and chronic inflammatory pain model and neuropathic pain model. Thus, our results provide further insight into peptide toxins that may prove useful in guiding the development of inhibitors with improved potency and selectivity for Na-v subtypes with robust analgesia.	[Zhang, Yunxiao; Wang, Li; Peng, Dezheng; Zhang, Qingfeng; Yang, Qiuchu; Li, Jiayan; Li, Dan; Tang, Dongfang; Chen, Minzhi; Liang, Songping; Liu, Zhonghua] Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha, Hunan, Peoples R China; [Zhang, Yunxiao; Peng, Dezheng; Liu, Yu] Hunan Inst Sci & Technol, Sch Chem & Chem Engn, Key Lab Hunan Prov Adv Carbon Based Funct Mat, Yueyang, Hunan, Peoples R China; [Wang, Sheng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China	Hunan Normal University; Hunan Institute of Science & Technology; Huazhong University of Science & Technology	Liu, ZH (corresponding author), Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha, Hunan, Peoples R China.; Liu, Y (corresponding author), Hunan Inst Sci & Technol, Sch Chem & Chem Engn, Key Lab Hunan Prov Adv Carbon Based Funct Mat, Yueyang, Hunan, Peoples R China.; Wang, S (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China.	hiliu2000@126.com; shengwang@hust.edu.cn; liuzh@hunnu.edu.cn			National Natural Science Foundation of China [31900906, 32071262, 31570782, 31770832]; Science and Technology Innovation Program of Hunan Province [2020RC4023]; Research Foundation of Education Bureau of Hunan Province [16A131, 18A318, 19B240]; Hunan Natural Science Foundation [2018JJ2150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Program of Hunan Province; Research Foundation of Education Bureau of Hunan Province; Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province)	This work was supported by the National Natural Science Foundation of China (No. 31900906, 32071262, 31570782, 31770832), the Science and Technology Innovation Program of Hunan Province (2020RC4023), the Research Foundation of Education Bureau of Hunan Province (16A131, 18A318, 19B240) and Hunan Natural Science Foundation (No. 2018JJ2150).	Adedeji HA, 2014, PROG NEURO-PSYCHOPH, V48, P245, DOI 10.1016/j.pnpbp.2013.10.014; Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Alexandrou AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152405; Bagal SK, 2014, BIOORG MED CHEM LETT, V24, P3690, DOI 10.1016/j.bmcl.2014.06.038; Beard E L Jr, 2001, JONAS Healthc Law Ethics Regul, V3, P78; Blanchard MG, 2015, J MED GENET, V52, P330, DOI 10.1136/jmedgenet-2014-102813; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Bourquin AF, 2006, PAIN, V122, P14, DOI 10.1016/j.pain.2005.10.036; Cardoso FC, 2017, BRIT J PHARMACOL, V174, P2528, DOI 10.1111/bph.13865; Cardoso FC, 2015, MOL PHARMACOL, V88, P291, DOI 10.1124/mol.115.098178; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen L., 2014, SCI REP-UK, V4; Chow CY, 2015, TOXINS, V7, P2494, DOI 10.3390/toxins7072494; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Deuis JR, 2017, SCI REP-UK, V7, DOI 10.1038/srep40883; Devigili G, 2014, PAIN, V155, P1702, DOI 10.1016/j.pain.2014.05.006; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Estacion M, 2014, NEUROBIOL DIS, V69, P117, DOI 10.1016/j.nbd.2014.05.017; Gingras J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105895; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Jensen TS, 2002, EUR J PAIN, V6, P61, DOI 10.1053/eujp.2001.0324; Kawamoto Y, 2019, BIOCHEM PHARMACOL, V163, P178, DOI 10.1016/j.bcp.2019.02.015; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Kornecook TJ, 2017, J PHARMACOL EXP THER, V362, P146, DOI 10.1124/jpet.116.239590; Liu M, 2011, PAIN MED, V12, pS93, DOI 10.1111/j.1526-4637.2011.01158.x; Liu Y, 2014, TOXINS, V6, P2363, DOI 10.3390/toxins6082363; Liu ZH, 2013, J BIOL CHEM, V288, P20392, DOI 10.1074/jbc.M112.426627; Lorenz D, 1998, J GEN PHYSIOL, V112, P577, DOI 10.1085/jgp.112.5.577; Mao JR, 2000, PAIN, V87, P7, DOI 10.1016/S0304-3959(00)00229-3; McKerrall SJ, 2019, J MED CHEM, V62, P4091, DOI 10.1021/acs.jmedchem.9b00141; Moyer BD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196791; Mulcahy JV, 2019, J MED CHEM, V62, P8695, DOI 10.1021/acs.jmedchem.8b01906; Murray JK, 2016, J MED CHEM, V59, P2704, DOI 10.1021/acs.jmedchem.5b01947; Murray JK, 2015, BIOORG MED CHEM LETT, V25, P4866, DOI 10.1016/j.bmcl.2015.06.033; Murray JK, 2015, J MED CHEM, V58, P2299, DOI 10.1021/jm501765v; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; Owoyele Victor B., 2005, Inflammopharmacology, V13, P479, DOI 10.1163/156856005774649386; Pi JH, 2007, CHIN J CHROMATOGR, V25, P399, DOI 10.1016/S1872-2059(07)60014-5; Rahnama S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173551; Redondo A, 2017, J PHARMACOL EXP THER, V363, P293, DOI 10.1124/jpet.117.244376; Revell JD, 2013, PEPTIDES, V44, P40, DOI 10.1016/j.peptides.2013.03.011; Sanna MD, 2017, BRIT J PHARMACOL, V174, P28, DOI 10.1111/bph.13644; Shcherbatko A, 2016, J BIOL CHEM, V291, P13974, DOI 10.1074/jbc.M116.725978; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; Suter MR, 2015, ANESTHESIOLOGY, V122, P414, DOI 10.1097/ALN.0000000000000476; Tanaka BS, 2016, MOL MED, V22, P338, DOI 10.2119/molmed.2016.00131; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Waxman SG, 2006, NATURE, V444, P831, DOI 10.1038/444831a; Wu B, 2017, CURR MOL MED, V17, P450, DOI 10.2174/1566524017666171009105029; Xie W, 2015, NEUROSCIENCE, V291, P317, DOI 10.1016/j.neuroscience.2015.02.010; Xie WR, 2013, PAIN, V154, P1170, DOI 10.1016/j.pain.2013.02.027; Xu H, 2019, CELL, V176, P702, DOI 10.1016/j.cell.2018.12.018; Yang Y, 2016, J NEUROSCI, V36, P7511, DOI 10.1523/JNEUROSCI.0462-16.2016; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhou X, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00852; Zhu YQ, 2014, BIOCHIMIE, V99, P38, DOI 10.1016/j.biochi.2013.10.017	61	4	4	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100326	10.1016/j.jbc.2021.100326	http://dx.doi.org/10.1016/j.jbc.2021.100326			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493520	Green Published, gold			2022-12-28	WOS:000672866400300
J	Cizmecioglu, NT; Huang, JL; Keskin, EG; Wang, XF; Esen, I; Chen, F; Orkin, SH				Cizmecioglu, Nihal Terzi; Huang, Jialiang; Keskin, Ezgi G.; Wang, Xiaofeng; Esen, Idil; Chen, Fei; Orkin, Stuart H.			ARID4B is critical for mouse embryonic stem cell differentiation towards mesoderm and endoderm, linking epigenetics to pluripotency exit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; cell differentiation; epigenetics; gene expression; chromatin modification; embryonic stem cell	CHROMATIN REMODELING COMPLEX; HISTONE DEACETYLASE; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; H3K4 TRIMETHYLATION; SUPER-ENHANCERS; GENE-EXPRESSION; RBP1 RECRUITS; RNAI SCREEN; POLYCOMB	Distinct cell types emerge from embryonic stem cells through a precise and coordinated execution of gene expression programs during lineage commitment. This is established by the action of lineage specific transcription factors along with chromatin complexes. Numerous studies have focused on epigenetic factors that affect embryonic stem cells (ESC) self-renewal and pluripotency. However, the contribution of chromatin to lineage decisions at the exit from pluripotency has not been as extensively studied. Using a pooled epigenetic shRNA screen strategy, we identified chromatin-related factors critical for differentiation toward mesodermal and endodermal lineages. Here we reveal a critical role for the chromatin protein, ARID4B. Arid4b-deficient mESCs are similar to WT mESCs in the expression of pluripotency factors and their self-renewal. However, ARID4B loss results in defects in up-regulation of the meso/endodermal gene expression program. It was previously shown that Arid4b resides in a complex with SIN3A and HDACS 1 and 2. We identified a physical and functional interaction of ARID4B with HDAC1 rather than HDAC2, suggesting functionally distinct Sin3a subcomplexes might regulate cell fate decisions Finally, we observed that ARID4B deficiency leads to increased H3K27me3 and a reduced H3K27Ac level in key developmental gene loci, whereas a subset of genomic regions gain H3K27Ac marks. Our results demonstrate that epigenetic control through ARID4B plays a key role in the execution of lineage-specific gene expression programs at pluripotency exit.	[Cizmecioglu, Nihal Terzi; Keskin, Ezgi G.] Middle East Tech Univ, Fac Arts & Sci, Dept Biol Sci, Ankara, Turkey; [Huang, Jialiang; Chen, Fei] Xiamen Univ, Innovat Ctr Cell Signaling Network, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Wang, Xiaofeng] Dartmouth Coll, Geisel Sch Med, Hanover, NH USA; [Esen, Idil; Orkin, Stuart H.] Harvard Med Sch, Dept Pediat, Howard Hughes Med Inst, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA	Middle East Technical University; Xiamen University; Dartmouth College; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Cizmecioglu, NT (corresponding author), Middle East Tech Univ, Fac Arts & Sci, Dept Biol Sci, Ankara, Turkey.; Orkin, SH (corresponding author), Harvard Med Sch, Dept Pediat, Howard Hughes Med Inst, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA.	nterzi@metu.edu.tr; Stuart_Orkin@dfci.harvard.edu	Cizmecioglu, Nihal Terzi/D-4803-2019	Stuart, Orkin/0000-0002-0313-152X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Baltus GA, 2009, J BIOL CHEM, V284, P6998, DOI 10.1074/jbc.M807670200; Baymaz HI, 2015, BBA-GENE REGUL MECH, V1849, P1051, DOI 10.1016/j.bbagrm.2015.06.012; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Boward B, 2016, STEM CELLS, V34, P1427, DOI 10.1002/stem.2345; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Cao JN, 2001, J NATL CANCER I, V93, P1159, DOI 10.1093/jnci/93.15.1159; Collinson A, 2016, CELL REP, V17, P2700, DOI 10.1016/j.celrep.2016.11.032; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Creech AL, 2015, METHODS, V72, P57, DOI 10.1016/j.ymeth.2014.10.033; Dalton S, 2015, TRENDS CELL BIOL, V25, P592, DOI 10.1016/j.tcb.2015.07.007; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Das PP, 2014, MOL CELL, V53, P32, DOI 10.1016/j.molcel.2013.11.011; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Denissov S, 2014, DEVELOPMENT, V141, P526, DOI 10.1242/dev.102681; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Goldberger N, 2013, CANCER RES, V73, P2671, DOI 10.1158/0008-5472.CAN-12-3513; Gong WB, 2012, J BIOL CHEM, V287, P8531, DOI 10.1074/jbc.M111.299149; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Icardi L, 2012, P NATL ACAD SCI USA, V109, P12058, DOI 10.1073/pnas.1206458109; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Lai A, 1999, ONCOGENE, V18, P2091, DOI 10.1038/sj.onc.1202520; Laj A, 1999, MOL CELL BIOL, V19, P6632; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li VC, 2014, P NATL ACAD SCI USA, V111, P9503, DOI 10.1073/pnas.1408638111; Li VC, 2012, P NATL ACAD SCI USA, V109, P12550, DOI 10.1073/pnas.1206740109; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Mas G, 2018, NAT GENET, V50, P1452, DOI 10.1038/s41588-018-0218-5; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Morey L, 2015, MOL CELL BIOL, V35, P2716, DOI 10.1128/MCB.00266-15; Nitarska J, 2016, CELL REP, V17, P1683, DOI 10.1016/j.celrep.2016.10.022; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Ruiz-Roig C, 2010, MOL MICROBIOL, V76, P1049, DOI 10.1111/j.1365-2958.2010.07167.x; Saha N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2428-5; Saunders A, 2017, CELL REP, V18, P1713, DOI 10.1016/j.celrep.2017.01.055; Sen P, 2017, CELL REP, V18, P2135, DOI 10.1016/j.celrep.2017.02.017; Seruggia D, 2019, MOL CELL, V74, P1148, DOI 10.1016/j.molcel.2019.03.025; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Streubel G, 2017, EMBO J, V36, P2216, DOI 10.15252/embj.201696307; Terzi N, 2011, MOL CELL BIOL, V31, P3569, DOI 10.1128/MCB.05590-11; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; van Oevelen C, 2010, MOL CELL BIOL, V30, P5686, DOI 10.1128/MCB.00975-10; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang K, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-23; Wang XF, 2017, NAT GENET, V49, P289, DOI 10.1038/ng.3746; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; Winter SF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002735; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; Wu MY, 2006, GENE DEV, V20, P2859, DOI 10.1101/gad.1452206; Wu RC, 2017, STEM CELLS, V35, P1554, DOI 10.1002/stem.2597; Wu RC, 2015, MOL ENDOCRINOL, V29, P1334, DOI 10.1210/me.2015-1089; Wu RC, 2013, P NATL ACAD SCI USA, V110, P4616, DOI 10.1073/pnas.1218318110; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu FG, 2018, NUCLEIC ACIDS RES, V46, P6026, DOI 10.1093/nar/gky347; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	103	6	6	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17738	17751		10.1074/jbc.RA120.015534	http://dx.doi.org/10.1074/jbc.RA120.015534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454011	Green Published, hybrid			2022-12-28	WOS:000603272300027
J	Fahrig-Kamarauskait, J; Wurth-Roderer, K; Thorbjornsrud, HV; Mailand, S; Krengel, U; Kast, P				Fahrig-Kamarauskait, Jurate; Wuerth-Roderer, Kathrin; Thorbjornsrud, Helen, V; Mailand, Susanne; Krengel, Ute; Kast, Peter			Evolving the naturally compromised chorismate mutase from Mycobacterium tuberculosis to top performance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						catalytic efficiency; conformational change; crystal structure; directed evolution; enzyme catalysis; enzyme mutation; molecular evolution; protein structure; structure-activity relationship; X-ray crystallography	ALLOSTERIC REGULATION; DIRECTED EVOLUTION; TRANSITION-STATE; COMBINATORIAL MUTAGENESIS; CRYSTAL-STRUCTURE; ACTIVE-SITE; ENZYME; SELECTION; OPTIMIZATION; STABILITY	Chorismate mutase (CM), an essential enzyme at the branch-point of the shikimate pathway, is required for the biosynthesis of phenylalanine and tyrosine in bacteria, archaea, plants, and fungi. MtCM, the CM from Mycobacterium tuberculosis, has less than 1% of the catalytic efficiency of a typical natural CM and requires complex formation with 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase for high activity. To explore the full potential of MtCM for catalyzing its native reaction, we applied diverse iterative cycles of mutagenesis and selection, thereby raising k(cat)/K-m 270-fold to 5 x 10(5) m(-1)s(-1), which is even higher than for the complex. Moreover, the evolutionarily optimized autonomous MtCM, which had 11 of its 90 amino acids exchanged, was stabilized compared with its progenitor, as indicated by a 9 degrees C increase in melting temperature. The 1.5 angstrom crystal structure of the top-evolved MtCM variant reveals the molecular underpinnings of this activity boost. Some acquired residues (e.g. Pro(52) and Asp(55)) are conserved in naturally efficient CMs, but most of them lie beyond the active site. Our evolutionary trajectories reached a plateau at the level of the best natural enzymes, suggesting that we have exhausted the potential of MtCM. Taken together, these findings show that the scaffold of MtCM, which naturally evolved for mediocrity to enable inter-enzyme allosteric regulation of the shikimate pathway, is inherently capable of high activity.	[Fahrig-Kamarauskait, Jurate; Wuerth-Roderer, Kathrin; Mailand, Susanne; Kast, Peter] Swiss Fed Inst Technol, Lab Organ Chem, Zurich, Switzerland; [Thorbjornsrud, Helen, V; Krengel, Ute] Univ Oslo, Dept Chem, Oslo, Norway	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oslo	Kast, P (corresponding author), Swiss Fed Inst Technol, Lab Organ Chem, Zurich, Switzerland.; Krengel, U (corresponding author), Univ Oslo, Dept Chem, Oslo, Norway.	ute.krengel@kjemi.uio.no; kast@org.chem.ethz.ch		Kast, Peter/0000-0002-0209-8975; Wurth-Roderer, Kathrin/0000-0002-0233-9863	University of Oslo; ETH Zurich; Norwegian Research Council [216625, 247730]; Swiss National Science Foundation [31003A-116475, 31003A-135651, 31003A-156453, 310030M_182648]	University of Oslo; ETH Zurich(ETH Zurich); Norwegian Research Council(Research Council of NorwayEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financed by funds from the University of Oslo (position of H. V. T.), the ETH Zurich (to P. K.), the Norwegian Research Council Grants 216625 and 247730 (to U. K.), and the Swiss National Science Foundation Grants 31003A-116475, 31003A-135651, 31003A-156453, and 310030M_182648 (to P. K.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADDADI L, 1983, BIOCHEMISTRY-US, V22, P4494, DOI 10.1021/bi00288a022; Bai Y, 2019, J BIOL CHEM, V294, P4828, DOI 10.1074/jbc.RA118.005220; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; BARTLETT PA, 1985, J AM CHEM SOC, V107, P7792, DOI 10.1021/ja00311a111; BENNER SA, 1989, CHEM REV, V89, P789, DOI 10.1021/cr00094a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bershtein S, 2008, CURR OPIN CHEM BIOL, V12, P151, DOI 10.1016/j.cbpa.2008.01.027; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; BLACKLOW SC, 1990, BIOCHEMISTRY-US, V29, P4099, DOI 10.1021/bi00469a012; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; Burschowsky D, 2018, BIOCHEMISTRY-US, V57, P557, DOI 10.1021/acs.biochem.7b01018; Butz M, 2011, BIOCHEMISTRY-US, V50, P8594, DOI 10.1021/bi2011338; Diaz-Lopez T, 2003, J BIOL CHEM, V278, P18606, DOI 10.1074/jbc.M212024200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fan YF, 2018, P NATL ACAD SCI USA, V115, P3006, DOI 10.1073/pnas.1717621115; FANGMAN WL, 1964, J BIOL CHEM, V239, P1839; Gamper M, 2000, BIOCHEMISTRY-US, V39, P14087, DOI 10.1021/bi0016570; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; GUILFORD WJ, 1987, J AM CHEM SOC, V109, P5013, DOI 10.1021/ja00250a041; Gustin DJ, 1999, J AM CHEM SOC, V121, P1756, DOI 10.1021/ja9841759; Haslam E., 1993, SHIKIMIC ACID METABO; Hecky J, 2005, BIOCHEMISTRY-US, V44, P12640, DOI 10.1021/bi0501885; Hecky J, 2007, METH MOL B, V352, P275; Helmstaedt K, 2004, ARCH MICROBIOL, V181, P195, DOI 10.1007/s00203-003-0639-z; Helmstaedt K, 2002, P NATL ACAD SCI USA, V99, P6631, DOI 10.1073/pnas.092130899; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hoskins JR, 2006, P NATL ACAD SCI USA, V103, P909, DOI 10.1073/pnas.0509154103; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Jiao WT, 2020, J BIOL CHEM, V295, P6252, DOI 10.1074/jbc.RA120.012605; Jiao W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180052; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kast P, 1996, P NATL ACAD SCI USA, V93, P5043, DOI 10.1073/pnas.93.10.5043; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; KAST P, 1991, J MOL BIOL, V222, P99, DOI 10.1016/0022-2836(91)90740-W; Kast P, 1996, PURE APPL CHEM, V68, P2017, DOI 10.1351/pac199668112017; Kim SK, 2008, FEBS J, V275, P4824, DOI 10.1111/j.1742-4658.2008.06621.x; Kiss C, 2009, PROTEIN ENG DES SEL, V22, P313, DOI 10.1093/protein/gzp006; Ladner JE, 2000, ACTA CRYSTALLOGR D, V56, P673, DOI 10.1107/S0907444900004625; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Light SH, 2013, PROTEIN SCI, V22, P395, DOI 10.1002/pro.2233; Liu DR, 1996, J AM CHEM SOC, V118, P1789, DOI 10.1021/ja953151o; MacBeath G, 1998, BIOTECHNIQUES, V24, P789, DOI 10.2144/98245st02; MacBeath G, 1998, BIOCHEMISTRY-US, V37, P10062, DOI 10.1021/bi980449t; MacBeath G, 1998, PROTEIN SCI, V7, P1757, DOI 10.1002/pro.5560070810; Mandal A, 2003, J AM CHEM SOC, V125, P5598, DOI 10.1021/ja029447t; Mattei P, 1999, EUR J BIOCHEM, V261, P25, DOI 10.1046/j.1432-1327.1999.00169.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullum EO, 2010, METHODS MOL BIOL, V634, P103, DOI 10.1007/978-1-60761-652-8_7; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; Munack S, 2016, J MOL BIOL, V428, P1237, DOI 10.1016/j.jmb.2016.01.001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nazmi AR, 2016, J BIOL CHEM, V291, P21836, DOI 10.1074/jbc.M116.741637; Newton MS, 2018, CURR OPIN STRUC BIOL, V48, P110, DOI 10.1016/j.sbi.2017.11.007; Okvist M, 2006, J MOL BIOL, V357, P1483, DOI 10.1016/j.jmb.2006.01.069; Pervushin K, 2007, NAT STRUCT MOL BIOL, V14, P1202, DOI 10.1038/nsmb1325; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Renata H, 2015, ANGEW CHEM INT EDIT, V54, P3351, DOI 10.1002/anie.201409470; RICHMOND MH, 1962, BACTERIOL REV, V26, P398, DOI 10.1128/MMBR.26.4.398-420.1962; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Roderer K., 2012, THESIS; Roderer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116234; Roderer K, 2009, CHIMIA, V63, P313, DOI 10.2533/chimia.2009.313; Russ WP, 2020, SCIENCE, V369, P440, DOI 10.1126/science.aba3304; Sambrook J., 2001, MOL CLONING LAB MANU; Sasso S, 2005, FEBS J, V272, P375, DOI 10.1111/j.1742-4658.2004.04478.x; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schnappauf G, 1997, P NATL ACAD SCI USA, V94, P8491, DOI 10.1073/pnas.94.16.8491; SMITH WW, 1993, J ORG CHEM, V58, P7308, DOI 10.1021/jo00077a070; Speck J, 2012, BIOCHEMISTRY-US, V51, P4850, DOI 10.1021/bi2018738; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Sterritt OW, 2018, BIOCHEMISTRY-US, V57, P2667, DOI 10.1021/acs.biochem.8b00082; Strater N, 1997, STRUCTURE, V5, P1437, DOI 10.1016/S0969-2126(97)00294-3; Studer S, 2018, SCIENCE, V362, P1285, DOI 10.1126/science.aau3744; Taylor SV, 2001, ANGEW CHEM INT EDIT, V40, P3310, DOI 10.1002/1521-3773(20010917)40:18<3310::AID-ANIE3310>3.0.CO;2-P; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Westfall CS, 2014, J BIOL CHEM, V289, P28619, DOI 10.1074/jbc.M114.591123; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; XUE YF, 1994, P NATL ACAD SCI USA, V91, P10814, DOI 10.1073/pnas.91.23.10814; Zhang HJ, 2005, ARCH BIOCHEM BIOPHYS, V441, P123, DOI 10.1016/j.abb.2005.07.006; Zhang S, 1996, BIOORGAN MED CHEM, V4, P1015, DOI 10.1016/0968-0896(96)00099-5	84	1	1	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17514	17534		10.1074/jbc.RA120.014924	http://dx.doi.org/10.1074/jbc.RA120.014924			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453995	Green Published, hybrid			2022-12-28	WOS:000603272300011
J	Mears, HV; Sweeney, TR				Mears, Harriet, V; Sweeney, Trevor R.			Mouse Ifit1b is a cap1-RNA-binding protein that inhibits mouse coronavirus translation and is regulated by complexing with Ifit1c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding protein; mRNA; translation control; innate immunity; viral immunology; mouse; interferon-induced proteins with tetratricopeptide repeats (IFIT)	DOUBLE-STRANDED-RNA; SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; INTERFERON; INDUCTION; BINDING; RECOGNITION; EXPRESSION; ELEMENTS; REVEALS	Knockout mouse models have been extensively used to study the antiviral activity of IFIT (interferon-induced protein with tetratricopeptide repeats). Human IFIT1 binds to cap0 (m7GpppN) RNA, which lacks methylation on the first and second cap-proximal nucleotides (cap1, m7GpppNm, and cap2, m7GpppNmNm, respectively). These modifications are signatures of "self" in higher eukaryotes, whereas unmodified cap0-RNA is recognized as foreign and, therefore, potentially harmful to the host cell. IFIT1 inhibits translation at the initiation stage by competing with the cap-binding initiation factor complex, eIF4F, restricting infection by certain viruses that possess "nonself" cap0-mRNAs. However, in mice and other rodents, the IFIT1 orthologue has been lost, and the closely related Ifit1b has been duplicated twice, yielding three paralogues: Ifit1, Ifit1b, and Ifit1c. Although murine Ifit1 is similar to human IFIT1 in its cap0-RNA-binding selectivity, the roles of Ifit1b and Ifit1c are unknown. Here, we found that Ifit1b preferentially binds to cap1-RNA, whereas binding is much weaker to cap0- and cap2-RNA. In murine cells, we show that Ifit1b can modulate host translation and restrict WT mouse coronavirus infection. We found that Ifit1c acts as a stimulatory cofactor for both Ifit1 and Ifit1b, promoting their translation inhibition. In this way, Ifit1c acts in an analogous fashion to human IFIT3, which is a cofactor to human IFIT1. This work clarifies similarities and differences between the human and murine IFIT families to facilitate better design and interpretation of mouse models of human infection and sheds light on the evolutionary plasticity of the IFIT family.	[Mears, Harriet, V; Sweeney, Trevor R.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge, England	Addenbrooke's Hospital; University of Cambridge	Mears, HV; Sweeney, TR (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge, England.	hym30@cam.ac.uk; ts629@cam.ac.uk		Mears, Harriet/0000-0003-0300-0885; Sweeney, Trevor/0000-0003-4016-7326	Royal Society/Wellcome Trust Sir Henry Dale Fellowship [202471/Z/16/Z]; University of Cambridge, Department of Pathology Ph.D. Studentship	Royal Society/Wellcome Trust Sir Henry Dale Fellowship; University of Cambridge, Department of Pathology Ph.D. Studentship	This work was funded by Royal Society/Wellcome Trust Sir Henry Dale Fellowship 202471/Z/16/Z (to T. R. S.). H. V. M. was supported by a University of Cambridge, Department of Pathology Ph.D. Studentship.	Abbas Y.M., 2017, CONSERVED HOMODIMERI, DOI [10.1101/152850, DOI 10.1101/152850]; Abbas YM, 2017, P NATL ACAD SCI USA, V114, pE2106, DOI 10.1073/pnas.1612444114; Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; BLUYSSEN HAR, 1994, EUR J BIOCHEM, V220, P395, DOI 10.1111/j.1432-1033.1994.tb18636.x; Butchi NB, 2014, J VIROL, V88, P1051, DOI 10.1128/JVI.02272-13; Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243; Coley SE, 2005, J VIROL, V79, P3097, DOI 10.1128/JVI.79.5.3097-3106.2005; Cook G., 2018, BIORXIV, DOI [10.1101/292979, DOI 10.1101/292979]; Cowling VH, 2010, BIOCHEM J, V425, P295, DOI 10.1042/BJ20091352; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Daugherty MD, 2016, ELIFE, V5, DOI 10.7554/eLife.14228; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng F, 2013, CELL RES, V23, P1055, DOI 10.1038/cr.2013.80; Fensterl V, 2015, J VIROL, V89, P2462, DOI 10.1128/JVI.02744-14; Fleith RC, 2018, NUCLEIC ACIDS RES, V46, P5269, DOI 10.1093/nar/gky191; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; Goodsell DS, 2019, STRUCTURE, V27, P1716, DOI 10.1016/j.str.2019.08.011; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo JJ, 2000, VIROLOGY, V267, P209, DOI 10.1006/viro.1999.0135; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663; Hou ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26150; Huang X, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2475; Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465; Irigoyen N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005473; Johnson B, 2018, IMMUNITY, V48, P487, DOI 10.1016/j.immuni.2018.01.014; Katibah GE, 2014, P NATL ACAD SCI USA, V111, P12025, DOI 10.1073/pnas.1412842111; Katibah GE, 2013, MOL CELL, V49, P743, DOI 10.1016/j.molcel.2012.12.015; Kumar P, 2014, NUCLEIC ACIDS RES, V42, P3228, DOI 10.1093/nar/gkt1321; Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066859; Liu ZQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02460-2; Mears Harriet V, 2019, Wellcome Open Res, V4, P82, DOI 10.12688/wellcomeopenres.15223.1; Mears HV, 2018, J GEN VIROL, V99, P1463, DOI 10.1099/jgv.0.001149; Menachery VD, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00346-17; Menachery VD, 2014, J VIROL, V88, P4251, DOI 10.1128/JVI.03571-13; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; PERRY RP, 1976, CELL, V8, P433, DOI 10.1016/0092-8674(76)90156-2; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Pidugu VK, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00148; Reolon LW, 2019, NUCLEIC ACIDS RES, V47, P5973, DOI 10.1093/nar/gkz339; Reynaud JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004863; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Smith JB, 1996, ARCH BIOCHEM BIOPHYS, V330, P290, DOI 10.1006/abbi.1996.0256; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; STURMAN LS, 1972, INFECT IMMUN, V6, P501, DOI 10.1128/IAI.6.4.501-507.1972; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Tamassia N, 2008, J IMMUNOL, V181, P6563, DOI 10.4049/jimmunol.181.9.6563; Terenzi F, 2005, VIROLOGY, V340, P116, DOI 10.1016/j.virol.2005.06.011; Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07; Tumescheit C., 2020, BIORXIV, DOI [10.1101/2020.09.14.291484, DOI 10.1101/2020.09.14.291484]; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Wang J, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz751; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yang ZL, 2012, CELL RES, V22, P1328, DOI 10.1038/cr.2012.111; Zamudio JR, 2006, EUKARYOT CELL, V5, P905, DOI 10.1128/EC.00080-06; Zamudio JR, 2009, MOL MICROBIOL, V72, P1100, DOI 10.1111/j.1365-2958.2009.06696.x; Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	66	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17781	17801		10.1074/jbc.RA120.014695	http://dx.doi.org/10.1074/jbc.RA120.014695			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454014	hybrid, Green Published			2022-12-28	WOS:000603272300030
J	Burley, SK				Burley, Stephen K.			Impact of structural biologists and the Protein Data Bank on small-molecule drug discovery and development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYSTAL-STRUCTURE; MACROMOLECULAR STRUCTURES; VALIDATION; IMATINIB; INHIBITORS; BINDING; TOOLS; RESISTANCE; REFINEMENT; EXPRESSION	The Protein Data Bank (PDB) is an international core data resource central to fundamental biology, biomedicine, bioenergy, and biotechnology/bioengineering. Now celebrating its 50th anniversary, the PDB houses >175,000 experimentally determined atomic structures of proteins, nucleic acids, and their complexes with one another and small molecules and drugs. The importance of three-dimensional (3D) biostructure information for research and education obtains from the intimate link between molecular form and function evident throughout biology. Among the most prolific consumers of PDB data are biomedical researchers, who rely on the open access resource as the authoritative source of well-validated, expertly curated biostructures. This review recounts how the PDB grew from just seven protein structures to contain more than 49,000 structures of human proteins that have proven critical for understanding their roles in human health and disease. It then describes how these structures are used in academe and industry to validate drug targets, assess target druggability, characterize how tool compounds and other small-molecules bind to drug targets, guide medicinal chemistry optimization of binding affinity and selectivity, and overcome challenges during preclinical drug development. Three case studies drawn from oncology exemplify how structural biologists and open access to PDB structures impacted recent regulatory approvals of antineoplastic drugs.	[Burley, Stephen K.] Rutgers State Univ, Dept Chem & Chem Biol, Inst Quantitat Biomed, Res Collaboratory Struct Bioinformat Prot Data Ba, Piscataway, NJ 08854 USA; [Burley, Stephen K.] Univ Med & Dent New Jersey, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA; [Burley, Stephen K.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego Supercomp Ctr, Res Collaboratory Struct Bioinformat Prot Data Ba, La Jolla, CA 92093 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of California System; University of California San Diego	Burley, SK (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Inst Quantitat Biomed, Res Collaboratory Struct Bioinformat Prot Data Ba, Piscataway, NJ 08854 USA.; Burley, SK (corresponding author), Univ Med & Dent New Jersey, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA.; Burley, SK (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego Supercomp Ctr, Res Collaboratory Struct Bioinformat Prot Data Ba, La Jolla, CA 92093 USA.	Stephen.Burley@RCSB.org			National Science Foundation [DBI-1832184]; U.S. Department of Energy [DE-SC0019749]; National Cancer Institute; National Institute of General Medical Sciences of the National Institutes of Health [R01GM133198]; National Institute of Allergy and Infectious Diseases	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RCSB PDB is jointly funded by the National Science Foundation (DBI-1832184), the U.S. Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2019, ACTA CRYSTALLOGR D, V75, P451, DOI 10.1107/S2059798319004522; Adams PD, 2016, STRUCTURE, V24, P502, DOI 10.1016/j.str.2016.02.017; Armstrong DR, 2020, NUCLEIC ACIDS RES, V48, pD335, DOI 10.1093/nar/gkz990; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Assenberg R, 2013, CURR OPIN STRUC BIOL, V23, P393, DOI 10.1016/j.sbi.2013.03.008; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Bank P. D., 1971, NATURE-NEW BIOL, V233, P223, DOI [10.1038/newbio233223a0, DOI 10.1038/NEWBIO233223A0, DOI 10.1038/NEWBIO233223B0]; Berdigaliyev N, 2020, FUTURE MED CHEM, V12, P939, DOI 10.4155/fmc-2019-0307; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Blay V, 2020, DRUG DISCOV TODAY, V25, P1807, DOI 10.1016/j.drudis.2020.07.024; Blundell TL, 2017, IUCRJ, V4, P308, DOI 10.1107/S2052252517009241; Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6; Boyer S, 2016, ATTRITION IN THE PHARMACEUTICAL INDUSTRY: REASONS, IMPLICATIONS, AND PATHWAYS FORWARD, P5; Brown KK, 2018, MEDCHEMCOMM, V9, P606, DOI 10.1039/c7md00633k; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Bruno IJ, 2004, J CHEM INF COMP SCI, V44, P2133, DOI 10.1021/ci049780b; Brzezinski D, 2021, PROTEIN SCI, V30, P115, DOI 10.1002/pro.3959; Buchanan SG, 2009, MOL CANCER THER, V8, P3181, DOI 10.1158/1535-7163.MCT-09-0477; Burley S. K., 2010, DRUG DESIGN STRUCTUR, P30; Burley SK, 2021, NUCLEIC ACIDS RES, V49, pD437, DOI 10.1093/nar/gkaa1038; Burley SK, 2020, NATURE, V580, P167, DOI 10.1038/d41586-020-00888-7; Burley SK, 2019, NUCLEIC ACIDS RES, V47, pD520, DOI 10.1093/nar/gky949; Burley SK, 2018, PROTEIN SCI, V27, P316, DOI 10.1002/pro.3331; Burns MC, 2018, ANAL BIOCHEM, V548, P44, DOI 10.1016/j.ab.2018.01.025; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; Chen P, 2016, MOL CANCER THER, V15, P2273, DOI 10.1158/1535-7163.MCT-16-0300; Chodera J, 2020, NAT CHEM, V12, P581, DOI 10.1038/s41557-020-0496-2; DAVIES JF, 1990, BIOCHEMISTRY-US, V29, P9467, DOI 10.1021/bi00492a021; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Douangamath A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18709-w; Dutta S, 2014, BIOPOLYMERS, V101, P659, DOI 10.1002/bip.22434; ENGH R, 1989, PROTEIN ENG, V2, P407, DOI 10.1093/protein/2.6.407; EPP O, 1975, BIOCHEMISTRY-US, V14, P4943, DOI 10.1021/bi00693a025; ERIKSSON AE, 1988, PROTEINS, V4, P283, DOI 10.1002/prot.340040407; Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109; Feng Z., 2021, STRUCTURE; Fitzgerald P. M. D., 2005, INT TABLES CRYSTALLO, P295; GILMER T, 1994, J BIOL CHEM, V269, P31711; Goodsell DS, 2020, PROTEIN SCI, V29, P52, DOI 10.1002/pro.3730; Gore S, 2017, STRUCTURE, V25, P1916, DOI 10.1016/j.str.2017.10.009; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; Groom CR, 2016, ACTA CRYSTALLOGR B, V72, P171, DOI 10.1107/S2052520616003954; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Helliwell JR, 1998, NAT STRUCT BIOL, V5, P614, DOI 10.1038/1307; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Henrick K, 2008, NUCLEIC ACIDS RES, V36, pD426, DOI 10.1093/nar/gkm937; Hochhaus A, 2017, NEW ENGL J MED, V376, P917, DOI 10.1056/NEJMoa1609324; HOPE H, 1988, ACTA CRYSTALLOGR B, V44, P22, DOI 10.1107/S0108768187008632; Hu TC, 2018, J MOL MED, V96, P9, DOI 10.1007/s00109-017-1565-x; Jones S, 2004, CURR OPIN CHEM BIOL, V8, P3, DOI 10.1016/j.cbpa.2003.11.001; Kinjo AR, 2017, NUCLEIC ACIDS RES, V45, pD282, DOI 10.1093/nar/gkw962; Klebe G., 2013, DRUG DESIGN METHODOL; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lawson CL, 2008, ACTA CRYSTALLOGR D, V64, P874, DOI 10.1107/S0907444908017393; Lepre CA, 2011, METHOD ENZYMOL, V493, P219, DOI 10.1016/B978-0-12-381274-2.00009-1; Levinson NM, 2014, NAT CHEM BIOL, V10, P127, DOI [10.1038/NCHEMBIO.1404, 10.1038/nchembio.1404]; Levinson NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029828; Lin JH, 2016, BIOPOLYMERS, V105, P2, DOI 10.1002/bip.22744; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lo YC, 2018, DRUG DISCOV TODAY, V23, P1538, DOI 10.1016/j.drudis.2018.05.010; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Lubin J. H., 2020, EVOLUTION SARS COV 2; Martinez L, 2014, FEBS J, V281, P673, DOI 10.1111/febs.12613; Mitra AK, 2019, ACTA CRYSTALLOGR F, V75, P3, DOI 10.1107/S2053230X18015133; Molenaar RJ, 2018, ONCOGENE, V37, P1949, DOI 10.1038/s41388-017-0077-z; Montelione GT, 2013, STRUCTURE, V21, P1563, DOI 10.1016/j.str.2013.07.021; Nagar B, 2002, CANCER RES, V62, P4236; Nar H, 2012, TRENDS PHARMACOL SCI, V33, P279, DOI 10.1016/j.tips.2012.03.004; Navratilova I, 2010, ACS MED CHEM LETT, V1, P44, DOI 10.1021/ml900002k; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; Orville AM, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0533-4; PADLAN EA, 1985, J BIOL CHEM, V260, P8280; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Renaud JP, 2016, NAT REV DRUG DISCOV, V15, P679, DOI 10.1038/nrd.2016.123; Rose Y., 2020, J MOL BIOL; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Rychter A, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0958-6; Sabini E, 2007, NUCLEIC ACIDS RES, V35, P186, DOI 10.1093/nar/gkl1038; Sali A, 2015, STRUCTURE, V23, P1156, DOI 10.1016/j.str.2015.05.013; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Sen S, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau116; Stoll F, 2011, DRUG DISCOV TODAY, V16, P530, DOI 10.1016/j.drudis.2011.04.008; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Turk M, 2020, FEBS LETT, V594, P3243, DOI 10.1002/1873-3468.13948; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vallat B, 2018, STRUCTURE, V26, P894, DOI 10.1016/j.str.2018.03.011; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Wang WW, 2017, CELL, V169, P422, DOI 10.1016/j.cell.2017.03.048; Waring MJ, 2015, NAT REV DRUG DISCOV, V14, P475, DOI 10.1038/nrd4609; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wenlock MC, 2003, J MED CHEM, V46, P1250, DOI 10.1021/jm021053p; Westbrook J., 2005, INT TABLES CRYSTALLO, P195; Westbrook JD, 2020, DRUG DISCOV TODAY, V25, P837, DOI 10.1016/j.drudis.2020.02.002; Westbrook JD, 2019, STRUCTURE, V27, P211, DOI 10.1016/j.str.2018.11.007; Westbrook JD, 2015, BIOINFORMATICS, V31, P1274, DOI 10.1093/bioinformatics/btu789; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249; Yen K, 2017, CANCER DISCOV, V7, P478, DOI 10.1158/2159-8290.CD-16-1034; Young JY, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay002; Young JY, 2017, STRUCTURE, V25, P536, DOI 10.1016/j.str.2017.01.004; Zardecki C, 2019, ACTA CRYSTALLOGR A, V75, pA25, DOI 10.1107/S0108767319099744	107	12	12	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100559	10.1016/j.jbc.2021.100559	http://dx.doi.org/10.1016/j.jbc.2021.100559			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744282	gold, Green Published			2022-12-28	WOS:000672866400532
J	Cai, R; Zhang, Q; Wang, YQ; Yong, WL; Zhao, R; Pang, WJ				Cai, Rui; Zhang, Que; Wang, Yingqian; Yong, Wenlong; Zhao, Rui; Pang, Weijun			Lnc-ORA interacts with microRNA-532-3p and IGF2BP2 to inhibit skeletal muscle myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-NONCODING RNA; TRANSCRIPTIONAL MECHANISMS; UBIQUITIN LIGASES; ATROPHY; DIFFERENTIATION; EXPRESSION; ADIPOGENESIS; CLASSIFICATION; STABILITY; REVEALS	Skeletal muscle is one of the most important organs of the animal body. Long noncoding RNAs play a crucial role in the regulation of skeletal muscle development via several mechanisms. We recently identified obesity-related lncRNA (lnc-ORA) in a search for long noncoding RNAs that influence adipogenesis, finding it impacted adipocyte differentiation by regulating the PI3K/protein kinase B/mammalian target of rapamycin pathway. However, whether lnc-ORA has additional roles, specifically in skeletal muscle myogenesis, is not known. Here, we found that lnc-ORA was significantly differentially expressed with age in mouse skeletal muscle tissue and predominantly located in the cytoplasm. Overexpression of lnc-ORA promoted C2C12 myoblast proliferation and inhibited myoblast differentiation. In contrast, lnc-ORA knockdown repressed myoblast proliferation and facilitated myoblast differentiation. Interestingly, silencing of lnc-ORA rescued dexamethasone-induced muscle atrophy in vitro. Furthermore, adeno-associated virus 9-mediated overexpression of lnc-ORA decreased muscle mass and the cross-sectional area of muscle fiber by upregulating the levels of muscle atrophy-related genes and downregulating the levels of myogenic differentiation-related genes in vivo. Mechanistically, lnc-ORA inhibited skeletal muscle myogenesis by acting as a sponge of miR-532-3p, which targets the phosphatase and tensin homolog gene; the resultant changes in phosphatase and tensin homolog suppressed the PI3K/protein kinase B signaling pathway. In addition, lnc-ORA interacted with insulin-like growth factor 2 mRNA-binding protein 2 and reduced the stability of myogenesis genes, such as myogenic differentiation 1 and myosin heavy chain. Collectively, these findings indicate that lnc-ORA could be a novel underlying regulator of skeletal muscle development.	[Cai, Rui; Zhang, Que; Wang, Yingqian; Yong, Wenlong; Zhao, Rui; Pang, Weijun] Northwest A&F Univ, Lab Anim Fat Deposit & Muscle Dev, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Pang, WJ (corresponding author), Northwest A&F Univ, Lab Anim Fat Deposit & Muscle Dev, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	pwj1226@nwsuaf.edu.cn	Cai, Rui/GRO-1869-2022		National Natural Science Foundation [31872979, 31572366]; National Key Research and Development Program of China [2017YFD0502002]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by grants from the National Natural Science Foundation (31872979 and 31572366) and the National Key Research and Development Program of China (2017YFD0502002).	Alessio E, 2019, NUCLEIC ACIDS RES, V47, P1653, DOI 10.1093/nar/gkz007; Ballarino M, 2015, MOL CELL BIOL, V35, P728, DOI 10.1128/MCB.01394-14; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Cai R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050477; Cai R, 2018, J BIOL CHEM, V293, P19177, DOI 10.1074/jbc.RA118.003198; Cai R, 2018, BBA-MOL CELL BIOL L, V1863, P420, DOI 10.1016/j.bbalip.2018.01.005; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen XN, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.2; Chen Z, 2018, STEM CELLS, V36, P1097, DOI 10.1002/stem.2824; d'Ydewalle C, 2017, NEURON, V93, P66, DOI 10.1016/j.neuron.2016.11.033; Dou ML, 2020, J BIOL CHEM, V295, P4937, DOI 10.1074/jbc.RA119.010498; Dumitru A, 2018, ADV EXP MED BIOL, V1088, P73, DOI 10.1007/978-981-13-1435-3_4; Geng TT, 2018, DIABETES, V67, P2183, DOI 10.2337/db18-0370; Gong CG, 2015, DEV CELL, V34, P181, DOI 10.1016/j.devcel.2015.05.009; Hitachi K, 2019, EMBO REP, V20, DOI 10.15252/embr.201847468; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Jackman RW, 2013, EXP PHYSIOL, V98, P19, DOI 10.1113/expphysiol.2011.063321; Jandura A, 2017, TRENDS GENET, V33, P665, DOI 10.1016/j.tig.2017.08.002; Jarroux J, 2017, ADV EXP MED BIOL, V1008, P1, DOI 10.1007/978-981-10-5203-3_1; Jiao JQ, 2017, CURR OPIN PHARMACOL, V34, P1, DOI 10.1016/j.coph.2017.03.009; Jin JJ, 2018, P NATL ACAD SCI USA, V115, pE9802, DOI 10.1073/pnas.1801471115; Kline WO, 2007, J APPL PHYSIOL, V102, P740, DOI 10.1152/japplphysiol.00873.2006; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Li ZH, 2019, J CACHEXIA SARCOPENI, V10, P391, DOI 10.1002/jcsm.12374; Liang TT, 2018, FASEB J, V32, P377, DOI 10.1096/fj.201700560RR; Ma ML, 2017, RNA BIOL, V14, P347, DOI 10.1080/15476286.2017.1279786; Ma YW, 2017, FEBS J, V284, P3262, DOI 10.1111/febs.14188; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Pang WJ, 2013, J CELL BIOCHEM, V114, P2500, DOI 10.1002/jcb.24595; Pin F, 2019, FASEB J, V33, P7778, DOI 10.1096/fj.201802799R; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Song CC, 2018, EPIGENETICS-US, V13, P591, DOI 10.1080/15592294.2018.1481705; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sun LJ, 2018, J CACHEXIA SARCOPENI, V9, P962, DOI 10.1002/jcsm.12321; Sun XM, 2016, BBA-MOL CELL RES, V1863, P2835, DOI 10.1016/j.bbamcr.2016.08.014; Wang GQ, 2015, J AGR FOOD CHEM, V63, P6212, DOI 10.1021/acs.jafc.5b01680; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Wang SS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091107; Wang Y, 2014, GENE, V539, P117, DOI 10.1016/j.gene.2014.01.037; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; Wimmer RJ, 2015, J NUTR BIOCHEM, V26, P1559, DOI 10.1016/j.jnutbio.2015.07.023; Yu XH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14016; Zhang XX, 2020, J GENET GENOMICS, V47, P466, DOI 10.1016/j.jgg.2020.07.003; Zhang ZK, 2018, MOL THER, V26, P2669, DOI 10.1016/j.ymthe.2018.09.014; Zhou L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10026	51	9	9	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100376	10.1016/j.jbc.2021.100376	http://dx.doi.org/10.1016/j.jbc.2021.100376			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548229	Green Published, gold			2022-12-28	WOS:000672866400350
J	Checler, F; Afram, E; Pardossi-Piquard, R; Lauritzen, I				Checler, Frederic; Afram, Elissa; Pardossi-Piquard, Raphaelle; Lauritzen, Inger			Is gamma-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; INTRACELLULAR A-BETA; APATHY-LIKE BEHAVIOR; DOWN-SYNDROME; MOUSE MODEL; INTRANEURONAL ACCUMULATION; LYSOSOMAL DYSFUNCTION; TRANSGENIC MICE; IN-VITRO	Genetic, biochemical, and anatomical grounds led to the proposal of the amyloid cascade hypothesis centered on the accumulation of amyloid beta peptides (A beta) to explain Alzheimer's disease (AD) etiology. In this context, a bulk of efforts have aimed at developing therapeutic strategies seeking to reduce A beta levels, either by blocking its production (gamma- and beta-secretase inhibitors) or by neutralizing it once formed (A beta-directed immunotherapies). However, so far the vast majority of, if not all, clinical trials based on these strategies have failed, since they have not been able to restore cognitive function in AD patients, and even in many cases, they have worsened the clinical picture. We here propose that AD could be more complex than a simple A beta-linked pathology and discuss the possibility that a way to reconcile undoubted genetic evidences linking processing of APP to AD and a consistent failure of A beta-based clinical trials could be to envision the pathological contribution of the direct precursor of A beta, the beta-secretase-derived C-terminal fragment of APP, beta CTF, also referred to as C99. In this review, we summarize scientific evidences pointing to C99 as an early contributor to AD and postulate that gamma-secretase should be considered as not only an A beta-generating protease, but also a beneficial C99-inactivating enzyme. In that sense, we discuss the limitations of molecules targeting gamma-secretase and propose alternative strategies seeking to reduce C99 levels by other means and notably by enhancing its lysosomal degradation.	[Checler, Frederic; Afram, Elissa; Pardossi-Piquard, Raphaelle; Lauritzen, Inger] Univ Cote dAzur, Inst Pharmacol Mol & Cellulaire, UMR7275, CNRS,Lab Excellence Distalz,Sophia Antipolis, Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Checler, F (corresponding author), Univ Cote dAzur, Inst Pharmacol Mol & Cellulaire, UMR7275, CNRS,Lab Excellence Distalz,Sophia Antipolis, Valbonne, France.	checler@ipmc.cnrs.fr	Lauritzen, Inger/AAE-9927-2022; Lauritzen, Inger/AFF-7261-2022; Pardossi-Piquard, Raphaëlle/ABA-4472-2021; Pardossi-Piquard, Raphaëlle/D-6263-2012; Checler, Frederic/C-1241-2009	Pardossi-Piquard, Raphaëlle/0000-0001-5292-4414; Checler, Frederic/0000-0003-2098-1750; lauritzen, inger/0000-0002-2011-1387	Fondation Alzheimer; Fondation pour la Recherche Medicale; French National Foundation for Alzheimer's Disease and Related Disorders; LABEX (excellence laboratory, program investment for the future); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease); University hospital Federation (FHU) OncoAge	Fondation Alzheimer; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French National Foundation for Alzheimer's Disease and Related Disorders; LABEX (excellence laboratory, program investment for the future); DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease); University hospital Federation (FHU) OncoAge	This work was partly supported by the "Fondation Alzheimer," the "Fondation pour la Recherche Medicale" and the French National Foundation for Alzheimer's Disease and Related Disorders. This work has been developed and supported through the LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease) and the University hospital Federation (FHU) OncoAge.	Acx H, 2017, EMBO MOL MED, V9, P1088, DOI 10.15252/emmm.201707561; Albright CF, 2013, J PHARMACOL EXP THER, V344, P686, DOI 10.1124/jpet.112.199356; Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Baranger K, 2016, CELL MOL LIFE SCI, V73, P217, DOI 10.1007/s00018-015-1992-1; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Becot A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051204; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Boche D, 2010, ACTA NEUROPATHOL, V120, P13, DOI 10.1007/s00401-010-0705-y; Boland B, 2010, J BIOL CHEM, V285, P37415, DOI 10.1074/jbc.M110.186411; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bourdenx M, 2016, AUTOPHAGY, V12, P472, DOI 10.1080/15548627.2015.1136769; Bourgeois A, 2018, NEUROBIOL AGING, V71, P21, DOI 10.1016/j.neurobiolaging.2018.06.038; BRION JP, 1986, LANCET, V2, P1098, DOI 10.1016/S0140-6736(86)90495-2; Brothers HM, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00118; Bursavich MG, 2016, J MED CHEM, V59, P7389, DOI 10.1021/acs.jmedchem.5b01960; Bussiere R, 2017, J BIOL CHEM, V292, P10153, DOI 10.1074/jbc.M116.743070; Bustos V, 2017, P NATL ACAD SCI USA, V114, P7148, DOI 10.1073/pnas.1705240114; Bustos V, 2017, P NATL ACAD SCI USA, V114, P7142, DOI 10.1073/pnas.1705235114; Cacace R, 2016, ALZHEIMERS DEMENT, V12, P733, DOI 10.1016/j.jalz.2016.01.012; Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057; Cacquevel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035133; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Caillava C, 2014, NEUROBIOL AGING, V35, P1570, DOI 10.1016/j.neurobiolaging.2014.01.011; Calderon-Garciduenas AL, 2018, HAND CLINIC, V145, P325, DOI 10.1016/B978-0-12-802395-2.00023-7; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Castellani Rudy J, 2006, Am J Alzheimers Dis Other Demen, V21, P126, DOI 10.1177/153331750602100213; Cavanagh C, 2013, J ALZHEIMERS DIS, V36, P233, DOI 10.3233/JAD-122131; Cebers G, 2017, J ALZHEIMERS DIS, V55, P1039, DOI 10.3233/JAD-160701; Chavez-Gutierrez L, 2020, SEMIN CELL DEV BIOL, V105, P75, DOI 10.1016/j.semcdb.2020.03.005; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Chen XQ, 2021, ALZHEIMERS DEMENT, V17, P271, DOI 10.1002/alz.12185; Chevallier N, 1997, BRAIN RES, V750, P11, DOI 10.1016/S0006-8993(96)01330-3; Chui DH, 2001, J ALZHEIMERS DIS, V3, P231; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Coric V, 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI 10.1001/archneurol.2012.2194; Crump CJ, 2012, BIOCHEMISTRY-US, V51, P7209, DOI 10.1021/bi301137h; Cummings JL, 2018, NEUROLOGY, V90, pE1889, DOI 10.1212/WNL.0000000000005550; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Del Prete D, 2017, J ALZHEIMERS DIS, V55, P1549, DOI 10.3233/JAD-160953; DeTure MA, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0333-5; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Dourlen P, 2019, ACTA NEUROPATHOL, V138, P221, DOI 10.1007/s00401-019-02004-0; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Duggan SP, 2016, CELL SIGNAL, V28, P1, DOI 10.1016/j.cellsig.2015.10.006; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Egan MF, 2019, NEW ENGL J MED, V380, P1408, DOI 10.1056/NEJMoa1812840; Escamilla-Ayala A, 2020, SEMIN CELL DEV BIOL, V105, P12, DOI 10.1016/j.semcdb.2020.02.005; Filser S, 2015, BIOL PSYCHIAT, V77, P729, DOI 10.1016/j.biopsych.2014.10.013; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Galasko DR, 2007, ALZ DIS ASSOC DIS, V21, P292, DOI 10.1097/WAD.0b013e31815d1048; Gerber H, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0660-3; Glebov K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0479-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Goutagny R, 2013, EUR J NEUROSCI, V37, P1896, DOI 10.1111/ejn.12233; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Guner G, 2020, SEMIN CELL DEV BIOL, V105, P27, DOI 10.1016/j.semcdb.2020.05.019; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; HAASS C, 1993, ANN NY ACAD SCI, V695, P109, DOI 10.1111/j.1749-6632.1993.tb23037.x; Haass C, 2019, NERVENARZT, V90, P884, DOI 10.1007/s00115-019-0751-1; Hamm V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601068; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hasegawa H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4917; Head E, 2004, CURR OPIN NEUROL, V17, P95, DOI 10.1097/00019052-200404000-00003; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Heilig EA, 2013, J NEUROSCI, V33, P11606, DOI 10.1523/JNEUROSCI.0954-13.2013; Henley D, 2019, NEW ENGL J MED, V380, P1483, DOI 10.1056/NEJMc1813435; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Honig LS, 2018, NEW ENGL J MED, V378, P321, DOI 10.1056/NEJMoa1705971; Hu C, 2016, J NEUROCHEM, V136, P1246, DOI 10.1111/jnc.13518; Huang YM, 2019, J AM GERIATR SOC, V67, P841, DOI 10.1111/jgs.15830; Hung COY, 2018, CELL REP, V25, P3647, DOI 10.1016/j.celrep.2018.11.095; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Imbimbo BP, 2019, EXPERT OPIN INV DRUG, V28, P967, DOI 10.1080/13543784.2019.1683160; Jeon AHW, 2013, J BIOL CHEM, V288, P15352, DOI 10.1074/jbc.M112.441840; Jiang Y, 2019, J NEUROSCI, V39, P5255, DOI 10.1523/JNEUROSCI.0578-19.2019; Jiang Y, 2016, NEUROBIOL AGING, V39, P90, DOI 10.1016/j.neurobiolaging.2015.11.013; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Johnson ECB, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00393-5; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Jurisch-Yaksi N, 2013, BBA-BIOMEMBRANES, V1828, P2815, DOI 10.1016/j.bbamem.2013.04.016; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kaur G, 2017, MOL PSYCHIATR, V22, P981, DOI 10.1038/mp.2016.189; Kennedy ME, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9704; Kent SA, 2020, ACTA NEUROPATHOL, V140, P417, DOI 10.1007/s00401-020-02196-w; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kim S, 2016, MOL PSYCHIATR, V21, P707, DOI 10.1038/mp.2015.97; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Klein G, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0559-z; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kuhnle N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.217745; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Kwart D, 2019, NEURON, V104, P1022, DOI 10.1016/j.neuron.2019.11.010; Lacampagne A, 2017, ACTA NEUROPATHOL, V134, P749, DOI 10.1007/s00401-017-1733-7; Lauritzen I, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0176-6; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lauritzen L, 2019, CURR ALZHEIMER RES, V16, P453, DOI 10.2174/1567205016666190325092841; Lee JH, 2015, CELL REP, V12, P1430, DOI 10.1016/j.celrep.2015.07.050; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Li NM, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00051; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lleo A, 2004, AM J GERIAT PSYCHIAT, V12, P146, DOI 10.1176/appi.ajgp.12.2.146; Logovinsky V, 2016, ALZHEIMERS RES THER, V8, DOI [10.1016/j.trci.2016.01.001, 10.1186/s13195-016-0181-2]; Lopez CL, 2019, ALZH DEMENT-TRCI, V5, P216, DOI 10.1016/j.trci.2019.02.005; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Lynch S. Y., 2018, ALZHEIMERS DEMENT, V14, pP1623, DOI DOI 10.1016/J.JALZ.2018.07.213; Maloney JA, 2014, J BIOL CHEM, V289, P30990, DOI 10.1074/jbc.M114.589069; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Matsumoto Y, 2002, J NEUROCHEM, V82, P234, DOI 10.1046/j.1471-4159.2002.00944.x; Meckler X, 2016, J BIOL CHEM, V291, P12821, DOI 10.1074/jbc.M115.708297; Mekala S, 2020, RSC MED CHEM, V11, P1003, DOI 10.1039/d0md00196a; Meyer PF, 2019, NEUROLOGY, V92, pE2070, DOI 10.1212/WNL.0000000000007232; Miranda AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02533-w; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Mondragon-Rodriguez S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00121; Montesinos J, 2020, EMBO J, V39, DOI 10.15252/embj.2019103791; Mosser S, 2015, HUM MOL GENET, V24, P371, DOI 10.1093/hmg/ddu449; Moussa-Pacha NM, 2020, MED RES REV, V40, P339, DOI 10.1002/med.21622; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Neumann U, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809316; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nie PJ, 2020, SEMIN CELL DEV BIOL, V105, P43, DOI 10.1016/j.semcdb.2020.03.002; Nistico R, 2012, MOL NEUROBIOL, V46, P572, DOI 10.1007/s12035-012-8324-3; Nixon RA, 2017, FASEB J, V31, P2729, DOI 10.1096/fj.201700359; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oikawa N, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030209; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Panza F, 2019, NAT REV NEUROL, V15, P73, DOI 10.1038/s41582-018-0116-6; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pardossi-Piquard R, 2016, CURR ALZHEIMER RES, V13, P942, DOI 10.2174/1567205013666160404120106; Pera M, 2017, EMBO J, V36, P3356, DOI 10.15252/embj.201796797; Pera M, 2013, ACTA NEUROPATHOL, V125, P201, DOI 10.1007/s00401-012-1062-9; Pulina MV, 2020, ALZHEIMERS DEMENT, V16, P273, DOI 10.1016/j.jalz.2019.09.002; Reddy PH, 2018, HUM MOL GENET, V27, P2502, DOI 10.1093/hmg/ddy154; Reines SA, 2004, NEUROLOGY, V62, P66, DOI 10.1212/WNL.62.1.66; Robert P, 2002, CURR MED RES OPIN, V18, P156, DOI 10.1185/030079902125000561; Robert PH, 2008, AM J GERIAT PSYCHIAT, V16, P770, DOI 10.1097/JGP.0b013e31817e73db; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sengoku R, 2020, NEUROPATHOLOGY, V40, P22, DOI 10.1111/neup.12626; Serneels L, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00399-z; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shi XP, 2003, J BIOL CHEM, V278, P21286, DOI 10.1074/jbc.M209859200; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Song DK, 1998, J NEUROCHEM, V71, P875; Song JX, 2020, AGING CELL, V19, DOI 10.1111/acel.13069; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114; Szaruga M, 2015, J EXP MED, V212, P2003, DOI 10.1084/jem.20150892; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Takeo K, 2014, P NATL ACAD SCI USA, V111, P10544, DOI 10.1073/pnas.1402171111; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tambini MD, 2020, ELIFE, V9, DOI 10.7554/eLife.52612; Tambini MD, 2019, AGING CELL, V18, DOI 10.1111/acel.13033; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Timmers M, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0415-6; Vaillant-Beuchot L, 2021, ACTA NEUROPATHOL, V141, P39, DOI 10.1007/s00401-020-02234-7; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; Vandenberghe Rik, 2017, Alzheimers Dement (N Y), V3, P10, DOI 10.1016/j.trci.2016.12.003; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wessels AM, 2020, JAMA NEUROL, V77, P199, DOI 10.1001/jamaneurol.2019.3988; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 2020, SEMIN CELL DEV BIOL, V105, P3, DOI 10.1016/j.semcdb.2020.01.005; Wolfe MS, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.07.004; Wong ET, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.614690; Xia D, 2015, NEURON, V85, P967, DOI 10.1016/j.neuron.2015.02.010; Xia WM, 2019, NEUROSCI LETT, V701, P162, DOI 10.1016/j.neulet.2019.02.011; Xiao QL, 2015, J NEUROSCI, V35, P12137, DOI 10.1523/JNEUROSCI.0705-15.2015; Xu TH, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.26; Xu W, 2016, J CLIN INVEST, V126, P1815, DOI 10.1172/JCI82409; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang DS, 2017, HUM MOL GENET, V26, P843, DOI 10.1093/hmg/ddx001; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yao W, 2019, J NEUROSCI, V39, P6992, DOI 10.1523/JNEUROSCI.0207-19.2019; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138; Zuhl AM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13042	230	16	16	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100489	10.1016/j.jbc.2021.100489	http://dx.doi.org/10.1016/j.jbc.2021.100489			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33662398	Green Published, gold			2022-12-28	WOS:000672866400463
J	Guo, YJ; Kawaguchi, A; Takeshita, M; Sekiya, T; Hirohama, M; Yamashita, A; Siomi, H; Murano, K				Guo, Youjia; Kawaguchi, Atsushi; Takeshita, Masaru; Sekiya, Takeshi; Hirohama, Mikako; Yamashita, Akio; Siomi, Haruhiko; Murano, Kensaku			Potent mouse monoclonal antibodies that block SARS-CoV-2 infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRALIZING ANTIBODIES; SPIKE; RACE	Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has developed into a global pandemic since its first outbreak in the winter of 2019. An extensive investigation of SARS-CoV-2 is critical for disease control. Various recombinant monoclonal antibodies of human origin that neutralize SARS-CoV-2 infection have been isolated from convalescent patients and will be applied as therapies and prophylaxis. However, the need for dedicated monoclonal antibodies suitable for molecular pathology research is not fully addressed. Here, we produced six mouse anti-SARS-CoV-2 spike monoclonal antibodies that not only exhibit robust performance in immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, but also demonstrate neutralizing activity against SARS-CoV-2 infection to VeroE6/TMPRSS2 cells. Due to their mouse origin, our monoclonal antibodies are compatible with the experimental immunoassay setups commonly used in basic molecular biology research laboratories, providing a useful tool for future research. Furthermore, in the hope of applying the antibodies of clinical setting, we determined the variable regions of the antibodies and used them to produce recombinant human/mouse chimeric antibodies.	[Guo, Youjia; Siomi, Haruhiko; Murano, Kensaku] Keio Univ, Dept Mol Biol, Sch Med, Tokyo, Japan; [Kawaguchi, Atsushi; Sekiya, Takeshi; Hirohama, Mikako] Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Ibaraki, Japan; [Kawaguchi, Atsushi] Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Ibaraki, Japan; [Kawaguchi, Atsushi] Univ Tsukuba, Microbiol Res Ctr Sustainabil, Tsukuba, Ibaraki, Japan; [Takeshita, Masaru] Keio Univ, Dept Internal Med, Div Rheumatol, Sch Med, Tokyo, Japan; [Yamashita, Akio] Yokohama City Univ, Dept Mol Biol, Sch Med, Yokohama, Kanagawa, Japan	Keio University; University of Tsukuba; University of Tsukuba; University of Tsukuba; Keio University; Yokohama City University	Siomi, H; Murano, K (corresponding author), Keio Univ, Dept Mol Biol, Sch Med, Tokyo, Japan.	awa403@keio.jp; kmurano@keio.jp		Guo, Youjia "Zach"/0000-0002-4837-9350; Murano, Kensaku/0000-0001-7269-8119; Takeshita, Masaru/0000-0002-3281-6595	Keio University Global Research Institute (KGRI) COVID-19 Pandemic Crisis Research Grant; Keio Donner Project; AMED [JP18fk0108076]; NOMURA Microbial Community Control Project in ERATO of the Japan Science and Technology Agency; Research Support Program to Tackle COVID-19 Related Emergency Problems, University of Tsukuba	Keio University Global Research Institute (KGRI) COVID-19 Pandemic Crisis Research Grant; Keio Donner Project; AMED; NOMURA Microbial Community Control Project in ERATO of the Japan Science and Technology Agency; Research Support Program to Tackle COVID-19 Related Emergency Problems, University of Tsukuba	This work was supported by the Keio University Global Research Institute (KGRI) COVID-19 Pandemic Crisis Research Grant (to M. T., H. S., and K. M.) and the Keio Donner Project, which is devoted to Shibasaburo Kitasato, the founder of Keio University School of Medicine. This study was also supported in part by AMED (JP18fk0108076 to A. K.), NOMURA Microbial Community Control Project in ERATO of the Japan Science and Technology Agency (to A. K.), and Research Support Program to Tackle COVID-19 Related Emergency Problems, University of Tsukuba (to A. K.).	Artika I Made, 2020, Heliyon, V6, pe04743, DOI 10.1016/j.heliyon.2020.e04743; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Callaway E, 2020, NATURE, V580, P576, DOI 10.1038/d41586-020-01221-y; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Caskey M, 2019, NAT MED, V25, P547, DOI 10.1038/s41591-019-0412-8; Chen XY, 2020, CELL MOL IMMUNOL, V17, P647, DOI 10.1038/s41423-020-0426-7; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Cohen J, 2020, SCIENCE, V368, P564, DOI 10.1126/science.368.6491.564; Connor E. M, 1999, RADIOLOGY, V210, P295; Corti D, 2017, CURR OPIN VIROL, V24, P60, DOI 10.1016/j.coviro.2017.03.002; Corti D, 2016, J INFECT PUBLIC HEAL, V9, P231, DOI 10.1016/j.jiph.2016.04.003; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Dhama K, 2020, HUM VACC IMMUNOTHER, V16, P1232, DOI 10.1080/21645515.2020.1735227; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Graham BS, 2015, CURR OPIN HIV AIDS, V10, P129, DOI 10.1097/COH.0000000000000154; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Israelow B, 2020, J EXP MED, V217, DOI [10.1101/2020.05.27.118893, 10.1084/jem.20201241]; Iwasaki YW, 2016, MOL CELL, V63, P408, DOI 10.1016/j.molcel.2016.06.008; Jawhara S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072272; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Jiang SB, 2020, TRENDS IMMUNOL, V41, P355, DOI 10.1016/j.it.2020.03.007; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Juste M, 2006, ANAL BIOCHEM, V349, P159, DOI 10.1016/j.ab.2005.10.046; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Klasse PJ, 2020, ELIFE, V9, DOI 10.7554/eLife.57877; Li Q., 2020, NEW ENGL J MED, V382, P1199; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; Meyer L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218717; Miroshnikov KA, 1998, PROTEIN ENG, V11, P329, DOI 10.1093/protein/11.4.329; Murano K, 2019, EMBO J, V38, DOI 10.15252/embj.2019102870; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; OPSTELTEN DJE, 1995, J CELL BIOL, V131, P339, DOI 10.1083/jcb.131.2.339; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Riva L, 2020, NATURE, V586, P113, DOI 10.1038/s41586-020-2577-1; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Sadasivan J, 2017, J BIOSCIENCES, V42, P231, DOI 10.1007/s12038-017-9676-7; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236; Stertz S, 2007, VIROLOGY, V361, P304, DOI 10.1016/j.virol.2006.11.027; Tai WB, 2020, ANTIVIR RES, V179, DOI 10.1016/j.antiviral.2020.104820; Tse LV, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00658; Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wan JK, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107918; Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Zeng Xin, 2020, Antib Ther, V3, P95, DOI 10.1093/abt/tbaa008; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	57	8	8	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100346	10.1016/j.jbc.2021.100346	http://dx.doi.org/10.1016/j.jbc.2021.100346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524396	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400320
J	Jia, R; Bonifacino, JS				Jia, Rui; Bonifacino, Juan S.			The ubiquitin isopeptidase USP10 deubiquitinates LC3B to increase LC3B levels and autophagic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; P62/SQSTM1; MODULATION; BORC	Components of the autophagy machinery are subject to regulation by various posttranslational modifications. Previous studies showed that monoubiquitination of LC3B catalyzed by the ubiquitin-activating enzyme UBA6 and ubiquitin-conjugating enzyme/ubiquitin ligase BIRC6 targets LC3B for proteasomal degradation, thus reducing LC3B levels and autophagic activity under conditions of stress. However, mechanisms capable of counteracting this process are not known. Herein, we report that LC3B ubiquitination is reversed by the action of the deubiquitinating enzyme USP10. We identified USP10 in a CRISPR-Cas9 knockout screen for ubiquitination-related genes that regulate LC3B levels. Biochemical analyses showed that silencing of USP10 reduces the levels of both the LC3B-I and LC3B-II forms of LC3B through increased ubiquitination and proteasomal degradation. In turn, the reduced LC3B levels result in slower degradation of the autophagy receptors SQSTM1 and NBR1 and an increased accumulation of puromycin-induced aggresome-like structures. Taken together, these findings indicate that the levels of LC3B and autophagic activity are controlled through cycles of LC3B ubiquitination and deubiquitination.	[Jia, Rui; Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Neurosci & Cellular & Struct Biol Div, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Jia, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Neurosci & Cellular & Struct Biol Div, NIH, Bethesda, MD 20892 USA.	rui.jia@hotmail.com		Bonifacino, Juan S./0000-0002-5673-6370; Jia, Rui/0000-0002-1797-4069	Intramural Program of NICHD [ZIA HD001607]	Intramural Program of NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Intramural Program of NICHD (ZIA HD001607) (to J. S. B.).	Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Clague MJ, 2019, NAT REV MOL CELL BIO, V20, P338, DOI 10.1038/s41580-019-0099-1; Deng M, 2016, MOL CELL, V61, P614, DOI 10.1016/j.molcel.2016.01.010; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Hung SY, 2015, NEUROPHARMACOLOGY, V93, P243, DOI 10.1016/j.neuropharm.2015.02.003; Jia R, 2019, ELIFE, V8, DOI 10.7554/eLife.50034; Jia R, 2017, AUTOPHAGY, V13, P1648, DOI 10.1080/15548627.2017.1343768; Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030; Jiang TX, 2019, P NATL ACAD SCI USA, V116, P13404, DOI 10.1073/pnas.1901039116; Kang HM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1520-6; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lee Min Jae, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.R110.003871; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Peng WX, 2015, EXP THER MED, V9, P1271, DOI 10.3892/etm.2015.2266; Pu J, 2015, DEV CELL, V33, P176, DOI 10.1016/j.devcel.2015.02.011; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Shrestha BK, 2020, J BIOL CHEM, V295, P1240, DOI 10.1074/jbc.RA119.010068; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Wani WY, 2015, LAB INVEST, V95, P14, DOI 10.1038/labinvest.2014.131; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xie YC, 2015, AUTOPHAGY, V11, P28, DOI 10.4161/15548627.2014.984267	30	11	11	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100405	10.1016/j.jbc.2021.100405	http://dx.doi.org/10.1016/j.jbc.2021.100405			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33577797	Green Published, gold			2022-12-28	WOS:000672866400379
J	Li, SZ; Jiang, LQ; Beckmann, K; Hojen, JF; Pessara, U; Powers, NE; De Graaf, DM; Azam, T; Lindenberger, J; Eisenmesser, EZ; Fischer, S; Dinarello, CA				Li, Suzhao; Jiang, Liqiong; Beckmann, Karsten; Hojen, Jesper Falkesgaard; Pessara, Ulrich; Powers, Nicholas E.; de Graaf, Dennis M.; Azam, Tania; Lindenberger, Jared; Eisenmesser, Elan Z.; Fischer, Stephan; Dinarello, Charles A.			A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; MACROPHAGE ACTIVATION SYNDROME; BLOOD MONONUCLEAR-CELLS; GAMMA-INDUCING FACTOR; NECROSIS-FACTOR-ALPHA; CYTOKINES IN-VITRO; CANDIDA-ALBICANS; INTERFERON-GAMMA; BINDING-PROTEIN; TNF-ALPHA	Unchecked inflammation can result in severe diseases with high mortality, such as macrophage activation syndrome (MAS). MAS and associated cytokine storms have been observed in COVID-19 patients exhibiting systemic hyperinflammation. Interleukin-18 (IL-18), a proinflammatory cytokine belonging to the IL-1 family, is elevated in both MAS and COVID-19 patients, and its level is known to correlate with the severity of COVID-19 symptoms. IL-18 binds its specific receptor IL-1 receptor 5 (IL-1R5, also known as IL-18 receptor alpha chain), leading to the recruitment of the coreceptor, IL-1 receptor 7 (IL-1R7, also known as IL-18 receptor beta chain). This heterotrimeric complex then initiates downstream signaling, resulting in systemic and local inflammation. Here, we developed a novel humanized monoclonal anti-IL-1R7 antibody to specifically block the activity of IL-18 and its inflammatory signaling. We characterized the function of this antibody in human cell lines, in freshly obtained peripheral blood mononuclear cells (PBMCs) and in human whole blood cultures. We found that the anti-IL-1R7 antibody significantly suppressed IL-18-mediated NF kappa B activation, reduced IL-18-stimulated IFN gamma and IL-6 production in human cell lines, and reduced IL-18-induced IFN gamma, IL-6, and TNF alpha production in PBMCs. Moreover, the anti-IL-1R7 antibody significantly inhibited LPS- and Candida albicans-induced IFN gamma production in PBMCs, as well as LPS-induced IFN gamma production in whole blood cultures. Our data suggest that blocking IL-1R7 could represent a potential therapeutic strategy to specifically modulate IL-18 signaling and may warrant further investigation into its clinical potential for treating IL-18-mediated diseases, including MAS and COVID-19.	[Li, Suzhao; Jiang, Liqiong; Powers, Nicholas E.; de Graaf, Dennis M.; Azam, Tania; Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Anschutz Med Campus, Aurora, CO 80204 USA; [Jiang, Liqiong] Shenzhen Eye Hosp, Shenzhen, Guangdong, Peoples R China; [Beckmann, Karsten; Pessara, Ulrich; Fischer, Stephan] MAB Discovery GmbH, Neuried, Germany; [Hojen, Jesper Falkesgaard] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark; [Lindenberger, Jared] Univ Colorado Denver, Biophys Core Facil, Anschutz Med Campus, Aurora, CO USA; [Eisenmesser, Elan Z.] Univ Colorado Denver, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO USA; [Beckmann, Karsten] BioNTech SE, Mainz, Germany	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Aarhus University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; BioNTech SE	Li, SZ; Dinarello, CA (corresponding author), Univ Colorado Denver, Dept Med, Anschutz Med Campus, Aurora, CO 80204 USA.	suzhao.li@cuanschutz.edu; cdinare333@aol.com		Powers, Nicholas/0000-0002-5403-4324; Hojen, Jesper Falkesgaard/0000-0002-2629-5391	National Institutes of Health [AI-015614, AI-128443, AI-151651]; Interleukin Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interleukin Foundation	This study was supported by National Institutes of Health Grants AI-015614 (to C. A. D.) and AI-128443 and AI-151651 (to S. L.) and Interleukin Foundation (to C.A.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banda NK, 2003, J IMMUNOL, V170, P2100, DOI 10.4049/jimmunol.170.4.2100; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Bouali E, 2015, IMMUNOL LETT, V167, P87, DOI 10.1016/j.imlet.2015.08.001; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; Canna SW, 2017, J ALLERGY CLIN IMMUN, V139, P1698, DOI 10.1016/j.jaci.2016.10.022; Canna SW, 2012, PEDIATR CLIN N AM, V59, P329, DOI 10.1016/j.pcl.2012.03.002; Charrad R, 2016, IMMUNOBIOLOGY, V221, P182, DOI 10.1016/j.imbio.2015.09.009; Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11; Chi YW, 2020, J MICROENCAPSUL, V37, P134, DOI 10.1080/02652048.2019.1705409; Dai SM, 2004, ARTHRITIS RHEUM-US, V50, P432, DOI 10.1002/art.20064; Dinarello CA, 2003, J INFECT DIS, V187, pS370, DOI 10.1086/374751; Dinarello CA, 2000, EUR CYTOKINE NETW, V11, P483; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Dinarello CA, 2019, NAT REV RHEUMATOL, V15, P612, DOI 10.1038/s41584-019-0277-8; Eisenmesser EZ, 2019, P NATL ACAD SCI USA, V116, P5514, DOI 10.1073/pnas.1819672116; Fischer CP, 2005, CLIN IMMUNOL, V117, P152, DOI 10.1016/j.clim.2005.07.008; Flament H, 2021, NAT IMMUNOL, V22, P322, DOI 10.1038/s41590-021-00870-z; Gabay C, 2018, ANN RHEUM DIS, V77, P840, DOI 10.1136/annrheumdis-2017-212608; Gao Z, 2019, MEDITERR J HEMATOL I, V11, DOI 10.4084/MJHID.2019.008; Gauglitz GG, 2012, ACTA DERM-VENEREOL, V92, P291, DOI 10.2340/00015555-1250; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GHEZZI P, 1988, J IMMUNOL, V140, P4238; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Girard C, 2016, RHEUMATOLOGY, V55, P2237, DOI 10.1093/rheumatology/kew300; GRANOWITZ EV, 1992, BLOOD, V79, P2364; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Hojen JF, 2019, NAT IMMUNOL, V20, P1138, DOI 10.1038/s41590-019-0467-1; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang JN, 1997, P NATL ACAD SCI USA, V94, P12829, DOI 10.1073/pnas.94.24.12829; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Huithe j., 2006, ATHEROSCLEROSIS, V188, P450; Hung J, 2005, ARTERIOSCL THROM VAS, V25, P1268, DOI 10.1161/01.ATV.0000163843.70369.12; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Jiang JF, 2018, GYNECOL ENDOCRINOL, V34, P83, DOI 10.1080/09513590.2017.1354367; Kanakaraj P, 1999, J EXP MED, V189, P1129, DOI 10.1084/jem.189.7.1129; Kang MJ, 2007, J IMMUNOL, V178, P1948, DOI 10.4049/jimmunol.178.3.1948; Kaplanski G, 2018, IMMUNOL REV, V281, P138, DOI 10.1111/imr.12616; Kerget B, 2021, J MED VIROL, V93, P2090, DOI 10.1002/jmv.26589; Kim SH, 2001, J IMMUNOL, V166, P148; Leach ST, 2008, INFLAMM BOWEL DIS, V14, P68, DOI 10.1002/ibd.20272; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Lewis EC, 2006, P NATL ACAD SCI USA, V103, P16852, DOI 10.1073/pnas.0607917103; Li SZ, 2015, P NATL ACAD SCI USA, V112, P2497, DOI 10.1073/pnas.1424626112; Li S, 2015, J BIOL CHEM, V290, P2368, DOI 10.1074/jbc.M114.618454; Liu SS, 2020, J MOL BIOL, V432, P1169, DOI 10.1016/j.jmb.2020.01.012; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Maeno N, 2004, ARTHRITIS RHEUM, V50, P1935, DOI 10.1002/art.20268; Mallat Z, 2001, CIRCULATION, V104, P1598, DOI 10.1161/hc3901.096721; Manigold T, 2000, CYTOKINE, V12, P1788, DOI 10.1006/cyto.2000.0783; Maruyama J, 2010, J RHEUMATOL, V37, P967, DOI 10.3899/jrheum.090662; Mavragani Clio P, 2012, Int J Inflam, V2012, P879020, DOI 10.1155/2012/879020; Mazodier K, 2005, BLOOD, V106, P3483, DOI 10.1182/blood-2005-05-1980; McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537; Monteleone G, 1999, J IMMUNOL, V163, P143; Naftali T, 2007, ISRAEL MED ASSOC J, V9, P504; Netea MG, 2000, EUR J IMMUNOL, V30, P3057, DOI 10.1002/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P; Netea MG, 2002, J INFECT DIS, V185, P963, DOI 10.1086/339410; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Nold-Petry CA, 2009, J BIOL CHEM, V284, P25900, DOI 10.1074/jbc.M109.004184; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Novick D, 2001, CYTOKINE, V14, P334, DOI 10.1006/cyto.2001.0914; Ojala JO, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050055; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Otsuka R, 2020, INFLAMM REGEN, V40, DOI 10.1186/s41232-020-00131-w; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Puren AJ, 1998, J CLIN INVEST, V101, P711, DOI 10.1172/JCI1379; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Puren AJ, 1998, J INFECT DIS, V178, P1830, DOI 10.1086/314481; Put K, 2015, RHEUMATOLOGY, V54, P1507, DOI 10.1093/rheumatology/keu524; Ravelli A, 2012, GENES IMMUN, V13, P289, DOI 10.1038/gene.2012.3; Rodrigues TS, 2021, J EXP MED, V218, DOI 10.1084/jem.20201707; Satis H, 2021, CYTOKINE, V137, DOI 10.1016/j.cyto.2020.155302; Sawada M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054623; Shimizu M, 2015, CLIN IMMUNOL, V160, P277, DOI 10.1016/j.clim.2015.06.005; Shimizu M, 2010, RHEUMATOLOGY, V49, P1645, DOI 10.1093/rheumatology/keq133; SIEGMUND B, 2001, AM J PHYSIOL-REG I, V281, pR126; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Sonmez HE, 2018, CLIN RHEUMATOL, V37, P3329, DOI 10.1007/s10067-018-4095-1; Soy M, 2020, CLIN RHEUMATOL, V39, P2085, DOI 10.1007/s10067-020-05190-5; Stuyt RJL, 2003, CYTOKINE, V21, P65, DOI 10.1016/S1043-4666(02)00501-X; Ten Hove T, 2001, GASTROENTEROLOGY, V121, P1372, DOI 10.1053/gast.2001.29579; Toldo S, 2014, AM J PHYSIOL-HEART C, V306, pH1025, DOI 10.1152/ajpheart.00795.2013; Toth A, 2013, J INFECT DIS, V208, P690, DOI 10.1093/infdis/jit188; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Van den Munckhof I, 2019, ATHEROSCLEROSIS, V287, pE75, DOI 10.1016/j.atherosclerosis.2019.06.217; Vecchie A, 2021, J CELL PHYSIOL, V236, P1638, DOI 10.1002/jcp.30008; Wada T, 2014, CYTOKINE, V65, P74, DOI 10.1016/j.cyto.2013.09.007; Weiss ES, 2018, BLOOD, V131, P1442, DOI 10.1182/blood-2017-12-820852; Wen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0168-9; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Yasin S, 2020, RHEUMATOLOGY, V59, P442, DOI 10.1093/rheumatology/kez284; Yasin S, 2020, RHEUMATOLOGY, V59, P361, DOI 10.1093/rheumatology/kez282; Yasuda K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030649; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P2043, DOI 10.1161/ATVBAHA.107.149484	101	7	7	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100630	10.1016/j.jbc.2021.100630	http://dx.doi.org/10.1016/j.jbc.2021.100630			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33823154	gold, Green Published			2022-12-28	WOS:000672866400601
J	McAndrews, KM; Che, SPY; LeBleu, VS; Kalluri, R				McAndrews, Kathleen M.; Che, Sara P. Y.; LeBleu, Valerie S.; Kalluri, Raghu			Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR VESICLES; INTERCELLULAR COMMUNICATION; CANCER; PLATFORM; ADJUVANT; PATHWAY; SYSTEM	The Stimulator of Interferon Genes (STING) pathway is implicated in the innate immune response and is important in both oncogenesis and cancer treatment. Specifically, activation of the cytosolic DNA sensor STING in antigen-presenting cells (APCs) induces a type I interferon response and cytokine production that facilitates antitumor immune therapy. However, use of STING agonists (STINGa) as a cancer therapeutic has been limited by unfavorable pharmacological properties and targeting inefficiency due to rapid clearance and limited uptake into the cytosol. Exosomes, a class of extracellular vesicles shed by all cells are under consideration for their use as effective carriers of drugs owing to their innate ability to be taken up by cells and their biocompatibility for optimal drug biodistribution. Therefore, we engineered exosomes to deliver the STING agonist cyclic GMP-AMP (iExo(STINGa)), to exploit their favorable pharmacokinetics and pharmacodynamics. Selective targeting of the STING pathway in APCs with iExo(STINGa) was associated with superior potency compared with STINGa alone in suppressing B16F10 tumor growth. Moreover, iExo(STINGa) showed superior uptake of STINGa into dendritic cells compared with STINGa alone, which led to increased accumulation of activated CD8(+) T-cells and an antitumor immune response. Our study highlights the potential of exosomes in general, and iExo(STINGa) specifically, in enhancing cancer therapy outcomes.	[McAndrews, Kathleen M.; Che, Sara P. Y.; LeBleu, Valerie S.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [LeBleu, Valerie S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Kalluri, Raghu] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Kalluri, Raghu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Northwestern University; Feinberg School of Medicine; Rice University; Baylor College of Medicine	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.; Kalluri, R (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.; Kalluri, R (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rkalluri@mdanderson.org	Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X; McAndrews, Kathleen/0000-0002-4092-4991	MD Anderson Cancer Center	MD Anderson Cancer Center	This work was primarily supported by funds from MD Anderson Cancer Center to R. K.	Baird JR, 2018, CANCER RES, V78, P6308, DOI 10.1158/0008-5472.CAN-18-1652; Batrakova EV, 2015, J CONTROL RELEASE, V219, P396, DOI 10.1016/j.jconrel.2015.07.030; Diamond JM, 2018, CANCER IMMUNOL RES, V6, P910, DOI 10.1158/2326-6066.CIR-17-0581; Kugeratski FG, 2021, FEBS J, V288, P10, DOI 10.1111/febs.15558; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Gonzalez H, 2018, GENE DEV, V32, P1267, DOI 10.1101/gad.314617.118; Gutierrez-Vazquez C, 2013, IMMUNOL REV, V251, P125, DOI 10.1111/imr.12013; Hoong Brandon Yi Da, 2020, Oncotarget, V11, P2930, DOI 10.18632/oncotarget.27673; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Junkins RD, 2018, J CONTROL RELEASE, V270, P1, DOI 10.1016/j.jconrel.2017.11.030; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Koshy ST, 2017, ADV BIOSYST, V1, DOI 10.1002/adbi.201600013; Le Naour J, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1777624; LeBleu VS, 2020, TRENDS CANCER, V6, P767, DOI 10.1016/j.trecan.2020.03.007; Luan X, 2017, ACTA PHARMACOL SIN, V38, P754, DOI 10.1038/aps.2017.12; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Ma Z, 2015, P NATL ACAD SCI USA, V112, pE4306, DOI 10.1073/pnas.1503831112; Mendt M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99263; Miyabe H, 2014, J CONTROL RELEASE, V184, P20, DOI 10.1016/j.jconrel.2014.04.004; Aval LM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103323; Nguyen TA, 2017, MOL IMMUNOL, V86, P16, DOI 10.1016/j.molimm.2016.10.002; Pitt JM, 2016, J CLIN INVEST, V126, P1139, DOI 10.1172/JCI87316; Reus JB, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020137; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Rutman AK, 2018, ENDOCRINOLOGY, V159, P3834, DOI 10.1210/en.2018-00649; Sharma P, 2020, NAT REV IMMUNOL, V20, P75, DOI 10.1038/s41577-020-0275-8; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Torralba D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05077-9; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vatner RE, 2019, MOL IMMUNOL, V110, P13, DOI 10.1016/j.molimm.2017.12.001; Watkins-Schulz R, 2019, BIOMATERIALS, V205, P94, DOI 10.1016/j.biomaterials.2019.03.011; Wilson DR, 2018, NANOMED-NANOTECHNOL, V14, P237, DOI 10.1016/j.nano.2017.10.013; Wu JJ, 2020, MED RES REV, V40, P1117, DOI 10.1002/med.21649; Zhou XN, 2020, CANCER SCI, V111, P3100, DOI 10.1111/cas.14563; Zhang YG, 2014, J IMMUNOL, V193, P2394, DOI 10.4049/jimmunol.1302718; Zhu YY, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1087-y	38	13	13	6	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100523	10.1016/j.jbc.2021.100523	http://dx.doi.org/10.1016/j.jbc.2021.100523			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33711340	Green Published, gold			2022-12-28	WOS:000672866400497
J	Peskin, AV; Meotti, FC; Kean, KM; Gobl, C; Peixoto, AS; Pace, PE; Horne, CR; Heath, SG; Crowther, JM; Dobson, RCJ; Karplus, PA; Winterbourn, CC				Peskin, Alexander, V; Meotti, Flavia C.; Kean, Kelsey M.; Gobl, Christoph; Peixoto, Albert Souza; Pace, Paul E.; Horne, Christopher R.; Heath, Sarah G.; Crowther, Jennifer M.; Dobson, Renwick C. J.; Karplus, P. Andrew; Winterbourn, Christine C.			Modifying the resolving cysteine affects the structure and hydrogen peroxide reactivity of peroxiredoxin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE; TRANSITION; CATALYSIS; DYNAMICS; MODEL; SUITE	Peroxiredoxin 2 (Prdx2) is a thiol peroxidase with an active site Cys (C52) that reacts rapidly with H2O2 and other peroxides. The sulfenic acid product condenses with the resolving Cys (C172) to form a disulfide which is recycled by thioredoxin or GSH via mixed disulfide intermediates or undergoes hyperoxidation to the sulfinic acid. C172 lies near the C terminus, outside the active site. It is not established whether structural changes in this region, such as mixed disulfide formation, affect H2O2 reactivity. To investigate, we designed mutants to cause minimal (C172S) or substantial (C172D and C172W) structural disruption. Stopped flow kinetics and mass spectrometry showed that mutation to Ser had minimal effect on rates of oxidation and hyperoxidation, whereas Asp and Trp decreased both by similar to 100-fold. To relate to structural changes, we solved the crystal structures of reduced WT and C172S Prdx2. The WT structure is highly similar to that of the published hyperoxidized form. C172S is closely related but more flexible and as demonstrated by size exclusion chromatography and analytical ultracentrifugation, a weaker decamer. Size exclusion chromatography and analytical ultracentrifugation showed that the C172D and C172W mutants are also weaker decamers than WT, and small-angle X-ray scattering analysis indicated greater flexibility with partially unstructured regions consistent with C-terminal unfolding. We propose that these structural changes around C172 negatively impact the active site geometry to decrease reactivity with H2O2. This is relevant for Prdx turnover as intermediate mixed disulfides with C172 would also be disruptive and could potentially react with peroxides before resolution is complete.	[Peskin, Alexander, V; Gobl, Christoph; Pace, Paul E.; Heath, Sarah G.; Winterbourn, Christine C.] Univ Otago Christchurch, Dept Pathol & Biomed Sci, Christchurch, New Zealand; [Meotti, Flavia C.; Peixoto, Albert Souza] Univ Sao Paulo, Chem Inst, Dept Biochem, Sao Paulo, SP, Brazil; [Kean, Kelsey M.; Karplus, P. Andrew] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Horne, Christopher R.; Crowther, Jennifer M.; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Kean, Kelsey M.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA	University of Otago; Universidade de Sao Paulo; Oregon State University; University of Canterbury; University of North Carolina; University of North Carolina Chapel Hill	Winterbourn, CC (corresponding author), Univ Otago Christchurch, Dept Pathol & Biomed Sci, Christchurch, New Zealand.; Karplus, PA (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	andy.karplus@oregonstate.edu; christine.winterbourn@otago.ac.nz	Dobson, Renwick/AAZ-7020-2021; Peixoto, Álbert Souza/E-4532-2018	Dobson, Renwick/0000-0002-5506-4939; Peixoto, Álbert Souza/0000-0002-7234-7252; peskin, alexander/0000-0001-9890-6043; Gobl, Christoph/0000-0001-8614-1434; Horne, Christopher R./0000-0003-1318-514X	Marsden Fund of New Zealand; US National Institutes of Health [R01-GM119227, K12-GM000678]; Health Research Council of New Zealand; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07937-8, 2018/14898-2, 2015/10411-3]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Council of New Zealand(Health Research Council of New Zealand); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE))	This work was supported by the Marsden Fund of New Zealand (C. C. W., A. V. P., P. E. P.); by the US National Institutes of Health (grant R01-GM119227 to P. A. K. and K12-GM000678 to K. M. K.); by a Sir Charles Hercus Fellowship from the Health Research Council of New Zealand (C. G.), the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) projects: CEPID-Redoxoma 2013/07937-8, Young Investigator 2018/14898-2 and multi-user equipment 2015/10411-3 grants (Brazil, FM). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC0205CH11231. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anschau V, 2020, FREE RADICAL BIO MED, V156, P207, DOI 10.1016/j.freeradbiomed.2020.06.015; Barranco-Medina S, 2008, BIOCHEMISTRY-US, V47, P7196, DOI 10.1021/bi8002956; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Bolduc JA, 2018, J BIOL CHEM, V293, P11901, DOI 10.1074/jbc.RA117.001690; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Carvalho LAC, 2017, J BIOL CHEM, V292, P8705, DOI 10.1074/jbc.M116.767657; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Dalla Rizza J, 2019, PROTEIN SCI, V28, P191, DOI 10.1002/pro.3520; Demeler B., 2016, ANAL UNTRACENTRIFUGA; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kriznik A, 2020, ACS CATAL, V10, P3326, DOI 10.1021/acscatal.9b04471; Kwak MS, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101203; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Loberg MA, 2019, CHEM RES TOXICOL, V32, P474, DOI 10.1021/acs.chemrestox.8b00346; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Nelson KJ, 2018, ANTIOXID REDOX SIGN, V28, P521, DOI 10.1089/ars.2016.6922; Nelson KJ, 2013, METHOD ENZYMOL, V527, P21, DOI 10.1016/B978-0-12-405882-8.00002-7; Nelson KJ, 2008, BIOCHEMISTRY-US, V47, P12860, DOI 10.1021/bi801718d; Pace PE, 2013, BIOCHEM J, V453, P475, DOI 10.1042/BJ20130030; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Parsonage D, 2015, BIOCHEMISTRY-US, V54, P1567, DOI 10.1021/bi501515w; Pastor-Flores D, 2020, P NATL ACAD SCI USA, V117, P16313, DOI 10.1073/pnas.1915275117; Perkins A, 2016, STRUCTURE, V24, P1668, DOI 10.1016/j.str.2016.07.012; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Perkins A, 2013, BIOCHEMISTRY-US, V52, P8708, DOI 10.1021/bi4011573; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2020, FREE RADICAL BIO MED, V158, P115, DOI 10.1016/j.freeradbiomed.2020.07.007; Peskin AV, 2016, J BIOL CHEM, V291, P3053, DOI 10.1074/jbc.M115.692798; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Portillo-Ledesma S, 2018, BIOCHEMISTRY-US, V57, P3416, DOI 10.1021/acs.biochem.8b00188; Reisz JA, 2013, FEBS J, V280, P6150, DOI 10.1111/febs.12535; Rhee SG, 2017, ANNU REV BIOCHEM, V86, P749, DOI 10.1146/annurev-biochem-060815-014431; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Tairum CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33133; Trujillo M, 2007, ARCH BIOCHEM BIOPHYS, V467, P95, DOI 10.1016/j.abb.2007.08.008; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117	46	6	6	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100494	10.1016/j.jbc.2021.100494	http://dx.doi.org/10.1016/j.jbc.2021.100494			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667550	gold, Green Published, Green Submitted			2022-12-28	WOS:000672866400468
J	Sebastian-Valverde, M; Wu, H; Al Rahim, M; Sanchez, R; Kumar, K; De Vita, RJ; Pasinetti, GM				Sebastian-Valverde, Maria; Wu, Henry; Al Rahim, Md; Sanchez, Roberto; Kumar, Kunal; De Vita, Robert J.; Pasinetti, Giulio Maria			Discovery and characterization of small-molecule inhibitors of NLRP3 and NLRC4 inflammasomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCURATE DOCKING; GASDERMIN D; INFLAMMATION; MICROGLIA; GLIDE; ASTROCYTES; ACTIVATION; RECEPTORS; SEVERITY; PROTEINS	Inflammasomes are macromolecular complexes involved in the host response to external and endogenous danger signals. Inflammasome-mediated sterile inflammation plays a central role in several human conditions such as autoimmune diseases, type-2 diabetes, and neurodegenerative disorders, indicating inflammasomes could be appealing therapeutic targets. Previous work has demonstrated that inhibiting the ATPase activity of the nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing protein 3 (NLRP3), disrupts inflammasome assembly and function. However, there is a necessity to find new potent compounds with therapeutic potential. Here we combine computational modeling of the target and virtual screening to discover a group of novel compounds predicted to inhibit NLRP3. We characterized the best compounds and determined their potency, specificity, and ability to inhibit processes downstream from NLRP3 activation. Moreover, we analyzed in mice the competence of a lead candidate to reduce lipopolysaccharide-induced inflammation. We also validated the active pharmacophore shared among all the NLRP3 inhibitors, and through computational docking, we clarify key structural features for compound positioning within the inflammasome ATP-binding site. Our study sets the basis for rational design and optimization of inflammasome-targeting probes and drugs.	[Sebastian-Valverde, Maria; Wu, Henry; Al Rahim, Md; Pasinetti, Giulio Maria] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Sanchez, Roberto; Kumar, Kunal; De Vita, Robert J.] Icahn Sch Med Mt Sinai, Drug Discovery Inst, New York, NY 10029 USA; [Sanchez, Roberto; Kumar, Kunal; De Vita, Robert J.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Pasinetti, Giulio Maria] James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Pasinetti, GM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Pasinetti, GM (corresponding author), James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA.	giulio.pasinetti@mssm.edu		Sebastian-Valverde, Maria/0000-0002-5593-8624; Pasinetti, Giulio/0000-0002-1524-5196	NIH's Office of Dietary Supplements (ODS) [AT008661]; National Center for Complementary and Integrative Health; Altschul Foundation; Senior VA Career Scientist Award	NIH's Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary and Integrative Health; Altschul Foundation; Senior VA Career Scientist Award	This research was supported by a grant (AT008661) from the NIH's Office of Dietary Supplements (ODS) and the National Center for Complementary and Integrative Health, awarded to G. M. P. The study was supported by the generous support of the Altschul Foundation to G. M. P. G. M. P. holds a Senior VA Career Scientist Award. We acknowledge that the contents of this study do not represent the views of the NCCIH, the ODS, the National Institutes of Health, the U.S. Department of Veterans Affairs, or the United States Government.	Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Bronstein R, 2013, JOVE-J VIS EXP, DOI 10.3791/50647; Chear CT, 2020, CLIN IMMUNOL, V211, DOI 10.1016/j.clim.2019.108328; Cocco M, 2017, J MED CHEM, V60, P3656, DOI 10.1021/acs.jmedchem.6b01624; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Dahlin JL, 2015, J MED CHEM, V58, P2091, DOI 10.1021/jm5019093; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Debye B, 2018, BRAIN PATHOL, V28, P14, DOI 10.1111/bpa.12467; Deora V, 2020, GLIA, V68, P407, DOI 10.1002/glia.23728; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Duncan JA, 2018, IMMUNOL REV, V281, P115, DOI 10.1111/imr.12607; Fan Z, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1670-6; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Franchi L, 2006, J IMMUNOL, V177, P3507, DOI 10.4049/jimmunol.177.6.3507; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Freeman L, 2017, J EXP MED, V214, P1351, DOI 10.1084/jem.20150237; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Ising C, 2019, NATURE, V575, P669, DOI 10.1038/s41586-019-1769-z; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jiang H, 2017, J EXP MED, V214, P3219, DOI 10.1084/jem.20171419; Johann S, 2015, GLIA, V63, P2260, DOI 10.1002/glia.22891; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kuemmerle-Deschner JB, 2011, ANN RHEUM DIS, V70, P2095, DOI 10.1136/ard.2011.152728; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lehmann S, 2018, NEUROPATH APPL NEURO, V44, P606, DOI 10.1111/nan.12483; Lempriere Sarah, 2020, Nat Rev Neurol, V16, P4, DOI 10.1038/s41582-019-0299-5; Liu L, 2014, AGEING RES REV, V15, P6, DOI 10.1016/j.arr.2013.12.007; Liu L, 2014, NEUROBIOL AGING, V35, P309, DOI 10.1016/j.neurobiolaging.2013.08.016; Maekawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11813; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Neven B, 2008, NAT CLIN PRACT RHEUM, V4, P481, DOI 10.1038/ncprheum0874; Perera AP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26775-w; Platnich JM, 2019, ARCH BIOCHEM BIOPHYS, V670, P4, DOI 10.1016/j.abb.2019.02.008; Romberg N, 2017, CURR OPIN ALLERGY CL, V17, P398, DOI 10.1097/ACI.0000000000000396; Saadi M, 2020, BRAIN RES BULL, V154, P81, DOI 10.1016/j.brainresbull.2019.10.010; Satoh T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.169; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shim DW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15314-8; Soares JLS, 2019, MULT SCLER RELAT DIS, V29, P26, DOI 10.1016/j.msard.2019.01.023; Stancu IC, 2019, ACTA NEUROPATHOL, V137, P599, DOI 10.1007/s00401-018-01957-y; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tapia-Abelian A, 2019, NAT CHEM BIOL, V15, P560, DOI 10.1038/s41589-019-0278-6; Tejera D, 2019, EMBO J, V38, DOI 10.15252/embj.2018101064; van Golen RF, 2019, BBA-MOL BASIS DIS, V1865, P1192, DOI 10.1016/j.bbadis.2019.01.014; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yu JR, 2011, CURR ALLERGY ASTHM R, V11, P12, DOI 10.1007/s11882-010-0160-9; Zhang CX, 2019, DIABETES METAB SYNDR, V12, P1297, DOI 10.2147/DMSO.S199802; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789	68	4	4	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100597	10.1016/j.jbc.2021.100597	http://dx.doi.org/10.1016/j.jbc.2021.100597			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781745	gold, Green Published			2022-12-28	WOS:000672866400569
J	Toth, AD; Garger, D; Prokop, S; Soltesz-Katona, E; Varnai, P; Balla, A; Turu, G; Hunyady, L				Toth, Andras David; Garger, Daniel; Prokop, Susanne; Soltesz-Katona, Eszter; Varnai, Peter; Balla, Andras; Turu, Gabor; Hunyady, Laszlo			A general method for quantifying ligand binding to unmodified receptors using Gaussia luciferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET RESIDENCE TIME; ANGIOTENSIN RECEPTOR; STRUCTURAL BASIS; SELECTIVITY; CELLS; LOCALIZATION; FLUORESCENCE; CONSTANT; KINETICS; FATE	Reliable measurement of ligand binding to cell surface receptors is of outstanding biological and pharmacological importance. Resonance energy transfer-based assays are powerful approaches to achieve this goal, but the currently available methods are hindered by the necessity of receptor tagging, which can potentially alter ligand binding properties. Therefore, we developed a tag-free system to measure ligand. receptor interactions in live cells using the Gaussia luciferase (GLuc) as a bioluminescence resonance energy transfer donor. GLuc is as small as the commonly applied Nanoluciferase but has enhanced brightness, and its proper substrate is the frequently used coelenterazine. In our assay, bystander bioluminescence resonance energy transfer is detected between a GLuc-based extracellular surface biosensor and fluorescent ligands bound to their unmodified receptors. The broad spectrum of applications includes equilibrium and kinetic ligand binding measurements for both labeled and competitive unlabeled ligands, and the assay can be utilized for different classes of plasma membrane receptors. Furthermore, the assay is suitable for high-throughput screening, as evidenced by the identification of novel alpha(1) adrenergic receptor ligands. Our data demonstrate that GLuc-based biosensors provide a simple, sensitive, and cost-efficient platform for drug characterization and development.	[Toth, Andras David; Garger, Daniel; Prokop, Susanne; Soltesz-Katona, Eszter; Varnai, Peter; Balla, Andras; Turu, Gabor; Hunyady, Laszlo] Semmelweis Univ, Fac Med, Dept Physiol, Budapest, Hungary; [Toth, Andras David; Soltesz-Katona, Eszter; Varnai, Peter; Balla, Andras; Turu, Gabor; Hunyady, Laszlo] Eotvos Lorand Res Network, MTA SE Lab Mol Physiol, Budapest, Hungary; [Toth, Andras David] Semmelweis Univ, Dept Internal Med & Hematol, Budapest, Hungary; [Prokop, Susanne] Semmelweis Univ, Szentagothai Janos Doctoral Sch Neurosci, Budapest, Hungary	Semmelweis University; Eotvos Lorand Research Network; Semmelweis University; Semmelweis University	Hunyady, L (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, Budapest, Hungary.; Hunyady, L (corresponding author), Eotvos Lorand Res Network, MTA SE Lab Mol Physiol, Budapest, Hungary.	hunyady.laszlo@med.semmelweis-univ.hu	Toth, Andras David/I-8898-2017	Toth, Andras David/0000-0003-2746-9370	Hungarian National Research, Development and Innovation Fund [NKFI K116954, NVKP_16-1-2016-0039]; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-3-III-SE-23, UNKP-20-3-II-SE-33]	Hungarian National Research, Development and Innovation Fund; New National Excellence Program of the Ministry of Human Capacities	This work was supported by the Hungarian National Research, Development and Innovation Fund (grants NKFI K116954 and NVKP_16-1-2016-0039) and the New National Excellence Program of the Ministry of Human Capacities (UNKP-17-3-III-SE-23, UNKP-20-3-II-SE-33).	Al-Sabah S, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01271; Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS21, DOI 10.1111/bph.14748; Balla A, 2012, J BIOL CHEM, V287, P9090, DOI 10.1074/jbc.M111.293944; Brothers SP, 2003, J CLIN ENDOCR METAB, V88, P6107, DOI 10.1210/jc.2003-031047; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christiansen E, 2016, J MED CHEM, V59, P4849, DOI 10.1021/acs.jmedchem.6b00202; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Copeland RA, 2016, NAT REV DRUG DISCOV, V15, P87, DOI 10.1038/nrd.2015.18; de Witte WEA, 2016, TRENDS PHARMACOL SCI, V37, P831, DOI 10.1016/j.tips.2016.06.008; Emami-Nemini A, 2013, NAT PROTOC, V8, P1307, DOI 10.1038/nprot.2013.073; Evers A, 2005, J MED CHEM, V48, P1088, DOI 10.1021/jm0491804; Gyombolai P, 2015, J MOL ENDOCRINOL, V54, P75, DOI 10.1530/JME-14-0219; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Herenbrink CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10842; Inouye S, 2013, BIOCHEM BIOPH RES CO, V437, P23, DOI 10.1016/j.bbrc.2013.06.026; Kaskova ZM, 2016, CHEM SOC REV, V45, P6048, DOI 10.1039/c6cs00296j; Kilpatrick LE, 2017, BIOCHEM PHARMACOL, V136, P62, DOI 10.1016/j.bcp.2017.04.006; Kozielewicz P, 2020, MOL PHARMACOL, V97, P23, DOI 10.1124/mol.119.118158; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lindberg E, 2013, CHEM SCI, V4, P4395, DOI 10.1039/c3sc51985f; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Mocking TAM, 2018, MOL PHARMACOL, V94, P1371, DOI 10.1124/mol.118.113373; MOTULSKY HJ, 1984, MOL PHARMACOL, V25, P1; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Stoddart LA, 2018, TRENDS PHARMACOL SCI, V39, P136, DOI 10.1016/j.tips.2017.10.006; Stoddart LA, 2016, BRIT J PHARMACOL, V173, P3028, DOI 10.1111/bph.13316; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/nmeth.3398, 10.1038/NMETH.3398]; Sykes DA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00716-z; Szakadati G, 2015, MOL PHARMACOL, V87, P972, DOI 10.1124/mol.114.097030; Szekeres M, 2012, J BIOL CHEM, V287, P31540, DOI 10.1074/jbc.M112.346296; Toth AD, 2018, J BIOL CHEM, V293, P876, DOI 10.1074/jbc.M117.813139; Toth AD, 2017, MOL CELL ENDOCRINOL, V442, P113, DOI 10.1016/j.mce.2016.11.027; Toth DJ, 2012, J CELL SCI, V125, P2185, DOI 10.1242/jcs.097279; Toth JT, 2016, BBA-MOL CELL BIOL L, V1861, P177, DOI 10.1016/j.bbalip.2015.12.005; Vauquelin G, 2016, BRIT J PHARMACOL, V173, P2319, DOI 10.1111/bph.13504; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Wingler LM, 2019, CELL, V176, P479, DOI 10.1016/j.cell.2018.12.006; Yano H, 2018, BIOTECHNIQUES, V65, P9, DOI 10.2144/btn-2018-0039; Zhang HT, 2017, NATURE, V544, P327, DOI 10.1038/nature22035; Zhang HT, 2015, J BIOL CHEM, V290, P29127, DOI 10.1074/jbc.M115.689000; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	45	2	2	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100366	10.1016/j.jbc.2021.100366	http://dx.doi.org/10.1016/j.jbc.2021.100366			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33545176	Green Published, Green Accepted, gold			2022-12-28	WOS:000672866400340
J	Wang, HB; Lu, J; Chen, XG; Schwalbe, M; Gorka, JE; Mandel, JA; Wang, JL; Goetzman, ES; Ranganathan, S; Dobrowolski, SF; Prochownik, EV				Wang, Huabo; Lu, Jie; Chen, Xiaoguang; Schwalbe, Marie; Gorka, Joanna E.; Mandel, Jordan A.; Wang, Jinglin; Goetzman, Eric S.; Ranganathan, Sarangarajan; Dobrowolski, Steven F.; Prochownik, Edward, V			Acquired deficiency of peroxisomal dicarboxylic acid catabolism is a metabolic vulnerability in hepatoblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; CANCER; GLYCOLYSIS; HALLMARKS; CATENIN; ALPHA; TUMOR	Metabolic reprogramming provides transformed cells with proliferative and/or survival advantages. Capitalizing on this therapeutically, however, has been only moderately successful because of the relatively small magnitude of these differences and because cancers may further adapt their metabolism to evade metabolic pathway inhibition. Mice lacking the peroxisomal bifunctional enzyme enoyl-CoA hydratase/3-hydroxyacyl CoA dehydrogenase (Ehhadh) and supplemented with the 12-carbon fatty acid lauric acid (C12) accumulate the toxic metabolite dodecanedioic acid (DDDA), which causes acute hepatocyte necrosis and liver failure. We noted that, in a murine model of pediatric hepatoblastoma (HB) and in primary human HBs, downregulation of Ehhadh occurs in association with the suppression of mitochondrial beta- and endosomal/peroxisomal omega-fatty acid oxidation pathways. This suggested that HBs might be more susceptible than normal liver tissue to C12 dietary intervention. Indeed, HB-bearing mice provided with C12- and/or DDDA-supplemented diets survived significantly longer than those on standard diets. In addition, larger tumors developed massive necrosis following short-term DDDA administration. In some HBs, the eventual development of DDDA resistance was associated with 129 transcript differences, similar to 90% of which were downregulated, and approximately two-thirds of which correlated with survival in numerous human cancers. These transcripts often encoded extracellular matrix components, suggesting that DDDA resistance arises from reduced Ehhadh uptake. Lower Ehhadh expression was also noted in murine hepatocellular carcinomas and in subsets of certain human cancers, supporting the likely generality of these results. Our results demonstrate the feasibility of C12 or DDDA dietary supplementation that is nontoxic, inexpensive, and likely compatible with more standard chemotherapies.	[Wang, Huabo; Lu, Jie; Chen, Xiaoguang; Schwalbe, Marie; Gorka, Joanna E.; Mandel, Jordan A.; Wang, Jinglin; Prochownik, Edward, V] UPMC Childrens Hosp Pittsburgh, Div Hematol Oncol, Dept Pediat, Pittsburgh, PA 15224 USA; [Chen, Xiaoguang] Henan Univ Sci & Technol, Sch Anim Sci & Technol, Luoyang, Henan, Peoples R China; [Wang, Jinglin] Cent South Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Goetzman, Eric S.; Dobrowolski, Steven F.] UPMC Childrens Hosp Pittsburgh, Dept Pediat, Div Med Genet, Pittsburgh, PA USA; [Ranganathan, Sarangarajan] Cincinnati Childrens Hosp, Dept Pathol, Cincinnati, OH USA; [Prochownik, Edward, V] Univ Pittsburgh, Hillman Canc Ctr, Med Ctr, Pittsburgh, PA 15260 USA; [Prochownik, Edward, V] Pittsburgh Liver Res Inst, Pittsburgh, PA 15261 USA; [Prochownik, Edward, V] Univ Pittsburgh, Dept Microbiol & Mol Genet, Med Ctr, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Henan University of Science & Technology; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cincinnati Children's Hospital Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC Childrens Hosp Pittsburgh, Div Hematol Oncol, Dept Pediat, Pittsburgh, PA 15224 USA.; Prochownik, EV (corresponding author), Univ Pittsburgh, Hillman Canc Ctr, Med Ctr, Pittsburgh, PA 15260 USA.; Prochownik, EV (corresponding author), Pittsburgh Liver Res Inst, Pittsburgh, PA 15261 USA.; Prochownik, EV (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Med Ctr, Pittsburgh, PA 15260 USA.	procev@chp.edu		Goetzman, Eric/0000-0001-9476-309X; Gorka, Joanna/0000-0001-9871-7664; Ranganathan, Sarangarajan/0000-0001-6214-9167; WANG, HUABO/0000-0003-2551-3243	National Institutes of Health [RO1CA174713, DK090242]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants RO1CA174713 to E. V. P. and DK090242 to E. S. G.	Akins NS, 2018, CURR TOP MED CHEM, V18, P494, DOI 10.2174/1568026618666180523111351; Allen BG, 2014, REDOX BIOL, V2, P963, DOI 10.1016/j.redox.2014.08.002; Altman BJ, 2016, NAT REV CANCER, V16, P749, DOI 10.1038/nrc.2016.114; Ambrosetti D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193477; Ashton TM, 2018, CLIN CANCER RES, V24, P2482, DOI 10.1158/1078-0432.CCR-17-3070; Bandari SK, 2018, MATRIX BIOL, V65, P104, DOI 10.1016/j.matbio.2017.09.001; Bell Danielle, 2017, Gene Expression, V17, P141, DOI 10.3727/105221616X693639; Brandhorst S, 2016, RECENT RESULTS CANC, V207, P241, DOI 10.1007/978-3-319-42118-6_12; Byrne FL, 2014, CANCER RES, V74, P5832, DOI 10.1158/0008-5472.CAN-14-0254; Chen GA, 2003, P NATL ACAD SCI USA, V100, P13537, DOI 10.1073/pnas.2233850100; Choi S, 2018, NUCL MED MOLEC IMAG, V52, P453, DOI 10.1007/s13139-018-0555-4; Chung HH, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e15; Czauderna P, 2014, CURR OPIN PEDIATR, V26, P19, DOI 10.1097/MOP.0000000000000046; Deshmukh A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0555-x; Di Francesco A, 2018, SCIENCE, V362, P770, DOI 10.1126/science.aau2095; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; DiNardo CD, 2018, NEW ENGL J MED, V378, P2386, DOI 10.1056/NEJMoa1716984; Ding J, 2013, CELL REP, V5, P248, DOI 10.1016/j.celrep.2013.08.032; Dolezal JM, 2017, J BIOL CHEM, V292, P10068, DOI 10.1074/jbc.M117.782052; Edmunds LR, 2016, ONCOTARGET, V7, P30379, DOI 10.18632/oncotarget.8856; Fan TWM, 2019, J BIOL CHEM, V294, P13464, DOI 10.1074/jbc.RA119.008743; Fendt SM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00150; Fransen M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061126; Goetzman ES, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00129; Guerra F, 2017, BBA-BIOENERGETICS, V1858, P686, DOI 10.1016/j.bbabio.2017.01.012; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Harisi R, 2015, ONCOTARGETS THER, V8, P1387, DOI 10.2147/OTT.S48883; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirata E, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026781; Holle AW, 2016, ADV DRUG DELIVER REV, V97, P270, DOI 10.1016/j.addr.2015.10.007; Hooks KB, 2018, HEPATOLOGY, V68, P89, DOI 10.1002/hep.29672; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Jackson LE, 2017, CANCER RES, V77, P5795, DOI 10.1158/0008-5472.CAN-17-1325; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Kanarek N, 2020, NATURE, V579, P507, DOI 10.1038/s41586-020-2124-0; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kulkarni S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182705; Kumar SN, 2011, J AGR FOOD CHEM, V59, P13050, DOI 10.1021/jf203182d; Lao-On U, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.165656; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228; Li T, 2018, ADV EXP MED BIOL, V1063, P13, DOI 10.1007/978-3-319-77736-8_2; Lucarelli G, 2015, ONCOTARGET, V6, P13371, DOI 10.18632/oncotarget.3823; Luengo A, 2017, CELL CHEM BIOL, V24, P1161, DOI 10.1016/j.chembiol.2017.08.028; Mandel J, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06756-x; Mandel J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5851-6; Marusyk A, 2020, CANCER CELL, V37, P471, DOI 10.1016/j.ccell.2020.03.007; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Montalban-Bravo G, 2018, FUTURE ONCOL, V14, P979, DOI 10.2217/fon-2017-0523; Morrow G, 2017, ADV EXP MED BIOL, V959, P9, DOI 10.1007/978-3-319-55780-9_2; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Nencioni A, 2018, NAT REV CANCER, V18, P707, DOI 10.1038/s41568-018-0061-0; Norsworthy KJ, 2019, CLIN CANCER RES, V25, P3205, DOI 10.1158/1078-0432.CCR-18-3749; Palm W, 2017, NATURE, V546, P234, DOI 10.1038/nature22379; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Phannasil P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129848; Placencio VR, 2015, CANCER RES, V75, P2969, DOI 10.1158/0008-5472.CAN-15-0876; Qi C, 1999, J BIOL CHEM, V274, P15775, DOI 10.1074/jbc.274.22.15775; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Schuurbiers OCJ, 2014, J THORAC ONCOL, V9, P1485, DOI 10.1097/JTO.0000000000000286; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sharma D, 2017, SEMIN DIAGN PATHOL, V34, P192, DOI 10.1053/j.semdp.2016.12.015; Sullivan MR, 2019, CRIT REV BIOCHEM MOL, V54, P193, DOI 10.1080/10409238.2019.1611733; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Torrence ME, 2018, ANNU REV CANC BIOL, V2, P251, DOI 10.1146/annurev-cancerbio-030617-050329; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Waitkus MS, 2018, CANCER CELL, V34, P186, DOI 10.1016/j.ccell.2018.04.011; Wang HB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218186; Wang HB, 2018, J BIOL CHEM, V293, P14740, DOI 10.1074/jbc.RA118.004099; Wang HB, 2016, J BIOL CHEM, V291, P26241, DOI 10.1074/jbc.M116.754218; Zhang WQ, 2019, J BIOL CHEM, V294, P17524, DOI 10.1074/jbc.RA119.009979; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	74	3	3	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100283	10.1016/j.jbc.2021.100283	http://dx.doi.org/10.1016/j.jbc.2021.100283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450224	gold, Green Published			2022-12-28	WOS:000672866400259
J	Yook, JS; You, M; Kim, Y; Zhou, M; Liu, ZH; Kim, YC; Lee, J; Chung, S				Yook, Jin-Seon; You, Mikyoung; Kim, Yongeun; Zhou, Mi; Liu, Zhenhua; Kim, Young-Cheul; Lee, Jaekwon; Chung, Soonkyu			The thermogenic characteristics of adipocytes are dependent on the regulation of iron homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; UP-REGULATION; BEIGE FAT; DEFICIENCY; DIFFERENTIATION; METABOLISM; OBESITY; THERMOREGULATION; EXPOSURE; CHILDREN	The development of thermogenic adipocytes concurs with mitochondrial biogenesis, an iron-dependent pathway. Iron regulatory proteins (IRP) 1 and 2 are RNA-binding proteins that regulate intracellular iron homeostasis. IRPs bind to the iron-response element (IRE) of their target mRNAs, balancing iron uptake and deposition at the posttranscriptional levels. However, IRP/IRE-dependent iron regulation in adipocytes is largely unknown. We hypothesized that iron demands are higher in brown/beige adipocytes than white adipocytes to maintain the thermogenic mitochondrial capacity. To test this hypothesis, we investigated the IRP/IRE regulatory system in different depots of adipose tissue. Our results revealed that 1) IRP/IRE interaction was increased in proportional to the thermogenic function of the adipose depot, 2) adipose iron content was increased in adipose tissue browning upon beta 3-adrenoceptor stimulation, while decreased in thermoneutral conditions, and 3) modulation of iron content was linked with mitochondrial biogenesis. Moreover, the iron requirement was higher in HIB1B brown adipocytes than 3T3-L1 white adipocytes during differentiation. The reduction of the labile iron pool (LIP) suppressed the differentiation of brown/beige adipocytes and mitochondrial biogenesis. Using the Fe-59-Tf, we also demonstrated that thermogenic stimuli triggered cell-autonomous iron uptake and mitochondrial compartmentalization as well as enhanced mitochondrial respiration. Collectively, our work demonstrated that IRP/IRE signaling and subsequent adaptation in iron metabolism are a critical determinant for the thermogenic function of adipocytes.	[Yook, Jin-Seon; You, Mikyoung; Liu, Zhenhua; Kim, Young-Cheul; Chung, Soonkyu] Univ Massachusetts, Dept Nutr & Hlth Sci, Amherst, MA 01003 USA; [Kim, Yongeun; Zhou, Mi; Chung, Soonkyu] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE 68588 USA; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Chung, S (corresponding author), Univ Massachusetts, Dept Nutr & Hlth Sci, Amherst, MA 01003 USA.; Chung, S (corresponding author), Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE 68588 USA.	soonkyuchung@umass.edu		Lee, Jaekwon/0000-0003-3179-7334; You, Mikyoung/0000-0002-0908-113X	Science, Engineering, and Medicine (SEM) Initiative from University of Nebraska-Lincoln; Nebraska EPSCoR Grant; NIDDK scholarship;  [NIH-1P20GM104320];  [R21 HD094273-02];  [DK079209]	Science, Engineering, and Medicine (SEM) Initiative from University of Nebraska-Lincoln; Nebraska EPSCoR Grant; NIDDK scholarship; ; ; 	This work was supported in part by NIH-1P20GM104320 (Project 5) and R21 HD094273-02 awarded to S. C., and DK079209 to J. L. This study is also supported in part by the Science, Engineering, and Medicine (SEM) Initiative Grant awarded to S. C. from the University of Nebraska-Lincoln, and Nebraska EPSCoR Grant awarded to J. L. and S. C. J. Y. received the NIDDK scholarship to present the study in Keystone 2018 symposia (J4). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aeberli I, 2009, INT J OBESITY, V33, P1111, DOI 10.1038/ijo.2009.146; Altshuler-Keylin S, 2016, CELL METAB, V24, P402, DOI 10.1016/j.cmet.2016.08.002; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; BEARD J, 1984, AM J PHYSIOL, V247, pR114, DOI 10.1152/ajpregu.1984.247.1.R114; BEARD JL, 1990, AM J CLIN NUTR, V52, P813, DOI 10.1093/ajcn/52.5.813; Betz MJ, 2018, NAT REV ENDOCRINOL, V14, P77, DOI 10.1038/nrendo.2017.132; Caslin HL, 2020, IMMUNOL REV, V295, P101, DOI 10.1111/imr.12853; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DILLMANN E, 1979, AM J PHYSIOL, V237, pR297, DOI 10.1152/ajpregu.1979.237.5.R297; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Ferrari A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00182-7; Festa M, 2000, J BIOL CHEM, V275, P36708, DOI 10.1074/jbc.M004988200; Fillebeen C, 2014, JOVE-J VIS EXP, DOI 10.3791/52230; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Gonzalez-Dominguez A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155529; Hubler MJ, 2018, AM J PHYSIOL-CELL PH, V315, pC319, DOI 10.1152/ajpcell.00103.2018; Ikeda K, 2018, TRENDS ENDOCRIN MET, V29, P191, DOI 10.1016/j.tem.2018.01.001; Kim J, 2016, J BIOL CHEM, V291, P20551, DOI 10.1074/jbc.M116.721480; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Li J, 2020, ADV SCI, V7, DOI 10.1002/advs.201903366; Liao JL, 2018, ENDOCRINOLOGY, V159, P2520, DOI 10.1210/en.2018-00257; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lu JL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01173; LUKASKI HC, 1990, AVIAT SPACE ENVIR MD, V61, P913; Ma XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179889; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Moreno-Navarrete JM, 2014, DIABETOLOGIA, V57, P1957, DOI 10.1007/s00125-014-3298-5; MARTINEZTORRES C, 1984, AM J PHYSIOL, V246, pR380, DOI 10.1152/ajpregu.1984.246.3.R380; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Min SY, 2019, P NATL ACAD SCI USA, V116, P17970, DOI 10.1073/pnas.1906512116; Moreno M, 2015, FASEB J, V29, P1529, DOI 10.1096/fj.14-258996; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Okla M, 2017, ADV NUTR, V8, P473, DOI 10.3945/an.116.014332; Okla M, 2015, J BIOL CHEM, V290, P26476, DOI 10.1074/jbc.M115.677724; Perez MO, 2020, CHILD OBES, V16, P440, DOI 10.1089/chi.2019.0276; Park Anna, 2014, World J Stem Cells, V6, P33, DOI 10.4252/wjsc.v6.i1.33; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Qiu J, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.572459; Rensvold JW, 2016, J BIOL CHEM, V291, P20827, DOI 10.1074/jbc.M116.727701; Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029; Rouault TA, 2017, J BIOL CHEM, V292, P12744, DOI 10.1074/jbc.R117.789537; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; THEIL EC, 1994, BIOCHEM J, V304, P1; Townsend KL, 2014, TRENDS ENDOCRIN MET, V25, P168, DOI 10.1016/j.tem.2013.12.004; Tussing-Humphreys L, 2012, J ACAD NUTR DIET, V112, P391, DOI 10.1016/j.jada.2011.08.038; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Xu WJ, 2013, CELL METAB, V17, P319, DOI 10.1016/j.cmet.2013.02.004; Zhang GQ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00029; Zimmermann MB, 2008, INT J OBESITY, V32, P1098, DOI 10.1038/ijo.2008.43	54	6	7	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100452	10.1016/j.jbc.2021.100452	http://dx.doi.org/10.1016/j.jbc.2021.100452			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33631196	gold, Green Published			2022-12-28	WOS:000672866400426
J	Baserga, SJ; DiMario, PJ; Duncan, FE				Baserga, Susan J.; DiMario, Patrick J.; Duncan, Francesca E.			Emerging Roles for the Nucleolus 2019	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									[Baserga, Susan J.] Yale Univ, Yale Sch Med, Dept Mol Biophys & Biochem Genet, New Haven, CT 06520 USA; [Baserga, Susan J.] Yale Univ, Yale Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [DiMario, Patrick J.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Duncan, Francesca E.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA	Yale University; Yale University; Louisiana State University System; Louisiana State University; Northwestern University; Feinberg School of Medicine	Baserga, SJ (corresponding author), Yale Univ, Yale Sch Med, Dept Mol Biophys & Biochem Genet, New Haven, CT 06520 USA.; Baserga, SJ (corresponding author), Yale Univ, Yale Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA.	susan.baserga@yale.edu			National Science Foundation [MCB 1949334, MCB 1712975]; Company of Biologists [EA137];  [R35GM131687]	National Science Foundation(National Science Foundation (NSF)); Company of Biologists; 	This meeting was supported in part by scientific meeting grants from the National Science Foundation (Grant MCB 1949334) and the Company of Biologists (Grant EA137). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Grant R35GM131687. To whom correspondence should be addressed. E-mail:susan.baserga@yale.edu.; Supported by National Science Foundation Grant MCB 1712975.	Baserga SJ, 2018, MOL BIOL CELL, V29, P773, DOI 10.1091/mbc.E17-12-0730; Cenik ES, 2019, DEV CELL, V48, P811, DOI 10.1016/j.devcel.2019.01.019; Fulka H, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136093; Gordon J, 2019, J MOL BIOL, V431, P3771, DOI 10.1016/j.jmb.2019.07.007; Mageeney CM, 2019, MOL BIOL CELL, V30, P2240, DOI 10.1091/mbc.E19-02-0086; Raje HS, 2018, TRANSCR-AUSTIN, V9, P273, DOI 10.1080/21541264.2018.1506682; Sondalle SB, 2019, P NATL ACAD SCI USA, V116, P2561, DOI 10.1073/pnas.1811557116; Sutton EC, 2019, J AM CHEM SOC, V141, P18411, DOI 10.1021/jacs.9b10319; Weeks SE, 2019, CELL MOL LIFE SCI, V76, P4511, DOI 10.1007/s00018-019-03231-0; White MR, 2019, MOL CELL, V74, P713, DOI 10.1016/j.molcel.2019.03.019; Zhang XK, 2018, RNA BIOL, V15, P251, DOI 10.1080/15476286.2017.1408764	11	1	1	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2020	295	16					5535	5537		10.1074/jbc.MT120.013346	http://dx.doi.org/10.1074/jbc.MT120.013346			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LJ6QR	33509595	Green Published, hybrid			2022-12-28	WOS:000530288000030
J	Avesani, A; Marino, V; Zanzoni, S; Koch, KW; Dell'Orco, D				Avesani, Anna; Marino, Valerio; Zanzoni, Serena; Koch, Karl-Wilhelm; Dell'Orco, Daniele			Molecular properties of human guanylate cyclase-activating protein 2 (GCAP2) and its retinal dystrophy-associated variant G157R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; MUTATION; GUCA1A; EXPRESSION; MECHANISM; CLONING; FAMILY; RETGC; GENE; LOCALIZATION	In murine and bovine photoreceptors, guanylate cyclase-activating protein 2 (GCAP2) activates retinal guanylate cyclases (GCs) at low Ca2+ levels, thus contributing to the Ca2+/cGMP negative feedback on the cyclase together with its paralog guanylate cyclase-activating protein 1, which has the same function but different Ca2+ sensitivity. In humans, a GCAP2 missense mutation (G157R) has been associated with inherited retinal degeneration (IRD) via an unknown molecular mechanism. Here, we characterized the biochemical properties of human GCAP2 and the G157R variant, focusing on its dimerization and the Ca2+/Mg2+-binding processes in the presence or absence of N-terminal myristoylation. We found that human GCAP2 and its bovine/murine orthologs significantly differ in terms of oligomeric properties, cation binding, and GC regulation. Myristoylated GCAP2 endothermically binds up to 3 Mg2+ with high affinity and forms a compact dimer that may reversibly dissociate in the presence of Ca2+. Conversely, nonmyristoylated GCAP2 does not bind Mg2+ over the physiological range and remains as a monomer in the absence of Ca2+. Both myristoylated and nonmyristoylated GCAP2 bind Ca2+ with high affinity. At odds with guanylate cyclase-activating protein 1 and independently of myristoylation, human GCAP2 does not significantly activate retinal GC1 in a Ca2+-dependent fashion. The IRD-associated G157R variant is characterized by a partly misfolded, molten globule-like conformation with reduced affinity for cations and prone to form aggregates, likely mediated by hydrophobic interactions. Our findings suggest that GCAP2 might be mostly implicated in processes other than phototransduction in human photoreceptors and suggest a possible molecular mechanism for G157R-associated IRD.	[Avesani, Anna; Marino, Valerio; Dell'Orco, Daniele] Univ Verona, Dept Neurosci Biomed & Movement Sci, Biol Chem Sect, Verona, Italy; [Zanzoni, Serena] Univ Verona, Ctr Piattaforme Tecnol, Verona, Italy; [Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Dept Neurosci, Div Biochem, Oldenburg, Germany	University of Verona; University of Verona; Carl von Ossietzky Universitat Oldenburg	Dell'Orco, D (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Biol Chem Sect, Verona, Italy.	daniele.dellorco@univr.it	Koch, Karl-Wilhelm/C-9551-2015	Koch, Karl-Wilhelm/0000-0003-1501-0044; zanzoni, serena/0000-0003-0495-295X; DELL'ORCO, Daniele/0000-0002-3724-3044	Fondazione Telethon, Italy [GGP16010]; University of Verona [2018 JPVR184ZZ5]; Italian Ministry of University and Research [201744NR8S]	Fondazione Telethon, Italy(Fondazione Telethon); University of Verona; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was funded by Fondazione Telethon, Italy, Grant number GGP16010, a grant from the University of Verona (Joint Project 2018 JPVR184ZZ5), and a grant from the Italian Ministry of University and Research (PRIN 2017, 201744NR8S) to D. D.	Abbas S, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3580; Ames JB, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00397; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Arai Y, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/819760; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chen X, 2017, GENET MED, V19, P945, DOI 10.1038/gim.2016.217; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; Dal Cortivo G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51573-3; Dell'Orco D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56606-5; Dell'Orco D, 2014, CELL MOL LIFE SCI, V71, P3829, DOI 10.1007/s00018-014-1593-4; Dell'Orco D, 2012, ANAL CHEM, V84, P2982, DOI 10.1021/ac300213j; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; Dell'Orco D, 2009, MOL BIOSYST, V5, P1232, DOI 10.1039/b908123b; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; Dizhoor AM, 1999, METHODS, V19, P521, DOI 10.1006/meth.1999.0894; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Frins S, 1996, J BIOL CHEM, V271, P8022, DOI 10.1074/jbc.271.14.8022; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; Helten A, 2007, J NEUROCHEM, V103, P1439, DOI 10.1111/j.1471-4159.2007.04923.x; Huang L, 2013, NEUROSCI LETT, V541, P179, DOI 10.1016/j.neulet.2013.02.013; Hughes RE, 1998, PROTEIN SCI, V7, P2675, DOI 10.1002/pro.5560071222; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Hwang JY, 2002, BBA-PROTEINS PROTEOM, V1600, P111, DOI 10.1016/S1570-9639(02)00451-X; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; Invergo BM, 2014, MOL BIOSYST, V10, P1481, DOI 10.1039/c3mb70584f; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jiang L, 2005, MOL VIS, V11, P143; Jiang L, 2008, VISION RES, V48, P2425, DOI 10.1016/j.visres.2008.07.016; Kachi S, 1999, EXP EYE RES, V68, P465, DOI 10.1006/exer.1998.0629; Kamenarova K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/517570; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; Koch KW, 2013, ACS CHEM NEUROSCI, V4, P909, DOI 10.1021/cn400027z; Koch Karl-Wilhelm, 2008, P121; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Lim S, 2016, J BIOL CHEM, V291, P4429, DOI 10.1074/jbc.M115.696161; Lim S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00019; Lopez-Begines S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20893-1; Lopez-del Hoyo N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004480; Lopez-del Hoyo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042994; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Marino V, 2018, HUM MOL GENET, V27, P4204, DOI 10.1093/hmg/ddy311; Marino V, 2017, NANOSCALE, V9, P11773, DOI 10.1039/c7nr03288a; Marino V, 2016, SCI REP-UK, V6, DOI 10.1038/srep34277; Marino V, 2015, HUM MOL GENET, V24, P6653, DOI 10.1093/hmg/ddv370; Marino V, 2015, BBA-MOL CELL RES, V1853, P2055, DOI 10.1016/j.bbamcr.2014.10.026; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Nong E, 2014, DOC OPHTHALMOL, V128, P59, DOI 10.1007/s10633-013-9420-z; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; Palczewski K, 2004, BIOCHEM BIOPH RES CO, V322, P1123, DOI 10.1016/j.bbrc.2004.07.122; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Peshenko I. V., 2004, BIOCHEMISTRY; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2020, J BIOL CHEM, V295, P18301, DOI 10.1074/jbc.RA120.015553; Peshenko IV, 2019, J BIOL CHEM, V294, P3476, DOI 10.1074/jbc.RA118.006180; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pettelkau J, 2013, J AM SOC MASS SPECTR, V24, P1969, DOI 10.1007/s13361-013-0734-6; Sato M, 2005, GRAEF ARCH CLIN EXP, V243, P235, DOI 10.1007/s00417-004-1015-7; Schmitz F, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00003; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Theisgen S, 2011, EUR BIOPHYS J BIOPHY, V40, P565, DOI 10.1007/s00249-011-0680-9; Vallone R, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00274; Vinberg F, 2018, J BIOL CHEM, V293, P7457, DOI 10.1074/jbc.RA117.001574; Viviano J, 2016, ANAL BIOCHEM, V494, P93, DOI 10.1016/j.ab.2015.11.005; Vocke F, 2017, HUM MOL GENET, V26, P133, DOI 10.1093/hmg/ddw374; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Wimberg H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00348; Zagel P, 2013, BIOCHEMISTRY-US, V52, P5065, DOI 10.1021/bi400288p	75	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100619	10.1016/j.jbc.2021.100619	http://dx.doi.org/10.1016/j.jbc.2021.100619			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33812995	Green Published, gold			2022-12-28	WOS:000672866400590
J	Boudko, SP; Bauer, R; Chetyrkin, SV; Ivanov, S; Smith, J; Voziyan, PA; Hudson, BG				Boudko, Sergei P.; Bauer, Ryan; Chetyrkin, Sergei, V; Ivanov, Sergey; Smith, Jarrod; Voziyan, Paul A.; Hudson, Billy G.			Collagen IV alpha 345 dysfunction in glomerular basement membrane diseases. II. Crystal structure of the alpha 345 hexamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOODPASTURE AUTOANTIGEN; IV COLLAGEN; STABILIZATION; ORGANIZATION; NETWORK; DOMAINS; ANTIGEN; CHAIN; AMBER	Our recent work identified a genetic variant of the alpha 345 hexamer of the collagen IV scaffold that is present in patients with glomerular basement membrane diseases, Goodpasture's disease (GP) and Alport syndrome (AS), and phenocopies of AS in knock-in mice. To understand the context of this "Zurich" variant, an 8-amino acid appendage, we developed a construct of the WT alpha 345 hexamer using the single-chain NC1 trimer technology, which allowed us to solve a crystal structure of this key connection module. The alpha 345 hexamer structure revealed a ring of 12 chloride ions at the trimer-trimer interface, analogous to the collagen alpha 121 hexamer, and the location of the 170 AS variants. The hexamer surface is marked by multiple pores and crevices that are potentially accessible to small molecules. Loop-crevice-loop features constitute bioactive sites, where pathogenic pathways converge that are linked to AS and GP, and, potentially, diabetic nephropathy. In Pedchenko et al., we demonstrate that these sites exhibit conformational plasticity, a dynamic property underlying assembly of bioactive sites and hexamer dysfunction. The alpha 345 hexamer structure is a platform to decipher how variants cause AS and how hypoepitopes can be triggered, causing GP. Furthermore, the bioactive sites, along with the pores and crevices on the hexamer surface, are prospective targets for therapeutic interventions.	[Boudko, Sergei P.; Bauer, Ryan; Chetyrkin, Sergei, V; Ivanov, Sergey; Voziyan, Paul A.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37235 USA; [Boudko, Sergei P.; Bauer, Ryan; Chetyrkin, Sergei, V; Ivanov, Sergey; Voziyan, Paul A.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37235 USA; [Boudko, Sergei P.; Smith, Jarrod; Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Ctr Struct Biol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Aspirnaut, Nashville, TN USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Inst Chem Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Boudko, SP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37235 USA.; Boudko, SP (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37235 USA.; Boudko, SP (corresponding author), Vanderbilt Univ, Dept Biochem, Ctr Struct Biol, Nashville, TN 37232 USA.	Sergey.Budko@vumc.org	Ivanov, Sergey/GSD-3061-2022	Boudko, Sergei/0000-0003-3856-4859	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK18381-50, R24DK103067, R01DK065138, R01DK018381-49S]; Center for Matrix Biology at Vanderbilt University Medical Center; Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Matrix Biology at Vanderbilt University Medical Center; Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center	This work was supported by Grants R01DK18381-50 and a supplement R01DK018381-49S (to B. G. H.), R24DK103067 (to B. G. H.), R01DK065138 (to B. G. H. and P. A. V.) from the National Institute of Diabetes and Digestive and Kidney Diseases. Additional support was provided by the Aspirnaut program from the Center for Matrix Biology at Vanderbilt University Medical Center. S. P. B. was supported, in part, by start-up funding from Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Borza DB, 2002, J BIOL CHEM, V277, P40075, DOI 10.1074/jbc.M207769200; Boudko SP, 2018, METHOD CELL BIOL, V143, P171, DOI 10.1016/bs.mcb.2017.08.010; Calvete JJ, 2006, PROTEOMICS, V6, pS237, DOI 10.1002/pmic.200500495; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Casino P, 2018, IUCRJ, V5, P765, DOI 10.1107/S2052252518012459; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kufareva Irina, 2012, Methods Mol Biol, V857, P231, DOI 10.1007/978-1-61779-588-6_10; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Naylor RW, 2021, NAT REV NEPHROL, V17, P112, DOI 10.1038/s41581-020-0329-y; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Ooi JD, 2017, NATURE, V545, P243, DOI 10.1038/nature22329; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Pedchenko V, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100592; Pedchenko V, 2019, J BIOL CHEM, V294, P7968, DOI 10.1074/jbc.RA119.007426; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Phelps RG, 1999, KIDNEY INT, V56, P1638, DOI 10.1046/j.1523-1755.1999.00720.x; Pokidysheva EN, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100590; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Silk M, 2019, NUCLEIC ACIDS RES, V47, pW121, DOI 10.1093/nar/gkz457; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Vanacore RM, 2004, J BIOL CHEM, V279, P44723, DOI 10.1074/jbc.M406344200; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Vanacore RM, 2008, J BIOL CHEM, V283, P22737, DOI 10.1074/jbc.M803451200; Xie LJ, 2017, IMMUNOLOGY, V151, P395, DOI 10.1111/imm.12736	36	6	6	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100591	10.1016/j.jbc.2021.100591	http://dx.doi.org/10.1016/j.jbc.2021.100591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33775698	Green Published, gold			2022-12-28	WOS:000672866400563
J	Darling, NJ; Arthur, JSC; Cohen, P				Darling, Nicola J.; Arthur, J. Simon C.; Cohen, Philip			Salt-inducible kinases are required for the IL-33-dependent secretion of cytokines and chemokines in mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY SMOOTH-MUSCLE; IL-13 PRODUCTION; IKK-BETA; IL-33; PHOSPHORYLATION; PROTEIN; INTERLEUKIN-13; INFLAMMATION; INHIBITION; EXPRESSION	Cytokines and chemokines are important regulators of airway hyper-responsiveness, immune cell infiltration, and inflammation and are produced when mast cells are stimulated with interleukin-33 (IL-33). Here, we establish that the salt-inducible kinases (SIKs) are required for the IL-33-stimulated transcription of il13, gm-csf and tnf and hence the production of these cytokines. The IL-33-stimulated secretion of IL-13, granulocyte-macrophage colony stimulating factor, and tumor necrosis factor was strongly reduced in fetal liver-derived mast cells from mice expressing a kinase-inactive mutant of SIK3 and abolished in cells expressing kinase-inactive mutants of SIK2 and SIK3. The IL-33-dependent secretion of these cytokines and several chemokines was also abolished in SIK2/3 double knock-out bone marrow-derived mast cells (BMMC), reduced in SIK3 KO cells but little affected in BMMC expressing kinase-inactive mutants of SIK1 and SIK2 or lacking SIK2 expression. In SIK2 knock-out BMMC, the expression of SIK3 was greatly increased. Our studies identify essential roles for SIK2 and SIK3 in producing inflammatory mediators that trigger airway inflammation. The effects of SIKs were independent of I kappa B kinase beta, I kappa B kinase beta-mediated NF-kappa B-dependent gene transcription, and activation of the mitogen-activated protein kinase family members p38 alpha and c-jun N-terminal kinases. Our results suggest that dual inhibitors of SIK2 and SIK3 may have therapeutic potential for the treatment of mast cell-driven diseases.	[Darling, Nicola J.; Cohen, Philip] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Angus, Scotland; [Arthur, J. Simon C.] Univ Dundee, Div Cell Signalling & Immunol, Dundee, Angus, Scotland	University of Dundee; University of Dundee	Cohen, P (corresponding author), Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Angus, Scotland.	p.cohen@dundee.ac.uk		Darling, Nicola/0000-0001-7278-6012; Arthur, Simon/0000-0002-8135-1958	U.K. Medical Research Council [MR/R021406/1]	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a Programme Grant (MR/R021406/1) from the U.K. Medical Research Council (to P. C.).	Aoki M, 2015, BLOOD CELL MOL DIS, V54, P353, DOI 10.1016/j.bcmd.2015.01.007; Balzar S, 2005, AM J RESP CRIT CARE, V171, P431, DOI 10.1164/rccm.200407-949OC; BRADDING P, 1994, AM J RESP CELL MOL, V10, P471, DOI 10.1165/ajrcmb.10.5.8179909; Bradding Peter, 2008, Allergy Asthma Clin Immunol, V4, P84, DOI 10.1186/1710-1492-4-2-84; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Carroll NG, 2002, THORAX, V57, P677, DOI 10.1136/thorax.57.8.677; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cieslewicz G, 1999, J CLIN INVEST, V104, P301, DOI 10.1172/JCI7010; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Darling NJ, 2017, BIOCHEM J, V474, P521, DOI 10.1042/BCJ20160646; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Drube S, 2016, J IMMUNOL, V197, P3662, DOI 10.4049/jimmunol.1600658; Durham AL, 2016, TRANSL RES, V167, P192, DOI 10.1016/j.trsl.2015.08.004; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fukuishi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060837; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Gopfert C, 2018, J IMMUNOL, V200, P1198, DOI 10.4049/jimmunol.1700727; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hamzaoui A, 2013, J ASTHMA, V50, P803, DOI 10.3109/02770903.2013.816317; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Howden AJM, 2019, NAT IMMUNOL, V20, P1542, DOI 10.1038/s41590-019-0495-x; Jensen B. M., 2006, CURR PROTOC IMMUNOL; Junttila IS, 2013, J ALLERGY CLIN IMMUN, V132, P704, DOI 10.1016/j.jaci.2013.03.033; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; Lipworth B, 2018, LANCET RESP MED, V6, pE46, DOI 10.1016/S2213-2600(18)30275-3; Llop-Guevara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088714; Lombardi MS, 2016, J LEUKOCYTE BIOL, V99, P711, DOI 10.1189/jlb.2A0715-307R; Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111; Luan B, 2014, CELL METAB, V19, P1058, DOI 10.1016/j.cmet.2014.03.024; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Matera MG, 2010, PULM PHARMACOL THER, V23, P121, DOI 10.1016/j.pupt.2009.10.007; McCarthy PC, 2019, IMMUNOL CELL BIOL, V97, P54, DOI 10.1111/imcb.12200; Molfino NA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-007709; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; Ozanne J, 2015, BIOCHEM J, V465, P271, DOI 10.1042/BJ20141165; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; Sundberg TB, 2014, P NATL ACAD SCI USA, V111, P12468, DOI 10.1073/pnas.1412308111; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Yahara Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10959; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	49	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100428	10.1016/j.jbc.2021.100428	http://dx.doi.org/10.1016/j.jbc.2021.100428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600797	Green Published, gold			2022-12-28	WOS:000672866400402
J	Garate, F; Dokas, S; Lanfranco, MF; Canavan, C; Wang, I; Correia, JJ; Maillard, RA				Garate, Fernanda; Dokas, Stephen; Lanfranco, Maria Fe; Canavan, Clare; Wang, Irina; Correia, John J.; Maillard, Rodrigo A.			cAMP is an allosteric modulator of DNA-binding specificity in the cAMP receptor protein from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE ACTIVATOR PROTEIN; ESCHERICHIA-COLI; CYCLIC-AMP; BOVIS BCG; CONFORMATIONAL-CHANGES; FREE-ENERGY; TRANSCRIPTION; CRP; RECOGNITION; MUTATIONS	Allosteric proteins with multiple subunits and ligand-binding sites are central in regulating biological signals. The cAMP receptor protein from Mycobacterium tuberculosis (CRPMTB) is a global regulator of transcription composed of two identical subunits, each one harboring structurally conserved cAMP- and DNA-binding sites. The mechanisms by which these four binding sites are allosterically coupled in CRPMTB remain unclear. Here, we investigate the binding mechanism between CRPMTB and cAMP, and the linkage between cAMP and DNA interactions. Using calorimetric and fluorescence-based assays, we find that cAMP binding is entropically driven and displays negative cooperativity. Fluorescence anisotropy experiments show that apo-CRPMTB forms high-order CRPMTB-DNA oligomers through interactions with nonspecific DNA sequences or preformed CRPMTB-DNA complexes. Moreover, we find that cAMP prevents and reverses the formation of CRPMTB-DNA oligomers, reduces the affinity of CRPMTB for nonspecific DNA sequences, and stabilizes a 1-to-1 CRPMTB-DNA complex, but does not increase the affinity for DNA like in the canonical CRP from Escherichia coli (CRPEcoli). DNA-binding assays as a function of cAMP concentration indicate that one cAMP molecule per homodimer dissociates high-order CRPMTB-DNA oligomers into 1-to-1 complexes. These cAMP-mediated allosteric effects are lost in the double-mutant L47P/E178K found in CRP from Mycobacterium bovis Bacille Calmette-Guerin (CRPBCG). The functional behavior, thermodynamic stability, and dimerization constant of CRPBCG are not due to additive effects of L47P and E178K, indicating long-range interactions between these two sites. Altogether, we provide a previously undescribed archetype of cAMP-mediated allosteric regulation that differs from CRPEcoli, illustrating that structural homology does not imply allosteric homology.	[Garate, Fernanda; Dokas, Stephen; Lanfranco, Maria Fe; Canavan, Clare; Wang, Irina; Maillard, Rodrigo A.] Georgetown Univ, Dept Chem, Washington, DC 20057 USA; [Correia, John J.] Univ Mississippi, Med Ctr, Dept Cell & Mol Biol, Jackson, MS 39216 USA; [Garate, Fernanda] Pontificia Univ Catolica Chile, Unidad Microscopia Avanzanda, Santiago, Chile; [Lanfranco, Maria Fe] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Canavan, Clare] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Wang, Irina] Guidehouse LLP, Mclean, VA USA	Georgetown University; University of Mississippi; University of Mississippi Medical Center; Pontificia Universidad Catolica de Chile; Georgetown University; Harvard University	Maillard, RA (corresponding author), Georgetown Univ, Dept Chem, Washington, DC 20057 USA.	rodrigo.maillard@georgetown.edu		Canavan, Clare/0000-0003-0648-2373	NSF [MCB1715572]; National Institutes of Health [1R15GM135866]; Georgetown Undergraduate Research Opportunities Program; Georgetown University; Clare Boothe Luce foundation	NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgetown Undergraduate Research Opportunities Program; Georgetown University; Clare Boothe Luce foundation	This work was supported by NSF grant MCB1715572 (to R. A. M.) and National Institutes of Health grant 1R15GM135866 (to R. A. M.). I.W. acknowledges support from the Georgetown Undergraduate Research Opportunities Program and Raines fellowships from Georgetown University. C. C. acknowledges support from the Clare Boothe Luce foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Agarwal N, 2009, INDIAN J EXP BIOL, V47, P393; Akhter Y, 2007, INT J MED MICROBIOL, V297, P451, DOI 10.1016/j.ijmm.2007.04.009; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Bai GC, 2007, INFECT IMMUN, V75, P5509, DOI 10.1128/IAI.00658-07; Bai G, 2011, MOL MICROBIOL, V82, P180, DOI 10.1111/j.1365-2958.2011.07806.x; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Barrick D. E., 2018, BIOMOLECULAR THERMOD; Belliveau NM, 2018, P NATL ACAD SCI USA, V115, pE4796, DOI 10.1073/pnas.1722055115; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Cook GM, 2009, ADV MICROB PHYSIOL, V55, P81, DOI 10.1016/S0065-2911(09)05502-7; Dai JY, 2004, BIOCHEMISTRY-US, V43, P8901, DOI 10.1021/bi0499359; Einav T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204275; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Evangelista W, 2019, J BIOL CHEM, V294, P15544, DOI 10.1074/jbc.RA119.009151; Fleming PJ, 2018, BIOPHYS J, V114, P856, DOI 10.1016/j.bpj.2018.01.002; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; Green J, 2014, CURR OPIN MICROBIOL, V18, P1, DOI 10.1016/j.mib.2014.01.003; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hunt DM, 2008, INFECT IMMUN, V76, P2227, DOI 10.1128/IAI.01410-07; Johnson RM, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty048; Johnson RM, 2017, MOL MICROBIOL, V105, P294, DOI 10.1111/mmi.13701; Kahramanoglou C, 2014, NUCLEIC ACIDS RES, V42, P8320, DOI 10.1093/nar/gku548; Kaprelyants AS, 2012, PROTEIN PEPTIDE LETT, V19, P1026; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Knapp GS, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0011-2013; Knapp GS, 2015, NUCLEIC ACIDS RES, V43, P5377, DOI 10.1093/nar/gkv420; Kozlov AG, 2000, PROTEINS, P8; Kumar P, 2010, BIOPHYS J, V98, P305, DOI 10.1016/j.bpj.2009.10.016; Lanfranco MF, 2017, J BIOL CHEM, V292, P6086, DOI 10.1074/jbc.M117.776047; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Li LW, 2007, J AM CHEM SOC, V129, P15668, DOI 10.1021/ja076046a; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Lin SH, 2002, BIOCHEMISTRY-US, V41, P14935, DOI 10.1021/bi026756n; Lin SH, 2002, BIOCHEMISTRY-US, V41, P11857, DOI 10.1021/bi026099z; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; McLeish TCB, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/5/056004; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reddy MCM, 2009, J BIOL CHEM, V284, P36581, DOI 10.1074/jbc.M109.041343; REZNIKOFF WS, 1992, J BACTERIOL, V174, P655, DOI 10.1128/jb.174.3.655-658.1992; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rodgers TL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001651; RYU S, 1993, P NATL ACAD SCI USA, V90, P75, DOI 10.1073/pnas.90.1.75; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Shen BA, 2019, J MOL BIOL, V431, P4040, DOI 10.1016/j.jmb.2019.05.041; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Soberon-Chavez G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00959; Soulages JL, 1998, BIOPHYS J, V75, P484, DOI 10.1016/S0006-3495(98)77537-X; Spreadbury CL, 2005, MICROBIOL-SGM, V151, P547, DOI 10.1099/mic.0.27444-0; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; TAKAHASHI M, 1989, J MOL BIOL, V207, P783, DOI 10.1016/0022-2836(89)90244-1; Tischer A, 2019, BIOCHEMISTRY-US, V58, P2875, DOI 10.1021/acs.biochem.9b00389; Toncrova H, 2010, BIOPHYS J, V98, P2317, DOI 10.1016/j.bpj.2010.01.039; Townsend PD, 2015, J BIOL CHEM, V290, P22225, DOI 10.1074/jbc.M115.669267; Townsend PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113265; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Wang JH, 2020, BIOCHEMISTRY-US, V59, P790, DOI 10.1021/acs.biochem.9b01006; Yu SN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404806; Yu SN, 2004, BIOCHEMISTRY-US, V43, P4662, DOI 10.1021/bi0362166; Zubay G, 1980, Methods Enzymol, V65, P856	68	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100480	10.1016/j.jbc.2021.100480	http://dx.doi.org/10.1016/j.jbc.2021.100480			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33640453	gold, Green Published			2022-12-28	WOS:000672866400454
J	Hornos, F; Feng, HZ; Rizzuti, B; Palomino-Schatzlein, M; Wieczorek, D; Neira, JL; Jin, JP				Hornos, Felipe; Feng, Han-Zhong; Rizzuti, Bruno; Palomino-Schatzlein, Martina; Wieczorek, David; Neira, Jose L.; Jin, J. -P.			The muscle-relaxing C-terminal peptide from troponin I populates a nascent helix, facilitating binding to tropomyosin with a potent therapeutic effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; PRESERVED EJECTION FRACTION; TRANSGENIC MOUSE MODEL; HUMAN CARDIAC TROPONIN; CIRCULAR-DICHROISM; FOLDING PROBLEM; DIASTOLIC DYSFUNCTION; HYDRODYNAMIC RADII; STRUCTURAL BASIS; HEART-FAILURE	The conserved C-terminal end segment of troponin I (TnI) plays a critical role in regulating muscle relaxation. This function is retained in the isolated C-terminal 27 amino acid peptide (residues 184-210) of human cardiac TnI (HcTnI-C27): When added to skinned muscle fibers, HcTnI-C27 reduces the Ca2+-sensitivity of activated myofibrils and facilitates relaxation without decreasing the maximum force production. However, the underlying mechanism of HcTnI-C27 function is unknown. We studied the conformational preferences of HcTnI-C27 and a myopathic mutant, Arg192His, (HcTnI-C27-H). Both peptides were mainly disordered in aqueous solution with a nascent helix involving residues from Trp191 to Ile195, as shown by NMR analysis and molecular dynamics simulations. The population of nascent helix was smaller in HcTnI-C27-H than in HcTnI-C27, as shown by circular dichroism (CD) titrations. Fluorescence and isothermal titration calorimetry (ITC) showed that both peptides bound tropomyosin (alpha Tm), with a detectably higher affinity (similar to 10 mu M) of HcTnI-C27 than that of HcTnI-C27-H (similar to 15 mu M), consistent with an impaired Ca2+-desensitization effect of the mutant peptide on skinned muscle strips. Upon binding to aTm, HcTnI-C27 acquired a weakly stable helix-like conformation involving residues near Trp191, as shown by transferred nuclear Overhauser effect spectroscopy and hydrogen/deuterium exchange experiments. With the potent Ca2+-desensitization effect of HcTnI-C27 on skinned cardiac muscle from a mouse model of hypertrophic cardiomyopathy, the data support that the C-terminal end domain of TnI can function as an isolated peptide with the intrinsic capacity of binding tropomyosin, providing a promising therapeutic approach to selectively improve diastolic function of the heart.	[Hornos, Felipe; Neira, Jose L.] Univ Miguel Hernandez, IDIBE, Alicante, Spain; [Feng, Han-Zhong; Jin, J. -P.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Rizzuti, Bruno] Licryl UOS Cosenza, CNR NANOTEC, Cosenza, Italy; [Rizzuti, Bruno] Univ Calabria, Dept Phys, CEMIF Cal, Cosenza, Italy; [Palomino-Schatzlein, Martina] Ctr Invest Principe Felipe Valencia, Dept NMR, Valencia, Spain; [Wieczorek, David] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cinncinnnati, OH USA; [Neira, Jose L.] Inst Biocomputac & Fis Sistemas Complejos, Zaragoza, Spain	Universidad Miguel Hernandez de Elche; Wayne State University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Nanotecnologia (NANOTEC-CNR); University of Calabria; Prince Felipe Research Center; University System of Ohio; University of Cincinnati	Neira, JL (corresponding author), Univ Miguel Hernandez, IDIBE, Alicante, Spain.; Jin, JP (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA.; Neira, JL (corresponding author), Inst Biocomputac & Fis Sistemas Complejos, Zaragoza, Spain.	jlneira@umh.es; jjin@med.wayne.edu	Neira, Jose/ABF-4210-2021; Rizzuti, Bruno/B-5781-2013	Rizzuti, Bruno/0000-0003-1110-764X; Jin, JP/0000-0001-9932-1063; Palomino-Schatzlein, Martina/0000-0001-7303-0743; Neira, Jose Luis/0000-0002-4933-0428	Spanish Ministry of Economy and Competitiveness; European ERDF Funds (MCIU/AEI/FEDER, EU) [RTI2018-097991-B-I00]; National Institutes of Health of USA [HL127691, HL138007]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European ERDF Funds (MCIU/AEI/FEDER, EU); National Institutes of Health of USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Spanish Ministry of Economy and Competitiveness and European ERDF Funds (MCIU/AEI/FEDER, EU) [RTI2018-097991-B-I00 to J. L. N.] and National Institutes of Health of USA [Grants HL127691 and HL138007 to J. P. J.].	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Beckett D, 2011, METHOD ENZYMOL, P1, DOI 10.1016/B978-0-12-381268-1.00001-X; BIRDSALL B, 1983, ANAL BIOCHEM, V132, P353, DOI 10.1016/0003-2697(83)90020-9; Bruix M, 1997, EUR J BIOCHEM, V243, P384, DOI 10.1111/j.1432-1033.1997.0384a.x; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; Czypionka A, 2007, BIOCHEMISTRY-US, V46, P12764, DOI 10.1021/bi701343q; Danielsson J, 2002, MAGN RESON CHEM, V40, pS89, DOI 10.1002/mrc.1132; Du J, 2006, ARCH BIOCHEM BIOPHYS, V456, P143, DOI 10.1016/j.abb.2006.08.018; Evoli S, 2014, PROTEINS, V82, P2609, DOI 10.1002/prot.24625; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feng HZ, 2020, EXP PHYSIOL, V105, P1869, DOI 10.1113/EP088521; Gay GD, 1996, ARCH BIOCHEM BIOPHYS, V335, P1, DOI 10.1006/abbi.1996.0475; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Grande F, 2018, MOLECULES, V23, DOI 10.3390/molecules23040894; Guntert P, 1998, Q REV BIOPHYS, V31, P145, DOI 10.1017/S0033583598003436; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakob U, 2014, CHEM REV, V114, P6779, DOI 10.1021/cr400459c; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; KEMMINK J, 1993, J MOL BIOL, V234, P861, DOI 10.1006/jmbi.1993.1631; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Launay H, 2018, J MOL BIOL, V430, P1218, DOI 10.1016/j.jmb.2018.02.020; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Melenovsky V, 2007, J AM COLL CARDIOL, V49, P198, DOI 10.1016/j.jacc.2006.08.050; Mitrea DM, 2013, FEBS LETT, V587, P1081, DOI 10.1016/j.febslet.2013.02.024; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; MUNOZ V, 1995, J MOL BIOL, V247, P648, DOI 10.1006/jmbi.1994.0170; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Neira JL, 2019, BBA-PROTEINS PROTEOM, V1867, DOI 10.1016/j.bbapap.2019.07.005; Neira JL, 2016, ARCH BIOCHEM BIOPHYS, V598, P18, DOI 10.1016/j.abb.2016.03.034; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Royer CA, 2008, METHOD ENZYMOL, V450, P79, DOI 10.1016/S0076-6879(08)03405-8; Sanches K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70034-w; SANCHO J, 1992, J MOL BIOL, V224, P749, DOI 10.1016/0022-2836(92)90559-3; Schultz JE, 2013, TRENDS BIOCHEM SCI, V38, P538, DOI 10.1016/j.tibs.2013.08.005; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Shah SJ, 2016, CIRCULATION, V134, P73, DOI 10.1161/CIRCULATIONAHA.116.021884; Sheng JJ, 2016, GENE, V576, P385, DOI 10.1016/j.gene.2015.10.052; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wei B, 2016, GENE, V582, P1, DOI 10.1016/j.gene.2016.01.006; Whitby FG, 2000, PROTEINS, V38, P49; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wong S, 2019, J MOL CELL CARDIOL, V136, P42, DOI 10.1016/j.yjmcc.2019.09.002; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yadahalli S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36589-5; Zhang ZL, 2011, FEBS J, V278, P3348, DOI 10.1111/j.1742-4658.2011.08250.x	73	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100228	10.1074/jbc.RA120.016012	http://dx.doi.org/10.1074/jbc.RA120.016012			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33814345	Green Published, gold			2022-12-28	WOS:000672866400206
J	Hutchinson, JP; Temponeras, I; Kuiper, J; Cortes, A; Korczynska, J; Kitchen, S; Stratikos, E				Hutchinson, Jonathan P.; Temponeras, Ioannis; Kuiper, Jonas; Cortes, Adrian; Korczynska, Justyna; Kitchen, Semra; Stratikos, Efstratios			Common allotypes of ER aminopeptidase 1 have substrate-dependent and highly variable enzymatic properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM AMINOPEPTIDASES; GENOME-WIDE ASSOCIATION; ANKYLOSING-SPONDYLITIS; ERAP1 HAPLOTYPES; STRUCTURAL BASIS; POLYMORPHISM; MECHANISM; HLA-B27; COMBINATIONS; EXPRESSION	Polymorphic variation of immune system proteins can drive variability of individual immune responses. Endoplasmic reticulum aminopeptidase 1 (ERAP1) generates antigenic peptides for presentation by major histocompatibility complex class I molecules. Coding SNPs in ERAP1 have been associated with predisposition to inflammatory rheumatic disease and shown to affect functional properties of the enzyme, but the interplay between combinations of these SNPs as they exist in allotypes has not been thoroughly explored. We used phased genotype data to estimate ERAP1 allotype frequency in 2504 individuals across five major human populations, generated highly pure recombinant enzymes corresponding to the ten most common ERAP1 allotypes, and systematically characterized their in vitro enzymatic properties. We find that ERAP1 allotypes possess a wide range of enzymatic activities, up to 60-fold, whose ranking is substrate dependent. Strikingly, allotype 10, previously associated with Behcet's disease, is consistently a low-activity outlier, suggesting that a significant percentage of individuals carry a subactive ERAP1 gene. Enzymatic analysis revealed that ERAP1 allotypes can differ in both catalytic efficiency and substrate affinity, differences that can change intermediate accumulation in multistep trimming reactions. Alterations in efficacy of an allosteric inhibitor that targets the regulatory site suggest that allotypic variation influences the communication between the regulatory and the active site. Our work defines the wide landscape of ERAP1 activity in human populations and demonstrates how common allotypes can induce substrate-dependent variability in antigen processing, thus contributing, in synergy with major histocompatibility complex haplotypes, to immune response variability and predisposition to chronic inflammatory conditions.	[Hutchinson, Jonathan P.; Korczynska, Justyna] GlaxoSmithKline, Med Sci & Technol, Stevenage, Herts, England; [Temponeras, Ioannis; Stratikos, Efstratios] Natl Ctr Sci Res Demokritos, Prot Chem Lab, Athens, Greece; [Kuiper, Jonas] Univ Utrecht, Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands; [Kuiper, Jonas] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Utrecht, Netherlands; [Cortes, Adrian] GlaxoSmithKline, Human Genet, Stevenage, Herts, England; [Kitchen, Semra] GlaxoSmithKline, Adapt Immun Res Unit, Stevenage, Herts, England; [Stratikos, Efstratios] Natl & Kapodistrian Univ Athens, Dept Chem, Lab Biochem, Athens, Greece	GlaxoSmithKline; National Centre of Scientific Research "Demokritos"; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; GlaxoSmithKline; GlaxoSmithKline; National & Kapodistrian University of Athens	Stratikos, E (corresponding author), Natl Ctr Sci Res Demokritos, Prot Chem Lab, Athens, Greece.; Stratikos, E (corresponding author), Natl & Kapodistrian Univ Athens, Dept Chem, Lab Biochem, Athens, Greece.	estratikos@chem.uoa.gr	Stratikos, Efstratios/N-2969-2014	Stratikos, Efstratios/0000-0002-3566-2309; Temponeras, Ioannis/0000-0002-7865-6152; Kuiper, Jonas/0000-0002-5370-6395	VENI award from the Netherlands Organization for Scientific Research (NWO) [016.186.006]	VENI award from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	J. K. is supported by a VENI award from the Netherlands Organization for Scientific Research (NWO project number 016.186.006).	Admon A, 2019, HUM IMMUNOL, V80, P296, DOI 10.1016/j.humimm.2019.03.004; Agrawal N, 2014, GENES IMMUN, V15, P521, DOI 10.1038/gene.2014.46; Alvarez-Navarro C, 2014, MOL IMMUNOL, V57, P12, DOI 10.1016/j.molimm.2013.06.012; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Ayres CM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00966; Blees A, 2017, NATURE, V551, P525, DOI 10.1038/nature24627; Cagliani R, 2010, HUM MOL GENET, V19, P4705, DOI 10.1093/hmg/ddq401; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Chen LY, 2014, ARTHRITIS RHEUMATOL, V66, P284, DOI 10.1002/art.38249; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Costantino F, 2015, ARTHRITIS RHEUMATOL, V67, P1525, DOI 10.1002/art.39072; de Castro JAL, 2019, HUM IMMUNOL, V80, P310, DOI 10.1016/j.humimm.2018.11.001; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Evnouchidou I, 2012, J IMMUNOL, V189, P2383, DOI 10.4049/jimmunol.1200918; Evnouchidou I, 2011, J IMMUNOL, V186, P1909, DOI 10.4049/jimmunol.1003337; Giastas P, 2019, P NATL ACAD SCI USA, V116, P26709, DOI 10.1073/pnas.1912070116; Giastas P, 2019, ACS MED CHEM LETT, V10, P708, DOI 10.1021/acsmedchemlett.9b00002; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Goto Y, 2006, FEBS LETT, V580, P1833, DOI 10.1016/j.febslet.2006.02.041; Guasp P, 2016, ARTHRITIS RHEUMATOL, V68, P505, DOI 10.1002/art.39430; Hanson AL, 2018, ARTHRITIS RHEUMATOL, V70, P255, DOI 10.1002/art.40369; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Komov L, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700248; Kuiper JJW, 2018, HUM MOL GENET, V27, P4333, DOI 10.1093/hmg/ddy319; Kuiper JJW, 2014, HUM MOL GENET, V23, P6081, DOI 10.1093/hmg/ddu307; Liddle J, 2020, J MED CHEM, V63, P3348, DOI 10.1021/acs.jmedchem.9b02123; Lim YW, 2018, P NATL ACAD SCI USA, V115, pE11701, DOI 10.1073/pnas.1804506115; de Castro JAL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02463; de Castro JAL, 2016, MOL IMMUNOL, V77, P193, DOI 10.1016/j.molimm.2016.08.005; Lorente E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079596; Martin-Esteban A, 2014, J BIOL CHEM, V289, P3978, DOI 10.1074/jbc.M113.529610; Mpakali A, 2015, J BIOL CHEM, V290, P26021, DOI 10.1074/jbc.M115.685909; Nguyen TT, 2011, NAT STRUCT MOL BIOL, V18, P604, DOI 10.1038/nsmb.2021; Ombrello MJ, 2015, CURR OPIN RHEUMATOL, V27, P349, DOI 10.1097/BOR.0000000000000189; Papakyriakou A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00946; Reeves E, 2020, EXPERT OPIN THER TAR, V24, P535, DOI 10.1080/14728222.2020.1751821; Reeves E, 2019, CANCER IMMUNOL RES, V7, P1202, DOI 10.1158/2326-6066.CIR-18-0498; Reeves E, 2014, P NATL ACAD SCI USA, V111, P17594, DOI 10.1073/pnas.1408882111; Reeves E, 2013, J IMMUNOL, V191, P35, DOI 10.4049/jimmunol.1300598; Roberts AR, 2017, P NATL ACAD SCI USA, V114, P558, DOI 10.1073/pnas.1618856114; Robinson J, 2020, NUCLEIC ACIDS RES, V48, pD948, DOI 10.1093/nar/gkz950; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sanz-Bravo A, 2015, ARTHRITIS RHEUMATOL, V67, P692, DOI 10.1002/art.38980; Song PP, 2020, CLIN CHIM ACTA, V509, P280, DOI 10.1016/j.cca.2020.06.017; Stamogiannos A, 2017, BIOCHEMISTRY-US, V56, P1546, DOI 10.1021/acs.biochem.6b01170; Stamogiannos A, 2015, MOL IMMUNOL, V67, P426, DOI 10.1016/j.molimm.2015.07.010; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stratikos E, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27568; Su SL, 2012, J ORTHOP RES, V30, P9, DOI 10.1002/jor.21494; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Weimershaus M, 2013, CURR OPIN IMMUNOL, V25, P90, DOI 10.1016/j.coi.2012.10.001; Wordsworth BP, 2017, P NATL ACAD SCI USA, V114, pE1577, DOI 10.1073/pnas.1700287114; Zervoudi E, 2013, P NATL ACAD SCI USA, V110, P19890, DOI 10.1073/pnas.1309781110; Zervoudi E, 2011, BIOCHEM J, V435, P411, DOI 10.1042/BJ20102049	55	7	7	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100443	10.1016/j.jbc.2021.100443	http://dx.doi.org/10.1016/j.jbc.2021.100443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33617882	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400417
J	Mariotti, M; Rogowska-Wrzesinska, A; Hagglund, P; Davies, MJ				Mariotti, Michele; Rogowska-Wrzesinska, Adelina; Hagglund, Per; Davies, Michael J.			Cross-linking and modification of fibronectin by peroxynitrous acid: Mapping and quantification of damage provides a new model for domain interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOPEROXIDASE-DERIVED OXIDANTS; PLASMA FIBRONECTIN; EXTRACELLULAR-MATRIX; OXIDATIVE DAMAGE; AMINO-ACIDS; PROTEIN; BINDING; O,O'-DITYROSINE; GENERATION; NITRATION	Fibronectin (FN) is an abundant glycoprotein found in plasma and the extracellular matrix (ECM). It is present at high concentrations at sites of tissue damage, where it is exposed to oxidants generated by activated leukocytes, including peroxynitrous acid (ONOOH) formed from nitric oxide (from inducible nitric oxide synthase) and superoxide radicals (from NADPH oxidases and other sources). ONOOH reacts rapidly with the abundant tyrosine and tryptophan residues in ECM proteins, resulting in the formation of 3-nitrotyrosine, dityrosine, and 6-nitrotryptophan. We have shown previously that human plasma FN is readily modified by ONOOH, but the extent and location of modifications, and the role of FN structure (compact versus extended) in determining these factors is poorly understood. Here, we provide a detailed LC-MS analysis of ONOOH-induced FN modifications, including the extent of their formation and the sites of intramolecular and intermolecular cross-links, including Tyr-Tyr, Trp-Trp, and Tyr-Trp linkages. The localization of these cross-links to specific domains provides novel data on the interactions between different modules in the compact conformation of plasma FN and allows us to propose a model of its unknown quaternary structure. Interestingly, the pattern of modifications is significantly different to that generated by another inflammatory oxidant, HOCl, in both extent and sites. The characterization and quantification of these modifications offers the possibility of the use of these materials as specific biomarkers of ECM modification and turnover in the many pathologies associated with inflammation-associated fibrosis.	[Mariotti, Michele; Hagglund, Per; Davies, Michael J.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, Copenhagen, Denmark; [Rogowska-Wrzesinska, Adelina] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Rogowska-Wrzesinska, Adelina] Univ Southern Denmark, VILLUM Ctr Bioanalyt Sci, Odense, Denmark	University of Copenhagen; University of Southern Denmark; University of Southern Denmark	Hagglund, P; Davies, MJ (corresponding author), Univ Copenhagen, Panum Inst, Dept Biomed Sci, Copenhagen, Denmark.	pmh@sund.ku.dk; davies@sund.ku.dk	Davies, Michael/GWV-2527-2022; Davies, Michael J/H-4939-2011; Davies, Michael/AGX-9184-2022; Rogowska-Wrzesinska, Adelina/F-2888-2013	Davies, Michael J/0000-0002-5196-6919; Davies, Michael/0000-0002-5196-6919; Rogowska-Wrzesinska, Adelina/0000-0002-9876-0061; Hagglund, Per/0000-0002-6627-7518	Novo Nordisk Foundation [NNF13OC0004294]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The authors are grateful to the Novo Nordisk Foundation (Grant NNF13OC0004294 to M. J. D.) for financial support.	Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Ambesi A, 2014, J CELL SCI, V127, P3805, DOI 10.1242/jcs.150458; Baldus S, 2002, FREE RADICAL BIO MED, V33, P1010, DOI 10.1016/S0891-5849(02)00993-0; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Bhattacharjee S, 2001, ARCH BIOCHEM BIOPHYS, V395, P69, DOI 10.1006/abbi.2001.2557; BOHLE DS, 1994, J AM CHEM SOC, V116, P7423, DOI 10.1021/ja00095a062; Cai H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57299-6; Cao Y, 2015, CANCER LETT, V360, P141, DOI 10.1016/j.canlet.2015.01.041; Chuang CY, 2014, FREE RADICAL RES, V48, P970, DOI 10.3109/10715762.2014.920087; Chuang CY, 2014, BIOCHEM J, V459, P313, DOI 10.1042/BJ20131471; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Curtis MP, 2011, CHEM RES TOXICOL, V24, P418, DOI 10.1021/tx100380d; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; DAVIES MJ, 1985, BRIT HEART J, V53, P363; Degendorfer G, 2018, FREE RADICAL BIO MED, V115, P202, DOI 10.1016/j.freeradbiomed.2017.11.019; Degendorfer G, 2016, FREE RADICAL BIO MED, V97, P602, DOI 10.1016/j.freeradbiomed.2016.06.013; Degendorfer G, 2015, FREE RADICAL BIO MED, V89, P721, DOI 10.1016/j.freeradbiomed.2015.09.018; ERICKSON HP, 1983, J BIOL CHEM, V258, P4539; Ferrer-Sueta G, 2018, CHEM REV, V118, P462, DOI 10.1021/acs.chemrev.7b00568; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; Halliwell B., 2015, Free radicals in biology and medicine; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Leeuwenburgh C, 1999, FREE RADICAL BIO MED, V27, P186, DOI 10.1016/S0891-5849(99)00071-4; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Mariotti M, 2018, J PROTEOME RES, V17, P2017, DOI 10.1021/acs.jproteome.7b00881; Maurer LM, 2016, CRIT REV BIOCHEM MOL, V51, P213, DOI 10.1080/10409238.2016.1184224; Moore KJ, 2012, EMBO MOL MED, V4, P561, DOI 10.1002/emmm.201200238; Nybo T, 2018, REDOX BIOL, V19, P388, DOI 10.1016/j.redox.2018.09.005; Orhan H, 2005, J CHROMATOGR B, V827, P104, DOI 10.1016/j.jchromb.2005.03.043; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Pennathur S, 2016, AM J RESP CRIT CARE, V193, P861, DOI 10.1164/rccm.201505-0992OC; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Song KS, 2001, ATHEROSCLEROSIS, V154, P449, DOI 10.1016/S0021-9150(00)00490-1; STENMAN S, 1980, ACTA MED SCAND, P165; STENMAN S, 1978, J EXP MED, V147, P1054, DOI 10.1084/jem.147.4.1054; Teng N, 2017, REDOX REP, V22, P51, DOI 10.1080/13510002.2016.1256119; Theocharis AD, 2019, FEBS J, V286, P2830, DOI 10.1111/febs.14818; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Uppu RM, 1996, ANAL BIOCHEM, V236, P242, DOI 10.1006/abio.1996.0162; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Valiente-Alandi I, 2018, CIRCULATION, V138, P1236, DOI 10.1161/CIRCULATIONAHA.118.034609; Vanichkitrungruang S, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101641; Vanichkitrungruang S, 2019, FREE RADICAL BIO MED, V136, P118, DOI 10.1016/j.freeradbiomed.2019.04.003; Vavalle JP, 2007, J THROMB HAEMOST, V5, P864, DOI 10.1111/j.1538-7836.2007.02420.x; Walker EJ, 2019, P NATL ACAD SCI USA, V116, P6081, DOI 10.1073/pnas.1819851116; Walraven M, 2018, MATRIX BIOL, V71-72, P205, DOI 10.1016/j.matbio.2018.02.020; White ES, 2011, IUBMB LIFE, V63, P538, DOI 10.1002/iub.493; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; Zollinger AJ, 2017, MATRIX BIOL, V60-61, P27, DOI 10.1016/j.matbio.2016.07.011	64	6	6	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100360	10.1016/j.jbc.2021.100360	http://dx.doi.org/10.1016/j.jbc.2021.100360			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539924	gold, Green Published			2022-12-28	WOS:000672866400334
J	Muha, V; Authier, F; Szoke-Kovacs, Z; Johnson, S; Gallagher, J; McNeilly, A; McCrimmon, RJ; Teboul, L; van Aalten, DMF				Muha, Villo; Authier, Florence; Szoke-Kovacs, Zsombor; Johnson, Sara; Gallagher, Jennifer; McNeilly, Alison; McCrimmon, Rory J.; Teboul, Lydia; van Aalten, Daan M. F.			Loss of O-GlcNAcase catalytic activity leads to defects in mouse embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; PROTEIN MODIFICATION; DYNAMIC GLYCOSYLATION; IN-VITRO; GLCNACYLATION; TRANSFERASE; GENE; IDENTIFICATION; MECHANISM; NEURONS	O-GlcNAcylation is an essential post-translational modification that has been implicated in neurodevelopmental and neurodegenerative disorders. O-GlcNAcase (OGA), the sole enzyme catalyzing the removal of O-GlcNAc from proteins, has emerged as a potential drug target. OGA consists of an N-terminal OGA catalytic domain and a C-terminal pseudo histone acetyltransferase (HAT) domain with unknown function. To investigate phenotypes specific to loss of OGA catalytic activity and dissect the role of the HAT domain, we generated a constitutive knock-in mouse line, carrying a mutation of a catalytic aspartic acid to alanine. These mice showed perinatal lethality and abnormal embryonic growth with skewed Mendelian ratios after day E18.5. We observed tissue-specific changes in O-GlcNAc homeostasis regulation to compensate for loss of OGA activity. Using X-ray microcomputed tomography on late gestation embryos, we identified defects in the kidney, brain, liver, and stomach. Taken together, our data suggest that developmental defects during gestation may arise upon prolonged OGA inhibition specifically because of loss of OGA catalytic activity and independent of the function of the HAT domain.	[Muha, Villo; Authier, Florence; van Aalten, Daan M. F.] Univ Dundee, Sch Life Sci, Div Gene Regulat & Express, Dundee, Scotland; [Szoke-Kovacs, Zsombor; Johnson, Sara; Teboul, Lydia] MRC Harwell Inst, Mary Lyon Ctr, Didcot, Oxon, England; [Gallagher, Jennifer; McCrimmon, Rory J.] Univ Dundee, Div Mol & Clin Med, Dundee, Scotland; [McNeilly, Alison] Univ Dundee, Sch Med, Syst Med, Dundee, Scotland	University of Dundee; MRC Harwell; University of Dundee; University of Dundee	van Aalten, DMF (corresponding author), Univ Dundee, Sch Life Sci, Div Gene Regulat & Express, Dundee, Scotland.	dmfvanaalten@dundee.ac.uk		van Aalten, Daan/0000-0002-1499-6908; McCrimmon, Rory/0000-0002-3957-1981; McNeilly, Alison/0000-0003-4869-178X; Muha, Villo/0000-0003-4156-8463; Johnson, Sara/0000-0001-6308-6401	Wellcome Trust Investigator Award [110061]; MRC [MC_UP_1502/1] Funding Source: UKRI	Wellcome Trust Investigator Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Wellcome Trust Investigator Award (110061) to D. M. F. v. A.	Andres LM, 2017, ACS CHEM BIOL, V12, P2030, DOI 10.1021/acschembio.7b00232; Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173; Butkinaree C, 2008, J BIOL CHEM, V283, P23557, DOI 10.1074/jbc.M804116200; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Constable S, 2017, GLYCOBIOLOGY, V27, P927, DOI 10.1093/glycob/cwx055; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Fujita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052272; Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020; Gorelik A, 2019, NAT STRUCT MOL BIOL, V26, P1071, DOI 10.1038/s41594-019-0325-8; Hastings NB, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0181-0; He Y, 2014, ACTA CRYSTALLOGR D, V70, P186, DOI 10.1107/S1399004713029155; Hsieh YL, 2019, CELL REP, V29, P2134, DOI 10.1016/j.celrep.2019.10.053; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Ishihara K, 2010, BIOCHEM BIOPH RES CO, V398, P489, DOI 10.1016/j.bbrc.2010.06.105; Ishihara K, 2010, CEREB CORTEX, V20, P1131, DOI 10.1093/cercor/bhp176; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Keembiyehetty C, 2015, GENOM DATA, V5, P30, DOI 10.1016/j.gdata.2015.04.026; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kim EJ, 2006, CARBOHYD RES, V341, P971, DOI 10.1016/j.carres.2006.03.004; Kim G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11655-6; Kim HS, 2009, FEBS LETT, V583, P2474, DOI 10.1016/j.febslet.2009.06.052; Koschutzke L, 2015, CELL TISSUE RES, V361, P645, DOI 10.1007/s00441-015-2224-6; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lagerlof O, 2017, P NATL ACAD SCI USA, V114, P1684, DOI 10.1073/pnas.1621367114; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; Li J, 2016, ACS CHEM BIOL, V11, P3002, DOI 10.1021/acschembio.6b00678; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; Ma JF, 2013, EXPERT REV PROTEOMIC, V10, P365, DOI 10.1586/14789450.2013.820536; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Mariappa D, 2015, BIOCHEM J, V470, P255, DOI 10.1042/BJ20150610; Marotta NP, 2015, NAT CHEM, V7, P913, DOI [10.1038/NCHEM.2361, 10.1038/nchem.2361]; Mills JL, 2010, BIRTH DEFECTS RES A, V88, P769, DOI 10.1002/bdra.20757; Muha V, 2020, J BIOL CHEM, V295, P8636, DOI 10.1074/jbc.RA119.010312; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Olivier-Van Stichelen S, 2017, J BIOL CHEM, V292, P6076, DOI 10.1074/jbc.M116.774042; Pantaleon M, 2010, BIOL REPROD, V82, P751, DOI 10.1095/biolreprod.109.076661; Park SK, 2017, CELL REP, V20, P1088, DOI 10.1016/j.celrep.2017.07.017; Parween S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00415; Peng CM, 2017, MOL CELL, V68, P591, DOI 10.1016/j.molcel.2017.10.010; Peterson SB, 2016, CRIT REV BIOCHEM MOL, V51, P150, DOI 10.3109/10409238.2015.1135102; Pravata VM, 2020, EUR J HUM GENET, V28, P706, DOI 10.1038/s41431-020-0589-9; Pravata VM, 2020, FEBS LETT, V594, P717, DOI 10.1002/1873-3468.13640; Pravata VM, 2019, P NATL ACAD SCI USA, V116, P14961, DOI 10.1073/pnas.1900065116; Qian KV, 2018, J BIOL CHEM, V293, P13989, DOI 10.1074/jbc.RA118.004709; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Rao FV, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130021; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; RORABACHER DB, 1991, ANAL CHEM, V63, P139, DOI 10.1021/ac00002a010; Ryan P, 2019, ACS CHEM NEUROSCI, V10, P2209, DOI 10.1021/acschemneuro.9b00143; Sanchez RG, 2019, NEUROBIOL DIS, V124, P531, DOI 10.1016/j.nbd.2019.01.001; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Schimpl M, 2012, CHEM BIOL, V19, P173, DOI 10.1016/j.chembiol.2012.01.011; Schimpl M, 2010, BIOCHEM J, V432, P1, DOI 10.1042/BJ20101338; Schultz J, 2002, FEBS LETT, V529, P179, DOI 10.1016/S0014-5793(02)03322-7; Schwartz R, 2000, SEMIN PERINATOL, V24, P120, DOI 10.1053/sp.2000.6363; Shaffer LG, 2005, GENET MED, V7, P650, DOI 10.1097/01.gim.0000186545.83160.1e; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Skorobogatko Y, 2014, J BIOL CHEM, V289, P3602, DOI 10.1074/jbc.M113.512814; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Tan ZW, 2020, NUCLEIC ACIDS RES, V48, P5656, DOI 10.1093/nar/gkaa263; Tardio L, 2014, OSTEOARTHR CARTILAGE, V22, P259, DOI 10.1016/j.joca.2013.12.001; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Vaidyanathan K, 2017, J BIOL CHEM, V292, P8948, DOI 10.1074/jbc.M116.771030; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wang AC, 2016, P NATL ACAD SCI USA, V113, P15120, DOI 10.1073/pnas.1606899113; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024763; Wani WY, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0311-1; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Willems AP, 2017, J BIOL CHEM, V292, P12621, DOI 10.1074/jbc.M117.790097; Yanagisawa M, 2009, J NEUROSCI RES, V87, P3535, DOI 10.1002/jnr.22170; Yang YR, 2017, SCI REP-UK, V7, DOI 10.1038/srep44921; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Yuzwa SA, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-42; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zachara NE, 2012, AM J PHYSIOL-HEART C, V302, pH1905, DOI 10.1152/ajpheart.00445.2011; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206; Zhu YP, 2018, ACS CHEM NEUROSCI, V9, P1366, DOI 10.1021/acschemneuro.8b00015; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	93	16	16	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100439	10.1016/j.jbc.2021.100439	http://dx.doi.org/10.1016/j.jbc.2021.100439			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610549	Green Published, gold			2022-12-28	WOS:000672866400413
J	Nichols, JC; Schiffer, CA; Royer, WE				Nichols, Jeffry C.; Schiffer, Celia A.; Royer, William E., Jr.			NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COREPRESSOR CTBP; CELLULAR PHOSPHOPROTEIN; NEGATIVE MODULATION; DROSOPHILA CTBP; ADENOVIRUS E1A; CANCER; EXPRESSION; REPRESSOR; ACTIVATION; INHIBITOR	C-terminal binding proteins (CtBPs) are cotranscriptional factors that play key roles in cell fate. We have previously shown that NAD(H) promotes the assembly of similar tetramers from either human CtBP1 and CtBP2 and that CtBP2 tetramer destabilizing mutants are defective for oncogenic activity. To assist structure-based design efforts for compounds that disrupt CtBP tetramerization, it is essential to understand how NAD(H) triggers tetramer assembly. Here, we investigate the moieties within NAD(H) that are responsible for triggering tetramer formation. Using multiangle light scattering (MALS), we show that ADP is able to promote tetramer formation of both CtBP1 and CtBP2, whereas AMP promotes tetramer assembly of CtBP1, but not CtBP2. Other NAD(H) moieties that lack the adenosine phosphate, including adenosine and those incorporating nicotinamide, all fail to promote tetramer assembly. Our crystal structures of CtBP1 with AMP reveal participation of the adenosine phosphate in the tetrameric interface, pinpointing its central role in NAD(H)-linked assembly. CtBP1 and CtBP2 have overlapping but unique roles, suggesting that a detailed understanding of their unique structural properties might have utility in the design of paralog-specific inhibitors. We investigated the different responses to AMP through a series of site-directed mutants at 13 positions. These mutations reveal a central role for a hinge segment, which we term the 120s hinge that connects the substrate with coenzyme-binding domains and influences nucleotide binding and tetramer assembly. Our results provide insight into suitable pockets to explore in structure-based drug design to interfere with cotranscriptional activity of CtBP in cancer.	[Nichols, Jeffry C.; Schiffer, Celia A.; Royer, William E., Jr.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; [Nichols, Jeffry C.] Worcester State Univ, Chem Dept, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Massachusetts System of Public Higher Education; Worcester State University	Royer, WE (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.	William.Royer@umassmed.edu		Schiffer, Celia/0000-0003-2270-6613	National Institutes of Health (NIH) [R01 GM119014, S10 OD012028]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grant R01 GM119014 to W. E. R. The Rigaku CCD system used for X-ray diffraction data collection was obtained through NIH shared instrumentation grant S10 OD012028 to C. A. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balasubramanian P, 2003, FEBS LETT, V537, P157, DOI 10.1016/S0014-5793(03)00119-4; Barroilhet L, 2013, ONCOGENE, V32, P3896, DOI 10.1038/onc.2012.380; Bellesis AG, 2018, J BIOL CHEM, V293, P9101, DOI 10.1074/jbc.RA118.002514; Bergman LM, 2006, APOPTOSIS, V11, P879, DOI 10.1007/s10495-006-6651-4; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; Bi CL, 2018, BIOCHEM BIOPH RES CO, V495, P1980, DOI 10.1016/j.bbrc.2017.12.018; Birts CN, 2011, BIOL CELL, V103, P1, DOI 10.1042/BC20100067; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Chawla AT, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0163-x; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Cubillos-Rojas M, 2017, ONCOTARGET, V8, P61824, DOI 10.18632/oncotarget.18699; Dcona MM, 2017, CANCER BIOL THER, V18, P379, DOI 10.1080/15384047.2017.1323586; Deng H, 2013, J INVEST DERMATOL, V133, P1294, DOI 10.1038/jid.2012.487; Deng Y, 2012, MOL CARCINOGEN, V51, P500, DOI 10.1002/mc.20813; Di LJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2438; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Guan CQ, 2013, J CELL BIOCHEM, V114, P1343, DOI 10.1002/jcb.24475; Hilbert BJ, 2015, ACS CHEM BIOL, V10, P1118, DOI 10.1021/cb500820b; Hilbert BJ, 2014, FEBS LETT, V588, P1743, DOI 10.1016/j.febslet.2014.03.026; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Jecrois AM, 2021, STRUCTURE, V29, P310, DOI 10.1016/j.str.2020.11.008; Jin W, 2007, BIOCHEM PHARMACOL, V74, P851, DOI 10.1016/j.bcp.2007.06.017; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Madison DL, 2013, J BIOL CHEM, V288, P27836, DOI 10.1074/jbc.M113.493569; Mani-Telang P, 2007, FEBS LETT, V581, P5241, DOI 10.1016/j.febslet.2007.10.011; Mannervik M, 2014, EXP CELL RES, V321, P47, DOI 10.1016/j.yexcr.2013.10.010; Nadauld LD, 2006, J BIOL CHEM, V281, P37828, DOI 10.1074/jbc.M602119200; Nardini M, 2006, PROTEIN SCI, V15, P1042, DOI 10.1110/ps.062115406; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paliwal Seema, 2012, Genes Cancer, V3, P481, DOI 10.1177/1947601912463695; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; Ray SK, 2017, FEBS LETT, V591, P205, DOI 10.1002/1873-3468.12501; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Sumner ET, 2017, ONCOGENE, V36, P4810, DOI 10.1038/onc.2017.106; Thio SSC, 2004, NUCLEIC ACIDS RES, V32, P1836, DOI 10.1093/nar/gkh344; Van Holde K. E., 1971, PHYS BIOCH; Wang C, 2019, ONCOTARGETS THER, V12, P5189, DOI 10.2147/OTT.S203479; Wang R, 2012, NEOPLASIA, V14, P905, DOI 10.1593/neo.121192; Zhang YW, 2011, MOL CELL BIOL, V31, P375, DOI 10.1128/MCB.00772-10; Zheng X, 2015, ONCOTARGET, V6, P3752, DOI 10.18632/oncotarget.2915	49	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100351	10.1016/j.jbc.2021.100351	http://dx.doi.org/10.1016/j.jbc.2021.100351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524397	Green Published, gold			2022-12-28	WOS:000672866400325
J	Pinto, PR; Yoshinaga, MY; Del Bianco, V; Bochi, AP; Ferreira, GS; Pinto, IFD; Rodrigues, LG; Nakandakare, ER; Okamoto, MM; Machado, UF; Miyamoto, S; Catanozi, S; Passarelli, M				Pinto, Paula Ramos; Yoshinaga, Marcos Y.; Del Bianco, Vanessa; Bochi, Ana Paula; Ferreira, Guilherme S.; Pinto, Isabella F. D.; Rodrigues, Leticia G.; Nakandakare, Edna R.; Okamoto, Maristela M.; Machado, Ubiratan F.; Miyamoto, Sayuri; Catanozi, Sergio; Passarelli, Marisa			Dietary sodium restriction alters muscle lipidomics that relates to insulin resistance in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-SALT DIET; SKELETAL-MUSCLE; ANGIOTENSIN-II; CHLORIDE RESTRICTION; GLUCOSE-TRANSPORT; GENE-EXPRESSION; FATTY-ACIDS; ACCUMULATION; SENSITIVITY; LIPOPROTEIN	A low-sodium (LS) diet has been shown to reduce blood pressure (BP) and the incidence of cardiovascular diseases. However, severe dietary sodium restriction promotes insulin resistance (IR) and dyslipidemia in animal models and humans. Thus, further clarification of the long-term consequences of LS is needed. Here, we investigated the effects of chronic LS on gastrocnemius gene and protein expression and lipidomics and its association with IR and plasma lipids in LDL receptor knockout mice. Three-month-old male mice were fed a normal sodium diet (NS; 0.5% Na; n = 12-19) or LS (0.06% Na; n = 14-20) over 90 days. Body mass (BM), BP, plasma total cholesterol, triacylglycerol (TG), glucose, hematocrit, and IR were evaluated. LS increased BM (9%), plasma TG (51%), blood glucose (19%), and IR (46%) when compared with the NS. RT-qPCR analysis revealed that genes involved in lipid uptake and oxidation were increased by the LS: Fabp3 (106%), Prkaa1 (46%), and Cpt1 (74%). Genes and proteins (assessed by Western blotting) involved in insulin signaling were not changed by the LS. Similarly, lipid species classically involved in muscle IR, such as diacylglycerols and ceramides detected by ultra-high-performance liquid chromatography coupled to mass spectrometry, were also unchanged by LS. Species of phosphatidylcholines (68%), phosphatidylinositol (90%), and free fatty acids (59%) increased while cardiolipins (41%) and acylcarnitines (9%) decreased in gastrocnemius in response to LS and were associated with glucose disposal rate. Together these results suggest that chronic LS alters glycerophospholipid and fatty acids species in gastrocnemius that may contribute to glucose and lipid homeostasis derangements in mice.	[Pinto, Paula Ramos; Del Bianco, Vanessa; Bochi, Ana Paula; Ferreira, Guilherme S.; Rodrigues, Leticia G.; Nakandakare, Edna R.; Catanozi, Sergio; Passarelli, Marisa] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Lab Lipides LIM 10, Sao Paulo, Brazil; [Yoshinaga, Marcos Y.; Pinto, Isabella F. D.; Miyamoto, Sayuri] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Okamoto, Maristela M.; Machado, Ubiratan F.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Passarelli, Marisa] Univ Nove Julho, Programa Posgrad Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nove de Julho	Passarelli, M (corresponding author), Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Lab Lipides LIM 10, Sao Paulo, Brazil.; Passarelli, M (corresponding author), Univ Nove Julho, Programa Posgrad Med, Sao Paulo, Brazil.	m.passarelli@fm.usp.br	Nakandakare, Edna R/D-6625-2012; Passarelli, Marisa/C-8129-2012; Miyamoto, Sayuri/A-2144-2008; Yoshinaga, Marcos Y/J-4715-2012; Ferreira, Guilherme da Silva/I-6532-2015	Miyamoto, Sayuri/0000-0002-5714-8984; Yoshinaga, Marcos Y/0000-0002-5533-5348; Ferreira, Guilherme da Silva/0000-0001-7125-441X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP [15/21072-5, 2016/15603-0, 2013/07937-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank the financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP (grants #15/21072-5 toM. P. and 2016/15603-0 toM. P. and U. F. M. and 2013/07937-8 to S. M.), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)Finance Code 001 to P. R. P. and G. S. F. M. P., U. F. M., and S. M. are recipients of a research award from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil.	Aguer C., 2008, CELL METAB, V7, P45; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Brink M, 2001, ENDOCRINOLOGY, V142, P1489, DOI 10.1210/en.142.4.1489; Catanozi S, 2003, J LIPID RES, V44, P727, DOI 10.1194/jlr.M200330-JLR200; Catanozi S, 2001, ATHEROSCLEROSIS, V158, P81, DOI 10.1016/S0021-9150(01)00415-4; Chaves AB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48059-7; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Coelho MS, 2006, NUTR METAB CARDIOVAS, V16, P148, DOI 10.1016/j.numecd.2005.09.001; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; Csibi A., 2013, AM J PHYSIOL-RENAL, V304, pF505; Daniele G, 2014, DIABETES, V63, P2812, DOI 10.2337/db13-1130; Das S., 2016, TRENDS BIOCHEM SCI, V41, P261; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; Dean DJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE957, DOI 10.1152/ajpendo.1998.275.6.E957; Diamond-Stanic Maggie K., 2010, Archives of Physiology and Biochemistry, V116, P88, DOI 10.3109/13813451003758703; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Eum JY, 2020, J CHROMATOGR B, V1141, DOI 10.1016/j.jchromb.2020.122022; Fusco FB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177086; Garg R., 2010, PLOS ONE, V5; Goto-Inoue N, 2013, SCI REP-UK, V3, DOI 10.1038/srep03267; Graudal NA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub4; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Katayama IA, 2014, J NUTR, V144, P1571, DOI 10.3945/jn.114.192054; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; Lee S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24976-x; Levin MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1772, DOI 10.1152/ajpendo.00158.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mejia E. M., 2015, CELL METAB, V21, P868; Nagata S., 2017, J ENDOCRINOL, V232, P547; Nakandakare ER, 2008, ATHEROSCLEROSIS, V200, P410, DOI 10.1016/j.atherosclerosis.2007.12.034; Newsom SA, 2016, J APPL PHYSIOL, V120, P1355, DOI 10.1152/japplphysiol.00664.2015; Okamoto MM, 2004, AM J PHYSIOL-REG I, V286, pR779, DOI 10.1152/ajpregu.00396.2003; Paran C. W., 2018, NAT REV MOL CELL BIO, V19, P654; Prada PD, 2000, HYPERTENSION, V35, P424, DOI 10.1161/01.HYP.35.1.424; Prada PO, 2005, J ENDOCRINOL, V185, P429, DOI 10.1677/joe.1.06028; Sabio G, 2010, MOL CELL BIOL, V30, P106, DOI 10.1128/MCB.01162-09; Sanders PW, 2009, AM J PHYSIOL-RENAL, V297, pF237, DOI 10.1152/ajprenal.00027.2009; Shaikh SR, 2014, BIOCHEMISTRY-US, V53, P5589, DOI 10.1021/bi500868g; Shao W., 2010, PEPTIDES, V31, P889; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; STAMLER J, 1991, HYPERTENSION, V17, pI9, DOI 10.1161/01.HYP.17.1_Suppl.I9; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Yang Q, 2018, NAT REV MOL CELL BIO, V19, P654, DOI 10.1038/s41580-018-0044-8; Zabielski P, 2014, AM J PHYSIOL-ENDOC M, V306, pE529, DOI 10.1152/ajpendo.00610.2012	51	3	3	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100344	10.1016/j.jbc.2021.100344	http://dx.doi.org/10.1016/j.jbc.2021.100344			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524391	Green Published, gold			2022-12-28	WOS:000672866400318
J	Rayani, K; Seffernick, J; Li, AY; Davis, JP; Spuches, AM; Van Petegem, F; Solaro, RJ; Lindert, S; Tibbits, GF				Rayani, Kaveh; Seffernick, Justin; Li, Alison Yueh; Davis, Jonathan P.; Spuches, Anne Marie; Van Petegem, Filip; Solaro, R. John; Lindert, Steffen; Tibbits, Glen F.			Binding of calcium and magnesium to human cardiac troponin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKINNED MUSCLE-FIBERS; SR2&-ACTIVATED TENSION GENERATION; ISOTHERMAL TITRATION CALORIMETRY; SKELETAL-MUSCLE; EF-HAND; HEAT-CAPACITY; CA2+ BINDING; CA2+-BINDING PROPERTIES; CONTRACTILE ACTIVATION; STRUCTURAL TRANSITION	Cardiac muscle thin filaments are composed of actin, tropomyosin, and troponin that change conformation in response to Ca2+ binding, triggering muscle contraction. Human cardiac troponin C (cTnC) is the Ca2+-sensing component of the thin filament. It contains structural sites (III/IV) that bind both Ca2+ and Mg2+ and a regulatory site (II) that has been thought to bind only Ca2+. Binding of Ca2+ at this site initiates a series of conformational changes that culminate in force production. However, the mechanisms that underpin the regulation of binding at site II remain unclear. Here, we have quantified the interaction between site II and Ca2+/Mg2+ through isothermal titration calorimetry and thermodynamic integration simulations. Direct and competitive binding titrations with WT N-terminal cTnC and full-length cTnC indicate that physiologically relevant concentrations of both Ca2+/Mg2+ interacted with the same locus. Moreover, the D67A/D73A N-terminal cTnC construct in which two coordinating residues within site II were removed was found to have significantly reduced affinity for both cations. In addition, 1 mM Mg2+ caused a 1.4-fold lower affinity for Ca2+. These experiments strongly suggest that cytosolic-free Mg2+ occupies a significant population of the available site II. Interaction of Mg2+ with site II of cTnC likely has important functional consequences for the heart both at baseline as well as in diseased states that decrease or increase the availability of Mg2+, such as secondary hyper-parathyroidism or ischemia, respectively.	[Rayani, Kaveh; Li, Alison Yueh; Tibbits, Glen F.] Simon Fraser Univ, Mol Cardiac Physiol Grp, Burnaby, BC, Canada; [Seffernick, Justin; Lindert, Steffen] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Li, Alison Yueh; Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Davis, Jonathan P.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Spuches, Anne Marie] East Carolina Univ, Dept Chem, 300 Sci & Technol Bldg, Greenville, NC USA; [Solaro, R. John] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL USA; [Solaro, R. John] Univ Illinois, Coll Med, Ctr Cardiovasc Res, Chicago, IL USA; [Tibbits, Glen F.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada; [Tibbits, Glen F.] BC Childrens Hosp, Cardiac Grp, Res Inst, Vancouver, BC, Canada	Simon Fraser University; University System of Ohio; Ohio State University; University of British Columbia; University System of Ohio; Ohio State University; University of North Carolina; East Carolina University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Simon Fraser University; BC Childrens Hospital; University of British Columbia	Tibbits, GF (corresponding author), Simon Fraser Univ, Mol Cardiac Physiol Grp, Burnaby, BC, Canada.; Tibbits, GF (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada.; Tibbits, GF (corresponding author), BC Childrens Hosp, Cardiac Grp, Res Inst, Vancouver, BC, Canada.	tibbits@sfu.ca	Lindert, Steffen/K-3558-2013	Lindert, Steffen/0000-0002-3976-3473; Tibbits, Glen/0000-0002-2586-3115	Canadian Institutes of Health Research [PJT-148964]; National Sciences and Engineering Research Council Canada Graduate Scholarship-Doctoral fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council Canada Graduate Scholarship-Doctoral fellowship	This work was primarily supported by a grant from the Canadian Institutes of Health Research (PJT-148964) to G. F. T. K. R. was supported by the National Sciences and Engineering Research Council Canada Graduate Scholarship-Doctoral fellowship.	Allen K, 2000, J APPL PHYSIOL, V88, P180, DOI 10.1152/jappl.2000.88.1.180; ALLEN TS, 1992, BIOPHYS J, V61, P399, DOI 10.1016/S0006-3495(92)81846-5; Amano T, 2000, BRIT J PHARMACOL, V130, P731, DOI 10.1038/sj.bjp.0703361; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; ASHLEY CC, 1977, J PHYSIOL-LONDON, V270, P627, DOI 10.1113/jphysiol.1977.sp011972; Badr MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164222; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; BEST PM, 1977, J PHYSIOL-LONDON, V265, P1; Boresch S, 2003, J PHYS CHEM B, V107, P9535, DOI 10.1021/jp0217839; Bowman JD, 2018, J PHYS CHEM B, V122, P7874, DOI 10.1021/acs.jpcb.8b05435; Brini M, 2012, COMPR PHYSIOL, V2, P1045, DOI 10.1002/cphy.c110034; Carafoli E, 2016, J BIOL CHEM, V291, P20849, DOI 10.1074/jbc.R116.735894; Case, 2016, AMBER 2016 REFERENCE, P1, DOI DOI 10.13140/RG.2.2.27958.70729; Cates MS, 1999, STRUCTURE, V7, P1269, DOI 10.1016/S0969-2126(00)80060-X; Cefaratti C, 2007, MOL CELL BIOCHEM, V303, P63, DOI 10.1007/s11010-007-9456-z; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CHEUNG JY, 1989, AM J PHYSIOL, V256, pC1120, DOI 10.1152/ajpcell.1989.256.6.C1120; Dai LJ, 1997, KIDNEY INT, V51, P1008, DOI 10.1038/ki.1997.141; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Davis JP, 2002, J BIOL CHEM, V277, P49716, DOI 10.1074/jbc.M208488200; DeLano W.L, PYMOL MOL GRAPHICS S; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; DONALDSON SKB, 1975, J GEN PHYSIOL, V66, P427, DOI 10.1085/jgp.66.4.427; DONALDSON SKB, 1978, J GEN PHYSIOL, V71, P645, DOI 10.1085/jgp.71.6.645; Ebashi S, 1980, Mol Biol Biochem Biophys, V32, P183; EBASHI S, 1988, BIOPHYS CHEM, V29, P137, DOI 10.1016/0301-4622(88)87033-9; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; FABIATO A, 1975, J PHYSIOL-LONDON, V249, P497, DOI 10.1113/jphysiol.1975.sp011027; Fagan TE, 2001, AM J PHYSIOL-GASTR L, V280, pG1145, DOI 10.1152/ajpgi.2001.280.6.G1145; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Filatov VL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P969; FOLLENIUS A, 1984, BIOCHEM BIOPH RES CO, V119, P1154, DOI 10.1016/0006-291X(84)90896-9; FRANCOIS JM, 1993, J MUSCLE RES CELL M, V14, P585, DOI 10.1007/BF00141555; Fuchs F, 2011, BIOCHEM BIOPH RES CO, V408, P697, DOI 10.1016/j.bbrc.2011.04.092; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gilli R, 1998, BIOCHEMISTRY-US, V37, P5450, DOI 10.1021/bi972083a; Gillis TE, 2005, PHYSIOL GENOMICS, V22, P1, DOI 10.1152/physiolgenomics.00007.2005; Gillis TE, 2003, BIOCHEMISTRY-US, V42, P6418, DOI 10.1021/bi0340494; Gillis TE, 2003, AM J PHYSIOL-CELL PH, V284, pC1176, DOI 10.1152/ajpcell.00339.2002; Gillis TE, 2000, AM J PHYSIOL-REG I, V279, pR1707, DOI 10.1152/ajpregu.2000.279.5.R1707; GODT RE, 1974, J GEN PHYSIOL, V63, P722, DOI 10.1085/jgp.63.6.722; GODT RE, 1984, ADV EXP MED BIOL, V170, P569; GODT RE, 1982, J GEN PHYSIOL, V80, P279, DOI 10.1085/jgp.80.2.279; Grossoehme NE, 2010, J BIOL INORG CHEM, V15, P1183, DOI 10.1007/s00775-010-0693-3; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hazard AL, 1998, PROTEIN SCI, V7, P2451, DOI 10.1002/pro.5560071123; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; HONGO K, 1994, JPN J PHYSIOL, V44, P357, DOI 10.2170/jjphysiol.44.357; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Howarth Frank C., 1994, Magnesium Research, V7, P187; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; JOHNSON JD, 1979, J BIOL CHEM, V254, P3497; JOHNSON JD, 1994, J BIOL CHEM, V269, P8919; Johnson RA, 2019, BBA-PROTEINS PROTEOM, V1867, P359, DOI 10.1016/j.bbapap.2019.01.004; KAWASAKI Y, 1972, BIOCHEM BIOPH RES CO, V49, P898, DOI 10.1016/0006-291X(72)90297-5; KERRICK WGL, 1975, PFLUG ARCH EUR J PHY, V358, P195, DOI 10.1007/BF00587216; Kirschenlohr HL, 2000, BIOCHEM J, V346, P385, DOI 10.1042/0264-6021:3460385; KOHAMA K, 1980, J BIOCHEM, V88, P591, DOI 10.1093/oxfordjournals.jbchem.a133007; Kolte D, 2014, CARDIOL REV, V22, P182, DOI 10.1097/CRD.0000000000000003; KOMETANI K, 1983, BIOCHEM BIOPH RES CO, V114, P162, DOI 10.1016/0006-291X(83)91608-X; Laires MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P262, DOI 10.2741/1223; LEAVIS PC, 1978, ARCH BIOCHEM BIOPHYS, V186, P411, DOI 10.1016/0003-9861(78)90453-8; Leelananda SP, 2016, BEILSTEIN J ORG CHEM, V12, P2694, DOI 10.3762/bjoc.12.267; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Li AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079363; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; LI MX, 1995, BIOCHEMISTRY-US, V34, P8330, DOI 10.1021/bi00026a014; LI MX, 1994, BIOCHEMISTRY-US, V33, P917, DOI 10.1021/bi00170a010; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Malmendal A, 1999, BIOCHEMISTRY-US, V38, P11844, DOI 10.1021/bi9909288; MORIMOTO S, 1991, J BIOCHEM-TOKYO, V109, P120, DOI 10.1093/oxfordjournals.jbchem.a123331; Morsy MS, 2017, AM J MED SCI, V354, P335, DOI 10.1016/j.amjms.2017.02.008; MURRAY AC, 1972, BIOCHEMISTRY-US, V11, P2622, DOI 10.1021/bi00764a012; Nara M, 2013, BIOPOLYMERS, V99, P342, DOI 10.1002/bip.22176; OGAWA Y, 1985, J BIOCHEM-TOKYO, V97, P1011, DOI 10.1093/oxfordjournals.jbchem.a135143; PAN BS, 1987, J BIOL CHEM, V262, P7839; Panteva MT, 2015, J COMPUT CHEM, V36, P970, DOI 10.1002/jcc.23881; Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POTTER JD, 1975, J BIOL CHEM, V250, P4628; POTTER JD, 1981, FED PROC, V40, P2653; Ramos CHI, 1999, J BIOL CHEM, V274, P18189, DOI 10.1074/jbc.274.26.18189; REID RE, 1995, ARCH BIOCHEM BIOPHYS, V323, P115, DOI 10.1006/abbi.1995.0016; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Rocklin GJ, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4826261; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Sacco C, 2012, J BIOL INORG CHEM, V17, P531, DOI 10.1007/s00775-012-0874-3; Schober T, 2012, CIRC RES, V111, P170, DOI 10.1161/CIRCRESAHA.112.270041; SEAMON KB, 1977, BIOCHEMISTRY-US, V16, P4039, DOI 10.1021/bi00637a016; She MD, 1998, EUR J BIOCHEM, V252, P600, DOI 10.1046/j.1432-1327.1998.2520600.x; Shirts MR., 2010, DRUG DESIGN STRUCTUR, P61, DOI [10.1017/cbo9780511730412.007, DOI 10.1017/CBO9780511730412.007]; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Siddiqui JK, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00632; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Skowronsky RA, 2013, J BIOL INORG CHEM, V18, P49, DOI 10.1007/s00775-012-0948-2; Slupsky CM, 1995, BIOCHEMISTRY-US, V34, P15953, DOI 10.1021/bi00049a010; SMITH DW, 1977, J CHEM EDUC, V54, P540, DOI 10.1021/ed054p540; SOLARO RJ, 1976, CIRC RES, V39, P8, DOI 10.1161/01.RES.39.1.8; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Steinbrecher T, 2011, J COMPUT CHEM, V32, P3253, DOI 10.1002/jcc.21909; STEPHENSON DG, 1982, J PHYSIOL-LONDON, V333, P637, DOI 10.1113/jphysiol.1982.sp014473; Stevens CM, 2017, J BIOL CHEM, V292, P11915, DOI 10.1074/jbc.M116.770776; Stevens CM, 2016, BIOPHYS J, V111, P38, DOI 10.1016/j.bpj.2016.05.029; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; SUNDARALINGAM M, 1985, SCIENCE, V227, P945, DOI 10.1126/science.3969570; Tanaka H, 2013, FEBS LETT, V587, P2612, DOI 10.1016/j.febslet.2013.06.042; Tessman PA, 1998, AM J PHYSIOL-GASTR L, V275, pG1106, DOI 10.1152/ajpgi.1998.275.5.G1106; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2001, BIOCHEMISTRY-US, V40, P3348, DOI 10.1021/bi0021333; VANEERD JP, 1976, BIOCHEMISTRY-US, V15, P1171, DOI 10.1021/bi00650a033; VORMANN J, 1987, MAGNESIUM, V6, P220; Wang KQ, 2020, J PHYSIOL-LONDON, V598, P1169, DOI 10.1113/JP279307; Wang SQ, 1997, CRYOBIOLOGY, V35, P193, DOI 10.1006/cryo.1997.2040; Wilcox DE, 2008, INORG CHIM ACTA, V361, P857, DOI 10.1016/j.ica.2007.10.032; WNUK W, 1984, J BIOL CHEM, V259, P9017; Wolf FI, 1996, ARCH BIOCHEM BIOPHYS, V331, P194, DOI 10.1006/abbi.1996.0298; YAMADA K, 1982, J BIOCHEM-TOKYO, V92, P1505, DOI 10.1093/oxfordjournals.jbchem.a134075; YAMADA K, 1978, BIOCHIM BIOPHYS ACTA, V535, P342, DOI 10.1016/0005-2795(78)90100-9; Yamada K, 2003, ADV EXP MED BIOL, V538, P203; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yumoto F, 2001, EUR J BIOCHEM, V268, P6284, DOI 10.1046/j.1432-1327.2001.02583.x; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	130	7	8	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100350	10.1016/j.jbc.2021.100350	http://dx.doi.org/10.1016/j.jbc.2021.100350			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548225	gold, Green Published			2022-12-28	WOS:000672866400324
J	Roopnarine, O; Thomas, DD				Roopnarine, Osha; Thomas, David D.			Mechanistic analysis of actin-binding compounds that affect the kinetics of cardiac myosin-actin interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTROPHIC CARDIOMYOPATHY; ATPASE; SKELETAL; INHIBITION; DYNAMICS; SUBFRAGMENT-1; ISOMERIZATION; DISSOCIATION; ACTIVATION; NUCLEOTIDE	Actin-myosin mediated contractile forces are crucial for many cellular functions, including cell motility, cytokinesis, and muscle contraction. We determined the effects of ten actin-binding compounds on the interaction of cardiac myosin subfragment 1 (S1) with pyrene-labeled F-actin (PFA). These compounds, previously identified from a small-molecule high-throughput screen (HTS), perturb the structural dynamics of actin and the steady-state actin-activated myosin ATPase activity. However, the mechanisms underpinning these perturbations remain unclear. Here we further characterize them by measuring their effects on PFA fluorescence, which is decreased specifically by the strong binding of myosin to actin. We measured these effects under equilibrium and steady-state conditions, and under transient conditions, in stopped-flow experiments following addition of ATP to S1-bound PFA. We observed that these compounds affect early steps of the myosin ATPase cycle to different extents. They increased the association equilibrium constant K-1 for the formation of the strongly bound collision complex, indicating increased ATP affinity for actin-bound myosin, and decreased the rate constant k(+2) for subsequent isomerization to the weakly bound ternary complex, thus slowing the strong-to-weak transition that actin-myosin interaction undergoes early in the ATPase cycle. The compounds' effects on actin structure allosterically inhibit the kinetics of the actin-myosin interaction in ways that may be desirable for treatment of hypercontractile forms of cardiomyopathy. This work helps to elucidate the mechanisms of action for these compounds, several of which are currently used therapeutically, and sets the stage for future HTS campaigns that aim to discover new drugs for treatment of heart failure.	[Roopnarine, Osha; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Roopnarine, O (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	roopn001@umn.edu		Roopnarine, Osha/0000-0001-7609-0573; Thomas, David D./0000-0002-8822-2040	National Institutes of Health [R01AR032961, R37AG026160, R01AR052360]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health grants to D. D. T. (R01AR032961 and R37AG026160) and toO. R. (R01AR052360).The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamek Nancy, 2014, Exp Suppl, V105, P87, DOI 10.1007/978-3-0348-0856-9_5; Alsulami K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249599; Anderson RL, 2018, P NATL ACAD SCI USA, V115, pEB143, DOI 10.1073/pnas.1809540115; Bidaud-Meynard A, 2013, BIOCHEM J, V450, P55, DOI 10.1042/BJ20120572; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; Colson BA, 2016, P NATL ACAD SCI USA, V113, P3233, DOI 10.1073/pnas.1521281113; Colson BA, 2012, J MUSCLE RES CELL M, V33, P419, DOI 10.1007/s10974-012-9317-6; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Despond EA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00405; Thomas David D, 2002, Results Probl Cell Differ, V36, P7; Fumagalli C, 2020, CURR CARDIOL REP, V22, DOI 10.1007/s11886-020-1258-x; GEEVES MA, 1988, BIOCHEM J, V256, P41, DOI 10.1042/bj2560041; GEEVES MA, 1986, BIOCHEMISTRY-US, V25, P8454, DOI 10.1021/bi00374a020; Geeves MA, 2016, BIOPOLYMERS, V105, P483, DOI 10.1002/bip.22853; GOODNO CC, 1982, P NATL ACAD SCI-BIOL, V79, P21, DOI 10.1073/pnas.79.1.21; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Guhathakurta P, 2020, J BIOL CHEM, V295, P14100, DOI 10.1074/jbc.RA120.014445; Guhathakurta P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092628; Guhathakurta P, 2018, J BIOL CHEM, V293, P12288, DOI 10.1074/jbc.RA118.002702; Guhathakurta P, 2017, BIOPHYS J, V113, P91, DOI 10.1016/j.bpj.2017.05.027; Gunther LK, 2019, J BIOL CHEM, V294, P1554, DOI 10.1074/jbc.RA118.006128; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Kawas RF, 2017, J BIOL CHEM, V292, P16571, DOI 10.1074/jbc.M117.776815; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lee S. H., 2010, MOL CELLS, V29, P311, DOI DOI 10.1007/s10059-010-0053-8; Liu YY, 2015, BIOCHEMISTRY-US, V54, P1963, DOI 10.1021/bi5015166; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Mamidi R, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004257; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Marston S, 2019, J MUSCLE RES CELL M, V40, P69, DOI 10.1007/s10974-019-09526-w; Marston S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072020; Mijailovich SM, 2017, BIOPHYS J, V112, P984, DOI 10.1016/j.bpj.2017.01.021; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; ODONOGHUE SI, 1992, ARCH BIOCHEM BIOPHYS, V293, P110, DOI 10.1016/0003-9861(92)90372-4; Onishi H, 2006, P NATL ACAD SCI USA, V103, P6136, DOI 10.1073/pnas.0601595103; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Parker F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093371; Planelles-Herrero VJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00176-5; Prochniewicz E, 1996, J MOL BIOL, V255, P446, DOI 10.1006/jmbi.1996.0037; Prochniewicz E, 1997, BIOCHEMISTRY-US, V36, P12845, DOI 10.1021/bi971201r; Ring B, 2014, METHODS MOL BIOL, V1113, P37, DOI 10.1007/978-1-62703-758-7_4; Rohde JA, 2018, P NATL ACAD SCI USA, V115, pE7486, DOI 10.1073/pnas.1720342115; Rohde JA, 2017, P NATL ACAD SCI USA, V114, pE1796, DOI 10.1073/pnas.1611698114; Roopnarine O, 1996, BIOPHYS J, V70, P2795, DOI 10.1016/S0006-3495(96)79849-1; Savich Y, 2019, J GEN PHYSIOL, V151, P1007, DOI 10.1085/jgp.201812210; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; Sparrow AJ, 2020, AM J PHYSIOL-HEART C, V318, pH715, DOI 10.1152/ajpheart.00023.2020; Spudich JA, 2019, PFLUG ARCH EUR J PHY, V471, P701, DOI 10.1007/s00424-019-02259-2; Squire J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225715; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; UTILI R, 1977, GASTROENTEROLOGY, V72, P610; Vera CD, 2019, J BIOL CHEM, V294, P17451, DOI 10.1074/jbc.RA119.010563; Wang L, 2018, COMPR PHYSIOL, V8, P631, DOI 10.1002/cphy.c170023; Xu J, 2000, BIOPHYS J, V79, P1498, DOI 10.1016/S0006-3495(00)76401-0; Yotti R, 2019, ANNU REV GENOM HUM G, V20, P129, DOI 10.1146/annurev-genom-083118-015306	59	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100471	10.1016/j.jbc.2021.100471	http://dx.doi.org/10.1016/j.jbc.2021.100471			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639160	Green Published, gold			2022-12-28	WOS:000672866400445
J	Whitlock, JM; Chernomordik, LV				Whitlock, Jarred M.; Chernomordik, Leonid, V			Flagging fusion: Phosphatidylserine signaling in cell-cell fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ENVELOPED VIRUS ENTRY; PLASMA-MEMBRANE; PHOSPHOLIPID SCRAMBLASE; MYOBLAST FUSION; TRANSMEMBRANE PEPTIDES; TRANSBILAYER MOVEMENT; INTERCELLULAR FUSION; LIPID FLIPPASES; SURFACE-CHARGE; OUTER LEAFLET	Formations of myofibers, osteoclasts, syncytiotrophoblasts, and fertilized zygotes share a common step, cell-cell fusion. Recent years have brought about considerable progress in identifying some of the proteins involved in these and other cell-fusion processes. However, even for the best-characterized cell fusions, we still do not know the mechanisms that regulate the timing of cell-fusion events. Are they fully controlled by the expression of fusogenic proteins or do they also depend on some triggering signal that activates these proteins? The latter scenario would be analogous to the mechanisms that control the timing of exocytosis initiated by Ca2+ influx and virus-cell fusion initiated by low pH- or receptor interaction. Diverse cell fusions are accompanied by the nonapoptotic exposure of phosphatidylserine at the surface of fusing cells. Here we review data on the dependence of membrane remodeling in cell fusion on phosphatidylserine and phosphatidylserine-recognizing proteins and discuss the hypothesis that cell surface phosphatidylserine serves as a conserved "fuse me" signal regulating the time and place of cell-fusion processes.	[Whitlock, Jarred M.; Chernomordik, Leonid, V] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Membrane Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Chernomordik, LV (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Membrane Biol, NIH, Bethesda, MD 20892 USA.	chernoml@mail.nih.gov		Chernomordik, Leonid/0000-0001-7131-9244	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; Office of AIDS Research, National Institutes of Health	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of AIDS Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are indebted to the past and present members of our laboratory and to our collaborators in some of the studies discussed in this review for their invaluable contributions. We are also grateful to Kamran Melikov and Benjamin Podbilewicz for critically reading and commenting on the manuscript. The research in L.V.C.'s laboratory was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health and by the Office of AIDS Research, National Institutes of Health.	Ablan S, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-104; Acharya U, 2006, J CELL BIOL, V173, P69, DOI 10.1083/jcb.200506159; ADLER RR, 1995, BIOL REPROD, V53, P905, DOI 10.1095/biolreprod53.4.905; Adu-Gyamfi E, 2015, J VIROL, V89, P9440, DOI 10.1128/JVI.01087-15; Alvadia C, 2019, ELIFE, V8, DOI 10.7554/eLife.44365; Amatore C, 2006, CHEMBIOCHEM, V7, P1998, DOI 10.1002/cbic.200600194; Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; Anglin TC, 2009, J STRUCT BIOL, V168, P37, DOI 10.1016/j.jsb.2009.06.001; Ansari IUH, 2015, J BIOL CHEM, V290, P23110, DOI 10.1074/jbc.M115.655027; Arraud N, 2015, J THROMB HAEMOST, V13, P237, DOI 10.1111/jth.12767; Avalos-Rodriguez A, 2004, ARCH ANDROLOGY, V50, P273, DOI 10.1080/01485010490448741; Azab W, 2015, MBIO, V6, DOI 10.1128/mBio.01552-15; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Bello OD, 2018, P NATL ACAD SCI USA, V115, pE7624, DOI 10.1073/pnas.1808792115; Bethel NP, 2016, P NATL ACAD SCI USA, V113, P14049, DOI 10.1073/pnas.1607574113; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; BEVERS EM, 1982, EUR J BIOCHEM, V122, P429, DOI 10.1111/j.1432-1033.1982.tb05898.x; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; BITBOL M, 1987, BIOCHIM BIOPHYS ACTA, V904, P268, DOI 10.1016/0005-2736(87)90376-2; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; Blazek AD, 2015, PHYSIOLOGY, V30, P438, DOI 10.1152/physiol.00019.2015; Bleibaum F, 2019, J MOL CELL BIOL, V11, P979, DOI 10.1093/jmcb/mjz008; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e; Brukman NG, 2019, J CELL BIOL, V218, P1436, DOI 10.1083/jcb.201901017; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Carneiro FA, 2002, J VIROL, V76, P3756, DOI 10.1128/JVI.76.8.3756-3764.2002; Caruso S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01486; Chan KMC, 2020, ELIFE, V9, DOI 10.7554/eLife.51358; Chen A, 2008, J CELL SCI, V121, P3619, DOI 10.1242/jcs.032169; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 2006, J CELL BIOL, V175, P201, DOI 10.1083/jcb.200607083; Cheshenko N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006766; Chua BA, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0452-1; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; COCCIA PF, 1980, NEW ENGL J MED, V302, P701, DOI 10.1056/NEJM198003273021301; Coil DA, 2005, J VIROL, V79, P11496, DOI 10.1128/JVI.79.17.11496-11500.2005; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Compton AA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006099; COUTIFARIS C, 1991, DEVELOPMENT, V113, P767; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; Das M, 2004, PLACENTA, V25, P396, DOI 10.1016/j.placenta.2003.11.004; Degrelle SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42173; Del Vecchio K, 2018, J BIOENERG BIOMEMBR, V50, P1, DOI 10.1007/s10863-018-9745-0; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Di Simone N, 2001, BIOL REPROD, V65, P1766, DOI 10.1095/biolreprod65.6.1766; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Duncan R, 2019, ANNU REV VIROL, V6, P341, DOI 10.1146/annurev-virology-092818-015523; Elliott JI, 2006, BLOOD, V108, P1611, DOI 10.1182/blood-2005-11-012328; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Ernst OP, 2015, PHOTOCH PHOTOBIO SCI, V14, P1922, DOI 10.1039/c5pp00195a; Evans JP, 2020, TRENDS MICROBIOL, V28, P224, DOI 10.1016/j.tim.2019.10.004; FADOK VA, 1992, J IMMUNOL, V148, P2207; Faust JJ, 2019, MOL BIOL CELL, V30, P2254, DOI 10.1091/mbc.E19-01-0009; Fedry J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006357; Feng SJ, 2019, CELL REP, V28, P1385, DOI 10.1016/j.celrep.2019.07.052; Fischer A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16893-3; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Foltz SJ, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202007059; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Gamage DG, 2017, J BIOL CHEM, V292, P17272, DOI 10.1074/jbc.M117.811372; Gasman S, 2017, BIOL CELL, V109, P381, DOI 10.1111/boc.201700030; Gast CE, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7828; Gerbaud P, 2015, PLACENTA, V36, pS35, DOI 10.1016/j.placenta.2014.12.015; Golani G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20804-x; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Han TW, 2019, P NATL ACAD SCI USA, V116, P1309, DOI 10.1073/pnas.1817498116; Handwerger S, 2010, MOL CELL ENDOCRINOL, V323, P94, DOI 10.1016/j.mce.2009.12.015; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200; Herate C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145617; Hiraizumi M, 2019, SCIENCE, V365, P1149, DOI 10.1126/science.aay3353; Hisamoto N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05478-w; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Hui EF, 2011, NAT STRUCT MOL BIOL, V18, P813, DOI 10.1038/nsmb.2075; Huovila APJ, 1996, CURR OPIN CELL BIOL, V8, P692, DOI 10.1016/S0955-0674(96)80111-6; Irie A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46715; Janko C, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065006; Jiang T, 2017, ELIFE, V6, DOI 10.7554/eLife.28671; Kalienkova V, 2019, ELIFE, V8, DOI 10.7554/eLife.44364; KATSURAGAWA H, 1995, AM J OBSTET GYNECOL, V172, P1592, DOI 10.1016/0002-9378(95)90502-2; Kay JG, 2013, ADV EXP MED BIOL, V991, P177, DOI 10.1007/978-94-007-6331-9_10; Kim GW, 2017, FEBS J, V284, P3575, DOI 10.1111/febs.14261; Kim JH, 2019, J CELL SCI, V132, DOI 10.1242/jcs.213124; Ko KS, 2001, J CELL SCI, V114, P1155; Kodigepalli KM, 2015, FEBS LETT, V589, P3, DOI 10.1016/j.febslet.2014.11.036; Kol MA, 2003, BIOCHEMISTRY-US, V42, P231, DOI 10.1021/bi0268403; KORNBERG RD, 1971, BIOCHEMISTRY-US, V10, P1111; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lauwers E, 2016, NEURON, V90, P11, DOI 10.1016/j.neuron.2016.02.033; Leikina E, 2015, SCI REP-UK, V5, DOI 10.1038/srep18246; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Lemke G, 2017, TRENDS BIOCHEM SCI, V42, P738, DOI 10.1016/j.tibs.2017.06.004; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Levental KR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15203-1; Lin YC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14045-w; Liou AY, 2019, J BIOL CHEM, V294, P6809, DOI 10.1074/jbc.RA118.007270; Lopez-Marques RL, 2014, PFLUG ARCH EUR J PHY, V466, P1227, DOI 10.1007/s00424-013-1363-4; Lorent JH, 2020, NAT CHEM BIOL, V16, P644, DOI 10.1038/s41589-020-0529-6; Lu XY, 2018, CELL REP, V23, P3979, DOI 10.1016/j.celrep.2018.06.043; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MBALAVIELE G, 1995, J CLIN INVEST, V95, P2757, DOI 10.1172/JCI117979; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Middel V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12875; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Mirnikjoo B, 2009, J BIOL CHEM, V284, P22512, DOI 10.1074/jbc.C109.022913; Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009; Moon SY, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120597; Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Moya-Diaz J, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13417; Naeini MB, 2020, CELL MOL BIOL LETT, V25, DOI 10.1186/s11658-020-00214-z; Nagata S, 2020, CURR OPIN IMMUNOL, V62, P31, DOI 10.1016/j.coi.2019.11.009; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nanbo A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006848; Neumann B, 2019, PROG NEUROBIOL, V173, P88, DOI 10.1016/j.pneurobio.2018.11.004; Noubissi FK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091587; Ohmann A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04821-5; Okabe M, 2018, BIOL REPROD, V99, P134, DOI 10.1093/biolre/ioy028; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Ory S, 2013, J NEUROSCI, V33, P3545, DOI 10.1523/JNEUROSCI.3654-12.2013; Ousingsawat J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7245; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Ozawa M, 2015, BIOL OPEN, V4, P1427, DOI 10.1242/bio.013938; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; PAPAHADJOPOULOS D, 1974, BIOCHIM BIOPHYS ACTA, V352, P10, DOI 10.1016/0005-2736(74)90175-8; Park SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10871; Park SY, 2012, BIOCHEM BIOPH RES CO, V427, P705, DOI 10.1016/j.bbrc.2012.09.119; Paulino C, 2017, ELIFE, V6, DOI 10.7554/eLife.26232; Pereira M, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216267; Perez-Lara A, 2016, ELIFE, V5, DOI 10.7554/eLife.15886; Petersen OH, 2017, J PHYSIOL-LONDON, V595, P2999, DOI 10.1113/JP272772; Petrany MJ, 2019, TRENDS CELL BIOL, V29, P964, DOI 10.1016/j.tcb.2019.09.002; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; PORTIS A, 1979, BIOCHEMISTRY-US, V18, P780, DOI 10.1021/bi00572a007; Prideaux M, 2016, CURR OPIN PHARMACOL, V28, P24, DOI 10.1016/j.coph.2016.02.003; Richard JP, 2011, BIOCHEM J, V440, P185, DOI 10.1042/BJ20111243; Ridone Pietro, 2019, Biophys Rev, V11, P795, DOI 10.1007/s12551-019-00584-5; Rival CM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12406-z; Rosenbaum S, 2011, J BIOL CHEM, V286, P5708, DOI 10.1074/jbc.M110.193086; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Samsonov AV, 2002, J VIROL, V76, P12691, DOI 10.1128/JVI.76.24.12691-12702.2002; Schreiber R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114065; Schutters K, 2010, APOPTOSIS, V15, P1072, DOI 10.1007/s10495-010-0503-y; Scott-Hewitt N, 2020, EMBO J, V39, DOI 10.15252/embj.2020105380; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Segawa K, 2016, J BIOL CHEM, V291, P762, DOI 10.1074/jbc.M115.690727; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Sharma B, 2018, SEMIN CANCER BIOL, V52, P17, DOI 10.1016/j.semcancer.2017.08.012; Simonsen AC, 2020, CURR MED CHEM, V27, P3600, DOI 10.2174/0929867326666190121121143; Smrz D, 2007, J BIOL CHEM, V282, P10487, DOI 10.1074/jbc.M611090200; Smurova K, 2016, CELL REP, V14, P1517, DOI 10.1016/j.celrep.2016.01.027; Soe K, 2011, BONE, V48, P837, DOI 10.1016/j.bone.2010.11.011; Sommer A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11523; Soygur B, 2016, REPRODUCTION, V152, pR167, DOI 10.1530/REP-16-0031; Stauffer F, 2008, MOL MEMBR BIOL, V25, P128, DOI 10.1080/09687680701633091; Sumida GM, 2013, P NATL ACAD SCI USA, V110, P18958, DOI 10.1073/pnas.1311135110; Suzuki J, 2014, J BIOL CHEM, V289, P30257, DOI 10.1074/jbc.M114.583419; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Symons JL, 2021, SOFT MATTER, V17, P288, DOI 10.1039/d0sm00404a; Tait JF, 1999, J BIOL CHEM, V274, P3048, DOI 10.1074/jbc.274.5.3048; Takatsu H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01338-1; Tanguy E, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108026; Teoh JS, 2018, NEURAL REGEN RES, V13, P591, DOI 10.4103/1673-5374.230271; Tsuchiya M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04436-w; TURNER DC, 1976, DEV BIOL, V48, P258, DOI 10.1016/0012-1606(76)90090-7; Umashankar M, 2008, J VIROL, V82, P9245, DOI 10.1128/JVI.00975-08; Uygur B, 2019, MOL CANCER RES, V17, P806, DOI 10.1158/1541-7786.MCR-18-0500; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Varga K, 2020, J NEUROCHEM, V152, P48, DOI 10.1111/jnc.14886; Verma SK, 2018, J BIOL CHEM, V293, P254, DOI 10.1074/jbc.M117.809681; Verma SK, 2014, BIOCHEM J, V464, P293, DOI 10.1042/BJ20141233; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vincelette RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063122; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Vitalle J, 2019, EUR J IMMUNOL, V49, P364, DOI 10.1002/eji.201847951; Wei H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28363-4; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Whitlock JM, 2018, J GEN PHYSIOL, V150, P1498, DOI 10.1085/jgp.201812097; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Wielders SJH, 2009, THROMB HAEMOSTASIS, V102, P76, DOI 10.1160/TH08-11-0719; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Winsor J, 2018, J CELL BIOL, V217, P4184, DOI 10.1083/jcb.201805039; Wu N, 2020, CELL REP, V30, P1129, DOI 10.1016/j.celrep.2019.12.066; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Younan P, 2018, J INFECT DIS, V218, pS335, DOI 10.1093/infdis/jiy485; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901; Zaitseva E, 2017, CELL HOST MICROBE, V22, P99, DOI 10.1016/j.chom.2017.06.012; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zhang R., 2020, NAT CELL BIOL, P674; Zhang Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba0310; Zhang Z, 2010, BIOPHYS J, V98, P2524, DOI 10.1016/j.bpj.2010.02.043; Zhang Z, 2009, MOL BIOL CELL, V20, P5086, DOI 10.1091/mbc.E09-08-0691; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zigon P, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/975704	207	27	28	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100411	10.1016/j.jbc.2021.100411	http://dx.doi.org/10.1016/j.jbc.2021.100411			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581114	gold, Green Published			2022-12-28	WOS:000672866400385
J	Yoshimura, A; Asahina, Y; Chang, LY; Angata, T; Tanaka, H; Kitajima, K; Sato, C				Yoshimura, Atsushi; Asahina, Yuki; Chang, Lan-Yi; Angata, Takashi; Tanaka, Hiroshi; Kitajima, Ken; Sato, Chihiro			Identification and functional characterization of a Siglec-7 counter-receptor on K562 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING LECTIN; LEUKOSIALIN CD43; NUCLEOLIN; EXPRESSION; LIGANDS; CYTOTOXICITY; DIVERSITY; UNDERGOES; RESIDUES; TRIGGERS	Sialic acid (Sia)-binding immunoglobulin-like lectin 7 (Siglec-7) is an inhibitory receptor primarily expressed on natural killer (NK) cells and monocytes. Siglec-7 is known to negatively regulate the innate immune system through Sia binding to distinguish self and nonself; however, a counter-receptor bearing its natural ligand remains largely unclear. Here, we identified a counter-receptor of Siglec-7 using K562 hematopoietic carcinoma cells presenting cell surface ligands for Siglec-7. We affinity-purified the ligands using Fc-ligated recombinant Siglec-7 and diSia-dextran polymer, a strong inhibitor for Siglec-7. We then confirmed the counter-receptor for Siglec-7 as leukosialin (CD43) through mass spectrometry, immunoprecipitation, and proximity labeling. Additionally, we demonstrated that the cytotoxicity of NK cells toward K562 cells was suppressed by overexpression of leukosialin in a Siglec-7-dependent manner. Taken together, our data suggest that leukosialin on K562 is a counter-receptor for Siglec-7 on NK cells and that a cluster of the Sia-containing glycan epitope on leukosialin is key as trans-ligand for unmasking the cis-ligand.	[Yoshimura, Atsushi; Asahina, Yuki; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi, Japan; [Yoshimura, Atsushi; Asahina, Yuki; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Chang, Lan-Yi; Angata, Takashi] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Tanaka, Hiroshi] Tokyo Inst Technol, Dept Chem Sci & Engn, Meguro, Tokyo, Japan; [Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Integrated Glyco Biomed Res Ctr iGMed, Nagoya, Aichi, Japan; [Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Inst Glyco Core Res iGCORE, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Academia Sinica - Taiwan; Tokyo Institute of Technology; Nagoya University; Nagoya University	Sato, C (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi, Japan.; Sato, C (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan.; Sato, C (corresponding author), Nagoya Univ, Integrated Glyco Biomed Res Ctr iGMed, Nagoya, Aichi, Japan.; Sato, C (corresponding author), Nagoya Univ, Inst Glyco Core Res iGCORE, Nagoya, Aichi, Japan.	chi@agr.nagoya-u.ac.jp		Kitajima, Ken/0000-0002-8541-6798	Mizutani Foundation; Daiko Foundation; AMED [20ae0101069h0005]; Academia Sinica Thematic Project Grant [AS-TP-108-ML06]	Mizutani Foundation; Daiko Foundation(Daiko Foundation); AMED; Academia Sinica Thematic Project Grant	This work was supported by grants from the Mizutani Foundation (C. S.), Daiko Foundation (C. S.), and AMED (20ae0101069h0005) (C. S.). This work was also supported by Academia Sinica Thematic Project Grant (AS-TP-108-ML06) (T. A.).	Alphey MS, 2003, J BIOL CHEM, V278, P3372, DOI 10.1074/jbc.M210602200; Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; Angata T, 2000, GLYCOBIOLOGY, V10, P431, DOI 10.1093/glycob/10.4.431; Angata T, 2015, TRENDS PHARMACOL SCI, V36, P645, DOI 10.1016/j.tips.2015.06.008; Attrill H, 2006, J BIOL CHEM, V281, P32774, DOI 10.1074/jbc.M601714200; Carpentier M, 2005, BIOCHEMISTRY-US, V44, P5804, DOI 10.1021/bi047831s; Chang LY, 2017, J PROTEOME RES, V16, P3929, DOI 10.1021/acs.jproteome.7b00625; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Daly J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01047; DRAGONE LL, 1995, P NATL ACAD SCI USA, V92, P626, DOI 10.1073/pnas.92.2.626; Fernandes E, 2020, CANCERS, V12, DOI 10.3390/cancers12040861; FREEMAN SD, 1995, BLOOD, V85, P2005, DOI 10.1182/blood.V85.8.2005.bloodjournal8582005; FUKUDA M, 1991, Glycobiology, V1, P347, DOI 10.1093/glycob/1.4.347; Galzio R, 2012, J CELL BIOCHEM, V113, P571, DOI 10.1002/jcb.23381; Hane M, 2021, GLYCOBIOLOGY, V31, P231, DOI 10.1093/glycob/cwaa082; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; Hoja-Lukowicz D, 2014, CELL MOL BIOL LETT, V19, P461, DOI 10.2478/s11658-014-0206-4; Huang CH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041073; Hudak JE, 2014, NAT CHEM BIOL, V10, P69, DOI [10.1038/NCHEMBIO.1388, 10.1038/nchembio.1388]; Iwaki Y, 2020, BIOCHEM BIOPH RES CO, V523, P487, DOI 10.1016/j.bbrc.2019.12.079; Jandus C, 2014, J CLIN INVEST, V124, P1810, DOI 10.1172/JCI65899; Joo EJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33873-2; Kawasaki Y, 2010, GLYCOBIOLOGY, V20, P1373, DOI 10.1093/glycob/cwq116; Ma N, 2011, J CELL SCI, V124, P394, DOI 10.1242/jcs.063347; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Malaker SA, 2019, P NATL ACAD SCI USA, V116, P7278, DOI 10.1073/pnas.1813020116; Mambole AS, 2008, J BIOL CHEM, V283, P23627, DOI 10.1074/jbc.M710286200; Mitic N, 2012, DIS MARKERS, V32, P187, DOI [10.1155/2012/309203, 10.3233/DMA-2011-0872]; Miyazaki K, 2012, J IMMUNOL, V188, P4690, DOI 10.4049/jimmunol.1100605; Munday J, 2001, BIOCHEM J, V355, P489, DOI 10.1042/0264-6021:3550489; Narimatsu Y, 2019, MOL CELL, V75, P394, DOI 10.1016/j.molcel.2019.05.017; Nicoll G, 2003, EUR J IMMUNOL, V33, P1642, DOI 10.1002/eji.200323693; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Sato C, 2004, TRENDS GLYCOSCI GLYC, V16, P331, DOI 10.4052/tigg.16.331; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Sumida M, 2015, J BIOL CHEM, V290, P13202, DOI 10.1074/jbc.M115.638759; Tuccillo FM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/742831; van den Berg TK, 2001, J IMMUNOL, V166, P3637, DOI 10.4049/jimmunol.166.6.3637; Vijayan M, 2020, J CELL SCI, V133, DOI 10.1242/jcs.244400; Wisnovsky S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015024118; Wu HR, 2019, EUR J MED CHEM, V180, P627, DOI 10.1016/j.ejmech.2019.07.046; Xiao H, 2016, P NATL ACAD SCI USA, V113, P10304, DOI 10.1073/pnas.1608069113; Yamaguchi S, 2017, CHEMBIOCHEM, V18, P1194, DOI 10.1002/cbic.201600694; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200; Yamakawa N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64887-4; Yoshimura A, 2021, BIOCHEM BIOPH RES CO, V534, P1069, DOI 10.1016/j.bbrc.2020.10.023	50	10	10	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100477	10.1016/j.jbc.2021.100477	http://dx.doi.org/10.1016/j.jbc.2021.100477			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33640457	gold, Green Published			2022-12-28	WOS:000672866400451
J	Hayashi, I				Hayashi, Ikuko			The C-terminal region of the plasmid partitioning protein TubY is a tetramer that can bind membranes and DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TubZ; crystal structure; bacteria; plasmid partitioning; DNA segregation; segrosome; MerR; amphipathic helix; plasmid; DNA binding protein; cytoskeleton; plasmid partioning	TUBULIN HOMOLOG TUBZ; COMPLEXES; SEQUENCE; REVEAL; DOMAIN; PARM; MIND; P53; REPLICATION; STABILITY	Bacterial low-copy-number plasmids require partition (par) systems to ensure their stable inheritance by daughter cells. In general, these systems consist of three components: a centromeric DNA sequence, a centromere-binding protein and a nucleotide hydrolase that polymerizes and functions as a motor. Type III systems, however, segregate plasmids using three proteins: the FtsZ/tubulin-like GTPase TubZ, the centromere-binding protein TubR and the MerR-like transcriptional regulator TubY. Although the TubZ filament is sufficient to transport the TubR-centromere complex in vitro, TubY is still necessary for the stable maintenance of the plasmid. TubY contains an N-terminal DNA-binding helix-turn-helix motif and a C-terminal coiled-coil followed by a cluster of lysine residues. This study determined the crystal structure of the C-terminal domain of TubY from the Bacillus cereus pXO1-like plasmid and showed that it forms a tetrameric parallel four-helix bundle that differs from the typical MerR family proteins with a dimeric anti-parallel coiled-coil. Biochemical analyses revealed that the C-terminal tail with the conserved lysine cluster helps TubY to stably associate with the TubR-centromere complex as well as to nonspecifically bind DNA. Furthermore, this C-terminal tail forms an amphipathic helix in the presence of lipids but must oligomerize to localize the protein to the membrane in vivo. Taken together, these data suggest that TubY is a component of the nucleoprotein complex within the partitioning machinery, and that lipid membranes act as mediators of type III systems.	[Hayashi, Ikuko] Yokohama City Univ, Dept Med Life Sci, Yokohama, Kanagawa, Japan	Yokohama City University	Hayashi, I (corresponding author), Yokohama City Univ, Dept Med Life Sci, Yokohama, Kanagawa, Japan.	ihay@yokohama-cu.ac.jp		Hayashi, Ikuko/0000-0003-4784-8933	MEXT, Japan Society for the Promotion of Science (JSPS) [15H01326, 19K05774]	MEXT, Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by MEXT, Japan Society for the Promotion of Science (JSPS) Grants 15H01326 and 19K05774 (to I. H.).	Aylett CHS, 2012, P NATL ACAD SCI USA, V109, P16522, DOI 10.1073/pnas.1210899109; Baxter JC, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0023-2014; Bharat TAM, 2015, NATURE, V523, P106, DOI 10.1038/nature14356; Brooks AC, 2017, PLASMID, V91, P37, DOI 10.1016/j.plasmid.2017.03.004; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DAVIS MA, 1988, EMBO J, V7, P1881, DOI 10.1002/j.1460-2075.1988.tb03021.x; DeLano W.L, PYMOL MOL GRAPHICS S; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Duman R, 2013, P NATL ACAD SCI USA, V110, pE4601, DOI 10.1073/pnas.1313978110; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fink G, 2015, P NATL ACAD SCI USA, V112, pE1845, DOI 10.1073/pnas.1423746112; Friedler A, 2005, STRUCTURE, V13, P629, DOI 10.1016/j.str.2005.01.020; FUNNELL BE, 1988, P NATL ACAD SCI USA, V85, P6657, DOI 10.1073/pnas.85.18.6657; Gayathri P, 2012, SCIENCE, V338, P1334, DOI 10.1126/science.1229091; Ge Y, 2014, J BACTERIOL, V196, P4304, DOI 10.1128/JB.01855-14; Ge Y, 2014, MICROBIOL-SGM, V160, P1112, DOI 10.1099/mic.0.075465-0; Gimenez-Andres M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8030045; Hayashi I, 2018, J MOL BIOL, V430, P5015, DOI 10.1016/j.jmb.2018.11.001; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hofbauer HF, 2018, J CELL BIOL, V217, P3109, DOI 10.1083/jcb.201802027; Hoshino S, 2012, J BIOL CHEM, V287, P32103, DOI 10.1074/jbc.M112.373803; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Jain SS, 2008, NAT PROTOC, V3, P1092, DOI 10.1038/nprot.2008.72; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Laptenko O, 2016, TRENDS BIOCHEM SCI, V41, P1022, DOI 10.1016/j.tibs.2016.08.011; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Martin-Garcia B, 2018, NUCLEIC ACIDS RES, V46, P5704, DOI 10.1093/nar/gky370; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Montabana EA, 2014, P NATL ACAD SCI USA, V111, P3407, DOI 10.1073/pnas.1318339111; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Oliva MA, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00051; Oliva MA, 2012, P NATL ACAD SCI USA, V109, P7711, DOI 10.1073/pnas.1121546109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2015, GENE DEV, V29, P451, DOI 10.1101/gad.254714.114; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Tang MJ, 2006, APPL ENVIRON MICROB, V72, P6948, DOI 10.1128/AEM.00976-06; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vecchiarelli AG, 2014, P NATL ACAD SCI USA, V111, P4880, DOI 10.1073/pnas.1401025111	50	1	1	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17770	17780		10.1074/jbc.RA120.014705	http://dx.doi.org/10.1074/jbc.RA120.014705			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454013	Green Published, hybrid			2022-12-28	WOS:000603272300029
J	Tavasoli, M; Lahire, S; Reid, T; Brodovsky, M; McMaster, CR				Tavasoli, Mahtab; Lahire, Sarah; Reid, Taryn; Brodovsky, Maren; McMaster, Christopher R.			Genetic diseases of the Kennedy pathways for membrane synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						lipid; metabolism; genetic disease; inherited; membrane; phospholipid; phosphatidylcholine; phosphatidylethanolamine	CHOLINE KINASE BETA; CONGENITAL MUSCULAR-DYSTROPHY; CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; CAUSE SPONDYLOMETAPHYSEAL DYSPLASIA; RAT-LIVER CTP; ENDOPLASMIC-RETICULUM; NUCLEAR-LOCALIZATION; FATTY-ACID; CHKB GENE; PHOSPHATIDYLCHOLINE	The two branches of the Kennedy pathways (CDP-choline and CDP-ethanolamine) are the predominant pathways responsible for the synthesis of the most abundant phospholipids, phosphatidylcholine and phosphatidylethanolamine, respectively, in mammalian membranes. Recently, hereditary diseases associated with single gene mutations in the Kennedy pathways have been identified. Interestingly, genetic diseases within the same pathway vary greatly, ranging from muscular dystrophy to spastic paraplegia to a childhood blinding disorder to bone deformations. Indeed, different point mutations in the same gene (PCYT1; CCT alpha) result in at least three distinct diseases. In this review, we will summarize and review the genetic diseases associated with mutations in genes of the Kennedy pathway for phospholipid synthesis. These single-gene disorders provide insight, indeed direct genotype-phenotype relationships, into the biological functions of specific enzymes of the Kennedy pathway. We discuss potential mechanisms of how mutations within the same pathway can cause disparate disease.	[Tavasoli, Mahtab; Reid, Taryn; Brodovsky, Maren; McMaster, Christopher R.] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada; [Lahire, Sarah] Univ Reims, Reims, France	Dalhousie University; Universite de Reims Champagne-Ardenne	McMaster, CR (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada.	christopher.mcmaster@dal.ca		Lahire, Sarah/0000-0003-2482-6432; McMaster, Christopher/0000-0003-0822-5776	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Work on this topic was supported by the Canadian Institutes of Health Research.	Ahmed MY, 2017, BRAIN, V140, P547, DOI 10.1093/brain/aww318; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Cabrera-Serrano Macarena, 2015, Muscle Nerve, V51, P140, DOI 10.1002/mus.24446; Castro-Gago M, 2014, EUR J PAEDIATR NEURO, V18, P796, DOI 10.1016/j.ejpn.2014.06.005; Chan SHS, 2020, NEUROMUSCULAR DISORD, V30, P47, DOI 10.1016/j.nmd.2019.10.009; Chang CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154702; Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b; CORNELL R, 1989, J BIOL CHEM, V264, P9077; Cornell RB, 2019, J BIOL CHEM, V294, P1490, DOI 10.1074/jbc.RA118.006457; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dennis MK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201715; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Farooqui AA, 2001, NEUROSCIENTIST, V7, P232, DOI 10.1177/107385840100700308; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; GLASER PE, 1994, BIOCHEMISTRY-US, V33, P5805, DOI 10.1021/bi00185a019; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Henneberry AL, 2000, J BIOL CHEM, V275, P29808, DOI 10.1074/jbc.M005786200; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Hoover-Fong J, 2014, AM J HUM GENET, V94, P105, DOI 10.1016/j.ajhg.2013.11.018; Horibata Y, 2020, J LIPID RES, V61, P1221, DOI 10.1194/jlr.RA120000898; Horibata Y, 2018, J LIPID RES, V59, P1015, DOI 10.1194/jlr.P081620; ISHIDATE K, 1992, METHOD ENZYMOL, V209, P121; Jacquemyn J, 2017, EMBO REP, V18, P1905, DOI 10.15252/embr.201643426; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Kaiyrzhanov R., 2020, BRAIN; Kumaran N, 2017, BRIT J OPHTHALMOL, V101, P1147, DOI 10.1136/bjophthalmol-2016-309975; Lagace TA, 2005, MOL BIOL CELL, V16, P1120, DOI 10.1091/mbc.E04-10-0874; MacKinnon MA, 2009, J BIOL CHEM, V284, P7376, DOI 10.1074/jbc.M809117200; McMaster CR, 2018, FEBS LETT, V592, P1256, DOI 10.1002/1873-3468.12919; Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Oliveira J, 2015, J HUM GENET, V60, P305, DOI 10.1038/jhg.2015.20; Parrales A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122074; Payne F, 2014, P NATL ACAD SCI USA, V111, P8901, DOI 10.1073/pnas.1408523111; Pomorski T, 2001, SEMIN CELL DEV BIOL, V12, P139, DOI 10.1006/scdb.2000.0231; POST JA, 1995, AM J PHYSIOL-HEART C, V268, pH773, DOI 10.1152/ajpheart.1995.268.2.H773; Quinlivan R, 2013, NEUROMUSCULAR DISORD, V23, P549, DOI 10.1016/j.nmd.2013.04.002; Ridgway ND, 2013, CRIT REV BIOCHEM MOL, V48, P20, DOI 10.3109/10409238.2012.735643; Rios PG, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333; Sayed-Zahid AA, 2019, HUM MOL GENET, V28, P2635, DOI 10.1093/hmg/ddz068; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; SUNDLER R, 1975, BIOCHEM J, V146, P309, DOI 10.1042/bj1460309; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; Testa F, 2017, EUR J HUM GENET, V25, P651, DOI 10.1038/ejhg.2017.23; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Vaz FM, 2019, BRAIN, V142, P3382, DOI 10.1093/brain/awz291; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WANG Y, 1995, J BIOL CHEM, V270, P18948, DOI 10.1074/jbc.270.32.18948; WANG YL, 1993, J BIOL CHEM, V268, P5899; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1315, DOI 10.1152/ajpendo.00561.2011; Wu GS, 2009, BBA-MOL CELL BIOL L, V1791, P347, DOI 10.1016/j.bbalip.2009.02.006; Yamamoto GL, 2014, AM J HUM GENET, V94, P113, DOI 10.1016/j.ajhg.2013.11.022; YAO ZM, 1990, J BIOL CHEM, V265, P4326	61	13	13	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17877	17886		10.1074/jbc.REV120.013529	http://dx.doi.org/10.1074/jbc.REV120.013529			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454021	Green Published, hybrid			2022-12-28	WOS:000603272300037
J	Barklis, E; Alfadhli, A; Kyle, JE; Bramer, LM; Bloodsworth, KJ; Barklis, RL; Leier, HC; Petty, RM; Zelnik, ID; Metz, TO; Futerman, AH; Tafesse, FG				Barklis, Eric; Alfadhli, Ayna; Kyle, Jennifer E.; Bramer, Lisa M.; Bloodsworth, Kent J.; Barklis, Robin Lid; Leier, Hans C.; Petty, R. Max; Zelnik, Iris D.; Metz, Thomas O.; Futerman, Anthony H.; Tafesse, Fikadu G.			Ceramide synthase 2 deletion decreases the infectivity of HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEINS; OMICS ANALYSIS; CELL-LINES; TYPE-1; MEMBRANE; CHOLESTEROL; INHIBITION; CD4; REPLICATION	The lipid composition of HIV-1 virions is enriched in sphingomyelin (SM), but the roles that SM or other sphingolipids (SLs) might play in the HIV-1 replication pathway have not been elucidated. In human cells, SL levels are regulated by ceramide synthase (CerS) enzymes that produce ceramides, which can be converted to SMs, hexosylceramides, and other SLs. In many cell types, CerS2, which catalyzes the synthesis of very long chain ceramides, is the major CerS. We have examined how CerS2 deficiency affects the assembly and infectivity of HIV-1. As expected, we observed that very long chain ceramide, hexosylceramide, and SM were reduced in CerS2 knockout cells. CerS2 deficiency did not affect HIV-1 assembly or the incorporation of the HIV-1 envelope (Env) protein into virus particles, but it reduced the infectivites of viruses produced in the CerS2-deficient cells. The reduced viral infection levels were dependent on HIV-1 Env, since HIV-1 particles that were pseudotyped with the vesicular stomatitis virus glycoprotein did not exhibit reductions in infectivity. Moreover, cell-cell fusion assays demonstrated that the functional defect of HIV-1 Env in CerS2-deficient cells was independent of other viral proteins. Overall, our results indicate that the altered lipid composition of CerS2-deficient cells specifically inhibit the HIV-1 Env receptor binding and/or fusion processes.	[Barklis, Eric; Alfadhli, Ayna; Barklis, Robin Lid; Leier, Hans C.; Petty, R. Max; Tafesse, Fikadu G.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Kyle, Jennifer E.; Bloodsworth, Kent J.; Metz, Thomas O.] Pacific Northwest Natl Lab, Biol Sci Div, Earth & Biol Sci Directorate, Richland, WA 99352 USA; [Bramer, Lisa M.] Natl Secur Directorate PNNL, Comp & Analyt Div, Richland, WA USA; [Zelnik, Iris D.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel	Oregon Health & Science University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Weizmann Institute of Science	Barklis, E; Tafesse, FG (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	barklis@ohsu.edu; tafesse@ohsu.edu	Bramer, Lisa/L-9184-2016; Leier, Hans Christian/CAJ-3082-2022; Leier, Hans Christian/ABI-4923-2020	Bramer, Lisa/0000-0002-8384-1926; Leier, Hans Christian/0000-0002-0363-1444; Tafesse, Fikadu/0000-0002-8575-4164; Metz, Tom/0000-0001-6049-3968	Medial Research Foundation of Oregon; National Institutes of Health (NIH) [R01 AI152579]; Collins Medical Trust; NIH [R21AI133631, 1R01 AI141549]; Oregon Health & Sciences University Department of Molecular Microbiology and Immunology seed grant; NIH, National Institute of Environmental Health Sciences [U2CES030170]; US Department of Energy; Department of Energy [DE-AC05 76RLO 1830]	Medial Research Foundation of Oregon; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collins Medical Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health & Sciences University Department of Molecular Microbiology and Immunology seed grant; NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Department of Energy(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE))	E. B. gratefully acknowledges support from the Medial Research Foundation of Oregon and from the National Institutes of Health (NIH; R01 AI152579). F. T. was supported by the Collins Medical Trust and NIH grants R21AI133631 and 1R01 AI141549. E. B. and F. T. also are grateful for an Oregon Health & Sciences University Department of Molecular Microbiology and Immunology seed grant to initiate this work. Additional support was provided by the NIH, National Institute of Environmental Health Sciences grant U2CES030170. The content in this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Lipidomics analyses were performed in the Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by the US Department of Energy and located at the Pacific Northwest National Laboratory in Richmond, WA. Pacific Northwest National Laboratory is a multiprogram national laboratory operated by Battelle for the Department of Energy under contract DE-AC05 76RLO 1830.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Alfadhli A, 2013, J BIOL CHEM, V288, P666, DOI 10.1074/jbc.M112.399865; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Barklis E, 2018, VIROLOGY, V518, P264, DOI 10.1016/j.virol.2018.03.004; Bhattacharya J, 2006, J VIROL, V80, P5292, DOI 10.1128/JVI.01469-05; Bowden JA, 2017, J LIPID RES, V58, P2275, DOI 10.1194/jlr.M079012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brovkovych V, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800370; Brown EL, 2003, VIROLOGY, V310, P343, DOI 10.1016/S0042-6822(03)00165-X; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Brun S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-57; Burnum-Johnson KE, 2017, ANALYST, V142, P442, DOI [10.1039/C6AN02486F, 10.1039/c6an02486f]; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chauhan G, 2017, BIOTECHNOL PROGR, V33, P795, DOI 10.1002/btpr.2441; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; CHEN JK, 1986, EXP CELL RES, V163, P117, DOI 10.1016/0014-4827(86)90563-X; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dautel SE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40555; De Livera AM, 2012, ANAL CHEM, V84, P10768, DOI 10.1021/ac302748b; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eisfeld AJ, 2017, CELL HOST MICROBE, V22, P817, DOI 10.1016/j.chom.2017.10.011; Feng SH, 2019, CHEM SCI, V10, P2253, DOI 10.1039/c8sc03614d; Finnegan CM, 2007, J VIROL, V81, P5294, DOI 10.1128/JVI.02553-06; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; Frank JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8118; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003; Harayama T., 2020, ESTABLISHMENT HIGHLY, DOI [10.1101/2020.11.24, DOI 10.1101/2020.11.24]; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001315; Joglekar AV, 2017, HUM GENE THER METHOD, V28, P291, DOI 10.1089/hgtb.2017.084; Johnson MC, 2011, AIDS RES HUM RETROV, V27, P239, DOI 10.1089/AID.2010.0350; JONES TA, 1990, J VIROL, V64, P2265, DOI 10.1128/JVI.64.5.2265-2279.1990; Kim IS, 2017, P NATL ACAD SCI USA, V114, pE28, DOI 10.1073/pnas.1618883114; Kyle JE, 2019, P NATL ACAD SCI USA, V116, P3919, DOI 10.1073/pnas.1815356116; Kyle JE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31640-x; Kyle JE, 2017, BIOINFORMATICS, V33, P1744, DOI 10.1093/bioinformatics/btx046; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Leier HC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17433-9; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lopez CS, 2014, VIROLOGY, V462, P126, DOI 10.1016/j.virol.2014.05.019; Lorizate M, 2013, CELL MICROBIOL, V15, P292, DOI 10.1111/cmi.12101; Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820; Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256; Lyles D, 2007, FIELDS VIROLOGY, P1364; Ma XC, 2018, ELIFE, V7, DOI 10.7554/eLife.34271; Matzke MM, 2011, BIOINFORMATICS, V27, P2866, DOI 10.1093/bioinformatics/btr479; Mucksch F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53939-z; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nieto-Garai JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01983; Noviello CM, 2011, J VIROL, V85, P4730, DOI 10.1128/JVI.00099-11; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Patil A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-3; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Puri A, 2004, AIDS, V18, P849, DOI 10.1097/00002030-200404090-00002; Riley RT, 2019, J LIPID RES, V60, P1183, DOI 10.1194/jlr.S093815; Ritchie C, 2017, CANCER GENOM PROTEOM, V14, P225, DOI 10.21873/cgp.20034; Ritchie C, 2015, J VIROL, V89, P3988, DOI 10.1128/JVI.03584-14; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Salimi H, 2020, J BIOL CHEM, V295, P348, DOI 10.1074/jbc.RA119.009481; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sorensen CM, 2010, CLIN BIOCHEM, V43, P948, DOI 10.1016/j.clinbiochem.2010.04.075; Staubus AO, 2019, VIROLOGY, V538, P1, DOI 10.1016/j.virol.2019.09.008; SULLIVAN N, 1995, J VIROL, V69, P4413, DOI 10.1128/JVI.69.7.4413-4422.1995; Swanstrom R., 1997, P263; t'kindt R, 2015, ANAL CHEM, V87, P4957, DOI 10.1021/acs.analchem.5b00732; Telenga ED, 2014, AM J RESP CRIT CARE, V190, P155, DOI 10.1164/rccm.201312-2210OC; Tidhar R, 2018, J BIOL CHEM, V293, P9912, DOI 10.1074/jbc.RA118.001936; Tisoncik-Go J, 2016, CELL HOST MICROBE, V19, P254, DOI 10.1016/j.chom.2016.01.002; Valsecchi M, 2007, J LIPID RES, V48, P417, DOI 10.1194/jlr.M600344-JLR200; Verlekar D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0964-4; Waheed AA, 2007, P NATL ACAD SCI USA, V104, P8467, DOI 10.1073/pnas.0701443104; Waheed AA, 2006, J BIOL CHEM, V281, P28699, DOI 10.1074/jbc.M603609200; Waheed AA, 2010, J VIROL, V84, P3121, DOI 10.1128/JVI.02002-09; Wang Pei, 2006, Pac Symp Biocomput, P315; Wattenberg BW, 2018, J BIOL CHEM, V293, P9922, DOI 10.1074/jbc.H118.003522; Webb-Robertson BJM, 2011, PROTEOMICS, V11, P4736, DOI 10.1002/pmic.201100078; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	94	4	4	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100340	10.1016/j.jbc.2021.100340	http://dx.doi.org/10.1016/j.jbc.2021.100340			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33515546	gold, Green Published			2022-12-28	WOS:000672866400314
J	Bukiya, AN; Leo, MD; Jaggar, JH; Dopico, AM				Bukiya, Anna N.; Leo, M. Dennis; Jaggar, Jonathan H.; Dopico, Alex M.			Cholesterol activates BK channels by increasing KCNMB1 protein levels in the plasmalemma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; MEMBRANE CHOLESTEROL; BETA-1 SUBUNIT; CALCIUM; KINETICS; COMPLEX; VASOCONSTRICTION; ORGANIZATION; SPECIFICITY	Calcium-/voltage-gated, large-conductance potassium channels (BKs) control critical physiological processes, including smooth muscle contraction. Numerous observations concur that elevated membrane cholesterol (CLR) inhibits the activity of homomeric BKs consisting of channel-forming alpha subunits. In mammalian smooth muscle, however, native BKs include accessory KCNMB1 (beta(1)) subunits, which enable BK activation at physiological intracellular calcium. Here, we studied the effect of CLR enrichment on BK currents from rat cerebral artery myocytes. Using inside-out patches from middle cerebral artery (MCA) myocytes at [Ca2+](free)=30 mu M, we detected BK activation in response to in vivo and in vitro CLR enrichment of myocytes. While a significant increase in myocyte CLR was achieved within 5 min of CLR in vitro loading, this brief CLR enrichment of membrane patches decreased BK currents, indicating that BK activation by CLR requires a protracted cellular process. Indeed, blocking intracellular protein trafficking with brefeldin A (BFA) not only prevented BK activation but led to channel inhibition upon CLR enrichment. Surface protein biotinylation followed by Western blotting showed that BFA blocked the increase in plasmalemmal KCNMB1 levels achieved via CLR enrichment. Moreover, CLR enrichment of arteries with naturally high KCNMB1 levels, such as basilar and coronary arteries, failed to activate BK currents. Finally, CLR enrichment failed to activate BK channels in MCA myocytes from KCNMB1(-/-) mouse while activation was detected in their wild-type (C57BL/6) counterparts. In conclusion, the switch in CLR regulation of BK from inhibition to activation is determined by a trafficking-dependent increase in membrane levels of KCNMB1 subunits.	[Bukiya, Anna N.; Dopico, Alex M.] Univ Tennessee, Coll Med, Dept Pharmacol Addict Sci & Toxicol, Hlth Sci Ctr, Memphis, TN 38163 USA; [Leo, M. Dennis; Jaggar, Jonathan H.] Univ Tennessee, Coll Med, Dept Physiol, Hlth Sci Ctr, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Bukiya, AN; Dopico, AM (corresponding author), Univ Tennessee, Coll Med, Dept Pharmacol Addict Sci & Toxicol, Hlth Sci Ctr, Memphis, TN 38163 USA.	abukiya@uthsc.edu; adopico@uthsc.edu			NIH [AA023764, HL147315, HL148941, HL133256, HL137745]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants AA023764 (A. B.), HL147315 (A. D.), HL148941 (A. B. and A. D.), HL133256, and HL137745 (J. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babiychuk EB, 2004, J MEMBRANE BIOL, V198, P95, DOI 10.1007/s00232-004-0663-1; Bailey CS, 2019, J GEN PHYSIOL, V151, P1173, DOI 10.1085/jgp.201912457; Bentzen BH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00389; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; BREGESTOVSKI PD, 1989, BIOMED BIOCHIM ACTA, V48, pS382; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Budiyanto M., 2019, J PHYS C SER, V1417; Bukiya A., 2017, ADDICTIVE SUBSTANCES, P355; Bukiya A, 2014, ALCOHOL CLIN EXP RES, V38, P1216, DOI 10.1111/acer.12373; Bukiya AN, 2008, FEBS LETT, V582, P673, DOI 10.1016/j.febslet.2008.01.036; Bukiya AN, 2011, ARTERIOSCL THROM VAS, V31, P2410, DOI 10.1161/ATVBAHA.111.233965; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Bukiya AN, 2009, FEBS LETT, V583, P2779, DOI 10.1016/j.febslet.2009.07.019; Choubey A, 2013, BIOPHYS J, V104, P2429, DOI 10.1016/j.bpj.2013.04.036; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; DiChiara TJ, 1997, J NEUROSCI, V17, P4942; Dopico AM, 2012, PHARMACOL THERAPEUT, V135, P133, DOI 10.1016/j.pharmthera.2012.05.002; Dopico AM, 2018, PFLUG ARCH EUR J PHY, V470, P1271, DOI 10.1007/s00424-018-2151-y; Evanson KW, 2014, CIRC RES, V115, P423, DOI 10.1161/CIRCRESAHA.115.303407; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Geng YY, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00532; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Gonzalez-Perez V, 2019, ANNU REV PHYSIOL, V81, P113, DOI 10.1146/annurev-physiol-022516-034038; Gu RX, 2019, J CHEM THEORY COMPUT, V15, P2064, DOI 10.1021/acs.jctc.8b00933; Hamilton JA, 2003, CURR OPIN LIPIDOL, V14, P263, DOI 10.1097/00041433-200306000-00006; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; JAGANNATHAN SN, 1974, J CLIN INVEST, V54, P366, DOI 10.1172/JCI107772; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Jiang QX, 2019, ADV EXP MED BIOL, V1115, P167, DOI 10.1007/978-3-030-04278-3_8; Kuntamallappanavar G, 2017, PFLUG ARCH EUR J PHY, V469, P263, DOI 10.1007/s00424-016-1929-z; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; Lange Y, 2016, CHEM PHYS LIPIDS, V199, P74, DOI 10.1016/j.chemphyslip.2016.02.003; Latorre R, 2017, PHYSIOL REV, V97, P39, DOI 10.1152/physrev.00001.2016; Leo MD, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah5417; Leo MD, 2015, AM J PHYSIOL-CELL PH, V309, pC392, DOI 10.1152/ajpcell.00127.2015; Leo MD, 2014, P NATL ACAD SCI USA, V111, P2361, DOI 10.1073/pnas.1317527111; Lin MW, 2006, CHINESE J PHYSIOL, V49, P1; Lippincott-Schwartz J, 2010, ANNU REV BIOPHYS, V39, P559, DOI 10.1146/annurev.biophys.093008.131357; MIETTINEN M, 1994, MODERN PATHOL, V7, P82; North K, 2018, J PHARMACOL EXP THER, V367, P234, DOI 10.1124/jpet.118.250514; Ogasawara F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39973-x; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Palacio S, 2015, ALCOHOL CLIN EXP RES, V39, P1619, DOI 10.1111/acer.12808; Perez GJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1769, DOI 10.1152/ajpcell.2001.281.6.C1769; Prendergast C, 2010, CELL CALCIUM, V47, P84, DOI 10.1016/j.ceca.2009.11.009; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Purcell EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026289; Ridsdale A, 2006, MOL BIOL CELL, V17, P1593, DOI 10.1091/mbc.E05-02-0100; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Silberberg SD, 1996, BIOPHYS J, V70, P2640, DOI 10.1016/S0006-3495(96)79833-8; Singh AK, 2012, J BIOL CHEM, V287, P20509, DOI 10.1074/jbc.M112.356261; Slayden A, 2020, JOVE-J VIS EXP, DOI 10.3791/60734; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Tajima N, 2011, J BIOL CHEM, V286, P5624, DOI 10.1074/jbc.M110.149898; Talukder G, 2000, BIOPHYS J, V78, P761, DOI 10.1016/S0006-3495(00)76634-3; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Wen DH, 2013, AM J PHYSIOL-RENAL, V305, pF463, DOI 10.1152/ajprenal.00171.2013; Wiecha J, 1997, BASIC RES CARDIOL, V92, P233, DOI 10.1007/BF00788518; Yuan CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027572; Zhai X, 2017, CIRC RES, V121, P650, DOI 10.1161/CIRCRESAHA.117.311102	69	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100381	10.1016/j.jbc.2021.100381	http://dx.doi.org/10.1016/j.jbc.2021.100381			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556372	gold, Green Published			2022-12-28	WOS:000672866400355
J	Cassim, AM; Navon, Y; Gao, Y; Decossas, M; Fouillen, L; Grelard, A; Nagano, M; Lambert, O; Bahammou, D; Van Delft, P; Maneta-Peyret, L; Simon-Plas, F; Heux, L; Jean, B; Fragneto, G; Mortimer, JC; Deleu, M; Lins, L; Mongrand, S				Cassim, Adiilah Mamode; Navon, Yotam; Gao, Yu; Decossas, Marion; Fouillen, Laetitia; Grelard, Axelle; Nagano, Minoru; Lambert, Olivier; Bahammou, Delphine; Van Delft, Pierre; Maneta-Peyret, Lilly; Simon-Plas, Francoise; Heux, Laurent; Jean, Bruno; Fragneto, Giovanna; Mortimer, Jenny C.; Deleu, Magali; Lins, Laurence; Mongrand, Sebastien			Biophysical analysis of the plant-specific GIPC sphingolipids reveals multiple modes of membrane regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; LIPID RAFTS; MAGNETIC-RESONANCE; CHOLESTEROL; TOBACCO; ORGANIZATION; ARABIDOPSIS; BILAYERS; DYNAMICS; PHASES	The plant plasma membrane (PM) is an essential barrier between the cell and the external environment, controlling signal perception and transmission. It consists of an asymmetrical lipid bilayer made up of three different lipid classes: sphingolipids, sterols, and phospholipids. The glycosyl inositol phosphoryl ceramides (GIPCs), representing up to 40% of total sphingolipids, are assumed to be almost exclusively in the outer leaflet of the PM. However, their biological role and properties are poorly defined. In this study, we investigated the role of GIPCs in membrane organization. Because GIPCs are not commercially available, we developed a protocol to extract and isolate GIPC-enriched fractions from eudicots (cauliflower and tobacco) and monocots (leek and rice). Lipidomic analysis confirmed the presence of trihydroxylated long chain bases and 2-hydroxylated very long-chain fatty acids up to 26 carbon atoms. The glycan head groups of the GIPCs from monocots and dicots were analyzed by gas chromatograph-mass spectrometry, revealing different sugar moieties. Multiple biophysics tools, namely Langmuir monolayer, zeta-Potential, light scattering, neutron reflectivity, solid state 2H-NMR, and molecular modeling, were used to investigate the physical properties of the GIPCs, as well as their interaction with free and conjugated phytosterols. We showed that GIPCs increase the thickness and electronegativity of model membranes, interact differentially with the different phytosterols species, and regulate the gel-to-fluid phase transition during temperature variations. These results unveil the multiple roles played by GIPCs in the plant PM.	[Cassim, Adiilah Mamode; Fouillen, Laetitia; Nagano, Minoru; Bahammou, Delphine; Van Delft, Pierre; Maneta-Peyret, Lilly; Mongrand, Sebastien] Univ Bordeaux, Lab Biogenese Membranaire, CNRS, UMR 5200, Villenave Dornon, France; [Navon, Yotam; Heux, Laurent; Jean, Bruno] Univ Grenoble Alpes, Ctr Rech Macromol Vegetales CERMAV, CNRS, Grenoble, France; [Gao, Yu; Mortimer, Jenny C.] Joint BioEnergy Inst, Emeryville, CA USA; [Gao, Yu; Mortimer, Jenny C.] Lawrence Berkeley Natl Lab, Environm & Syst Genom, Berkeley, CA USA; [Decossas, Marion; Grelard, Axelle; Lambert, Olivier] Univ Bordeaux, Inst Chem & Biol Membranes & Nanoobjects UMR5248, Inst Polytech Bordeaux, CNRS, Pessac, France; [Nagano, Minoru] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Japan; [Cassim, Adiilah Mamode; Simon-Plas, Francoise] Univ Bourgogne Franche Comte, INRA, CNRS, AgroSup Dijon,Agroecol, F-21000 Dijon, France; [Fragneto, Giovanna] Inst Laue Langevin ILL, Grenoble, France; [Deleu, Magali; Lins, Laurence] Univ Liege, TERRA Res Ctr, Lab Biophys Mol Interfaces, GX ABT, Gembloux, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Ritsumeikan University; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Institut Laue-Langevin (ILL); University of Liege	Mongrand, S (corresponding author), Univ Bordeaux, Lab Biogenese Membranaire, CNRS, UMR 5200, Villenave Dornon, France.	sebastien.mongrand@u-bordeaux.fr	FOUILLEN, Laetitia/AAV-9710-2020; Mortimer, Jenny C/AAY-6648-2021	FOUILLEN, Laetitia/0000-0002-1204-9296; Mortimer, Jenny C/0000-0001-6624-636X; Gao, Yu/0000-0002-8696-442X; decossas, marion/0000-0003-0810-4309; Van Delft, Pierre/0000-0001-5839-8427	French Ministry of Higher Education and Research (MESR); ANR PlayMobil [ANR-19-CE20-0016-02]; DOE Joint BioEnergy Institute - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC0205CH11231]; Bordeaux Metabolome Facility-MetaboHUB [ANR-11-INBS-0010]	French Ministry of Higher Education and Research (MESR)(Ministry of Research, France); ANR PlayMobil(French National Research Agency (ANR)); DOE Joint BioEnergy Institute - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Bordeaux Metabolome Facility-MetaboHUB	A. M. C. PhD project was funded by the French Ministry of Higher Education and Research (MESR). F. S. -P., S. M., L. L., L. F., and D. B. are funded by the ANR PlayMobil (ANR-19-CE20-0016-02). Y. G., J. C. M. were funded as was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC0205CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. We thank Bordeaux-Metabolome platform for lipid analysis supported by ANR PlayMobil (grant no. ANR-19-CE20-0016-02 to S. M., L. F., F. S. -P.) and Bordeaux Metabolome Facility-MetaboHUB (grant no. ANR-11-INBS-0010 to S. M. and L. F.).	Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; Bure C, 2016, J MASS SPECTROM, V51, P305, DOI 10.1002/jms.3758; Bure C, 2014, ANAL BIOANAL CHEM, V406, P995, DOI 10.1007/s00216-013-7130-8; Bure C, 2011, RAPID COMMUN MASS SP, V25, P3131, DOI 10.1002/rcm.5206; Cacas JL, 2016, PLANT PHYSIOL, V170, P367, DOI 10.1104/pp.15.00564; Cacas JL, 2013, PHYTOCHEMISTRY, V96, P191, DOI 10.1016/j.phytochem.2013.08.002; Campbell RA, 2011, EUR PHYS J PLUS, V126, DOI 10.1140/epjp/i2011-11107-8; CARTER HE, 1969, J LIPID RES, V10, P356; CARTER HE, 1958, J BIOL CHEM, V233, P1309; CARTER HE, 1969, J LIPID RES, V10, P363; Cassim AM, 2019, PROG LIPID RES, V73, P1, DOI 10.1016/j.plipres.2018.11.002; Courtney KC, 2018, ELIFE, V7, DOI 10.7554/eLife.38493; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Deleu M, 2014, BBA-BIOMEMBRANES, V1838, P3171, DOI 10.1016/j.bbamem.2014.08.023; Eeman M, 2005, LANGMUIR, V21, P2505, DOI 10.1021/la0475775; Fang L, 2016, PLANT CELL, V28, P2991, DOI 10.1105/tpc.16.00186; Furt F, 2007, PLANT SIGNAL BEHAV, V2, P508, DOI 10.4161/psb.2.6.4636; Gerbeau-Pissot P, 2014, PLANT PHYSIOL, V164, P273, DOI 10.1104/pp.113.225755; Goldenberg NM, 2010, CANCER RES, V70, P1277, DOI 10.1158/0008-5472.CAN-09-2905; Gronnier J, 2018, TRENDS PLANT SCI, V23, P899, DOI 10.1016/j.tplants.2018.07.007; Grosjean K, 2015, J BIOL CHEM, V290, P5810, DOI 10.1074/jbc.M114.598805; Gutierrez ALS, 2007, GLYCOBIOLOGY, V17, p1C, DOI 10.1093/glycob/cwm030; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; HSIEH TCY, 1981, J BIOL CHEM, V256, P7747; Ishikawa T, 2018, PLANT PHYSIOL, V177, P938, DOI 10.1104/pp.18.00396; Jiang ZH, 2019, NATURE, V572, P341, DOI 10.1038/s41586-019-1449-z; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; KANG SY, 1979, BIOCHEMISTRY-US, V18, P3268, DOI 10.1021/bi00582a011; KAUL K, 1978, BIOCHEMISTRY-US, V17, P3569, DOI 10.1021/bi00610a023; KAUL K, 1975, PLANT PHYSIOL, V55, P120, DOI 10.1104/pp.55.1.120; Kitazawa K, 2013, PLANT PHYSIOL, V161, P1117, DOI 10.1104/pp.112.211722; Kubsch B, 2017, JOVE-J VIS EXP, DOI 10.3791/56034; Lefebvre B, 2007, PLANT PHYSIOL, V144, P402, DOI 10.1104/pp.106.094102; Lenarcic T, 2017, SCIENCE, V358, P1431, DOI 10.1126/science.aan6874; Levental I, 2016, J MOL BIOL, V428, P4749, DOI 10.1016/j.jmb.2016.08.022; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Luttgeharm KD, 2015, PHYTOCHEMISTRY, V115, P121, DOI 10.1016/j.phytochem.2015.02.019; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; Mannock DA, 2010, CHEM PHYS LIPIDS, V163, P403, DOI 10.1016/j.chemphyslip.2010.03.011; Markham JE, 2007, RAPID COMMUN MASS SP, V21, P1304, DOI 10.1002/rcm.2962; Markham JE, 2013, CURR OPIN PLANT BIOL, V16, P350, DOI 10.1016/j.pbi.2013.02.009; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Montis C, 2016, COLLOID SURFACE B, V137, P203, DOI 10.1016/j.colsurfb.2015.07.039; Moreau RA, 2018, PROG LIPID RES, V70, P35, DOI 10.1016/j.plipres.2018.04.001; Morikawa T, 2006, PLANT CELL, V18, P1008, DOI 10.1105/tpc.105.036012; Morre DM, 2000, J CHROMATOGR B, V743, P377, DOI 10.1016/S0378-4347(00)00058-X; Mortimer JC, 2020, TRENDS PLANT SCI, V25, P522, DOI 10.1016/j.tplants.2020.03.007; Mortimer JC, 2013, PLANT CELL, V25, P1881, DOI 10.1105/tpc.113.111500; Nagano M, 2016, PLANT CELL, V28, P1966, DOI 10.1105/tpc.16.00201; Navon Y, 2017, BIOMACROMOLECULES, V18, P2918, DOI 10.1021/acs.biomac.7b00872; Nelson A, 2006, J APPL CRYSTALLOGR, V39, P273, DOI 10.1107/S0021889806005073; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Rennie EA, 2014, PLANT CELL, V26, P3314, DOI 10.1105/tpc.114.129171; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Rog T, 2004, BIOPHYS CHEM, V107, P151, DOI 10.1016/j.bpc.2003.09.002; Rog T, 2016, BBA-BIOMEMBRANES, V1858, P281, DOI 10.1016/j.bbamem.2015.12.003; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; SEELIG J, 1977, Q REV BIOPHYS, V10, P353, DOI 10.1017/S0033583500002948; Seneviratne V, 2003, ELECTROCHIM ACTA, V48, P2221, DOI 10.1016/S0013-4686(03)00208-1; Sibille E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168794; Simenel C, 2008, GLYCOBIOLOGY, V18, P84, DOI 10.1093/glycob/cwm122; Sipione S, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.572965; Smondyrev AM, 2001, BIOPHYS J, V80, P1649, DOI 10.1016/S0006-3495(01)76137-1; Sonnino S, 2010, ADV EXP MED BIOL, V688, P165; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Tarazona P, 2015, PLANT J, V84, P621, DOI 10.1111/tpj.13013; Tellier F, 2014, PHYTOCHEMISTRY, V103, P50, DOI 10.1016/j.phytochem.2014.03.023; Tjellstrom H, 2010, FASEB J, V24, P1128, DOI 10.1096/fj.09-139410; Voxeur A, 2014, PLANT J, V79, P139, DOI 10.1111/tpj.12547; Wacklin HP, 2010, CURR OPIN COLLOID IN, V15, P445, DOI 10.1016/j.cocis.2010.05.008; YEAGLE PL, 1977, P NATL ACAD SCI USA, V74, P4924, DOI 10.1073/pnas.74.11.4924; Yetukuri L, 2008, MOL BIOSYST, V4, P121, DOI 10.1039/b715468b	77	14	14	10	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100602	10.1016/j.jbc.2021.100602	http://dx.doi.org/10.1016/j.jbc.2021.100602			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33785359	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400574
J	Chatterjee, T; Zhang, S; Posey, TA; Jacob, J; Wu, L; Yu, WS; Francisco, LE; Liu, QJ; Carmon, KS				Chatterjee, Treena; Zhang, Sheng; Posey, Tressie A.; Jacob, Joan; Wu, Ling; Yu, Wangsheng; Francisco, Liezl E.; Liu, Qingyun J.; Carmon, Kendra S.			Anti-GPR56 monoclonal antibody potentiates GPR56-mediated Src-Fak signaling to modulate cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; ACUTE MYELOID-LEUKEMIA; TUMOR PROGRESSION; GPR56; KINASE; GPR56/ADGRG1; CARCINOMA; ACTIVATION; INHIBITOR; DOMAINS	GPR56 is a member of the adhesion G-protein-coupled receptor family shown to play important roles in cell adhesion, brain development, immune function, and tumorigenesis. GPR56 is highly upregulated in colorectal cancer and correlates with poor prognosis. Several studies have shown GPR56 couples to the G alpha(12/13) class of heterotrimeric G-proteins to promote RhoA activation. However, due to its structural complexity and lack of a high-affinity receptor-specific ligand, the complete GPR56 signaling mechanism remains largely unknown. To delineate the activation mechanism and intracellular signaling functions of GPR56, we generated a monoclonal antibody (mAb) that binds with high affinity and specificity to the extracellular domain (ECD). Using deletion mutants, we mapped the mAb binding site to the GAIN domain, which mediates membrane-proximal autoproteolytic cleavage of the ECD. We showed that GPR56 overexpression in 293T cells leads to increased phosphorylation of Src, Fak, and paxillin adhesion proteins and activation of the G alpha(12/13)-RhoA-mediated serum response factor (SRF) pathway. Treatment with the mAb potentiated Src-Fak phosphorylation, RhoA-SRF signaling, and cell adhesion. Consistently, GPR56 knockdown in colorectal cancer cells decreased Src-Fak pathway phosphorylation and cell adhesion. Interestingly, GPR56-mediated activation of Src-Fak phosphorylation occurred independent of RhoA, yet mAb-induced potentiation of RhoA-SRF signaling was Src-dependent. Furthermore, we show that the C-terminal portion of the Serine-Threonine-Proline-rich (STP) region, adjacent to the GAIN domain, was required for Src-Fak activation. However, autoproteolytic cleavage of the ECD was dispensable. These data support a new ECD-dependent mechanism by which GPR56 functions to regulate adhesion through activation of Src-Fak signaling.	[Carmon, Kendra S.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Ctr Translat Canc Res, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Carmon, KS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA.	Kendra.S.Carmon@uth.tmc.edu		Francisco, Liezl/0000-0002-3680-3767; Posey, Tressie Alexandra Capri/0000-0002-8141-4760	National Institutes of Health [R01CA226894, R01GM102485]; Welch Foundation Endowment Fund Award [L-AU-0002-19940421]; Cancer Prevention and Research Institute of Texas [RP170245]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation Endowment Fund Award; Cancer Prevention and Research Institute of Texas	This work was supported by funding from the National Institutes of Health (R01CA226894) and Welch Foundation Endowment Fund Award (L-AU-0002-19940421) to K. S. C. and National Institutes of Health (R01GM102485) and Cancer Prevention and Research Institute of Texas (RP170245) to Q. J. L.	Ackerman SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7122; Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Arcaroli JJ, 2010, CLIN CANCER RES, V16, P4165, DOI 10.1158/1078-0432.CCR-10-0066; Azhdarinia A, 2018, MOL PHARMACEUT, V15, P2448, DOI 10.1021/acs.molpharmaceut.8b00275; Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Carmon KS, 2017, J BIOL CHEM, V292, P14989, DOI 10.1074/jbc.M117.786798; Chang GW, 2016, CELL REP, V15, P1757, DOI 10.1016/j.celrep.2016.04.053; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Daria D, 2016, LEUKEMIA, V30, P1734, DOI 10.1038/leu.2016.76; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Gargalionis AN, 2014, INT J CANCER, V134, P2019, DOI 10.1002/ijc.28299; Gong X, 2016, MOL CANCER THER, V15, P1580, DOI 10.1158/1535-7163.MCT-16-0114; Green TP, 2009, MOL ONCOL, V3, P248, DOI 10.1016/j.molonc.2009.01.002; Hutchings CJ, 2014, MABS-AUSTIN, V6, P246, DOI 10.4161/mabs.27226; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Jeong SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068781; Ji B, 2018, ONCOL REP, V40, P1885, DOI 10.3892/or.2018.6582; Jin GC, 2017, ONCOTARGET, V8, P40606, DOI 10.18632/oncotarget.16506; Ke N, 2008, BIOCHEM BIOPH RES CO, V366, P314, DOI 10.1016/j.bbrc.2007.11.071; Ke N, 2007, MOL CANCER THER, V6, P1840, DOI 10.1158/1535-7163.MCT-07-0066; Kishore A, 2016, J BIOL CHEM, V291, P3385, DOI 10.1074/jbc.M115.689349; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Lark AL, 2003, CLIN CANCER RES, V9, P215; Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Liu Z, 2017, NEOPLASMA, V64, P32, DOI 10.4149/neo_2017_104; Luo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029818; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Millar MW, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00008; Ohta S, 2015, BIOL PHARM BULL, V38, P594, DOI 10.1248/bpb.b14-00752; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Pabst C, 2016, BLOOD, V127, P2018, DOI 10.1182/blood-2015-11-683649; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Saito Y, 2013, LEUKEMIA, V27, P1637, DOI 10.1038/leu.2013.75; Salzman GS, 2017, P NATL ACAD SCI USA, V114, P10095, DOI 10.1073/pnas.1708810114; Salzman GS, 2016, NEURON, V91, P1292, DOI 10.1016/j.neuron.2016.08.022; Sewda K, 2016, ONCOTARGET, V7, P17773, DOI 10.18632/oncotarget.7402; Spring FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062654; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yang LQ, 2011, CANCER RES, V71, P5558, DOI 10.1158/0008-5472.CAN-10-4543; Yeung J, 2020, P NATL ACAD SCI USA, V117, P28275, DOI 10.1073/pnas.2008921117; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Yu J, 2017, BIOCHEM J, V474, P589, DOI 10.1042/BCJ20160998; Zeltz C, 2016, J CELL SCI, V129, P653, DOI 10.1242/jcs.180992; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200; Zhang S, 2019, MOL CANCER RES, V17, P2196, DOI 10.1158/1541-7786.MCR-19-0436; Zhu BK, 2019, J BIOL CHEM, V294, P19246, DOI 10.1074/jbc.RA119.008234	59	8	8	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100261	10.1016/j.jbc.2021.100261	http://dx.doi.org/10.1016/j.jbc.2021.100261			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837725	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400237
J	Chen, K; Gunay-Esiyok, O; Klingeberg, M; Marquardt, S; Pomorski, TG; Gupta, N				Chen, Kai; Gunay-Esiyok, Ozlem; Klingeberg, Melissa; Marquardt, Stephan; Pomorski, Thomas Guenther; Gupta, Nishith			Aminoglycerophospholipid flipping and P4-ATPases in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; PHOSPHOLIPID FLIPPASE; SACCHAROMYCES-CEREVISIAE; PARASITOPHOROUS VACUOLE; PARASITE MITOCHONDRION; PLASMA-MEMBRANE; TRANSPORT; PROTEIN; PHOSPHATIDYLSERINE; BIOGENESIS	Lipid flipping in the membrane bilayers is a widespread eukaryotic phenomenon that is catalyzed by assorted P4-ATPases. Its occurrence, mechanism, and importance in apicomplexan parasites have remained elusive, however. Here we show that Toxoplasma gondii, an obligate intracellular parasite with high clinical relevance, can salvage phosphatidylserine (PtdSer) and phosphatidylethanolamine (PtdEtn) but not phosphatidylcholine (PtdCho) probes from its milieu. Consistently, the drug analogs of PtdCho are broadly ineffective in the parasite culture. NBD-PtdSer imported to the parasite interior is decarboxylated to NBD-PtdEtn, while the latter is not methylated to yield PtdCho, which confirms the expression of PtdSer decarboxylase but a lack of PtdEtn methyltransferase activity and suggests a role of exogenous lipids in membrane biogenesis of T. gondii. Flow cytometric quantitation of NBD-probes endorsed the selectivity of phospholipid transport and revealed a dependence of the process on energy and protein. Accordingly, our further work identified five P4-ATPases (TgP4-ATPase1-5), all of which harbor the signature residues and motifs required for phospholipid flipping. Of the four proteins expressed during the lytic cycle, TgP4-ATPase1 is present in the apical plasmalemma; TgP4-ATPase3 resides in the Golgi network along with its noncatalytic partner Ligand Effector Module 3 (TgLem3), whereas TgP4-ATPase2 and TgP4-ATPase5 localize in the plasmalemma as well as endo/cytomembranes. Last but not least, auxin-induced degradation of TgP4-ATPase1-3 impaired the parasite growth in human host cells, disclosing their crucial roles during acute infection. In conclusion, we show selective translocation of PtdEtn and PtdSer at the parasite surface and provide the underlying mechanistic and physiological insights in a model eukaryotic pathogen.	[Chen, Kai; Gunay-Esiyok, Ozlem; Klingeberg, Melissa; Marquardt, Stephan; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, Fac Life Sci, Berlin, Germany; [Marquardt, Stephan; Pomorski, Thomas Guenther] Humboldt Univ, Fac Life Sci, Dept Expt Biophys, Berlin, Germany; [Gupta, Nishith] Birla Inst Technol & Sci Pilani BITS P, Dept Biol Sci, Hyderabad, India; [Pomorski, Thomas Guenther] Ruhr Univ, Fac Chem & Biochem, Dept Mol Biochem, Bochum, Germany	Humboldt University of Berlin; Humboldt University of Berlin; Birla Institute of Technology & Science Pilani (BITS Pilani); Ruhr University Bochum	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Fac Life Sci, Berlin, Germany.; Gupta, N (corresponding author), Birla Inst Technol & Sci Pilani BITS P, Dept Biol Sci, Hyderabad, India.	Gupta.Nishith@hu-berlin.de		Gupta, Nishith/0000-0003-1452-5126; Gunay-Esiyok, Ozlem/0000-0003-1245-9030	German Research Foundation (DFG) [GU1100/4-3, GU1100/16]; China Scholarship Council (CSC); DFG via a Heisenberg program [PO 748/9-1]; Open-Access Fund of Humboldt University, Berlin	German Research Foundation (DFG)(German Research Foundation (DFG)); China Scholarship Council (CSC)(China Scholarship Council); DFG via a Heisenberg program(German Research Foundation (DFG)); Open-Access Fund of Humboldt University, Berlin	The work was sponsored by a standard research grant (GU1100/4-3) and a Heisenberg program grant (GU1100/16) awarded to N. G. by the German Research Foundation (DFG). Financial support to K. C. was endowed through the China Scholarship Council (CSC). T. G. P. acknowledges funding by DFG via a Heisenberg program grant (PO 748/9-1). The cost of this publication was defrayed through Open-Access Fund of Humboldt University, Berlin. The funders had no role in the design of this study, data collection and analysis, the decision to publish, or preparation of this manuscript.	Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Arroyo-Olarte RD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002288; Bai L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12191-9; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; Best JT, 2019, CURR OPIN CELL BIOL, V59, P8, DOI 10.1016/j.ceb.2019.02.004; Bisanz C, 2006, BIOCHEM J, V394, P197, DOI 10.1042/BJ20050609; Bisio H, 2019, NAT MICROBIOL, V4, P420, DOI 10.1038/s41564-018-0339-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Brown K. M., 2018, BIOPROTOC, V8; Brown KM, 2018, CELL HOST MICROBE, V24, P804, DOI 10.1016/j.chom.2018.10.015; Caffaro CE, 2011, EUKARYOT CELL, V10, P1095, DOI 10.1128/EC.00002-11; CARSON MA, 1984, J BIOL CHEM, V259, P6267; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Eissa MM, 2015, EXP PARASITOL, V157, P12, DOI 10.1016/j.exppara.2015.06.005; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frenal K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15710; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Garcia-Sanchez S, 2014, BIOCHEM J, V459, P83, DOI 10.1042/BJ20131318; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gunay-Esiyok O, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900402; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Gupta N, 2012, J BIOL CHEM, V287, P22938, DOI 10.1074/jbc.M112.373639; Hager KM, 1999, J CELL SCI, V112, P2631; Hamai C, 2006, BIOPHYS J, V90, P1241, DOI 10.1529/biophysj.105.069435; Hartmann A, 2014, J BIOL CHEM, V289, P6809, DOI 10.1074/jbc.M113.509406; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000754; Hiraizumi M, 2019, SCIENCE, V365, P1149, DOI 10.1126/science.aay3353; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Huang YN, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.158581; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Keranen LM, 1997, J BIOL CHEM, V272, P25959, DOI 10.1074/jbc.272.41.25959; Kong PF, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0023-4; Kong PF, 2017, J BIOL CHEM, V292, P7145, DOI 10.1074/jbc.M116.765487; Kuchipudi A, 2016, MICROB CELL, V3, P215, DOI 10.15698/mic2016.05.500; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lee S, 2015, EMBO J, V34, P669, DOI 10.15252/embj.201489703; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Liang XH, 2020, J BIOL CHEM, V295, P7743, DOI 10.1074/jbc.RA120.013004; Lopez-Marques RL, 2014, PFLUG ARCH EUR J PHY, V466, P1227, DOI 10.1007/s00424-013-1363-4; Lorenzi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10147; Lyons RE, 2002, TRENDS PARASITOL, V18, P198, DOI 10.1016/S1471-4922(02)02248-1; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Miyoshi N, 2010, ONCOL REP, V23, P505, DOI 10.3892/or_00000662; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Muthusamy BP, 2009, MOL BIOL CELL, V20, P2920, DOI 10.1091/mbc.E08-10-1036; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Nitzsche R, 2017, J BIOL CHEM, V292, P15225, DOI 10.1074/jbc.M117.802702; Nolan SJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006362; Palmgren M, 2019, BBA-BIOMEMBRANES, V1861, P1135, DOI 10.1016/j.bbamem.2019.02.006; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pernas L, 2018, CELL METAB, V27, P886, DOI 10.1016/j.cmet.2018.02.018; Pittman KJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-806; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Ren BJ, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01480-5; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Roland BP, 2016, P NATL ACAD SCI USA, V113, pE4460, DOI 10.1073/pnas.1525730113; Sampels V, 2012, J BIOL CHEM, V287, P16289, DOI 10.1074/jbc.M112.347138; Segawa K, 2018, P NATL ACAD SCI USA, V115, P12212, DOI 10.1073/pnas.1814323115; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Shin HW, 2019, FASEB J, V33, P3087, DOI 10.1096/fj.201801873R; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sinai AP, 1997, J CELL SCI, V110, P2117; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; SMYTH DG, 1964, BIOCHEM J, V91, P589, DOI 10.1042/bj0910589; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Soupene E, 2006, BRIT J HAEMATOL, V133, P436, DOI 10.1111/j.1365-2141.2006.06051.x; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Timcenko M, 2019, NATURE, V571, P366, DOI 10.1038/s41586-019-1344-7; Tomavo S, 2014, INT J PARASITOL, V44, P133, DOI 10.1016/j.ijpara.2013.10.003; Triana MAH, 2018, J EUKARYOT MICROBIOL, V65, P709, DOI 10.1111/jeu.12626; van der Velden LM, 2010, BIOCHEM J, V431, P1, DOI 10.1042/BJ20100644; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Weingartner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012443; Welti R, 2007, BIOCHEMISTRY-US, V46, P13882, DOI 10.1021/bi7011993; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yang LN, 2019, J BIOL CHEM, V294, P8959, DOI 10.1074/jbc.RA118.005491; Zhou XM, 2013, J BIOL CHEM, V288, P31807, DOI 10.1074/jbc.M113.481986	96	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100315	10.1016/j.jbc.2021.100315	http://dx.doi.org/10.1016/j.jbc.2021.100315			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33485966	Green Published, gold			2022-12-28	WOS:000672866400289
J	Kotlar, RM; Jones, ND; Senavirathne, G; Gardner, AM; Messer, RK; Tan, YY; Rabe, AJ; Fishel, R; Yoder, KE				Kotlar, Randi M.; Jones, Nathan D.; Senavirathne, Gayan; Gardner, Anne M.; Messer, Ryan K.; Tan, Yow Yong; Rabe, Anthony J.; Fishel, Richard; Yoder, Kristine E.			Retroviral prototype foamy virus intasome binding to a nucleosome target does not determine integration efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CORE PARTICLES; DNA; PROTEINS; DOMAINS; SITES; MECHANISM; AFFINITY	Retroviral integrases must navigate host DNA packaged as chromatin during integration of the viral genome. Prototype foamy virus (PFV) integrase (IN) forms a tetramer bound to two viral DNA (vDNA) ends in a complex termed an intasome. PFV IN consists of four domains: the amino terminal extension domain (NED), amino terminal domain (NTD), catalytic core domain (CCD), and carboxyl terminal domain (CTD). The domains of the two inner IN protomers have been visualized, as well as the CCDs of the two outer IN protomers. However, the roles of the amino and carboxyl terminal domains of the PFV intasome outer subunits during integration to a nucleosome target substrate are not clear. We used the well-characterized 601 nucleosome to assay integration activity as well as intasome binding. PFV intasome integration to 601 nucleosomes occurs in clusters at four independent sites. We find that the outer protomer NED and NTD domains have no significant effects on integration efficiency, site selection, or binding. The CTDs of the outer PFV intasome subunits dramatically affect nucleosome binding but have little effect on total integration efficiency. The outer PFV IN CTDs did significantly alter the integration efficiency at one site. Histone tails also significantly affect intasome binding, but have little impact on PFV integration efficiency or site selection. These results indicate that binding to nucleosomes does not correlate with integration efficiency and suggests most intasome-binding events are unproductive.	[Kotlar, Randi M.; Jones, Nathan D.; Senavirathne, Gayan; Gardner, Anne M.; Messer, Ryan K.; Tan, Yow Yong; Rabe, Anthony J.; Fishel, Richard; Yoder, Kristine E.] Ohio State Univ, Coll Med, Canc Biol & Genet, Columbus, OH 43210 USA; [Jones, Nathan D.; Senavirathne, Gayan; Gardner, Anne M.; Messer, Ryan K.; Tan, Yow Yong; Rabe, Anthony J.; Fishel, Richard; Yoder, Kristine E.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Kotlar, Randi M.] Tessera Therapeut, Cambridge, MA USA; [Jones, Nathan D.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Johns Hopkins University	Yoder, KE (corresponding author), Ohio State Univ, Coll Med, Canc Biol & Genet, Columbus, OH 43210 USA.; Yoder, KE (corresponding author), Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA.	yoder.176@osu.edu	Yoder, Kristine/E-4353-2011	Yoder, Kristine/0000-0002-5598-9018; Senavirathne, Gayan/0000-0002-9113-4201; Kotlar, Randi/0000-0002-2513-6479; Gardner, Anne/0000-0001-7095-772X	National Institutes of Health [AI099854, AI126742]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (AI099854 to K. E. Y. and AI126742 to K. E. Y. and R. F.). Funding for open access charge: National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Anderson JD, 2002, MOL CELL BIOL, V22, P7147, DOI 10.1128/MCB.22.20.7147-7157.2002; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Ballandras-Colas A, 2017, SCIENCE, V355, P93, DOI 10.1126/science.aah7002; Ballandras-Colas A, 2016, NATURE, V530, P358, DOI 10.1038/nature16955; Brehove M, 2015, J BIOL CHEM, V290, P22612, DOI 10.1074/jbc.M115.661363; Bucceri A, 2006, EMBO J, V25, P3123, DOI 10.1038/sj.emboj.7601196; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Chou KM, 2003, J BIOL CHEM, V278, P18289, DOI 10.1074/jbc.M212143200; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Coffin J, 1997, RETROVIRUSES; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Engelman AN, 2017, CURR OPIN STRUC BIOL, V47, P23, DOI 10.1016/j.sbi.2017.04.005; Gracey LE, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-13; Guo H, 2003, P NATL ACAD SCI USA, V100, P3743, DOI 10.1073/pnas.0737062100; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hart DJ, 1999, NUCLEIC ACIDS RES, V27, P1063, DOI 10.1093/nar/27.4.1063; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Jones ND, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36725-1; Jones ND, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11409; Li M, 2016, PROTEIN SCI, V25, P472, DOI 10.1002/pro.2837; Li M, 2012, METHOD ENZYMOL, V513, P29, DOI 10.1016/B978-0-12-391938-0.00002-1; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mackler R. M., 2018, J VIS EXP, V57453; Mackler RM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212764; Maertens GN, 2016, NUCLEIC ACIDS RES, V44, P364, DOI 10.1093/nar/gkv1347; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Maskell DP, 2015, NATURE, V523, P366, DOI 10.1038/nature14495; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; MILLS JB, 1994, BIOCHEMISTRY-US, V33, P1797, DOI 10.1021/bi00173a024; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Wilson MD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12007-w; Winans S, 2017, J VIROL, V91, DOI 10.1128/JVI.00082-17; Yang ZY, 2007, J BIOL CHEM, V282, P7930, DOI 10.1074/jbc.M610584200; Yin ZQ, 2016, NATURE, V530, P362, DOI 10.1038/nature16950	51	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100550	10.1016/j.jbc.2021.100550	http://dx.doi.org/10.1016/j.jbc.2021.100550			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744295	gold, Green Published			2022-12-28	WOS:000672866400523
J	Liu, XX; Liu, XY; Zhou, CC; Lv, JN; He, XB; Liu, YY; Xie, HH; Wang, B; Lv, XJ; Tang, LC; Li, MC; Liu, CB; Zhao, JZ; Liu, Y; Song, ZM; Gu, F				Liu, Xiexie; Liu, Xiaoyu; Zhou, Chenchen; Lv, Jineng; He, Xiubin; Liu, Yuanyuan; Xie, Haihua; Wang, Bang; Lv, Xiujuan; Tang, Lianchao; Li, Mingchun; Liu, Changbao; Zhao, Junzhao; Liu, Yong; Song, Zongming; Gu, Feng			Engineered FnCas12a with enhanced activity through directional evolution in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPF1; DNA; ENDONUCLEASE; RNA; COMPLEX; MICE	Clustered regularly interspaced short palindromic repeat-Cas12a has been harnessed to manipulate the human genome; however, low cleavage efficiency and stringent protospacer adjacent motif hinder the use of Cas12a-based therapy and applications. Here, we have described a directional evolving and screening system in human cells to identify novel FnCas12a variants with high activity. By using this system, we identified IV-79 (enhanced activity FnCas12a, eaFnCas12a), which possessed higher DNA cleavage activity than WT FnCas12a. Furthermore, to widen the target selection spectrum, eaFnCas12a was engineered through site-directed mutagenesis. eaFnCas12a and one engineered variant (eaFnCas12a-RR), used for correcting human RS1 mutation responsible for X-linked retinoschisis, had a 3.28- to 4.04-fold improved activity compared with WT. Collectively, eaFnCas12a and its engineered variants can be used for genome-editing applications that requires high activity.	[Liu, Xiexie; Liu, Xiaoyu; Zhou, Chenchen; Lv, Jineng; He, Xiubin; Liu, Yuanyuan; Xie, Haihua; Wang, Bang; Lv, Xiujuan; Tang, Lianchao; Li, Mingchun; Liu, Yong; Song, Zongming; Gu, Feng] Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, State Key Lab, Wenzhou, Zhejiang, Peoples R China; [Liu, Xiexie; Liu, Xiaoyu; Zhou, Chenchen; Lv, Jineng; He, Xiubin; Liu, Yuanyuan; Xie, Haihua; Wang, Bang; Lv, Xiujuan; Tang, Lianchao; Li, Mingchun; Liu, Yong; Song, Zongming; Gu, Feng] Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Key Lab Vis Sci,Minist Hlth, Wenzhou, Zhejiang, Peoples R China; [Liu, Xiexie; Liu, Xiaoyu; Zhou, Chenchen; Lv, Jineng; He, Xiubin; Liu, Yuanyuan; Xie, Haihua; Wang, Bang; Lv, Xiujuan; Tang, Lianchao; Li, Mingchun; Liu, Yong; Song, Zongming; Gu, Feng] Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Liu, Changbao; Zhao, Junzhao] Wenzhou Med Univ, Clin Coll 2, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Liu, Changbao; Zhao, Junzhao] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Song, Zongming] Henan Prov Peoples Hosp, Henan Eye Hosp, Henan Eye Inst, Zhengzhou, Henan, Peoples R China; [Song, Zongming] Zhengzhou Univ, Peoples Hosp, Zhengzhou, Henan, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Zhengzhou University; Zhengzhou University	Gu, F (corresponding author), Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, State Key Lab, Wenzhou, Zhejiang, Peoples R China.; Gu, F (corresponding author), Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Key Lab Vis Sci,Minist Hlth, Wenzhou, Zhejiang, Peoples R China.; Gu, F (corresponding author), Wenzhou Med Univ, Eye Hosp, Sch Ophthalmol & Optometry, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	gufenguw@gmail.com	liu, yuanyuan/GWZ-5838-2022	Gu, Feng/0000-0002-9019-2960; Gu, Feng/0000-0002-9600-8407	National Key R&D Program of China [2018YFA0107304]; National Natural Science Foundation of China [81201181, 81670882]; Science and Technology Project of Zhejiang Province [2017C37176]; Natural Science Foundation of Zhejiang Provincial [LQ18C060003]; Zhejiang Provincial &Ministry of Health research fund for medical sciences [WKJ-ZJ-1828]; Wenzhou City Key Innovation Team of Reproductive Genetics Grant, Zhejiang, China [C20170007]; Lin He's Academician Workstation of New Medicine and Clinical Translation [17331209, 18331105]; Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University [J02-20190201]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhejiang Province; Natural Science Foundation of Zhejiang Provincial(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial &Ministry of Health research fund for medical sciences; Wenzhou City Key Innovation Team of Reproductive Genetics Grant, Zhejiang, China; Lin He's Academician Workstation of New Medicine and Clinical Translation; Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University	This work was supported by grants from National Key R&D Program of China (2018YFA0107304), National Natural Science Foundation of China (81201181 and 81670882), Science and Technology Project of Zhejiang Province (2017C37176), Natural Science Foundation of Zhejiang Provincial (LQ18C060003), Zhejiang Provincial &Ministry of Health research fund for medical sciences (WKJ-ZJ-1828), Wenzhou City Key Innovation Team of Reproductive Genetics Grant, Zhejiang, China (No. C20170007), Lin He's Academician Workstation of New Medicine and Clinical Translation (17331209 and 18331105) and Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University (J02-20190201).	Ambrosio L, 2019, INVEST OPHTH VIS SCI, V60, P4872, DOI 10.1167/iovs.19-27897; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Chen D, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00453; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Chen XY, 2018, ISCIENCE, V6, P247, DOI 10.1016/j.isci.2018.08.001; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Jiang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15179; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2019, NAT BIOTECHNOL, V37, P276, DOI 10.1038/s41587-018-0011-0; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Li SY, 2018, CELL RES, V28, P491, DOI 10.1038/s41422-018-0022-x; Lin L, 2018, MOL THER, V26, P2650, DOI 10.1016/j.ymthe.2018.08.021; Lin QP, 2020, NAT BIOTECHNOL, V38, P582, DOI 10.1038/s41587-020-0455-x; Moon SB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06129-w; Park HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05641-3; Schindele P, 2018, FEBS LETT, V592, P1954, DOI 10.1002/1873-3468.13073; Stella S, 2017, NATURE, V546, P559, DOI 10.1038/nature22398; Tang Lianchao, 2019, Cell Regen, V8, P44, DOI 10.1016/j.cr.2019.08.002; Tang X, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.18; Teng F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1620-8; Toth E, 2018, NUCLEIC ACIDS RES, V46, P10272, DOI 10.1093/nar/gky815; Tu MJ, 2017, NUCLEIC ACIDS RES, V45, P11295, DOI 10.1093/nar/gkx783; Wu WY, 2018, NAT CHEM BIOL, V14, P642, DOI 10.1038/s41589-018-0080-x; Xie HH, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000747; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang FY, 2018, J GENET GENOMICS, V45, P329, DOI 10.1016/j.jgg.2018.02.009; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; Zhang Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602814; Zhu HC, 2020, NAT REV MOL CELL BIO, V21, P661, DOI 10.1038/s41580-020-00288-9	37	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100394	10.1016/j.jbc.2021.100394	http://dx.doi.org/10.1016/j.jbc.2021.100394			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33567342	Green Published, gold			2022-12-28	WOS:000672866400368
J	Pokidysheva, EN; Seeger, H; Pedchenko, V; Chetyrkin, S; Bergmann, C; Abrahamson, D; Cui, ZW; Delpire, E; Fervenza, FC; Fidler, AL; Fogo, AB; Gaspert, A; Grohmann, M; Gross, O; Haddad, G; Harris, RC; Kashtan, C; Kitching, AR; Lorenzen, JM; McAdoo, S; Pusey, CD; Segelmark, M; Simmons, A; Voziyan, PA; Wagner, T; Wuthrich, RP; Zhao, MH; Boudko, SP; Kistler, AD; Hudson, BG				Pokidysheva, Elena N.; Seeger, Harald; Pedchenko, Vadim; Chetyrkin, Sergei; Bergmann, Carsten; Abrahamson, Dale; Cui, Zhao Wei; Delpire, Eric; Fervenza, Fernando C.; Fidler, Aaron L.; Fogo, Agnes B.; Gaspert, Ariana; Grohmann, Maik; Gross, Oliver; Haddad, George; Harris, Raymond C.; Kashtan, Clifford; Kitching, A. Richard; Lorenzen, Johan M.; McAdoo, Stephen; Pusey, Charles D.; Segelmark, Marten; Simmons, Alicia; Voziyan, Paul A.; Wagner, Timo; Wuethrich, Rudolf P.; Zhao, Ming-Hui; Boudko, Sergei P.; Kistler, Andreas D.; Hudson, Billy G.			Collagen IV alpha 345 dysfunction in glomerular basement membrane diseases. I. Discovery of a COL4A3 variant in familial Goodpasture's and Alport diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGEN; MOLECULAR-CLONING; ALPHA-3 CHAIN; X-CHROMOSOME; IDENTIFICATION; ANTIGEN; MODEL; GENE; LOCALIZATION; ORGANIZATION	Diseases of the glomerular basement membrane (GBM), such as Goodpasture's disease (GP) and Alport syndrome (AS), are a major cause of chronic kidney failure and an unmet medical need. Collagen IV alpha 345 is an important architectural element of the GBM that was discovered in previous research on GP and AS. How this collagen enables GBM to function as a permselective filter and how structural defects cause renal failure remain an enigma. We found a distinctive genetic variant of collagen IV alpha 345 in both a familial GP case and four AS kindreds that provided insights into these mechanisms. The variant is an 8-residue appendage at the C-terminus of the a3 subunit of the alpha 345 hexamer. A knock-in mouse harboring the variant displayed GBM abnormalities and proteinuria. This pathology phenocopied AS, which pinpointed the alpha 345 hexamer as a focal point in GBM function and dysfunction. Crystallography and assembly studies revealed underlying hexamer mechanisms, as described in Boudko et al. and Pedchenko et al. Bioactive sites on the hexamer surface were identified where pathogenic pathways of GP and AS converge and, potentially, that of diabetic nephropathy (DN). We conclude that the hexamer functions include signaling and organizing macromolecular complexes, which enable GBM assembly and function. Therapeutic modulation or replacement of alpha 345 hexamer could therefore be a potential treatment for GBM diseases, and this knock-in mouse model is suitable for developing gene therapies.	[Pokidysheva, Elena N.; Pedchenko, Vadim; Chetyrkin, Sergei; Fidler, Aaron L.; Fogo, Agnes B.; Harris, Raymond C.; Simmons, Alicia; Voziyan, Paul A.; Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Pokidysheva, Elena N.; Pedchenko, Vadim; Chetyrkin, Sergei; Fidler, Aaron L.; Simmons, Alicia; Voziyan, Paul A.; Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Ctr Matrix Biol, Med Ctr, Nashville, TN 37232 USA; [Seeger, Harald; Haddad, George; Lorenzen, Johan M.; Wuethrich, Rudolf P.] Univ Hosp Zurich, Nephrol Div, Zurich, Switzerland; [Bergmann, Carsten] Univ Hosp Freiburg, Dept Med & Nephrol, Freiburg, Germany; [Bergmann, Carsten; Grohmann, Maik; Wagner, Timo] Limbach Genet, Med Genet Mainz, Mainz, Germany; [Abrahamson, Dale] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Cui, Zhao Wei; Zhao, Ming-Hui] Peking Univ First Hosp, Renal Div, Beijing, Peoples R China; [Delpire, Eric] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Fervenza, Fernando C.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Fidler, Aaron L.; Simmons, Alicia; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Aspirnaut Program, Nashville, TN 37232 USA; [Fogo, Agnes B.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Gaspert, Ariana] Univ Hosp Zurich, Dept Pathol & Mol Pathol, Zurich, Switzerland; [Gross, Oliver] Univ Goettingen, Univ Med Ctr Goettingen, Clin Nephrol & Rheumatol, Gottingen, Germany; [Kashtan, Clifford] Univ Minnesota, Sch Med, Div Pediat Nephrol, Minneapolis, MN 55455 USA; [Kitching, A. Richard] Monash Univ, Ctr Inflammatory Dis, Monash Hlth, Dept Med,Nephrol, Clayton, Vic, Australia; [McAdoo, Stephen; Pusey, Charles D.] Imperial Coll London, Ctr Inflammatory Dis, London, England; [Segelmark, Marten; Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Kistler, Andreas D.] Kantonsspital Frauenfeld, Dept Internal Med, Frauenfeld, Switzerland; [Hudson, Billy G.] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; University of Zurich; University Zurich Hospital; University of Freiburg; University of Kansas; University of Kansas Medical Center; Vanderbilt University; Mayo Clinic; Vanderbilt University; Vanderbilt University; University of Zurich; University Zurich Hospital; University of Gottingen; University of Minnesota System; University of Minnesota Twin Cities; Monash University; Imperial College London; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Ctr Matrix Biol, Med Ctr, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Aspirnaut Program, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	billy.hudson@vumc.org	Kitching, A Richard/B-6947-2013; Cui, Zhao/ABZ-9262-2022; McAdoo, Stephen Paul/AAP-7427-2021; Fidler, Aaron/C-4031-2014	Kitching, A Richard/0000-0002-2713-2391; Cui, Zhao/0000-0002-5837-1926; McAdoo, Stephen Paul/0000-0001-8260-8770; Kistler, Andreas/0000-0002-4114-9560; Fidler, Aaron/0000-0002-2519-8864; Fervenza, Fernando/0000-0002-9952-209X; Boudko, Sergei/0000-0003-3856-4859; Gross, Oliver/0000-0002-8390-8852	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK18381-50, R01DK018381, R24DK103067, R01DK065138, R01DK93501, P30DK114809, RO1DK56942]; Center for Matrix Biology at Vanderbilt University Medical Center; Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center; German Research Foundation DFG [GR 1852/6-1]; Federal Ministry of Education and Research (BMBF) [01GM1903I, 01GM1903G]; Deutsche Forschungsgemeinschaft (DFG) [BE 3910/8-1, BE 3910/9-1, 431984000 - SFB 1453]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Matrix Biology at Vanderbilt University Medical Center; Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center; German Research Foundation DFG(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Y Supported by grants R01DK18381-50 and a supplement R01DK018381 (to Dr Billy G Hudson), R24DK103067 (to Dr Raymond Harris and Dr Billy G Hudson), R01DK065138 (to Dr Billy G Hudson and Dr Paul Voziyan), R01DK93501 (to Dr Eric Delpire), and P30DK114809 (to Dr Raymond Harris), and RO1DK56942 (to Dr Agnes Fogo) from the National Institute of Diabetes and Digestive and Kidney Diseases. Additional support was provided by the Aspirnaut program from the Center for Matrix Biology at Vanderbilt University Medical Center. Dr Sergei Boudko was supported, in part, by start-up funding from Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center. Dr Oliver Gross is supported by the German Research Foundation DFG (GR 1852/6-1). Dr Carsten Bergmann is supported by the Deutsche Forschungsgemeinschaft (DFG) (BE 3910/8-1, BE 3910/9-1, and Project-ID 431984000 -SFB 1453) and the Federal Ministry of Education and Research (BMBF, 01GM1903I and 01GM1903G).	Abrahamson DR, 2012, SEMIN NEPHROL, V32, P342, DOI 10.1016/j.semnephrol.2012.06.005; Angioi A, 2017, CLIN NEPHROL, V88, P277, DOI 10.5414/CN109206; Backus KM, 2019, CURR TOP MICROBIOL, V420, P375, DOI 10.1007/82_2018_120; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BEISSWENGER PJ, 1970, SCIENCE, V168, P596, DOI 10.1126/science.168.3931.596; Bikbov B, 2018, NEPHRON, V139, P313, DOI 10.1159/000489897; Borza CM, 2008, J AM SOC NEPHROL, V19, P677, DOI 10.1681/ASN.2007070793; Boudko SP, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100591; Boudko SP, 2018, METHOD CELL BIOL, V143, P171, DOI 10.1016/bs.mcb.2017.08.010; Brown KL, 2017, PROTEIN SCI, V26, P2151, DOI 10.1002/pro.3283; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Cui Z, 2016, J AUTOIMMUN, V70, P1, DOI 10.1016/j.jaut.2016.04.001; Cummings CF, 2016, J CELL BIOL, V213, P479, DOI 10.1083/jcb.201510065; Fan Hao, 2007, Genomics Proteomics & Bioinformatics, V5, P7, DOI 10.1016/S1672-0229(07)60009-6; Fidler AL, 2017, ELIFE, V6, DOI 10.7554/eLife.24176; Groopman EE, 2019, NEW ENGL J MED, V380, P142, DOI 10.1056/NEJMoa1806891; Gross O, 2020, KIDNEY INT, V97, P1275, DOI 10.1016/j.kint.2019.12.015; Guin D, 2019, CHEM REV, V119, P10691, DOI 10.1021/acs.chemrev.8b00753; GUNWAR S, 1990, J BIOL CHEM, V265, P5466; GUNWAR S, 1991, AM J RESP CELL MOL, V5, P107, DOI 10.1165/ajrcmb/5.2.107; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUDSON BG, 1972, J BIOL CHEM, V247, P4229; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hudson BG, 2004, J AM SOC NEPHROL, V15, P2514, DOI 10.1097/01.ASN.0000141462.00630.76; Kashtan CE, 2018, KIDNEY INT, V93, P1045, DOI 10.1016/j.kint.2017.12.018; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; KEFALIDES NA, 1968, BIOCHEMISTRY-US, V7, P3103, DOI 10.1021/bi00849a012; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Levin Adeera, 2017, Lancet, V390, P1888, DOI 10.1016/S0140-6736(17)30788-2; Lin MH, 2018, J AM SOC NEPHROL, V29, P1426, DOI 10.1681/ASN.2017060690; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; McAdoo SP, 2017, CLIN J AM SOC NEPHRO, V12, P1162, DOI 10.2215/CJN.01380217; MCCOY RC, 1982, KIDNEY INT, V21, P642, DOI 10.1038/ki.1982.72; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; MORRISON KE, 1991, AM J HUM GENET, V49, P545; Mott JD, 1997, KIDNEY INT, V52, P1302, DOI 10.1038/ki.1997.455; MYERS JC, 1990, AM J HUM GENET, V46, P1024; Naylor RW, 2021, NAT REV NEPHROL, V17, P112, DOI 10.1038/s41581-020-0329-y; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; Ooi JD, 2017, NATURE, V545, P243, DOI 10.1038/nature22329; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Pedchenko V, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100592; Pedchenko V, 2018, MATRIX BIOL, V71-72, P240, DOI 10.1016/j.matbio.2018.05.004; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Phelps RG, 1999, KIDNEY INT, V56, P1638, DOI 10.1046/j.1523-1755.1999.00720.x; Pirson Y, 1999, KIDNEY INT, V56, P760, DOI 10.1046/j.1523-1755.1999.00601.x; Polosukhin VV, 2005, ULTRASTRUCT PATHOL, V29, P53, DOI 10.1080/019131290882286; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Sado Y, 1998, KIDNEY INT, V53, P664, DOI 10.1046/j.1523-1755.1998.00795.x; SAUS J, 1988, J BIOL CHEM, V263, P13374; Savige J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161802; Savige J, 2013, J AM SOC NEPHROL, V24, P364, DOI 10.1681/ASN.2012020148; Seeger H. P., 2018, J AM SOC NEPHROLOGY, P692; SPIRO RG, 1973, NEW ENGL J MED, V288, P1337; SPIRO RG, 1967, J BIOL CHEM, V242, P1915; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; Xie LJ, 2017, IMMUNOLOGY, V151, P395, DOI 10.1111/imm.12736; Yamamura T, 2017, KIDNEY INT REP, V2, P850, DOI 10.1016/j.ekir.2017.04.011; YURCHENCO PD, 1987, J CELL BIOL, V105, P2559, DOI 10.1083/jcb.105.6.2559	65	8	8	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100590	10.1016/j.jbc.2021.100590	http://dx.doi.org/10.1016/j.jbc.2021.100590			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33774048	Green Published, gold			2022-12-28	WOS:000672866400562
J	Wu, XZ; Brombacher, F; Chroneos, ZC; Norbury, CC; Gowda, DC				Wu, Xianzhu; Brombacher, Frank; Chroneos, Zissis C.; Norbury, Christopher C.; Gowda, D. Channe			IL-4R alpha signaling by CD8 alpha(+) dendritic cells contributes to cerebral malaria by enhancing inflammatory, Th1, and cytotoxic CD8(+) T cell responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTTING EDGE; PATHOGENESIS; PARASITE; HISTORY	Persistent high levels of proinflammatory and Th1 responses contribute to cerebral malaria (CM). Suppression of inflammatory responses and promotion of Th2 responses prevent pathogenesis. IL-4 commonly promotes Th2 responses and inhibits inflammatory and Th1 responses. Therefore, IL-4 is widely considered as a beneficial cytokine via its Th2-promoting role that is predicted to provide protection against severe malaria by inhibiting inflammatory responses. However, IL-4 may also induce inflammatory responses, as the result of IL-4 action depends on the timing and levels of its production and the tissue environment in which it is produced. Recently, we showed that dendritic cells (DCs) produce IL-4 early during malaria infection in response to a parasite protein and that this IL-4 response may contribute to severe malaria. However, the mechanism by which IL-4 produced by DCs contributing to lethal malaria is unknown. Using Plasmodium berghei ANKA-infected C57BL/6 mice, a CM model, we show here that mice lacking IL-4R alpha only in CD8 alpha(+) DCs are protected against CM pathogenesis and survive, whereas WT mice develop CM and die. Compared with WT mice, mice lacking IL-4R alpha in CD11c(+) or CD8 alpha(+) DCs showed reduced inflammatory responses leading to decreased Th1 and cytotoxic CD8(+) T cell responses, lower infiltration of CD8(+) T cells to the brain, and negligible brain pathology. The novel results presented here reveal a paradoxical role of IL-4R alpha signaling in CM pathogenesis that promotes CD8 alpha(+) DC-mediated inflammatory responses that generate damaging Th1 and cytotoxic CD8(+) T cell responses.	[Wu, Xianzhu; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Brombacher, Frank] Univ Cape Town, Fac Hlth Sci, Int Ctr Genet Engn & Biotechnol ICGEB, Component, Cape Town, South Africa; [Brombacher, Frank] Univ Cape Town, Fac Hlth Sci, Int Ctr Genet Engn & Biotechnol ICGEB, Div Immunol, Cape Town, South Africa; [Chroneos, Zissis C.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA USA; [Norbury, Christopher C.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gowda, DC (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	gowda@psu.edu		Brombacher, Frank/0000-0001-8881-6781; Norbury, Christopher/0000-0001-7411-6987; Gowda, Channe/0000-0002-6860-5108; Wu, Xianzhu/0000-0002-6892-378X; , Zissis/0000-0002-9841-7917	National Institute of Allergy and Infectious Diseases, NIH [R01 AI41139]; Pennsylvania Department of Health [4100083097]	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pennsylvania Department of Health	This work was funded in parts by the grant R01 AI41139 from the National Institute of Allergy and Infectious Diseases, NIH, and the grant with the Pennsylvania Department of Health using Tobacco CURE Funds SAP#4100083097 (D. C. G. and C. C. N.). The Pennsylvania Department of Health specifically disclaims responsibility for any analysis, interpretations, or conclusions. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amorim KNS, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2926436; Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725; Cabantous S, 2009, J INFECT DIS, V200, P1530, DOI 10.1086/644600; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; de Souza MC, 2016, CURRENT TOPICS IN MALARIA, P85, DOI 10.5772/65348; Deroost K, 2016, FEMS MICROBIOL REV, V40, P208, DOI 10.1093/femsre/fuv046; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; Ghazanfari N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02016; Guenova E, 2008, EUR J IMMUNOL, V38, P3138, DOI 10.1002/eji.200838463; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; MAKGOBA MW, 1988, EUR J IMMUNOL, V18, P637, DOI 10.1002/eji.1830180423; Mencacci A, 1998, J EXP MED, V187, P307, DOI 10.1084/jem.187.3.307; Mohrs M, 1999, J IMMUNOL, V162, P7302; Morris SC, 2009, J IMMUNOL, V182, P1429, DOI 10.4049/jimmunol.182.3.1429; Morrot A, 2004, INT J PARASITOL, V34, P1529, DOI 10.1016/j.ijpara.2004.10.001; Naves R, 2013, J IMMUNOL, V191, P2967, DOI 10.4049/jimmunol.1300419; Paul WE, 2015, CYTOKINE, V75, P3, DOI 10.1016/j.cyto.2015.01.038; Piva L, 2012, J IMMUNOL, V189, P1128, DOI 10.4049/jimmunol.1201171; Renia L, 2020, J CLIN INVEST, V130, P1109, DOI 10.1172/JCI135510; Riggle BA, 2020, J CLIN INVEST, V130, P1128, DOI 10.1172/JCI133474; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Sebina I, 2018, IMMUNOLOGY, V155, P176, DOI 10.1111/imm.12971; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Storm J, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00100; Swanson PA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006022; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Verra F, 2004, ACTA TROP, V90, P205, DOI 10.1016/j.actatropica.2003.11.014; Vigario AM, 2007, J IMMUNOL, V178, P6416, DOI 10.4049/jimmunol.178.10.6416; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Walsh KP, 2013, TRENDS IMMUNOL, V34, P521, DOI 10.1016/j.it.2013.07.006; Wu XZ, 2018, J BIOL CHEM, V293, P10425, DOI 10.1074/jbc.AC118.001720; Wu XZ, 2017, J BIOL CHEM, V292, P13615, DOI [10.1074/jbc.M116.770313, 10.1074/jbc.m116.770313]; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324	36	3	3	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100615	10.1016/j.jbc.2021.100615	http://dx.doi.org/10.1016/j.jbc.2021.100615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33798555	gold, Green Published			2022-12-28	WOS:000672866400586
J	Choi, BH; Kou, ZY; Colon, TM; Chen, CH; Chen, Y; Dai, W				Choi, Byeong Hyeok; Kou, Ziyue; Colon, Tania Marlyn; Chen, Chih-Hong; Chen, Yuan; Dai, Wei			Identification of Radil as a Ras binding partner and putative activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-RAS; ACTIN CYTOSKELETON; CELL-MIGRATION; ONCOGENIC RAS; E-CADHERIN; MOTILITY; ADHESION; INVASION; EMT	Ras genes are among the most frequently mutated oncogenes in human malignancies. To date, there are no successful anticancer drugs in the clinic that target Ras proteins or their pathways. Therefore, it is imperative to identify and characterize new components that regulate Ras activity or mediate its downstream signaling. To this end, we used a combination of affinity-pulldown and mass spectrometry to search for proteins that are physically associated with KRas. One of the top hits was Radil, a gene product with a Ras-association domain. Radil is known to be a downstream effector of Rap1, inhibiting RhoA signaling to regulate cell adhesion and migration. We demonstrate that Radil interacted with all three isoforms of Ras including HRas, NRas, and KRas, although it exhibited the strongest interaction with KRas. Moreover, Radil interacts with GTP-bound Ras more efficiently, suggesting a possibility that Radil may be involved in Ras activation. Supporting this, ectopic expression of Radil led to transient activation of mitogen-activated protein kinase kinase and extracellular signal-regulated kinase; Radil knockdown resulted in weakened activation of Ras downstream signaling components, which was coupled with decreased cell proliferation and invasion, and reduced expression of mesenchymal cell markers. Moreover, Radil knockdown greatly reduced the number of adhesion foci and depolymerized actin filaments, molecular processes that facilitate cancer cell migration. Taken together, our present studies strongly suggest that Radil is an important player for regulating Ras signaling, cell adhesion, and the epithelial-mesenchymal transition and may provide new directions for Ras-related anticancer drug development.	[Choi, Byeong Hyeok; Kou, Ziyue; Colon, Tania Marlyn; Dai, Wei] NYU, Dept Environm Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Chen, Chih-Hong; Chen, Yuan] UC San Diego Hlth, Dept Surg, La Jolla, CA USA; [Chen, Chih-Hong; Chen, Yuan] UC San Diego Hlth, Moores Canc Ctr, La Jolla, CA USA; [Dai, Wei] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, New York, NY 10003 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Dai, W (corresponding author), NYU, Dept Environm Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.; Dai, W (corresponding author), NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, New York, NY 10003 USA.	wei.dai@nyumc.org	Kou, Ziyue/GQB-5681-2022	Choi, Byeong Hyeok/0000-0002-8866-1131; Dai, Wei/0000-0003-0169-8327	US Public Service Awards [CA213159, CA216987]; NIEHS Center grant [ES000260]	US Public Service Awards; NIEHS Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by US Public Service Awards to W.D. (CA213159 and CA216987) and Y.C. (CA216987), and NIEHS Center grant (ES000260).	Ahmed SM, 2012, J CELL BIOL, V199, P951, DOI 10.1083/jcb.201206051; Bezdekova M, 2012, INT J MOL SCI, V13, P1632, DOI 10.3390/ijms13021632; Campbell K, 2016, DEVELOPMENT, V143, P4291, DOI 10.1242/dev.139071; Campbell K, 2010, MECH DEVELOP, V127, P345, DOI 10.1016/j.mod.2010.04.002; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Choi BH, 2018, J BIOL CHEM, V293, P17574, DOI 10.1074/jbc.RA118.003723; Chrzanowska-Wodnicka M, 2017, CURR OPIN HEMATOL, V24, P248, DOI 10.1097/MOH.0000000000000332; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Gingras AR, 2016, STRUCTURE, V24, P2152, DOI 10.1016/j.str.2016.10.001; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Konig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057996; Liu LH, 2012, MOL BIOL CELL, V23, P4751, DOI 10.1091/mbc.E12-05-0408; Lynch SJ, 2015, J CELL PHYSIOL, V230, P610, DOI 10.1002/jcp.24779; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nakhaeizadeh H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167145; Peled M, 2018, P NATL ACAD SCI USA, V115, pE468, DOI 10.1073/pnas.1710437115; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shah S, 2019, SEMIN CANCER BIOL, V54, P29, DOI 10.1016/j.semcancer.2018.03.005; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Smolen GA, 2007, GENE DEV, V21, P2131, DOI 10.1101/gad.1561507; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zhang Haibo, 2016, Small GTPases, V7, P39, DOI 10.1080/21541248.2016.1161698	34	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100314	10.1016/j.jbc.2021.100314	http://dx.doi.org/10.1016/j.jbc.2021.100314			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482197	gold, Green Published			2022-12-28	WOS:000672866400288
J	Cook, I; Cacace, M; Wang, T; Darrah, K; Deiters, A; Leyh, TS				Cook, Ian; Cacace, Mary; Wang, Ting; Darrah, Kristie; Deiters, Alexander; Leyh, Thomas S.			Small-molecule control of neurotransmitter sulfonation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTAL-DISORDERS; SULFOTRANSFERASE; DOPAMINE; LOCALIZATION; EXPRESSION; PARALLEL; GOVERNS; COMPLEX; SULT1A3; 1A1	Controlling unmodified serotonin levels in brain synapses is a primary objective when treating major depressive disorder-a disease that afflicts similar to 20% of the world's population. Roughly 60% of patients respond poorly to first-line treatments and thus new therapeutic strategies are sought. To this end, we have constructed isoform-specific inhibitors of the human cytosolic sulfotransferase 1A3 (SULT1A3)-the isoform responsible for sulfonating similar to 80% of the serotonin in the extracellular brain fluid. The inhibitor design includes a core ring structure, which anchors the inhibitor into a SULT1A3-specific binding pocket located outside the active site, and a side chain crafted to act as a latch to inhibit turnover by fastening down the SULT1A3 activesite cap. The inhibitors are allosteric, they bind with nanomolar affinity and are highly specific for the 1A3 isoform. The capstabilizing effects of the latch can be accurately calculated and are predicted to extend throughout the cap and into the surrounding protein. A free-energy correlation demonstrates that the percent inhibition at saturating inhibitor varies linearly with cap stabilization - the correlation is linear because the rate-limiting step of the catalytic cycle, nucleotide release, scales linearly with the fraction of enzyme in the cap-open form. Inhibitor efficacy in cultured cells was studied using a human mammary epithelial cell line that expresses SULT1A3 at levels comparable with those found in neurons. The inhibitors perform similarly in ex vivo and in vitro studies; consequently, SULT1A3 turnover can now be potently suppressed in an isoform-specific manner in human cells.	[Cook, Ian; Wang, Ting; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Cacace, Mary; Darrah, Kristie; Deiters, Alexander] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Wang, Ting] Boehringer Ingelheim GmbH & Co KG, Drug Metab & Pharmacokinet Dept, Danbury, CT USA	Yeshiva University; Albert Einstein College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Boehringer Ingelheim	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	tom.leyh@einsteinmed.org			National Institutes of Health [GM112728, GM121849, GM127144]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research supported by the National Institutes of Health Grants GM112728 (to A. D.), GM121849 (to T. S. L.), and GM127144 (to T. S. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker J, 2009, J COMPUT CHEM, V30, P317, DOI 10.1002/jcc.21052; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case DA, 2012, AMBER 12; Chesney E, 2014, WORLD PSYCHIATRY, V13, P153, DOI 10.1002/wps.20128; Cook I, 2019, BIOCHEM PHARMACOL, V159, P25, DOI 10.1016/j.bcp.2018.11.010; Cook I, 2016, CELL CHEM BIOL, V23, P579, DOI 10.1016/j.chembiol.2016.04.009; Cook I, 2015, BIOCHEMISTRY-US, V54, P6114, DOI 10.1021/acs.biochem.5b00406; Cook I, 2015, DRUG METAB DISPOS, V43, P418, DOI 10.1124/dmd.114.061887; Cook I, 2013, J BIOL CHEM, V288, P8619, DOI 10.1074/jbc.M112.445015; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook I, 2012, BIOCHEMISTRY-US, V51, P5674, DOI 10.1021/bi300631g; Cook IT, 2009, DRUG METAB DISPOS, V37, P2069, DOI 10.1124/dmd.108.025759; Dajani R, 1998, MOL PHARMACOL, V54, P942, DOI 10.1124/mol.54.6.942; Darrah K, 2019, J BIOL CHEM, V294, P2293, DOI 10.1074/jbc.RA118.006511; EBERHARDT ES, 1994, J AM CHEM SOC, V116, P2149, DOI 10.1021/ja00084a067; Eisenhofer G, 1999, CLIN EXP PHARMACOL P, V26, pS41; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Falany JL, 1996, CANCER RES, V56, P1551; Falany JL, 2006, DRUG METAB DISPOS, V34, P361, DOI 10.1124/dmd.105.006551; Grant GA, 2018, ARCH BIOCHEM BIOPHYS, V653, P10, DOI 10.1016/j.abb.2018.06.009; Lu JH, 2005, BIOCHEM BIOPH RES CO, V335, P417, DOI 10.1016/j.bbrc.2005.07.091; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Nowell S, 2006, ONCOGENE, V25, P1673, DOI 10.1038/sj.onc.1209376; Nurisso A, 2012, J CHEM INF MODEL, V52, P1319, DOI 10.1021/ci200515g; Olgiati P, 2018, J AFFECT DISORDERS, V227, P777, DOI 10.1016/j.jad.2017.11.004; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Salman ED, 2009, DRUG METAB DISPOS, V37, P706, DOI 10.1124/dmd.108.025767; Souery D, 1999, EUR NEUROPSYCHOPHARM, V9, P83, DOI 10.1016/S0924-977X(98)00004-2; STEWART MJ, 1983, BRIT J CLIN PHARMACO, V16, P3, DOI 10.1111/j.1365-2125.1983.tb02136.x; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Suominen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068007; Thomas SJ, 2015, PHARMACOTHERAPY, V35, P433, DOI 10.1002/phar.1576; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang T, 2017, J BIOL CHEM, V292, P20305, DOI 10.1074/jbc.M117.817387; Wang T, 2016, BIOCHEMISTRY-US, V55, P4036, DOI 10.1021/acs.biochem.6b00401; Wang T, 2014, BIOCHEMISTRY-US, V53, P6893, DOI 10.1021/bi501120p; Wang T, 2014, J BIOL CHEM, V289, P26474, DOI 10.1074/jbc.M114.573501; Weisz J, 2000, AM J PATHOL, V156, P1841, DOI 10.1016/S0002-9440(10)65057-2; Whiteley CG, 1999, BIOCHEM EDUC, V27, P15, DOI 10.1016/S0307-4412(98)00265-9; Zhu W, 2010, AAPS J, V12, P525, DOI 10.1208/s12248-010-9209-x	44	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100094	10.1074/jbc.RA120.015177	http://dx.doi.org/10.1074/jbc.RA120.015177			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33485192	gold, Green Published			2022-12-28	WOS:000672866400074
J	Gao, YG; Zhai, XH; Boldyrev, IA; Molotkovsky, JG; Patel, DJ; Malinina, L; Brown, RE				Gao, Yong-Guang; Zhai, Xiuhong; Boldyrev, Ivan A.; Molotkovsky, Julian G.; Patel, Dinshaw J.; Malinina, Lucy; Brown, Rhoderick E.			Ceramide-1-phosphate transfer protein (CPTP) regulation by phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLIPID TRANSFER PROTEIN; LIPID-TRANSFER; WEB SERVER; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; STRUCTURAL BASIS; MOLECULAR-BASIS; C2 DOMAINS; BINDING; TRANSPORT; CERAMIDE	Ceramide-1-phosphate transfer proteins (CPTPs) are members of the glycolipid transfer protein (GLTP) superfamily that shuttle ceramide-1-phosphate (C1P) between membranes. CPTPs regulate cellular sphingolipid homeostasis in ways that impact programmed cell death and inflammation. CPTP down-regulation specifically alters C1P levels in the plasma and trans-Golgi membranes, stimulating proinflammatory eicosanoid production and autophagy-dependent inflammasome-mediated cytokine release. However, the mechanisms used by CPTP to target the trans-Golgi and plasma membrane are not well understood. Here, we monitored C1P intervesicular transfer using fluorescence energy transfer (FRET) and showed that certain phosphoinositides (phosphatidylinositol 4,5 bisphosphate (PI(4,5)P-2) and phosphatidylinositol 4-phosphate (PI-4P)) increased CPTP transfer activity, whereas others (phosphatidylinositol 3-phosphate (PI-3P) and PI) did not. PIPs that stimulated CPTP did not stimulate GLTP, another superfamily member. Short-chain PI-(4,5)P-2, which is soluble and does not remain membrane-embedded, failed to activate CPTP. CPTP stimulation by physiologically relevant PI-(4,5)P-2 levels surpassed that of phosphatidylserine (PS), the only known non-PIP stimulator of CPTP, despite PI-(4,5)P-2 increasing membrane equilibrium binding affinity less effectively than PS. Functional mapping of mutations that led to altered FRET lipid transfer and assessment of CPTP membrane interaction by surface plasmon resonance indicated that di-arginine motifs located in the alpha-6 helix and the alpha 3-alpha 4 helix regulatory loop of the membrane-interaction region serve as PI-(4,5)P-2 headgroup-specific interaction sites. Haddock modeling revealed specific interactions involving the PI-(4,5)P-2 headgroup that left the acyl chains oriented favorably for membrane embedding. We propose that PI-(4,5)P-2 interaction sites enhance CPTP activity by serving as preferred membrane targeting/docking sites that favorably orient the protein for function.	[Gao, Yong-Guang; Zhai, Xiuhong; Malinina, Lucy; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Boldyrev, Ivan A.; Molotkovsky, Julian G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA; [Zhai, Xiuhong] Aveda Estee Lauder Co Inc, Res & Dev Dept, 4000 Pheast Ridge Dr NE, Blaine, MN 55449 USA	University of Minnesota System; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Memorial Sloan Kettering Cancer Center	Brown, RE (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	reb@umn.edu		Brown, Rhoderick/0000-0002-7337-3604	NHLBI [HL125353]; NIGMS [GM45928]; NCI [CA121493]; Russian Foundation for Basic Research [015-0407415]; Abby Rockefeller Mauze Trust; Maloris Foundation; Hormel Foundation	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Abby Rockefeller Mauze Trust; Maloris Foundation; Hormel Foundation	The research presented here was supported by NHLBI HL125353, NIGMS GM45928, and NCI CA121493; the Russian Foundation for Basic Research 015-0407415; Abby Rockefeller Mauze Trust, the Maloris Foundation, and the Hormel Foundation.	Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BERGELSON LD, 1985, CHEM PHYS LIPIDS, V37, P165, DOI 10.1016/0009-3084(85)90083-0; Boldyrev IA, 2013, RUSS J BIOORG CHEM+, V39, P539, DOI 10.1134/S106816201305004X; Brown R E, 1990, Subcell Biochem, V16, P333; BROWN RE, 1992, BIOCHIM BIOPHYS ACTA, V1113, P375, DOI 10.1016/0304-4157(92)90007-W; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Collins MD, 2013, BIOPHYS J, V105, P2485, DOI 10.1016/j.bpj.2013.09.035; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dickson EJ, 2014, P NATL ACAD SCI USA, V111, pE2281, DOI 10.1073/pnas.1407133111; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Grabon A, 2019, J LIPID RES, V60, P242, DOI 10.1194/jlr.R089730; Guillen J, 2013, P NATL ACAD SCI USA, V110, P20503, DOI 10.1073/pnas.1316179110; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hirano Y, 2019, ELIFE, V8, DOI 10.7554/eLife.44760; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Jian XY, 2015, STRUCTURE, V23, P1977, DOI 10.1016/j.str.2015.08.008; Johnson JL, 2012, J BIOL CHEM, V287, P5764, DOI 10.1074/jbc.M111.336487; Kamlekar RK, 2013, BBA-MOL CELL BIOL L, V1831, P417, DOI 10.1016/j.bbalip.2012.10.010; Kamlekar RK, 2010, BIOPHYS J, V99, P2626, DOI 10.1016/j.bpj.2010.08.038; Kenoth R, 2019, METHODS MOL BIOL, V1949, P237, DOI 10.1007/978-1-4939-9136-5_17; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kjellberg MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097263; Kumagai K, 2019, FEBS LETT, V593, P2366, DOI 10.1002/1873-3468.13511; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leon L, 2012, P NATL ACAD SCI USA, V109, P4357, DOI 10.1073/pnas.1200764109; Li LB, 2013, J PHYS CHEM B, V117, P11906, DOI 10.1021/jp405418y; Li XM, 2004, BIOCHEMISTRY-US, V43, P10285, DOI 10.1021/bi0495432; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; Lipp NF, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00663; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Luo J, 2019, TRENDS BIOCHEM SCI, V44, P273, DOI 10.1016/j.tibs.2018.10.001; MacCallum JL, 2011, TRENDS BIOCHEM SCI, V36, P653, DOI 10.1016/j.tibs.2011.08.003; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Malinina L, 2017, ANNU REV BIOCHEM, V86, P609, DOI 10.1146/annurev-biochem-061516-044445; Malinina L, 2015, Q REV BIOPHYS, V48, P281, DOI 10.1017/S003358351400016X; Mattjus P, 1999, ANAL BIOCHEM, V268, P297, DOI 10.1006/abio.1998.3065; Mattjus P, 2016, CHEM PHYS LIPIDS, V194, P72, DOI 10.1016/j.chemphyslip.2015.07.018; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; Mishra SK, 2020, PROG LIPID RES, V78, DOI 10.1016/j.plipres.2020.101031; Mishra SK, 2019, BBA-MOL CELL BIOL L, V1864, P158, DOI 10.1016/j.bbalip.2018.11.002; Mishra SK, 2018, AUTOPHAGY, V14, P862, DOI 10.1080/15548627.2017.1393129; MOLOTKOVSKY JG, 1991, CHEM PHYS LIPIDS, V58, P199, DOI 10.1016/0009-3084(91)90093-Q; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Ochoa-Lizarralde B, 2018, J BIOL CHEM, V293, P16709, DOI 10.1074/jbc.RA117.000733; Ohvo-Rekila H, 2011, BBA-BIOMEMBRANES, V1808, P47, DOI 10.1016/j.bbamem.2010.08.018; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picas L., 2016, F1000RESEARCH, V5, DOI [10.12688/f1000research.7537.1, DOI 10.12688/F1000RESEARCH.7537.1]; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Ran Y, 2009, BIOPHYS J, V97, P257, DOI 10.1016/j.bpj.2009.03.065; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Rao CS, 2004, BIOCHEMISTRY-US, V43, P13805, DOI 10.1021/bi0492197; Rovina P, 2006, BIOCHEM J, V400, P255, DOI 10.1042/BJ20060316; Samygina VR, 2011, STRUCTURE, V19, P1644, DOI 10.1016/j.str.2011.09.011; Scacioc A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14337-5; Schink KO, 2016, ANNU REV CELL DEV BI, V32, P143, DOI 10.1146/annurev-cellbio-111315-125349; Schulze H, 2014, BBA-MOL CELL BIOL L, V1841, P799, DOI 10.1016/j.bbalip.2013.10.015; Simanshu DK, 2014, CELL REP, V6, P388, DOI 10.1016/j.celrep.2013.12.023; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stahelin RV, 2014, CHEM PHYS LIPIDS, V182, P3, DOI 10.1016/j.chemphyslip.2014.02.002; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Tan XJ, 2015, J CELL SCI, V128, P4047, DOI 10.1242/jcs.175208; Teyton L, 2018, J LIPID RES, V59, P1367, DOI 10.1194/jlr.R083212; Thompson PM, 2017, STRUCTURE, V25, P264, DOI 10.1016/j.str.2016.12.002; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Ward KE, 2013, J LIPID RES, V54, P636, DOI 10.1194/jlr.M031088; Wen Y, 2018, BIOPHYS J, V114, P2630, DOI 10.1016/j.bpj.2018.04.048; Wong LH, 2019, NAT REV MOL CELL BIO, V20, P85, DOI 10.1038/s41580-018-0071-5; Wong LH, 2017, TRENDS BIOCHEM SCI, V42, P516, DOI 10.1016/j.tibs.2017.05.001; WONG M, 1984, BIOCHEMISTRY-US, V23, P6498, DOI 10.1021/bi00321a035; Yamaji T, 2015, TRAFFIC, V16, P101, DOI 10.1111/tra.12239; Zhai XH, 2017, J BIOL CHEM, V292, P2531, DOI 10.1074/jbc.M116.760256	85	3	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100600	10.1016/j.jbc.2021.100600	http://dx.doi.org/10.1016/j.jbc.2021.100600			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33781749	gold, Green Published			2022-12-28	WOS:000672866400572
J	Irmscher, T; Roske, Y; Gayk, I; Dunsing, V; Chiantia, S; Heinemann, U; Barbirz, S				Irmscher, Tobias; Roske, Yvette; Gayk, Igor; Dunsing, Valentin; Chiantia, Salvatore; Heinemann, Udo; Barbirz, Stefanie			Pantoea stewartii WceF is a glycan biofilm-modifying enzyme with a bacteriophage tailspike-like fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAD-BINDING DOMAIN; CRYSTAL-STRUCTURE; CAPSULAR EXOPOLYSACCHARIDE; O-ANTIGEN; PROTEIN; BIOSYNTHESIS; REVEALS; ENDORHAMNOSIDASE; RECOGNITION; AMYLOVORAN	Pathogenic microorganisms often reside in glycan-based biofilms. Concentration and chain length distribution of these mostly anionic exopolysaccharides (EPS) determine the overall biophysical properties of a biofilm and result in a highly viscous environment. Bacterial communities regulate this biofilm state via intracellular small-molecule signaling to initiate EPS synthesis. Reorganization or degradation of this glycan matrix, however, requires the action of extracellular glycosidases. So far, these were mainly described for bacteriophages that must degrade biofilms for gaining access to host bacteria. The plant pathogen Pantoea stewartii (P. stewartii) encodes the protein WceF within its EPS synthesis cluster. WceF has homologs in various biofilm forming plant pathogens of the Erwinia family. In this work, we show that WceF is a glycosidase active on stewartan, the main P. stewartii EPS biofilm component. WceF has remarkable structural similarity with bacteriophage tailspike proteins (TSPs). Crystal structure analysis showed a native trimer of right-handed parallel beta-helices. Despite its similar fold, WceF lacks the high stability found in bacteriophage TSPs. WceF is a stewartan hydrolase and produces oligosaccharides, corresponding to single stewartan repeat units. However, compared with a stewartan-specific glycan hydrolase of bacteriophage origin, WceF showed lectin-like autoagglutination with stewartan, resulting in notably slower EPS cleavage velocities. This emphasizes that the bacterial enzyme WceF has a role in P. stewartii biofilm glycan matrix reorganization clearly different from that of a bacteriophage exopolysaccharide depolymerase.	[Irmscher, Tobias; Gayk, Igor; Barbirz, Stefanie] Univ Potsdam, Phys Biochem, Potsdam, Germany; [Irmscher, Tobias] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany; [Roske, Yvette; Heinemann, Udo] Max Delbruck Ctr Mol Med, Crystallog, Berlin, Germany; [Dunsing, Valentin; Chiantia, Salvatore] Univ Potsdam, Phys Zellbiochem, Potsdam, Germany; [Heinemann, Udo] Freie Univ, Inst Chem & Biochem, Berlin, Germany	University of Potsdam; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Potsdam; Free University of Berlin	Barbirz, S (corresponding author), Univ Potsdam, Phys Biochem, Potsdam, Germany.; Heinemann, U (corresponding author), Max Delbruck Ctr Mol Med, Crystallog, Berlin, Germany.; Heinemann, U (corresponding author), Freie Univ, Inst Chem & Biochem, Berlin, Germany.	heinemann@mdc-berlin.de; barbirz@uni-potsdam.de	Heinemann, Udo/S-3379-2016; Chiantia, Salvatore/U-6363-2019	Heinemann, Udo/0000-0002-8191-3850; Chiantia, Salvatore/0000-0003-0791-967X; Dunsing, Valentin/0000-0003-2482-1498; Barbirz, Stefanie/0000-0001-6101-9862	Deutsche Forschungsgemeinschaft [BA 4046/1-2]; Max Planck Society grant [IMPRS Multiscale BioSystems]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society grant [IMPRS Multiscale BioSystems]	S.B. was funded by the Deutsche Forschungsgemeinschaft [grant number BA 4046/1-2]. T.I. received a Max Planck Society grant [IMPRS Multiscale BioSystems].	Adriaenssens EM, 2012, ARCH VIROL, V157, P2035, DOI 10.1007/s00705-012-1360-5; Albrecht MT, 2005, J BACTERIOL, V187, P3869, DOI 10.1128/JB.187.11.3869-3872.2005; Andres D, 2010, J BIOL CHEM, V285, P36768, DOI 10.1074/jbc.M110.169003; Baker P, 2015, J BIOL CHEM, V290, P28374, DOI 10.1074/jbc.M115.674929; Bamford NC, 2019, J BIOL CHEM, V294, P13833, DOI 10.1074/jbc.RA119.009910; Bamford NC, 2015, J BIOL CHEM, V290, P27438, DOI 10.1074/jbc.M115.679050; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Barbirz S, 2009, MACROMOL BIOSCI, V9, P169, DOI 10.1002/mabi.200800278; Bradley P, 2001, P NATL ACAD SCI USA, V98, P14819, DOI 10.1073/pnas.251267298; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Broeker NK, 2019, J BIOL CHEM, V294, P11751, DOI 10.1074/jbc.RA119.008133; Broeker NK, 2017, MOL MICROBIOL, V105, P353, DOI 10.1111/mmi.13729; Broeker NK., 2017, PERSPECT SCI, V11, P45, DOI DOI 10.1016/J.PISC.2016.10.001; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Carlier A, 2009, MOL MICROBIOL, V74, P903, DOI 10.1111/j.1365-2958.2009.06906.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherny KE, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00575-19; Cline K, 2015, J BIOL CHEM, V290, P16530, DOI 10.1074/jbc.R114.626820; Collins RF, 2017, STRUCTURE, V25, P806, DOI 10.1016/j.str.2017.03.017; DANNER M, 1993, EUR J BIOCHEM, V215, P653, DOI 10.1111/j.1432-1033.1993.tb18076.x; Dunsing V, 2019, BIOMACROMOLECULES, V20, P3842, DOI 10.1021/acs.biomac.9b00938; Duran-Pinedo AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028438; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleming D, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01998-16; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Greenfield J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43748-9; Hartung J. S., 1988, Molecular Plant-Microbe Interactions, V1, P87, DOI 10.1094/MPMI-1-087; Hengge R, 2019, MOLECULES, V24, DOI 10.3390/molecules24132403; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Latka A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02649; Latka A, 2017, APPL MICROBIOL BIOT, V101, P3103, DOI 10.1007/s00253-017-8224-6; Liston SD, 2018, P NATL ACAD SCI USA, V115, pE4870, DOI 10.1073/pnas.1801336115; Little DJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006998; Lohse MB, 2018, NAT REV MICROBIOL, V16, P19, DOI 10.1038/nrmicro.2017.107; Malinova I, 2014, PLANT PHYSIOL, V164, P907, DOI 10.1104/pp.113.227843; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller S, 1998, PROTEIN SCI, V7, P2223, DOI 10.1002/pro.5560071021; Moradali MF, 2020, NAT REV MICROBIOL, V18, P195, DOI 10.1038/s41579-019-0313-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nimtz M, 1996, CARBOHYD RES, V288, P189, DOI 10.1016/S0008-6215(96)90797-1; Nimtz M, 1996, CARBOHYD RES, V287, P59, DOI 10.1016/0008-6215(96)00070-5; Olsen NMC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080438; Patel KK, 2019, INT J PHARMACEUT, V563, P30, DOI 10.1016/j.ijpharm.2019.03.051; Pestrak MJ, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00234-19, 10.1128/aac.00234-19]; Plattner M, 2019, J MOL BIOL, V431, P3718, DOI 10.1016/j.jmb.2019.07.022; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Roper MC, 2011, MOL PLANT PATHOL, V12, P628, DOI [10.1111/j.1364-3703.2010.00698.x, 10.1111/J.1364-3703.2010.00698.X]; Rumbaugh KP, 2020, NAT REV MICROBIOL, V18, P571, DOI 10.1038/s41579-020-0385-0; Schollmeyer M, 2012, INT J BIOL MACROMOL, V50, P518, DOI 10.1016/j.ijbiomac.2012.01.003; Serra DO, 2014, ENVIRON MICROBIOL, V16, P1455, DOI 10.1111/1462-2920.12483; Seul A, 2014, ACTA CRYSTALLOGR D, V70, P1336, DOI 10.1107/S1399004714002685; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Snarr BD, 2017, P NATL ACAD SCI USA, V114, P7124, DOI 10.1073/pnas.1702798114; Sparta KM, 2016, J APPL CRYSTALLOGR, V49, P1085, DOI 10.1107/S1600576716004416; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; Stewart EJ, 2013, LANGMUIR, V29, P7017, DOI 10.1021/la401322k; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tielen P, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-159; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vidakovic L, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0050-1; Whitfield GB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00471; Witten J, 2017, NANOSCALE, V9, P8080, DOI 10.1039/c6nr09736g; Zhang JC, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00219-18; Zhang YQ, 2011, CARBOHYD POLYM, V85, P554, DOI 10.1016/j.carbpol.2011.03.009; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	70	0	0	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100286	10.1016/j.jbc.2021.100286	http://dx.doi.org/10.1016/j.jbc.2021.100286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450228	Green Accepted, Green Published, gold			2022-12-28	WOS:000672866400262
J	Islam, S; Dutta, P; Sahay, O; Santra, MK				Islam, Sehbanul; Dutta, Parul; Sahay, Osheen; Santra, Manas Kumar			beta-TrCP1 facilitates cell cycle checkpoint activation, DNA repair, and cell survival through ablation of beta-TrCP2 in response to genotoxic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEINS; KAPPA-B-ALPHA; BETA-TRCP; MEDIATED DEGRADATION; DEPENDENT DEGRADATION; TUMOR SUPPRESSION; DAMAGE; ATM; UBIQUITINATION; PROMOTES	F-box proteins beta-TrCP1 and beta-TrCP2 are paralogs present in the human genome. They control several cellular processes including cell cycle and DNA damage signaling. Moreover, it is reported that they facilitate DNA damage-induced accumulation of p53 by directing proteasomal degradation of MDM2, a protein that promotes p53 degradation. However, the individual roles of beta-TrCP1 and beta-TrCP2 in the genotoxic stress-induced activation of cell cycle checkpoints and DNA damage repair remain largely unknown. Here, using biochemical, molecular biology, flow cytometric, and immunofluorescence techniques, we show that beta-TrCP1 and beta-TrCP2 communicate during genotoxic stress. We found that expression levels of beta-TrCP1 are significantly increased while levels of beta-TrCP2 are markedly decreased upon induction of genotoxic stress. Further, our results revealed that DNA damage-induced activation of ATM kinase plays an important role in maintaining the reciprocal expression levels of beta-TrCP1 and beta-TrCP2 via the phosphorylation of beta-TrCP1 at Ser158. Phosphorylated beta-TrCP1 potently promotes the proteasomal degradation of beta-TrCP2 and MDM2, resulting in the activation of p53. Additionally, beta-TrCP1 impedes MDM2 accumulation via abrogation of its lysine 63-linked polyubiquitination by beta-TrCP2. Thus, beta-TrCP1 helps to arrest cells at the G2/M phase of the cell cycle and promotes DNA repair upon DNA damage through attenuation of beta-TrCP2. Collectively, our findings elucidate an intriguing posttranslational regulatory mechanism of these two paralogs under genotoxic stress and revealed beta-TrCP1 as a key player in maintaining the genome integrity through the attenuation of beta-TrCP2 levels in response to genotoxic stress.	[Islam, Sehbanul; Dutta, Parul; Sahay, Osheen; Santra, Manas Kumar] Natl Ctr Cell Sci, Mol Oncol Lab, Pune, Maharashtra, India; [Islam, Sehbanul; Dutta, Parul; Sahay, Osheen] Savitribai Phule Pune Univ, Dept Biotechnol, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University	Santra, MK (corresponding author), Natl Ctr Cell Sci, Mol Oncol Lab, Pune, Maharashtra, India.	manas@nccs.res.in		Dutta, Parul/0000-0003-1082-2617; Sahay, Osheen/0000-0001-5972-7632; Islam, Sehbanul/0000-0003-2686-2787	National Centre for Cell Science; Department of Biotechnology, Government of India [BT/HRD/NBA/39/01/2018-19]	National Centre for Cell Science; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	We thank Prof. Michael R. Green (University of Massachusetts Medical School, USA) for providing cell lines and shRNAs used in this study. We would like to thank Prof. Edward Yeh (University of California, USA), Dr Wuhan Xiao (Chinese Academy of Science, China), and Prof. Jae U. Jung (University of Southern California, USA) for providing cDNA constructs. We thank Dr Jayati Mullick for editorial assistance. This work was partly supported by National Centre for Cell Science and partly by Department of Biotechnology, Government of India (BT/HRD/NBA/39/01/2018-19). S. I. is senior DBT research fellow and P. D., O. S. are Senior UGC research fellows.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Bufalieri F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11093-0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cui DR, 2020, CELL DEATH DIFFER, V27, P1119, DOI 10.1038/s41418-019-0402-x; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; He NG, 2005, MOL CARCINOGEN, V42, P18, DOI 10.1002/mc.20063; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Janic A, 2018, NAT MED, V24, P947, DOI 10.1038/s41591-018-0043-5; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Kuo LJ, 2008, IN VIVO, V22, P305; Li JM, 2012, FRONT ONCOL, V2, P1, DOI [10.3389/fonc.2012.00029, 10.3389/fonc.2012.00079]; Liang J, 2017, ONCOL LETT, V14, P3131, DOI 10.3892/ol.2017.6533; Loveless TB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005292; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Nakagawa T, 2015, MOL CELL BIOL, V35, P3517, DOI 10.1128/MCB.00343-15; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; OConnor PM, 1997, CANCER RES, V57, P4285; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Ray D, 2005, MOL CELL BIOL, V25, P3338, DOI 10.1128/MCB.25.8.3338-3347.2005; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Wang LN, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0440-1; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Wang ZW, 2012, ONCOTARGET, V3, P1026; Wang ZW, 2012, AM J PHYSIOL-ENDOC M, V303, pE163, DOI 10.1152/ajpendo.00105.2012; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Yang QZ, 2020, MOL THER-NUCL ACIDS, V19, P974, DOI 10.1016/j.omtn.2019.11.035; Zhang Q, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-1030-8; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng NN, 2016, INT J BIOCHEM CELL B, V73, P99, DOI 10.1016/j.biocel.2016.02.005	54	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100511	10.1016/j.jbc.2021.100511	http://dx.doi.org/10.1016/j.jbc.2021.100511			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676897	Green Published, gold			2022-12-28	WOS:000672866400485
J	Liang, L; Wang, ZY; Qu, LH; Huang, W; Guo, S; Guan, XC; Zhang, W; Sun, FP; Yuan, HR; Zou, HR; Liu, HT; Yu, ZB				Liang, Lin; Wang, Zeyu; Qu, Lihua; Huang, Wei; Guo, Shuang; Guan, Xiangchen; Zhang, Wei; Sun, Fuping; Yuan, Hongrui; Zou, Huiru; Liu, Haitao; Yu, Zhongbo			Single-molecule multiplexed profiling of protein-DNA complexes using magnetic tweezers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-STRUCTURE; CXXC DOMAIN; BINDING; TET1; METHYLATION; GENE; FORK	Epigenetics, such as the dynamic interplay between DNA methylation and demethylation, play diverse roles in critical cellular events. Enzymatic activity at CpG sites, where cytosines are methylated or demethylated, is known to be influenced by the density of CpGs, methylation states, and the flanking sequences of a CpG site. However, how the relevant enzymes are recruited to and recognize their target DNA is less clear. Moreover, although DNA-binding epigenetic enzymes are ideal targets for therapeutic intervention, these targets have been rarely exploited. Single-molecule techniques offer excellent capabilities to probe site-specific protein-DNA interactions and unravel the dynamics. Here, we develop a single-molecule approach that allows multiplexed profiling of protein-DNA complexes using magnetic tweezers. When a DNA hairpin with multiple binding sites is unzipping, strand separation pauses at the positions bound by a protein. We can thus measure site-specific binding probabilities and dissociation time directly. Taking the TET1 CXXC domain as an example, we show that TET1 CXXC binds multiple CpG motifs with various flanking nucleotides or different methylation patterns in an AT-rich DNA. We are able to establish for the first time, at nanometer resolution, that TET1 CXXC prefers G/C flanked CpG motif over C/G, A/T, or T/A flanked ones. CpG methylation strengthens TET1 CXXC recruitment but has little effect on dissociation time. Finally, we demonstrate that TET1 CXXC can distinguish five CpG clusters in a CpG island with crowded binding motifs. We anticipate that the feasibility of single-molecule multiplexed profiling assays will contribute to the understanding of protein-DNA interactions.	[Liang, Lin; Wang, Zeyu; Qu, Lihua; Huang, Wei; Guo, Shuang; Guan, Xiangchen; Yu, Zhongbo] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Zhang, Wei; Sun, Fuping; Yuan, Hongrui; Liu, Haitao] Nankai Univ, Coll Elect Informat & Opt Engn, Inst Modern Opt, Tianjin Key Lab Optoelect Sensor & Sensing Networ, Tianjin, Peoples R China; [Zou, Huiru] Nankai Univ, Tianjin Stomatol Hosp, Affiliated Stomatol Hosp, Cent Lab, Tianjin, Peoples R China	Nankai University; Nankai University; Nankai University; Tianjin Medical University	Yu, ZB (corresponding author), Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin, Peoples R China.	zyu@nankai.edu.cn	Liang, Lin/AAH-9280-2021		Fundamental Research Funds for the Central Universities, Nankai University [035-63161138, 035-63191141, 035-63191735]; National Natural Science Foundation of China [31670763, 32071227]; National Natural Science Foundation of China	Fundamental Research Funds for the Central Universities, Nankai University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities, Nankai University [035-63161138, 035-63191141 and 035-63191735 to Z. Y.]. We also acknowledge support from the National Natural Science Foundation of China [Grants 31670763 and 32071227 to Z. Y.]. Funding for open access charge: National Natural Science Foundation of China.	Aguilar CA, 2013, NAT NANOTECHNOL, V8, P709, DOI 10.1038/nnano.2013.195; Berghuis BA, 2015, NAT CHEM BIOL, V11, P579, DOI [10.1038/NCHEMBIO.1857, 10.1038/nchembio.1857]; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Blackledge NP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a018648; Bosco A, 2014, NUCLEIC ACIDS RES, V42, P2064, DOI 10.1093/nar/gkt1089; Camunas-Soler J, 2017, SCIENCE, V355, P412, DOI 10.1126/science.aah4077; Chandradoss SD, 2015, CELL, V162, P96, DOI 10.1016/j.cell.2015.06.032; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Cnossen JP, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4898178; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Good CR, 2017, NUCLEIC ACIDS RES, V45, P8269, DOI 10.1093/nar/gkx435; Gulvady R, 2018, NUCLEIC ACIDS RES, V46, P10216, DOI 10.1093/nar/gky826; Guo SW, 2018, CHEM SCI, V9, P5871, DOI 10.1039/c8sc01319e; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Huang H, 2013, P NATL ACAD SCI USA, V110, P11994, DOI 10.1073/pnas.1310656110; Jiang X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02290-w; Kilchherr F, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5508; Koch SJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.028103; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Li N, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz464; Lipfert J, 2009, BIOPHYS J, V96, P5040, DOI 10.1016/j.bpj.2009.03.055; Lovkvist C, 2016, NUCLEIC ACIDS RES, V44, P5123, DOI 10.1093/nar/gkw124; Mandal S, 2015, ANGEW CHEM INT EDIT, V54, P7607, DOI 10.1002/anie.201502580; Manosas M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00379-w; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Ngo TTM, 2015, CELL, V160, P1135, DOI 10.1016/j.cell.2015.02.001; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schmutz I, 2017, NAT STRUCT MOL BIOL, V24, P734, DOI 10.1038/nsmb.3451; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Velthuis AJWT, 2010, BIOPHYS J, V99, P1292, DOI 10.1016/j.bpj.2010.06.008; Visacka K, 2012, J BIOL CHEM, V287, P32206, DOI 10.1074/jbc.M112.385591; Wang YN, 2019, BIOCHEMISTRY-US, V58, P4696, DOI 10.1021/acs.biochem.9b00453; Whitaker JW, 2015, NAT METHODS, V12, P265, DOI [10.1038/NMETH.3065, 10.1038/nmeth.3065]; Wu H, 2014, NAT BIOTECHNOL, V32, P1231, DOI 10.1038/nbt.3073; Xu C, 2018, STRUCTURE, V26, P85, DOI 10.1016/j.str.2017.11.022; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yan J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011905; Yu ZB, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4904148; Zhang Q, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw9807; Zhao XD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09104-5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	5	5	2	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100327	10.1016/j.jbc.2021.100327	http://dx.doi.org/10.1016/j.jbc.2021.100327			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493518	gold, Green Published			2022-12-28	WOS:000672866400301
J	Meier-Stephenson, V; Badmalia, MD; Mrozowich, T; Lau, KCK; Schultz, SK; Gemmill, DL; Osiowy, C; van Marle, G; Coffin, CS; Patel, TR				Meier-Stephenson, Vanessa; Badmalia, Maulik D.; Mrozowich, Tyler; Lau, Keith C. K.; Schultz, Sarah K.; Gemmill, Darren L.; Osiowy, Carla; van Marle, Guido; Coffin, Carla S.; Patel, Trushar R.			Identification and characterization of a G-quadruplex structure in the pre-core promoter region of hepatitis B virus covalently closed circular DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL MACROMOLECULES; HUMAN TELOMERASE; NATURAL-HISTORY; RNA; GENOME; TRANSCRIPTION; REPLICATION; PERSISTENCE; RECOGNITION; SCATTERING	Approximately 250 million people worldwide are chronically infected with the hepatitis B virus (HBV) and are at increased risk of developing cirrhosis and hepatocellular carcinoma. The HBV genome persists as covalently closed circular DNA (cccDNA), which serves as the template for all HBV mRNA transcripts. Current nucleos(t)ide analogs used to treat HBV do not directly target the HBV cccDNA genome and thus cannot eradicate HBV infection. Here, we report the discovery of a unique G-quadruplex structure in the pre-core promoter region of the HBV genome that is conserved among nearly all genotypes. This region is central to critical steps in the viral life cycle, including the generation of pregenomic RNA, synthesis of core and polymerase proteins, and genome encapsidation; thus, an increased understanding of the HBV pre-core region may lead to the identification of novel anti-HBV cccDNA targets. We utilized biophysical methods (circular dichroism and small-angle X-ray scattering) to characterize the HBV G-quadruplex and the effect of three distinct G to A mutants. We also used microscale thermophoresis to quantify the binding affinity of G-quadruplex and its mutants with a known quadruplex-binding protein (DHX36). To investigate the physiological relevance of HBV G-quadruplex, we employed assays using DHX36 to pull-down cccDNA and compared HBV infection in HepG2 cells transfected with wild-type and mutant HBV plasmids by monitoring the levels of genomic DNA, pregenomic RNA, and antigens. Further evaluation of this critical host-protein interaction site in the HBV cccDNA genome may facilitate the development of novel anti-HBV therapeutics against the resilient cccDNA template.	[Meier-Stephenson, Vanessa; Badmalia, Maulik D.; Mrozowich, Tyler; Schultz, Sarah K.; Gemmill, Darren L.; Patel, Trushar R.] Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, Lethbridge, AB, Canada; [Meier-Stephenson, Vanessa; Lau, Keith C. K.; van Marle, Guido; Coffin, Carla S.; Patel, Trushar R.] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Meier-Stephenson, Vanessa; Coffin, Carla S.] Cumming Sch Med, Dept Med, Calgary, AB, Canada; [Osiowy, Carla] Publ Hlth Agcy Canada, Natl Microbiol Lab, Viral Hepatitis & Bloodborne Pathogens, Winnipeg, MB, Canada; [Patel, Trushar R.] Univ Alberta, Fac Med & Dent, DiscoveryLab, Edmonton, AB, Canada	University of Lethbridge; University of Calgary; Public Health Agency of Canada; University of Alberta	Patel, TR (corresponding author), Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, Lethbridge, AB, Canada.; Coffin, CS; Patel, TR (corresponding author), Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.; Coffin, CS (corresponding author), Cumming Sch Med, Dept Med, Calgary, AB, Canada.; Patel, TR (corresponding author), Univ Alberta, Fac Med & Dent, DiscoveryLab, Edmonton, AB, Canada.	cscoffin@ucalgary.ca; trushar.patel@uleth.ca	; Patel, Trushar/F-2776-2011	Lau, Keith/0000-0001-7870-6597; van Marle, Guido/0000-0002-5148-6229; Patel, Trushar/0000-0003-0627-2923; Gemmill, Darren/0000-0003-2834-9063	Canadian Network on Hepatitis C Postdoctoral Fellowship; Canada Foundation for Innovation infrastructure grant; Cumming School of Medicine Seed Grant; Alberta Innovates Strategic Research Program grant; NSERC [RGPIN-2017-04004]; NSERC PGS-D fellowship; MITACS fellowship	Canadian Network on Hepatitis C Postdoctoral Fellowship; Canada Foundation for Innovation infrastructure grant(Canada Foundation for Innovation); Cumming School of Medicine Seed Grant; Alberta Innovates Strategic Research Program grant; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-D fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); MITACS fellowship	V. M. S. acknowledges the Canadian Network on Hepatitis C Postdoctoral Fellowship. T. R. P. is a Canada Research Chair in RNA and Protein Biophysics and acknowledges the Canada Foundation for Innovation infrastructure grant. T.R. P. and C. C. acknowledge the Cumming School of Medicine Seed Grant and Alberta Innovates Strategic Research Program grant. T. M. and M. B. were hired using NSERC Discovery (RGPIN-2017-04004) and Alberta Innovates Strategic Research Program grant, respectively. T. M. and M. B. also acknowledge NSERC PGS-D and MITACS fellowships. HPLC-SAXS data were collected at the B21 beamline, DIAMOND synchrotron (BAG proposal: SM22113), United Kingdom.	Ariyo EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144510; Artusi S, 2015, ANTIVIR RES, V118, P123, DOI 10.1016/j.antiviral.2015.03.016; Asamitsu S, 2019, MOLECULES, V24, DOI 10.3390/molecules24030429; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bartholomeusz A, 2004, REV MED VIROL, V14, P3, DOI 10.1002/rmv.400; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Biswas B, 2017, NUCLEIC ACIDS RES, V45, P11268, DOI 10.1093/nar/gkx823; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Buti M, 2005, J CLIN VIROL, V34, pS79, DOI 10.1016/S1386-6532(05)80015-0; Carvalho J, 2017, J CHEM EDUC, V94, P1547, DOI 10.1021/acs.jchemed.7b00160; Chauhan R, 2018, WORLD J HEPATOL, V10, P352, DOI 10.4254/wjh.v10.i3.352; Chen MC, 2018, NATURE, V558, P465, DOI 10.1038/s41586-018-0209-9; Coffin CS, 2018, CAN LIVER J, V1, P156, DOI 10.3138/canlivj.2018-0008; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Dapic V, 2003, NUCLEIC ACIDS RES, V31, P2097, DOI 10.1093/nar/gkg316; del Villar-Guerra R, 2018, ANGEW CHEM INT EDIT, V57, P7171, DOI 10.1002/anie.201709184; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Entzian C, 2016, METHODS, V97, P27, DOI 10.1016/j.ymeth.2015.08.023; Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Frasson I., 2020, TRANSCRIPTION FACTOR, DOI [10.1101/2020.07.14.202747, DOI 10.1101/2020.07.14.202747]; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gao S, 2017, J CLIN VIROL, V94, P8, DOI 10.1016/j.jcv.2017.06.009; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Guinier A., 1955, SMALL ANGLE SCATTERI; Guo HT, 2007, J VIROL, V81, P10072, DOI 10.1128/JVI.00541-07; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Hayer J, 2013, NUCLEIC ACIDS RES, V41, pD566, DOI 10.1093/nar/gks1022; Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Konig Sebastian L B, 2010, Biomol Concepts, V1, P197, DOI 10.1515/bmc.2010.011; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; Lau KCK, 2018, J VIRAL HEPATITIS, V25, P724, DOI 10.1111/jvh.12860; Lau KCK, 2020, CANCER LETT, V480, P39, DOI 10.1016/j.canlet.2020.03.022; Lau KCK, 2019, DIAGN MICR INFEC DIS, V93, P318, DOI 10.1016/j.diagmicrobio.2018.10.015; Lavezzo E, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006675; Lee Hannah M, 2019, Curr Treat Options Gastroenterol, V17, P271, DOI 10.1007/s11938-019-00236-3; Li J, 2001, J VIROL, V75, P8400, DOI 10.1128/JVI.75.18.8400-8406.2001; Lin CL, 2017, BEST PRACT RES CL GA, V31, P249, DOI 10.1016/j.bpg.2017.04.010; Luo XY, 2019, J AM CHEM SOC, V141, P5182, DOI 10.1021/jacs.8b10265; Madireddy A, 2016, NUCLEIC ACIDS RES, V44, P3675, DOI 10.1093/nar/gkw038; Magnez R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17963-1; Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494; Meier M, 2018, NUCLEIC ACIDS RES, V46, P5319, DOI 10.1093/nar/gky307; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Meier-Stephenson V, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110603; Metifiot M, 2014, NUCLEIC ACIDS RES, V42, P12352, DOI 10.1093/nar/gku999; MICHALAK TI, 1994, J CLIN INVEST, V93, P230, DOI 10.1172/JCI116950; Mitra B, 2019, J VIROL, V93, DOI 10.1128/JVI.00196-19; Monsen RC, 2020, NUCLEIC ACIDS RES, V48, P5720, DOI 10.1093/nar/gkaa107; Mrozowich T., 2019, BIOCHEMIST, V41, P8, DOI [10.1042/bio04102008, DOI 10.1042/BIO04102008]; Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/nchembio.1479, 10.1038/NCHEMBIO.1479]; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Osiowy C, 2008, J GEN VIROL, V89, P3009, DOI 10.1099/vir.0.2008/005124-0; Patel TR, 2012, MATRIX BIOL, V31, P135, DOI 10.1016/j.matbio.2011.11.004; Piekna-Przybylska D, 2014, BIOCHEMISTRY-US, V53, P2581, DOI 10.1021/bi4016692; Qin YL, 2017, METHODS MOL BIOL, V1540, P219, DOI 10.1007/978-1-4939-6700-1_18; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Rambo R., 2017, SCATTER JAVA BASED A; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Reuten R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13515; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Rigo R, 2017, BBA-GEN SUBJECTS, V1861, P1399, DOI 10.1016/j.bbagen.2016.12.024; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Song JW, 2016, TRANSLATION, V4, DOI 10.1080/21690731.2016.1244031; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanaka Y, 2008, VIROLOGY, V376, P408, DOI 10.1016/j.virol.2008.04.001; Terrault NA, 2018, HEPATOLOGY, V67, P1560, DOI 10.1002/hep.29800; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tippana R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09802-w; Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Turton KL, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020160; van Bommel F, 2015, HEPATOLOGY, V61, P66, DOI 10.1002/hep.27381; van der Kuyl AC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-540; Vlasenok M, 2017, DATA BRIEF, V11, P258, DOI 10.1016/j.dib.2017.02.023; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vorlickova M, 2012, METHODS, V57, P64, DOI 10.1016/j.ymeth.2012.03.011; Ward H, 2016, FUTURE MICROBIOL, V11, P1581, DOI 10.2217/fmb-2016-0128; Xu H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14432; Yang HC, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.64; Zoulim F, 2005, J HEPATOL, V42, P302, DOI 10.1016/j.jhep.2004.12.015; Zoulim F, 2016, CURR OPIN VIROL, V18, P109, DOI 10.1016/j.coviro.2016.06.004	94	5	5	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100589	10.1016/j.jbc.2021.100589	http://dx.doi.org/10.1016/j.jbc.2021.100589			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33774051	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400561
J	Narimatsu, Y; Bull, C; Chen, YH; Wandall, HH; Yang, Z; Clausen, H				Narimatsu, Yoshiki; Bull, Christian; Chen, Yen-Hsi; Wandall, Hans H.; Yang, Zhang; Clausen, Henrik			Genetic glycoengineering in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							O-LINKED GLYCOSYLATION; HAMSTER OVARY CELLS; ENZYME REPLACEMENT THERAPIES; N-GLYCOLYLNEURAMINIC ACID; FC-GAMMA-RIII; SIALIC-ACID; CHO-CELLS; PROTEIN GLYCOSYLATION; HIGH-THROUGHPUT; ANTIBODY GLYCOSYLATION	Advances in nuclease-based gene-editing technologies have enabled precise, stable, and systematic genetic engineering of glycosylation capacities in mammalian cells, opening up a plethora of opportunities for studying the glycome and exploiting glycans in biomedicine. Glycoengineering using chemical, enzymatic, and genetic approaches has a long history, and precise gene editing provides a nearly unlimited playground for stable engineering of glycosylation in mammalian cells to explore and dissect the glycome and its many biological functions. Genetic engineering of glycosylation in cells also brings studies of the glycome to the single cell level and opens up wider use and integration of data in traditional omics workflows in cell biology. The last few years have seen new applications of glycoengineering in mammalian cells with perspectives for wider use in basic and applied glycosciences, and these have already led to discoveries of functions of glycans and improved designs of glycoprotein therapeutics. Here, we review the current state of the art of genetic glycoengineering in mammalian cells and highlight emerging opportunities.	[Narimatsu, Yoshiki; Bull, Christian; Wandall, Hans H.; Yang, Zhang; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Copenhagen, Denmark; [Narimatsu, Yoshiki; Chen, Yen-Hsi; Yang, Zhang] GlycoDisplay ApS, Copenhagen, Denmark	University of Copenhagen	Narimatsu, Y; Bull, C; Clausen, H (corresponding author), Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Copenhagen, Denmark.; Narimatsu, Y (corresponding author), GlycoDisplay ApS, Copenhagen, Denmark.	yoshiki@sund.ku.dk; cbull@sund.ku.dk; hclau@sund.ku.dk	Büll, Christian/L-9417-2013; Büll, Christian/AAN-1946-2021; Narimatsu, Yoshiki/G-8388-2019	Büll, Christian/0000-0001-7785-2920; Büll, Christian/0000-0001-7785-2920; Narimatsu, Yoshiki/0000-0003-1428-5695; Wandall, Hans H./0000-0003-0240-9232; Chen, Yen-Hsi/0000-0001-9484-3145; Clausen, Henrik/0000-0002-0915-5055	Lundbeck Foundation; Danish National Research Foundation [DNRF107]; European Union [787684]; ERC Consolidator program [772735]; MSCA-ITN-2020 innovative training networks Imgene H2020	Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); European Union(European Commission); ERC Consolidator program; MSCA-ITN-2020 innovative training networks Imgene H2020	This work was supported by the Lundbeck Foundation, the Danish National Research Foundation (DNRF107), the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement No 787684 (to C. B.), the ERC Consolidator program (grant agreement No 772735 to H. W.), and the MSCA-ITN-2020 innovative training networks Imgene H2020 (to H. W.)	Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005; ACHORD DT, 1978, CELL, V15, P269, DOI 10.1016/0092-8674(78)90102-2; Agarwal K, 2013, J AM CHEM SOC, V135, P14189, DOI 10.1021/ja405189k; Agatemor C, 2019, NAT REV CHEM, V3, P605, DOI 10.1038/s41570-019-0126-y; Al Rifai O, 2020, ELIFE, V9, DOI 10.7554/eLife.61174; Alter G, 2018, SEMIN IMMUNOL, V39, P102, DOI 10.1016/j.smim.2018.05.003; Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; An HJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010660; Anthony RM, 2012, ANN NY ACAD SCI, V1253, P170, DOI 10.1111/j.1749-6632.2011.06305.x; Anzalone AV, 2020, NAT BIOTECHNOL, V38, P824, DOI 10.1038/s41587-020-0561-9; AQUINO D, 1980, FEBS LETT, V112, P195, DOI 10.1016/0014-5793(80)80178-5; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Ashwell G, 1978, Methods Enzymol, V50, P287; Bagdonaite I, 2020, EMBO REP, V21, DOI 10.15252/embr.201948885; Baggen J, 2016, P NATL ACAD SCI USA, V113, P1399, DOI 10.1073/pnas.1524498113; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Bas M, 2019, J IMMUNOL, V202, P1582, DOI 10.4049/jimmunol.1800896; Baumann S, 2016, J BIOL CHEM, V291, P18514, DOI 10.1074/jbc.M116.723379; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Belardi B, 2015, CHEM BIOL, V22, P983, DOI 10.1016/j.chembiol.2015.07.009; Bennett EP, 2020, NUCLEIC ACIDS RES, V48, P11958, DOI 10.1093/nar/gkaa975; Blanas A, 2019, GLYCOBIOLOGY, V29, P137, DOI 10.1093/glycob/cwy096; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2010, J PROTEOME RES, V9, P5250, DOI 10.1021/pr1005229; Blondel CJ, 2016, CELL HOST MICROBE, V20, P226, DOI 10.1016/j.chom.2016.06.010; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bork K, 2009, J PHARM SCI-US, V98, P3499, DOI 10.1002/jps.21684; Bosques CJ, 2010, NAT BIOTECHNOL, V28, P1153, DOI 10.1038/nbt1110-1153; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; BRADY RO, 1994, J INHERIT METAB DIS, V17, P510, DOI 10.1007/BF00711365; Buettner MJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02485; Bull Christian, 2020, STAR Protoc, V1, P100017, DOI 10.1016/j.xpro.2020.100017; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; Bydlinski N, 2018, J BIOTECHNOL, V282, P101, DOI 10.1016/j.jbiotec.2018.07.015; Byrne G, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005817; Campos D, 2015, MOL CELL PROTEOMICS, V14, P1616, DOI 10.1074/mcp.M114.046862; Carillo S, 2017, METHODS MOL BIOL, V1603, P227, DOI 10.1007/978-1-4939-6972-2_15; Caval T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05536-3; Chan KF, 2016, BIOTECHNOL J, V11, P399, DOI 10.1002/biot.201500331; Chang MM, 2019, NAT CHEM BIOL, V15, P730, DOI 10.1038/s41589-019-0288-4; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/NMETH.3312, 10.1038/nmeth.3312]; Chen XY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00687-1; Chen YH, 2018, NAT METHODS, V15, P881, DOI 10.1038/s41592-018-0086-z; Cherepanova NA, 2019, J CELL BIOL, V218, P2782, DOI 10.1083/jcb.201904004; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Choi J, 2019, J AM CHEM SOC, V141, P13442, DOI 10.1021/jacs.9b04695; Cioce Anna, 2021, Curr Opin Chem Biol, V60, P66, DOI 10.1016/j.cbpa.2020.09.001; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Cobb BA, 2020, GLYCOBIOLOGY, V30, P202, DOI 10.1093/glycob/cwz065; Cohen M, 2014, INT REV CEL MOL BIO, V308, P75, DOI 10.1016/B978-0-12-800097-7.00003-8; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coutinho MF, 2012, MOL GENET METAB, V105, P542, DOI 10.1016/j.ymgme.2011.12.012; Crispin M, 2013, P NATL ACAD SCI USA, V110, pE3544, DOI 10.1073/pnas.1310657110; Cummings RD, 2014, CHEM BIOL, V21, P1, DOI 10.1016/j.chembiol.2013.12.010; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; D'Atri V, 2019, ANAL CHEM, V91, P873, DOI 10.1021/acs.analchem.8b03584; DABELSTEEN E, 1982, J INVEST DERMATOL, V79, P3, DOI 10.1111/1523-1747.ep12510411; Dabelsteen S, 2020, DEV CELL, V54, P669, DOI 10.1016/j.devcel.2020.06.039; Darula Z, 2009, MOL CELL PROTEOMICS, V8, P2515, DOI 10.1074/mcp.M900211-MCP200; Das A, 2020, NAT MICROBIOL, V5, P1069, DOI 10.1038/s41564-020-0727-8; de las Rivas M, 2020, NAT CHEM BIOL, V16, P351, DOI 10.1038/s41589-019-0444-x; de las Rivas M, 2019, CURR OPIN STRUC BIOL, V56, P87, DOI 10.1016/j.sbi.2018.12.007; de Vries T, 2001, GLYCOBIOLOGY, V11, p119R, DOI 10.1093/glycob/11.10.119R; Debets MF, 2020, P NATL ACAD SCI USA, V117, P25293, DOI 10.1073/pnas.2007297117; Decker CE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56670-x; DeFrees S, 2006, GLYCOBIOLOGY, V16, P833, DOI 10.1093/glycob/cwl004; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Dekkers G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00877; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146/annurev-genom-090711-163739; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Dicker M, 2015, EXPERT OPIN BIOL TH, V15, P1501, DOI 10.1517/14712598.2015.1069271; DOEBBER TW, 1982, J BIOL CHEM, V257, P2193; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doudna JA, 2020, NATURE, V578, P229, DOI 10.1038/s41586-020-1978-5; Dube DH, 2006, P NATL ACAD SCI USA, V103, P4819, DOI 10.1073/pnas.0506855103; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Erting FH, 2014, LEUKEMIA LYMPHOMA, V55, P2151, DOI 10.3109/10428194.2013.856008; Esko J. D., 2009, ESSENTIALS GLYCOBIOL, P627; Esko J. D., 2015, ESSENTIALS GLYCOBIOL, P627; Esko J. D., 2015, ESSENTIALS GLYCOBIOL, P701, DOI DOI 10.1101/GLYCOBIOLOGY.3E.055; Falck D, 2021, MABS-AUSTIN, V13, DOI 10.1080/19420862.2020.1865596; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Flint M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08135-4; Flores A, 2019, P NATL ACAD SCI USA, V116, P18098, DOI 10.1073/pnas.1908051116; Freeze H H, 2015, ESSENTIALS GLYCOBIOL, P521; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; FUKUDA MN, 1989, BLOOD, V73, P84; FURBISH FS, 1978, BIOCHEM BIOPH RES CO, V81, P1047, DOI 10.1016/0006-291X(78)91456-0; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gao C, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00833; Geisler C, 2015, METHODS MOL BIOL, V1321, P131, DOI 10.1007/978-1-4939-2760-9_10; Geissner A, 2016, ANNU REV ANAL CHEM, V9, P223, DOI 10.1146/annurev-anchem-071015-041641; Gerdes CA, 2014, CLIN CANCER RES, V20, P1055, DOI 10.1158/1078-0432.CCR-13-2699; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goh JB, 2018, CRIT REV BIOTECHNOL, V38, P851, DOI 10.1080/07388551.2017.1416577; Goncalves MAFV, 2012, NUCLEIC ACIDS RES, V40, P3443, DOI 10.1093/nar/gkr1234; Goth CK, 2017, J BIOL CHEM, V292, P4714, DOI 10.1074/jbc.M116.730614; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; GOTTLIEB C, 1976, J BIOL CHEM, V251, P7761; GOTTLIEB C, 1974, P NATL ACAD SCI USA, V71, P1078, DOI 10.1073/pnas.71.4.1078; Griffin ME, 2016, CELL CHEM BIOL, V23, P108, DOI 10.1016/j.chembiol.2015.12.007; Gudelja I, 2018, CELL IMMUNOL, V333, P65, DOI 10.1016/j.cellimm.2018.07.009; Ha TK, 2020, METAB ENG, V57, P182, DOI 10.1016/j.ymben.2019.11.008; Haga K, 2020, MBIO, V11, DOI 10.1128/mBio.00251-20; Han J, 2018, CELL REP, V23, P596, DOI 10.1016/j.celrep.2018.03.045; Hang HC, 2004, CHEM BIOL, V11, P337, DOI 10.1016/j.chembiol.2004.02.023; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hanna RE, 2020, NAT BIOTECHNOL, V38, P813, DOI 10.1038/s41587-020-0490-7; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Heaton BE, 2017, CELL REP, V20, P1503, DOI 10.1016/j.celrep.2017.07.060; Heise T, 2019, J MED CHEM, V62, P1014, DOI 10.1021/acs.jmedchem.8b01757; Hennet T, 2019, CURR OPIN STRUC BIOL, V56, P131, DOI 10.1016/j.sbi.2019.01.015; Henrissat B., 2015, ESSENTIALS GLYCOBIOL, P89; Herter S, 2014, J IMMUNOL, V192, P2252, DOI 10.4049/jimmunol.1301249; Hintze J, 2018, J BIOL CHEM, V293, P19064, DOI 10.1074/jbc.RA118.004516; Hirata T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02799-0; Hong SL, 2021, ANGEW CHEM INT EDIT, V60, P3603, DOI 10.1002/anie.202005934; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hudak JE, 2014, CHEM BIOL, V21, P16, DOI 10.1016/j.chembiol.2013.09.010; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jefferis R, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5358272; Jennewein MF, 2017, TRENDS IMMUNOL, V38, P358, DOI 10.1016/j.it.2017.02.004; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joshi HJ, 2018, GLYCOBIOLOGY, V28, P284, DOI 10.1093/glycob/cwy015; Joshi HJ, 2018, CELL, V172, P632, DOI 10.1016/j.cell.2018.01.016; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Kaji H, 2006, NAT PROTOC, V1, P3019, DOI 10.1038/nprot.2006.444; Kampmann M, 2020, NAT REV NEUROL, V16, P465, DOI 10.1038/s41582-020-0373-z; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Kanda Y, 2007, J BIOTECHNOL, V130, P300, DOI 10.1016/j.jbiotec.2007.04.025; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Katayama K, 2019, CURR OPIN CHEM BIOL, V52, P79, DOI 10.1016/j.cbpa.2019.05.020; Kelkar A, 2020, MOL THER, V28, P29, DOI 10.1016/j.ymthe.2019.09.006; Kellokumpu S, 2016, CELL MOL LIFE SCI, V73, P305, DOI 10.1007/s00018-015-2066-0; Khetarpal SA, 2016, CELL METAB, V24, P234, DOI 10.1016/j.cmet.2016.07.012; Khoo KH, 2019, CURR OPIN STRUC BIOL, V56, P146, DOI 10.1016/j.sbi.2019.02.007; Kightlinger W, 2020, ACS SYNTH BIOL, V9, P1534, DOI 10.1021/acssynbio.0c00210; Kim SY, 2020, ANTIVIR RES, V181, DOI 10.1016/j.antiviral.2020.104873; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Koch B, 2018, NAT PROTOC, V13, P1465, DOI 10.1038/nprot.2018.042; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; Kuwabara N, 2016, P NATL ACAD SCI USA, V113, P9280, DOI 10.1073/pnas.1525545113; Labeau A, 2020, J VIROL, V94, DOI 10.1128/JVI.01751-19; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lackman JJ, 2018, CELL SIGNAL, V42, P184, DOI 10.1016/j.cellsig.2017.10.016; LAI PH, 1986, J BIOL CHEM, V261, P3116; Lalonde ME, 2017, J BIOTECHNOL, V251, P128, DOI 10.1016/j.jbiotec.2017.04.028; Larsen ISB, 2017, P NATL ACAD SCI USA, V114, P11163, DOI 10.1073/pnas.1708319114; Larsen ISB, 2017, J BIOL CHEM, V292, P11586, DOI 10.1074/jbc.M117.794487; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Laukens B, 2015, FUTURE MICROBIOL, V10, P21, DOI 10.2217/fmb.14.104; Lavrsen K, 2018, J BIOL CHEM, V293, P1298, DOI 10.1074/jbc.M117.812826; LEE EU, 1989, J BIOL CHEM, V264, P13848; Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034; Leney AC, 2017, J AM SOC MASS SPECTR, V28, P5, DOI 10.1007/s13361-016-1545-3; Levery SB, 2015, BBA-GEN SUBJECTS, V1850, P33, DOI 10.1016/j.bbagen.2014.09.026; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Li HY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-019-0089-y; Li HJ, 2009, CURR OPIN BIOTECH, V20, P678, DOI 10.1016/j.copbio.2009.10.009; Lin DL, 2017, MBIO, V8, DOI [10.1128/mbio.00939-17, 10.1128/mBio.00939-17]; Lindberg Linda, 2013, Methods Mol Biol, V988, P3, DOI 10.1007/978-1-62703-327-5_1; Lino CA, 2018, DRUG DELIV, V25, P1234, DOI 10.1080/10717544.2018.1474964; Liu TW, 2012, GLYCOBIOLOGY, V22, P630, DOI 10.1093/glycob/cwr189; Lonowski LA, 2017, NAT PROTOC, V12, P581, DOI 10.1038/nprot.2016.165; Lopez-Sambrooks C, 2016, NAT CHEM BIOL, V12, P1023, DOI 10.1038/nchembio.2194; Louie S, 2017, BIOTECHNOL BIOENG, V114, P632, DOI 10.1002/bit.26188; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Majumder S, 2020, J BIOL CHEM, V295, P4341, DOI 10.1074/jbc.AC119.011170; Malphettes L, 2010, BIOTECHNOL BIOENG, V106, P774, DOI 10.1002/bit.22751; Manya H, 2016, J BIOL CHEM, V291, P24618, DOI 10.1074/jbc.M116.751917; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Marth JD, 1996, GLYCOBIOLOGY, V6, P701, DOI 10.1093/glycob/6.7.701; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; Matharu N, 2019, SCIENCE, V363, P246, DOI 10.1126/science.aau0629; Mathiesen CBK, 2018, J ALLERGY CLIN IMMUN, V142, P1983, DOI 10.1016/j.jaci.2018.07.030; Mbua NE, 2013, ANGEW CHEM INT EDIT, V52, P13012, DOI 10.1002/anie.201307095; Mehta AY, 2020, CELL CHEM BIOL, V27, P1207, DOI 10.1016/j.chembiol.2020.06.007; Mehta AY, 2020, CURR OPIN STRUC BIOL, V62, P102, DOI 10.1016/j.sbi.2019.12.002; Meuris L, 2014, NAT BIOTECHNOL, V32, P485, DOI 10.1038/nbt.2885; Miyazaki H, 1997, J BIOL CHEM, V272, P24794, DOI 10.1074/jbc.272.40.24794; Mizukami A, 2018, METHODS MOL BIOL, V1674, P1, DOI 10.1007/978-1-4939-7312-5_1; Molla KA, 2019, TRENDS BIOTECHNOL, V37, P1121, DOI 10.1016/j.tibtech.2019.03.008; Mondal N, 2018, J BIOL CHEM, V293, P7300, DOI 10.1074/jbc.RA117.000775; Mondal N, 2015, BLOOD, V125, P687, DOI 10.1182/blood-2014-07-588590; Montero-Morales L, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00081; Monti E, 2015, TOP CURR CHEM, V366, P183, DOI 10.1007/128_2012_328; Moons SJ, 2019, GLYCOBIOLOGY, V29, P433, DOI 10.1093/glycob/cwz026; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Moremen KW, 2019, NAT CHEM BIOL, V15, P853, DOI 10.1038/s41589-019-0350-2; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Mottram L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29258-0; Naegeli A, 2015, METHODS MOL BIOL, V1321, P3, DOI 10.1007/978-1-4939-2760-9_1; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Nairn AV, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405233; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Narimatsu H, 2018, J PROTEOME RES, V17, P4097, DOI 10.1021/acs.jproteome.8b00515; Narimatsu Y, 2019, MOL CELL PROTEOMICS, V18, P1396, DOI 10.1074/mcp.RA118.001121; Narimatsu Y, 2019, MOL CELL, V75, P394, DOI 10.1016/j.molcel.2019.05.017; Narimatsu Y, 2018, GLYCOBIOLOGY, V28, P295, DOI 10.1093/glycob/cwx101; Nielsen MI, 2018, J BIOL CHEM, V293, P20249, DOI 10.1074/jbc.RA118.004636; Nilsson J, 2013, GLYCOCONJUGATE J, V30, P119, DOI 10.1007/s10719-012-9438-6; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; NOGUCHI A, 1995, J BIOCHEM-TOKYO, V117, P59, DOI 10.1093/oxfordjournals.jbchem.a124721; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Oh S, 2018, METHODS, V133, P29, DOI 10.1016/j.ymeth.2017.10.008; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ooi YS, 2019, NAT MICROBIOL, V4, P2369, DOI 10.1038/s41564-019-0518-2; Oppenheim DE, 2014, BRIT J CANCER, V110, P1221, DOI 10.1038/bjc.2014.35; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Orr SL, 2013, GLYCOBIOLOGY, V23, P363, DOI 10.1093/glycob/cws150; Pacheco AR, 2018, MBIO, V9, DOI 10.1128/mBio.01003-18; Packer N. H., 2015, ESSENTIALS GLYCOBIOL, P729; Papapetrou EP, 2016, MOL THER, V24, P678, DOI 10.1038/mt.2016.38; Park DD, 2018, CHEM SCI, V9, P6271, DOI 10.1039/c8sc01875h; Parsons TB, 2016, ANGEW CHEM INT EDIT, V55, P2361, DOI 10.1002/anie.201508723; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Paulson JC, 2009, NAT STRUCT MOL BIOL, V16, P1121, DOI 10.1038/nsmb1109-1121; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Pereira NA, 2018, MABS-AUSTIN, V10, P693, DOI 10.1080/19420862.2018.1466767; Peschke B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00646; Pinto R, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx371; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Plomp R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12495-0; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Qiu H, 2018, NAT METHODS, V15, P889, DOI 10.1038/s41592-018-0189-6; Quast I, 2015, J CLIN INVEST, V125, P4160, DOI 10.1172/JCI82695; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren CH, 2019, TRENDS BIOTECHNOL, V37, P56, DOI 10.1016/j.tibtech.2018.07.017; Riemersma M, 2015, CHEM BIOL, V22, P1643, DOI 10.1016/j.chembiol.2015.10.014; Riemersma M, 2015, HUM MOL GENET, V24, P2241, DOI 10.1093/hmg/ddu742; Riley NM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09222-w; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rillahan CD, 2011, ANGEW CHEM INT EDIT, V50, P12534, DOI 10.1002/anie.201105065; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Rinis N, 2018, CELL CHEM BIOL, V25, P1231, DOI 10.1016/j.chembiol.2018.07.005; Rosati S, 2012, ANGEW CHEM INT EDIT, V51, P12992, DOI 10.1002/anie.201206745; Rose RJ, 2012, NAT METHODS, V9, P1084, DOI [10.1038/NMETH.2208, 10.1038/nmeth.2208]; Roy G, 2018, MABS-AUSTIN, V10, P416, DOI 10.1080/19420862.2018.1433975; Rudd P., 2015, ESSENTIALS GLYCOBIOL, P653; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Sales MD, 2021, J BIOTECHNOL, V327, P18, DOI 10.1016/j.jbiotec.2020.12.016; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Schjoldager KT, 2020, NAT REV MOL CELL BIO, V21, P729, DOI 10.1038/s41580-020-00294-x; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schmid-Burgk JL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12338; Schulz MA, 2018, GLYCOBIOLOGY, V28, P542, DOI 10.1093/glycob/cwy022; Schumann B, 2020, MOL CELL, V78, P824, DOI 10.1016/j.molcel.2020.03.030; Seeling M, 2017, NAT REV RHEUMATOL, V13, P621, DOI 10.1038/nrrheum.2017.146; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shcherbakova A, 2017, P NATL ACAD SCI USA, V114, P2574, DOI 10.1073/pnas.1613165114; Shi WX, 1996, J BIOL CHEM, V271, P15130, DOI 10.1074/jbc.271.25.15130; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Simon EJ, 2018, J BIOL CHEM, V293, P19866, DOI 10.1074/jbc.RA118.005375; Slade PG, 2012, J PROTEOME RES, V11, P6175, DOI 10.1021/pr300810f; Solomon M, 2017, ADV DRUG DELIVER REV, V118, P109, DOI 10.1016/j.addr.2017.05.004; Song L, 2017, ELIFE, V6, DOI 10.7554/eLife.24051; Song LN, 2014, J BIOL CHEM, V289, P30556, DOI 10.1074/jbc.M114.599563; Sorensen ALT, 2012, BBA-GEN SUBJECTS, V1820, P1797, DOI 10.1016/j.bbagen.2012.07.008; STANLEY P, 1983, SOMAT CELL GENET, V9, P593, DOI 10.1007/BF01574260; STANLEY P, 1980, J CELL BIOL, V85, P60, DOI 10.1083/jcb.85.1.60; Stanley P, 2016, J MOL BIOL, V428, P3166, DOI 10.1016/j.jmb.2016.03.025; Steentoft C, 2014, GLYCOBIOLOGY, V24, P663, DOI 10.1093/glycob/cwu046; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Stewart SE, 2017, J CELL SCI, V130, P3234, DOI 10.1242/jcs.206425; Stolfa G, 2016, SCI REP-UK, V6, DOI 10.1038/srep30392; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Stopschinski BE, 2018, J BIOL CHEM, V293, P10826, DOI 10.1074/jbc.RA117.000378; Strasser R, 2014, CURR OPIN BIOTECH, V30, P95, DOI 10.1016/j.copbio.2014.06.008; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; TAKATSUKI A, 1971, J ANTIBIOT, V24, P215, DOI 10.7164/antibiotics.24.215; Takeuchi H, 2018, P NATL ACAD SCI USA, V115, pE8395, DOI 10.1073/pnas.1804005115; Termini JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179949; Thomann M, 2016, MOL IMMUNOL, V73, P69, DOI 10.1016/j.molimm.2016.03.002; Tian E, 2008, J BIOL CHEM, V283, P4460; Tian E, 2019, P NATL ACAD SCI USA, V116, P25196, DOI 10.1073/pnas.1909573116; Tian SH, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006951; Tian WH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09809-3; Tiels P, 2012, NAT BIOTECHNOL, V30, P1225, DOI 10.1038/nbt.2427; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; Togayachi A, 2006, METHOD ENZYMOL, V416, P91, DOI 10.1016/S0076-6879(06)16006-1; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; van Beers MMC, 2012, BIOTECHNOL J, V7, P1473, DOI 10.1002/biot.201200065; van Haasteren J, 2020, NAT BIOTECHNOL, V38, P845, DOI 10.1038/s41587-020-0565-5; Van Landuyt L, 2019, CURR OPIN BIOTECH, V60, P17, DOI 10.1016/j.copbio.2018.11.017; van Wijk XM, 2013, ACS CHEM BIOL, V8, P2331, DOI 10.1021/cb4004332; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Walsh G, 2018, NAT BIOTECHNOL, V36, P1136, DOI 10.1038/nbt.4305; Walsh G, 2010, DRUG DISCOV TODAY, V15, P773, DOI 10.1016/j.drudis.2010.06.009; Walton RT, 2020, SCIENCE, V368, P290, DOI 10.1126/science.aba8853; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Wang Q, 2018, METHODS MOL BIOL, V1850, P237, DOI 10.1007/978-1-4939-8730-6_16; Wang SJ, 2018, J BIOL CHEM, V293, P7408, DOI 10.1074/jbc.M117.817981; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang YC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14678-2; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Weber J, 2020, NAT REV CANCER, V20, P573, DOI 10.1038/s41568-020-0275-9; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; Willems AP, 2019, BBA-GEN SUBJECTS, V1863, P1471, DOI 10.1016/j.bbagen.2019.05.011; Wohlschlager T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04061-7; Woo CM, 2017, J PROTEOME RES, V16, P1706, DOI 10.1021/acs.jproteome.6b01053; Xu YJ, 2016, J BIOL CHEM, V291, P23477, DOI 10.1074/jbc.M116.743955; Yamaji T, 2019, ISCIENCE, V15, P407, DOI 10.1016/j.isci.2019.05.005; Yamaji T, 2019, ISCIENCE, V11, P409, DOI 10.1016/j.isci.2018.12.039; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yang S, 2018, ANAL CHEM, V90, P8261, DOI 10.1021/acs.analchem.8b01834; Yang WM, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188486; Yang WH, 2012, BLOOD, V120, P1015, DOI 10.1182/blood-2012-04-424366; Yang Y, 2017, TRENDS BIOTECHNOL, V35, P598, DOI 10.1016/j.tibtech.2017.04.010; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280; Yang Z, 2014, MOL CELL PROTEOMICS, V13, P3224, DOI 10.1074/mcp.M114.041541; Ye ZL, 2019, NAT METHODS, V16, P902, DOI 10.1038/s41592-019-0504-x; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Zhang HX, 2019, MOL THER, V27, P735, DOI 10.1016/j.ymthe.2019.01.014; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhen L, 2018, FEBS LETT, V592, P3976, DOI 10.1002/1873-3468.13217; Zhu YQ, 2021, GLYCOBIOLOGY, V31, P173, DOI 10.1093/glycob/cwaa074; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	340	26	26	3	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100448	10.1016/j.jbc.2021.100448	http://dx.doi.org/10.1016/j.jbc.2021.100448			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33617880	gold, Green Published			2022-12-28	WOS:000672866400422
J	Soares, AC; Ferreira, A; Marien, J; Delay, C; Lee, E; Trojanowski, JQ; Moechars, D; Annaert, W; De Muynck, L				Soares, Alberto Carpinteiro; Ferreira, Andreia; Marieen, Jonas; Delay, Charlotte; Lee, Edward; Trojanowski, John Q.; Moechars, Dieder; Annaert, Wim; De Muynck, Louis			PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; PTDINS(4,5)P-2 SYNTHESIS; ALZHEIMER-DISEASE; ACTIN DYNAMICS; PROTEIN-KINASE; SYNTHETIC TAU; PATHOLOGY; NEURONS; IDENTIFICATION; TELENCEPHALIN	Tauopathies, such as Alzheimer's disease (AD), are neuro-degenerative disorders characterized by the deposition of hyperphosphorylated tau aggregates. Proteopathic tau seeds spread through the brain in a temporospatial pattern, indicative of transsynaptic propagation. It is hypothesized that reducing the uptake of tau seeds and subsequent induction of tau aggregation could be a potential approach for abrogating disease progression in AD. Here, we studied to what extent different endosomal routes play a role in the neuronal uptake of preformed tau seeds. Using pharmacological and genetic tools, we identified dynamin-1, actin, and Rac1 as key players. Furthermore, inhibition of PIKfyve, a protein downstream of Rac1, reduced both the trafficking of tau seeds into lysosomes and the induction of tau aggregation. Our work shows that tau aggregates are internalized by a specific endocytic mechanism and that their fate once internalized can be pharmacologically modulated to reduce tau seeding in neurons.	[Soares, Alberto Carpinteiro; Ferreira, Andreia; Marieen, Jonas; Delay, Charlotte; Moechars, Dieder; De Muynck, Louis] Janssen Res & Dev, Div Janssen Pharmaceut NV, Neurosci Dept, Beerse, Belgium; [Soares, Alberto Carpinteiro; Annaert, Wim] VIB Ctr Brain & Dis Res, Leuven, Belgium; [Soares, Alberto Carpinteiro; Annaert, Wim] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium; [Ferreira, Andreia] VIB Ctr Med Biotechnol, Ghent, Belgium; [Ferreira, Andreia] Univ Ghent, Dept Biochem & Microbiol, Ghent, Belgium; [Lee, Edward; Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Inst Aging, Perelman Sch Med, Philadelphia, PA USA; [Lee, Edward; Trojanowski, John Q.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA	Johnson & Johnson; Janssen Pharmaceuticals; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	De Muynck, L (corresponding author), Janssen Res & Dev, Div Janssen Pharmaceut NV, Neurosci Dept, Beerse, Belgium.; Annaert, W (corresponding author), VIB Ctr Brain & Dis Res, Leuven, Belgium.; Annaert, W (corresponding author), Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium.	wim.annaert@kuleuven.vib.be; ldemuync@its.jnj.com		Ferreira, Andreia/0000-0002-6049-2399; De Muynck, Louis/0000-0003-4432-945X	VLAIO Baekeland mandate [HBC.2016.0219]; VIB, KU Leuven [C16/15/073]; FWO [S006617N, G078117N, G056017N, G0C422N, G0C3620N]; FWO-Hercules Foundation [AKUL/11/30, 13/39]; SAO-FRA [2020030]	VLAIO Baekeland mandate; VIB, KU Leuven; FWO(FWO); FWO-Hercules Foundation; SAO-FRA	A. C. S is the recipient of a VLAIO Baekeland mandate (HBC.2016.0219). W. A. is financially supported by VIB, KU Leuven (C16/15/073), FWO (S006617N, G078117N, G056017N, G0C422N, and G0C3620N), the FWO-Hercules Foundation (AKUL/11/30, 13/39), and SAO-FRA (S#2020030).	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Balklava Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130485; Bissig C, 2017, TRAFFIC, V18, P747, DOI 10.1111/tra.12525; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2015, BRAIN, V138, P2814, DOI 10.1093/brain/awv236; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Calafate S, 2016, CELL REP, V17, P931, DOI 10.1016/j.celrep.2016.09.063; Calafate S, 2015, CELL REP, V11, P1176, DOI 10.1016/j.celrep.2015.04.043; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Chen JJ, 2019, J BIOL CHEM, V294, P18952, DOI 10.1074/jbc.RA119.009432; Clavaguera F, 2015, NEUROPATH APPL NEURO, V41, P47, DOI 10.1111/nan.12197; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Currinn H, 2016, CELL MOL LIFE SCI, V73, P393, DOI 10.1007/s00018-015-1993-0; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Demaegd K, 2018, CHEMBIOCHEM, V19, P2424, DOI 10.1002/cbic.201800288; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Evans LD, 2018, CELL REP, V22, P3612, DOI 10.1016/j.celrep.2018.03.021; Falcon B, 2018, J BIOL CHEM, V293, P2438, DOI 10.1074/jbc.M117.809293; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gayle S, 2017, BLOOD, V129, P1768, DOI 10.1182/blood-2016-09-736892; Gibbons GS, 2017, J NEUROSCI, V37, P11485, DOI 10.1523/JNEUROSCI.2393-17.2017; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Goggs R, 2015, BIOCHEM J, V466, P431, DOI 10.1042/BJ20141404; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Guo JL, 2013, FEBS LETT, V587, P717, DOI 10.1016/j.febslet.2013.01.051; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Halstead JR, 2010, J CELL SCI, V123, P3535, DOI 10.1242/jcs.062679; Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Ikonomov OC, 2002, J BIOL CHEM, V277, P9206, DOI 10.1074/jbc.M108750200; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Karch Celeste M, 2015, Biol Psychiatry, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Li JG, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-019-0350-4; Liu AZ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600925; Loijens JC, 1996, ADV ENZYME REGUL, V36, P115, DOI 10.1016/0065-2571(95)00005-4; McNally KE, 2018, TRENDS CELL BIOL, V28, P807, DOI 10.1016/j.tcb.2018.06.005; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Peric A, 2015, ACTA NEUROPATHOL, V129, P363, DOI 10.1007/s00401-014-1379-7; Polanco JC, 2021, ACTA NEUROPATHOL, V141, P235, DOI 10.1007/s00401-020-02254-3; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rauch JN, 2020, NATURE, V580, P381, DOI 10.1038/s41586-020-2156-5; Rauch JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24904-z; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sbrissa D, 2000, BIOCHEMISTRY-US, V39, P15980, DOI 10.1021/bi001897f; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Senju Y, 2019, CURR OPIN CELL BIOL, V56, P7, DOI 10.1016/j.ceb.2018.08.003; Sharma G, 2019, AUTOPHAGY, V15, P1694, DOI 10.1080/15548627.2019.1586257; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Staats K.A., 2019, BIORXIV, DOI DOI 10.1101/685800; Stopschinski BE, 2020, J BIOL CHEM, V295, P2974, DOI 10.1074/jbc.RA119.010353; Uemura N, 2020, TRENDS MOL MED, V26, P936, DOI 10.1016/j.molmed.2020.03.012; Van Acker ZP, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0323-7; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Young JE, 2018, STEM CELL REP, V10, P1046, DOI 10.1016/j.stemcr.2018.01.031; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	77	8	7	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100636	10.1016/j.jbc.2021.100636	http://dx.doi.org/10.1016/j.jbc.2021.100636			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33831417	Green Published, gold			2022-12-28	WOS:000672866400607
J	Zhou, WJ; Li, YH; Meng, XJ; Liu, A; Mao, Y; Zhu, X; Meng, Q; Jin, Y; Zhang, Z; Tao, WJ				Zhou, Wenjie; Li, Yanhua; Meng, Xiaojing; Liu, An; Mao, Yu; Zhu, Xia; Meng, Qian; Jin, Yan; Zhang, Zhi; Tao, Wenjuan			Switching of delta opioid receptor subtypes in central amygdala microcircuits is associated with anxiety states in pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MU; KAPPA; EXPRESSION; CIRCUITS; AGONIST; NEURONS; ANTAGONIST; MODULATION; LIGANDS; SNC80	Anxiety is often comorbid with pain. Delta opioid receptors (DORs) are promising targets for the treatment of pain and mental disorders with little addictive potential. However, their roles in anxiety symptoms at different stages of pain are unclear. In the current study, mice with inflammatory pain at the fourth hour following complete Freund's adjuvant (CFA) injection displayed significant anxiety-like behavior, which disappeared at the seventh day. Combining electrophysiology, optogenetics, and pharmacology, we found that activation of delta opioid receptor 1 (DOR1) in the central nucleus amygdala (CeA) inhibited both the anxiolytic excitatory input from the basolateral amygdala (BLA) and the anxiogenic excitatory input from the parabrachial nucleus (PBN). In contrast, activation of delta opioid receptor 2 (DOR2) did not affect CeA excitatory synaptic transmission in normal and 4-h CFA mice but inhibited the excitatory projection from the PBN rather than the BLA in 7-day CFA mice. Furthermore, the function of both DOR1 and DOR2 was downregulated to the point of not being detectable in the CeA of mice at the 21st day following CFA injection. Taken together, these results suggest that functional switching of DOR1 and DOR2 is associated with anxiety states at different stages of pain via modulating the activity of specific pathways (BLA-CeA and PBN-CeA).	[Zhou, Wenjie; Li, Yanhua; Mao, Yu; Zhu, Xia; Meng, Qian; Jin, Yan; Zhang, Zhi; Tao, Wenjuan] Univ Sci & Technol China, Dept Biophys & Neurobiol, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China; [Meng, Xiaojing] Anhui Med Univ, Affiliated Psychol Hosp, Dept Sci & Educ, Hefei, Peoples R China; [Liu, An; Mao, Yu; Meng, Qian; Tao, Wenjuan] Anhui Med Univ, Sch Basic Med Sci, Dept Physiol, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui Medical University	Zhang, Z; Tao, WJ (corresponding author), Univ Sci & Technol China, Dept Biophys & Neurobiol, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China.; Tao, WJ (corresponding author), Anhui Med Univ, Sch Basic Med Sci, Dept Physiol, Hefei, Peoples R China.	zhizhang@ustc.edu.cn; wjtao01@ahmu.edu.cn			National Natural Science Foundation of China [31600851, 91849119, 32000717, 81870877]; Anhui Medical University [XJ201809]; University of Science and Technology of China Research Funds of the Double First-Class Initiative [YD3460002001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Medical University; University of Science and Technology of China Research Funds of the Double First-Class Initiative	This work was supported by the National Natural Science Foundation of China (31600851, 91849119, 32000717, and 81870877), Grant's for Scientific Research of BSKY (XJ201809) from Anhui Medical University, University of Science and Technology of China Research Funds of the Double First-Class Initiative (YD3460002001).	Ballantyne JC, 2007, PAIN, V129, P235, DOI 10.1016/j.pain.2007.03.028; Bhushan RG, 2004, J MED CHEM, V47, P2969, DOI 10.1021/jm0342358; Bie BH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-37; Bilsky EJ, 2000, J PHARMACOL EXP THER, V293, P151; Brainin-Mattos J, 2006, PAIN, V122, P174, DOI 10.1016/j.pain.2006.01.032; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Cai YQ, 2018, J NEUROSCI, V38, P6340, DOI 10.1523/JNEUROSCI.2780-17.2018; Contet C, 2004, CURR OPIN NEUROBIOL, V14, P370, DOI 10.1016/j.conb.2004.05.005; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Gaveriaux-Ruff C, 2011, PAIN, V152, P1238, DOI 10.1016/j.pain.2010.12.031; Gerrits MMJG, 2014, PAIN, V155, P53, DOI 10.1016/j.pain.2013.09.005; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Han S, 2015, CELL, V162, P363, DOI 10.1016/j.cell.2015.05.057; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hawker GA, 2011, ARTHRIT CARE RES, V63, P1382, DOI 10.1002/acr.20298; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Ji G, 2008, J NEUROPHYSIOL, V99, P1201, DOI 10.1152/jn.01148.2007; JIANG Q, 1991, J PHARMACOL EXP THER, V257, P1069; Jin Y, 2020, PAIN, V161, P416, DOI 10.1097/j.pain.0000000000001724; Jutkiewicz EM, 2003, BEHAV PHARMACOL, V14, P509, DOI 10.1097/00008877-200311000-00003; Kim J, 2017, NEURON, V93, P1464, DOI 10.1016/j.neuron.2017.02.034; Li JN, 2020, PAIN, V161, P166, DOI 10.1097/j.pain.0000000000001691; Li JN, 2018, J PHYSIOL-LONDON, V596, P6289, DOI 10.1113/JP276935; Lunzer MM, 2007, J PHARMACOL EXP THER, V322, P166, DOI 10.1124/jpet.107.120279; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Margolis EB, 2017, NEUROPHARMACOLOGY, V123, P420, DOI 10.1016/j.neuropharm.2017.06.019; McCullough KM, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0010-18.2018; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Mika J, 2001, EUR J PHARMACOL, V415, P31, DOI 10.1016/S0014-2999(01)00814-7; Nakamura T, 2013, OPEN DENT J, V7, P27, DOI 10.2174/1874210601307010027; Narita M, 2006, NEUROPSYCHOPHARMACOL, V31, P739, DOI 10.1038/sj.npp.1300858; Navratilova E, 2015, J NEUROSCI, V35, P7264, DOI 10.1523/JNEUROSCI.3862-14.2015; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Neugebauer V, 2020, NEUROPHARMACOLOGY, V170, DOI 10.1016/j.neuropharm.2020.108052; Peckys D, 1999, NEUROSCIENCE, V88, P1093, DOI 10.1016/S0306-4522(98)00251-6; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; Pomrenze MB, 2019, CELL REP, V29, P13, DOI 10.1016/j.celrep.2019.08.083; Pradhan AA, 2011, TRENDS PHARMACOL SCI, V32, P581, DOI 10.1016/j.tips.2011.06.008; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Raehal KM, 2005, AAPS J, V7, pE587, DOI 10.1208/aapsj070360; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; Ren WJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-93; Saitoh A, 2004, J PHARMACOL SCI, V95, P374, DOI 10.1254/jphs.FPJ04014X; Shiwarski DJ, 2017, J NEUROSCI, V37, P3741, DOI 10.1523/JNEUROSCI.2923-16.2017; SIMONIN F, 1994, MOL PHARMACOL, V46, P1015; SOFUOGLU M, 1993, LIFE SCI, V52, P769, DOI 10.1016/0024-3205(93)90240-4; Sugiyama A, 2014, NEUROPHARMACOLOGY, V79, P314, DOI 10.1016/j.neuropharm.2013.11.021; Suzuki T, 1997, EUR J PHARMACOL, V324, P21, DOI 10.1016/S0014-2999(97)00062-9; Suzuki T, 2007, ANESTH ANALG, V104, P1570, DOI 10.1213/01.ane.0000261514.19946.66; Thorat SN, 1997, J PHARMACOL EXP THER, V283, P1185; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Wilson TD, 2019, CELL REP, V29, P332, DOI 10.1016/j.celrep.2019.09.011; Yekkirala AS, 2013, ACS CHEM BIOL, V8, P1412, DOI 10.1021/cb400113d; Yekkirala AS, 2010, ACS CHEM NEUROSCI, V1, P146, DOI 10.1021/cn9000236; Zarrindast MR, 2008, LIFE SCI, V82, P1175, DOI 10.1016/j.lfs.2008.03.020; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442; Zhou WJ, 2019, NAT NEUROSCI, V22, P1649, DOI 10.1038/s41593-019-0468-2; Zhuo M, 2016, TRENDS NEUROSCI, V39, P136, DOI 10.1016/j.tins.2016.01.006	59	5	5	5	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100277	10.1016/j.jbc.2021.100277	http://dx.doi.org/10.1016/j.jbc.2021.100277			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428940	gold, Green Published			2022-12-28	WOS:000672866400253
J	Gerner, MC; Bileck, A; Janker, L; Ziegler, LS; Ohlinger, T; Raeven, P; Mullner, EW; Salzer, U; Gerner, C; Schmetterer, KG; Baron, DM				Gerner, Marlene C.; Bileck, Andrea; Janker, Lukas; Ziegler, Liesa S.; Oehlinger, Thomas; Raeven, Pierre; Muellner, Ernst W.; Salzer, Ulrich; Gerner, Christopher; Schmetterer, Klaus G.; Baron, David M.			Packed red blood cells inhibit T-cell activation via ROS-dependent signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURVIVAL BIOACTIVITIES; TRANSFUSION; GROWTH; TRANSCRIPTION; EXPRESSION; KINETICS; REVEALS	Numerous observations indicate that red blood cells (RBCs) affect T-cell activation and proliferation. We have studied effects of packed RBCs (PRBCs) on T-cell receptor (TCR) signaling and the molecular mechanisms whereby (P)RBCs modulate T-cell activation. In line with previous reports, PRBCs attenuated the expression of T-cell activation markers CD25 and CD69 upon costimulation via CD3/CD28. In addition, T-cell proliferation and cytokine expression were markedly reduced when T-cells were stimulated in the presence of PRBCs. Inhibitory activity of PRBCs required direct cell-cell contact and intact PRBCs. The production of activation-induced cellular reactive oxygen species, which act as second messengers in T-cells, was completely abrogated to levels of unstimulated T-cells in the presence of PRBCs. Phosphorylation of the TCR-related zeta chain and thus proximal TCR signal transduction was unaffected by PRBCs, ruling out mechanisms based on secreted factors and steric interaction restrictions. In large part, downstream signaling events requiring reactive oxygen species for full functionality were affected, as confirmed by an untargeted MS-based phosphoproteomics approach. PRBCs inhibited T-cell activation more efficiently than treatment with 1 mM of the antioxidant N-acetyl cysteine. Taken together, our data imply that inflammation-related radical reactions are modulated by PRBCs. These immunomodulating effects may be responsible for clinical observations associated with transfusion of PRBCs.	[Gerner, Marlene C.] Univ Appl Sci FH Campus Wien, Div Biomed Sci, Vienna, Austria; [Gerner, Marlene C.; Ziegler, Liesa S.; Schmetterer, Klaus G.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Bileck, Andrea; Janker, Lukas; Gerner, Christopher] Univ Vienna, Fac Chem, Dept Analyt Chem, Vienna, Austria; [Bileck, Andrea; Janker, Lukas; Gerner, Christopher] Univ Vienna, Fac Chem, Joint Metabolome Facil, Vienna, Austria; [Oehlinger, Thomas; Raeven, Pierre; Baron, David M.] Med Univ Vienna, Dept Anaesthesia Intens Care Med & Pain Med, Vienna, Austria; [Muellner, Ernst W.; Salzer, Ulrich] Med Univ Vienna, Ctr Med Biochem, Max Perutz Labs MPL, Vienna, Austria	Medical University of Vienna; University of Vienna; University of Vienna; Medical University of Vienna; Medical University of Vienna	Baron, DM (corresponding author), Med Univ Vienna, Dept Anaesthesia Intens Care Med & Pain Med, Vienna, Austria.	david.baron@meduniwien.ac.at		Janker, Lukas/0000-0002-3084-2212; Schmetterer, Klaus/0000-0001-9328-4871; Salzer, Ulrich/0000-0002-3721-7225; Bileck, Andrea/0000-0002-7053-8856; Gerner, Marlene/0000-0002-4378-9254	Austrian Science Funds, Austria (FWF) [P29654-B30]; Medical-Scientific Fund of the Mayor of the City of Vienna, Austria [15070]	Austrian Science Funds, Austria (FWF)(Austrian Science Fund (FWF)); Medical-Scientific Fund of the Mayor of the City of Vienna, Austria	This work was supported by the grants from the Austrian Science Funds, Austria (FWF; project no.: P29654-B30) to K. G. S. and the Medical-Scientific Fund of the Mayor of the City of Vienna, Austria (project no.: 15070) to D. M. B.	Almasalmeh A, 2014, FEBS J, V281, P647, DOI 10.1111/febs.12653; Almizraq RJ, 2018, BLOOD ADV, V2, P2296, DOI 10.1182/bloodadvances.2018021931; Antunes RF, 2011, IMMUNOL CELL BIOL, V89, P111, DOI 10.1038/icb.2010.60; Antunes RF, 2009, CELL MOL LIFE SCI, V66, P3387, DOI 10.1007/s00018-009-0119-y; Arosa FA, 2004, CURR PHARM DESIGN, V10, P191, DOI 10.2174/1381612043453432; Asquith B, 2006, P R SOC B, V273, P1165, DOI 10.1098/rspb.2005.3432; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Baker PR, 2014, MOL CELL PROTEOMICS, V13, P1392, DOI 10.1074/mcp.O113.037200; Baron DM, 2020, CURR OPIN ANESTHESIO, V33, P234, DOI 10.1097/ACO.0000000000000824; Belizaire RM, 2012, J AM COLL SURGEONS, V214, P648, DOI 10.1016/j.jamcollsurg.2011.12.032; Bernard A, 2010, J TRAUMA, V69, P320, DOI 10.1097/TA.0b013e3181e401f0; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Bileck A, 2014, J PROTEOME RES, V13, P5989, DOI 10.1021/pr5008625; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Casado P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003573; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Closa D, 2004, IUBMB LIFE, V56, P185, DOI 10.1080/15216540410001701642; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; DAlessandro A., 2020, J PROTEOME RES; Danesh A, 2014, BLOOD, V123, P687, DOI 10.1182/blood-2013-10-530469; Ferraris VA, 2013, AM J SURG, V205, P457, DOI 10.1016/j.amjsurg.2012.07.042; Fonseca AM, 2001, BLOOD, V97, P3152, DOI 10.1182/blood.V97.10.3152; Franchina DG, 2018, TRENDS IMMUNOL, V39, P489, DOI 10.1016/j.it.2018.01.005; Francis RO, 2020, J CLIN INVEST, V130, P2270, DOI 10.1172/JCI133530; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Gerner MC, 2020, FASEB J, V34, P8367, DOI 10.1096/fj.201902664; Gerner MC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00727; Groessl M, 2014, J PROTEOME RES, V13, P4773, DOI 10.1021/pr500727h; Guram K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00491; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Humphrey SJ, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0014-9; Le Bourgeois T, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00237; Long K, 2014, J TRAUMA ACUTE CARE, V77, P198, DOI 10.1097/TA.0000000000000330; Martins R, 2016, NAT IMMUNOL, V17, P1361, DOI 10.1038/ni.3590; Mendonca R, 2016, INFLAMM RES, V65, P665, DOI 10.1007/s00011-016-0955-9; Menocha Somaang, 2019, Transfusion, V59, P3553, DOI 10.1111/trf.15461; Metz KS, 2018, CELL SYST, V7, P347, DOI 10.1016/j.cels.2018.07.001; Minetti M, 2006, ANTIOXID REDOX SIGN, V8, P1165, DOI 10.1089/ars.2006.8.1165; Moon C, 2004, AM J HEMATOL, V75, P128, DOI 10.1002/ajh.10476; OGURA Y, 1983, J BIOCHEM-TOKYO, V94, P403, DOI 10.1093/oxfordjournals.jbchem.a134369; Prosenz J, 2019, TRANSFUSION, V59, P454, DOI 10.1111/trf.14956; Roumenina LT, 2016, TRENDS MOL MED, V22, P200, DOI 10.1016/j.molmed.2016.01.004; Schmetterer KG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01790; Schmidt RLJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42191; Seiser S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79378-9; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shyer JA, 2020, CELL RES, V30, P649, DOI 10.1038/s41422-020-0379-5; Torrance HDT, 2015, ANN SURG, V261, P751, DOI 10.1097/SLA.0000000000000653; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Ziegler LS, 2021, FEBS J, V288, P640, DOI 10.1111/febs.15361	55	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100487	10.1016/j.jbc.2021.100487	http://dx.doi.org/10.1016/j.jbc.2021.100487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676898	gold, Green Published			2022-12-28	WOS:000672866400461
J	Kesavardhana, S; Samir, P; Zheng, M; Malireddi, RKS; Karki, R; Sharma, BR; Place, DE; Briard, B; Vogel, P; Kanneganti, TD				Kesavardhana, Sannula; Samir, Parimal; Zheng, Min; Malireddi, R. K. Subbarao; Karki, Rajendra; Sharma, Bhesh Raj; Place, David E.; Briard, Benoit; Vogel, Peter; Kanneganti, Thirumala-Devi			DDX3X coordinates host defense against influenza virus by activating the NLRP3 inflammasome and type I interferon response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; NS1 PROTEIN; RNA; RECOGNITION; INFECTION; CASPASE-1; ROLES; INTERLEUKIN-1-BETA; REPLICATION; STRATEGIES	Viruses and hosts have coevolved for millions of years, leading to the development of complex host-pathogen interactions. Influenza A virus (IAV) causes severe pulmonary pathology and is a recurrent threat to human health. Innate immune sensing of IAV triggers a complex chain of host responses. IAV has adapted to evade host defense mechanisms, and the host has coevolved to counteract these evasion strategies. However, the molecular mechanisms governing the balance between host defense and viral immune evasion is poorly understood. Here, we show that the host protein DEAD-box helicase 3 X-linked (DDX3X) is critical to orchestrate a multifaceted antiviral innate response during IAV infection, coordinating the activation of the nucleotide-binding oligomerization domain-like receptor with a pyrin domain 3 (NLRP3) inflammasome, assembly of stress granules, and type I interferon (IFN) responses. DDX3X activated the NLRP3 inflammasome in response to WT IAV, which carries the immune evasive nonstructural protein 1 (NS1). However, in the absence of NS1, DDX3X promoted the formation of stress granules that facilitated efficient activation of type I IFN signaling. Moreover, induction of DDX3X-containing stress granules by external stimuli after IAV infection led to increased type I IFN signaling, suggesting that NS1 actively inhibits stress granule-mediated host responses and DDX3X-mediated NLRP3 activation counteracts this action. Furthermore, the loss of DDX3X expression in myeloid cells caused severe pulmonary pathogenesis and morbidity in IAV-infected mice. Together, our findings show that DDX3X orchestrates alternate modes of innate host defense which are critical to fight against NS1-mediated immune evasion strategies during IAV infection.	[Kesavardhana, Sannula; Samir, Parimal; Zheng, Min; Malireddi, R. K. Subbarao; Karki, Rajendra; Sharma, Bhesh Raj; Place, David E.; Briard, Benoit; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kesavardhana, Sannula] Indian Inst Sci, Dept Biochem, Bengaluru 560012, Karnataka, India; [Briard, Benoit] Univ Tours, INSERM, Ctr Etud Pathol Resp UMR 1100, Tours, France	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Indian Institute of Science (IISC) - Bangalore; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Samir, Parimal/N-4144-2014; Kanneganti, Thirumala-Devi/Y-2503-2019; Place, David/ABD-6703-2021; Sharma, Bhesh Raj/H-3782-2014	Samir, Parimal/0000-0001-7655-5713; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Place, David/0000-0002-1904-4164; Sharma, Bhesh Raj/0000-0003-3609-833X	US NIH [AR056296, CA253095, AI101935, AI124346]; American Lebanese Syrian Associated Charities	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This study was supported by grants from the US NIH (AR056296, CA253095, AI101935, and AI124346) and the American Lebanese Syrian Associated Charities to T. D. -K. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Chen CY, 2016, HUM MOL GENET, V25, P2905, DOI 10.1093/hmg/ddw143; Cheong WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126456; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI [10.2217/fmb.09.108, 10.2217/FMB.09.108]; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Hondele M, 2019, NATURE, V573, P144, DOI 10.1038/s41586-019-1502-y; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kesavardhana S, 2020, ANNU REV IMMUNOL, V38, P567, DOI 10.1146/annurev-immunol-073119-095439; Kesavardhana S, 2017, J EXP MED, V214, P2217, DOI 10.1084/jem.20170550; Khaperskyy DA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004217; Khaperskyy DA, 2012, FASEB J, V26, P1629, DOI 10.1096/fj.11-196915; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Li Q, 2014, J BIOMED RES, V28, P282, DOI 10.7555/JBR.27.20130047; Lupfer C, 2015, CURR OPIN VIROL, V12, P38, DOI 10.1016/j.coviro.2015.02.007; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Moriyama M, 2016, J VIROL, V90, P4105, DOI 10.1128/JVI.00120-16; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy EA, 2011, J INTERF CYTOK RES, V31, P501, DOI 10.1089/jir.2010.0143; Nogales A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120708; Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Oslund KL, 2011, FUTURE VIROL, V6, P951, DOI 10.2217/FVL.11.63; Park ES, 2019, EMBO J, V38, DOI 10.15252/embj.201899475; Park HS, 2018, J VIROL, V92, DOI [10.1128/JVI.00022-18, 10.1128/jvi.00022-18]; Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Raman SNT, 2016, J VIROL, V90, P3661, DOI 10.1128/JVI.03010-15; Reineke LC, 2015, J VIROL, V89, P2575, DOI 10.1128/JVI.02791-14; Samir P, 2019, TRENDS IMMUNOL, V40, P1082, DOI 10.1016/j.it.2019.10.005; Samir P, 2019, NATURE, V573, P590, DOI 10.1038/s41586-019-1551-2; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Tate MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27912; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tsai WC, 2014, ANNU REV VIROL, V1, P147, DOI 10.1146/annurev-virology-031413-085505; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Zheng M, 2015, J VIROL, V89, P10273, DOI 10.1128/JVI.00919-15	56	13	13	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100579	10.1016/j.jbc.2021.100579	http://dx.doi.org/10.1016/j.jbc.2021.100579			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33766561	gold, Green Published			2022-12-28	WOS:000672866400552
J	Liang, JB; Zhou, YC; Zhang, N; Wang, DD; Cheng, XW; Li, K; Huang, R; Lu, Y; Wang, HL; Han, DQ; Wu, W; Han, M; Miao, SY; Wang, LF; Zhao, H; Song, W				Liang, Junbo; Zhou, Yanchi; Zhang, Ning; Wang, Dingding; Cheng, Xiaowen; Li, Kai; Huang, Rong; Lu, Yan; Wang, Hailong; Han, Deqiang; Wu, Wei; Han, Meng; Miao, Shiying; Wang, Linfang; Zhao, Hong; Song, Wei			The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-beta signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE ANTAGONIST; NLK; PROTEIN; IDENTIFICATION; TURNOVER; BMP	Smad2 and Smad3 (Smad2/3) are structurally similar proteins that primarily mediate the transforming growth factor-beta (TGF-beta) signaling responsible for driving cell proliferation, differentiation, and migration. The dynamics of the Smad2/3 phosphorylation provide the key mechanism for regulating the TGF-beta signaling pathway, but the details surrounding this phosphorylation remain unclear. Here, using in vitro kinase assay coupled with mass spectrometry, we identified for the first time that nemo-like kinase (NLK) regulates TGF-beta signaling via modulation of Smad2/3 phosphorylation in the linker region. TGF-beta-mediated transcriptional and cellular responses are suppressed by NLK overexpression, whereas NLK depletion exerts opposite effects. Specifically, we discovered that NLK associates with Smad3 and phosphorylates the designated serine residues located in the linker region of Smad2 and Smad3, which inhibits phosphorylation at the C terminus, thereby decreasing the duration of TGF-beta signaling. Overall, this work demonstrates that phosphorylation on the linker region of Smad2/3 by NLK counteracts the canonical phosphorylation in response to TGF-beta signals, thus providing new insight into the mechanisms governing TGF-beta signaling transduction.	[Liang, Junbo; Zhang, Ning; Wang, Dingding; Cheng, Xiaowen; Li, Kai; Huang, Rong; Lu, Yan; Wang, Hailong; Han, Deqiang; Wu, Wei; Miao, Shiying; Wang, Linfang; Song, Wei] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing, Peoples R China; [Zhou, Yanchi; Zhao, Hong] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,Natl Canc Ctr, Beijing, Peoples R China; [Han, Meng] Tsinghua Univ, Prot Res Technol Ctr Prot Chem & Omics Platform, Beijing, Peoples R China; [Zhang, Ning] Univ Dundee, Wellcome Ctr Antiinfect Res WCAIR, Dundee, Scotland; [Cheng, Xiaowen] Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei 230022, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Tsinghua University; University of Dundee; Anhui Medical University	Song, W (corresponding author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing, Peoples R China.; Zhao, H (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,Natl Canc Ctr, Beijing, Peoples R China.	zhaohong@cicams.ac.cn; songwei@ibms.pumc.edu.cn	Han, Deqiang/GXG-9968-2022; Liang, Junbo/AFN-3446-2022; HAN, Hanley/GNH-5315-2022	Liang, Junbo/0000-0001-6230-1421	National Key R&D Program of China [2018YFC1003500]; CAMS Innovation Fund for Medical Sciences [2017-I2M-3-009, 2016-I2M-1-001, 2017-I2M-4-002]; National Natural Science Foundation of China [81672472, 81672461, 81972311, 31970794, 32000586]; State Key Laboratory Special fund from the Ministry of Science [2060204]; State Key Project on Infection Diseases of China [2017ZX10201021-007-003]; Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences [2019PT310026]; Sanming Project of Medicine in Shenzhen [SZSM202011010]	National Key R&D Program of China; CAMS Innovation Fund for Medical Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory Special fund from the Ministry of Science; State Key Project on Infection Diseases of China; Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences; Sanming Project of Medicine in Shenzhen	This work was supported by grants from the National Key R&D Program of China (2018YFC1003500), CAMS Innovation Fund for Medical Sciences (2017-I2M-3-009, 2016-I2M-1-001, 2017-I2M-4-002), the National Natural Science Foundation of China (81672472, 81672461, 81972311, 31970794, 32000586), the State Key Laboratory Special fund from the Ministry of Science (2060204), the State Key Project on Infection Diseases of China (2017ZX10201021-007-003), the Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019PT310026), and Sanming Project of Medicine in Shenzhen (SZSM202011010).	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Derynck R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav5183; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Han Y, 2014, BIOMED PHARMACOTHER, V68, P497, DOI 10.1016/j.biopha.2014.05.003; Huang Y, 2015, TUMOR BIOL, V36, P9147, DOI 10.1007/s13277-015-4159-7; Ishitani T, 2013, CELL SIGNAL, V25, P190, DOI 10.1016/j.cellsig.2012.09.017; Ishitani T, 2010, NAT CELL BIOL, V12, P278, DOI 10.1038/ncb2028; Kamato D, 2020, CELL MOL LIFE SCI, V77, P243, DOI 10.1007/s00018-019-03266-3; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Li SZ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11258-x; Li SZ, 2014, BBA-MOL CELL RES, V1843, P1365, DOI 10.1016/j.bbamcr.2014.03.028; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2762; Masoumi KC, 2017, MOL BIOL CELL, V28, P346, DOI 10.1091/mbc.E16-07-0547; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Millet C, 2009, J BIOL CHEM, V284, P19808, DOI 10.1074/jbc.M109.016667; Moon S, 2017, EMBO REP, V18, P61, DOI 10.15252/embr.201642683; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Moses HL, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021865; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Ota R, 2011, BIOCHEMISTRY-US, V50, P5648, DOI 10.1021/bi2002696; Ota S, 2012, EMBO J, V31, P1904, DOI 10.1038/emboj.2012.46; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Yoon JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8600; Yu JSL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8212; Yu Y, 2019, CURR OPIN CELL BIOL, V61, P56, DOI 10.1016/j.ceb.2019.07.007; Yuan HX, 2015, GENE DEV, V29, P2362, DOI 10.1101/gad.265116.115; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177; Zeng YA, 2007, DEVELOPMENT, V134, P2061, DOI 10.1242/dev.02853	42	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100512	10.1016/j.jbc.2021.100512	http://dx.doi.org/10.1016/j.jbc.2021.100512			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676893	gold, Green Published			2022-12-28	WOS:000672866400486
J	Phintha, A; Prakinee, K; Jaruwat, A; Lawan, N; Visitsatthawong, S; Kantiwiriyawanitch, C; Songsungthong, W; Trisrivirat, D; Chenprakhon, P; Mulholland, A; van Pee, KH; Chitnumsub, P; Chaiyen, P				Phintha, Aisaraphon; Prakinee, Kridsadakorn; Jaruwat, Aritsara; Lawan, Narin; Visitsatthawong, Surawit; Kantiwiriyawanitch, Chadaporn; Songsungthong, Warangkhana; Trisrivirat, Duangthip; Chenprakhon, Pirom; Mulholland, Adrian; van Pee, Karl-Heinz; Chitnumsub, Penchit; Chaiyen, Pimchai			Dissecting the low catalytic capability of flavin-dependent halogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN 7-HALOGENASE PRNA; ENZYMATIC HALOGENATION; MEDICINAL CHEMISTRY; KINETIC MECHANISM; ELECTRON-TRANSFER; QM/MM METHODS; PROTON; OXYGEN; MONOOXYGENASE; CHLORINATION	Although flavin-dependent halogenases (FDHs) are attractive biocatalysts, their practical applications are limited because of their low catalytic efficiency. Here, we investigated the reaction mechanisms and structures of tryptophan 6-halogenase (Thal) from Streptomyces albogriseolus using stopped-flow, rapid-uench flow, quantum/mechanics molecular mechanics calculations, crystallography, and detection of intermediate (hypohalous acid [HOX]) liberation. We found that the key flavin intermediate, C4a-hydroperoxyflavin (C4aOOH-FAD), formed by Thal and other FDHs (tryptophan 7-halogenase [PrnA] and tryptophan 5-halogenase [PyrH]), can react with I-, Br-, and Cl- but not F- to form C4a-hydroxyflavin and HOX. Our experiments revealed that I- reacts with C4aOOH-FAD the fastest with the lowest energy barrier and have shown for the first time that a significant amount of the HOX formed leaks out as free HOX. This leakage is probably a major cause of low product coupling ratios in all FDHs. Site-saturation mutagenesis of Lys79 showed that changing Lys79 to any other amino acid resulted in an inactive enzyme. However, the levels of liberated HOX of these variants are all similar, implying that Lys79 probably does not form a chloramine or bromamine intermediate as previously proposed. Computational calculations revealed that Lys79 has an abnormally lower pKa compared with other Lys residues, implying that the catalytic Lys may act as a proton donor in catalysis. Analysis of new X-ray structures of Thal also explains why premixing of FDHs with reduced flavin adenine dinucleotide generally results in abolishment of C4aOOH-FAD formation. These findings reveal the hidden factors restricting FDHs capability which should be useful for future development of FDHs applications.	[Phintha, Aisaraphon; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Phintha, Aisaraphon; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok, Thailand; [Phintha, Aisaraphon; Prakinee, Kridsadakorn; Visitsatthawong, Surawit; Kantiwiriyawanitch, Chadaporn; Trisrivirat, Duangthip; Chaiyen, Pimchai] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Rayong, Thailand; [Jaruwat, Aritsara; Songsungthong, Warangkhana; Chitnumsub, Penchit] Natl Ctr Genet Engn & Biotechnol, Biomol Anal & Applicat Res Team, Klongluang, Pathumthani, Thailand; [Lawan, Narin] Chiang Mai Univ, Fac Sci, Dept Chem, Chiang Mai, Thailand; [Chenprakhon, Pirom] Mahidol Univ, Inst Innovat Learning, Salaya, Nakhon Pathom, Thailand; [Mulholland, Adrian] Univ Bristol, Ctr Computat Chem, Sch Chem, Bristol, Avon, England; [van Pee, Karl-Heinz] Tech Univ Dresden, Fac Chem & Food Chem, Gen Biochem, Dresden, Germany	Mahidol University; Mahidol University; Vidyasirimedhi Institute of Science & Technology; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chiang Mai University; Mahidol University; University of Bristol; Technische Universitat Dresden	Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.; Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok, Thailand.; Chaiyen, P (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Rayong, Thailand.; Chitnumsub, P (corresponding author), Natl Ctr Genet Engn & Biotechnol, Biomol Anal & Applicat Res Team, Klongluang, Pathumthani, Thailand.	penchit@biotec.or.th; pimchai.chaiyen@vistec.ac.th		Trisrivirat, Duangthip/0000-0003-0079-4739; Mulholland, Adrian/0000-0003-1015-4567; Phintha, Aisaraphon/0000-0001-6565-998X; Prakinee, Kridsadakorn/0000-0003-2421-1518; Lawan, Narin/0000-0003-0940-9278	Thailand Science Research Innovation; National Research Council of Thailand through grants Royal Golden Jubilee [PHD/0135/2557]; Vidyasirimedhi Institute of Science and Technology (VISTEC); EPSRC [EP/M022609/1, EP/M013219/1]; Chiang Mai University; Program Management Unit-B through Global Partnership grant; BBSRC [BB/L01386X/1] Funding Source: UKRI; EPSRC [EP/J010588/1, EP/M027546/1] Funding Source: UKRI	Thailand Science Research Innovation; National Research Council of Thailand through grants Royal Golden Jubilee; Vidyasirimedhi Institute of Science and Technology (VISTEC); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Chiang Mai University; Program Management Unit-B through Global Partnership grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was financially supported by Thailand Science Research Innovation and National Research Council of Thailand through grants Royal Golden Jubilee PHD/0135/2557 (to A. P.), Program Management Unit-B through Global Partnership grant (to P. C.) and from Vidyasirimedhi Institute of Science and Technology (VISTEC) (to K.P. and P. C.). We thank Ms Waraporn Pinyo and NSTDA Characterization and Testing Center (NCTC, NSTDA Thailand) for X-ray data collection on the single crystal X-ray diffraction D8 venture. A. J. M. thanks EPSRC for funding (grant numbers EP/M022609/1 and EP/M013219/1). This research work was partially supported by Chiang Mai University (to N. L.). We also thank Ms Pornkanok Pongpamorn for analyzing NMR of the products. We thank the Frontier Research Center (FRC) at VISTEC for providing assistance and facilities for NMR and high resolution mass spectrometry for the analysis of the products.	Agarwal V, 2017, CHEM REV, V117, P5619, DOI 10.1021/acs.chemrev.6b00571; Alonso F, 2002, CHEM REV, V102, P4009, DOI 10.1021/cr0102967; Andorfer MC, 2018, ANNU REV BIOCHEM, V87, P159, DOI 10.1146/annurev-biochem-062917-012042; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Belsare KD, 2017, ACS SYNTH BIOL, V6, P416, DOI 10.1021/acssynbio.6b00297; Bitto E, 2008, PROTEINS, V70, P289, DOI 10.1002/prot.21627; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P13856, DOI 10.1021/bi9715122; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P8060, DOI 10.1021/bi970089u; Chitnumsub P, 2004, ACTA CRYSTALLOGR D, V60, P780, DOI 10.1107/S0907444904001544; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; EBERLEIN G, 1983, J AM CHEM SOC, V105, P6685, DOI 10.1021/ja00360a024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flecks S, 2008, ANGEW CHEM INT EDIT, V47, P9533, DOI 10.1002/anie.200802466; Frese M, 2015, ANGEW CHEM INT EDIT, V54, P298, DOI 10.1002/anie.201408561; Gkotsi DS, 2019, NAT CHEM, V11, P1091, DOI 10.1038/s41557-019-0349-z; Hartwig JF, 2017, ACCOUNTS CHEM RES, V50, P549, DOI 10.1021/acs.accounts.6b00546; Harvey JN, 2004, FARADAY DISCUSS, V127, P165, DOI 10.1039/b314768a; Hernandes MZ, 2010, CURR DRUG TARGETS, V11, P303, DOI 10.2174/138945010790711996; Hertwig RH, 1997, CHEM PHYS LETT, V268, P345, DOI 10.1016/S0009-2614(97)00207-8; Jeschke P, 2010, PEST MANAG SCI, V66, P10, DOI 10.1002/ps.1829; Karabencheva-Christova TG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17789-x; Keller S, 2000, ANGEW CHEM INT EDIT, V39, P2300, DOI 10.1002/1521-3773(20000703)39:13<2300::AID-ANIE2300>3.0.CO;2-I; Kelly BC, 2007, SCIENCE, V317, P236, DOI 10.1126/science.1138275; Lang A, 2011, ANGEW CHEM INT EDIT, V50, P2951, DOI 10.1002/anie.201007896; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Latham J, 2018, CHEM REV, V118, P232, DOI 10.1021/acs.chemrev.7b00032; Mascotti ML, 2016, J MOL BIOL, V428, P3131, DOI 10.1016/j.jmb.2016.07.003; Lawan N, 2019, J MOL GRAPH MODEL, V87, P250, DOI 10.1016/j.jmgm.2018.12.011; Lawan N, 2014, CHEM PHYS LETT, V608, P380, DOI 10.1016/j.cplett.2014.06.010; Lu YX, 2012, EXPERT OPIN DRUG DIS, V7, P375, DOI 10.1517/17460441.2012.678829; Lu YX, 2009, J MED CHEM, V52, P2854, DOI 10.1021/jm9000133; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09215-9; Moritzer AC, 2019, PROTEIN SCI, V28, P2112, DOI 10.1002/pro.3739; Moritzer AC, 2019, J BIOL CHEM, V294, P2529, DOI 10.1074/jbc.RA118.005393; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Payne JT, 2015, ANGEW CHEM INT EDIT, V54, P4226, DOI 10.1002/anie.201411901; Phintha Aisaraphon, 2020, Enzymes, V47, P327, DOI 10.1016/bs.enz.2020.05.009; Pimviriyakul P, 2017, J BIOL CHEM, V292, P4818, DOI 10.1074/jbc.M116.774448; Poor CB, 2014, CHEMBIOCHEM, V15, P1286, DOI 10.1002/cbic.201300780; Prakash GKS, 2004, J AM CHEM SOC, V126, P15770, DOI 10.1021/ja0465247; Prongjit M, 2009, BIOCHEMISTRY-US, V48, P4170, DOI 10.1021/bi802331r; Ranaghan KE, 2017, J PHYS CHEM B, V121, P9785, DOI 10.1021/acs.jpcb.7b06892; Santos-Aberturas J, 2015, CHEM BIOL, V22, P1406, DOI 10.1016/j.chembiol.2015.08.014; Shah MB, 2017, ACS CHEM BIOL, V12, P1204, DOI 10.1021/acschembio.7b00056; Shepherd SA, 2015, CHEM SCI, V6, P3454, DOI 10.1039/c5sc00913h; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sullivan B, 2013, ENZYME MICROB TECH, V53, P70, DOI 10.1016/j.enzmictec.2013.02.012; van der Kamp MW, 2010, J PHYS CHEM B, V114, P11303, DOI 10.1021/jp104069t; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Werner HJ, 2012, WIRES COMPUT MOL SCI, V2, P242, DOI 10.1002/wcms.82; Wilcken R, 2013, J MED CHEM, V56, P1363, DOI 10.1021/jm3012068; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wongnate T, 2014, J AM CHEM SOC, V136, P241, DOI 10.1021/ja4088055; Xu B, 2012, WATER AIR SOIL POLL, V223, P4429, DOI 10.1007/s11270-012-1206-5; Xu ZJ, 2014, J CHEM INF MODEL, V54, P69, DOI 10.1021/ci400539q; Xu ZJ, 2011, J MED CHEM, V54, P5607, DOI 10.1021/jm200644r; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zhan X, 2008, BIOCHEMISTRY-US, V47, P2221, DOI 10.1021/bi701853w; Zhu XF, 2009, J MOL BIOL, V391, P74, DOI 10.1016/j.jmb.2009.06.008	72	8	8	5	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100068	10.1074/jbc.RA120.016004	http://dx.doi.org/10.1074/jbc.RA120.016004			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465708	Green Published, gold			2022-12-28	WOS:000672866400049
J	Restelli, E; Capone, V; Pozzoli, M; Ortolan, D; Quaglio, E; Corbelli, A; Fiordaliso, F; Beznoussenko, GV; Artuso, V; Roiter, I; Sallese, M; Chiesa, R				Restelli, Elena; Capone, Vanessa; Pozzoli, Manuela; Ortolan, Davide; Quaglio, Elena; Corbelli, Alessandro; Fiordaliso, Fabio; Beznoussenko, Galina, V; Artuso, Vladimiro; Roiter, Ignazio; Sallese, Michele; Chiesa, Roberto			Activation of Src family kinase ameliorates secretory trafficking in mutant prion protein cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI; PRP; AGGREGATION; EXPRESSION; NEURONS; SURFACE; GENE; CONVERSION; MUTATIONS; DELIVERY	Fatal familial insomnia (FFI), genetic Creutzfeldt-Jakob disease (gCJD), and Gerstmann-Straussler-Scheinker (GSS) syndrome are neurodegenerative disorders linked to prion protein (PrP) mutations. The pathogenic mechanisms are not known, but increasing evidence points to mutant PrP misfolding and retention in the secretory pathway. We previously found that the D178N/M129 mutation associated with FFI accumulates in the Golgi of neuronal cells, impairing post-Golgi trafficking. In this study we further characterized the trafficking defect induced by the FFI mutation and tested the 178N/V129 variant linked to gCJD and a nine-octapeptide repeat insertion associated with GSS. We used transfected HeLa cells, embryonic fibroblasts and primary neurons from transgenic mice, and fibroblasts from carriers of the FFI mutation. In all these cell types, the mutant PrPs showed abnormal intracellular localizations, accumulating in the endoplasmic reticulum (ER) and Golgi. To test the efficiency of the membrane trafficking system, we monitored the intracellular transport of the temperature-sensitive vesicular stomatite virus glycoprotein (VSV-G), a well-established cargo reporter, and of endogenous procollagen I (PC-I). We observed marked alterations in secretory trafficking, with VSV-G accumulating mainly in the Golgi complex and PC-I in the ER and Golgi. A redacted version of mutant PrP with reduced propensity to misfold did not impair VSV-G trafficking, nor did artificial ER or Golgi retention of wild-type PrP; this indicates that both misfolding and intracellular retention were required to induce the transport defect. Pharmacological activation of Src family kinase (SFK) improved intracellular transport, suggesting that mutant PrP impairs secretory trafficking through corruption of SFK-mediated signaling.	[Restelli, Elena; Pozzoli, Manuela; Ortolan, Davide; Quaglio, Elena; Chiesa, Roberto] Dept Neurosci, Lab Prion Neurobiol, Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy; [Capone, Vanessa; Sallese, Michele] Univ G DAnnunzio, Dept Innovat Technol Med & Dent, Chieti, Italy; [Capone, Vanessa; Sallese, Michele] Univ G DAnnunzio, Ctr Adv Studies & Technol CAST, Chieti, Italy; [Corbelli, Alessandro; Fiordaliso, Fabio] Ist Ric Farmacol Mario Negri IRCCS, Bioimaging Unit, Dept Cardiovasc Med, Milan, Italy; [Beznoussenko, Galina, V] IFOM FIRC Inst Mol Oncol, Milan, Italy; [Artuso, Vladimiro] ULSS 3 Serenissima, Venice, Italy; [Roiter, Ignazio] CaFoncello Hosp, ULSS 2 Marca Trevigiana, Treviso, Italy; [Ortolan, Davide] NEI, Unit Ocular & Stem Cell Translat Res, NIH, Bethesda, MD USA	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IFOM - FIRC Institute of Molecular Oncology; ULSS 3 Serenissima; Ospedale SS Giovanni Paolo Venezia; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Chiesa, R (corresponding author), Dept Neurosci, Lab Prion Neurobiol, Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy.	roberto.chiesa@marionegri.it	Ortolan, Davide/AFP-8878-2022; Chiesa, Roberto/G-1561-2017	Ortolan, Davide/0000-0002-8236-9391; Chiesa, Roberto/0000-0002-3842-3733	Italian Ministry of Health [RF-2010-2314035]; Telethon Italy [TCR08005, GGP12115, GGP10208]; Fondazione Cariplo [2012-0560]	Italian Ministry of Health(Ministry of Health, Italy); Telethon Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from the Italian Ministry of Health (RF-2010-2314035), Telethon Italy (TCR08005; GGP12115; GGP10208), and "Fondazione Cariplo" (2012-0560). We thank Antonella De Matteis (Telethon Institute of Genetics and Medicine) for providing anti-VSV-G and anti-GM130 antibodies for immuno-EM and Roman Polishchuk (Telethon Institute of Genetics and Medicine) for the CD59-GFP plasmid. We are grateful to members of the Italian Fatal Familial Insomnia Family Association (AFIFF; https://www.afiff.net/) for skin biopsies.	Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Biasini E, 2008, J NEUROCHEM, V104, P1293, DOI 10.1111/j.1471-4159.2007.05082.x; Biasini E, 2010, BIOCHEM J, V430, P477, DOI 10.1042/BJ20100615; Bouybayoune I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004796; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Capone V, 2018, BBA-MOL BASIS DIS, V1864, P3164, DOI 10.1016/j.bbadis.2018.07.003; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Chiesa R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004745; Chiesa R, 2009, PLOS BIOL, V7, P439, DOI 10.1371/journal.pbio.1000075; Daude N, 1997, J BIOL CHEM, V272, P11604, DOI 10.1074/jbc.272.17.11604; Dossena S, 2008, NEURON, V60, P598, DOI 10.1016/j.neuron.2008.09.008; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; Ghirardini E, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008654; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Kim MO, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033134; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; Lee S, 2010, EMBO J, V29, P251, DOI 10.1038/emboj.2009.333; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Griffiths Gareth, 1993, Trends in Cell Biology, V3, P214, DOI 10.1016/0962-8924(93)90114-G; Malaga-Trillo E, 2016, PRION, V10, P352, DOI 10.1080/19336896.2016.1221873; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; MANSON J, 1992, DEVELOPMENT, V115, P117; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Massignan T, 2010, MOL CELL PROTEOMICS, V9, P611, DOI 10.1074/mcp.M900271-MCP200; MCKINLEY MP, 1987, DEV BIOL, V121, P105, DOI 10.1016/0012-1606(87)90143-6; Minikel EV, 2019, NEUROLOGY, V93, pE125, DOI 10.1212/WNL.0000000000007745; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Park SY, 2015, NATURE, V521, P529, DOI 10.1038/nature14457; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Priola SA, 1998, J BIOL CHEM, V273, P11980, DOI 10.1074/jbc.273.19.11980; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Quaglio E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019339; Restelli E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013725; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Sallese M, 2009, SEMIN CELL DEV BIOL, V20, P801, DOI 10.1016/j.semcdb.2009.04.004; Senatore A, 2013, INT J CELL BIOL, V2013, DOI DOI 10.1155/2013/543803; Senatore A, 2012, NEURON, V74, P300, DOI 10.1016/j.neuron.2012.02.027; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Tapella L, 2013, BIOCHEM J, V454, P417, DOI 10.1042/BJ20130563; Uchiyama K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2873; Yu SL, 2007, BIOCHEM J, V403, P343, DOI 10.1042/BJ20061592; Zavodszky E, 2019, ELIFE, V8, DOI 10.7554/eLife.46740	54	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100490	10.1016/j.jbc.2021.100490	http://dx.doi.org/10.1016/j.jbc.2021.100490			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33662396	Green Published, gold			2022-12-28	WOS:000672866400464
J	Sang, LJ; Vieira, DCO; Yue, DT; Ben-Johny, M; Dick, IE				Sang, Lingjie; Vieira, Daiana C. O.; Yue, David T.; Ben-Johny, Manu; Dick, Ivy E.			The molecular basis of the inhibition of Ca(V)1 calcium-dependent inactivation by the distal carboxy tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINUS; CA2+-DEPENDENT INACTIVATION; FLUORESCENT PROTEIN; SKELETAL-MUSCLE; CA2+ REGULATION; STAC PROTEINS; IQ DOMAIN; CHANNEL; CALMODULIN; BINDING	Ca2+/calmodulin-dependent inactivation (CDI) of Ca-V channels is a critical regulatory process that tunes the kinetics of Ca2+ entry for different cell types and physiologic responses. CDI is mediated by calmodulin (CaM), which is bound to the IQ domain of the Ca-V carboxy tail. This modulatory process is tailored by alternative splicing such that select splice variants of Ca(V)1.3 and Ca(V)1.4 contain a long distal carboxy tail (DCT). The DCT harbors an inhibitor of CDI (ICDI) module that competitively displaces CaM from the IQ domain, thereby diminishing CDI. While this overall mechanism is now well described, the detailed interactions required for ICDI binding to the IQ domain are yet to be elucidated. Here, we perform alanine-scanning mutagenesis of the IQ and ICDI domains and evaluate the contribution of neighboring regions to CDI inhibition. Through FRET binding analysis, we identify functionally relevant residues within the Ca(V)1.3 IQ domain and the Ca(V)1.4 ICDI and nearby A region, which are required for high-affinity IQ/ICDI binding. Importantly, patch-clamp recordings demonstrate that disruption of this interaction commensurately diminishes ICDI function resulting in the re-emergence of CDI in mutant channels. Furthermore, Ca(V)1.2 channels harbor a homologous DCT; however, the ICDI region of this channel does not appear to appreciably modulate Ca(V)1.2 CDI. Yet coexpression of Ca(V)1.2 ICDI with select Ca(V)1.3 splice variants significantly disrupts CDI, implicating a cross-channel modulatory scheme in cells expressing both channel subtypes. In all, these findings provide new insights into a molecular rheostat that fine-tunes Ca2+-entry and supports normal neuronal and cardiac function.	[Sang, Lingjie; Yue, David T.; Ben-Johny, Manu; Dick, Ivy E.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Vieira, Daiana C. O.; Dick, Ivy E.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Ben-Johny, Manu] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Columbia University	Dick, IE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.; Dick, IE (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	ied@som.umaryand.edu		Dick, Ivy/0000-0002-7253-6846	NIH/NINDS [5R01NS085074]; NIH/NHLBI [1R01HL149926]	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This grant was supported by an NIH/NINDS grant 5R01NS085074 and by an NIH/NHLBI grant 1R01HL149926. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PJ, 2014, CELL, V159, P608, DOI 10.1016/j.cell.2014.09.047; Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Bazzazi H, 2013, CELL REP, V5, P367, DOI 10.1016/j.celrep.2013.09.006; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Bock G, 2011, J BIOL CHEM, V286, P42736, DOI 10.1074/jbc.M111.269951; Campiglio M, 2018, P NATL ACAD SCI USA, V115, P1376, DOI 10.1073/pnas.1715997115; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; Christel CJ, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2012.239954; Doering CJ, 2005, BIOPHYS J, V89, P3042, DOI 10.1529/biophysj.105.067124; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Gao TY, 2000, J BIOL CHEM, V275, P25436, DOI 10.1074/jbc.M003465200; Gerhardstein BL, 2000, J BIOL CHEM, V275, P8556, DOI 10.1074/jbc.275.12.8556; Ghosh D, 2017, Adv Pharmacol, V78, P49, DOI 10.1016/bs.apha.2016.08.002; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Griessmeier K, 2009, J BIOL CHEM, V284, P29809, DOI 10.1074/jbc.M109.048082; GUTIERREZ LM, 1991, J BIOL CHEM, V266, P16387; Haeseleer F, 2016, J BIOL CHEM, V291, P15663, DOI 10.1074/jbc.M116.731737; Harvey RD, 2013, J MOL CELL CARDIOL, V58, P143, DOI 10.1016/j.yjmcc.2012.12.006; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; Huang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5481; Huang H, 2012, NEURON, V73, P304, DOI 10.1016/j.neuron.2011.11.022; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Hurley MJ, 2013, BRAIN, V136, P2077, DOI 10.1093/brain/awt134; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Lieb A, 2012, CHANNELS, V6, P197, DOI 10.4161/chan.21002; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Liu N, 2017, ELIFE, V6, DOI 10.7554/eLife.21989; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Niu J, 2018, ELIFE, V7, DOI 10.7554/eLife.35222; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Polster E, 2018, J NEUROSCI, V38, P9215, DOI 10.1523/JNEUROSCI.0695-18.2018; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sang LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12239; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; Shaltiel L, 2012, J BIOL CHEM, V287, P36312, DOI 10.1074/jbc.M112.392811; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Striessnig J, 2006, BIOCHEM SOC T, V34, P903, DOI 10.1042/BST0340903; Striessnig J, 2015, CURR MOL PHARMACOL, V8, P110, DOI 10.2174/1874467208666150507105845; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Tan GMY, 2012, J BIOL CHEM, V287, P832, DOI 10.1074/jbc.M111.268722; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; WEI XY, 1991, J BIOL CHEM, V266, P21943; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Yang PS, 2014, NAT CHEM BIOL, V10, P231, DOI [10.1038/NCHEMBIO.1436, 10.1038/nchembio.1436]; Yuen SMWK, 2017, P NATL ACAD SCI USA, V114, pE9520, DOI 10.1073/pnas.1708852114; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	60	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100502	10.1016/j.jbc.2021.100502	http://dx.doi.org/10.1016/j.jbc.2021.100502			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667546	Green Published, gold			2022-12-28	WOS:000672866400476
J	Sorkina, T; Cheng, MH; Bagalkot, TR; Wallace, C; Watkins, SC; Bahar, I; Sorkin, A				Sorkina, Tatiana; Cheng, Mary Hongying; Bagalkot, Tarique R.; Wallace, Callen; Watkins, Simon C.; Bahar, Ivet; Sorkin, Alexander			Direct coupling of oligomerization and oligomerization-driven endocytosis of the dopamine transporter to its conformational mechanics and activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; PLASMA-MEMBRANE; CROSS-LINKING; DYNAMICS; PROTEINS; TRAFFICKING; RECEPTOR; REWARD; DIMER	Dopamine transporter (DAT) mediates the reuptake of synaptically released dopamine, and thus controls the duration and intensity of dopamine neurotransmission. Mammalian DAT has been observed to form oligomers, although the mechanisms of oligomerization and its role in DAT activity and trafficking remain largely unknown. We discovered a series of small molecule compounds that stabilize trimers and induce high-order oligomers of DAT and concomitantly promote its clathrin-independent endocytosis. Using a combination of chemical cross-linking, fluorescence resonance energy transfer microscopy, antibody-uptake endocytosis assay, live-cell lattice light sheet microscopy, ligand binding and substrate transport kinetics analyses, and molecular modeling and simulations, we investigated molecular basis of DAT oligomerization and endocytosis induced by these compounds. Our study showed that small molecule-induced DAT oligomerization and endocytosis are favored by the inward-facing DAT conformation and involve interactions of four hydrophobic residues at the interface between transmembrane (TM) helices TM4 and TM9. Surprisingly, a corresponding quadruple DAT mutant displays altered dopamine transport kinetics and increased cocaine-analog binding. The latter is shown to originate from an increased preference for outward-facing conformation and inward-to-outward transition. Taken together, our results demonstrate a direct coupling between conformational dynamics of DAT, functional activity of the transporter, and its oligomerization leading to endocytosis. The high specificity of such coupling for DAT makes the TM4-9 hub a new target for pharmacological modulation of DAT activity and subcellular localization.	[Sorkina, Tatiana; Bagalkot, Tarique R.; Wallace, Callen; Watkins, Simon C.; Sorkin, Alexander] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Cheng, Mary Hongying; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sorkin, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	sorkin@pitt.edu	Cheng, Mary Hongying/AAU-3768-2021; Bagalkot, Tarique/N-1189-2019	Cheng, Mary Hongying/0000-0001-5833-8221; Bagalkot, Tarique/0000-0002-2827-0040; bahar, ivet/0000-0001-9959-4176; Sorkin, Alexander/0000-0002-4446-1920	National Institutes of Health [DA014204, P30DA035778, P41GM103712]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants DA014204 (A. S.), P30DA035778 (I. B.) and P41GM103712 (I. B.) from National Institutes of Health.	Aimon S, 2014, DEV CELL, V28, P212, DOI 10.1016/j.devcel.2013.12.012; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Apaja PM, 2010, J CELL BIOL, V191, P553, DOI 10.1083/jcb.201006012; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bellam R, 2016, TRANSIT METAL CHEM, V41, P271, DOI 10.1007/s11243-015-0018-z; Callenberg KM, 2012, J GEN PHYSIOL, V140, P55, DOI 10.1085/jgp.201110766; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Cheng MH, 2019, NAT STRUCT MOL BIOL, V26, P545, DOI 10.1038/s41594-019-0253-7; Cheng MH, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.107676; Cheng MH, 2018, J PHYS CHEM B, V122, P5336, DOI 10.1021/acs.jpcb.7b10340; Cheng MHY, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00134; Cheng MH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003879; Coleman JA, 2019, NATURE, V569, P141, DOI 10.1038/s41586-019-1135-1; Das AK, 2019, J BIOL CHEM, V294, P5632, DOI 10.1074/jbc.RA118.006178; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Fleckenstein AE, 1997, J PHARMACOL EXP THER, V282, P834; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; Gowrishankar R, 2014, NEUROCHEM INT, V73, P42, DOI 10.1016/j.neuint.2013.10.016; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hilgemann DW, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.06.006; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jaber M, 1997, MOVEMENT DISORD, V12, P629, DOI 10.1002/mds.870120502; Jayaraman K, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006229; Johannes L, 2018, TRENDS CELL BIOL, V28, P405, DOI 10.1016/j.tcb.2018.01.009; Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Li Y, 2010, J NEUROCHEM, V114, P873, DOI 10.1111/j.1471-4159.2010.06818.x; Ma S., 2018, BIO-PROTOCOL, V8, pE2996; Ma SQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05637-x; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Navratna V, 2019, CURR OPIN STRUC BIOL, V54, P161, DOI 10.1016/j.sbi.2019.03.011; Navratna V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200085; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ponzoni L, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0177; Rahbek-Clemmensen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00790-3; Rao A, 2012, FASEB J, V26, P1921, DOI 10.1096/fj.11-196113; Rosholm KR, 2017, NAT CHEM BIOL, V13, P724, DOI 10.1038/nchembio.2372; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2018, ELIFE, V7, DOI 10.7554/eLife.32293; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vivian D, 2014, EUR J PHARM SCI, V64, P44, DOI 10.1016/j.ejps.2014.08.007; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; WESTERMARK B, 1990, P NATL ACAD SCI USA, V87, P128, DOI 10.1073/pnas.87.1.128; Wise RA, 2008, NEUROTOX RES, V14, P169, DOI 10.1007/BF03033808; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Wu SJ, 2017, J NEUROSCI, V37, P9438, DOI 10.1523/JNEUROSCI.3885-16.2017; Wu S, 2015, P NATL ACAD SCI USA, V112, P15480, DOI 10.1073/pnas.1512957112; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459; Zhen J, 2018, J NEUROCHEM, V144, P162, DOI 10.1111/jnc.14259; Zhen J, 2015, J NEUROCHEM, V133, P167, DOI 10.1111/jnc.13025	69	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100430	10.1016/j.jbc.2021.100430	http://dx.doi.org/10.1016/j.jbc.2021.100430			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610553	Green Published, gold			2022-12-28	WOS:000672866400404
J	Taniguchi, R; Utani, K; Thakur, B; Ishine, K; Aladjem, MI; Shimizu, N				Taniguchi, Ryonosuke; Utani, Koichi; Thakur, Bhushan; Ishine, Kazuho; Aladjem, Mirit, I; Shimizu, Noriaki			SIRT1 stabilizes extrachromosomal gene amplification and contributes to repeat-induced gene silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOGENEOUSLY STAINING REGIONS; REPLICATION INITIATION REGION; DOUBLE MINUTES; CIRCULAR DNA; MYC GENES; ELIMINATION; CELLS; PLASMIDS	Sirtuin 1 (SIRT1) is a protein deacetylase that maintains genome stability by preventing the activation of latent replication origins. Amplified genes in cancer cells localize on either extrachromosomal double minutes (DMs) or the chromosomal homogeneously staining region. Previously, we found that a plasmid with a mammalian replication initiation region and a matrix attachment region spontaneously mimics gene amplification in cultured animal cells and efficiently generates DMs and/or an homogeneously staining region. Here, we addressed the possibility that SIRT1 might be involved in initiation region/matrix attachment region-mediated gene amplification using SIRT1-knockout human COLO 320DM cells. Consequently, we found that extrachromosomal amplification was infrequent in SIRT1-deficient cells, suggesting that DNA breakage caused by latent origin activation prevented the formation of stable extrachromosomal amplicons. Moreover, we serendipitously found that reporter gene expression from the amplified repeats, which is commonly silenced by repeat-induced gene silencing (RIGS) in SIRT1-proficient cells, was strikingly higher in SIRT1-deficient cells, especially in the culture treated with the histone deacetylase inhibitor butyrate. Compared with the SIRT1-proficient cells, the gene expression per copy was up to thousand-fold higher in the sorter-isolated highest 10% cells among the SIRT1-deficient cells. These observations suggest that SIRT1 depletion alleviates RIGS. Thus, SIRT1 may stabilize extrachromosomal amplicons and facilitate RIGS. This result could have implications in cancer malignancy and protein expression.	[Taniguchi, Ryonosuke; Ishine, Kazuho; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan; [Utani, Koichi; Thakur, Bhushan; Aladjem, Mirit, I] NCI, Lab Mol Pharmacol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Shimizu, Noriaki] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan; [Utani, Koichi] Kanazawa Med Univ, Dept Microbiol, Uchinada, Ishikawa, Japan	Hiroshima University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hiroshima University; Kanazawa Medical University	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan.; Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp		Thakur, Bhushan L./0000-0002-8426-3478; Utani, Koichi/0000-0002-8065-3161; Shimizu, Noriaki/0000-0002-7979-897X	AMED [JP19ae0101054]; NIH, Center of Cancer Research, National Cancer Institute	AMED; NIH, Center of Cancer Research, National Cancer Institute	This research was supported in part by AMED under Grant Number JP19ae0101054 awarded to N. S. and by the intramural program of the NIH, Center of Cancer Research, National Cancer Institute to M. I. A.	Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; Asoshina M, 2019, NUCLEIC ACIDS RES, V47, P5998, DOI 10.1093/nar/gkz343; BENNER SE, 1991, ANTI-CANCER DRUG, V2, P11, DOI 10.1097/00001813-199102000-00002; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; deCarvalho AC, 2018, NAT GENET, V50, P708, DOI 10.1038/s41588-018-0105-0; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; ECKHARDT SG, 1994, P NATL ACAD SCI USA, V91, P6674, DOI 10.1073/pnas.91.14.6674; Fukuma M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153338; Fusco S, 2012, CELL CYCLE, V11, P4135, DOI 10.4161/cc.22074; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Harada S, 2009, J BIOL CHEM, V284, P24320, DOI 10.1074/jbc.M109.008128; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Koche RP, 2020, NAT GENET, V52, P29, DOI 10.1038/s41588-019-0547-z; Kondo Y, 2003, J BIOL CHEM, V278, P27658, DOI 10.1074/jbc.M304072200; Koo DH, 2018, P NATL ACAD SCI USA, V115, P3332, DOI 10.1073/pnas.1719354115; Lin Zhenghong, 2013, Genes Cancer, V4, P97, DOI 10.1177/1947601912475079; Luna Augustin, 2013, Genome Integr, V4, P6, DOI 10.1186/2041-9414-4-6; McBurney MW, 2002, EXP CELL RES, V274, P1, DOI 10.1006/excr.2001.5443; Mitsuda SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161288; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Noguchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052990; Okada N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077350; Oobatake Y, 2020, GENE CHROMOSOME CANC, V59, P133, DOI 10.1002/gcc.22810; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rahman S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-11; Reddy BD, 2011, GENE DEV, V25, P214, DOI 10.1101/gad.1993611; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2003, CANCER RES, V63, P5281; SHIMIZU N, 1994, CANCER RES, V54, P3561; Shimizu N, 1996, NAT GENET, V12, P65, DOI 10.1038/ng0196-65; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2001, EXP CELL RES, V268, P201, DOI 10.1006/excr.2001.5286; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Tanaka SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103439; Turner KM, 2017, NATURE, V543, P122, DOI 10.1038/nature21356; Utani K, 2017, NUCLEIC ACIDS RES, V45, P7807, DOI 10.1093/nar/gkx468; Verhaak RGW, 2019, NAT REV CANCER, V19, P283, DOI 10.1038/s41568-019-0128-6; Von Hoff D D, 1991, Cancer Treat Res, V57, P1; VONHOFF DD, 1991, CANCER RES, V51, P6273; VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165, DOI 10.1073/pnas.89.17.8165; WAHL GM, 1989, CANCER RES, V49, P1333; Yang G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14941; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	46	8	8	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100356	10.1016/jbc.2021.100356	http://dx.doi.org/10.1016/jbc.2021.100356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539925				2022-12-28	WOS:000672866400330
J	Tao, JH; Berthet, A; Citron, YR; Tsiolaki, PL; Stanley, R; Gestwicki, JE; Agard, DA; McConlogue, L				Tao, Jiahui; Berthet, Amandine; Citron, Y. Rose; Tsiolaki, Paraskevi L.; Stanley, Robert; Gestwicki, Jason E.; Agard, David A.; McConlogue, Lisa			Hsp70 chaperone blocks alpha-synuclein oligomer formation via a novel engagement mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; HEAT-SHOCK-PROTEIN-70 HSP70; FIBRIL FORMATION; AGGREGATION; BINDING; INHIBITION; TOXICITY; MODEL	Overexpression and aggregation of alpha-synuclein (ASyn) are linked to the onset and pathology of Parkinson's disease and related synucleinopathies. Elevated levels of the stress-induced chaperone Hsp70 protect against ASyn misfolding and ASyn-driven neurodegeneration in cell and animal models, yet there is minimal mechanistic understanding of this important protective pathway. It is generally assumed that Hsp70 binds to ASyn using its canonical and promiscuous substrate-binding cleft to limit aggregation. Here we report that this activity is due to a novel and unexpected mode of Hsp70 action, involving neither ATP nor the typical substrate-binding cleft. We use novel ASyn oligomerization assays to show that Hsp70 directly blocks ASyn oligomerization, an early event in ASyn misfolding. Using truncations, mutations, and inhibitors, we confirm that Hsp70 interacts with ASyn via an as yet unidentified, noncanonical interaction site in the C-terminal domain. Finally, we report a biological role for a similar mode of action in H4 neuroglioma cells. Together, these findings suggest that new chemical approaches will be required to target the Hsp70-ASyn interaction in synucleinopathies. Such approaches are likely to be more specific than targeting Hsp70's canonical action. Additionally, these results raise the question of whether other misfolded proteins might also engage Hsp70 via the same noncanonical mechanism.	[Tao, Jiahui; Citron, Y. Rose; Tsiolaki, Paraskevi L.; Agard, David A.; McConlogue, Lisa] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Berthet, Amandine; Stanley, Robert; McConlogue, Lisa] Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Gestwicki, Jason E.] Univ Calif San Francisco, Inst Neurodegenerat Dis, Dept Pharmaceut Chem, San Francisco, CA USA; [Gestwicki, Jason E.] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Agard, DA; McConlogue, L (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; McConlogue, L (corresponding author), Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu; lisam@trp.ucsf.edu		McConlogue, Lisa/0000-0001-7319-3534	Rogers Family Foundation; Howard Hughes Medical Institute; EMBO long term fellowship [ALTF 154-2020]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R21NS092897]	Rogers Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EMBO long term fellowship(European Molecular Biology Organization (EMBO)); National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported by the Rogers Family Foundation (L. M., D. A. A.), by the Howard Hughes Medical Institute (D. A. A.), by an EMBO long term fellowship award number ALTF 154-2020 (P. L. T.) and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R21NS092897 (L. M.). "The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."	Alam P, 2019, J NEUROCHEM, V150, P522, DOI 10.1111/jnc.14808; Aprile FA, 2017, BIOCHEMISTRY-US, V56, P1177, DOI 10.1021/acs.biochem.6b01178; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burmann BM, 2020, NATURE, V577, P127, DOI 10.1038/s41586-019-1808-9; Burre J, 2015, J NEUROSCI, V35, P5221, DOI 10.1523/JNEUROSCI.4650-14.2015; Cesa LC, 2018, J BIOL CHEM, V293, P2370, DOI 10.1074/jbc.RA117.000634; Chaari A, 2016, INT J BIOL MACROMOL, V83, P433, DOI 10.1016/j.ijbiomac.2015.10.089; Chen SW, 2018, METHODS MOL BIOL, V1779, P45, DOI 10.1007/978-1-4939-7816-8_4; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; Clerico EM, 2019, BIOCHEM J, V476, P1653, DOI 10.1042/BCJ20170380; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Flagmeier P, 2016, P NATL ACAD SCI USA, V113, P10328, DOI 10.1073/pnas.1604645113; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hu F, 2019, CELL REP, V26, P168, DOI 10.1016/j.celrep.2018.12.032; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Ingelsson M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00408; Jones DR, 2014, THER ADV NEUROL DISO, V7, P33, DOI 10.1177/1756285613493469; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Levin J, 2016, BIOCHEM BIOPH RES CO, V477, P76, DOI 10.1016/j.bbrc.2016.06.023; Li XK, 2016, CURR TOP MED CHEM, V16, P2729, DOI 10.2174/1568026616666160413140911; Li XK, 2015, MOL CANCER THER, V14, P642, DOI 10.1158/1535-7163.MCT-14-0650; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Moloney TC, 2014, CNS NEUROSCI THER, V20, P50, DOI 10.1111/cns.12200; Morozova K, 2016, J BIOL CHEM, V291, P18096, DOI 10.1074/jbc.M116.736744; Morris M, 2015, ANN CLIN TRANSL NEUR, V2, P1012, DOI 10.1002/acn3.257; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Outeiro TF, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0306-8; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Redeker V, 2012, J BIOL CHEM, V287, P32630, DOI 10.1074/jbc.M112.387530; Rockenstein E, 2014, BRAIN, V137, P1496, DOI 10.1093/brain/awu057; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Schneider M. M., 2020, HSC70 DISAGGREGATION, DOI [10.1101/2020.11.02.365825, DOI 10.1101/2020.11.02.365825]; Shao H, 2018, J MED CHEM, V61, P6163, DOI 10.1021/acs.jmedchem.8b00583; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steiner JA, 2018, CELL TISSUE RES, V373, P161, DOI 10.1007/s00441-018-2814-1; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Toth G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52598-4; Toth G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087133; van Ham TJ, 2010, J MOL BIOL, V395, P627, DOI 10.1016/j.jmb.2009.10.066; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107; Wu N, 2015, BBA-PROTEINS PROTEOM, V1854, P1392, DOI 10.1016/j.bbapap.2015.05.008; Wu YR, 2004, HUM GENET, V114, P236, DOI 10.1007/s00439-003-1050-1; Yamaguchi K, 2005, ACTA NEUROPATHOL, V110, P298, DOI 10.1007/s00401-005-1042-4; Ysselstein D, 2015, NEUROBIOL DIS, V79, P150, DOI 10.1016/j.nbd.2015.04.007; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	71	11	11	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100613	10.1016/j.jbc.2021.100613	http://dx.doi.org/10.1016/j.jbc.2021.100613			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33798554	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400584
J	Pilliod, J; Desjardins, A; Pernegre, C; Jamann, H; Larochelle, C; Fon, EA; Leclerc, N				Pilliod, Julie; Desjardins, Alexandre; Pernegre, Camille; Jamann, Helene; Larochelle, Catherine; Fon, Edward A.; Leclerc, Nicole			Clearance of intracellular tau protein from neuronal cells via VAMP8-induced secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						VAMP8; secretion; late endosomes; tau mutants; TIRF microscopy; Tau protein (Tau); endosome; Alzheimer disease; SNARE proteins	MILD COGNITIVE IMPAIRMENT; FRONTOTEMPORAL LOBAR DEGENERATION; MICROTUBULE-ASSOCIATED PROTEINS; ALZHEIMERS-DISEASE; UNCONVENTIONAL SECRETION; NEUROFIBRILLARY TANGLES; REGULATED EXOCYTOSIS; UP-REGULATION; DEMENTIA; GENE	In Alzheimer's disease (AD), tau, a microtubule-associated protein (MAP), becomes hyperphosphorylated, aggregates, and accumulates in the somato-dendritic compartment of neurons. In parallel to its intracellular accumulation in AD, tau is also released in the extracellular space, as revealed by its increased presence in cerebrospinal fluid (CSF). Consistent with this, recent studies, including ours, have reported that neurons secrete tau, and several therapeutic strategies aim to prevent the intracellular tau accumulation. Previously, we reported that late endosomes were implicated in tau secretion. Here, we explore the possibility of preventing intracellular tau accumulation by increasing tau secretion. Using neuronal models, we investigated whether overexpression of the vesicle-associated membrane protein 8 (VAMP8), an R-SNARE found on late endosomes, could increase tau secretion. The overexpression of VAMP8 significantly increased tau secretion, decreasing its intracellular levels in the neuroblastoma (N2a) cell line. Increased tau secretion by VAMP8 was also observed in murine hippocampal slices. The intracellular reduction of tau by VAMP8 overexpression correlated to a decrease of acetylated tubulin induced by tau overexpression in N2a cells. VAMP8 staining was preferentially found on late endosomes in N2a cells. Using total internal reflection fluorescence (TIRF) microscopy, the fusion of VAMP8-positive vesicles with the plasma membrane was correlated to the depletion of tau in the cytoplasm. Finally, overexpression of VAMP8 reduced the intracellular accumulation of tau mutants linked to frontotemporal dementia with parkinsonism and alpha-synuclein by increasing their secretion. Collectively, the present data indicate that VAMP8 could be used to increase tau and alpha-synuclein clearance to prevent their intracellular accumulation.	[Pilliod, Julie; Desjardins, Alexandre; Pernegre, Camille; Jamann, Helene; Larochelle, Catherine; Leclerc, Nicole] Univ Montreal Hosp CRCHUM, Res Ctr, Montreal, PQ, Canada; [Pernegre, Camille; Jamann, Helene; Larochelle, Catherine; Leclerc, Nicole] Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ, Canada; [Fon, Edward A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, McGill Parkinson Program, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University	Leclerc, N (corresponding author), Univ Montreal Hosp CRCHUM, Res Ctr, Montreal, PQ, Canada.; Leclerc, N (corresponding author), Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ, Canada.	Nicole.leclerc@umontreal.ca	Jamann, Hélène/ABD-8456-2021	Jamann, Hélène/0000-0002-3610-3090	Canadian Institute of Health Research (CIHR) [PJT-155993]; CRCHUM internal funds	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CRCHUM internal funds	This work was supported in part by Canadian Institute of Health Research (CIHR) Grant PJT-155993 (to N. L. and E. A. F.) and from CRCHUM internal funds (to N. L.).	Ahmed T, 2014, NEUROBIOL AGING, V35, P2474, DOI 10.1016/j.neurobiolaging.2014.05.005; ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Barthelemy NR, 2016, J ALZHEIMERS DIS, V51, P1033, DOI 10.3233/JAD-150962; Benskey MJ, 2016, J NEUROCHEM, V137, P331, DOI 10.1111/jnc.13570; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bright J, 2015, NEUROBIOL AGING, V36, P693, DOI 10.1016/j.neurobiolaging.2014.09.007; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; Diaz-Vera J, 2017, J CELL SCI, V130, P697, DOI 10.1242/jcs.190835; Dujardin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100760; Emmanouilidou E, 2016, BRAIN PATHOL, V26, P398, DOI 10.1111/bpa.12373; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Forrest SL, 2018, BRAIN, V141, P521, DOI 10.1093/brain/awx328; Gao S, 2018, BRAIN, V141, P2711, DOI 10.1093/brain/awy197; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; Ginsberg SD, 2011, J CHEM NEUROANAT, V42, P102, DOI 10.1016/j.jchemneu.2011.05.012; Ginsberg SD, 2010, J ALZHEIMERS DIS, V22, P631, DOI 10.3233/JAD-2010-101080; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; Goedert M, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0298-7; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2009, EUR NEUROPSYCHOPHARM, V19, P708, DOI 10.1016/j.euroneuro.2009.04.006; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Han PC, 2017, J NEUROPATH EXP NEUR, V76, P44, DOI 10.1093/jnen/nlw105; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iguchi Y, 2016, BRAIN, V139, P3187, DOI 10.1093/brain/aww237; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jadhav S, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0664-z; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kucera Ana, 2016, Commun Integr Biol, V9, pe1204498, DOI 10.1080/19420889.2016.1204498; Kumar-Singh S, 2007, BRAIN PATHOL, V17, P104, DOI 10.1111/j.1750-3639.2007.00055.x; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Le Guennec K, 2017, MOL PSYCHIATR, V22, P1119, DOI 10.1038/mp.2016.226; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDIN B, 1993, HIPPOCAMPUS, V3, P61; Mandell JW, 1996, PERSPECT DEV NEUROBI, V4, P125; Marshall MR, 2015, J CELL BIOL, V210, P135, DOI 10.1083/jcb.201411093; Mohamed NV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178288; Mohamed NV, 2014, SCI REP-UK, V4, DOI 10.1038/srep05715; Mohamed NV, 2013, EUR J NEUROSCI, V37, P1939, DOI 10.1111/ejn.12229; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Ossenkoppele R, 2016, BRAIN, V139, P1551, DOI 10.1093/brain/aww027; Pernegre C, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00649; Plouffe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036873; Pontecorvo MJ, 2019, BRAIN, V142, P1723, DOI 10.1093/brain/awz090; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Poorkaj P, 2001, ARCH NEUROL-CHICAGO, V58, P383, DOI 10.1001/archneur.58.3.383; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Rodriguez L, 2017, J NEUROCHEM, V141, P592, DOI 10.1111/jnc.13994; Russell CL, 2017, J ALZHEIMERS DIS, V55, P303, DOI 10.3233/JAD-160633; Schraen-Maschke S, 2004, NEUROBIOL DIS, V15, P449, DOI 10.1016/j.nbd.2003.12.009; Shrivastava AN, 2019, EMBO J, V38, DOI 10.15252/embj.201899871; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tang MP, 2019, ADV EXP MED BIOL, V1184, P57, DOI 10.1007/978-981-32-9358-8_5; Tiernan CT, 2016, NEUROBIOL AGING, V42, P80, DOI 10.1016/j.neurobiolaging.2016.02.031; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; Tsunemi T, 2019, J NEUROSCI, V39, P5760, DOI 10.1523/JNEUROSCI.3085-18.2019; Vaz-Silva J, 2018, EMBO J, V37, DOI 10.15252/embj.201899084; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; Wang TL, 2012, J CELL PHYSIOL, V227, P2788, DOI 10.1002/jcp.23023; Wang Y, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0143-y; Xu Y, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0012-7; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	82	9	9	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17827	17841		10.1074/jbc.RA120.013553	http://dx.doi.org/10.1074/jbc.RA120.013553			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454017	Green Published, hybrid			2022-12-28	WOS:000603272300033
J	Fan, C; An, H; Sharif, M; Kim, D; Park, Y				Fan, Chuandong; An, Hongjoo; Sharif, Mohamed; Kim, Dongkyeong; Park, Yungki			Functional mechanisms of MYRF DNA-binding domain mutations implicated in birth defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE REGULATORY FACTOR; DE-NOVO VARIANTS; TRANSCRIPTION FACTOR; MYELIN; CELLS	Myrf is a pleiotropic membrane-bound transcription factor that plays critical roles in diverse organisms, including in oligodendrocyte differentiation, embryonic development, molting, and synaptic plasticity. Upon autolytic cleavage, the Myrf N-terminal fragment enters the nucleus as a homo-trimer and functions as a transcription factor. Homo-trimerization is essential for this function because it imparts DNA-binding specificity and affinity. Recent exome sequencing studies have implicated four de novo MYRF DNA-binding domain (DBD) mutations (F387S, Q403H, G435R, and L479V) in novel syndromic birth defects involving the diaphragm, heart, and the urogenital tract. It remains unknown whether and how these four mutations alter the transcription factor function of MYRF. Here, we studied them by introducing homologous mutations to the mouse Myrf protein. We found that the four DBD mutations abolish the transcriptional activity of the Myrf N-terminal fragment by interfering with its homo-trimerization ability by perturbing the DBD structure. Since the Myrf N-terminal fragment strictly functions as a homo-trimer, any loss-of-function mutation has the potential to act as a dominant negative. We observed that one copy of Myrf-F387S, Myrf-Q403H, or Myrf-L479V, but not Myrf-G435R, was tolerated by the Myrf N-terminal homo-trimer for structural and functional integrity. These data suggest that F387S, Q403H, and L479V cause birth defects by haploinsufficiency, while G435R does so via dominant negative functionality.	[Fan, Chuandong; An, Hongjoo; Sharif, Mohamed; Kim, Dongkyeong; Park, Yungki] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Hunter James Kelly Res Inst, Dept Biochem, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Park, Y (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Hunter James Kelly Res Inst, Dept Biochem, Buffalo, NY 14260 USA.	yungkipa@buffalo.edu			National Institutes of Health [R01NS094181, R21NS102558]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [R01NS094181 and R21NS102558 to Y. P.]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57593-8; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Bujalka H, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001625; Chen BH, 2018, J STRUCT BIOL, V203, P170, DOI 10.1016/j.jsb.2018.04.007; Choi JO, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31477-4; Duncan GJ, 2017, ACTA NEUROPATHOL, V134, P403, DOI 10.1007/s00401-017-1741-7; Emery Ben, 2013, Cold Spring Harb Protoc, V2013, P854, DOI 10.1101/pdb.prot073973; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Garnai SJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008130; Hagedorn J, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01659-8; Hamanaka K, 2019, HUM MOL GENET, V28, P2319, DOI 10.1093/hmg/ddz066; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kim D, 2017, NUCLEIC ACIDS RES, V45, P5112, DOI 10.1093/nar/gkx080; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Kowarz E, 2015, BIOTECHNOL J, V10, P647, DOI 10.1002/biot.201400821; Kurahashi H, 2018, ANN NEUROL, V83, P98, DOI 10.1002/ana.25125; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li ZH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001624; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Meng J, 2017, DEV CELL, V41, P180, DOI 10.1016/j.devcel.2017.03.022; Milan M, 2020, DEV CELL, V55, P398, DOI 10.1016/j.devcel.2020.09.011; Pinz H, 2018, AM J MED GENET A, V176, P969, DOI 10.1002/ajmg.a.38620; Qi HJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007822; Rossetti LZ, 2019, AM J MED GENET A, V179, P1376, DOI 10.1002/ajmg.a.61182; Russel S, 2011, DEV BIOL, V360, P297, DOI 10.1016/j.ydbio.2011.09.025; Schulz EC, 2010, NAT STRUCT MOL BIOL, V17, P210, DOI 10.1038/nsmb.1746; Senoo H, 2013, J CELL SCI, V126, P5247, DOI 10.1242/jcs.133231; Senoo H, 2012, INT J DEV BIOL, V56, P325, DOI 10.1387/ijdb.120030jw; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhen XK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03768-9	32	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100612	10.1016/j.jbc.2021.100612	http://dx.doi.org/10.1016/j.jbc.2021.100612			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33798553	gold, Green Published			2022-12-28	WOS:000672866400583
J	Furze, CM; Delso, I; Casal, E; Guy, CS; Seddon, C; Brown, CM; Parker, HL; Radhakrishnan, A; Pacheco-Gomez, R; Stansfeld, PJ; Angulo, J; Cameron, AD; Fullam, E				Furze, Christopher M.; Delso, Ignacio; Casal, Enriqueta; Guy, Collette S.; Seddon, Chloe; Brown, Chelsea M.; Parker, Hadyn L.; Radhakrishnan, Anjana; Pacheco-Gomez, Raul; Stansfeld, Phillip J.; Angulo, Jesus; Cameron, Alexander D.; Fullam, Elizabeth			Structural basis of trehalose recognition by the mycobacterial LpqY-SugABC transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; BINDING PROTEIN; TUBERCULOSIS; SMEGMATIS; ANALOGS; GROWTH	The Mycobacterium tuberculosis (Mtb) LpqY-SugABC ATP-binding cassette transporter is a recycling system that imports trehalose released during remodeling of the Mtb cell-envelope. As this process is essential for the virulence of the Mtb pathogen, it may represent an important target for tuberculosis drug and diagnostic development, but the transporter specificity and molecular determinants of substrate recognition are unknown. To address this, we have determined the structural and biochemical basis of how mycobacteria transport trehalose using a combination of crystallography, saturation transfer difference NMR, molecular dynamics, site-directed mutagenesis, biochemical/biophysical assays, and the synthesis of trehalose analogs. This analysis pinpoints key residues of the LpqY substrate binding lipoprotein that dictate substrate-specific recognition and has revealed which disaccharide modifications are tolerated. These findings provide critical insights into how the essential Mtb LpqY-SugABC transporter reuses trehalose and modified analogs and specifies a framework that can be exploited for the design of new antitubercular agents and/or diagnostic tools.	[Furze, Christopher M.; Guy, Collette S.; Seddon, Chloe; Brown, Chelsea M.; Parker, Hadyn L.; Radhakrishnan, Anjana; Stansfeld, Phillip J.; Cameron, Alexander D.; Fullam, Elizabeth] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Delso, Ignacio] Univ Zaragoza, Inst Sintesis Quim & Catalisis Homogenea ISQCH, CSIC, Zaragoza, Spain; [Delso, Ignacio; Casal, Enriqueta; Angulo, Jesus] Univ East Anglia, Sch Pharm, Norwich, Norfolk, England; [Pacheco-Gomez, Raul] Malvern Panalyt Ltd, Malvern, Worcs, England; [Stansfeld, Phillip J.] Univ Warwick, Dept Chem, Coventry, W Midlands, England; [Angulo, Jesus] Univ Seville, Dept Quim Organ, Seville, Spain; [Angulo, Jesus] Inst Invest Quim CSIC Us, Seville, Spain	University of Warwick; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC-UZA - Instituto de Sintesis Quimica y Catalisis Homogenea (ISQCH); University of Zaragoza; University of East Anglia; Malvern Panalytical; University of Warwick; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ)	Fullam, E (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.	e.fullam@warwick.ac.uk	Delso, Ignacio/AAW-2250-2021	Delso, Ignacio/0000-0001-8355-2289; Guy, Collette/0000-0002-5153-0613; Parker, Hadyn L./0000-0001-8779-4541; Brown, Chelsea/0000-0003-2006-5015; Cumley, Anjana/0000-0002-5785-546X	Sir Henry Dale Fellowship; Wellcome Trust; Royal Society [104193/Z/14/Z, 104193/Z/14/B, RG120405]; Leverhulme Trust [RPG-2019-087]; BBSRC [BB/M01116X/1, BB/M017982/1, BB/P010660/1]; MRC [MR/N014294/1]; EPSRC [EP/R029407/1, EP/P020232/1]; Universidad de Sevilla (Acciones Especiales del VI Plan Propio de Investigacion y Transferencia); University of Warwick Scientific Computing Research Technology Platform; BBSRC [1786898] Funding Source: UKRI	Sir Henry Dale Fellowship; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Universidad de Sevilla (Acciones Especiales del VI Plan Propio de Investigacion y Transferencia); University of Warwick Scientific Computing Research Technology Platform; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Sir Henry Dale Fellowship to E. F. jointly funded by the Wellcome Trust and Royal Society (104193/Z/14/Z and 104193/Z/14/B), a research grant from the Royal Society (RG120405), a research grant from the Leverhulme Trust (RPG-2019-087), the BBSRC for a studentship to H. P. and A. R. (BB/M01116X/1) and the MRC for a studentship for CMB (MR/N014294/1). We acknowledge equipment access, training, and support made available by the Research Technology Facility (managed by Dr Sarah Bennett) of the Warwick Integrative Synthetic Biology center (WISB), which received funding from EPSRC and BBSRC (BB/M017982/1). J. A. acknowledges support from the BBSRC through a New Investigator grant (BB/P010660/1) and the Universidad de Sevilla (Acciones Especiales del VI Plan Propio de Investigacion y Transferencia). We are also grateful for the use of the University of East Anglia (UEA) Faculty of Science NMR facility. This project made use of time on ARCHER and JADE granted via the UK High-End Computing Consortium for Biomolecular Simulation, HECBioSim (http://hecbiosim.ac.uk), supported by the EPSRC (EP/R029407/1), Athena, at HPC Midlands+ funded by the EPSRC (EP/P020232/1) and used the University of Warwick Scientific Computing Research Technology Platform for computational access.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belisle John T., 2008, V465, P1, DOI 10.1007/978-1-59745-207-6_1; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Bell A, 2019, NAT MICROBIOL, V4, P2393, DOI 10.1038/s41564-019-0590-7; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chandravanshi M, 2020, FEBS J, V287, P1576, DOI 10.1111/febs.15093; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; ELBEIN AD, 1973, J BACTERIOL, V113, P863, DOI 10.1128/JB.113.2.863-873.1973; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn JS, 2019, ACS CHEM BIOL, V14, P1879, DOI 10.1021/acschembio.9b00204; Fullam E, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160105; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jackson M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a021105; JEFFREY GA, 1985, CARBOHYD RES, V137, P21, DOI 10.1016/0008-6215(85)85146-6; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalscheuer R, 2010, P NATL ACAD SCI USA, V107, P21761, DOI 10.1073/pnas.1014642108; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lowery R, 2015, CHEM COMMUN, V51, P4838, DOI 10.1039/c4cc09588j; Maqbool A, 2015, BIOCHEM SOC T, V43, P1011, DOI 10.1042/BST20150135; Mayer M, 2004, J AM CHEM SOC, V126, P4453, DOI 10.1021/ja0398870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Monaco S, 2017, ANGEW CHEM INT EDIT, V56, P15289, DOI 10.1002/anie.201707682; Moriarty NW, 2017, ACTA CRYSTALLOGR D, V73, P123, DOI 10.1107/S2059798316016570; Niederweis M, 2008, MICROBIOL-SGM, V154, P679, DOI 10.1099/mic.0.2007/012872-0; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Parker HL, 2020, ORG BIOMOL CHEM, V18, P3607, DOI 10.1039/d0ob00253d; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Scheepers GH, 2016, FEBS LETT, V590, P4393, DOI 10.1002/1873-3468.12445; Sikharulidze I, 2016, ACTA CRYSTALLOGR A, V72, pS193, DOI 10.1107/S2053273316097114; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Swarts BM, 2012, J AM CHEM SOC, V134, P16123, DOI 10.1021/ja3062419; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Titgemeyer F, 2007, J BACTERIOL, V189, P5903, DOI 10.1128/JB.00257-07; Yamagami H, 2001, INFECT IMMUN, V69, P810, DOI 10.1128/IAI.69.2.810-815.2001; Yang Y, 2014, CELL HOST MICROBE, V15, P153, DOI 10.1016/j.chom.2014.01.008	49	4	4	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100307	10.1016/j.jbc.2021.100307	http://dx.doi.org/10.1016/j.jbc.2021.100307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33476646	gold, Green Published, Green Accepted			2022-12-28	WOS:000672866400281
J	Gan, SF; Rozhon, W; Varga, E; Halder, J; Berthiller, F; Poppenberger, B				Gan, Sufu; Rozhon, Wilfried; Varga, Elisabeth; Halder, Jyotirmoy; Berthiller, Franz; Poppenberger, Brigitte			The acyltransferase PMAT1 malonylates brassinolide glucoside	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRASSINOSTEROID LEVELS; GENE-EXPRESSION; ARABIDOPSIS; IDENTIFICATION; DETOXIFICATION; HOMEOSTASIS; XENOBIOTICS; METABOLISM; PROTEIN; GROWTH	Brassinosteroids (BRs) are steroid hormones of plants that coordinate fundamental growth and development processes. Their homeostasis is controlled by diverse means, including glucosylation of the bioactive BR brassinolide (BL), which is catalyzed by the UDP-glycosyltransferases (UGTs) UGT73C5 and UGT73C6 and occurs mainly at the C-23 position. Additional evidence had suggested that the resultant BL-23-O-glucoside (BL-23-O-Glc) can be malonylated, but the physiological significance of and enzyme required for this reaction had remained unknown. Here, we show that in Arabidopsis thaliana malonylation of BL-23-O-Glc is catalyzed by the acyltransferase phenolic glucoside malonyl-transferase 1 (PMAT1), which is also known to malonylate phenolic glucosides and lipid amides. Loss of PMAT1 abolished BL-23-O-malonylglucoside formation and enriched BL-23-O-Glc, showing that the enzyme acts on the glucoside. An over-expression of PMAT1 in plants where UGT73C6 was also overexpressed, and thus, BL-23-O-Glc formation was promoted, enhanced the symptoms of BR-deficiency of UGT73-C6oe plants, providing evidence that PMAT1 contributes to BL inactivation. Based on these results, a model is proposed in which PMAT1 acts in the conversion of both endogenous and xenobiotic glucosides to adjust metabolic homeostasis in spatial and temporal modes.	[Gan, Sufu; Rozhon, Wilfried; Halder, Jyotirmoy; Poppenberger, Brigitte] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Biotechnol Hort Crops, Freising Weihenstephan, Germany; [Varga, Elisabeth; Berthiller, Franz] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Inst Bioanalyt & Agrometabol, Vienna, Tulln, Austria	Technical University of Munich; University of Natural Resources & Life Sciences, Vienna	Poppenberger, B (corresponding author), Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Biotechnol Hort Crops, Freising Weihenstephan, Germany.	brigitte.poppenberger@wzw.tum.de	Rozhon, Wilfried/AAG-3162-2022; Rozhon, Wilfried/AFK-4445-2022	Rozhon, Wilfried/0000-0003-0659-0593; Rozhon, Wilfried/0000-0003-0659-0593; Poppenberger, Brigitte/0000-0003-1020-0500; Berthiller, Franz/0000-0001-5883-2879; Varga, Elisabeth/0000-0001-6046-3259	China Scholarship Council (CSC fellowship)	China Scholarship Council (CSC fellowship)(China Scholarship Council)	We thank Yanhai Yin for the BES1 antibody, Shozo Fujioka for the BL-O-glucosides used as analytical references and the Nottingham Arabidopsis stock center for the T-DNA insertion lines. Annette Beck, Maria Obermaier, Shafikur Rhaman, and Irene Ziegler are thanked for technical assistance and Tobias Sieberer for valuable discussions. This work was supported by the China Scholarship Council (CSC fellowship to S. G.). S. G. was a member of the TUM graduate school.	Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse Steven D, 2011, Arabidopsis Book, V9, pe0151, DOI 10.1199/tab.0151; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; D'Auria JC, 2007, FEBS LETT, V581, P872, DOI 10.1016/j.febslet.2007.01.060; Ervin SM, 2019, J BIOL CHEM, V294, P18586, DOI 10.1074/jbc.RA119.010950; Gan SF, 2020, PLANT PHYSIOL, V184, P23, DOI 10.1104/pp.20.00338; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Hoyerova K, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00741; Husar S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-51; Khan BR, 2016, J BIOL CHEM, V291, P27112, DOI 10.1074/jbc.M116.751065; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Luo J, 2007, PLANT J, V50, P678, DOI 10.1111/j.1365-313X.2007.03079.x; Ma YL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113643; Marsolais F, 2007, PLANTA, V225, P1233, DOI 10.1007/s00425-006-0413-y; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Raftogianis R, 2000, J Natl Cancer Inst Monogr, P113; Regan SL, 2010, BIOPHARM DRUG DISPOS, V31, P367, DOI 10.1002/bdd.720; Roh H, 2012, PLANT PHYSIOL, V159, P696, DOI 10.1104/pp.112.197202; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; SANDERMANN H, 1994, PHARMACOGENETICS, V4, P225, DOI 10.1097/00008571-199410000-00001; Schiffer L, 2019, J STEROID BIOCHEM, V194, DOI 10.1016/j.jsbmb.2019.105439; Schneider K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046805; Singh AP, 2015, J EXP BOT, V66, P1123, DOI 10.1093/jxb/erv026; Suzuki H, 2002, PLANT PHYSIOL, V130, P2142, DOI 10.1104/pp.010447; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Taguchi G, 2010, PLANT J, V63, P1031, DOI 10.1111/j.1365-313X.2010.04298.x; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; Tuominen LK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-236; Unterholzner SJ, 2017, METHODS MOL BIOL, V1564, P133, DOI 10.1007/978-1-4939-6813-8_11; Van de Poel B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00640; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Yu XH, 2009, PLANT MOL BIOL, V70, P421, DOI 10.1007/s11103-009-9482-1	40	0	0	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100424	10.1016/j.jbc.2021.100424	http://dx.doi.org/10.1016/j.jbc.2021.100424			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600798	gold, Green Published			2022-12-28	WOS:000672866400398
J	Gruner, K; Leissing, F; Sinitski, D; Thieron, H; Axstmann, C; Baumgarten, K; Reinstadler, A; Winkler, P; Altmann, M; Flatley, A; Jaouannet, M; Zienkiewicz, K; Feussner, I; Keller, H; Coustau, C; Falter-Braun, P; Feederle, R; Bernhagen, J; Panstruga, R				Gruner, Katrin; Leissing, Franz; Sinitski, Dzmitry; Thieron, Hannah; Axstmann, Christian; Baumgarten, Kira; Reinstadler, Anja; Winkler, Pascal; Altmann, Melina; Flatley, Andrew; Jaouannet, Maelle; Zienkiewicz, Krzysztof; Feussner, Ivo; Keller, Harald; Coustau, Christine; Falter-Braun, Pascal; Feederle, Regina; Bernhagen, Jurgen; Panstruga, Ralph			Chemokine-like MDL proteins modulate flowering time and innate immunity in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION INHIBITORY FACTOR; SALICYLIC-ACID; PSEUDOMONAS-SYRINGAE; FACTOR MIF; ARABIDOPSIS; CYTOKINE; RESISTANCE; RECRUITMENT; REVEALS; MUTANT	Human macrophage migration inhibitory factor (MIF) is an atypical chemokine implicated in intercellular signaling and innate immunity. MIF orthologs (MIF/D-DT-like proteins, MDLs) are present throughout the plant kingdom, but remain experimentally unexplored in these organisms. Here, we provide an in planta characterization and functional analysis of the three-member gene/protein MDL family in Arabidopsis thaliana. Subcellular localization experiments indicated a nucleo-cytoplasmic distribution of MDL1 and MDL2, while MDL3 is localized to peroxisomes. Protein-protein interaction assays revealed the in vivo formation of MDL1, MDL2, and MDL3 homo-oligomers, as well as the formation of MDL1-MDL2 hetero-oligomers. Functionally, Arabidopsis mdl mutants exhibited a delayed transition from vegetative to reproductive growth (flowering) under long-day conditions, but not in a short-day environment. In addition, mdl mutants were more resistant to colonization by the bacterial pathogen Pseudomonas syringae pv. maculicola. The latter phenotype was compromised by the additional mutation of SALICYLIC ACID INDUCTION DEFICIENT 2 (SID2), a gene implicated in the defense-induced biosynthesis of the key signaling molecule salicylic acid. However, the enhanced antibacterial immunity was not associated with any constitutive or pathogen-induced alterations in the levels of characteristic phytohormones or defense-associated metabolites. Interestingly, bacterial infection triggered relocalization and accumulation of MDL1 and MDL2 at the peripheral lobes of leaf epidermal cells. Collectively, our data indicate redundant functionality and a complex interplay between the three chemokine-like Arabidopsis MDL proteins in the regulation of both developmental and immune-related processes. These insights expand the comparative cross-kingdom analysis of MIF/MDL signaling in human and plant systems.	[Gruner, Katrin; Leissing, Franz; Thieron, Hannah; Axstmann, Christian; Baumgarten, Kira; Reinstadler, Anja; Winkler, Pascal; Panstruga, Ralph] Rhein Westfal TH Aachen, Inst Biol 1, Unit Plant Mol Cell Biol, Aachen, Germany; [Sinitski, Dzmitry; Bernhagen, Jurgen] Ludwig Maximilians Univ LMU, LMU Univ Hosp, Inst Stroke & Dementia Res ISD, Chair Vasc Biol, Munich, Germany; [Altmann, Melina; Falter-Braun, Pascal] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Network Biol INET, Munich, Germany; [Flatley, Andrew; Feederle, Regina] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Diabet & Obes, Monoclonal Antibody Core Facil, Munich, Germany; [Jaouannet, Maelle; Keller, Harald; Coustau, Christine] Univ Cote Azur, Inst Sophia Agrobiotech, INRAE, CNRS, Sophia Antipolis, France; [Zienkiewicz, Krzysztof; Feussner, Ivo] Univ Goettingen, Albrecht von Haller Inst, Gottingen, Germany; [Zienkiewicz, Krzysztof; Feussner, Ivo] Univ Goettingen, Goettingen Ctr Mol Biosci GZMB, Dept Plant Biochem, Gottingen, Germany; [Zienkiewicz, Krzysztof; Feussner, Ivo] Univ Goettingen, Goettingen Ctr Mol Biosci GZMB, Serv Unit Metabol & Lipid, Gottingen, Germany; [Falter-Braun, Pascal] Ludwig Maximilians Univ LMU, Fac Biol, Chair Microbe Host Interact, Planegg Martinsried, Germany; [Feederle, Regina; Bernhagen, Jurgen] Munich Cluster Syst Neurol SyNergy, Munich, Germany	RWTH Aachen University; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; University of Gottingen; University of Gottingen; University of Gottingen; University of Munich; University of Munich	Panstruga, R (corresponding author), Rhein Westfal TH Aachen, Inst Biol 1, Unit Plant Mol Cell Biol, Aachen, Germany.; Bernhagen, J (corresponding author), Ludwig Maximilians Univ LMU, LMU Univ Hosp, Inst Stroke & Dementia Res ISD, Chair Vasc Biol, Munich, Germany.; Bernhagen, J (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	Juergen.Bernhagen@med.uni-muenchen.de; panstruga@bio1.rwth-aachen.de	Leissing, Franz/R-5496-2019	Leissing, Franz/0000-0002-9746-7162; Feederle, Regina/0000-0002-3981-367X; COUSTAU, Christine/0000-0001-7524-0947	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Agence Nationale Recherche (ANR); DFG [BE 1977/10-1, PA 861/15-1, 390857198, INST 186/822-1]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Agence Nationale Recherche (ANR); DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Agence Nationale Recherche (ANR) co-funded project "X-KINGDOM-MIF -Cross-kingdom analysis of macrophage migration inhibitory factor (MIF) functions". Respective DFG grants are BE 1977/10-1 to J. B., PA 861/15-1 to R. P. The monoclonal antibody facility and the Chair of Vascular Biology are funded by the DFG under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy; ID 390857198). The Service Unit for Metabolomics and Lipidomics and the Department of Plant Biochemistry are supported by a grant of the DFG (INST 186/822-1) to I. F.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Altmann Melina, 2018, Curr Protoc Plant Biol, V3, pe20067, DOI 10.1002/cppb.20067; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bernsdorff F, 2016, PLANT CELL, V28, P102, DOI 10.1105/tpc.15.00496; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Campe R, 2016, NEW PHYTOL, V209, P294, DOI 10.1111/nph.13582; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Ding PT, 2020, TRENDS PLANT SCI, V25, P549, DOI 10.1016/j.tplants.2020.01.004; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Ellis C, 2002, MOL PLANT MICROBE IN, V15, P1025, DOI 10.1094/MPMI.2002.15.10.1025; Fan CP, 2013, P NATL ACAD SCI USA, V110, P10994, DOI 10.1073/pnas.1221817110; Fan J, 2008, PLANT J, V53, P393, DOI 10.1111/j.1365-313X.2007.03303.x; Feederle Regina, 2016, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V35, P259, DOI 10.1089/mab.2016.0029; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Foley J. F., 2020, SCI SIGNAL, V13; Garcia AB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05041-7; Gruner K, 2018, PLANT J, V94, P1064, DOI 10.1111/tpj.13920; Hartmann M, 2018, CELL, V173, P456, DOI 10.1016/j.cell.2018.02.049; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; He Q, 2018, P NATL ACAD SCI USA, V115, pE7834, DOI 10.1073/pnas.1808585115; Herrfurth C, 2020, METHODS MOL BIOL, V2085, P169, DOI 10.1007/978-1-0716-0142-6_13; Holowka T, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5010046; Holowka T, 2016, FASEB J, V30, P2249, DOI 10.1096/fj.201500189R; Israelson A, 2015, NEURON, V86, P218, DOI 10.1016/j.neuron.2015.02.034; Jedd G, 2002, PLANT CELL PHYSIOL, V43, P384, DOI 10.1093/pcp/pcf045; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; Kang I, 2019, NAT REV RHEUMATOL, V15, P427, DOI 10.1038/s41584-019-0238-2; Kapurniotu A, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00003; Kemen E., 2017, SCI REP-UK, V7, P27; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuhn Hannah, 2016, Arabidopsis Book, V14, pe0184, DOI 10.1199/tab.0184; Lai ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4064; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li HY, 2018, ELIFE, V7, DOI 10.7554/eLife.40039; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; Li W, 2013, PLANT PHYSIOL, V161, P2062, DOI 10.1104/pp.112.211748; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Lyons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127699; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Michelet C, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100740; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Mohnike L., 2021, PLANT CELL; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Naessens E, 2015, CURR BIOL, V25, P1898, DOI 10.1016/j.cub.2015.05.047; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Niehaus TD, 2015, PLANT PHYSIOL, V169, P1436, DOI 10.1104/pp.15.00959; Ogawara T, 2003, J PLANT PHYSIOL, V160, P1335, DOI 10.1078/0176-1617-01129; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Pan RH, 2018, J INTEGR PLANT BIOL, V60, P1028, DOI 10.1111/jipb.12670; Panstruga R, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0337-x; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; Philo JS, 2004, BIOPHYS CHEM, V108, P77, DOI 10.1016/j.bpc.2003.10.010; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Shao XL, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3237; Sinitski D, 2020, J BIOL CHEM, V295, P850, DOI 10.1074/jbc.RA119.009716; Sinitski D, 2020, METHODS MOL BIOL, V2080, P249, DOI 10.1007/978-1-4939-9936-1_22; Sinitski D, 2019, THROMB HAEMOSTASIS, V119, P553, DOI 10.1055/s-0039-1677803; Song SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003653; Sparkes A, 2017, IMMUNOBIOLOGY, V222, P473, DOI 10.1016/j.imbio.2016.10.006; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Sun T, 2012, P NATL ACAD SCI USA, V109, pE2117, DOI 10.1073/pnas.1206573109; Tilstam PV, 2017, EXPERT OPIN THER TAR, V21, P671, DOI 10.1080/14728222.2017.1336227; Turnbull D, 2019, PLANT PHYSIOL, V180, P571, DOI 10.1104/pp.18.01143; Tynan A, 2017, FASEB J, V31, P5102, DOI 10.1096/fj.201700463R; Underwood W, 2017, MOL PLANT, V10, P805, DOI 10.1016/j.molp.2017.04.003; Underwood W, 2013, P NATL ACAD SCI USA, V110, P12492, DOI 10.1073/pnas.1218701110; van Wersch R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01717; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	91	1	1	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100611	10.1016/j.jbc.2021.100611	http://dx.doi.org/10.1016/j.jbc.2021.100611			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33798552	Green Published, gold			2022-12-28	WOS:000672866400582
J	Heier, JA; Pokutta, S; Dale, IW; Kim, SK; Hinck, AP; Weis, WI; Kwiatkowski, AV				Heier, Jonathon A.; Pokutta, Sabine; Dale, Ian W.; Kim, Sun Kyung; Hinck, Andrew P.; Weis, William, I; Kwiatkowski, Adam, V			Distinct intramolecular interactions regulate autoinhibition of vinculin binding in alpha T-catenin and alpha E-catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING; BETA-CATENIN; MECHANICAL STABILITY; ADHERENS JUNCTION; AREA COMPOSITA; COMPLEX; CARDIOMYOPATHY; ACTIVATION; CADHERINS; ALTERS	alpha-Catenin binds directly to beta-catenin and connects the cadherin-catenin complex to the actin cytoskeleton. Tension regulates alpha-catenin conformation. Actomyosin-generated force stretches the middle (M)-region to relieve autoinhibition and reveal a binding site for the actin-binding protein vinculin. It is not known whether the intramolecular interactions that regulate epithelial (alpha E)-catenin binding are conserved across the alpha-catenin family. Here, we describe the biochemical properties of testes (alpha T)-catenin, an alpha-catenin isoform critical for cardiac function and how intramolecular interactions regulate vinculin-binding autoinhibition. Isothermal titration calorimetry showed that alpha T-catenin binds the beta-catenin-N-cadherin complex with a similar low nanomolar affinity to that of alpha E-catenin. Limited proteolysis revealed that the alpha T-catenin M-region adopts a more open conformation than alpha E-catenin. The alpha T-catenin M-region binds the vinculin N-terminus with low nanomolar affinity, indicating that the isolated alpha T-catenin Mregion is not autoinhibited and thereby distinct from alpha E-catenin. However, the alpha T-catenin head (N- and M-regions) binds vinculin 1000-fold more weakly (low micromolar affinity), indicating that the N-terminus regulates the M-region binding to vinculin. In cells, alpha T-catenin recruitment of vinculin to cell-cell contacts requires the actin-binding domain and actomyosin-generated tension, indicating that force regulates vinculin binding. Together, our results show that the alpha T-catenin N-terminus is required to maintain M-region autoinhibition and modulate vinculin binding. We postulate that the unique molecular properties of alpha T-catenin allow it to function as a scaffold for building specific adhesion complexes.	[Heier, Jonathon A.; Dale, Ian W.; Kwiatkowski, Adam, V] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Pokutta, Sabine; Weis, William, I] Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA; [Pokutta, Sabine; Weis, William, I] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Kim, Sun Kyung; Hinck, Andrew P.] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kwiatkowski, AV (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	adamkwi@pitt.edu	Weis, William/G-1437-2011	Weis, William/0000-0002-5583-6150; Kwiatkowski, Adam/0000-0003-3997-7057; Heier, Jonathon/0000-0002-4898-0357	NIH [HL127711, GM131747, GM058670, CA233622, S10 OD023481]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH Grants HL127711 (A. V. K.), GM131747 (W. I. W.), GM058670 (A. P. H.), and CA233622 (A. P. H.). The Malvern MicroCal PEAQ-ITC calorimeter purchase was made possible through NIH Grant S10 OD023481. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barrick S, 2018, MOL BIOL CELL, V29, P111, DOI 10.1091/mbc.E17-03-0168; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Chiarella SE, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2018.1463896; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Choi HJ, 2009, J BIOL CHEM, V284, P31776, DOI 10.1074/jbc.M109.047928; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Folmsbee Stephen Sai, 2016, J Mol Psychiatry, V4, P2, DOI 10.1186/s40303-016-0017-9; Folmsbee SS, 2015, AM J PHYSIOL-LUNG C, V308, pL253, DOI 10.1152/ajplung.00331.2014; Goossens S, 2007, J CELL SCI, V120, P2126, DOI 10.1242/jcs.004713; Hansen SD, 2013, MOL BIOL CELL, V24, P3710, DOI 10.1091/mbc.E13-07-0388; Hulpiau P, 2013, PROG MOL BIOL TRANSL, V116, P71, DOI 10.1016/B978-0-12-394311-8.00004-2; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Ishiyama N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07481-7; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Janssens B, 2001, J CELL SCI, V114, P3177; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Kowalczyk AP, 2013, PROG MOL BIOL TRANSL, V116, P95, DOI 10.1016/B978-0-12-394311-8.00005-4; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Li JF, 2012, J CELL SCI, V125, P1058, DOI 10.1242/jcs.098640; Li J, 2015, J BIOL CHEM, V290, P18890, DOI 10.1074/jbc.M115.647941; Li Y, 2019, J CELL SCI, V132, DOI 10.1242/jcs.221606; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; Maki K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20115-8; Maki K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24878; Mege RM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028738; Mei L, 2020, ELIFE, V9, DOI 10.7554/eLife.62514; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Merkel CD, 2019, MOL BIOL CELL, V30, P2639, DOI 10.1091/mbc.E19-04-0216; Nieset JE, 1997, J CELL SCI, V110, P1013; Pang SM, 2019, MOL BIOL CELL, V30, P1930, DOI 10.1091/mbc.E19-02-0102; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Priest AV, 2017, EXP CELL RES, V358, P10, DOI 10.1016/j.yexcr.2017.03.015; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Rubsam M, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029207; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sheikh F, 2006, CIRCULATION, V114, P1046, DOI 10.1161/CIRCULATIONAHA.106.634469; Terekhova K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51816-3; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; van Hengel J, 2013, EUR HEART J, V34, P201, DOI 10.1093/eurheartj/ehs373; Vite A, 2014, CELL COMMUN ADHES, V21, P169, DOI 10.3109/15419061.2014.908853; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Wickline ED, 2016, J BIOL CHEM, V291, P15687, DOI 10.1074/jbc.M116.735423; Wood MN, 2017, J CELL BIOL, V216, P3767, DOI 10.1083/jcb.201612006; Xu XP, 2020, ELIFE, V9, DOI 10.7554/eLife.60878; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhao ZM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-198	57	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100582	10.1016/j.jbc.2021.100582	http://dx.doi.org/10.1016/j.jbc.2021.100582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33771561	Green Published, gold			2022-12-28	WOS:000672866400554
J	Jiang, YC; Li, WT; Lindsey-Boltz, LA; Yang, YC; Li, Y; Sancar, A				Jiang, Yuchao; Li, Wentao; Lindsey-Boltz, Laura A.; Yang, Yuchen; Li, Yun; Sancar, Aziz			Super hotspots and super coldspots in the repair of UV-induced DNA damage in the human genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTION FACTORS; ESCHERICHIA-COLI; CHROMATIN-STATE; MUTATIONS; LANDSCAPE; DOMAINS; BINDING; MAPS; MECHANISMS	The formation of UV-induced DNA damage and its repair are influenced by many factors that modulate lesion formation and the accessibility of repair machinery. However, it remains unknown which genomic sites are prioritized for immediate repair after UV damage induction, and whether these prioritized sites overlap with hotspots of UV damage. We identified the super hotspots subject to the earliest repair for (6-4) pyrimidine-pyrimidone photoproduct by using the eXcision Repairsequencing (XR-seq) method. We further identified super coldspots for (6-4) pyrimidine-pyrimidone photoproduct repair and super hotspots for cyclobutane pyrimidine dimer repair by analyzing available XR-seq time-course data. By integrating datasets of XR-seq, Damage-seq, adductSeq, and cyclobutane pyrimidine dimer-seq, we show that neither repair super hotspots nor repair super coldspots overlap hotspots of UV damage. Furthermore, we demonstrate that repair super hotspots are significantly enriched in frequently interacting regions and superenhancers. Finally, we report our discovery of an enrichment of cytosine in repair super hotspots and super coldspots. These findings suggest that local DNA features together with large-scale chromatin features contribute to the orders of magnitude variability in the rates of UV damage repair.	[Jiang, Yuchao; Li, Yun] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Jiang, Yuchao; Yang, Yuchen; Li, Yun] Univ N Carolina, Dept Genet, Sch Med, Chapel Hill, NC 27515 USA; [Jiang, Yuchao; Sancar, Aziz] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Li, Wentao; Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA; [Li, Yun] Univ N Carolina, Dept Comp Sci, Coll Arts & Sci, Chapel Hill, NC 27515 USA; [Li, Wentao] Univ Georgia, Coll Publ Hlth, Dept Environm Hlth Sci, Athens, GA 30602 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; University of Georgia	Jiang, YC (corresponding author), Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.; Jiang, YC (corresponding author), Univ N Carolina, Dept Genet, Sch Med, Chapel Hill, NC 27515 USA.; Jiang, YC; Sancar, A (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Sancar, A (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA.	yuchaoj@email.unc.edu; aziz_sancar@med.unc.edu	Yang, Yuchen/GZK-6062-2022	Jiang, Yuchao/0000-0001-6905-6377; Li, Wentao/0000-0003-2313-6384	National Institutes of Health [R35 GM118102, R01 ES027255, R35 GM138342, R00 ES030015]; University of North Carolina Computational Medicine Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina Computational Medicine Program	This work was supported by the National Institutes of Health grants R35 GM118102 (to A. S.), R01 ES027255(to A. S.), R35 GM138342 (to Y. J.), R00 ES030015 (to W. L.), and a pilot award from the University of North Carolina Computational Medicine Program (to Y. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adar S, 2016, P NATL ACAD SCI USA, V113, pE2124, DOI 10.1073/pnas.1603388113; Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Akkose U., 2020, COMP ANAL 2 PRIMATE, DOI [10.1101/2020.04.06.027201, DOI 10.1101/2020.04.06.027201]; Ay F, 2014, GENOME RES, V24, P999, DOI 10.1101/gr.160374.113; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bryan DS, 2014, GENOME RES, V24, P1534, DOI 10.1101/gr.174052.114; Choul-Ii S, 2018, BIOSCI BIOTECH BIOCH, V82, P1753, DOI 10.1080/09168451.2018.1484276; Choul-li S, 2009, BIOCHEM BIOPH RES CO, V390, P839, DOI 10.1016/j.bbrc.2009.10.059; Crowley C., 2020, FIRECALLER DETECTING, DOI [10.1101/619288, DOI 10.1101/619288]; Deger N, 2019, J BIOL CHEM, V294, P18092, DOI 10.1074/jbc.AC119.011448; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elliott K, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007849; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fong YW, 2013, MOL CELL, V52, P291, DOI 10.1016/j.molcel.2013.10.018; Frigola J, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1219; Garcia-Nieto PE, 2017, EMBO J, V36, P2829, DOI 10.15252/embj.201796717; Giusti-Rodriguez P., 2019, USING 3 DIMENSIONAL; Gonzalez-Perez A, 2019, CELL, V177, P101, DOI 10.1016/j.cell.2019.02.051; Han CH, 2016, CARCINOGENESIS, V37, P129, DOI 10.1093/carcin/bgv247; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hauer MH, 2017, GENE DEV, V31, P2204, DOI 10.1101/gad.307702.117; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Hu JC, 2017, P NATL ACAD SCI USA, V114, P6758, DOI 10.1073/pnas.1706522114; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; Jiang YC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1363; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kaul A, 2020, NAT PROTOC, V15, P991, DOI 10.1038/s41596-019-0273-0; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; Legrand AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055883; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WT, 2020, ENVIRON MOL MUTAGEN, V61, P664, DOI 10.1002/em.22365; Li WT, 2019, J BIOL CHEM, V294, P5914, DOI 10.1074/jbc.RA119.007861; Li WT, 2018, P NATL ACAD SCI USA, V115, pE3408, DOI 10.1073/pnas.1801687115; Li WT, 2017, P NATL ACAD SCI USA, V114, P6752, DOI 10.1073/pnas.1706021114; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu F, 2016, BIOINFORMATICS, V32, P641, DOI 10.1093/bioinformatics/btv643; Mao P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05064-0; Mao P, 2017, PHOTOCHEM PHOTOBIOL, V93, P216, DOI 10.1111/php.12646; Mao P, 2016, P NATL ACAD SCI USA, V113, P9057, DOI 10.1073/pnas.1606667113; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Oztas O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03922-5; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Poulos RC, 2017, NUCLEIC ACIDS RES, V45, P7786, DOI 10.1093/nar/gkx463; Poulos RC, 2016, CELL REP, V17, P2865, DOI 10.1016/j.celrep.2016.11.055; Premi S, 2019, P NATL ACAD SCI USA, V116, P24196, DOI 10.1073/pnas.1907860116; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Roberts SA, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201800152; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Sanders JT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20047-w; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Selby CP, 2020, J BIOL CHEM, V295, P17374, DOI 10.1074/jbc.AC120.016325; Sobhy H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40770-9; TORNALETTI S, 1995, J MOL BIOL, V249, P714, DOI 10.1006/jmbi.1995.0331; van Eijk P, 2019, GENOME RES, V29, P74, DOI 10.1101/gr.237198.118; Witten DM, 2011, ANN APPL STAT, V5, P2493, DOI 10.1214/11-AOAS493; Wolfe D, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-18; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Yang YY, 2019, J BIOL CHEM, V294, P210, DOI 10.1074/jbc.RA118.006121; Yimit A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08290-2; Zheng H, 2019, NAT REV MOL CELL BIO, V20, P535, DOI 10.1038/s41580-019-0132-4	75	6	6	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100581	10.1016/j.jbc.2021.100581	http://dx.doi.org/10.1016/j.jbc.2021.100581			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33771559	Green Published, gold			2022-12-28	WOS:000672866400553
J	Karki, P; Ke, YB; Zhang, CO; Li, Y; Tian, YF; Son, S; Yoshimura, A; Kaibuchi, K; Birukov, KG; Birukova, AA				Karki, Pratap; Ke, Yunbo; Zhang, Chen-Ou; Li, Yue; Tian, Yufeng; Son, Sophia; Yoshimura, Akihiko; Kaibuchi, Kozo; Birukov, Konstantin G.; Birukova, Anna A.			SOCS3-microtubule interaction via CLIP-170 and CLASP2 is critical for modulation of endothelial inflammation and lung injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; BARRIER DYSFUNCTION; SOCS BOX; CYTOKINE; MICROTUBULES; INHIBITION; SUPPRESSOR; IQGAP1; MODEL; PERMEABILITY	Proinflammatory cytokines such as IL-6 induce endothelial cell (EC) barrier disruption and trigger an inflammatory response in part by activating the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway. The protein suppressor of cytokine signaling-3 (SOCS3) is a negative regulator of JAK-STAT, but its role in modulation of lung EC barrier dysfunction caused by bacterial pathogens has not been investigated. Using human lung ECs and EC-specific SOCS3 knockout mice, we tested the hypothesis that SOCS3 confers microtubule (MT)-mediated protection against endothelial dysfunction. SOCS3 knockdown in cultured ECs or EC-specific SOCS3 knockout in mice resulted in exacerbated lung injury characterized by increased permeability and inflammation in response to IL-6 or heat-killed Staphylococcus aureus (HKSA). Ectopic expression of SOCS3 attenuated HKSA-induced EC dysfunction, and this effect required assembled MTs. SOCS3 was enriched in the MT fractions, and treatment with HKSA disrupted SOCS3-MT association. We discovered that-in addition to its known partners gp130 and JAK2-SOCS3 interacts with MT plus-end binding proteins CLIP-170 and CLASP2 via its N-terminal domain. The resulting SOCS3-CLIP-170/CLASP2 complex was essential for maximal SOCS3 anti-inflammatory effects. Both IL-6 and HKSA promoted MT disassembly and disrupted SOCS3 interaction with CLIP-170 and CLASP2. Moreover, knockdown of CLIP-170 or CLASP2 impaired SOCS3-JAK2 interaction and abolished the anti-inflammatory effects of SOCS3. Together, these findings demonstrate for the first time an interaction between SOCS3 and CLIP-170/CLASP2 and reveal that this interaction is essential to the protective effects of SOCS3 in lung endothelium.	[Karki, Pratap; Zhang, Chen-Ou; Li, Yue; Birukova, Anna A.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Ke, Yunbo; Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Tian, Yufeng; Son, Sophia] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Tokyo, Japan; [Kaibuchi, Kozo] Nagoya Univ, Dept Cell Pharmacol, Nagoya, Aichi, Japan	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Chicago; Keio University; Nagoya University	Birukova, AA (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	abirukova@som.umaryland.edu	Birukov, Konstantin/FJB-5755-2022	, Pratap/0000-0002-3087-5516	National Heart, Lung, and Blood Institute [HL107920, HL130431, HL076259, HL087823]; National Institute of General Medical Sciences [GM114171]; JSPS KAKENHI [JP17H06175, JP18H05376]; AMED-CREST [JP 20GM1110009]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED-CREST	This work was supported by the grants HL107920, HL130431 from the National Heart, Lung, and Blood Institute, and GM114171 from the National Institute of General Medical Sciences for A. A. B.; HL076259, HL087823 from the National Heart, Lung, and Blood Institute for K. G. B.; JSPS KAKENHI (S) JP17H06175, Challenging Research (P) JP18H05376, and AMED-CREST JP 20GM1110009 grants for A. Y. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alieva IB, 2014, BIOCHEMISTRY-MOSCOW+, V79, P964, DOI 10.1134/S0006297914090119; Alieva IB, 2013, J CELL BIOCHEM, V114, P2258, DOI 10.1002/jcb.24575; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Bergamin E, 2006, STRUCTURE, V14, P1285, DOI 10.1016/j.str.2006.06.011; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2005, J CELL PHYSIOL, V204, P934, DOI 10.1002/jcp.20359; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Borgas D, 2016, AM J RESP CELL MOL, V54, P683, DOI 10.1165/rcmb.2015-0149OC; Boyle K, 2007, BLOOD, V110, P1466, DOI 10.1182/blood-2007-03-079178; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Chen YD, 2019, J BIOL CHEM, V294, P918, DOI 10.1074/jbc.RA118.006125; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Duan WN, 2017, MOL MED REP, V16, P2668, DOI 10.3892/mmr.2017.6941; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Fang XZ, 2016, INT IMMUNOPHARMACOL, V31, P66, DOI 10.1016/j.intimp.2015.12.017; Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Gao HW, 2007, EXPERT OPIN THER TAR, V11, P869, DOI 10.1517/14728222.11.7.869; Higginbotham K, 2014, CELL SIGNAL, V26, P2306, DOI 10.1016/j.cellsig.2014.07.032; Hoegl S, 2011, AM J RESP CELL MOL, V44, P369, DOI 10.1165/rcmb.2009-0440OC; Horvath Curt M, 2004, Sci STKE, V2004, ptr9, DOI 10.1126/stke.2602004tr9; Jiang ZL, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0707-6; Karki P, 2019, J BIOL CHEM, V294, P3369, DOI 10.1074/jbc.RA118.004030; Karki P, 2019, CELL SIGNAL, V53, P246, DOI 10.1016/j.cellsig.2018.10.010; Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC; Krebs DL, 2000, J CELL SCI, V113, P2813; Leonard WJ, 2000, J ALLERGY CLIN IMMUN, V105, P877, DOI 10.1067/mai.2000.106899; Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Mu ST, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0925-6; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Norkina O, 2008, ALCOHOL CLIN EXP RES, V32, P1565, DOI 10.1111/j.1530-0277.2008.00726.x; Pedroso JAB, 2019, HORM-INT J ENDOCRINO, V18, P127, DOI 10.1007/s42000-018-0078-5; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; SHALABY MR, 1989, CELL IMMUNOL, V121, P372, DOI 10.1016/0008-8749(89)90036-1; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Tian YF, 2015, BBA-MOL BASIS DIS, V1852, P104, DOI 10.1016/j.bbadis.2014.10.012; Tian YF, 2014, MOL CELL BIOL, V34, P3546, DOI 10.1128/MCB.00248-14; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Watson C, 1996, CLIN EXP IMMUNOL, V105, P112, DOI 10.1046/j.1365-2249.1996.d01-717.x; White Christine A, 2013, JAKSTAT, V2, pe25045, DOI 10.4161/jkst.25045; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu JY, 2016, AM J PHYSIOL-LUNG C, V311, pL39, DOI 10.1152/ajplung.00051.2016; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zou TT, 2008, FEBS LETT, V582, P4015, DOI 10.1016/j.febslet.2008.10.055	58	5	6	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100239	10.1074/jbc.RA120.014232	http://dx.doi.org/10.1074/jbc.RA120.014232			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33372035	gold, Green Published			2022-12-28	WOS:000672866400217
J	Martin-Sanchez, C; Ales, E; Balseiro-Gomez, S; Atienza, G; Arnalich, F; Bordas, A; Cedillo, JL; Extremera, M; Chavez-Reyes, A; Montiel, C				Martin-Sanchez, Carolina; Ales, Eva; Balseiro-Gomez, Santiago; Atienza, Gema; Arnalich, Francisco; Bordas, Anna; Cedillo, Jose L.; Extremera, Maria; Chavez-Reyes, Arturo; Montiel, Carmen			The human-specific duplicated alpha 7 gene inhibits the ancestral alpha 7, negatively regulating nicotinic acetylcholine receptor-mediated transmitter release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSCRIPTIONAL EXPRESSION REGULATION; POSITIVE ALLOSTERIC MODULATOR; ACH RECEPTORS; PREFRONTAL CORTEX; IN-VITRO; CHRFAM7A; SUBUNIT; DOPAMINE; CHRNA7; AGONIST	Gene duplication generates new functions and traits, enabling evolution. Human-specific duplicated genes in particular are primary sources of innovation during our evolution although they have very few known functions. Here we examine the brain function of one of these genes (CHRFAM7A) and its product (dup alpha 7 subunit). This gene results from a partial duplication of the ancestral CHRNA7 gene encoding the alpha 7 subunit that forms the homopentameric alpha 7 nicotinic acetylcholine receptor (alpha 7-nAChR). The functions of alpha 7-nAChR in the brain are well defined, including the modulation of synaptic transmission and plasticity underlying normal attention, cognition, learning, and memory processes. However, the role of the dup alpha 7 subunit remains unexplored at the neuronal level. Here, we characterize that role by combining immunoblotting, quantitative RT-PCR and FRET techniques with functional assays of alpha 7-nAChR activity using human neuroblastoma SH-SY5Y cell variants with different dup alpha 7 expression levels. Our findings reveal a physical interaction between dup alpha 7 and alpha 7 subunits in fluorescent protein-tagged dup alpha 7/alpha 7 transfected cells that negatively affects normal alpha 7-nAChR activity. Specifically, in both single cells and cell populations, the [Ca2+] i signal and the exocytotic response induced by selective stimulation of alpha 7-nAChR were either significantly inhibited by stable dup alpha 7 overexpression or augmented after silencing dup alpha 7 gene expression with specific siRNAs. These findings identify a new role for the dup alpha 7 subunit as a negative regulator of alpha 7-nAChR-mediated control of exocytotic neurotransmitter release. If this effect is excessive, it would result in an impaired synaptic transmission that could underlie the neurocognitive and neuropsychiatric disorders associated with alpha 7-nAChR dysfunction.	[Martin-Sanchez, Carolina; Atienza, Gema; Bordas, Anna; Cedillo, Jose L.; Extremera, Maria; Montiel, Carmen] Univ Autonoma Madrid, Med Sch, Dept Pharmacol & Therapeut, Madrid, Spain; [Ales, Eva; Balseiro-Gomez, Santiago] Univ Seville, Med Sch, Dept Med Physiol & Biophys, Seville, Spain; [Arnalich, Francisco] Univ Hosp La Paz IdiPAZ, Internal Med Serv, Madrid, Spain; [Chavez-Reyes, Arturo] Univ Finis Terrae, Med Sch, Santiago, Chile	Autonomous University of Madrid; University of Sevilla; Universidad Finis Terrae	Montiel, C (corresponding author), Univ Autonoma Madrid, Med Sch, Dept Pharmacol & Therapeut, Madrid, Spain.	carmen.montiel@uam.es		Chavez-Reyes, Arturo/0000-0002-6655-815X	Ministry of Economy, Industry and Competitiveness, Government of Spain [SAF2017-82689-R]; FPI fellowship (Ministry of Economy, Industry and Competitiveness); FPI fellowship (Autonomous University of Madrid); FPU fellowship (Ministry of Education, Culture and Sports, Government of Spain)	Ministry of Economy, Industry and Competitiveness, Government of Spain(Spanish Government); FPI fellowship (Ministry of Economy, Industry and Competitiveness); FPI fellowship (Autonomous University of Madrid); FPU fellowship (Ministry of Education, Culture and Sports, Government of Spain)	This work was supported by a Grant from the Ministry of Economy, Industry and Competitiveness, Government of Spain (SAF2017-82689-R) to C. M. and F. A. C. M. -S. was recipient of an FPI fellowship (Ministry of Economy, Industry and Competitiveness). A. B. was recipient of an FPI fellowship (Autonomous University of Madrid). J. L. C. was recipient of an FPU fellowship (Ministry of Education, Culture and Sports, Government of Spain). M. E. and G. A. were hired with funds from the above Grant.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Beilharz Traude H., 2004, Briefings in Functional Genomics & Proteomics, V3, P103, DOI 10.1093/bfgp/3.2.103; Bertrand D, 2015, PHARMACOL REV, V67, P1025, DOI 10.1124/pr.113.008581; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Biton B, 2007, NEUROPSYCHOPHARMACOL, V32, P1, DOI 10.1038/sj.npp.1301189; Bordas A, 2017, ONCOTARGET, V8, P67878, DOI 10.18632/oncotarget.18948; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Cedillo JL, 2015, J INFECT DIS, V211, P146, DOI 10.1093/infdis/jiu425; Cedillo JL, 2019, LUNG CANCER, V128, P134, DOI 10.1016/j.lungcan.2018.12.029; Chan T, 2019, NEUROSCI LETT, V690, P126, DOI 10.1016/j.neulet.2018.10.010; Cheng Q, 2015, BIOCHEM PHARMACOL, V97, P439, DOI 10.1016/j.bcp.2015.07.015; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; Dickinson JA, 2008, MOL PHARMACOL, V74, P348, DOI 10.1124/mol.108.046623; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Faro LRF, 2019, TOXICOLOGY, V426, DOI 10.1016/j.tox.2019.152285; Fasoli F, 2015, CURR TOP BEHAV NEURO, V23, P1, DOI 10.1007/978-3-319-13665-3_1; Freedman R, 2010, PROG NEUROBIOL, V90, P263, DOI 10.1016/j.pneurobio.2009.10.008; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Girod R, 2000, NEUROPHARMACOLOGY, V39, P2715, DOI 10.1016/S0028-3908(00)00145-3; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Hajos M, 2005, J PHARMACOL EXP THER, V312, P1213, DOI 10.1124/jpet.104.076968; Hashemi A, 2012, Tsitol Genet, V46, P19; Huang M, 2014, PSYCHOPHARMACOLOGY, V231, P4541, DOI 10.1007/s00213-014-3596-0; Huang M, 2014, PSYCHOPHARMACOLOGY, V231, P2199, DOI 10.1007/s00213-013-3373-5; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jones IW, 2004, J NEUROSCI, V24, P11244, DOI 10.1523/JNEUROSCI.3009-04.2004; Kabbani N, 2018, TRENDS PHARMACOL SCI, V39, P354, DOI 10.1016/j.tips.2018.01.002; Kalmady SV, 2018, J NEURAL TRANSM, V125, P741, DOI 10.1007/s00702-017-1833-5; Koranda JL, 2014, J NEUROPHYSIOL, V111, P103, DOI 10.1152/jn.00269.2013; Kunii Y, 2015, AM J PSYCHIAT, V172, P1122, DOI 10.1176/appi.ajp.2015.14080978; Lasala M, 2018, J BIOL CHEM, V293, P10707, DOI 10.1074/jbc.RA117.001698; Livingstone PD, 2009, EUR J NEUROSCI, V29, P539, DOI 10.1111/j.1460-9568.2009.06613.x; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; Lozada AF, 2012, J NEUROSCI, V32, P7651, DOI 10.1523/JNEUROSCI.6246-11.2012; Ly T, 2014, ELIFE, V3, DOI 10.7554/eLife.01630; Magin S, 2013, DNA REPAIR, V12, P148, DOI 10.1016/j.dnarep.2012.11.008; Maldifassi MC, 2018, J BIOL CHEM, V293, P13874, DOI 10.1074/jbc.RA118.003443; Maldifassi MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108397; Maurisse R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-9; Parikh V, 2010, J NEUROSCI, V30, P3518, DOI 10.1523/JNEUROSCI.5712-09.2010; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Rossi S, 2005, NEUROCHEM RES, V30, P541, DOI 10.1007/s11064-005-2689-x; Rousseau SJ, 2005, NEUROPHARMACOLOGY, V49, P59, DOI 10.1016/j.neuropharm.2005.01.030; Sadigh-Eteghad S, 2015, EUR J PHARMACOL, V755, P34, DOI 10.1016/j.ejphar.2015.02.047; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sinkus ML, 2015, NEUROPHARMACOLOGY, V96, P274, DOI 10.1016/j.neuropharm.2015.02.006; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Sydserff S, 2009, BIOCHEM PHARMACOL, V78, P880, DOI 10.1016/j.bcp.2009.07.005; Tabar MS, 2015, CELL J, V17, P438; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Yakel JL, 2013, PFLUG ARCH EUR J PHY, V465, P441, DOI 10.1007/s00424-012-1200-1; Zhu PJ, 2005, J NEUROPHYSIOL, V94, P3081, DOI 10.1152/jn.00974.2004	61	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100341	10.1016/j.jbc.2021.100341	http://dx.doi.org/10.1016/j.jbc.2021.100341			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33515545	gold, Green Published			2022-12-28	WOS:000672866400315
J	Nagashima, S; Ito, N; Kobayashi, R; Shiiba, I; Shimura, H; Fukuda, T; Hagihara, H; Miyakawa, T; Inatome, R; Yanagi, S				Nagashima, Shun; Ito, Naoki; Kobayashi, Reiki; Shiiba, Isshin; Shimura, Hiroki; Fukuda, Toshifumi; Hagihara, Hideo; Miyakawa, Tsuyoshi; Inatome, Ryoko; Yanagi, Shigeru			Forebrain-specific deficiency of the GTPase CRAG/Centaurin-gamma 3 leads to immature dentate gyri and hyperactivity in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEURONAL DIFFERENTIATION; EXPRESSION; PROTEIN; CRAG; MODELS; CELLS; SRF	Mouse models of various neuropsychiatric disorders, such as schizophrenia, often display an immature dentate gyrus, characterized by increased numbers of immature neurons and neuronal progenitors and a dearth of mature neurons. We previously demonstrated that the CRMP5-associated GTPase (CRAG), a short splice variant of Centaurin-gamma 3/AGAP3, is highly expressed in the dentate gyrus. CRAG promotes cell survival and antioxidant defense by inducing the activation of serum response factors at promyelocytic leukemia protein bodies, which are nuclear stress-responsive domains, during neuronal development. However, the physiological role of CRAG in neuronal development remains unknown. Here, we analyzed the role of CRAG using dorsal forebrain-specific CRAG/Centaurin-gamma 3 knockout mice. The mice revealed maturational abnormality of the hippocampal granule cells, including increased doublecortin-positive immature neurons and decreased calbindin-positive mature neurons, a typical phenotype of immature dentate gyri. Furthermore, the mice displayed hyperactivity in the open-field test, a common measure of exploratory behavior, suggesting that these mice may serve as a novel model for neuropsychiatric disorder associated with hyperactivity. Thus, we conclude that CRAG is required for the maturation of neurons in the dentate gyrus, raising the possibility that its deficiency might promote the development of psychiatric disorders in humans.	[Nagashima, Shun; Ito, Naoki; Kobayashi, Reiki; Shiiba, Isshin; Shimura, Hiroki; Fukuda, Toshifumi; Yanagi, Shigeru] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Hachioji, Tokyo, Japan; [Ito, Naoki; Shiiba, Isshin; Inatome, Ryoko; Yanagi, Shigeru] Gakushuin Univ, Fac Sci, Dept Life Sci, Lab Mol Biochem,Toshima Ku, Tokyo, Japan; [Hagihara, Hideo; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi, Japan	Tokyo University of Pharmacy & Life Sciences; Gakushuin University; Fujita Health University	Nagashima, S; Yanagi, S (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Hachioji, Tokyo, Japan.; Yanagi, S (corresponding author), Gakushuin Univ, Fac Sci, Dept Life Sci, Lab Mol Biochem,Toshima Ku, Tokyo, Japan.	nagashi@toyaku.ac.jp; syanagi@ls.toyaku.ac.jp	Yanagi, Shigeru/AAU-9513-2020	Yanagi, Shigeru/0000-0002-1392-8663; Fukuda, Toshifumi/0000-0003-2400-5319	MEXT/JSPS KAKENHI [16K08246, 18H04869, 20H04911]; MEXT; Uehara Memorial Foundation; Naito Foundation; Takeda Foundation; Sumitomo Foundation; Ono Medical Research Foundation; Tokyo Biochemical Research Foundation; AMED [17gm5010002, 18gm5010002, 19gm5010002, 20gm5010002]; Cosmetology Research Foundation;  [16H06276]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Ono Medical Research Foundation; Tokyo Biochemical Research Foundation; AMED; Cosmetology Research Foundation; 	This study was supported in part by MEXT/JSPS KAKENHI (16K08246 to S. N., 18H04869 and 20H04911 to S. Y.) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (to S. N., R. I., and S. Y.), The Uehara Memorial Foundation, The Naito Foundation (to S. N. and S. Y.), a Grant-in-Aid for Scientific Research on Innovative Areas-Platform for Advanced Technologies and Research Resources (16H06276 to T. M.), The Takeda Foundation, The Sumitomo Foundation, The Cosmetology Research Foundation, The Ono Medical Research Foundation, The Tokyo Biochemical Research Foundation and AMED under Grant Number 17gm5010002, 18gm5010002, 19gm5010002, and 20gm5010002 (to S. Y.).	Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Furutachi S, 2013, EMBO J, V32, P970, DOI 10.1038/emboj.2013.50; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Hagihara H, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0522-8; Hagihara Hideo, 2019, Neuropsychopharmacology Reports, V39, P78, DOI 10.1002/npr2.12048; Hagihara H, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0378-3; Hagihara H, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/318596; Imoto Y, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0288-9; Iwasato T, 2004, GENESIS, V38, P130, DOI 10.1002/gene.20009; Kang EC, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019026; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Kobayashi M, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-12; Mairet-Coello G, 2012, DEVELOPMENT, V139, P475, DOI 10.1242/dev.067314; Nader K, 2019, BRAIN STRUCT FUNCT, V224, P2691, DOI 10.1007/s00429-019-01925-6; Nagashima S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56559-9; Nagashima S, 2011, J BIOL CHEM, V286, P33879, DOI 10.1074/jbc.M111.234997; Oku Y, 2013, J NEUROSCI, V33, P12586, DOI 10.1523/JNEUROSCI.0341-13.2013; Qin QY, 2006, J CELL BIOL, V172, P497, DOI 10.1083/jcb.200505079; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shin R, 2013, BIPOLAR DISORD, V15, P405, DOI 10.1111/bdi.12064; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38; Terashima M, 2010, J NEUROSCI RES, V88, P1387, DOI 10.1002/jnr.22315; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Walton NM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.56; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; You JC, 2017, NAT MED, V23, P1377, DOI 10.1038/nm.4413; Zhang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/727542	37	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100620	10.1016/j.jbc.2021.100620	http://dx.doi.org/10.1016/j.jbc.2021.100620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811862	gold, Green Published			2022-12-28	WOS:000672866400591
J	Pineau, C; Guschinskaya, N; Goncalves, IR; Ruaudel, F; Robert, X; Gouet, P; Ballut, L; Shevchik, VE				Pineau, Camille; Guschinskaya, Natalia; Goncalves, Isabelle R.; Ruaudel, Florence; Robert, Xavier; Gouet, Patrice; Ballut, Lionel; Shevchik, Vladimir E.			Structure-function analysis of pectate lyase Pel3 reveals essential facets of protein recognition by the bacterial type 2 secretion system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERWINIA-CHRYSANTHEMI; CRYSTAL-STRUCTURE; DOMAIN; ARCHITECTURE; MOLECULE; SEQUENCE; PATHWAY; BINDING; REGION	The type II secretion system (T2SS) transports fully folded proteins of various functions and structures through the outer membrane of Gram-negative bacteria. The molecular mechanisms of substrate recruitment by T2SS remain elusive but a prevailing view is that the secretion determinants could be of a structural nature. The phytopathogenic gamma-proteobacteria, Pectobacterium carotovorum and Dickeya dadantii, secrete similar sets of homologous plant cell wall degrading enzymes, mainly pectinases, by similar T2SSs, called Out. However, the orthologous pectate lyases Pel3 and PelI from these bacteria, which share 67% of sequence identity, are not secreted by the counterpart T2SS of each bacterium, indicating a fine-tuned control of protein recruitment. To identify the related secretion determinants, we first performed a structural characterization and comparison of Pel3 with PelI using X-ray crystallography. Then, to assess the biological relevance of the observed structural variations, we conducted a loop-substitution analysis of Pel3 combined with secretion assays. We showed that there is not one element with a definite secondary structure but several distant and structurally flexible loop regions that are essential for the secretion of Pel3 and that these loop regions act together as a composite secretion signal. Interestingly, depending on the crystal contacts, one of these key secretion determinants undergoes disorder-to-order transitions that could reflect its transient structuration upon the contact with the appropriate T2SS components. We hypothesize that such T2SS-induced structuration of some intrinsically disordered zones of secretion substrates could be part of the recruitment mechanism used by T2SS.	[Pineau, Camille; Guschinskaya, Natalia; Goncalves, Isabelle R.; Ruaudel, Florence; Shevchik, Vladimir E.] Univ Lyon, Microbiol Adaptat & Pathogenie, Univ Lyon 1, UMR5240,CNRS, Villeurbanne, France; [Pineau, Camille; Guschinskaya, Natalia; Shevchik, Vladimir E.] Lyon, Microbiol Adaptat & Pathogenie, INSA Lyon, UMR5240, Villeurbanne, France; [Robert, Xavier; Gouet, Patrice; Ballut, Lionel] Univ Lyon, Mol Microbiol & Struct Biochem, UMR5086, CNRS, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Shevchik, VE (corresponding author), Univ Lyon, Microbiol Adaptat & Pathogenie, Univ Lyon 1, UMR5240,CNRS, Villeurbanne, France.; Shevchik, VE (corresponding author), Lyon, Microbiol Adaptat & Pathogenie, INSA Lyon, UMR5240, Villeurbanne, France.; Ballut, L (corresponding author), Univ Lyon, Mol Microbiol & Struct Biochem, UMR5086, CNRS, Lyon, France.	lionel.ballut@ibcp.fr; vladimir.shevchik@insa-lyon.fr		Shevchik, Vladimir/0000-0002-8031-8638	CNRS (Centre National de la Recherche Scientifique); ANR (Agence Nationale de la Recherche) [SYNERGY_T2SS ANR-19-CE11-0020]	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR))	This research was supported by funding from CNRS (Centre National de la Recherche Scientifique) and a grant from ANR (Agence Nationale de la Recherche) SYNERGY_T2SS ANR-19-CE11-0020.	Akita M, 2001, ACTA CRYSTALLOGR D, V57, P1786, DOI 10.1107/S0907444901014482; Alahuhta M, 2011, ACTA CRYSTALLOGR F, V67, P1498, DOI 10.1107/S1744309111038449; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BORK P, 1992, P NATL ACAD SCI USA, V89, P8990, DOI 10.1073/pnas.89.19.8990; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Castang S, 2004, ACTA CRYSTALLOGR D, V60, P190, DOI 10.1107/S0907444903026222; Chandler PG, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030610; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Cianciotto NP, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00014-17; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Creze C, 2008, J BIOL CHEM, V283, P18260, DOI 10.1074/jbc.M709931200; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Ekiert DC, 2017, CELL, V169, P273, DOI 10.1016/j.cell.2017.03.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filloux A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00155; Filloux A, 2010, J BACTERIOL, V192, P3847, DOI 10.1128/JB.00565-10; Francetic O, 2005, J BACTERIOL, V187, P7045, DOI 10.1128/JB.187.20.7045-7055.2005; Gu S, 2017, BBA-PROTEINS PROTEOM, V1865, P1255, DOI 10.1016/j.bbapap.2017.07.006; Gu S, 2012, J BIOL CHEM, V287, P9072, DOI 10.1074/jbc.M111.300624; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Healey EG, 2015, NAT STRUCT MOL BIOL, V22, P458, DOI 10.1038/nsmb.3016; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HIRST TR, 1987, P NATL ACAD SCI USA, V84, P7418, DOI 10.1073/pnas.84.21.7418; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugouvieux-Cotte--Pattat N, ELS 2020, DOI [10.1002/9780470015902.a0028932, DOI 10.1002/9780470015902.A0028932]; Hugouvieux-Cotte-Pattat N, 2014, ENV MICROBIOL REP, V6, P427, DOI 10.1111/1758-2229.12166; Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397; JOHNSON BH, 1994, BIO-TECHNOL, V12, P1357, DOI 10.1038/nbt1294-1357; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kavran JM, 2010, J BIOL CHEM, V285, P24584, DOI 10.1074/jbc.M110.131680; Koide S, 2012, METHOD ENZYMOL, V503, P135, DOI 10.1016/B978-0-12-396962-0.00006-9; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lindeberg M, 1998, J BACTERIOL, V180, P1431, DOI 10.1128/JB.180.6.1431-1437.1998; LITTLE E, 1994, J MOL EVOL, V39, P631, DOI 10.1007/BF00160409; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; Miller SI, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004935; Palomaki T, 2002, MOL MICROBIOL, V43, P585, DOI 10.1046/j.1365-2958.2002.02793.x; Pineau C, 2014, MOL MICROBIOL, V94, P126, DOI 10.1111/mmi.12744; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sherman DJ, 2018, SCIENCE, V359, P798, DOI 10.1126/science.aar1886; Shevchik VE, 1998, MOL MICROBIOL, V29, P1459, DOI 10.1046/j.1365-2958.1998.01028.x; SHEVCHIK VE, 1995, MOL MICROBIOL, V16, P745, DOI 10.1111/j.1365-2958.1995.tb02435.x; Sidar A, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00871; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Thomassin JL, 2017, MOL MICROBIOL, V105, P211, DOI 10.1111/mmi.13704; Tsai HH, 2006, STRUCTURE, V14, P1059, DOI 10.1016/j.str.2006.03.015; White RC, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000273	57	1	1	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100305	10.1016/j.jbc.2021.100305	http://dx.doi.org/10.1016/j.jbc.2021.100305			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465378	Green Published, gold			2022-12-28	WOS:000672866400279
J	Stypulkowski, E; Feng, Q; Joseph, I; Farrell, V; Flores, J; Yu, SY; Sakamori, R; Sun, JX; Bandyopadhyay, S; Das, S; Dobrowolski, R; Bonder, EM; Chen, MH; Gao, N				Stypulkowski, Ewa; Feng, Qiang; Joseph, Ivor; Farrell, Victoria; Flores, Juan; Yu, Shiyan; Sakamori, Ryotaro; Sun, Jiaxin; Bandyopadhyay, Sheila; Das, Soumyashree; Dobrowolski, Radek; Bonder, Edward M.; Chen, Miao-Hsueh; Gao, Nan			Rab8 attenuates Wnt signaling and is required for mesenchymal differentiation into adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY-CILIUM; CILIARY MEMBRANE; GENE-EXPRESSION; PPAR-GAMMA; STEM-CELLS; BETA; GTPASE; PROTEINS; RECEPTOR; COMPLEX	Differentiation of mesenchymal stem cells into adipocyte requires coordination of external stimuli and depends upon the functionality of the primary cilium. The Rab8 small GTPases are regulators of intracellular transport of membrane-bound structural and signaling cargo. However, the physiological contribution of the intrinsic trafficking network controlled by Rab8 to mesenchymal tissue differentiation has not been fully defined in vivo and in primary tissue cultures. Here, we show that mouse embryonic fibroblasts (MEFs) lacking Rab8 have severely impaired adipocyte differentiation in vivo and ex vivo. Immunofluorescent localization and biochemical analyses of Rab8a-deficient, Rab8b-deficient, and Rab8a and Rab8b double-deficient MEFs revealed that Rab8 controls the Lrp6 vesicular compartment, clearance of basal signalosome, traffic of frizzled two receptor, and thereby a proper attenuation of Wnt signaling in differentiating MEFs. Upon induction of adipogenesis program, Rab8a- and Rab8b-deficient MEFs exhibited severely defective lipid-droplet formation and abnormal cilia morphology, despite overall intact cilia growth and ciliary cargo transport. Our results suggest that intracellular Rab8 traffic regulates induction of adipogenesis via proper positioning of Wnt receptors for signaling control in mesenchymal cells.	[Stypulkowski, Ewa; Feng, Qiang; Joseph, Ivor; Farrell, Victoria; Flores, Juan; Yu, Shiyan; Sakamori, Ryotaro; Sun, Jiaxin; Bandyopadhyay, Sheila; Das, Soumyashree; Dobrowolski, Radek; Bonder, Edward M.; Gao, Nan] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07103 USA; [Chen, Miao-Hsueh] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Gao, Nan] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Baylor College of Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Gao, N (corresponding author), Rutgers State Univ, Dept Biol Sci, Newark, NJ 07103 USA.; Chen, MH (corresponding author), Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA.; Gao, N (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA.	miaohsuc@bcm.edu; ngao@rutgers.edu	Sakamori, Ryotaro/B-4406-2014	Sakamori, Ryotaro/0000-0002-1580-607X; Das, Soumyashree/0000-0003-1236-3194	National Institutes of Health [DK102934, AT010243, DK119198, DK116899, AG062475, AG061040]; National Science Foundation/BIO/IDBR [1353890, 1952823]; American Cancer Society [RSG-15-06001-TBE]; Initiative for Multidisciplinary Research Teams (IMRT) award from Rutgers University; USDA ARS grant [3092-5-001-059]; CCFA career development award [406794]; New Jersey Commission on Cancer Research (NJCCR) [DFHS16PPC045]; NIH [F31 DK121428]; NJCCR fellowship [DFHS17PPC036]; RU-N SASN Research Funds	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation/BIO/IDBR; American Cancer Society(American Cancer Society); Initiative for Multidisciplinary Research Teams (IMRT) award from Rutgers University; USDA ARS grant; CCFA career development award; New Jersey Commission on Cancer Research (NJCCR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NJCCR fellowship; RU-N SASN Research Funds	This work was supported by National Institutes of Health grants (DK102934, AT010243, and DK119198 to N. G.; DK116899 to M. -H. C.; AG062475 and AG061040 to R. D.); National Science Foundation/BIO/IDBR [1353890] and [1952823]; a Research Scholar Grant [RSG-15-06001-TBE] from the American Cancer Society to N. G.; an Initiative for Multidisciplinary Research Teams (IMRT) award from Rutgers University; an USDA ARS grant (3092-5-001-059) to M. -H. C.; a CCFA career development award (406794) to S. Y.; a postdoctoral fellowship from New Jersey Commission on Cancer Research (NJCCR) (DFHS16PPC045) to Q. F. NJCCR fellowship DFHS17PPC036 and an NIH F31 DK121428 to S. B. RU-N SASN Research Funds to E. M. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackers I, 2018, DIABETES VASC DIS RE, V15, P3, DOI 10.1177/1479164117738442; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Chung SS, 2012, OBESITY, V20, P482, DOI 10.1038/oby.2011.212; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; D'Agostino L, 2019, CANCER RES, V79, P4099, DOI 10.1158/0008-5472.CAN-18-4075; Dalbay MT, 2015, STEM CELLS, V33, P1952, DOI 10.1002/stem.1975; Das S, 2015, DEVELOPMENT, V142, P2147, DOI 10.1242/dev.121046; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Demir K, 2013, CELL REP, V4, P1224, DOI 10.1016/j.celrep.2013.08.008; Donzelli E, 2011, J MOL CELL BIOL, V3, P123, DOI 10.1093/jmcb/mjq050; Feng Q, 2017, J CELL SCI, V130, P2491, DOI 10.1242/jcs.201897; Feng Q, 2015, J CELL PHYSIOL, V230, P1170, DOI 10.1002/jcp.24853; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Geng DH, 2016, TUMOR BIOL, V37, P7713, DOI 10.1007/s13277-015-4606-5; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guichard A, 2014, NAT REV MICROBIOL, V12, P624, DOI 10.1038/nrmicro3325; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; Heidrych P, 2008, HUM MOL GENET, V17, P3814, DOI 10.1093/hmg/ddn279; Hou R, 2016, TUMOR BIOL, V37, P16005, DOI 10.1007/s13277-016-5420-4; Huang Z, 2017, ONCOL RES, V25, P651, DOI 10.3727/096504016X14752792816791; Jonassen JA, 2012, J AM SOC NEPHROL, V23, P641, DOI 10.1681/ASN.2011080829; Kiral FR, 2018, CURR BIOL, V28, pR471, DOI 10.1016/j.cub.2018.02.010; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Knowles BC, 2015, J CELL SCI, V128, P1617, DOI 10.1242/jcs.163303; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Lee H, 2015, BMB REP, V48, P647, DOI 10.5483/BMBRep.2015.48.12.229; Li CM, 2016, CELL BIOL INT, V40, P1026, DOI 10.1002/cbin.10650; Lorenowicz MJ, 2009, EXP CELL RES, V315, P2683, DOI 10.1016/j.yexcr.2009.06.015; Lu DS, 2010, EUR J PHARMACOL, V636, P198, DOI 10.1016/j.ejphar.2010.03.010; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; Mok CA, 2010, CLIN GENET, V77, P18, DOI 10.1111/j.1399-0004.2009.01305.x; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Mosca TJ, 2010, NAT NEUROSCI, V13, P935, DOI 10.1038/nn.2593; Murga-Zamalloa CA, 2010, HUM MOL GENET, V19, P3591, DOI 10.1093/hmg/ddq275; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nosavanh L, 2015, P NATL ACAD SCI USA, V112, P5069, DOI 10.1073/pnas.1420978112; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Qiu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015240; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sakamori R, 2014, CANCER RES, V74, P5480, DOI 10.1158/0008-5472.CAN-14-0267; Sakamori R, 2012, J CLIN INVEST, V122, P1052, DOI 10.1172/JCI60282; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Scott CC, 2015, EMBO REP, V16, P741, DOI 10.15252/embr.201540081; Sen Gupta P, 2009, J ENDOCRINOL, V203, P327, DOI 10.1677/JOE-09-0116; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sun JX, 2017, J CELL SCI, V130, P2159, DOI 10.1242/jcs.200634; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Takada I, 2010, PPAR RES, V2010, DOI 10.1155/2010/341671; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Wu LZ, 2014, DEV CELL, V30, P378, DOI 10.1016/j.devcel.2014.07.005; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Yu L, 2016, TUMOR BIOL, V37, P13821, DOI 10.1007/s13277-016-5172-1; Yu SY, 2015, CELL MOL LIFE SCI, V72, P3343, DOI 10.1007/s00018-015-1931-1; Yu SY, 2014, J BIOL CHEM, V289, P32030, DOI 10.1074/jbc.M113.538223; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang X, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135923; Zhang X, 2018, J CELL PHYSIOL, V233, P5908, DOI 10.1002/jcp.26400; Zhang Xiao, 2016, Small GTPases, V7, P59, DOI 10.1080/21541248.2016.1159274; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276; Zilber Y, 2013, MOL BIOL CELL, V24, P555, DOI 10.1091/mbc.E12-06-0437	84	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100488	10.1016/j.jbc.2021.100488	http://dx.doi.org/10.1016/j.jbc.2021.100488			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33662399	Green Published, gold			2022-12-28	WOS:000672866400462
J	Sulpizio, A; Crawford, CEW; Koweek, RS; Charkoudian, LK				Sulpizio, Ariana; Crawford, Callie E. W.; Koweek, Rebecca S.; Charkoudian, Louise K.			Probing the structure and function of acyl carrier proteins to unlock the strategic redesign of type II polyketide biosynthetic pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FATTY-ACID; CROSS-LINKING; AROMATIC POLYKETIDES; MECHANISTIC INSIGHTS; SYNTHASE; DOMAIN; RECOGNITION; KETOSYNTHASE; DYNAMICS; BINDING	Type II polyketide synthases (PKSs) are protein assemblies, encoded by biosynthetic gene clusters in microorganisms, that manufacture structurally complex and pharmacologically relevant molecules. Acyl carrier proteins (ACPs) play a central role in biosynthesis by shuttling malonyl-based building blocks and polyketide intermediates to catalytic partners for chemical transformations. Because ACPs serve as central hubs in type II PKSs, they can also represent roadblocks to successfully engineering synthases capable of manufacturing `unnatural natural products.' Therefore, understanding ACP conformational dynamics and protein interactions is essential to enable the strategic redesign of type II PKSs. However, the inherent flexibility and transience of ACP interactions pose challenges to gaining insight into ACP structure and function. In this review, we summarize how the application of chemical probes and molecular dynamic simulations has increased our understanding of the structure and function of type II PKS ACPs. We also share how integrating these advances in type II PKS ACP research with newfound access to key enzyme partners, such as the ketosynthase-chain length factor, sets the stage to unlock new biosynthetic potential.	[Sulpizio, Ariana; Crawford, Callie E. W.; Koweek, Rebecca S.; Charkoudian, Louise K.] Haverford Coll, Dept Chem, Haverford, PA 19041 USA	Haverford College	Charkoudian, LK (corresponding author), Haverford Coll, Dept Chem, Haverford, PA 19041 USA.	lcharkou@haverford.edu		Koweek, Rebecca/0000-0001-8594-7495	National Science Foundation CAREER Award [CHE-1652424]; Dreyfus Foundation [TH-10-2020]; Research Corporation for Scientific Advancement [24350]; National Institutes of Health [R15 GM120704-02]	National Science Foundation CAREER Award(National Science Foundation (NSF)); Dreyfus Foundation; Research Corporation for Scientific Advancement(Research Corporation for Science Advancement); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge generous support from the National Science Foundation CAREER Award (CHE-1652424 to L. K. C.), the Dreyfus Foundation (TH-10-2020 to L. K. C.), the Research Corporation for Scientific Advancement (Cottrell Scholars Award 24350 to L.K.C), and the National Institutes of Health (R15 GM120704-02 to L. K. C.) for our research related to polyketide and fatty acid biosynthesis. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acheampong KK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51554-6; Akey DL, 2012, NAT PROD REP, V29, P1038, DOI 10.1039/c2np20016c; Alanjary M, 2019, NAT PROD REP, V36, P1249, DOI 10.1039/c9np00021f; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Arthur CJ, 2005, BIOCHEMISTRY-US, V44, P15414, DOI 10.1021/bi051499i; Barajas JF, 2017, P NATL ACAD SCI USA, V114, pE4142, DOI 10.1073/pnas.1609001114; Beld J, 2015, MOL BIOSYST, V11, P38, DOI 10.1039/c4mb00443d; Beld J, 2014, NAT PROD REP, V31, P61, DOI 10.1039/c3np70054b; Brauer A, 2020, NAT CHEM, V12, DOI 10.1038/s41557-020-0491-7; Broadhurst RW, 2003, CHEM BIOL, V10, P723, DOI 10.1016/S1074-5521(03)00156-X; Bruegger J, 2014, NATURAL PRODUCTS: DISCOURSE, DIVERSITY, AND DESIGN, P219; Bruegger J, 2013, CHEM BIOL, V20, P1135, DOI 10.1016/j.chembiol.2013.07.012; Buchholz TJ, 2009, ACS CHEM BIOL, V4, P41, DOI 10.1021/cb8002607; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Callahan B, 2009, P NATL ACAD SCI USA, V106, P19410, DOI 10.1073/pnas.0902364106; Cantu DC, 2012, PROTEIN SCI, V21, P655, DOI 10.1002/pro.2050; Chan DI, 2008, J BIOL CHEM, V283, P33620, DOI 10.1074/jbc.M805323200; Charkoudian LK, 2011, PROTEIN SCI, V20, P1244, DOI 10.1002/pro.652; Chen AC, 2018, NAT PROD REP, V35, DOI 10.1039/c8np00040a; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Condurso HL, 2012, NAT PROD REP, V29, P1099, DOI 10.1039/c2np20023f; Cronan JE, 2014, BIOCHEM J, V460, P157, DOI 10.1042/BJ20140239; Crosby J, 1998, FEBS LETT, V433, P132, DOI 10.1016/S0014-5793(98)00840-0; Crosby J, 2012, NAT PROD REP, V29, P1111, DOI 10.1039/c2np20062g; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; Crump MP, 1996, FEBS LETT, V391, P302, DOI 10.1016/0014-5793(96)00756-9; Cummings M, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000347; Das A, 2009, ACCOUNTS CHEM RES, V42, P631, DOI 10.1021/ar8002249; Dias DA, 2012, METABOLITES, V2, DOI 10.3390/metabo2020303; Dodge GJ, 2019, P NATL ACAD SCI USA, V116, P6775, DOI 10.1073/pnas.1818686116; Dong X, 2016, CHEM SCI, V7, P1779, DOI 10.1039/c5sc03864b; Dreier J, 2000, BIOCHEMISTRY-US, V39, P2088, DOI 10.1021/bi992121l; Dreier J, 1999, J BIOL CHEM, V274, P25108, DOI 10.1074/jbc.274.35.25108; Du DY, 2020, NAT CHEM BIOL, V16, P776, DOI 10.1038/s41589-020-0530-0; Ellis BD, 2018, J AM CHEM SOC, V140, P4961, DOI 10.1021/jacs.7b11793; Epstein SC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10184-2; Evans SE, 2008, CHEMBIOCHEM, V9, P2424, DOI 10.1002/cbic.200800180; Evans SE, 2009, J MOL BIOL, V389, P511, DOI 10.1016/j.jmb.2009.03.072; Farmer R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219435; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Florova G, 2002, BIOCHEMISTRY-US, V41, P10462, DOI 10.1021/bi0258804; Gulick AM, 2018, NAT PROD REP, V35, P1156, DOI 10.1039/c8np00044a; Haslinger K, 2014, ANGEW CHEM INT EDIT, V53, P8518, DOI 10.1002/anie.201404977; Haushalter RW, 2011, ACS CHEM BIOL, V6, P413, DOI 10.1021/cb200004k; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hertweck C, 2015, TRENDS BIOCHEM SCI, V40, P189, DOI 10.1016/j.tibs.2015.02.001; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hillenmeyer ME, 2015, P NATL ACAD SCI USA, V112, P13952, DOI 10.1073/pnas.1511688112; HOLAK TA, 1988, EUR J BIOCHEM, V175, P9, DOI 10.1111/j.1432-1033.1988.tb14159.x; Ishikawa F, 2013, J AM CHEM SOC, V135, P8846, DOI 10.1021/ja4042059; Ishikawa F, 2012, J AM CHEM SOC, V134, P769, DOI 10.1021/ja2082334; Jackson DR, 2016, ACS CHEM BIOL, V11, P95, DOI 10.1021/acschembio.5b00500; Kapur S, 2012, P NATL ACAD SCI USA, V109, P4110, DOI 10.1073/pnas.1118734109; Kapur S, 2010, P NATL ACAD SCI USA, V107, P22066, DOI 10.1073/pnas.1014081107; Keatinge-Clay A, 2004, NAT STRUCT MOL BIOL, V11, P888, DOI 10.1038/nsmb808; Keatinge-Clay AT, 2017, CHEM REV, V117, P5334, DOI 10.1021/acs.chemrev.6b00683; Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Khosla C, 2014, BIOCHEMISTRY-US, V53, P2875, DOI 10.1021/bi500290t; Kilgour SL, 2019, CHEM-EUR J, V25, P16515, DOI 10.1002/chem.201903662; Klaus M, 2020, ACS CHEM BIOL, V15, P2422, DOI 10.1021/acschembio.0c00405; Klaus M, 2019, ACS CHEM BIOL, V14, P426, DOI 10.1021/acschembio.8b01060; Klaus M, 2018, NAT PROD REP, V35, P1070, DOI 10.1039/c8np00030a; Klaus M, 2016, J BIOL CHEM, V291, P16404, DOI 10.1074/jbc.M116.730531; Klein JG, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2020.115686; Kohli GS, 2016, ISME J, V10, P1877, DOI 10.1038/ismej.2015.263; Konno S, 2018, ANGEW CHEM INT EDIT, V57, P17009, DOI 10.1002/anie.201806865; Korman TP, 2004, BIOCHEMISTRY-US, V43, P14529, DOI 10.1021/bi048133a; Korman TP, 2008, BIOCHEMISTRY-US, V47, P1837, DOI 10.1021/bi7016427; Ladner CC, 2016, J IND MICROBIOL BIOT, V43, P371, DOI 10.1007/s10295-015-1704-8; Li Q, 2003, BIOCHEMISTRY-US, V42, P4648, DOI 10.1021/bi0274120; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; Matharu AL, 1998, CHEM BIOL, V5, P699, DOI 10.1016/S1074-5521(98)90663-9; McDaniel R, 1997, CHEM BIOL, V4, P667, DOI 10.1016/S1074-5521(97)90222-2; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; Meier JL, 2009, METHOD ENZYMOL, V458, P219, DOI 10.1016/S0076-6879(09)04809-5; Mercer AC, 2007, NAT PROD REP, V24, P750, DOI 10.1039/b603921a; Milligan JC, 2019, NAT CHEM BIOL, V15, P669, DOI 10.1038/s41589-019-0301-y; Mindrebo J. T., 2020, COMPREHENSIVE NATURA, P66; Mindrebo JT, 2020, BIOCHEMISTRY-US, V59, P3626, DOI 10.1021/acs.biochem.0c00605; Mindrebo JT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15455-x; Misra A, 2007, CHEM BIOL, V14, P775, DOI 10.1016/j.chembiol.2007.05.013; Miyanaga A, 2020, ACS CHEM BIOL, V15, P1808, DOI 10.1021/acschembio.0c00403; Ostrowski MP, 2016, J ANTIBIOT, V69, P507, DOI 10.1038/ja.2016.41; Pan H, 2002, STRUCTURE, V10, P1559, DOI 10.1016/S0969-2126(02)00889-4; Passmore M, 2020, TRENDS BIOTECHNOL, V38, P682, DOI 10.1016/j.tibtech.2020.04.001; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Ploskon E, 2010, CHEM BIOL, V17, P776, DOI 10.1016/j.chembiol.2010.05.024; Porter fi eld W. B., 2020, ISCIENCE, V23; Ranganathan A, 1999, CHEM BIOL, V6, P731, DOI 10.1016/S1074-5521(00)80020-4; Rivas MA, 2018, AICHE J, V64, P4308, DOI 10.1002/aic.16402; Robbins T, 2016, CURR OPIN STRUC BIOL, V41, P10, DOI 10.1016/j.sbi.2016.05.009; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Santin O, 2020, BIOCHEMISTRY-US, V59, P4735, DOI 10.1021/acs.biochem.0c00785; Schaub AJ, 2019, METHOD ENZYMOL, V622, P375, DOI 10.1016/bs.mie.2019.03.001; Shakya G, 2014, J AM CHEM SOC, V136, P16792, DOI 10.1021/ja5064857; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Smith JL, 2015, CURR OPIN STRUC BIOL, V31, P9, DOI 10.1016/j.sbi.2015.02.014; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Soltani J., 2016, NEW FUTURE DEV 312 M, P275; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Sztain T, 2019, ANGEW CHEM INT EDIT, V58, P10888, DOI 10.1002/anie.201903815; Tang Y, 2004, PLOS BIOL, V2, P227, DOI 10.1371/journal.pbio.0020031; Tang Y, 2003, J AM CHEM SOC, V125, P12708, DOI 10.1021/ja0378759; Tang Y, 2003, BIOCHEMISTRY-US, V42, P6588, DOI 10.1021/bi0341962; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; Tarry MJ, 2015, PROTEIN ENG DES SEL, V28, P163, DOI 10.1093/protein/gzv009; Thiele GAR, 2017, BIOCHEMISTRY-US, V56, P2533, DOI 10.1021/acs.biochem.7b00219; Tsai SC, 2018, ANNU REV BIOCHEM, V87, P503, DOI 10.1146/annurev-biochem-063011-164509; Vance S, 2016, BIOCHEM J, V473, P1097, DOI 10.1042/BCJ20160041; Walker PD, 2019, ANGEW CHEM INT EDIT, V58, P12446, DOI 10.1002/anie.201905482; Wong FT, 2010, BIOCHEMISTRY-US, V49, P95, DOI 10.1021/bi901826g; Worthington AS, 2008, CHEMBIOCHEM, V9, P2096, DOI 10.1002/cbic.200800198; Worthington AS, 2006, ACS CHEM BIOL, V1, P687, DOI 10.1021/cb6003965; Worthington AS, 2006, ORG BIOMOL CHEM, V4, P44, DOI 10.1039/b512735a; Ye ZX, 2014, BIOCHEMISTRY-US, V53, P7494, DOI 10.1021/bi500936u; Ye ZX, 2011, MOL BIOSYST, V7, P3152, DOI 10.1039/c1mb05270e; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang Zhuan, 2017, F1000Res, V6, P172, DOI 10.12688/f1000research.10466.1; Zhou P, 1999, CHEM BIOL, V6, P577, DOI 10.1016/S1074-5521(99)80090-8; Zhu L, 2015, J BIOL CHEM, V290, P13791, DOI 10.1074/jbc.M115.648402; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	123	3	3	4	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100328	10.1016/j.jbc.2021.100328	http://dx.doi.org/10.1016/j.jbc.2021.100328			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493513	Green Published, gold			2022-12-28	WOS:000672866400302
J	Sun, J; Patel, K; Hume, J; Pigza, JA; Donahue, MG; Kessl, JJ				Sun, Jian; Patel, Krunal; Hume, Jared; Pigza, Julie A.; Donahue, Matthew G.; Kessl, Jacques J.			Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABERRANT PROTEIN MULTIMERIZATION; SMALL-MOLECULE INHIBITORS; ALLOSTERIC INHIBITORS; STRUCTURAL BASIS; LEDGF/P75; SITE; REPLICATION; RESISTANCE; MECHANISM; KNOCKOUT	During the integration step, human immunodeficiency virus type 1 integrase (IN) interacts with viral DNA and the cellular cofactor LEDGF/p75 to effectively integrate the reverse transcript into the host chromatin. Allosteric human immunodeficiency virus type 1 integrase inhibitors (ALLINIs) are a new class of antiviral agents that bind at the dimer interface of the IN catalytic core domain and occupy the binding site of LEDGF/p75. While originally designed to block IN-LEDGF/p75 interactions during viral integration, several of these compounds have been shown to also severely impact viral maturation through an IN multimerization mechanism. In this study, we tested the hypothesis that these dual properties of ALLINIs could be decoupled toward late stage viral replication effects by generating additional contact points between the bound ALLINI and a third subunit of IN. By sequential derivatization at position 7 of a quinoline-based ALLINI scaffold, we show that IN multimerization properties are enhanced by optimizing hydrophobic interactions between the compound and the C-terminal domain of the third IN subunit. These features not only improve the overall antiviral potencies of these compounds but also significantly shift the ALLINIs selectivity toward the viral maturation stage. Thus, we demonstrate that to fully maximize the potency of ALLINIs, the interactions between the inhibitor and all three IN subunits need to be simultaneously optimized.	[Sun, Jian; Patel, Krunal; Hume, Jared; Pigza, Julie A.; Donahue, Matthew G.; Kessl, Jacques J.] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Sun, Jian; Patel, Krunal; Kessl, Jacques J.] Univ Southern Mississippi, Ctr Mol & Cellular Biosci, Hattiesburg, MS 39406 USA	University of Southern Mississippi; University of Southern Mississippi	Kessl, JJ (corresponding author), Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.; Kessl, JJ (corresponding author), Univ Southern Mississippi, Ctr Mol & Cellular Biosci, Hattiesburg, MS 39406 USA.	Jacques.kessl@usm.edu	Donahue, Matthew/I-1687-2013	Donahue, Matthew/0000-0002-2608-1529	National Institutes of Health [AI140985, GM129751]; National Science Foundation [1848257]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	d This work was supported by National Institutes of Health Grants AI140985 (to J. J. K.), GM129751 (to M. G. D.) and the National Science Foundation Grant 1848257 (to J. A. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Bonnard D, 2018, J BIOL CHEM, V293, P6172, DOI 10.1074/jbc.M117.816793; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Deng NJ, 2016, PROTEIN SCI, V25, P1911, DOI 10.1002/pro.2997; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Elliott JL, 2020, ELIFE, V9, DOI 10.7554/eLife.54311; Engelman Alan, 2014, Microbiol Spectr, V2, P1; Engelman A, 2012, NAT REV MICROBIOL, V10, P279, DOI 10.1038/nrmicro2747; Engelman AN, 2019, J BIOL CHEM, V294, P15137, DOI 10.1074/jbc.REV119.006901; Fadel HJ, 2014, J VIROL, V88, P9704, DOI 10.1128/JVI.01397-14; Fader LD, 2014, ACS MED CHEM LETT, V5, P422, DOI 10.1021/ml500002n; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Gupta K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002584; Jentsch NG, 2018, ACS MED CHEM LETT, V9, P1007, DOI 10.1021/acsmedchemlett.8b00269; Jentsch NG, 2018, BEILSTEIN J ORG CHEM, V14, P2529, DOI 10.3762/bjoc.14.229; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kessl JJ, 2007, TRENDS PARASITOL, V23, P494, DOI 10.1016/j.pt.2007.08.004; Kessl JJ, 2007, BBA-BIOENERGETICS, V1767, P319, DOI 10.1016/j.bbabio.2007.02.014; Kessl JJ, 2016, CELL, V166, P1257, DOI 10.1016/j.cell.2016.07.044; Kessl JJ, 2016, METHODS MOL BIOL, V1354, P149, DOI 10.1007/978-1-4939-3046-3_10; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2003, J BIOL CHEM, V278, P31312, DOI 10.1074/jbc.M304042200; Koneru PC, 2019, ELIFE, V8, DOI 10.7554/eLife.46344; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Patel PA, 2016, BIOORG MED CHEM LETT, V26, P4748, DOI 10.1016/j.bmcl.2016.08.037; Sharma A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004171; Shkriabai N, 2014, J BIOL CHEM, V289, P26430, DOI 10.1074/jbc.M114.589572; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Slaughter A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0100-1; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913	43	4	4	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100363	10.1016/j.jbc.2021.100363	http://dx.doi.org/10.1016/j.jbc.2021.100363			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539919	gold, Green Published			2022-12-28	WOS:000672866400337
J	Truman, AW; Bourboulia, D; Mollapour, M				Truman, Andrew W.; Bourboulia, Dimitra; Mollapour, Mehdi			Decrypting the chaperone code	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; HSP90		[Truman, Andrew W.] Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA; [Bourboulia, Dimitra; Mollapour, Mehdi] SUNY Upstate Med Univ, Dept Urol, Syracuse, NY 13210 USA; [Bourboulia, Dimitra; Mollapour, Mehdi] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Bourboulia, Dimitra; Mollapour, Mehdi] SUNY Upstate Med Univ, Upstate Canc Ctr, Syracuse, NY 13210 USA	University of North Carolina; University of North Carolina Charlotte; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Truman, AW (corresponding author), Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA.; Bourboulia, D; Mollapour, M (corresponding author), SUNY Upstate Med Univ, Dept Urol, Syracuse, NY 13210 USA.; Bourboulia, D; Mollapour, M (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.; Bourboulia, D; Mollapour, M (corresponding author), SUNY Upstate Med Univ, Upstate Canc Ctr, Syracuse, NY 13210 USA.	aruman1@uncc.edu; bourmpod@upstate.edu; mollapom@upstate.edu		Mollapour, Mehdi/0000-0002-2144-1361; Truman, Andrew/0000-0002-6409-3723	National Institute of General Medical Sciences of the National Institutes of Health [R15GM139059, R01GM139885, R01GM139932, R35GM139584, R01GM124256]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R15GM139059 and R01GM139885 (A. W. T.), R01GM139932 (D. B.), R35GM139584, and R01GM124256 (M. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alaalm L., 2020, NOVEL HSP90 PHOSPHO; Baker-Williams AJ, 2019, CELL REP, V28, P1894, DOI 10.1016/j.celrep.2019.07.045; Dunn DM, 2015, CELL REP, V12, P1006, DOI 10.1016/j.celrep.2015.07.004; Himanen SV, 2019, J CELL SCI, V132, DOI 10.1242/jcs.238402; Jakobsson ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11464; Jakobsson ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140168; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Lotz SK, 2019, CURR GENET, V65, P1127, DOI 10.1007/s00294-019-00978-8; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; Masgras I, 2017, CELL REP, V18, P659, DOI 10.1016/j.celrep.2016.12.056; Mayer MP, 2019, J BIOL CHEM, V294, P2085, DOI 10.1074/jbc.REV118.002810; Moss SM, 2019, CELL HOST MICROBE, V25, P454, DOI 10.1016/j.chom.2019.01.006; Mukherjee M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao2464; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Nitika, 2020, J BIOL CHEM, V295, P10689, DOI 10.1074/jbc.REV120.011666; Rehn A, 2016, J MOL BIOL, V428, P4559, DOI 10.1016/j.jmb.2016.09.014; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; Sanchez-Pozo J, 2018, ISCIENCE, V1, P87, DOI 10.1016/j.isci.2018.02.004; Sanyal A., 2018, KINETIC STRUCTURAL P, DOI [10.1101/494930, DOI 10.1101/494930]; Sanyal A, 2015, J BIOL CHEM, V290, P8482, DOI 10.1074/jbc.M114.618348; Schmid PWN, 2021, NAT STRUCT MOL BIOL, V28, P143, DOI 10.1038/s41594-020-00543-9; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Szewczyk MM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16271-z; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; Truttmann MC, 2018, P NATL ACAD SCI USA, V115, pE5008, DOI 10.1073/pnas.1801989115; Vihervaara A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00151-0; Weissman Z, 2020, BBA-PROTEINS PROTEOM, V1868, DOI 10.1016/j.bbapap.2018.09.001; Woodford MR, 2016, CURR TOP MED CHEM, V16, P2792, DOI 10.2174/1568026616666160413141753; Xu WP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10463-y; Zachara N., 2015, ESSENTIALS GLYCOBIOL, P239, DOI DOI 10.1101/GLYCOBIOLOGY.3E.019; Zemanovic S, 2018, CELL REP, V25, P2605, DOI 10.1016/j.celrep.2018.11.015	31	7	7	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100293	10.1016/j.jbc.2021.100293	http://dx.doi.org/10.1016/j.jbc.2021.100293			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837727	Green Published, gold			2022-12-28	WOS:000672866400267
J	Vilalta, A; Zhou, Y; Sevalle, J; Griffin, JK; Satoh, K; Allendorf, DH; De, S; Puigdellivol, M; Bruzas, A; Burguillos, MA; Dodd, RB; Chen, FS; Zhang, YL; Flagmeier, P; Needham, LM; Enomoto, M; Qamar, S; Henderson, J; Walter, J; Fraser, PE; Klenerman, D; Lee, SF; St George-Hyslop, P; Brown, GC				Vilalta, Anna; Zhou, Ye; Sevalle, Jean; Griffin, Jennifer K.; Satoh, Kanayo; Allendorf, David H.; De, Suman; Puigdellivol, Mar; Bruzas, Arturas; Burguillos, Miguel A.; Dodd, Roger B.; Chen, Fusheng; Zhang, Yalun; Flagmeier, Patrick; Needham, Lisa-Maria; Enomoto, Masahiro; Qamar, Seema; Henderson, James; Walter, Jochen; Fraser, Paul E.; Klenerman, David; Lee, Steven F.; St George-Hyslop, Peter; Brown, Guy C.			Wild-type sTREM2 blocks A beta aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases A beta aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREM2; DISEASE; PROTEIN; MICE; PROTOFIBRILS; VARIANTS; CLEAVAGE; PLAQUES; INFLUX	TREM2 is a pattern recognition receptor, expressed on microglia and myeloid cells, detecting lipids and A beta and inducing an innate immune response. Missense mutations (e.g., R47H) of TREM2 increase risk of Alzheimer's disease (AD). The soluble ectodomain of wild-type TREM2 (sTREM2) has been shown to protect against AD in vivo, but the underlying mechanisms are unclear. We show that A beta oligomers bind to cellular TREM2, inducing shedding of the sTREM2 domain. Wild-type sTREM2 bound to A beta oligomers (measured by single-molecule imaging, dot blots, and Bio-Layer Interferometry) inhibited A beta oligomerization and disaggregated preformed A beta oligomers and protofibrils (measured by transmission electron microscopy, dot blots, and size-exclusion chromatography). Wild-type sTREM2 also inhibited A beta fibrillization (measured by imaging and thioflavin T fluorescence) and blocked A beta-induced neurotoxicity (measured by permeabilization of artificial membranes and by loss of neurons in primary neuronal-glial cocultures). In contrast, the R47H AD-risk variant of sTREM2 is less able to bind and disaggregate oligomeric A beta but rather promotes A beta protofibril formation and neurotoxicity. Thus, in addition to inducing an immune response, wild-type TREM2 may protect against amyloid pathology by the A beta-induced release of sTREM2, which blocks A beta aggregation and neurotoxicity. In contrast, R47H sTREM2 promotes A beta aggregation into protofibril that may be toxic to neurons. These findings may explain how wild-type sTREM2 apparently protects against AD in vivo and why a single copy of the R47H variant gene is associated with increased AD risk.	[Vilalta, Anna; Allendorf, David H.; Puigdellivol, Mar; Bruzas, Arturas; Burguillos, Miguel A.; Brown, Guy C.] Univ Cambridge, Dept Biochem, Cambridge, England; [Zhou, Ye; Sevalle, Jean; Griffin, Jennifer K.; Satoh, Kanayo; Chen, Fusheng; Zhang, Yalun; Fraser, Paul E.; St George-Hyslop, Peter] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Zhou, Ye; Sevalle, Jean; Griffin, Jennifer K.; Satoh, Kanayo; Chen, Fusheng; Zhang, Yalun; Fraser, Paul E.; St George-Hyslop, Peter] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Zhou, Ye; Sevalle, Jean; Griffin, Jennifer K.; Satoh, Kanayo; Chen, Fusheng; Zhang, Yalun; Fraser, Paul E.; St George-Hyslop, Peter] Univ Hlth Network, Toronto, ON, Canada; [De, Suman; Dodd, Roger B.] AstraZeneca, Cambridge, England; [Burguillos, Miguel A.; Dodd, Roger B.; Qamar, Seema; Henderson, James; St George-Hyslop, Peter] Cambridge Inst Med Res, Cambridge, England; [Flagmeier, Patrick; Needham, Lisa-Maria; Klenerman, David; Lee, Steven F.] Univ Cambridge, Dept Chem, Cambridge, England; [Enomoto, Masahiro] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med Biophys, Toronto, ON, Canada; [Walter, Jochen] Univ Bonn, Dept Neurol, Mol Cell Biol, Bonn, Germany; [Klenerman, David] Cambridge Dementia Res Inst, Cambridge Biomed Campus, Cambridge, England	University of Cambridge; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Cambridge; University of Cambridge; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Bonn	Brown, GC (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.; St George-Hyslop, P (corresponding author), Univ Toronto, Dept Med Neurol, Toronto, ON, Canada.; St George-Hyslop, P (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; St George-Hyslop, P (corresponding author), Univ Hlth Network, Toronto, ON, Canada.; St George-Hyslop, P (corresponding author), Cambridge Inst Med Res, Cambridge, England.	phs22@cam.ac.uk; gcb3@cam.ac.uk	Brown, Guy C./HHC-1102-2022; Burguillos, Miguel/N-4806-2019; Puigdellivol Canadell, Mar/E-6656-2019	Burguillos, Miguel/0000-0002-3165-9997; Vilalta, Anna/0000-0002-2183-072X; Satoh, Kanayo/0000-0001-9684-239X; Dodd, Roger/0000-0003-4268-1863; Puigdellivol Canadell, Mar/0000-0002-9955-3558; Enomoto, Masahiro/0000-0002-9411-2999	Canadian Institutes of Health Research; Canadian Consortium on Neurodegeneration in Aging; Wellcome Trust; Medical Research Council; Zenith Award Alzheimer Association; Innovative Medicines Initiative 2 [115976]; European Union; European Federation of Pharmaceutical Industries and Associations	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Consortium on Neurodegeneration in Aging; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Zenith Award Alzheimer Association; Innovative Medicines Initiative 2; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations	This project has received funding from the Canadian Institutes of Health Research (P. S. G.H. and P. E. F.), Canadian Consortium on Neurodegeneration in Aging, Wellcome Trust, Medical Research Council, Zenith Award Alzheimer Association (P. S. G.-H.). This project has received funding from the Innovative Medicines Initiative 2 joint undertaking under grant agreement no. 115976. This joint undertaking receives support from the European Union's Horizon 2020 research and innovation program and European Federation of Pharmaceutical Industries and Associations (G. C. B., J. W., and P. S. G.-H.).	Bal-Price A, 2001, J NEUROSCI, V21, P6480; Chia S, 2017, P NATL ACAD SCI USA, V114, P8005, DOI 10.1073/pnas.1700239114; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; De S, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0777-4; De S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09477-3; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Drews A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31910; Edwards FA, 2019, TRENDS NEUROSCI, V42, P310, DOI 10.1016/j.tins.2019.03.003; Ewers M, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012308; Ewers M, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav6221; Flagmeier P, 2017, ANGEW CHEM INT EDIT, V56, P7750, DOI 10.1002/anie.201700966; Franzmeier N, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00407-2; Gertsenstein Marina, 2018, Curr Protoc Mouse Biol, V8, P28, DOI 10.1002/cpmo.40; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Horrocks MH, 2016, ACS CHEM NEUROSCI, V7, P399, DOI 10.1021/acschemneuro.5b00324; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iljina M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0390-6; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kang SS, 2018, HUM MOL GENET, V27, P211, DOI 10.1093/hmg/ddx366; Kober DL, 2021, ALZHEIMERS DEMENT, V17, P475, DOI 10.1002/alz.12194; Lessard CB, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809027; Ma LZ, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00374-8; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; Nichols MR, 2005, J BIOL CHEM, V280, P2471, DOI 10.1074/jbc.M410553200; Parhizkar S, 2019, NAT NEUROSCI, V22, P191, DOI 10.1038/s41593-018-0296-9; Piccio L, 2016, ACTA NEUROPATHOL, V131, P925, DOI 10.1007/s00401-016-1533-5; Schlepckow K, 2017, EMBO MOL MED, V9, P1356, DOI 10.15252/emmm.201707672; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Suarez-Calvet M, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-018-0301-5; Suarez-Calvet M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1767; Suarez-Calvet M, 2016, EMBO MOL MED, V8, P466, DOI 10.15252/emmm.201506123; Thornton P, 2017, EMBO MOL MED, V9, P1366, DOI 10.15252/emmm.201707673; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xiang XY, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0280-6; Yang T, 2017, J NEUROSCI, V37, P152, DOI 10.1523/JNEUROSCI.1698-16.2016; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zhong L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09118-9; Zhong L, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0247-7	45	18	18	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100631	10.1016/j.jbc.2021.100631	http://dx.doi.org/10.1016/j.jbc.2021.100631			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33823153	gold, Green Published, Green Submitted			2022-12-28	WOS:000672866400602
J	Wanna-Udom, S; Terashima, M; Suphakhong, K; Ishimura, A; Takino, T; Suzuki, T				Wanna-Udom, Sasithorn; Terashima, Minoru; Suphakhong, Kusuma; Ishimura, Akihiko; Takino, Takahisa; Suzuki, Takeshi			KDM2B is involved in the epigenetic regulation of TGF-beta-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; POLYCOMB; PROGRESSION; EXPRESSION; CHROMATIN; PROTEIN; PRC2; MARK	Polycomb repressive complex-1 (PRC1) induces transcriptional repression by regulating monoubiquitination of lysine 119 of histone H2A (H2AK119) and as such is involved in a number of biological and pathological processes including cancer development. Previously we demonstrated that PRC2, which catalyzes the methylation of histone H3K27, has an essential function in TGF-beta-induced epithelial-mesenchymal transition (EMT) of lung and pancreatic cancer cell lines. Since the cooperative activities of PRC1 and PRC2 are thought to be important for transcriptional repression in EMT program, we investigated the role of KDM2B, a member of PRC1 complex, on TGF-beta-induced EMT in this study. Knockdown of KDM2B inhibited TGF-beta-induced morphological conversion of the cells and enhanced cell migration and invasion potentials as well as the expression changes of EMT-related marker genes. Overexpression of KDM2B influenced the expression of several epithelial marker genes such as CDH1, miR200a, and CGN and enhanced the effects of TGF-beta. Mechanistic investigations revealed that KDM2B specifically recognized the regulatory regions of CDH1, miR200a, and CGN genes and induced histone H2AK119 monoubiquitination as a component of PRC1 complex, thereby mediating the subsequent EZH2 recruitment and histone H3K27 methylation process required for gene repression. Studies using KDM2B mutants confirmed that its DNA recognition property but not its histone H3 demethylase activity was indispensable for its function during EMT. This study demonstrated the significance of the regulation of histone H2A ubiquitination in EMT process and provided the possibility to develop novel therapeutic strategies for the treatment of cancer metastasis.	[Wanna-Udom, Sasithorn; Terashima, Minoru; Suphakhong, Kusuma; Ishimura, Akihiko; Suzuki, Takeshi] Kanazawa Univ, Div Funct Genom, Canc Res Inst, Kanazawa, Ishikawa, Japan; [Takino, Takahisa] Kanazawa Univ, Div Educ Global Stand, Inst Liberal Arts & Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Suzuki, T (corresponding author), Kanazawa Univ, Div Funct Genom, Canc Res Inst, Kanazawa, Ishikawa, Japan.	suzuki-t@staff.kanazawa-u.ac.jp		Suzuki, Takeshi/0000-0002-1737-0900; Wanna-udom, Sasithorn/0000-0002-8593-9126	Ministry of Education, Culture, Sports, Science and Technology of Japan [19K07346, 18K06057, 19K07686]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research C (grant numbers: 19K07346 to T. S., 18K06057 to M. T. and 19K07686 to A. I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aranda S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500737; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen JZ, 2014, CANCER RES, V74, P4353, DOI 10.1158/0008-5472.CAN-14-0181; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Fursova NA, 2019, MOL CELL, V74, P1020, DOI 10.1016/j.molcel.2019.03.024; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gil J, 2014, TRENDS CELL BIOL, V24, P632, DOI 10.1016/j.tcb.2014.06.005; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Kang JY, 2018, FASEB J, V32, P5737, DOI 10.1096/fj.201800242R; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Miyazono K, 2012, UPSALA J MED SCI, V117, P143, DOI 10.3109/03009734.2011.638729; Oktyabri D, 2014, BIOCHEM BIOPH RES CO, V453, P124, DOI 10.1016/j.bbrc.2014.09.082; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Samatov TR, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-107; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schuettengruber B, 2017, CELL, V171, P34, DOI 10.1016/j.cell.2017.08.002; Skrypek N, 2017, TRENDS GENET, V33, P943, DOI 10.1016/j.tig.2017.08.004; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Suzuki T, 2013, CANCER SCI, V104, P795, DOI 10.1111/cas.12169; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tange S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115684; Terashima M, 2018, J BIOL CHEM, V293, P18016, DOI 10.1074/jbc.RA118.004006; Terashima M, 2017, BIOCHEM BIOPH RES CO, V490, P1407, DOI 10.1016/j.bbrc.2017.07.048; Terashima M, 2017, J BIOL CHEM, V292, P82, DOI 10.1074/jbc.M116.750950; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu KJ, 2011, BIOSCIENCE REP, V31, P449, DOI 10.1042/BSR20100114; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Yoshida M, 2011, BIOCHEM J, V437, P555, DOI 10.1042/BJ20110343; Zacharopoulou N, 2018, CELL PHYSIOL BIOCHEM, V47, P368, DOI 10.1159/000489917; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	44	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100213	10.1074/jbc.RA120.015502	http://dx.doi.org/10.1074/jbc.RA120.015502			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33779563	Green Published, gold			2022-12-28	WOS:000672866400191
J	Wiedmann, M; Dranchak, PK; Aitha, M; Queme, B; Collmus, CD; Kashipathy, MM; Kanter, L; Lamy, L; Rogers, JM; Tao, DY; Battaile, KP; Rai, G; Lovell, S; Suga, H; Inglese, J				Wiedmann, Mareike; Dranchak, Patricia K.; Aitha, Mahesh; Queme, Bryan; Collmus, Christopher D.; Kashipathy, Maithri M.; Kanter, Liza; Lamy, Laurence; Rogers, Joseph M.; Tao, Dingyin; Battaile, Kevin P.; Rai, Ganesha; Lovell, Scott; Suga, Hiroaki; Inglese, James			Structure-activity relationship of ipglycermide binding to phosphoglycerate mutases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLYTIC-ENZYMES; PROTEIN; METAL; MECHANISM; DESIGN	Catalysis of human phosphoglycerate mutase is dependent on a 2,3-bisphosphoglycerate cofactor (dPGM), whereas the nonhomologous isozyme in many parasitic species is cofactor independent (iPGM). This mechanistic and phylogenetic diversity offers an opportunity for selective pharmacologic targeting of glycolysis in disease-causing organisms. We previously discovered ipglycermide, a potent inhibitor of iPGM, from a large combinatorial cyclic peptide library. To fully delineate the ipglycermide pharmacophore, herein we construct a detailed structure-activity relationship using 280 substituted ipglycermide analogs. Binding affinities of these analogs to immobilized Caenorhabditis elegans iPGM, measured as fold enrichment relative to the index residue by deep sequencing of an mRNA display library, illuminated the significance of each amino acid to the pharmacophore. Using cocrystal structures and binding kinetics, we show that the high affinity of ipglycermide for iPGM orthologs, from Brugia malayi, Onchocerca volvulus, Dirofilaria immitis, and Escherichia coli, is achieved by a codependence between (1) the offrate mediated by the macrocycle Cys14 thiolate coordination to an active-site Zn2+ in the iPGM phosphatase domain and (2) shape complementarity surrounding the macrocyclic core at the phosphotransferase-phosphatase domain interface. Our results show that the high-affinity binding of ipglycermide to iPGMs freezes these structurally dynamic enzymes into an inactive, stable complex.	[Wiedmann, Mareike; Rogers, Joseph M.; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo, Japan; [Dranchak, Patricia K.; Aitha, Mahesh; Queme, Bryan; Collmus, Christopher D.; Kanter, Liza; Lamy, Laurence; Tao, Dingyin; Rai, Ganesha; Inglese, James] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Kashipathy, Maithri M.; Lovell, Scott] Univ Kansas, Struct Biol Ctr, Prot Struct Lab, Lawrence, KS 66045 USA; [Battaile, Kevin P.] Argonne Natl Lab, IMCA CAT Adv Photon Source, 9700 S Cass Ave, Argonne, IL 60439 USA; [Inglese, James] NHGRI, NIH, Bethesda, MD 20892 USA; [Wiedmann, Mareike] Bayer Pharmaceut, R&D Div, Wuppertal, Germany; [Kanter, Liza] Univ Florida, Coll Dent, Gainesville, FL 32610 USA; [Rogers, Joseph M.] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Battaile, Kevin P.] Brookhaven Natl Lab, Beamline NYX, New York Struct Biol Ctr, NSLS 2 Synchrotron Brookhaven Ave, Upton, NY 11973 USA	University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Kansas; United States Department of Energy (DOE); Argonne National Laboratory; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Bayer AG; Bayer Healthcare Pharmaceuticals; State University System of Florida; University of Florida; University of Copenhagen; United States Department of Energy (DOE); Brookhaven National Laboratory	Suga, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo, Japan.; Inglese, J (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA.; Inglese, J (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	hsuga@chem.s.u-tokyo.ac.jp; jinglese@mail.nih.gov	Rogers, Joseph/AGZ-9056-2022	Queme, Bryan/0000-0003-1509-9982; Aitha, Mahesh/0000-0003-0377-4792; Lamy, Laurence/0000-0002-6967-9969; Dranchak, Patricia/0000-0002-1349-4885; Rogers, Joseph/0000-0002-1313-4089; Kanter, Liza/0000-0002-8616-764X; Tao, Dingyin/0000-0001-6531-2740	Intramural Research Program of the National Center for Advancing Translational Sciences (NCATS), NIH [1ZIATR000247]; Japan Agency for Medical Research and Development (AMED), Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research) [JP19am0101090]; Japanese Society for the Promotion of Science	Intramural Research Program of the National Center for Advancing Translational Sciences (NCATS), NIH; Japan Agency for Medical Research and Development (AMED), Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by the Intramural Research Program of the National Center for Advancing Translational Sciences (NCATS), NIH, under project 1ZIATR000247 (J. I.). H. S. thanks the Japan Agency for Medical Research and Development (AMED), Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research), under JP19am0101090. M. W. was supported by the Japanese Society for the Promotion of Science as an International Research Fellow. Accession number 7KNG denotes 2.10 A resolution structure of independent phosphoglycerate mutase from C. elegans in complex with a macrocyclic peptide inhibitor (Ce-2 Y7F) and 7KNF denotes 1.80 A resolution structure of independent phosphoglycerate mutase from C. elegans in complex with a macrocyclic peptide inhibitor (Ce-1 NHOH). The E. coli expression plasmids enabling site-specific C-terminal biotinylation described in this study, pET21a Ce-iPGM-bio (ID 162559), pET21a Bm-iPGM-bio (ID 162565), and pET21a Ec-iPGM-bio (ID 162575) have been deposited into Addgene. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aldrich C, 2017, J MED CHEM, V60, P2165, DOI 10.1021/acs.jmedchem.7b00229; Bashiruddin NK, 2015, CURR OPIN CHEM BIOL, V24, P131, DOI 10.1016/j.cbpa.2014.11.011; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CHAN WWC, 1982, J BIOL CHEM, V257, P7955; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collins JM, 2014, ORG LETT, V16, P940, DOI 10.1021/ol4036825; Crowther GJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002628; Darby JF, 2019, J AM CHEM SOC, V141, P15818, DOI 10.1021/jacs.9b06275; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Dougherty PG, 2019, CHEM REV, V119, P10241, DOI 10.1021/acs.chemrev.9b00008; Dutow P, 2010, J MOL MICROB BIOTECH, V19, P134, DOI 10.1159/000321499; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Filipuzzi I, 2017, NAT CHEM BIOL, V13, P1239, DOI [10.1038/NCHEMBIO.2493, 10.1038/nchembio.2493]; Floyd CD, 1996, TETRAHEDRON LETT, V37, P8045, DOI 10.1016/0040-4039(96)01821-7; Foster JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013576; Goto Y, 2008, ACS CHEM BIOL, V3, P120, DOI 10.1021/cb700233t; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Haanstra JR, 2017, SCI REP-UK, V7, DOI 10.1038/srep40406; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Harris MT, 2014, CURR MED CHEM, V21, P1668, DOI 10.2174/09298673113206660286; INGLESE J, 1989, J MED CHEM, V32, P937, DOI 10.1021/jm00125a002; Istvan ES, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14240; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Jin LY, 2014, ANNU REV PHARMACOL, V54, P435, DOI 10.1146/annurev-pharmtox-011613-140028; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh T, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz143; Kawamura A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14773; Kim BK, 2014, CURR TOP MED CHEM, V14, P2759, DOI 10.2174/1568026615666141208105614; ledrzejas, 2000, EMBO J, V19, p1419 1431; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Mercaldi GF, 2012, FEBS J, V279, P2012, DOI 10.1111/j.1742-4658.2012.08586.x; Miao ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37024; Miller TW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218897; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Niemeyer CM, 1999, BIOCONJUGATE CHEM, V10, P708, DOI 10.1021/bc980150n; Nowicki MW, 2009, J MOL BIOL, V394, P535, DOI 10.1016/j.jmb.2009.09.041; Okuma R, 2020, CHEM-ASIAN J, V15, P2631, DOI 10.1002/asia.202000700; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Raj M, 2013, BIOORGAN MED CHEM, V21, P4051, DOI 10.1016/j.bmc.2012.11.023; Rogers JM, 2018, P NATL ACAD SCI USA, V115, P10959, DOI 10.1073/pnas.1809901115; Roskoski R, 2015, PHARMACOL RES, V100, P1, DOI 10.1016/j.phrs.2015.07.010; Roychowdhury A, 2015, FEBS J, V282, P1097, DOI 10.1111/febs.13205; Ryan DP, 2005, CURR OPIN STRUC BIOL, V15, P441, DOI 10.1016/j.sbi.2005.06.001; Straus OH, 1943, J GEN PHYSIOL, V26, P559, DOI 10.1085/jgp.26.6.559; Tautermann CS, 2014, BIOORG MED CHEM LETT, V24, P4073, DOI 10.1016/j.bmcl.2014.07.009; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Xintaropoulou C, 2015, ONCOTARGET, V6, P25677, DOI 10.18632/oncotarget.4499; Yang J, 2020, ACS OMEGA, V5, P3979, DOI 10.1021/acsomega.9b03493; Yu H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14932; Zhang YH, 2004, J BIOL CHEM, V279, P37185, DOI 10.1074/jbc.M405877200; Zhang ZY, 2020, ACS CENTRAL SCI, V6, P1753, DOI 10.1021/acscentsci.0c00514	63	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100628	10.1016/j.jbc.2021.100628	http://dx.doi.org/10.1016/j.jbc.2021.100628			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33812994	Green Published, gold			2022-12-28	WOS:000672866400599
J	Kasperkiewicz, P; Hempel, A; Janiszewski, T; Kolt, S; Snipas, SJ; Drag, M; Salvesen, GS				Kasperkiewicz, Paulina; Hempel, Anne; Janiszewski, Tomasz; Kolt, Sonia; Snipas, Scott J.; Drag, Marcin; Salvesen, Guy S.			NETosis occurs independently of neutrophil serine proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						activity-based probes; neutrophil extracellular traps; NETosis; pyroptosis; neutrophil; cell death; protease; serine protease; protease inhibitor	GASDERMIN D; CATHEPSIN-G; ELASTASE; PYROPTOSIS; GSDMD; DNA; INHIBITION; CASPASE-11; MECHANISM; SERPINB1	Neutrophils are primary host innate immune cells defending against pathogens. One proposed mechanism by which neutrophils prevent the spread of pathogens is NETosis, the extrusion of cellular DNA resulting in neutrophil extracellular traps (NETs). The protease neutrophil elastase (NE) has been implicated in the formation of NETs through proteolysis of nuclear proteins leading to chromatin decondensation. In addition to NE, neutrophils contain three other serine proteases that could compensate if the activity of NE was neutralized. However, whether they do play such a role is unknown. Thus, we deployed recently described specific inhibitors against all four of the neutrophil serine proteases (NSPs). Using specific antibodies to the NSPs along with our labeled inhibitors, we show that catalytic activity of these enzymes is not required for the formation of NETs. Moreover, the NSPs that decorate NETs are in an inactive conformation and thus cannot participate in further catalytic events. These results indicate that NSPs play no role in either NETosis or arming NETs with proteolytic activity.	[Kasperkiewicz, Paulina; Hempel, Anne; Snipas, Scott J.; Salvesen, Guy S.] NCI Designated Canc Ctr, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92093 USA; [Kasperkiewicz, Paulina; Janiszewski, Tomasz; Kolt, Sonia; Drag, Marcin] Wroclaw Univ Sci & Technol, Dept Chem Biol & Bioimaging, Wroclaw, Poland	Sanford Burnham Prebys Medical Discovery Institute; Wroclaw University of Science & Technology	Kasperkiewicz, P; Salvesen, GS (corresponding author), NCI Designated Canc Ctr, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92093 USA.; Kasperkiewicz, P (corresponding author), Wroclaw Univ Sci & Technol, Dept Chem Biol & Bioimaging, Wroclaw, Poland.	paulina.kasperkiewicz@pwr.edu.pl; gsalvesen@sbpdiscovery.org		Kasperkiewicz, Paulina/0000-0002-1291-047X; Snipas, Scott/0000-0002-4239-6862; Kolt, Sonia/0000-0003-4076-0445	National Institutes of Health [R01 GM99040, P30 CA30199]; National Science Centre in Poland [2014/14/M/ST5/00619]; START scholarship from the Foundation for Polish Science	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Centre in Poland(National Science Centre, Poland); START scholarship from the Foundation for Polish Science	This work was supported by National Institutes of Health Grants R01 GM99040 and P30 CA30199 (to G. S. S.) and by National Science Centre Grant 2014/14/M/ST5/00619 in Poland (to M. D.). This work was also supported by a START scholarship from the Foundation for Polish Science (to P. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aglietti RA, 2017, TRENDS IMMUNOL, V38, P261, DOI 10.1016/j.it.2017.01.003; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; BELORGEY D, 1995, FEBS LETT, V361, P265, DOI 10.1016/0014-5793(95)00173-7; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Burgener SS, 2019, CELL REP, V27, P3646, DOI 10.1016/j.celrep.2019.05.065; Clancy DM, 2017, FEBS J, V284, P1712, DOI 10.1111/febs.14075; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; DEWALD B, 1975, J EXP MED, V141, P709; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Duranton J, 2000, J BIOL CHEM, V275, P3787, DOI 10.1074/jbc.275.6.3787; Farley K, 2012, J IMMUNOL, V189, P4574, DOI 10.4049/jimmunol.1201167; Frank D, 2019, CELL DEATH DIFFER, V26, P99, DOI 10.1038/s41418-018-0212-6; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hoppenbrouwers T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176472; Kambara H, 2018, CELL REP, V22, P2924, DOI 10.1016/j.celrep.2018.02.067; Kasperkiewicz P, 2017, J AM CHEM SOC, V139, P10115, DOI 10.1021/jacs.7b04394; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P2653, DOI 10.1016/B978-0-12-382219-2.00587-1; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; O'Donoghue AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075141; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Salvesen GS, 2016, FEBS J, V283, P2577, DOI 10.1111/febs.13616; Salvesen GS, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P2661, DOI 10.1016/B978-0-12-382219-2.00588-3; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vande Walle L, 2016, CURR BIOL, V26, pR568, DOI 10.1016/j.cub.2016.02.019; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Zabieglo K, 2015, J LEUKOCYTE BIOL, V98, P99, DOI 10.1189/jlb.4AB1114-543R	40	13	13	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17624	17631		10.1074/jbc.RA120.015682	http://dx.doi.org/10.1074/jbc.RA120.015682			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454002	Green Published, hybrid			2022-12-28	WOS:000603272300018
J	Castel, P; Holtz-Morris, A; Kwon, Y; Suter, BP; McCormick, F				Castel, Pau; Holtz-Morris, Ann; Kwon, Yongwon; Suter, Bernhard P.; McCormick, Frank			DoMY-Seq: A yeast two-hybrid-based technique for precision mapping of protein-protein interaction motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; RAS; KINASE; BINDING; P53; MDM2; BRAF; IDENTIFICATION; ACTIVATION; GENERATION	Interactions between proteins are fundamental for every biological process and especially important in cell signaling pathways. Biochemical techniques that evaluate these protein-protein interactions (PPIs), such as in vitro pull downs and coimmunoprecipitations, have become popular in most laboratories and are essential to identify and validate novel protein binding partners. Most PPIs occur through small domains or motifs, which are challenging and laborious to map by using standard biochemical approaches because they generally require the cloning of several truncation mutants. Moreover, these classical methodologies provide limited resolution of the interacting interface. Here, we describe the development of an alternative technique to overcome these limitations termed "Protein Domain mapping using Yeast 2 Hybrid-Next Generation Sequencing" (DoMY-Seq), which leverages both yeast two-hybrid and next-generation sequencing techniques. In brief, our approach involves creating a library of fragments derived from an open reading frame of interest and enriching for the interacting fragments using a yeast two-hybrid reporter system. Next-generation sequencing is then subsequently employed to read and map the sequence of the interacting fragment, yielding a high-resolution plot of the binding interface. We optimized DoMY-Seq by taking advantage of the well-described and high-affinity interaction between KRAS and CRAF, and we provide high-resolution domain mapping on this and other protein-interacting pairs, including CRAF-MEK1, RIT1-RGL3, and p53-MDM2. Thus, DoMY-Seq provides an unbiased alternative method to rapidly identify the domains involved in PPIs by advancing the use of yeast two-hybrid technology.	[Castel, Pau; McCormick, Frank] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Holtz-Morris, Ann; Kwon, Yongwon; Suter, Bernhard P.] Next Interact, Richmond, CA USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Castel, P (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	Pau.castel@ucsf.edu		Castel, Pau/0000-0002-4972-4347	NIH/NCI [R35CA197709-01]; NCI K99/R00 Pathway to Independence Award [K99CA245122]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI K99/R00 Pathway to Independence Award	Funding was provided by the NIH/NCI grant R35CA197709-01 (to F. M.). P. C.'s work is supported by the NCI K99/R00 Pathway to Independence Award (K99CA245122). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; Bonetta L, 2010, NATURE, V468, P851, DOI [10.1038/468851a, 10.1038/468854a, 10.1038/468852a]; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Castel P, 2019, SCIENCE, V363, P1226, DOI 10.1126/science.aav1444; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Erffelinck ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201270; GIBBS JB, 1987, J BIOL CHEM, V262, P10426; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; He Runtao, 2008, V439, P327, DOI 10.1007/978-1-59745-188-8_22; Karoulia Z, 2017, NAT REV CANCER, V17, P676, DOI 10.1038/nrc.2017.79; Karoulia Z, 2016, CANCER CELL, V30, P485, DOI 10.1016/j.ccell.2016.06.024; Khazak V, 2005, METH MOL B, V310, P253; Kiel C, 2008, ANNU REV BIOCHEM, V77, P415, DOI 10.1146/annurev.biochem.77.062706.133317; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Li Q, 2013, CLIN CANCER RES, V19, P34, DOI 10.1158/1078-0432.CCR-12-0053; Lin DTS, 2017, BIOCHEM SOC T, V45, P913, DOI 10.1042/BST20160303; Luck K., 2019, REFERENCE MAP HUMAN, DOI 10.1101/605451; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Mehla Jitender, 2015, Cold Spring Harb Protoc, V2015, P425, DOI 10.1101/pdb.top083345; Miura K, 2018, PROTEIN PEPTIDE LETT, V25, P728, DOI 10.2174/0929866525666180821122240; Modell AE, 2016, TRENDS PHARMACOL SCI, V37, P702, DOI 10.1016/j.tips.2016.05.008; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; MURPHY E, 1985, MOL GEN GENET, V200, P33, DOI 10.1007/BF00383309; Park E, 2019, NATURE, V575, P545, DOI 10.1038/s41586-019-1660-y; Pickar-Oliver A, 2019, NAT REV MOL CELL BIO, V20, P490, DOI 10.1038/s41580-019-0131-5; Piskacek M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162842; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Ryan DP, 2005, CURR OPIN STRUC BIOL, V15, P441, DOI 10.1016/j.sbi.2005.06.001; SCHEFFLER JE, 1994, J BIOL CHEM, V269, P22340; Shao HP, 2000, J BIOL CHEM, V275, P26914; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Suter B, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00346; Thevakumaran N, 2015, NAT STRUCT MOL BIOL, V22, P37, DOI 10.1038/nsmb.2924; Trigg SA, 2017, NAT METHODS, V14, P819, DOI [10.1038/nmeth.4343, 10.1038/NMETH.4343]; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Winkler DG, 1998, J BIOL CHEM, V273, P21578, DOI 10.1074/jbc.273.34.21578; Wong JH, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0446-7; Xia YZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1189; Xing SP, 2016, PLANT PHYSIOL, V171, P727, DOI 10.1104/pp.16.00470; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]	53	4	4	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100023	10.1074/jbc.RA120.014284	http://dx.doi.org/10.1074/jbc.RA120.014284			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33410398	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400008
J	Chiu, W; Schmid, MF; Pintilie, GD; Lawson, CL				Chiu, Wah; Schmid, Michael F.; Pintilie, Grigore D.; Lawson, Catherine L.			Evolution of standardization and dissemination of cryo-EM structures and data jointly by the community, PDB, and EMDB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RESOLUTION ELECTRON-MICROSCOPY; ACETYLCHOLINE-RECEPTOR; PURPLE MEMBRANE; ATOMIC MODEL; VIRUS; VALIDATION; COMPLEX; PROTEIN; MICROGRAPHS; FROZEN	Cryogenic electronmicroscopy (cryo-EM) methods began to be used in the mid-1970s to study thin and periodic arrays of proteins. Following a half-century of development in cryo-specimen preparation, instrumentation, data collection, data processing, andmodeling software, cryo-EMhas become a routine method for solving structures from large biological assemblies to small biomolecules at near to true atomic resolution. This review explores the critical roles played by the Protein Data Bank (PDB) and Electron Microscopy Data Bank (EMDB) in partnership with the community to develop the necessary infrastructure to archive cryo-EM maps and associated models. Public access to cryo-EM structure data has in turn facilitated better understanding of structure-function relationships and advancement of image processing and modeling tool development. The partnership between the global cryo-EM community and PDB and EMDB leadership has synergistically shaped the standards for metadata, one-stop deposition of maps and models, and validation metrics to assess the quality of cryo-EM structures. The advent of cryoelectron tomography (cryo-ET) for in situ molecular cell structures at a broad resolution range and their correlations with other imaging data introduce new data archival challenges in terms of data size and complexity in the years to come.	[Chiu, Wah; Pintilie, Grigore D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chiu, Wah; Schmid, Michael F.] Stanford Univ, SLAC Natl Accelerator Lab, Div CryoEM & Bioimaging, Menlo Pk, CA 94025 USA; [Lawson, Catherine L.] Rutgers State Univ, Inst Quantitat Biomed & Res Collaboratory Struct, Piscataway, NJ USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Rutgers State University New Brunswick	Chiu, W (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Chiu, W (corresponding author), Stanford Univ, SLAC Natl Accelerator Lab, Div CryoEM & Bioimaging, Menlo Pk, CA 94025 USA.	wahc@stanford.edu		Pintilie, Grigore/0000-0002-0848-5335; Schmid, Michael/0000-0003-1077-5750	National Institutes of Health [R01GM079429]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research has been supported by National Institutes of Health (R01GM079429). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank Drs Helen Berman, Ardan Patwardhan, Gerard Kleywegt, and Kim Henrick for their continuous support, collaboration, and advice.	ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; BAUMEISTER W, 1976, ULTRAMICROSCOPY, V1, P377, DOI 10.1016/0304-3991(76)90052-8; Berman HM, 2018, Q REV BIOPHYS, V51, DOI 10.1017/S0033583518000057; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Chen LF, 2002, J STRUCT BIOL, V138, P92, DOI 10.1016/S1047-8477(02)00013-8; Chen M, 2019, NAT METHODS, V16, P1161, DOI 10.1038/s41592-019-0591-8; Chen M, 2017, NAT METHODS, V14, P983, DOI [10.1038/NMETH.4405, 10.1038/nmeth.4405]; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; Dahlberg PD, 2020, P NATL ACAD SCI USA, V117, P13937, DOI 10.1073/pnas.2001849117; Dai W, 2013, NATURE, V502, P707, DOI 10.1038/nature12604; DUBOCHET J, 1982, J MICROSC-OXFORD, V128, P219, DOI 10.1111/j.1365-2818.1982.tb04625.x; DUBOCHET J, 1981, J MICROSC-OXFORD, V124, pRP3; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; GLAESER RM, 1971, J ULTRA MOL STRUCT R, V36, P466, DOI 10.1016/S0022-5320(71)80118-1; Glaeser RM, 2019, ANNU REV BIOPHYS, V48, P45, DOI 10.1146/annurev-biophys-070317-032828; Gore S, 2017, STRUCTURE, V25, P1916, DOI 10.1016/j.str.2017.10.009; Grimes JM, 1997, STRUCTURE, V5, P885, DOI 10.1016/S0969-2126(97)00243-8; HAYWARD SB, 1981, J MOL BIOL, V151, P491, DOI 10.1016/0022-2836(81)90007-3; Henderson R, 2004, Q REV BIOPHYS, V37, P3, DOI 10.1017/S0033583504003920; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; HENDERSON R, 1985, ULTRAMICROSCOPY, V16, P139, DOI 10.1016/0304-3991(85)90069-5; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Henrick K, 2003, J STRUCT BIOL, V144, P228, DOI 10.1016/j.jsb.2003.09.009; Hewat EA, 1997, EMBO J, V16, P1492, DOI 10.1093/emboj/16.7.1492; Iudin A, 2016, NAT METHODS, V13, P387, DOI 10.1038/nmeth.3806; JENG TW, 1984, J MOL BIOL, V175, P93, DOI 10.1016/0022-2836(84)90449-2; JENG TW, 1983, J MOL BIOL, V164, P329, DOI 10.1016/0022-2836(83)90080-3; JENG TW, 1989, J MOL BIOL, V205, P251, DOI 10.1016/0022-2836(89)90379-3; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Kryshtafovych A, 2018, DATA BRIEF, V20, P1629, DOI 10.1016/j.dib.2018.08.214; Kryshtafovych A, 2018, J STRUCT BIOL, V204, P96, DOI 10.1016/j.jsb.2018.07.006; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; KUO IAM, 1975, ULTRAMICROSCOPY, V1, P53, DOI 10.1016/S0304-3991(75)80007-6; Lawson CL, 2021, NAT METHODS, V18, P156, DOI 10.1038/s41592-020-01051-w; Lawson CL, 2020, STRUCT DYNAM-US, V7, DOI 10.1063/1.5138589; Lawson CL, 2018, J STRUCT BIOL, V204, P523, DOI 10.1016/j.jsb.2018.10.004; Lawson CL, 2011, NUCLEIC ACIDS RES, V39, pD456, DOI 10.1093/nar/gkq880; LEPAULT J, 1983, J MICROSC-OXFORD, V129, P89, DOI 10.1111/j.1365-2818.1983.tb04163.x; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 2008, STRUCTURE, V16, P441, DOI 10.1016/j.str.2008.02.007; Ludtke SJ, 2012, BIOPOLYMERS, V97, P651, DOI 10.1002/bip.22081; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; McMullan G, 2014, ULTRAMICROSCOPY, V147, P156, DOI 10.1016/j.ultramic.2014.08.002; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nakane T, 2020, NATURE, V587, P152, DOI 10.1038/s41586-020-2829-0; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Orlova EV, 1996, NAT STRUCT BIOL, V3, P547, DOI 10.1038/nsb0696-547; Pintilie G, 2020, NAT METHODS, V17, P328, DOI 10.1038/s41592-020-0731-1; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109; Roh SH, 2017, P NATL ACAD SCI USA, V114, P8259, DOI 10.1073/pnas.1704725114; SAXTON WO, 1977, ULTRAMICROSCOPY, V2, P219; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Scheres SHW, 2010, METHOD ENZYMOL, V482, P295, DOI 10.1016/S0076-6879(10)82012-9; Schmid MF, 2004, NATURE, V431, P104, DOI 10.1038/nature02881; TALMON Y, 1987, J VIROL, V61, P2319, DOI 10.1128/JVI.61.7.2319-2321.1987; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0; Wang Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5808; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Wu GH, 2020, STRUCTURE, V28, P1231, DOI 10.1016/j.str.2020.07.017; Yip KM, 2020, NATURE, V587, P157, DOI 10.1038/s41586-020-2833-4; Young JY, 2017, STRUCTURE, V25, P536, DOI 10.1016/j.str.2017.01.004; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang KM, 2020, CELL RES, V30, P1136, DOI 10.1038/s41422-020-00432-2; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zhou ZH, 2000, SCIENCE, V288, P877, DOI 10.1126/science.288.5467.877	77	7	7	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100560	10.1016/j.jbc.2021.100560	http://dx.doi.org/10.1016/j.jbc.2021.100560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744287	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400533
J	Cho, H; Shim, WJ; Liu, YM; Shan, SO				Cho, Hyunju; Shim, Woo Jun; Liu, Yumeng; Shan, Shu-ou			J-domain proteins promote client relay from Hsp70 during tail-anchored membrane protein targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; ATPASE ACTIVITY; CHAPERONE YDJ1; SUBSTRATE; COCHAPERONE; NETWORK; DNAK; TRANSLOCATION; MECHANISM; INSERTION	J-domain proteins (JDPs) play essential roles in Hsp70 function by assisting Hsp70 in client trapping and regulating the Hsp70 ATPase cycle. Here, we report that JDPs can further enhance the targeting competence of Hsp70-bound client proteins during tail-anchored protein (TA) biogenesis. In the guided-entry-of-tail-anchored protein pathway in yeast, nascent TAs are captured by cytosolic Hsp70 and sequentially relayed to downstream chaperones, Sgt2 and Get3, for delivery to the ER. We found that two JDPs, Ydj1 and Sis1, function in parallel to support TA targeting to the ER in vivo. Biochemical analyses showed that, while Ydj1 and Sis1 differ in their ability to assist Hsp70 in TA trapping, both JDPs enhance the transfer of Hsp70-bound TAs to Sgt2. The ability of the JDPs to regulate the ATPase cycle of Hsp70 is essential for enhancing the transfer competence of Hsp70-bound TAs in vitro and for supporting TA insertion in vivo. These results demonstrate a role of JDPs in regulating the conformation of Hsp70-bound clients during membrane protein biogenesis.	[Cho, Hyunju; Shim, Woo Jun; Liu, Yumeng; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	sshan@caltech.edu		Shim, Woo Jun/0000-0001-9596-7393	NIH [R01 GM107368, R35 GM136321]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R01 GM107368 and R35 GM136321 to S. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aprile FA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08324-z; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Banerjee R, 2016, FEBS J, V283, P2853, DOI 10.1111/febs.13769; Barthel TK, 2001, J BACTERIOL, V183, P5482, DOI 10.1128/JB.183.19.5482-5490.2001; Becker J, 1996, MOL CELL BIOL, V16, P4378; Becker T, 2019, TRENDS CELL BIOL, V29, P534, DOI 10.1016/j.tcb.2019.03.007; Borgese N, 2019, PROTEIN J, V38, P289, DOI 10.1007/s10930-019-09845-4; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; Chio US, 2017, ANNU REV CELL DEV BI, V33, P417, DOI 10.1146/annurev-cellbio-100616-060839; Cho HJ, 2018, EMBO J, V37, DOI 10.15252/embj.201899264; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Craig EA, 2018, BMC BIOL, V16, DOI 10.1186/s12915-017-0474-3; Craig EA, 2017, TRENDS BIOCHEM SCI, V42, P355, DOI 10.1016/j.tibs.2017.02.007; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Gowda NKC, 2018, NAT STRUCT MOL BIOL, V25, P83, DOI 10.1038/s41594-017-0008-2; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Imamoglu R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14245-4; Jiang YJ, 2019, SCIENCE, V365, P1313, DOI 10.1126/science.aax1280; Jores T, 2018, J CELL BIOL, V217, P3091, DOI 10.1083/jcb.201712029; Kampinga HH, 2019, CELL STRESS CHAPERON, V24, P7, DOI 10.1007/s12192-018-0948-4; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; Kota P, 2009, P NATL ACAD SCI USA, V106, P11073, DOI 10.1073/pnas.0900746106; Krantz KC, 2013, J BIOL CHEM, V288, P26721, DOI 10.1074/jbc.M113.491753; Lai AL, 2017, J BIOL CHEM, V292, P8773, DOI 10.1074/jbc.M116.770404; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Opalinski L, 2018, CELL REP, V25, P2036, DOI 10.1016/j.celrep.2018.10.083; Papic D, 2013, MOL CELL BIOL, V33, P4083, DOI 10.1128/MCB.00227-13; Powis K, 2013, J CELL SCI, V126, P473, DOI 10.1242/jcs.112151; Rao M, 2016, ELIFE, V5, DOI 10.7554/eLife.21301; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Sahi C, 2010, MOL CELL BIOL, V30, P33, DOI 10.1128/MCB.00842-09; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; WALL D, 1994, J BIOL CHEM, V269, P5446; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Weyer FA, 2017, NAT STRUCT MOL BIOL, V24, P144, DOI 10.1038/nsmb.3349; Wu S, 2020, P NATL ACAD SCI USA, V117, P7814, DOI 10.1073/pnas.1914376117; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yu HY, 2015, J MOL BIOL, V427, P1632, DOI 10.1016/j.jmb.2015.02.007; ZIEGELHOFFER T, 1995, J BIOL CHEM, V270, P10412, DOI 10.1074/jbc.270.18.10412	59	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100546	10.1016/j.jbc.2021.100546	http://dx.doi.org/10.1016/j.jbc.2021.100546			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33741343	Green Accepted, Green Published, gold			2022-12-28	WOS:000672866400519
J	Gagnon, M; Savard, M; Jacques, JF; Bkaily, G; Geha, S; Roucou, X; Gobeil, F				Gagnon, Maxime; Savard, Martin; Jacques, Jean-Francois; Bkaily, Ghassan; Geha, Sameh; Roucou, Xavier; Gobeil, Fernand			Potentiation of B2 receptor signaling by AltB2R, a newly identified alternative protein encoded in the human bradykinin B2 receptor gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KININ RECEPTORS; READING FRAMES; CANCER; CLASSIFICATION; AGONISTS; TARGETS	Recent functional and proteomic studies in eukaryotes (www.openprot.org) predict the translation of alternative open reading frames (AltORFs) in mature G-protein-coupled receptor (GPCR) mRNAs, including that of bradykinin B2 receptor (B2R). Our main objective was to determine the implication of a newly discovered AltORF resulting protein, termed AltB2R, in the known signaling properties of B2R using complementary methodological approaches. When ectopically expressed in HeLa cells, AltB2R presented predominant punctate cytoplasmic/perinuclear distribution and apparent cointeraction with B2R at plasma and endosomal/vesicular membranes. The presence of AltB2R increases intracellular [Ca2+] and ERK1/2-MAPK activation (via phosphorylation) following B2R stimulation. Moreover, HEK293A cells expressing mutant B2R lacking concomitant expression of AltB2R displayed significantly decreased maximal responses in agonist-stimulated G alpha(q)-G alpha(i2/3)-protein coupling, IP3 generation, and ERK1/2-MAPK activation as compared with wild-type controls. Conversely, there was no difference in cell-surface density as well as ligand-binding properties of B2R and in efficiencies of cognate agonists at promoting B2R internalization and beta-arrestin 2 recruitment. Importantly, both AltB2R and B2R proteins were overexpressed in prostate and breast cancers, compared with their normal counterparts suggesting new associative roles of AltB2R in these diseases. Our study shows that BDKRB2 is a dual-coding gene and identifies AltB2R as a novel positive modulator of some B2R signaling pathways. More broadly, it also supports a new, unexpected alternative proteome for GPCRs, which opens new frontiers in fields of GPCR biology, diseases, and drug discovery.	[Gagnon, Maxime; Roucou, Xavier] Univ Sherbrooke, Dept Biochem, Sherbrooke, PQ, Canada; [Gagnon, Maxime; Savard, Martin; Roucou, Xavier; Gobeil, Fernand] Univ Sherbrooke, Inst Pharmacol, Sherbrooke, PQ, Canada; [Savard, Martin; Jacques, Jean-Francois; Gobeil, Fernand] Univ Sherbrooke, Dept Pharmacol & Physiol, Sherbrooke, PQ, Canada; [Bkaily, Ghassan] Univ Sherbrooke, Dept Immunol & Cellular Biol, Sherbrooke, PQ, Canada; [Geha, Sameh] Ctr Hosp Univ Sherbrooke, Dept Pathol, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Roucou, X (corresponding author), Univ Sherbrooke, Dept Biochem, Sherbrooke, PQ, Canada.; Roucou, X; Gobeil, F (corresponding author), Univ Sherbrooke, Inst Pharmacol, Sherbrooke, PQ, Canada.; Gobeil, F (corresponding author), Univ Sherbrooke, Dept Pharmacol & Physiol, Sherbrooke, PQ, Canada.	Xavier.Roucou@USherbrooke.ca; Fernand.Gobeil@USherbrooke.ca		GEHA, Sameh/0000-0002-4851-9034	Canadian Institutes of Health Research [MOP-136962]; Canada Research Chair in Functional Proteomics and Discovery of Novel Proteins; PROTEO, Quebec Network; Fonds de Recherche du Quebec Sante (FRQS)-funded Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Functional Proteomics and Discovery of Novel Proteins; PROTEO, Quebec Network; Fonds de Recherche du Quebec Sante (FRQS)-funded Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke	This work was supported by the Canadian Institutes of Health Research Grant MOP-136962 (to F. G. and X. R.) and the Canada Research Chair in Functional Proteomics and Discovery of Novel Proteins (X. R.). M. G. is a former graduate scholarship recipient of the PROTEO, Quebec Network. G. B., S. G., X. R., and F. G. are members of the Fonds de Recherche du Quebec Sante (FRQS)-funded Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke.	Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; Akimoto C, 2013, BBA-GEN SUBJECTS, V1830, P2728, DOI 10.1016/j.bbagen.2012.12.010; Alla SA, 1996, J BIOL CHEM, V271, P1748, DOI 10.1074/jbc.271.3.1748; Anderson DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaj1460; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Bausch-Fluck D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121314; Belanger S, 2009, PEPTIDES, V30, P777, DOI 10.1016/j.peptides.2008.12.003; Bergeron D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.472654; Bkaily G, 1997, MOL CELL BIOCHEM, V172, P171, DOI 10.1023/A:1006840228104; Bkaily G, 2017, METHODS MOL BIOL, V1527, P177, DOI 10.1007/978-1-4939-6625-7_14; Blaukat A, 2003, ANDROLOGIA, V35, P17, DOI 10.1046/j.1439-0272.2003.00533.x; Brule C, 2014, FASEB J, V28, P5148, DOI 10.1096/fj.14-249771; Brunet MA, 2019, NUCLEIC ACIDS RES, V47, pD403, DOI 10.1093/nar/gky936; Brunet MA, 2018, GENOME RES, V28, P609, DOI 10.1101/gr.230938.117; Cabrera-Quio LE, 2016, RNA BIOL, V13, P1051, DOI 10.1080/15476286.2016.1218589; Campbell DJ, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00257; Cardon T, 2020, ANAL CHEM, V92, P1122, DOI 10.1021/acs.analchem.9b04188; Chalick M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165031; Chu Q, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12816-z; Cote J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037485; Cote J, 2009, PEPTIDES, V30, P788, DOI 10.1016/j.peptides.2008.12.018; Couso JP, 2017, NAT REV MOL CELL BIO, V18, P575, DOI 10.1038/nrm.2017.58; Couture R, 2014, CURR VASC PHARMACOL, V12, P223, DOI 10.2174/1570161112666140226121627; D'Lima NG, 2017, NAT CHEM BIOL, V13, P174, DOI [10.1038/NCHEMBIO.2249, 10.1038/nchembio.2249]; da Costa PLN, 2014, CANCER LETT, V345, P27, DOI 10.1016/j.canlet.2013.12.009; Delcourt V, 2017, EBIOMEDICINE, V21, P55, DOI 10.1016/j.ebiom.2017.06.001; Dubuc Celena, 2018, Oncotarget, V9, P9885, DOI 10.18632/oncotarget.24009; Figueroa CD, 2012, EXPERT OPIN THER TAR, V16, P299, DOI 10.1517/14728222.2012.662957; Furuno M, 2003, GENOME RES, V13, P1478, DOI 10.1101/gr.1060303; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hellens RP, 2016, TRENDS PLANT SCI, V21, P317, DOI 10.1016/j.tplants.2015.11.005; Khoury E, 2014, J BIOL CHEM, V289, P23302, DOI 10.1074/jbc.M114.568147; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Lee CF, 2014, J BIOL CHEM, V289, P1257, DOI 10.1074/jbc.M113.509059; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Leschner J, 2013, J PHARMACOL EXP THER, V344, P85, DOI 10.1124/jpet.112.199190; Liu J, 2014, AM J PHYSIOL-REG I, V306, pR619, DOI 10.1152/ajpregu.00562.2013; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Mouilleron H, 2016, NUCLEIC ACIDS RES, V44, P14, DOI 10.1093/nar/gkv1218; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Nesvizhskii AI, 2014, NAT METHODS, V11, P1114, DOI [10.1038/NMETH.3144, 10.1038/nmeth.3144]; Olexiouk V, 2018, NUCLEIC ACIDS RES, V46, pD497, DOI 10.1093/nar/gkx1130; Orr MW, 2020, NUCLEIC ACIDS RES, V48, P1029, DOI 10.1093/nar/gkz734; QUELLE DE, 1995, CELL, V83, P993; Rathore A, 2018, BIOCHEMISTRY-US, V57, P5564, DOI 10.1021/acs.biochem.8b00726; Regoli D, 1998, EUR J PHARMACOL, V348, P1, DOI 10.1016/S0014-2999(98)00165-4; Regoli D, 2012, PHARMACOL THERAPEUT, V135, P94, DOI 10.1016/j.pharmthera.2012.04.002; Samandi S, 2017, ELIFE, V6, DOI [10.7754/eLife.27860, 10.7554/eLife.27860]; Savard M, 2016, BIOL CHEM, V397, P365, DOI 10.1515/hsz-2015-0246; Shenoy SK, 2005, NAT CELL BIOL, V7, P1159, DOI 10.1038/ncb1205-1159; Vanderperre B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070698; Vanderperre B, 2011, FASEB J, V25, P2373, DOI 10.1096/fj.10-173815; Wang GJ, 2017, J CELL BIOCHEM, V118, P4444, DOI 10.1002/jcb.26100; Yeasmin F, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00144; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016	59	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100329	10.1016/j.jbc.2021.100329	http://dx.doi.org/10.1016/j.jbc.2021.100329			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33497625	Green Published, gold			2022-12-28	WOS:000672866400303
J	Gutbrod, P; Yang, WT; Grujicic, GV; Peisker, H; Gutbrod, K; Du, LF; Dormann, P				Gutbrod, Philipp; Yang, Wentao; Grujicic, Goran Vuk; Peisker, Helga; Gutbrod, Katharina; Du, Lin Fang; Doermann, Peter			Phytol derived from chlorophyll hydrolysis in plants is metabolized via phytenal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS LEAVES; PHOTOSYSTEM-I; IDENTIFICATION; BREAKDOWN; CHAIN; DEFICIENCY; SENESCENCE; OXIDATION; PATHWAY; GROWTH	Phytol is the isoprenoid alcohol bound in ester linkage to chlorophyll, the most abundant photosynthetic pigment in plants. During leaf senescence, large amounts of phytol are released by chlorophyll degradation. However, the pathway of phytol catabolism in plants is unknown. We hypothesized that phytol degradation in plants might involve its oxidation into the long-chain aldehyde phytenal. Using GC-MS for aldehyde quantification after derivatization with methylhydroxylamine, phytenal was identified in leaves, whereas other long-chain aldehydes (phytanal and pristanal) were barely detectable. We found that phytenal accumulates during chlorotic stresses, for example, salt stress, dark-induced senescence, and nitrogen deprivation. The increase in the phytenal content is mediated at least in part independently of enzyme activities, and it is independent of light. Characterization of phytenal accumulation in the pao1 mutant affected in chlorophyll degradation revealed that phytenal is an authentic phytol metabolite derived from chlorophyll breakdown. The increase in phytenal was even stronger in mutants affected in the production of other phytol metabolites including vte5-2 (tocopherol deficient) and pes1 pes2 (fatty acid phytyl ester deficient). Therefore, phytenal accumulation is controlled by competing, alternative pathways of phosphorylation (leading to tocopherol production) or esterification (fatty acid phytyl ester production). As a consequence, the content of phytenal is maintained at low levels, presumably to minimize its toxic effects caused by its highly reactive aldehyde group that can form covalent bonds with and inactivate the amino groups of proteins.	[Gutbrod, Philipp; Yang, Wentao; Grujicic, Goran Vuk; Peisker, Helga; Gutbrod, Katharina; Doermann, Peter] Univ Bonn, Inst Mol Physiol & Biotechnol Plants IMBIO, Bonn, Germany; [Yang, Wentao; Du, Lin Fang] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Peoples R China	University of Bonn; Sichuan University	Dormann, P (corresponding author), Univ Bonn, Inst Mol Physiol & Biotechnol Plants IMBIO, Bonn, Germany.; Du, LF (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Peoples R China.	dulinfang@scu.edu.cn; doermann@uni-bonn.de		Dormann, Peter/0000-0002-5845-9370	University of Bonn; China Government Scholarship Council (CSC) of the P.R. China [201606240026]	University of Bonn; China Government Scholarship Council (CSC) of the P.R. China	P. G. and W. Y. were supported by University of Bonn. Furthermore, W. Y. received funding from the China Government Scholarship Council (CSC) of the P.R. China (Grant No. 201606240026).	Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; Gaude N, 2007, PLANT J, V49, P729, DOI 10.1111/j.1365-313X.2006.02992.x; GELLERMAN JL, 1975, BIOCHIM BIOPHYS ACTA, V388, P277, DOI 10.1016/0005-2760(75)90133-2; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; Ischebeck T, 2006, J BIOL CHEM, V281, P2470, DOI 10.1074/jbc.M509222200; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Lin YP, 2016, PLANT CELL, V28, P2974, DOI 10.1105/tpc.16.00478; Lippold F, 2012, PLANT CELL, V24, P2001, DOI 10.1105/tpc.112.095588; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Mishev K, 2009, PLANT GROWTH REGUL, V58, P61, DOI 10.1007/s10725-008-9352-x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKAJIMA K, 1974, AGR BIOL CHEM TOKYO, V38, P1859, DOI 10.1080/00021369.1974.10861446; Nass R, 1998, PHYTOCHEM ANALYSIS, V9, P112, DOI 10.1002/(SICI)1099-1565(199805/06)9:3&lt;112::AID-PCA400&gt;3.0.CO;2-A; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pruzinska A, 2005, PLANT PHYSIOL, V139, P52, DOI 10.1104/pp.105.065870; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rontani JF, 1996, PHYTOCHEMISTRY, V42, P347, DOI 10.1016/0031-9422(95)00872-1; SAKAMOTO T, 1992, J ORG CHEM, V57, P3245, DOI 10.1021/jo00037a053; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Shimada H, 2005, PLANT J, V41, P627, DOI 10.1111/j.1365-313X.2004.02326.x; Stiti N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00065; Valentin HE, 2006, PLANT CELL, V18, P212, DOI 10.1105/tpc.105.037077; Verhoeven NM, 1997, BIOCHEM BIOPH RES CO, V237, P33, DOI 10.1006/bbrc.1997.7066; vom Dorp K, 2015, PLANT CELL, V27, P2846, DOI 10.1105/tpc.15.00395; Wanders RJA, 2011, BBA-MOL CELL BIOL L, V1811, P498, DOI 10.1016/j.bbalip.2011.06.006; Weaver LM, 2001, PLANT PHYSIOL, V127, P876, DOI 10.1104/pp.010312; Zbierzak AM, 2010, BIOCHEM J, V425, P389, DOI 10.1042/BJ20090704	28	3	3	4	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100530	10.1016/j.jbc.2021.100530	http://dx.doi.org/10.1016/j.jbc.2021.100530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713704	Green Published, gold			2022-12-28	WOS:000672866400504
J	Hocky, GM; Sindelar, CV; Cao, WX; Voth, GA; De La Cruz, EM				Hocky, Glen M.; Sindelar, Charles, V; Cao, Wenxiang; Voth, Gregory A.; De La Cruz, Enrique M.			Structural basis of fast- and slow-severing actin-cofilactin boundaries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COFILIN-LINKED CHANGES; F-ACTIN; FILAMENTS; DYNAMICS; FLEXIBILITY; TWIST; DEPOLYMERIZATION; INCREASES; MECHANISM; KINETICS	Members of the ADF/cofilin family of regulatory proteins bind actin filaments cooperatively, locally change actin subunit conformation and orientation, and sever filaments at "boundaries" between bare and cofilin-occupied segments. A cluster of bound cofilin introduces two distinct classes of boundaries due to the intrinsic polarity of actin filaments, one at the "pointed" end side and the other at the "barbed" end-side of the cluster; severing occurs more readily at the pointed end side of the cluster ("fast-severing" boundary) than the barbed end side ("slow-severing" boundary). A recent electron-cryomicroscopy (cryo-EM) model of the slow-severing boundary revealed structural "defects" at the interface that potentially contribute to severing. However, the structure of the fast-severing boundary remains uncertain. Here, we use extensive molecular dynamics simulations to produce atomic resolution models of both severing boundaries. Our equilibrated simulation model of the slow-severing boundary is consistent with the cryo-EM structural model. Simulations indicate that actin subunits at both boundaries adopt structures intermediate between those of bare and cofilin-bound actin subunits. These "intermediate" states have compromised intersubunit contacts, but those at the slow-severing boundary are stabilized by cofilin bridging interactions, accounting for its lower fragmentation probability. Simulations where cofilin proteins are removed from cofilactin filaments favor a mechanism in which a cluster of two contiguously bound cofilins is needed to fully stabilize the cofilactin conformation, promote cooperative binding interactions, and accelerate filament severing. Together, these studies provide a molecular-scale foundation for developing coarse-grained and theoretical descriptions of cofilin-mediated actin filament severing.	[Hocky, Glen M.] NYU, Dept Chem, New York, NY 10003 USA; [Sindelar, Charles, V; Cao, Wenxiang; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Voth, Gregory A.] Univ Chicago, Dept Chem, Chicago Ctr Theoret Chem, Inst Biophys Dynam, Chicago, IL 60637 USA; [Voth, Gregory A.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA	New York University; Yale University; University of Chicago; University of Chicago	Hocky, GM (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.; De La Cruz, EM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA.	hockyg@nyu.edu; enrique.delacruz@yale.edu	Hocky, Glen M/E-9412-2012; Hocky, Glen M/AAD-7662-2019	Hocky, Glen M/0000-0002-5637-0698; De La Cruz, Enrique/0000-0003-4798-2892; Sindelar, Charles/0000-0002-6646-7776	DOD ARO MURI [W911NF1410403]; NIH [R01-GM-110530, R35-GM136656, R35-GM138312]	DOD ARO MURI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by DOD ARO MURI W911NF1410403, on which G. A. V. and E. M. D. L. C. are coinvestigators, and by NIH R35-GM136656 (awarded to E. M. D. L. C.). Support for G. M. H. was provided by NIH R35-GM138312. C. V. S. was supported by NIH R01-GM-110530.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bibeau JP, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166833; Bobkov AA, 2006, J MOL BIOL, V356, P325, DOI 10.1016/j.jmb.2005.11.072; Bonomi M, 2019, NAT METHODS, V16, P670, DOI 10.1038/s41592-019-0506-8; Chou SZ, 2019, P NATL ACAD SCI USA, V116, P4265, DOI 10.1073/pnas.1807028115; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; De La Cruz EM, 2015, J BIOL CHEM, V290, P17137, DOI 10.1074/jbc.R115.636472; De la Cruz EM, 2015, BIOPHYS J, V108, P2270, DOI 10.1016/j.bpj.2015.03.058; De La Cruz EM, 2010, BIOPHYS J, V98, P1893, DOI 10.1016/j.bpj.2010.01.023; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Dedova IV, 2004, BIOPHYS CHEM, V110, P119, DOI 10.1016/j.bpc.2004.01.009; Elam WA, 2017, J BIOL CHEM, V292, P19565, DOI 10.1074/jbc.M117.808378; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; Fan J, 2013, J MOL BIOL, V425, P1225, DOI 10.1016/j.jmb.2013.01.020; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Hocky GM, 2016, J PHYS CHEM B, V120, P4558, DOI 10.1021/acs.jpcb.6b02741; Huehn A, 2018, J BIOL CHEM, V293, P5377, DOI 10.1074/jbc.AC118.001843; Huehn AR, 2020, P NATL ACAD SCI USA, V117, P1478, DOI 10.1073/pnas.1915987117; Huehn AR, 2018, BIOPHYS J, V114, p145A, DOI 10.1016/j.bpj.2017.11.812; Jermyn AS, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.032409; Kang HR, 2014, P NATL ACAD SCI USA, V111, P17821, DOI 10.1073/pnas.1413397111; Lorenzo AMM, 2020, SOFT MATTER, V16, P2017, DOI 10.1039/c9sm01637f; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Ngo KX, 2015, ELIFE, V4, DOI 10.7554/eLife.04806; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Pollard T.D., 2016, CELL BIOL; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Saunders MG, 2014, BIOPHYS J, V106, P1710, DOI 10.1016/j.bpj.2014.03.012; Saunders MG, 2012, STRUCTURE, V20, P641, DOI 10.1016/j.str.2012.02.008; Schramm AC, 2019, BIOPHYS J, V117, P453, DOI 10.1016/j.bpj.2019.06.018; Schramm AC, 2017, BIOPHYS J, V112, P2624, DOI 10.1016/j.bpj.2017.05.016; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Tanaka K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04290-w; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Wioland H, 2017, CURR BIOL, V27, P1956, DOI 10.1016/j.cub.2017.05.048; Wong DY, 2011, J MOL BIOL, V413, P97, DOI 10.1016/j.jmb.2011.08.039	44	6	6	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100337	10.1016/j.jbc.2021.100337	http://dx.doi.org/10.1016/j.jbc.2021.100337			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33508320	Green Published, gold			2022-12-28	WOS:000672866400311
J	Horn, IP; Marks, DL; Koenig, AN; Hogenson, TL; Almada, LL; Goldstein, LE; Duran, PAR; Vera, R; Vrabel, AM; Cui, GF; Rabe, KG; Bamlet, WR; Mer, G; Sicotte, H; Zhang, C; Li, H; Petersen, GM; Fernandez-Zapico, ME				Horn, Isaac P.; Marks, David L.; Koenig, Amanda N.; Hogenson, Tara L.; Almada, Luciana L.; Goldstein, Lauren E.; Duran, Paola A. Romecin; Vera, Renzo; Vrabel, Anne M.; Cui, Gaofeng; Rabe, Kari G.; Bamlet, William R.; Mer, Georges; Sicotte, Hugues; Zhang, Cheng; Li, Hu; Petersen, Gloria M.; Fernandez-Zapico, Martin E.			A rare germline CDKN2A variant (47T > G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY MELANOMA UPDATE; FAMILIAL MELANOMA; MOLECULAR-DYNAMICS; SKIN FIBROBLASTS; LINE MUTATIONS; PRONE FAMILIES; P16(INK4A); GENES; RISK; P16	Germline mutations in CDKN2A, encoding the tumor suppressor p16, are responsible for a large proportion of familial melanoma cases and also increase risk of pancreatic cancer. We identified four families through pancreatic cancer probands that were affected by both cancers. These families bore a germline missense variant of CDKN2A (47T>G), encoding a p16-L16R mutant protein associated with high cancer occurrence. Here, we investigated the biological significance of this variant. When transfected into p16-null pancreatic cancer cells, p16-L16R was expressed at lower levels than wild-type (WT) p16. In addition, p16-L16R was unable to bind CDK4 or CDK6 compared with WT p16, as shown by coimmunoprecipitation assays and also was impaired in its ability to inhibit the cell cycle, as demonstrated by flow cytometry analyses. In silico molecular modeling predicted that the L16R mutation prevents normal protein folding, consistent with the observed reduction in expression/stability and diminished function of this mutant protein. We isolated normal dermal fibroblasts from members of the families expressing WT or L16R proteins to investigate the impact of endogenous p16-L16R mutant protein on cell growth. In culture, p16-L16R fibroblasts grew at a faster rate, and most survived until later passages than p16-WT fibroblasts. Further, western blotting demonstrated that p16 protein was detected at lower levels in p16-L16R than in p16-WT fibroblasts. Together, these results suggest that the presence of a CDKN2A (47T>G) mutant allele contributes to an increased risk of pancreatic cancer as a result of reduced p16 protein levels and diminished p16 tumor suppressor function.	[Horn, Isaac P.; Marks, David L.; Koenig, Amanda N.; Hogenson, Tara L.; Almada, Luciana L.; Goldstein, Lauren E.; Duran, Paola A. Romecin; Vera, Renzo; Vrabel, Anne M.; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55901 USA; [Cui, Gaofeng; Mer, Georges] Mayo Clin, Div Biochem & Mol Biol, Rochester, MN USA; [Rabe, Kari G.; Bamlet, William R.; Sicotte, Hugues] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Zhang, Cheng; Li, Hu] Mayo Clin, Div Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Petersen, Gloria M.] Mayo Clin, Div Epidemiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55901 USA.	fernandezzapico.martin@mayo.edu	Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578; Romecin Duran, Paola Alejandra/0000-0001-6890-5883	Rolfe Pancreatic Cancer Foundation [R01CA208517, P50CA102701, R01CA97075]	Rolfe Pancreatic Cancer Foundation	Grant support: R01CA208517, P50CA102701, R01CA97075, Rolfe Pancreatic Cancer Foundation. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Khalaf HH, 2018, MOL CANCER RES, V16, P1299, DOI 10.1158/1541-7786.MCR-18-0017; AZZARONE B, 1984, INT J CANCER, V33, P759, DOI 10.1002/ijc.2910330608; AZZARONE B, 1988, MUTAT RES, V199, P313, DOI 10.1016/0027-5107(88)90211-4; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bishop DT, 2002, J NATL CANCER I, V94, P894, DOI 10.1093/jnci/94.12.894; Boyle JM, 1999, BRIT J CANCER, V79, P1657, DOI 10.1038/sj.bjc.6690265; Brule CE, 2017, TRENDS GENET, V33, P283, DOI 10.1016/j.tig.2017.02.001; Buj R, 2019, MOL CELL ONCOL, V6, DOI 10.1080/23723556.2019.1677140; Byeon IJL, 1998, MOL CELL, V1, P421, DOI 10.1016/S1097-2765(00)80042-8; Chaffee KG, 2018, GENET MED, V20, P119, DOI 10.1038/gim.2017.85; Chang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101452; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Unamuno B, 2018, MELANOMA RES, V28, P246, DOI 10.1097/CMR.0000000000000442; Del Rey MJ, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0169-4; Dickson MA, 2014, CLIN CANCER RES, V20, P3379, DOI 10.1158/1078-0432.CCR-13-1551; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan MY, 2013, ONCOTARGET, V4, P128, DOI 10.18632/oncotarget.786; Freedberg DE, 2008, JNCI-J NATL CANCER I, V100, P784, DOI 10.1093/jnci/djn157; Funk JO, 1998, J CUTAN PATHOL, V25, P291, DOI 10.1111/j.1600-0560.1998.tb01748.x; Gast A, 2010, GENE CHROMOSOME CANC, V49, P733, DOI 10.1002/gcc.20785; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Goldstein AM, 2004, HUM MUTAT, V23, P630, DOI 10.1002/humu.9247; Goldstein AM, 2004, J MED GENET, V41, P421, DOI 10.1136/jmg.2004.019349; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hu CL, 2018, JAMA-J AM MED ASSOC, V319, P2401, DOI 10.1001/jama.2018.6228; Jenkins NC, 2013, J INVEST DERMATOL, V133, P1043, DOI 10.1038/jid.2012.401; Kannengiesser C, 2009, HUM MUTAT, V30, P564, DOI 10.1002/humu.20845; Lynch HT, 2002, CANCER-AM CANCER SOC, V94, P84, DOI 10.1002/cncr.10159; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McKenzie HA, 2010, HUM MUTAT, V31, P692, DOI 10.1002/humu.21245; McWilliams RR, 2018, CANCER EPIDEM BIOMAR, V27, P1364, DOI 10.1158/1055-9965.EPI-17-1065; McWilliams RR, 2011, EUR J HUM GENET, V19, P472, DOI 10.1038/ejhg.2010.198; Middlebrooks CD, 2019, CANCER RES, V79, P2992, DOI 10.1158/0008-5472.CAN-18-1580; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Petersen GM, 2016, SEMIN ONCOL, V43, P548, DOI 10.1053/j.seminoncol.2016.09.002; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; Sharpless NE, 2003, ONCOGENE, V22, P3092, DOI 10.1038/sj.onc.1206461; Solomon S, 2012, CANCER J, V18, P485, DOI 10.1097/PPO.0b013e318278c4a6; Soura E, 2016, J AM ACAD DERMATOL, V74, P395, DOI 10.1016/j.jaad.2015.08.038; Soura E, 2016, J AM ACAD DERMATOL, V74, P411, DOI 10.1016/j.jaad.2015.08.037	45	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100634	10.1016/j.jbc.2021.100634	http://dx.doi.org/10.1016/j.jbc.2021.100634			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33823155	Green Published, gold			2022-12-28	WOS:000672866400605
J	Li, A; Yuen, SL; Stroik, DR; Kleinboehl, E; Cornea, RL; Thomas, DD				Li, Ang; Yuen, Samantha L.; Stroik, Daniel R.; Kleinboehl, Evan; Cornea, Razvan L.; Thomas, David D.			The transmembrane peptide DWORF activates SERCA2a via dual mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLAMBAN; ISOFORMS; DYNAMICS; MUTANTS	The Ca-ATPase isoform 2a (SERCA2a) pumps cytosolic Ca2+ into the sarcoplasmic reticulum (SR) of cardiac myocytes, enabling muscle relaxation during diastole. Abnormally high cytosolic [Ca2+] is a central factor in heart failure, suggesting that augmentation of SERCA2a Ca2+ transport activity could be a promising therapeutic approach. SERCA2a is inhibited by the protein phospholamban (PLB), and a novel transmembrane peptide, dwarf open reading frame (DWORF), is proposed to enhance SR Ca2+ uptake and myocyte contractility by displacing PLB from binding to SERCA2a. However, establishing DWORF's precise physiological role requires further investigation. In the present study, we developed cell-based FRET biosensor systems that can report on protein-protein interactions and structural changes in SERCA2a complexes with PLB and/or DWORF. To test the hypothesis that DWORF competes with PLB to occupy the SERCA2a-binding site, we transiently transfected DWORF into a stable HEK cell line expressing SERCA2a labeled with a FRET donor and PLB labeled with a FRET acceptor. We observed a significant decrease in FRET efficiency, consistent with a decrease in the fraction of SERCA2a bound to PLB. Surprisingly, we also found that DWORF also activates SERCA's enzymatic activity directly in the absence of PLB at subsaturating calcium levels. Using site-directed mutagenesis, we generated DWORF variants that do not activate SERCA, thus identifying residues P15 and W22 as necessary for functional SERCA2a-DWORF interactions. This work advances our mechanistic understanding of the regulation of SERCA2a by small transmembrane proteins and sets the stage for future therapeutic development in heart failure research.	[Li, Ang; Yuen, Samantha L.; Stroik, Daniel R.; Kleinboehl, Evan; Cornea, Razvan L.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Thomas, DD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	DDT@ddt.umn.edu		Thomas, David D./0000-0002-8822-2040; Cornea, Razvan/0000-0001-5739-0992	NIH [R01HL139065, R37AG026160]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH grants R01HL139065 (to D. D. T. and R. L. C.; formerly R01GM027906) and R37AG026160 (to D. D. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Ceholski DK, 2018, J MOL CELL CARDIOL, V119, P147, DOI 10.1016/j.yjmcc.2018.05.007; Cornea RL, 2013, J BIOMOL SCREEN, V18, P97, DOI 10.1177/1087057112456878; Dode L, 2003, J BIOL CHEM, V278, P47877, DOI 10.1074/jbc.M306784200; Dong XQ, 2014, BIOCHEM BIOPH RES CO, V449, P196, DOI 10.1016/j.bbrc.2014.04.166; Gruber SJ, 2012, BIOCHEM BIOPH RES CO, V420, P236, DOI 10.1016/j.bbrc.2012.02.125; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Li J, 2012, J MOL BIOL, V418, P379, DOI 10.1016/j.jmb.2012.02.011; Liu ZH, 2020, HEART FAIL REV, V25, P523, DOI 10.1007/s10741-019-09873-3; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Makarewich CA, 2018, ELIFE, V7, DOI 10.7554/eLife.38319; McCarthy MR, 2020, BIOPHYS J, V118, P1090, DOI 10.1016/j.bpj.2020.01.010; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Schaaf TM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051170; Schaaf TM, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8040099; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Singh DR, 2019, J MOL BIOL, V431, P4429, DOI 10.1016/j.jmb.2019.07.037; Smeazzetto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052744; Smith KA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00517; Stammers AN, 2015, CAN J PHYSIOL PHARM, V93, P843, DOI 10.1139/cjpp-2014-0463; Stroik DR, 2020, J MOL CELL CARDIOL, V138, P59, DOI 10.1016/j.yjmcc.2019.11.147; Stroik DR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29685-z; THOMAS DD, 1994, PORTL PR P, P1	27	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100412	10.1016/j.jbc.2021.100412	http://dx.doi.org/10.1016/j.jbc.2021.100412			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581112	gold, Green Published			2022-12-28	WOS:000672866400386
J	Lopez-Soldado, I; Guinovart, JJ; Duran, J				Lopez-Soldado, Iliana; Guinovart, Joan J.; Duran, Jordi			Increasing hepatic glycogen moderates the diabetic phenotype in insulin-deficient Akita mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOKINASE OVEREXPRESSION; PROTEIN PHOSPHATASE-1; LEPTIN THERAPY; MIXED MEAL; GLUCOSE; METABOLISM; LIVER; RATS; HYPERGLYCEMIA; EXPRESSION	Hepatic glycogen metabolism is impaired in diabetes. We previously demonstrated that strategies to increase liver glycogen content in a high-fat-diet mouse model of obesity and insulin resistance led to a reduction in food intake and ameliorated obesity and glucose tolerance. These effects were accompanied by a decrease in insulin levels, but whether this decrease contributed to the phenotype observed in this animal was unclear. Here we sought to evaluate this aspect directly, by examining the long-term effects of increasing liver glycogen in an animal model of insulin-deficient and monogenic diabetes, namely the Akita mouse, which is characterized by reduced insulin production. We crossed Akita mice with animals overexpressing protein targeting to glycogen (PTG) in the liver to generate Akita mice with increased liver glycogen content (Akita-PTG(OE)). Akita-PTG(OE) animals showed lower glycemia, lower food intake, and decreased water consumption and urine output compared with Akita mice. Furthermore, Akita-PTG(OE) mice showed a restoration of the hepatic energy state and a normalization of gluconeogenesis and glycolysis back to nondiabetic levels. Moreover, hepatic lipogenesis, which is reduced in Akita mice, was reverted in Akita-PTG(OE) animals. These results demonstrate that strategies to increase liver glycogen content lead to the long-term reduction of the diabetic phenotype, independently of circulating insulin.	[Lopez-Soldado, Iliana; Guinovart, Joan J.; Duran, Jordi] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Lopez-Soldado, Iliana; Guinovart, Joan J.; Duran, Jordi] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biomed, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona	Lopez-Soldado, I (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain.; Lopez-Soldado, I (corresponding author), Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain.	iliana.lopez@irbbarcelona.org	Duran, Jordi/J-7298-2017; Duran, Jordi/AGP-2068-2022	Duran, Jordi/0000-0002-8342-4882	Severo Ochoa Award of Excellence from MINECO (Government of Spain); MINECO [BFU2017-84345-P]; CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministerio de Ciencia e Innovacion); "La Marato de TV3" Foundation (Barcelona, Spain) [201613-10]	Severo Ochoa Award of Excellence from MINECO (Government of Spain)(Spanish Government); MINECO(Spanish Government); CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministerio de Ciencia e Innovacion); "La Marato de TV3" Foundation (Barcelona, Spain)	IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). This study was supported by a grant BFU201784345-P from MINECO to J. G. and J. D., the CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministerio de Ciencia e Innovacion), and "La Marato de TV3" Foundation (Barcelona, Spain) (project 201613-10).	Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; Bischof MG, 2002, DIABETES, V51, P49, DOI 10.2337/diabetes.51.1.49; Bischof MG, 2001, DIABETES, V50, P392, DOI 10.2337/diabetes.50.2.392; BRICHARD SM, 1993, DIABETOLOGIA, V36, P292, DOI 10.1007/BF00400230; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; DULLAART RPF, 1995, NETH J MED, V46, P44, DOI 10.1016/0300-2977(94)00048-E; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fujikawa T, 2010, P NATL ACAD SCI USA, V107, P17391, DOI 10.1073/pnas.1008025107; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; Hu ZX, 2019, INT J BIOL MACROMOL, V128, P665, DOI 10.1016/j.ijbiomac.2019.01.186; HWANG JH, 1995, J CLIN INVEST, V95, P783, DOI 10.1172/JCI117727; Jiang SZ, 2019, J CELL MOL MED, V23, P5794, DOI 10.1111/jcmm.14504; Kramer KL, 1999, ARCH BIOCHEM BIOPHYS, V368, P291, DOI 10.1006/abbi.1999.1299; Lin ZF, 2012, J CLIN ENDOCR METAB, V97, pE1224, DOI 10.1210/jc.2012-1132; Lopez-Soldado I, 2020, FEBS LETT, V594, P1698, DOI 10.1002/1873-3468.13770; Lopez-Soldado I, 2015, DIABETES, V64, P796, DOI 10.2337/db14-0728; Mason TM, 2000, METABOLISM, V49, P1411, DOI 10.1053/meta.2000.17731; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Mehta MB, 2017, J BIOL CHEM, V292, P10444, DOI 10.1074/jbc.M116.766329; Miyamoto A, 2008, J TOXICOL SCI, V33, P209, DOI 10.2131/jts.33.209; Naito M, 2011, DIABETES, V60, P2265, DOI 10.2337/db10-1795; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; PEHLING G, 1984, J CLIN INVEST, V74, P985, DOI 10.1172/JCI111519; Regnell SE, 2015, METABOLISM, V64, P872, DOI 10.1016/j.metabol.2015.04.002; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Ros S, 2011, DIABETOLOGIA, V54, P2639, DOI 10.1007/s00125-011-2238-x; Ros S, 2010, J BIOL CHEM, V285, P37170, DOI 10.1074/jbc.M110.157396; SALMON DMW, 1985, INT J OBESITY, V9, P443; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Seoane J, 1999, J BIOL CHEM, V274, P31833, DOI 10.1074/jbc.274.45.31833; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; Sivitz WI, 1998, METABOLISM, V47, P584, DOI 10.1016/S0026-0495(98)90244-X; Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; Testoni G, 2017, CELL METAB, V26, P256, DOI 10.1016/j.cmet.2017.06.008; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974; Verges B, 2009, DIABETES METAB, V35, P353, DOI 10.1016/j.diabet.2009.04.004; Wang CJ, 2014, DIABETES, V63, P947, DOI 10.2337/db13-1096; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Willecke F, 2015, ARTERIOSCL THROM VAS, V35, P102, DOI 10.1161/ATVBAHA.114.304615; Yang ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026359; Yang RJ, 2003, J BIOL CHEM, V278, P23418, DOI 10.1074/jbc.M213112200; Yechoor V, 2009, ENDOCRINOLOGY, V150, P4863, DOI 10.1210/en.2009-0527; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang J, 2018, INT J BIOL SCI, V14, P1000, DOI 10.7150/ijbs.25026	51	4	4	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100498	10.1016/j.jbc.2021.100498	http://dx.doi.org/10.1016/j.jbc.2021.100498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33667544	gold, Green Published			2022-12-28	WOS:000672866400472
J	Minnow, YVT; Harijan, RK; Schramm, VL				Minnow, Yacoba V. T.; Harijan, Rajesh K.; Schramm, Vern L.			A resistant mutant of Plasmodium falciparum purine nucleoside phosphorylase uses wild-type neighbors to maintain parasite survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOG; DRUG-RESISTANCE; MALARIA; INHIBITORS; PIPERAQUINE; MUTATIONS; PATHWAYS; TARGETS; SALVAGE; BIOLOGY	Plasmodium falciparum purine nucleoside phosphorylase (PfPNP) catalyzes an essential step in purine salvage for parasite growth. 4'-Deaza-1'-Aza-2'-Deoxy-1'-(9-Methylene)-Immucillin-G (DADMe-ImmG) is a transition state analog inhibitor of this enzyme, and P. falciparum infections in an Aotus primate malaria model can be cleared by oral administration of DADMe-ImmG. P. falciparum cultured under increasing DADMe-ImmG drug pressure exhibited PfPNP gene amplification, increased protein expression, and point mutations involved in DADMe-ImmG binding. However, the weak catalytic properties of the M183L resistance mutation (similar to 17,000-fold decrease in catalytic efficiency) are inconsistent with the essential function of PfPNP. We hypothesized that M183L subunits may form mixed oligomers of native and mutant PfPNP monomers to give hybrid hexameric enzymes with properties conferring DADMe-ImmG resistance. To test this hypothesis, we designed PfPNP constructs that covalently linked native and the catalytically weak M183L mutant subunits. Engineered hybrid PfPNP yielded trimer-of-dimer hexameric protein with alternating native and catalytically weak M183L subunits. This hybrid PfPNP gave near-native K-m values for substrate, but the affinity for DADMe-ImmG and catalytic efficiency were both reduced approximately ninefold relative to a similar construct of native subunits. Contact between the relatively inactive M183L and native subunits is responsible for altered properties of the hybrid protein. Thus, gene amplification of PfPNP provides adequate catalytic activity while resistance to DADMe-ImmGoccurs in the hybrid oligomer to promote parasite survival. Coupled with the slow development of drug resistance, this resistance mechanism highlights the potential for DADMe-ImmG use in antimalarial combination therapies.	[Minnow, Yacoba V. T.; Harijan, Rajesh K.; Schramm, Vern L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Schramm, VL (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	vern.schramm@einsteinmed.org	Harijan, Rajesh K./AAY-3277-2021		NIH [T32 AI070117, AI127807, GM041916]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH research grants (AI127807 and GM041916) and NIH training grant (T32 AI070117) for geographic medicine and emerging infectious disease. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam I, 2012, AM J TROP MED HYG, V87, P35, DOI 10.4269/ajtmh.2012.11-0410; Bayih AG, 2016, AM J TROP MED HYG, V94, P132, DOI 10.4269/ajtmh.15-0477; Blasco B, 2017, NAT MED, V23, P917, DOI 10.1038/nm.4381; Cassera MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026916; Cassera MB, 2011, CURR TOP MED CHEM, V11, P2103; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Chaudhary K, 2006, J BIOL CHEM, V281, P25652, DOI 10.1074/jbc.M602624200; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cowell AN, 2018, SCIENCE, V359, P191, DOI 10.1126/science.aan4472; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Ducati RG, 2018, P NATL ACAD SCI USA, V115, P2114, DOI 10.1073/pnas.1525670115; Ducati RG, 2013, FUTURE MED CHEM, V5, P1341, DOI 10.4155/fmc.13.51; Dziekan JM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau3174; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Haldar K, 2018, NAT REV MICROBIOL, V16, P156, DOI 10.1038/nrmicro.2017.161; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/s1473-3099(17)30048-8, 10.1016/S1473-3099(17)30048-8]; Jagannathan P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002606; Kakuru A, 2016, NEW ENGL J MED, V374, P928, DOI 10.1056/NEJMoa1509150; Khammanee T, 2019, KOREAN J PARASITOL, V57, P369, DOI 10.3347/kjp.2019.57.4.369; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Li CM, 1999, NAT STRUCT BIOL, V6, P582, DOI 10.1038/9367; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Madrid DC, 2008, J BIOL CHEM, V283, P35899, DOI 10.1074/jbc.M807218200; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Preechapornkul P, 2009, ANTIMICROB AGENTS CH, V53, P1509, DOI 10.1128/AAC.00241-08; Schramm VL, 2018, CHEM REV, V118, P11194, DOI 10.1021/acs.chemrev.8b00369; Schramm VL, 2015, ACCOUNTS CHEM RES, V48, P1032, DOI 10.1021/acs.accounts.5b00002; Schramm VL, 2013, ACS CHEM BIOL, V8, P71, DOI 10.1021/cb300631k; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; Stokes BH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007722; Tilley L, 2016, TRENDS PARASITOL, V32, P682, DOI 10.1016/j.pt.2016.05.010; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; van der Pluijm RW, 2020, LANCET, V395, P1345, DOI 10.1016/S0140-6736(20)30552-3; Wang SZ, 2014, BIOCHEMISTRY-US, V53, P1527, DOI 10.1021/bi401589n; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yagnik K, 2019, CASE REP INFECT DIS, V2019, DOI 10.1155/2019/2630825	40	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100342	10.1016/j.jbc.2021.100342	http://dx.doi.org/10.1016/j.jbc.2021.100342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524395	gold, Green Published			2022-12-28	WOS:000672866400316
J	Onken, MD; Makepeace, CM; Kaltenbronn, KM; Choi, J; Hernandez-Aya, L; Weilbaecher, KN; Piggott, KD; Rao, PK; Yuede, CM; Dixon, AJ; Osei-Owusu, P; Cooper, JA; Blumer, KJ				Onken, Michael D.; Makepeace, Carol M.; Kaltenbronn, Kevin M.; Choi, Joelle; Hernandez-Aya, Leonel; Weilbaecher, Katherine N.; Piggott, Kisha D.; Rao, P. Kumar; Yuede, Carla M.; Dixon, Alethia J.; Osei-Owusu, Patrick; Cooper, John A.; Blumer, Kendall J.			Targeting primary and metastatic uveal melanoma with a G protein inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREATMENT OPTIONS; MUTATIONS; GNAQ; DEFECTS; GENE; VALIDATION; YM-254890; OCCUR; G(Q); RB	Uveal melanoma (UM) is the most common intraocular tumor in adults. Nearly half of UM patients develop metastatic disease and often succumb within months because effective therapy is lacking. A novel therapeutic approach has been suggested by the discovery that UM cell lines driven by mutant constitutively active Gq or G11 can be targeted by FR900359 (FR) or YM-254890, which are bioavailable, selective inhibitors of the Gq/11/14 subfamily of heterotrimeric G proteins. Here, we have addressed the therapeutic potential of FR for UM. We found that FR inhibited all oncogenic Gq/11 mutants reported in UM. FR arrested growth of all Gq/11-driven UM cell lines tested, but induced apoptosis only in a few. Similarly, FR inhibited growth of, but did not efficiently kill, UM tumor cells from biopsies of primary or metastatic tumors. FR evoked melanocytic redifferentiation of UM tumor cells with low (class 1), but not high (class 2), metastatic potential. FR administered systemically below its LD50 strongly inhibited growth of PDX-derived class 1 and class 2 UM tumors in mouse xenograft models and reduced blood pressure transiently. FR did not regress xenografted UM tumors or significantly affect heart rate, liver function, hematopoiesis, or behavior. These results indicated the existence of a therapeutic window in which FR can be explored for treating UM and potentially other diseases caused by constitutively active Gq/11.	[Onken, Michael D.; Cooper, John A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Makepeace, Carol M.; Kaltenbronn, Kevin M.; Choi, Joelle; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Hernandez-Aya, Leonel; Weilbaecher, Katherine N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Piggott, Kisha D.; Rao, P. Kumar] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Yuede, Carla M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Dixon, Alethia J.; Osei-Owusu, Patrick] Drexel Univ, Coll Med, Dept Pharmacol & Physiol, Philadelphia, PA USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Drexel University	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	kblumer@wustl.edu	Onken, Michael D/H-5620-2013	Onken, Michael D/0000-0003-4082-1105; Dixon, Alethia/0000-0002-4374-0688	NIH [GM124093, CA234533, GM118171, HL139754]; AHA [16SDG2726027]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association)	This work was supported by NIH grants GM124093 and CA234533 to K. J. B. GM118171 to J. A. C., and HL139754 to P. O. and by an AHA grant 16SDG2726027 to P. O.	Amirouchene-Angelozzi N, 2014, MOL ONCOL, V8, P1508, DOI 10.1016/j.molonc.2014.06.004; Annala S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau5948; Bichsel CA, 2019, JAMA OPHTHALMOL, V137, P91, DOI 10.1001/jamaophthalmol.2018.5141; Brantley MA, 2000, AM J PATHOL, V157, P1795, DOI 10.1016/S0002-9440(10)64817-1; Carvajal RD, 2017, BRIT J OPHTHALMOL, V101, P38, DOI 10.1136/bjophthalmol-2016-309034; Chen X, 2017, CANCER CELL, V31, P685, DOI 10.1016/j.ccell.2017.04.002; Chua V, 2017, MOL CANCER RES, V15, P501, DOI 10.1158/1541-7786.MCR-17-0007; Delston RB, 2011, ONCOGENE, V30, P588, DOI 10.1038/onc.2010.442; Dettlaff-Swiercz DA, 2005, DEV BIOL, V282, P174, DOI 10.1016/j.ydbio.2005.03.006; Eschelman DJ, 2013, SEMIN INTERVENT RAD, V30, P39, DOI 10.1055/s-0033-1333652; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Feng XD, 2019, CANCER CELL, V35, P457, DOI 10.1016/j.ccell.2019.01.009; Francis JH, 2019, OPHTHALMOLOGY, V126, P759, DOI 10.1016/j.ophtha.2018.12.011; FUJIOKA M, 1988, J ORG CHEM, V53, P2820, DOI 10.1021/jo00247a030; Gonsalves CF, 2019, RADIOLOGY, V293, P223, DOI 10.1148/radiol.2019190199; Graham DL, 2015, SYNAPSE, V69, P434, DOI 10.1002/syn.21830; Griewank KG, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00971.x; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hitchman T. D., 2020, CLIN CANCER RES; Johnson CP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178189; Joseph NM, 2018, AM J SURG PATHOL, V42, P1201, DOI 10.1097/PAS.0000000000001110; Kawasaki T, 2005, THROMB HAEMOSTASIS, V94, P184, DOI 10.1160/TH04-09-0635; Kawasaki T, 2003, THROMB HAEMOSTASIS, V90, P406, DOI 10.1160/TH03-02-0115; Kostenis E, 2020, J BIOL CHEM, V295, P5206, DOI 10.1074/jbc.REV119.007061; Krantz BA, 2017, CLIN OPHTHALMOL, V11, P279, DOI 10.2147/OPTH.S89591; Kusters-Vandevelde HVN, 2010, ACTA NEUROPATHOL, V119, P317, DOI 10.1007/s00401-009-0611-3; Lapadula D, 2019, MOL CANCER RES, V17, P963, DOI 10.1158/1541-7786.MCR-18-0574; Li D, 2014, J CLIN ENDOCR METAB, V99, pE1774, DOI 10.1210/jc.2014-1029; Matatall KA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-371; Matthey M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2288; Meleka MM, 2019, PHARMACOL RES, V141, P264, DOI 10.1016/j.phrs.2019.01.012; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Onken MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6852; Onken MD, 2012, OPHTHALMOLOGY, V119, P1596, DOI 10.1016/j.ophtha.2012.02.017; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Owens EA, 2017, KIDNEY INT, V92, P1100, DOI 10.1016/j.kint.2017.04.044; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Sheng XA, 2016, EUR J CANCER, V65, P156, DOI 10.1016/j.ejca.2016.06.019; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Singh AD, 2005, OPHTHALMOLOGY, V112, P1784, DOI 10.1016/j.ophtha.2005.06.011; Sivaraj KK, 2015, CARDIOVASC RES, V108, P171, DOI 10.1093/cvr/cvv216; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Woll E, 1999, MELANOMA RES, V9, P575; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006	52	11	11	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100403	10.1016/j.jbc.2021.100403	http://dx.doi.org/10.1016/j.jbc.2021.100403			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33577798	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400377
J	Thakur, B; Arora, K; Gupta, A; Guptasarma, P				Thakur, Bhishem; Arora, Kanika; Gupta, Archit; Guptasarma, Purnananda			The DNA-binding protein HU is a molecular glue that attaches bacteria to extracellular DNA in biofilms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI	In biofilms, bacteria that possess a negatively charged surface are embedded within a matrix of polymers consisting mainly of negatively charged extracellular DNA (e-DNA). In all likelihood, a multivalent positively charged substance, for example, a basic protein, exists within biofilms to neutralize charge-charge repulsions and act as a 'glue' attaching negatively charged bacteria to negatively charged e-DNA; however, no protein capable of doing so has yet been identified. We decided to investigate whether a highly abundant nucleoid-associated histone-like protein (HU) happens to be the glue in question. In recent years, HU has been shown to possess qualities that could be considered desirable in the proposed glue, for example, (a) availability in association with e-DNA; (b) multivalent DNA binding; (c) non-sequence-specific DNA-binding; (d) enhancement of biofilm formation upon exogenous addition, and (e) disruption of biofilms, upon removal by HU-cognate antibodies. Geometric considerations suggest that basic residues in HU's canonical and noncanonical DNA-binding sites can interact with sugar-linked terminal phosphates in lipopolysaccharide (LPS) molecules in bacterial outer membranes. Here, using genetic, spectroscopic, biophysical-chemical, microscopy-based, and cytometry-based experiments, we demonstrate that HU's DNA-binding sites also bind to LPS, that this facilitates DNA-DNA, DNA-LPS, and LPS-LPS interactions, and that this facilitates bacterial clumping and attachment of bacteria to DNA. Exogenous addition of HU to bacteria in (nonshaken) cultures is shown to cause cells to become engulfed in a matrix of DNA, potentially arising from the lysis of bacteria with vulnerable cell walls (as they strain to grow, divide, and move away from each other, in opposition to the accreting influence of HUs).	[Thakur, Bhishem; Arora, Kanika; Gupta, Archit; Guptasarma, Purnananda] Indian Inst Sci Educ & Res IISER Mohali, Ctr Prot Sci Design & Engn CPSDE, Dept Biol Sci, Knowledge City, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Guptasarma, P (corresponding author), Indian Inst Sci Educ & Res IISER Mohali, Ctr Prot Sci Design & Engn CPSDE, Dept Biol Sci, Knowledge City, Punjab, India.	guptasarma@iisermohali.ac.in	; Guptasarma, Purnananda/C-3976-2009	Thakur, Bhishem/0000-0002-2050-982X; Guptasarma, Purnananda/0000-0002-4801-3180; Gupta, Archit/0000-0002-2978-3251	Council of Scientific and Industrial Research (CSIR); University Grants Commission (UGC); Department of Biotechnology (DBT), Government of India; Ministry of Human Resource Development (MHRD), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC)(University Grants Commission, India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Ministry of Human Resource Development (MHRD), Government of India(Ministry of Human Resource Development (MHRD), Government of India)	We thank Ms Ipsita Pani and Dr Santanu Pal of the Department of Chemical Sciences, Indian Institute of Science Education and Research Mohali, for making their liquid crystalbased assay for protein-lipopolysaccharide binding available for us to test whether highly abundant nucleoid-associated histonelike protein binds to lipopolysaccharide using their assay. We thank Ms Angel for technical assistance. B. T., K. A., and A. G., respectively, thank the Council of Scientific and Industrial Research (CSIR), the University Grants Commission (UGC), and the Department of Biotechnology (DBT), Government of India, for research fellowships. P. G. thanks the Ministry of Human Resource Development (MHRD), Government of India, for the grant of a Centre of Excellence in Frontier Areas of Science and Technology in the area of Protein Science, Design, and Engineering.	Arora K, 2015, ANAL BIOCHEM, V484, P180, DOI 10.1016/j.ab.2015.06.011; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Das D, 2015, CHEMPHYSCHEM, V16, P753, DOI 10.1002/cphc.201402739; Dengler V, 2015, J BACTERIOL, V197, P3779, DOI 10.1128/JB.00726-15; Devaraj A, 2015, MOL MICROBIOL, V96, P1119, DOI 10.1111/mmi.12994; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; Foulston L, 2014, MBIO, V5, DOI 10.1128/mBio.01667-14; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; Guo FS, 2007, P NATL ACAD SCI USA, V104, P4309, DOI 10.1073/pnas.0611686104; Haji-Ghassemi O, 2016, J BIOL CHEM, V291, P10104, DOI 10.1074/jbc.M115.712448; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hammel M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600650; Hyldgaard M, 2014, APPL ENVIRON MICROB, V80, P7758, DOI 10.1128/AEM.02204-14; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Jurcisek JA, 2017, P NATL ACAD SCI USA, V114, pE6632, DOI 10.1073/pnas.1705508114; Kamashev D, 1999, EMBO J, V18, P5434, DOI 10.1093/emboj/18.19.5434; Kumar S, 2016, BIOCHEM BIOPH RES CO, V477, P575, DOI 10.1016/j.bbrc.2016.06.087; LAQUA K, 1988, PURE APPL CHEM, V60, P1449, DOI 10.1351/pac198860091449; Novotny LA, 2016, EBIOMEDICINE, V10, P33, DOI 10.1016/j.ebiom.2016.06.022; ROUVIEREYANIV J, 1979, FEBS LETT, V106, P297, DOI 10.1016/0014-5793(79)80518-9; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; TANAKA H, 1993, J BIOCHEM-TOKYO, V113, P568, DOI 10.1093/oxfordjournals.jbchem.a124084; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Turnbull L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11220; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	26	5	5	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100532	10.1016/j.jbc.2021.100532	http://dx.doi.org/10.1016/j.jbc.2021.100532			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713701	Green Published, gold			2022-12-28	WOS:000672866400506
J	Vitner, EB; Achdout, H; Avraham, R; Politi, B; Cherry, L; Tamir, H; Yahalom-Ronen, Y; Paran, N; Melamed, S; Erez, N; Israely, T				Vitner, Einat B.; Achdout, Hagit; Avraham, Roy; Politi, Boaz; Cherry, Lilach; Tamir, Hadas; Yahalom-Ronen, Yfat; Paran, Nir; Melamed, Sharon; Erez, Noam; Israely, Tomer			Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE REDUCTION THERAPY; N-BUTYLDEOXYNOJIRIMYCIN; GAUCHER-DISEASE; ELIGLUSTAT; SENSITIVITY; IMINOSUGARS; MODULATION; EFFICACY; TYPE-1	The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health. Vaccines are ideal solutions to prevent infection, but treatments are also needed for those who have contracted the virus to limit negative outcomes, when vaccines are not applicable. Viruses must cross host cell membranes during their life cycle, creating a dependency on processes involving membrane dynamics. Thus, in this study, we examined whether the synthetic machinery for glycosphingolipids, biologically active components of cell membranes, can serve as a therapeutic target to combat SARS-CoV-2. We examined the antiviral effect of two specific inhibitors of glucosylceramide synthase (GCS): (i) Genz-123346, an analogue of the United States Food and Drug Administration-approved drug Cerdelga and (ii) GENZ-667161, an analogue of venglustat, which is currently under phase III clinical trials. We found that both GCS inhibitors inhibit replication of SARS-CoV-2. Moreover, these inhibitors also disrupt replication of influenza virus A/PR/8/34 (H1N1). Our data imply that synthesis of glycosphingolipids is necessary to support viral life cycles and suggest that GCS inhibitors should be further explored as antiviral therapies.	[Vitner, Einat B.; Achdout, Hagit; Avraham, Roy; Politi, Boaz; Cherry, Lilach; Tamir, Hadas; Yahalom-Ronen, Yfat; Paran, Nir; Melamed, Sharon; Erez, Noam; Israely, Tomer] Israel Inst Biol Res, Dept Infect Dis, Ness Ziona, Israel		Vitner, EB (corresponding author), Israel Inst Biol Res, Dept Infect Dis, Ness Ziona, Israel.	einatv@iibr.gov.il		Avraham, Roy/0000-0002-3010-3372; Bleiberg Vitner, Einat/0000-0001-8578-8551; Erez, Noam/0000-0001-5241-8028; Achdout, Hagit/0000-0003-0664-8628	Israel Science Foundation [521/18]; Katzir Foundation; Sanofi [GZ-161, GZ-346]	Israel Science Foundation(Israel Science Foundation); Katzir Foundation; Sanofi	R. A. is supported by the Israel Science Foundation (grant 521/18). E. B. V. is supported by the Katzir Foundation. GZ-161 and GZ-346 obtained from Sanofi through an material transfer agreement.	Achdout H, 2008, J VIROL, V82, P8030, DOI 10.1128/JVI.00870-08; Araujo DB, 2020, MEM I OSWALDO CRUZ, V115, DOI 10.1590/0074-02760200342; Ashe KM, 2015, MOL MED, V21, P389, DOI 10.2119/molmed.2015.00088; Belmatoug N, 2017, EUR J INTERN MED, V37, P25, DOI 10.1016/j.ejim.2016.07.011; Cabrera-Salazar MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043310; Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; Coutinho MF, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071065; De Clercq E, 2004, NAT REV MICROBIOL, V2, P704, DOI 10.1038/nrmicro975; Drake MJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006316; Drews K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228735; Drews K, 2019, J VIROL, V93, DOI 10.1128/JVI.00017-19; Fischer PB, 1996, J VIROL, V70, P7153, DOI 10.1128/JVI.70.10.7153-7160.1996; Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679; Gualtierotti R, 2017, ADV THER, V34, P396, DOI 10.1007/s12325-016-0474-7; Hidari KIPJ, 2006, BIOL PHARM BULL, V29, P1575, DOI 10.1248/bpb.29.1575; Hussain S, 2015, J ANTIMICROB CHEMOTH, V70, P136, DOI 10.1093/jac/dku349; Khan I, 2014, J VIROL, V88, P12276, DOI 10.1128/JVI.00970-14; Low H, 2016, CELL REP, V16, P186, DOI 10.1016/j.celrep.2016.05.070; Marshall J, 2016, MOL THER, V24, P1019, DOI 10.1038/mt.2016.53; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Mehta A, 2001, HEPATOLOGY, V33, P1488, DOI 10.1053/jhep.2001.25103; Mehta A, 1997, P NATL ACAD SCI USA, V94, P1822, DOI 10.1073/pnas.94.5.1822; Miller JL, 2012, ANTIMICROB AGENTS CH, V56, P6379, DOI 10.1128/AAC.01554-12; Mistry PK, 2015, JAMA-J AM MED ASSOC, V313, P695, DOI 10.1001/jama.2015.459; Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377; Ogando NS, 2020, J GEN VIROL, V101, P925, DOI 10.1099/jgv.0.001453; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Platt FM, 2014, NATURE, V510, P68, DOI 10.1038/nature13476; Pollock S, 2008, AIDS, V22, P1961, DOI 10.1097/QAD.0b013e32830efd96; Qu XW, 2011, ANTIMICROB AGENTS CH, V55, P1036, DOI 10.1128/AAC.01319-10; Sayce AC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004524; Sayce AC, 2010, TRENDS MICROBIOL, V18, P323, DOI 10.1016/j.tim.2010.04.003; Shayman JA, 2010, DRUG FUTURE, V35, P613, DOI 10.1358/dof.2010.035.08.1505566; Talevi A, 2020, EXPERT OPIN DRUG DIS, V15, P397, DOI 10.1080/17460441.2020.1704729; Tanner LB, 2014, J LIPID RES, V55, P1357, DOI 10.1194/jlr.M049148; Vitner EB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0570-2; Vitner Einat B, 2013, Handb Exp Pharmacol, P405, DOI 10.1007/978-3-7091-1511-4_20; Yu WQ, 2012, J MED CHEM, V55, P6061, DOI 10.1021/jm300171v; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	40	10	10	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100470	10.1016/j.jbc.2021.100470	http://dx.doi.org/10.1016/j.jbc.2021.100470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639165	Green Published, gold			2022-12-28	WOS:000672866400444
J	Wang, T; Cook, I; Leyh, TS				Wang, Ting; Cook, Ian; Leyh, Thomas S.			The molecular basis of OH-PCB estrogen receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFURYL-TRANSFER; POLYCHLORINATED-BIPHENYLS; GENETIC ALGORITHM; SULFOTRANSFERASE; SULFATION; LIGAND; PARALLEL; GROMACS; SITE; NMR	Polychlorinated bisphenols (PCBs) continue to contaminate food chains globally where they concentrate in tissues and disrupt the endocrine systems of species throughout the ecosphere. Hydroxylated PCBs (OH-PCBs) are major PCB metabolites and high-affinity inhibitors of human estrogen sulfotransferase (SULT1E1), which sulfonates estrogens and thus prevents them from binding to and activating their receptors. OH-PCB inhibition of SULT1E1 is believed to contribute significantly to PCB-based endocrine disruption. Here, for the first time, the molecular basis of OH-PCB inhibition of SULT1E1 is revealed in a structure of SULT1E1 in complex with OH-PCB1 (4'-OH-2,6-dichlorobiphenol) and its substrates, estradiol (E2), and PAP (3'-phosphoadenosine-5-phosphosulfate). OH-PCB1 prevents catalysis by intercalating between E2 and catalytic residues and establishes a new E2-binding site whose E2 affinity and positioning are greater than and competitive with those of the reactive-binding pocket. Such complexes have not been observed previously and offer a novel template for the design of high-affinity inhibitors. Mutating residues in direct contact with OH-PCB weaken its affinity without compromising the enzyme's catalytic parameters. These OH-PCB resistant mutants were used in stable transfectant studies to demonstrate that OH-PCBs regulate estrogen receptors in cultured human cell lines by binding the OH-PCB binding pocket of SULT1E1.	[Wang, Ting; Cook, Ian; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA; [Wang, Ting] Boehringer Ingelheim GmbH & Co KG, Drug Metab & Pharmacokinet Dept, Danbury, CT USA	Yeshiva University; Boehringer Ingelheim	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA.	tom.leyh@einsteinmed.org			National Institutes of Health [GM121849, GM127144]; NIH [1S10OD016305]; Albert Einstein College of Medicine	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine	Research supported by the National Institutes of Health Grants GM121849 (T. S. L.) and GM127144 (T. S. L.). The Bruker 600 MHz NMR instrument in the Einstein Structural NMR Resource was purchased using funds from NIH award 1S10OD016305 and is supported by the Albert Einstein College of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JAM, 2001, J BIOL CHEM, V276, P9755, DOI 10.1074/jbc.M010048200; [Anonymous], 2019, NATL SPREADSHEET FAC; Bai QM, 2011, ATHEROSCLEROSIS, V214, P350, DOI 10.1016/j.atherosclerosis.2010.11.021; Baker J, 2009, J COMPUT CHEM, V30, P317, DOI 10.1002/jcc.21052; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bertini I, 2001, METHOD ENZYMOL, V339, P314, DOI 10.1016/S0076-6879(01)39320-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cleland W W, 1979, Methods Enzymol, V63, P103; CLELAND WW, 1963, NATURE, V198, P463, DOI 10.1038/198463a0; Cook I, 2017, P NATL ACAD SCI USA, V114, pE5317, DOI 10.1073/pnas.1704500114; Cook I, 2016, P NATL ACAD SCI USA, V113, P14312, DOI 10.1073/pnas.1613913113; Cook I, 2016, CELL CHEM BIOL, V23, P579, DOI 10.1016/j.chembiol.2016.04.009; Cook I, 2015, BIOCHEMISTRY-US, V54, P6114, DOI 10.1021/acs.biochem.5b00406; Cook I, 2013, J BIOL CHEM, V288, P34494, DOI 10.1074/jbc.M113.510974; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook IT, 2010, HORM MOL BIOL CLIN I, V1, P81, DOI 10.1515/HMBCI.2010.012; Darrah K, 2019, J BIOL CHEM, V294, P2293, DOI 10.1074/jbc.RA118.006511; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickerson SM, 2011, ENDOCRINOLOGY, V152, P581, DOI 10.1210/en.2010-1103; Falany JL, 2006, STEROIDS, V71, P880, DOI 10.1016/j.steroids.2006.05.018; Faroon O. M., 2003, CONCISE INT CHEM ASS, P12; FAYZ S, 1984, DRUG METAB DISPOS, V12, P323; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GIRVIN ME, 1995, BIOCHEMISTRY-US, V34, P1635, DOI 10.1021/bi00005a020; Gochin M, 2011, ACS CHEM BIOL, V6, P267, DOI 10.1021/cb100368d; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; Gosavi RA, 2013, ENVIRON HEALTH PERSP, V121, P1194, DOI 10.1289/ehp.1306902; Guan JY, 2013, J AM CHEM SOC, V135, P5859, DOI 10.1021/ja401323m; Ihunnah CA, 2014, MOL CELL BIOL, V34, P1682, DOI 10.1128/MCB.01147-13; Jackson EN, 2019, ENVIRON HEALTH PERSP, V127, DOI [10.1289/EHP4133, 10.1289/ehp4133]; JENSEN S, 1972, Ambio, V1, P123; John M, 2006, J AM CHEM SOC, V128, P12910, DOI 10.1021/ja063584z; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kester MHA, 2000, ENDOCRINOLOGY, V141, P1897, DOI 10.1210/en.141.5.1897; KORACH KS, 1988, MOL PHARMACOL, V33, P120; KOSEN PA, 1989, METHOD ENZYMOL, V177, P86; Kotov A, 1999, J STEROID BIOCHEM, V68, P137, DOI 10.1016/S0960-0760(99)00022-9; Koziara KB, 2014, J COMPUT AID MOL DES, V28, P221, DOI 10.1007/s10822-014-9713-7; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lauby-Secretan B, 2013, LANCET ONCOL, V14, P287, DOI 10.1016/S1470-2045(13)70104-9; LITTLEFIELD BA, 1990, ENDOCRINOLOGY, V127, P2757, DOI 10.1210/endo-127-6-2757; Ma B, 2003, DRUG METAB DISPOS, V31, P1300, DOI 10.1124/dmd.31.11.1300; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; MAN M, 1974, ANAL BIOCHEM, V57, P429, DOI 10.1016/0003-2697(74)90098-0; Matsubayashi Y, 2006, ANNU REV PLANT BIOL, V57, P649, DOI 10.1146/annurev.arplant.56.032604.144204; Mauvais-Jarvis F, 2012, DIABETES, V61, P1353, DOI 10.2337/db12-0357; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Otake Y, 2000, J STEROID BIOCHEM, V73, P265, DOI 10.1016/S0960-0760(00)00073-X; Parker CR, 1999, STEROIDS, V64, P640, DOI 10.1016/S0039-128X(99)00046-X; Pedersen LC, 2002, J BIOL CHEM, V277, P17928, DOI 10.1074/jbc.M111651200; Porta M, 2002, OCCUP ENVIRON MED, V59, P651, DOI 10.1136/oem.59.10.651; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Quinete N, 2017, TOXICOL LETT, V276, P100, DOI 10.1016/j.toxlet.2017.05.025; Quintaneiro C, 2019, J ENVIRON SCI HEAL A, V54, P478, DOI 10.1080/10934529.2019.1568793; Satake A, 2008, KIDNEY INT, V73, P308, DOI 10.1038/sj.ki.5002690; SCHMITZ U, 1993, J MOL BIOL, V234, P373, DOI 10.1006/jmbi.1993.1593; Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014; Sechman A, 2016, TOXICOL LETT, V264, P29, DOI 10.1016/j.toxlet.2016.11.001; Selvan RS, 1996, ANN NY ACAD SCI, V797, P127, DOI 10.1111/j.1749-6632.1996.tb52955.x; Shen L, 2006, ENVIRON POLLUT, V144, P434, DOI 10.1016/j.envpol.2005.12.054; Silva MS, 2017, MOLECULES, V22, DOI 10.3390/molecules22020247; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P770, DOI 10.1016/j.conb.2010.08.015; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; TANABE S, 1988, ENVIRON POLLUT, V50, P5, DOI 10.1016/0269-7491(88)90183-2; Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; VISSER TJ, 1994, CHEM-BIOL INTERACT, V92, P293, DOI 10.1016/0009-2797(94)90071-X; Wang T, 2017, J BIOL CHEM, V292, P20305, DOI 10.1074/jbc.M117.817387; Yu DZ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122178; Zhang HJ, 2007, CLIN PHARMACOKINET, V46, P133, DOI 10.2165/00003088-200746020-00003; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	76	2	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100353	10.1016/j.jbc.2021.100353	http://dx.doi.org/10.1016/j.jbc.2021.100353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524392	Green Published, gold			2022-12-28	WOS:000672866400327
J	Zhang, X; Gao, T; Deng, SW; Shang, L; Chen, XC; Chen, K; Li, P; Cui, XJ; Zeng, J				Zhang, Xiao; Gao, Ting; Deng, Senwen; Shang, Lin; Chen, Xiaocui; Chen, Kai; Li, Ping; Cui, Xiaojuan; Zeng, Jia			Fasting induces hepatic lipid accumulation by stimulating peroxisomal dicarboxylic acid oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; BETA-OXIDATION; RAT-LIVER; OMEGA-OXIDATION; FATTY-ACIDS; CARNITINE ACYLTRANSFERASES; ACYL-COENZYME; SHORT-CHAIN; PIG-KIDNEY; PPAR-ALPHA	Fasting induces lipid accumulation in the liver, while the mechanisms by which fasting dysregulates liver fatty acid oxidation are not clear. Fatty acid omega-oxidation is induced in the fasting state, and administration of dicarboxylic acids to fasting animals decreases plasma ketone bodies. We hypothesized that endogenous dicarboxylic acids might play a role in controlling mitochondrial beta-oxidation in fasting animals. A peroxisome proliferator-activated receptor-alpha agonist and an inhibitor for peroxisomal beta-oxidation were administered to the fasting rats to investigate the role of dicarboxylic acids in liver fatty acid oxidation and lipid homeostasis. We observed that excessive beta-oxidation of endogenous dicarboxylic acids by peroxisomes generated considerable levels of succinate in the liver. Excessive succinate oxidation subsequently increased the mitochondrial NADH/NAD(+) ratio and led to an accumulation of 3-OH-CoA and 2-enoyl-CoA intermediates in the liver. This further induced feedback suppression of mitochondrial beta-oxidation and promoted hepatic lipid deposition and steatosis. Specific inhibition of peroxisomal beta-oxidation attenuated fasting-induced lipid deposition in the liver by reducing succinate production and enhancing mitochondrial fatty acid oxidation. We conclude that suppression of mitochondrial beta-oxidation by oxidation of dicarboxylic acids serves as a mechanism for fasting-induced hepatic lipid accumulation and identifies cross talk between peroxisomal and mitochondrial fatty acid oxidation.	[Zhang, Xiao; Gao, Ting; Deng, Senwen; Shang, Lin; Chen, Xiaocui; Chen, Kai; Li, Ping; Cui, Xiaojuan; Zeng, Jia] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China	Hunan University of Science & Technology	Zeng, J (corresponding author), Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China.	zengj@hnu.edu.cn			National Natural Science Fund of P. R. China [30900024]; Natural Science Fund of Hunan Province [2020JJ5157]; Distinguished Professor Funds from Hunan University of Science and Technology; Project of graduate innovation in Hunan province [CX20190814]	National Natural Science Fund of P. R. China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Hunan Province; Distinguished Professor Funds from Hunan University of Science and Technology; Project of graduate innovation in Hunan province	This work was supported by the National Natural Science Fund of P. R. China (30900024), Natural Science Fund of Hunan Province (2020JJ5157), Distinguished Professor Funds from Hunan University of Science and Technology, and Project of graduate innovation in Hunan province (CX20190814).	Antonenkov VD, 2006, BBA-MOL CELL RES, V1763, P1697, DOI 10.1016/j.bbamcr.2006.08.044; Antoni R, 2017, P NUTR SOC, V76, P361, DOI 10.1017/S0029665116002986; BERGSETH S, 1990, BIOCHIM BIOPHYS ACTA, V1042, P182, DOI 10.1016/0005-2760(90)90005-I; BJORKHEM I, 1976, J BIOL CHEM, V251, P5259; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bloom K, 2018, J INHERIT METAB DIS, V41, P49, DOI 10.1007/s10545-017-0013-y; BREMER J, 1966, BIOCHIM BIOPHYS ACTA, V116, P1, DOI 10.1016/0005-2760(66)90087-7; BREMER J, 1972, BIOCHIM BIOPHYS ACTA, V280, P515, DOI 10.1016/0005-2760(72)90131-2; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; CAPUZZI DM, 1974, BIOCHEM BIOPH RES CO, V60, P1499, DOI 10.1016/0006-291X(74)90367-2; CEDERBAUM AI, 1974, BIOCHEM PHARMACOL, V23, P1985, DOI 10.1016/0006-2952(74)90257-3; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; CHOI YR, 1977, J BIOL CHEM, V252, P7930; CIMAN M, 1972, FEBS LETT, V22, P8, DOI 10.1016/0014-5793(72)80205-9; Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388; de Cabo R, 2019, NEW ENGL J MED, V381, P2541, DOI 10.1056/NEJMra1905136; Derks TGJ, 2008, HEPATOLOGY, V47, P1032, DOI 10.1002/hep.22101; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Eaton S, 1996, CLIN SCI, V90, P307, DOI 10.1042/cs0900307; EATON S, 1994, EUR J BIOCHEM, V220, P671, DOI 10.1111/j.1432-1033.1994.tb18668.x; Erguven M, 2007, ANN NUTR METAB, V51, P331, DOI 10.1159/000107675; Faust PL, 2014, BIOCHIMIE, V98, P75, DOI 10.1016/j.biochi.2013.10.019; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; GRUNNET N, 1986, ALCOHOL CLIN EXP RES, V10, pS64, DOI 10.1111/j.1530-0277.1986.tb05182.x; HE XY, 1992, ARCH BIOCHEM BIOPHYS, V298, P527, DOI 10.1016/0003-9861(92)90445-3; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Holden PR, 1999, J MOL ENDOCRINOL, V22, P1, DOI 10.1677/jme.0.0220001; Houten SM, 2013, HUM MOL GENET, V22, P5249, DOI 10.1093/hmg/ddt382; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; KAIKAUS RM, 1993, J BIOL CHEM, V268, P9593; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Khare P, 2016, BIOFACTORS, V42, P201, DOI 10.1002/biof.1265; KING MT, 1988, METHOD ENZYMOL, V166, P70; KREBS HA, 1961, BIOCHEM J, V80, P225, DOI 10.1042/bj0800225; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; LATIPAA PM, 1988, ANAL BIOCHEM, V171, P67, DOI 10.1016/0003-2697(88)90125-X; Lazarow P B, 1981, Methods Enzymol, V72, P315; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li D, 1999, J AM CHEM SOC, V121, P9034, DOI 10.1021/ja991908w; LIEBER CS, 1961, J CLIN INVEST, V40, P394, DOI 10.1172/JCI104266; Liu XJ, 2004, PROTEIN EXPRES PURIF, V37, P344, DOI 10.1016/j.pep.2004.06.026; LUMENG L, 1976, J BIOL CHEM, V251, P277; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; MCGARRY JD, 1969, BIOCHIM BIOPHYS ACTA, V177, P35, DOI 10.1016/0304-4165(69)90061-0; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Moller L, 2008, CLIN SCI, V114, P547, DOI 10.1042/CS20070217; MORTENSEN PB, 1980, BIOCHIM BIOPHYS ACTA, V620, P177, DOI 10.1016/0005-2760(80)90199-X; NEAT CE, 1980, BIOCHEM J, V186, P369, DOI 10.1042/bj1860369; NILSSON A, 1986, BIOCHIM BIOPHYS ACTA, V879, P209, DOI 10.1016/0005-2760(86)90104-9; OSMUNDSEN H, 1977, BIOCHEM J, V164, P621, DOI 10.1042/bj1640621; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; PEARSON DJ, 1964, NATURE, V202, P91, DOI 10.1038/202091a0; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Pourfarzam M, 1997, METHOD ENZYMOL, V279, P240; POWELL PJ, 1987, BIOCHEMISTRY-US, V26, P3704, DOI 10.1021/bi00386a066; PREISS B, 1964, J BIOL CHEM, V239, P85; Prip-Buus C, 1998, FEBS LETT, V429, P173, DOI 10.1016/S0014-5793(98)00584-5; QUANT PA, 1989, BIOCHEM J, V262, P159, DOI 10.1042/bj2620159; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; REICH NO, 1986, BIOCHEM PHARMACOL, V35, P1227, DOI 10.1016/0006-2952(86)90264-9; Secor SM, 2016, COMPR PHYSIOL, V6, P773, DOI 10.1002/cphy.c150013; SUZUKI H, 1989, BIOCHIM BIOPHYS ACTA, V990, P25, DOI 10.1016/S0304-4165(89)80007-8; TEIJEMA HL, 1980, EUR J PEDIATR, V134, P51, DOI 10.1007/BF00442403; THORPE C, 1979, BIOCHEMISTRY-US, V18, P331, DOI 10.1021/bi00569a016; TSERNG KY, 1991, J BIOL CHEM, V266, P2924; Tubbs P.K., 1969, METHODS ENZYMOL, V13, P535, DOI [10.1016/0076-6879(69)13079-7, DOI 10.1016/0076-6879(69)13079-7]; TUBBS PK, 1964, BIOCHEM J, V93, P550, DOI 10.1042/bj0930550; VAMECQ J, 1987, J BIOCHEM-TOKYO, V102, P225, DOI 10.1093/oxfordjournals.jbchem.a122035; VAMECQ J, 1985, BIOCHEM J, V230, P683, DOI 10.1042/bj2300683; Vamecq J, 1989, J BIOCH, V106, P216; Verkade PE, 1934, BIOCHEM J, V28, P31, DOI 10.1042/bj0280031; WADA F, 1977, BIOCHIM BIOPHYS ACTA, V487, P261, DOI 10.1016/0005-2760(77)90002-9; WANG HY, 1991, ARCH BIOCHEM BIOPHYS, V289, P274, DOI 10.1016/0003-9861(91)90472-U; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6; WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090; Wu L, 2008, ORG LETT, V10, P3355, DOI 10.1021/ol801267e; Yokota SI, 2014, FEBS OPEN BIO, V4, P905, DOI 10.1016/j.fob.2014.10.009; Zeevalk GD, 1995, J PHARMACOL EXP THER, V275, P1124; Zeng J, 2008, ORG LETT, V10, P4287, DOI 10.1021/ol801571n; Zeng J, 2017, J BIOL CHEM, V292, P3800, DOI 10.1074/jbc.M116.763532	88	6	7	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100622	10.1016/j.jbc.2021.100622	http://dx.doi.org/10.1016/j.jbc.2021.100622			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811861	Green Published, gold			2022-12-28	WOS:000672866400593
J	Zheng, YX; Huang, YP; Mencius, J; Li, YJ; Zhao, LJ; Luo, WT; Chen, Y; Quan, S				Zheng, Yongxin; Huang, Yinping; Mencius, Jun; Li, Yanjing; Zhao, Lijie; Luo, Wanting; Chen, Yong; Quan, Shu			Distinct kinetic mechanisms of H3K4 methylation catalyzed by MLL3 and MLL4 core complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; METHYLTRANSFERASE ACTIVITY; FAMILY; METABOLISM; MONOMETHYLATION; INHIBITION; EXPRESSION; CANCER; ROLES; ASSAY	The methyltransferases MLL3 and MLL4 primarily catalyze the monomethylation of histone H3 lysine 4 (H3K4) on enhancers to regulate cell-type-specific gene expression and cell fate transition. MLL3 and MLL4 share almost identical binding partners and biochemical activities, but perform specific and nonredundant functions. The features and functions that distinguish MLL3 and MLL4 remain elusive. Here, we characterize the kinetic mechanisms of MLL3 and MLL4 ternary complexes containing the catalytic SET domain from MLL3 or MLL4 (MLL3(SET) or MLL4(SET)), the SPRY domain of ASH2L (ASH2L(SPRY)), and a short fragment of RBBP5 (RBBP5(AS-ABM)) to search for possible explanations. Steady-state kinetic analyses and inhibition studies reveal that the MLL3 complex catalyzes methylation in a random sequential bi-bi mechanism. In contrast, the MLL4 complex adopts an ordered sequential bi-bi mechanism, in which the cofactor S-adenosylmethionine (AdoMet) binds to the enzyme prior to the H3 peptide, and the methylated H3 peptide dissociates from the enzyme before S-adenosylhomocysteine (AdoHcy) detaches after methylation. Substrate-binding assays using fluorescence polarization (FP) confirm that AdoMet binding is a prerequisite for H3 binding for the MLL4 complex but not for the MLL3 complex. Molecular dynamic simulations reveal that the binding of AdoMet exclusively induces conformational constraints on the AdoMet-binding groove and the H3 substrate-binding pocket of MLL4, therefore stabilizing a specific active conformation to ease entry of the substrate H3. The distinct kinetic mechanisms and conformational plasticities provide important insights into the differential functions of MLL3 and MLL4 and may also guide the development of selective inhibitors targeting MLL3 or MLL4.	[Zheng, Yongxin; Huang, Yinping; Mencius, Jun; Quan, Shu] East China Univ Sci & Technol, Shanghai Collaborat Innovat Ctr Biomfg SCICB, State Key Lab Bioreactor Engn, Shanghai, Peoples R China; [Li, Yanjing; Zhao, Lijie; Luo, Wanting; Chen, Yong] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Zhao, Lijie; Luo, Wanting; Chen, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Luo, Wanting; Chen, Yong] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	East China University of Science & Technology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Quan, S (corresponding author), East China Univ Sci & Technol, Shanghai Collaborat Innovat Ctr Biomfg SCICB, State Key Lab Bioreactor Engn, Shanghai, Peoples R China.; Chen, Y (corresponding author), Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China.; Chen, Y (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Chen, Y (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	yongchen@sibcb.ac.cn; shuquan@ecust.edu.cn		Jun, Mencius/0000-0001-5959-4737; Lijie, Zhao/0000-0002-0490-0175; chen, yong/0000-0001-5857-6086; Li, Yanjing/0000-0002-0747-6947	National Natural Science Foundation of China [31670802, 31970576, 31900934]; Fundamental Research Funds for the Central Universities [22221818014]; Research Program of State Key Laboratory of Bioreactor Engineering	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Program of State Key Laboratory of Bioreactor Engineering	This work was supported by grants from the National Natural Science Foundation of China (Grant Nos. 31670802 to S. Q., 31970576 to Y. C., and 31900934 to Y. L.), the Fundamental Research Funds for the Central Universities (Grant No. 22221818014), and the Research Program of State Key Laboratory of Bioreactor Engineering.	Ang SY, 2016, DEVELOPMENT, V143, P810, DOI 10.1242/dev.132688; Ashokkumar D, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.186999; Barsyte-Lovejoy D, 2014, P NATL ACAD SCI USA, V111, P12853, DOI 10.1073/pnas.1407358111; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BOLHUIS PA, 1988, CLIN CHEM, V34, P1607; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Collins BE, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-018-0251-8; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Dorgan KM, 2006, ANAL BIOCHEM, V350, P249, DOI 10.1016/j.ab.2006.01.004; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Faundes V, 2019, J HUM GENET, V64, P161, DOI 10.1038/s10038-018-0536-6; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hermes M, 2005, CELL PHYSIOL BIOCHEM, V15, P233, DOI 10.1159/000086410; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hu DQ, 2013, NAT STRUCT MOL BIOL, V20, P1093, DOI 10.1038/nsmb.2653; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Ibanez G, 2010, ANAL BIOCHEM, V401, P203, DOI 10.1016/j.ab.2010.03.010; Jang Y, 2019, NUCLEIC ACIDS RES, V47, P607, DOI 10.1093/nar/gky982; Jang YH, 2017, J MOL BIOL, V429, P2046, DOI 10.1016/j.jmb.2016.12.016; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Leskovac, 2003, COMPREHENSIVE ENZYME; Li YJ, 2016, NATURE, V530, P447, DOI 10.1038/nature16952; Liu YL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07906-3; Longnecker DS, 2002, J NUTR, V132, p2373S, DOI 10.1093/jn/132.8.2373S; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Marangoni A.G., 2003, ENZYME KINETICS MODE; Meeks JJ, 2017, ANNU REV CANC BIOL, V1, P425, DOI 10.1146/annurev-cancerbio-050216-034333; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Purich I., 2009, CONT ENZYME KINETICS; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Schapira M, 2016, CELL CHEM BIOL, V23, P1067, DOI 10.1016/j.chembiol.2016.07.014; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stein R.L., 2011, KINETICS ENZYME ACTI; Wang CC, 2016, P NATL ACAD SCI USA, V113, P11871, DOI 10.1073/pnas.1606857113; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weinberg DN, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026443; Yan J, 2018, CELL RES, V28, P204, DOI 10.1038/cr.2018.1; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10324-8; Zhang Y, 2015, STRUCTURE, V23, P1921, DOI 10.1016/j.str.2015.07.018; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p	59	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100635	10.1016/j.jbc.2021.100635	http://dx.doi.org/10.1016/j.jbc.2021.100635			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33823156	Green Published, gold			2022-12-28	WOS:000672866400606
J	Pibuel, MA; Poodts, D; Diaz, M; Hajos, SE; Lompardia, SL				Arturo Pibuel, Matias; Poodts, Daniela; Diaz, Mariangeles; Elvira Hajos, Silvia; Laura Lompardia, Silvina			The scrambled story between hyaluronan and glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOMA-CELL INVASION; BRAIN EXTRACELLULAR-MATRIX; CENTRAL-NERVOUS-SYSTEM; BINDING PROTEIN RHAMM; HUMAN CEREBRAL-TUMORS; IN-VITRO; CD44 EXPRESSION; MEDIATED MOTILITY; RECEPTOR RHAMM; ACID-MUCOPOLYSACCHARIDES	Advances in cancer biology are revealing the importance of the cancer cell microenvironment on tumorigenesis and cancer progression. Hyaluronan (HA), the main glycosaminoglycan in the extracellular matrix, has been associated with the progression of glioblastoma (GBM), the most frequent and lethal primary tumor in the central nervous system, for several decades. However, the mechanisms by which HA impacts GBM properties and processes have been difficult to elucidate. In this review, we provide a comprehensive assessment of the current knowledge on HA's effects on GBM biology, introducing its primary receptors CD44 and RHAMM and the plethora of relevant downstream signaling pathways that can scramble efforts to directly link HA activity to biological outcomes. We consider the complexities of studying an extracellular polymer and the different strategies used to try to capture its function, including 2D and 3D in vitro studies, patient samples, and in vivo models. Given that HA affects not only migration and invasion, but also cell proliferation, adherence, and chemoresistance, we highlight the potential role of HA as a therapeutic target. Finally, we review the different existing approaches to diminish its protumor effects, such as the use of 4-methylumbelliferone, HA oligomers, and hyaluronidases and encourage further research along these lines in order to improve the survival and quality of life of GBM patients.	[Arturo Pibuel, Matias; Poodts, Daniela; Elvira Hajos, Silvia; Laura Lompardia, Silvina] Univ Buenos Aires, Dept Microbiol Inmunol Biotecnol & Genet, Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Diaz, Mariangeles] Univ Buenos Aires, Inst Estudios Inmunidad Humoral IDEHU, CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Pibuel, MA; Lompardia, SL (corresponding author), Univ Buenos Aires, Dept Microbiol Inmunol Biotecnol & Genet, Fac Farm & Bioquim, Buenos Aires, DF, Argentina.	pibuelmatias@gmail.com; sil.lompardia@gmail.com		Diaz, Mariangeles/0000-0003-2343-5915; Lompardia, Silvina/0000-0002-8499-5417; Pibuel, Matias/0000-0003-4769-6570	Universidad de Buenos Aires [UBACYT 20020170100454BA]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2017-2971]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Universidad de Buenos Aires grant [UBACYT 20020170100454BA] to S. E. H. and S. L. L. and by Agencia Nacional de Promocion Cientifica y Tecnologica, grant [PICT-2017-2971] to S. L. L.	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Akiyama Y, 2001, J NEURO-ONCOL, V53, P115, DOI 10.1023/A:1012297132047; Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Albini A, 2015, CONNECT TISSUE RES, V56, P414, DOI 10.3109/03008207.2015.1066780; An ZY, 2018, ONCOGENE, V37, P1561, DOI 10.1038/s41388-017-0045-7; Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005; Anjum K, 2017, BIOMED PHARMACOTHER, V92, P681, DOI 10.1016/j.biopha.2017.05.125; Annabi B, 2005, J NEUROCHEM, V94, P906, DOI 10.1111/j.1471-4159.2005.03256.x; Annabi B, 2004, J BIOL CHEM, V279, P21888, DOI 10.1074/jbc.M313694200; ASHER R, 1992, EXP CELL RES, V203, P80, DOI 10.1016/0014-4827(92)90042-7; Asplund T, 1998, BBA-GEN SUBJECTS, V1380, P377, DOI 10.1016/S0304-4165(98)00010-5; Assmann V, 1999, J CELL SCI, V112, P3943; Auvinen P, 2013, INT J CANCER, V132, P531, DOI 10.1002/ijc.27707; Baumgartner G, 1998, CANCER LETT, V131, P85, DOI 10.1016/S0304-3835(98)00204-3; BERTOLOTTO A, 1982, ACTA NEUROPATHOL, V58, P115, DOI 10.1007/BF00691651; Boregowda Rajeev K, 2006, J Carcinog, V5, P2, DOI 10.1186/1477-3163-5-2; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon V, 2016, FASEB J, V30, P2108, DOI 10.1096/fj.201500178R; Breyer R, 2000, J NEUROSURG, V92, P140, DOI 10.3171/jns.2000.92.1.0140; Buhren BA, 2016, EUR J MED RES, V21, DOI 10.1186/s40001-016-0201-5; Buttermore ST, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0360-1; Caon I, 2021, J HISTOCHEM CYTOCHEM, V69, P35, DOI 10.1369/0022155420929772; Caon I, 2020, J BIOL CHEM, V295, P3485, DOI 10.1074/jbc.RA119.011982; Caon I, 2020, SEMIN CANCER BIOL, V62, P9, DOI 10.1016/j.semcancer.2019.07.007; Cha J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24912; CHAUZY C, 1992, EUR J CANCER, V28A, P1129, DOI 10.1016/0959-8049(92)90471-D; Chen JWE, 2018, FRONT MATER, V5, DOI 10.3389/fmats.2018.00039; Chen JWE, 2018, BIOMATER SCI-UK, V6, P854, DOI 10.1039/c7bm01195d; Chen JWE, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201700018; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; Cheung WF, 1999, BIOCHEM SOC T, V27, P135, DOI 10.1042/bst0270135; Chintala SK, 1999, INT J DEV NEUROSCI, V17, P495, DOI 10.1016/S0736-5748(99)00010-6; Chintala SK, 1996, CLIN EXP METASTAS, V14, P358, DOI 10.1007/BF00123395; Chovanec M, 2004, BIOTECH HISTOCHEM, V79, P139, DOI 10.1080/10520290400011554; Cohen ZR, 2015, ACS NANO, V9, P1581, DOI 10.1021/nn506248s; Connell M, 2017, ELIFE, V6, DOI 10.7554/eLife.28672; Coquerel B, 2009, GLIA, V57, P1716, DOI 10.1002/glia.20884; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Csoka AB, 2013, GLYCOBIOLOGY, V23, P398, DOI 10.1093/glycob/cws218; Daginakatte GC, 2007, HUM MOL GENET, V16, P1098, DOI 10.1093/hmg/ddm059; Daher A, 2018, EXP NEUROL, V299, P281, DOI 10.1016/j.expneurol.2017.09.006; DELPECH B, 1993, EUR J CANCER, V29A, P1012, DOI 10.1016/S0959-8049(05)80214-X; DeSouza LV, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-74; Ding HY, 2019, J ZHEJIANG UNIV-SC B, V20, P428, DOI 10.1631/jzus.B1900155; DORFMAN A, 1970, P NATL ACAD SCI USA, V66, P495, DOI 10.1073/pnas.66.2.495; Du Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063463; Dzwonek J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00175; Eibl RH, 1995, J NEURO-ONCOL, V26, P165, DOI 10.1007/BF01052619; Enegd B, 2002, NEUROSURGERY, V50, P1311, DOI 10.1097/00006123-200206000-00023; ENGELHARDT A, 1980, ACTA NEUROPATHOL, V49, P199, DOI 10.1007/BF00707107; Erickson AE, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201800295; Ferrandez E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24444-6; Ferrer VP, 2018, GLIA, V66, P1542, DOI 10.1002/glia.23309; Florczyk SJ, 2013, BIOMATERIALS, V34, P10143, DOI 10.1016/j.biomaterials.2013.09.034; Friese MA, 2004, ONKOLOGIE, V27, P487, DOI 10.1159/000080371; GATELY CL, 1984, J IMMUNOL, V133, P3387; GIESE A, 1995, NEUROSURGERY, V37, P294, DOI 10.1227/00006123-199508000-00015; Gilg AG, 2008, CLIN CANCER RES, V14, P1804, DOI 10.1158/1078-0432.CCR-07-1228; GIORDANA MT, 1982, ACTA NEUROPATHOL, V57, P299, DOI 10.1007/BF00692187; GLIMELIUS B, 1988, APMIS, V96, P433, DOI 10.1111/j.1699-0463.1988.tb05327.x; GLIMELIUS B, 1978, BIOCHEM J, V172, P443, DOI 10.1042/bj1720443; GLIMELIUS B, 1979, J CELL PHYSIOL, V98, P527, DOI 10.1002/jcp.1040980311; Gritsenko P, 2017, HISTOCHEM CELL BIOL, V148, P395, DOI 10.1007/s00418-017-1604-2; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Hao JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040716; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; Haring AP, 2019, BIOFABRICATION, V11, DOI 10.1088/1758-5090/ab02c9; Hartheimer JS, 2019, CANCER MICROENVIRON, V12, P47, DOI 10.1007/s12307-019-00224-2; Hascall VC, 2014, MATRIX BIOL, V35, P14, DOI 10.1016/j.matbio.2014.01.014; Haselsberger K, 1998, CANCER LETT, V131, P109, DOI 10.1016/S0304-3835(98)00206-7; Hatano H, 2011, LAB INVEST, V91, P379, DOI 10.1038/labinvest.2010.176; Hayen W, 1999, J CELL SCI, V112, P2241; He ZC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040819; Heffernan JM, 2015, ANN BIOMED ENG, V43, P1965, DOI 10.1007/s10439-014-1223-1; Hermida Miguel A., 2020, Advances in Biological Regulation, V75, P100658, DOI 10.1016/j.jbior.2019.100658; Houy N, 2018, J THEOR BIOL, V446, P71, DOI 10.1016/j.jtbi.2018.02.034; Huang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30011; Jaworski DM, 1996, CANCER RES, V56, P2293; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jiglaire CJ, 2014, EXP CELL RES, V321, P99, DOI 10.1016/j.yexcr.2013.12.010; Jin SG, 2009, J KOREAN NEUROSURG S, V46, P472, DOI 10.3340/jkns.2009.46.5.472; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Jordan AR, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00182; Joy Reenu Anne, 2018, Drug Metabolism and Personalized Therapy, V33, P15, DOI 10.1515/dmpt-2017-0031; Karamanos NK, 2018, CHEM REV, V118, P9152, DOI 10.1021/acs.chemrev.8b00354; Karbownik MS, 2014, WSPOLCZESNA ONKOL, V18, P323, DOI 10.5114/wo.2014.43493; Karbownik MS, 2013, PHARMACOL REP, V65, P1056, DOI 10.1016/S1734-1140(13)71465-8; Karousou E, 2017, MATRIX BIOL, V59, P3, DOI 10.1016/j.matbio.2016.10.001; Kashyap T, 2018, ORAL ONCOL, V86, P234, DOI 10.1016/j.oraloncology.2018.09.028; Kast RE, 2012, ARCH MED RES, V43, P243, DOI 10.1016/j.arcmed.2012.04.005; Khaldoyanidi SK, 2014, ADV CANCER RES, V123, P149, DOI 10.1016/B978-0-12-800092-2.00006-X; Kim MS, 2008, MOL CANCER RES, V6, P1657, DOI 10.1158/1541-7786.MCR-08-0034; Kim MS, 2005, CANCER RES, V65, P686; Kim MS, 2005, INT J ONCOL, V27, P839; Kim Y, 2014, MOL CANCER RES, V12, P1416, DOI 10.1158/1541-7786.MCR-13-0629; Kingsmore KM, 2016, INTEGR BIOL-UK, V8, P1246, DOI 10.1039/c6ib00167j; Klank RL, 2017, CELL REP, V18, P23, DOI 10.1016/j.celrep.2016.12.024; Knupfer MM, 1999, CLIN EXP METASTAS, V17, P71; Knupfer MM, 2000, CYTOKINE, V12, P409, DOI 10.1006/cyto.1999.0575; Knupfer MM, 1998, ANTICANCER RES, V18, P353; Knupfer MM, 2001, ANTICANCER RES, V21, P3989; Koh I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22681-3; KOOCHEKPOUR S, 1995, INT J CANCER, V63, P450, DOI 10.1002/ijc.2910630325; Koochekpour S, 1996, ONCOL REP, V3, P133; Korkes F, 2014, BJU INT, V113, P822, DOI 10.1111/bju.12339; Korshunov A, 2019, NEUROPATH APPL NEURO, V45, P108, DOI 10.1111/nan.12523; Kouvidi K, 2014, ADV CANCER RES, V123, P319, DOI 10.1016/B978-0-12-800092-2.00012-5; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Lamontagne CA, 2008, EXP CELL RES, V314, P227, DOI 10.1016/j.yexcr.2007.07.013; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lompardia SL, 2017, INVEST NEW DRUG, V35, P1, DOI 10.1007/s10637-016-0397-9; Lompardia SL, 2016, GLYCOBIOLOGY, V26, P343, DOI 10.1093/glycob/cwv107; Lompardia SL, 2013, GLYCOBIOLOGY, V23, P1463, DOI 10.1093/glycob/cwt074; Le Rhun E, 2019, CANCER TREAT REV, V80, DOI 10.1016/j.ctrv.2019.101896; Lee KH, 2014, J BIOMED MATER RES A, V102, P1164, DOI 10.1002/jbm.a.34772; Li HB, 2017, STEM CELL REP, V9, P1071, DOI 10.1016/j.stemcr.2017.08.013; Li JY, 2017, ONCOTARGET, V8, P87353, DOI 10.18632/oncotarget.20928; Li XN, 1997, NEUROSURGERY, V40, P1250, DOI 10.1097/00006123-199706000-00027; Lim EJ, 2017, ONCOTARGET, V8, P1438, DOI 10.18632/oncotarget.13638; Liu MH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00947; Liu X, 2018, MOL PHARMACEUT, V15, P1203, DOI 10.1021/acs.molpharmaceut.7b01035; LiverTox, 2012, CLIN RES INF DRUG IN; Logun MT, 2016, J MATER CHEM B, V4, P6052, DOI [10.1039/c6tb01083k, 10.1039/C6TB01083K]; Lompardia S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47248-8; Long KR, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.180216; Long KR, 2018, NEURON, V99, P702, DOI 10.1016/j.neuron.2018.07.013; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Luongo F, 2019, CANCERS, V11, DOI 10.3390/cancers11081076; Lynn BD, 2001, J NEUROSCI RES, V65, P6, DOI 10.1002/jnr.1122; Lynn BD, 2001, J COMP NEUROL, V439, P315, DOI 10.1002/cne.1353; MACKIE AE, 1988, BRIT J CANCER, V58, P101; Manou D., 1952, METHODS MOL BIOL, P1; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; Maria BL, 2008, J CHILD NEUROL, V23, P1214, DOI 10.1177/0883073808321771; Martinez-Quintanilla J, 2015, MOL THER, V23, P108, DOI 10.1038/mt.2014.204; Martinez-Ramos C, 2015, J BIOMED MATER RES B, V103, P1249, DOI 10.1002/jbm.b.33304; Mascaro M, 2017, HISTOCHEM CELL BIOL, V148, P173, DOI 10.1007/s00418-017-1559-3; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Miyata S, 2017, BBA-GEN SUBJECTS, V1861, P2420, DOI 10.1016/j.bbagen.2017.06.010; Mooney KL, 2016, J CLIN NEUROSCI, V34, P1, DOI 10.1016/j.jocn.2016.05.012; Morath I, 2016, INT J BIOCHEM CELL B, V81, P166, DOI 10.1016/j.biocel.2016.09.009; Munson JM, 2013, CANCER RES, V73, P1536, DOI 10.1158/0008-5472.CAN-12-2838; Murai T, 2004, J BIOL CHEM, V279, P4541, DOI 10.1074/jbc.M307356200; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Nagy JI, 1998, NEUROSCIENCE, V86, P241, DOI 10.1016/S0306-4522(98)00017-7; Nagy N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00123; Nakagawa T, 1996, ANTICANCER RES, V16, P2917; Naor D, 2009, HYALURONAN IN CANCER BIOLOGY, 1ST EDITION, P127, DOI 10.1016/B978-012374178-3.10008-0; Ngo MT, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700687; OBERCGREENWOOD MA, 1986, J NEURO-ONCOL, V3, P387, DOI 10.1007/BF00165589; Okada H, 1996, INT J CANCER, V66, P255, DOI 10.1002/(SICI)1097-0215(19960410)66:2<255::AID-IJC20>3.0.CO;2-A; Park D, 2012, MOL CELLS, V33, P563, DOI 10.1007/s10059-012-2294-1; Park MJ, 2002, CANCER RES, V62, P6318; Passi A, 2019, ADV DRUG DELIVER REV, V146, P83, DOI 10.1016/j.addr.2019.08.006; Pedron S, 2013, J BIOMED MATER RES A, V101, P3404, DOI 10.1002/jbm.a.34637; Pedron S, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700529; Perus LJM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02294; PHILIPSON LH, 1985, BIOCHEMISTRY-US, V24, P7899, DOI 10.1021/bi00348a008; Philteos J, 2019, AM J CLIN ONCOL-CANC, V42, P117, DOI 10.1097/COC.0000000000000490; Pibuel MA, 2021, GLYCOBIOLOGY, V31, P29, DOI 10.1093/glycob/cwaa046; Pilkington GJ, 1996, BRAZ J MED BIOL RES, V29, P1159; Piperigkou Z, 2019, TRENDS BIOCHEM SCI, V44, P1076, DOI 10.1016/j.tibs.2019.06.007; Pogoda K, 2017, BIOMACROMOLECULES, V18, P3040, DOI 10.1021/acs.biomac.7b00324; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Preston Marnie, 2011, Front Biosci (Schol Ed), V3, P1165; Provenzano PP, 2013, BRIT J CANCER, V108, P1, DOI 10.1038/bjc.2012.569; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Raber J, 2014, BEHAV BRAIN RES, V275, P146, DOI 10.1016/j.bbr.2014.09.010; Radotra B, 1997, ANTICANCER RES, V17, P945; Radotra B, 1997, J PATHOL, V181, P434; RADOTRA B, 1994, NEUROPATH APPL NEURO, V20, P399, DOI 10.1111/j.1365-2990.1994.tb00986.x; Rajaratnam V, 2020, CANCERS, V12, DOI 10.3390/cancers12040937; Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j; Rao SS, 2013, BIOMATERIALS, V34, P5181, DOI 10.1016/j.biomaterials.2013.03.069; Rape A, 2014, ADV DRUG DELIVER REV, V79-80, P172, DOI 10.1016/j.addr.2014.08.012; Rape AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9129; REICHARDBROWN JL, 1983, DEV BIOL, V96, P304, DOI 10.1016/0012-1606(83)90167-7; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Sadeghi N, 2003, AM J ROENTGENOL, V181, P235, DOI 10.2214/ajr.181.1.1810235; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; Serres E, 2014, ONCOGENE, V33, P3451, DOI 10.1038/onc.2013.305; Shankar A, 2014, CHIN J CANCER, V33, P148, DOI 10.5732/cjc.013.10095; Sim H, 2009, J BIOL CHEM, V284, P26547, DOI 10.1074/jbc.M109.013185; Simon T, 2014, NEUROMOL MED, V16, P752, DOI 10.1007/s12017-014-8324-8; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; Soysal SD, 2015, PATHOBIOLOGY, V82, P142, DOI 10.1159/000430499; STECK PA, 1989, CANCER RES, V49, P2096; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Strobel H, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7030069; Su WP, 2019, MATRIX BIOL, V78-79, P272, DOI 10.1016/j.matbio.2018.01.022; Tamaki M, 1997, J NEUROSURG, V87, P602, DOI 10.3171/jns.1997.87.4.0602; Tavianatou AG, 2019, FEBS J, V286, P2883, DOI 10.1111/febs.14777; Termeer C, 2003, TRENDS IMMUNOL, V24, P112, DOI 10.1016/S1471-4906(03)00029-2; Tian CH, 2018, COLLOID SURFACE B, V165, P45, DOI 10.1016/j.colsurfb.2018.02.016; Tilghman J, 2014, CANCER RES, V74, P3168, DOI 10.1158/0008-5472.CAN-13-2103; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Torre C, 2010, ARCH OTOLARYNGOL, V136, P493, DOI 10.1001/archoto.2010.25; Tsatas D, 2002, J CLIN NEUROSCI, V9, P282, DOI 10.1054/jocn.2001.1063; TURLEY EA, 1994, GLIA, V12, P68, DOI 10.1002/glia.440120109; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146; Tye SL, 2008, J CHILD NEUROL, V23, P1221, DOI 10.1177/0883073808321066; Valkonen M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4569-1; van Vulpen M, 2002, ONCOL REP, V9, P683; Varga I, 2010, CENT EUR NEUROSURG, V71, P173, DOI 10.1055/s-0030-1249698; Vigetti D, 2014, FEBS J, V281, P4980, DOI 10.1111/febs.12938; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Virga J, 2018, PATHOL ONCOL RES, V24, P35, DOI 10.1007/s12253-017-0194-6; Wade A, 2013, FEBS J, V280, P2399, DOI 10.1111/febs.12109; Wakahara K, 2005, J CELL BIOCHEM, V94, P995, DOI 10.1002/jcb.20364; Waker CA, 2019, ADV EXP MED BIOL, V1190, P281, DOI 10.1007/978-981-32-9636-7_18; Wang C, 1998, CLIN CANCER RES, V4, P567; Wang C, 2014, MOL PHARMACEUT, V11, P2115, DOI 10.1021/mp5000828; Wang HH, 2017, AM J TRANSL RES, V9, P4785; Wang K, 2016, ADV HEALTHC MATER, V5, P3173, DOI 10.1002/adhm.201600684; Wang XZ, 2018, BIOCHEM BIOPH RES CO, V498, P1052, DOI 10.1016/j.bbrc.2018.03.114; WASTESON A, 1973, INT J CANCER, V12, P169, DOI 10.1002/ijc.2910120118; Weller M, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.17; WIRANOWSKA M, 1994, J NEURO-ONCOL, V18, P9, DOI 10.1007/BF01324598; Wiranowska M, 2006, BRAIN CELL BIOL, V35, P159, DOI 10.1007/s11068-007-9009-0; Wiranowska M, 2010, INT J CANCER, V127, P532, DOI 10.1002/ijc.25085; Wirsching Hans-Georg, 2016, Handb Clin Neurol, V134, P381, DOI 10.1016/B978-0-12-802997-8.00023-2; Wolburg H, 2012, MOL ASPECTS MED, V33, P579, DOI 10.1016/j.mam.2012.02.003; Won WJ, 2019, CELL STRESS, V3, P47, DOI 10.15698/cst2019.02.176; Xiao W., 2017, PHYSIOL BEHAV, V176, P139; Yang LQ, 2018, DRUG DELIV, V25, P388, DOI 10.1080/10717544.2018.1431979; Yang TB, 2002, CANCER RES, V62, P2583; Yang YL, 2011, BIOMATERIALS, V32, P7932, DOI 10.1016/j.biomaterials.2011.07.018; Yeldag G, 2018, CANCERS, V10, DOI 10.3390/cancers10120471; Yoo KC, 2018, ONCOGENE, V37, P3317, DOI 10.1038/s41388-018-0199-y; Zhang GL, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1172154; Zhang H, 1998, J NEUROSCI, V18, P2370; Zhang HZ, 2019, FASEB J, V33, P6365, DOI 10.1096/fj.201802186R; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; Zhao ZY, 2019, J CELL BIOCHEM, V120, P11510, DOI 10.1002/jcb.28430; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	240	14	14	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100549	10.1016/j.jbc.2021.100549	http://dx.doi.org/10.1016/j.jbc.2021.100549			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744285	gold, Green Published			2022-12-28	WOS:000672866400522
J	Bruno, J; Edwards, JC				Bruno, Jonathan; Edwards, John C.			Kidney-disease-associated variants of Apolipoprotein L1 show gain of function in cation channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOL1 RISK VARIANTS; SIZE DISTRIBUTION; EXTRUSION; PROTEIN	Variants in Apolipoprotein L1 (ApoL1) are known to be responsible for increased risk of some progressive kidney diseases among people of African ancestry. ApoL1 is an amphitropic protein that can insert into phospholipid membranes and confer anion- or cation-selective permeability to phospholipid membranes depending on pH. Whether these activities differ among the variants or whether they contribute to disease pathogenesis is unknown. We used assays of voltage-driven ion flux from phospholipid vesicles and of stable membrane association to assess differences among ApoL1 isoforms. There is a significant (approximately twofold) increase in the cation-selective ion permease activity of the two kidney-disease-associated variants compared with the reference protein. In contrast, we find no difference in the anion-selective permease activity at low pH among the isoforms. Compared with the reference sequence, the two disease-associated variants show increased stable association with phospholipid vesicles under conditions that support the cation permease activity, suggesting that the increased activity may be due to more efficient membrane association and insertion. There is no difference in membrane association among isoforms under optimal conditions for the anion permease activity. These data support a model in which enhanced cation permeability may contribute to the progressive kidney diseases associated with high-risk ApoL1 alleles.	[Bruno, Jonathan; Edwards, John C.] St Louis Univ, Dept Internal Med, Nephrol Div, St Louis, MO 63103 USA	Saint Louis University	Edwards, JC (corresponding author), St Louis Univ, Dept Internal Med, Nephrol Div, St Louis, MO 63103 USA.	John.Edwards@health.slu.edu	Bruno, Jonathan/HII-3034-2022		institutional resources of Saint Louis University; National Institutes of Health [R01 DK120651]	institutional resources of Saint Louis University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was funding by institutional resources of Saint Louis University and by National Institutes of Health grant R01 DK120651 to J. C. E. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armitage P., 1971, STAT METHODS MED RES, V1; Bruggeman LA, 2017, J AM SOC NEPHROL, V28, P1008, DOI 10.1681/ASN.2016111262; Bruno J, 2017, J BIOL CHEM, V292, P18344, DOI 10.1074/jbc.M117.813444; Friedman DJ, 2020, ANNU REV PHYSIOL, V82, P323, DOI 10.1146/annurev-physiol-021119-034345; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Harrington JM, 2009, J BIOL CHEM, V284, P13505, DOI 10.1074/jbc.M900151200; Hayek SS, 2017, NAT MED, V23, P945, DOI 10.1038/nm.4362; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Kopp JB, 2018, CURR OPIN NEPHROL HY, V27, P153, DOI 10.1097/MNH.0000000000000399; Ma LJ, 2017, J AM SOC NEPHROL, V28, P1093, DOI 10.1681/ASN.2016050567; O'Toole JF, 2018, J AM SOC NEPHROL, V29, P869, DOI 10.1681/ASN.2016121322; Olabisi OA, 2016, P NATL ACAD SCI USA, V113, P830, DOI 10.1073/pnas.1522913113; OLSON F, 1979, BIOCHIM BIOPHYS ACTA, V557, P9, DOI 10.1016/0005-2736(79)90085-3; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Shah SS, 2019, J AM SOC NEPHROL, V30, P2355, DOI 10.1681/ASN.2019020114; Thomson R, 2015, P NATL ACAD SCI USA, V112, P2894, DOI 10.1073/pnas.1421953112; Vanhollebeke B, 2006, CELL MOL LIFE SCI, V63, P1937, DOI 10.1007/s00018-006-6091-x; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200	19	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100238	10.1074/jbc.RA120.013943	http://dx.doi.org/10.1074/jbc.RA120.013943			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33380423	Green Published, gold			2022-12-28	WOS:000672866400216
J	Chen, L; Hao, M; Yan, JM; Sun, L; Tai, GH; Cheng, HR; Zhou, YF				Chen, Lei; Hao, Miao; Yan, Jingmin; Sun, Lin; Tai, Guihua; Cheng, Hairong; Zhou, Yifa			Citrus-derived DHCP inhibits mitochondrial complex II to enhance TRAIL sensitivity via ROS-induced DR5 upregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; INDUCED APOPTOSIS; DEATH RECEPTORS; DOWN-REGULATION; TUMOR-CELLS; LIGAND; INDUCTION; PECTIN; IDENTIFICATION; SENSITIZATION	Heat-modified citrus pectin, a water-soluble indigestible polysaccharide fiber derived from citrus fruits and modified by temperature treatment, has been reported to exhibit anticancer effects. However, the bioactive fractions and their mechanisms remain unclear. In this current study, we isolated an active compound, trans-4,5-dihydroxy-2-cyclopentene-l-one (DHCP), from heat-treated citrus pectin, and found that is induces cell death in colon cancer cells via induction of mitochondrial ROS. On the molecular level, DHCP triggers ROS production by inhibiting the activity of succinate ubiquinone reductase (SQR) in mitochondrial complex II. Furthermore, cytotoxicity, apoptotic activity, and activation of caspase cascades were determined in HCT116 and HT-29 cell-based systems, the results indicated that DHCP enhances the sensitivity of cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), with DHCP-induced ROS accounting for the synergistic effect between DHCP and TRAIL. Furthermore, the combination of DHCP and TRAIL inhibits the growth of HCT116 and HT-29 xenografts synergistically. ROS significantly increases the expression of TRAIL death receptor 5 (DR5) via the p53 and C/EBP homologous protein pathways. Collectively, our findings indicate that DHCP has a favorable toxicity profile and is a new TRAIL sensitizer that shows promise in the development of pectin-based pharmaceuticals, nutraceuticals, and dietary agents aimed at combating human colon cancer.	[Chen, Lei; Hao, Miao; Yan, Jingmin; Sun, Lin; Tai, Guihua; Cheng, Hairong; Zhou, Yifa] Northeast Normal Univ, Engn Res Ctr Glycoconjugates, Sch Life Sci,Minist Educ, Jilin Prov Key Lab Chem & Biol Changbai Mt Nat Dr, Changchun, Peoples R China	Northeast Normal University - China	Cheng, HR; Zhou, YF (corresponding author), Northeast Normal Univ, Engn Res Ctr Glycoconjugates, Sch Life Sci,Minist Educ, Jilin Prov Key Lab Chem & Biol Changbai Mt Nat Dr, Changchun, Peoples R China.	chenghr893@nenu.edu.cn; zhouyf383@nenu.edu.cn		Hao, Miao/0000-0002-8386-2145	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China [2019ZX09735-001]; National Natural Science Foundation of China [31770852, 31870796]	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China (2019ZX09735-001) and the National Natural Science Foundation of China (31770852, 31870796). We are thankful for HCT116 variants with deletion of p53 gift from Dr Xinshan Ye, (Peking University, Beijing, China). Dr Qiang Yu (Chinese Academy of Sciences, Shanghai, China) kindly provided human lung epithelial A549 cells and A549.0 cells.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bezawork-Geleta A, 2017, TRENDS BIOCHEM SCI, V42, P312, DOI 10.1016/j.tibs.2017.01.003; Chang CC, 2015, CHEM RES TOXICOL, V28, P1574, DOI 10.1021/acs.chemrestox.5b00150; Chen CY, 2010, J AGR FOOD CHEM, V58, P5604, DOI 10.1021/jf904260b; Chen L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.234; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Cheng HR, 2011, MED ONCOL, V28, P175, DOI 10.1007/s12032-010-9449-8; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Earel JK, 2006, CANCER RES, V66, P499, DOI 10.1158/0008-5472.CAN-05-3017; Forero-Torres A, 2015, CLIN CANCER RES, V21, P2722, DOI 10.1158/1078-0432.CCR-14-2780; Gillissen B, 2017, J BIOL CHEM, V292, P6478, DOI 10.1074/jbc.M116.754184; Guan BX, 2001, J CELL PHYSIOL, V188, P98, DOI 10.1002/jcp.1101; Guan Y, 2018, J FUNCT FOODS, V48, P190, DOI 10.1016/j.jff.2018.07.001; Guo LL, 2016, J BIOL CHEM, V291, P42, DOI 10.1074/jbc.M115.697516; Hao M, 2013, FOOD FUNCT, V4, P960, DOI 10.1039/c3fo30350k; Holze C, 2018, NAT IMMUNOL, V19, P130, DOI 10.1038/s41590-017-0013-y; Hung CM, 2017, J AGR FOOD CHEM, V65, P11179, DOI 10.1021/acs.jafc.7b02358; Ishii T, 2005, CANCER RES, V65, P203; Jackson CL, 2007, GLYCOBIOLOGY, V17, P805, DOI 10.1093/glycob/cwm054; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Kim B, 2020, INT J ONCOL, V56, P821, DOI 10.3892/ijo.2020.4970; Kim JH, 2012, ANTIOXID REDOX SIGN, V16, P413, DOI 10.1089/ars.2011.3982; Kim SH, 2004, J BIOL CHEM, V279, P40044, DOI 10.1074/jbc.M404541200; Koyama N., 2000, US patent, Patent No. [US6087401, 6087401]; Kruspig B, 2016, BBA-MOL CELL RES, V1863, P2065, DOI 10.1016/j.bbamcr.2016.04.026; Lara-Espinoza C, 2018, MOLECULES, V23, DOI 10.3390/molecules23040942; Leclere L, 2016, CARBOHYD POLYM, V137, P39, DOI 10.1016/j.carbpol.2015.10.055; Leclere L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115831; Leclere L, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00128; Lee JH, 2014, J NAT PROD, V77, P2438, DOI 10.1021/np500452e; Liu Y, 2014, CANCER SCI, V105, P520, DOI 10.1111/cas.12395; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Noreen A, 2017, INT J BIOL MACROMOL, V101, P254, DOI 10.1016/j.ijbiomac.2017.03.029; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Prasad S, 2014, TRENDS PHARMACOL SCI, V35, P520, DOI 10.1016/j.tips.2014.07.004; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Ralff MD, 2018, EXPERT REV PRECIS ME, V3, P197, DOI 10.1080/23808993.2018.1476062; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; Sayers TJ, 2006, CANCER IMMUNOL IMMUN, V55, P76, DOI 10.1007/s00262-005-0676-3; Seo BR, 2017, ANTIOXID REDOX SIGN, V27, P215, DOI 10.1089/ars.2016.6749; Shankar S, 2008, CLIN CANCER RES, V14, P6855, DOI 10.1158/1078-0432.CCR-08-0903; Shi YS, 2020, BIOMATERIALS, V233, DOI 10.1016/j.biomaterials.2019.119753; Singh TR, 2005, ONCOGENE, V24, P4609, DOI 10.1038/sj.onc.1208585; Sun XX, 2013, J BIOL CHEM, V288, P8826, DOI 10.1074/jbc.M112.429316; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02915-8; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yadav VR, 2012, BRIT J PHARMACOL, V165, P741, DOI 10.1111/j.1476-5381.2011.01603.x; Zhang B, 2015, FREE RADICAL BIO MED, V89, P486, DOI 10.1016/j.freeradbiomed.2015.09.021; Zhang WB, 2015, TRENDS FOOD SCI TECH, V44, P258, DOI 10.1016/j.tifs.2015.04.001	55	2	2	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100515	10.1016/j.jbc.2021.100515	http://dx.doi.org/10.1016/j.jbc.2021.100515			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676890	Green Published, gold			2022-12-28	WOS:000672866400489
J	Granados, JC; Richelle, A; Gutierrez, JM; Zhang, P; Zhang, XL; Bhatnagar, V; Lewis, NE; Nigam, SK				Granados, Jeffry C.; Richelle, Anne; Gutierrez, Jahir M.; Zhang, Patrick; Zhang, Xinlian; Bhatnagar, Vibha; Lewis, Nathan E.; Nigam, Sanjay K.			Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTERS; ARYL-HYDROCARBON RECEPTOR; UREMIC TOXINS; KYNURENINE PATHWAY; CHOROID-PLEXUS; ACID; SLC22A8; REVEALS; DETERMINANTS; SECRETION	How organs sense circulating metabolites is a key question. Here, we show that the multispecific organic anion transporters of drugs, OAT1 (SLC22A6 or NKT) and OAT3 (SLC22A8), play a role in organ sensing. Metabolomics analyses of the serum of Oat1 and Oat3 knockout mice revealed changes in tryptophan derivatives involved in metabolism and signaling. Several of these metabolites are derived from the gut microbiome and are implicated as uremic toxins in chronic kidney disease. Direct interaction with the transporters was supported with cell-based transport assays. To assess the impact of the loss of OAT1 or OAT3 function on the kidney, an organ where these uptake transporters are highly expressed, knockout transcriptomic data were mapped onto a "metabolic task"-based computational model that evaluates over 150 cellular functions. Despite the changes of tryptophan metabolites in both knockouts, only in the Oat1 knockout were multiple tryptophan-related cellular functions increased. Thus, deprived of the ability to take up kynurenine, kynurenate, anthranilate, and N-formylanthranilate through OAT1, the kidney responds by activating its own tryptophan-related biosynthetic pathways. The results support the Remote Sensing and Signaling Theory, which describes how "drug" transporters help optimize levels of metabolites and signaling molecules by facilitating organ cross talk. Since OAT1 and OAT3 are inhibited by many drugs, the data implies potential for drug-metabolite interactions. Indeed, treatment of humans with probenecid, an OATinhibitor used to treat gout, elevated circulating tryptophan metabolites. Furthermore, given that regulatory agencies have recommended drugs be tested for OAT1 and OAT3 binding or transport, it follows that these metabolites can be used as endogenous biomarkers to determine if drug candidates interact with OAT1 and/or OAT3.	[Granados, Jeffry C.; Gutierrez, Jahir M.; Lewis, Nathan E.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Richelle, Anne; Lewis, Nathan E.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Zhang, Patrick] Univ Calif San Diego, Dept Biol, La Jolla, CA USA; [Zhang, Xinlian] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Biostat & Bioinformat, La Jolla, CA 92093 USA; [Bhatnagar, Vibha] Univ Calif San Diego, Dept Family & Preventat Med, La Jolla, CA 92093 USA; [Lewis, Nathan E.] Univ Calif San Diego, UC San Diego, Novo Nordisk Fdn, Ctr Biosustainabil, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Nigam, SK (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	snigam@health.ucsd.edu		Granados, Jeffry/0000-0003-0393-7141; Gutierrez, Jahir/0000-0001-9188-4726; Zhang, Patrick/0000-0003-0241-4525	National Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS) [R01GM132938]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [T32EB009380]; NIGMS [R35GM119850]; National Institute of Allergy and Infectious Diseases (NIAID) [UH2AI153029]; Government of Mexico (CONACYT); University of California Institute for Mexico and the United States (UC-MEXUS); LIFA fellowship	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Government of Mexico (CONACYT); University of California Institute for Mexico and the United States (UC-MEXUS); LIFA fellowship	This work was supported by a grant from the National Institutes of Health (NIH) to S. K. N. from the National Institute of General Medical Sciences (NIGMS) (R01GM132938). Support for J. C. G. comes from the training grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) (T32EB009380) and a supplement to R01GM132938. This work was funded in part by generous funding from NIGMS to N. E. L. (R35GM119850), National Institute of Allergy and Infectious Diseases (NIAID) to N. E. L. (UH2AI153029), a LIFA fellowship to A. R., and a fellowship to J. M. G. from the Government of Mexico (CONACYT) and the University of California Institute for Mexico and the United States (UC-MEXUS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Some figures were generated using Biorender. This article is dedicated to the memory of Vibha Bhatnagar, MD, MPH.	Ahn SY, 2008, CURR OPIN NEPHROL HY, V17, P499, DOI 10.1097/MNH.0b013e32830b5d5d; Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, DOI 10.1177/1178646917691938; Bahn A, 2005, AM J PHYSIOL-CELL PH, V289, pC1075, DOI 10.1152/ajpcell.00619.2004; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bhatnagar V, 2016, CLIN KIDNEY J, V9, P444, DOI 10.1093/ckj/sfw010; Brady KP, 1999, GENOMICS, V56, P254, DOI 10.1006/geno.1998.5722; Burckhardt G, 2012, PHARMACOL THERAPEUT, V136, P106, DOI 10.1016/j.pharmthera.2012.07.010; Bush KT, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133817; Bush KT, 2017, J BIOL CHEM, V292, P15789, DOI 10.1074/jbc.M117.796516; Deguchi T, 2004, KIDNEY INT, V65, P162, DOI 10.1111/j.1523-1755.2004.00354.x; DiNatale BC, 2010, TOXICOL SCI, V115, P89, DOI 10.1093/toxsci/kfq024; Divorty N, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00041; Duan P, 2012, MOL PHARMACEUT, V9, P3340, DOI 10.1021/mp300365t; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Engelhart DC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062002; Engelhart DC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051791; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Evers R, 2018, CLIN PHARMACOL THER, V104, P900, DOI 10.1002/cpt.1115; Govindarajan R, 2016, CLIN PHARMACOL THER, V100, P398, DOI 10.1002/cpt.454; Granados J. C., 2021, J BIOL CHEM; Hoglund E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00158; Jansen J, 2019, P NATL ACAD SCI USA, V116, P16105, DOI 10.1073/pnas.1821809116; Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Lepist EI, 2017, EXPERT OPIN DRUG MET, V13, P1075, DOI 10.1080/17425255.2017.1372425; Lisowska-Myjak B, 2014, NEPHRON CLIN PRACT, V128, P303, DOI 10.1159/000369817; Liu HC, 2016, J BIOL CHEM, V291, P19474, DOI 10.1074/jbc.M116.745216; Liu Y, 2016, CELL REP, V14, P2889, DOI 10.1016/j.celrep.2016.02.079; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lowenstein J, 2016, AM J PHYSIOL-RENAL, V310, pF1351, DOI 10.1152/ajprenal.00055.2016; Lu H, 2017, PEERJ, V5, DOI 10.7717/peerj.3333; Manzella C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24213-5; Masereeuw R, 2014, SEMIN NEPHROL, V34, P191, DOI 10.1016/j.semnephrol.2014.02.010; Masereeuw R, 2010, PHARMACOL THERAPEUT, V126, P200, DOI 10.1016/j.pharmthera.2010.02.007; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Nagle MA, 2013, NEUROSCI LETT, V534, P133, DOI 10.1016/j.neulet.2012.11.027; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nigam AK, 2020, J BIOL CHEM, V295, P1829, DOI 10.1074/jbc.RA119.010729; Nigam SK, 2020, CLIN PHARMACOL THER, V108, P40, DOI 10.1002/cpt.1818; Nigam SK, 2019, NAT REV NEPHROL, V15, P301, DOI 10.1038/s41581-019-0111-1; Nigam SK, 2018, CURR OPIN NEPHROL HY, V27, P305, DOI 10.1097/MNH.0000000000000427; Nigam SK, 2018, ANNU REV PHARMACOL, V58, P663, DOI 10.1146/annurev-pharmtox-010617-052713; Nigam SK, 2015, CLIN J AM SOC NEPHRO, V10, P2039, DOI 10.2215/CJN.02440314; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Niwa T, 2010, NAGOYA J MED SCI, V72, P1; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Poeggeler B, 2007, NEUROSCIENCE, V148, P188, DOI 10.1016/j.neuroscience.2007.05.033; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Rael LT, 2018, BIOCHEM BIOPHYS REP, V15, DOI 10.1016/j.bbrep.2018.06.006; Richard DM, 2009, INT J TRYPTOPHAN RES, V2, P45; Richelle A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007185; Richelle A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006867; Riedmaier AE, 2012, PHARMACOL REV, V64, P421, DOI 10.1124/pr.111.004614; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Rosenthal SB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47798-x; Saito H, 2010, PHARMACOL THERAPEUT, V125, P79, DOI 10.1016/j.pharmthera.2009.09.008; Sallee M, 2014, TOXINS, V6, P934, DOI 10.3390/toxins6030934; Savitz J, 2020, MOL PSYCHIATR, V25, P131, DOI 10.1038/s41380-019-0414-4; Schwarcz R, 2017, NEUROPHARMACOLOGY, V112, P237, DOI 10.1016/j.neuropharm.2016.08.003; Sirianni AC, 2015, J NEUROCHEM, V134, P956, DOI 10.1111/jnc.13190; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Tankiewicz A, 2003, ADV EXP MED BIOL, V527, P409; Torres AM, 2011, J BIOL CHEM, V286, P26391, DOI 10.1074/jbc.M111.249292; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Uwai Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1517, DOI 10.1271/bbb.130178; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Vallon V, 2012, AM J PHYSIOL-RENAL, V302, pF1293, DOI 10.1152/ajprenal.00013.2012; van den Brand JAJG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168117; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; VanWert AL, 2007, AM J PHYSIOL-RENAL, V293, pF1332, DOI 10.1152/ajprenal.00319.2007; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wu W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04949-2; Wu W, 2013, DRUG METAB DISPOS, V41, P1825, DOI 10.1124/dmd.113.052647; You G, 2014, WILEY SER DRUG DISC, P1, DOI 10.1002/9781118705308; Zhao ZH, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0304-5; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140569	82	14	14	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100575	10.1016/j.jbc.2021.100575	http://dx.doi.org/10.1016/j.jbc.2021.100575			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33757768	Green Published, gold			2022-12-28	WOS:000672866400548
J	Hayek, H; Gross, L; Janvier, A; Schaeffer, L; Martin, F; Eriani, G; Allmang, C				Hayek, Hassan; Gross, Lauriane; Janvier, Aurelie; Schaeffer, Laure; Martin, Franck; Eriani, Gilbert; Allmang, Christine			eIF3 interacts with histone H4 messenger RNA to regulate its translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 3; CAP-BINDING PROTEIN; EUKARYOTIC TRANSLATION; STRUCTURAL INSIGHTS; RECOGNITION MOTIF; FACTOR 4G; COMPLEX; SUBUNIT; REPLICATION; ROLES	In eukaryotes, various alternative translation initiation mechanisms have been unveiled for the translation of specific mRNAs. Some do not conform to the conventional scanning-initiation model. Translation initiation of histone H4 mRNA combines both canonical (cap-dependent) and viral initiation strategies (no-scanning, internal recruitment of initiation factors). Specific H4 mRNA structures tether the translation machinery directly onto the initiation codon and allow massive production of histone H4 during the S phase of the cell cycle. The human eukaryotic translation initiation factor 3 (eIF3), composed of 13 subunits (a-m), was shown to selectively recruit and control the expression of several cellular mRNAs. Whether eIF3 mediates H4 mRNA translation remains to be elucidated. Here, we report that eIF3 binds to a stem-loop structure (eIF3-BS) located in the coding region of H4 mRNA. Combining cross-linking and ribonucleoprotein immunoprecipitation experiments in vivo and in vitro, we also found that eIF3 binds to H1, H2A, H2B, and H3 histone mRNAs. We identified direct contacts between eIF3c, d, e, g subunits, and histone mRNAs but observed distinct interaction patterns to each histone mRNA. Our results show that eIF3 depletion in vivo reduces histone mRNA binding and modulates histone neosynthesis, suggesting that synthesis of histones is sensitive to the levels of eIF3. Thus, we provide evidence that eIF3 acts as a regulator of histone translation.	[Hayek, Hassan; Gross, Lauriane; Janvier, Aurelie; Schaeffer, Laure; Martin, Franck; Eriani, Gilbert; Allmang, Christine] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, Strasbourg, France; [Hayek, Hassan] Temple Univ, Dept Thorac Med & Surg, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19140 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Eriani, G; Allmang, C (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, Strasbourg, France.	g.eriani@unistra.fr; c.allmang@unistra.fr	MARTIN, Franck/D-9042-2015	MARTIN, Franck/0000-0001-9724-4025; Hayek, Hassan/0000-0001-6250-0535; Eriani, Gilbert/0000-0002-8518-4675; Allmang, Christine/0000-0001-8883-0874	French Centre National de la Recherche CNRS; Universite de Strasbourg; Agence Nationale de la Recherche [ANR-17-CE11-0024]; Libanese Doctoralship from the municipality of Adchit; University of Strasbourg Doctoralship	French Centre National de la Recherche CNRS; Universite de Strasbourg; Agence Nationale de la Recherche(French National Research Agency (ANR)); Libanese Doctoralship from the municipality of Adchit; University of Strasbourg Doctoralship	This work was supported by the French Centre National de la Recherche CNRS; Universite de Strasbourg; Agence Nationale de la Recherche [ANR-17-CE11-0024, H4translation]; Libanese Doctoralship from the municipality of Adchit (to H. H.); University of Strasbourg Doctoralship (to L. G.).	Aitken CE, 2016, ELIFE, V5, DOI 10.7554/eLife.20934; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044; Cai Q, 2010, J MOL BIOL, V403, P185, DOI 10.1016/j.jmb.2010.07.054; Cakmakci NG, 2008, MOL CELL BIOL, V28, P1182, DOI 10.1128/MCB.01500-07; Cate JHD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0176; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; de la Parra C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05539-0; de Tacca LMA, 2019, RNA, V25, P1324, DOI 10.1261/rna.070193.118; des Georges A, 2015, NATURE, V525, P491, DOI 10.1038/nature14891; Dominski Z, 2007, GENE, V396, P373, DOI 10.1016/j.gene.2007.04.021; Dong ZZ, 2009, EXP CELL RES, V315, P1889, DOI 10.1016/j.yexcr.2009.03.009; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; Ellisdon Andrew M, 2012, Bioarchitecture, V2, P118, DOI 10.4161/bioa.21131; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Eriani G, 2018, RNA BIOL, V15, P1250, DOI 10.1080/15476286.2018.1518855; Erzberger JP, 2014, CELL, V159, P1227, DOI 10.1016/j.cell.2014.11.001; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Gribling-Burrer AS, 2017, NUCLEIC ACIDS RES, V45, P5399, DOI 10.1093/nar/gkx031; Gross L, 2018, METHODS, V137, P3, DOI 10.1016/j.ymeth.2017.12.019; Gross L, 2017, NUCLEIC ACIDS RES, V45, P8993, DOI 10.1093/nar/gkx622; Hayek H., 2020, ADV EXPT MED BIOL, V2; Hershey JWB, 2015, BBA-GENE REGUL MECH, V1849, P792, DOI 10.1016/j.bbagrm.2014.10.005; Higareda-Mendoza AE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-10; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2017, TRENDS BIOCHEM SCI, V42, P589, DOI 10.1016/j.tibs.2017.03.004; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jaeger S, 2005, BIOCHIMIE, V87, P827, DOI 10.1016/j.biochi.2005.03.012; Jivotovskaya AV, 2006, MOL CELL BIOL, V26, P1355, DOI 10.1128/MCB.26.4.1355-1372.2006; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; Karaskova M, 2012, J BIOL CHEM, V287, P28420, DOI 10.1074/jbc.M112.386656; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Lee ASY, 2016, NATURE, V536, P96, DOI 10.1038/nature18954; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103; Llacer JL, 2015, MOL CELL, V59, P399, DOI 10.1016/j.molcel.2015.06.033; Martin F, 1997, EMBO J, V16, P769, DOI 10.1093/emboj/16.4.769; Martin F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12622; Martin F, 2011, MOL CELL, V41, P197, DOI 10.1016/j.molcel.2010.12.019; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Mejlvang J, 2014, J CELL BIOL, V204, P29, DOI 10.1083/jcb.201305017; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; Neusiedler J, 2012, RNA, V18, P1163, DOI 10.1261/rna.032631.112; Obayashi E, 2017, CELL REP, V18, P2651, DOI 10.1016/j.celrep.2017.02.052; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pulos-Holmes MC, 2019, ELIFE, V8, DOI 10.7554/eLife.48193; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Querido JB, 2020, SCIENCE, V369, P1220, DOI 10.1126/science.aba4904; Shah M, 2016, CELL REP, V16, P1891, DOI 10.1016/j.celrep.2016.07.006; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Smith MD, 2016, STRUCTURE, V24, P886, DOI 10.1016/j.str.2016.02.024; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Sun YD, 2020, SCIENCE, V367, P700, DOI 10.1126/science.aaz7758; Szostak E, 2018, NUCLEIC ACIDS RES, V46, P4099, DOI 10.1093/nar/gky246; Takeuchi A, 2009, NUCLEIC ACIDS RES, V37, P2126, DOI 10.1093/nar/gkp078; Ujino S, 2012, VIRUS RES, V163, P390, DOI 10.1016/j.virusres.2011.10.003; Valasek LS, 2017, NUCLEIC ACIDS RES, V45, P10948, DOI 10.1093/nar/gkx805; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; van der Meijden CMJ, 2002, CANCER RES, V62, P3233; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; von Moeller H, 2013, NUCLEIC ACIDS RES, V41, P7960, DOI 10.1093/nar/gkt558; Wagner S, 2016, NUCLEIC ACIDS RES, V44, P10772, DOI 10.1093/nar/gkw972; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Wurth L, 2014, NUCLEIC ACIDS RES, V42, P8663, DOI 10.1093/nar/gku580; Yin YT, 2018, GENE, V673, P130, DOI 10.1016/j.gene.2018.06.034; Zeman J, 2019, NUCLEIC ACIDS RES, V47, P8282, DOI 10.1093/nar/gkz570; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	78	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100578	10.1016/j.jbc.2021.100578	http://dx.doi.org/10.1016/j.jbc.2021.100578			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33766559	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400551
J	Inaba, H; Miao, QQ; Nakata, T				Inaba, Hironori; Miao, Qianqian; Nakata, Takao			Optogenetic control of small GTPases reveals RhoA mediates intracellular calcium signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C-EPSILON; PROTEIN-COUPLED-RECEPTOR; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; PLASMA-MEMBRANE; RAS SUPERFAMILY; PLC-EPSILON; ACTIVATION; LIGHT; KINASE; PATHWAYS	Rho/Ras family small GTPases are known to regulate numerous cellular processes, including cytoskeletal reorganization, cell proliferation, and cell differentiation. These processes are also controlled by Ca2+, and consequently, cross talk between these signals is considered likely. However, systematic quantitative evaluation has not yet been reported. To fill this gap, we constructed optogenetic tools to control the activity of small GTPases (RhoA, Rac1, Cdc42, Ras, Rap, and Ral) using an improved light-inducible dimer system (iLID). We characterized these optogenetic tools with genetically encoded red fluorescence intensity-based small GTPase biosensors and confirmed these optogenetic tools' specificities. Using these optogenetic tools, we investigated calcium mobilization immediately after small GTPase activation. Unexpectedly, we found that a transient intracellular calcium elevation was specifically induced by RhoA activation in RPE1 and HeLa cells. RhoA activation also induced transient intracellular calcium elevation in MDCK and HEK293T cells, suggesting that generally RhoA induces calcium signaling. Interestingly, the molecular mechanisms linking RhoA activation to calcium increases were shown to be different among the different cell types: In RPE1 and HeLa cells, RhoA activated phospholipase C epsilon (PLCe) at the plasma membrane, which in turn induced Ca2+ release from the endoplasmic reticulum (ER). The RhoA-PLCe axis induced calcium-dependent nuclear factor of activated T cells nuclear translocation, suggesting that it does activate intracellular calcium signaling. Conversely, in MDCK and HEK293T cells, RhoA-ROCK-myosin II axis induced the calcium transients. These data suggest universal coordination of RhoA and calcium signaling in cellular processes, such as cellular contraction and gene expression.	[Inaba, Hironori; Miao, Qianqian; Nakata, Takao] Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Cell Biol, Tokyo, Japan; [Inaba, Hironori; Miao, Qianqian; Nakata, Takao] Tokyo Med & Dent Univ TMDU, Ctr Brain Integrat Res CBIR, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Nakata, T (corresponding author), Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Cell Biol, Tokyo, Japan.; Nakata, T (corresponding author), Tokyo Med & Dent Univ TMDU, Ctr Brain Integrat Res CBIR, Tokyo, Japan.	info.cbio@tmd.ac.jp	Inaba, Hironori/C-7794-2016	Inaba, Hironori/0000-0002-9622-6017	JSPS KAKENHI [18K15002, 20K16105, 18K19328]; Takeda Science Foundation; Kanehara Ichiro Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanehara Ichiro Memorial Foundation	This work was supported in part by JSPS KAKENHI (18K15002 and 20K16105 to H. I., and 18K19328 to T. N.), by Research Grants from the Takeda Science Foundation (to H. I. and T. N.), and the Kanehara Ichiro Memorial Foundation (to H. I.).	Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Alford SC, 2012, CHEM BIOL, V19, P353, DOI 10.1016/j.chembiol.2012.01.006; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Aspenstrom P, 2004, BBA-MOL CELL RES, V1742, P51, DOI 10.1016/j.bbamcr.2004.09.029; Atilla-Gokcumen GE, 2010, ACS CHEM BIOL, V5, P79, DOI 10.1021/cb900256m; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bong AHL, 2018, BBA-MOL CELL RES, V1865, P1786, DOI 10.1016/j.bbamcr.2018.05.015; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; CHAO TSO, 1992, J BIOL CHEM, V267, P19876; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; de Beco S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07286-8; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Guglielmi G, 2016, TRENDS CELL BIOL, V26, P864, DOI 10.1016/j.tcb.2016.09.006; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; IKEBE M, 1985, J BIOL CHEM, V260, P27; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Ishii T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9021; Jin P, 2020, ANNU REV NEUROSCI, V43, P207, DOI 10.1146/annurev-neuro-070918-050509; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kakumoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070861; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08217-3; Knoepp L, 1999, Int J Surg Investig, V1, P285; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li Y, 2017, J CEREBR BLOOD F MET, V37, P140, DOI 10.1177/0271678X15621069; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Madukwe JC, 2018, J BIOL CHEM, V293, P6387, DOI 10.1074/jbc.RA118.002354; Malik S, 2015, MOL BIOL CELL, V26, P1188, DOI 10.1091/mbc.E14-10-1476; Martins M, 2012, J CELL SCI, V125, P5758, DOI 10.1242/jcs.110007; Martz MK, 2013, MOL BIOL CELL, V24, P2785, DOI 10.1091/mbc.E12-07-0533; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Miller AL, 2011, CURR BIOL, V21, pR976, DOI 10.1016/j.cub.2011.10.044; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Nash CA, 2019, ELIFE, V8, DOI 10.7554/eLife.48167; O'Neill PR, 2018, DEV CELL, V46, P9, DOI 10.1016/j.devcel.2018.05.029; O'Neill PR, 2016, MOL BIOL CELL, V27, P1442, DOI 10.1091/mbc.E15-12-0832; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Poddar A, 2021, MOL BIOL CELL, V32, P15, DOI 10.1091/mbc.E20-09-0609; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seifert JP, 2008, J BIOL CHEM, V283, P29690, DOI 10.1074/jbc.M805038200; Shiwarski DJ, 2017, MOL BIOL CELL, V28, P2202, DOI 10.1091/mbc.E17-01-0030; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Toettcher JE, 2011, NAT METHODS, V8, P35, DOI [10.1038/nmeth.f.326, 10.1038/NMETH.F.326]; Valon L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14396; Wagner E, 2016, J CELL BIOL, V213, P641, DOI 10.1083/jcb.201603025; Weng YQ, 2018, AIP ADV, V8, DOI 10.1063/1.5025036; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yu OM, 2015, MOL PHARMACOL, V88, P171, DOI 10.1124/mol.115.097857; Zago G, 2018, ELIFE, V7, DOI 10.7554/eLife.40474; Zhang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092917; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	80	4	4	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100290	10.1016/j.jbc.2021.100290	http://dx.doi.org/10.1016/j.jbc.2021.100290			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33453281	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400264
J	Kline, JM; Heusinkveld, LE; Taranto, E; Martin, CB; Tomasi, AG; Hsu, IJ; Cho, K; Khillan, JS; Murphy, PM; Pontejo, SM				Kline, Jaclyn M.; Heusinkveld, Lauren E.; Taranto, Eleanor; Martin, Clare B.; Tomasi, Alessandra G.; Hsu, Isabel J.; Cho, Kyoungin; Khillan, Jaspal S.; Murphy, Philip M.; Pontejo, Sergio M.			Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE SULFATION; DRY MOTIF; EXTRACELLULAR CYSTEINES; DISULFIDE BRIDGES; CRYSTAL-STRUCTURE; LIGAND-BINDING; RESIDUES; DOMAIN; IDENTIFICATION; MUTAGENESIS	Mouse Ccr1l1 (Ccr1-like 1) encodes an orphan G-protein-coupled receptor (GPCR) with the highest homology to the inflammatory and highly promiscuous chemokine receptors Ccr1 and Ccr3 (70 and 50% amino acid identity, respectively). Ccr1l1 was first cloned in 1995, yet current knowledge of this putative chemokine receptor is limited to its gene organization and chromosomal localization. Here we report that Ccr1l1 is a Rodentia-specific gene selectively expressed in eosinophils. However, eosinophil phenotypes, development, and responsiveness to chemokines were all normal in naive Ccr1l1 knockout mice. We demonstrate for the first time that recombinant Ccr1l1 is expressed on the plasma membrane of transfected cells and contains an extracellular N terminus and an intracellular C terminus, consistent with GPCR topology. Using receptor internalization, beta-arrestin recruitment, calcium flux, and chemotaxis assays, we excluded all 37 available mouse chemokines, including Ccr1 ligands, and two viral chemokines as Ccr1l1 ligands, and demonstrated that mouse Ccr1, but not Ccr1l1, exhibits constitutive signaling activity. However, sequence analysis and structural modeling revealed that Ccr1l1 is well equipped to act as a classical signaling GPCR, with N-terminal sulfotyrosines as the only signaling and chemokine-binding determinant absent in Ccr1l1. Hereof, we show that a sulfatable N-terminal Ccr1 Y-18 residue is essential for chemotaxis and calcium responses induced by Ccl3 and Ccl9/10, but substituting the corresponding Ccr1l1 F-19 residue with tyrosine failed to confer responsiveness to Ccr1 ligands. Although Ccr1l1 remains an extreme outlier in the chemokine receptor family, our study supports that it might respond to unidentified mouse chemokine ligands in eosinophil-driven immune responses.	[Kline, Jaclyn M.; Heusinkveld, Lauren E.; Taranto, Eleanor; Martin, Clare B.; Tomasi, Alessandra G.; Hsu, Isabel J.; Murphy, Philip M.; Pontejo, Sergio M.] NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Cho, Kyoungin; Khillan, Jaspal S.] NIAID, Comparat Med Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pontejo, SM (corresponding author), NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jesussergio.martinpontejo@nih.gov		Kline, Jaclyn/0000-0002-6897-5520; Hsu, Isabel/0000-0001-5867-0806; PONTEJO, SERGIO/0000-0002-7756-9831; Martin, Clare/0000-0002-1175-6562; Tomasi, Alessandra/0000-0001-9898-9838	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai LS, 2002, BIOCHEMISTRY-US, V41, P8332, DOI 10.1021/bi025855y; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Barington L, 2016, J BIOL CHEM, V291, P16208, DOI 10.1074/jbc.M115.706747; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Bolus WR, 2018, MOL METAB, V8, P86, DOI 10.1016/j.molmet.2017.12.004; Bonecchi R, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00224; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Chen KQ, 2018, CELL MOL IMMUNOL, V15, P324, DOI 10.1038/cmi.2017.134; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; Dairaghi DJ, 1999, J BIOL CHEM, V274, P21569, DOI 10.1074/jbc.274.31.21569; Endres MJ, 1999, J EXP MED, V189, P1993, DOI 10.1084/jem.189.12.1993; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; Fox JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27710-9; Gao JM, 2009, ACTA PHARMACOL SIN, V30, P193, DOI 10.1038/aps.2008.24; GAO JL, 1995, J BIOL CHEM, V270, P17494, DOI 10.1074/jbc.270.29.17494; Gilliland CT, 2013, J BIOL CHEM, V288, P32194, DOI 10.1074/jbc.M113.503797; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Gustavsson M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw3657; Gustavsson M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14135; Gyombolai P, 2015, J MOL ENDOCRINOL, V54, P75, DOI 10.1530/JME-14-0219; Han XB, 2015, FEBS OPEN BIO, V5, P182, DOI 10.1016/j.fob.2015.03.001; Han XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042765; Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Imai T, 1998, J BIOL CHEM, V273, P1764, DOI 10.1074/jbc.273.3.1764; Islam SA, 2013, J EXP MED, V210, P1889, DOI 10.1084/jem.20130240; Kitaura M, 1999, J BIOL CHEM, V274, P27975, DOI 10.1074/jbc.274.39.27975; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kleist AB, 2016, BIOCHEM PHARMACOL, V114, P53, DOI 10.1016/j.bcp.2016.04.007; Kufareva I, 2016, CURR OPIN PHARMACOL, V30, P27, DOI 10.1016/j.coph.2016.07.006; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Legler Daniel F, 2018, F1000Res, V7, P95, DOI 10.12688/f1000research.13130.1; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Limatola C, 2005, EXP CELL RES, V307, P65, DOI 10.1016/j.yexcr.2005.02.020; Liu J, 2008, AM J RESP CELL MOL, V38, P738, DOI 10.1165/rcmb.2007-0118OC; Ludeman JP, 2014, BRIT J PHARMACOL, V171, P1167, DOI 10.1111/bph.12455; Munoz LM, 2012, IMMUNOL LETT, V145, P23, DOI 10.1016/j.imlet.2012.04.012; Munoz LM, 2009, J IMMUNOL, V183, P7337, DOI 10.4049/jimmunol.0901802; Martinez-Munoz L, 2018, J LEUKOCYTE BIOL, V104, P323, DOI 10.1002/JLB.2MR1217-503R; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; Montpas N, 2015, BIOCHEMISTRY-US, V54, P1505, DOI 10.1021/bi501526s; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Nakayama T, 2010, J IMMUNOL, V185, P6472, DOI 10.4049/jimmunol.0904126; Ngo T, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000656; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Nomiyama H, 2015, J LEUKOCYTE BIOL, V97, P39, DOI 10.1189/jlb.2RU0614-290R; Patel J, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/459520; Pease JE, 1998, J BIOL CHEM, V273, P19972, DOI 10.1074/jbc.273.32.19972; Petit SJ, 2008, EUR J IMMUNOL, V38, P2337, DOI 10.1002/eji.200838269; Pontejo SM, 2018, J INNATE IMMUN, V10, P465, DOI 10.1159/000492161; Pontejo SM, 2017, J LEUKOCYTE BIOL, V102, P1199, DOI 10.1189/jlb.4RU0417-145RR; POST TW, 1995, J IMMUNOL, V155, P5299; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rosenkilde MM, 2004, J BIOL CHEM, V279, P32524, DOI 10.1074/jbc.M313392200; Rummel PC, 2013, MOL PHARMACOL, V84, P335, DOI 10.1124/mol.113.086702; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Simpson LS, 2009, CHEM BIOL, V16, P153, DOI 10.1016/j.chembiol.2008.12.007; Smith JS, 2017, MOL PHARMACOL, V92, P136, DOI 10.1124/mol.117.108522; Sozzani S, 1998, BLOOD, V92, P4036, DOI 10.1182/blood.V92.11.4036.423k17_4036_4039; Stephens BS, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aay5024; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Wasilko DJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16820-6; Weber KSC, 2001, EUR J IMMUNOL, V31, P2458, DOI 10.1002/1521-4141(200108)31:8<2458::AID-IMMU2458>3.0.CO;2-L; Wescott MP, 2016, P NATL ACAD SCI USA, V113, P9928, DOI 10.1073/pnas.1601278113; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118; Yoshida T, 1998, J BIOL CHEM, V273, P16551, DOI 10.1074/jbc.273.26.16551; Zheng Y, 2017, IMMUNITY, V46, P1005, DOI 10.1016/j.immuni.2017.05.002; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	77	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100373	10.1016/j.jbc.2021.100373	http://dx.doi.org/10.1016/j.jbc.2021.100373			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548230	Green Published, gold			2022-12-28	WOS:000672866400347
J	Lan, QY; Li, YC; Wang, FQ; Li, ZD; Gao, Y; Lu, H; Wang, YH; Zhao, ZW; Deng, ZX; He, FC; Wu, JZ; Xu, P				Lan, Qiuyan; Li, Yanchang; Wang, Fuqiang; Li, Zhaodi; Gao, Yuan; Lu, Hui; Wang, Yihao; Zhao, Zhenwen; Deng, Zixin; He, Fuchu; Wu, Junzhu; Xu, Ping			Deubiquitinase Ubp3 enhances the proteasomal degradation of key enzymes in sterol homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS; TERBINAFINE RESISTANCE; GENE-EXPRESSION; 26S PROTEASOME; UBIQUITIN; PROTEIN; MECHANISMS; REDUCTASE; BRE5; RPN4	Sterol homeostasis is tightly controlled by molecules that are highly conserved from yeast to humans, the dysregulation of which plays critical roles in the development of antifungal resistance and various cardiovascular diseases. Previous studies have shown that sterol homeostasis is regulated by the ubiquitin-proteasome system. Two E3 ubiquitin ligases, Hrd1 and Doa10, are known to mediate the proteasomal degradation of 3-hydroxy-3-methylglutaryl-CoA reductase Hmg2 and squalene epoxidase Erg1 with accumulation of the toxic sterols in cells, but the deubiquitinases (DUBs) involved are unclear. Here, we screened for DUBs responsible for sterol homeostasis using yeast strains from a DUB-deletion library. The defective growth observed in ubp3-deleted (ubp3.) yeast upon fluconazole treatment suggests that lack of Ubp3 disrupts sterol homeostasis. Deep-coverage quantitative proteomics reveals that ergosterol biosynthesis is rerouted into a sterol pathway that generates toxic products in the absence of Ubp3. Further genetic and biochemical analysis indicated that Ubp3 enhances the proteasome's ability to degrade the ergosterol biosynthetic enzymes Erg1 and Erg3. The retardation of ergosterol enzyme degradation in the ubp3. strain resulted in the severe accumulation of the intermediate lanosterol and a branched toxic sterol, and ultimately disrupted sterol homeostasis and led to the fluconazole susceptibility. Our findings uncover a role for Ubp3 in sterol homeostasis and highlight its potential as a new antifungal target.	[Lan, Qiuyan; Deng, Zixin; Wu, Junzhu; Xu, Ping] Wuhan Univ, Sch Pharmaceut Sci, Sch Basic Med Sci, Minist Educ,Key Lab Combinatorial Biosynth & Drug, Wuhan, Peoples R China; [Lan, Qiuyan; Li, Yanchang; Wang, Fuqiang; Gao, Yuan; Lu, Hui; Wang, Yihao; He, Fuchu; Xu, Ping] Chinese Acad Med Sci, Beijing Inst Life, Natl Ctr Prot Sci Beijing, State Key Lab Prote,Beijing Proteome Res Ctr,Res, Beijing, Peoples R China; [Li, Zhaodi] Chongqing Med Univ, Mol Med & Canc Res Ctr, Dept Cell Biol & Genet, Chongqing, Peoples R China; [Zhao, Zhenwen] Chinese Acad Sci, CAS Res Educ Ctr Excellence Mol Sci, Inst Chem, Beijing Natl Lab Mol Sci,Key Lab Analyt Chem Livi, Beijing, Peoples R China; [Xu, Ping] Guizhou Univ, Med Sch, Guiyang, Peoples R China	Wuhan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chongqing Medical University; Chinese Academy of Sciences; Institute of Chemistry, CAS; Guizhou University	Wu, JZ; Xu, P (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Sch Basic Med Sci, Minist Educ,Key Lab Combinatorial Biosynth & Drug, Wuhan, Peoples R China.; Li, YC; Xu, P (corresponding author), Chinese Acad Med Sci, Beijing Inst Life, Natl Ctr Prot Sci Beijing, State Key Lab Prote,Beijing Proteome Res Ctr,Res, Beijing, Peoples R China.; Xu, P (corresponding author), Guizhou Univ, Med Sch, Guiyang, Peoples R China.	liyanchang1017@163.com; wujunzhu@whu.edu.cn; xuping@ncpsb.org.cn			Ministry of Science and Technology [2017YFA0505002, 2017YFA0505100, 2016YFA0501300]; National Natural Science Foundation of China [32071431, 31700723, 31670834, 31870824, 91839302]; Innovation Foundation of Medicine [BWS17J032, AWS17J008, 20SWAQX34, 19SWAQ17]; National Megaprojects for Key Infectious Diseases [2018ZX10302302]; Guangzhou Science and Technology Innovation & Development Project [201802020016]; Unilevel 21th Century Toxicity Program [MA-2018-02170N]; Foundation of State Key Lab of Proteomics [SKLP-K201704, SKLP-Y201901]; China Postdoctoral Science Foundation [2019M664016]; CAMS Innovation Fund for Medical Sciences [2019-I2M-5-017]; Beijing-Tianjin-Hebei Basic Research Cooperation Project [J200001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Foundation of Medicine; National Megaprojects for Key Infectious Diseases; Guangzhou Science and Technology Innovation & Development Project; Unilevel 21th Century Toxicity Program; Foundation of State Key Lab of Proteomics; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); CAMS Innovation Fund for Medical Sciences; Beijing-Tianjin-Hebei Basic Research Cooperation Project	We thank Drs Guanghua Huang, Lilin Du, and Cong Xu for gracious gifts of their reagents and strains. We thank Drs Guangwei Du and Hua Mo for the kindness advice for our article. This study was funded by the Ministry of Science and Technology (2017YFA0505002, 2017YFA0505100, and 2016YFA0501300), the National Natural Science Foundation of China (32071431, 31700723, 31670834, 31870824, and 91839302), the Innovation Foundation of Medicine (BWS17J032, AWS17J008, 20SWAQX34, and 19SWAQ17), National Megaprojects for Key Infectious Diseases (2018ZX10302302), Guangzhou Science and Technology Innovation & Development Project (201802020016), the Unilevel 21th Century Toxicity Program (MA-2018-02170N), the Foundation of State Key Lab of Proteomics (SKLP-K201704 and SKLP-Y201901), the China Postdoctoral Science Foundation (2019M664016), CAMS Innovation Fund for Medical Sciences (2019-I2M-5-017), and the Beijing-Tianjin-Hebei Basic Research Cooperation Project (J200001).	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Bhattacharya S, 2018, MBIO, V9, DOI 10.1128/mBio.01291-18; Bilsland E, 2007, DNA REPAIR, V6, P1471, DOI 10.1016/j.dnarep.2007.04.010; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; Chew BS, 2010, BIOCHEM J, V431, P391, DOI 10.1042/BJ20101152; Christiano R, 2014, CELL REP, V9, P1959, DOI 10.1016/j.celrep.2014.10.065; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Della Corte A, 2015, TALANTA, V140, P52, DOI 10.1016/j.talanta.2015.03.003; EDWARDS PA, 1972, J BIOL CHEM, V247, P1520; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Gao Y, 2016, MOL CELL PROTEOMICS, V15, P1381, DOI [10.1074/mcp.O115.051839, 10.1074/mcp.O115.051839 ]; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Isasa M, 2015, J PROTEOME RES, V14, P5306, DOI 10.1021/acs.jproteome.5b00802; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Kelly SL, 1997, FEBS LETT, V400, P80, DOI 10.1016/S0014-5793(96)01360-9; Klobucnikova V, 2003, BIOCHEM BIOPH RES CO, V309, P666, DOI 10.1016/j.bbrc.2003.08.051; Kodedova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139306; Kvint K, 2008, MOL CELL, V30, P498, DOI 10.1016/j.molcel.2008.04.018; Leber R, 2003, ANTIMICROB AGENTS CH, V47, P3890, DOI 10.1128/AAC.47.12.3890-3900.2003; Li KQ, 2007, J MOL BIOL, V372, P194, DOI 10.1016/j.jmb.2007.06.052; Li KQ, 2005, J BIOL CHEM, V280, P29176, DOI 10.1074/jbc.M502975200; Li YC, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100984; Li YC, 2019, MOL CELL, V76, P126, DOI 10.1016/j.molcel.2019.07.001; Mao P, 2010, J BIOL CHEM, V285, P37542, DOI 10.1074/jbc.M110.170175; Menzies SA, 2018, ELIFE, V7, DOI [10.7554/eLife.40009.001, 10.7554/eLife.40009]; MERCER EI, 1984, PESTIC SCI, V15, P133, DOI 10.1002/ps.2780150206; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Mor V, 2015, MBIO, V6, DOI 10.1128/mBio.00647-15; Nakatsukasa K, 2015, CRIT REV BIOCHEM MOL, V50, P489, DOI 10.3109/10409238.2015.1081869; Oling D, 2014, EMBO J, V33, P747, DOI 10.1002/embj.201386822; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Poulsen JW, 2012, J PROTEOMICS, V75, P3886, DOI 10.1016/j.jprot.2012.04.055; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Sanglard D, 2003, ANTIMICROB AGENTS CH, V47, P2404, DOI 10.1128/AAC.47.8.2404-2412.2003; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; South PF, 2013, P NATL ACAD SCI USA, V110, pE1016, DOI 10.1073/pnas.1215768110; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Vik A, 2001, MOL CELL BIOL, V21, P6395, DOI 10.1128/MCB.21.19.6395-6405.2001; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Wang YQ, 2008, J BIOL CHEM, V283, P1954, DOI 10.1074/jbc.M705682200; Xiao WD, 2019, ANAL CHEM, V91, P15890, DOI 10.1021/acs.analchem.9b04340; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yan L, 2008, ACTA BIOCH BIOPH SIN, V40, P1048, DOI 10.1111/j.1745-7270.2008.00483.x; Yang H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7129; Zhang Xibo, 2015, Kobe J Med Sci, V61, pE54	56	3	3	2	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100348	10.1016/j.jbc.2021.100348	http://dx.doi.org/10.1016/j.jbc.2021.100348			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524398	Green Published, gold			2022-12-28	WOS:000672866400322
J	Papke, CM; Smolen, KA; Swingle, MR; Cressey, L; Heng, RA; Toporsian, M; Deng, L; Hagen, J; Shen, YF; Chung, WK; Kettenbach, AN; Honkanen, RE				Papke, Cinta M.; Smolen, Kali A.; Swingle, Mark R.; Cressey, Lauren; Heng, Richard A.; Toporsian, Mourad; Deng, Liyong; Hagen, Jacob; Shen, Yufeng; Chung, Wendy K.; Kettenbach, Arminja N.; Honkanen, Richard E.			A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; REGULATORY SUBUNIT; OKADAIC-ACID; BETA-CATENIN; CONSENSUS SEQUENCES; B56 FAMILY; PP2A; INHIBITION; PHOSPHORYLATION; KINASE	Functional genomic approaches have facilitated the discovery of rare genetic disorders and improved efforts to decipher their underlying etiology. PPP2R5D-related disorder is an early childhood onset condition characterized by intellectual disability, hypotonia, autism-spectrum disorder, macrocephaly, and dysmorphic features. The disorder is caused by de novo single nucleotide changes in PPP2R5D, which generate heterozygous dominant missense variants. PPP2R5D is known to encode a B'-type (B'56d) regulatory subunit of a PP2A-serine/threonine phosphatase. To help elucidate the molecular mechanisms altered in PPP2R5D-related disorder, we used a CRISPR-single-base editor to generate HEK-293 cells in which a single transition (c.1258G>A) was introduced into one allele, precisely recapitulating a clinically relevant E420K variant. Unbiased quantitative proteomic and phosphoproteomic analyses of endogenously expressed proteins revealed heterozygous-dominant changes in kinase/phosphatase signaling. These data combined with orthogonal validation studies revealed a previously unrecognized interaction of PPP2R5D with AKT in human cells, leading to constitutively active AKT-mTOR signaling, increased cell size, and uncoordinated cellular growth in E420K-variant cells. Rapamycin reduced cell size and dose-dependently reduced RPS6 phosphorylation in E420K-variant cells, suggesting that inhibition of mTOR1 can suppress both the observed RPS6 hyperphosphorylation and increased cell size. Together, our findings provide a deeper understanding of PPP2R5D and insight into how the E420K-variant alters signaling networks influenced by PPP2R5D. Our comprehensive approach, which combines precise genome editing, isobaric tandem mass tag labeling of peptides generated from endogenously expressed proteins, and concurrent liquid chromatography-mass spectrometry (LC-MS3), also provides a roadmap that can be used to rapidly explore the etiologies of additional genetic disorders.	[Papke, Cinta M.; Swingle, Mark R.; Heng, Richard A.; Toporsian, Mourad; Honkanen, Richard E.] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Smolen, Kali A.; Cressey, Lauren; Kettenbach, Arminja N.] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA; [Smolen, Kali A.; Cressey, Lauren; Kettenbach, Arminja N.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03755 USA; [Deng, Liyong; Hagen, Jacob; Chung, Wendy K.] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA; [Shen, Yufeng] Columbia Univ, Dept Syst Biol, Irving Med Ctr, New York, NY USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Chung, Wendy K.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA	University of South Alabama; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University	Honkanen, RE (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA.; Kettenbach, AN (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA.; Kettenbach, AN (corresponding author), Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03755 USA.	Arminja.N.Kettenbach@dartmouth.edu; rhonkanen@southalabama.edu		Papke, Cinta Maria/0000-0003-0719-2642	Jordan's Guardians Angels (JGA); National Institutes of Health/National Institute of General Medical Sciences, United States [R35GM119455]	Jordan's Guardians Angels (JGA); National Institutes of Health/National Institute of General Medical Sciences, United States	The research was supported by the Jordan's Guardians Angels (JGA) and National Institutes of Health/National Institute of General Medical Sciences, United States, R35GM119455 to A. N. K.	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Alcantara D, 2017, BRAIN, V140, P2610, DOI 10.1093/brain/awx203; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Buck SB, 2003, J AM CHEM SOC, V125, P15694, DOI 10.1021/ja038672n; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chattopadhyay D, 2016, BIOCHEM PHARMACOL, V109, P14, DOI 10.1016/j.bcp.2016.03.011; Chong ZZ, 2016, DRUG DISCOV TODAY, V21, P1222, DOI 10.1016/j.drudis.2016.04.005; Choy MS, 2017, J AM CHEM SOC, V139, P17703, DOI 10.1021/jacs.7b09368; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cundell MJ, 2016, J CELL BIOL, V214, P539, DOI 10.1083/jcb.201606033; Dean DA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-6; Edelstein J, 2012, NEUROSCI LETT, V531, P74, DOI 10.1016/j.neulet.2012.10.052; Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Galbo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027424; Grassetti AV, 2017, ANAL BIOANAL CHEM, V409, P4615, DOI 10.1007/s00216-017-0407-6; Gu XD, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20175920, 10.1590/1414-431x20175920]; Hastie CJ, 1998, FEBS LETT, V431, P357, DOI 10.1016/S0014-5793(98)00775-3; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Houge G, 2015, J CLIN INVEST, V125, P3051, DOI 10.1172/JCI79860; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jong CJ, 2020, J BIOL CHEM, V295, P5654, DOI 10.1074/jbc.RA119.011270; Jordens J, 2006, J BIOL CHEM, V281, P6349, DOI 10.1074/jbc.M507760200; Kaplanis J, 2019, GENOME RES, V29, P1047, DOI 10.1101/gr.239756.118; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kruse T, 2020, EMBO J, V39, DOI 10.15252/embj.2019103695; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lee TY, 2010, J BIOL CHEM, V285, P21567, DOI 10.1074/jbc.M109.094953; Leontieva OV, 2014, P NATL ACAD SCI USA, V111, P8832, DOI 10.1073/pnas.1405723111; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2019, MOL METAB, V28, P26, DOI 10.1016/j.molmet.2019.07.009; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Loveday C, 2015, HUM MOL GENET, V24, P4775, DOI 10.1093/hmg/ddv182; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; McCright B, 1996, GENOMICS, V36, P168, DOI 10.1006/geno.1996.0438; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mirzaa G, 2019, GENEREVIEWS, P1193; Ni L, 2007, ASSAY DRUG DEV TECHN, V5, P645, DOI 10.1089/adt.2007.079; NOVAKHOFER I, 1984, J BIOL CHEM, V259, P5995; Onore C, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00043; Pei JJ, 2003, AM J PATHOL, V163, P845, DOI 10.1016/S0002-9440(10)63445-1; Prickett TD, 2006, J BIOL CHEM, V281, P30503, DOI 10.1074/jbc.M601054200; Qi HJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007822; Ray RM, 2005, J BIOL CHEM, V280, P31091, DOI 10.1074/jbc.M503041200; Reece KM, 2009, BIOCHEM BIOPH RES CO, V386, P582, DOI 10.1016/j.bbrc.2009.06.062; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; RUEDIGER R, 1991, MOL CELL BIOL, V11, P4282, DOI 10.1128/MCB.11.8.4282; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036; Schmidt T, 2018, NUCLEIC ACIDS RES, V46, pD1271, DOI 10.1093/nar/gkx1029; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shang LS, 2016, NEUROGENETICS, V17, P43, DOI 10.1007/s10048-015-0466-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slupe A. M, 2011, ENZYME RES, V2011; Smith RJ, 2019, CELL REP, V28, P2206, DOI 10.1016/j.celrep.2019.07.067; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Swingle Mark, 2007, V365, P23; Swingle MR, 2019, CURR MED CHEM, V26, P2634, DOI 10.2174/0929867325666180508095242; Swingle MR, 2014, ASSAY DRUG DEV TECHN, V12, P481, DOI 10.1089/adt.2014.603; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Ueda K, 2018, DIABETES, V67, P1524, DOI 10.2337/db17-1342; Vignoli A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0371-1; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wegner Adam M., 2007, V365, P61; Weinbrenner C, 1998, CIRCULATION, V98, P899, DOI 10.1161/01.CIR.98.9.899; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wu CG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02405-3; Xu P, 2013, BIOL OPEN, V2, P479, DOI 10.1242/bio.20134051; Yan Y, 2010, ONCOGENE, V29, P4317, DOI 10.1038/onc.2010.187; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; Yeung KS, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0182-4; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zhou H, 2017, ONCOTARGET, V8, P80770, DOI 10.18632/oncotarget.20415; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	93	6	6	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100313	10.1016/j.jbc.2021.100313	http://dx.doi.org/10.1016/j.jbc.2021.100313			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482199	Green Published, gold			2022-12-28	WOS:000672866400287
J	Rottenaicher, GJ; Weber, B; Ruhrnossl, F; Kazman, P; Absmeier, RM; Hitzenberger, M; Zacharias, M; Buchner, J				Rottenaicher, Georg J.; Weber, Benedikt; Ruehrnoessl, Florian; Kazman, Pamine; Absmeier, Ramona M.; Hitzenberger, Manuel; Zacharias, Martin; Buchner, Johannes			Molecular mechanism of amyloidogenic mutations in hypervariable regions of antibody light chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANONICAL STRUCTURES; FIBRIL FORMATION; LAMBDA-III; STABILITY; SEQUENCE; PROTEINS; DOMAIN; CONFORMATIONS; DETERMINANTS; EVOLUTIONARY	Systemic light chain (AL) amyloidosis is a fatal protein misfolding disease in which excessive secretion, misfolding, and subsequent aggregation of free antibody light chains eventually lead to deposition of amyloid plaques in various organs. Patient-specific mutations in the antibody V-L domain are closely linked to the disease, but the molecular mechanisms by which certain mutations induce misfolding and amyloid aggregation of antibody domains are still poorly understood. Here, we compare a patient V-L domain with its non-amyloidogenic germline counterpart and show that, out of the five mutations present, two of them strongly destabilize the protein and induce amyloid fibril formation. Surprisingly, the decisive, disease-causing mutations are located in the highly variable complementarity determining regions (CDRs) but exhibit a strong impact on the dynamics of conserved core regions of the patient V-L domain. This effect seems to be based on a deviation from the canonical CDR structures of CDR2 and CDR3 induced by the substitutions. The amyloid-driving mutations are not necessarily involved in propagating fibril formation by providing specific side chain interactions within the fibril structure. Rather, they destabilize the V-L domain in a specific way, increasing the dynamics of framework regions, which can then change their conformation to form the fibril core. These findings reveal unexpected influences of CDR-framework interactions on antibody architecture, stability, and amyloid propensity.	[Rottenaicher, Georg J.; Weber, Benedikt; Ruehrnoessl, Florian; Kazman, Pamine; Absmeier, Ramona M.; Buchner, Johannes] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, Garching, Germany; [Hitzenberger, Manuel; Zacharias, Martin] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Phys Dept, Garching, Germany; [Weber, Benedikt] Roche Diagnost GmbH, Nonnenwald 2, D-82377 Penzberg, Germany	Technical University of Munich; Technical University of Munich; Roche Holding	Buchner, J (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, Garching, Germany.	johannes.buchner@tum.de	Buchner, Johannes/A-2651-2010		German Research Foundation DFG [FOR2969]	German Research Foundation DFG(German Research Foundation (DFG))	This study was performed in the framework of the research unit FOR2969 on systemic light chain amyloidosis (German Research Foundation DFG; Project SP03). We thank Prof. Dr Sevil Weinkauf and Dr Carsten Peters for help with TEM data acquisition. We also thank Sonja Engler and Jacqueline Bambach for help with protein purification and biophysical experiments.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Abraham RS, 2004, J CLIN IMMUNOL, V24, P340, DOI 10.1023/B:JOCI.0000029113.68758.9f; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Annamalai K, 2017, ANGEW CHEM INT EDIT, V56, P7510, DOI 10.1002/anie.201701761; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Blancas-Mejia LM, 2018, CHEM COMMUN, V54, P10664, DOI 10.1039/c8cc04396e; Blancas-Mejia LM, 2015, BIOPHYS CHEM, V207, P13, DOI 10.1016/j.bpc.2015.07.005; Blancas-Mejia LM, 2014, J MOL BIOL, V426, P347, DOI 10.1016/j.jmb.2013.10.016; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Brumshtein B, 2018, J BIOL CHEM, V293, P19659, DOI 10.1074/jbc.RA118.004142; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Buxbaum Joel N., 2004, Current Opinion in Rheumatology, V16, P67, DOI 10.1097/00002281-200401000-00013; Case DA, AMBER 18; Chang HJ, 2014, STRUCTURE, V22, P9, DOI 10.1016/j.str.2013.10.005; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Creighton T. E., 1993, PROTEINS STRUCTURES; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; del Pozo-Yauner L, 2014, BIOCHEM BIOPH RES CO, V443, P495, DOI 10.1016/j.bbrc.2013.11.123; DiCostanzo AC, 2012, J BIOL CHEM, V287, P27997, DOI 10.1074/jbc.M112.362921; Dondelinger M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02278; ELHAWRANI AS, 1994, TRENDS BIOTECHNOL, V12, P207, DOI 10.1016/0167-7799(94)90084-1; Emily M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079722; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; Enqvist S, 2009, J PATHOL, V219, P473, DOI 10.1002/path.2607; Enqvist S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000981; Feige MJ, 2008, P NATL ACAD SCI USA, V105, P13373, DOI 10.1073/pnas.0802809105; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Fontana A., 1999, PROTEOLYTIC ENZYMES, P253; Gaciarz A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189964; Gertz MA, 2018, AM J HEMATOL, V93, P1169, DOI 10.1002/ajh.25149; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Gonzalez-Andrade M, 2013, FEBS J, V280, P6173, DOI 10.1111/febs.12538; HELMS LR, 1995, PROTEIN SCI, V4, P2073, DOI 10.1002/pro.5560041012; Hernandez-Santoyo A, 2010, J MOL BIOL, V396, P280, DOI 10.1016/j.jmb.2009.11.038; Herold EM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12519-9; Hora M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181799; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kazman P, 2020, ELIFE, V9, DOI 10.7554/eLife.52300; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kim YS, 2000, J BIOL CHEM, V275, P1570, DOI 10.1074/jbc.275.3.1570; Klimtchuk ES, 2010, BIOCHEMISTRY-US, V49, P9848, DOI 10.1021/bi101351c; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Le Marchand T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04078-y; Lecoq L, 2019, CHEMBIOCHEM, V20, P1027, DOI 10.1002/cbic.201800732; Luna-Martinez OD, 2017, FEBS J, V284, P3702, DOI [10.1111/febs.14265, 10.1111/febs.14266]; Malmos KG, 2017, AMYLOID, V24, P1, DOI 10.1080/13506129.2017.1304905; Marin-Argany M, 2015, PROTEIN SCI, V24, P1829, DOI 10.1002/pro.2790; Maritan M, 2020, J MOL BIOL, V432, P845, DOI 10.1016/j.jmb.2019.12.015; Merlini G, 2017, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/asheducation-2017.1.1; Morgan GJ, 2016, J MOL BIOL, V428, P4280, DOI 10.1016/j.jmb.2016.08.021; Murphy KM., 2016, JANEWAYS IMMUNOBIOLO, V9, DOI DOI 10.1201/9781315533247; Nokwe CN, 2016, J MOL BIOL, V428, P1315, DOI 10.1016/j.jmb.2016.01.015; Nokwe CN, 2015, J MOL BIOL, V427, P3572, DOI 10.1016/j.jmb.2015.09.012; Nokwe CN, 2014, J BIOL CHEM, V289, P26829, DOI 10.1074/jbc.M114.582247; Oberti L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16953-7; Perfetti V, 2002, BLOOD, V100, P948, DOI 10.1182/blood-2002-01-0114; Poshusta TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005169; Pradhan T, 2020, J BIOL CHEM, V295, P18474, DOI 10.1074/jbc.RA120.016006; Radamaker L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21126-2; Radamaker L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09032-0; Rennella E, 2019, J AM CHEM SOC, V141, P13562, DOI 10.1021/jacs.9b05499; Rennella E, 2019, P NATL ACAD SCI USA, V116, P854, DOI 10.1073/pnas.1817538116; Rouet R, 2014, FEBS LETT, V588, P269, DOI 10.1016/j.febslet.2013.11.029; Ruiz-Zamora RA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39781-3; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Swuec P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09133-w; Thies MJW, 2000, J CHROMATOGR B, V737, P63, DOI 10.1016/S0378-4347(99)00377-1; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; van der Kant R, 2019, PROTEIN ENG DES SEL, V32, P109, DOI 10.1093/protein/gzz012; Villalba MI, 2015, J BIOL CHEM, V290, P2577, DOI 10.1074/jbc.M114.629550; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weber B, 2018, J MOL BIOL, V430, P4925, DOI 10.1016/j.jmb.2018.10.024; Weber B, 2018, J BIOL CHEM, V293, P17107, DOI 10.1074/jbc.RA118.005475; Weiss BM, 2014, J CLIN ONCOL, V32, P2699, DOI 10.1200/JCO.2013.50.0892; Woody R. W., 1995, 4 CIRCULAR DICHROISM; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Yauner LD, 2006, PROTEINS, V62, P122, DOI 10.1002/prot.20779; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhang CL, 2017, BLOOD REV, V31, P261, DOI 10.1016/j.blre.2017.03.002	92	12	12	2	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100334	10.1016/j.jbc.2021.100334	http://dx.doi.org/10.1016/j.jbc.2021.100334			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33508322	gold, Green Published			2022-12-28	WOS:000672866400308
J	Solovyev, N; El-Khatib, AH; Costas-Rodriguez, M; Schwab, K; Griffin, E; Raab, A; Platt, B; Theuring, F; Vogl, J; Vanhaecke, F				Solovyev, Nikolay; El-Khatib, Ahmed H.; Costas-Rodriguez, Marta; Schwab, Karima; Griffin, Elizabeth; Raab, Andrea; Platt, Bettina; Theuring, Franz; Vogl, Jochen; Vanhaecke, Frank			Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; AMYLOID-BETA; NEUROFIBRILLARY TANGLES; TRANSGENIC MICE; MOUSE MODEL; METAL-IONS; TAU; COPPER; ZINC; MUTATIONS	Alzheimer's disease (AD) is characterized by accumulation of tau and amyloid-beta in the brain, and recent evidence suggests a correlation between associated protein aggregates and trace elements, such as copper, iron, and zinc. In AD, a distorted brain redox homeostasis and complexation by amyloid-beta and hyperphosphorylated tau may alter the isotopic composition of essential mineral elements. Therefore, high-precision isotopic analysis may reveal changes in the homeostasis of these elements. We used inductively coupled plasma-mass spectrometry (ICP-MS)-based techniques to determine the total Cu, Fe, and Zn contents in the brain, as well as their isotopic compositions in both mouse brain and serum. Results for male transgenic tau (Line 66, L66) and amyloid/presenilin (5xFAD) mice were compared with those for the corresponding age- and sex-matched wild-type control mice (WT). Our data show that L66 brains showed significantly higher Fe levels than did those from the corresponding WT. Significantly less Cu, but more Zn was found in 5xFAD brains. We observed significantly lighter isotopic compositions of Fe (enrichment in the lighter isotopes) in the brain and serum of L66 mice compared with WT. For 5xFAD mice, Zn exhibited a trend toward a lighter isotopic composition in the brain and a heavier isotopic composition in serum compared with WT. Neither mouse model yielded differences in the isotopic composition of Cu. Our findings indicate significant pathology-specific alterations of Fe and Zn brain homeostasis in mouse models of AD. The associated changes in isotopic composition may serve as a marker for proteinopathies underlying AD and other types of dementia.	[Solovyev, Nikolay; Costas-Rodriguez, Marta; Vanhaecke, Frank] Univ Ghent, Dept Chem, Atom & Mass Spectrometry A&MS Res Unit, Ghent, Belgium; [El-Khatib, Ahmed H.; Vogl, Jochen] BAM Bundesanstalt Mat Forsch & Prufung, Div Inorgan Trace Anal 1 1, Berlin, Germany; [El-Khatib, Ahmed H.] Ain Shams Univ, Fac Pharm, Dept Pharmaceut Analyt Chem, African Union Author St, Cairo, Egypt; [Schwab, Karima; Platt, Bettina] Univ Aberdeen, Sch Med Med Sci & Nutr, Inst Med Sci, Foresterhill, Aberdeen, Scotland; [Griffin, Elizabeth; Raab, Andrea] Univ Aberdeen, Dept Chem, Trace Element Speciat Lab TESLA, Aberdeen, Scotland; [Raab, Andrea] Karl Franzens Univ Graz, Inst Chem, Environm Analyt Chem, Graz, Austria; [Theuring, Franz] Charite Univ Med Berlin, Inst Pharmacol, Berlin, Germany; [Solovyev, Nikolay] Inst Technol Sligo, Ash Lane, Sligo F91 YW50, Ireland	Ghent University; Federal Institute for Materials Research & Testing; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Aberdeen; University of Aberdeen; University of Graz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institute of Technology Sligo	Vanhaecke, F (corresponding author), Univ Ghent, Dept Chem, Atom & Mass Spectrometry A&MS Res Unit, Ghent, Belgium.	frank.vanhaecke@ugent.be	Elkhatib, Ahmed/GXF-8385-2022; Vogl, Jochen/A-5960-2009; Solovyev, Nikolay/B-8100-2013; Vanhaecke, Frank/F-5341-2014	Vogl, Jochen/0000-0002-0104-748X; Solovyev, Nikolay/0000-0002-6217-6963; Platt, Bettina/0000-0002-7852-0749; Vanhaecke, Frank/0000-0002-1884-3853; Schwab, Karima/0000-0001-7063-7136	EMPIR research project [15HLT02]; EMPIR programme; European Union	EMPIR research project; EMPIR programme; European Union(European Commission)	This work was carried out in the context of the EMPIR research project 15HLT02 (ReMiND). This project has received funding from the EMPIR programme cofinanced by the Participating States and from the European Union's Horizon 2020 research and innovation program.	Adlard PA, 2018, J ALZHEIMERS DIS, V62, P1369, DOI 10.3233/JAD-170662; Ahmadi S, 2019, J INORG BIOCHEM, V194, P44, DOI 10.1016/j.jinorgbio.2019.02.007; Albarede F, 2016, METALLOMICS, V8, P1056, DOI 10.1039/c5mt00316d; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Anoshkina Y, 2017, METALLOMICS, V9, P517, DOI 10.1039/c7mt00021a; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Bal W, 2013, BBA-GEN SUBJECTS, V1830, P5444, DOI 10.1016/j.bbagen.2013.06.018; Balter V, 2015, P NATL ACAD SCI USA, V112, P982, DOI 10.1073/pnas.1415151112; Balter V, 2013, METALLOMICS, V5, P1470, DOI 10.1039/c3mt00151b; Balusu S, 2016, NEURAL REGEN RES, V11, P534, DOI 10.4103/1673-5374.180372; Baum L, 2010, BIOMETALS, V23, P173, DOI 10.1007/s10534-009-9277-5; Baxter DC, 2006, J ANAL ATOM SPECTROM, V21, P427, DOI 10.1039/b517457k; Bonda DJ, 2011, METALLOMICS, V3, P267, DOI 10.1039/c0mt00074d; Boopathi S, 2016, PROTEINS, V84, P1257, DOI 10.1002/prot.25075; Born HA, 2014, J NEUROSCI, V34, P3826, DOI 10.1523/JNEUROSCI.5171-13.2014; Bundy JL, 2019, J COMP NEUROL, V527, P462, DOI 10.1002/cne.24551; Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011; Buskila Y, 2013, NEUROSCIENCE, V254, P152, DOI 10.1016/j.neuroscience.2013.09.016; Campos-Bedolla P, 2014, ARCH MED RES, V45, P610, DOI 10.1016/j.arcmed.2014.11.018; Choi TS, 2017, J AM CHEM SOC, V139, P15437, DOI 10.1021/jacs.7b08584; Cicero CE, 2017, ENVIRON RES, V159, P82, DOI 10.1016/j.envres.2017.07.048; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Costas-Rodriguez M, 2019, METALLOMICS, V11, P1093, DOI 10.1039/c8mt00362a; Costas-Rodriguez M, 2016, TRAC-TREND ANAL CHEM, V76, P182, DOI 10.1016/j.trac.2015.10.008; Costas-Rodriguez M, 2015, METALLOMICS, V7, P491, DOI 10.1039/c4mt00319e; Cranston AL, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa033; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Crowe SE, 2014, BRAIN STRUCT FUNCT, V219, P571, DOI 10.1007/s00429-013-0518-6; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Esquerda-Canals G, 2017, J ALZHEIMERS DIS, V57, P1171, DOI 10.3233/JAD-170045; Ferretti MT, 2018, NAT REV NEUROL, V14, P457, DOI 10.1038/s41582-018-0032-9; Fukuchi K, 1996, AM J PATHOL, V149, P219; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Geilert S, 2019, RAPID COMMUN MASS SP, V33, P1137, DOI 10.1002/rcm.8455; Gerber H, 2017, J BIOL CHEM, V292, P3751, DOI 10.1074/jbc.M116.754101; Gernot R., 2020, CURR ALZHEIMER RES, V17, P1; Giannoni P, 2016, NEUROBIOL DIS, V88, P107, DOI 10.1016/j.nbd.2016.01.001; Goedert M, 1998, NEURON, V21, P955, DOI 10.1016/S0896-6273(00)80615-7; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gray P. J., 2015, INDUCTIVELY COUPLED; Grochowski C, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00115; Guo C, 2013, NEUROCHEM INT, V62, P165, DOI 10.1016/j.neuint.2012.12.005; Guo QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080706; Guo QX, 2012, NEUROBIOL AGING, V33, P2678, DOI 10.1016/j.neurobiolaging.2012.01.002; Guzman EA, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-13; Halliday MR, 2016, J CEREBR BLOOD F MET, V36, P216, DOI 10.1038/jcbfm.2015.44; Hastuti AAMB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71764-7; Hotz K, 2011, J ANAL ATOM SPECTROM, V26, P1347, DOI 10.1039/c0ja00195c; Huo ZG, 2020, NEUROBIOL AGING, V86, P123, DOI 10.1016/j.neurobiolaging.2019.10.014; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Kametani F, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00025; Killin LOJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0342-y; Kim AC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010128; Kitazawa M, 2009, J NEUROCHEM, V108, P1550, DOI 10.1111/j.1471-4159.2009.05901.x; Koss DJ, 2016, ACTA NEUROPATHOL, V132, P875, DOI 10.1007/s00401-016-1632-3; Kozlowski H, 2012, COORDIN CHEM REV, V256, P2129, DOI 10.1016/j.ccr.2012.03.013; Larner F, 2015, METALLOMICS, V7, P107, DOI 10.1039/c4mt00260a; Lauwens S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30683; Lee JC, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0250-2; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Linert W., 2012, METAL IONS NEUROLOGI; Loef M, 2011, J ALZHEIMERS DIS, V26, P81, DOI 10.3233/JAD-2011-110414; Mahan B, 2018, METALLOMICS, V10, P1264, DOI [10.1039/c8mt00179k, 10.1039/C8MT00179K]; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Melis V, 2015, CELL MOL LIFE SCI, V72, P2199, DOI 10.1007/s00018-014-1804-z; Michalke B, 2018, TRAC-TREND ANAL CHEM, V104, P160, DOI 10.1016/j.trac.2017.08.008; Michalke B, 2010, ANAL CHIM ACTA, V682, P23, DOI 10.1016/j.aca.2010.09.054; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Moynier F, 2017, GEOCHEM PERSPECT LET, V3, P142, DOI 10.7185/geochemlet.1717; Moynier F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47790-5; Muoio V, 2014, ACTA PHYSIOL, V210, P790, DOI 10.1111/apha.12250; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Plucinska K, 2016, DIABETOLOGIA, V59, P1513, DOI 10.1007/s00125-016-3960-1; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; Rao SS, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00276; Roberts BR, 2012, J NEUROCHEM, V120, P149, DOI 10.1111/j.1471-4159.2011.07500.x; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Savelieff MG, 2013, ACS CHEM BIOL, V8, P856, DOI 10.1021/cb400080f; Schilling K, 2020, METALLOMICS, V12, P752, DOI 10.1039/d0mt00061b; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Skillback T, 2017, NEUROBIOL AGING, V59, P1, DOI 10.1016/j.neurobiolaging.2017.06.028; Solovyev N, 2019, J TRACE ELEM MED BIO, V56, P69, DOI 10.1016/j.jtemb.2019.07.005; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Sullivan K, 2020, METALLOMICS, V12, P1380, DOI [10.1039/d0mt00122h, 10.1039/D0MT00122H]; Van Heghe L, 2012, J ANAL ATOM SPECTROM, V27, P1327, DOI 10.1039/c2ja30070b; Vanhaecke F, 2012, ISOTOPIC ANAL FUNDAM, DOI DOI 10.1002/9783527650484.CH2; Vanhaecke F, 2009, J ANAL ATOM SPECTROM, V24, P863, DOI 10.1039/b903887f; Vogl J, 2010, J ANAL ATOM SPECTROM, V25, P923, DOI 10.1039/c000509f; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Xiong Y, 2015, NEUROSCI BULL, V31, P331, DOI 10.1007/s12264-014-1519-z; Yanamandra K, 2015, ANN CLIN TRANSL NEUR, V2, P278, DOI 10.1002/acn3.176; Zenaro E, 2017, NEUROBIOL DIS, V107, P41, DOI 10.1016/j.nbd.2016.07.007	96	8	8	2	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100292	10.1016/j.jbc.2021.100292	http://dx.doi.org/10.1016/j.jbc.2021.100292			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33453282	Green Published, gold			2022-12-28	WOS:000672866400266
J	Su, GS; Wang, WB; Chen, J; Liu, M; Zheng, J; Guo, DAH; Bi, JF; Zhao, ZF; Shi, JD; Zhang, L; Lu, WG				Su, Guangsong; Wang, Wenbin; Chen, Jun; Liu, Man; Zheng, Jian; Guo, Dianhao; Bi, Jinfang; Zhao, Zhongfang; Shi, Jiandang; Zhang, Lei; Lu, Wange			CTCF-binding element regulates ESC differentiation via orchestrating long-range chromatin interaction between enhancers and HoxA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; TRANSCRIPTION; OCT4; DOMAINS; NANOG; PLURIPOTENCY; CONFORMATION; CLUSTERS; LOCUS	Proper expression of Homeobox A cluster genes (HoxA) is essential for embryonic stem cell (ESC) differentiation and individual development. However, mechanisms controlling precise spatiotemporal expression of HoxA during early ESC differentiation remain poorly understood. Herein, we identified a functional CTCF-binding element (CBE+47) closest to the 3'-end of HoxA within the same topologically associated domain (TAD) in ESC. CRISPR-Cas9-mediated deletion of CBE+47 significantly upregulated HoxA expression and enhanced early ESC differentiation induced by retinoic acid (RA) relative to wild-type cells. Mechanistic analysis by chromosome conformation capture assay (Capture-C) revealed that CBE+47 deletion decreased interactions between adjacent enhancers, enabling formation of a relatively loose enhancer-enhancer interaction complex (EEIC), which overall increased interactions between that EEIC and central regions of HoxA chromatin. These findings indicate that CBE+47 organizes chromatin interactions between its adjacent enhancers and HoxA. Furthermore, deletion of those adjacent enhancers synergistically inhibited HoxA activation, suggesting that these enhancers serve as an EEIC required for RA-induced HoxA activation. Collectively, these results provide new insight into RA-induced HoxA expression during early ESC differentiation, also highlight precise regulatory roles of the CTCF-binding element in orchestrating high-order chromatin structure.	[Su, Guangsong; Wang, Wenbin; Chen, Jun; Liu, Man; Zheng, Jian; Guo, Dianhao; Bi, Jinfang; Zhao, Zhongfang; Shi, Jiandang; Zhang, Lei; Lu, Wange] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China	Nankai University	Zhang, L; Lu, WG (corresponding author), Nankai Univ, Coll Life Sci, Tianjin, Peoples R China.	joyleizhang@nankai.edu.cn; wangelv@gmail.com			National Key R&D Program of China [2017YFA0102600]; Chinese National Natural Science Foundation of China [NSFC31530027]	National Key R&D Program of China; Chinese National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank all members of our laboratory for many helpful discussions. We also thank Dr Elise Lamar for editing our article. This work was supported by the National Key R&D Program of China (NO.2017YFA0102600), Chinese National Natural Science Foundation of China (NSFC31530027).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arzate-Mejia RG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.137729; Ba ZQ, 2020, NATURE, V586, P305, DOI 10.1038/s41586-020-2578-0; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Beagan JA, 2017, GENOME RES, V27, P1139, DOI 10.1101/gr.215160.116; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Cao KX, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap8747; Cao KX, 2017, GENE DEV, V31, P787, DOI 10.1101/gad.294744.116; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davies JOJ, 2016, NAT METHODS, V13, P74, DOI [10.1038/NMETH.3664, 10.1038/nmeth.3664]; De Kumar B, 2017, P NATL ACAD SCI USA, V114, P5838, DOI 10.1073/pnas.1610612114; De Kumar B, 2015, GENOME RES, V25, P1229, DOI 10.1101/gr.184978.114; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; Denissov S, 2014, DEVELOPMENT, V141, P526, DOI 10.1242/dev.102681; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Ferraiuolo MA, 2010, NUCLEIC ACIDS RES, V38, P7472, DOI 10.1093/nar/gkq644; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Ghasemi R, 2021, LEUKEMIA, V35, P404, DOI 10.1038/s41375-020-0856-3; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Jain S, 2018, CELL, V174, P102, DOI 10.1016/j.cell.2018.04.035; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Korkmaz G, 2019, NUCLEIC ACIDS RES, V47, P9557, DOI 10.1093/nar/gkz675; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Li Y, 2020, NUCLEIC ACIDS RES, V48, P3119, DOI 10.1093/nar/gkaa098; Liang YC, 2020, DEV CELL, V53, P561, DOI 10.1016/j.devcel.2020.05.007; Liu GY, 2016, NUCLEIC ACIDS RES, V44, P2613, DOI 10.1093/nar/gkv1315; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo HC, 2019, JOVE-J VIS EXP, DOI 10.3791/59382; Luo HC, 2018, BLOOD, V132, P837, DOI 10.1182/blood-2017-11-814319; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Luppino JM, 2020, NAT GENET, V52, P840, DOI 10.1038/s41588-020-0647-9; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nanni L, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02108-x; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Qian YY, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw6710; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rousseau M, 2014, NUCLEIC ACIDS RES, V42, P1524, DOI 10.1093/nar/gkt998; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sato T, 2020, ELIFE, V9, DOI 10.7554/eLife.53608; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simandi Z, 2016, MOL CELL, V63, P647, DOI 10.1016/j.molcel.2016.06.039; Su GS, 2019, NUCLEIC ACIDS RES, V47, P6737, DOI 10.1093/nar/gkz482; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tastemel M, 2017, STEM CELL RES, V25, P250, DOI 10.1016/j.scr.2017.11.012; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; VALCARCEL R, 1994, GENE DEV, V8, P3068, DOI 10.1101/gad.8.24.3068; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Wang P, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02030-2; Wang YL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1519-9; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Xiao S, 2012, CELL, V149, P1381, DOI 10.1016/j.cell.2012.04.029; Yin YF, 2015, CELL STEM CELL, V16, P504, DOI 10.1016/j.stem.2015.03.007; Zhang L, 2020, GENOME RES, V30, P155, DOI 10.1101/gr.251058.119; Zhao H, 2020, NUCLEIC ACIDS RES, V48, P9621, DOI 10.1093/nar/gkaa711; Zheng H, 2019, NAT REV MOL CELL BIO, V20, P535, DOI 10.1038/s41580-019-0132-4; Zheng RB, 2019, NUCLEIC ACIDS RES, V47, pD729, DOI 10.1093/nar/gky1094; Zhou X, 2013, NAT METHODS, V10, P375, DOI 10.1038/nmeth.2440; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	83	4	4	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100413	10.1016/j.jbc.2021.100413	http://dx.doi.org/10.1016/j.jbc.2021.100413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33581110	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400387
J	Taleski, G; Schuhmacher, D; Su, H; Sontag, JM; Sontag, E				Taleski, Goce; Schuhmacher, Diana; Su, Henry; Sontag, Jean-Marie; Sontag, Estelle			Disturbances in PP2A methylation and one-carbon metabolism compromise Fyn distribution, neuritogenesis, and APP regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; AMYLOID PRECURSOR PROTEIN; PLASMA-MEMBRANE MICRODOMAINS; LIPID RAFTS; CELL-ADHESION; KINASE FYN; SRC; TAU; HOMOCYSTEINE; ACTIVATION	The nonreceptor protein tyrosine kinase Fyn and protein Ser/Thr phosphatase 2A (PP2A) are major multifunctional signaling molecules. Deregulation of Fyn and altered PP2A methylation are implicated in cancer and Alzheimer's disease (AD). Here, we tested the hypothesis that the methylation state of PP2A catalytic subunit, which influences PP2A subunit composition and substrate specificity, can affect Fyn regulation and function. Using Neuro-2a (N2a) neuroblastoma cell models, we first show that methylated PP2A holoenzymes containing the B alpha subunit coimmunoprecipitate and copurify with Fyn in membrane rafts. PP2A methylation status regulates Fyn distribution and Fyn-dependent neuritogenesis, likely in part by affecting actin dynamics. A methylation-incompetent PP2A mutant fails to interact with Fyn. It perturbs the normal partitioning of Fyn and amyloid precursor protein (APP) in membrane microdomains, which governs Fyn function and APP processing. This correlates with enhanced amyloidogenic cleavage of APP, a hallmark of AD pathogenesis. Conversely, enhanced PP2A methylation promotes the non-amyloidogenic cleavage of APP in a Fyn-dependent manner. Disturbances in one-carbon metabolic pathways that control cellular methylation are associated with AD and cancer. Notably, they induce a parallel loss of membrane-associated methylated PP2A and Fyn enzymes in N2a cells and acute mouse brain slices. One-carbon metabolism also modulates Fyn-dependent process outgrowth in N2a cells. Thus, our findings identify a novel methylation-dependent PP2A/Fyn signaling module. They highlight the underestimated importance of cross talks between essential metabolic pathways and signaling scaffolds that are involved in normal cell homeostasis and currently being targeted for cancer and AD treatment.	[Taleski, Goce; Schuhmacher, Diana; Sontag, Jean-Marie; Sontag, Estelle] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Su, Henry] UT Southwestern Med Ctr, Dept Pathol, Dallas, TX USA; [Su, Henry] North Lake Coll, Irving, TX USA	University of Newcastle; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sontag, E (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia.	Estelle.Sontag@newcastle.edu.au		Schuhmacher, Diana/0000-0002-8332-9009	Kiriwina Investment Co Pty Ltd [G1700055]; Hunter Medical Research Institute, NSW, Australia; NIH [AG018883]	Kiriwina Investment Co Pty Ltd; Hunter Medical Research Institute, NSW, Australia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grant G1700055 from Kiriwina Investment Co Pty Ltd and the Hunter Medical Research Institute, NSW, Australia (to E. S. and J. -M. S.) and NIH R01 grant AG018883 (to E. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Bachovchin D.A., 2010, PROBE REPORTS NIH MO; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Chu PH, 2014, P NATL ACAD SCI USA, V111, P12420, DOI 10.1073/pnas.1404487111; Diaz-Rohrer B, 2014, BBA-BIOMEMBRANES, V1838, P3003, DOI 10.1016/j.bbamem.2014.07.029; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fowler Brian, 2005, Semin Vasc Med, V5, P77; Frohner IE, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax6490; Gottlieb-Abraham E, 2016, MOL BIOL CELL, V27, P3926, DOI 10.1091/mbc.E16-08-0622; Grimm MOW, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00063; Hasan T, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0216-4; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Hoffman A, 2017, MOL CELL NEUROSCI, V84, P119, DOI 10.1016/j.mcn.2017.01.005; Ittner A, 2018, NEURON, V99, P13, DOI 10.1016/j.neuron.2018.06.003; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Kudithipudi S, 2016, CELL CHEM BIOL, V23, P1049, DOI 10.1016/j.chembiol.2016.07.013; Kumar A, 2015, FUND CLIN PHARMACOL, V29, P115, DOI 10.1111/fcp.12097; Li J, 2014, CANCER BIOL THER, V15, P128, DOI 10.4161/cbt.27146; Liang XQ, 2004, J BIOL CHEM, V279, P8133, DOI 10.1074/jbc.M311180200; Matrone C, 2019, AGEING RES REV, V52, P120, DOI 10.1016/j.arr.2019.04.003; Minami SS, 2011, J NEUROCHEM, V118, P879, DOI 10.1111/j.1471-4159.2011.07296.x; Mollinedo F, 2020, J LIPID RES, V61, P611, DOI 10.1194/jlr.TR119000439; Nicholls RE, 2016, P NATL ACAD SCI USA, V113, P3347, DOI 10.1073/pnas.1521018113; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Poulsen ET, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00059; Ramseger R, 2009, J BIOL CHEM, V284, P7697, DOI 10.1074/jbc.M806719200; Reinecke James, 2014, Biomol Concepts, V5, P143, DOI 10.1515/bmc-2014-0003; Ricotta D, 2008, J BIOL CHEM, V283, P5510, DOI 10.1074/jbc.M707166200; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Shima T, 2001, J BIOL CHEM, V276, P42233, DOI 10.1074/jbc.M102699200; Smith AD, 2018, J ALZHEIMERS DIS, V62, P561, DOI 10.3233/JAD-171042; Smith AD, 2016, ANNU REV NUTR, V36, P211, DOI 10.1146/annurev-nutr-071715-050947; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Sontag JM, 2008, J NEUROSCI, V28, P11477, DOI 10.1523/JNEUROSCI.2816-08.2008; Sontag JM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00214; Sontag JM, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00016; Sontag JM, 2013, J BIOL CHEM, V288, P27396, DOI 10.1074/jbc.M113.490102; Sontag JM, 2012, J BIOL CHEM, V287, P14984, DOI 10.1074/jbc.M111.338681; Sontag JM, 2010, J NEUROCHEM, V115, P1455, DOI 10.1111/j.1471-4159.2010.07049.x; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Tadros MA, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0014-5; Takahashi K, 2006, J CELL PHYSIOL, V206, P814, DOI 10.1002/jcp.20524; Taleski G, 2018, FEBS LETT, V592, P1079, DOI 10.1002/1873-3468.12907; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vacaresse N, 2008, J BIOL CHEM, V283, P35815, DOI 10.1074/jbc.M807964200; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Yokoyama N, 2001, FEBS LETT, V505, P460, DOI 10.1016/S0014-5793(01)02874-5; Zhang CE, 2008, NEUROBIOL AGING, V29, P1654, DOI 10.1016/j.neurobiolaging.2007.04.015; Zhang SX, 2016, NEUROSCI BULL, V32, P1, DOI 10.1007/s12264-016-0012-2; Zhang T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010209	59	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100237	10.1074/jbc.RA120.016069	http://dx.doi.org/10.1074/jbc.RA120.016069			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33380425	Green Published, gold			2022-12-28	WOS:000672866400215
J	Tandon, V; de la Vega, L; Banerjee, S				Tandon, Vasudha; de la Vega, Laureano; Banerjee, Sourav			Emerging roles of DYRK2 in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							REGULATED KINASE 2; EPITHELIAL-MESENCHYMAL-TRANSITION; HEAT-SHOCK FACTOR-1; DUAL-SPECIFICITY; C-MYC; PROTEIN-KINASES; CELL-PROLIFERATION; HEPATOCELLULAR-CARCINOMA; SELECTIVE INHIBITORS; APOPTOTIC RESPONSE	Over the last decade, the CMGC kinase DYRK2 has been reported as a tumor suppressor across various cancers triggering major antitumor and proapoptotic signals in breast, colon, liver, ovary, brain, and lung cancers, with lower DYRK2 expression correlated with poorer prognosis in patients. Contrary to this, various medicinal chemistry studies reported robust antiproliferative properties of DYRK2 inhibitors, whereas unbiased 'omics' and genome-wide association study-based studies identified DYRK2 as a highly overexpressed kinase in various patient tumor samples. A major paradigm shift occurred in the last 4 years when DYRK2 was found to regulate proteostasis in cancer via a two-pronged mechanism. DYRK2 phosphorylated and activated the 26S proteasome to enhance degradation of misfolded/tumor-suppressor proteins while also promoting the nuclear stability and transcriptional activity of its substrate, heat-shock factor 1 triggering protein folding. Together, DYRK2 regulates proteostasis and promotes protumorigenic survival for specific cancers. Indeed, potent and selective small-molecule inhibitors of DYRK2 exhibit in vitro and in vivo anti-tumor activity in triple-negative breast cancer and myeloma models. However, with conflicting and contradictory reports across different cancers, the overarching role of DYRK2 remains enigmatic. Specific cancer (sub)types coupled to spatiotemporal interactions with substrates could decide the procancer or anticancer role of DYRK2. The current review aims to provide a balanced and critical appreciation of the literature to date, highlighting top substrates such as p53, c-Myc, c-Jun, heat-shock factor 1, proteasome, or NOTCH1, to discuss DYRK2 inhibitors available to the scientific community and to shed light on this duality of protumorigenic and antitumorigenic roles of DYRK2.	[Tandon, Vasudha; de la Vega, Laureano; Banerjee, Sourav] Univ Dundee, Sch Med, Div Cellular Med, Dundee, Scotland	University of Dundee	Banerjee, S (corresponding author), Univ Dundee, Sch Med, Div Cellular Med, Dundee, Scotland.	s.y.banerjee@dundee.ac.uk	huang, dezhi/ABC-6566-2021; Banerjee, Sourav/J-3853-2019	Banerjee, Sourav/0000-0003-2043-2989; de la Vega, Laureano/0000-0003-2707-7414	Ninewells Cancer Campaign PhD studentship; Cancer Research UK [C52419/A22869]; Ninewells Cancer Campaign Cancer Research Award; Tayside Health Funds	Ninewells Cancer Campaign PhD studentship; Cancer Research UK(Cancer Research UK); Ninewells Cancer Campaign Cancer Research Award; Tayside Health Funds	This work was supported by grants from the Ninewells Cancer Campaign PhD studentship (to V. T.), Cancer Research UK C52419/A22869 (to L. d. l. V.), and the Ninewells Cancer Campaign Cancer Research Award and Tayside Health Funds (to S. B.).	An T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005179; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Banerjee S, 2019, P NATL ACAD SCI USA, V116, P24881, DOI 10.1073/pnas.1912033116; Banerjee S, 2018, P NATL ACAD SCI USA, V115, P8155, DOI 10.1073/pnas.1806797115; Banerjee S, 2014, BIOCHEM J, V457, P215, DOI 10.1042/BJ20131152; Bellmaine SF, 2017, ELIFE, V6, DOI 10.7554/eLife.24502; Besche HC, 2009, CELL, V138, P25, DOI 10.1016/j.cell.2009.06.035; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Bijnsdorp IV, 2016, ONCOTARGET, V7, P16676, DOI 10.18632/oncotarget.7572; Boni J, 2020, CANCERS, V12, DOI 10.3390/cancers12082106; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Chaikuad A, 2016, J MED CHEM, V59, P10315, DOI 10.1021/acs.jmedchem.6b01083; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Colebatch AJ, 2019, J CLIN PATHOL, V72, P281, DOI 10.1136/jclinpath-2018-205653; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Correa-Saez A, 2020, CELL MOL LIFE SCI, V77, P4747, DOI 10.1007/s00018-020-03556-1; Coutadeur S, 2015, J NEUROCHEM, V133, P440, DOI 10.1111/jnc.13018; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cozza G, 2013, BBA-PROTEINS PROTEOM, V1834, P1402, DOI 10.1016/j.bbapap.2013.01.018; Creasy C., 2007, BLOOD, V110, P510; Cuny GD, 2012, BIOORG MED CHEM LETT, V22, P2015, DOI 10.1016/j.bmcl.2012.01.028; Cuny GD, 2010, BIOORG MED CHEM LETT, V20, P3491, DOI 10.1016/j.bmcl.2010.04.150; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052162; Debdab M, 2011, J MED CHEM, V54, P4172, DOI 10.1021/jm200274d; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Donehower LA, 2019, CELL REP, V28, P1370, DOI 10.1016/j.celrep.2019.07.001; Donnelly N, 2015, CELL CYCLE, V14, P495, DOI 10.1080/15384101.2015.1006043; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Falke H, 2015, J MED CHEM, V58, P3131, DOI 10.1021/jm501994d; Fanucchi S, 2009, FEBS LETT, V583, P3557, DOI 10.1016/j.febslet.2009.10.059; Fernandez-Martinez P, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970048; Galoczova M, 2018, CELL MOL BIOL LETT, V23, DOI 10.1186/s11658-018-0078-0; Gelbert LM, 2014, INVEST NEW DRUG, V32, P825, DOI 10.1007/s10637-014-0120-7; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Guo X, 2016, NAT CELL BIOL, V18, P202, DOI 10.1038/ncb3289; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Hossain D, 2018, J BIOL CHEM, V293, P9448, DOI 10.1074/jbc.RA117.001444; Hossain D, 2017, EMBO REP, V18, P632, DOI 10.15252/embr.201642377; Hu SH, 2015, CANCER RES, V75, P2029, DOI 10.1158/0008-5472.CAN-14-1494; Huang CC, 2008, ONCOGENE, V27, P2422, DOI 10.1038/sj.onc.1210888; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Hutterer C, 2017, ANTIVIR RES, V143, P113, DOI 10.1016/j.antiviral.2017.04.003; Imawari Y, 2018, CANCER SCI, V109, P363, DOI 10.1111/cas.13459; Ito D, 2017, CANCER SCI, V108, P1565, DOI 10.1111/cas.13280; Jarvinen AK, 2006, ONCOGENE, V25, P6997, DOI 10.1038/sj.onc.1209690; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Katlinski KV, 2017, CANCER CELL, V31, P194, DOI 10.1016/j.ccell.2017.01.004; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kii I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11391; Kim H, 2016, DIS MODEL MECH, V9, P839, DOI 10.1242/dmm.025668; Kumamoto T, 2020, INT J ONCOL, V56, P1529, DOI 10.3892/ijo.2020.5020; Kumamoto T, 2019, J AM COLL SURGEONS, V229, pE91, DOI 10.1016/j.jamcollsurg.2019.08.961; Kwon MC, 2013, MOL ONCOL, V7, P165, DOI 10.1016/j.molonc.2013.02.010; Laham AJ, 2021, CELL MOL LIFE SCI, V78, P603, DOI 10.1007/s00018-020-03626-4; Lan X, 2020, MOL THER-NUCL ACIDS, V20, P468, DOI 10.1016/j.omtn.2020.03.008; Lee HJ, 2015, BMB REP, V48, P431, DOI 10.5483/BMBRep.2015.48.8.107; Lee SB, 2020, MOL CELL, V79, P376, DOI 10.1016/j.molcel.2020.06.021; Leiszter K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074140; Liebl MC, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201900127; Liu YHA, 2020, J MED CHEM, V63, P2958, DOI 10.1021/acs.jmedchem.9b01624; Loaec N, 2017, MAR DRUGS, V15, DOI 10.3390/md15100316; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lutterbach B, 1997, ONCOGENE, V14, P967, DOI 10.1038/sj.onc.1200920; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; Matsuura K, 2017, ONCOGENE, V36, P1698, DOI 10.1038/onc.2016.336; Mehnert M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17387-y; Melchior B, 2019, AGING CELL, V18, DOI 10.1111/acel.13000; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Miller CT, 2003, CANCER RES, V63, P4136; Mimoto R, 2017, ONCOGENE, V36, P1862, DOI 10.1038/onc.2016.349; Mimoto R, 2013, CANCER LETT, V339, P214, DOI 10.1016/j.canlet.2013.06.005; Moreno P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143376; Moreno R, 2021, CELL DEATH DIFFER, V28, P1563, DOI 10.1038/s41418-020-00686-8; Morrugares R, 2020, CELL MOL LIFE SCI, V77, P2621, DOI 10.1007/s00018-019-03309-9; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Murshid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013830; Myrianthopoulos V, 2013, ACS MED CHEM LETT, V4, P22, DOI 10.1021/ml300207a; Naidu SD, 2017, FEBS J, V284, P1606, DOI 10.1111/febs.13999; Nelson KM, 2017, J MED CHEM, V60, P1620, DOI 10.1021/acs.jmedchem.6b00975; Neumann F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20984-z; Ogawa Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1090; Ohashi A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8668; Owusu M, 2019, CELL REP, V26, P555, DOI 10.1016/j.celrep.2018.12.087; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Park CS, 2019, BLOOD, V134, P1960, DOI 10.1182/blood.2018875922; Perez M, 2012, J MOL CELL BIOL, V4, P316, DOI 10.1093/jmcb/mjs047; Pirkkala L, 2000, MOL CELL BIOL, V20, P2670, DOI 10.1128/MCB.20.8.2670-2675.2000; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Ruben K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132453; Ryu KJ, 2019, CANCER RES, V79, P4135, DOI 10.1158/0008-5472.CAN-19-0049; Sakamoto Kazuhito, 2015, Methods Mol Biol, V1267, P47, DOI 10.1007/978-1-4939-2297-0_3; Schiewek J, 2018, J CANCER RES CLIN, V144, P2195, DOI 10.1007/s00432-018-2710-9; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Seo HR, 2008, J BIOL CHEM, V283, P15601, DOI 10.1074/jbc.M800987200; Sha Z, 2020, P NATL ACAD SCI USA, V117, P21588, DOI 10.1073/pnas.2001323117; Shah SP, 2015, MOL CANCER RES, V13, P1163, DOI 10.1158/1541-7786.MCR-15-0135; Sharma C., 2018, MOLECULES BASEL SWIT, P23; Shen YF, 2017, NEUROCHEM RES, V42, P3093, DOI 10.1007/s11064-017-2345-2; Shi YH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233672; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Sonamoto R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12728; Soundararajan M, 2013, STRUCTURE, V21, P986, DOI 10.1016/j.str.2013.03.012; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Taira N, 2010, J BIOL CHEM, V285, P4909, DOI 10.1074/jbc.M109.042341; Tang ZJ, 2015, CELL, V160, P729, DOI 10.1016/j.cell.2015.01.028; Velazquez R, 2019, MOL NEUROBIOL, V56, P8364, DOI 10.1007/s12035-019-01684-9; Wang HM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09903-6; Wang X, 2013, J BIOL CHEM, V288, P15474, DOI 10.1074/jbc.M112.416735; Wang Y, 2017, ONCOTARGETS THER, V10, P1091, DOI 10.2147/OTT.S125724; Wang YC, 2015, INT J BIOL MACROMOL, V81, P809, DOI 10.1016/j.ijbiomac.2015.08.067; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Wolf E, 2020, ANNU REV CANC BIOL, V4, P61, DOI 10.1146/annurev-cancerbio-030518-055826; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Wu XY, 2015, ONCOTARGET, V6, P29143, DOI 10.18632/oncotarget.5020; Yamaguchi N, 2015, TUMOR BIOL, V36, P5913, DOI 10.1007/s13277-015-3264-y; Yamashita S, 2009, J THORAC CARDIOV SUR, V138, P1303, DOI 10.1016/j.jtcvs.2009.08.003; Yamashita SI, 2009, ANTICANCER RES, V29, P2753; Yan HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159954; Yeh YT, 2006, INT J CANCER, V118, P2943, DOI 10.1002/ijc.21771; Yokoyama-Mashima S, 2019, CANCER LETT, V451, P100, DOI 10.1016/j.canlet.2019.02.046; Yoshida S, 2020, ELIFE, V9, DOI 10.7554/eLife.57381; Yoshida S, 2019, FEBS LETT, V593, P2953, DOI 10.1002/1873-3468.13601; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616; Zhang XB, 2016, PATHOL RES PRACT, V212, P162, DOI 10.1016/j.prp.2016.01.002; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845; Zou CH, 2020, ONCOL LETT, V20, P2280, DOI 10.3892/ol.2020.11779	145	15	15	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100233	10.1074/jbc.REV120.015217	http://dx.doi.org/10.1074/jbc.REV120.015217			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33376136	gold, Green Published			2022-12-28	WOS:000672866400211
J	Teanphonkrang, S; Suginta, W; Sucharitakul, J; Fukamizo, T; Chaiyen, P; Schulte, A				Teanphonkrang, Somjai; Suginta, Wipa; Sucharitakul, Jeerus; Fukamizo, Tamo; Chaiyen, Pimchai; Schulte, Albert			An electrochemical method for detecting the biomarker 4-HPA by allosteric activation of Acinetobacter baumannii reductase C1 subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; DRUG-RELEASE; VOLTAMMETRY; HYDROXYLASE; ENZYMES; URINE	The C1 (reductase) subunit of 4-hydroxy-phenylacetate (4-HPA) 3-hydroxylase (HPAH) from the soil-based bacterium Acinetobacter baumannii catalyzes NADH oxidation by molecular oxygen, with hydrogen peroxide as a by-product. 4-HPA is a potent allosteric modulator of C1, but also a known urinary biomarker for intestinal bacterial imbalance and for some cancers and brain defects. We thus envisioned that C1 could be used to facilitate 4-HPA detection. The proposed test protocol is simple and in situ and involves addition of NADH to C1 in solution, with or without 4-HPA, and direct acquisition of the H2O2 current with an immersed Prussian Blue-coated screen-printed electrode (PB-SPE) assembly. We confirmed that cathodic H2O2 amperometry at PB-SPEs is a reliable electrochemical assay for intrinsic and allosterically modulated redox enzyme activity. We further validated this approach for quantitative NADH electroanalysis and used it to evaluate the activation of NADH oxidation of C1 by 4-HPA and four other phenols. Using 4-HPA, the most potent effector, allosteric activation of C1 was related to effector concentration by a simple saturation function. The use of C1 for cathodic biosensor analysis of 4-HPA is the basis of the development of a simple and affordable clinical routine for assaying 4-HPA in the urine of patients with a related disease risk. Extension of this principle to work with other allosteric redox enzymes and their effectors is feasible.	[Teanphonkrang, Somjai; Suginta, Wipa; Chaiyen, Pimchai; Schulte, Albert] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Rayong, Thailand; [Teanphonkrang, Somjai; Schulte, Albert] Suranaree Univ Technol SUT, Sch Chem, Inst Sci, Nakhon Ratchasima, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Fac Dent, Res Unit Integrat Immunomicrobial Biochem & Biore, Bangkok, Thailand; [Fukamizo, Tamo] Kindai Univ, Dept Adv Biosci, Nara, Japan	Vidyasirimedhi Institute of Science & Technology; Chulalongkorn University; Chulalongkorn University; Kindai University (Kinki University)	Schulte, A (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Rayong, Thailand.; Schulte, A (corresponding author), Suranaree Univ Technol SUT, Sch Chem, Inst Sci, Nakhon Ratchasima, Thailand.	albert.s@vistec.ac.th		Schulte, Albert/0000-0002-3034-6075	Vidyasirimedhi Institute of Science and Technology, Thailand; Thailand Science Research and Innovation public funding agency, Thailand; Suranaree University of Technology, Thailand; Thailand Research Fund, Thailand, under the Royal Thai government (TRF) through a Royal Golden Jubilee (RGJ) PhD scholarship	Vidyasirimedhi Institute of Science and Technology, Thailand; Thailand Science Research and Innovation public funding agency, Thailand; Suranaree University of Technology, Thailand; Thailand Research Fund, Thailand, under the Royal Thai government (TRF) through a Royal Golden Jubilee (RGJ) PhD scholarship	This work was primarily supported by a faculty startup grant from the Vidyasirimedhi Institute of Science and Technology, Thailand (to A. S.), with additional funding support obtained from the Thailand Science Research and Innovation public funding agency, Thailand through a grant within the organization's Global Partnership Program (to A. S., W. S., and P. C.). S. T. was supported by a Vidyasirimedhi Institute of Science and Technology, Thailand, Postdoctoral Researcher Fellowship and received support from Suranaree University of Technology, Thailand, and The Thailand Research Fund, Thailand, under the Royal Thai government (TRF) through a Royal Golden Jubilee (RGJ) PhD scholarship.	An MX, 2015, GENOM PROTEOM BIOINF, V13, P345, DOI 10.1016/j.gpb.2015.08.005; Arey BJ, 2008, ENDOCRINE, V34, P1, DOI 10.1007/s12020-008-9098-2; Bollella P, 2020, CHEM COMMUN, V56, P9206, DOI 10.1039/d0cc04284f; Bollella P, 2020, J PHYS CHEM LETT, V11, P5549, DOI 10.1021/acs.jpclett.0c01223; Campitelli P, 2020, ANNU REV BIOPHYS, V49, P267, DOI 10.1146/annurev-biophys-052118-115517; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; CHALMERS RA, 1979, CLIN CHEM, V25, P1791; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x; Fastrez J, 2009, CHEMBIOCHEM, V10, P2824, DOI 10.1002/cbic.200900590; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Intarakamhang S, 2013, J SOLID STATE ELECTR, V17, P1535, DOI 10.1007/s10008-013-2018-2; Intarakamhang S, 2012, ANAL CHEM, V84, P6767, DOI 10.1021/ac301292c; Intarakamhang S, 2011, ANAL CHIM ACTA, V687, P1, DOI 10.1016/j.aca.2010.11.023; Jaikaew W, 2018, ANAL CHIM ACTA, V1041, P33, DOI 10.1016/j.aca.2018.08.033; Jarvis L. M, 2019, CHEM ENG NEWS, V97, P39; Jung J, 2014, ANN SURG ONCOL, V21, pS736, DOI 10.1245/s10434-014-3886-0; Khoury E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00068; Ladbury JE, 2004, BIOTECHNIQUES, V37, P885, DOI 10.2144/04376TE01; Lord RS, 2008, ALTERN MED REV, V13, P292; Ma BY, 2009, P NATL ACAD SCI USA, V106, P6887, DOI 10.1073/pnas.0903024106; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Nussinov R, 2014, J AM CHEM SOC, V136, P17692, DOI 10.1021/ja510028c; Rocheville M., 2010, DRUG DISCOV TODAY-TE, V7, pE87; Ruff A, 2020, CHEMPLUSCHEM, V85, P627, DOI 10.1002/cplu.202000129; Sarosiek I, 2016, WORLD J GASTRO ONCOL, V8, P459, DOI 10.4251/wjgo.v8.i5.459; Sim WC, 2020, ACS SUSTAIN CHEM ENG, V8, P5082, DOI 10.1021/acssuschemeng.9b07034; Sripirom J, 2018, ANAL CHEM, V90, P10105, DOI 10.1021/acs.analchem.8b01135; Stec DF, 2015, BIOCHEM BIOPH RES CO, V456, P610, DOI 10.1016/j.bbrc.2014.12.003; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Teanphonkrang S, 2020, IEEE SENS J, V20, P14050, DOI 10.1109/JSEN.2020.3008925; Teanphonkrang S, 2019, ACS SENSORS, V4, P1270, DOI 10.1021/acssensors.9b00144; Teanphonkrang S, 2018, ANAL CHEM, V90, P5703, DOI 10.1021/acs.analchem.7b05467; Teanphonkrang S, 2017, ANAL CHEM, V89, P5261, DOI 10.1021/acs.analchem.6b04694; Theanponkrang S, 2015, INT J NANOMED, V10, P859, DOI 10.2147/IJN.S75237; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Villaverde A, 2003, FEBS LETT, V554, P169, DOI 10.1016/S0014-5793(03)01160-8; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; WOLLENBERGER U, 1993, BIOSENS BIOELECTRON, V8, P291, DOI 10.1016/0956-5663(93)85009-D; Yang YL, 2017, J SEP SCI, V40, P2117, DOI 10.1002/jssc.201700014; Yuen JWM, 2003, FREE RADICAL RES, V37, P1209, DOI 10.1080/10715760310001616032; Zamora-Ros R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26905; Zhao MS, 2018, BIOSENS BIOELECTRON, V105, P42, DOI 10.1016/j.bios.2018.01.015	45	0	0	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100467	10.1016/j.jbc.2021.100467	http://dx.doi.org/10.1016/j.jbc.2021.100467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639166	Green Published, gold			2022-12-28	WOS:000672866400441
J	Zhang, ZY; Zhou, Q; Liu, R; Liu, L; Shen, WJ; Azhar, S; Qu, YF; Guo, ZG; Hu, ZG				Zhang, Ziyu; Zhou, Qian; Liu, Rui; Liu, Li; Shen, Wen-Jun; Azhar, Salman; Qu, Yan-Fu; Guo, Zhigang; Hu, Zhigang			The adaptor protein GIPC1 stabilizes the scavenger receptor SR-B1 and increases its cholesterol uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; PDZ DOMAIN PROTEIN; SR-BI; LIPOPROTEIN; HDL; METABOLISM; EXPRESSION; TRANSPORT	The scavenger receptor class B type 1 (SR-B1), a high-density lipoprotein (HDL) receptor, is a membrane glycoprotein that mediates selective uptake of HDL-cholesterol and cholesterol ester (CE) into cells. SR-B1 is subject to posttranslational regulation; however, the underlying mechanisms still remain obscure. Here, we identified a novel SR-B1-interacting protein, GIPC1 (GAIP-interacting protein, C terminus 1) that interacts with SR-B1 and stabilizes SR-B1 by negative regulation of its proteasomal and lysosomal degradation pathways. The physiological interaction between SR-B1 and GIPC1 was supported by co-immunoprecipitation of wild-type and mutant GIPC1 constructs in SR-B1 +/- GIPC1 overexpressing cells, in native liver cells, and in mouse liver tissues. Overexpression of GIPC1 increased endogenous SR-B1 protein levels, subsequently increasing selective HDL-cholesterol/CE uptake and cellular triglyceride (TG) and total cholesterol (TC) levels, whereas silencing of GIPC1 in the mouse liver was associated with blunted hepatic SR-B1 levels, elevated plasma TG and TC, and attenuated hepatic TG and TC content. A positive correlation was identified between GIPC1 and SR-B1 expression, and both expressions of GIPC1 and SR-B1 from human liver samples were inversely correlated with body mass index (BMI) from human subjects. We therefore conclude that GIPC1 plays a key role in the stability and function of SR-B1 and can also effectively regulate hepatic lipid and cholesterol metabolism. These findings expand our knowledge of the regulatory roles of GIPC1 and suggest that GIPC1 exerts a major effect on cell surface receptors such as SR-B1 and its associated hepatic lipid and cholesterol metabolic processes.	[Zhang, Ziyu; Zhou, Qian; Liu, Rui; Qu, Yan-Fu; Guo, Zhigang; Hu, Zhigang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Peoples R China; [Liu, Li] Nanjing Med Univ, Dept Geriatr, Affiliated Hosp 1, Nanjing, Peoples R China; [Shen, Wen-Jun; Azhar, Salman] VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA; [Shen, Wen-Jun; Azhar, Salman] Stanford Univ, Sch Med, Dept Med, Div Endocrinol Gerontol & Metab, Stanford, CA 94305 USA	Nanjing Normal University; Nanjing Medical University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Hu, ZG (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Peoples R China.	huzg_2000@126.com		Shen, Wen-Jun/0000-0001-5150-1698	Natural Science Fund of Colleges and Universities in Jiangsu Province [19KJA180010]; National Natural Science Foundation of China [31400659]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Fund of Colleges and Universities in Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by Natural Science Fund of Colleges and Universities in Jiangsu Province (19KJA180010), National Natural Science Foundation of China (31400659) and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Carretero-Ortega J, 2019, ELIFE, V8, DOI 10.7554/eLife.30454; Cui XW, 2018, J BIOL CHEM, V293, P4097, DOI 10.1074/jbc.M117.812818; Dunn HA, 2015, MOL PHARMACOL, V88, P624, DOI 10.1124/mol.115.098509; Gutierrez-Pajares JL, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00338; Hu ZG, 2016, DNA CELL BIOL, V35, P280, DOI 10.1089/dna.2015.3185; Hu ZG, 2015, BIOCHEMISTRY-US, V54, P6917, DOI 10.1021/acs.biochem.5b00147; Hu ZG, 2013, J BIOL CHEM, V288, P11416, DOI 10.1074/jbc.M112.437368; Hu ZG, 2012, MOL CELL BIOL, V32, P5035, DOI 10.1128/MCB.01002-12; Katoh M, 2002, INT J MOL MED, V9, P585; Katoh M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.49; Kent AP, 2011, HEPATIC MED-EVID RES, V3, P29, DOI 10.2147/HMER.S7860; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; Langlois AC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70468-2; Ligensa T, 2001, J BIOL CHEM, V276, P33419, DOI 10.1074/jbc.M104509200; Liu R, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158640; Lu X, 2017, BIOCHEM BIOPH RES CO, V490, P1168, DOI 10.1016/j.bbrc.2017.06.175; Mizutani T, 2000, J BIOL CHEM, V275, P22512, DOI 10.1074/jbc.M001631200; Ouimet M, 2019, CIRC RES, V124, P1505, DOI 10.1161/CIRCRESAHA.119.312617; Rajora MA, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00326; Ren K, 2018, ATHEROSCLEROSIS, V270, P57, DOI 10.1016/j.atherosclerosis.2018.01.045; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen WJ, 2018, J LIPID RES, V59, P1114, DOI 10.1194/jlr.R083121; Shen WJ, 2018, ANNU REV PHYSIOL, V80, P95, DOI 10.1146/annurev-physiol-021317-121550; Shen WJ, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00042; Shen WJ, 2014, METABOLISM, V63, P875, DOI 10.1016/j.metabol.2014.03.011; Trigatti BL, 2017, CURR OPIN LIPIDOL, V28, P201, DOI 10.1097/MOL.0000000000000396; Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84; Tsugita M, 2017, CELL REP, V18, P1298, DOI 10.1016/j.celrep.2017.01.004; Wang L, 2013, MOL CELL BIOL, V33, P1956, DOI 10.1128/MCB.01580-12; Wang MN, 2018, GENE, V668, P196, DOI 10.1016/j.gene.2018.05.072; Wang W, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.158554; Wei CW, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00324-0; Westhaus S, 2017, J HEPATOL, V67, P237, DOI 10.1016/j.jhep.2017.03.020; Wieman HL, 2009, BIOCHEM J, V418, P345, DOI 10.1042/BJ20081422; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yi ZH, 2007, J NEUROSCI, V27, P11663, DOI 10.1523/JNEUROSCI.3252-07.2007	38	1	1	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100616	10.1016/j.jbc.2021.100616	http://dx.doi.org/10.1016/j.jbc.2021.100616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33811857	gold, Green Published			2022-12-28	WOS:000672866400587
J	Bulus, N; Brown, KL; Mernaugh, G; Bottcher, A; Dong, XY; Sanders, CR; Pozzi, A; Fassler, R; Zent, R				Bulus, Nada; Brown, Kyle L.; Mernaugh, Glenda; Boettcher, Anika; Dong, Xinyu; Sanders, Charles R.; Pozzi, Ambra; Faessler, Reinhard; Zent, Roy			Disruption of the integrin-linked kinase (ILK) pseudokinase domain affects kidney development in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DISSECTION; CELL MORPHOLOGY; PROTEIN; ADHESION; BINDING; DYNAMICS; REVEALS; DIFFERENTIATION; LOCALIZATION; GENERATION		[Bulus, Nada; Brown, Kyle L.; Mernaugh, Glenda; Dong, Xinyu; Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN 37232 USA; [Brown, Kyle L.; Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Brown, Kyle L.; Sanders, Charles R.] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Boettcher, Anika; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, Martinsried, Germany; [Boettcher, Anika] HelmholtzZentrum, Inst Diabet & Regenerat Res, Munich, Germany; [Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Pozzi, Ambra; Zent, Roy] Vet Affairs Hosp, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Vanderbilt University	Zent, R (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN 37232 USA.; Zent, R (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA.; Zent, R (corresponding author), Vet Affairs Hosp, Nashville, TN 37212 USA.	roy.zent@vumc.org		Sanders, Charles/0000-0003-2046-2862	VA Merit Awards [I01 BX002196, I01 BX002025]; ERC Award; Max Planck Society; Senior Research Career Scientist award from the Veteran Affairs;  [R01 DK069921];  [R01 DK119212];  [P30-DK114809]	VA Merit Awards; ERC Award; Max Planck Society(Max Planck SocietyFoundation CELLEX); Senior Research Career Scientist award from the Veteran Affairs; ; ; 	This work was supported by VA Merit Awards I01 BX002196 (R. Z.) and I01 BX002025 (A. P.) as well as R01 DK069921 (R. Z.) and R01 DK119212 (A. P.), ERC Award (R. F.), the Max Planck Society (R. F.), and P30-DK114809 (A. P. and R. Z.). A. P. is the recipient of a Senior Research Career Scientist award from the Veteran Affairs.	Akhtar N, 2009, DEVELOPMENT, V136, P1019, DOI 10.1242/dev.028423; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Delarue M, 2002, J MOL BIOL, V320, P1011, DOI 10.1016/S0022-2836(02)00562-4; Demirel MC, 1998, PROTEIN SCI, V7, P2522, DOI 10.1002/pro.5560071205; Diskar M, 2010, J BIOL CHEM, V285, P35910, DOI 10.1074/jbc.M110.155150; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fukuda K, 2014, J BIOL CHEM, V289, P28363, DOI 10.1074/jbc.M114.596692; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Galindo-Murillo R, 2015, BBA-GEN SUBJECTS, V1850, P1041, DOI 10.1016/j.bbagen.2014.09.007; Galindo-Murillo R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6152; Ghatak S, 2013, BIOCHEM SOC T, V41, P995, DOI 10.1042/BST20130062; Hwangbo C, 2011, J BIOL CHEM, V286, P33601, DOI 10.1074/jbc.M110.206789; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Khyrul WAKM, 2004, J BIOL CHEM, V279, P54131, DOI 10.1074/jbc.M410051200; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim MK, 2002, BIOPHYS J, V83, P1620, DOI 10.1016/S0006-3495(02)73931-3; Kumar AS, 2004, ONCOGENE, V23, P3454, DOI 10.1038/sj.onc.1207473; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2000, PROTEINS, V38, P368, DOI 10.1002/(SICI)1097-0134(20000301)38:4<368::AID-PROT3>3.0.CO;2-R; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Larini L, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2464095; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Levinson H, 2004, ANN PLAS SURG, V52, P204, DOI 10.1097/01.sap.0000100893.35542.f6; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Miller MG, 2003, BIOCHEM BIOPH RES CO, V310, P796, DOI 10.1016/j.bbrc.2003.09.080; Mills J, 2003, J NEUROSCI, V23, P1638; Moik D, 2013, J BIOL CHEM, V288, P18863, DOI 10.1074/jbc.M113.470476; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Pozzi A, 2006, MOL BIOL CELL, V17, P2046, DOI 10.1091/mbc.E05-08-0800; Qin J, 2012, CURR OPIN CELL BIOL, V24, P607, DOI 10.1016/j.ceb.2012.06.003; Radovanac K, 2013, EMBO J, V32, P1409, DOI 10.1038/emboj.2013.90; Rooney N, 2016, J CELL PHYSIOL, V231, P2408, DOI 10.1002/jcp.25390; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Smeeton J, 2010, DEVELOPMENT, V137, P3233, DOI 10.1242/dev.052845; Tan C, 2002, J BIOL CHEM, V277, P3109, DOI 10.1074/jbc.M108673200; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Vaynberg J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06906-7; Wang H, 2016, J CHEM THEORY COMPUT, V12, P5596, DOI 10.1021/acs.jctc.6b00701; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Wu XW, 2016, J COMPUT CHEM, V37, P595, DOI 10.1002/jcc.24015; Yang J, 2012, J MOL BIOL, V415, P666, DOI 10.1016/j.jmb.2011.11.035; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang X, 2009, DEVELOPMENT, V136, P3357, DOI 10.1242/dev.036269; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200	50	3	3	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100361	10.1016/j.jbc.2021.100361	http://dx.doi.org/10.1016/j.jbc.2021.100361			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539921	Green Published, gold			2022-12-28	WOS:000672866400335
J	Cavus, O; Williams, J; Musa, H; El Refaey, M; Gratz, D; Shaheen, R; Schwieterman, NA; Koenig, S; Antwi-Boasiako, S; Young, LJ; Xu, XY; Han, M; Wold, LE; Hund, TJ; Mohler, PJ; Bradley, EA				Cavus, Omer; Williams, Jordan; Musa, Hassan; El Refaey, Mona; Gratz, Dan; Shaheen, Rebecca; Schwieterman, Neill A.; Koenig, Sara; Antwi-Boasiako, Steve; Young, Lindsay J.; Xu, Xianyao; Han, Mei; Wold, Loren E.; Hund, Thomas J.; Mohler, Peter J.; Bradley, Elisa A.			Giant ankyrin-G regulates cardiac function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; INITIAL SEGMENT; EXCITABILITY; DISEASE; ROLES; GENE	Cardiovascular disease (CVD) remains the most common cause of adult morbidity and mortality in developed nations. As a result, predisposition for CVD is increasingly important to understand. Ankyrins are intracellular proteins required for the maintenance of membrane domains. Canonical ankyrin-G (AnkG) has been shown to be vital for normal cardiac function, specifically cardiac excitability, via targeting and regulation of the cardiac voltage-gated sodium channel. Noncanonical (giant) AnkG isoforms play a key role in neuronal membrane biogenesis and excitability, with evidence for human neurologic disease when aberrant. However, the role of giant AnkG in cardiovascular tissue has yet to be explored. Here, we identify giant AnkG in the myocardium and identify that it is enriched in 1-week-old mice. Using a new mouse model lacking giant AnkG expression in myocytes, we identify that young mice displayed a dilated cardiomyopathy phenotype with aberrant electrical conduction and enhanced arrhythmogenicity. Structural and electrical dysfunction occurred at 1 week of age, when giant AnkG was highly expressed and did not appreciably change in adulthood until advanced age. At a cellular level, loss of giant AnkG results in delayed and early afterdepolarizations. However, surprisingly, giant AnkG cKO myocytes display normal I-Na, but abnormal myocyte contractility, suggesting unique roles of the large isoform in the heart. Finally, transcript analysis provided evidence for unique pathways that may contribute to the structural and electrical findings shown in giant AnkG cKO animals. In summary, we identify a critical role for giant AnkG that adds to the diversity of ankyrin function in the heart.	[Cavus, Omer; Williams, Jordan; Musa, Hassan; El Refaey, Mona; Schwieterman, Neill A.; Koenig, Sara; Young, Lindsay J.; Xu, Xianyao; Han, Mei; Wold, Loren E.; Mohler, Peter J.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Cavus, Omer; Williams, Jordan; Musa, Hassan; Gratz, Dan; Shaheen, Rebecca; Schwieterman, Neill A.; Koenig, Sara; Antwi-Boasiako, Steve; Young, Lindsay J.; Xu, Xianyao; Han, Mei; Wold, Loren E.; Hund, Thomas J.; Mohler, Peter J.; Bradley, Elisa A.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Frick Ctr Heart Failure & Arrhythmia, Columbus, OH 43210 USA; [El Refaey, Mona; Gratz, Dan; Shaheen, Rebecca; Hund, Thomas J.] Ohio State Univ, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA; [Hund, Thomas J.; Mohler, Peter J.; Bradley, Elisa A.] Ohio State Univ, Dept Internal Med, Div Cardiovasc Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bradley, EA (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Frick Ctr Heart Failure & Arrhythmia, Columbus, OH 43210 USA.; Bradley, EA (corresponding author), Ohio State Univ, Dept Internal Med, Div Cardiovasc Med, Columbus, OH 43210 USA.	elisa.bradley@osumc.edu		El Refaey, Mona/0000-0003-3989-0920; Shaheen, Rebecca/0000-0002-5121-8558; Koenig, Sara/0000-0002-5416-8621	NIH [HL148701, HL146969, HL135096, HL134824, HL135754, HL139348]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are supported by NIH grants: HL148701 (E. A. B.), HL146969 (M. E. R.), HL135096 (T. J. H., P. J. M.), HL134824 (T. J. H., P. J. M.), HL135754 (P. J. M.), and HL139348 (P. J. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartoli F, 2017, ADV EXP MED BIOL, V993, P523, DOI 10.1007/978-3-319-57732-6_26; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2002, CIRC RES, V90, P14, DOI 10.1161/res.90.1.14; Bondarenko VE, 2004, AM J PHYSIOL-HEART C, V287, pH1378, DOI 10.1152/ajpheart.00185.2003; Bootman MD, 2017, ADV EXP MED BIOL, V993, P363, DOI 10.1007/978-3-319-57732-6_19; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Collins HE, 2013, AM J PHYSIOL-HEART C, V305, pH446, DOI 10.1152/ajpheart.00104.2013; DOCTOR RB, 1993, AM J PHYSIOL, V264, pC1003, DOI 10.1152/ajpcell.1993.264.4.C1003; Freal A, 2016, J NEUROSCI, V36, P4421, DOI 10.1523/JNEUROSCI.3219-15.2016; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Jenkins PM, 2015, P NATL ACAD SCI USA, V112, P957, DOI 10.1073/pnas.1416544112; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Joki Y, 2015, CIRC-HEART FAIL, V8, P342, DOI 10.1161/CIRCHEARTFAILURE.114.001647; Kong MH, 2011, J AM COLL CARDIOL, V57, P794, DOI 10.1016/j.jacc.2010.09.064; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Makara MA, 2018, JACC-BASIC TRANSL SC, V3, P675, DOI 10.1016/j.jacbts.2018.07.008; Makara MA, 2014, CIRC RES, V115, P929, DOI 10.1161/CIRCRESAHA.115.305154; Messa M, 2014, ELIFE, V3, DOI 10.7554/eLife.03311; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2002, J CELL SCI, V115, P1565; Mozaffarian D, 2016, CIRCULATION, V133, P447, DOI 10.1161/CIR.0000000000000366; Onal B, 2017, AM J PHYSIOL-HEART C, V313, pH1227, DOI 10.1152/ajpheart.00185.2017; Onal B, 2016, METHODSX, V3, P589, DOI 10.1016/j.mex.2016.11.002; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; SAWADA K-I, 1991, Heart and Vessels, V6, P129, DOI 10.1007/BF02058278; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Williams JL, 2018, LIFE SCI, V196, P118, DOI 10.1016/j.lfs.2018.01.021; Yang R, 2019, P NATL ACAD SCI USA, V116, P19717, DOI 10.1073/pnas.1909989116; Yoshimura T, 2014, CURR OPIN NEUROBIOL, V27, P96, DOI 10.1016/j.conb.2014.03.004	34	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100507	10.1016/j.jbc.2021.100507	http://dx.doi.org/10.1016/j.jbc.2021.100507			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675749	Green Published, gold			2022-12-28	WOS:000672866400481
J	Hsu, HP; Chen, YT; Chen, YY; Lin, CY; Chen, PY; Liao, SY; Lim, CCY; Yamaguchi, Y; Hsu, CL; Dzhagalov, IL				Hsu, Hsuan-Po; Chen, Yun-Tzu; Chen, Yu-Ying; Lin, Chih-Yu; Chen, Po-Yu; Liao, Shio-Yi; Lim, Ciara Christianne Y.; Yamaguchi, Yu; Hsu, Chia-Lin; Dzhagalov, Ivan L.			Heparan sulfate is essential for thymus growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITORS; CHEMOKINE PRESENTATION; NEGATIVE SELECTION; DENDRITIC CELLS; THYMOCYTE MIGRATION; SKELETAL DYSPLASIA; MEDULLA MIGRATION; MESENCHYME; MICE; DISRUPTION	Thymus organogenesis and T cell development are coordinated by various soluble and cell-bound molecules. Heparan sulfate (HS) proteoglycans can interact with and immobilize many soluble mediators, creating fields or gradients of secreted ligands. While the role of HS in the development of many organs has been studied extensively, little is known about its function in the thymus. Here, we examined the distribution of HS in the thymus and the effect of its absence on thymus organogenesis and T cell development. We found that HS was expressed most abundantly on the thymic fibroblasts and at lower levels on endothelial, epithelial, and hematopoietic cells. To study the function of HS in the thymus, we eliminated most of HS in this organ by genetically disrupting the glycosyl-transferase Ext1 that is essential for its synthesis. The absence of HS greatly reduced the size of the thymus in fetal thymic organ cultures and in vivo, in mice, and decreased the production of T cells. However, no specific blocks in T cell development were observed. Wild-type thymic fibroblasts were able to physically bind the homeostatic chemokines CCL19, CCL21, and CXCL12 ex vivo. However, this binding was abolished upon HS degradation, disrupting the CCL19/CCL21 chemokine gradients and causing impaired migration of dendritic cells in thymic slices. Thus, our results show that HS plays an essential role in the development and growth of the thymus and in regulating interstitial cell migration.	[Hsu, Hsuan-Po; Chen, Yun-Tzu; Chen, Yu-Ying; Lin, Chih-Yu; Chen, Po-Yu; Liao, Shio-Yi; Lim, Ciara Christianne Y.; Hsu, Chia-Lin; Dzhagalov, Ivan L.] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan; [Yamaguchi, Yu] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA	National Yang Ming Chiao Tung University; Sanford Burnham Prebys Medical Discovery Institute	Dzhagalov, IL (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan.	ivan.dzhagalov@ym.edu.tw		Hsu, Chia-Lin/0000-0001-9383-6330; Lin, Chih-Yu/0000-0002-5315-3786; Chen, Yu-Ying/0000-0003-3580-9961; Dzhagalov, Ivan/0000-0001-9209-4582	MOST [103-2321-B-010-028, 104-2321-B-010-025-, 105-2321-B-010-015-, 106-2320-B-010-026-MY3, 107-2320-B-010-016-MY3, 104-2628-B-010-002-MY4, 107-2320-B-010-020]; Yen Tjing Ling Medical Foundation [CI-107-6, CI-108-5]	MOST; Yen Tjing Ling Medical Foundation	This work was supported by grants from MOST, 103-2321-B-010-028-, 104-2321-B-010-025-, 105-2321-B-010-015-, 106-2320-B-010-026-MY3, 107-2320-B-010-016-MY3 (I. L. D.), 104-2628-B-010-002-MY4 (C. L. H.), and 107-2320-B-010-020 (C. L. H.), and grants from the Yen Tjing Ling Medical Foundation, CI-107-6, and CI-108-5 (I. L. D.).	Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Anderson G, 1997, EUR J IMMUNOL, V27, P1200, DOI 10.1002/eji.1830270522; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Banwell CM, 2000, EUR J IMMUNOL, V30, P2125, DOI 10.1002/1521-4141(2000)30:8<2125::AID-IMMU2125>3.0.CO;2-H; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Bellomo A, 2020, IMMUNITY, V53, P127, DOI 10.1016/j.immuni.2020.06.008; Benz C, 2004, EUR J IMMUNOL, V34, P3652, DOI 10.1002/eji.200425248; Breed ER, 2018, SEMIN CELL DEV BIOL, V84, P2, DOI 10.1016/j.semcdb.2017.07.045; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; de Paz LL, 2007, ACS CHEM BIOL, V2, P735, DOI 10.1021/cb700159m; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Gallagher J, 2015, INT J EXP PATHOL, V96, P203, DOI 10.1111/iep.12135; Garner OB, 2008, IMMUNOLOGY, V125, P420, DOI 10.1111/j.1365-2567.2008.02856.x; Gordts PLSM, 2014, CELL METAB, V20, P813, DOI 10.1016/j.cmet.2014.09.016; Graham GJ, 2019, TRENDS IMMUNOL, V40, P472, DOI 10.1016/j.it.2019.03.009; Halkias J, 2013, J CLIN INVEST, V123, P2131, DOI 10.1172/JCI67175; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Hu ZC, 2015, J EXP MED, V212, P1947, DOI 10.1084/jem.20150178; Hu ZC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00398; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jenkinson WE, 2003, J EXP MED, V198, P325, DOI 10.1084/jem.20022135; Jenkinson WE, 2007, BLOOD, V109, P954, DOI 10.1182/blood-2006-05-023143; Kadakia T, 2019, J EXP MED, V216, P1749, DOI 10.1084/jem.20182285; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lund J, 2014, J MOL ENDOCRINOL, V52, P345, DOI 10.1530/JME-13-0184; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Nitta T, 2020, NAT IMMUNOL, V21, P1172, DOI 10.1038/s41590-020-0756-8; Odaka C, 2009, J HISTOCHEM CYTOCHEM, V57, P373, DOI 10.1369/jhc.2008.952895; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Oud MM, 2017, AM J HUM GENET, V100, P281, DOI 10.1016/j.ajhg.2017.01.013; Peske JD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8114; Porritt HE, 2003, J EXP MED, V198, P957, DOI 10.1084/jem.20030837; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reijmers RM, 2011, BLOOD, V117, P6162, DOI 10.1182/blood-2010-12-325522; Reijmers RM, 2010, J IMMUNOL, V184, P3656, DOI 10.4049/jimmunol.0902200; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Sitnik KM, 2016, CELL REP, V14, P2375, DOI 10.1016/j.celrep.2016.02.033; Sitnik KM, 2012, J IMMUNOL, V188, P4801, DOI 10.4049/jimmunol.1200358; Sun LN, 2015, SCI REP-UK, V5, DOI 10.1038/srep14871; Tsuboi K, 2013, J IMMUNOL, V191, P448, DOI 10.4049/jimmunol.1203061; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Volpi S, 2017, J EXP MED, V214, P623, DOI 10.1084/jem.20161525; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Weist BM, 2015, NAT IMMUNOL, V16, P635, DOI 10.1038/ni.3171; Wrenshall LE, 1999, J IMMUNOL, V163, P3793; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yin X, 2014, J IMMUNOL, V192, P2133, DOI 10.4049/jimmunol.1301286; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhang FM, 2019, MOLECULES, V24, DOI 10.3390/molecules24183360; Zhou TA, 2020, METHODS MOL BIOL, V2111, P205, DOI 10.1007/978-1-0716-0266-9_17; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	70	3	3	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100419	10.1016/j.jbc.2021.100419	http://dx.doi.org/10.1016/j.jbc.2021.100419			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600795	gold, Green Published			2022-12-28	WOS:000672866400393
J	Ishikawa, Y; Taga, Y; Zientek, K; Mizuno, N; Salo, AM; Semenova, O; Tufa, SF; Keene, DR; Holden, P; Mizuno, K; Gould, DB; Myllyharju, J; Bachinger, HP				Ishikawa, Yoshihiro; Taga, Yuki; Zientek, Keith; Mizuno, Nobuyo; Salo, Antti M.; Semenova, Olesya; Tufa, Sara F.; Keene, Douglas R.; Holden, Paul; Mizuno, Kazunori; Gould, Douglas B.; Myllyharju, Johanna; Bachinger, Hans Peter			Type I and type V procollagen triple helix uses different subsets of the molecular ensemble for lysine posttranslational modifications in the rER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN TYPE SPECIFICITY; PROLYL 3-HYDROXYLASE 1; CROSS-LINKING; LYSYL HYDROXYLATION; OSTEOGENESIS IMPERFECTA; CYCLOPHILIN-B; PROTEIN; DOMAINS; CELL; MUTATIONS	Collagen is the most abundant protein in humans. It has a characteristic triple-helix structure and is heavily posttranslationally modified. The complex biosynthesis of collagen involves processing by many enzymes and chaperones in the rough endoplasmic reticulum. Lysyl hydroxylase 1 (LH1) is required to hydroxylate lysine for cross-linking and carbohydrate attachment within collagen triple helical sequences. Additionally, a recent study of prolyl 3-hydroxylase 3 (P3H3) demonstrated that this enzyme may be critical for LH1 activity; however, the details surrounding its involvement remain unclear. If P3H3 is an LH1 chaperone that is critical for LH1 activity, P3H3 and LH1 null mice should display a similar deficiency in lysyl hydroxylation. To test this hypothesis, we compared the amount and location of hydroxylysine in the triple helical domains of type V and I collagen from P3H3 null, LH1 null, and wild-type mice. The amount of hydroxylysine in type V collagen was reduced in P3H3 null mice, but surprisingly type V collagen from LH1 null mice contained as much hydroxylysine as type V collagen from wild-type mice. In type I collagen, our results indicate that LH1 plays a global enzymatic role in lysyl hydroxylation. P3H3 is also involved in lysyl hydroxylation, particularly at cross-link formation sites, but is not required for all lysyl hydroxylation sites. In summary, our study suggests that LH1 and P3H3 likely have two distinct mechanisms to recognize different collagen types and to distinguish cross-link formation sites from other sites in type I collagen.	[Ishikawa, Yoshihiro; Bachinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Ishikawa, Yoshihiro; Zientek, Keith; Mizuno, Nobuyo; Semenova, Olesya; Tufa, Sara F.; Keene, Douglas R.; Holden, Paul] Shriners Hosp Children, Res Dept, Portland, OR 97201 USA; [Ishikawa, Yoshihiro; Gould, Douglas B.] Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA 94110 USA; [Taga, Yuki; Mizuno, Kazunori] Nippi Res Inst Biomatrix, Ibaraki, Japan; [Salo, Antti M.; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland; [Salo, Antti M.; Myllyharju, Johanna] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Gould, Douglas B.] Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA USA; [Zientek, Keith] Oregon Hlth & Sci Univ, Prote Core Facil, Portland, OR 97201 USA; [Mizuno, Nobuyo] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA	Oregon Health & Science University; University of California System; University of California San Francisco; University of Oulu; University of Oulu; University of California System; University of California San Francisco; Oregon Health & Science University; Oregon Health & Science University	Ishikawa, Y (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.; Ishikawa, Y (corresponding author), Shriners Hosp Children, Res Dept, Portland, OR 97201 USA.; Ishikawa, Y (corresponding author), Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA 94110 USA.	yoshihiro.ishikawa@uscf.edu	Taga, Yuki/I-2781-2019; Mizuno, Kazunori/AAY-7613-2021	Taga, Yuki/0000-0001-9100-758X; Mizuno, Kazunori/0000-0003-3354-6264; Salo, Antti/0000-0002-8781-217X; Tufa, Sara/0000-0002-6447-8041; Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospital for Children [85100, 85500]; Academy of Finland [296498, 251314]; S. Juselius Foundation; Jane and Aatos Erkko Foundation; National Institutes of Neurological Disease and Stroke [R01NS096173]	Shriners Hospital for Children; Academy of Finland(Academy of Finland); S. Juselius Foundation; Jane and Aatos Erkko Foundation; National Institutes of Neurological Disease and Stroke	This study was supported by grants from Shriners Hospital for Children (85100 and 85500 to H. P. B.), the Academy of Finland Project Grant 296498 and Center of Excellence 2012-2017 Grant 251314 (J. M.), the S. Juselius Foundation (J. M.), the Jane and Aatos Erkko Foundation (J. M.) and National Institutes of Neurological Disease and Stroke (R01NS096173 to D. B. G.).	Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bella J, 2017, SUBCELL BIOCHEM, V82, P457, DOI 10.1007/978-3-319-49674-0_14; BERG RA, 1973, BIOCHEMISTRY-US, V12, P3395, DOI 10.1021/bi00742a005; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Cabral WA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004465; Chang WZ, 2010, HUM MOL GENET, V19, P223, DOI 10.1093/hmg/ddp481; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; DiChiara AS, 2016, ACS CHEM BIOL, V11, P1408, DOI 10.1021/acschembio.5b01083; Duran I, 2017, J BONE MINER RES, V32, P1309, DOI 10.1002/jbmr.3095; Ellgaard L, 2016, TRAFFIC, V17, P615, DOI 10.1111/tra.12392; Exposito JY, 2010, INT J MOL SCI, V11, P407, DOI 10.3390/ijms11020407; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Forlino A, 2016, LANCET, V387, P1657, DOI 10.1016/S0140-6736(15)00728-X; Gjaltema RAF, 2017, CRIT REV BIOCHEM MOL, V52, P74, DOI 10.1080/10409238.2016.1269716; Heard ME, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006002; Hennet T, 2019, CURR OPIN STRUC BIOL, V56, P131, DOI 10.1016/j.sbi.2019.01.015; Hieta R, 2003, J BIOL CHEM, V278, P34966, DOI 10.1074/jbc.M303624200; Hudson DM, 2017, J BIOL CHEM, V292, P3877, DOI 10.1074/jbc.M116.762245; Hudson DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019336; Hyry M, 2009, J BIOL CHEM, V284, P30917, DOI 10.1074/jbc.M109.021238; IHME A, 1984, J INVEST DERMATOL, V83, P161, DOI 10.1111/1523-1747.ep12263502; Ishikawa Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57374-y; Ishikawa Y, 2015, BBA-GEN SUBJECTS, V1850, P1983, DOI 10.1016/j.bbagen.2014.12.024; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Kozlov G, 2017, STRUCTURE, V25, P1415, DOI 10.1016/j.str.2017.07.010; Kuznetsova NV, 2003, J MOL BIOL, V331, P191, DOI 10.1016/S0022-2836(03)00715-0; Malfait F, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0194-9; Malfait F, 2018, MATRIX BIOL, V71-72, P380, DOI 10.1016/j.matbio.2018.04.013; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; Marini JC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.52; Marini JC, 2010, CELL TISSUE RES, V339, P59, DOI 10.1007/s00441-009-0872-0; Mizuno K, 2003, J BIOL CHEM, V278, P32373, DOI 10.1074/jbc.M304741200; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Okuda S, 2017, NUCLEIC ACIDS RES, V45, pD1107, DOI 10.1093/nar/gkw1080; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; RISTELI L, 1980, BIOCHEM BIOPH RES CO, V96, P1778, DOI 10.1016/0006-291X(80)91380-7; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Scietti L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05631-5; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Taga Y, 2016, J BIOL CHEM, V291, P837, DOI 10.1074/jbc.M115.686105; Taga Y, 2014, J PROTEOME RES, V13, P3671, DOI 10.1021/pr500213a; Taga Y, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010397; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; Takaluoma K, 2007, J BIOL CHEM, V282, P6588, DOI 10.1074/jbc.M608830200; Terajima M, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008196; Terajima M, 2016, J BIOL CHEM, V291, P9501, DOI 10.1074/jbc.M115.699470; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Trackman PC, 2016, MATRIX BIOL, V52-54, P7, DOI 10.1016/j.matbio.2016.01.001; Van Dijk FS, 2009, EUR J HUM GENET, V17, P1560, DOI 10.1038/ejhg.2009.75; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wang CG, 2000, DNA CELL BIOL, V19, P71, DOI 10.1089/104454900314582; WU GY, 1981, BIOCHEMISTRY-US, V20, P4321, DOI 10.1021/bi00518a013; Wu JW, 2019, CELL MOL LIFE SCI, V76, P3899, DOI 10.1007/s00018-019-03102-8; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/bse0520113, 10.1042/BSE0520113]; Yang CX, 2012, J BIOL CHEM, V287, P40598, DOI 10.1074/jbc.M112.406850; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076	64	7	7	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100453	10.1016/j.jbc.2021.100453	http://dx.doi.org/10.1016/j.jbc.2021.100453			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33631195	Green Submitted, Green Published, gold			2022-12-28	WOS:000672866400427
J	Johe, P; Jaenicke, E; Neuweiler, H; Schirmeister, T; Kersten, C; Hellmich, UA				Johe, Patrick; Jaenicke, Elmar; Neuweiler, Hannes; Schirmeister, Tanja; Kersten, Christian; Hellmich, Ute A.			Structure, interdomain dynamics, and pH-dependent autoactivation of pro-rhodesain, the main lysosomal cysteine protease from African trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROCATHEPSIN L; CATHEPSIN-L; DELETION ANALYSIS; CHAGAS-DISEASE; ACTIVE-SITE; ACTIVATION; PROTEINASE; EXPRESSION; MECHANISM; PRECURSOR	Rhodesain is the lysosomal cathepsin L-like cysteine protease of Trypanosoma brucei rhodesiense, the causative agent of Human African Trypanosomiasis. The enzyme is essential for the proliferation and pathogenicity of the parasite as well as its ability to overcome the blood-brain barrier of the host. Lysosomal cathepsins are expressed as zymogens with an inactivating prodomain that is cleaved under acidic conditions. A structure of the uncleaved maturation intermediate from a trypanosomal cathepsin L-like protease is currently not available. We thus established the heterologous expression of T. brucei rhodesiense pro-rhodesain in Escherichia coli and determined its crystal structure. The trypanosomal prodomain differs from nonparasitic pro-cathepsins by a unique, extended alpha-helix that blocks the active site and whose side-chain interactions resemble those of the antiprotozoal inhibitor K11777. Interdomain dynamics between pro- and core protease domain as observed by photoinduced electron transfer fluorescence correlation spectroscopy increase at low pH, where pro-rhodesain also undergoes autocleavage. Using the crystal structure, molecular dynamics simulations, and mutagenesis, we identify a conserved interdomain salt bridge that prevents pre-mature intramolecular cleavage at higher pH values and may thus present a control switch for the observed pH sensitivity of proenzyme cleavage in (trypanosomal) CathL-like proteases.	[Johe, Patrick; Schirmeister, Tanja; Kersten, Christian] Johannes Gutenberg Univ Mainz, Inst Pharmaceut & Biomed Sci, Mainz, Germany; [Jaenicke, Elmar] Johannes Gutenberg Univ Mainz, Inst Mol Physiol, Mainz, Germany; [Neuweiler, Hannes] Julius Maximilians Univ, Dept Biotechnol & Biophys, Wurzburg, Germany; [Hellmich, Ute A.] Johannes Gutenberg Univ Mainz, Dept Chem, Biochem Div, Mainz, Germany; [Hellmich, Ute A.] Goethe Univ, Ctr Biomol Magnet Resonance BMRZ, Frankfurt, Germany; [Hellmich, Ute A.] Friedrich Schiller Univ, Fac Chem & Earth Sci, Inst Organ Chem & Macromol Chem, Jena, Germany; [Hellmich, Ute A.] Friedrich Schiller Univ, Cluster Excellence Balance Microverse, Jena, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Wurzburg; Johannes Gutenberg University of Mainz; Goethe University Frankfurt; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Kersten, C (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharmaceut & Biomed Sci, Mainz, Germany.; Hellmich, UA (corresponding author), Johannes Gutenberg Univ Mainz, Dept Chem, Biochem Div, Mainz, Germany.; Hellmich, UA (corresponding author), Goethe Univ, Ctr Biomol Magnet Resonance BMRZ, Frankfurt, Germany.; Hellmich, UA (corresponding author), Friedrich Schiller Univ, Fac Chem & Earth Sci, Inst Organ Chem & Macromol Chem, Jena, Germany.; Hellmich, UA (corresponding author), Friedrich Schiller Univ, Cluster Excellence Balance Microverse, Jena, Germany.	kerstec@uni-mainz.de; ute.hellmich@uni-jena.de		Kersten, Christian/0000-0001-9976-7639	Carl-Zeiss Foundation; Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe-University Frankfurt - State of Hesse; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [390713860]	Carl-Zeiss Foundation; Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe-University Frankfurt - State of Hesse; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	Research was supported by the Carl-Zeiss Foundation (to U. A. H.) and the Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe-University Frankfurt, funded by the State of Hesse. Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC 2051-Project ID390713860.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alsford S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004130; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bietz S, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-12; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; Case D., 2017, AMBER; Clayton J, 2010, NATURE, V465, pS12, DOI 10.1038/nature09224; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; Doyle PS, 2007, ANTIMICROB AGENTS CH, V51, P3932, DOI 10.1128/AAC.00436-07; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ettari R, 2013, J MED CHEM, V56, P5637, DOI 10.1021/jm301424d; FLOCCO MW, 1995, J MOL BIOL, V254, P96, DOI 10.1006/jmbi.1995.0602; Giroud M, 2018, J MED CHEM, V61, P3350, DOI 10.1021/acs.jmedchem.7b01869; Goretzki B, 2018, STRUCTURE, V26, P1583, DOI 10.1016/j.str.2018.08.002; Grab D. J., 2009, PLOS NEGL TROP DIS, V3, P1; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; Gunner MR, 2006, BBA-BIOENERGETICS, V1757, P942, DOI 10.1016/j.bbabio.2006.06.005; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; HARPER E, 1972, BIOCHEM BIOPH RES CO, V46, P1956, DOI 10.1016/0006-291X(72)90076-9; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Heiby JC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12365-5; Huete-Perez JA, 1999, J BIOL CHEM, V274, P16249, DOI 10.1074/jbc.274.23.16249; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johe P., 2021, ACS CHEM BIOL; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Kennedy PGE, 2004, J CLIN INVEST, V113, P496, DOI 10.1172/JCI200421052; Kerr ID, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000701; Kerr ID, 2009, J BIOL CHEM, V284, P25697, DOI 10.1074/jbc.M109.014340; Koeller CM, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12980; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Mackey ZB, 2004, J BIOL CHEM, V279, P48426, DOI 10.1074/jbc.M402470200; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MARTINEZ J, 1995, FEMS MICROBIOL LETT, V129, P135, DOI 10.1016/0378-1097(95)00147-W; MCDONALD JK, 1995, ARCH BIOCHEM BIOPHYS, V323, P409, DOI 10.1006/abbi.1995.0062; McKerrow J. H., 2018, PLOS NEGL TROP DIS, V12, P4; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; MOTTRAM JC, 1989, FEBS LETT, V258, P211, DOI 10.1016/0014-5793(89)81655-2; Nikolskaia OV, 2006, J CLIN INVEST, V116, P2739, DOI [10.1172/JC127798, 10.1172/JCI27798.]; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; NISHIMURA Y, 1989, ARCH BIOCHEM BIOPHYS, V271, P400, DOI 10.1016/0003-9861(89)90289-0; Nomura T, 1997, BIOCHEM BIOPH RES CO, V230, P143, DOI 10.1006/bbrc.1996.5905; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; PAMER EG, 1991, INFECT IMMUN, V59, P1074, DOI 10.1128/IAI.59.3.1074-1078.1991; PEPIN J, 1994, ADV PARASIT, V33, P1, DOI 10.1016/S0065-308X(08)60410-8; Phillips JC, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0014475; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reif MM, 2012, BIOCHEMISTRY-US, V51, P8636, DOI 10.1021/bi300802a; Roccatano D, 2002, P NATL ACAD SCI USA, V99, P12179, DOI 10.1073/pnas.182199699; Roy S, 2012, ACTA CRYSTALLOGR D, V68, P1591, DOI 10.1107/S0907444912038607; Sauer M., 2014, FLUORESC SPECTROSC M, V1076, P371; Schirmeister T, 2016, J AM CHEM SOC, V138, P8332, DOI 10.1021/jacs.6b03052; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; SMITH SM, 1989, J BIOL CHEM, V264, P20487; Steverding D, 2012, INT J PARASITOL, V42, P481, DOI 10.1016/j.ijpara.2012.03.009; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; VERNET T, 1995, J BIOL CHEM, V270, P10838, DOI 10.1074/jbc.270.18.10838; von Hammerstein F, 2019, FEBS LETT, V593, P2204, DOI 10.1002/1873-3468.13507; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WIEDERANDERS B, 1989, ARCH BIOCHEM BIOPHYS, V272, P516, DOI 10.1016/0003-9861(89)90247-6	68	6	6	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100565	10.1016/j.jbc.2021.100565	http://dx.doi.org/10.1016/j.jbc.2021.100565			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33745969	Green Submitted, Green Published, gold			2022-12-28	WOS:000672866400538
J	Khayyat, NH; Zaika, O; Tomilin, VN; Pyrshev, K; Pochynyuk, O				Khayyat, Naghmeh Hassanzadeh; Zaika, Oleg; Tomilin, Viktor N.; Pyrshev, Kyrylo; Pochynyuk, Oleh			Angiotensin II increases activity of the ClC-K2 Cl- channel in collecting duct intercalated cells by stimulating production of reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE; CHLORIDE CHANNEL; DISTAL NEPHRON; SENSORINEURAL DEAFNESS; BASOLATERAL MEMBRANE; PARACELLULAR PATHWAY; CONNECTING TUBULE; BARTTER-SYNDROME; PRINCIPAL CELLS; MICE LACKING	The renal collecting duct plays a critical role in setting urinary volume and composition, with principal cells transporting Na+ and K+ and intercalated cells mediating Cl- reabsorption. Published evidence implies Angiotensin II (Ang II) is a potent regulator of the collecting duct apical transport systems in response to systemic volume depletion. However, virtually nothing is known about Ang II actions on the basolateral conductance of principal and intercalated cells. Here, we combined macroscopic and single channel patch clamp recordings from freshly isolated mouse collecting ducts with biochemical and fluorescence methods to demonstrate an acute stimulation of the basolateral Cl- conductance and specifically the ClC-K2 Cl- channel by nanomolar Ang II concentrations in intercalated cells. In contrast, Ang II did not exhibit measurable effects on the basolateral conductance and on K(ir)4.1/5.1 potassium channel activity in principal cells. Although both Ang II receptors AT(1) and AT(2) are expressed in collecting duct cells, we show that AT(1) receptors were essential for stimulatory actions of Ang II on ClC-K2. Moreover, AT(1)R(-/-) mice had decreased renal ClC-K2 expression. We further demonstrated that activation of NADPH oxidases is the major signaling pathway downstream of Ang II-AT(1)R that leads to stimulation of ClC-K2. Treatment of freshly isolated collecting ducts with Ang II led to production of reactive oxygen species on the same timescale as single channel ClC-K2 activation. Overall, we propose that Ang II-dependent regulation of ClC-K2 in intercalated cells is instrumental for stimulation of Cl- reabsorption by the collecting duct, particularly during hypovolemic states.	[Khayyat, Naghmeh Hassanzadeh; Zaika, Oleg; Tomilin, Viktor N.; Pyrshev, Kyrylo; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Pochynyuk, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	Oleh.M.Pochynyuk@uth.tmc.edu	Pyrshev, Kyrylo/P-3003-2018	Pyrshev, Kyrylo/0000-0001-5722-0707	NIH-NIDDK [DK095029, DK117865]; AHA [EIA35260097];  [AHA-19CDA34660148]	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHA(American Heart Association); 	This research was supported by NIH-NIDDK DK095029, DK117865, AHA EIA35260097 (to O. P.) and AHA-19CDA34660148 (to V. N. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrini O, 2015, AM J PHYSIOL-RENAL, V308, pF1324, DOI 10.1152/ajprenal.00004.2015; Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337, DOI 10.1152/ajpheart.2001.281.6.H2337; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; Carey RM, 2000, HYPERTENSION, V35, P155, DOI 10.1161/01.HYP.35.1.155; Crowley SD, 2012, EXP CELL RES, V318, P1049, DOI 10.1016/j.yexcr.2012.02.023; Cuevas CA, 2017, J AM SOC NEPHROL, V28, P1814, DOI 10.1681/ASN.2016090935; Dilauro M, 2009, THESCIENTIFICWORLDJO, V9, P522, DOI 10.1100/tsw.2009.70; Gonzalez-Villalobos RA, 2008, AM J PHYSIOL-RENAL, V295, pF772, DOI 10.1152/ajprenal.00019.2008; Gonzalez-Villalobos RA, 2010, AM J PHYSIOL-RENAL, V298, pF150, DOI 10.1152/ajprenal.00477.2009; Gradogna A, 2010, J GEN PHYSIOL, V136, P311, DOI 10.1085/jgp.201010455; Gray DA, 2005, AM J PHYSIOL-RENAL, V288, pF493, DOI 10.1152/ajprenal.00301.2004; Hennings JC, 2017, J AM SOC NEPHROL, V28, P209, DOI 10.1681/ASN.2016010085; Hilliard LM, 2011, HYPERTENSION, V57, P275, DOI 10.1161/HYPERTENSIONAHA.110.166827; Hu QH, 1998, CIRC RES, V83, P644, DOI 10.1161/01.RES.83.6.644; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; IKEBUCHI Y, 1991, J BIOL CHEM, V266, P13233; Kaschina E, 2003, BLOOD PRESSURE, V12, P70, DOI 10.1080/08037050310001057; Kobayashi K, 2001, J AM SOC NEPHROL, V12, P1327, DOI 10.1681/ASN.V1271327; KOTCHEN TA, 1983, ANN INTERN MED, V98, P817, DOI 10.7326/0003-4819-98-5-817; KOTCHEN TA, 1976, AM J PHYSIOL, V231, P1050, DOI 10.1152/ajplegacy.1976.231.4.1050; Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606; Lachheb S, 2008, AM J PHYSIOL-RENAL, V294, pF1398, DOI 10.1152/ajprenal.00288.2007; Lara LS, 2012, AM J PHYSIOL-RENAL, V302, pF85, DOI 10.1152/ajprenal.00351.2011; Lourdel S, 2003, J GEN PHYSIOL, V121, P287, DOI 10.1085/jgp.200208737; LUFT FC, 1988, CLIN SCI, V74, P577, DOI 10.1042/cs0740577; Mamenko M, 2018, J CELL PHYSIOL, V233, P7217, DOI 10.1002/jcp.26552; Mamenko M, 2013, HYPERTENSION, V62, P1111, DOI 10.1161/HYPERTENSIONAHA.113.01797; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; McCallum L, 2015, PFLUG ARCH EUR J PHY, V467, P595, DOI 10.1007/s00424-015-1690-8; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Miyata N, 1999, AM J PHYSIOL-RENAL, V277, pF437, DOI 10.1152/ajprenal.1999.277.3.F437; Monzon CM, 2015, HYPERTENSION, V65, P1245, DOI 10.1161/HYPERTENSIONAHA.115.05356; MUTO S, 1990, J CLIN INVEST, V86, P1829, DOI 10.1172/JCI114913; MUTO S, 1988, J CLIN INVEST, V81, P376, DOI 10.1172/JCI113329; Navar LG, 2011, CURR OPIN PHARMACOL, V11, P180, DOI 10.1016/j.coph.2011.01.009; Navar LG, 2011, HYPERTENSION, V57, P355, DOI 10.1161/HYPERTENSIONAHA.110.163519; NAVAR LG, 1994, J AM SOC NEPHROL, V5, P1153; Nissant A, 2006, AM J PHYSIOL-RENAL, V290, pF1421, DOI 10.1152/ajprenal.00274.2005; Ortiz RM, 2007, AM J PHYSIOL-RENAL, V293, pF139, DOI 10.1152/ajprenal.00504.2006; Ozono R, 1997, HYPERTENSION, V30, P1238, DOI 10.1161/01.HYP.30.5.1238; Palygin O, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92331; Paulais M, 2011, P NATL ACAD SCI USA, V108, P10361, DOI 10.1073/pnas.1101400108; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Pech V, 2007, AM J PHYSIOL-RENAL, V292, pF914, DOI 10.1152/ajprenal.00361.2006; Pessoa BS, 2013, NAT REV NEPHROL, V9, P26, DOI 10.1038/nrneph.2012.249; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; Pinelli L, 2016, J GEN PHYSIOL, V148, P213, DOI 10.1085/jgp.201611623; Pratt JH, 2005, J AM SOC NEPHROL, V16, P3154, DOI 10.1681/ASN.2005050460; Roy A, 2015, CLIN J AM SOC NEPHRO, V10, P305, DOI 10.2215/CJN.08880914; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; SCHUSTER VL, 1987, AM J PHYSIOL, V253, pF203, DOI 10.1152/ajprenal.1987.253.2.F203; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; SIRAGY HM, 1995, HYPERTENSION, V25, P1021, DOI 10.1161/01.HYP.25.5.1021; Staruschenko A, 2012, COMPR PHYSIOL, V2, P1541, DOI 10.1002/cphy.c110052; Terker AS, 2015, CELL METAB, V21, P39, DOI 10.1016/j.cmet.2014.12.006; Tomilin VN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226381; Tomilin VN, 2018, PFLUG ARCH EUR J PHY, V470, P339, DOI 10.1007/s00424-017-2084-x; Wall SM, 2013, AM J PHYSIOL-RENAL, V305, pF427, DOI 10.1152/ajprenal.00022.2013; WARDEN DH, 1988, AM J PHYSIOL, V255, pF720, DOI 10.1152/ajprenal.1988.255.4.F720; Wei YA, 2007, J BIOL CHEM, V282, P6455, DOI 10.1074/jbc.M607477200; Whelton PK, 2018, CIRCULATION, V138, pE426, DOI 10.1161/CIR.0000000000000597; Zaika O, 2020, AM J PHYSIOL-RENAL, V318, pF870, DOI 10.1152/ajprenal.00572.2019; Zaika O, 2016, AM J PHYSIOL-RENAL, V310, pF311, DOI 10.1152/ajprenal.00436.2015; Zaika O, 2015, AM J PHYSIOL-RENAL, V308, pF39, DOI 10.1152/ajprenal.00545.2014; Zaika OL, 2013, AM J PHYSIOL-RENAL, V305, pF1277, DOI 10.1152/ajprenal.00363.2013; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873	71	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100347	10.1016/j.jbc.2021.100347	http://dx.doi.org/10.1016/j.jbc.2021.100347			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524393	Green Published, gold			2022-12-28	WOS:000672866400321
J	Lysyk, L; Brassard, R; Arutyunova, E; Siebert, V; Jiang, ZZ; Takyi, E; Morrison, M; Young, HS; Lemberg, MK; O'Donoghue, AJ; Lemieux, MJ				Lysyk, Laine; Brassard, Raelynn; Arutyunova, Elena; Siebert, Verena; Jiang, Zhenze; Takyi, Emmanuella; Morrison, Melissa; Young, Howard S.; Lemberg, Marius K.; O'Donoghue, Anthony J.; Lemieux, M. Joanne			Insights into the catalytic properties of the mitochondrial rhomboid protease PARL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE PROTEOLYSIS; GAMMA-SECRETASE; SUBSTRATE-SPECIFICITY; LIPID-COMPOSITION; MEMBRANE; PINK1; CLEAVAGE; CARDIOLIPIN; INHIBITORS; PROTEINS	The rhomboid protease PARL is a critical regulator of mitochondrial homeostasis through its cleavage of substrates such as PINK1, PGAM5, and Smac/Diablo, which have crucial roles in mitochondrial quality control and apoptosis. However, the catalytic properties of PARL, including the effect of lipids on the protease, have never been characterized in vitro. To address this, we isolated human PARL expressed in yeast and used FRET-based kinetic assays to measure proteolytic activity in vitro. We show that PARL activity in detergent is enhanced by cardiolipin, a lipid enriched in the mitochondrial inner membrane. Significantly higher turnover rates were observed for PARL reconstituted in proteoliposomes, with Smac/Diablo being cleaved most rapidly at a rate of 1 min-1. In contrast, PGAM5 is cleaved with the highest efficiency (k(cat)/K-M) compared with PINK1 and Smac/Diablo. In proteoliposomes, a truncated beta-cleavage form of PARL, a physiological form known to affect mitochondrial fragmentation, is more active than the full-length enzyme for hydrolysis of PINK1, PGAM5, and Smac/Diablo. Multiplex profiling of 228 peptides reveals that PARL prefers substrates with a bulky side chain such as Phe in P1, which is distinct from the preference for small side chain residues typically found with bacterial rhomboid proteases. This study using recombinant PARL provides fundamental insights into its catalytic activity and substrate preferences that enhance our understanding of its role in mitochondrial function and has implications for specific inhibitor design.	[Lysyk, Laine; Brassard, Raelynn; Arutyunova, Elena; Takyi, Emmanuella; Morrison, Melissa; Young, Howard S.; Lemieux, M. Joanne] Univ Alberta, Fac Med & Dent, Dept Biochem, Membrane Prot Dis Res Grp, Edmonton, AB, Canada; [Siebert, Verena; Lemberg, Marius K.] Ctr Mol Biol Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Heidelberg, Germany; [Jiang, Zhenze; O'Donoghue, Anthony J.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of Alberta; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Diego	Lemieux, MJ (corresponding author), Univ Alberta, Fac Med & Dent, Dept Biochem, Membrane Prot Dis Res Grp, Edmonton, AB, Canada.	miemieux@ualberta.ca	Jiang, Zhenze/AAF-7238-2021; Lemberg, Marius K/B-8881-2016	Jiang, Zhenze/0000-0001-9570-1739; Lemieux, Joanne/0000-0003-4745-9153; Siebert, Verena/0000-0002-6951-6887; Lemberg, Marius K/0000-0002-0996-1268	Parkinson Canada; Canadian Institutes of Health Research [MOP-93557]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-06478]; Neuroscience and Mental Health Institute (Johnston Family Endowment Fund); Parkinson Alberta; Alberta Innovates Health Solutions; Parkinson Canada New Investigator Program; Deutsche Forschungsgemeinschaft (German Research Foundation) [263531414/FOR2290, Le2749/1-2]; Department of Biochemistry, University of Alberta; Neuroscience and Mental Health Institute (Brad Mates Foundation)	Parkinson Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Neuroscience and Mental Health Institute (Johnston Family Endowment Fund); Parkinson Alberta; Alberta Innovates Health Solutions; Parkinson Canada New Investigator Program; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Department of Biochemistry, University of Alberta; Neuroscience and Mental Health Institute (Brad Mates Foundation)	M. J. L. gratefully acknowledges support from the Parkinson Canada and by grants from the Canadian Institutes of Health Research (MOP-93557, Funder ID: 10.13039/501100000030), Natural Sciences and Engineering Research Council of Canada (NSERC) (RGPIN-2016-06478), Neuroscience and Mental Health Institute (Johnston Family Endowment Fund, and the Brad Mates Foundation), Parkinson Alberta, and the Department of Biochemistry, University of Alberta and was supported in part by funding from Alberta Innovates Health Solutions and the Parkinson Canada New Investigator Program. M. K. L. was supported by the grant Le2749/1-2 of the Deutsche Forschungsgemeinschaft (German Research Foundation) as part of 263531414/FOR2290.	Alford SC, 2013, BIOL CELL, V105, P14, DOI 10.1111/boc.201200054; Arutyunova E, 2018, BIOL CHEM, V399, P1389, DOI 10.1515/hsz-2018-0255; Arutyunova E, 2016, BIOL CHEM, V397, P907, DOI 10.1515/hsz-2016-0124; Arutyunova E, 2014, EMBO J, V33, P1869, DOI 10.15252/embj.201488149; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Bondar AN, 2019, CHEM REV, V119, P6162, DOI 10.1021/acs.chemrev.8b00596; Brooks CL, 2013, PROTEIN SCI, V22, P425, DOI 10.1002/pro.2223; Chan EYL, 2013, BBA-BIOMEMBRANES, V1828, P2916, DOI 10.1016/j.bbamem.2013.05.012; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; COMTE J, 1976, BIOCHIM BIOPHYS ACTA, V419, P271, DOI 10.1016/0005-2736(76)90353-9; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Fersht A., 2002, STRUCTURE MECH PROTE, V2nd, P191; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Ghosh S, 2020, P NATL ACAD SCI USA, V117, P16383, DOI 10.1073/pnas.2000640117; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Jeyaraju DV, 2011, CELL DEATH DIFFER, V18, P1531, DOI 10.1038/cdd.2011.22; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Kuhnle N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.217745; Langosch D, 2017, BIOL CHEM, V398, P441, DOI 10.1515/hsz-2016-0269; Lapek JD, 2019, MOL CELL PROTEOMICS, V18, P968, DOI 10.1074/mcp.TIR118.001099; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Lu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147792; Lu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5930; Lysyk L, 2020, J MOL BIOL, V432, P5052, DOI 10.1016/j.jmb.2020.04.006; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; MENARD R, 1992, BIOL CHEM H-S, V373, P393, DOI 10.1515/bchm3.1992.373.2.393; Naing SH, 2018, J BIOL CHEM, V293, P4653, DOI 10.1074/jbc.RA117.001436; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Planas-Iglesias J, 2015, BIOPHYS J, V109, P1282, DOI 10.1016/j.bpj.2015.07.034; RUGGIERO FM, 1992, J NEUROCHEM, V59, P487, DOI 10.1111/j.1471-4159.1992.tb09396.x; Ryabichko S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63280-5; Saita S, 2017, NAT CELL BIOL, V19, P318, DOI 10.1038/ncb3488; Schafer A, 2010, J MOL BIOL, V401, P182, DOI 10.1016/j.jmb.2010.06.014; Sekine S, 2012, J BIOL CHEM, V287, P34635, DOI 10.1074/jbc.M112.357509; Sherratt AR, 2012, BIOCHEMISTRY-US, V51, P7794, DOI 10.1021/bi301087c; Shi G, 2017, CELL REP, V18, P1458, DOI 10.1016/j.celrep.2017.01.029; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Sik A, 2004, J BIOL CHEM, V279, P15323, DOI 10.1074/jbc.M313756200; Spinazzi M, 2019, P NATL ACAD SCI USA, V116, P277, DOI 10.1073/pnas.1811938116; Spinazzi M, 2016, SEMIN CELL DEV BIOL, V60, P19, DOI 10.1016/j.semcdb.2016.07.034; Strisovsky K, 2016, SEMIN CELL DEV BIOL, V60, P52, DOI 10.1016/j.semcdb.2016.08.021; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Ticha A, 2018, TRENDS BIOCHEM SCI, V43, P726, DOI 10.1016/j.tibs.2018.06.009; Ticha AZ, 2017, CELL CHEM BIOL, V24, P1523, DOI 10.1016/j.chembiol.2017.09.007; Ticha A, 2017, J BIOL CHEM, V292, P2703, DOI 10.1074/jbc.M116.762849; Torres-Arancivia C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013072; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Verhelst SHL, 2017, FEBS J, V284, P1489, DOI 10.1111/febs.13979; Wai T, 2016, EMBO REP, V17, P1844, DOI 10.15252/embr.201642698; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zoll S, 2014, EMBO J, V33, P2408, DOI 10.15252/embj.201489367	63	5	5	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100383	10.1016/j.jbc.2021.100383	http://dx.doi.org/10.1016/j.jbc.2021.100383			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556373	Green Submitted, Green Published, gold			2022-12-28	WOS:000672866400357
J	Miyajima, K; Kawamoto, C; Hara, S; Mori-Kojima, M; Ohye, T; Sumi-Ichinose, C; Saito, N; Sasaoka, T; Metzger, D; Ichinose, H				Miyajima, Katsuya; Kawamoto, Chiaki; Hara, Satoshi; Mori-Kojima, Masayo; Ohye, Tamae; Sumi-Ichinose, Chiho; Saito, Nae; Sasaoka, Toshikuni; Metzger, Daniel; Ichinose, Hiroshi			Tyrosine hydroxylase conditional KO mice reveal peripheral tissue-dependent differences in dopamine biosynthetic pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; ADRENAL-GLAND; EXPRESSION; RAT; NOREPINEPHRINE; TRANSPORTER; RELEASE; KIDNEY; ACID; 3,4-DIHYDROXYPHENYLALANINE	Dopamine (DA) exerts well-known functions in the brain as a neurotransmitter. In addition, it plays important physiological roles in peripheral organs, but it is largely unknown how and where peripheral DA is synthesized and regulated. Catecholamines in peripheral tissues are either produced within the tissue itself and/or derived from sympathetic neurons, which release neurotransmitters for uptake by peripheral tissues. To evaluate DA-producing ability of each peripheral tissue, we generated conditional KO mice (cKO mice) in which the tyrosine hydroxylase (TH) gene is ablated in the sympathoadrenal system, thus eliminating sympathetic neurons as a DA source. We then examined the alterations in the noradrenaline (NA), DA, and 3,4-dihydroxyphenylalanine (DOPA) contents in peripheral organs and performed immunohistochemical analyses of TH-expressing cells. In the heart and pancreas of cKO mice, both the TH protein and NA levels were significantly decreased, and the DA contents were decreased in parallel with NA contents, indicating that the DA supply originated from sympathetic neurons. We found TH-immunoreactive cells in the stomach and lung, where the TH protein showed a decreasing trend, but the DA levels were not decreased in cKO mice. Moreover, we found a significant correlation between the DA content in the kidney and the plasma DOPA concentration, suggesting that the kidney takes up DOPA from blood to make DA. The aforementioned data unravel differences in the DA biosynthetic pathway among tissues and support the role of sympathetic neurons as a DA supplier.	[Miyajima, Katsuya; Kawamoto, Chiaki; Hara, Satoshi; Mori-Kojima, Masayo; Ichinose, Hiroshi] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan; [Ohye, Tamae] Fujita Hlth Univ, Grad Sch Hlth Sci, Dept Genet Counseling, Toyoake, Aichi, Japan; [Sumi-Ichinose, Chiho] Fujita Hlth Univ, Sch Med, Dept Pharmacol, Toyoake, Aichi, Japan; [Saito, Nae; Sasaoka, Toshikuni] Niigata Univ, Ctr Bioresource Based Res, Brain Res Inst, Dept Comparat & Expt Med, Niigata, Japan; [Saito, Nae] Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Med, Niigata, Japan; [Metzger, Daniel] Univ Strasbourg, CNRS, UMR 7104, INSERM,IGBMC,U 1258, Illkirch Graffenstaden, France	Tokyo Institute of Technology; Fujita Health University; Fujita Health University; Niigata University; Niigata University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ichinose, H (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan.	hichinos@bio.titech.ac.jp	, 笹岡俊邦/N-9152-2015	, 笹岡俊邦/0000-0002-7797-4394; Sumi-Ichinose, Chiho/0000-0001-5261-0853; Metzger, Daniel/0000-0002-5555-046X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15H01422, 17H05555]; Smoking Research Foundation; Collaborative Research Project of Brain Research Institute, Niigata University [201930]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; Collaborative Research Project of Brain Research Institute, Niigata University	This work was supported by a Grant-in-aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (adaptive circuit shift grants, 15H01422 and 17H05555), the Smoking Research Foundation, and by the Collaborative Research Project (201930) of Brain Research Institute, Niigata University.	Adir Y, 2004, AM J RESP CRIT CARE, V169, P757, DOI 10.1164/rccm.200207-744OC; Banday AA, 2019, AM J PHYSIOL-RENAL, V317, pF949, DOI 10.1152/ajprenal.00135.2019; Barnard ML, 1999, AM J RESP CRIT CARE, V160, P982, DOI 10.1164/ajrccm.160.3.9812003; Cavallotti C, 2010, HEART VESSELS, V25, P432, DOI 10.1007/s00380-009-1224-4; Chiken S, 2015, CEREB CORTEX, V25, P4885, DOI 10.1093/cercor/bhv209; Cleary S, 2005, CELL TISSUE RES, V322, P443, DOI 10.1007/s00441-005-0026-y; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Eisenhofer G, 2001, PHARMACOL THERAPEUT, V91, P35, DOI 10.1016/S0163-7258(01)00144-9; EISENHOFER G, 1988, J NEUROCHEM, V51, P1204, DOI 10.1111/j.1471-4159.1988.tb03088.x; ELDRUP E, 1989, AM J PHYSIOL, V256, pE284, DOI 10.1152/ajpendo.1989.256.2.E284; Farino ZJ, 2020, MOL PSYCHIATR, V25, P2070, DOI 10.1038/s41380-018-0344-6; Gildea JJ, 2014, KIDNEY INT, V86, P118, DOI 10.1038/ki.2014.5; GLAVIN GB, 1990, DIGEST DIS SCI, V35, P1153, DOI 10.1007/BF01537589; Goldstein D., 1995, HYPERTENTION RES, V18, P93; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; GROSSMAN E, 1992, CLIN SCI, V83, P65, DOI 10.1042/cs0830065; Harris RC, 2012, CURR HYPERTENS REP, V14, P138, DOI 10.1007/s11906-012-0253-z; HOLMES C, 1994, J CHROMATOGR B, V653, P131, DOI 10.1016/0378-4347(93)E0430-X; HOYLE GW, 1994, J NEUROSCI, V14, P2455; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kempadoo KA, 2016, P NATL ACAD SCI USA, V113, P14835, DOI 10.1073/pnas.1616515114; Khunweeraphong N, 2012, J PHARMACOL SCI, V119, P368, DOI 10.1254/jphs.12124FP; Korner J, 2019, MOL METAB, V23, P37, DOI 10.1016/j.molmet.2019.02.008; KVETNANSKY R, 1992, J PHARMACOL EXP THER, V261, P899; LEE K, 1987, J PHARMACOL EXP THER, V240, P954; Lubomski M, 2020, J NEUROL, V267, P1377, DOI 10.1007/s00415-020-09723-5; Matsuyama N, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0757-4; Mezey E, 1996, P NATL ACAD SCI USA, V93, P10377, DOI 10.1073/pnas.93.19.10377; Mitok KA, 2018, J BIOL CHEM, V293, P5860, DOI 10.1074/jbc.RA117.001102; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Newcomer JW, 2002, ARCH GEN PSYCHIAT, V59, P337, DOI 10.1001/archpsyc.59.4.337; O'Connell DP, 1998, AM J PHYSIOL-RENAL, V274, pF232, DOI 10.1152/ajprenal.1998.274.1.F232; OOMORI Y, 1994, HISTOCHEMISTRY, V101, P313, DOI 10.1007/BF00268992; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rasheed N, 2010, EUR J PHARMACOL, V643, P121, DOI 10.1016/j.ejphar.2010.06.032; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHOMIG A, 1984, CIRC RES, V55, P689, DOI 10.1161/01.RES.55.5.689; Simpson N, 2012, MOL ENDOCRINOL, V26, P1757, DOI 10.1210/me.2012-1101; Soares-Da-Silva P, 2004, FASEB J, V18, P1489, DOI 10.1096/fj.04-1787com; Stanley WC, 1997, BRIT J PHARMACOL, V121, P1803, DOI 10.1038/sj.bjp.0701315; Sumi-Ichinose C, 2005, J NEUROCHEM, V95, P703, DOI 10.1111/j.1471-4159.2005.03402.x; Tokuoka H, 2011, J BIOL CHEM, V286, P43549, DOI 10.1074/jbc.M111.284729; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; Ustione A, 2013, MOL ENDOCRINOL, V27, P1198, DOI 10.1210/me.2013-1083; Ustione A, 2012, MOL ENDOCRINOL, V26, P1928, DOI 10.1210/me.2012-1226; Wu YH, 2017, MOL MED REP, V16, P887, DOI 10.3892/mmr.2017.6620; Xu P, 2020, J MOL ENDOCRINOL, V64, P53, DOI 10.1530/JME-19-0053; Yamaguchi T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18128-x; Zhang MZ, 2011, J CLIN INVEST, V121, P2845, DOI 10.1172/JCI57324; Zheng LF, 2014, ACTA PHYSIOL, V211, P434, DOI 10.1111/apha.12229	51	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100544	10.1016/j.jbc.2021.100544	http://dx.doi.org/10.1016/j.jbc.2021.100544			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33737022	Green Published, gold			2022-12-28	WOS:000672866400517
J	Moore, PB				Moore, Peter B.			The PDB and the ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							3-DIMENSIONAL FOURIER SYNTHESIS; STRUCTURAL BASIS; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; SUBUNIT; RESOLUTION; PROTEIN; CRYSTALLIZATION; INSIGHTS; COMPLEX	This essay, which was written to commemorate the 50th anniversary of the Protein Data Bank, opens with some comments about the intentions of the scientists who pressed for its establishment and the nature of services it provides. It includes a brief account of the events that resulted in the determination of the crystal structure of the large ribosomal subunit from Haloarcula marismortui. The magnitude of the challenge the first ribosome crystal structures posed for the PDB is commented upon, and in the description of subsequent developments in the ribosome structure field that follows, it is pointed out that cryo-EM has replaced X-ray crystallography as the method of choice for investigating ribosome structure.	[Moore, Peter B.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Moore, PB (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.	peter.moore@yale.edu						Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P11; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Bashan A., RIBOSOME STRUCTURE F, P21; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bieri P, 2017, EMBO J, V36, P475, DOI 10.15252/embj.201695959; BYERS B, 1966, J CELL BIOL, V30, pC1; CAPEL MS, 1987, SCIENCE, V238, P1403, DOI 10.1126/science.3317832; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Davis JH, 2016, CELL, V167, P1610, DOI 10.1016/j.cell.2016.11.020; Fermi G., 1981, HAEMOGLOBIN MYOGLOBI; FOX GE, 1975, NATURE, V256, P505, DOI 10.1038/256505a0; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Holton JM, 2014, FEBS J, V281, P4046, DOI 10.1111/febs.12922; HOPE H, 1989, ACTA CRYSTALLOGR B, V45, P190, DOI 10.1107/S0108768188013710; Hunefeld F. L., 1840, CHEMISMUS TIERSCHEN; Huter P, 2017, MOL CELL, V68, P515, DOI 10.1016/j.molcel.2017.10.014; James R.W., 1965, OPTICAL PRINCIPLES D; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Moore PB, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P555; Moore PB, 2012, ANNU REV BIOPHYS, V41, P1, DOI 10.1146/annurev-biophys-050511-102314; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; NOLLER HF, 1981, SCIENCE, V212, P403, DOI 10.1126/science.6163215; Noller HF, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P129; PERUTZ MF, 1968, NATURE, V219, P131, DOI 10.1038/219131a0; Ramakrishnan V, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P3; Ramakrishnan V., 2018, BASIC BOOKS; Richards F. M., 1973, RIBONUCLEASE S; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; ROSSMANN MG, 1990, ACTA CRYSTALLOGR A, V46, P73, DOI 10.1107/S0108767389009815; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Tissieres A., 1974, RIBOSOME RES HIST BA, P3; TRAKHANOV SD, 1987, FEBS LETT, V220, P319, DOI 10.1016/0014-5793(87)80838-4; Vila-Sanjurjo A, 2003, P NATL ACAD SCI USA, V100, P8682, DOI 10.1073/pnas.1133380100; VONBOHLEN K, 1991, J MOL BIOL, V222, P11, DOI 10.1016/0022-2836(91)90730-T; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wang JM, 2017, PROTEIN SCI, V26, P122, DOI 10.1002/pro.3060; Wang JM, 2015, PROTEIN SCI, V24, P621, DOI 10.1002/pro.2595; Watson J. D., 1971, COLD SPRING HARBOR S; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; YONATH AE, 1980, BIOCHEM INT, V1, P428	52	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100561	10.1016/j.jbc.2021.100561	http://dx.doi.org/10.1016/j.jbc.2021.100561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744288	gold, Green Published			2022-12-28	WOS:000672866400534
J	Murakami, C; Sakane, F				Murakami, Chiaki; Sakane, Fumio			Sphingomyelin synthase-related protein generates diacylglycerol via the hydrolysis of glycerophospholipids in the absence of ceramide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE; LIPID PHOSPHATE PHOSPHATASE-1; PLECKSTRIN HOMOLOGY DOMAIN; PHORBOL ESTER; KINASE-C; INTRACELLULAR LEVELS; MOLECULAR-CLONING; KINETIC-ANALYSIS; MIXED MICELLES; ACTIVE-SITE	Diacylglycerol (DG) is a well-established lipid second messenger. Sphingomyelin synthase (SMS)-related protein (SMSr) produces DG and ceramide phosphoethanolamine (CPE) by the transfer of phosphoethanolamine from phosphatidylethanolamine (PE) to ceramide. We previously reported that human SMSr overexpressed in COS-7 cells significantly increased DG levels, particularly saturated and/or mono-unsaturated fatty acid-containing DG molecular species, and provided DG to DG kinase (DGK) delta, which regulates various pathophysiological events, including epidermal growth factor-dependent cell proliferation, type 2 diabetes, and obsessive-compulsive disorder. However, mammalian SMSr puzzlingly produces only trace amounts of CPE/DG. To clarify this discrepancy, we highly purified SMSr and examined its activities other than CPE synthase. Intriguingly, purified SMSr showed a DG-generating activity via hydrolysis of PE, phosphatidic acid (PA), phosphatidylinositol (PI), and phosphatidylcholine (PC) in the absence of ceramide. DG generation through the PA phosphatase (PAP) activity of SMSr was approximately 300-fold higher than that with PE and ceramide. SMSr hydrolyzed PI ten times stronger than PI(4,5)bisphosphate (PI(4,5)P-2). The PAP and PC-phospholipase C (PLC) activities of SMSr were inhibited by propranolol, a PAP inhibitor, and by D609, an SMS/PC-PLC inhibitor. Moreover, SMSr showed substrate selectivity for saturated and/or monounsaturated fatty acid-containing PA molecular species, but not arachidonic-acid-containing PA, which is exclusively generated in the PI(4,5)P-2 cycle. We confirmed that SMSr expressed in COS-7 cells showed PAP and PI-PLC activities. Taken together, our study indicated that SMSr possesses previously unrecognized enzyme activities, PAP and PI/PE/PC-PLC, and constitutes a novel DG/PA signaling pathway together with DGK delta, which is independent of the PI(4,5)P-2 cycle.	[Murakami, Chiaki; Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan; [Murakami, Chiaki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Chiba University; University of Tokyo	Murakami, C; Sakane, F (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan.; Murakami, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	cm55abcde@gmail.com; sakane@faculty.chiba-u.jp	Murakami, Chiaki/O-2622-2016	Murakami, Chiaki/0000-0003-3645-8382	MEXT/JSPS KAKENHI [JP18J20003, 25116704, 26291017, 20H03205, 17H03650, 15K14470]; Japan Science and Technology Agency [AS251Z01788Q, AS2621643Q]; Futaba Electronic Memorial Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Hamaguchi Foundation for the Advancement of Biochemistry; Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation; Asahi Group Foundation; Japan Milk Academic Alliance; Japan Food Chemical Research Foundation; SENSHIN Medical Research Foundation	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Futaba Electronic Memorial Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation(Terumo Life Science Foundation); Asahi Group Foundation; Japan Milk Academic Alliance; Japan Food Chemical Research Foundation(Japan Food Chemical Research Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This work was supported in part by grants from MEXT/JSPS KAKENHI (Grant Numbers: JP18J20003 (C. M.) and 25116704, 26291017, 20H03205, 17H03650 and 15K14470 (F. S.)); the Japan Science and Technology Agency (AS251Z01788Q and AS2621643Q) (F. S.); the Futaba Electronic Memorial Foundation (F. S.); the Ono Medical Research Foundation (F. S.); the Japan Foundation for Applied Enzymology (F. S.); the Food Science Institute Foundation (F. S.); the Skylark Food Science Institute (F. S.); the Hamaguchi Foundation for the Advancement of Biochemistry (F. S.); the Daiichi-Sankyo Foundation of Life Science (F. S.); the Terumo Life Science Foundation (F. S.); the Asahi Group Foundation (F. S.); the Japan Milk Academic Alliance (F. S.); the Japan Food Chemical Research Foundation (F. S.); and the SENSHIN Medical Research Foundation (F. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the article.	Adachi R, 2017, EUR J MED CHEM, V136, P283, DOI 10.1016/j.ejmech.2017.04.067; Adibhatla RM, 2012, NEUROCHEM RES, V37, P671, DOI 10.1007/s11064-011-0659-z; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; Bickert A, 2015, J LIPID RES, V56, P821, DOI 10.1194/jlr.M055269; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Cabukusta B, 2017, SCI REP-UK, V7, DOI 10.1038/srep41290; Cabukusta B, 2016, J BIOL CHEM, V291, P24735, DOI 10.1074/jbc.M116.749812; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Casares D, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092167; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; Deng XD, 2014, EUR J MED CHEM, V73, P1, DOI 10.1016/j.ejmech.2013.12.002; Ding TB, 2015, J LIPID RES, V56, P537, DOI 10.1194/jlr.M054627; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; GINGER RS, 1992, EUR J BIOCHEM, V210, P155, DOI 10.1111/j.1432-1033.1992.tb17403.x; Gusain A, 2012, MOL NEUROBIOL, V45, P455, DOI 10.1007/s12035-012-8254-0; Gutierrez-Martinez E, 2013, J CELL SCI, V126, P2641, DOI 10.1242/jcs.117705; HAFEZ MM, 1989, EXP CELL RES, V184, P37, DOI 10.1016/0014-4827(89)90361-3; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HOSTETLER KY, 1980, BIOCHEM BIOPH RES CO, V96, P388, DOI 10.1016/0006-291X(80)91227-9; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; JAMES SR, 1995, J BIOL CHEM, V270, P11872, DOI 10.1074/jbc.270.20.11872; Jia YJ, 2003, FEBS LETT, V552, P240, DOI 10.1016/S0014-5793(03)00931-1; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kai M, 2006, J BIOCHEM, V140, P677, DOI 10.1093/jb/mvj195; KANOH H, 1992, J BIOL CHEM, V267, P25309; KISS Z, 1990, J BIOL CHEM, V265, P7345; KISS Z, 1995, BBA-LIPID LIPID MET, V1259, P105, DOI 10.1016/0005-2760(95)00148-6; KISS Z, 1991, EUR J BIOCHEM, V197, P785, DOI 10.1111/j.1432-1033.1991.tb15972.x; KISS Z, 1992, EUR J BIOCHEM, V209, P467, DOI 10.1111/j.1432-1033.1992.tb17311.x; Klein RR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191783; Kol M, 2017, J LIPID RES, V58, P962, DOI 10.1194/jlr.M076133; Li B, 2015, EXP NEUROL, V272, P145, DOI 10.1016/j.expneurol.2015.02.031; Li YL, 2015, BIOORGAN MED CHEM, V23, P6173, DOI 10.1016/j.bmc.2015.07.060; Li YL, 2019, EUR J MED CHEM, V163, P864, DOI 10.1016/j.ejmech.2018.12.028; Lu Q, 2020, FEBS LETT, V594, P1787, DOI 10.1002/1873-3468.13765; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Mateos MV, 2010, BBA-BIOMEMBRANES, V1798, P624, DOI 10.1016/j.bbamem.2009.12.008; Mateos MV, 2006, LIPIDS, V41, P273, DOI 10.1007/s11745-006-5097-3; MATSUZAWA Y, 1980, J BIOL CHEM, V255, P646; MELDRUM E, 1991, BIOCHIM BIOPHYS ACTA, V1092, P49, DOI 10.1016/0167-4889(91)90177-Y; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Morimoto K, 2019, NAT CHEM BIOL, V15, P8, DOI 10.1038/s41589-018-0171-8; Morris KE, 2006, J BIOL CHEM, V281, P9297, DOI 10.1074/jbc.M511710200; MULLERDECKER K, 1989, BIOCHEM BIOPH RES CO, V162, P198, DOI 10.1016/0006-291X(89)91981-5; Murakami C, 2020, J BIOL CHEM, V295, P2932, DOI 10.1074/jbc.RA119.012369; Murakami C, 2017, ANAL BIOCHEM, V526, P43, DOI 10.1016/j.ab.2017.03.010; Nakamura Y, 2017, J BIOCHEM, V161, P315, DOI 10.1093/jb/mvw094; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Othman MA, 2019, ACS MED CHEM LETT, V10, P1154, DOI 10.1021/acsmedchemlett.9b00171; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Podo F, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00171; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Saito T, 2019, ACS OMEGA, V4, P5540, DOI 10.1021/acsomega.9b00079; Sakai H, 2014, J BIOL CHEM, V289, P26607, DOI 10.1074/jbc.M114.590950; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sakane F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186794; Sakane Fumio, 2018, Advances in Biological Regulation, V67, P101, DOI 10.1016/j.jbior.2017.09.003; Sarkes D, 2010, BIOCHEM J, V428, P375, DOI 10.1042/BJ20100129; Sharma VP, 2008, J LEUKOCYTE BIOL, V84, P440, DOI 10.1189/jlb.0907636; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Tafesse FG, 2014, J CELL SCI, V127, P445, DOI 10.1242/jcs.138933; Takahashi D, 2018, PEERJ, V6, DOI 10.7717/peerj.5449; Taniguchi Makoto, 2020, J Lipid Atheroscler, V9, P380, DOI 10.12997/jla.2020.9.3.380; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Usuki T, 2016, BRAIN RES, V1648, P193, DOI 10.1016/j.brainres.2016.07.017; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yeang C, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-89; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; ZAMBRANO F, 1975, BIOCHIM BIOPHYS ACTA, V380, P357, DOI 10.1016/0005-2760(75)90104-6; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	86	5	5	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100454	10.1016/j.jbc.2021.100454	http://dx.doi.org/10.1016/j.jbc.2021.100454			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33621517	Green Published, gold			2022-12-28	WOS:000672866400428
J	Okuyama, M; Serizawa, R; Tanuma, M; Kikuchi, A; Sadahiro, J; Tagami, T; Lang, W; Kimura, A				Okuyama, Masayuki; Serizawa, Ryo; Tanuma, Masanari; Kikuchi, Asako; Sadahiro, Juri; Tagami, Takayoshi; Lang, Weeranuch; Kimura, Atsuo			Molecular insight into regioselectivity of transfructosylation catalyzed by GH68 levansucrase and beta-fructofuranosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR LEVANSUCRASE; ERWINIA-AMYLOVORA; CRYSTAL-STRUCTURE; FRUCTAN; PURIFICATION; CDNA; CRYSTALLIZATION; MUTAGENESIS; EXPRESSION; SEQUENCE	Glycoside hydrolase family 68 (GH68) enzymes catalyze beta-fructosyltransfer from sucrose to another sucrose, the so-called transfructosylation. Although regioselectivity of transfructosylation is divergent in GH68 enzymes, there is insufficient information available on the structural factor(s) involved in the selectivity. Here, we found two GH68 enzymes, beta-fructofuranosidase (FFZm) and levansucrase (LSZm), encoded tandemly in the genome of Zymomonas mobilis, displayed different selectivity: FFZm catalyzed the beta-(2 -> 1)-trans-fructosylation (1-TF), whereas LSZm did both of 1-TF and beta-(2 -> 6)-trans-fructosylation (6-TF). We identified His79(FFZm) and Ala343(FFZm) and their corresponding Asn84(LSZm) and Ser345(LSZm) respectively as the structural factors for those regioselectivities. LSZm with the respective substitution of FFZm-type His and Ala for its Asn84(LSZm) and Ser345(LSZm) (N84H/S345A-LSZm) lost 6-TF and enhanced 1-TF. Conversely, the LSZm-type replacement of His79(FFZm) and Ala343(FFZm) in FFZm (H79N/A343S-FFZm) almost lost 1-TF and acquired 6-TF. H79N/A343S-FFZm exhibited the selectivity like LSZm but did not produce the beta-(2 -> 6)-fructoside-linked levan and/or long levanooligo-saccharides that LSZm did. We assumed Phe189(LSZm) to be a responsible residue for the elongation of levan chain in LSZm and mutated the corresponding Leu187(FFZm) in FFZm to Phe. An H79N/L187F/A343S-FFZm produced a higher quantity of long levanooligosaccharides than H79N/A343S-FFZm (or H79N-FFZm), although without levan formation, suggesting that LSZm has another structural factor for levan production. We also found that FFZm generated a sucrose analog, beta-D-fructofuranosyl alpha-D-mannopyranoside, by beta-fructosyltransfer to D-mannose and regarded His79(FFZm) and Ala343(FFZm) as key residues for this acceptor specificity. In summary, this study provides insight into the structural factors of regioselectivity and acceptor specificity in transfructosylation of GH68 enzymes.	[Okuyama, Masayuki; Serizawa, Ryo; Tanuma, Masanari; Kikuchi, Asako; Sadahiro, Juri; Tagami, Takayoshi; Lang, Weeranuch; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan	Hokkaido University	Okuyama, M; Kimura, A (corresponding author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan.	okuyama@abs.agr.hokudai.ac.jp; kimura@abs.agr.hokudai.ac.jp		Okuyama, Masayuki/0000-0001-7013-6032	Japan Society for the Promotion of Science KAKENHI [26450114, 17H03801]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Japan Society for the Promotion of Science KAKENHI Grant Nos. 26450114 and 17H03801.	Alvaro-Benito M, 2012, J BIOL CHEM, V287, P19674, DOI 10.1074/jbc.M112.355503; Belorkar SA, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0253-5; Brumer H, 1999, BIOCHEM J, V339, P43, DOI 10.1042/0264-6021:3390043; Cairns AJ, 1999, NEW PHYTOL, V142, P79, DOI 10.1046/j.1469-8137.1999.00378.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caputi L, 2013, J AGR FOOD CHEM, V61, P12265, DOI 10.1021/jf4023178; de Abreu M, 2013, ADV SYNTH CATAL, V355, P1698, DOI 10.1002/adsc.201200769; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Goldman D, 2008, J BIOL CHEM, V283, P32209, DOI 10.1074/jbc.M805985200; He CJ, 2018, APPL MICROBIOL BIOT, V102, P3217, DOI 10.1007/s00253-018-8854-3; HERNANDEZ L, 1995, BIOCHEM J, V309, P113, DOI 10.1042/bj3090113; Homann A, 2007, BIOCHEM J, V407, P189, DOI 10.1042/BJ20070600; Kawabata T, 2007, PROTEINS, V68, P516, DOI 10.1002/prot.21283; Kawabata T, 2010, PROTEINS, V78, P1195, DOI 10.1002/prot.22639; KYONO K, 1995, BIOSCI BIOTECH BIOCH, V59, P289, DOI 10.1271/bbb.59.289; Lasseur B, 2006, J EXP BOT, V57, P2719, DOI 10.1093/jxb/erl034; Li SY, 2011, MOL BIOL REP, V38, P2437, DOI 10.1007/s11033-010-0379-5; Liao JL, 2016, BIOSCI BIOTECH BIOCH, V80, P1747, DOI 10.1080/09168451.2015.1136884; Linde D, 2012, BIORESOURCE TECHNOL, V109, P123, DOI 10.1016/j.biortech.2012.01.023; LIU JH, 1991, CARBOHYD RES, V217, P43, DOI 10.1016/0008-6215(91)84115-U; Loehlin DW, 2016, P NATL ACAD SCI USA, V113, P5988, DOI 10.1073/pnas.1605886113; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ortiz-Soto ME, 2008, PROTEIN ENG DES SEL, V21, P589, DOI 10.1093/protein/gzn036; Ortiz-Soto ME, 2019, CARBOHYD POLYM, V219, P130, DOI 10.1016/j.carbpol.2019.05.014; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porras-Dominguez JR, 2015, CARBOHYD POLYM, V132, P338, DOI 10.1016/j.carbpol.2015.06.056; Possiel C., 2019, SCI REP-UK, V9, P1; Raga-Carbajal E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32872-7; Rodrigo-Frutos D, 2019, APPL MICROBIOL BIOT, V103, P279, DOI 10.1007/s00253-018-9446-y; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scholz-Ahrens KE, 2007, J NUTR, V137, p2513S, DOI 10.1093/jn/137.11.2513S; Seibel J, 2005, TETRAHEDRON, V61, P7081, DOI 10.1016/j.tet.2005.05.063; Seibel J, 2006, CARBOHYD RES, V341, P2335, DOI 10.1016/j.carres.2006.07.001; Strube CP, 2011, J BIOL CHEM, V286, P17593, DOI 10.1074/jbc.M110.203166; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamura K, 2009, J EXP BOT, V60, P893, DOI 10.1093/jxb/ern337; Tochio T, 2018, FOODS, V7, DOI 10.3390/foods7090140; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ueno K, 2005, NEW PHYTOL, V165, P813, DOI 10.1111/j.1469-8137.2004.01294.x; Versluys M, 2018, PLANT CELL ENVIRON, V41, P16, DOI 10.1111/pce.13070; Win TT, 2004, BIOTECHNOL LETT, V26, P499, DOI 10.1023/B:BILE.0000019557.44196.63; Wu C, 2015, CARBOHYD RES, V401, P122, DOI 10.1016/j.carres.2014.11.001; Wuerges J, 2015, J STRUCT BIOL, V191, P290, DOI 10.1016/j.jsb.2015.07.010; YANASE H, 1992, BIOSCI BIOTECH BIOCH, V56, P1335, DOI 10.1271/bbb.56.1335; YANASE H, 1995, J FERMENT BIOENG, V79, P367, DOI 10.1016/0922-338X(95)93997-X; Yanase H, 2002, J BIOCHEM, V132, P565, DOI 10.1093/oxfordjournals.jbchem.a003258	48	3	3	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100398	10.1016/j.jbc.2021.100398	http://dx.doi.org/10.1016/j.jbc.2021.100398			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571525	gold, Green Published			2022-12-28	WOS:000672866400372
J	Pedchenko, V; Boudko, SP; Barber, M; Mikhailova, T; Saus, J; Harmange, JC; Hudson, BG				Pedchenko, Vadim; Boudko, Sergei P.; Barber, Mary; Mikhailova, Tatiana; Saus, Juan; Harmange, Jean-Christophe; Hudson, Billy G.			Collagen IV alpha 345 dysfunction in glomerular basement membrane diseases. III. A functional framework for alpha 345 hexamer assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGEN; GOODPASTURE AUTOANTIGEN; CRYPTIC EPITOPES; IDENTIFICATION; GENE; ORGANIZATION; DOMAIN; SITES; CHAIN	We identified a genetic variant, an 8-residue appendage, of the alpha 345 hexamer of collagen IV present in patients with glomerular basement membrane diseases, Goodpasture's disease and Alport syndrome, and determined the long-awaited crystal structure of the hexamer. We sought to elucidate how variants cause glomerular basement membrane disease by exploring the mechanism of the hexamer assembly. Chloride ions induced in vitro hexamer assembly in a composition-specific manner in the presence of equimolar concentrations of alpha 3, alpha 4, and alpha 5 NC1 monomers. Chloride ions, together with sulfilimine crosslinks, stabilized the assembled hexamer. Furthermore, the chloride ion-dependent assembly revealed the conformational plasticity of the loop-crevice-loop bioactive sites, a critical property underlying bioactivity and pathogenesis. We explored the native mechanism by expressing recombinant alpha 345 miniprotomers in the cell culture and characterizing the expressed proteins. Our findings revealedNC1-directed trimerization, forming protomers inside the cell; hexamerization, forming scaffolds outside the cell; and a Cl gradient-signaled hexamerization. This assembly detail, along with a crystal structure, provides a framework for understanding hexamer dysfunction. Restoration of the native conformation of bioactive sites and alpha 345 hexamer replacement are prospective approaches to therapeutic intervention.	[Pedchenko, Vadim; Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37235 USA; [Pedchenko, Vadim; Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37235 USA; [Boudko, Sergei P.; Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Ctr Struct Biol, Nashville, TN 37232 USA; [Barber, Mary; Mikhailova, Tatiana; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Aspirnaut, Nashville, TN 37235 USA; [Saus, Juan] Univ Valencia, Fac Med & Odontol, Dept Bioquim & Biol Mol, Valencia, Spain; [Harmange, Jean-Christophe] Goldfinch Bio, Cambridge, MA USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Valencia; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Dept Biochem, Ctr Struct Biol, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Aspirnaut, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37235 USA.	billy.hudson@vumc.org		Barber, Mary/0000-0001-5394-8071; Mikhailova, Tatiana/0000-0003-4169-1322; Boudko, Sergei/0000-0003-3856-4859	Universidad de Buenos Aires [UBACYT 20020170100454BA]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2017-2971]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Universidad de Buenos Aires grant [UBACYT 20020170100454BA] to S. E. H. and S. L. L. and by Agencia Nacional de Promocion Cientifica y Tecnologica, grant [PICT-2017-2971] to S. L. L.	BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Borza DB, 2000, J BIOL CHEM, V275, P6030, DOI 10.1074/jbc.275.8.6030; Borza DB, 2005, J BIOL CHEM, V280, P27147, DOI 10.1074/jbc.M504050200; Boudko SP, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100591; Boudko SP, 2018, METHOD CELL BIOL, V143, P171, DOI 10.1016/bs.mcb.2017.08.010; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; Cummings CF, 2016, J CELL BIOL, V213, P479, DOI 10.1083/jcb.201510065; Fidler AL, 2018, J CELL SCI, V131, DOI 10.1242/jcs.203950; GUNWAR S, 1990, J BIOL CHEM, V265, P5466; Hong P, 2012, J LIQ CHROMATOGR R T, V35, P2923, DOI 10.1080/10826076.2012.743724; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kang JS, 2007, J BIOL CHEM, V282, P10670, DOI 10.1074/jbc.M611892200; Kang JS, 2008, J BIOL CHEM, V283, P35070, DOI 10.1074/jbc.M806396200; Keene DR, 2018, METHOD CELL BIOL, V143, P1, DOI 10.1016/bs.mcb.2017.08.002; MCCOY RC, 1982, KIDNEY INT, V21, P642, DOI 10.1038/ki.1982.72; Mizuno K, 2010, BIOPHYS J, V98, P3004, DOI 10.1016/j.bpj.2010.03.019; MYERS JC, 1990, AM J HUM GENET, V46, P1024; Naylor RW, 2021, NAT REV NEPHROL, V17, P112, DOI 10.1038/s41581-020-0329-y; Pedchenko V, 2019, J BIOL CHEM, V294, P7968, DOI 10.1074/jbc.RA119.007426; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Pokidysheva EN, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100590; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; YURCHENCO PD, 1987, J CELL BIOL, V105, P2559, DOI 10.1083/jcb.105.6.2559	26	9	9	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100592	10.1016/j.jbc.2021.100592	http://dx.doi.org/10.1016/j.jbc.2021.100592			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33775696	gold, Green Published			2022-12-28	WOS:000672866400564
J	Rios, SC; Saez, JOC; Quesada, O; Figueroa, KQ; Dominicci, JAL				Rios, Sonnieliz Cotto; Saez, Jose O. Colon; Quesada, Orestes; Figueroa, Katherine Quiroz; Dominicci, Jose A. Lasalde			Disruption of the cholinergic anti-inflammatory response by R5-tropic HIV-1 protein gp120(JRFL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; NECROSIS-FACTOR-ALPHA; SMOKING-CESSATION; MACROPHAGE HETEROGENEITY; INFLAMMATORY RESPONSE; BUPROPION LOWERS; IMMUNE-SYSTEM; SUBTYPE C; VIRUS; GP120	Despite current pharmacological intervention strategies, patients with HIV still suffer from chronic inflammation. The nicotinic acetylcholine receptors (nAChRs) are widely distributed throughout the nervous and immune systems. In macrophages, activation of alpha7-nAChR (alpha 7-nAChR) controls inflammatory processes through the cholinergic anti-inflammatory response (CAR). Given that this innate immune response controls inflammation and alpha 7-nAChR plays a critical role in the regulation of systemic inflammation, we investigated the effects of an R5-tropic HIV soluble component, gp120(JRFL), on the CAR functioning. We previously demonstrated that X4-tropic HIV-1 gp120(IIIB) disrupts the CAR as well as inducing upregulation of the alpha 7-nAChR in vitro in monocyte-derived macrophages (MDMs), which correlates with the upregulation observed in monocytes, T-lymphocytes, and MDMs recovered from HIV-infected people. We demonstrate here using imaging and molecular assays that the R5-tropic HIV-1 glycoprotein gp120(JRFL) upregulates the alpha 7-nAChR in MDMs dependent on CD4 and/or CCR5 activation. This upregulation was also dependent on MEK1 since its inhibition attenuates the upregulation of alpha 7-nAChR induced by gp120(JRFL) and was concomitant with an increase in basal calcium levels, which did not result in apoptosis. Moreover, the CAR was determined to be disrupted, since alpha 7-nAChR activation in MDMs did not reduce the production of the proinflammatory cytokines IL-6, GRO-alpha, or I-309. Furthermore, a partial antagonist of alpha 7-nAChR, bupropion, rescued IL-6 but not GRO-alpha or I-309 production. Together, these results demonstrate that gp120(JRFL) disrupts the CAR in MDMs. Other medications targeting the alpha 7-nAChR need to be tested to reactivate the CAR to ameliorate inflammation in HIV-infected subjects.	[Rios, Sonnieliz Cotto; Dominicci, Jose A. Lasalde] Univ Puerto Rico, Dept Chem, Rio Piedras Campus, San Juan, PR 00936 USA; [Saez, Jose O. Colon] Univ Puerto Rico, Dept Pharmaceut Sci, Med Sci Campus, San Juan, PR 00936 USA; [Quesada, Orestes] Univ Puerto Rico, Dept Phys Sci, Rio Piedras Campus, San Juan, PR 00936 USA; [Figueroa, Katherine Quiroz; Dominicci, Jose A. Lasalde] Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA; [Dominicci, Jose A. Lasalde] Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00936 USA; [Dominicci, Jose A. Lasalde] Univ Puerto Rico, Mol Sci Res Ctr, San Juan, PR 00936 USA; [Figueroa, Katherine Quiroz] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Pennsylvania	Dominicci, JAL (corresponding author), Univ Puerto Rico, Dept Chem, Rio Piedras Campus, San Juan, PR 00936 USA.; Dominicci, JAL (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA.; Dominicci, JAL (corresponding author), Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00936 USA.; Dominicci, JAL (corresponding author), Univ Puerto Rico, Mol Sci Res Ctr, San Juan, PR 00936 USA.	jose.lasalde@upr.edu			RISE-MBRS-NIH Program [2R25GM061151]	RISE-MBRS-NIH Program	S. C. R. was supported by the RISE-MBRS-NIH Program (2R25GM061151).	Alexander JK, 2010, J NEUROSCI, V30, P10112, DOI 10.1523/JNEUROSCI.6344-09.2010; Altschuler EL, 2003, PSYCHOSOM MED, V65, P719, DOI 10.1097/01.PSY.0000073874.55003.EE; Anderson G., 2020, MELATONIN RES, V3, P322, DOI [10.32794/mr11250066, DOI 10.32794/MR11250066]; Ballester LY, 2012, J BIOL CHEM, V287, P3079, DOI 10.1074/jbc.M111.262543; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brumme ZL, 2005, ANTIVIR THER, V10, P849; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Camara-Lemarroy CR, 2013, TRANSPL P, V45, P2502, DOI 10.1016/j.transproceed.2013.04.010; Capo-Velez CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20271-x; Castellano P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12758-w; Cedillo JL, 2015, J INFECT DIS, V211, P146, DOI 10.1093/infdis/jiu425; Chernyavsky AI, 2010, INT IMMUNOPHARMACOL, V10, P308, DOI 10.1016/j.intimp.2009.12.001; Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Criado M, 1997, J NEUROSCI, V17, P6554; Cummins NW, 2013, CELL MOL LIFE SCI, V70, P3355, DOI 10.1007/s00018-012-1239-3; Currier MB, 2003, PSYCHOSOMATICS, V44, P120, DOI 10.1176/appi.psy.44.2.120; de Almeida SM, 2017, J NEUROVIROL, V23, P460, DOI 10.1007/s13365-017-0518-z; de Almeida SM, 2016, J NEUROVIROL, V22, P715, DOI 10.1007/s13365-016-0437-4; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Delgado-Velez M, 2008, J NEUROIMMUNOL, V196, P94, DOI 10.1016/j.jneuroim.2008.03.004; Delgado-Velez M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051473; Delgado-Velez M, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.31; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Drach L, 2010, AIDS PATIENT CARE ST, V24, P139, DOI 10.1089/apc.2009.0274; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Fantuzzi L, 2001, J IMMUNOL, V166, P5381, DOI 10.4049/jimmunol.166.9.5381; Farsalinos K, 2020, INTERN EMERG MED, V15, P845, DOI 10.1007/s11739-020-02355-7; Fryer JD, 1999, J PHARMACOL EXP THER, V288, P88; GILBERT M, 1991, J CLIN MICROBIOL, V29, P142, DOI 10.1128/JCM.29.1.142-147.1991; Gingo MR, 2012, J ALLERGY CLIN IMMUN, V129, P708, DOI 10.1016/j.jaci.2011.11.015; Giri MS, 2009, J IMMUNOL, V182, P4459, DOI 10.4049/jimmunol.0801450; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Haughey NJ, 2002, JAIDS-J ACQ IMM DEF, V31, pS55, DOI 10.1097/00126334-200210012-00005; Hileman CO, 2017, CURR HIV-AIDS REP, V14, P93, DOI 10.1007/s11904-017-0356-x; Hoover DB, 2017, PHARMACOL THERAPEUT, V179, P1, DOI 10.1016/j.pharmthera.2017.05.002; Huecker M. R., 2020, BUPROPION STAT PEARL; Islas-Weinstein L, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.581911; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Kabbani N, 2018, TRENDS PHARMACOL SCI, V39, P354, DOI 10.1016/j.tips.2018.01.002; Kane SV, 2003, GASTROENTEROLOGY, V125, P1290, DOI 10.1016/j.gastro.2003.02.004; Kast RE, 2003, GEN HOSP PSYCHIAT, V25, P495, DOI 10.1016/S0163-8343(03)00093-8; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Khan MAS, 2012, SHOCK, V38, P213, DOI 10.1097/SHK.0b013e31825d628c; King JR, 2018, MOL PHARMACOL, V93, P601, DOI 10.1124/mol.117.111401; King JR, 2017, FEBS OPEN BIO, V7, P1350, DOI 10.1002/2211-5463.12270; Klasse PJ, 2004, VIROLOGY, V323, P1, DOI 10.1016/j.virol.2004.03.003; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; Liu QH, 2000, P NATL ACAD SCI USA, V97, P4832, DOI 10.1073/pnas.090521697; Luo YQ, 2008, J BIOL CHEM, V283, P24789, DOI 10.1074/jbc.M800649200; Maciel IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077227; Malnati MS, 1997, J BIOL REG HOMEOS AG, V11, P40; Massanella M, 2016, CURR OPIN HIV AIDS, V11, P234, DOI 10.1097/COH.0000000000000230; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Moyle GJ, 2005, J INFECT DIS, V191, P866, DOI 10.1086/428096; Murakami K, 2013, NEUROSCIENCE, V252, P443, DOI 10.1016/j.neuroscience.2013.08.024; OH SK, 1992, J ACQ IMMUN DEF SYND, V5, P251; Padilla A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11586-2; Park-Wyllie LY, 2003, AIDS, V17, P638, DOI 10.1097/00002030-200303070-00025; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Pedrol-Clotet E, 2006, ENFERM INFEC MICR CL, V24, P509, DOI 10.1157/13092468; Popik W, 2000, VIROLOGY, V276, P1, DOI 10.1006/viro.2000.0581; RAFF HV, 1980, J EXP MED, V152, P581, DOI 10.1084/jem.152.3.581; Rana S, 1997, J VIROL, V71, P3219, DOI 10.1128/JVI.71.4.3219-3227.1997; Rashidian A, 2020, INFLAMMATION, V43, P1999, DOI 10.1007/s10753-020-01273-2; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Shahrir S, 2020, PROG CARDIOVASC DIS, V63, P118, DOI 10.1016/j.pcad.2020.01.003; Siniavin AE, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040507; Slemmer JE, 2000, J PHARMACOL EXP THER, V295, P321; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; Thomsen MS, 2012, CURR DRUG TARGETS, V13, P707, DOI 10.2174/138945012800399035; Tindle HA, 2020, NICOTINE TOB RES, V22, P1669, DOI 10.1093/ntr/ntaa077; Trumpfheller C, 1998, CLIN EXP IMMUNOL, V112, P92; Ugolini S, 1997, J IMMUNOL, V159, P3000; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang JH, 2004, J CELL BIOCHEM, V93, P753, DOI 10.1002/jcb.20161; WITSELL AL, 1991, P NATL ACAD SCI USA, V88, P1963, DOI 10.1073/pnas.88.5.1963; Xiao XD, 2000, EXP MOL PATHOL, V68, P133, DOI 10.1006/exmp.1999.2300; Yi YJ, 1999, J VIROL, V73, P7117, DOI 10.1128/JVI.73.9.7117-7125.1999; Yuan ZH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42028; Zanetti SR, 2016, J BIOL CHEM, V291, P16541, DOI 10.1074/jbc.M115.710574; Zdanowski R, 2015, CENT EUR J IMMUNOL, V40, P373, DOI 10.5114/ceji.2015.54602	88	1	1	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100618	10.1016/j.jbc.2021.100618	http://dx.doi.org/10.1016/j.jbc.2021.100618			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	TI5TQ	33811859	gold, Green Published			2022-12-28	WOS:000672866400589
J	Tewari, R; Shayahati, B; Fan, Y; Akimzhanov, AM				Tewari, Ritika; Shayahati, Bieerkehazhi; Fan, Ying; Akimzhanov, Askar M.			T cell receptor-dependent S-acylation of ZAP-70 controls activation of T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLIPID-ENRICHED MICRODOMAINS; TYROSINE KINASE; PROTEIN PALMITOYLATION; LCK; LOCALIZATION; LAT; FAMILY; ZAP70; SITES	ZAP-70 is a tyrosine kinase essential for T cell immune responses. Upon engagement of the T cell receptor (TCR), ZAP-70 is recruited to the specialized plasma membrane domains, becomes activated, and is released to phosphorylate its laterally segregated targets. A shift in ZAP-70 distribution at the plasma membrane is recognized as a critical step in TCR signal transduction and amplification. However, the molecular mechanism supporting stimulation-dependent plasma membrane compartmentalization of ZAP-70 remains poorly understood. In this study, we identified previously uncharacterized lipidation (S-acylation) of ZAP-70 using Acyl-Biotin Exchange assay, a technique that selectively captures S-acylated proteins. We found that this posttranslational modification of ZAP-70 is dispensable for its enzymatic activity. However, the lipidation-deficient mutant of ZAP-70 failed to propagate the TCR pathway suggesting that S-acylation is essential for ZAP-70 interaction with its protein substrates. The kinetics of ZAP-70 S-acylation were consistent with TCR signaling events indicating that agonist-induced S-acylation is a part of the signaling mechanism controlling T cell activation and function. Taken together, our results suggest that TCR-induced S-acylation of ZAP-70 can serve as a critical regulator of T cell-mediated immunity.	[Tewari, Ritika; Shayahati, Bieerkehazhi; Fan, Ying; Akimzhanov, Askar M.] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX 77030 USA; [Fan, Ying] Rowan Univ, Dept Biomed Sci, Cooper Med Sch, Camden, NJ USA	University of Texas System; University of Texas Health Science Center Houston; Rowan University; Cooper Medical School of Rowan University	Akimzhanov, AM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX 77030 USA.	Askar.M.Akimzhanov@uth.tmc.edu	Bieerkehazhi, Shayahati/ABG-2791-2021	Akimzhanov, Askar/0000-0002-5592-8215	National Institutes of Health [1R01GM115446]; University of Texas Health Science Center at Houston	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Health Science Center at Houston	This work was supported by National Institutes of Health Grant 1R01GM115446 (to A.M.A) and startup funds provided by the University of Texas Health Science Center at Houston (to A.M.A.).	Akimzhanov AM, 2015, P NATL ACAD SCI USA, V112, P11876, DOI 10.1073/pnas.1509929112; Akimzhanov AM, 2010, P NATL ACAD SCI USA, V107, P15105, DOI 10.1073/pnas.1005419107; Au-Yeung BB, 2018, ANNU REV IMMUNOL, V36, P127, DOI 10.1146/annurev-immunol-042617-053335; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Fan Y, 2020, MOL BIOL REP, V47, P6471, DOI 10.1007/s11033-020-05691-1; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Hsu LY, 2017, J EXP MED, V214, P833, DOI 10.1084/jem.20161575; Hundt M, 2006, IMMUNITY, V24, P513, DOI 10.1016/j.immuni.2006.03.011; Hundt M, 2009, J IMMUNOL, V183, P1685, DOI 10.4049/jimmunol.0803921; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Katz ZB, 2017, NAT IMMUNOL, V18, P86, DOI 10.1038/ni.3631; Kosugi A, 2001, IMMUNOL LETT, V76, P133, DOI 10.1016/S0165-2478(01)00174-2; Ladygina N, 2011, ADV IMMUNOL, V109, P1, DOI 10.1016/B978-0-12-387664-5.00001-7; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lin DTS, 2015, ELIFE, V4, DOI 10.7554/eLife.11306; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Tewari R, 2020, JOVE-J VIS EXP, DOI 10.3791/61016; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Torchia MLG, 2018, P NATL ACAD SCI USA, V115, P2174, DOI 10.1073/pnas.1713301115; Turul T, 2009, EUR J PEDIATR, V168, P87, DOI 10.1007/s00431-008-0718-x; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Yokoi N, 2016, J NEUROSCI, V36, P6431, DOI 10.1523/JNEUROSCI.0419-16.2016; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; YURCHAK LK, 1995, MOL CELL BIOL, V15, P6914, DOI 10.1128/mcb.15.12.6914	41	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100311	10.1016/j.jbc.2021.100311	http://dx.doi.org/10.1016/j.jbc.2021.100311			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482200	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400285
J	Vester, SK; Beavil, RL; Lynham, S; Beavil, AJ; Graham, DSC; McDonnell, JM; Vyse, TJ				Vester, Susan K.; Beavil, Rebecca L.; Lynham, Steven; Beavil, Andrew J.; Graham, Deborah S. Cunninghame; McDonnell, James M.; Vyse, Timothy J.			Nucleolin acts as the receptor for C1QTNF4 and supports C1QTNF4-mediated innate immunity modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C1QTNF-RELATED PROTEIN 4; NF-KAPPA-B; CELL-SURFACE; FOOD-INTAKE; EXPRESSION; BINDING; C1Q; IDENTIFICATION; FAMILY; CTRP4	The C1q and TNF related 4 (C1QTNF4) protein is a structurally unique member of the C1QTNF family, a family of secreted proteins that have structural homology with both complement C1q and the tumor necrosis factor superfamily. C1QTNF4 has been linked to the autoimmune disease systemic lupus erythematosus through genetic studies; however, its role in immunity and inflammation remains poorly defined and a cell surface receptor of C1QTNF4 has yet to be identified. Here we report identification of nucleolin as a cell surface receptor of C1QTNF4 using mass spectrometric analysis. Additionally, we present evidence that the interaction between C1QTNF4 and nucleolin is mediated by the second C1q-like domain of C1QTNF4 and the C terminus of nucleolin. We show that monocytes and B cells are target cells of C1QTNF4 and observe extensive binding to dead cells. Imaging flow cytometry experiments in monocytes show that C1QTNF4 becomes actively internalized upon cell binding. Our results suggest that nucleolin may serve as a docking molecule for C1QTNF4 and act in a context-dependent manner through coreceptors. Taken together, these findings further our understanding of C1QTNF4's function in the healthy immune system and how dysfunction may contribute to the development of systemic lupus erythematosus.	[Vester, Susan K.; Graham, Deborah S. Cunninghame; Vyse, Timothy J.] Kings Coll London, Dept Med & Mol Genet, London, England; [Beavil, Rebecca L.; Beavil, Andrew J.; McDonnell, James M.] Kings Coll London, Randall Ctr Cell & Mol Biophys, London, England; [Beavil, Rebecca L.; Beavil, Andrew J.; McDonnell, James M.] Asthma UK Ctr Allerg Mech Asthma, London, England; [Lynham, Steven] Kings Coll London, Ctr Excellence Mass Spectrometry, Prote Facil, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Vyse, TJ (corresponding author), Kings Coll London, Dept Med & Mol Genet, London, England.	timothy.vyse@kcl.ac.uk		Lynham, Steven/0000-0003-3756-6430; Vester, Susan/0000-0002-4210-118X	Versus Arthritis PhD studentship [21252]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; NIHR-funded BRC Flow Cytometry Core at Guy's and St Thomas' NHS Foundation Trust; King's College London	Versus Arthritis PhD studentship; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London(General Electric); NIHR-funded BRC Flow Cytometry Core at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric)	This work was primarily funded by Versus Arthritis PhD studentship 21252 (to S. K. V., D. S. C. G., and T. J. V.). This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London (to T. J. V.). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. We acknowledge financial support through the NIHR-funded BRC Flow Cytometry Core at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Ando K, 2010, FEBS J, V277, P2051, DOI 10.1111/j.1742-4658.2010.07620.x; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Cao LL, 2021, EUR J IMMUNOL, V51, P380, DOI 10.1002/eji.202048617; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; Feng SQ, 2018, PEDIATR RES, V83, P999, DOI 10.1038/pr.2018.16; Grinstein E, 2007, J BIOL CHEM, V282, P12439, DOI 10.1074/jbc.M608068200; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Hu T, 2019, J CELL BIOCHEM, V120, P16206, DOI 10.1002/jcb.28902; Huang TS, 2008, STEM CELLS, V26, P1186, DOI 10.1634/stemcells.2007-0821; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Korb LC, 1997, J IMMUNOL, V158, P4525; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Langefeld CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16021; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Li Q, 2011, CANCER LETT, V308, P203, DOI 10.1016/j.canlet.2011.05.005; Li YJ, 2020, NEUROSCIENCE, V429, P1, DOI 10.1016/j.neuroscience.2019.12.039; Liu MX, 2019, J CELL PHYSIOL, V234, P18731, DOI 10.1002/jcp.28513; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luo Y, 2016, CELL MOL IMMUNOL, V13, P688, DOI 10.1038/cmi.2016.16; Mabbott NA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-632; Mahotka C, 2018, LEUKEMIA, V32, P1865, DOI 10.1038/s41375-018-0090-4; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041; Murayama MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9483; Murayama MA, 2014, BIOCHEM BIOPH RES CO, V443, P42, DOI 10.1016/j.bbrc.2013.11.040; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Navratil JS, 2001, J IMMUNOL, V166, P3231, DOI 10.4049/jimmunol.166.5.3231; Neumeier M, 2006, J LEUKOCYTE BIOL, V79, P803, DOI 10.1189/jlb.0905521; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Okamura Y, 2015, NUCLEIC ACIDS RES, V43, pD82, DOI 10.1093/nar/gku1163; Omeka WKM, 2019, FISH SHELLFISH IMMUN, V84, P158, DOI 10.1016/j.fsi.2018.09.078; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Pakzad B, 2020, INT J RHEUM DIS, V23, P1594, DOI 10.1111/1756-185X.13981; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Phillips GN, 1997, CURR OPIN STRUC BIOL, V7, P821, DOI 10.1016/S0959-440X(97)80153-4; Pradeep A. N., 2016, J CELL SCI R, V7; Pullabhatla V, 2018, HUM MOL GENET, V27, P421, DOI 10.1093/hmg/ddx407; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; Sarver DC, 2020, AM J PHYSIOL-ENDOC M, V319, pE1084, DOI 10.1152/ajpendo.00448.2020; Schilling D, 2002, J IMMUNOL, V169, P5874, DOI 10.4049/jimmunol.169.10.5874; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Song HJ, 2009, TRANSL RES, V154, P18, DOI 10.1016/j.trsl.2009.04.003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAKE M, 1994, J BIOCHEM-TOKYO, V116, P1063, DOI 10.1093/oxfordjournals.jbchem.a124628; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; Tsokos GC, 2016, NAT REV RHEUMATOL, V12, P716, DOI 10.1038/nrrheum.2016.186; Wang Y, 2011, CELL BIOL INT, V35, P677, DOI 10.1042/CBI20100625; WARRENER P, 1991, BIOCHEM BIOPH RES CO, V180, P716, DOI 10.1016/S0006-291X(05)81124-6; Wise JF, 2013, BLOOD, V121, P4729, DOI 10.1182/blood-2012-12-471094; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu WS, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.05.01; Yuan XL, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0416-6; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	67	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100513	10.1016/j.jbc.2021.100513	http://dx.doi.org/10.1016/j.jbc.2021.100513			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676896	gold, Green Published			2022-12-28	WOS:000672866400487
J	Wei, Z; Xu, X; Fang, YQ; Khater, M; Naughton, SX; Hu, G; Terry, AV; Wu, GY				Wei, Zhe; Xu, Xin; Fang, Yinquan; Khater, Mostafa; Naughton, Sean X.; Hu, Gang; Terry, Alvin, V; Wu, Guangyu			Rab43 GTPase directs postsynaptic trafficking and neuron-specific sorting of G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM EXPORT; CELL-SURFACE; ANGIOTENSIN-II; MEMBRANE TRAFFICKING; SEROTONIN RECEPTOR; TRANSPORT; GPCR; DISTINCT; MOTIF; INTERACTS	G protein-coupled receptors (GPCRs) are important modulators of synaptic functions. A fundamental but poorly addressed question in neurobiology is how targeted GPCR trafficking is achieved. Rab GTPases are the master regulators of vesicle-mediated membrane trafficking, but their functions in the synaptic presentation of newly synthesized GPCRs are virtually unknown. Here, we investigate the role of Rab43, via dominant-negative inhibition and CRISPR-Cas9-mediated KO, in the export trafficking of alpha 2-adrenergic receptor (alpha 2-AR) and muscarinic acetylcholine receptor (mAChR) in primary neurons and cells. We demonstrate that Rab43 differentially regulates the overall surface expression of endogenous alpha(2)-AR and mAChR, as well as their signaling, in primary neurons. In parallel, Rab43 exerts distinct effects on the dendritic and postsynaptic transport of specific alpha(2B)-AR and M3 mAChR subtypes. More interestingly, the selective actions of Rab43 toward alpha(2B)-AR and M3 mAChR are neuronal cell specific and dictated by direct interaction. These data reveal novel, neuronspecific functions for Rab43 in the dendritic and postsynaptic targeting and sorting of GPCRs and imply multiple forward delivery routes for different GPCRs in neurons. Overall, this study provides important insights into regulatory mechanisms of GPCR anterograde traffic to the functional destination in neurons.	[Wei, Zhe; Xu, Xin; Fang, Yinquan; Khater, Mostafa; Naughton, Sean X.; Terry, Alvin, V; Wu, Guangyu] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Fang, Yinquan; Hu, Gang] Nanjing Med Univ, Dept Pharmacol, Nanjing, Peoples R China	University System of Georgia; Augusta University; Nanjing Medical University	Wu, GY (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@augusta.edu		Khater, Mostafa/0000-0001-7080-6534; Terry, Alvin/0000-0003-2071-4767	NIH [R01GM118915, R35GM136397]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the NIH (R01GM118915 and R35GM136397 to G. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Awabdh S, 2012, J NEUROSCI, V32, P14227, DOI 10.1523/JNEUROSCI.6329-11.2012; Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Binotti B, 2015, ELIFE, V4, DOI 10.7554/eLife.05597; Carrel D, 2008, J NEUROSCI, V28, P8063, DOI 10.1523/JNEUROSCI.4487-07.2008; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Chan CC, 2011, CURR BIOL, V21, P1704, DOI 10.1016/j.cub.2011.08.058; Cherry S, 2013, ELIFE, V2, DOI 10.7554/eLife.01064; Choy RWY, 2014, NEURON, V82, P55, DOI 10.1016/j.neuron.2014.02.018; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cox JV, 2016, MOL BIOL CELL, V27, P1834, DOI 10.1091/mbc.E15-03-0123; Cui-Wang TT, 2012, CELL, V148, P309, DOI 10.1016/j.cell.2011.11.056; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; Doly S, 2016, MOL PSYCHIATR, V21, P480, DOI 10.1038/mp.2015.72; Dong C, 2008, CELL SIGNAL, V20, P1035, DOI 10.1016/j.cellsig.2008.01.014; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Esseltine JL, 2012, J NEUROSCI, V32, P16933, DOI 10.1523/JNEUROSCI.0625-12.2012; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Foster DJ, 2017, NEURON, V94, P431, DOI 10.1016/j.neuron.2017.03.016; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hanus C, 2008, TRAFFIC, V9, P1437, DOI 10.1111/j.1600-0854.2008.00775.x; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Holmes KD, 2006, J NEUROCHEM, V96, P934, DOI 10.1111/j.1471-4159.2005.03603.x; Huang YH, 2015, FEBS LETT, V589, P1607, DOI 10.1016/j.febslet.2015.05.007; HUBER LA, 1995, MOL CELL BIOL, V15, P918; Jolimay N, 2000, J NEUROSCI, V20, P9111; Kiral FR, 2018, CURR BIOL, V28, pR471, DOI 10.1016/j.cub.2018.02.010; Kobayashi H, 2013, J CELL SCI, V126, P2424, DOI 10.1242/jcs.117846; Kretzer NM, 2016, J EXP MED, V213, P2871, DOI 10.1084/jem.20160597; Lai YC, 2015, EMBO J, V34, P2840, DOI 10.15252/embj.201591593; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lesage S, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000009; Li CM, 2017, CELL REP, V21, P1089, DOI 10.1016/j.celrep.2017.10.011; Li CM, 2012, J BIOL CHEM, V287, P42784, DOI 10.1074/jbc.M112.410936; Liebmann T, 2012, J NEUROSCI, V32, P17998, DOI 10.1523/JNEUROSCI.1804-12.2012; Lodowski KH, 2013, J NEUROSCI, V33, P13621, DOI 10.1523/JNEUROSCI.1520-13.2013; Mignogna ML, 2018, SMALL GTPASES, V9, P145, DOI [10.1080/21541248.2016.1277001, DOI 10.1080/21541248.2016.1277001]; Mori Y, 2012, J BIOL CHEM, V287, P8963, DOI 10.1074/jbc.M111.314385; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nakazawa H, 2012, J NEUROSCI, V32, P12712, DOI 10.1523/JNEUROSCI.0989-12.2012; Ng EL, 2008, BRAIN RES REV, V58, P236, DOI 10.1016/j.brainresrev.2008.04.006; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Shiwarski DJ, 2019, MOL BIOL CELL, V30, P680, DOI 10.1091/mbc.E18-05-0292; Shiwarski DJ, 2017, MOL BIOL CELL, V28, P2202, DOI 10.1091/mbc.E17-01-0030; Valdes V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044168; Valenzuela JI, 2014, J CELL SCI, V127, P3382, DOI 10.1242/jcs.151092; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wei Z, 2019, CELL REP, V28, P554, DOI 10.1016/j.celrep.2019.05.033; Wei Z, 2018, MOL NEUROBIOL, V55, P6215, DOI 10.1007/s12035-017-0836-4; Wei Z, 2015, J BIOL CHEM, V290, P5105, DOI 10.1074/jbc.M114.599969; Weinberg ZY, 2019, CURR OPIN CELL BIOL, V57, P83, DOI 10.1016/j.ceb.2018.12.006; Wilson GR, 2014, AM J HUM GENET, V95, P729, DOI 10.1016/j.ajhg.2014.10.015; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Xu X, 2020, BIO-PROTOCOL, V10, DOI [10.21769/bioprotoc.3761, 10.21769/BioProtoc.3761]; Yin G, 2014, NEUROBIOL DIS, V70, P149, DOI 10.1016/j.nbd.2014.06.018; Zhang MX, 2019, TRAFFIC, V20, P110, DOI 10.1111/tra.12624; Zhang MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep37921; Zhang MX, 2016, MOL CELL BIOL, V36, P1152, DOI 10.1128/MCB.00009-16	68	7	7	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100517	10.1016/j.jbc.2021.100517	http://dx.doi.org/10.1016/j.jbc.2021.100517			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33676895	gold, Green Published			2022-12-28	WOS:000672866400491
J	Asangani, I; Blair, IA; Van Duyne, G; Hilser, VJ; Moiseenkova-Bell, V; Plymate, S; Sprenger, C; Wand, AJ; Penning, TM				Asangani, Irfan; Blair, Ian A.; Van Duyne, Gregory; Hilser, Vincent J.; Moiseenkova-Bell, Vera; Plymate, Stephen; Sprenger, Cynthia; Wand, A. Joshua; Penning, Trevor M.			Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							N-TERMINAL DOMAIN; LIGAND-BINDING DOMAIN; INTRINSICALLY UNSTRUCTURED PROTEINS; STEROIDOGENIC ENZYME AKR1C3; GLUCOCORTICOID-RECEPTOR; MEDIATOR COMPLEX; SPLICE VARIANTS; ABIRATERONE ACETATE; CRYSTAL-STRUCTURES; STRUCTURAL BASIS	Castration resistant prostate cancer (CRPC) continues to be androgen receptor (AR) driven. Inhibition of AR signaling in CRPC could be advanced using state-of-the-art biophysical and biochemical techniques. Structural characterization of AR and its complexes by cryo-electron microscopy would advance the development of N-terminal domain (NTD) and ligand-binding domain (LBD) antagonists. The structural basis of AR function is unlikely to be determined by any single structure due to the intrinsic disorder of its NTD, which not only interacts with coregulators but likely accounts for the constitutive activity of AR-splice variants (SV), which lack the LBD and emerge in CRPC. Using different AR constructs lacking the LBD, their effects on protein folding, DNA binding, and transcriptional activity could reveal how interdomain coupling explains the activity of AR-SVs. The AR also interacts with coregulators that promote chromatin looping. Elucidating the mechanisms involved can identify vulnerabilities to treat CRPC, which do not involve targeting the AR. Phosphorylation of the AR coactivator MED-1 by CDK7 is one mechanism that can be blocked by the use of CDK7 inhibitors. CRPC gains resistance to AR signaling inhibitors (ARSI). Drug resistance may involve AR-SVs, but their role requires their reliable quantification by SILAC-mass spectrometry during disease progression. ARSI drug resistance also occurs by intratumoral androgen biosynthesis catalyzed by AKR1C3 (type 5 17 beta-hydroxysteroid dehydrogenase), which is unique in that its acts as a coactivator of AR. Novel bifunctional inhibitors that competitively inhibit AKR1C3 and block its coactivator function could be developed using reverse-micelle NMR and fragment-based drug discovery.	[Asangani, Irfan] Univ Penn, Dept Canc Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Blair, Ian A.; Moiseenkova-Bell, Vera; Penning, Trevor M.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Van Duyne, Gregory] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hilser, Vincent J.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Plymate, Stephen; Sprenger, Cynthia] Univ Washington, Div Gerontol & Geriatr Med, Dept Med, Seattle, WA 98195 USA; [Plymate, Stephen; Sprenger, Cynthia] GRECC Seattle, Seattle, WA USA; [Wand, A. Joshua] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; University of Washington; University of Washington Seattle; Texas A&M University System; Texas A&M University College Station	Penning, TM (corresponding author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA.	penning@upenn.edu		Moiseenkova-Bell, Vera/0000-0002-0589-4053; Penning, Trevor/0000-0002-3937-1066; Blair, Ian/0000-0003-0366-8658	National Institutes of Health [P30-ES013508]; DoD Idea Development [W81XWH-17-1-0404, R01CA249210]; DoD Prostate Cancer Research Program [W81XWH-17-1-0484, W81XWH-20-1-0146]; Institute for Prostate Cancer Research and Veterans Affairs Research Program [R01GM103899, R01GM129357, R01-GM129076, R01GM126130]; Lopker Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD Idea Development; DoD Prostate Cancer Research Program; Institute for Prostate Cancer Research and Veterans Affairs Research Program; Lopker Foundation	Supported by the National Institutes of Health grants P30-ES013508 (T. M. P.); by DoD Idea Development grant: W81XWH-17-1-0404 and R01CA249210 (I. A.); by DoD Prostate Cancer Research Program (W81XWH-17-1-0484, W81XWH-20-1-0146, Lopker Foundation, Institute for Prostate Cancer Research and Veterans Affairs Research Program (S. R. P. and C. T. S); by R01GM103899 and R01GM129357 (V. B. M.); by R01-GM129076 (A. J. W.); and by R01GM126130 (V. J. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abida W, 2019, JAMA ONCOL, V5, P471, DOI 10.1001/jamaoncol.2018.5801; Aggarwal R, 2018, J CLIN ONCOL, V36, P2492, DOI 10.1200/JCO.2017.77.6880; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Andersson S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15840; Antonarakis ES, 2017, EUR UROL, V71, P4, DOI 10.1016/j.eururo.2016.08.038; Antonarakis ES, 2015, JAMA ONCOL, V1, P582, DOI 10.1001/jamaoncol.2015.1341; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Bernemann C, 2019, CLIN CANCER RES, V25, P3856, DOI 10.1158/1078-0432.CCR-18-4276; Bernemann C, 2018, BJU INT, V122, P219, DOI 10.1111/bju.14146; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Bohl CE, 2005, J BIOL CHEM, V280, P37747, DOI 10.1074/jbc.M507464200; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Borgmann-Winter KE, 2020, SCHIZOPHR RES, V217, P148, DOI 10.1016/j.schres.2019.07.025; Brown LC, 2020, PROSTATE CANCER P D, V23, P367, DOI 10.1038/s41391-020-0215-5; Byrns MC, 2008, BIOCHEM PHARMACOL, V75, P484, DOI 10.1016/j.bcp.2007.09.008; Callewaert L, 2003, J BIOL CHEM, V278, P8212, DOI 10.1074/jbc.M210744200; Cano LQ, 2013, MOL CELL ENDOCRINOL, V369, P52, DOI 10.1016/j.mce.2013.01.023; Caro JA, 2017, P NATL ACAD SCI USA, V114, P6563, DOI 10.1073/pnas.1621154114; Cato L, 2019, CANCER CELL, V35, P401, DOI 10.1016/j.ccell.2019.01.008; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Chen M, 2012, BIOORG MED CHEM LETT, V22, P3492, DOI 10.1016/j.bmcl.2012.03.085; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; Coffey K, 2012, J ENDOCRINOL, V215, P221, DOI 10.1530/JOE-12-0238; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Culig Z, 2004, J STEROID BIOCHEM, V92, P265, DOI 10.1016/j.jsbmb.2004.10.003; Culig Z, 2016, J CELL PHYSIOL, V231, P270, DOI 10.1002/jcp.25099; DAHLMANWRIGHT K, 1994, P NATL ACAD SCI USA, V91, P1619, DOI 10.1073/pnas.91.5.1619; Dalton J. T., 2013, Aldo-Keto Reductase Subfamily 1C3 (AKR1C3) Inhibitors, World Intellectual Property Organization, Patent No. [WO2013142390, 2013142390]; Danila DC, 2010, J CLIN ONCOL, V28, P1496, DOI 10.1200/JCO.2009.25.9259; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; De Jesus-Tran KP, 2006, PROTEIN SCI, V15, P987, DOI 10.1110/ps.051905906; De Mol E, 2016, ACS CHEM BIOL, V11, P2499, DOI 10.1021/acschembio.6b00182; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fan LL, 2015, J BIOL CHEM, V290, P20865, DOI 10.1074/jbc.M115.662155; Fankhauser M, 2014, CLIN CANCER RES, V20, P5547, DOI 10.1158/1078-0432.CCR-13-3483; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fisher RP, 2019, TRANSCR-AUSTIN, V10, P47, DOI 10.1080/21541264.2018.1553483; Fizazi K, 2019, NEW ENGL J MED, V380, P1235, DOI 10.1056/NEJMoa1815671; Fizazi K, 2018, CLIN GENITOURIN CANC, V16, P332, DOI 10.1016/j.clgc.2018.07.017; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Fondell JD, 2013, BBA-GEN SUBJECTS, V1830, P3867, DOI 10.1016/j.bbagen.2012.02.012; Ford J, 1997, MOL ENDOCRINOL, V11, P1467, DOI 10.1210/me.11.10.1467; Fuglestad B, 2019, ACS CHEM BIOL, V14, P2224, DOI 10.1021/acschembio.9b00537; Goodwin JF, 2015, CANCER CELL, V28, P97, DOI 10.1016/j.ccell.2015.06.004; Graf RP, 2020, EUR UROL, V77, P170, DOI 10.1016/j.eururo.2019.08.020; Guedes LB, 2016, CLIN CANCER RES, V22, P4651, DOI 10.1158/1078-0432.CCR-16-0205; Guo LL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35346-y; Guo LL, 2018, ANAL CHEM, V90, P2216, DOI 10.1021/acs.analchem.7b04590; Hamid ARAH, 2012, MOL MED, V18, P1449, DOI 10.2119/molmed.2012.00296; Harner MJ, 2013, J BIOMOL NMR, V56, P65, DOI 10.1007/s10858-013-9740-z; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Hofland J, 2010, CANCER RES, V70, P1256, DOI 10.1158/0008-5472.CAN-09-2092; Hsing AW, 2000, CANCER RES, V60, P5111; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Jernberg E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077407; Jin F, 2012, J BIOL CHEM, V287, P858, DOI 10.1074/jbc.M111.304519; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Kaczorowski A., 2020, RES COMMUN BIOCHEM C, V24; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Kumar R, 2004, BIOCHEMISTRY-US, V43, P3008, DOI 10.1021/bi035934p; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; Kumar R, 2013, J BIOL CHEM, V288, P30285, DOI 10.1074/jbc.M113.491787; Labrecque MP, 2019, J CLIN INVEST, V129, P4492, DOI 10.1172/JCI128212; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Le Moigne R, 2020, J CLIN ONCOL, V38; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li J, 2017, ELIFE, V6, DOI 10.7554/eLife.30688; Li J, 2012, J BIOL CHEM, V287, P26777, DOI 10.1074/jbc.M112.355651; Li YM, 2020, CLIN CANCER RES, V26, P1965, DOI 10.1158/1078-0432.CCR-19-3023; Liedtke AJ, 2013, J MED CHEM, V56, P2429, DOI 10.1021/jm3017656; Liu CF, 2019, MOL CANCER THER, V18, P1875, DOI 10.1158/1535-7163.MCT-18-1322; Liu CF, 2017, MOL CANCER THER, V16, P35, DOI 10.1158/1535-7163.MCT-16-0186; Liu CF, 2015, CANCER RES, V75, P1413, DOI 10.1158/0008-5472.CAN-14-3080; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Liu LL, 2014, ONCOGENE, V33, P3140, DOI 10.1038/onc.2013.284; Lu CX, 2020, PROSTATE CANCER P D, V23, P381, DOI 10.1038/s41391-020-0217-3; Lu NZ, 2006, TRENDS CELL BIOL, V16, P301, DOI 10.1016/j.tcb.2006.04.005; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Malik R, 2015, NAT MED, V21, P344, DOI 10.1038/nm.3830; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Mitsiades N, 2012, CANCER RES, V72, P6142, DOI 10.1158/0008-5472.CAN-12-1335; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Nadal M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14388; Nelson AW, 2017, MOL CELL ENDOCRINOL, V440, P138, DOI 10.1016/j.mce.2016.11.016; Neubert H, 2020, CLIN CHEM, V66, P282, DOI 10.1093/clinchem/hvz022; O'Brien ES, 2018, J BIOMOL NMR, V71, P263, DOI 10.1007/s10858-018-0200-7; Penning TM, 2007, MOL CELL ENDOCRINOL, V265, P77, DOI 10.1016/j.mce.2006.12.007; Penning TM, 2017, EXPERT OPIN THER PAT, V27, P1329, DOI 10.1080/13543776.2017.1379503; Pfeiffer MJ, 2011, MOL MED, V17, P657, DOI 10.2119/molmed.2010.00143; Plymate SR, 2018, JAMA ONCOL, V4, P1187, DOI 10.1001/jamaoncol.2018.1615; Powell K, 2015, CLIN CANCER RES, V21, P2569, DOI 10.1158/1078-0432.CCR-14-2352; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039; Rasool RU, 2019, CANCER DISCOV, V9, P1538, DOI 10.1158/2159-8290.CD-19-0189; Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Robinson D, 2015, CELL, V162, P454, DOI 10.1016/j.cell.2015.06.053; Russo JW, 2018, CANCER LETT, V438, P97, DOI 10.1016/j.canlet.2018.09.014; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Salami J, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0105-8; Sava GP, 2020, CANCER METAST REV, V39, P805, DOI 10.1007/s10555-020-09885-8; Scher HI, 2018, JAMA ONCOL, V4, P1179, DOI 10.1001/jamaoncol.2018.1621; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schweizer MT, 2016, EXPERT OPIN THER TAR, V20, P903, DOI 10.1517/14728222.2016.1159676; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; SHARIFI R, 1990, J UROLOGY, V143, P68, DOI 10.1016/S0022-5347(17)39868-3; Sharp A, 2019, J CLIN INVEST, V129, P192, DOI 10.1172/JCI122819; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sprenger CCT, 2014, HORM CANCER-US, V5, P207, DOI 10.1007/s12672-014-0177-y; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stelloo S, 2018, ONCOGENE, V37, P313, DOI 10.1038/onc.2017.330; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Takeda DY, 2018, CELL, V174, P422, DOI 10.1016/j.cell.2018.05.037; Taplin ME, 1999, CANCER RES, V59, P2511; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Tian YT, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-42; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Udayakumar TS, 2006, J BIOL CHEM, V281, P14691, DOI 10.1074/jbc.M600163200; Uo T, 2017, ENDOCR-RELAT CANCER, V24, pR335, DOI 10.1530/ERC-17-0108; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vijayvargia R, 2007, CANCER RES, V67, P4034, DOI 10.1158/0008-5472.CAN-06-3039; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wand AJ, 2018, ANNU REV BIOPHYS, V47, P41, DOI 10.1146/annurev-biophys-060414-034042; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192779; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Weng LW, 2018, ANAL CHEM, V90, P7552, DOI 10.1021/acs.analchem.8b01175; Wilson C, 2015, SCIENCE, V347, P882, DOI 10.1126/science.aaa1823; WILSON CM, 1994, P NATL ACAD SCI USA, V91, P1234, DOI 10.1073/pnas.91.4.1234; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu D, 2015, CANCER RES, V75, P3663, DOI 10.1158/0008-5472.CAN-15-0381; Yepuru M, 2013, CLIN CANCER RES, V19, P5613, DOI 10.1158/1078-0432.CCR-13-1151; Yi P, 2015, MOL CELL, V57, P1047, DOI 10.1016/j.molcel.2015.01.025; Yu XZ, 2020, MOL CELL, V79, P812, DOI 10.1016/j.molcel.2020.06.031; Zamudio AV, 2019, MOL CELL, V76, P753, DOI 10.1016/j.molcel.2019.08.016; Zeng R, 2012, ONCOL REP, V27, P492, DOI 10.3892/or.2011.1516; Zhan Y, 2017, MOL CANCER RES, V15, P59, DOI 10.1158/1541-7786.MCR-16-0236; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200; Zhu ZX, 2001, BIOCHEMISTRY-US, V40, P10756, DOI 10.1021/bi010525j; Zhu ZX, 2001, BIOCHEM BIOPH RES CO, V284, P836, DOI 10.1006/bbrc.2001.5030	169	8	8	2	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100240	10.1074/jbc.REV120.012411	http://dx.doi.org/10.1074/jbc.REV120.012411			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33384381	Green Published, gold			2022-12-28	WOS:000672866400218
J	Chandler, PG; Tan, L; Porebski, BT; Green, JS; Riley, BT; Broendum, SS; Hoke, DE; Falconer, RJ; Munro, TP; Buckle, M; Jackson, CJ; Buckle, AM				Chandler, Peter G.; Tan, Li Lynn; Porebski, Benjamin T.; Green, James S.; Riley, Blake T.; Broendum, Sebastian S.; Hoke, David E.; Falconer, Robert J.; Munro, Trent P.; Buckle, Malcolm; Jackson, Colin J.; Buckle, Ashley M.			Mutational and biophysical robustness in a prestabilized monobody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN STABILITY; HUMAN FIBRONECTIN; BINDING-PROTEINS; ADNECTIN INHIBITOR; HIGH-AFFINITY; III DOMAIN; ANTIBODY; GROWTH; ARGININE; CT-322	The fibronectin type III (FN3) monobody domain is a promising non-antibody scaffold, which features a less complex architecture than an antibody while maintaining analogous binding loops. We previously developed FN3Con, a hyperstable monobody derivative with diagnostic and therapeutic potential. Prestabilization of the scaffold mitigates the stability-function trade-off commonly associated with evolving a protein domain toward biological activity. Here, we aimed to examine if the FN3Con monobody could take on antibody-like binding to therapeutic targets, while retaining its extreme stability. We targeted the first of the Adnectin derivative of monobodies to reach clinical trials, which was engineered by directed evolution for binding to the therapeutic target VEGFR2; however, this function was gained at the expense of large losses in thermostability and increased oligomerization. In order to mitigate these losses, we grafted the binding loops from Adnectin-anti-VEGFR2 (CT-322) onto the prestabilized FN3Con scaffold to produce a domain that successfully bound with high affinity to the therapeutic target VEGFR2. This FN3Con-anti-VEGFR2 construct also maintains high thermostability, including remarkable long-term stability, retaining binding activity after 2 years of storage at 36 degrees C. Further investigations into buffer excipients doubled the presence of monomeric monobody in accelerated stability trials. These data suggest that loop grafting onto a prestabilized scaffold is a viable strategy for the development of monobody domains with desirable biophysical characteristics and that FN3Con is therefore well-suited to applications such as the evolution of multiple paratopes or shelf-stable diagnostics and therapeutics.	[Chandler, Peter G.; Green, James S.; Riley, Blake T.; Broendum, Sebastian S.; Hoke, David E.; Buckle, Ashley M.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Tan, Li Lynn; Jackson, Colin J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Porebski, Benjamin T.] Med Res Council Lab Mol Biol, Cambridge, England; [Riley, Blake T.] CUNY Adv Sci Res Ctr, Struct Biol Initiat, New York, NY USA; [Falconer, Robert J.] Univ Adelaide, Sch Chem Engn & Adv Mat, Adelaide, SA, Australia; [Munro, Trent P.] Univ Queensland, Australian Inst Bioengn & Nanotechnol AIBN, Brisbane, Qld, Australia; [Buckle, Malcolm] Univ Paris Saclay, LBPA, ENS Paris Saclay, UMR 8113 CNRS, Gif Sur Yvette, France	Monash University; Australian National University; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Adelaide; University of Queensland; UDICE-French Research Universities; Universite Paris Saclay	Buckle, AM (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Jackson, CJ (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia.	colin.jackson@anu.edu.au; ashley.buckle@monash.edu		Buckle, Ashley/0000-0003-2943-9044; Tan, Li Lynn/0000-0003-0606-4446; Malcolm, Buckle/0000-0001-7596-3467; Munro, Trent/0000-0003-1987-2020				Ackermann M., 2010, INT J ONCOL, V38, P267; Ackermann M, 2012, ANGIOGENESIS, V15, P685, DOI 10.1007/s10456-012-9294-9; Addis R., 2019, P AM ASS CANC RES AN; Addis R. C., 2020, P ANN M AM ASS CANC; Agarkhed M, 2013, AAPS PHARMSCITECH, V14, P1, DOI 10.1208/s12249-012-9878-0; Aghaabdollahian S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39776-0; [Anonymous], 2019, CANCER RES, V79; [Anonymous], 2020, CANCER RES, V80; [Anonymous], 2018, CANCER RES, V78; Arakawa T, 2003, BIOCHEM BIOPH RES CO, V304, P148, DOI 10.1016/S0006-291X(03)00578-3; Asghar W, 2016, SCI REP-UK, V6, DOI 10.1038/srep21163; Berteau C, 2015, MED DEVICES-EVID RES, V8, P473, DOI 10.2147/MDER.S91019; Besenmatter W, 2007, PROTEINS, V66, P500, DOI 10.1002/prot.21227; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Chandler PG, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030610; Chandler PG, 2020, METHODS MOL BIOL, V2073, P163, DOI 10.1007/978-1-4939-9869-2_10; Chen B, 2003, PHARM RES, V20, P1952, DOI 10.1023/B:PHAM.0000008042.15988.c0; Chen TF, 2013, METHOD ENZYMOL, V523, P303, DOI 10.1016/B978-0-12-394292-0.00014-X; Cota E, 2000, PROTEIN SCI, V9, P112; Crook ZR, 2020, TRENDS BIOCHEM SCI, V45, P332, DOI 10.1016/j.tibs.2019.12.008; Deonarain MP, 2021, EXPERT OPIN DRUG DIS, V16, P613, DOI 10.1080/17460441.2021.1858050; Dineen SP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-352; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Falconer RJ, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.06.011; Falconer RJ, 2011, J CHEM TECHNOL BIOT, V86, P942, DOI 10.1002/jctb.2657; Getmanova EV, 2006, CHEM BIOL, V13, P549, DOI 10.1016/j.chembiol.2005.12.009; Goldenzweig A, 2018, ANNU REV BIOCHEM, V87, P105, DOI 10.1146/annurev-biochem-062917-012102; Gregory T. K., 2018, P AM ASS CANC RES AN; Harrison RE, 2020, CANCER RES, V80, DOI 10.1158/1538-7445.AM2020-598; Jain T, 2017, P NATL ACAD SCI USA, V114, P944, DOI 10.1073/pnas.1616408114; Jarasch A, 2015, J PHARM SCI-US, V104, P1885, DOI 10.1002/jps.24430; Jorgensen L, 2009, EXPERT OPIN DRUG DEL, V6, P1219, DOI 10.1517/17425240903199143; Kadonosono T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57713-4; Karnell JL, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aar6584; Katayama DS, 2006, J PHARM SCI-US, V95, P1212, DOI 10.1002/jps.20471; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide S, 2012, METHOD ENZYMOL, V503, P135, DOI 10.1016/B978-0-12-396962-0.00006-9; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Lau SY, 2018, PROTEIN ENG DES SEL, V31, P301, DOI 10.1093/protein/gzy018; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002; Mamluk R, 2010, MABS-AUSTIN, V2, P199, DOI 10.4161/mabs.2.2.11304; Natarajan A, 2019, CLIN CANCER RES, V25, P1774, DOI 10.1158/1078-0432.CCR-18-1871; Oliver H, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14545; Olson CA, 2008, ACS CHEM BIOL, V3, P480, DOI 10.1021/cb800069c; Ota C, 2020, LANGMUIR, V36, P14243, DOI 10.1021/acs.langmuir.0c02367; Ota N, 2018, BIOCHIMIE, V150, P100, DOI 10.1016/j.biochi.2018.05.006; Parker MH, 2005, PROTEIN ENG DES SEL, V18, P435, DOI 10.1093/protein/gzi050; Petrovic D, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0330; PIKE RM, 1972, INFECT IMMUN, V5, P416, DOI 10.1128/IAI.5.3.416-417.1972; Platts L, 2015, INT J PHARMACEUT, V486, P131, DOI 10.1016/j.ijpharm.2015.03.051; Pluckthun A, 2015, ANNU REV PHARMACOL, V55, P489, DOI 10.1146/annurev-pharmtox-010611-134654; Porebski B. T, 2016, PROTEIN ENG DES SEL, V29, P1; Porebski BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep33958; Porebski BT, 2016, PROTEIN ENG DES SEL, V29, P245, DOI 10.1093/protein/gzw015; Porebski BT, 2015, PROTEIN ENG DES SEL, V28, P67, DOI 10.1093/protein/gzv002; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Sachdev E, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-015-0459-8; Schiff D, 2015, INVEST NEW DRUG, V33, P247, DOI 10.1007/s10637-014-0186-2; See K, 2020, BIOTECHNOL J, V15, DOI 10.1002/biot.202000078; Shukla D, 2010, J PHYS CHEM B, V114, P13426, DOI 10.1021/jp108399g; Stein E, 2019, ATHEROSCLEROSIS, V287, pE7, DOI 10.1016/j.atherosclerosis.2019.06.019; Sternke M, 2019, P NATL ACAD SCI USA, V116, P11275, DOI 10.1073/pnas.1816707116; Stimple SD, 2020, AICHE J, V66, DOI 10.1002/aic.16814; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tolcher AW, 2011, CLIN CANCER RES, V17, P363, DOI 10.1158/1078-0432.CCR-10-1411; Vazquez-Lombardi R, 2015, DRUG DISCOV TODAY, V20, P1271, DOI 10.1016/j.drudis.2015.09.004; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; Wang W, 2015, INT J PHARMACEUT, V490, P308, DOI 10.1016/j.ijpharm.2015.05.069; Waters JD, 2012, J NEURO-ONCOL, V110, P37, DOI 10.1007/s11060-012-0948-7; Wensel D, 2019, J VIROL, V93, DOI 10.1128/JVI.00907-19; Wilding M, 2019, BIOCHEM SOC T, V47, P701, DOI 10.1042/BST20180614; Zbacnik TJ, 2017, J PHARM SCI-US, V106, P713, DOI 10.1016/j.xphs.2016.11.014; Zheng J, 2020, SCIENCE, V370, P1183, DOI 10.1126/science.abb5962	76	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100447	10.1016/j.jbc.2021.100447	http://dx.doi.org/10.1016/j.jbc.2021.100447			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33617878	gold, Green Published, Green Submitted			2022-12-28	WOS:000672866400421
J	Feinberg, H; Jegouzo, SAF; Lasanajak, Y; Smith, DF; Drickamer, K; Weis, WI; Taylor, ME				Feinberg, Hadar; Jegouzo, Sabine A. F.; Lasanajak, Yi; Smith, David F.; Drickamer, Kurt; Weis, William, I; Taylor, Maureen E.			Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; RECOGNITION DOMAIN; LIGAND-BINDING; DC-SIGN; REPLACEMENT THERAPY; CRYSTAL-STRUCTURE; CANDIDA-ALBICANS; SUGAR-BINDING; MECHANISM; OLIGOSACCHARIDES	The human mannose receptor expressed on macrophages and hepatic endothelial cells scavenges released lysosomal enzymes, glycopeptide fragments of collagen, and pathogenic microorganisms and thus reduces damage following tissue injury. The receptor binds mannose, fucose, or N-acetylglucosamine (GlcNAc) residues on these targets. C-type carbohydrate-recognition domain 4 (CRD4) of the receptor contains the site for Ca2+-dependent interaction with sugars. To investigate the details of CRD4 binding, glycan array screening was used to identify oligosaccharide ligands. The strongest signals were for glycans that contain either Man alpha 1-2Man constituents or fucose in various linkages. The mechanisms of binding to monosaccharides and oligosaccharide substructures present in many of these ligands were examined in multiple crystal structures of CRD4. Binding of mannose residues to CRD4 results primarily from interaction of the equatorial 3- and 4-OH groups with a conserved principal Ca2+ common to almost all sugar-binding C-type CRDs. In the Man alpha 1-2Man complex, supplementary interactions with the reducing mannose residue explain the enhanced affinity for this disaccharide. Bound GlcNAc also interacts with the principal Ca2+ through equatorial 3- and 4-OH groups, whereas fucose residues can bind in several orientations, through either the 2- and 3-OH groups or the 3- and 4-OH groups. Secondary contacts with additional sugars in fucose-containing oligosaccharides, such as the Lewis-a trisaccharide, provide enhanced affinity for these glycans. These results explain many of the biologically important interactions of the mannose receptor with both mammalian glycoproteins and microbes such as yeast and suggest additional classes of ligands that have not been previously identified.	[Feinberg, Hadar; Weis, William, I] Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA; [Feinberg, Hadar; Weis, William, I] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Jegouzo, Sabine A. F.; Drickamer, Kurt; Taylor, Maureen E.] Imperial Coll London, Dept Life Sci, London, England; [Lasanajak, Yi; Smith, David F.] Emory Univ, Sch Med, Emory Comprehens Glyc Core, Atlanta, GA USA	Stanford University; Stanford University; Imperial College London; Emory University	Weis, WI (corresponding author), Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA.; Weis, WI (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.; Taylor, ME (corresponding author), Imperial Coll London, Dept Life Sci, London, England.	bill.weis@stanford.edu; maureen.taylor@imperial.ac.uk	Smith, David/GQQ-8257-2022; Weis, William/G-1437-2011	Feinberg, Hadar/0000-0002-9937-4699; Taylor, Maureen/0000-0001-8300-4987; Jegouzo, Sabine/0000-0001-7768-0102; Weis, William/0000-0002-5583-6150	Biotechnology and Biological Sciences Research Council [BB/P005659/1]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P30GM133894]; Emory University School of Medicine; BBSRC [BB/P005659/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Emory University School of Medicine; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant BB/P005659/1 from the Biotechnology and Biological Sciences Research Council to Maureen E. Taylor and Kurt Drickamer. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, NIGMS Grant P30GM133894. Glycan array analyses were performed by the Emory Comprehensive Glycomics Core (ECGC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities.	Azad A. K., 2014, J CYTOL MOL BIOL, V1, P5; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Boskovic J, 2006, J BIOL CHEM, V281, P8780, DOI 10.1074/jbc.M513277200; BRADY RO, 1994, J INHERIT METAB DIS, V17, P510, DOI 10.1007/BF00711365; Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Feinberg H, 2017, J BIOL CHEM, V292, P13402, DOI 10.1074/jbc.M117.799080; Feinberg H, 2013, J BIOL CHEM, V288, P36762, DOI 10.1074/jbc.M113.528000; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hitchen PG, 1998, BIOCHEM J, V333, P601, DOI 10.1042/bj3330601; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Hu ZZ, 2019, J STRUCT BIOL, V208, DOI 10.1016/j.jsb.2019.09.001; Hu ZZ, 2018, STRUCTURE, V26, P60, DOI 10.1016/j.str.2017.11.006; IOBST ST, 1994, J BIOL CHEM, V269, P15505; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang BK, 1998, INFECT IMMUN, V66, P2769, DOI 10.1128/IAI.66.6.2769-2777.1998; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; LENNARTZ MR, 1987, BIOCHEM J, V245, P705, DOI 10.1042/bj2450705; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; Liu Y, 2001, J MOL BIOL, V305, P481, DOI 10.1006/jmbi.2000.4326; Liu Y, 2017, GLYCOBIOLOGY, V27, P280, DOI 10.1093/glycob/cww118; Lozniewski A, 2003, INFECT IMMUN, V71, P2902, DOI 10.1128/IAI.71.5.2902-2906.2003; Lubow J, 2020, ELIFE, V9, DOI 10.7554/eLife.51035; Monteiro JT, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030059; Mullin NP, 1997, J BIOL CHEM, V272, P5668, DOI 10.1074/jbc.272.9.5668; MULLIN NP, 1994, J BIOL CHEM, V269, P28405; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Napper CE, 2001, J BIOL CHEM, V276, P14759, DOI 10.1074/jbc.M100425200; Ng KKS, 1996, J BIOL CHEM, V271, P663, DOI 10.1074/jbc.271.2.663; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Paracuellos P, 2015, STRUCTURE, V23, P2133, DOI 10.1016/j.str.2015.09.004; Porcaro I, 2003, J LEUKOCYTE BIOL, V74, P206, DOI 10.1189/jlb.1202608; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SHIBATA N, 1995, J BIOL CHEM, V270, P1113, DOI 10.1074/jbc.270.3.1113; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Takahashi K, 1998, CELL TISSUE RES, V292, P311, DOI 10.1007/s004410051062; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Taylor ME, 1997, GLYCOBIOLOGY, V7, pR5; Van Patten SM, 2007, GLYCOBIOLOGY, V17, P467, DOI 10.1093/glycob/cwm008; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0	61	22	24	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100368	10.1016/j.jbc.2021.100368	http://dx.doi.org/10.1016/j.jbc.2021.100368			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33545173	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400342
J	Kosuge, H; Nakakido, M; Nagatoishi, S; Fukuda, T; Bando, Y; Ohnuma, S; Tsumoto, K				Kosuge, Hirofumi; Nakakido, Makoto; Nagatoishi, Satoru; Fukuda, Tetsuya; Bando, Yasuhiko; Ohnuma, Shin-ichi; Tsumoto, Kouhei			Proteomic identification and validation of novel interactions of the putative tumor suppressor PRELP with membrane proteins including IGFI-R and p75NTR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; NERVE GROWTH-FACTOR; STATISTICAL-MODEL; DECORIN; PROTEOGLYCANS; RECEPTOR; INSULIN; BINDS; PROLIFERATION; ANTAGONIST	Proline and arginine-rich end leucine-rich repeat protein (PRELP) is a member of the small leucine-rich repeat proteoglycans (SLRPs) family. Levels of PRELP mRNA are downregulated in many types of cancer, and PRELP has been reported to have suppressive effects on tumor cell growth, although the molecular mechanism has yet to be fully elucidated. Given that other SLRPs regulate signaling pathways through interactions with various membrane proteins, we reasoned that PRELP likely interacts with membrane proteins to maintain cellular homeostasis. To identify membrane proteins that interact with PRELP, we carried out coimmunoprecipitation coupled with mass spectrometry (CoIP-MS). We prepared membrane fractions from Expi293 cells transfected to overexpress FLAG-tagged PRELP or control cells and analyzed samples precipitated with anti-FLAG antibody by mass spectrometry. Comparison of membrane proteins in each sample identified several that seem to interact with PRELP; among them, we noted two growth factor receptors, insulin-like growth factor I receptor (IGFI-R) and low-affinity nerve growth factor receptor (p75NTR), interactions with which might help to explain PRELP's links to cancer. We demonstrated that PRELP directly binds to extracellular domains of these two growth factor receptors with low micromolar affinities by surface plasmon resonance analysis using recombinant proteins. Furthermore, cell-based analysis using recombinant PRELP protein showed that PRELP suppressed cell growth and affected cell morphology of A549 lung carcinoma cells, also at micromolar concentration. These results suggest that PRELP regulates cellular functions through interactions with IGFI-R and p75NTR and provide a broader set of candidate partners for further exploration.	[Kosuge, Hirofumi; Nakakido, Makoto; Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Tokyo, Japan; [Nagatoishi, Satoru; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Fukuda, Tetsuya; Bando, Yasuhiko] Biosys Technol, Tokyo, Japan; [Ohnuma, Shin-ichi] UCL, Inst Ophthalmol, London, England	University of Tokyo; University of Tokyo; University of London; University College London	Tsumoto, K (corresponding author), Univ Tokyo, Sch Engn, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Inst Med Sci, Tokyo, Japan.	tsumoto@bioeng.t.u-tokyo.ac.jp	Satoru, NAGATOISHI/AAY-8198-2021	Satoru, NAGATOISHI/0000-0002-0794-3963	Japan Society for the Promotion of Science [16H02420, 19H05766, 18H02082]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science (grant no. 16H02420 and 19H05766 to K. T. and 18H02082 to S. N.).	Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker K, 2018, VET PATHOL, V55, P786, DOI 10.1177/0300985818781930; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; Bengtsson E, 2016, BIOCHEM J, V473, P1153, DOI 10.1042/BCJ20160095; Borch J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O110.006775; Bothwell M., 2019, F1000RES, V8; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Brandan E, 2006, J BIOL CHEM, V281, P31562, DOI 10.1074/jbc.M602919200; Cabello-Verrugio C, 2012, J BIOL CHEM, V287, P6773, DOI 10.1074/jbc.M111.312488; Chen HX, 2013, CHIN J CANCER, V32, P242, DOI 10.5732/cjc.012.10263; Dellett M, 2012, DEV GROWTH DIFFER, V54, P327, DOI 10.1111/j.1440-169X.2012.01339.x; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; Furstenberger G, 2002, LANCET ONCOL, V3, P298, DOI 10.1016/S1470-2045(02)00731-3; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Hakuno F, 2018, J MOL ENDOCRINOL, V61, pT69, DOI 10.1530/JME-17-0311; Happonen KE, 2012, J BIOL CHEM, V287, P8092, DOI 10.1074/jbc.M111.291476; Hayashi S, 2015, J CELL SCI, V128, P1455, DOI 10.1242/jcs.166306; Hong RQ, 2020, J CANCER, V11, P6376, DOI 10.7150/jca.46309; Hopper JTS, 2012, ANAL BIOCHEM, V421, P788, DOI 10.1016/j.ab.2011.10.034; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Kamal AM, 2019, MOL CELL PROTEOMICS, V18, P1732, DOI 10.1074/mcp.RA119.001377; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khan GA, 2011, MOL ENDOCRINOL, V25, P1431, DOI 10.1210/me.2010-0426; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Lewis M, 2003, AGEING RES REV, V2, P95, DOI 10.1016/S1568-1637(02)00044-2; Luehders K, 2015, DEVELOPMENT, V142, P3351, DOI 10.1242/dev.124438; Molloy Niamh H, 2011, Cancers (Basel), V3, P510, DOI 10.3390/cancers3010510; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohta K, 2011, P NATL ACAD SCI USA, V108, P14962, DOI 10.1073/pnas.1100513108; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Papadaki V, 2020, CANCERS, V12, DOI 10.3390/cancers12113362; Pietraszek-Gremplewicz K, 2019, MATRIX BIOL, V75-76, P271, DOI 10.1016/j.matbio.2017.12.006; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rucci N, 2013, J BONE MINER RES, V28, P1912, DOI 10.1002/jbmr.1951; Rucci N, 2009, J CELL BIOL, V187, P669, DOI 10.1083/jcb.200906014; Scalf M, 2000, ANAL CHEM, V72, P52, DOI 10.1021/ac990878c; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Urner LH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14424-8; Werner H, 2019, EXPERT OPIN INV DRUG, V28, P1101, DOI 10.1080/13543784.2019.1694660; Wu CC, 2003, NAT BIOTECHNOL, V21, P532, DOI 10.1038/nbt819; Xie HW, 2006, J PROTEOME RES, V5, P1003, DOI 10.1021/pr050472i; Yin H, 2016, ANNU REV BIOMED ENG, V18, P51, DOI 10.1146/annurev-bioeng-092115-025322; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200; Zougman A, 2014, PROTEOMICS, V14, P1006, DOI 10.1002/pmic.201300553	55	3	4	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100278	10.1016/j.jbc.2021.100278	http://dx.doi.org/10.1016/j.jbc.2021.100278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428936	gold, Green Published			2022-12-28	WOS:000672866400254
J	Ojala, KS; Ginebaugh, SP; Wu, M; Miller, EW; Ortiz, G; Covarrubias, M; Meriney, SD				Ojala, Kristine S.; Ginebaugh, Scott P.; Wu, Man; Miller, Evan W.; Ortiz, Gloria; Covarrubias, Manuel; Meriney, Stephen D.			A high-affinity, partial antagonist effect of 3,4-diaminopyridine mediates action potential broadening and enhancement of transmitter release at NMJs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EATON-MYASTHENIC-SYNDROME; GATED K+ CHANNELS; CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; POTASSIUM CHANNELS; DIHYDROPYRIDINE SENSITIVITY; SYNAPTIC-TRANSMISSION; PASSIVE TRANSFER; KV3 CHANNELS; 4-AMINOPYRIDINE	3,4-Diaminopyridine (3,4-DAP) increases transmitter release from neuromuscular junctions (NMJs), and low doses of 3,4-DAP (estimated to reach similar to 1 mu M in serum) are the Food and Drug Administration (FDA)-approved treatment for neuromuscular weakness caused by Lambert-Eaton myasthenic syndrome. Canonically, 3,4-DAP is thought to block voltage-gated potassium (Kv) channels, resulting in prolongation of the pre-synaptic action potential (AP). However, recent reports have shown that low millimolar concentrations of 3,4-DAP have an off-target agonist effect on the Cav1 subtype ("L-type") of voltage-gated calcium (Cav) channels and have speculated that this agonist effect might contribute to 3,4-DAP effects on transmitter release at the NMJ. To address 3,4-DAP's mechanism(s) of action, we first used the patch-clamp electrophysiology to characterize the concentration-dependent block of 3,4-DAP on the predominant presynaptic Kv channel subtypes found at the mammalian NMJ (Kv3.3 and Kv3.4). We identified a previously unreported high-affinity (1-10 mu M) partial antagonist effect of 3,4-DAP in addition to the well-known low-affinity (0.1-1 mM) antagonist activity. We also showed that 1.5-mu M DAP had no effects on Cav1.2 or Cav2.1 current. Next, we used voltage imaging to show that 1.5- or 100-mu M 3,4-DAP broadened the AP waveform in a dose-dependent manner, independent of Cav1 calcium channels. Finally, we demonstrated that 1.5- or 100-mu M 3,4-DAP augmented transmitter release in a dose-dependent manner and this effect was also independent of Cav1 channels. From these results, we conclude that low micromolar concentrations of 3,4-DAP act solely on Kv channels to mediate AP broadening and enhance transmitter release at the NMJ.	[Ojala, Kristine S.; Ginebaugh, Scott P.; Wu, Man; Meriney, Stephen D.] Univ Pittsburgh, Dept Neurosci, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Miller, Evan W.; Ortiz, Gloria] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Miller, Evan W.; Ortiz, Gloria] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Covarrubias, Manuel] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Jefferson University	Meriney, SD (corresponding author), Univ Pittsburgh, Dept Neurosci, Ctr Neurosci, Pittsburgh, PA 15260 USA.	meriney@pitt.edu		Covarrubias, Manuel/0000-0002-0881-4143; Ginebaugh, Scott/0000-0001-8820-606X; Meriney, Stephen/0000-0002-2005-9726	NIH [NS090644, F31 NS106753, NS098088]; MDA grant [603852]; Cure SMA grant [MER2021]; Gilliam Fellowship from the Howard Hughes Medical Institute; Farber Discovery Fund; Jefferson Synaptic Biology Center	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDA grant; Cure SMA grant; Gilliam Fellowship from the Howard Hughes Medical Institute; Farber Discovery Fund; Jefferson Synaptic Biology Center	This work was supported by the NIH grant NS090644, MDA grant 603852, and Cure SMA grant MER2021 to S. D. M., NIH F31 NS106753 to K. S. O., a Gilliam Fellowship from the Howard Hughes Medical Institute to G. O., NIH grant NS098088 to E. W. M, and grants from the Farber Discovery Fund and Jefferson Synaptic Biology Center to M. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alle H, 2011, J NEUROSCI, V31, P8001, DOI 10.1523/JNEUROSCI.0972-11.2011; ATCHISON WD, 1989, J PHARMACOL EXP THER, V251, P672; ATCHISON WD, 1987, BRAIN RES, V419, P315, DOI 10.1016/0006-8993(87)90599-3; Banwell BL, 2004, NEUROMUSCULAR DISORD, V14, P202, DOI 10.1016/j.nmd.2003.11.004; Bonanno S, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118819013; Brooke RE, 2004, EUR J NEUROSCI, V20, P3313, DOI 10.1111/j.1460-9568.2004.03730.x; CASTLE NA, 1994, MOL PHARMACOL, V45, P1242; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Cruz PMR, 2019, BRAIN, V142, P1547, DOI 10.1093/brain/awz107; Cruz PMR, 2016, J NEUROL NEUROSUR PS, V87, P802, DOI 10.1136/jnnp-2016-313163; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; FDA, 2019, FDA APPR 1 TREATM CH; FDA, 2018, FDA APPR 1 TREATM LA; Flet L, 2010, J NEUROL, V257, P937, DOI 10.1007/s00415-009-5442-6; Flink MT, 2002, J PHYSIOL-LONDON, V543, P567, DOI 10.1113/jphysiol.2002.021048; Ginebaugh SP, 2020, J NEUROSCI, V40, P3504, DOI 10.1523/JNEUROSCI.2415-19.2020; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Haroldsen PE, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.99; Haroldsen PE, 2015, CLIN THER, V37, P1555, DOI 10.1016/j.clinthera.2015.05.498; Heredia DJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00276; Huang YL, 2015, J AM CHEM SOC, V137, P10767, DOI 10.1021/jacs.5b06644; Ishida N, 2015, INT J CLIN PHARM TH, V53, P674, DOI 10.5414/CP202133; Kaczmarek LK, 2017, PHYSIOL REV, V97, P1431, DOI 10.1152/physrev.00002.2017; KIRSCH GE, 1993, J GEN PHYSIOL, V102, P797, DOI 10.1085/jgp.102.5.797; KIRSCH GE, 1978, BIOPHYS J, V22, P507, DOI 10.1016/S0006-3495(78)85503-9; LAMBERT EH, 1956, AM J PHYSIOL, V187, P612; LANG B, 1983, J PHYSIOL-LONDON, V344, P335, DOI 10.1113/jphysiol.1983.sp014943; LEMEIGNAN M, 1984, BRAIN RES, V304, P166, DOI 10.1016/0006-8993(84)90875-8; Li L, 2014, MOL PHARMACOL, V86, P760, DOI 10.1124/mol.114.095505; Lindquist S, 2014, EXPERT OPIN ORPHAN D, V2, P293, DOI 10.1517/21678707.2014.887464; Lindquist S, 2011, NEUROPSYCH DIS TREAT, V7, P341, DOI 10.2147/NDT.S10464; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; Luo FJ, 2015, J NEUROPHYSIOL, V113, P2480, DOI 10.1152/jn.00879.2014; Luo FJ, 2011, J NEUROSCI, V31, P11268, DOI 10.1523/JNEUROSCI.1394-11.2011; Mainero C, 2004, NEUROLOGY, V62, P2044, DOI 10.1212/01.WNL.0000129263.14219.A8; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; Meriney SD, 1996, ANN NEUROL, V40, P739, DOI 10.1002/ana.410400510; Meriney SD, 2018, J BIOL CHEM, V293, P16100, DOI 10.1074/jbc.L118.005425; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; MOLGO J, 1980, EUR J PHARMACOL, V61, P25, DOI 10.1016/0014-2999(80)90378-7; Muqeem T, 2018, J NEUROSCI, V38, P3729, DOI 10.1523/JNEUROSCI.3212-17.2018; NAGEL A, 1988, ANN NEUROL, V24, P552, DOI 10.1002/ana.410240412; Natera-de Benito D, 2016, NEUROMUSCULAR DISORD, V26, P789, DOI 10.1016/j.nmd.2016.08.005; Natera-de Benito D, 2016, NEUROMUSCULAR DISORD, V26, P153, DOI 10.1016/j.nmd.2015.10.013; Ng F, 2017, MUSCLE NERVE, V55, P223, DOI 10.1002/mus.25208; Oh SJ, 2016, MUSCLE NERVE, V53, P20, DOI 10.1002/mus.24921; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PANCRAZIO JJ, 1989, NEUROSCIENCE, V30, P215, DOI 10.1016/0306-4522(89)90366-7; POLMAN CH, 1994, ARCH NEUROL-CHICAGO, V51, P292, DOI 10.1001/archneur.1994.00540150090022; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; Rosenthal JC, 1996, J GEN PHYSIOL, V108, P207, DOI 10.1085/jgp.108.3.207; Rowan MJM, 2017, CELL REP, V18, P2018, DOI 10.1016/j.celrep.2017.01.068; Rowan MJM, 2016, NEURON, V91, P370, DOI 10.1016/j.neuron.2016.05.035; Rowan MJM, 2014, J NEUROSCI, V34, P6611, DOI 10.1523/JNEUROSCI.4208-13.2014; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sanders DB, 1998, ANN NY ACAD SCI, V841, P811, DOI 10.1111/j.1749-6632.1998.tb11022.x; Sanders DB, 2018, MUSCLE NERVE, V57, P561, DOI 10.1002/mus.26052; Schaarschmidt G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006168; Sheean GL, 1998, BRAIN, V121, P967, DOI 10.1093/brain/121.5.967; Sheng ZH, 1998, J BIOENERG BIOMEMBR, V30, P335, DOI 10.1023/A:1021985521748; Shieh Perry, 2019, J Clin Neuromuscul Dis, V20, P111, DOI 10.1097/CND.0000000000000239; SOSA MA, 1993, NEUROSCI LETT, V157, P235, DOI 10.1016/0304-3940(93)90745-7; STEPHENS GJ, 1994, J PHYSIOL-LONDON, V477, P187, DOI 10.1113/jphysiol.1994.sp020183; Strupp M, 2017, NEUROL-CLIN PRACT, V7, P65, DOI 10.1212/CPJ.0000000000000321; Tarr TB, 2014, J PHYSIOL-LONDON, V592, P3687, DOI 10.1113/jphysiol.2014.276493; Tarr TB, 2013, J NEUROSCI, V33, P10559, DOI 10.1523/JNEUROSCI.4629-12.2013; Tarr TB, 2013, TRENDS NEUROSCI, V36, P14, DOI 10.1016/j.tins.2012.09.009; Thakkar N, 2017, CPT-PHARMACOMET SYST, V6, P625, DOI 10.1002/psp4.12218; Thurtell MJ, 2012, CURR TREAT OPTION NE, V14, P60, DOI 10.1007/s11940-011-0154-5; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Tseng QZ, 2011, LAB CHIP, V11, P2231, DOI 10.1039/c0lc00641f; Urbano FJ, 2002, MOL MEMBR BIOL, V19, P293, DOI 10.1080/0968768021000035087; VEGA-SAENZ DE MIERA E, 1992, P ROY SOC B-BIOL SCI, V248, P9, DOI 10.1098/rspb.1992.0036; VINCENT A, 1989, TRENDS NEUROSCI, V12, P496, DOI 10.1016/0166-2236(89)90109-4; Voelker R, 2019, JAMA-J AM MED ASSOC, V321, P239, DOI 10.1001/jama.2018.21321; Wirtz PW, 2009, CLIN PHARMACOL THER, V86, P44, DOI 10.1038/clpt.2009.35; Wirtz PW, 2010, EXPERT REV CLIN IMMU, V6, P867, DOI 10.1586/ECI.10.57; Witting N, 2015, CLIN NEUROL NEUROSUR, V130, P168, DOI 10.1016/j.clineuro.2015.01.010; Wu M, 2018, NEUROPHARMACOLOGY, V131, P176, DOI 10.1016/j.neuropharm.2017.12.022; Wu ZZ, 2018, J BIOL CHEM, V293, P16101, DOI 10.1074/jbc.RL118.005655; Wu ZZ, 2009, J BIOL CHEM, V284, P36453, DOI 10.1074/jbc.M109.075523; Xu YF, 1998, J NEUROPHYSIOL, V80, P1056, DOI 10.1152/jn.1998.80.3.1056; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; Yoon CH, 2020, ANN PHARMACOTHER, V54, P56, DOI 10.1177/1060028019864574; Zemel BM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00253	85	7	7	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100302	10.1016/j.jbc.2021.100302	http://dx.doi.org/10.1016/j.jbc.2021.100302			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33465376	Green Published, gold			2022-12-28	WOS:000672866400276
J	Shields, LY; Li, HH; Nguyen, K; Kim, H; Doric, Z; Garcia, JH; Gill, TM; Haddad, D; Vossel, K; Calvert, M; Nakamura, K				Shields, Lauren Y.; Li, Huihui; Nguyen, Kevin; Kim, Hwajin; Doric, Zak; Garcia, Joseph H.; Gill, T. Michael; Haddad, Dominik; Vossel, Keith; Calvert, Meredith; Nakamura, Ken			Mitochondrial fission is a critical modulator of mutant APP-induced neural toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; AMYLOID-BETA; SYNAPTIC MITOCHONDRIA; IN-VITRO; DRP1; CALCIUM; DYNAMICS; INHIBITION; MUTATION	Alterations in mitochondrial fission may contribute to the pathophysiology of several neurodegenerative diseases, including Alzheimer's disease (AD). However, we understand very little about the normal functions of fission or how fission disruption may interact with AD-associated proteins to modulate pathogenesis. Here we show that loss of the central mitochondrial fission protein dynamin-related protein 1 (Drp1) in CA1 and other forebrain neurons markedly worsens the learning and memory of mice expressing mutant human amyloid precursor protein (hAPP) in neurons. In cultured neurons, Drp1KO and hAPP converge to produce mitochondrial Ca2+ (mitoCa(2+)) overload, despite decreasing mitochondria-associated ER membranes (MAMs) and cytosolic Ca2+. This mitoCa(2+) overload occurs independently of ATP levels. These findings reveal a potential mechanism by which mitochondrial fission protects against hAPP-driven pathology.	[Shields, Lauren Y.; Li, Huihui; Nguyen, Kevin; Kim, Hwajin; Doric, Zak; Garcia, Joseph H.; Gill, T. Michael; Haddad, Dominik; Vossel, Keith; Calvert, Meredith; Nakamura, Ken] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Shields, Lauren Y.; Doric, Zak; Nakamura, Ken] Univ Calif San Francisco, Grad Programs Neurosci & Biomed Sci, San Francisco, CA 94143 USA; [Nakamura, Ken] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Shields, Lauren Y.] Benchling, 555 Montgomery St,Suite 1700, San Francisco, CA 94111 USA; [Kim, Hwajin] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Pharmacol, 15-816 Beon Gil, Jinju 660751, Gyeongnam, South Korea; [Haddad, Dominik] Alector, Neuroimmunol Grp, San Francisco, CA 94080 USA; [Vossel, Keith] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Mary S Easton Ctr Alzheimers Dis Res, Los Angeles, CA 90095 USA; [Calvert, Meredith] Denali Therapeut, 161 Oyster Point Blvd, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Gyeongsang National University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nakamura, K (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.; Nakamura, K (corresponding author), Univ Calif San Francisco, Grad Programs Neurosci & Biomed Sci, San Francisco, CA 94143 USA.; Nakamura, K (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	ken.nakamura@gladstone.ucsf.edu		Nakamura, Ken/0000-0002-9192-182X; Doric, Zak/0000-0003-2608-4196	NIH [5P30 NS069496, RR18928, RO1NS091902, RF1AG064170]; California Department of Public Health; Larry L. Hillblom Foundation; American Health Assistance Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Department of Public Health; Larry L. Hillblom Foundation; American Health Assistance Foundation	K. N., L. S., H. L., KNguyen, H. K., D. H., and Z. D. were supported by NIH RO1NS091902 and RF1AG064170 to K. N. This work was also supported by grants from the California Department of Public Health (K. N.), Larry L. Hillblom Foundation (L. S.), and the American Health Assistance Foundation (H. K.). This work was also supported by NIH 5P30 NS069496 and NIH RR18928 to Gladstone Institutes.	Abdul-Khabir W, 2014, J PSYCHOACTIVE DRUGS, V46, P310, DOI 10.1080/02791072.2014.934978; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Andrew Gelman Y.-S. S, 2014, ARM DATA ANAL USING; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Balding DJ, 2004, APPL LONGITUDINAL AN; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauer P, 1998, STAT MED, V17, P2133, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2133::AID-SIM901>3.0.CO;2-2; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Berthet A, 2014, J NEUROSCI, V34, P14304, DOI 10.1523/JNEUROSCI.0930-14.2014; Calvo-Rodriguez M, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00022; Calvo-Rodriguez M, 2016, BBA-MOL CELL RES, V1863, P2637, DOI 10.1016/j.bbamcr.2016.08.001; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Fahrner JA, 2016, AM J MED GENET A, V170, P2002, DOI 10.1002/ajmg.a.37721; Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Granatiero V, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1681254; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Hedskog L, 2013, P NATL ACAD SCI USA, V110, P7916, DOI 10.1073/pnas.1300677110; HOLM S, 1979, SCAND J STAT, V6, P65; Hom J, 2010, BBA-BIOENERGETICS, V1797, P913, DOI 10.1016/j.bbabio.2010.03.018; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Jadiya P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11813-6; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kandimalla R, 2016, BBA-MOL BASIS DIS, V1862, P814, DOI 10.1016/j.bbadis.2015.12.018; Kaufman RJ, 2014, BBA-MOL CELL RES, V1843, P2233, DOI 10.1016/j.bbamcr.2014.03.022; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MAURER W., 1995, BIOMETRIE CHEM PHARM, V6, P3; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Oules B, 2012, J NEUROSCI, V32, P11820, DOI 10.1523/JNEUROSCI.0875-12.2012; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Pathak D, 2015, J BIOL CHEM, V290, P22325, DOI 10.1074/jbc.M115.656405; Rappold PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6244; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Shields LY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.94; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Song MS, 2015, CIRC RES, V117, P346, DOI 10.1161/CIRCRESAHA.117.306859; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Surmeier DJ, 2013, J BIOL CHEM, V288, P10736, DOI 10.1074/jbc.R112.410530; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Tambini MD, 2016, EMBO REP, V17, P27, DOI 10.15252/embr.201540614; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vanstone JR, 2016, EUR J HUM GENET, V24, P1084, DOI 10.1038/ejhg.2015.243; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150441; Wang WZ, 2016, NAT MED, V22, P54, DOI 10.1038/nm.3983; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yang L, 2009, J NEUROSCI, V29, P15660, DOI 10.1523/JNEUROSCI.4104-09.2009; Yang ZY, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208686; Yoon G, 2016, J PEDIATR-US, V171, P313, DOI 10.1016/j.jpeds.2015.12.060; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	88	2	2	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100469	10.1016/j.jbc.2021.100469	http://dx.doi.org/10.1016/j.jbc.2021.100469			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639169	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400443
J	Tao, YQ; Xie, JF; Zhong, QL; Wang, YY; Zhang, SN; Luo, F; Wen, FC; Xie, JJ; Zhao, JW; Sun, XO; Long, HF; Ma, JF; Zhang, Q; Long, JG; Fang, XY; Lu, Y; Li, D; Li, M; Zhu, JD; Sun, B; Li, GH; Diao, JJ; Liu, C				Tao, Youqi; Xie, Jingfei; Zhong, Qinglu; Wang, Yongyao; Zhang, Shengnan; Luo, Feng; Wen, Fengcai; Xie, Jingjing; Zhao, Jiawei; Sun, Xiaoou; Long, Houfang; Ma, Junfeng; Zhang, Qian; Long, Jiangang; Fang, Xianyang; Lu, Ying; Li, Dan; Li, Ming; Zhu, Jidong; Sun, Bo; Li, Guohui; Diao, Jiajie; Liu, Cong			A novel partially open state of SHP2 points to a "multiple gear" regulation mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; HELICOBACTER-PYLORI CAGA; SH2 DOMAIN; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; LEOPARD-SYNDROME; MUTATIONS; BINDING; IDENTIFICATION; ACTIVATION	The protein tyrosine phosphatase SHP2 mediates multiple signal transductions in various cellular pathways, controlled by a variety of upstream inputs. SHP2 dysregulation is causative of different types of cancers and developmental disorders, making it a promising drug target. However, how SHP2 is modulated by its different regulators remains largely unknown. Here, we use single-molecule fluorescence resonance energy transfer and molecular dynamics simulations to investigate this question. We identify a partially open, semiactive conformation of SHP2 that is intermediate between the known open and closed states. We further demonstrate a "multiple gear" regulatory mechanism, in which different activators (e.g., insulin receptor substrate-1 and CagA), oncogenic mutations (e.g., E76A), and allosteric inhibitors (e.g., SHP099) can shift the equilibrium of the three conformational states and regulate SHP2 activity to different levels. Our work reveals the essential role of the intermediate state in fine-tuning the activity of SHP2, which may provide new opportunities for drug development for relevant cancers.	[Tao, Youqi; Li, Dan] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai, Peoples R China; [Xie, Jingfei; Zhang, Shengnan; Luo, Feng; Xie, Jingjing; Long, Houfang; Zhu, Jidong; Liu, Cong] Chinese Acad Sci, Interdisciplinary Res Ctr Biol & Chem, Shanghai Inst Organ Chem, Shanghai, Peoples R China; [Xie, Jingfei; Zhong, Qinglu; Zhang, Shengnan; Luo, Feng; Xie, Jingjing; Long, Houfang; Lu, Ying; Li, Ming; Zhu, Jidong; Li, Guohui; Liu, Cong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhong, Qinglu; Li, Guohui] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Mol Modeling & Design, State Key Lab Mol React Dynam, Dalian, Peoples R China; [Wang, Yongyao; Long, Jiangang] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Ctr Mitochondrial Biol & Med,Key Lab Biomed Infor, Xian, Peoples R China; [Wang, Yongyao; Diao, Jiajie] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA; [Wen, Fengcai; Zhang, Qian; Sun, Bo] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Zhao, Jiawei; Sun, Xiaoou; Ma, Junfeng; Fang, Xianyang] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing, Peoples R China; [Lu, Ying; Li, Ming] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing, Peoples R China; [Lu, Ying; Li, Ming] Chinese Acad Sci, Inst Phys, CAS Key Lab Soft Matter Phys, Beijing, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Xi'an Jiaotong University; University System of Ohio; University of Cincinnati; ShanghaiTech University; Tsinghua University; Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Institute of Physics, CAS	Liu, C (corresponding author), Chinese Acad Sci, Interdisciplinary Res Ctr Biol & Chem, Shanghai Inst Organ Chem, Shanghai, Peoples R China.; Li, GH; Liu, C (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Li, GH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, Lab Mol Modeling & Design, State Key Lab Mol React Dynam, Dalian, Peoples R China.; Diao, JJ (corresponding author), Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA.	ghli@dicp.ac.cn; jiajie.diao@uc.edu; liulab@sioc.ac.cn	Zhang, Qian/AAS-5468-2021; Diao, Jiajie/A-3425-2008; xie, jing/GRY-1689-2022	Zhang, Qian/0000-0002-9187-4277; Diao, Jiajie/0000-0003-4288-3203; Sun, Bo/0000-0002-4590-7795	Major State Basic Research Development Program [2016YFA0501902]; National Natural Science Foundation (NSF) of China [31872716]; Science and Technology Commission of Shanghai Municipality [18JC1420500]; Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]	Major State Basic Research Development Program(National Basic Research Program of China); National Natural Science Foundation (NSF) of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Science and Technology Major Project	This work was supported by the Major State Basic Research Development Program (2016YFA0501902), the National Natural Science Foundation (NSF) of China (31872716), the Science and Technology Commission of Shanghai Municipality (18JC1420500) and The Shanghai Municipal Science and Technology Major Project (2019SHZDZX02).	Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bone H, 1997, J BIOL CHEM, V272, P14470, DOI 10.1074/jbc.272.22.14470; Brandao TAS, 2010, J BIOL CHEM, V285, P15874, DOI 10.1074/jbc.M109.066951; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chandradoss SD, 2014, JOVE-J VIS EXP, DOI 10.3791/50549; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Craggs TD, 2017, NAT METHODS, V14, P123, DOI 10.1038/nmeth.4159; Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2017, P JPN ACAD B-PHYS, V93, P196, DOI 10.2183/pjab.93.013; Hayashi T, 2017, CELL REP, V20, P2876, DOI 10.1016/j.celrep.2017.08.080; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Imhof D, 2006, J BIOL CHEM, V281, P20271, DOI 10.1074/jbc.M601047200; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; LaRochelle JR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06823-9; LaRochelle JR, 2017, BIOORGAN MED CHEM, V25, P6479, DOI 10.1016/j.bmc.2017.10.025; LaRochelle JR, 2016, BIOCHEMISTRY-US, V55, P2269, DOI 10.1021/acs.biochem.5b01287; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Lerner E, 2018, SCIENCE, V359, P288, DOI 10.1126/science.aan1133; Liu BA, 2012, PHILOS T R SOC B, V367, P2556, DOI 10.1098/rstb.2012.0107; Liu W, 2013, J MED CHEM, V56, P7212, DOI 10.1021/jm400474r; Mainardi S, 2018, NAT MED, V24, P961, DOI 10.1038/s41591-018-0023-9; Marchi M, 1999, J CHEM PHYS, V110, P3697, DOI 10.1063/1.478259; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; Mellor P, 2012, BIOCHEM J, V441, P23, DOI 10.1042/BJ20111164; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Padua RAP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06814-w; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Pedersen AK, 2004, ACTA CRYSTALLOGR D, V60, P1527, DOI 10.1107/S0907444904015094; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Ruess DA, 2018, NAT MED, V24, P954, DOI 10.1038/s41591-018-0024-8; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Siveen KS, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0788-y; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; Tyagi S, 2012, METHOD CELL BIOL, V113, P169, DOI 10.1016/B978-0-12-407239-8.00009-4; Wang W, 2011, J CELL BIOCHEM, V112, P2062, DOI 10.1002/jcb.23125; WELHAM MJ, 1994, J BIOL CHEM, V269, P23764; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Xie JJ, 2017, J MED CHEM, V60, P10205, DOI 10.1021/acs.jmedchem.7b01520; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yu ZH, 2013, J BIOL CHEM, V288, P10472, DOI 10.1074/jbc.M113.450023; Zhang YY, 2011, BIOCHEMISTRY-US, V50, P7637, DOI 10.1021/bi200439v; Zhang YL, 2018, J MOL BIOL, V430, P405, DOI 10.1016/j.jmb.2017.12.019	60	9	9	2	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100538	10.1016/j.jbc.2021.100538	http://dx.doi.org/10.1016/j.jbc.2021.100538			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33722610	gold, Green Published			2022-12-28	WOS:000672866400511
J	Wang, H; Xu, M; Engelhart, CA; Zhang, X; Yan, BH; Pan, MM; Xu, YY; Fan, SL; Liu, RH; Xu, L; Hua, L; Schnappinger, D; Chen, S				Wang, Heng; Xu, Min; Engelhart, Curtis A.; Zhang, Xi; Yan, Baohua; Pan, Miaomiao; Xu, Yuanyuan; Fan, Shilong; Liu, Renhe; Xu, Lan; Hua, Lan; Schnappinger, Dirk; Chen, Shawn			Rediscovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECTROPHOTOMETRIC ASSAY; CRYSTAL-STRUCTURES; FAAH INHIBITOR; BACTERIAL; DISCOVERY; ACTIVATION; TRNA(PHE); POCKET	Mycobacterium tuberculosis (Mtb) remains the deadliest pathogenic bacteria worldwide. The search for new antibiotics to treat drug-sensitive as well as drug-resistant tuberculosis has become a priority. The essential enzyme phenylalanyl-tRNA synthetase (PheRS) is an antibacterial drug target because of the large differences between bacterial and human PheRS counterparts. In a high-throughput screening of 2148 bioactive compounds, PF-3845, which is a known inhibitor of human fatty acid amide hydrolase, was identified inhibiting Mtb PheRS at K-i similar to 0.73 +/- 0.06 mu M. The inhibition mechanism was studied with enzyme kinetics, protein structural modeling, and crystallography, in comparison to a PheRS inhibitor of the noted phenyl-thiazolylurea-sulfonamide class. The 2.3-angstrom crystal structure of Mtb PheRS in complex with PF-3845 revealed its novel binding mode, in which a trifluoromethyl-pyridinylphenyl group occupies the phenylalanine pocket, whereas a piperidine-piperazine urea group binds into the ATP pocket through an interaction network enforced by a sulfate ion. It represents the first non-nucleoside bisubstrate competitive inhibitor of bacterial PheRS. PF-3845 inhibits the in vitro growth of Mtb H37Rv at similar to 24 mu M, and the potency of PF-3845 increased against an engineered strain Mtb pheS-FDAS, suggesting on target activity in mycobacterial whole cells. PF-3845 does not inhibit human cytoplasmic or mitochondrial PheRS in biochemical assay, which can be explained from the crystal structures. Further medicinal chemistry efforts focused on the piperidine-piperazine urea moiety may result in the identification of a selective antibacterial lead compound.	[Wang, Heng; Xu, Min; Zhang, Xi; Pan, Miaomiao; Xu, Yuanyuan; Liu, Renhe; Xu, Lan; Hua, Lan; Chen, Shawn] Global Hlth Drug Discovery Inst, Beijing, Peoples R China; [Engelhart, Curtis A.; Schnappinger, Dirk] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Yan, Baohua; Fan, Shilong] Tsinghua Univ, Ctr Prot Sci Facil, Beijing, Peoples R China	Cornell University; Tsinghua University	Chen, S (corresponding author), Global Hlth Drug Discovery Inst, Beijing, Peoples R China.	shuo.chen@ghddi.org		Chen, Shawn/0000-0002-6678-3293; Fan, Shilong/0000-0001-9272-2438	Bill & Melinda Gates Foundation in China; Global Health Drug Discovery Institute in China	Bill & Melinda Gates Foundation in China; Global Health Drug Discovery Institute in China	This work is supported by Bill & Melinda Gates Foundation and Global Health Drug Discovery Institute sponsors in China.	Abibi A, 2014, J BIOL CHEM, V289, P21651, DOI 10.1074/jbc.M114.574061; Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Baragana B, 2019, P NATL ACAD SCI USA, V116, P7015, DOI 10.1073/pnas.1814685116; Beyer D, 2004, ANTIMICROB AGENTS CH, V48, P525, DOI 10.1128/AAC.48.2.525-532.2004; Bhuniya D, 2019, BIOORG MED CHEM LETT, V29, P238, DOI 10.1016/j.bmcl.2018.11.048; Cestari I, 2013, J BIOMOL SCREEN, V18, P490, DOI 10.1177/1087057112465980; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Cowell AN, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0673-3; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Du X, 2002, BIOCHEMISTRY-US, V41, P10623, DOI 10.1021/bi026000o; Finarov I, 2010, STRUCTURE, V18, P343, DOI 10.1016/j.str.2010.01.002; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Francklyn CS, 2019, J BIOL CHEM, V294, P5365, DOI 10.1074/jbc.REV118.002956; Gallant P, 2000, EMERG THER TARGETS, V4(, P1; Grube CD, 2018, RNA BIOL, V15, P659, DOI 10.1080/15476286.2017.1397262; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Hewitt SN, 2017, ACS INFECT DIS, V3, P34, DOI 10.1021/acsinfecdis.6b00078; Hu YM, 2016, ANTIMICROB AGENTS CH, V60, P4820, DOI 10.1128/AAC.00800-16; IBBA M, 1994, BIOCHEMISTRY-US, V33, P7107, DOI 10.1021/bi00189a013; Itoh Y, 2008, RNA BIOL, V5, P169, DOI 10.4161/rna.5.3.6876; Janes J, 2018, P NATL ACAD SCI USA, V115, P10750, DOI 10.1073/pnas.1810137115; Johnson DS, 2011, ACS MED CHEM LETT, V2, P91, DOI 10.1021/ml100190t; Kato N, 2016, NATURE, V538, P344, DOI 10.1038/nature19804; Keith JM, 2008, BIOORG MED CHEM LETT, V18, P4838, DOI 10.1016/j.bmcl.2008.07.081; Klipcan L, 2008, STRUCTURE, V16, P1095, DOI 10.1016/j.str.2008.03.020; Kwon NH, 2019, NAT REV DRUG DISCOV, V18, P629, DOI 10.1038/s41573-019-0026-3; Lechler A, 1998, J MOL BIOL, V278, P897, DOI 10.1006/jmbi.1998.1744; LLOYD AJ, 1995, NUCLEIC ACIDS RES, V23, P2886, DOI 10.1093/nar/23.15.2886; MARTIN F, 1993, J MOL BIOL, V234, P965, DOI 10.1006/jmbi.1993.1651; Mermershtain I, 2011, PROTEIN SCI, V20, P160, DOI 10.1002/pro.549; Montgomery JI, 2009, BIOORG MED CHEM LETT, V19, P665, DOI 10.1016/j.bmcl.2008.12.054; Moor N, 2006, BIOCHEMISTRY-US, V45, P10572, DOI 10.1021/bi060491l; Moor N, 2011, CHEM BIOL, V18, P1221, DOI 10.1016/j.chembiol.2011.08.008; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Reshetnikova L, 1999, J MOL BIOL, V287, P555, DOI 10.1006/jmbi.1999.2617; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Safro M., 2005, AMINOACYL TRNA SYNTH, P265; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Tenero D, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00240-19; Tommasi R, 2015, NAT REV DRUG DISCOV, V14, P529, DOI 10.1038/nrd4572; Wang LN, 2016, COGENT CHEM, V2, DOI 10.1080/23312009.2016.1181536; Wasilewski A, 2017, ACTA BIOCHIM POL, V64, P519, DOI 10.18388/abp.2017_1520; [张志明 Zhang Zhiming], 2012, [微生物学通报, Microbiology], V39, P1437; Zhou MY, 2010, NUCLEIC ACIDS RES, V38, P3399, DOI 10.1093/nar/gkp1254	45	5	5	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100257	10.1016/j.jbc.2021.100257	http://dx.doi.org/10.1016/j.jbc.2021.100257			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837735	gold, Green Published, Green Submitted			2022-12-28	WOS:000672866400233
J	Xu, HY; Qing, XY; Wang, Q; Li, CM; Lai, LH				Xu, Hanyu; Qing, Xiaoyu; Wang, Qian; Li, Chunmei; Lai, Luhua			Dimerization of PHGDH via the catalytic unit is essential for its enzymatic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; L-SERINE BIOSYNTHESIS; PHOSPHOGLYCERATE DEHYDROGENASE; 3-PHOSPHOGLYCERATE DEHYDROGENASE; HOT-SPOTS; CRYSTAL-STRUCTURES; INHIBITOR; CANCER; METABOLISM; PATHWAY	Human D-3-phosphoglycerate dehydrogenase (PHGDH), a key enzyme in de novo serine biosynthesis, is amplified in various cancers and serves as a potential target for anticancer drug development. To facilitate this process, more information is needed on the basic biochemistry of this enzyme. For example, PHGDH was found to form tetramers in solution and the structure of its catalytic unit (sPHGDH) was solved as a dimer. However, how the oligomeric states affect PHGDH enzyme activity remains elusive. We studied the dependence of PHGDH enzymatic activity on its oligomeric states. We found that sPHGDH forms a mixture of monomers and dimers in solution with a dimer dissociation constant of similar to 0.58 mu M, with the enzyme activity depending on the dimer content. We computationally identified hotspot residues at the sPHGDH dimer interface. Single-point mutants at these sites disrupt dimer formation and abolish enzyme activity. Molecular dynamics simulations showed that dimer formation facilitates substrate binding and maintains the correct conformation required for enzyme catalysis. We further showed that the full-length PHGDH exists as a dynamic mixture of monomers, dimers, and tetramers in solution with enzyme concentrationdependent activity. Mutations that can completely disrupt the sPHGDH dimer show different abilities to interrupt the fulllength PHGDH tetramer. Among them, E108A and I121A can also disrupt the oligomeric structures of the full-length PHGDH and abolish its enzyme activity. Our study indicates that disrupting the oligomeric structure of PHGDH serves as a novel strategy for PHGDH drug design and the hotspot residues identified can guide the design process.	[Xu, Hanyu; Qing, Xiaoyu; Lai, Luhua] Peking Univ, Coll Chem & Mol Engn, BNLMS, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Wang, Qian] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Li, Chunmei; Lai, Luhua] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Quantitat Biol, Beijing, Peoples R China	Peking University; Peking University; Peking University	Lai, LH (corresponding author), Peking Univ, Coll Chem & Mol Engn, BNLMS, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Lai, LH (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Quantitat Biol, Beijing, Peoples R China.	lhlai@pku.edu.cn			National Natural Science Foundation of China [21633001]; Ministry of Science and Technology of China [2016YFA0502303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This project was supported in part by the National Natural Science Foundation of China (21633001) and the Ministry of Science and Technology of China (2016YFA0502303).	Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Buss O, 2018, COMPUT STRUCT BIOTEC, V16, P25, DOI 10.1016/j.csbj.2018.01.002; Delgado J, 2019, BIOINFORMATICS, V35, P4168, DOI 10.1093/bioinformatics/btz184; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Dey S, 2005, J BIOL CHEM, V280, P14892, DOI 10.1074/jbc.M414489200; Dong JK, 2018, THERANOSTICS, V8, P1808, DOI 10.7150/thno.23177; Garton M, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0190; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Grant GA, 1999, J BIOL CHEM, V274, P5357, DOI 10.1074/jbc.274.9.5357; Grant GA, 2000, ARCH BIOCHEM BIOPHYS, V375, P171, DOI 10.1006/abbi.1999.1652; Grant GA, 2004, J BIOL CHEM, V279, P13452, DOI 10.1074/jbc.M313593200; Grant GA, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00110; Grant GA, 2018, BIOCHEMISTRY-US, V57, P1798, DOI 10.1021/acs.biochem.8b00074; Guharoy M, 2005, P NATL ACAD SCI USA, V102, P15447, DOI 10.1073/pnas.0505425102; Halperin I, 2004, STRUCTURE, V12, P1027, DOI 10.1016/j.str.2004.04.009; Hancock RD, 1996, INORG CHEM, V35, P2165, DOI 10.1021/ic951422q; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; Hilbert BJ, 2014, FEBS LETT, V588, P1743, DOI 10.1016/j.febslet.2014.03.026; Huang PS, 2020, ACS OMEGA, V5, P6487, DOI 10.1021/acsomega.9b04105; Ruiz-Pernia JJ, 2019, ACS CATAL, V9, P5902, DOI 10.1021/acscatal.9b01250; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Liu JL, 2013, J NEURO-ONCOL, V111, P245, DOI 10.1007/s11060-012-1018-x; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; London N, 2013, CURR OPIN CHEM BIOL, V17, P952, DOI 10.1016/j.cbpa.2013.10.011; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Matelska D, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1309-8; Mattaini KR, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0131-7; Mishra V, 2012, MOL BIOCHEM PARASIT, V181, P117, DOI 10.1016/j.molbiopara.2011.10.008; Mullarky E, 2019, BIOORG MED CHEM LETT, V29, P2503, DOI 10.1016/j.bmcl.2019.07.011; Mullarky E, 2016, P NATL ACAD SCI USA, V113, P1778, DOI 10.1073/pnas.1521548113; Ngo B, 2020, CANCER DISCOV, V10, P1352, DOI 10.1158/2159-8290.CD-19-1228; Nishi H, 2013, PROG MOL BIOL TRANSL, V117, P3, DOI 10.1016/B978-0-12-386931-9.00001-5; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rathore R, 2020, CANCER DRUG RESIST, V3, P762, DOI 10.20517/cdr.2020.46; Ravez S, 2017, J MED CHEM, V60, P1591, DOI 10.1021/acs.jmedchem.6b01166; Ravez S, 2017, J MED CHEM, V60, P1227, DOI 10.1021/acs.jmedchem.6b01167; Reid MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07868-6; Ross KC, 2017, MOL CANCER THER, V16, P1596, DOI 10.1158/1535-7163.MCT-16-0798; Shaheen R, 2014, AM J HUM GENET, V94, P898, DOI 10.1016/j.ajhg.2014.04.015; Singh RK, 2014, FEBS J, V281, P5498, DOI 10.1111/febs.13091; Song ZW, 2018, GENE, V642, P43, DOI 10.1016/j.gene.2017.11.014; Spillier Q, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41187-0; Tabatabaie L, 2009, HUM MUTAT, V30, P749, DOI 10.1002/humu.20934; Tanner JM, 2017, MOL CANCER RES, V15, P1517, DOI 10.1158/1541-7786.MCR-17-0182; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; Unterlass Judith E, 2018, Oncotarget, V9, P13139, DOI 10.18632/oncotarget.11487; Unterlass JE, 2017, ONCOTARGET, V8, P104478, DOI 10.18632/oncotarget.22327; Wang H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32511-1; Wang Q, 2017, CELL CHEM BIOL, V24, P55, DOI 10.1016/j.chembiol.2016.11.013; Wei L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12606-7; Weinstabl H, 2019, J MED CHEM, V62, P7976, DOI 10.1021/acs.jmedchem.9b00718; Xu XL, 2015, ARCH BIOCHEM BIOPHYS, V570, P32, DOI 10.1016/j.abb.2015.02.008; Yang JH, 2010, J BIOL CHEM, V285, P41380, DOI 10.1074/jbc.M110.187443; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yoshino H, 2017, CANCER RES, V77, P6321, DOI 10.1158/0008-5472.CAN-17-1589; Zhang X, 2016, CANCER CHEMOTH PHARM, V78, P655, DOI 10.1007/s00280-016-3117-4; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	60	3	3	3	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100572	10.1016/j.jbc.2021.100572	http://dx.doi.org/10.1016/j.jbc.2021.100572			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753166	Green Published, gold			2022-12-28	WOS:000672866400545
J	Yuan, MK; Zhang, JC; Gao, YP; Yuan, ZK; Zhu, ZL; Yongke, W; Wu, T; Han, J; Zhang, Y				Yuan, Mengke; Zhang, Jingcheng; Gao, Yuanpeng; Yuan, Zikun; Zhu, Zhenliang; Yongke Wei; Wu, Teng; Han, Jing; Zhang, Yong			HMEJ-based safe-harbor genome editing enables efficient generation of cattle with increased resistance to tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KNOCK-IN; TARGETED INTEGRATION; BOVINE TUBERCULOSIS; MYCOBACTERIUM-BOVIS; ROSA26 LOCUS; GENE; REPAIR; EXPRESSION; IDENTIFICATION; INSERTION	The CRISPR/Cas9 system has been used in a wide range of applications in the production of gene-edited animals and plants. Most efforts to insert genes have relied on homology-directed repair (HDR)-mediated integration, but this strategy remains inefficient for the production of gene-edited livestock, especially monotocous species such as cattle. Although efforts have been made to improve HDR efficiency, other strategies have also been proposed to circumvent these challenges. Here we demonstrate that a homology-mediated end-joining (HMEJ)-basedmethod can be used to create gene-edited cattle that displays precise integration of a functional gene at the ROSA26 locus. We found that the HMEJ-based method increased the knock-in efficiency of reporter genes by eightfold relative to the traditionalHDR-basedmethod in bovine fetal fibroblasts. Moreover, we identified the bovine homology of themouse Rosa26 locus that is an accepted genomic safe harbor and produced three live-borngene-edited cattlewith higher rates of pregnancy and birth, compared with previous work. These gene-edited cattle exhibited predictable expression of the functional gene natural resistance-associated macrophage protein-1 (NRAMP1), a metal ion transporter that should and, in our experiments does, increase resistance to bovine tuberculosis, one of the most detrimental zoonotic diseases. This research contributes to the establishment of a safe and efficient genome editing system and provides insights for gene-edited animal breeding.	[Yuan, Mengke; Zhang, Jingcheng; Gao, Yuanpeng; Yuan, Zikun; Zhu, Zhenliang; Yongke Wei; Wu, Teng; Han, Jing; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Yuan, Mengke; Zhang, Jingcheng; Gao, Yuanpeng; Yuan, Zikun; Zhu, Zhenliang; Yongke Wei; Wu, Teng; Han, Jing; Zhang, Yong] Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr & Rural Affairs, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.; Zhang, Y (corresponding author), Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr & Rural Affairs, Yangling, Shaanxi, Peoples R China.	zhangyong1956@nwsuaf.edu.cn			National Major Project for Production of Transgenic Breeding [2016ZX08007003]	National Major Project for Production of Transgenic Breeding	We greatly appreciate Tong Xu and Ruizhi Deng for carefully correcting the paper and the Keyuan Cloning Company for their assistance in the gene-edited cattle production. This work was supported by the National Major Project for Production of Transgenic Breeding (No. 2016ZX08007003).	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Bhakta MS, 2010, METHODS MOL BIOL, V649, P3, DOI 10.1007/978-1-60761-753-2_1; Bressan RB, 2017, DEVELOPMENT, V144, P635, DOI 10.1242/dev.140855; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; Giel-Moloney M, 2007, GENESIS, V45, P83, DOI 10.1002/dvg.20269; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Hedges JF, 2013, J IMMUNOL, V190, P4263, DOI 10.4049/jimmunol.1200732; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jung CJ, 2017, TRANSGENIC RES, V26, P263, DOI 10.1007/s11248-016-9998-5; Kobayashi T, 2012, STEM CELLS DEV, V21, P2981, DOI 10.1089/scd.2012.0065; Li XP, 2014, CELL RES, V24, P501, DOI 10.1038/cr.2014.15; Ma T, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12406; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Miao XY, 2013, CELL MOL LIFE SCI, V70, P815, DOI 10.1007/s00018-012-1081-7; Niu D, 2017, SCIENCE, V357, P1303, DOI 10.1126/science.aan4187; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; Ochiai H, 2012, P NATL ACAD SCI USA, V109, P10915, DOI 10.1073/pnas.1202768109; Papapetrou EP, 2016, MOL THER, V24, P678, DOI 10.1038/mt.2016.38; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Shanthalingam S, 2016, P NATL ACAD SCI USA, V113, P13186, DOI 10.1073/pnas.1613428113; Shi ZY, 2015, FASEB J, V29, P4914, DOI 10.1096/fj.15-273425; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28502-x; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Wu MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24360; Yang DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25161; Yang HQ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00360; Yao X, 2018, CELL RES, V28, P379, DOI 10.1038/cr.2018.9; Yao X, 2017, CELL RES, V27, P801, DOI 10.1038/cr.2017.76; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8	45	5	5	7	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100497	10.1016/j.jbc.2021.100497	http://dx.doi.org/10.1016/j.jbc.2021.100497			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33675752	Green Published, gold			2022-12-28	WOS:000672866400471
J	Kunz, HE; Dorschner, JM; Berent, TE; Meyer, T; Wang, XW; Jatoi, A; Kumar, R; Lanza, IR				Kunz, Hawley E.; Dorschner, Jessica M.; Berent, Taylor E.; Meyer, Thomas; Wang, Xuewei; Jatoi, Aminah; Kumar, Rajiv; Lanza, Ian R.			Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; protein synthesis; protein turnover; metabolomics; mitochondria; cachexia; ADMA; l-NMMA; skeletal muscle; methylarginines	SKELETAL-MUSCLE; ASYMMETRIC DIMETHYLARGININE; MITOCHONDRIAL FISSION; INSULIN-RESISTANCE; DIAPHRAGM MUSCLE; ENDOGENOUS METHYLARGININES; PLASMA-CONCENTRATIONS; QUALITY-CONTROL; CACHEXIA; DYNAMICS	Cancer cachexia is characterized by reductions in peripheral lean muscle mass. Prior studies have primarily focused on increased protein breakdown as the driver of cancer-associated muscle wasting. Therapeutic interventions targeting catabolic pathways have, however, largely failed to preserve muscle mass in cachexia, suggesting that other mechanisms might be involved. In pursuit of novel pathways, we used untargeted metabolomics to search for metabolite signatures that may be linked with muscle atrophy. We injected 7-week-old C57/BL6 mice with LLC1 tumor cells or vehicle. After 21 days, tumor-bearing mice exhibited reduced body and muscle mass and impaired grip strength compared with controls, which was accompanied by lower synthesis rates of mixed muscle protein and the myofibrillar and sarcoplasmic muscle fractions. Reductions in protein synthesis were accompanied by mitochondrial enlargement and reduced coupling efficiency in tumor-bearing mice. To generate mechanistic insights into impaired protein synthesis, we performed untargeted metabolomic analyses of plasma and muscle and found increased concentrations of two methylarginines, asymmetric dimethylarginine (ADMA) and N-G-monomethyl-l-arginine, in tumor-bearing mice compared with control mice. Compared with healthy controls, human cancer patients were also found to have higher levels of ADMA in the skeletal muscle. Treatment of C2C12 myotubes with ADMA impaired protein synthesis and reduced mitochondrial protein quality. These results suggest that increased levels of ADMA and mitochondrial changes may contribute to impaired muscle protein synthesis in cancer cachexia and could point to novel therapeutic targets by which to mitigate cancer cachexia.	[Kunz, Hawley E.; Lanza, Ian R.] Mayo Clin, Endocrine Res Unit, Div Endocrinol, Dept Internal Med, Rochester, MN 55905 USA; [Dorschner, Jessica M.; Berent, Taylor E.; Meyer, Thomas; Kumar, Rajiv] Mayo Clin, Nephrol & Hypertens Res Unit, Div Nephrol & Hypertens, Dept Internal Med, Rochester, MN 55905 USA; [Wang, Xuewei] Mayo Clin, Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Jatoi, Aminah] Mayo Clin, Dept Med Oncol, Rochester, MN USA; [Kumar, Rajiv] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Dorschner, Jessica M.] Oakland Univa, Auburn Hills, MI USA; [Meyer, Thomas] Amherst Coll, Amherst, MA 01002 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Amherst College	Lanza, IR (corresponding author), Mayo Clin, Endocrine Res Unit, Div Endocrinol, Dept Internal Med, Rochester, MN 55905 USA.; Kumar, R (corresponding author), Mayo Clin, Nephrol & Hypertens Res Unit, Div Nephrol & Hypertens, Dept Internal Med, Rochester, MN 55905 USA.; Kumar, R (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	rkumar@mayo.edu; Lanza.lan@mayo.edu		Wang, Xuewei/0000-0003-3679-7421; Kunz, Hawley/0000-0002-4291-4455; Berent, Taylor/0000-0002-9421-7176; Kumar, Rajiv/0000-0003-3497-3057	Fred C. and Katherine B. Andersen Foundation [T32AR056950]	Fred C. and Katherine B. Andersen Foundation	This work was supported by a grant from the Fred C. and Katherine B. Andersen Foundation (to I. R. L. and R. K.). Dr. Hawley Kunz is supported by T32AR056950.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Aoyagi T, 2015, WORLD J GASTRO ONCOL, V7, P17, DOI 10.4251/wjgo.v7.i4.17; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Argiles JM, 2015, CURR OPIN CLIN NUTR, V18, P221, DOI 10.1097/MCO.0000000000000164; Argiles JM, 2014, J CACHEXIA SARCOPENI, V5, P279, DOI 10.1007/s13539-014-0154-x; Asp ML, 2010, INT J CANCER, V126, P756, DOI 10.1002/ijc.24784; Aversa Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep30340; Baltgalvis KA, 2010, J APPL PHYSIOL, V109, P1155, DOI 10.1152/japplphysiol.00442.2010; Baracos VE, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.105; Berent TE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226440; Biesemann N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27614-8; Blackwell TA, 2018, PHYSIOL GENOMICS, V50, P1071, DOI 10.1152/physiolgenomics.00061.2018; Brown JL, 2018, J CACHEXIA SARCOPENI, V9, P987, DOI 10.1002/jcsm.12354; Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232; Busquets S, 2007, CLIN NUTR, V26, P614, DOI 10.1016/j.clnu.2007.06.005; Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200; Carson JA, 2016, SEMIN CELL DEV BIOL, V54, P53, DOI 10.1016/j.semcdb.2015.11.005; Castro B, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2237; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Coen PM, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01883; Cold Spring Harbor Press, 2017, COLD SPRING HARB PRO, DOI 10.1101/pdb.rec101428; Craig TA, 2012, MOL ENDOCRINOL, V26, P1630, DOI 10.1210/me.2012-1113; Fontes-Oliveira CC, 2013, BBA-GEN SUBJECTS, V1830, P2770, DOI 10.1016/j.bbagen.2012.11.009; de Castro GS, 2019, CANCERS, V11, DOI 10.3390/cancers11091264; Dev R, 2018, ANN ONCOL, V29, P18, DOI 10.1093/annonc/mdx815; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; EVANS WK, 1985, CANCER RES, V45, P3347; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Garcia RG, 2007, INT J CARDIOL, V122, P176, DOI 10.1016/j.ijcard.2006.11.058; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Greising SM, 2015, MUSCLE NERVE, V52, P76, DOI 10.1002/mus.24641; Greising SM, 2013, EXP GERONTOL, V48, P881, DOI 10.1016/j.exger.2013.06.001; Guido C, 2012, ONCOTARGET, V3, P798, DOI 10.18632/oncotarget.574; Halle JL, 2019, AM J PHYSIOL-REG I, V317, pR68, DOI 10.1152/ajpregu.00028.2019; Holley AK, 2009, FUTURE ONCOL, V5, P117, DOI 10.2217/14796694.5.1.117; Hou C, 2008, SCIENCE, V322, P736, DOI 10.1126/science.1162302; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jaleel A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1255, DOI 10.1152/ajpendo.90586.2008; Johnson ML, 2015, AGING CELL, V14, P734, DOI 10.1111/acel.12352; Judge SM, 2018, JNCI CANCER SPECT, V2, DOI 10.1093/jncics/pky043; Judge SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-997; Julienne CM, 2012, J CACHEXIA SARCOPENI, V3, P265, DOI 10.1007/s13539-012-0071-9; Kielstein JT, 2003, CIRCULATION, V107, P1891, DOI 10.1161/01.CIR.0000060496.23144.A7; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Krumschnabel Gerhard, 2015, Methods Mol Biol, V1264, P245, DOI 10.1007/978-1-4939-2257-4_22; Lalia AZ, 2017, AGING-US, V9, P1096, DOI 10.18632/aging.101210; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235; Lee DE, 2017, PHYSIOL GENOMICS, V49, P253, DOI 10.1152/physiolgenomics.00006.2017; Lee W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20549-0; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Maas R, 2007, CRIT CARE MED, V35, P1876, DOI 10.1097/01.CCM.0000277038.11630.71; Marchenko ND, 2014, MOL CELL ONCOL, V1, DOI 10.1080/23723548.2014.955995; Marliss EB, 2006, DIABETOLOGIA, V49, P351, DOI 10.1007/s00125-005-0066-6; Marzetti E, 2017, EXP GERONTOL, V87, P92, DOI 10.1016/j.exger.2016.10.003; Miyamoto Y, 2016, CLIN CANCER RES, V22, P3999, DOI 10.1158/1078-0432.CCR-16-0495; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Padrao AI, 2013, INT J BIOCHEM CELL B, V45, P1399, DOI 10.1016/j.biocel.2013.04.014; Penna F, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7153610; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Pope AJ, 2009, PHARMACOL RES, V60, P461, DOI 10.1016/j.phrs.2009.07.016; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Ryan ZC, 2016, J BIOL CHEM, V291, P1514, DOI 10.1074/jbc.M115.684399; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shum AMY, 2012, AGING-US, V4, P133, DOI 10.18632/aging.100436; Shutt TE, 2013, BBA-MOL CELL RES, V1833, P417, DOI 10.1016/j.bbamcr.2012.05.024; Sieck DC, 2012, RESP PHYSIOL NEUROBI, V180, P88, DOI 10.1016/j.resp.2011.10.015; Smuder AJ, 2010, FREE RADICAL BIO MED, V49, P1152, DOI 10.1016/j.freeradbiomed.2010.06.025; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sydow K, 2005, VASC MED, V10, pS35, DOI 10.1191/1358863x05vm604oa; Tardif N, 2013, AM J CLIN NUTR, V98, P1485, DOI 10.3945/ajcn.113.063859; TAYEK JA, 1992, J AM COLL NUTR, V11, P445; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tsoli M, 2013, TRENDS ENDOCRIN MET, V24, P174, DOI 10.1016/j.tem.2012.10.006; Tzika AA, 2013, INT J ONCOL, V43, P886, DOI 10.3892/ijo.2013.1998; van der Ende M, 2018, BBA-REV CANCER, V1870, P137, DOI 10.1016/j.bbcan.2018.07.008; VanderVeen BN, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/3292087; Vitorino R, 2015, CURR OPIN CLIN NUTR, V18, P226, DOI 10.1097/MCO.0000000000000161; Wang RX, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7569127; Wang WL, 2010, BIOCHEM BIOPH RES CO, V400, P587, DOI 10.1016/j.bbrc.2010.08.108; White JP, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-14; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang LQ, 2009, FREE RADICAL BIO MED, V46, P1500, DOI 10.1016/j.freeradbiomed.2009.03.001; Zhou JY, 2012, AUTOPHAGY, V8, P1712, DOI 10.4161/auto.21830	100	7	7	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17441	17459		10.1074/jbc.RA120.014884	http://dx.doi.org/10.1074/jbc.RA120.014884			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453990	hybrid, Green Published			2022-12-28	WOS:000603272300006
J	Barnawi, H; Woodward, L; Fava, N; Roubakha, M; Shaw, SD; Kubinec, C; Naismith, JH; Creuzenet, C				Barnawi, Heba; Woodward, Laura; Fava, Natalie; Roubakha, Mikhail; Shaw, Steve D.; Kubinec, Chelsea; Naismith, James H.; Creuzenet, Carole			Structure-function studies of the C3/C5 epimerases and C4 reductases of the Campylobacter jejuni capsular heptose modification pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CATALYTIC MECHANISM; ACTIVE-SITE; O-ANTIGENS; BIOSYNTHESIS; COMPLEX; ENZYME; FUCOSE; DIVERSITY; VIRULENCE	Many bacteria produce polysaccharide-based capsules that protect them from environmental insults and play a role in virulence, host invasion, and other functions. Understanding how the polysaccharide components are synthesized could provide new means to combat bacterial infections. We have previously characterized two pairs of homologous enzymes involved in the biosynthesis of capsular sugar precursors GDP-6-deoxy-D-altro-heptose and GDP-6-OMe-L-gluco-heptose in Campylobacter jejuni. However, the substrate specificity and mechanism of action of these enzymes-C3 and/or C5 epimerases DdahB and MlghB and C4 reductases DdahC and MlghC-are unknown. Here, we demonstrate that these enzymes are highly specific for heptose substrates, using mannose substrates inefficiently with the exception of MlghB. We show that DdahB and MlghB feature a jellyroll fold typical of cupins, which possess a range of activities including epimerizations, GDP occupying a similar position as in cupins. DdahC and MlghC contain a Rossman fold, a catalytic triad, and a small C-terminal domain typical of short-chain dehydratase reductase enzymes. Integrating structural information with site-directed mutagenesis allowed us to identify features unique to each enzyme and provide mechanistic insight. In the epimerases, mutagenesis of H67, D173, N121, Y134, and Y132 suggested the presence of alternative catalytic residues. We showed that the reductases could reduce GDP-4-keto-6-deoxy-mannulose without prior epimerization although DdahC preferred the pre-epimerized substrate and identified T110 and H180 as important for substrate specificity and catalytic efficacy. This information can be exploited to identify inhibitors for therapeutic applications or to tailor these enzymes to synthesize novel sugars useful as glycobiology tools.	[Barnawi, Heba; Fava, Natalie; Roubakha, Mikhail; Shaw, Steve D.; Kubinec, Chelsea; Creuzenet, Carole] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Woodward, Laura; Naismith, James H.] St Andrews Univ, Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Naismith, James H.] Res Complex Harwell, Rosalind Franklin Inst, Harwell Campus, Didcot, Oxon, England; [Naismith, James H.] Univ Oxford, Div Struct Biol, Oxford, England	Western University (University of Western Ontario); University of St Andrews; University of Oxford	Creuzenet, C (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.; Naismith, JH (corresponding author), St Andrews Univ, Biomed Sci Res Complex, St Andrews, Fife, Scotland.; Naismith, JH (corresponding author), Res Complex Harwell, Rosalind Franklin Inst, Harwell Campus, Didcot, Oxon, England.; Naismith, JH (corresponding author), Univ Oxford, Div Struct Biol, Oxford, England.	naismith@strubi.ox.ac.uk; ccreuzen@uwo.ca	Naismith, James Henderson/H-3408-2012; Naismith, James Henderson/AAB-8614-2020	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Shaw, Steve/0000-0002-5556-5629; Kubinec, Chelsea/0000-0002-2814-3287; Creuzenet, Carole/0000-0002-7435-5862; Barnawi, Heba/0000-0001-5156-0647	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 240762-2010, 05717-2015, RGPIN 04765-2016]; Wellcome Trust [100209/Z/12/Z]; King Abdullah scholarship from Saudi Arabia	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wellcome Trust(Wellcome Trust); King Abdullah scholarship from Saudi Arabia	This work was supported through operating grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada (RGPIN 240762-2010, 05717-2015, and RGPIN 04765-2016) to C. C. and Wellcome Trust to J. H. N. (100209/Z/12/Z). H. B. was the recipient of a King Abdullah scholarship from Saudi Arabia.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Blankenfeldt W, 2002, STRUCTURE, V10, P773, DOI 10.1016/S0969-2126(02)00770-0; Butty FD, 2009, BIOCHEMISTRY-US, V48, P7764, DOI 10.1021/bi901065t; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Committee to Advise on Tropical Medicine and Travel (CATMAT), 2009, Can Commun Dis Rep, V35 Suppl 1, P1; Creuzenet C, 2002, J BIOL CHEM, V277, P26769, DOI 10.1074/jbc.M202882200; DeLaBarre B, 2000, NAT STRUCT BIOL, V7, P238; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Dong CJ, 2003, STRUCTURE, V11, P715, DOI 10.1016/S0969-2126(03)00098-4; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Giraud MF, 2000, NAT STRUCT BIOL, V7, P398; Ho N, 2008, MOL MICROBIOL, V68, P424, DOI 10.1111/j.1365-2958.2008.06163.x; Huddleston JP, 2020, BIOCHEMISTRY-US, V59, P1314, DOI 10.1021/acs.biochem.0c00096; Huddleston JP, 2020, BIOCHEMISTRY-US, V59, P1328, DOI 10.1021/acs.biochem.0c00097; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Kondakova AN, 2008, CARBOHYD RES, V343, P1383, DOI 10.1016/j.carres.2008.04.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2011, ACTA CRYSTALLOGR D, V67, P376, DOI 10.1107/S0907444911007232; Kubiak RL, 2012, BIOCHEMISTRY-US, V51, P9375, DOI 10.1021/bi3012737; Lau STB, 2008, J AM CHEM SOC, V130, P17593, DOI 10.1021/ja807799k; Lin J, 2007, ANTIMICROB AGENTS CH, V51, P1678, DOI 10.1128/AAC.01411-06; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu HT, 2009, PROTEIN EXPRES PURIF, V63, P102, DOI 10.1016/j.pep.2008.09.008; Major LL, 2005, J AM CHEM SOC, V127, P18309, DOI 10.1021/ja056490i; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; McCallum M, 2013, J BIOL CHEM, V288, P19569, DOI 10.1074/jbc.M113.468066; McCallum M, 2012, J BIOL CHEM, V287, P29776, DOI 10.1074/jbc.M112.390492; McCallum M, 2011, BIOCHEM J, V439, P235, DOI 10.1042/BJ20110890; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merkel AB, 2004, J BIOL CHEM, V279, P32684, DOI 10.1074/jbc.M404091200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PERRY MB, 1995, INFECT IMMUN, V63, P3348, DOI 10.1128/IAI.63.9.3348-3352.1995; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Rizzi M, 1998, STRUCTURE, V6, P1453, DOI 10.1016/S0969-2126(98)00144-0; Somers WS, 1998, STRUCTURE, V6, P1601, DOI 10.1016/S0969-2126(98)00157-9; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wong A, 2015, MOL MICROBIOL, V96, P1136, DOI 10.1111/mmi.12995	46	4	4	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100352	10.1016/j.jbc.2021.100352	http://dx.doi.org/10.1016/j.jbc.2021.100352			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524389	Green Published, gold			2022-12-28	WOS:000672866400326
J	Brzezinska, P; Simpson, NJ; Hubert, F; Jacobs, AN; Umana, MB; MacKeil, JL; Burke-Kleinman, J; Payne, DM; Ferguson, AV; Maurice, DH				Brzezinska, Paulina; Simpson, Nicholas J.; Hubert, Fabien; Jacobs, Ariana N.; Umana, M. Bibiana; MacKeil, Jodi L.; Burke-Kleinman, Jonah; Payne, Darrin M.; Ferguson, Alastair, V; Maurice, Donald H.			Phosphodiesterase 1C integrates store-operated calcium entry and cAMP signaling in leading-edge protrusions of migrating human arterial myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CAPACITATIVE CA2+ ENTRY; CA2+-INHIBITABLE ADENYLYL-CYCLASE; PROTEIN-KINASE-A; PDE1C; PROLIFERATION; ACTIVATION; VARIANTS; ORAI1; LOOP	In addition to maintaining cellular ER Ca2+ stores, store-operated Ca2+ entry (SOCE) regulates several Ca2+-sensitive cellular enzymes, including certain adenylyl cyclases (ADCYs), enzymes that synthesize the secondary messenger cyclic AMP (cAMP). Ca2+, acting with calmodulin, can also increase the activity of PDE1-family phosphodiesterases (PDEs), which cleave the phosphodiester bond of cAMP. Surprisingly, SOCE-regulated cAMP signaling has not been studied in cells expressing both Ca2+-sensitive enzymes. Here, we report that depletion of ER Ca2+ activates PDE1C in human arterial smooth muscle cells (HASMCs). Inhibiting the activation of PDE1C reduced the magnitude of both SOCE and subsequent Ca2+/calmodulin-mediated activation of ADCY8 in these cells. Because inhibiting or silencing Ca2+-insensitive PDEs had no such effects, these data identify PDE1C-mediated hydrolysis of cAMP as a novel and important link between SOCE and its activation of ADCY8. Functionally, we showed that PDE1C regulated the formation of leading-edge protrusions in HASMCs, a critical early event in cell migration. Indeed, we found that PDE1C populated the tips of newly forming leading-edge protrusions in polarized HASMCs, and co-localized with ADCY8, the Ca2+ release activated Ca2+ channel subunit, Orai1, the cAMP-effector, protein kinase A, and an A-kinase anchoring protein, AKAP79. Because this polarization could allow PDE1C to control cAMP signaling in a hyper-localized manner, we suggest that PDE1C-selective therapeutic agents could offer increased spatial specificity in HASMCs over agents that regulate cAMP globally in cells. Similarly, such agents could also prove useful in regulating crosstalk between Ca2+/cAMP signaling in other cells in which dysregulated migration contributes to human pathology, including certain cancers.	[Brzezinska, Paulina; Simpson, Nicholas J.; Hubert, Fabien; Jacobs, Ariana N.; Umana, M. Bibiana; MacKeil, Jodi L.; Burke-Kleinman, Jonah; Ferguson, Alastair, V; Maurice, Donald H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Payne, Darrin M.] Queens Univ, Dept Surg, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Maurice, DH (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	mauriced@queensu.ca	Hubert, Fabien/ABE-6866-2021	Hubert, Fabien/0000-0003-1360-4092; Burke-Kleinman, Jonah/0000-0003-3399-3339	Canadian Institutes of Health Research (CIHR) [PJT-156283]; Ontario Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by funds from the Canadian Institutes of Health Research (CIHR) (PJT-156283) to D. H. M and P. B. is a recipient of an Ontario Graduate Scholarship.	Ahuja M, 2014, CELL CALCIUM, V55, P385, DOI 10.1016/j.ceca.2014.01.006; Avila-Medina J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00257; Bender AT, 2005, P NATL ACAD SCI USA, V102, P497, DOI 10.1073/pnas.0408535102; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Brzezinska P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121473; Chen YF, 2019, CANCERS, V11, DOI 10.3390/cancers11070899; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Cooper DMF, 2015, CELL CALCIUM, V58, P368, DOI 10.1016/j.ceca.2015.04.004; Depry C, 2011, MOL BIOSYST, V7, P52, DOI 10.1039/c0mb00079e; Dunkerley HA, 2002, MOL PHARMACOL, V61, P1033, DOI 10.1124/mol.61.5.1033; Espinosa-Tanguma R, 2011, AM J PHYSIOL-HEART C, V301, pH315, DOI 10.1152/ajpheart.00355.2010; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Gao XH, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0594-7; Gros R, 2006, CIRC RES, V99, P845, DOI 10.1161/01.RES.0000245189.21703.c0; Gueguen M, 2010, J PATHOL, V221, P331, DOI 10.1002/path.2716; Hashimoto T, 2018, CIRCULATION, V138, P1974, DOI 10.1161/CIRCULATIONAHA.117.030490; Howe AK, 2011, CURR OPIN CELL BIOL, V23, P554, DOI 10.1016/j.ceb.2011.05.006; Jia L, 2013, AM J RESP CELL MOL, V49, P601, DOI 10.1165/rcmb.2013-0040OC; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Knight WE, 2016, P NATL ACAD SCI USA, V113, pE7116, DOI 10.1073/pnas.1607728113; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Maiellaro I, 2012, J CELL MOL MED, V16, P2715, DOI 10.1111/j.1582-4934.2012.01592.x; Martin ACL, 2009, MOL PHARMACOL, V75, P830, DOI 10.1124/mol.108.051748; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Michelucci A, 2018, CELL CALCIUM, V76, P101, DOI 10.1016/j.ceca.2018.10.004; Miller CL, 2009, CIRC RES, V105, P956, DOI 10.1161/CIRCRESAHA.109.198515; Moss SC, 2007, OCHSNER J, V7, P133; Motiani RK, 2018, EMBO J, V37, DOI 10.15252/embj.201797597; Palmer D, 1998, CIRC RES, V82, P852; Parker T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43821-3; Putney JW, 2017, ADV EXP MED BIOL, V981, P205, DOI 10.1007/978-3-319-55858-5_9; Putney James W., 2018, Advances in Biological Regulation, V68, P88, DOI 10.1016/j.jbior.2017.11.006; Putney JW, 2017, BBA-MOL CELL RES, V1864, P900, DOI 10.1016/j.bbamcr.2016.11.028; Raymond DR, 2009, AM J PHYSIOL-HEART C, V296, pH263, DOI 10.1152/ajpheart.00425.2008; Rowther FB, 2016, MOL CARCINOGEN, V55, P268, DOI 10.1002/mc.22276; Rybalkin SD, 2002, CIRC RES, V90, P151, DOI 10.1161/hh0202.104108; Rybalkin SD, 1997, J CLIN INVEST, V100, P2611, DOI 10.1172/JCI119805; Spirli C, 2017, J HEPATOL, V66, P571, DOI 10.1016/j.jhep.2016.10.032; Thompson W J, 1974, Methods Enzymol, V38, P205; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Willoughby D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002299; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725; Yan C, 1996, J BIOL CHEM, V271, P25699, DOI 10.1074/jbc.271.41.25699; Zhang XX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09593-0; Zhang YS, 2018, CIRCULATION, V138, P1988, DOI 10.1161/CIRCULATIONAHA.118.034189	49	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100606	10.1016/j.jbc.2021.100606	http://dx.doi.org/10.1016/j.jbc.2021.100606			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33789162	Green Published, gold			2022-12-28	WOS:000672866400578
J	Cui, M; Alhamshari, Y; Cantwell, L; El-Haou, S; Eptaminitaki, GC; Chang, MM; Abou-Assali, O; Tan, HZ; Xu, KM; Masotti, M; Plant, LD; Thakur, GA; Noujaim, SF; Milnes, J; Logothetis, DE				Cui, Meng; Alhamshari, Yaser; Cantwell, Lucas; El-Haou, Said; Eptaminitaki, Giasemi C.; Chang, Mengmeng; Abou-Assali, Obada; Tan, Haozhou; Xu, Keman; Masotti, Meghan; Plant, Leigh D.; Thakur, Ganesh A.; Noujaim, Sami F.; Milnes, James; Logothetis, Diomedes E.			A benzopyran with antiarrhythmic activity is an inhibitor of Kir3.1-containing potassium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY INHIBITOR; K-ACH CHANNEL; ATRIAL-FIBRILLATION; NIP-142; AGENT; DRUG; TERTIAPIN; CURRENTS; BLOCKER; TARGET	Atrial fibrillation (AF) is the most commonly diagnosed cardiac arrhythmia and is associated with increased morbidity and mortality. Currently approved AF antiarrhythmic drugs have limited efficacy and/or carry the risk of ventricular proarrhythmia. The cardiac acetylcholine activated inwardly rectifying K+ current (I-KACh), composed of Kir3.1/Kir3.4 heterotetrameric and Kir3.4 homotetrameric channel subunits, is one of the best validated atrial-specific ion channels. Previous research pointed to a series of benzopyran derivatives with potential for treatment of arrhythmias, but their mechanism of action was not defined. Here, we characterize one of these compounds termed Benzopyran-G1 (BP-G1) and report that it selectively inhibits the Kir3.1 (GIRK1 or G1) subunit of the K-ACh channel. Homology modeling, molecular docking, and molecular dynamics simulations predicted that BP-G1 inhibits the IKACh channel by blocking the central cavity pore. We identified the unique F137 residue of Kir3.1 as the critical determinant for the IKACh-selective response to BP-G1. The compound interacts with Kir3.1 residues E141 and D173 through hydrogen bonds that proved critical for its inhibitory activity. BP-G1 effectively blocked the IKACh channel response to carbachol in an in vivo rodent model and displayed good selectivity and pharmacokinetic properties. Thus, BP-G1 is a potent and selective small-molecule inhibitor targeting Kir3.1-containing channels and is a useful tool for investigating the role of Kir3.1 heteromeric channels in vivo. The mechanism reported here could provide the molecular basis for future discovery of novel, selective I-KACh channel blockers to treat atrial fibrillation with minimal side effects.	[Cui, Meng; Alhamshari, Yaser; Cantwell, Lucas; Eptaminitaki, Giasemi C.; Tan, Haozhou; Xu, Keman; Masotti, Meghan; Plant, Leigh D.; Thakur, Ganesh A.; Logothetis, Diomedes E.] Northeastern Univ, Sch Pharm, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [El-Haou, Said; Milnes, James] Xention Ltd, Dept Cardiac Biol, Cambridge, England; [Chang, Mengmeng; Abou-Assali, Obada; Noujaim, Sami F.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33620 USA; [Plant, Leigh D.; Logothetis, Diomedes E.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Logothetis, Diomedes E.] Northeastern Univ, Dept Chem & Chem Biol, Coll Sci, Boston, MA 02115 USA	Northeastern University; State University System of Florida; University of South Florida; Northeastern University; Northeastern University	Cui, M; Logothetis, DE (corresponding author), Northeastern Univ, Sch Pharm, Dept Pharmaceut Sci, Bouve Coll Hlth Sci, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, Coll Sci, Boston, MA 02115 USA.	m.cui@northeastern.edu; d.logothetis@northeastern.edu		Eptaminitaki, Giasemi Chrysovalanti/0000-0001-9202-2183	NIH [R01 HL059949, R21 HL138064, R01 HL129136]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by NIH R01 HL059949 grant award to D. E. L., NIH R21 HL138064, and R01 HL129136 to S. N. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (United States).	BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Cha TJ, 2006, CIRCULATION, V113, P1730, DOI 10.1161/CIRCULATIONAHA.105.561738; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Cui M., 2021, HDB EXPT PHARM; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dobrev D, 2005, CIRCULATION, V112, P3697, DOI 10.1161/circulationaha.105.575332; Dobrzynski H, 2001, J HISTOCHEM CYTOCHEM, V49, P1221, DOI 10.1177/002215540104901004; Ehrlich JR, 2008, J CARDIOVASC PHARM, V52, P129, DOI 10.1097/FJC.0b013e31816c4325; Ehrlich JR, 2008, J AM COLL CARDIOL, V51, P787, DOI 10.1016/j.jacc.2007.08.067; Ehrlich JR, 2004, J PHYSIOL-LONDON, V557, P583, DOI 10.1113/jphysiol.2004.061119; El-Haou S, 2015, J CARDIOVASC PHARM, V66, P412, DOI 10.1097/FJC.0000000000000277; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Hashimoto N, 2012, ATRIAL FIBRILLATION, P321; Hashimoto N, 2008, J CARDIOVASC PHARM, V51, P162, DOI 10.1097/FJC.0b013e31815e854c; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; Kanjhan R, 2005, J PHARMACOL EXP THER, V314, P1353, DOI 10.1124/jpet.105.085928; LEALPINTO E, 1995, J MEMBRANE BIOL, V146, P123; Lee SW, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00943; Li DL, 2019, J BIOL CHEM, V294, P18934, DOI 10.1074/jbc.RA119.010047; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Machida T, 2011, CIRC-ARRHYTHMIA ELEC, V4, P94, DOI 10.1161/CIRCEP.110.951608; Matsuda T, 2005, J PHARMACOL SCI, V98, P33, DOI 10.1254/jphs.FPJ04045X; Matsuda T, 2001, LIFE SCI, V68, P2017, DOI 10.1016/S0024-3205(01)01003-7; Nagasawa H, 2002, CIRC J, V66, P185, DOI 10.1253/circj.66.185; Nattel S, 2006, NAT REV DRUG DISCOV, V5, P1034, DOI 10.1038/nrd2112; Okada T., 2008, United States, United States Patent Office, Alexandria, VA. Patent Number:, Patent No. [US20080004262A1, 20080004262]; Ravens U, 2008, EUROPACE, V10, P1133, DOI 10.1093/europace/eun193; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Torp-Pedersen C, 1999, NEW ENGL J MED, V341, P857, DOI 10.1056/NEJM199909163411201; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Voigt Niels, 2016, Card Electrophysiol Clin, V8, P411, DOI 10.1016/j.ccep.2016.02.005; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; Walfridsson H, 2015, EUROPACE, V17, P473, DOI 10.1093/europace/euu192; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wydeven N, 2014, P NATL ACAD SCI USA, V111, P10755, DOI 10.1073/pnas.1405190111; Xu Y, 2020, J BIOL CHEM, V295, P3614, DOI 10.1074/jbc.RA119.011527; Yamamoto W, 2014, J CARDIOVASC PHARM, V63, P421, DOI 10.1097/FJC.0000000000000065	39	2	3	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100535	10.1016/j.jbc.2021.100535	http://dx.doi.org/10.1016/j.jbc.2021.100535			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33713702	gold, Green Published			2022-12-28	WOS:000672866400509
J	Dekeyser, JM; Thompson, CH; George, AL				Dekeyser, Jean-Marc; Thompson, Christopher H.; George, Alfred L., Jr.			Cryptic prokaryotic promoters explain instability of recombinant neuronal sodium channels in bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-TRANSFER-RNA; EPILEPSY; EXPRESSION	Mutations in genes encoding the human-brain-expressed voltage-gated sodium (Na-V) channels Na(V)1.1, Na(V)1.2, and Na(V)1.6 are associated with a variety of human diseases including epilepsy, autism spectrum disorder, familial migraine, and other neurodevelopmental disorders. A major obstacle hindering investigations of the functional consequences of brain NaV channel mutations is an unexplained instability of the corresponding recombinant complementary DNA (cDNA) when propagated in commonly used bacterial strains manifested by high spontaneous rates of mutation. Here, using a combination of in silico analysis, random and site-directed mutagenesis, we investigated the cause for instability of human Na(V)1.1 cDNA. We identified nucleotide sequences within the Na(V)1.1 coding region that resemble prokaryotic promoter-like elements, which are presumed to drive transcription of translationally toxic mRNAs in bacteria as the cause of the instability. We further demonstrated that mutations disrupting these elements mitigate the instability. Extending these observations, we generated full-length human Na(V)1.1, Na(V)1.2, and Na(V)1.6 plasmids using one or two introns that interrupt the latent reading frames along with a minimum number of silent nucleotide changes that achieved stable propagation in bacteria. Expression of the stabilized sequences in cultured mammalian cells resulted in functional Na-V channels with properties that matched their parental constructs. Our findings explain a widely observed instability of recombinant neuronal human Na-V channels, and we describe re-engineered plasmids that attenuate this problem.	[Dekeyser, Jean-Marc; Thompson, Christopher H.; George, Alfred L., Jr.] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	George, AL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA.	al.george@northwestern.edu			National Institutes of Health [NS108874]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant NS108874 (A. L. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertalovitz AC, 2018, J BIOL CHEM, V293, P12120, DOI 10.1074/jbc.RA118.001805; Bertelli S, 2019, CEPHALALGIA, V39, P477, DOI 10.1177/0333102418788336; Bhattacharjee, 2019, OXFORD HDB NEURONAL, P1; Bieth E, 1997, GENE, V194, P97, DOI 10.1016/S0378-1119(97)00173-X; Catterall WA, 2014, ANNU REV PHARMACOL, V54, P317, DOI 10.1146/annurev-pharmtox-011112-140232; Cruz-Vera LR, 2003, J BIOL CHEM, V278, P26065, DOI 10.1074/jbc.M301129200; Feldman DH, 2014, METHODSX, V1, P6, DOI 10.1016/j.mex.2014.01.002; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Hernandez-Sanchez J, 1998, EMBO J, V17, P3758, DOI 10.1093/emboj/17.13.3758; Johansen IE, 1996, P NATL ACAD SCI USA, V93, P12400, DOI 10.1073/pnas.93.22.12400; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Mason E. R., 2019, ENEURO 6 ENEURO; Mauro VP, 2014, TRENDS MOL MED, V20, P604, DOI 10.1016/j.molmed.2014.09.003; Patel RR, 2016, BRAIN, V139, P2164, DOI 10.1093/brain/aww129; Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10; Shabalina SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/nar/gks1205; Solovjev V, 2011, METAGENOMICITAPP, P61; Thompson CH, 2012, J BIOL CHEM, V287, P42001, DOI 10.1074/jbc.M112.421883; Thompson CH, 2011, EPILEPSIA, V52, P1000, DOI 10.1111/j.1528-1167.2011.03040.x	21	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100298	10.1016/j.jbc.2021.100298	http://dx.doi.org/10.1016/j.jbc.2021.100298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33460646	Green Submitted, Green Published, gold			2022-12-28	WOS:000672866400272
J	Herrmann, GK; Russell, WK; Garg, NJ; Yin, YW				Herrmann, Geoffrey K.; Russell, William K.; Garg, Nisha J.; Yin, Y. Whitney			Poly(ADP-ribose) polymerase 1 regulates mitochondrial DNA repair in an NAD-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; STRUCTURAL BASIS; CELL-DEATH; DAMAGE; NUCLEAR; DEPLETION; REDOX; HEART; PARP1	Mitochondrial DNA is located in organelle that house essential metabolic reactions and contains high reactive oxygen species. Therefore, mitochondrial DNA suffers more oxidative damage than its nuclear counterpart. Formation of a repair enzyme complex is beneficial to DNA repair. Recent studies have shown that mitochondrial DNA polymerase (Pol gamma) and poly(ADP-ribose) polymerase 1 (PARP1) were found in the same complex along with other mitochondrial DNA repair enzymes, and mitochondrial PARP1 level is correlated with mtDNA integrity. However, the molecular basis for the functional connection between Pol gamma and PARP1 has not yet been elucidated because cellular functions of PARP1 in DNA repair are intertwined with metabolism via NAD(+) (nicotinamide adenosine dinucleotide), the substrate of PARP1, and a metabolic cofactor. To dissect the direct effect of PARP1 on mtDNA from the secondary perturbation of metabolism, we report here biochemical studies that recapitulated Pol gamma PARylation observed in cells and showed that PARP1 regulates Pol gamma activity during DNA repair in a metabolic cofactor NAD(+) (nicotinamide adenosine dinucleotide)-dependent manner. In the absence of NAD(+), PARP1 completely inhibits Pol gamma, while increasing NAD(+) levels to a physiological concentration that enables Pol gamma to resume maximum repair activity. Because cellular NAD(+) levels are linked to metabolism and to ATP production via oxidative phosphorylation, our results suggest that mtDNA damage repair is coupled to cellular metabolic state and the integrity of the respiratory chain.	[Herrmann, Geoffrey K.; Russell, William K.; Yin, Y. Whitney] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Herrmann, Geoffrey K.; Yin, Y. Whitney] Univ Texas Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA; [Garg, Nisha J.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Yin, Y. Whitney] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Yin, YW (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Yin, YW (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA.; Yin, YW (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	ywyin@utmb.edu		Herrmann, Geoffrey/0000-0002-0581-616X	National Institutes of Health [GM 110591, AI 134970, AI 136031]; CPRIT grant [RP190682]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT grant	The work is supported by National Institutes of Health grants GM 110591 and AI 134970 to Y. W. Y. and AI 136031 to N. J. G. The UTMB Mass Spectrometry Facility is supported in part by CPRIT grant RP190682 to W. K. R. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312; Bian CJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08530-5; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; BURZIO LO, 1977, ANN NY ACAD SCI, V286, P398, DOI 10.1111/j.1749-6632.1977.tb29432.x; Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Fischer JMF, 2014, FEBS J, V281, P3625, DOI 10.1111/febs.12885; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Fouquerel E, 2014, CELL REP, V8, P1819, DOI 10.1016/j.celrep.2014.08.036; FREI B, 1988, BIOCHEMISTRY-US, V27, P529, DOI 10.1021/bi00402a004; He Q, 2013, MITOCHONDRION, V13, P592, DOI 10.1016/j.mito.2013.08.003; Hegedus C, 2020, CANCERS, V12, DOI 10.3390/cancers12010005; Henning RJ, 2018, CARDIOVASC TOXICOL, V18, P493, DOI 10.1007/s12012-018-9462-2; Jarrett SG, 2007, OPHTHALMIC RES, V39, P213, DOI 10.1159/000104683; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Kalesh K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43154-1; Krainz T, 2018, ACS CHEM BIOL, V13, P2868, DOI 10.1021/acschembio.8b00423; KUN E, 1975, P NATL ACAD SCI USA, V72, P1436, DOI 10.1073/pnas.72.4.1436; Langelier MF, 2017, METHODS MOL BIOL, V1608, P431, DOI 10.1007/978-1-4939-6993-7_27; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Langelier MF, 2011, J BIOL CHEM, V286, P10690, DOI 10.1074/jbc.M110.202507; Lavrik OI, 2001, J BIOL CHEM, V276, P25541, DOI 10.1074/jbc.M102125200; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; LOETSCHER P, 1987, P NATL ACAD SCI USA, V84, P1286, DOI 10.1073/pnas.84.5.1286; Lombardi AA, 2015, AM J PHYSIOL-HEART C, V309, pH393, DOI 10.1152/ajpheart.00475.2015; MASMOUDI A, 1987, BIOCHEMISTRY-US, V26, P1965, DOI 10.1021/bi00381a027; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MENISSIERDEMURCIA J, 1989, J MOL BIOL, V210, P229, DOI 10.1016/0022-2836(89)90302-1; Mosgoeller W, 1996, J CELL SCI, V109, P409; Nissink J. W., 2012, PLOS ONE, V7, pE5088; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Pascal JM, 2015, DNA REPAIR, V32, P10, DOI 10.1016/j.dnarep.2015.04.008; Picca A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080647; Prasad R, 2017, DNA REPAIR, V60, P77, DOI 10.1016/j.dnarep.2017.10.011; RICHTER C, 1983, P NATL ACAD SCI-BIOL, V80, P3188, DOI 10.1073/pnas.80.11.3188; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Sukhanova MV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P558, DOI 10.1023/B:BIRY.0000029855.68502.fa; Sykora P, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00237-17; Szczesny B, 2014, NUCLEIC ACIDS RES, V42, P13161, DOI 10.1093/nar/gku1089; Szymanski MR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14959; Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; Van Houten B, 2016, FRONT BIOSCI-LANDMRK, V21, P42, DOI 10.2741/4375; VEECH RL, 1972, BIOCHEM J, V127, P387, DOI 10.1042/bj1270387; Wen JJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007065; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; ZAHRADKA P, 1982, EUR J BIOCHEM, V127, P579; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603	60	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100309	10.1016/j.jbc.2021.100309	http://dx.doi.org/10.1016/j.jbc.2021.100309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482196	Green Published, gold			2022-12-28	WOS:000672866400283
J	Hu, Z; Ma, JC; Chen, YC; Tong, WH; Zhu, L; Wang, HH; Cronan, JE				Hu, Zhe; Ma, Jincheng; Chen, Yicai; Tong, Wenhua; Zhu, Lei; Wang, Haihong; Cronan, John E.			Escherichia coli FabG 3-ketoacyl-ACP reductase proteins lacking the assigned catalytic triad residues are active enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-CARRIER PROTEIN; SITE-DIRECTED MUTAGENESIS; MISMATCH-REPAIR; DEHYDROGENASE; CRYSTALLIZATION; BIOSYNTHESIS; COFACTOR; MUTANTS	The FabG 3-ketoacyl-acyl carrier protein (ACP) reductase of Escherichia coli has long been thought to be a classical member of the short-chain alcohol dehydrogenase/reductase (SDR) family. FabG catalyzes the essential 3-ketoacyl-ACP reduction step in the FAS II fatty acid synthesis pathway. Site-directed mutagenesis studies of several other SDR enzymes has identified three highly conserved amino acid residues, Ser, Tyr, and Lys, as the catalytic triad. Structural analyses of E. coli FabG suggested the triad S138-Y151-K155 to form a catalytically competent active site. To test this hypothesis, we constructed a series of E. coli FabG mutants and tested their 3-ketoacyl-ACP reductase activities both in vivo and in vitro. Our data show that plasmid-borne FabG mutants, including the double and triple mutants, restored growth of E. coli and Salmonella enterica fabG temperature-sensitive mutant strains under nonpermissive conditions. In vitro assays demonstrated that all of the purified FabG mutant proteins maintained fatty acid synthetic ability, although the activities of the single mutant proteins were 20% to 50% lower than that of wildtype FabG. The S138A, Y151F, and K155A residue substitutions were confirmed by tandem mass spectral sequencing of peptides that spanned all three residues. We conclude that FabG is not a classical short-chain alcohol dehydrogenase/reductase, suggesting that an alternative mode of 3-ketoacyl-ACP reduction awaits discovery.	[Hu, Zhe; Ma, Jincheng; Chen, Yicai; Tong, Wenhua; Zhu, Lei; Wang, Haihong] South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China; [Hu, Zhe; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Tong, Wenhua; Zhu, Lei] Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China; [Tong, Wenhua] Sichuan Univ Sci & Engn, Coll Bioengn, Yibin 644000, Sichuan, Peoples R China	South China Agricultural University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Shandong Agricultural University; Sichuan University of Science & Engineering	Wang, HH (corresponding author), South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China.; Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA.; Cronan, JE (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	wanghh36@scau.edu.cn; jecronan@illinois.edu		Tong, Wenhua/0000-0002-3952-0025; Hu, Zhe/0000-0002-6864-2099	National Natural Science Foundation of China [31671987, 31972232]; NIH [AI15650]; National Institute of Allergy and Infectious Diseases	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Natural Science Foundation of China (Grant numbers: 31671987 and 31972232) and by NIH grant AI15650 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; CHEN Z, 1993, BIOCHEMISTRY-US, V32, P3342, DOI 10.1021/bi00064a017; Cheng JL, 2012, APPL ENVIRON MICROB, V78, P1563, DOI 10.1128/AEM.07335-11; COLS N, 1993, FEBS LETT, V319, P90, DOI 10.1016/0014-5793(93)80043-T; Cronan JE, 2004, CHEM BIOL, V11, P1601, DOI 10.1016/j.chembiol.2004.11.011; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fisher M, 2000, STRUCTURE, V8, P339, DOI 10.1016/S0969-2126(00)00115-5; Fisher M, 2000, ACTA CRYSTALLOGR D, V56, P86, DOI 10.1107/S0907444999013918; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; Heath RJ, 2001, PROG LIPID RES, V40, P467, DOI 10.1016/S0163-7827(01)00012-1; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Karmodiya K, 2006, FEBS J, V273, P4093, DOI 10.1111/j.1742-4658.2006.05412.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kristan K, 2009, CHEM-BIOL INTERACT, V178, P310, DOI 10.1016/j.cbi.2008.09.030; Lai CY, 2004, J BACTERIOL, V186, P1869, DOI 10.1128/JB.186.6.1869-1878.2004; Mao QL, 2007, ACTA CRYSTALLOGR F, V63, P106, DOI 10.1107/S1744309107000103; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Oppermann UCT, 1997, BIOCHEMISTRY-US, V36, P34, DOI 10.1021/bi961803v; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; RADMAN M, 1986, ANNU REV GENET, V20, P523, DOI 10.1146/annurev.ge.20.120186.002515; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; Tanabe T, 1998, J BIOCHEM, V124, P634, DOI 10.1093/oxfordjournals.jbchem.a022159; ULRICH AK, 1983, J BACTERIOL, V154, P221, DOI 10.1128/JB.154.1.221-230.1983; Wang HH, 2004, BIOCHEMISTRY-US, V43, P11782, DOI 10.1021/bi0487600; Wang HH, 2003, J BACTERIOL, V185, P4930, DOI 10.1128/JB.185.16.4930-4937.2003; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Zhang YM, 2004, J BIOL CHEM, V279, P30994, DOI 10.1074/jbc.M403697200; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	34	1	1	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100365	10.1016/j.jbc.2021.100365	http://dx.doi.org/10.1016/j.jbc.2021.100365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33545175	gold, Green Published			2022-12-28	WOS:000672866400339
J	Irie, F; Tobisawa, Y; Murao, A; Yamamoto, H; Ohyama, C; Yamaguchi, Y				Irie, Fumitoshi; Tobisawa, Yuki; Murao, Ayako; Yamamoto, Hayato; Ohyama, Chikara; Yamaguchi, Yu			The cell surface hyaluronidase TMEM2 regulates cell adhesion and migration via degradation of hyaluronan at focal adhesion sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX ADHESION; CANCER; CHONDROCYTES; EXPRESSION; INTEGRINS; PROTEIN; FORMS; HYAL2; GENE	The extracellular matrix (ECM) plays an important role in maintaining tissue homeostasis and poses a significant physical barrier to in vivo cell migration. Accordingly, as a means of enhancing tissue invasion, tumor cells use matrix metal-loproteinases to degrade ECM proteins. However, the in vivo ECM is comprised not only of proteins but also of a variety of nonprotein components. Hyaluronan (HA), one of the most abundant nonprotein components of the interstitial ECM, forms a gel-like antiadhesive barrier that is impenetrable to particulate matter and cells. Mechanisms by which tumor cells penetrate the HA barrier have not been addressed. Here, we demonstrate that transmembrane protein 2 (TMEM2), the only known transmembrane hyaluronidase, is the predominant mediator of contact-dependent HA degradation and subsequent integrin-mediated cell-substrate adhesion. We show that a variety of tumor cells are able to eliminate substrate-bound HA in a tightly localized pattern corresponding to the distribution of focal adhesions (FAs) and stress fibers. This FA-targeted HA degradation is mediated by TMEM2, which itself is localized at site of FAs. TMEM2 depletion inhibits the ability of tumor cells to attach and migrate in an HA-rich environment. Importantly, TMEM2 directly binds at least two integrins via interaction between extracellular domains. Our findings demonstrate a critical role for TMEM2-mediated HA degradation in the adhesion and migration of cells on HA-rich ECM substrates and provide novel insight into the early phase of FA formation.	[Irie, Fumitoshi; Tobisawa, Yuki; Murao, Ayako; Yamaguchi, Yu] Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA 92037 USA; [Yamamoto, Hayato; Ohyama, Chikara] Hirosaki Univ, Dept Urol, Grad Sch Med, Hirosaki, Aomori, Japan	Sanford Burnham Prebys Medical Discovery Institute; Hirosaki University	Yamaguchi, Y (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA 92037 USA.	yyamaguchi@sbpdiscovery.org	; Tobisawa, Yuki/G-3802-2014	Yamaguchi, Yu/0000-0003-0098-281X; Tobisawa, Yuki/0000-0001-8026-9541	National Institutes of Health [R01 AR062692]; Mizutani Foundation Research Grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation Research Grant	This work was supported by National Institutes of Health grant R01 AR062692 and the Mizutani Foundation Research Grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aaltomaa S, 2002, UROL INT, V69, P266, DOI 10.1159/000066123; AFIFY AM, 1993, ARCH BIOCHEM BIOPHYS, V305, P434, DOI 10.1006/abbi.1993.1443; Andre B, 2011, BIOCHEM BIOPH RES CO, V411, P175, DOI 10.1016/j.bbrc.2011.06.125; BARD JBL, 1983, J CELL SCI, V62, P371; Bassani S, 2012, INT J BIOCHEM CELL B, V44, P703, DOI 10.1016/j.biocel.2012.01.020; Chanmee T, 2016, CANCER LETT, V375, P20, DOI 10.1016/j.canlet.2016.02.031; Chow G, 2006, OSTEOARTHR CARTILAGE, V14, P1312, DOI 10.1016/j.joca.2006.08.005; Cohen M, 2004, CHEMBIOCHEM, V5, P1393, DOI 10.1002/cbic.200400162; Cowman Mary K, 2015, F1000Res, V4, P622, DOI 10.12688/f1000research.6885.1; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; GOLDBERG RL, 1984, J CELL BIOL, V99, P2114, DOI 10.1083/jcb.99.6.2114; Grotzinger J, 2017, BBA-MOL CELL RES, V1864, P2088, DOI 10.1016/j.bbamcr.2017.05.024; Knudson Warren, 1998, Frontiers in Bioscience, V3, pD604; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee H, 2016, CANCER RES, V76, P4994, DOI 10.1158/0008-5472.CAN-15-2322; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lipponen P, 2001, EUR J CANCER, V37, P849, DOI 10.1016/S0959-8049(00)00448-2; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Lokeshwar VB, 1996, CANCER RES, V56, P651; MCBRIDE WH, 1979, J EXP MED, V149, P507, DOI 10.1084/jem.149.2.507; Petty HR, 1996, IMMUNOL TODAY, V17, P209, DOI 10.1016/0167-5699(96)30013-3; Porter JC, 1998, TRENDS CELL BIOL, V8, P390, DOI 10.1016/S0962-8924(98)01344-0; Provenzano PP, 2013, BRIT J CANCER, V108, P1, DOI 10.1038/bjc.2012.569; Puissant E, 2014, TRAFFIC, V15, P500, DOI 10.1111/tra.12162; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Scott JE, 1999, P NATL ACAD SCI USA, V96, P4850, DOI 10.1073/pnas.96.9.4850; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2005, PATHOL BIOL, V53, P372, DOI 10.1016/j.patbio.2004.12.021; Stern R, 2008, SEMIN CANCER BIOL, V18, P275, DOI 10.1016/j.semcancer.2008.03.017; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Voutouri C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193801; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153; Whatcott CJ, 2011, CANCER DISCOV, V1, P291, DOI 10.1158/2159-8290.CD-11-0136; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yamada KM, 2019, NAT REV MOL CELL BIO, V20, P738, DOI 10.1038/s41580-019-0172-9; Yamaguchi Y, 2019, MATRIX BIOL, V78-79, P139, DOI 10.1016/j.matbio.2018.03.020; Yamamoto H, 2017, J BIOL CHEM, V292, P7304, DOI 10.1074/jbc.M116.770149; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5	43	10	10	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100481	10.1016/j.jbc.2021.100481	http://dx.doi.org/10.1016/j.jbc.2021.100481			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33647313	gold, Green Published			2022-12-28	WOS:000672866400455
J	Kamble, P; Hall, K; Chandak, M; Tang, Q; Caglayan, M				Kamble, Pradnya; Hall, Kalen; Chandak, Mahesh; Tang, Qun; Caglayan, Melike			DNA ligase I fidelity mediates the mutagenic ligation of pol beta oxidized and mismatch nucleotide insertion products in base excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; POLYMERASE-BETA; APRATAXIN DEFICIENCY; STRUCTURAL INSIGHTS; INDUCED-FIT; REPLICATION; MECHANISM; ERROR; MISINCORPORATION; COMPLEMENTATION	DNA ligase I (LIG1) completes the base excision repair (BER) pathway at the last nick-sealing step after DNA polymerase (pol) beta gap-filling DNA synthesis. However, the mechanism by which LIG1 fidelity mediates the faithful substrate-product channeling and ligation of repair intermediates at the final steps of the BER pathway remains unclear. We previously reported that pol beta 8-oxo-2'-deoxyribonucleoside 5'-triphosphate insertion confounds LIG1, leading to the formation of ligation failure products with a 5'-adenylate block. Here, using reconstituted BER assays in vitro, we report the mutagenic ligation of pol beta 8-oxo-2'-deoxyribonucleoside 5'-triphosphate insertion products and an inefficient ligation of pol beta Watson-Crick-like dG:T mismatch insertion by the LIG1 mutant with a perturbed fidelity (E346A/E592A). Moreover, our results reveal that the substrate discrimination of LIG1 for the nicked repair intermediates with preinserted 3'-8-oxodG or mismatches is governed by mutations at both E346 and E592 residues. Finally, we found that aprataxin and flap endonuclease 1, as compensatory DNA-end processing enzymes, can remove the 5'-adenylate block from the abortive ligation products harboring 3'-8-oxodG or the 12 possible non-canonical base pairs. These findings contribute to the understanding of the role of LIG1 as an important determinant in faithful BER and how a multiprotein complex (LIG1, pol beta, aprataxin, and flap endonuclease 1) can coordinate to prevent the formation of mutagenic repair intermediates with damaged or mismatched ends at the downstream steps of the BER pathway.	[Kamble, Pradnya; Hall, Kalen; Chandak, Mahesh; Tang, Qun; Caglayan, Melike] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Caglayan, M (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	caglayanm@ufl.edu	Tang, Qun/AHC-5915-2022	Tang, Qun/0000-0001-8943-0012; CAGLAYAN, MELIKE/0000-0003-1107-1042	National Institutes of Health/National Institute of Environmental Health Sciences [4R00ES026191]; University of Florida Thomas H. Maren Junior Investigator Fund [P0158597]	National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Florida Thomas H. Maren Junior Investigator Fund	This work was supported by the National Institutes of Health/National Institute of Environmental Health Sciences Grant 4R00ES026191 and the University of Florida Thomas H. Maren Junior Investigator Fund P0158597 to M. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Ahn JW, 1998, BIOCHEM J, V331, P79, DOI 10.1042/bj3310079; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2010, NAT STRUCT MOL BIOL, V17, P889, DOI 10.1038/nsmb.1852; Beard WA, 2019, ANNU REV BIOCHEM, V88, P137, DOI 10.1146/annurev-biochem-013118-111315; Bebenek K, 2011, P NATL ACAD SCI USA, V108, P1862, DOI 10.1073/pnas.1012825108; Bentley DJ, 2002, J CELL SCI, V115, P1551; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Caglayan M, 2020, DNA REPAIR, V95, DOI 10.1016/j.dnarep.2020.102945; Caglayan M, 2020, NUCLEIC ACIDS RES, V48, P3708, DOI 10.1093/nar/gkaa151; Caglayan M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57886-y; Caglayan M, 2019, J MOL BIOL, V431, P2068, DOI 10.1016/j.jmb.2019.04.028; Caglayan M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06700-5; Caglayan M, 2017, J RADIAT RES, V58, P603, DOI 10.1093/jrr/rrx027; Caglayan M, 2017, NUCLEIC ACIDS RES, V45, P10079, DOI 10.1093/nar/gkx654; Caglayan M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14045; Caglayan M, 2015, DNA REPAIR, V35, P85, DOI 10.1016/j.dnarep.2015.09.010; Caglayan M, 2015, NUCLEIC ACIDS RES, V43, P2271, DOI 10.1093/nar/gkv079; Caglayan M, 2014, NAT STRUCT MOL BIOL, V21, P497, DOI 10.1038/nsmb.2818; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Cherepanov AV, 2002, EUR J BIOCHEM, V269, P5993, DOI 10.1046/j.1432-1033.2002.03309.x; Conlin MP, 2017, CELL REP, V20, P2810, DOI 10.1016/j.celrep.2017.08.091; Cooley N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/152909; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Dickson KS, 2000, J BIOL CHEM, V275, P15828, DOI 10.1074/jbc.M910044199; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; El-Khamisy SF, 2009, DNA REPAIR, V8, P760, DOI 10.1016/j.dnarep.2009.02.002; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freudenthal BD, 2015, NATURE, V517, P635, DOI 10.1038/nature13886; Harrison C, 2002, CANCER RES, V62, P4065; Howes Timothy R L, 2012, Subcell Biochem, V62, P327, DOI 10.1007/978-94-007-4572-8_17; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Jurkiw TJ, 2021, NUCLEIC ACIDS RES, V49, P1619, DOI 10.1093/nar/gkaa1297; Kaminski AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05024-8; Katafuchi A, 2010, MUTAT RES-GEN TOX EN, V703, P24, DOI 10.1016/j.mrgentox.2010.06.004; Kimsey IJ, 2018, NATURE, V554, P195, DOI 10.1038/nature25487; Kimsey IJ, 2015, NATURE, V519, P315, DOI 10.1038/nature14227; Kirouac KN, 2011, P NATL ACAD SCI USA, V108, P3210, DOI 10.1073/pnas.1013909108; Koag MC, 2014, NUCLEIC ACIDS RES, V42, P11233, DOI 10.1093/nar/gku789; Krahn JM, 2004, STRUCTURE, V12, P1823, DOI 10.1016/j.str.2004.08.001; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Lindahl T, 2001, PROG NUCLEIC ACID RE, V68, pXVII; Liu PF, 2004, NUCLEIC ACIDS RES, V32, P4503, DOI 10.1093/nar/gkh781; Nakabeppu Y, 2006, BIOL CHEM, V387, P373, DOI 10.1515/BC.2006.050; Ochi T, 2013, STRUCTURE, V21, P672, DOI 10.1016/j.str.2013.02.014; Ochi T, 2012, STRUCTURE, V20, P1212, DOI 10.1016/j.str.2012.04.012; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Prasad R, 2011, MOL BIOL+, V45, P536, DOI 10.1134/S0026893311040091; Prasad R, 2010, J BIOL CHEM, V285, P40479, DOI 10.1074/jbc.M110.155267; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; Reynolds JJ, 2009, MOL CELL BIOL, V29, P1354, DOI 10.1128/MCB.01471-08; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Showalter AK, 2006, CHEM REV, V106, P340, DOI 10.1021/cr040487k; Simonelli V, 2017, ONCOTARGET, V8, P84827, DOI 10.18632/oncotarget.10185; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Tang Q, 2020, MUTAGENESIS, V35, P391, DOI 10.1093/mutage/geaa023; Taylor MR, 2011, J BIOL CHEM, V286, P23054, DOI 10.1074/jbc.M111.248831; Timson DJ, 2000, MUTAT RES-DNA REPAIR, V460, P301, DOI 10.1016/S0921-8777(00)00033-1; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Tomkinson AE, 1998, MUTAT RES-DNA REPAIR, V407, P1, DOI 10.1016/S0921-8777(97)00050-5; Tumbale P, 2018, EMBO J, V37, DOI 10.15252/embj.201798875; Tumbale PP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13478-7; Ventura I, 2010, MUTAT RES-GEN TOX EN, V703, P59, DOI 10.1016/j.mrgentox.2010.06.008; Wang WN, 2011, P NATL ACAD SCI USA, V108, P17644, DOI 10.1073/pnas.1114496108; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; Whitaker AM, 2018, DNA REPAIR, V71, P93, DOI 10.1016/j.dnarep.2018.08.012; Williams JS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20800-1; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; YANG SW, 1992, J BIOL CHEM, V267, P8117	73	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100427	10.1016/j.jbc.2021.100427	http://dx.doi.org/10.1016/j.jbc.2021.100427			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600799	gold, Green Published, Green Submitted			2022-12-28	WOS:000672866400401
J	Kapoor, S; Kodesia, A; Kalidas, N; Ashish; Thakur, KG				Kapoor, Srajan; Kodesia, Akriti; Kalidas, Nidhi; Ashish; Thakur, Krishan Gopal			Structural characterization of Myxococcus xanthus MglC, a component of the polarity control system, and its interactions with its paralog MglB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIDING MOTILITY; EVOLUTIONARY CONSERVATION; RESPONSE REGULATOR; CELL POLARITY; PROTEIN; CONSURF; REFINEMENT; SCATTERING; ALIGNMENT; MYXOBACTERALES	The delta-proteobacteria Myxococcus xanthus displays social (S) and adventurous (A) motilities, which require pole-to-pole reversal of the motility regulator proteins. Mutual gliding motility protein C (MglC), a paralog of GTPase-activating protein Mutual gliding motility protein B (MglB), is a member of the polarity module involved in regulating motility. However, little is known about the structure and function of MglC. Here, we determined similar to 1.85 angstrom resolution crystal structure of MglC using Selenomethionine Single-wavelength anomalous diffraction. The crystal structure revealed that, despite sharing <9% sequence identity, both MglB and MglC adopt a Regulatory Light Chain 7 family fold. However, MglC has a distinct similar to 30 degrees to 40 degrees shift in the orientation of the functionally important alpha 2 helix compared with other structural homologs. Using isothermal titration calorimetry and size-exclusion chromatography, we show that MglC binds MglB in 2:4 stoichiometry with submicromolar range dissociation constant. Using small-angle X-ray scattering and molecular docking studies, we show that the MglBC complex consists of a MglC homodimer sandwiched between two homodimers of MglB. A combination of size-exclusion chromatography and site-directed mutagenesis studies confirmed the MglBC interacting interface obtained by molecular docking studies. Finally, we show that the C-terminal region of MglB, crucial for binding its established partner MglA, is not required for binding MglC. These studies suggest that the MglB uses distinct interfaces to bind MglA and MglC. Based on these data, we propose a model suggesting a new role for MglC in polarity reversal in M. xanthus.	[Kapoor, Srajan; Kodesia, Akriti; Thakur, Krishan Gopal] GN Ramachandran Prot Ctr, Struct Biol Lab, Chandigarh, India; [Kalidas, Nidhi; Ashish] GN Ramachandran Prot Ctr, CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Thakur, KG (corresponding author), GN Ramachandran Prot Ctr, Struct Biol Lab, Chandigarh, India.	krishang@imtech.res.in	Kapoor, Srajan/GRO-5233-2022	Kapoor, Srajan/0000-0003-1347-550X; Kalidas, Nidhi/0000-0001-7956-4009; Thakur, Krishan/0000-0003-4500-2133	Council of Scientific and Industrial Research, India; Department of Biotechnology, India; Department of Science and Technology-INSPIRE, India; BIRAC fellowship, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology-INSPIRE, India; BIRAC fellowship, India	This work was supported by grant to K. G. T. and Ashish by the Council of Scientific and Industrial Research, India. S. K. is a recipient of senior research fellowship from the Department of Biotechnology, India. A. K. is a recipient of junior research fellowship from the Department of Science and Technology-INSPIRE, India. N. K. is a recipient of BIRAC fellowship, India.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Badmalia MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04975-0; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baranwal J, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000459; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BLACKHART BD, 1985, P NATL ACAD SCI USA, V82, P8767, DOI 10.1073/pnas.82.24.8767; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Galicia C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13274-3; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Guzzo M, 2018, NAT MICROBIOL, V3, P948, DOI 10.1038/s41564-018-0203-x; HARTZELL P, 1991, J BACTERIOL, V173, P7615, DOI 10.1128/jb.173.23.7615-7624.1991; Herrou J, 2020, CURR OPIN CELL BIOL, V62, P54, DOI 10.1016/j.ceb.2019.09.001; HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004; HODGKIN J, 1979, MOL GEN GENET, V171, P167, DOI 10.1007/BF00270003; Inclan YF, 2007, MOL MICROBIOL, V65, P90, DOI 10.1111/j.1365-2958.2007.05774.x; Islam ST, 2015, SEMIN CELL DEV BIOL, V46, P143, DOI 10.1016/j.semcdb.2015.10.033; Kaimer C, 2013, MOL MICROBIOL, V88, P740, DOI 10.1111/mmi.12219; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kanade M, 2021, FEBS J, V288, P1565, DOI 10.1111/febs.15513; Keilberg D, 2014, BIOCHEMISTRY-US, V53, P1899, DOI 10.1021/bi500141f; Keilberg D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002951; Konovalova A, 2010, FEMS MICROBIOL REV, V34, P89, DOI 10.1111/j.1574-6976.2009.00194.x; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; Kovalevskiy O, 2018, ACTA CRYSTALLOGR D, V74, P215, DOI 10.1107/S2059798318000979; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Leonardy S, 2007, EMBO J, V26, P4433, DOI 10.1038/sj.emboj.7601877; Leonardy S, 2010, EMBO J, V29, P2276, DOI 10.1038/emboj.2010.114; Levine Timothy P, 2013, Small GTPases, V4, P62, DOI 10.4161/sgtp.24262; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Mauriello EMF, 2007, CURR OPIN MICROBIOL, V10, P624, DOI 10.1016/j.mib.2007.09.012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLoon AL, 2016, J BACTERIOL, V198, P510, DOI 10.1128/JB.00548-15; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholls RA, 2018, ACTA CRYSTALLOGR D, V74, P492, DOI 10.1107/S2059798318007313; Pandey K, 2014, J PHYS CHEM B, V118, P5059, DOI 10.1021/jp501641r; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Peddada N, 2013, J BIOL CHEM, V288, P28266, DOI 10.1074/jbc.M113.463224; Putnam CD, 2016, J APPL CRYSTALLOGR, V49, P1412, DOI 10.1107/S1600576716010906; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schumacher D, 2017, ANNU REV MICROBIOL, V71, P61, DOI 10.1146/annurev-micro-102215-095415; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Shen K, 2019, CELL, V179, P1319, DOI 10.1016/j.cell.2019.10.036; SHI WY, 1993, MOL MICROBIOL, V9, P601, DOI 10.1111/j.1365-2958.1993.tb01720.x; Spormann AM, 1999, J BACTERIOL, V181, P2593, DOI 10.1128/JB.181.8.2593-2601.1999; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Sun MZ, 2011, P NATL ACAD SCI USA, V108, P7559, DOI 10.1073/pnas.1101101108; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Szadkowski D, 2019, NAT MICROBIOL, V4, P1344, DOI 10.1038/s41564-019-0451-4; Vajda S, 2017, PROTEINS, V85, P435, DOI 10.1002/prot.25219; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004; Zhang TL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01567-4; Zhang Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002872; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]; ZUSMAN DR, 1982, J BACTERIOL, V150, P1430, DOI 10.1128/JB.150.3.1430-1437.1982	71	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100308	10.1016/j.jbc.2021.100308	http://dx.doi.org/10.1016/j.jbc.2021.100308			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493516	Green Published, gold			2022-12-28	WOS:000672866400282
J	Khater, M; Wei, Z; Xu, X; Huang, W; Lokeshwar, BL; Lambert, NA; Wu, GY				Khater, Mostafa; Wei, Zhe; Xu, Xin; Huang, Wei; Lokeshwar, Bal L.; Lambert, Nevin A.; Wu, Guangyu			G protein beta gamma translocation to the Golgi apparatus activates MAPK via p110 gamma-p101 heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; COMPLEX TRANSLOCATION; SIGNALING PATHWAY; COUPLED RECEPTORS; ANGIOTENSIN-II; KINASE; ARRESTIN; SUBUNITS; ORGANIZATION; TRAFFICKING	The Golgi apparatus (GA) is a cellular organelle that plays a critical role in the processing of proteins for secretion. Activation of G protein-coupled receptors at the plasma membrane (PM) induces the translocation of G protein beta gamma dimers to the GA. However, the functional significance of this translocation is largely unknown. Here, we study PM-GA translocation of all 12 G gamma subunits in response to chemokine receptor CXCR4 activation and demonstrate that G gamma 9 is a unique Golgi-translocating G gamma subunit. CRISPR-Cas9-mediated knockout of G gamma 9 abolishes activation of extracellular signal-regulated kinase 1 and 2 (ERK1/2), two members of the mitogen-activated protein kinase family, by CXCR4. We show that chemically induced recruitment to the GA of G beta gamma dimers containing different G gamma subunits activates ERK1/2, whereas recruitment to the PM is ineffective. We also demonstrate that pharmacological inhibition of phosphoinositide 3-kinase. (PI3K gamma) and depletion of its subunits p110 gamma and p101 abrogate ERK1/2 activation by CXCR4 and G beta gamma recruitment to the GA. Knockout of either G gamma 9 or PI3K gamma significantly suppresses prostate cancer PC3 cell migration, invasion, and metastasis. Collectively, our data demonstrate a novel function for G beta gamma translocation to the GA, via activating PI3K gamma heterodimers p110 gamma-p101, to spatiotemporally regulate mitogen-activated protein kinase activation by G protein-coupled receptors and ultimately control tumor progression.	[Khater, Mostafa; Wei, Zhe; Xu, Xin; Huang, Wei; Lambert, Nevin A.; Wu, Guangyu] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Lokeshwar, Bal L.] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Wu, GY (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@augusta.edu		Khater, Mostafa/0000-0001-7080-6534; Lambert, Nevin/0000-0001-7550-0921	National Institutes of Health, United States [R35GM136397, R01GM118915, R01GM130142]; Veterans Affairs Office of Research and Development, United States [BX003862]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Office of Research and Development, United States	This work was supported by grants from the National Institutes of Health, United States (R35GM136397 and R01GM118915 to G. W. and R01GM130142 to N. A. L.) and Veterans Affairs Office of Research and Development, United States (BX003862 to B. L. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Azpiazu I, 2006, CELL SIGNAL, V18, P1190, DOI 10.1016/j.cellsig.2005.09.007; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bilanges B, 2019, NAT REV MOL CELL BIO, V20, P515, DOI 10.1038/s41580-019-0129-z; Bookout AL, 2003, J BIOL CHEM, V278, P37569, DOI 10.1074/jbc.M306276200; Campbell AP, 2018, NAT REV DRUG DISCOV, V17, P789, DOI 10.1038/nrd.2018.135; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Davis JE, 2016, ONCOTARGET, V7, P39834, DOI 10.18632/oncotarget.9405; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Eichel K, 2016, NAT CELL BIOL, V18, P303, DOI 10.1038/ncb3307; Eichel K, 2018, TRENDS PHARMACOL SCI, V39, P200, DOI 10.1016/j.tips.2017.11.009; El-Haibi CP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-64; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gioeli D, 1999, CANCER RES, V59, P279; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jensen DD, 2016, J BIOL CHEM, V291, P11285, DOI 10.1074/jbc.M115.710681; Kallifatidis G, 2016, MOL CANCER RES, V14, P493, DOI 10.1158/1541-7786.MCR-15-0498; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Klayman LM, 2017, J BIOL CHEM, V292, P1773, DOI 10.1074/jbc.M116.750430; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; Madukwe JC, 2018, J BIOL CHEM, V293, P6387, DOI 10.1074/jbc.RA118.002354; Malik S, 2015, MOL BIOL CELL, V26, P1188, DOI 10.1091/mbc.E14-10-1476; O'Hayre M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3395; O'Neill PR, 2012, P NATL ACAD SCI USA, V109, pE3568, DOI 10.1073/pnas.1205345109; Ono F, 1998, J BIOL CHEM, V273, P7731, DOI 10.1074/jbc.273.13.7731; Paudyal P, 2017, ONCOTARGET, V8, P36067, DOI 10.18632/oncotarget.16428; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schutzman JL, 2012, P NATL ACAD SCI USA, V109, P20023, DOI 10.1073/pnas.1217204109; Senarath K, 2018, J BIOL CHEM, V293, P2974, DOI 10.1074/jbc.RA117.000872; Smrcka AV, 2019, CELL MOL LIFE SCI, V76, P4447, DOI 10.1007/s00018-019-03275-2; Smrcka AV, 2013, TRENDS PHARMACOL SCI, V34, P290, DOI 10.1016/j.tips.2013.02.006; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Taichman RS, 2002, CANCER RES, V62, P1832; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975; Wei Z, 2019, CELL REP, V28, P554, DOI 10.1016/j.celrep.2019.05.033; Weis WI, 2018, ANNU REV BIOCHEM, V87, P897, DOI 10.1146/annurev-biochem-060614-033910; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu V, 2019, J BIOL CHEM, V294, P11062, DOI 10.1074/jbc.REV119.005601; Zhou FG, 2015, CELL SIGNAL, V27, P2035, DOI 10.1016/j.cellsig.2015.06.007	58	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100325	10.1016/j.jbc.2021.100325	http://dx.doi.org/10.1016/j.jbc.2021.100325			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493514	Green Published, gold			2022-12-28	WOS:000672866400299
J	Maidment, JHR; Franceschetti, M; Maqbool, A; Saitoh, H; Jantasuriyarat, C; Kamoun, S; Terauchi, R; Banfield, MJ				Maidment, Josephine H. R.; Franceschetti, Marina; Maqbool, Abbas; Saitoh, Hiromasa; Jantasuriyarat, Chatchawan; Kamoun, Sophien; Terauchi, Ryohei; Banfield, Mark J.			Multiple variants of the fungal effector AVR-Pik bind the HMA domain of the rice protein OsHIPP19, providing a foundation to engineer plant defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLAST RESISTANCE GENE; PATHOGEN EFFECTORS; ARMS-RACE; DECOY; IMMUNITY; TARGETS; MODEL	Microbial plant pathogens secrete effector proteins, which manipulate the host to promote infection. Effectors can be recognized by plant intracellular nucleotide-binding leucine-rich repeat (NLR) receptors, initiating an immune response. The AVR-Pik effector from the rice blast fungus Magnaporthe oryzae is recognized by a pair of rice NLR receptors, Pik-1 and Pik-2. Pik-1 contains a noncanonical integrated heavy-metal-associated (HMA) domain, which directly binds AVR-Pik to activate plant defenses. The host targets of AVR-Pik are also HMA-domain-containing proteins, namely heavy-metal-associated isoprenylated plant proteins (HIPPs) and heavy-metal-associated plant proteins (HPPs). Here, we demonstrate that one of these targets interacts with a wider set of AVR-Pik variants compared with the Pik-1 HMA domains. We define the biochemical and structural basis of the interaction between AVR-Pik and OsHIPP19 and compare the interaction to that formed with the HMA domain of Pik-1. Using analytical gel filtration and surface plasmon resonance, we show that multiple AVR-Pik variants, including the stealthy variants AVR-PikC and AVR-PikF, which do not interact with any characterized Pik-1 alleles, bind to OsHIPP19 with nanomolar affinity. The crystal structure of OsHIPP19 in complex with AVR-PikF reveals differences at the interface that underpin high-affinity binding of OsHIPP19-HMA to a wider set of AVR-Pik variants than achieved by the integrated HMA domain of Pik-1. Our results provide a foundation for engineering the HMA domain of Pik-1 to extend binding to currently unrecognized AVR-Pik variants and expand disease resistance in rice to divergent pathogen strains.	[Maidment, Josephine H. R.; Franceschetti, Marina; Maqbool, Abbas; Jantasuriyarat, Chatchawan; Banfield, Mark J.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich, Norfolk, England; [Saitoh, Hiromasa] Tokyo Univ Agr, Fac Life Sci, Dept Mol Microbiol, Tokyo, Japan; [Jantasuriyarat, Chatchawan] Kasetsart Univ, Dept Genet, Fac Sci, Natl Res Univ,CASTNAR,NRU KU, Bangkok, Thailand; [Jantasuriyarat, Chatchawan] Kasetsart Univ, Natl Res Univ, CASTNAR, NRU KU,Ctr Adv Studies Trop Nat Resources, Bangkok, Thailand; [Maidment, Josephine H. R.; Maqbool, Abbas; Kamoun, Sophien] Univ East Anglia, Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Div Genom & Breeding, Kitakami, Iwate, Japan; [Terauchi, Ryohei] Kyoto Univ, Grad Sch Agr, Lab Crop Evolut, Kyoto, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Tokyo University of Agriculture; Kasetsart University; Kasetsart University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; Iwate Biotechnology Research Center; Kyoto University	Banfield, MJ (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich, Norfolk, England.	mark.banfield@jic.ac.uk	Kamoun, Sophien/B-3529-2009; Banfield, Mark/C-7453-2013; Maqbool, Abbas/ABF-8279-2021; Terauchi, Ryohei/Y-2992-2019; Maqbool, Abbas/G-3191-2016	Kamoun, Sophien/0000-0002-0290-0315; Banfield, Mark/0000-0001-8921-3835; Terauchi, Ryohei/0000-0002-0095-4651; Saitoh, Hiromasa/0000-0002-0124-9276; Maqbool, Abbas/0000-0002-6189-5560; Maidment, Josephine/0000-0002-8229-2718	UKRI Biotechnology and Biological Sciences Research Council (BBSRC) Norwich Research Park Biosciences Doctoral Training Partnership, UK [BB/M011216/1]; UKRI BBSRC, UK [BB/P012574, BB/M02198X]; European Research Council [ERC] [743165]; John Innes Foundation; JSPS [15H05779, 20H05681]; JSPS/The Royal Society Bilateral Research; BBSRC [BBS/E/J/000PR9795, BB/M022315/1, BBS/E/J/000PR9797, 1654182] Funding Source: UKRI	UKRI Biotechnology and Biological Sciences Research Council (BBSRC) Norwich Research Park Biosciences Doctoral Training Partnership, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UKRI BBSRC, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council [ERC](European Research Council (ERC)European Commission); John Innes Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS/The Royal Society Bilateral Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Diamond Light Source (beamline I03) for access to X-ray data collection facilities. We thank Professor David Lawson and Dr Clare Stevenson (JIC X-ray Crystallography/Biophysical Analysis Platform) for help with X-ray data collection and SPR and Andrew Davies and Phil Robinson from JIC Scientific Photography. We also thank Dr Freya Varden for constructive discussions. This work was supported by the UKRI Biotechnology and Biological Sciences Research Council (BBSRC) Norwich Research Park Biosciences Doctoral Training Partnership, UK [grantBB/M011216/1]; the UKRI BBSRC, UK [grants BB/P012574, BB/M02198X]; the European Research Council [ERC; proposal 743165] the John Innes Foundation; the JSPS [grants 15H05779, 20H05681]; and the JSPS/The Royal Society Bilateral Research for the project "Retooling rice immunity for resistance against rice blast disease" (2018-2019).	Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Cesari S, 2018, NEW PHYTOL, V219, P17, DOI 10.1111/nph.14877; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chaipanya C, 2017, RICE, V10, DOI 10.1186/s12284-017-0159-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collier SM, 2011, MOL PLANT MICROBE IN, V24, P918, DOI 10.1094/MPMI-03-11-0050; Cowan GH, 2018, PLANT PHYSIOL, V176, P2052, DOI 10.1104/pp.17.01698; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dagdas YF, 2016, ELIFE, V5, DOI 10.7554/eLife.10856; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Abreu-Neto JB, 2013, FEBS J, V280, P1604, DOI 10.1111/febs.12159; de Guillen K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005228; De la Concepcion J. C., 2020, ALLELIC RICE IMMUNE; De la Concepcion JC, 2019, ELIFE, V8, DOI 10.7554/eLife.47713; De la Concepcion JC, 2018, NAT PLANTS, V4, P576, DOI 10.1038/s41477-018-0194-x; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Guo LW, 2018, P NATL ACAD SCI USA, V115, P11637, DOI 10.1073/pnas.1810705115; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Kanzaki H, 2012, PLANT J, V72, P894, DOI 10.1111/j.1365-313X.2012.05110.x; Kato Hajime, 2000, Journal of General Plant Pathology, V66, P30, DOI 10.1007/PL00012919; Khan IU, 2019, ECOTOX ENVIRON SAFE, V175, P8, DOI 10.1016/j.ecoenv.2019.03.040; Khanthong S, 2018, CHIANG MAI J SCI, V45, P2312; Krissinel E, 2015, NUCLEIC ACIDS RES, V43, pW314, DOI 10.1093/nar/gkv314; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroj T, 2016, NEW PHYTOL, V210, P618, DOI 10.1111/nph.13869; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Longya A, 2019, MOL PLANT MICROBE IN, V32, P740, DOI 10.1094/MPMI-09-18-0245-R; Maqbool A, 2015, ELIFE, V4, DOI 10.7554/eLife.08709; Maqbool A, 2016, J BIOL CHEM, V291, P20270, DOI 10.1074/jbc.M116.744995; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oikawa K., 2020, BLAST PATHOGEN EFFEC; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Ortiz D, 2017, PLANT CELL, V29, P156, DOI 10.1105/tpc.16.00435; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Park CH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005529; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Petit-Houdenot Y, 2020, MOL PLANT MICROBE IN, V33, P1032, DOI 10.1094/MPMI-03-20-0052-A; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Radakovic ZS, 2018, MOL PLANT PATHOL, V19, P1917, DOI 10.1111/mpp.12668; Sarris PF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0228-7; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Saucet SB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7338; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tang MZ, 2017, RICE, V10, DOI 10.1186/s12284-017-0144-7; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang RY, 2016, CURR BIOL, V26, P2399, DOI 10.1016/j.cub.2016.06.072; Wang XY, 2014, RICE - GERMPLASM, GENETICS AND IMPROVEMENT, P195, DOI 10.5772/56824; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wongsaprom C, 2010, FIELD CROP RES, V119, P245, DOI 10.1016/j.fcr.2010.07.013; Wu CH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00134; Wu WH, 2014, MOL PLANT MICROBE IN, V27, P759, DOI 10.1094/MPMI-02-14-0046-R; Yoshida K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2690-6; Yoshida K, 2009, PLANT CELL, V21, P1573, DOI 10.1105/tpc.109.066324; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zhai C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098067; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x	72	15	15	4	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100371	10.1016/j.jbc.2021.100371	http://dx.doi.org/10.1016/j.jbc.2021.100371			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33548226	Green Published, Green Accepted, gold			2022-12-28	WOS:000672866400345
J	McKinzey, DR; Gomathinayagam, S; Griffin, WC; Klinzing, KN; Jeffries, EP; Rajkovic, A; Trakselis, MA				McKinzey, David R.; Gomathinayagam, Shivasankari; Griffin, Wezley C.; Klinzing, Kathleen N.; Jeffries, Elizabeth P.; Rajkovic, Aleksandar; Trakselis, Michael A.			Motifs of the C-terminal domain of MCM9 direct localization to sites of mitomycin-C damage for RAD51 recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; NUCLEOTIDE EXCISION-REPAIR; DNA MISMATCH REPAIR; CROSS-LINK REPAIR; FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; COLORECTAL-CANCER; OVARIAN FAILURE; REPLICATION; PROTEIN	The MCM8/9 complex is implicated in aiding fork progression and facilitating homologous recombination (HR) in response to several DNA damage agents. MCM9 itself is an outlier within the MCM family containing a long C-terminal extension (CTE) comprising 42% of the total length, but with no known functional components and high predicted disorder. In this report, we identify and characterize two unique motifs within the primarily unstructured CTE that are required for localization of MCM8/9 to sites of mitomycin C (MMC)-induced DNA damage. First, an unconventional "bipartite-like" nuclear localization (NLS) motif consisting of two positively charged amino acid stretches separated by a long intervening sequence is required for the nuclear import of both MCM8 and MCM9. Second, a variant of the BRC motif (BRCv) similar to that found in other HR helicases is necessary for localization to sites of MMC damage. The MCM9-BRCv directly interacts with and recruits RAD51 downstream to MMC-induced damage to aid in DNA repair. Patient lymphocytes devoid of functional MCM9 and discrete MCM9 knockout cells have a significantly impaired ability to form RAD51 foci after MMC treatment. Therefore, the disordered CTE in MCM9 is functionally important in promoting MCM8/9 activity and in recruiting downstream interactors; thus, requiring full-length MCM9 for proper DNA repair.	[McKinzey, David R.; Gomathinayagam, Shivasankari; Griffin, Wezley C.; Klinzing, Kathleen N.; Trakselis, Michael A.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA; [Jeffries, Elizabeth P.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Rajkovic, Aleksandar] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Rajkovic, Aleksandar] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Rajkovic, Aleksandar] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Baylor University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Trakselis, MA (corresponding author), Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA.	michael_trakselis@baylor.edu		Gomathinayagam, Shivasankari/0000-0003-2676-2647; Griffin, Wezley/0000-0003-2062-1253; Trakselis, Michael/0000-0001-7054-8475; Klinzing, Kathleen N/0000-0002-3220-4783; McKinzey, David/0000-0003-0845-5352; Rajkovic, Aleksandar/0000-0001-8390-0263	Baylor University; NIH [GM13791]	Baylor University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Baylor University and a NIH R15 (GM13791 to M. A. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AlAsiri S, 2015, J CLIN INVEST, V125, P258, DOI 10.1172/JCI78473; ALLEN GC, 1991, J BIOL CHEM, V266, P11610; ALTER BP, 1991, BRIT J HAEMATOL, V77, P410, DOI 10.1111/j.1365-2141.1991.tb08593.x; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bhat KP, 2018, NAT STRUCT MOL BIOL, V25, P446, DOI 10.1038/s41594-018-0075-z; BIZANEK R, 1992, BIOCHEMISTRY-US, V31, P3084, DOI 10.1021/bi00127a008; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Chemes Lucia B, 2012, Methods Mol Biol, V895, P387, DOI 10.1007/978-1-61779-927-3_22; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Crickard JB, 2018, CELL CYCLE, V17, P2520, DOI 10.1080/15384101.2018.1553355; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Desai S, 2017, J CLIN ENDOCR METAB, V102, P576, DOI 10.1210/jc.2016-2565; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; EASTMAN A, 1986, BIOCHEMISTRY-US, V25, P3912, DOI 10.1021/bi00361a026; Fink D, 1996, CANCER RES, V56, P4881; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Furuta T, 2002, CANCER RES, V62, P4899; Gambus A, 2013, CELL CYCLE, V12, P1225, DOI 10.4161/cc.24310; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; GIAMPIETRO PF, 1993, PEDIATRICS, V91, P1116; Goldberg Y, 2015, CANCER GENET-NY, V208, P621, DOI 10.1016/j.cancergen.2015.10.001; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Griffin WC, 2019, DNA REPAIR, V76, P1, DOI 10.1016/j.dnarep.2019.02.003; Hartford SA, 2011, P NATL ACAD SCI USA, V108, P17702, DOI 10.1073/pnas.1113524108; He DM, 2017, ONCOGENE, V36, P3629, DOI 10.1038/onc.2017.123; HUANG HF, 1995, SCIENCE, V270, P1842, DOI 10.1126/science.270.5243.1842; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Huselid E, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050498; Hustedt N, 2019, GENE DEV, V33, P1397, DOI 10.1101/gad.329508.119; Iakoucheva LM, 2001, PROTEIN SCI, V10, P560, DOI 10.1110/ps.29401; Islam MN, 2012, J BIOL CHEM, V287, P23808, DOI 10.1074/jbc.M112.375014; Jeffries EP, 2013, GENE, V519, P41, DOI 10.1016/j.gene.2013.01.054; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kato N, 2017, CELL REP, V21, P1375, DOI 10.1016/j.celrep.2017.10.032; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Kim KH, 2002, MOL GENET GENOMICS, V268, P287, DOI 10.1007/s00438-002-0758-2; Kim Y, 2019, NUCLEIC ACIDS RES, V47, P1823, DOI 10.1093/nar/gky1244; Kirby TW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13405; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Laptenko O, 2016, TRENDS BIOCHEM SCI, V41, P1022, DOI 10.1016/j.tibs.2016.08.011; Lee K. Y., 2015, NAT COMMUN, V6; Lee YJ, 2006, CARCINOGENESIS, V27, P446, DOI 10.1093/carcin/bgi254; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-60; Lutzmann M, 2012, MOL CELL, V47, P523, DOI 10.1016/j.molcel.2012.05.048; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Moore SP, 1998, MOL CELL BIOL, V18, P1105, DOI 10.1128/MCB.18.2.1105; Morii I, 2019, CANCER SCI, V110, P1044, DOI 10.1111/cas.13941; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Natsume T, 2017, GENE DEV, V31, P816, DOI 10.1101/gad.297663.117; Nishimura K, 2012, MOL CELL, V47, P511, DOI 10.1016/j.molcel.2012.05.047; Park J, 2013, MOL CELL BIOL, V33, P1632, DOI 10.1128/MCB.01503-12; Parker MW, 2019, ELIFE, V8, DOI 10.7554/eLife.48562; Pichierri P, 2002, HUM MOL GENET, V11, P2531, DOI 10.1093/hmg/11.21.2531; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pryor JM, 2014, NUCLEIC ACIDS MOL BI, V30, P85, DOI 10.1007/978-3-642-39796-7_4; Quinet A, 2017, MOL CELL, V68, P830, DOI 10.1016/j.molcel.2017.11.022; Rasband W.S., 1997, IMAGEJ; Rickman K, 2019, J CELL BIOL, V218, P1096, DOI 10.1083/jcb.201809012; Rink SM, 1996, CHEM RES TOXICOL, V9, P382, DOI 10.1021/tx950156q; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Shivji MKK, 2009, P NATL ACAD SCI USA, V106, P13254, DOI 10.1073/pnas.0906208106; Spies M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a022657; Sung CO, 2011, BLOOD, V117, P1291, DOI 10.1182/blood-2010-07-297861; TENG SP, 1989, BIOCHEMISTRY-US, V28, P3901, DOI 10.1021/bi00435a041; Tham KC, 2016, DNA REPAIR, V38, P75, DOI 10.1016/j.dnarep.2015.11.010; Traver S, 2015, MOL CELL, V59, P831, DOI 10.1016/j.molcel.2015.07.010; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Welsh C, 2004, INT J CANCER, V110, P352, DOI 10.1002/ijc.20134; Wood-Trageser MA, 2014, AM J HUM GENET, V95, P754, DOI 10.1016/j.ajhg.2014.11.002; Wright WD, 2018, J BIOL CHEM, V293, P10524, DOI 10.1074/jbc.TM118.000372; Xiao Z, 2003, ONCOGENE, V22, P1057, DOI 10.1038/sj.onc.1206212; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Zhao JH, 2009, NUCLEIC ACIDS RES, V37, P4420, DOI 10.1093/nar/gkp399; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	84	5	5	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100355	10.1016/j.jbc.2021.100355	http://dx.doi.org/10.1016/j.jbc.2021.100355			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539926	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400329
J	Mischler, A; Karakis, V; Mahinthakumar, J; Carberry, CK; San Miguel, A; Rager, JE; Fry, RC; Rao, BM				Mischler, Adam; Karakis, Victoria; Mahinthakumar, Jessica; Carberry, Celeste K.; San Miguel, Adriana; Rager, Julia E.; Fry, Rebecca C.; Rao, Balaji M.			Two distinct trophectoderm lineage stem cells from human pluripotent stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO-YAP PATHWAY; TROPHOBLAST DIFFERENTIATION; GENE-EXPRESSION; TEAD4; SPHINGOSINE-1-PHOSPHATE; INHIBITION; FATE; ICM; TE	The trophectoderm layer of the blastocyst-stage embryo is the precursor for all trophoblast cells in the placenta. Human trophoblast stem (TS) cells have emerged as an attractive tool for studies on early trophoblast development. However, the use of TS cell models is constrained by the limited genetic diversity of existing TS cell lines and restrictions on using human fetal tissue or embryos needed to generate additional lines. Here we report the derivation of two distinct stem cell types of the trophectoderm lineage from human pluripotent stem cells. Analogous to villous cytotrophoblasts in vivo, the first is a CDX2(-) stem cell comparable with placenta-derived TS cells-they both exhibit identical expression of key markers, are maintained in culture and differentiate under similar conditions, and share high transcriptome similarity. The second is a CDX2(+) stem cell with distinct cell culture requirements, and differences in gene expression and differentiation, relative to CDX2(-) stem cells. Derivation of TS cells from pluripotent stem cells will significantly enable construction of in vitro models for normal and pathological placental development.	[Mischler, Adam; Karakis, Victoria; Mahinthakumar, Jessica; San Miguel, Adriana; Rao, Balaji M.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Carberry, Celeste K.; Rager, Julia E.; Fry, Rebecca C.] Univ N Carolina, Inst Environm Hlth Solut, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA; [Rao, Balaji M.] North Carolina State Univ, Golden LEAF Biomfg Training & Educ Ctr BTEC, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Rao, BM (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.; Rao, BM (corresponding author), North Carolina State Univ, Golden LEAF Biomfg Training & Educ Ctr BTEC, Raleigh, NC 27695 USA.	bmrao@ncsu.edu	San Miguel, Adriana/C-3937-2017	San Miguel, Adriana/0000-0003-0172-2163	NIH [HD092741, HD093982]; NSF [CBET 1706118]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work was supported by NIH grants HD092741, HD093982 and NSF grant CBET 1706118. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benirschke K, 2012, PATHOLOGY HUMAN PLAC; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Chi FT, 2020, DEV CELL, V53, P9, DOI 10.1016/j.devcel.2020.02.015; Choi Inchul, 2012, Development, V139, P4623, DOI 10.1242/dev.086645; Cinkornpumin JK, 2020, STEM CELL REP, V15, P198, DOI 10.1016/j.stemcr.2020.06.003; Cornacchia D, 2019, CELL STEM CELL, V25, P120, DOI 10.1016/j.stem.2019.05.001; Dong C, 2020, ELIFE, V9, DOI 10.7554/eLife.52504; Du Toit A, 2019, NAT REV MICROBIOL, V17, P462, DOI 10.1038/s41579-019-0228-z; Gao XF, 2019, NAT CELL BIOL, V21, P687, DOI 10.1038/s41556-019-0333-2; Guo G., 2020, TROPHECTODERM POTENC, DOI [10.1101/2020.02.04.933812, DOI 10.1101/2020.02.04.933812]; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Horii M, 2016, P NATL ACAD SCI USA, V113, pE3882, DOI 10.1073/pnas.1604747113; Hsiao C, 2016, BIOTECHNOL J, V11, P662, DOI 10.1002/biot.201500374; Johnstone ED, 2005, J LIPID RES, V46, P1833, DOI 10.1194/jlr.M500095-JLR200; Klaren WD, 2019, TOXICOL SCI, V167, P157, DOI 10.1093/toxsci/kfy220; Knofler M, 2019, CELL MOL LIFE SCI, V76, P3479, DOI 10.1007/s00018-019-03104-6; Knott JG, 2014, REPRODUCTION, V148, pR121, DOI 10.1530/REP-14-0072; Kono K, 2014, DEV BIOL, V394, P142, DOI 10.1016/j.ydbio.2014.06.023; Li Z, 2018, BIOCHEM BIOPH RES CO, V505, P671, DOI 10.1016/j.bbrc.2018.09.181; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Meinhardt G, 2020, P NATL ACAD SCI USA, V117, P13562, DOI 10.1073/pnas.2002630117; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Moser G, 2011, PLACENTA, V32, P197, DOI 10.1016/j.placenta.2010.11.008; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ohgushi M, 2015, CELL STEM CELL, V17, P448, DOI 10.1016/j.stem.2015.07.009; Okae H, 2018, CELL STEM CELL, V22, P50, DOI 10.1016/j.stem.2017.11.004; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.08.009, 10.1016/j.cell.2016.03.023]; Rager JE, 2019, TOXICOL LETT, V305, P40, DOI 10.1016/j.toxlet.2019.01.011; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Roberts RM, 2018, BIOL REPROD, V99, P212, DOI 10.1093/biolre/ioy070; Roberts RM, 2014, REPRODUCTION, V147, pD1, DOI 10.1530/REP-14-0080; Saha B, 2020, P NATL ACAD SCI USA, V117, P17864, DOI 10.1073/pnas.2002449117; Sarkar P, 2016, J PROTEOME RES, V15, P2433, DOI 10.1021/acs.jproteome.5b01118; Sarkar P, 2015, J BIOL CHEM, V290, P8834, DOI 10.1074/jbc.M114.620641; Shahbazi MN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17764-7; Sheridan MA, 2019, P NATL ACAD SCI USA, V116, P4336, DOI 10.1073/pnas.1816150116; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Yabe S, 2016, P NATL ACAD SCI USA, V113, pE2598, DOI 10.1073/pnas.1601630113; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037	50	18	18	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100386	10.1016/j.jbc.2021.100386	http://dx.doi.org/10.1016/j.jbc.2021.100386			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556374	Green Submitted, gold, Green Published			2022-12-28	WOS:000672866400360
J	Munier, CC; De Maria, L; Edman, K; Gunnarsson, A; Longo, M; MacKintosh, C; Patel, S; Snijder, A; Wissler, L; Brunsveld, L; Ottmann, C; Perry, MWD				Munier, Claire C.; De Maria, Leonardo; Edman, Karl; Gunnarsson, Anders; Longo, Marianna; MacKintosh, Carol; Patel, Saleha; Snijder, Arjan; Wissler, Lisa; Brunsveld, Luc; Ottmann, Christian; Perry, Matthew W. D.			Glucocorticoid receptor Thr524 phosphorylation by MINK1 induces interactions with 14-3-3 protein regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE STABILIZATION; CRYSTAL-STRUCTURE; LIGAND-BINDING; DOMAIN; DIMERIZATION; INHIBITION; PLASTICITY; MECHANISM; REVEALS; INSULIN	The glucocorticoid receptor (GR) is a ligand-dependent transcription factor that plays a central role in inflammation. The GR activity is also modulated via protein-protein interactions, including binding of 14-3-3 proteins induced by GR phosphorylation. However, the specific phosphorylation sites on the GR that trigger these interactions and their functional consequences are less clear. Hence, we sought to examine this system in more detail. We used phosphorylated GR peptides, biophysical studies, and X-ray crystallography to identify key residues within the ligand-binding domain of the GR, T524 and S617, whose phosphorylation results in binding of the representative 14-3-3 protein 14-3-3 zeta. A kinase screen identified misshapen-like kinase 1 (MINK1) as responsible for phosphorylating T524 and Rho-associated protein kinase 1 for phosphorylating S617; cell-based approaches confirmed the importance of both GR phosphosites and MINK1 but not Rhoassociated protein kinase 1 alone in inducing GR-14-3-3 binding. Together our results provide molecular-level insight into 14-3-3-mediated regulation of the GR and highlight both MINK1 and the GR-14-3-3 axis as potential targets for future therapeutic intervention.	[Munier, Claire C.; De Maria, Leonardo; Perry, Matthew W. D.] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Res & Early Dev, Gothenburg, Sweden; [Munier, Claire C.; Brunsveld, Luc; Ottmann, Christian] Tech Univ Eindhoven, Lab Chem Biol, Dept Biomed Engn, Eindhoven, Netherlands; [Munier, Claire C.; Brunsveld, Luc; Ottmann, Christian] Tech Univ Eindhoven, Inst Complex Mol Syst, Eindhoven, Netherlands; [Edman, Karl; Gunnarsson, Anders; Snijder, Arjan; Wissler, Lisa] AstraZeneca, BioPharmaceut R&D, Discovery Sci, Gothenburg, Sweden; [Longo, Marianna; MacKintosh, Carol] Univ Dundee, Coll Life Sci, Div Cell & Dev Biol CM, Dundee, Scotland; [Patel, Saleha] AstraZeneca, R&D, Discovery Sci, Discovery Biol, Cambridge, England	AstraZeneca; Eindhoven University of Technology; Eindhoven University of Technology; AstraZeneca; University of Dundee; AstraZeneca	Perry, MWD (corresponding author), AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Res & Early Dev, Gothenburg, Sweden.	Matthew.Perry@astrazeneca.com	; MacKintosh, Carol/B-8210-2011	Snijder, Arjan/0000-0003-2829-3098; Brunsveld, Luc/0000-0001-5675-511X; Wissler, Lisa/0000-0002-8152-8522; Edman, Karl/0000-0002-2560-2388; Perry, Matthew/0000-0002-9799-0746; Munier, Claire/0000-0002-8517-8398; MacKintosh, Carol/0000-0001-9166-589X	H2020 Marie Curie Actions of the European Commission [675179]	H2020 Marie Curie Actions of the European Commission	This work was supported by the Initial Training Network TASPPI, funded by the H2020 Marie Curie Actions of the European Commission under Grant Agreement 675179.	Aghazadeh Y, 2016, DRUG DISCOV TODAY, V21, P278, DOI 10.1016/j.drudis.2015.09.012; Bartel M, 2014, FUTURE MED CHEM, V6, P903, DOI [10.4155/FMC.14.47, 10.4155/fmc.14.47]; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Bier D, 2016, CHEMMEDCHEM, V11, P911, DOI 10.1002/cmdc.201500484; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Deroo BJ, 2002, MOL CELL BIOL, V22, P4113, DOI 10.1128/MCB.22.12.4113-4123.2002; Edman K, 2015, STRUCTURE, V23, P2280, DOI 10.1016/j.str.2015.09.012; Galliher-Beckley AJ, 2011, MOL CELL BIOL, V31, P4663, DOI 10.1128/MCB.05866-11; Habib T, 2017, MOL CELL ENDOCRINOL, V439, P431, DOI 10.1016/j.mce.2016.10.002; Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x; Hwang Y, 2018, BIOCHEM BIOPH RES CO, V501, P800, DOI 10.1016/j.bbrc.2018.05.077; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kim DK, 2014, DIABETOLOGIA, V57, P2576, DOI 10.1007/s00125-014-3366-x; Kim SW, 2017, CELL SIGNAL, V31, P124, DOI 10.1016/j.cellsig.2017.01.001; Kim YS, 2005, ENDOCRINOLOGY, V146, P3133, DOI 10.1210/en.2004-1455; Kino T, 2003, J BIOL CHEM, V278, P25651, DOI 10.1074/jbc.M302818200; Kino T, 2018, TRENDS ENDOCRIN MET, V29, P260, DOI 10.1016/j.tem.2018.01.010; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Kuna P, 2017, BASIC CLIN PHARMACOL, V121, P279, DOI 10.1111/bcpt.12768; De Vries-van Leeuwen IJ, 2013, P NATL ACAD SCI USA, V110, P8894, DOI 10.1073/pnas.1220809110; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Madeira F, 2015, BIOINFORMATICS, V31, P2276, DOI 10.1093/bioinformatics/btv133; Molzan M, 2012, J MOL BIOL, V423, P486, DOI 10.1016/j.jmb.2012.08.009; Nixon M, 2013, STEROIDS, V78, P59, DOI 10.1016/j.steroids.2012.09.013; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Pennington KL, 2018, ONCOGENE, V37, P5587, DOI 10.1038/s41388-018-0348-3; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Petta Ioanna, 2016, Microbiol Mol Biol Rev, V80, P495, DOI 10.1128/MMBR.00064-15; Pippal JB, 2009, MOL ENDOCRINOL, V23, P1360, DOI 10.1210/me.2009-0032; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Scheschowitsch K, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00016; Sluchanko NN, 2019, PROG MOL BIOL TRANSL, V166, P19, DOI 10.1016/bs.pmbts.2019.03.007; Souffriau J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31150-w; Stevers LM, 2018, J AM CHEM SOC, V140, P14498, DOI 10.1021/jacs.8b09618; Stevers LM, 2016, P NATL ACAD SCI USA, V113, pE1152, DOI 10.1073/pnas.1516631113; Vandevyver S, 2014, ENDOCR REV, V35, P671, DOI 10.1210/er.2014-1010; Wakui H, 1997, J BIOL CHEM, V272, P8153, DOI 10.1074/jbc.272.13.8153; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Widen C, 2000, J BIOL CHEM, V275, P39296, DOI 10.1074/jbc.M006943200; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200	44	6	6	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100551	10.1016/j.jbc.2021.100551	http://dx.doi.org/10.1016/j.jbc.2021.100551			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744286	gold, Green Published			2022-12-28	WOS:000672866400524
J	Sorimachi, Y; Karigane, D; Ootomo, Y; Kobayashi, H; Morikawa, T; Otsu, K; Kubota, Y; Okamoto, S; Goda, N; Takubo, K				Sorimachi, Yuriko; Karigane, Daiki; Ootomo, Yukako; Kobayashi, Hiroshi; Morikawa, Takayuki; Otsu, Kinya; Kubota, Yoshiaki; Okamoto, Shinichiro; Goda, Nobuhito; Takubo, Keiyo			p38 alpha plays differential roles in hematopoietic stem cell activity dependent on aging contexts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; PROTEIN-KINASE; P38 MAPK; RECOMBINATION; QUIESCENCE; SENESCENCE	Hematopoietic stem cells (HSCs) and their progeny sustain lifetime hematopoiesis. Aging alters HSC function, number, and composition and increases risk of hematological malignancies, but how these changes occur in HSCs remains unclear. Signaling via p38 mitogen-activated kinase (p38MAPK) has been proposed as a candidate mechanism underlying induction of HSC aging. Here, using genetic models of both chronological and premature aging, we describe a multimodal role for p38 alpha, the major p38MAPK isozyme in hematopoiesis, in HSC aging. We report that p38 alpha regulates differentiation bias and sustains transplantation capacity of HSCs in the early phase of chronological aging. However, p38 alpha decreased HSC transplantation capacity in the late progression phase of chronological aging. Furthermore, codeletion of p38 alpha in mice deficient in ataxia-telangiectasia mutated, a model of premature aging, exacerbated aging-related HSC phenotypes seen in ataxia-telangiectasia mutated single-mutant mice. Overall, these studies provide new insight into multiple functions of p38MAPK, which both promotes and suppresses HSC aging context dependently.	[Sorimachi, Yuriko; Karigane, Daiki; Ootomo, Yukako; Kobayashi, Hiroshi; Morikawa, Takayuki; Takubo, Keiyo] Natl Ctr Global Hlth & Med, Res Inst, Dept Stem Cell Biol, Tokyo, Japan; [Sorimachi, Yuriko; Ootomo, Yukako; Goda, Nobuhito] Waseda Univ, Dept Life Sci & Med BioSci, Sch Adv Sci & Engn, Tokyo, Japan; [Karigane, Daiki; Okamoto, Shinichiro] Keio Univ, Dept Med, Div Hematol, Sch Med, Tokyo, Japan; [Otsu, Kinya] Kings Coll London, Sch Cardiovasc Med & Sci, London, England; [Kubota, Yoshiaki] Keio Univ, Dept Anat, Sch Med, Tokyo, Japan; [Karigane, Daiki] Stanford Canc Inst, Stanford, CA 94305 USA	National Center for Global Health & Medicine - Japan; Waseda University; Keio University; University of London; King's College London; Keio University; Stanford Cancer Institute	Karigane, D; Takubo, K (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Stem Cell Biol, Tokyo, Japan.; Karigane, D (corresponding author), Keio Univ, Dept Med, Div Hematol, Sch Med, Tokyo, Japan.; Karigane, D (corresponding author), Stanford Canc Inst, Stanford, CA 94305 USA.	karigane@keio.jp; ktakubo@ri.ncgm.go.jp		Takubo, Keiyo/0000-0002-1736-7592; Karigane, Daiki/0000-0002-4017-5193	KAKENHI grant from Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) [19K17877]; Takeda Science Foundation; KAKENHI grant from MEXT/JSPS [19K17847]; National Center for Global Health and Medicine [26-001, 19A2002]; KAKENHI grants from MEXT/JSPS [18H02845, 18K19570, 20K21621]; Japan Health Research Promotion Bureau, Japan Agency for Medical Research and Development [JP18ck0106444, JP18ae0201014, JP20bm0704042, JP20gm1210011]; Ono Medical Research Foundation; Kanzawa Medical Research Foundation; National Center for Global Health and Medicine	KAKENHI grant from Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS); Takeda Science Foundation(Takeda Science Foundation (TSF)); KAKENHI grant from MEXT/JSPS; National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); KAKENHI grants from MEXT/JSPS; Japan Health Research Promotion Bureau, Japan Agency for Medical Research and Development; Ono Medical Research Foundation; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	D. K. was supported in part by a KAKENHI grant from Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) (19K17877), JB research grants, and the Takeda Science Foundation. H. K. was supported in part by a KAKENHI grant from MEXT/JSPS (19K17847) and a grant from the National Center for Global Health and Medicine. K. T. was supported in part by KAKENHI grants from MEXT/JSPS (18H02845, 18K19570, and 20K21621), grants from the National Center for Global Health and Medicine (26-001 and 19A2002), a grant from Japan Health Research Promotion Bureau, Japan Agency for Medical Research and Development grants (JP18ck0106444, JP18ae0201014, JP20bm0704042, and JP20gm1210011), and grants from the Ono Medical Research Foundation, the Kanzawa Medical Research Foundation, and the Takeda Science Foundation.	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Baudet A, 2012, BLOOD, V119, P6255, DOI 10.1182/blood-2012-01-403949; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen ZY, 2019, J EXP MED, V216, P152, DOI 10.1084/jem.20181505; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; de Haan G, 2018, BLOOD, V131, P479, DOI 10.1182/blood-2017-06-746412; Dzierzak E, 2018, CELL STEM CELL, V22, P639, DOI 10.1016/j.stem.2018.04.015; Florian MC, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003389; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Gutierrez-Martinez P, 2018, NAT CELL BIOL, V20, P413, DOI 10.1038/s41556-018-0054-y; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Ho YH, 2019, CELL STEM CELL, V25, P407, DOI 10.1016/j.stem.2019.06.007; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Ju ZY, 2011, INT J HEMATOL, V94, P33, DOI 10.1007/s12185-011-0882-z; Jung H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13674; Karigane D, 2016, CELL STEM CELL, V19, P192, DOI 10.1016/j.stem.2016.05.013; Kobayashi H, 2019, CELL REP, V28, P145, DOI 10.1016/j.celrep.2019.06.008; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Lee J., 2019, INT J MOL SCI, V20; Li TL, 2016, GENOM PROTEOM BIOINF, V14, P147, DOI 10.1016/j.gpb.2016.04.002; Maryanovich M, 2018, NAT MED, V24, P782, DOI 10.1038/s41591-018-0030-x; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Nitta E, 2011, BLOOD, V117, P4169, DOI 10.1182/blood-2010-08-297390; Pietras EM, 2017, BLOOD, V130, P1693, DOI 10.1182/blood-2017-06-780882; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Shao LJ, 2011, INT J HEMATOL, V94, P24, DOI 10.1007/s12185-011-0872-1; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wahlestedt M, 2013, BLOOD, V121, P4257, DOI 10.1182/blood-2012-11-469080; Wang Y, 2011, RADIAT RES, V176, P743, DOI 10.1667/RR2727.1; Yamashita M, 2021, HAEMATOLOGICA, V106, P320, DOI 10.3324/haematol.2020.272898; Zha S, 2011, P NATL ACAD SCI USA, V108, P2028, DOI 10.1073/pnas.1019293108	39	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100563	10.1016/j.jbc.2021.100563	http://dx.doi.org/10.1016/j.jbc.2021.100563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33745970	gold, Green Published			2022-12-28	WOS:000672866400536
J	Tsujimura, M; Ishikita, H				Tsujimura, Masaki; Ishikita, Hiroshi			Identification of intermediate conformations in the photocycle of the light-driven sodium-pumping rhodopsin KR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-RESIDUES; IMIDAZOLE RING; ACID-BASE; DYNAMICS; MICROENVIRONMENTS; TAUTOMERISM; ENERGETICS; MECHANISM; H-1-NMR; ION	The light-driven rhodopsin KR2 transports Na+ via the M- and O-states. However, the mechanisms by which the retinal regulates Na+ pumping is unknown, in part because KR2 adopts both pentamer and monomer forms in crystal structures and in part because these structures show differences in the protein conformation near the Schiff base, even when they are of the same intermediate state within the photocycle. A particular open question is the nature of the H-bond networks and protonation state in the active site, including Asp116. Here, we analyze the protonation state and the absorption wavelength for each crystal structure, using a quantum mechanical/molecular mechanical approach. In the pentamer ground state, the calculated absorption wavelength reproduces the experimentally measured absorption wavelength (530 nm). The analysis also shows that ionized Asp116 is stabilized by the H-bond donations of both Ser70 and a cluster of water molecules. The absorption wavelength of 400 nm in the M-state can be best reproduced when the two O atoms of Asp116 interact strongly with the Schiff base, as reported in one of the previous monomer ground state structures. The absorption wavelengths calculated for the two Na+-incorporated O-state structures are consistent with the measured absorption wavelength (similar to 600 nm), which suggests that two conformations represent the O-state. These results may provide a key to designing enhanced tools in optogenetics.	[Tsujimura, Masaki; Ishikita, Hiroshi] Univ Tokyo, Dept Appl Chem, Bunkyo Ku, Tokyo, Japan; [Ishikita, Hiroshi] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Tsujimura, M; Ishikita, H (corresponding author), Univ Tokyo, Dept Appl Chem, Bunkyo Ku, Tokyo, Japan.; Ishikita, H (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan.	mtsujimura@protein.rcast.u-tokyo.ac.jp; hiro@appchem.t.u-tokyo.ac.jp	Tsujimura, Masaki/HIR-1900-2022; Ishikita, Hiroshi/G-9864-2018	Tsujimura, Masaki/0000-0002-7554-7372; Ishikita, Hiroshi/0000-0002-5849-8150	JST CREST [JPMJCR1656]; JSPS KAKENHI [JP18H05155, JP18H01937, JP20H03217, JP20H05090]; Interdisciplinary Computational Science Program in CCS, University of Tsukuba	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Interdisciplinary Computational Science Program in CCS, University of Tsukuba	This research was supported by JST CREST (JPMJCR1656 to H. I.), JSPS KAKENHI (JP18H05155, JP18H01937, JP20H03217, and JP20H05090 to H. I.), and the Interdisciplinary Computational Science Program in CCS, University of Tsukuba.	BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cieplak P, 2001, J COMPUT CHEM, V22, P1048, DOI 10.1002/jcc.1065; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Fujimoto KJ, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0013642; Gushchin I, 2016, FEBS J, V283, P1232, DOI 10.1111/febs.13585; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; Inoue K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10000-x; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kandori H, 2018, CHEM REV, V118, P10646, DOI 10.1021/acs.chemrev.7b00548; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kawashima K, 2018, BIOCHEMISTRY-US, V57, P4997, DOI 10.1021/acs.biochem.8b00574; Kovalev K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16032-y; Kovalev K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav2671; Kurihara M, 2015, BIOPHYS PHYSICOBIOL, V12, P121, DOI 10.2142/biophysico.12.0_121; LOZIER RH, 1975, BIOPHYS J, V15, P955, DOI 10.1016/S0006-3495(75)85875-9; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Miyahara T, 2019, J PHYS CHEM A, V123, P1766, DOI 10.1021/acs.jpca.8b10203; Nishimura N, 2019, J PHYS CHEM B, V123, P3430, DOI 10.1021/acs.jpcb.9b00928; NOZAKI Y, 1967, J AM CHEM SOC, V89, P736, DOI 10.1021/ja00980a002; Rabenstein B, 2001, BIOPHYS J, V80, P1141, DOI 10.1016/S0006-3495(01)76091-2; Saito K, 2020, BIOCHEMISTRY-US, V59, P3216, DOI 10.1021/acs.biochem.0c00177; Saito K, 2014, BBA-BIOENERGETICS, V1837, P159, DOI 10.1016/j.bbabio.2013.09.013; Saito K, 2011, BIOCHEMISTRY-US, V50, P9836, DOI 10.1021/bi201366j; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Shibata M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26606-y; Skopintsev P, 2020, NATURE, V583, P314, DOI 10.1038/s41586-020-2307-8; Suomivuori CM, 2017, P NATL ACAD SCI USA, V114, P7043, DOI 10.1073/pnas.1703625114; Tamura H, 2020, P NATL ACAD SCI USA, V117, P16373, DOI 10.1073/pnas.2000895117; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P586, DOI 10.1016/0167-4838(83)90277-7; TANOKURA M, 1983, J BIOCHEM-TOKYO, V94, P51, DOI 10.1093/oxfordjournals.jbchem.a134353; Tomida S, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2020.148190; Tsujimura M, 2021, BBA-BIOENERGETICS, V1862, DOI 10.1016/j.bbabio.2020.148349; Tsujimura M, 2020, J PHYS CHEM B, V124, P11819, DOI 10.1021/acs.jpcb.0c08910; Vogt A, 2019, BIOPHYS J, V116, P1941, DOI 10.1016/j.bpj.2019.04.001	39	5	6	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100459	10.1016/j.jbc.2021.100459	http://dx.doi.org/10.1016/j.jbc.2021.100459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639164	gold, Green Published			2022-12-28	WOS:000672866400433
J	Wang, CK; Craik, DJ				Wang, Conan K.; Craik, David J.			Linking molecular evolution to molecular grafting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYSTINE-KNOT; DIFFERENTIAL SENSITIVITY; ACYCLIC PERMUTANTS; PROTEIN EVOLUTION; PEPTIDE; CYCLOTIDES; SCAFFOLD; SPECIFICITY; PRINCIPLES; DIVERSITY	Molecular grafting is a strategy for the engineering of molecular scaffolds into new functional agents, such as next-generation therapeutics. Despite its wide use, studies so far have focused almost exclusively on demonstrating its utility rather than understanding the factors that lead to either poor or successful grafting outcomes. Here, we examine protein evolution and identify parallels between the natural process of protein functional diversification and the artificial process of molecular grafting. We discuss features of natural proteins that are correlated to innovability-the capacity to acquire newfunctions-and describe their implications to molecular grafting scaffolds. Disulfide-rich peptides are used as exemplars because they are particularly promising scaffolds onto which new functions can be grafted. This article provides a perspective on why some scaffolds are more suitable for grafting than others, identifying opportunities on how molecular grafting might be improved.	[Wang, Conan K.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; Univ Queensland, Australian Res Council, Ctr Excellence Innovat Peptide & Prot Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Wang, CK (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	c.wang@imb.uq.edu.au	Craik, David/B-1695-2010; Wang, Conan/D-1481-2010	Craik, David/0000-0003-0007-6796; Wang, Conan/0000-0002-7973-7632	Australian Research Council (ARC) [FL150100146]; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science [CE200100012]	Australian Research Council (ARC)(Australian Research Council); Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science(Australian Research Council)	D. J. C. is an Australian Research Council (ARC) Australian Laureate (FL150100146). Our work on peptide grafting is supported by access to the facilities of the Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science (CE200100012).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Atkinson JT, 2019, PROTEIN ENG DES SEL, V32, P489, DOI 10.1093/protein/gzaa012; Bagowski CP, 2010, CURR GENOMICS, V11, P368, DOI 10.2174/138920210791616725; Bastolla U, 2017, CURR OPIN STRUC BIOL, V42, P59, DOI 10.1016/j.sbi.2016.10.020; Bhardwaj G, 2016, NATURE, V538, P329, DOI 10.1038/nature19791; Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Buchholz PCF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200815; Campbell E, 2016, NAT CHEM BIOL, V12, P944, DOI [10.1038/NCHEMBIO.2175, 10.1038/nchembio.2175]; Campitelli P, 2020, ANNU REV BIOPHYS, V49, P267, DOI 10.1146/annurev-biophys-052118-115517; Chassagnon IR, 2017, P NATL ACAD SCI USA, V114, P3750, DOI 10.1073/pnas.1614728114; Chiu ML, 2019, ANTIBODIES, V8, DOI 10.3390/antib8040055; Choi SS, 2013, J MOL EVOL, V76, P98, DOI 10.1007/s00239-013-9543-6; Correnti CE, 2018, NAT STRUCT MOL BIOL, V25, P270, DOI 10.1038/s41594-018-0033-9; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Crean RM, 2020, J AM CHEM SOC, V142, P11324, DOI 10.1021/jacs.0c04924; Crook ZR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02098-8; Daly NL, 2000, J BIOL CHEM, V275, P19068, DOI 10.1074/jbc.M000450200; Dawson WM, 2019, CURR OPIN CHEM BIOL, V52, P102, DOI 10.1016/j.cbpa.2019.06.011; de Veer SJ, 2019, CHEM REV, V119, P12375, DOI 10.1021/acs.chemrev.9b00402; Dellus-Gur E, 2013, J MOL BIOL, V425, P2609, DOI 10.1016/j.jmb.2013.03.033; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Echave J, 2017, ANNU REV BIOPHYS, V46, P85, DOI 10.1146/annurev-biophys-070816-033819; Echave J, 2016, NAT REV GENET, V17, P109, DOI 10.1038/nrg.2015.18; England JL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.218101; Forslund SK, 2019, METHODS MOL BIOL, V1910, P469, DOI 10.1007/978-1-4939-9074-0_15; Gebauer M, 2020, ANNU REV PHARMACOL, V60, P391, DOI 10.1146/annurev-pharmtox-010818-021118; Getz JA, 2011, ACS CHEM BIOL, V6, P837, DOI 10.1021/cb200039s; Gilbreth RN, 2012, CURR OPIN STRUC BIOL, V22, P413, DOI 10.1016/j.sbi.2012.06.001; Gould A, 2017, CHEMBIOCHEM, V18, P1350, DOI 10.1002/cbic.201700153; Grishin AA, 2010, J BIOL CHEM, V285, P22254, DOI 10.1074/jbc.M110.111880; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Grundemann C, 2019, INT J PEPT RES THER, V25, P9, DOI 10.1007/s10989-018-9701-1; Gumulya Y, 2017, BIOCHEM J, V474, P1, DOI 10.1042/BCJ20160507; Huang YH, 2019, TOXICON, V172, P33, DOI 10.1016/j.toxicon.2019.10.244; Jin AH, 2019, CHEM REV, V119, P11510, DOI 10.1021/acs.chemrev.9b00207; Kelil A, 2016, P NATL ACAD SCI USA, V113, pE3862, DOI 10.1073/pnas.1518469113; Kim JW, 2020, P NATL ACAD SCI USA, V117, P14110, DOI 10.1073/pnas.1922729117; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kimura RH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11863-w; Kintzing JR, 2016, CURR OPIN CHEM BIOL, V34, P143, DOI 10.1016/j.cbpa.2016.08.022; Kolodny R, 2013, ANNU REV BIOPHYS, V42, P559, DOI 10.1146/annurev-biophys-083012-130432; Korendovych IV, 2020, Q REV BIOPHYS, V53, DOI 10.1017/S0033583519000131; Li H, 1996, SCIENCE, V273, P666, DOI 10.1126/science.273.5275.666; Lui BG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13948-y; Mahatmanto T, 2015, MOL BIOL EVOL, V32, P392, DOI 10.1093/molbev/msu307; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Molesini B, 2017, BRIT J CLIN PHARMACO, V83, P63, DOI 10.1111/bcp.12932; Morris E.R., 2012, CURR PROTOC PROTEIN, P1; Nguyen GKT, 2014, NAT CHEM BIOL, V10, P732, DOI [10.1038/NCHEMBIO.1586, 10.1038/nchembio.1586]; Ohno S., 1970, P1; Pabis A, 2018, CURR OPIN STRUC BIOL, V48, P83, DOI 10.1016/j.sbi.2017.10.020; Park S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02058; Patil CG, 2019, NEUROSURGERY, V85, pE641, DOI 10.1093/neuros/nyz125; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Pineda SS, 2020, P NATL ACAD SCI USA, V117, P11399, DOI 10.1073/pnas.1914536117; Porebski BT, 2016, PROTEIN ENG DES SEL, V29, P245, DOI 10.1093/protein/gzw015; Postic G, 2018, NUCLEIC ACIDS RES, V46, pD454, DOI 10.1093/nar/gkx1084; REES DC, 1980, P NATL ACAD SCI-BIOL, V77, P277, DOI 10.1073/pnas.77.1.277; Rehm FBH, 2019, P NATL ACAD SCI USA, V116, P7831, DOI 10.1073/pnas.1901807116; Risso VA, 2018, CURR OPIN STRUC BIOL, V51, P106, DOI 10.1016/j.sbi.2018.02.007; Salinas VH, 2018, ELIFE, V7, DOI 10.7554/eLife.34300; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Simeon R, 2018, PROTEIN CELL, V9, P3, DOI 10.1007/s13238-017-0386-6; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Simonsen SM, 2004, FEBS LETT, V577, P399, DOI 10.1016/j.febslet.2004.10.034; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Sternke M, 2019, P NATL ACAD SCI USA, V116, P11275, DOI 10.1073/pnas.1816707116; Sutto L, 2015, P NATL ACAD SCI USA, V112, P13567, DOI 10.1073/pnas.1508584112; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Toll-Riera M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002542; Tombling BJ, 2020, ANGEW CHEM INT EDIT, V59, P11218, DOI 10.1002/anie.201913809; Toth-Petroczy A, 2014, CURR OPIN STRUC BIOL, V26, P131, DOI 10.1016/j.sbi.2014.06.007; Toth-Petroczy A, 2011, P NATL ACAD SCI USA, V108, P11151, DOI 10.1073/pnas.1015994108; Trudeau DL, 2019, CURR OPIN BIOTECH, V60, P46, DOI 10.1016/j.copbio.2018.12.002; Tummers WS, 2018, CLIN CANCER RES, V24, P1667, DOI 10.1158/1078-0432.CCR-17-2491; Tzul FO, 2017, P NATL ACAD SCI USA, V114, pE1627, DOI 10.1073/pnas.1613892114; Vazquez-Lombardi R, 2015, DRUG DISCOV TODAY, V20, P1271, DOI 10.1016/j.drudis.2015.09.004; Vervoort J, 1997, FEBS LETT, V404, P153, DOI 10.1016/S0014-5793(97)00117-8; Wang CK, 2018, ACS CHEM BIOL, V13, P1659, DOI 10.1021/acschembio.8b00291; Wang CK, 2018, NAT CHEM BIOL, V14, P417, DOI 10.1038/s41589-018-0039-y; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wheeler LC, 2016, CURR OPIN STRUC BIOL, V38, P37, DOI 10.1016/j.sbi.2016.05.015; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yin HW, 2019, ANGEW CHEM INT EDIT, V58, P7652, DOI 10.1002/anie.201901572; Zakas PM, 2017, NAT BIOTECHNOL, V35, P35, DOI 10.1038/nbt.3677; Zhangsun DT, 2017, NEUROPHARMACOLOGY, V127, P243, DOI 10.1016/j.neuropharm.2017.04.015; Zhao J., 2018, FEMS MICROBIOL LETT, V365, P1	90	2	2	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100425	10.1016/j.jbc.2021.100425	http://dx.doi.org/10.1016/j.jbc.2021.100425			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33600801	Green Published, gold			2022-12-28	WOS:000672866400399
J	Weston, LJ; Stackhouse, TL; Spinelli, KJ; Boutros, SW; Rose, EP; Osterberg, VR; Luk, KC; Raber, J; Weissman, TA; Unni, VK				Weston, Leah J.; Stackhouse, Teresa L.; Spinelli, Kateri J.; Boutros, Sydney W.; Rose, Elizabeth P.; Osterberg, Valerie R.; Luk, Kelvin C.; Raber, Jacob; Weissman, Tamily A.; Unni, Vivek K.			Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; RAT MODEL; SER129 PHOSPHORYLATION; MOUSE MODEL; PROTEIN; AGGREGATION; INHIBITOR; TOXICITY; PLK2; S129	Phosphorylation of alpha-synuclein at serine-129 is an important marker of pathologically relevant, aggregated forms of the protein in several important human diseases, including Parkinson's disease, Dementia with Lewy bodies, and Multiple system atrophy. Although several kinases have been shown to be capable of phosphorylating alpha-synuclein in various model systems, the identity of the kinase that phosphorylates alpha-synuclein in the Lewy body remains unknown. One member of the Polo-like kinase family, PLK2, is a strong candidate for being the Lewy body kinase. To examine this possibility, we have used a combination of approaches, including biochemical, immunohistochemical, and in vivo multiphoton imaging techniques to study the consequences of PLK2 genetic deletion on alpha-synuclein phosphorylation in both the presynaptic terminal and preformed fibril-induced Lewy body pathology in mouse cortex. We find that PLK2 deletion reduces presynaptic terminal alpha-synuclein serine-129 phosphorylation, but has no effect on Lewy body phosphorylation levels. Serine-129 mutation to the phosphomimetic alanine or the unphosphorylatable analog aspartate does not change the rate of cell death of Lewy inclusion-bearing neurons in our in vivo multiphoton imaging paradigm, but PLK2 deletion does slow the rate of neuronal death. Our data indicate that inhibition of PLK2 represents a promising avenue for developing new therapeutics, but that the mechanism of neuroprotection by PLK2 inhibition is not likely due to reducing alpha-synuclein serine-129 phosphorylation and that the true Lewy body kinase still awaits discovery.	[Weston, Leah J.; Stackhouse, Teresa L.; Spinelli, Kateri J.; Rose, Elizabeth P.; Osterberg, Valerie R.; Unni, Vivek K.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Weston, Leah J.; Stackhouse, Teresa L.; Spinelli, Kateri J.; Rose, Elizabeth P.; Osterberg, Valerie R.; Unni, Vivek K.] Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA; [Boutros, Sydney W.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Rose, Elizabeth P.] Oregon Hlth & Sci Univ, Vollum Inst, Neurosci Grad Program, L474, Portland, OR 97201 USA; [Luk, Kelvin C.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Luk, Kelvin C.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Behav Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Neurol, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Radiat Med, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Div Neurosci, Portland, OR 97201 USA; [Weissman, Tamily A.] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA; [Unni, Vivek K.] Oregon Hlth & Sci Univ, OHSU Parkinson Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Unni, VK (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.; Unni, VK (corresponding author), Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA.; Unni, VK (corresponding author), Oregon Hlth & Sci Univ, OHSU Parkinson Ctr, Portland, OR 97201 USA.	unni@ohsu.edu	Luk, Kelvin/AAZ-4202-2020	Luk, Kelvin/0000-0002-6591-6269; Unni, Vivek/0000-0001-8833-6542; Boutros, Sydney/0000-0001-5832-150X; Weissman, Tamily/0000-0001-9361-6071	NIH [NS102227, NS096190, NS061800]; Storm Family Foundation; Parkinson's Disease Foundation; American Parkinson Disease Association	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Storm Family Foundation; Parkinson's Disease Foundation; American Parkinson Disease Association	This work was supported in part by the NIH (grants NS102227 (VKU), NS096190 (VKU), NS061800 (VKU), the Storm Family Foundation (VKU), the Parkinson's Disease Foundation (KJS), and the American Parkinson Disease Association (VKU).	Adler CH, 2016, MOVEMENT DISORD, V31, P1114, DOI 10.1002/mds.26605; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Aubele DL, 2013, CHEMMEDCHEM, V8, P1295, DOI 10.1002/cmdc.201300166; Ball N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00218; Basso E, 2013, MOL NEUROBIOL, V48, P854, DOI 10.1007/s12035-013-8473-z; Beach TG, 2008, ACTA NEUROPATHOL, V116, P277, DOI 10.1007/s00401-008-0409-8; Bergeron M, 2014, NEUROSCIENCE, V256, P72, DOI 10.1016/j.neuroscience.2013.09.061; Buck K, 2015, NEUROBIOL DIS, V78, P100, DOI 10.1016/j.nbd.2015.03.008; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Chen M, 2016, ONCOTARGET, V7, P8466, DOI 10.18632/oncotarget.6445; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; Eckerdt F, 2005, J BIOL CHEM, V280, P36575, DOI 10.1074/jbc.M504548200; Escobar VD, 2014, NEUROSCI LETT, V563, P96, DOI 10.1016/j.neulet.2014.01.033; Febbraro F, 2013, NEUROBIOL DIS, V56, P47, DOI 10.1016/j.nbd.2013.03.014; Goncalves S, 2013, MOL NEUROBIOL, V47, P1081, DOI 10.1007/s12035-013-8406-x; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Karampetsou M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15813-8; Kim JY, 2014, JOVE-J VIS EXP, DOI 10.3791/51863; Kofoed RH, 2017, NEUROBIOL DIS, V106, P49, DOI 10.1016/j.nbd.2017.06.014; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; NAKAJO S, 1993, EUR J BIOCHEM, V217, P1057, DOI 10.1111/j.1432-1033.1993.tb18337.x; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Osterberg VR, 2015, CELL REP, V10, P1252, DOI 10.1016/j.celrep.2015.01.060; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pinho R, 2019, HUM MOL GENET, V28, P31, DOI 10.1093/hmg/ddy326; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Sakamoto M, 2009, BIOCHEM BIOPH RES CO, V384, P378, DOI 10.1016/j.bbrc.2009.04.130; Sancenon V, 2012, HUM MOL GENET, V21, P2432, DOI 10.1093/hmg/dds058; Sato H, 2011, J NEUROSCI, V31, P16884, DOI 10.1523/JNEUROSCI.3967-11.2011; Schaser AJ, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01026-0; Schaser AJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47227-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schoffski P, 2012, EUR J CANCER, V48, P179, DOI 10.1016/j.ejca.2011.11.001; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Seeburg DP, 2005, ONCOGENE, V24, P292, DOI 10.1038/sj.onc.1208277; Spinelli KJ, 2014, J NEUROSCI, V34, P2037, DOI 10.1523/JNEUROSCI.2581-13.2014; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Surguchov A, 2015, INT REV CEL MOL BIO, V320, P103, DOI 10.1016/bs.ircmb.2015.07.007; Unni VK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010589; Vancraenenbroeck R, 2011, CNS NEUROL DISORD-DR, V10, P724, DOI 10.2174/187152711797247858; Villasana LE, 2016, J NEUROCHEM, V138, P896, DOI 10.1111/jnc.13737; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Waxman EA, 2011, J NEUROSCI RES, V89, P231, DOI 10.1002/jnr.22537	55	12	12	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100273	10.1016/j.jbc.2021.100273	http://dx.doi.org/10.1016/j.jbc.2021.100273			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428941	gold, Green Published			2022-12-28	WOS:000672866400249
J	Wu, CH; Rismondo, J; Morgan, RML; Shen, Y; Loessner, MJ; Larrouy-Maumus, G; Freemont, PS; Grundling, A				Wu, Chih-Hung; Rismondo, Jeanine; Morgan, Rhodri M. L.; Shen, Yang; Loessner, Martin J.; Larrouy-Maumus, Gerald; Freemont, Paul S.; Grundling, Angelika			Bacillus subtilis YngB contributes to wall teichoic acid glucosylation and glycolipid formation during anaerobic growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UGTP MUTANT-CELLS; LIPOTEICHOIC ACID; ESCHERICHIA-COLI; ABNORMAL MORPHOLOGY; BIOSYNTHESIS; EXPRESSION; URIDYLYLTRANSFERASE; GLYCOSYLTRANSFERASE; PYROPHOSPHORYLASE; IDENTIFICATION	UTP-glucose-1-phosphate uridylyltransferases are enzymes that produce UDP-glucose from UTP and glucose-1-phosphate. In Bacillus subtilis 168, UDP-glucose is required for the decoration of wall teichoic acid (WTA) with glucose residues and the formation of glucolipids. The B. subtilis UGPase GtaB is essential for UDP-glucose production under standard aerobic growth conditions, and gtaB mutants display severe growth and morphological defects. However, bioinformatics predictions indicate that two other UTP-glucose-1-phosphate uridylyltransferases are present in B. subtilis. Here, we investigated the function of one of them named YngB. The crystal structure of YngB revealed that the protein has the typical fold and all necessary active site features of a functional UGPase. Furthermore, UGPase activity could be demonstrated in vitro using UTP and glucose-1-phosphate as substrates. Expression of YngB from a synthetic promoter in a B. subtilis gtaB mutant resulted in the reintroduction of glucose residues on WTA and production of glycolipids, demonstrating that the enzyme can function as UGPase in vivo. When WT and mutant B. subtilis strains were grown under anaerobic conditions, YngB-dependent glycolipid production and glucose decorations on WTA could be detected, revealing that YngB is expressed from its native promoter under anaerobic condition. Based on these findings, along with the structure of the operon containing yngB and the transcription factor thought to be required for its expression, we propose that besides WTA, potentially other cell wall components might be decorated with glucose residues during oxygen-limited growth condition.	[Wu, Chih-Hung; Rismondo, Jeanine; Grundling, Angelika] Imperial Coll London, Sect Mol Microbiol, London, England; [Wu, Chih-Hung; Rismondo, Jeanine; Grundling, Angelika] Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, London, England; [Morgan, Rhodri M. L.] Imperial Coll London, Dept Life Sci, London, England; [Shen, Yang; Loessner, Martin J.] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Zurich, Switzerland; [Larrouy-Maumus, Gerald] Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, Dept Life Sci, London, England; [Freemont, Paul S.] Imperial Coll Translat & Innovat Hub, London Biofoundry, White City Campus, London, England; [Freemont, Paul S.] Imperial Coll London, Dept Infect Dis, Sect Struct & Synthet Biol, London, England; [Freemont, Paul S.] Imperial Coll London, UK Dementia Res Inst Ctr Care Res & Technol, London, England	Imperial College London; Imperial College London; Imperial College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; Imperial College London; Imperial College London; Imperial College London	Grundling, A (corresponding author), Imperial Coll London, Sect Mol Microbiol, London, England.; Grundling, A (corresponding author), Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, London, England.; Freemont, PS (corresponding author), Imperial Coll Translat & Innovat Hub, London Biofoundry, White City Campus, London, England.; Freemont, PS (corresponding author), Imperial Coll London, Dept Infect Dis, Sect Struct & Synthet Biol, London, England.; Freemont, PS (corresponding author), Imperial Coll London, UK Dementia Res Inst Ctr Care Res & Technol, London, England.	p.freemont@imperial.ac.uk; a.grundling@imperial.ac.uk	shen, yang/X-2665-2018	shen, yang/0000-0003-4278-1477; Grundling, Angelika/0000-0002-6235-8687; Rismondo, Jeanine/0000-0001-5337-3829	MRC [MR/P011071/1]; German research foundation (DFG) [RI 2920/1]; BBSRC [BB/D524840/1]; Wellcome Trust [202926/Z/16/Z]; MRC [MR/P028225/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German research foundation (DFG)(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the MRC grant MR/P011071/1 to A. G. and P. S. F. and the German research foundation (DFG) grant RI 2920/1 to J. R. The crystallization facility at Imperial College was funded by the BBSRC (BB/D524840/1) and the Wellcome Trust (202926/Z/16/Z). Datasets were collected at the I03 Beamline at the Diamond Light Source (Harwell Campus, Didcot, UK).	Allison SE, 2011, J BIOL CHEM, V286, P23708, DOI 10.1074/jbc.M111.241265; Berbis MA, 2015, CURR MED CHEM, V22, P1687, DOI 10.2174/0929867322666150114151248; Aragao D, 2007, J BACTERIOL, V189, P4520, DOI 10.1128/JB.00277-07; Arrieta-Ortiz ML, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156236; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Benini S, 2017, BBA-PROTEINS PROTEOM, V1865, P1348, DOI 10.1016/j.bbapap.2017.08.015; Bonofiglio L, 2005, CURR MICROBIOL, V51, P217, DOI 10.1007/s00284-005-4466-0; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cools F, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty069; Cress BF, 2014, FEMS MICROBIOL REV, V38, P660, DOI [10.1111/1574-6976.12056, 10.1111/1574-69]; Doerrler WT, 2013, J BACTERIOL, V195, P3, DOI 10.1128/JB.01006-12; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999; Genevaux P, 1999, ARCH MICROBIOL, V172, P1, DOI 10.1007/s002030050732; Habusha M, 2019, MOL MICROBIOL, V111, P1463, DOI 10.1111/mmi.14231; Hanukoglu I, 2015, BIOCHEM MOL BIOL EDU, V43, P206, DOI 10.1002/bmb.20849; Hartig E, 2004, J BACTERIOL, V186, P6477, DOI 10.1128/JB.186.19.6477-6484.2004; HORECKER BL, 1966, ANNU REV MICROBIOL, V20, P253, DOI 10.1146/annurev.mi.20.100166.001345; IWASAKI H, 1989, J BACTERIOL, V171, P424, DOI 10.1128/jb.171.1.424-429.1989; Jorasch P, 1998, MOL MICROBIOL, V29, P419, DOI 10.1046/j.1365-2958.1998.00930.x; Kim H, 2010, MOL CELLS, V29, P397, DOI 10.1007/s10059-010-0047-6; Kobayashi K, 2001, J BACTERIOL, V183, P7365, DOI 10.1128/JB.183.24.7365-7370.2001; Kovalevskiy O, 2018, ACTA CRYSTALLOGR D, V74, P215, DOI 10.1107/S2059798318000979; Lahooti M, 1999, MICROBIOL-UK, V145, P3409, DOI 10.1099/00221287-145-12-3409; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarevic V, 2005, APPL ENVIRON MICROB, V71, P39, DOI 10.1128/AEM.71.1.39-45.2005; Luo Yu, 2016, F1000Res, V5, P155, DOI 10.12688/f1000research.8007.1; MANCUSO DJ, 1982, J BACTERIOL, V152, P616; Matsuoka S, 2017, GENES GENET SYST, V92, P217, DOI 10.1266/ggs.17-00017; Matsuoka S, 2016, BIOSCI BIOTECH BIOCH, V80, P2325, DOI 10.1080/09168451.2016.1217147; Matsuoka S, 2011, GENES GENET SYST, V86, P295, DOI 10.1266/ggs.86.295; MAUEL C, 1994, MICROBIOL-UK, V140, P2279, DOI 10.1099/13500872-140-9-2279; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; Missiakas D, 2017, ANNU REV MICROBIOL, V71, P79, DOI 10.1146/annurev-micro-090816-093512; Nakano MM, 1996, J BACTERIOL, V178, P3796, DOI 10.1128/jb.178.13.3796-3802.1996; Ogura M, 2010, ARCH MICROBIOL, V192, P569, DOI 10.1007/s00203-010-0586-4; Panta PR, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02532; Percy MG, 2016, J BACTERIOL, V198, P2029, DOI 10.1128/JB.00116-16; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; POOLEY HM, 1987, J GEN MICROBIOL, V133, P3481; Price KD, 1997, J BACTERIOL, V179, P4959, DOI 10.1128/jb.179.15.4959-4961.1997; Rismondo Jeanine, 2020, Cell Surf, V6, P100038, DOI 10.1016/j.tcsw.2020.100038; Rismondo J, 2018, J BIOL CHEM, V293, P3293, DOI 10.1074/jbc.RA117.001614; Shen Y, 2017, J BIOL CHEM, V292, P17832, DOI 10.1074/jbc.M117.813964; Shuster B, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00321-19; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Sun GF, 1996, J BACTERIOL, V178, P1374, DOI 10.1128/jb.178.5.1374-1385.1996; Thoden JB, 2007, PROTEIN SCI, V16, P1379, DOI 10.1110/ps.072864707; Thoden JB, 2007, PROTEIN SCI, V16, P432, DOI 10.1110/ps.062626007; Thompkins K, 2008, J BACTERIOL, V190, P4489, DOI 10.1128/JB.00414-08; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wagner JK, 2009, MOL MICROBIOL, V73, P963, DOI 10.1111/j.1365-2958.2009.06825.x; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wormann ME, 2011, MOL MICROBIOL, V79, P566, DOI 10.1111/j.1365-2958.2010.07472.x; YASBIN RE, 1976, J BACTERIOL, V125, P1120, DOI 10.1128/JB.125.3.1120-1126.1976; Ye RW, 2000, J BACTERIOL, V182, P4458, DOI 10.1128/JB.182.16.4458-4465.2000; YOKOYAMA K, 1988, EUR J BIOCHEM, V173, P453, DOI 10.1111/j.1432-1033.1988.tb14020.x; YOUNG FE, 1969, J BACTERIOL, V98, P1087, DOI 10.1128/JB.98.3.1087-1097.1969; YOUNG FE, 1967, P NATL ACAD SCI USA, V58, P2377, DOI 10.1073/pnas.58.6.2377	64	3	3	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100384	10.1016/j.jbc.2021.100384	http://dx.doi.org/10.1016/j.jbc.2021.100384			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33556370	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400358
J	Wu, K; Ching, K; Chong, RA; Pan, ZQ				Wu, Kenneth; Ching, Kevin; Chong, Robert A.; Pan, Zhen-Qiang			A new FRET-based platform to track substrate ubiquitination by fluorescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSAY; DESTRUCTION; DEGRADATION; ACTIVATION; INHIBITOR; MECHANISM; SNAPSHOT; SYSTEM; SCF; E2	Post-translational modification of protein by ubiquitin (Ub) alters the stability, subcellular location, or function of the target protein, thereby impacting numerous biological processes and directly contributing to myriad cellular defects or disease states, such as cancer. Tracking substrate ubiquitination by fluorescence provides opportunities for advanced reaction dynamics studies and for translational research including drug discovery. However, fluorescence-based techniques in ubiquitination studies remain underexplored at least partly because of challenges associated with Ub chain complexity and requirement for additional substrate modification. Here we describe a general strategy, FRET diubiquitination, to track substrate ubiquitination by fluorescence. This platform produces a uniform di-Ub product depending on specific interactions between a substrate and its cognate E3 Ub ligase. The diubiquitination creates proximity between the Ub-linked donor and acceptor fluorophores, respectively, enabling energy transfer to yield a distinct fluorescent signal. FRET diubiquitination relies on Ub-substrate fusion, which can be implemented using either one of the two validated strategies. Method 1 is the use of recombinant substrate-Ub fusion, applicable to all substrate peptides that can bind to E3. Method 2 is a chemoenzymatic ligation approach that employs synthetic chemistry to fuse Ub with a substrate peptide containing desired modification. Taken together, our new FRET-based diubiquitination system provides a timely technology of potential to advance both basic research and translation sciences.	[Wu, Kenneth; Ching, Kevin; Chong, Robert A.; Pan, Zhen-Qiang] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Pan, ZQ (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.	zhen-qiang.pan@mssm.edu			National Institutes of Health (NIH) fellowship [1F30DK095572-01]; NIH [GM122751, 1R01CA251425-01]; Mount Sinai Technology and Development Fund Award	National Institutes of Health (NIH) fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mount Sinai Technology and Development Fund Award	The following grants supported this work: National Institutes of Health (NIH) fellowship 1F30DK095572-01 to R. A. C. as well as NIH grants GM122751 and 1R01CA251425-01 to Z.-Q. P. Z.-Q. P. was also supported by Mount Sinai Technology and Development Fund Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Baek K, 2020, NATURE, V578, P461, DOI 10.1038/s41586-020-2000-y; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Burchak ON, 2006, CHEMBIOCHEM, V7, P1667, DOI 10.1002/cbic.200600283; Carlson CB, 2009, ASSAY DRUG DEV TECHN, V7, DOI 10.1089/adt.2008.0188; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Chong RA, 2015, METHODS MOL BIOL, V1280, P339, DOI 10.1007/978-1-4939-2422-6_20; Chong RA, 2014, P NATL ACAD SCI USA, V111, P8434, DOI 10.1073/pnas.1407849111; Gururaja TL, 2005, METHOD ENZYMOL, V399, P663, DOI 10.1016/S0076-6879(05)99044-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang JN, 2005, METHOD ENZYMOL, V399, P740, DOI 10.1016/S0076-6879(05)99049-6; Kenten JH, 2005, METHOD ENZYMOL, V399, P682, DOI 10.1016/S0076-6879(05)99045-9; Kovacev J, 2014, J BIOL CHEM, V289, P7068, DOI 10.1074/jbc.M113.530576; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Madiraju C, 2012, J BIOMOL SCREEN, V17, P163, DOI 10.1177/1087057111423417; Morreale FE, 2016, CELL, V165, P248, DOI 10.1016/j.cell.2016.03.003; Nakajima H, 2008, BIOCHEM BIOPH RES CO, V368, P1007, DOI 10.1016/j.bbrc.2008.01.166; Rajalingam K, 2016, CELL, V164, DOI 10.1016/j.cell.2016.02.019; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2016, P NATL ACAD SCI USA, V113, pE2011, DOI 10.1073/pnas.1601089113; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Xu SC, 2005, METHOD ENZYMOL, V399, P729, DOI 10.1016/S0076-6879(05)99048-4; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100230	10.1074/jbc.RA120.016858	http://dx.doi.org/10.1074/jbc.RA120.016858			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361156	gold, Green Published			2022-12-28	WOS:000672866400208
J	Yang, DZ; Jiang, CZ; Ning, B; Kong, W; Shi, YX				Yang, Dezhi; Jiang, Chizhou; Ning, Bo; Kong, Wei; Shi, Yixin			The PorX/PorY system is a virulence factor of Porphyromonas gingivalis and mediates the activation of the type IX secretion system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL RESPONSE REGULATORS; CYSTEINE PROTEINASE; ENCODING GENES; DNA-BINDING; GINGIPAINS; IDENTIFICATION; ARGININE; DOMAIN; INVOLVEMENT; CLONING	PorX/PorY is a two-component system (TCS) of Porphyromonas gingivalis that governs transcription of numerous genes including those encoding a type IX secretion system (T9SS) for gingipain secretion and heme accumulation. Here, an in vitro analysis showed that the response regulator PorX specifically bound to two regions in the promoter of porT, a known PorX-regulated T9SS gene, thus demonstrating that PorX/PorY can directly regulate specific target genes. A truncated PorX protein containing the N-terminal receiver and effector domains retained a wild-type ability in both transcription regulation and heme accumulation, ruling out the role of the C-terminal ALP domain in gene regulation. The PorX/PorY system was the only TCS essential for heme accumulation and concomitantly responded to hemin to stimulate transcription of several known PorX-dependent genes in a concentration-dependent manner. We found that PorX/PorY activated the sigH gene, which encodes a sigma factor known for P. gingivalis adaptation to hydrogen peroxide (H2O2). Consistently, both Delta porX and Delta sigH mutants were susceptible to H2O2, suggesting a PorX/PorY-sigma(H) regulatory cascade to confer resistance to oxidative stress. Furthermore, the.porX mutant became susceptible to high hemin levels that could induce oxidative stress. Therefore, a possible reason why hemin activates PorX/PorY is to confer resistance to hemin-induced oxidative stress. We also demonstrated that PorX/PorY was essential for P. gingivalis virulence because the Delta porX mutant was avirulent in a mouse model. Specifically, this TCS was required for the repression of proinflammatory cytokines secreted by dendritic cells and T cells in the P. gingivalis-infected mice.	[Yang, Dezhi; Jiang, Chizhou; Shi, Yixin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Yang, Dezhi; Jiang, Chizhou; Kong, Wei; Shi, Yixin] Arizona State Univ, Biodesign Ctr Immunotherapy Vaccines & Virotherap, Tempe, AZ 85281 USA; [Ning, Bo] Tulane Univ, Sch Med, Ctr Cellular & Mol Diagnost, 1430 Tulane Ave, New Orleans, LA 70112 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Tulane University	Shi, YX (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.; Kong, W; Shi, YX (corresponding author), Arizona State Univ, Biodesign Ctr Immunotherapy Vaccines & Virotherap, Tempe, AZ 85281 USA.	wei.kong@asu.edu; yixin.shi@asu.edu	Yang, Dezhi/HGB-2668-2022	Yang, Dezhi/0000-0003-4653-9856	NIDCR [R01 DE024607]	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by Research Project Grant R01 DE024607 from NIDCR (Y. S. and W. K.).	Abdi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182164; [Anonymous], 2005, NAT METHODS, V2, P557; Armitage G C, 1996, Ann Periodontol, V1, P37, DOI 10.1902/annals.1996.1.1.37; Curtis MA, 2002, INFECT IMMUN, V70, P6968, DOI 10.1128/IAI.70.12.6968-6975.2002; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; Egger LA, 1997, GENES CELLS, V2, P167, DOI 10.1046/j.1365-2443.1997.d01-311.x; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Fujise K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185027; Gallagher A, 2003, CURR PROTEIN PEPT SC, V4, P427, DOI 10.2174/1389203033486974; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; GROSS R, 1989, MOL MICROBIOL, V3, P1661, DOI 10.1111/j.1365-2958.1989.tb00152.x; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hasegawa Y, 2003, MICROBIOL IMMUNOL, V47, P849, DOI 10.1111/j.1348-0421.2003.tb03451.x; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Huffman LJ, 2000, EXP LUNG RES, V26, P203; Irfan U M, 2001, J Int Acad Periodontol, V3, P14; Kadowaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23288; Kato A, 1999, J BACTERIOL, V181, P5516, DOI 10.1128/JB.181.17.5516-5520.1999; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; Lasica AM, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00215; Lou YC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9838; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mattos-Graner RO, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2017.1400858; McKenzie RME, 2012, MICROBIOL-SGM, V158, P2465, DOI 10.1099/mic.0.056416-0; Mikolajczyk-Pawlinska J, 1998, BIOL CHEM, V379, P205, DOI 10.1515/bchm.1998.379.2.205; Naito M, 2019, MICROBIOL IMMUNOL, V63, P11, DOI 10.1111/1348-0421.12665; Nakayama K, 1997, MICROBIOL IMMUNOL, V41, P185, DOI 10.1111/j.1348-0421.1997.tb01189.x; Nakayama K, 1998, MOL MICROBIOL, V27, P51, DOI 10.1046/j.1365-2958.1998.00656.x; NEIDERS ME, 1989, J PERIODONTAL RES, V24, P192, DOI 10.1111/j.1600-0765.1989.tb02005.x; Nonaka M, 2014, FEMS MICROBIOL LETT, V354, P60, DOI 10.1111/1574-6968.12426; Okamoto K, 1996, J BIOCHEM-TOKYO, V120, P398; OKAMOTO K, 1995, ARCH BIOCHEM BIOPHYS, V316, P917, DOI 10.1006/abbi.1995.1123; Page RC, 1997, PERIODONTOL 2000, V14, P216, DOI 10.1111/j.1600-0757.1997.tb00199.x; Palm E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-155; Papapanou P N, 1999, J Int Acad Periodontol, V1, P110; Pavloff N, 1997, J BIOL CHEM, V272, P1595, DOI 10.1074/jbc.272.3.1595; Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Sato K, 2011, J ORAL BIOSCI, V53, P187, DOI 10.2330/joralbiosci.53.187; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Scott JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073351; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681; Vincent MS, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00096; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Yanamandra SS, 2012, MOL ORAL MICROBIOL, V27, P202, DOI 10.1111/j.2041-1014.2012.00643.x	54	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100574	10.1016/j.jbc.2021.100574	http://dx.doi.org/10.1016/j.jbc.2021.100574			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33757767	Green Published, gold			2022-12-28	WOS:000672866400547
J	Karmakar, B; Saha, B; Jana, K; Bhattacharya, SG				Karmakar, Bijoya; Saha, Bodhisattwa; Jana, Kuladip; Bhattacharya, Swati Gupta			Identification and biochemical characterization of Asp t 36, a new fungal allergen from Aspergillus terreus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspergillus terreus; allergen; triose-phosphate isomerase; proteomics; chromatography; circular dichroism; epitope mapping; airway inflammation; immunoglobulin E (IgE); immunoglobulin G (IgG); circular dichroism (CD)	MAJOR ALLERGEN; TRIOSEPHOSPHATE ISOMERASE; IGE; EPITOPES; REACTIVITY; ORYZAE	Aspergillus terreus is an allergenic fungus, in addition to causing infections in both humans and plants. However, the allergens in this fungus are still unknown, limiting the development of diagnostic and therapeutic strategies. We used a proteomic approach to search for allergens, identifying 16 allergens based on two-dimensional immunoblotting with A. terreus susceptible patient sera. We further characterized triose-phosphate isomerase (Asp t 36), one of the dominant IgE (IgE)-reactive proteins. The gene was cloned and expressed in Escherichia coli. Phylogenetic analysis showed Asp t 36 to be highly conserved with close similarity to the triose-phosphate isomerase protein sequence from Dermatophagoides farinae, an allergenic dust mite. We identified four immunodominant epitopes using synthetic peptides, and mapped them on a homology-based model of the tertiary structure of Asp t 36. Among these, two were found to create a continuous surface patch on the 3D structure, rendering it an IgE-binding hotspot. Biophysical analysis indicated that Asp t 36 shows similar secondary structure content and temperature sensitivity with other reported triose-phosphate isomerase allergens. In vivo studies using a murine model displayed that the recombinant Asp t 36 was able to stimulate airway inflammation, as demonstrated by an influx of eosinophils, goblet cell hyperplasia, elevated serum Igs, and induction of Th2 cytokines. Collectively, our results reveal the immunogenic property of Asp t 36, a major allergen from A. terreus, and define a new fungal allergen more broadly. This allergen could serve as a potent candidate for investigating component resolved diagnosis and immunotherapy.	[Karmakar, Bijoya; Bhattacharya, Swati Gupta] Bose Inst, Div Plant Biol, Main Campus, Kolkata, India; [Saha, Bodhisattwa] CSIR Inst Genom & Integrat Biol, New Delhi, India; [Jana, Kuladip] Bose Inst, Div Mol Med, Centenary Bldg, Kolkata, India	Department of Science & Technology (India); Bose Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Science & Technology (India); Bose Institute	Bhattacharya, SG (corresponding author), Bose Inst, Div Plant Biol, Main Campus, Kolkata, India.; Saha, B (corresponding author), CSIR Inst Genom & Integrat Biol, New Delhi, India.	bodhisattwasaha@gmail.com; swati@jcbose.ac.in	Jana, Kuladip/GXG-3481-2022	Jana, Kuladip/0000-0003-4748-253X	Department of Science and Technology (DST), India; DST	Department of Science and Technology (DST), India(Department of Science & Technology (India)); DST(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology (DST), India and DST, Inspire-Faculty Grant (to B. K. and B. S.).	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Adhikari A, 2004, SCI TOTAL ENVIRON, V326, P123, DOI 10.1016/j.scitotenv.2003.12.007; Banerjee B, 1998, INFECT IMMUN, V66, P5175, DOI 10.1128/IAI.66.11.5175-5182.1998; Bhattacharya K, 2018, INT ARCH ALLERGY IMM, V177, P219, DOI 10.1159/000490805; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Chuang JG, 2010, PROTEOMICS, V10, P3854, DOI 10.1002/pmic.201000348; Devos FC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180690; Ganguly HK, 2013, BIOCHEMISTRY-US, V52, P6348, DOI 10.1021/bi4007918; Ghosh D, 2014, J BIOL CHEM, V289, P21374, DOI 10.1074/jbc.M114.559971; Groeme R, 2016, J BIOL CHEM, V291, P13076, DOI 10.1074/jbc.M115.702001; Haahtela T, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-3; Hasan MK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01492; Jayanthi Savio, 2019, Indian Journal of Allergy, Asthma & Immunology, V33, P19; Kamath SD, 2014, MOL NUTR FOOD RES, V58, P1144, DOI 10.1002/mnfr.201300584; Karmakar B, 2020, SN APPL SCI, V2, DOI 10.1007/s42452-020-2323-1; Li XH, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/483905; Louis Bengyella, 2014, BMC Res Notes, V7, P350, DOI 10.1186/1756-0500-7-350; MALDONADO H, 2015, CHEST S, V148, DOI DOI 10.1378/chest.2278744; Marth K, 2013, J IMMUNOL, V190, P3068, DOI 10.4049/jimmunol.1202441; Mattes J, 2001, J IMMUNOL, V167, P1683, DOI 10.4049/jimmunol.167.3.1683; Nayak AP, 2013, ANN ALLERG ASTHMA IM, V111, P32, DOI 10.1016/j.anai.2013.04.018; Negi SS, 2017, BIOINFORMATICS, V33, P1014, DOI 10.1093/bioinformatics/btw767; Nugraha R, 2018, J ALLERGY CLIN IMMUN, V141, P1501, DOI 10.1016/j.jaci.2017.11.028; Pekar J, 2018, MOL IMMUNOL, V100, P14, DOI 10.1016/j.molimm.2018.03.017; Ramachandran H, 2002, CLIN IMMUNOL, V103, P324, DOI 10.1006/clim.2002.5219; Saha B, 2017, J PROTEOMICS, V165, P1, DOI 10.1016/j.jprot.2017.05.021; Saha B, 2015, J PROTEOME RES, V14, P4823, DOI 10.1021/acs.jproteome.5b00657; Sander I, 2011, ALLERGY, V66, P1208, DOI 10.1111/j.1398-9995.2011.02636.x; Shankar J, 2006, MOL IMMUNOL, V43, P1927, DOI 10.1016/j.molimm.2005.12.006; Shen HD, 1998, INT ARCH ALLERGY IMM, V116, P29, DOI 10.1159/000023921; Sircar G, 2020, J BIOL CHEM, V295, P2736, DOI 10.1074/jbc.RA119.011659; Sircar G, 2016, J BIOL CHEM, V291, P18016, DOI 10.1074/jbc.M116.732032; Sircar G, 2012, J PROTEOMICS, V77, P455, DOI 10.1016/j.jprot.2012.09.023; Templeton SP, 2010, MED MYCOL, V48, P217, DOI 10.3109/13693780903420658; Xia F, 2019, J AGR FOOD CHEM, V67, P12918, DOI 10.1021/acs.jafc.9b05279; Yang Y, 2017, MOL IMMUNOL, V85, P35, DOI 10.1016/j.molimm.2017.02.004; Yang Y, 2017, J AGR FOOD CHEM, V65, P950, DOI 10.1021/acs.jafc.6b04587; Yu CJ, 1999, BIOCHEM BIOPH RES CO, V261, P669, DOI 10.1006/bbrc.1999.1093; Zahirovic A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01449; Zinsser VL, 2013, BIOCHIMIE, V95, P2182, DOI 10.1016/j.biochi.2013.08.014	40	3	3	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17852	17864		10.1074/jbc.RA120.015801	http://dx.doi.org/10.1074/jbc.RA120.015801			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454019	hybrid, Green Published			2022-12-28	WOS:000603272300035
J	Bugge, K; Staby, L; Salladini, E; Falbe-Hansen, RG; Kragelund, BB; Skriver, K				Bugge, Katrine; Staby, Lasse; Salladini, Edoardo; Falbe-Hansen, Rasmus G.; Kragelund, Birthe B.; Skriver, Karen			alpha alpha-Hub domains and intrinsically disordered proteins: A decisive combo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COACTIVATOR BINDING DOMAIN; TRANSCRIPTION FACTOR; PAH2 DOMAIN; HISTONE DEACETYLASES; STRUCTURAL INSIGHTS; MEDIATES REPRESSION; FUNCTIONAL-ANALYSIS; SIN3 COREPRESSOR; LINEAR MOTIF; CO-REPRESSOR	Hub proteins are central nodes in protein-protein interaction networks with critical importance to all living organisms. Recently, a new group of folded hub domains, the alpha alpha-hubs, was defined based on a shared alpha alpha-hairpin supersecondary structural foundation. The members PAH, RST, TAFH, NCBD, and HHD are found in large proteins such as Sin3, RCD1, TAF4, CBP, and harmonin, which organize disordered transcriptional regulators and membrane scaffolds in interactomes of importance to human diseases and plant quality. In this review, studies of structures, functions, and complexes across the alpha alpha-hubs are described and compared to provide a unified description of the group. This analysis expands the associated molecular concepts of "one domain-one binding site", motif-based ligand binding, and coupled folding and binding of intrinsically disordered ligands to additional concepts of importance to signal fidelity. These include context, motif reversibility, multivalency, complex heterogeneity, synergistic alpha alpha-hub:ligand folding, accessory binding sites, and supramodules. We propose that these multifaceted protein-protein interaction properties are made possible by the characteristics of the alpha alpha-hub fold, including supersite properties, dynamics, variable topologies, accessory helices, and malleability and abetted by adaptability of the disordered ligands. Critically, these features provide additional filters for specificity. With the presentations of new concepts, this review opens for new research questions addressing properties across the group, which are driven from concepts discovered in studies of the individual members. Combined, the members of the alpha alpha-hubs are ideal models for deconvoluting signal fidelity maintained by folded hubs and their interactions with intrinsically disordered ligands.	[Bugge, Katrine; Staby, Lasse; Salladini, Edoardo; Falbe-Hansen, Rasmus G.; Kragelund, Birthe B.; Skriver, Karen] Univ Copenhagen, REPIN, Copenhagen, Denmark; [Bugge, Katrine; Staby, Lasse; Salladini, Edoardo; Falbe-Hansen, Rasmus G.; Kragelund, Birthe B.; Skriver, Karen] Univ Copenhagen, Linderstrom Lang Ctr Prot Sci, Copenhagen, Denmark; [Bugge, Katrine; Staby, Lasse; Kragelund, Birthe B.] Univ Copenhagen, Struct Biol & NMR Lab, Dept Biol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Kragelund, BB; Skriver, K (corresponding author), Univ Copenhagen, REPIN, Copenhagen, Denmark.; Kragelund, BB; Skriver, K (corresponding author), Univ Copenhagen, Linderstrom Lang Ctr Prot Sci, Copenhagen, Denmark.; Kragelund, BB (corresponding author), Univ Copenhagen, Struct Biol & NMR Lab, Dept Biol, Copenhagen, Denmark.	bbk@bio.ku.dk; KSkriver@bio.ku.dk	Skriver, Karen/K-9860-2014; Kragelund, Birthe/M-3927-2014	Skriver, Karen/0000-0003-2225-4012; Kragelund, Birthe/0000-0002-7454-1761; Bugge, Katrine/0000-0002-6286-6243; Falbe-Hansen, Rasmus Greve/0000-0002-2832-6622	REPIN; Novo Nordisk Foundation [NNF18OC0033926, NNF18OC0052177]	REPIN; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by REPIN, rethinking protein interactions, the Novo Nordisk Foundation Challenge grant #NNF18OC0033926 to B. B. K. and K. S. Support was also achieved from the Novo Nordisk Foundation grant #NNF18OC0052177 to K. S.	Adams GE, 2018, BIOCHEM J, V475, P3921, DOI 10.1042/BCJ20170314; Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Alhindi T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44948; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Bahloul A, 2017, FEBS LETT, V591, P2299, DOI 10.1002/1873-3468.12729; Berlow RB, 2019, BIOCHEMISTRY-US, V58, P1354, DOI 10.1021/acs.biochem.8b01290; Berlow RB, 2017, NATURE, V543, P447, DOI 10.1038/nature21705; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Borgia A, 2018, NATURE, V555, P61, DOI 10.1038/nature25762; Bowen AJ, 2010, J MOL BIOL, V395, P937, DOI 10.1016/j.jmb.2009.11.065; Brodsky S, 2020, MOL CELL, V79, P459, DOI 10.1016/j.molcel.2020.05.032; Brubaker K, 2000, CELL, V103, P655, DOI 10.1016/S0092-8674(00)00168-9; Bugge K, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00110; Bugge K, 2018, STRUCTURE, V26, P734, DOI 10.1016/j.str.2018.03.013; Burki F, 2020, TRENDS ECOL EVOL, V35, P43, DOI 10.1016/j.tree.2019.08.008; Bustos DM, 2012, MOL BIOSYST, V8, P178, DOI 10.1039/c1mb05216k; Chandrasekhar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31632-x; Chaubal A, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0188-y; Chen WY, 2013, GENE DEV, V27, P1596, DOI 10.1101/gad.216192.113; Christensen LF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55385-3; Clark MD, 2015, P NATL ACAD SCI USA, V112, pE3669, DOI 10.1073/pnas.1504021112; Cowley SM, 2004, MOL CELL BIOL, V24, P2698, DOI 10.1128/MCB.24.7.2698-2709.2004; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Dai WT, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0351-7; Das RK, 2016, P NATL ACAD SCI USA, V113, P5616, DOI 10.1073/pnas.1516277113; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; De Clercq I, 2013, PLANT CELL, V25, P3472, DOI 10.1105/tpc.113.117168; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; Delhommel F, 2018, FEBS J, V285, P3738, DOI 10.1111/febs.14614; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dogan J, 2015, BIOCHEMISTRY-US, V54, P4741, DOI 10.1021/acs.biochem.5b00520; Dyson HJ, 2016, J BIOL CHEM, V291, P6714, DOI 10.1074/jbc.R115.692020; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; EFIMOV AV, 1991, PROTEIN ENG, V4, P245, DOI 10.1093/protein/4.3.245; Engel DE, 2005, PROTEINS, V61, P325, DOI 10.1002/prot.20522; Erijman A, 2020, MOL CELL, V78, P890, DOI 10.1016/j.molcel.2020.04.020; Faure G, 2014, PROTEINS, V82, P897, DOI 10.1002/prot.24438; Ferreira RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056579; Fisher OS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8937; Fisher OS, 2013, FEBS LETT, V587, P272, DOI 10.1016/j.febslet.2012.12.011; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Gazit K, 2009, J BIOL CHEM, V284, P26286, DOI 10.1074/jbc.M109.011486; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Haberz P, 2016, PROTEIN SCI, V25, P2256, DOI 10.1002/pro.3059; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hasan T, 2015, BIOCHEMISTRY-MOSCOW+, V80, P424, DOI 10.1134/S0006297915040057; He Y, 2008, PROTEIN SCI, V17, P171, DOI 10.1110/ps.073097308; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Heller GT, 2015, TRENDS BIOCHEM SCI, V40, P491, DOI 10.1016/j.tibs.2015.07.004; Henley MJ, 2020, P NATL ACAD SCI USA, V117, P27346, DOI 10.1073/pnas.2013244117; Henricson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-412; Higo J, 2011, J AM CHEM SOC, V133, P10448, DOI 10.1021/ja110338e; Holehouse AS, 2017, BIOPHYS J, V112, P16, DOI 10.1016/j.bpj.2016.11.3200; Hu G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122761; Huang JR, 2014, J AM CHEM SOC, V136, P7068, DOI 10.1021/ja502030n; Hultqvist G, 2017, ELIFE, V6, DOI 10.7554/eLife.16059; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; Iesmantavicius V, 2014, ANGEW CHEM INT EDIT, V53, P1548, DOI 10.1002/anie.201307712; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Jaspers P, 2009, PLANT J, V60, P268, DOI 10.1111/j.1365-313X.2009.03951.x; Jemth P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau4130; Jespersen N, 2020, TRENDS BIOCHEM SCI, V45, P375, DOI 10.1016/j.tibs.2020.01.004; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Karlsson E, 2020, PROTEIN SCI, V29, P1687, DOI 10.1002/pro.3868; Karlsson E, 2019, J BIOL CHEM, V294, P1230, DOI 10.1074/jbc.RA118.005854; Kazantseva J, 2014, INT J MOL SCI, V15, P16680, DOI 10.3390/ijms150916680; Kjaergaard M, 2013, BIOCHEMISTRY-US, V52, P1686, DOI 10.1021/bi4001062; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; Kjaersgaard T, 2011, J BIOL CHEM, V286, P35418, DOI 10.1074/jbc.M111.247221; Koipally J, 2002, J BIOL CHEM, V277, P27697, DOI 10.1074/jbc.M201694200; Kragelund BB, 2012, TRENDS PLANT SCI, V17, P625, DOI 10.1016/j.tplants.2012.06.010; Krishna SS, 2004, STRUCTURE, V12, P1125, DOI 10.1016/j.str.2004.06.004; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar GS, 2011, J MOL BIOL, V408, P987, DOI 10.1016/j.jmb.2011.03.043; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Le Guezennec X, 2004, J BIOL CHEM, V279, P25823, DOI 10.1074/jbc.M313860200; Le Guezennec X, 2006, NUCLEIC ACIDS RES, V34, P3929, DOI 10.1093/nar/gkl537; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Li J., 2018, ELIFE, V7, P1; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Liu XR, 2019, J MOL BIOL, V431, P422, DOI 10.1016/j.jmb.2018.12.001; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Lyle N, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4812791; Marcum RD, 2020, FEBS LETT, V594, P2322, DOI 10.1002/1873-3468.13811; Mergner J, 2020, NATURE, V579, P409, DOI 10.1038/s41586-020-2094-2; Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nady N, 2015, ELIFE, V4, DOI 10.7554/eLife.10150; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Nomura M, 2005, J MOL BIOL, V354, P903, DOI 10.1016/j.jmb.2005.10.008; Novatchkova M, 2004, CURR BIOL, V14, pR54, DOI 10.1016/j.cub.2003.12.042; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; O'Shea C, 2017, J BIOL CHEM, V292, P512, DOI 10.1074/jbc.M116.753426; O'Shea C, 2015, BIOCHEM J, V465, P281, DOI 10.1042/BJ20141045; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Olsen JG, 2017, CELL MOL LIFE SCI, V74, P3175, DOI 10.1007/s00018-017-2560-7; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Pan LF, 2009, P NATL ACAD SCI USA, V106, P5575, DOI 10.1073/pnas.0901819106; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Papaleo E, 2018, PEERJ, V6, DOI 10.7717/peerj.5125; Park S, 2009, BLOOD, V113, P3558, DOI 10.1182/blood-2008-06-161307; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Plevin MJ, 2006, P NATL ACAD SCI USA, V103, P10242, DOI 10.1073/pnas.0603463103; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Prestel A, 2019, CELL MOL LIFE SCI, V76, P4923, DOI 10.1007/s00018-019-03150-0; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Russell RB, 1997, J MOL BIOL, V269, P423, DOI 10.1006/jmbi.1997.1019; Russell RB, 1998, J MOL BIOL, V282, P903, DOI 10.1006/jmbi.1998.2043; Sahu SC, 2008, J MOL BIOL, V375, P1444, DOI 10.1016/j.jmb.2007.11.079; Saihan Z, 2009, CURR OPIN NEUROL, V22, P19, DOI 10.1097/WCO.0b013e3283218807; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Shapiguzov A, 2019, ELIFE, V8, DOI 10.7554/eLife.43284; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sorensen CS, 2019, P NATL ACAD SCI USA, V116, P23124, DOI 10.1073/pnas.1904813116; Sorusch N, 2014, ADV EXP MED BIOL, V801, P527, DOI 10.1007/978-1-4614-3209-8_67; Spronk CAEM, 2000, NAT STRUCT BIOL, V7, P1100; Staby L, 2021, CELL COMMUN SIGNAL, V19, DOI 10.1186/s12964-020-00686-8; Staby L, 2017, BIOCHEM J, V474, P2509, DOI 10.1042/BCJ20160631; Streubel G, 2017, EMBO J, V36, P2216, DOI 10.15252/embj.201696307; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; Teilum K, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00040; Thuault S, 2002, J BIOL CHEM, V277, P45510, DOI 10.1074/jbc.M206556200; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Vainonen J., 2020, ARABIDOPSIS POLY ADP; Vainonen JP, 2012, BIOCHEM J, V442, P573, DOI 10.1042/BJ20111739; van Ingen H, 2006, J MOL BIOL, V358, P485, DOI 10.1016/j.jmb.2006.01.100; van Ingen H, 2004, BIOCHEMISTRY-US, V43, P46, DOI 10.1021/bi0355645; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Villalobo A, 2019, CELL MOL LIFE SCI, V76, P2299, DOI 10.1007/s00018-019-03062-z; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Wang XY, 2015, STRUCTURE, V23, P1087, DOI 10.1016/j.str.2015.04.003; Warfield L, 2014, P NATL ACAD SCI USA, V111, pE3506, DOI 10.1073/pnas.1412088111; Warmerdam S, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-2285-x; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wirthmueller L, 2018, NEW PHYTOL, V220, P232, DOI 10.1111/nph.15277; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu L, 2012, J BIOL CHEM, V287, P33460, DOI 10.1074/jbc.M112.378505; Xie T, 2011, J BIOL CHEM, V286, P27814, DOI 10.1074/jbc.M111.252494; Yan J, 2010, P NATL ACAD SCI USA, V107, P4040, DOI 10.1073/pnas.0911385107; Yang K, 2018, P NATL ACAD SCI USA, V115, P10040, DOI 10.1073/pnas.1810397115; Yang Q, 2000, BIOCHEM J, V345, P335, DOI 10.1042/0264-6021:3450335; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001; Yu QF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078318, 10.1371/journal.pone.0059627]; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001; Zhang JS, 2004, SCIENCE, V305, P1286, DOI 10.1126/science.1097937; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhang YB, 2006, J MOL BIOL, V360, P7, DOI 10.1016/j.jmb.2006.04.069; Zosel F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05725-0	158	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100226	10.1074/jbc.REV120.012928	http://dx.doi.org/10.1074/jbc.REV120.012928			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361159	Green Published, gold			2022-12-28	WOS:000672866400204
J	Chundawat, SPS; Nemmaru, B; Hackl, M; Brady, SK; Hilton, MA; Johnson, MM; Chang, S; Lang, MJ; Huh, H; Lee, SH; Yarbrough, JM; Lopez, CA; Gnanakaran, S				Chundawat, Shishir P. S.; Nemmaru, Bhargava; Hackl, Markus; Brady, Sonia K.; Hilton, Mark A.; Johnson, Madeline M.; Chang, Sungrok; Lang, Matthew J.; Huh, Hyun; Lee, Sang-Hyuk; Yarbrough, John M.; Lopez, Cesar A.; Gnanakaran, Sandrasegaram			Molecular origins of reduced activity and binding commitment of processive cellulases and associated carbohydrate-binding proteins to cellulose III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNCHROTRON X-RAY; HYDROGEN-BONDING SYSTEM; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; CELLOBIOHYDROLASE-I; BIOMASS RECALCITRANCE; FUNGAL CELLULASES; IMAGING ANALYSIS; AMINO-ACIDS; MODULE	Efficient enzymatic saccharification of cellulosic biomass into fermentable sugars can enable production of bioproducts like ethanol. Native crystalline cellulose, or cellulose I, is inefficiently processed via enzymatic hydrolysis but can be converted into the structurally distinct cellulose III allomorph that is processed via cellulase cocktails derived from Trichoderma reesei up to 20-fold faster. However, characterization of individual cellulases from T. reesei, like the processive exocellulase Cel7A, shows reduced binding and activity at low enzyme loadings toward cellulose III. To clarify this discrepancy, we monitored the single-molecule initial binding commitment and subsequent processive motility of Cel7A enzymes and associated carbohydrate-binding modules (CBMs) on cellulose using optical tweezers force spectroscopy. We confirmed a 48% lower initial binding commitment and 32% slower processive motility of Cel7A on cellulose III, which we hypothesized derives from reduced binding affinity of the Cel7A binding domain CBM1. Classical CBM-cellulose pull-down assays, depending on the adsorption model fitted, predicted between 1.2- and 7-fold reduction in CBM1 binding affinity for cellulose III. Force spectroscopy measurements of CBM1-cellulose interactions, along with molecular dynamics simulations, indicated that previous interpretations of classical binding assay results using multisite adsorption models may have complicated analysis, and instead suggest simpler single-site models should be used. These findings were corroborated by binding analysis of other type-A CBMs (CBM2a, CBM3a, CBM5, CBM10, and CBM64) on both cellulose allomorphs. Finally, we discuss how complementary analytical tools are critical to gain insight into the complex mechanisms of insoluble polysaccharides hydrolysis by cellulolytic enzymes and associated carbohydrate-binding proteins.	[Chundawat, Shishir P. S.; Nemmaru, Bhargava; Hackl, Markus] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA; [Brady, Sonia K.; Hilton, Mark A.; Johnson, Madeline M.; Chang, Sungrok; Lang, Matthew J.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Lang, Matthew J.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Huh, Hyun; Lee, Sang-Hyuk] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ USA; [Yarbrough, John M.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA; [Lopez, Cesar A.; Gnanakaran, Sandrasegaram] Los Alamos Natl Lab, Theoret Div, Los Alamos, NM USA	Rutgers State University New Brunswick; Vanderbilt University; Vanderbilt University; Rutgers State University New Brunswick; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Los Alamos National Laboratory	Chundawat, SPS (corresponding author), Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.	shishir.chundawat@rutgers.edu	Nemmaru, Bhargava/GPP-5485-2022	Nemmaru, Bhargava/0000-0002-5005-4678; Chundawat, Shishir/0000-0003-3677-6735	NSF CBET awards [1604421, 1846797]; ORAU Ralph E. Powe Award; NSF MCB award [1330792]; NIH [R01GM101001]; Rutgers Global Grant, Rutgers Division of Continuing Studies, Rutgers School of Engineering, DOE Bioimaging Award (Office of Science) [DE-SC0019313]; Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; Department of Energy, Office of Energy Efficiency and Renewable Energy (EERE) [28598]	NSF CBET awards(National Science Foundation (NSF)); ORAU Ralph E. Powe Award; NSF MCB award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Global Grant, Rutgers Division of Continuing Studies, Rutgers School of Engineering, DOE Bioimaging Award (Office of Science); Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); Department of Energy, Office of Energy Efficiency and Renewable Energy (EERE)(United States Department of Energy (DOE))	The authors acknowledge support from the NSF CBET awards (1604421 and 1846797), ORAU Ralph E. Powe Award, NSF MCB award (1330792), NIH Grant (R01GM101001), Rutgers Global Grant, Rutgers Division of Continuing Studies, Rutgers School of Engineering, DOE Bioimaging Award (Office of Science DE-SC0019313), and the Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494). C. A. L. and S. G. acknowledge support from LANL LDRD ER (XWX2) and LANL institutional program for computational resources. J. M. Y. acknowledges support from the Department of Energy, Office of Energy Efficiency and Renewable Energy (EERE) under agreement no. 28598. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott DW, 2012, METHOD ENZYMOL, V510, P211, DOI 10.1016/B978-0-12-415931-0.00011-2; Alekozai EM, 2014, CELLULOSE, V21, P951, DOI 10.1007/s10570-013-0026-0; Atalla R. J., 1987, IPC TECHNICAL PAPER, V217; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Brady SK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10149; Brunecky R, 2020, GREEN CHEM, V22, P478, DOI 10.1039/c9gc03062j; Buffon G, 1777, HIST NAT G N RALE ER, P46; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Dale BE, 2010, ENVIRON SCI TECHNOL, V44, P8385, DOI [10.1021/es101864b, 10.1021/es1031618]; Das DK, 2016, J BIOL CHEM, V291, P25292, DOI 10.1074/jbc.M116.752865; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; Gao DH, 2011, BIOTECHNOL BIOENG, V108, P1788, DOI 10.1002/bit.23140; Garvey CJ, 2005, MACROMOL CHEM PHYS, V206, P1568, DOI 10.1002/macp.200500008; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hu FH, 2018, CELLULOSE, V25, P1185, DOI 10.1007/s10570-017-1629-7; Igarashi K, 2012, METHOD ENZYMOL, V510, P169, DOI 10.1016/B978-0-12-415931-0.00009-4; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jana S, 2016, J PHYS CHEM B, V120, P1236, DOI 10.1021/acs.jpcb.5b12610; Jobst MA, 2015, ELIFE, V4, DOI 10.7554/eLife.10319; Kari J, 2018, ACS CATAL, V8, P11966, DOI 10.1021/acscatal.8b03547; King JR, 2015, LANGMUIR, V31, P3431, DOI 10.1021/la504836u; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Kont R, 2016, J BIOL CHEM, V291, P26013, DOI 10.1074/jbc.M116.756007; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Latour RA, 2015, J BIOMED MATER RES A, V103, P949, DOI 10.1002/jbm.a.35235; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Lim S, 2014, PROTEIN EXPRES PURIF, V98, P1, DOI 10.1016/j.pep.2014.02.013; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Liu YX, 2020, ACS SUSTAIN CHEM ENG, V8, P5028, DOI 10.1021/acssuschemeng.9b06792; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Moran-Mirabal JM, 2011, BIOPHYS CHEM, V155, P20, DOI 10.1016/j.bpc.2011.02.003; Mudinoor AR, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-1649-7; Nakamura A, 2016, J BIOL CHEM, V291, P22404, DOI 10.1074/jbc.M116.752048; Nemmaru B, 2021, BIOTECHNOL BIOENG, V118, P1141, DOI 10.1002/bit.27637; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Novy V, 2019, P NATL ACAD SCI USA, V116, P22545, DOI 10.1073/pnas.1912354116; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; Rakshit S, 2012, P NATL ACAD SCI USA, V109, P18815, DOI 10.1073/pnas.1208349109; REINIKAINEN T, 1992, PROTEINS, V14, P475, DOI 10.1002/prot.340140408; Rico F, 2019, P NATL ACAD SCI USA, V116, P6594, DOI 10.1073/pnas.1816909116; Santoro N, 2010, BIOENERG RES, V3, P93, DOI 10.1007/s12155-009-9074-6; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Sousa LD, 2019, ACS SUSTAIN CHEM ENG, V7, P14411, DOI 10.1021/acssuschemeng.9b00606; Sousa LD, 2016, ENERG ENVIRON SCI, V9, P1215, DOI [10.1039/c5ee03051j, 10.1039/C5EE03051J]; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Varnai A, 2014, ADV APPL MICROBIOL, V88, P103, DOI 10.1016/B978-0-12-800260-5.00004-8; Vermaas JV, 2019, P NATL ACAD SCI USA, V116, P23061, DOI 10.1073/pnas.1913398116; Wada M, 2004, MACROMOLECULES, V37, P8548, DOI 10.1021/ma0485585; Walker JA, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0402-0; WILEY JH, 1987, CARBOHYD RES, V160, P113, DOI 10.1016/0008-6215(87)80306-3; Wu M, 2013, J BIOL CHEM, V288, P33107, DOI 10.1074/jbc.M113.502765	72	3	3	5	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100431	10.1016/j.jbc.2021.100431	http://dx.doi.org/10.1016/j.jbc.2021.100431			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33610545	gold, Green Published			2022-12-28	WOS:000672866400405
J	Gerak, CAN; Cho, SY; Kolesnikov, M; Okon, M; Murphy, MEP; Sessions, RB; Roberge, M; McIntosh, LP				Gerak, Chloe A. N.; Cho, Sophia Y.; Kolesnikov, Maxim; Okon, Mark; Murphy, Michael E. P.; Sessions, Richard B.; Roberge, Michel; McIntosh, Lawrence P.			Biophysical characterization of the ETV6 PNT domain polymerization interfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; HYDROGEN-EXCHANGE; TYROSINE KINASE; SAM DOMAIN; BINDING; TEL; IDENTIFICATION; DIVERSITY; INSIGHTS; SYSTEM	ETV6 is an E26 transformation specific family transcriptional repressor that self-associates by its PNT domain to facilitate cooperative DNA binding. Chromosomal translocations frequently generate constitutively active oncoproteins with the ETV6 PNT domain fused to the kinase domain of one of many protein tyrosine kinases. Although an attractive target for therapeutic intervention, the propensity of the ETV6 PNT domain to polymerize via the tight head-to-tail association of two relatively flat interfaces makes it challenging to identify suitable small molecule inhibitors of this protein-protein interaction. Herein, we provide a comprehensive biophysical characterization of the ETV6 PNT domain interaction interfaces to aid future drug discovery efforts and help define the mechanisms by which its self-association mediates transcriptional repression. Using NMR spectroscopy, X-ray crystallography, and molecular dynamics simulations, along with amide hydrogen exchange measurements, we demonstrate that monomeric PNT domain variants adopt very stable helical bundle folds that do not change in conformation upon self-association into heterodimer models of the ETV6 polymer. Surface plasmon resonance-monitored alanine scanning mutagenesis studies identified hot spot regions within the self-association interfaces. These regions include both central hydrophobic residues and flanking salt-bridging residues. Collectively, these studies indicate that small molecules targeted to these hydrophobic or charged regions within the relatively rigid interfaces could potentially serve as orthosteric inhibitors of ETV6 PNT domain polymerization.	[Gerak, Chloe A. N.; Cho, Sophia Y.; Okon, Mark; Roberge, Michel; McIntosh, Lawrence P.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Kolesnikov, Maxim; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Sessions, Richard B.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [McIntosh, Lawrence P.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of Bristol; University of British Columbia	McIntosh, LP (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.; McIntosh, LP (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC, Canada.	mcintosh@chem.ubc.ca		Gerak, Chloe/0000-0002-5329-9443; Sessions, Richard/0000-0003-0320-0895	Canadian Cancer Society Research Institute [703349]; Canadian Institutes of Health Research [CIHR MOP-136834]; University of British Columbia; CIHR	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia; CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by funds from the Canadian Cancer Society Research Institute (703349) to L.P.M and M.R., and from the Canadian Institutes of Health Research (CIHR MOP-136834) to L.P.M. C.A.N.G. held graduate scholarships from CIHR and the University of British Columbia.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPHICS S; Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; Ashraf SS, 2004, PROTEIN EXPRES PURIF, V33, P238, DOI 10.1016/j.pep.2003.10.016; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Cetinbas N, 2013, J BIOL CHEM, V288, P27940, DOI 10.1074/jbc.M113.475301; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; De Braekeleer E, 2012, LEUKEMIA RES, V36, P945, DOI 10.1016/j.leukres.2012.04.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2008, FEBS LETT, V582, P1495, DOI 10.1016/j.febslet.2008.03.043; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodje M, 2014, J SYNCHROTRON RADIAT, V21, P633, DOI 10.1107/S1600577514005578; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gerak CAN, 2021, SLAS DISCOV, V26, P698, DOI 10.1177/2472555220979599; Goddard T. D., 1999, SPARKY 3; Green SM, 2010, J BIOL CHEM, V285, P18496, DOI 10.1074/jbc.M109.096958; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang-Hobbs H., 2013, THESIS U BRIT COLUMB; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Knight MJ, 2011, PROTEIN SCI, V20, P1697, DOI 10.1002/pro.703; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Mackereth CD, 2004, J MOL BIOL, V342, P1249, DOI 10.1016/j.jmb.2004.07.094; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; McIntosh-Smith S, 2015, INT J HIGH PERFORM C, V29, P119, DOI 10.1177/1094342014528252; Mercurio FA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17684-5; Nauli S, 2007, PROTEIN SCI, V16, P2542, DOI 10.1110/ps.073074207; PATERSON Y, 1990, SCIENCE, V249, P755, DOI 10.1126/science.1697101; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Potter MD, 2000, BLOOD, V95, P3341, DOI 10.1182/blood.V95.11.3341.011k44_3341_3348; Poulos S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174485; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sessions RB, 1998, BIOPHYS J, V74, P138, DOI 10.1016/S0006-3495(98)77775-6; Shen Y, 2012, J BIOMOL NMR, V52, P211, DOI 10.1007/s10858-012-9602-0; Skinner JJ, 2012, PROTEIN SCI, V21, P987, DOI 10.1002/pro.2082; Tognon CE, 2004, MOL CELL BIOL, V24, P4636, DOI 10.1128/MCB.24.11.4636-4650.2004; Tran Hoang H, 2002, BMC Struct Biol, V2, P5, DOI 10.1186/1472-6807-2-5; Vivekanand P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037151; Wai DH, 2000, ONCOGENE, V19, P906, DOI 10.1038/sj.onc.1203396; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Zhang Y. Z., 1995, THESIS U PENNSYLVANN	58	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100284	10.1016/j.jbc.2021.100284	http://dx.doi.org/10.1016/j.jbc.2021.100284			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33450226	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400260
J	Hackl, S; Ng, XW; Lu, DQ; Wohland, T; Becker, CFW				Hackl, Stefanie; Ng, Xue Wen; Lu, Danqin; Wohland, Thorsten; Becker, Christian F. W.			Cytoskeleton-dependent clustering of membrane-bound prion protein on the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ANCHORED PROTEINS; PLASMA-MEMBRANE; LIPID RAFTS; COLOCALIZATION; DIFFUSION; MODEL; ORGANIZATION; CONVERSION; PRPSC	Prion diseases are a group of neurodegenerative disorders that infect animals and humans with proteinaceous particles called prions. Prions consist of scrapie prion protein (PrPSc), a misfolded version of the cellular prion protein (PrPC). During disease progression, PrPSc replicates by interacting with PrPC and inducing its conversion to PrPSc. Attachment of PrPC to cellular membranes via a glycosylphosphatidylinositol (GPI) anchor is critical for the conversion of PrPC into PrPSc. However, the mechanisms governing PrPC conversion and replication on the membrane remain largely unclear. Here, a site-selectively modified PrP variant equipped with a fluorescent GPI anchor mimic (PrP-GPI) was employed to directly observe PrP at the cellular membrane in neuronal SH-SY5Y cells. PrP-GPI exhibits a cholesterol-dependent membrane accumulation and a cytoskeleton-dependent mobility. More specifically, inhibition of actin polymerization reduced the diffusion of PrP-GPI indicating protein clustering, which resembles the initial step of PrP aggregation and conversion into its pathogenic isoform. An intact actin cytoskeleton might therefore prevent conversion of PrPC into PrPSc and offer new therapeutic angles.	[Hackl, Stefanie; Becker, Christian F. W.] Univ Vienna, Fac Chem, Inst Biol Chem, Vienna, Austria; [Ng, Xue Wen; Lu, Danqin; Wohland, Thorsten] Natl Univ Singapore NUS, Dept Biol Sci, Singapore, Singapore; [Ng, Xue Wen; Lu, Danqin; Wohland, Thorsten] Natl Univ Singapore NUS, Dept Chem, Singapore, Singapore; [Ng, Xue Wen; Lu, Danqin; Wohland, Thorsten] Natl Univ Singapore NUS, Ctr Bioimaging Sci CBIS, Singapore, Singapore; [Lu, Danqin] East China Normal Univ, Sch Chem & Mol Engn, Shanghai, Peoples R China	University of Vienna; East China Normal University	Becker, CFW (corresponding author), Univ Vienna, Fac Chem, Inst Biol Chem, Vienna, Austria.	christian.becker@univie.ac.at	Becker, Christian F/A-4891-2010	Becker, Christian F/0000-0002-8890-7082	Wien Kultur; Singapore Ministry of Education [R-154-000-B53-114]; Vienna Science and Technology Fund (WWTF) [LS17-008]	Wien Kultur; Singapore Ministry of Education(Ministry of Education, Singapore); Vienna Science and Technology Fund (WWTF)	S. H. is grateful for financial support by Wien Kultur. T. W. received support from the Singapore Ministry of Education (R-154-000-B53-114). C. F. W. B. was funded by the Vienna Science and Technology Fund (WWTF, LS17-008).	Aguzzi A, 2000, CELL DEATH DIFFER, V7, P889, DOI 10.1038/sj.cdd.4400737; Aguzzi A, 1998, HAEMOPHILIA, V4, P619, DOI 10.1046/j.1365-2516.1998.440619.x; Araman C, 2017, CHEM SCI, V8, P6626, DOI 10.1039/c7sc02719b; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Bag N, 2015, BIOPHYS J, V109, P1925, DOI 10.1016/j.bpj.2015.09.007; Bag N, 2013, CHEM COMMUN, V49, P9155, DOI 10.1039/c3cc44880k; Bag N, 2012, CHEMPHYSCHEM, V13, P2784, DOI 10.1002/cphc.201200032; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Becker CFW, 2008, ANGEW CHEM INT EDIT, V47, P8215, DOI 10.1002/anie.200802161; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chu NK, 2014, J BIOL CHEM, V289, P30144, DOI 10.1074/jbc.M114.587345; Chu NK, 2009, METHOD ENZYMOL, V462, P177, DOI 10.1016/S0076-6879(09)62009-7; Conibear AC, 2018, CHEM SOC REV, V47, P9046, DOI 10.1039/c8cs00573g; Cordelieres F., 2008, IMAGEJ USER DEVELOPE, P174; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; de la Serna JB, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00106; Dertinger T, 2007, CHEMPHYSCHEM, V8, P433, DOI 10.1002/cphc.200600638; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Han Sen, 2008, V459, P145, DOI 10.1007/978-1-59745-234-2_11; Huang S, 2017, BBA-BIOMEMBRANES, V1859, P1483, DOI 10.1016/j.bbamem.2016.12.009; Kapusta P., 2010, ABSOLUTE DIFFUSION C, V1, P1, DOI DOI 10.1209/0295-5075/83/46001; KOPPEL DE, 1974, PHYS REV A, V10, P1938, DOI 10.1103/PhysRevA.10.1938; Korbel GA, 2001, J AM CHEM SOC, V123, P361, DOI 10.1021/ja0034747; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Metzner C, 2013, MOL BIOTECHNOL, V53, P9, DOI 10.1007/s12033-012-9616-6; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Ng XW, 2016, BIOPHYS J, V111, P418, DOI 10.1016/j.bpj.2016.06.021; Olschewski D, 2007, CHEM BIOL, V14, P994, DOI 10.1016/j.chembiol.2007.08.007; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raghupathy R, 2015, CELL, V161, P581, DOI 10.1016/j.cell.2015.03.048; Rao MD, 2014, CURR OPIN CELL BIOL, V29, P126, DOI 10.1016/j.ceb.2014.05.007; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rigler R., 1992, SPIE LASER SPECTROSC, V1921, P239; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; Saha S, 2015, MOL BIOL CELL, V26, P4033, DOI 10.1091/mbc.E15-06-0397; Sang JC, 2019, CHEM SCI, V10, P4588, DOI 10.1039/c8sc05627g; Sang JC, 2018, J AM CHEM SOC, V140, P14789, DOI 10.1021/jacs.8b08311; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Sankaran J, 2013, ANAL CHEM, V85, P3948, DOI 10.1021/ac303485t; Sankaran J, 2010, OPT EXPRESS, V18, P25468, DOI 10.1364/OE.18.025468; Sasse J., 2004, CURR PROTOC IMMUNOL; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sun GY, 2015, ANAL CHEM, V87, P4326, DOI 10.1021/acs.analchem.5b00022; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Thompson R. E., 2019, CHEM REV; vanSteensel B, 1996, J CELL SCI, V109, P787; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weissmann C, 1999, J BIOL CHEM, V274, P3, DOI 10.1074/jbc.274.1.3; Weissmann Charles, 1994, Trends in Cell Biology, V4, P10, DOI 10.1016/0962-8924(94)90032-9; Widengren J, 2000, J PHYS CHEM A, V104, P6416, DOI 10.1021/jp000059s; Widengren J, 1999, CHEM PHYS, V250, P171, DOI 10.1016/S0301-0104(99)00255-4; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Wohland T, 2001, BIOPHYS J, V80, P2987, DOI 10.1016/S0006-3495(01)76264-9; Yamane T, 2011, BIOCONJUGATE CHEM, V22, P2227, DOI 10.1021/bc200127t; Yu H, 2015, P NATL ACAD SCI USA, V112, P8308, DOI 10.1073/pnas.1419197112; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang LY, 2015, CHEM COMMUN, V51, P7386, DOI 10.1039/c5cc01601k; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	80	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100359	10.1016/j.jbc.2021.100359	http://dx.doi.org/10.1016/j.jbc.2021.100359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33539927	gold, Green Published			2022-12-28	WOS:000672866400333
J	Li, GL; Wang, HQ; Zhang, XW; Wu, ZF; Yang, HQ				Li, Guoling; Wang, Haoqiang; Zhang, Xianwei; Wu, Zhenfang; Yang, Huaqiang			A Cas9-transcription factor fusion protein enhances homology-directed repair efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Precise gene insertion or replacement in cells and animals that requires incorporation of a foreign DNA template into the genome target site by homology-directed repair (HDR) remains an inefficient process. One of the limiting factors for the inefficiency of HDR lies in the limited chance for colocalization of the donor template and target in the huge genome space. We here present a strategy to enhance HDR efficiency in animal cells by spatial and temporal colocalization of the donor and Cas9 by coupling the CRISPR system with a transcription factor (TF). We first identified that THAP domain-containing 11 (THAP11) can coordinate with CRISPR/Cas9 to increase HDR stably through screening multiple TFs from different species. We next designed donor structures with different fusion patterns with TF-specific DNA-binding motifs and found that appending two copies of THAP11-specific DNA binding motifs to both ends of the double-stranded donor DNA has an optimal effect to promote HDR. The THAP11-fused CRISPR system achieved more than twofold increase in HDR-mediated knock-in efficiency for enhanced green fluorescent protein (EGFP) tagging of endogenous genes in 293T cells. We also demonstrated up to 6-fold increases of knock-in through the combinational use of the TF-fused CRISPR and valnemulin, a recently discovered small-molecule HDR enhancer. This modified CRISPR system provides a simple but highly efficient platform to facilitate CRISPR-mediated KI manipulations.	[Li, Guoling; Wang, Haoqiang; Zhang, Xianwei; Wu, Zhenfang; Yang, Huaqiang] South China Agr Univ, Coll Anim Sci, Guangzhou, Peoples R China; [Li, Guoling] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci,State Key Lab Neurosci,CAS Ctr Exce, Key Lab Primate Neurobiol,Shanghai Res Ctr Brain, Shanghai 200031, Peoples R China	South China Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wu, ZF; Yang, HQ (corresponding author), South China Agr Univ, Coll Anim Sci, Guangzhou, Peoples R China.	wzf@scau.edu.cn; yangh@scau.edu.cn	; Wang, Haoqiang/A-6243-2019	Yang, Huaqiang/0000-0002-4287-0026; Wang, Haoqiang/0000-0003-4944-1117; Li, Guoling/0000-0003-0422-6157	National Natural Science Foundation of China [31772555]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Natural Science Foundation of China (31772555).	Aird EJ, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0054-2; Carlson-Stevermer J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01875-9; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Gu B, 2018, NAT BIOTECHNOL, V36, P632, DOI 10.1038/nbt.4166; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Lee K, 2017, ELIFE, V6, DOI 10.7554/eLife.25312; Li HL, 2016, METHODS, V101, P27, DOI 10.1016/j.ymeth.2015.10.015; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Ling XY, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz0051; Ma M, 2017, CELL RES, V27, P578, DOI 10.1038/cr.2017.29; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Riesenberg S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04609-7; Savic N, 2018, ELIFE, V7, DOI 10.7554/eLife.33761; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stipkovits L, 2005, RES VET SCI, V78, P207, DOI 10.1016/j.rvsc.2004.09.005; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Yang HQ, 2014, CELL RES, V24, P464, DOI 10.1038/cr.2014.25; Zhang JP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1164-8; Zhang XW, 2018, ELIFE, V7, DOI 10.7554/eLife.34286	21	7	9	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100525	10.1016/j.jbc.2021.100525	http://dx.doi.org/10.1016/j.jbc.2021.100525			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33689695	gold, Green Published			2022-12-28	WOS:000672866400499
J	Maurya, GK; Chaudhary, R; Pandey, N; Misra, HS				Maurya, Ganesh K.; Chaudhary, Reema; Pandey, Neha; Misra, Hari S.			Molecular insights into replication initiation in a multipartite genome harboring bacterium Deinococcus radiodurans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADIATION-RESISTANT BACTERIUM; DNA-BINDING DOMAIN; CHROMOSOMAL REPLICATION; VIBRIO-CHOLERAE; HELICOBACTER-PYLORI; CELL-CYCLE; FUNCTIONAL-CHARACTERIZATION; ORIGIN REGION; STRANDED-DNA; PROTEIN DNAA	Deinococcus radiodurans harbors a multipartite ploid genome system consisting of two chromosomes and two plasmids present in multiple copies. How these discrete genome elements are maintained and inherited is not well understood. PprA, a pleiotropic protein involved in radioresistance, has been characterized for its roles in DNA repair, genome segregation, and cell division in this bacterium. Here, we show that PprA regulates ploidy of chromosome I and II and inhibits the activity of drDnaA, the initiator protein in D. radiodurans. We found that pprA deletion resulted in an increased genomic content and ploidy of both the chromosomal elements. Expression of PprA in trans rescued the phenotypes of the pprA mutant. To understand the molecular mechanism underlying these phenotypes, we characterized drDnaA and drDnaB. As expected for an initiator protein, recombinant drDnaA showed sequence-specific interactions with the putative oriC sequence in chromosome I (oriCI). Both drDnaA and drDnaB showed ATPase activity, also typical of initiator proteins, but only drDnaB exhibited 5'-> 3' dsDNA helicase activity in vitro. drDnaA and drDnaB showed homotypic and heterotypic interactions with each other, which were perturbed by PprA. Interestingly, PprA has inhibited the ATPase activity of drDnaA but showed no effect on the activity of drDnaB. Regulation of chromosome copy number and inhibition of the initiator protein functions by PprA strongly suggest that it plays a role as a checkpoint regulator of the DNA replication initiation in D. radiodurans perhaps through its interaction with the replication initiation machinery.	[Maurya, Ganesh K.; Chaudhary, Reema; Pandey, Neha; Misra, Hari S.] Bhabha Atom Res Ctr, Mumbai, Maharashtra, India; [Maurya, Ganesh K.; Chaudhary, Reema; Misra, Hari S.] Homi Bhabha Natl Inst, Life Sci, Mumbai, Maharashtra, India; [Pandey, Neha] Univ Mumbai, Life Sci, Mumbai, Maharashtra, India; [Maurya, Ganesh K.] Banaras Hindu Univ, Mahila Mahavidyalaya, Zool, Varanasi 221005, Uttar Pradesh, India	Bhabha Atomic Research Center (BARC); Homi Bhabha National Institute; University of Mumbai; Banaras Hindu University (BHU)	Misra, HS (corresponding author), Bhabha Atom Res Ctr, Mumbai, Maharashtra, India.; Misra, HS (corresponding author), Homi Bhabha Natl Inst, Life Sci, Mumbai, Maharashtra, India.	hsmisra@barc.gov.in		Misra, Hari/0000-0002-9349-1229; Chaudhary, Reema/0000-0002-0529-7080; K Maurya, Ganesh/0000-0002-3801-0808				Adachi M, 2019, FASEB J, V33, P3647, DOI 10.1096/fj.201801506R; Adachi M, 2014, PROTEIN SCI, V23, P1349, DOI 10.1002/pro.2519; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Biswas EE, 2009, J BACTERIOL, V191, P249, DOI 10.1128/JB.01259-08; Blaesing F, 2000, MOL MICROBIOL, V36, P557, DOI 10.1046/j.1365-2958.2000.01881.x; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; Bruhn M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02932; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CALCUTT MJ, 1992, J BACTERIOL, V174, P3220, DOI 10.1128/jb.174.10.3220-3226.1992; Caspi R, 2001, EMBO J, V20, P3262, DOI 10.1093/emboj/20.12.3262; Chodavarapu S, 2016, ENZYMES, V39, P1, DOI 10.1016/bs.enz.2016.03.001; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Das AD, 2012, BBA-GEN SUBJECTS, V1820, P1052, DOI 10.1016/j.bbagen.2012.03.014; Devigne A, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00036-15; Devigne A, 2013, DNA REPAIR, V12, P265, DOI 10.1016/j.dnarep.2013.01.004; Egan ES, 2005, MOL MICROBIOL, V56, P1129, DOI 10.1111/j.1365-2958.2005.04622.x; Egan ES, 2003, CELL, V114, P521, DOI 10.1016/S0092-8674(03)00611-1; Fournes F, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01833; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Green MR, 2012, MOL CLONING LAB MANU, V1; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; Huang H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01370; Jha JK, 2012, BBA-GENE REGUL MECH, V1819, P826, DOI 10.1016/j.bbagrm.2012.01.012; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Khairnar NP, 2019, MOL MICROBIOL, V112, P854, DOI 10.1111/mmi.14321; Koch B, 2010, J BACTERIOL, V192, P3903, DOI 10.1128/JB.00311-10; Kota S, 2006, APPL MICROBIOL BIOT, V72, P790, DOI 10.1007/s00253-006-0340-7; Kota S, 2016, EXTREMOPHILES, V20, P195, DOI 10.1007/s00792-016-0814-1; Kota S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085288; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Leonard AC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00545; Luo H, 2019, NUCLEIC ACIDS RES, V47, pD74, DOI 10.1093/nar/gky1014; Majka J, 1999, EUR J BIOCHEM, V260, P325, DOI 10.1046/j.1432-1327.1999.00168.x; Matthews LA, 2019, MOL MICROBIOL, V111, P118, DOI 10.1111/mmi.14142; Maurya GK, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000856; Maurya GK, 2019, MICROBIOL RES, V223, P22, DOI 10.1016/j.micres.2019.03.005; Maurya GK, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00325-18; Maurya GK, 2016, MICROBIOL-SGM, V162, P1321, DOI 10.1099/mic.0.000330; Maurya GK, 2019, BIOCHEM J, V476, P909, DOI 10.1042/BCJ20180799; McHenry CS, 2011, CURR OPIN CHEM BIOL, V15, P587, DOI 10.1016/j.cbpa.2011.07.018; Messer W, 1999, BIOCHIMIE, V81, P819, DOI 10.1016/S0300-9084(00)87165-5; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Misra HS, 2013, CURR SCI INDIA, V104, P194; Misra HS, 2018, J GENET, V97, P1013, DOI 10.1007/s12041-018-0969-x; Misra HS, 2006, MOL MICROBIOL, V59, P1308, DOI 10.1111/j.1365-2958.2005.05005.x; Modi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115918; MORIYA S, 1988, EMBO J, V7, P2911, DOI 10.1002/j.1460-2075.1988.tb03149.x; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Naqvi A, 2003, J BACTERIOL, V185, P6633, DOI 10.1128/JB.185.22.6633-6639.2003; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Nitharwal RG, 2012, FEBS J, V279, P234, DOI 10.1111/j.1742-4658.2011.08418.x; Ogura Y, 2003, J BACTERIOL, V185, P6316, DOI 10.1128/JB.185.21.6316-6324.2003; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Rajpurohit YS, 2013, INT J BIOCHEM CELL B, V45, P2541, DOI 10.1016/j.biocel.2013.08.011; Ramachandran R, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/mmbr.00033-16, 10.1128/MMBR.00033-16]; Rasmussen T, 2007, EMBO J, V26, P3124, DOI 10.1038/sj.emboj.7601747; ROTH A, 1995, EMBO J, V14, P2106, DOI 10.1002/j.1460-2075.1995.tb07202.x; Schafer M, 2000, PHOTOCHEM PHOTOBIOL, V71, P514, DOI 10.1562/0031-8655(2000)071<0514:SSOPIT>2.0.CO;2; Schaper S, 2000, J MOL BIOL, V299, P655, DOI 10.1006/jmbi.2000.3764; Scholefield G, 2011, MOL MICROBIOL, V79, P1089, DOI 10.1111/j.1365-2958.2010.07507.x; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Skarstad K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012922; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Soni RK, 2003, NUCLEIC ACIDS RES, V31, P6828, DOI 10.1093/nar/gkg895; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P4051, DOI 10.1093/nar/gkf527; Spencer W, 2009, J BACTERIOL, V191, P5458, DOI 10.1128/JB.00355-09; Sutton MD, 1997, J MOL BIOL, V274, P546, DOI 10.1006/jmbi.1997.1425; Val ME, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501914; Val ME, 2014, CURR OPIN MICROBIOL, V22, P120, DOI 10.1016/j.mib.2014.10.003; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yao NY, 2010, CELL, V141, P1088, DOI 10.1016/j.cell.2010.05.042; YE FC, 1994, CURR MICROBIOL, V29, P23, DOI 10.1007/BF01570187; Yoshiakwa H., 1993, P507; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x; Zawilak A, 2004, BIOCHEM J, V382, P247, DOI 10.1042/BJ20040338; Zawilak A, 2001, NUCLEIC ACIDS RES, V29, P2251, DOI 10.1093/nar/29.11.2251; Zawilak-Pawlik A, 2017, GENES-BASEL, V8, DOI 10.3390/genes8050136; Zhang H, 2014, FEBS J, V281, P1256, DOI 10.1111/febs.12703	82	1	1	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100451	10.1016/j.jbc.2021.100451	http://dx.doi.org/10.1016/j.jbc.2021.100451			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33626388	gold, Green Published			2022-12-28	WOS:000672866400425
J	Popov, AV; Endutkin, AV; Yatsenko, DD; Yudkina, AV; Barmatov, AE; Makasheva, KA; Raspopova, DY; Diatlova, EA; Zharkov, DO				Popov, Aleksandr V.; Endutkin, Anton V.; Yatsenko, Darya D.; Yudkina, Anna V.; Barmatov, Alexander E.; Makasheva, Kristina A.; Raspopova, Darya Yu.; Diatlova, Evgeniia A.; Zharkov, Dmitry O.			Molecular dynamics approach to identification of new OGG1 cancer-associated somatic variants with impaired activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HUMAN 8-OXOGUANINE-DNA GLYCOSYLASE; AMINO-ACID SUBSTITUTIONS; DNA GLYCOSYLASE; SUBSTRATE RECOGNITION; HUMAN LUNG; ESCHERICHIA-COLI; PROTEIN HOGG1; MUTATIONS; PREDICTION	DNA of living cells is always exposed to damaging factors. To counteract the consequences of DNA lesions, cells have evolved several DNA repair systems, among which base excision repair is one of the most important systems. Many currently used antitumor drugs act by damaging DNA, and DNA repair often interferes with chemotherapy and radiotherapy in cancer cells. Tumors are usually extremely genetically heterogeneous, often bearing mutations in DNA repair genes. Thus, knowledge of the functionality of cancer-related variants of proteins involved in DNA damage response and repair is of great interest for personalization of cancer therapy. Although computational methods to predict the variant functionality have attracted much attention, at present, they are mostly based on sequence conservation and make little use of modern capabilities in computational analysis of 3D protein structures. We have used molecular dynamics (MD) to model the structures of 20 clinically observed variants of a DNA repair enzyme, 8-oxoguanine DNA glycosylase. In parallel, we have experimentally characterized the activity, thermostability, and DNA binding in a subset of these mutant proteins. Among the analyzed variants of 8-oxoguanine DNA glycosylase, three (I145M, G202C, and V267M) were significantly functionally impaired and were successfully predicted by MD. Alone or in combination with sequence-based methods, MD may be an important functional prediction tool for cancer-related protein variants of unknown significance.	[Popov, Aleksandr V.; Endutkin, Anton V.; Yatsenko, Darya D.; Yudkina, Anna V.; Barmatov, Alexander E.; Diatlova, Evgeniia A.; Zharkov, Dmitry O.] RAS, Inst Chem Biol & Fundamental Med, SB, Lab Genome & Prot Engn, Novosibirsk, Russia; [Yatsenko, Darya D.; Makasheva, Kristina A.; Raspopova, Darya Yu.; Zharkov, Dmitry O.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University	Popov, AV; Zharkov, DO (corresponding author), RAS, Inst Chem Biol & Fundamental Med, SB, Lab Genome & Prot Engn, Novosibirsk, Russia.; Zharkov, DO (corresponding author), Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia.	apopov@niboch.nsc.ru; dzharkov@niboch.nsc.ru	Zharkov, Dmitry/K-2158-2012; Yudkina, Anna/ABA-5710-2020; Barmatov, Alexander/ABE-2455-2021; Diatlova, Evgeniia/AAF-7949-2021; Yatsenko, Darya/ABE-1887-2021	Zharkov, Dmitry/0000-0001-5013-0194; Yudkina, Anna/0000-0003-3682-3431; Barmatov, Alexander/0000-0003-4478-1200; Yatsenko, Darya/0000-0002-4230-7364; Endutkin, Anton/0000-0002-3647-6591; Diatlova, Evgeniia/0000-0001-5808-8568; Makasheva, Kristina/0000-0002-0645-6848	Russian Foundation for Basic Research [17-00-00261/17-00-00265-komfi]; Russian Science Foundation [18-74-00052]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This research was supported by the Russian Foundation for Basic Research (grant 17-00-00261/17-00-00265-komfi to D. O. Z) and Russian Science Foundation (grant 18-74-00052 to A. V. P.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anderson PC, 2009, J AM CHEM SOC, V131, P9506, DOI 10.1021/ja809726e; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P15020, DOI 10.1073/pnas.0603644103; Beckman RA, 2017, DNA REPAIR, V56, P7, DOI 10.1016/j.dnarep.2017.06.002; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Blumenthal DT, 2015, INT J CLIN ONCOL, V20, P650, DOI 10.1007/s10147-014-0769-0; Boldinova EO, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133279; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Calvaresi M, 2007, J PHYS CHEM B, V111, P6557, DOI 10.1021/jp071581i; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Case D. A., 2021, AMBER 2022; Castellana S, 2013, BRIEF BIOINFORM, V14, P448, DOI 10.1093/bib/bbt013; Chae YK, 2016, ONCOTARGET, V7, P23312, DOI 10.18632/oncotarget.8196; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Chung SJ, 2004, CHEM BIOL, V11, P1643, DOI 10.1016/j.chembiol.2004.09.014; Crenshaw CM, 2012, J BIOL CHEM, V287, P24916, DOI 10.1074/jbc.M111.316497; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Dalhus B, 2011, STRUCTURE, V19, P117, DOI 10.1016/j.str.2010.09.023; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dehghanpoor R, 2018, MOLECULES, V23, DOI 10.3390/molecules23020251; Deza M.M, 2014, ENCY DISTANCES, Vthird; Esadze A, 2017, BIOCHEMISTRY-US, V56, P1974, DOI 10.1021/acs.biochem.7b00017; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Germano G, 2017, NATURE, V552, P116, DOI 10.1038/nature24673; Gibbons DL, 2014, P NATL ACAD SCI USA, V111, P3550, DOI 10.1073/pnas.1321173111; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; He YH, 2002, AM J PHYSIOL-LUNG C, V282, pL50, DOI 10.1152/ajplung.00316.2001; Hill JW, 2007, CANCER DETECT PREV, V31, P237, DOI 10.1016/j.cdp.2007.05.001; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Hyun JW, 2000, ONCOGENE, V19, P4476, DOI 10.1038/sj.onc.1203787; Hyun JW, 2002, FREE RADICAL BIO MED, V32, P212, DOI 10.1016/S0891-5849(01)00793-6; Kaina B, 2010, CELL MOL LIFE SCI, V67, P3663, DOI 10.1007/s00018-010-0491-7; Kamps R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020308; Kellie JL, 2015, J PHYS CHEM B, V119, P8013, DOI 10.1021/acs.jpcb.5b04051; Kellie JL, 2012, J PHYS CHEM B, V116, P10786, DOI 10.1021/jp306344g; Khafizov K, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2794-y; Kobune M, 2001, CANCER RES, V61, P5116; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Kucukkal TG, 2015, CURR OPIN STRUC BIOL, V32, P18, DOI 10.1016/j.sbi.2015.01.003; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Lawley PD, 1996, MUTAT RES-FUND MOL M, V355, P13, DOI 10.1016/0027-5107(96)00020-6; Lee S, 2008, J AM CHEM SOC, V130, P7784, DOI 10.1021/ja800821t; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li HQ, 2017, J AM CHEM SOC, V139, P2682, DOI 10.1021/jacs.6b11433; Liu LA, 2012, CURR OPIN STRUC BIOL, V22, P397, DOI 10.1016/j.sbi.2012.06.002; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Lukina MV, 2013, J BIOL CHEM, V288, P28936, DOI 10.1074/jbc.M113.487322; Martelotto LG, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0484-1; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; Norman DPG, 2001, J AM CHEM SOC, V123, P359, DOI 10.1021/ja003144m; Oliver C, 2017, EUR J MED GENET, V60, P289, DOI 10.1016/j.ejmg.2017.03.008; Pejaver V, 2017, HUM MUTAT, V38, P1092, DOI 10.1002/humu.23258; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Popov AV, 2020, BIOCHEMISTRY-MOSCOW+, V85, P192, DOI 10.1134/S0006297920020066; Popov AV, 2013, J COMPUT CHEM, V34, P319, DOI 10.1002/jcc.23135; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Preston TJ, 2009, MOL CANCER THER, V8, P2015, DOI 10.1158/1535-7163.MCT-08-0929; Radom CT, 2007, J BIOL CHEM, V282, P9182, DOI 10.1074/jbc.M608989200; Raimondi D, 2016, BIOINFORMATICS, V32, P1797, DOI 10.1093/bioinformatics/btw094; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sadeghian K, 2015, J AM CHEM SOC, V137, P9824, DOI 10.1021/jacs.5b01449; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Schyman P, 2005, J PHYS CHEM A, V109, P1713, DOI 10.1021/jp045686m; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Sidorenko VS, 2007, DNA REPAIR, V6, P317, DOI 10.1016/j.dnarep.2006.10.022; Sidorenko VS, 2008, FEBS J, V275, P3747, DOI 10.1111/j.1742-4658.2008.06521.x; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Sneha P, 2016, ADV PROTEIN CHEM STR, V102, P181, DOI 10.1016/bs.apcsb.2015.09.004; Sowlati-Hashjin S, 2018, BIOCHEMISTRY-US, V57, P1144, DOI 10.1021/acs.biochem.7b01292; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tyugashev TE, 2019, J PHYS CHEM B, V123, P4878, DOI 10.1021/acs.jpcb.9b02949; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wong KC, 2014, BIOINFORMATICS, V30, P1112, DOI 10.1093/bioinformatics/btt769; Wu M, 2008, TOXICOL APPL PHARM, V228, P395, DOI 10.1016/j.taap.2007.12.020; Xu Y, 2001, J PHARMACOL EXP THER, V296, P825; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	90	2	2	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100229	10.1074/jbc.RA120.014455	http://dx.doi.org/10.1074/jbc.RA120.014455			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361155	gold, Green Published			2022-12-28	WOS:000672866400207
J	Ramalingam, N; Dettmer, U				Ramalingam, Nagendran; Dettmer, Ulf			Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE; PARKINSONS-DISEASE; GAMMA-SYNUCLEIN; PATHOGENIC MUTATIONS; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; LEWY BODIES; DEMENTIA; LOCALIZATION; ACCUMULATION	Aggregation of alpha-synuclein (alpha S) leads to the hallmark neuropathology of Parkinson's disease (PD) and related synucleinopathies. alpha S has been described to exist in both cytosolic and membrane-associated forms, the relative abundance of which has remained unsettled. To study alpha S under the most relevant conditions by a quantitative method, we cultured and matured rodent primary cortical neurons for >17 days and determined alpha S cytosol:membrane distribution via centrifugation-free sequential extractions based on the weak ionic detergent digitonin. We noticed that at lower temperatures (4 degrees C or room temperature), alpha S was largely membrane-associated. At 37 degrees C, however, alpha S solubility was markedly increased. In contrast, the extraction of control proteins (GAPDH, cytosolic; calnexin, membrane) was not affected by temperature. When we compared the relative distribution of the synuclein homologs alpha S and beta-synuclein (beta S) under various conditions that differed in temperature and digitonin concentration (200-1200 mu g/ml), we consistently found alpha S to be more membrane-associated than beta S. Both proteins, however, exhibited temperature-dependent membrane binding. Under the most relevant conditions (37 degrees C and 800 mu g/ml digitonin, i.e., the lowest digitonin concentration that extracted cytosolic GAPDH to near completion), cytosolic distribution was 49.8% +/- 9.0% for alpha S and 63.6% +/- 6.6% for beta S. PD-linked alpha S A30P was found to be largely cytosolic, confirming previous studies that had used different methods. Our work highlights the dynamic nature of cellular synuclein behavior and has important implications for protein-biochemical and cell-biological studies of alpha S proteostasis, such as testing the effects of genetic and pharmacological manipulations.	[Ramalingam, Nagendran; Dettmer, Ulf] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ramalingam, N; Dettmer, U (corresponding author), Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.	nramalingam@bwh.harvard.edu; udettmer@bwh.harvard.edu		Dettmer, Ulf/0000-0001-6676-0107	NIH [NS099328]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant NS099328 (to U. D). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baba M, 1998, AM J PATHOL, V152, P879; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; Buchman VL, 1998, J NEUROSCI, V18, P9335; Burre J, 2015, J NEUROSCI, V35, P5221, DOI 10.1523/JNEUROSCI.4650-14.2015; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2017, HUM MOL GENET, V26, P3466, DOI 10.1093/hmg/ddx227; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fanning S, 2019, MOL CELL, V73, P1001, DOI 10.1016/j.molcel.2018.11.028; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Fortin DL, 2010, MOVEMENT DISORD, V25, pS21, DOI 10.1002/mds.22722; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Imberdis T, 2019, P NATL ACAD SCI USA, V116, P20760, DOI 10.1073/pnas.1903216116; Inigo-Marco I, 2017, P NATL ACAD SCI USA, V114, pE8274, DOI 10.1073/pnas.1703420114; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kim YS, 2006, J MOL BIOL, V360, P386, DOI 10.1016/j.jmb.2006.05.004; Lavedan C, 1998, HUM GENET, V103, P106, DOI 10.1007/s004390050792; Lavedan C, 1998, DNA Res, V5, P401, DOI 10.1093/dnares/5.6.401; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Lincoln S, 1999, NEUROSCI LETT, V269, P107, DOI 10.1016/S0304-3940(99)00420-6; Liu XY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002373; MAROTEAUX L, 1991, MOL BRAIN RES, V11, P335, DOI 10.1016/0169-328X(91)90043-W; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nishioka K, 2010, ARCH NEUROL-CHICAGO, V67, P970, DOI 10.1001/archneurol.2010.177; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; SCHULZ I, 1990, METHOD ENZYMOL, V192, P280; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Unni VK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010589; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Viennet T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0049-z; Vincent BM, 2018, CELL REP, V25, P2742, DOI 10.1016/j.celrep.2018.11.028; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yeboah F, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104543	43	5	5	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100271	10.1016/j.jbc.2021.100271	http://dx.doi.org/10.1016/j.jbc.2021.100271			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33428933	gold, Green Published			2022-12-28	WOS:000672866400247
J	Roberts, JP; Stokoe, SA; Sathler, MF; Nichols, RA; Kim, S				Roberts, Jessica P.; Stokoe, Sarah A.; Sathler, Matheus F.; Nichols, Robert A.; Kim, Seonil			Selective coactivation of alpha 7-and alpha 4 beta 2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACH RECEPTORS; LIGAND-BINDING DOMAIN; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; COGNITIVE FUNCTION; INTERNEURONS; PEPTIDE; SUBTYPES; ACTIVATION; LONG	Beta-amyloid (A beta) has been recognized as an early trigger in the pathogenesis of Alzheimer's disease (AD) leading to synaptic and cognitive impairments. A beta can alter neuronal signaling through interactions with nicotinic acetylcholine receptors (nAChRs), contributing to synaptic dysfunction in AD. The three major nAChR subtypes in the hippocampus are composed of alpha 7-, alpha 4 beta 2-, and alpha 3 beta 4-nAChRs. A beta selectively affects alpha 7- and alpha 4 beta 2-nAChRs, but not alpha 3 beta 4-nAChRs in hippocampal neurons, resulting in neuronal hyperexcitation. However, how nAChR subtype selectivity for A beta affects synaptic function in AD is not completely understood. Here, we showed that A beta associated with alpha 7- and alpha 4 beta 2-nAChRs but not alpha 3 beta 4-nAChRs. Computational modeling suggested that two amino acids in alpha 7-nAChRs, arginine 208 and glutamate 211, were important for the interaction between A beta and alpha 7-containing nAChRs. These residues are conserved only in the alpha 7 and alpha 4 subunits. We therefore mutated these amino acids in alpha 7-containing nAChRs to mimic the alpha 3 subunit and found that mutant alpha 7-containing receptors were unable to interact with A beta. In addition, mutant alpha 3-containing nAChRs mimicking the alpha 7 subunit interact with A beta. This provides direct molecular evidence for how A beta selectively interacted with alpha 7- and alpha 4 beta 2-nAChRs, but not alpha 3 beta 4-nAChRs. Selective coactivation of alpha 7- and alpha 4 beta 2-nAChRs also sufficiently reversed A beta-induced AMPA receptor dysfunction, including A beta-induced reduction of AMPA receptor phosphorylation and surface expression in hippocampal neurons. Moreover, costimulation of alpha 7- and alpha 4 beta 2-nAChRs reversed the A beta-induced disruption of long-term potentiation. These findings support a novel mechanism for A beta's impact on synaptic function in AD, namely, the differential regulation of nAChR subtypes.	[Roberts, Jessica P.; Stokoe, Sarah A.; Kim, Seonil] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Roberts, Jessica P.; Stokoe, Sarah A.; Sathler, Matheus F.; Kim, Seonil] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Nichols, Robert A.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	Colorado State University; Colorado State University; University of Hawaii System; University of Hawaii Manoa	Kim, S (corresponding author), Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA.; Kim, S (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	soenil.kim@colostate.edu			University of Hawai'i Foundation Preclinical Alzheimer's Research Fund; Colorado Clinical and Translational Sciences Institute; College Research Council Shared Research Program from Colorado State University; Boettcher Foundation's Webb-Waring Biomedical Research Program; The Barry Goldwater Scholarship and Excellence in Education Foundation; Astronaut Scholarship Foundation; Student Experiential Learning Grant from Colorado State University	University of Hawai'i Foundation Preclinical Alzheimer's Research Fund; Colorado Clinical and Translational Sciences Institute; College Research Council Shared Research Program from Colorado State University; Boettcher Foundation's Webb-Waring Biomedical Research Program; The Barry Goldwater Scholarship and Excellence in Education Foundation; Astronaut Scholarship Foundation; Student Experiential Learning Grant from Colorado State University	This work is supported by the University of Hawai'i Foundation Preclinical Alzheimer's Research Fund (R. A. N.), the pilot program from the Colorado Clinical and Translational Sciences Institute (S. K.), College Research Council Shared Research Program from Colorado State University (S. K.), the Boettcher Foundation's Webb-Waring Biomedical Research Program (S. K.), The Barry Goldwater Scholarship and Excellence in Education Foundation (J. P. R.), Astronaut Scholarship Foundation (J. P. R.), and Student Experiential Learning Grant from Colorado State University (J. P. R. and S. A. S.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alkondon M, 2001, J NEUROPHYSIOL, V86, P3043, DOI 10.1152/jn.2001.86.6.3043; Alkondon M, 1998, BRAIN RES, V810, P257, DOI 10.1016/S0006-8993(98)00880-4; Alkondon M, 2003, J NEUROPHYSIOL, V90, P1613, DOI 10.1152/jn.00214.2003; Auld DS, 1998, TRENDS NEUROSCI, V21, P43, DOI 10.1016/S0166-2236(97)01144-2; Barykin EP, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176272; Benson DL, 1996, J NEUROSCI, V16, P6424; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Blaszczyk M, 2016, METHODS, V93, P72, DOI 10.1016/j.ymeth.2015.07.004; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Buccafusco J, 2004, MOL INTERV, V4, P285, DOI 10.1124/mi.4.5.8; Buhler AV, 2002, J NEUROPHYSIOL, V87, P548, DOI 10.1152/jn.00316.2001; Buhler AV, 2001, NEUROSCIENCE, V106, P55, DOI 10.1016/S0306-4522(01)00257-3; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cincotta SL, 2008, CURR OPIN INVEST DR, V9, P47; Clementi F, 2000, EUR J PHARMACOL, V393, P3, DOI 10.1016/S0014-2999(00)00066-2; DAVIES P, 1976, LANCET, V2, P1403; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Dimidschstein J, 2016, NAT NEUROSCI, V19, P1743, DOI 10.1038/nn.4430; Dineley KT, 2007, FRONT BIOSCI-LANDMRK, V12, P5030, DOI 10.2741/2445; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Espinoza-Fonseca LM, 2004, BIOCHEM BIOPH RES CO, V320, P587, DOI 10.1016/j.bbrc.2004.05.207; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Ferreira-Vieira TH, 2016, CURR NEUROPHARMACOL, V14, P101, DOI 10.2174/1570159X13666150716165726; Forest KH, 2018, J NEUROCHEM, V144, P201, DOI 10.1111/jnc.14257; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Ge SY, 2005, J NEUROSCI, V25, P6084, DOI 10.1523/JNEUROSCI.0542-05.2005; Gharpure A, 2019, NEURON, V104, P501, DOI 10.1016/j.neuron.2019.07.030; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grassi F, 2003, J PHYSIOL-LONDON, V547, P147, DOI 10.1113/jphysiol.2002.035436; Guan ZZ, 2000, J NEUROCHEM, V74, P237, DOI 10.1046/j.1471-4159.2000.0740237.x; Guntupalli S, 2017, J BIOL CHEM, V292, P8186, DOI 10.1074/jbc.M116.774554; Haider Syed R, 2012, Methods Mol Biol, V869, P81, DOI 10.1007/978-1-61779-821-4_8; Hefft S, 1999, J PHYSIOL-LONDON, V515, P769, DOI 10.1111/j.1469-7793.1999.769ab.x; Heinitz K, 2006, J NEUROCHEM, V98, P1930, DOI 10.1111/j.1471-4159.2006.04015.x; Hoskin JL, 2019, NICOTINE TOB RES, V21, P370, DOI 10.1093/ntr/nty116; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jahn Holger, 2013, Dialogues Clin Neurosci, V15, P445; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; Jurgensen S, 2010, J MOL NEUROSCI, V40, P221, DOI 10.1007/s12031-009-9237-0; Kabbani N, 2018, TRENDS PHARMACOL SCI, V39, P354, DOI 10.1016/j.tips.2018.01.002; Kadir A, 2006, PSYCHOPHARMACOLOGY, V188, P509, DOI 10.1007/s00213-006-0447-7; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim S, 2016, MOL PSYCHIATR, V21, P707, DOI 10.1038/mp.2015.97; Kim S, 2015, NEUROBIOL AGING, V36, P3239, DOI 10.1016/j.neurobiolaging.2015.09.007; Kim S, 2015, P NATL ACAD SCI USA, V112, P3122, DOI 10.1073/pnas.1417498112; Kim S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001900; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lawrence JLM, 2014, J NEUROSCI, V34, P14210, DOI 10.1523/JNEUROSCI.0326-14.2014; Levin ED, 1998, PSYCHOPHARMACOLOGY, V138, P217, DOI 10.1007/s002130050667; Levin ED, 2002, DRUG DEVELOP RES, V55, P97, DOI 10.1002/ddr.10024; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Lindstrom JM, 2003, ANN NY ACAD SCI, V998, P41, DOI 10.1196/annals.1254.007; Liu Q, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-155; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Lombardo S, 2015, NEUROPHARMACOLOGY, V96, P255, DOI 10.1016/j.neuropharm.2014.11.018; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Ma T, 2012, J NEUROCHEM, V120, P140, DOI 10.1111/j.1471-4159.2011.07506.x; Maatuk N, 2013, NEUROTOXICOLOGY, V34, P236, DOI 10.1016/j.neuro.2012.09.007; Magdesian MH, 2005, J BIOL CHEM, V280, P31085, DOI 10.1074/jbc.M502406200; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; McClure-Begley TD, 2009, MOL PHARMACOL, V75, P918, DOI 10.1124/mol.108.052274; McQuiston AR, 1999, J NEUROSCI, V19, P2887; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mulugeta E, 2003, BRAIN RES, V960, P259, DOI 10.1016/S0006-8993(02)03542-4; Nashmi R, 2003, J NEUROSCI, V23, P11554; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; Olivero G, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00166; Oloris SCS, 2010, TOXICOL APPL PHARM, V242, P299, DOI 10.1016/j.taap.2009.10.020; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Parri HR, 2010, CURR ALZHEIMER RES, V7, P27, DOI 10.2174/156720510790274464; Parri HR, 2011, BIOCHEM PHARMACOL, V82, P931, DOI 10.1016/j.bcp.2011.06.039; Pettit DL, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-01-j0003.2001; Pym L, 2005, BRIT J PHARMACOL, V146, P964, DOI 10.1038/sj.bjp.0706403; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Redrobe JR, 2009, EUR J PHARMACOL, V602, P58, DOI 10.1016/j.ejphar.2008.09.035; Rui YF, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-10; Sathler M. F., PHOSPHORYLATION AMPA; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Son JH, 2008, J COMP NEUROL, V511, P286, DOI 10.1002/cne.21828; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sudweeks SN, 2000, J PHYSIOL-LONDON, V527, P515, DOI 10.1111/j.1469-7793.2000.00515.x; Sun JL, 2019, NEUROBIOL AGING, V84, P166, DOI 10.1016/j.neurobiolaging.2019.09.005; Sun Y, 2008, EUR J NEUROL, V15, P278, DOI 10.1111/j.1468-1331.2007.02049.x; SVENSSON AL, 1992, BRAIN RES, V596, P142, DOI 10.1016/0006-8993(92)91541-L; Sztukowski K, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005315; Thompson Sarah, 2004, Expert Opin Drug Saf, V3, P425, DOI 10.1517/14740338.3.5.425; Tong M, 2011, J BIOL CHEM, V286, P34373, DOI 10.1074/jbc.M111.241299; Tozaki H, 2002, BIOCHEM BIOPH RES CO, V294, P42, DOI 10.1016/S0006-291X(02)00429-1; Vicens Paloma, 2003, Neural Plasticity, V10, P303, DOI 10.1155/NP.2003.303; Vicens P, 2011, BEHAV BRAIN RES, V216, P341, DOI 10.1016/j.bbr.2010.08.015; Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009; Wang HY, 2003, J BIOL CHEM, V278, P31547, DOI 10.1074/jbc.M212532200; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200; Wu Jin, 2010, Int J Alzheimers Dis, V2010, P548913, DOI 10.4061/2010/548913; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	114	12	12	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100402	10.1016/j.jbc.2021.100402	http://dx.doi.org/10.1016/j.jbc.2021.100402			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33571523	Green Submitted, Green Published, gold			2022-12-28	WOS:000672866400376
J	Scherer, KM; Manton, JD; Soh, TK; Mascheroni, L; Connor, V; Crump, CM; Kaminski, CF				Scherer, Katharina M.; Manton, James D.; Soh, Timothy K.; Mascheroni, Luca; Connor, Vivienne; Crump, Colin M.; Kaminski, Clemens F.			A fluorescent reporter system enables spatiotemporal analysis of host cell modification during herpes simplex virus-1 replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL DYNAMICS; HERPESVIRUSES REMODEL; HUMAN-FIBROBLASTS; TYPE-1 INFECTION; GOLGI-APPARATUS; PROTEINS; REDISTRIBUTION; GLYCOPROTEINS; ENVELOPMENT; MICROSCOPY	Herpesviruses are large and complex viruses that have a long history of coevolution with their host species. One important factor in the virus-host interaction is the alteration of intracellular morphology during viral replication with critical implications for viral assembly. However, the details of this remodeling event are not well understood, in part because insufficient tools are available to deconstruct this highly heterogeneous process. To provide an accurate and reliable method of investigating the spatiotemporal dynamics of virus-induced changes to cellular architecture, we constructed a dual-fluorescent reporter virus that enabled us to classify four distinct stages in the infection cycle of herpes simplex virus-1 at the single cell level. This timestamping method can accurately track the infection cycle across a wide range of multiplicities of infection. We used high-resolution fluorescence microscopy analysis of cellular structures in live and fixed cells in concert with our reporter virus to generate a detailed and chronological overview of the spatial and temporal reorganization during viral replication. The highly orchestrated and striking relocation of many organelles around the compartments of secondary envelopment during transition from early to late gene expression suggests that the reshaping of these compartments is essential for virus assembly. We furthermore find that accumulation of HSV-1 capsids in the cytoplasm is accompanied by fragmentation of the Golgi apparatus with potential impact on the late steps of viral assembly. We anticipate that in the future similar tools can be systematically applied for the systems-level analysis of intracellular morphology during replication of other viruses.	[Scherer, Katharina M.; Manton, James D.; Mascheroni, Luca; Kaminski, Clemens F.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Manton, James D.] MRC Lab Mol Biol, Cambridge, England; [Soh, Timothy K.; Connor, Vivienne; Crump, Colin M.] Univ Cambridge, Dept Pathol, Cambridge, England; [Soh, Timothy K.] Heinrich Pette Inst, Martinistr 52, D-20251 Hamburg, Germany	University of Cambridge; MRC Laboratory Molecular Biology; University of Cambridge; Heinrich Pette Institute	Kaminski, CF (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.; Crump, CM (corresponding author), Univ Cambridge, Dept Pathol, Cambridge, England.	cmc56@cam.ac.uk; cfk23@cam.ac.uk	Kaminski, Clemens/G-7488-2016	Kaminski, Clemens/0000-0002-5194-0962; Scherer, Katharina/0000-0002-2042-5407	Deutsche Forschungsgemeinschaft (DFG) [SCHE 1672/2-1]; Fitzwilliam College, Cambridge; MedImmune; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M021424/1]; UK Engineering and Physical Sciences Research Council, EPSRC [EP/L015889/1, EP/H018301/1]; Wellcome Trust [3-3249/Z/16/Z, 089703/Z/09/Z]; UK Medical Research Council, MRC [MR/K015850/1, MR/K02292X/1]; Infinitus (China) Ltd.; BBSRC [BB/M021424/1] Funding Source: UKRI; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [MR/K02292X/1, MR/K015850/1, MC_U105184326] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fitzwilliam College, Cambridge; MedImmune(AstraZenecaMedimmune); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Engineering and Physical Sciences Research Council, EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome Trust); UK Medical Research Council, MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Infinitus (China) Ltd.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	K. M. S. was supported by a research fellowship from the Deutsche Forschungsgemeinschaft (DFG; award SCHE 1672/2-1). J. D. M. acknowledges support from Fitzwilliam College, Cambridge, through a Research Fellowship. L. M. acknowledges funding from MedImmune. C. M. C. acknowledges funding from Biotechnology and Biological Sciences Research Council (BBSRC, BB/M021424/1). C. F. K. acknowledges funding from the UK Engineering and Physical Sciences Research Council, EPSRC (grants EP/L015889/1 and EP/H018301/1), the Wellcome Trust (grants 3-3249/Z/16/Z and 089703/Z/09/Z) and the UK Medical Research Council, MRC (grants MR/K015850/1 and MR/K02292X/1), MedImmune, and Infinitus (China) Ltd.	Aho V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100935; Albecka A, 2016, TRAFFIC, V17, P21, DOI 10.1111/tra.12340; Atkin-Smith GK, 2017, TRENDS CELL BIOL, V27, P151, DOI 10.1016/j.tcb.2016.08.011; AVITABILE E, 1995, J VIROL, V69, P7472, DOI 10.1128/JVI.69.12.7472-7482.1995; Beltran PMJ, 2018, CELL HOST MICROBE, V24, P526, DOI 10.1016/j.chom.2018.09.002; Bosse JB, 2016, NUCLEUS-PHILA, V7, P13, DOI 10.1080/19491034.2016.1149665; CAMPADELLI G, 1993, P NATL ACAD SCI USA, V90, P2798, DOI 10.1073/pnas.90.7.2798; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chiang JJ, 2018, NAT IMMUNOL, V19, P53, DOI 10.1038/s41590-017-0005-y; Chozinski TJ, 2016, NAT METHODS, V13, P485, DOI [10.1038/NMETH.3833, 10.1038/nmeth.3833]; Close WL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01888; Crump C, 2018, ADV EXP MED BIOL, V1045, P23, DOI 10.1007/978-981-10-7230-7_2; Das S, 2011, J VIROL, V85, P5864, DOI 10.1128/JVI.00155-11; Edelstein A. D., 2014, J BIOL METHODS, V1; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Gierasch WW, 2006, J VIROL METHODS, V135, P197, DOI 10.1016/j.jviromet.2006.03.014; Glingston RS, 2019, MICROBES INFECT, V21, P20, DOI 10.1016/j.micinf.2018.06.002; Hollinshead M, 2012, EMBO J, V31, P4204, DOI 10.1038/emboj.2012.262; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Khan M, 2015, BBA-MOL CELL RES, V1853, P2822, DOI 10.1016/j.bbamcr.2014.12.040; Koshiba Takumi, 2011, Int J Biochem Mol Biol, V2, P257; Kotsakis A, 2001, J VIROL, V75, P8697, DOI 10.1128/JVI.75.18.8697-8711.2001; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010975; Lopez P, 2001, J VIROL, V75, P3832, DOI 10.1128/JVI.75.8.3832-3840.2001; Lyman MG, 2009, J VIROL, V83, P2058, DOI 10.1128/JVI.01718-08; Machamer CE, 2003, TRENDS CELL BIOL, V13, P279, DOI 10.1016/S0962-8924(03)00101-6; McSharry BP, 2001, J GEN VIROL, V82, P855, DOI 10.1099/0022-1317-82-4-855; Moen E, 2019, NAT METHODS, V16, P1233, DOI 10.1038/s41592-019-0403-1; Monier K, 2000, NAT CELL BIOL, V2, P661, DOI 10.1038/35023615; Muller M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10980; Murata T, 2000, J GEN VIROL, V81, P401, DOI 10.1099/0022-1317-81-2-401; Naghavi MH, 2013, P NATL ACAD SCI USA, V110, P18268, DOI 10.1073/pnas.1310760110; NORRILD B, 1986, J GEN VIROL, V67, P97, DOI 10.1099/0022-1317-67-1-97; Owen DJ, 2015, VIRUSES-BASEL, V7, P5084, DOI 10.3390/v7092861; Parkinson J, 2000, J VIROL, V74, P10006, DOI 10.1128/JVI.74.21.10006-10017.2000; Poulton JS, 2019, GENETICS, V212, P187, DOI 10.1534/genetics.119.302051; Procter DJ, 2018, DEV CELL, V45, P83, DOI 10.1016/j.devcel.2018.03.010; Rebmann GM, 2016, MBIO, V7, DOI 10.1128/mBio.01554-16; Shaw M, 2015, METHODS, V88, P11, DOI 10.1016/j.ymeth.2015.03.020; Soh TK, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108235; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Valm AM, 2017, NATURE, V546, P162, DOI 10.1038/nature22369; von Chamier L, 2019, BIOCHEM SOC T, V47, P1029, DOI 10.1042/BST20180391; Young LJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53988	46	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100236	10.1074/jbc.RA120.016571	http://dx.doi.org/10.1074/jbc.RA120.016571			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33380421	Green Submitted, Green Published, gold			2022-12-28	WOS:000672866400214
J	Bailleul, G; Nicoll, CR; Mascotti, ML; Mattevi, A; Fraaije, MW				Bailleul, Gautier; Nicoll, Callum R.; Mascotti, Maria Laura; Mattevi, Andrea; Fraaije, Marco W.			Ancestral reconstruction of mammalian FMO1 enables structural determination, revealing unique features that explain its catalytic properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN-CONTAINING MONOOXYGENASES; SUBSTRATE SPECIFICITIES; DRUG-METABOLISM; HALF-REACTION; VISUALIZATION; LOCALIZATION; EXPRESSION; TAMOXIFEN; OXIDATION	Mammals rely on the oxidative flavin-containing mono-oxygenases (FMOs) to detoxify numerous and potentially deleterious xenobiotics; this activity extends to many drugs, giving FMOs high pharmacological relevance. However, our knowledge regarding these membrane-bound enzymes has been greatly impeded by the lack of structural information. We anticipated that ancestral-sequence reconstruction could help us identify protein sequences that are more amenable to structural analysis. As such, we hereby reconstructed the mammalian ancestral protein sequences of both FMO1 and FMO4, denoted as ancestral flavin-containing monooxygenase (AncFMO)1 and AncFMO4, respectively. AncFMO1, sharing 89.5% sequence identity with human FMO1, was successfully expressed as a functional enzyme. It displayed typical FMO activities as demonstrated by oxygenating benzydamine, tamoxifen, and thioanisole, drug-related compounds known to be also accepted by human FMO1, and both NADH and NADPH cofactors could act as electron donors, a feature only described for the FMO1 paralogs. AncFMO1 crystallized as a dimer and was structurally resolved at 3.0 angstrom resolution. The structure harbors typical FMO aspects with the flavin adenine dinucleotide and NAD(P)H binding domains and a C-terminal transmembrane helix. Intriguingly, AncFMO1 also contains some unique features, including a significantly porous and exposed active site, and NADPH adopting a new conformation with the 2'-phosphate being pushed inside the NADP(+) binding domain instead of being stretched out in the solvent. Overall, the ancestrally reconstructed mammalian AncFMO1 serves as the first structural model to corroborate and rationalize the catalytic properties of FMO1.	[Bailleul, Gautier; Mascotti, Maria Laura; Fraaije, Marco W.] Univ Groningen, Mol Enzymol Grp, Groningen, Netherlands; [Nicoll, Callum R.; Mattevi, Andrea] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Pavia, Italy; [Mascotti, Maria Laura] Univ Nacl San Luis, Fac Quim Bioquim & Farm, IMIBIO SL CONICET, San Luis, Argentina	University of Groningen; University of Pavia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Luis	Fraaije, MW (corresponding author), Univ Groningen, Mol Enzymol Grp, Groningen, Netherlands.; Mattevi, A (corresponding author), Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Pavia, Italy.	andrea.mattevi@unipv.it; m.w.fraaije@rug.nl	Mattevi, Andrea/K-5464-2012; Mascotti, Maria Laura/H-9501-2017	Mattevi, Andrea/0000-0002-9523-7128; Mascotti, Maria Laura/0000-0002-5817-4631; Bailleul, Gautier/0000-0001-5083-2727; Fraaije, Marco/0000-0001-6346-5014; Nicoll, Callum/0000-0002-2122-9387	European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant [722390]; Italian Ministry of Education, University and Research (MIUR); ANPCyT (Argentina) [PICT 2016-2839]; European Union [847675]	European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant; Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); ANPCyT (Argentina)(ANPCyT); European Union(European Commission)	The research for this work has received funding from the European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant agreement no. 722390; the Italian Ministry of Education, University and Research (MIUR) under the "Dipartimenti di Eccellenza (2018-2022)" program; The European Union's Horizon 2020 Research and Innovation Programme under grant agreement No 847675 and ANPCyT (Argentina) PICT 2016-2839 to M. L. M. M. L. M. is a member of the Research Career of CONICET, Argentina.	Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; [Anonymous], 2020, EXPR ATL QUER ENSG00; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basarab T, 1999, BRIT J DERMATOL, V140, P164; BEATY NB, 1981, J BIOL CHEM, V256, P4619; BEATY NB, 1981, J BIOL CHEM, V256, P4611; Campbell AC, 2020, BIOCHEMISTRY-US, V59, P4609, DOI 10.1021/acs.biochem.0c00783; Cashman JR, 2006, ANNU REV PHARMACOL, V46, P65, DOI 10.1146/annurev.pharmtox.46.120604.141043; Chitra M., 1993, DRUG METAB DISPOS, V21, P657; Cruciani G, 2014, J MED CHEM, V57, P6183, DOI 10.1021/jm5007098; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; Dolphin CT, 1996, EUR J BIOCHEM, V235, P683, DOI 10.1111/j.1432-1033.1996.00683.x; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fabara AN, 2020, APPL MICROBIOL BIOT, V104, P925, DOI 10.1007/s00253-019-10292-5; Fiorentini F, 2017, ACS CHEM BIOL, V12, P2379, DOI 10.1021/acschembio.7b00470; Fiorentini F, 2016, ACS CHEM BIOL, V11, P1039, DOI 10.1021/acschembio.5b01016; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Hines RN, 2002, MOL PHARMACOL, V62, P320, DOI 10.1124/mol.62.2.320; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hochberg GKA, 2017, ANNU REV BIOPHYS, V46, P247, DOI 10.1146/annurev-biophys-070816-033631; Hu Steven X, 2018, Drug Metab Lett, V12, P125, DOI 10.2174/1872312812666180913145334; Itagaki K, 1996, J BIOL CHEM, V271, P20102, DOI 10.1074/jbc.271.33.20102; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAWAJI A, 1993, ANAL BIOCHEM, V214, P409, DOI 10.1006/abio.1993.1515; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; McCombie RR, 1996, GENOMICS, V34, P426, DOI 10.1006/geno.1996.0308; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merkl R, 2016, BIOL CHEM, V397, P1, DOI 10.1515/hsz-2015-0158; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGATA T, 1990, CHEM RES TOXICOL, V3, P372, DOI 10.1021/tx00016a016; Nicoll CR, 2020, NAT STRUCT MOL BIOL, V27, DOI 10.1038/s41594-019-0347-2; Parte P, 2005, DRUG METAB DISPOS, V33, P1446, DOI 10.1124/dmd.104.000802; Perez-Jimenez R, 2011, NAT STRUCT MOL BIOL, V18, P592, DOI 10.1038/nsmb.2020; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips IR, 2020, XENOBIOTICA, V50, P19, DOI 10.1080/00498254.2019.1643515; Phillips IR, 2017, EXPERT OPIN DRUG MET, V13, P167, DOI 10.1080/17425255.2017.1239718; Robinson R, 2013, BIOCHEMISTRY-US, V52, P9089, DOI 10.1021/bi4014903; Romero E., 2012, J VIS EXP, V10, P3791; Sambrook J., 2001, MOL CLONING LAB MANU; SHEPHARD EA, 1993, GENOMICS, V16, P85, DOI 10.1006/geno.1993.1144; Siddens LK, 2014, BIOCHEM PHARMACOL, V89, P141, DOI 10.1016/j.bcp.2014.02.006; Siddiq MA, 2017, CURR OPIN STRUC BIOL, V47, P113, DOI 10.1016/j.sbi.2017.07.003; SOFER SS, 1978, DRUG METAB DISPOS, V6, P232; Uno Y, 2013, BIOCHEM PHARMACOL, V85, P1837, DOI 10.1016/j.bcp.2013.04.012; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Veeravalli S, 2020, DRUG METAB DISPOS, V48, P378, DOI 10.1124/dmd.119.089995; Vonrhein C, 2018, ACTA CRYSTALLOGR A, V74, pA360, DOI 10.1107/S010876731809640X; Voordeckers K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001446; Zhang J, 2006, DRUG METAB DISPOS, V34, P19, DOI 10.1124/dmd.105.006171; Ziegler D M, 1978, Methods Enzymol, V52, P142; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	53	5	5	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100221	10.1074/jbc.RA120.016297	http://dx.doi.org/10.1074/jbc.RA120.016297			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33759784	Green Published, gold			2022-12-28	WOS:000672866400199
J	Booy, EP; Gussakovsky, D; Choi, T; McKenna, SA				Booy, Evan P.; Gussakovsky, Daniel; Choi, Taegi; McKenna, Sean A.			The noncoding RNA BC200 associates with polysomes to positively regulate mRNA translation in tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC BC1 RNA; ADENOVIRUS TYPE-5; ALU ELEMENTS; IN-VITRO; EXPRESSION; TRANSCRIPTION; PROTEIN; ACTIVATION; CANCER; PROLIFERATION	BC200 is a noncoding RNA elevated in a broad spectrum of tumor cells that is critical for cell viability, invasion, and migration. Overexpression studies have implicated BC200 and the rodent analog BC1 as negative regulators of translation in both cell-based and in vitro translation assays. Although these studies are consistent, they have not been confirmed in knockdown studies and direct evidence for this function is lacking. Herein, we have demonstrated that BC200 knockdown is correlated with a decrease in global translation rates. As this conflicts with the hypothesis that BC200 is a translational suppressor, we overexpressed BC200 by transfection of in vitro transcribed RNA and transient expression from transfected plasmids. In this context BC200 suppressed translation; however, an innate immune response confounded the data. To overcome this, breast cancer cells stably overexpressing BC200 and various control RNAs were developed by selection for genomic incorporation of a plasmid coexpressing BC200 and the neomycin resistance gene. Stable overexpression of BC200 was associated with elevated translation levels in pooled stable cell lines and isolated single-cell clones. Cross-linking sucrose density gradient centrifugation demonstrated an association of BC200 and its reported binding partners SRP9/14, CSDE1, DHX36, and PABPC1 with both ribosomal subunits and polysomal RNA, an association not previously observed owing to the labile nature of the interactions. In summary, these data present a novel understanding of BC200 function as well as optimized methodology that has far reaching implications in the study of noncoding RNAs, particularly within the context of translational regulatory mechanisms.	[Booy, Evan P.; Gussakovsky, Daniel; Choi, Taegi; McKenna, Sean A.] Univ Manitoba, Dept Chem, Winnipeg, MB, Canada	University of Manitoba	McKenna, SA (corresponding author), Univ Manitoba, Dept Chem, Winnipeg, MB, Canada.	sean.mckenna@umanitoba.ca		McKenna, Sean/0000-0002-9407-7257; Gussakovsky, Daniel/0000-0003-3909-4414	Canadian Cancer Society Research Institute Innovation Grant [703809]; CIHR Project Grant; NSERC USRA program	Canadian Cancer Society Research Institute Innovation Grant; CIHR Project Grant(Canadian Institutes of Health Research (CIHR)); NSERC USRA program	This work was supported by a Canadian Cancer Society Research Institute Innovation Grant [703809] and a CIHR Project Grant. D. G. was supported by the NSERC USRA program.	Barton M, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6179-y; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Booy EP, 2018, NUCLEIC ACIDS RES, V46, P11575, DOI 10.1093/nar/gky860; Booy EP, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0679-7; Booy EP, 2016, J BIOL CHEM, V291, P5355, DOI 10.1074/jbc.M115.711499; Booy Evan P, 2012, Methods Mol Biol, V941, P69, DOI 10.1007/978-1-62703-113-4_6; Bosnjak M, 2018, J MEMBRANE BIOL, V251, P179, DOI 10.1007/s00232-017-9948-z; Chasse H, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw907; Chen J, 2014, J CELL MOL MED, V18, P2425, DOI 10.1111/jcmm.12431; Chen LL, 2017, TRENDS CELL BIOL, V27, P480, DOI 10.1016/j.tcb.2017.01.002; Chen W, 1997, J PATHOL, V183, P345, DOI 10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8; Cheng JG, 1997, NEUROSCI LETT, V224, P206, DOI 10.1016/S0304-3940(97)13471-1; Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; Comeaux MS, 2009, GENOME RES, V19, P545, DOI 10.1101/gr.089789.108; DECHIARA TM, 1987, P NATL ACAD SCI USA, V84, P2624, DOI 10.1073/pnas.84.9.2624; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Dempsey A, 2015, VIROLOGY, V479, P146, DOI 10.1016/j.virol.2015.03.013; Eom T, 2011, MOL CELL BIOL, V31, P4538, DOI 10.1128/MCB.05885-11; Filonov GS, 2015, CHEM BIOL, V22, P649, DOI 10.1016/j.chembiol.2015.04.018; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P2374, DOI 10.1093/nar/gkl246; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Herrmannova A, 2020, NUCLEIC ACIDS RES, V48, P1969, DOI 10.1093/nar/gkz1185; Hu T, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0183-3; Iacoangeli A, 2004, CARCINOGENESIS, V25, P2125, DOI 10.1093/carcin/bgh228; JANG KL, 1989, FEBS LETT, V258, P255, DOI 10.1016/0014-5793(89)81667-9; Jang S, 2020, BMB REP, V53, P94, DOI 10.5483/BMBRep.2020.53.2.153; Jang S, 2017, FEBS LETT, V591, P393, DOI 10.1002/1873-3468.12544; Khanam T, 2007, NUCLEIC ACIDS RES, V35, P529, DOI 10.1093/nar/gkl1082; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Lin D, 2008, MOL CELL BIOL, V28, P3008, DOI 10.1128/MCB.01800-07; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; LIU WM, 1995, NUCLEIC ACIDS RES, V23, P1758, DOI 10.1093/nar/23.10.1758; Ludwig A, 2005, J MOL BIOL, V350, P200, DOI 10.1016/j.jmb.2005.03.058; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Morlando M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020570; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muslimov IA, 2019, J NEUROSCI, V39, P7759, DOI 10.1523/JNEUROSCI.1657-18.2019; Noh JH, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1471; Panchapakesan SSS, 2017, RNA, V23, P1592, DOI 10.1261/rna.062166.117; Panchapakesan SSS, 2015, ANN NY ACAD SCI, V1341, P149, DOI 10.1111/nyas.12663; PANNING B, 1995, J MOL BIOL, V248, P513, DOI 10.1006/jmbi.1995.0239; PANNING B, 1993, MOL CELL BIOL, V13, P3231, DOI 10.1128/MCB.13.6.3231; Ponicsan SL, 2010, CURR OPIN GENET DEV, V20, P149, DOI 10.1016/j.gde.2010.01.004; Pringle Eric S, 2019, Curr Protoc Mol Biol, V125, pe79, DOI 10.1002/cpmb.79; Roy AM, 2000, J MOL BIOL, V302, P17, DOI 10.1006/jmbi.2000.4027; Rubin CM, 2002, NUCLEIC ACIDS RES, V30, P3253, DOI 10.1093/nar/gkf419; Samson J, 2018, Noncoding RNA Res, V3, P131, DOI 10.1016/j.ncrna.2018.05.003; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shen MR, 1997, NUCLEIC ACIDS RES, V25, P1641, DOI 10.1093/nar/25.8.1641; Singh R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.168; Sosinska P, 2015, MUTAT RES-REV MUTAT, V766, P58, DOI 10.1016/j.mrrev.2015.08.002; Tan N, 2020, ONCOL REP, V43, P461, DOI 10.3892/or.2019.7447; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Trachman RJ, 2017, NAT CHEM BIOL, V13, P807, DOI 10.1038/nchembio.2392; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Wang HD, 2002, J NEUROSCI, V22, P10232; WATSON JB, 1987, MOL CELL BIOL, V7, P3324, DOI 10.1128/MCB.7.9.3324; Wienert B, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005840; Wu KM, 2018, INT J BIOCHEM CELL B, V99, P219, DOI 10.1016/j.biocel.2018.04.001; Yu JH, 2019, EUR REV MED PHARMACO, V23, P9371, DOI 10.26355/eurrev_201911_19430; Zhai H., 2019, BIOSCIENCE REP, V39	64	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100036	10.1074/jbc.RA120.015775	http://dx.doi.org/10.1074/jbc.RA120.015775			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33410401	gold, Green Published			2022-12-28	WOS:000672866400020
J	Brodolin, K; Morichaud, Z				Brodolin, Konstantin; Morichaud, Zakia			Region 4 of the RNA polymerase sigma subunit counteracts pausing during initial transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; DNA HYBRID; TRIGGER LOOP; PROMOTER DNA; FLAP DOMAIN; TFIIB; ELONGATION; RECOGNITION; INHIBITION; STABILITY	All cellular genetic information is transcribed into RNA by multisubunit RNA polymerases (RNAPs). The basal transcription initiation factors of cellular RNAPs stimulate the initial RNA synthesis via poorly understood mechanisms. Here, we explored the mechanism employed by the bacterial factor s in promoter-independent initial transcription. We found that the RNAP holoenzyme lacking the promoter-binding domain s4 is ineffective in de novo transcription initiation and displays high propensity to pausing upon extension of RNAs 3 to 7 nucleotides in length. The nucleotide at the RNA 3' end determines the pause lifetime. The sigma 4 domain stabilizes short RNA:DNA hybrids and suppresses pausing by stimulating RNAP active-center translocation. The antipausing activity of sigma 4 is modulated by its interaction with the beta subunit flap domain and by the s remodeling factors AsiA and RbpA. Our results suggest that the presence of sigma 4 within the RNA exit channel compensates for the intrinsic instability of short RNA:DNA hybrids by increasing RNAP processivity, thus favoring productive transcription initiation. This "RNAP boosting" activity of the initiation factor is shaped by the thermodynamics of RNA:DNA interactions and thus, should be relevant for any factordependent RNAP.	[Brodolin, Konstantin; Morichaud, Zakia] Univ Montpellier, CNRS, Inst Rech Infectiol Montpellier, Montpellier, France; [Brodolin, Konstantin] Inst Rech Infectiol Montpellier, INSERM, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Brodolin, K (corresponding author), Univ Montpellier, CNRS, Inst Rech Infectiol Montpellier, Montpellier, France.; Brodolin, K (corresponding author), Inst Rech Infectiol Montpellier, INSERM, Montpellier, France.	konstantin.brodolin@inserm.fr	; Brodolin, Konstantin/I-2996-2016	Morichaud, Zakia/0000-0002-4701-7788; Brodolin, Konstantin/0000-0003-3124-7586	French National Research Agency [MycoMaster ANR-16-CE11-0025-01]	French National Research Agency(French National Research Agency (ANR))	Funding was from the French National Research Agency [MycoMaster ANR-16-CE11-0025-01].	Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Belogurov GA, 2019, J MOL BIOL, V431, P3975, DOI 10.1016/j.jmb.2019.05.042; Boyaci H, 2018, ELIFE, V7, DOI 10.7554/eLife.34823; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Callaci S, 1999, MOL CELL, V3, P229, DOI 10.1016/S1097-2765(00)80313-5; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Chen BS, 2004, MOL CELL BIOL, V24, P3983, DOI 10.1128/MCB.24.9.3983-3991.2004; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Duchi D, 2016, MOL CELL, V63, P939, DOI 10.1016/j.molcel.2016.08.011; Dulin D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03902-9; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geszvain K, 2004, J MOL BIOL, V343, P569, DOI 10.1016/j.jmb.2004.08.063; Hein PP, 2014, NAT STRUCT MOL BIOL, V21, P794, DOI 10.1038/nsmb.2867; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; Hinton DM, 2000, J MOL BIOL, V304, P731, DOI 10.1006/jmbi.2000.4113; Hu YB, 2014, NUCLEIC ACIDS RES, V42, P10399, DOI 10.1093/nar/gku742; Huang YG, 2009, BIOCHEMISTRY-US, V48, P3988, DOI 10.1021/bi900070f; Kang JY, 2018, MOL CELL, V69, P802, DOI 10.1016/j.molcel.2018.01.018; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Keene RG, 1999, J BIOL CHEM, V274, P11526, DOI 10.1074/jbc.274.17.11526; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Kulbachinskiy AV, 2002, RUSS J GENET+, V38, P1207, DOI 10.1023/A:1020665123810; KUMAR A, 1994, J MOL BIOL, V235, P405, DOI 10.1006/jmbi.1994.1001; KUMAR A, 1993, J MOL BIOL, V232, P406, DOI 10.1006/jmbi.1993.1400; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; Li LT, 2020, P NATL ACAD SCI USA, V117, P5801, DOI 10.1073/pnas.1920747117; Lin W, 2017, MOL CELL, V66, P169, DOI 10.1016/j.molcel.2017.03.001; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; METZGER W, 1993, J MOL BIOL, V232, P35, DOI 10.1006/jmbi.1993.1368; Morichaud Z, 2016, J MOL BIOL, V428, P463, DOI 10.1016/j.jmb.2015.12.017; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; PAN GH, 1994, J BIOL CHEM, V269, P30101; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pupov D, 2014, NUCLEIC ACIDS RES, V42, P4494, DOI 10.1093/nar/gkt1384; Pupov D, 2010, NUCLEIC ACIDS RES, V38, P5784, DOI 10.1093/nar/gkq355; Ruff EF, 2015, BIOMOLECULES, V5, P1035, DOI 10.3390/biom5021035; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Shi J, 2019, NUCLEIC ACIDS RES, V47, P9423, DOI 10.1093/nar/gkz682; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Tupin A, 2010, EMBO J, V29, P2527, DOI 10.1038/emboj.2010.135; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vishwakarma RK, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao5498; Vvedenskaya IO, 2014, SCIENCE, V344, P1285, DOI 10.1126/science.1253458; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Winkelman JT, 2020, MOL CELL, V79, P797, DOI 10.1016/j.molcel.2020.07.006; Zenkin N, 2006, NATURE, V439, P617, DOI 10.1038/nature04337; Zenkin N, 2004, P NATL ACAD SCI USA, V101, P4396, DOI 10.1073/pnas.0400886101; Zenkin N, 2007, EMBO J, V26, P955, DOI 10.1038/sj.emboj.7601555; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	66	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100253	10.1074/jbc.RA120.016299	http://dx.doi.org/10.1074/jbc.RA120.016299			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33380428	gold, Green Published, Green Submitted			2022-12-28	WOS:000672866400229
J	Dai, DL; Li, XY; Wang, L; Xie, C; Jin, YA; Zeng, MS; Zuo, ZX; Xia, TL				Dai, Dan-Ling; Li, Xingyang; Wang, Lin; Xie, Chu; Jin, Yanan; Zeng, Mu-Sheng; Zuo, Zhixiang; Xia, Tian-Liang			Identification of an N6-methyladenosine-mediated positive feedback loop that promotes Epstein-Barr virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ZTA; MESSENGER-RNA METHYLATION; NASOPHARYNGEAL CARCINOMA; GENE; CYCLE; REACTIVATION; TRANSLATION; REPRESSION; REGION; EBV	N6-methyladenosine (m(6)A) is among the most abundant mRNA modifications, particularly in eukaryotes, and is found in mammals, plants, and even some viruses. Although essential for the regulation of many biological processes, the exact role of m(6)A modification in virus-host interaction remains largely unknown. Here, using m(6)A -immunoprecipitation and sequencing, we find that Epstein-Barr virus (EBV) infection decreases the m(6)A modification of transcriptional factor KLF4 mRNA and subsequently increases its protein level. Mechanistically, EBV immediate-early protein BZLF1 interacts with the promoter of m(6)A methyltransferase METTL3, inhibiting its expression. Subsequently, the decrease of METTL3 reduces the level of KLF4 mRNA m(6)A modification, preventing its decay by the m(6)A reader protein YTHDF2. As a result, KLF4 protein level is upregulated and, in turn, promotes EBV infection of nasopharyngeal epithelial cells. Thus, our results suggest the existence of a positive feedback loop formed between EBV and host molecules via cellular mRNA m(6)A levels, and this feedback loop acts to facilitate viral infection. This mechanism contains multiple potential targets for controlling viral infectious diseases.	[Dai, Dan-Ling; Wang, Lin; Xie, Chu; Jin, Yanan; Zeng, Mu-Sheng; Zuo, Zhixiang; Xia, Tian-Liang] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China; [Li, Xingyang] Guangzhou Med Univ, Dept Temporomandibular Joint Surg, Guangzhou Key Lab Basic & Appl Res Oral Regenerat, Affiliated Stomatol Hosp, Guangzhou, Peoples R China; [Wang, Lin] Sun Yat Sen Univ, Canc Ctr, Dept Nasopharyngeal Carcinoma, Guangzhou, Peoples R China; [Jin, Yanan] Sun Yat Sen Univ, Canc Ctr, Dept VIP Reg, Guangzhou, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University	Zuo, ZX; Xia, TL (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China.	zuozhx@sysucc.org.cn; xiatl@sysucc.org.cn	Zuo, Zhixiang/M-4441-2016	Zuo, Zhixiang/0000-0002-2492-2689	National Key R&D Program of China [2017YFA0505600, 2017YFC0908503, 2016YFA0502100]; National Natural Science Foundation of China [81830090, 81802775, 82003081]; Guangdong Province Key Research And Development Program [2019B020226002]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Key Research And Development Program	This study was supported by the National Key R&D Program of China (2017YFA0505600, 2017YFC0908503, and 2016YFA0502100), the National Natural Science Foundation of China (81830090, 81802775, and 82003081), and Guangdong Province Key Research And Development Program (2019B020226002).	Balan N, 2016, J GEN VIROL, V97, P725, DOI 10.1099/jgv.0.000369; Bristol JA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007179; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; Courtney DG, 2019, MBIO, V10, DOI 10.1128/mBio.01209-19; Courtney DG, 2017, CELL HOST MICROBE, V22, P377, DOI 10.1016/j.chom.2017.08.004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Farrell PJ, 2019, ANNU REV PATHOL-MECH, V14, P29, DOI 10.1146/annurev-pathmechdis-012418-013023; Fiches GN, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008778; Gokhale NS, 2020, MOL CELL, V77, P542, DOI 10.1016/j.molcel.2019.11.007; Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015; Hahn AM, 2005, J VIROL, V79, P10040, DOI 10.1128/JVI.79.15.10040-10052.2005; Hao HJ, 2019, NUCLEIC ACIDS RES, V47, P362, DOI 10.1093/nar/gky1007; Henle W, 1980, Ann N Y Acad Sci, V354, P326, DOI 10.1111/j.1749-6632.1980.tb27975.x; Hesser CR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006995; Hicks MR, 2003, J VIROL, V77, P8173, DOI 10.1128/JVI.77.14.8173-8177.2003; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Imam H, 2018, P NATL ACAD SCI USA, V115, P8829, DOI 10.1073/pnas.1808319115; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Lang FC, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007796; LAVI S, 1975, P NATL ACAD SCI USA, V72, P2012, DOI 10.1073/pnas.72.6.2012; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li HD, 2016, INT J BIOL SCI, V12, P1309, DOI 10.7150/ijbs.16564; Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu SL, 2019, CANCER COMMUN, V39, DOI 10.1186/s40880-019-0357-9; Liu X, 2020, CELL, V182, P24, DOI 10.1016/j.cell.2020.06.023; Lu WX, 2018, J BIOL CHEM, V293, P12992, DOI 10.1074/jbc.RA118.004215; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Luo WW, 2016, CELL MOL IMMUNOL, V13, P65, DOI 10.1038/cmi.2014.125; Martinez-Perez M, 2017, P NATL ACAD SCI USA, V114, P10755, DOI 10.1073/pnas.1703139114; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Morrison TE, 2004, J VIROL, V78, P544, DOI 10.1128/JVI.78.1.544-549.2004; Morrison TE, 2001, IMMUNITY, V15, P787, DOI 10.1016/S1074-7613(01)00226-6; MOSS B, 1977, J VIROL, V23, P234, DOI 10.1128/JVI.23.2.234-239.1977; Munz C, 2019, NAT REV MICROBIOL, V17, P691, DOI 10.1038/s41579-019-0249-7; Murata T, 2010, J BIOL CHEM, V285, P23925, DOI 10.1074/jbc.M109.095356; Nawandar DM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005195; PACKHAM G, 1990, J VIROL, V64, P2110, DOI 10.1128/JVI.64.5.2110-2116.1990; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Ramasubramanyan S, 2015, NUCLEIC ACIDS RES, V43, P3563, DOI 10.1093/nar/gkv212; Rane MJ, 2019, EBIOMEDICINE, V40, P743, DOI 10.1016/j.ebiom.2019.01.021; Rubio RM, 2018, GENE DEV, V32, P1472, DOI 10.1101/gad.319475.118; Schaeffner M, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800108; Schelcher C, 2005, J VIROL, V79, P13822, DOI 10.1128/JVI.79.21.13822-13828.2005; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Shaverdashvili K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215746; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Sun XS, 2020, CANCER COMMUN, V40, P32, DOI 10.1002/cac2.12004; Tan B, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0056-8; Tirumuru N, 2019, J BIOL CHEM, V294, P3249, DOI 10.1074/jbc.RA118.005608; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Tsai K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006919; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wille CK, 2015, P NATL ACAD SCI USA, V112, pE7257, DOI 10.1073/pnas.1513432112; Winkler R, 2019, NAT IMMUNOL, V20, P173, DOI 10.1038/s41590-018-0275-z; Wu CF, 2021, CANCER COMMUN, V41, P37, DOI 10.1002/cac2.12113; Xiong D, 2015, P NATL ACAD SCI USA, V112, P11036, DOI 10.1073/pnas.1513359112; Yan M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4661; Yang L, 2020, J PINEAL RES, V69, DOI 10.1111/jpi.12669; Ye FC, 2017, J VIROL, V91, DOI 10.1128/JVI.00466-17; Young LS, 2020, CANCER COMMUN, V40, P60, DOI 10.1002/cac2.12006; Young LS, 2016, NAT REV CANCER, V16, P789, DOI 10.1038/nrc.2016.92; Zhang H, 2018, NAT MICROBIOL, V3, P164, DOI 10.1038/s41564-017-0080-8; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2020, CANCER COMMUN, V40, P721, DOI 10.1002/cac2.12104; ZURHAUSEN H, 1978, NATURE, V272, P373	72	10	10	6	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100547	10.1016/j.jbc.2021.100547	http://dx.doi.org/10.1016/j.jbc.2021.100547			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33741341	gold, Green Published			2022-12-28	WOS:000672866400520
J	Garza, NM; Griffin, AT; Zulkifli, M; Qiu, CX; Kaplan, CD; Gohil, VM				Garza, Natalie M.; Griffin, Aaron T.; Zulkifli, Mohammad; Qiu, Chenxi; Kaplan, Craig D.; Gohil, Vishal M.			A genome-wide copper-sensitized screen identifies novel regulators of mitochondrial cytochrome c oxidase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-DISULFIDE OXIDOREDUCTASE; SACCHAROMYCES-CEREVISIAE; EMERGING ROLE; H+-ATPASE; YEAST; IRON; MUTATIONS; GENES; METAL; COA6	Copper is essential for the activity and stability of cytochrome c oxidase (CcO), the terminal enzyme of the mitochondrial respiratory chain. Loss-of-function mutations in genes required for copper transport to CcO result in fatal human disorders. Despite the fundamental importance of copper in mitochondrial and organismal physiology, systematic identification of genes that regulate mitochondrial copper homeostasis is lacking. To discover these genes, we performed a genome-wide screen using a library of DNA-barcoded yeast deletion mutants grown in copper-supplemented media. Our screen recovered a number of genes known to be involved in cellular copper homeostasis as well as genes previously not linked to mitochondrial copper biology. These newly identified genes include the subunits of the adaptor protein 3 complex (AP-3) and components of the cellular pH-sensing pathway Rim20 and Rim21, both of which are known to affect vacuolar function. We find that AP-3 and Rim mutants exhibit decreased vacuolar acidity, which in turn perturbs mitochondrial copper homeostasis and CcO function. CcO activity of these mutants could be rescued by either restoring vacuolar pH or supplementing growth media with additional copper. Consistent with these genetic data, pharmacological inhibition of the vacuolar proton pump leads to decreased mitochondrial copper content and a concomitant decrease in CcO abundance and activity. Taken together, our study uncovered novel genetic regulators of mitochondrial copper homeostasis and provided a mechanism by which vacuolar pH impacts mitochondrial respiration through copper homeostasis.	[Garza, Natalie M.; Griffin, Aaron T.; Zulkifli, Mohammad; Qiu, Chenxi; Kaplan, Craig D.; Gohil, Vishal M.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Griffin, Aaron T.] Columbia Univ, Dept Syst Biol, New York, NY USA; [Qiu, Chenxi] Harvard Med Sch, Div Translat Therapeut, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Kaplan, Craig D.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Texas A&M University System; Texas A&M University College Station; Columbia University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gohil, VM (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	vgohil@tamu.edu	Kaplan, Craig/AAO-4500-2021; Zulkifli, Mohammad/V-5115-2019	Kaplan, Craig/0000-0002-7518-695X; Zulkifli, Mohammad/0000-0002-9110-9508; Garza, Natalie/0000-0002-0467-5094; Griffin, Aaron/0000-0002-8027-0822; Gohil, Vishal/0000-0002-9920-2563	National Institutes of Health [R01GM111672, R0GM1097260, 5F31GM128339]; Welch Foundation [A-1810]; National Science Foundation [HRD-1502335]; T3 grant from Texas AM University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); T3 grant from Texas AM University	This work was supported by the National Institutes of Health awards R01GM111672 to V. M. G., R0GM1097260 to C. D. K., and 5F31GM128339 to N. M. G. and the Welch Foundation Grant (A-1810) to V. M. G. N. M. G. was also supported by National Science Foundation award HRD-1502335 in the first year of this work. This work was also supported by a T3 grant from Texas A&M University to V. M. G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Ammann S, 2016, BLOOD, V127, P997, DOI 10.1182/blood-2015-09-671636; Baertling F, 2015, HUM MUTAT, V36, P34, DOI 10.1002/humu.22715; Bagh MB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14612; Blaby-Haas CE, 2014, J BIOL CHEM, V289, P28129, DOI 10.1074/jbc.R114.592618; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Chen KL, 2020, GEROSCIENCE, V42, P749, DOI 10.1007/s11357-020-00159-3; Chun CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012503; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Cobine PA, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2020.118867; Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004; Corrionero A, 2018, CURR BIOL, V28, P1522, DOI 10.1016/j.cub.2018.03.063; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Desai V, 2008, AM J CLIN NUTR, V88, p855S, DOI 10.1093/ajcn/88.3.855S; Diakov TT, 2013, JOVE-J VIS EXP, DOI 10.3791/50261; Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003; Dodani SC, 2011, J AM CHEM SOC, V133, P8606, DOI 10.1021/ja2004158; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; El-Chemaly S, 2016, CLIN CHEST MED, V37, P505, DOI 10.1016/j.ccm.2016.04.012; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Foster AW, 2014, MOL MICROBIOL, V93, P317, DOI 10.1111/mmi.12661; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; Ghosh A, 2016, HUM MOL GENET, V25, P660, DOI 10.1093/hmg/ddv503; Ghosh A, 2014, HUM MOL GENET, V23, P3596, DOI 10.1093/hmg/ddu069; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Huang Z, 2013, CELL REP, V3, P577, DOI 10.1016/j.celrep.2013.01.019; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Hughes CE, 2020, CELL, V180, P296, DOI 10.1016/j.cell.2019.12.035; Ishizaki H, 2010, DIS MODEL MECH, V3, P639, DOI 10.1242/dmm.005769; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jo WJ, 2008, TOXICOL SCI, V101, P140, DOI 10.1093/toxsci/kfm226; Jo WJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-130; Kaler SG, 2013, HAND CLINIC, V113, P1745, DOI 10.1016/B978-0-444-59565-2.00045-9; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Korvatska O, 2013, HUM MOL GENET, V22, P3259, DOI 10.1093/hmg/ddt180; Lamb TM, 2001, J BIOL CHEM, V276, P1850, DOI 10.1074/jbc.M008381200; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; Little AG, 2018, COMP BIOCHEM PHYS B, V224, P170, DOI 10.1016/j.cbpb.2017.11.005; Llinares E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16665; Maeda T, 2012, FEBS J, V279, P1407, DOI 10.1111/j.1742-4658.2012.08548.x; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nguyen M, 2019, TRENDS NEUROSCI, V42, P140, DOI 10.1016/j.tins.2018.11.001; Nguyen TQ, 2019, METALLOMICS, V11, P1298, DOI 10.1039/c9mt00104b; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Papadopoulou LC, 1999, NAT GENET, V23, P333; Perez-Sampietro M, 2014, FUNGAL GENET BIOL, V71, P76, DOI 10.1016/j.fgb.2014.09.001; Polishchuk EV, 2016, METALLOMICS, V8, P853, DOI [10.1039/c6mt00058d, 10.1039/C6MT00058D]; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Read T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005746; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Rigo A, 2004, J INORG BIOCHEM, V98, P1495, DOI 10.1016/j.jinorgbio.2004.06.008; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Schlecht U, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-263; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Soma S, 2019, CELL REP, V29, P4114, DOI 10.1016/j.celrep.2019.11.054; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Stenger M, 2020, MICROB CELL, V7, P234, DOI 10.15698/mic2020.09.729; Stepien KM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082596; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Timon-Gomez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055; Valnot I, 2000, AM J HUM GENET, V67, P1104; Vogtle FN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00359-0; Weber RA, 2020, MOL CELL, V77, P645, DOI 10.1016/j.molcel.2020.01.003; Wu XB, 2016, J BIOL CHEM, V291, P9796, DOI 10.1074/jbc.M115.700500; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Yambire KF, 2019, ELIFE, V8, DOI 10.7554/eLife.51031	81	3	3	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100485	10.1016/j.jbc.2021.100485	http://dx.doi.org/10.1016/j.jbc.2021.100485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33662401	Green Submitted, gold, Green Published			2022-12-28	WOS:000672866400459
J	Jonnalagadda, R; Flores, AD; Cai, WL; Mehmood, R; Narayanamoorthy, M; Ren, CX; Zaragoza, JPT; Kulik, HJ; Zhang, WJ; Drennan, CL				Jonnalagadda, Rohan; Flores, Antonio Del Rio; Cai, Wenlong; Mehmood, Rimsha; Narayanamoorthy, Maanasa; Ren, Chaoxiang; Zaragoza, Jan Paulo T.; Kulik, Heather J.; Zhang, Wenjun; Drennan, Catherine L.			Biochemical and crystallographic investigations into isonitrile formation by a nonheme iron-dependent oxidase/decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAURINE/ALPHA-KETOGLUTARATE DIOXYGENASE; MECHANISM; BIOSYNTHESIS; INTERMEDIATE; TAUD	The isonitrile moiety is found in marine sponges and some microbes, where it plays a role in processes such as virulence and metal acquisition. Until recently only one route was known for isonitrile biosynthesis, a condensation reaction that brings together a nitrogen atom of L-Trp/L-Tyr with a carbon atom from ribulose-5-phosphate. With the discovery of ScoE, a mononuclear Fe(II) alpha-ketoglutarate-dependent dioxygenase from Streptomyces coeruleorubidus, a second route was identified. ScoE forms isonitrile from a glycine adduct, with both the nitrogen and carbon atoms coming from the same glycyl moiety. This reaction is part of the nonribosomal biosynthetic pathway of isonitrile lipopeptides. Here, we present structural, biochemical, and computational investigations of the mechanism of isonitrile formation by ScoE, an unprecedented reaction in the mononuclear Fe(II) alpha-ketoglutarate-dependent dioxygenase superfamily. The stoichiometry of this enzymatic reaction is measured, and multiple high-resolution (1.45-1.96 angstrom resolution) crystal structures of Fe(II)-bound ScoE are presented, providing insight into the binding of substrate, (R)-3-((carboxylmethyl)amino)butanoic acid (CABA), cosubstrate alpha-ketoglutarate, and an Fe(IV)=O mimic oxovanadium. Comparison to a previously published crystal structure of ScoE suggests that ScoE has an "inducible" alpha-ketoglutarate binding site, in which two residues arginine-157 and histidine-299 move by approximately 10 angstrom from the surface of the protein into the active site to create a transient alpha-ketoglutarate binding pocket. Together, data from structural analyses, site-directed mutagenesis, and computation provide insight into the mode of alpha-ketoglutarate binding, the mechanism of isonitrile formation, and how the structure of ScoE has been adapted to perform this unusual chemical reaction.	[Jonnalagadda, Rohan; Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Flores, Antonio Del Rio; Cai, Wenlong; Ren, Chaoxiang; Zhang, Wenjun] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Mehmood, Rimsha; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Mehmood, Rimsha; Kulik, Heather J.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Narayanamoorthy, Maanasa; Zaragoza, Jan Paulo T.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Zaragoza, Jan Paulo T.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Zhang, Wenjun] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Zhang, WJ (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.; Drennan, CL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Kulik, HJ (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Zhang, WJ (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	hjkulik@mit.edu; wjzhang@berkeley.edu; drennan@mit.edu		Zhang, Wenjun/0000-0001-9348-972X; Ren, Chaoxiang/0000-0002-0151-1713; Del Rio Flores, Antonio/0000-0001-5893-3557; Zaragoza, Jan Paulo/0000-0002-2583-6571; Drennan, Catherine/0000-0001-5486-2755; Narayanamoorthy, Maanasa/0000-0002-7418-2607; Mehmood, Rimsha/0000-0002-2175-5133	National Institutes of Health [R35 GM126982]; NIH Pre-Doctoral Training Grant [T32GM007287, R01 GM136758]; Chan Zuckerberg Biohub Investigator Program; NSF [CBET-1704266]; Burroughs Wellcome Fund Career Award at the Scientific Interface; UC Berkeley Chancellor's Fellowship; Office of Science, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Institute of General Medical Sciences from the National Institutes of Health [P30 GM124165]; NIH-ORIP HEI grant [S10 OD021527]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pre-Doctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chan Zuckerberg Biohub Investigator Program; NSF(National Science Foundation (NSF)); Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); UC Berkeley Chancellor's Fellowship; Office of Science, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE))	This research was supported by National Institutes of Health Grants R35 GM126982 (C. L. D.), NIH Pre-Doctoral Training Grant T32GM007287 (R. J.), and R01 GM136758 (W. Z.). C. L. D. is a Howard Hughes Medical Institute Investigator, and W. Z. is supported by the Chan Zuckerberg Biohub Investigator Program. This research was also financially supported by grants to H. J. K. from the NSF (CBET-1704266) and a Burroughs Wellcome Fund Career Award at the Scientific Interface. A. D. R. F. is funded by the UC Berkeley Chancellor's Fellowship. The GC-MS work was made possible by the Catalysis Facility of Lawrence Berkeley National Laboratory, supported by the Director, Office of Science, of the U.S. Department of Energy (contract no. DE-AC02-05CH11231). This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P30 GM124165). The Pilatus 6M detector on 24-ID-E beam line is funded by an NIH-ORIP HEI grant (S10 OD021527). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bollinger JM, 2005, EUR J INORG CHEM, P4245, DOI 10.1002/ejic.200500476; Brady SF, 2005, ANGEW CHEM INT EDIT, V44, P7063, DOI 10.1002/anie.200501941; Case D. A., 2018, AMBER 2019; Chen TY, 2020, ANGEW CHEM INT EDIT, V59, P7367, DOI 10.1002/anie.201914896; Clarke-Pearson MF, 2008, J BACTERIOL, V190, P6927, DOI 10.1128/JB.00801-08; Davis KM, 2019, BIOCHEMISTRY-US, V58, P4218, DOI 10.1021/acs.biochem.9b00598; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Harris NC, 2018, ANGEW CHEM INT EDIT, V57, P9707, DOI 10.1002/anie.201804307; Harris NC, 2017, P NATL ACAD SCI USA, V114, P7025, DOI 10.1073/pnas.1705016114; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; HAY PJ, 1985, J CHEM PHYS, V82, P270, DOI 10.1063/1.448799; Huang YB, 2020, ANAL CHEM, V92, P599, DOI 10.1021/acs.analchem.9b05147; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li PF, 2016, J CHEM INF MODEL, V56, P599, DOI 10.1021/acs.jcim.5b00674; Martinez S, 2015, J BIOL CHEM, V290, P20702, DOI 10.1074/jbc.R115.648691; Martinie RJ, 2017, INORG CHEM, V56, P13382, DOI 10.1021/acs.inorgchem.7b02113; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell AJ, 2017, J AM CHEM SOC, V139, P13830, DOI 10.1021/jacs.7b07374; Muthukumaran RB, 2007, BIOCHEMISTRY-US, V46, P5951, DOI 10.1021/bi700562t; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; O'Brien JR, 2003, BIOCHEMISTRY-US, V42, P5547, DOI 10.1021/bi0341096; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2003, J AM CHEM SOC, V125, P13008, DOI 10.1021/ja037400h; Rui Z, 2014, P NATL ACAD SCI USA, V111, P18237, DOI 10.1073/pnas.1419701112; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Smart O.S., 2011, GRADE VERSION 1220; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; TUDERMAN L, 1977, EUR J BIOCHEM, V80, P341, DOI 10.1111/j.1432-1033.1977.tb11888.x; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x	43	6	6	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100231	10.1074/jbc.RA120.015932	http://dx.doi.org/10.1074/jbc.RA120.015932			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33361191	Green Published, gold			2022-12-28	WOS:000672866400209
J	Kmiecik, SW; Drzewicka, K; Melchior, F; Mayer, MP				Kmiecik, Szymon W.; Drzewicka, Katarzyna; Melchior, Frauke; Mayer, Matthias P.			Heat shock transcription factor 1 is SUMOylated in the activated trimeric state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO MODIFICATION; DNA-BINDING; PROTEIN; PHOSPHORYLATION; CONJUGATION; REPRESSION; TEMPERATURE; KINASE; ALPHA	The heat shock response is a transcriptional program of organisms to counteract an imbalance in protein homeostasis. It is orchestrated in all eukaryotic cells by heat shock transcription factor 1 (Hsf1). Despite very intensive research, the intricacies of the Hsf1 activation-attenuation cycle remain elusive at a molecular level. Post-translational modifications belong to one of the key mechanisms proposed to adapt the Hsf1 activity to the needs of individual cells, and phosphorylation of Hsf1 at multiple sites has attracted much attention. According to cell biological and proteomics data, Hsf1 is also modified by small ubiquitin-like modifier (SUMO) at several sites. How SUMOylation affects Hsf1 activity at a molecular level is still unclear. Here, we analyzed Hsf1 SUMOylation in vitro with purified components to address questions that could not be answered in cell culture models. In vitro Hsf1 is primarily conjugated at lysine 298 with a single SUMO, though we did detect low-level SUMOylation at other sites. Different SUMO E3 ligases such as protein inhibitor of activated STAT 4 enhanced the efficiency of in vitro modification but did not alter SUMO site preferences. We provide evidence that Hsf1 trimerization and phosphorylation at serines 303 and 307 increases SUMOylation efficiency, suggesting that Hsf1 is SUMOylated in its activated state. Hsf1 can be SUMOylated when DNA bound, and SUMOylation of Hsf1 does neither alter DNA-binding affinity nor affects heat shock cognate 71kDa protein (HSPA8)+DnaJ homolog subfamily B member 1-mediated monomerization of Hsf1 trimers and concomitant dislocation from DNA. We propose that SUMOylation acts at the transcription level of the heat shock response.	[Kmiecik, Szymon W.; Drzewicka, Katarzyna; Melchior, Frauke; Mayer, Matthias P.] Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Drzewicka, Katarzyna] Oncoarendi Therapeut SA, Warsaw, Poland	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Mayer, MP (corresponding author), Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany.	m.mayer@zmbh.uni-heidelberg.de	Melchior, Frauke/E-2014-2014	Melchior, Frauke/0000-0001-9546-8797; Kmiecik, Szymon/0000-0001-6139-1680; Mayer, Matthias/0000-0002-7859-3112	Deutsche Forschungsgemeinschaft (German Research Foundation) [201348542-SFB 1036 TP9, SFB1036 TP15]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation)-project ID: 201348542-SFB 1036 TP9 to M. P. M. and SFB1036 TP15 to F. M.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Anderson DD, 2012, J BIOL CHEM, V287, P4790, DOI 10.1074/jbc.M111.302174; Bekhbat M, 2017, FRONT NEUROENDOCRIN, V46, P15, DOI 10.1016/j.yfrne.2017.05.001; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Cappadocia L, 2018, CHEM REV, V118, P889, DOI 10.1021/acs.chemrev.6b00737; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Chymkowitch P, 2015, BIOESSAYS, V37, P1095, DOI 10.1002/bies.201500065; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Flotho A, 2012, METHODS MOL BIOL, V832, P93, DOI 10.1007/978-1-61779-474-2_5; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hentze N, 2016, ELIFE, V5, DOI 10.7554/eLife.11576; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Kmiecik SW, 2020, EMBO J, V39, DOI 10.15252/embj.2019104096; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; LARSON JS, 1988, NATURE, V335, P372, DOI 10.1038/335372a0; Liebelt F, 2019, CELL REP, V26, P236, DOI 10.1016/j.celrep.2018.12.027; Liu YQ, 2019, J MOL CELL BIOL, V11, P564, DOI 10.1093/jmcb/mjz060; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Niskanen EA, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600263; Niskanen EA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0717-y; Park-Sarge Ok-Kyong, 2008, V464, P255; Parker JL, 2008, EMBO J, V27, P2422, DOI 10.1038/emboj.2008.162; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler Andrea, 2017, BioMolecular Concepts, V8, P13, DOI 10.1515/bmc-2016-0030; Ptak C, 2017, ADV EXP MED BIOL, V963, P111, DOI 10.1007/978-3-319-50044-7_7; Raychaudhuri S, 2014, CELL, V156, P975, DOI 10.1016/j.cell.2014.01.055; Rosonina E, 2019, CURR GENET, V65, P1307, DOI 10.1007/s00294-019-00992-w; Rosonina E, 2017, TRANSCR-AUSTIN, V8, P220, DOI 10.1080/21541264.2017.1311829; Rosonina E, 2012, GENE DEV, V26, P350, DOI 10.1101/gad.184689.111; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Seifert A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2213; Simioni MB, 2009, ONCOGENE, V28, P3332, DOI 10.1038/onc.2009.188; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wu SY, 2009, EMBO J, V28, P1246, DOI 10.1038/emboj.2009.83; Zilio N, 2013, DNA REPAIR, V12, P761, DOI 10.1016/j.dnarep.2013.07.001	51	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100324	10.1016/j.jbc.2021.100324	http://dx.doi.org/10.1016/j.jbc.2021.100324			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493517	gold, Green Published			2022-12-28	WOS:000672866400298
J	Mangiapane, G; Parolini, I; Conte, K; Malfatti, MC; Corsi, J; Sanchez, M; Pietrantoni, A; D'Agostino, VG; Tell, G				Mangiapane, Giovanna; Parolini, Isabella; Conte, Kristel; Malfatti, Matilde Clarissa; Corsi, Jessica; Sanchez, Massimo; Pietrantoni, Agostina; D'Agostino, Vito G.; Tell, Gianluca			Enzymatically active apurinic/apyrimidinic endodeoxyribonuclease 1 is released by mammalian cells through exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; AP-ENDONUCLEASE APE1/REF-1; HUMAN ABASIC ENDONUCLEASE; DNA-REPAIR; BIOGENESIS; DAMAGE; ACETYLATION; EXPRESSION; VESICLES; RESIDUES	The apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1), the main AP-endonuclease of the DNA base excision repair pathway, is a key molecule of interest to researchers due to its unsuspected roles in different nonrepair activities, such as: i) adaptive cell response to genotoxic stress, ii) regulation of gene expression, and iii) processing of microRNAs, which make it an excellent drug target for cancer treatment. We and others recently demonstrated that APE1 can be secreted in the extracellular environment and that serum APE1 may represent a novel prognostic biomarker in hepatocellular and non-small-cell lung cancers. However, the mechanism by which APE1 is released extracellularly was not described before. Here, using three different approaches for exosomes isolation: commercial kit, nickel-based isolation, and ultracentrifugation methods and various mammalian cell lines, we elucidated the mechanisms responsible for APE1 secretion. We demonstrated that APE1 p37 and p33 forms are actively secreted through extra-cellular vesicles (EVs), including exosomes from different mammalian cell lines. We then observed that APE1 p33 form is generated by proteasomal-mediated degradation and is enzymatically active in EVs. Finally, we revealed that the p33 form of APE1 accumulates in EVs upon genotoxic treatment by cisplatin and doxorubicin, compounds commonly found in chemotherapy pharmacological treatments. Taken together, these findings provide for the first time evidence that a functional Base Excision Repair protein is delivered through exosomes in response to genotoxic stresses, shedding new light into the complex noncanonical biological functions of APE1 and opening new intriguing perspectives on its role in cancer biology.	[Mangiapane, Giovanna; Conte, Kristel; Malfatti, Matilde Clarissa; Tell, Gianluca] Univ Udine, Dept Med DAME, Lab Mol Biol & DNA Repair, Udine, Italy; [Parolini, Isabella] Ist Super Sanita, Dept Oncol & Mol Med, Rome, Italy; [Corsi, Jessica; D'Agostino, Vito G.] Univ Trento, Dept Cellular Computat & Integrat Biol CIBIO, Trento, Italy; [Sanchez, Massimo; Pietrantoni, Agostina] Ist Super Sanita, Core Facil, Rome, Italy	University of Udine; Istituto Superiore di Sanita (ISS); University of Trento; Istituto Superiore di Sanita (ISS)	Tell, G (corresponding author), Univ Udine, Dept Med DAME, Lab Mol Biol & DNA Repair, Udine, Italy.	gianluca.tell@uniud.it	parolini, Isabella/J-9955-2016; Pietrantoni, Agostina/ABA-6900-2021; Sanchez, Massimo/K-4385-2018	parolini, Isabella/0000-0001-9863-1051; Pietrantoni, Agostina/0000-0002-1121-4464; Mangiapane, Giovanna/0000-0001-6633-0481; Tell, Gianluca/0000-0001-8845-6448; D'AGOSTINO, VITO/0000-0003-3379-2254; MALFATTI, MATILDE CLARISSA/0000-0002-8101-568X; Sanchez, Massimo/0000-0003-3696-7582	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG19862]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC) [grant number IG19862] to G. T.	Ageta H, 2019, CELL MOL LIFE SCI, V76, P4829, DOI 10.1007/s00018-019-03246-7; Antoniali G, 2021, CHEM BIO, V15, P24; Antoniali G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00842-8; Antoniali G, 2017, DNA REPAIR, V56, P65, DOI 10.1016/j.dnarep.2017.06.008; Antoniali G, 2014, MOL BIOL CELL, V25, P532, DOI 10.1091/mbc.E13-05-0286; Antoniali G, 2014, ANTIOXID REDOX SIGN, V20, P621, DOI 10.1089/ars.2013.5491; Ayyildiz D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56981-z; Bebelman MP, 2018, PHARMACOL THERAPEUT, V188, P1, DOI 10.1016/j.pharmthera.2018.02.013; Berquist BR, 2008, J MOL BIOL, V379, P17, DOI 10.1016/j.jmb.2008.03.053; Bhakat KK, 2016, ONCOTARGET, V7, P22590, DOI 10.18632/oncotarget.8026; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Boussadia Z, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0915-z; Burra S, 2019, DNA REPAIR, V73, P129, DOI 10.1016/j.dnarep.2018.11.010; Choi S, 2013, BIOCHEM BIOPH RES CO, V435, P403, DOI 10.1016/j.bbrc.2013.04.101; Codrich M, 2019, DNA REPAIR, V82, DOI 10.1016/j.dnarep.2019.102675; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Coscia C, 2016, METHODS MOL BIOL, V1448, P217, DOI 10.1007/978-1-4939-3753-0_16; Dai N, 2013, NEOPLASMA, V60, P384, DOI 10.4149/neo_2013_050; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Fantini D, 2010, NUCLEIC ACIDS RES, V38, P8239, DOI 10.1093/nar/gkq691; Friand V, 2015, BIOL CELL, V107, P331, DOI 10.1111/boc.201500010; Graham John M, 2002, ScientificWorldJournal, V2, P1356; Greening DW, 2018, EXPERT REV PROTEOMIC, V15, P887, DOI 10.1080/14789450.2018.1537788; Gurunathan S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040307; Hazrin-Chong NH, 2012, J MICROBIOL METH, V90, P96, DOI 10.1016/j.mimet.2012.04.014; Jin SA, 2015, KOREAN CIRC J, V45, P364, DOI 10.4070/kcj.2015.45.5.364; Kajimoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3712; Kalimuthu S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01116; Lee YR, 2015, ONCOTARGET, V6, P23383, DOI 10.18632/oncotarget.4345; Li B, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0126-2; Lirussi L, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040531; Luo MH, 2012, BIOCHEMISTRY-US, V51, P695, DOI 10.1021/bi201034z; Malfatti MC, 2020, MUTAGENESIS, V35, P129, DOI 10.1093/mutage/gez051; Malfatti MC, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1294-9; Malfatti MC, 2019, J BIOL CHEM, V294, P13061, DOI 10.1074/jbc.RA119.009493; Malfatti MC, 2017, NUCLEIC ACIDS RES, V45, P11193, DOI 10.1093/nar/gkx723; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; Nakajima S, 2011, FEBS LETT, V585, P2249, DOI 10.1016/j.febslet.2011.05.047; Nath S, 2017, CELL SIGNAL, V39, P18, DOI 10.1016/j.cellsig.2017.07.019; Notarangelo M, 2019, EBIOMEDICINE, V43, P114, DOI 10.1016/j.ebiom.2019.04.039; Park MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23015; Park MS, 2013, BIOCHEM BIOPH RES CO, V435, P621, DOI 10.1016/j.bbrc.2013.05.030; Pascut Devis, 2019, Oncotarget, V10, P383, DOI 10.18632/oncotarget.26555; Poletto M, 2016, MOL CARCINOGEN, V55, P688, DOI 10.1002/mc.22313; Prasad R, 2011, MOL BIOL+, V45, P536, DOI 10.1134/S0026893311040091; Rai G, 2012, J MED CHEM, V55, P3101, DOI 10.1021/jm201537d; Rossi A, 2016, EXPERT REV ANTICANC, V16, P653, DOI 10.1586/14737140.2016.1170596; Sanderson RD, 2019, MATRIX BIOL, V75-76, P160, DOI 10.1016/j.matbio.2017.10.007; Scognamiglio PL, 2016, ONCOTARGET, V7, P59129, DOI 10.18632/oncotarget.10991; Scott TL, 2017, MOL CARCINOGEN, V56, P325, DOI 10.1002/mc.22495; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Shimoda M, 2013, PROTEOMICS, V13, P1624, DOI 10.1002/pmic.201200458; Shin JH, 2015, CANCER RES TREAT, V47, P823, DOI 10.4143/crt.2014.074; Shu XT, 2016, ANGEW CHEM INT EDIT, V55, P14244, DOI 10.1002/anie.201607380; Simms CL, 2016, CELL MOL LIFE SCI, V73, P3639, DOI 10.1007/s00018-016-2261-7; SPETH PAJ, 1988, CLIN PHARMACOKINET, V15, P15, DOI 10.2165/00003088-198815010-00002; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Su DA, 2011, BIOCHEMISTRY-US, V50, P82, DOI 10.1021/bi101248s; Sun FR, 2018, ONCOL RES, V26, P655, DOI 10.3727/096504017X15119525209765; Tell G, 2015, ONCOTARGET, V6, P584, DOI 10.18632/oncotarget.2705; Tell G, 2013, BIOTECHNIQUES, V55, P198, DOI 10.2144/000114088; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vascotto C, 2015, ONCOGENE, V34, P3482, DOI 10.1038/onc.2015.191; Vascotto C, 2009, PROTEOMICS, V9, P1058, DOI 10.1002/pmic.200800638; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Ye PJ, 2018, ARTIF CELL NANOMED B, V46, pS661, DOI 10.1080/21691401.2018.1505745; Yokoi A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax8849; Zhang SH, 2016, ONCOTARGET, V7, P77482, DOI 10.18632/oncotarget.13030	75	9	9	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100569	10.1016/j.jbc.2021.100569	http://dx.doi.org/10.1016/j.jbc.2021.100569			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753167	gold, Green Published			2022-12-28	WOS:000672866400542
J	Reed, F; Larsuel, ST; Mayday, MY; Scanlon, V; Krause, DS				Reed, Fiona; Larsuel, Shannon T.; Mayday, Madeline Y.; Scanlon, Vanessa; Krause, Diane S.			MRTFA: A critical protein in normal and malignant hematopoiesis and beyond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SERUM RESPONSE FACTOR; TRANSCRIPTION-FACTOR-B; MEGAKARYOCYTE MATURATION; MYELOID-LEUKEMIA; FACTOR SRF; MYOCARDIN; MKL1; COACTIVATOR; DIFFERENTIATION; ACTIVATION	Myocardin-related transcription factor A (MRTFA) is a coactivator of serum response factor, a transcription factor that participates in several critical cellular functions including cell growth and apoptosis. MRTFA couples transcriptional regulation to actin cytoskeleton dynamics, and the transcriptional targets of the MRTFA-serum response factor complex include genes encoding cytoskeletal proteins as well as immediate early genes. Previous work has shown that MRTFA promotes the differentiation of many cell types, including various types of muscle cells and hematopoietic cells, and MRTFA's interactions with other protein partners broaden its cellular roles. However, despite being first identified as part of the recurrent t(1;22) chromosomal translocation in acute megakaryoblastic leukemia, the mechanisms by which MRTFA functions in malignant hematopoiesis have yet to be defined. In this review, we provide an in-depth examination of the structure, regulation, and known functions of MRTFA with a focus on hematopoiesis. We conclude by identifying areas of study that merit further investigation.	[Reed, Fiona; Larsuel, Shannon T.; Scanlon, Vanessa; Krause, Diane S.] Yale Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Reed, Fiona; Larsuel, Shannon T.; Mayday, Madeline Y.; Scanlon, Vanessa; Krause, Diane S.] Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Mayday, Madeline Y.; Krause, Diane S.] Yale Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Krause, DS (corresponding author), Yale Sch Med, Dept Lab Med, New Haven, CT 06510 USA.; Krause, DS (corresponding author), Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA.; Krause, DS (corresponding author), Yale Sch Med, Dept Pathol, New Haven, CT 06510 USA.	diane.krause@yale.edu		Mayday, Madeline/0000-0002-7209-0434; Reed, Fiona/0000-0003-1479-7236	National Institutes of Health [CA222518, DK114031, DK120798]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this study came from the National Institutes of Health CA222518 (D. S. K.), DK114031 (D. S. K.), and DK120798 (V. S.). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Asparuhova MB, 2015, MOL ONCOL, V9, P1510, DOI 10.1016/j.molonc.2015.04.003; Asparuhova MB, 2011, FASEB J, V25, P3477, DOI 10.1096/fj.11-187310; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; BRANEHOG I, 1975, SCAND J HAEMATOL, V15, P321; BROUDY VC, 1995, J LEUKOCYTE BIOL, V57, P719, DOI 10.1002/jlb.57.5.719; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Cheng EC, 2009, BLOOD, V113, P2826, DOI 10.1182/blood-2008-09-180596; Cheng X, 2015, ONCOGENE, V34, P5570, DOI 10.1038/onc.2015.14; Costello P, 2015, BLOOD, V125, P1244, DOI 10.1182/blood-2014-08-595603; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Descot A, 2008, MOL CELL BIOL, V28, P6171, DOI 10.1128/MCB.00303-08; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Gao YM, 2020, IMMUNITY, V52, P1007, DOI 10.1016/j.immuni.2020.05.003; Gao Y, 2012, DEV CELL, V22, P573, DOI 10.1016/j.devcel.2011.12.019; Gau D, 2018, J CELL SCI, V131, DOI 10.1242/jcs.218222; Geddis AE, 2007, CELL CYCLE, V6, P455, DOI 10.4161/cc.6.4.3836; Gilles L, 2009, BLOOD, V114, P4221, DOI 10.1182/blood-2009-03-209932; Gruber TA, 2015, BLOOD, V126, P943, DOI 10.1182/blood-2015-05-567859; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Gurbuz I, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-22; Halene S, 2010, BLOOD, V116, P1942, DOI 10.1182/blood-2010-01-261743; Hayashi K, 2013, J BIOL CHEM, V288, P5743, DOI 10.1074/jbc.M112.408120; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hinson JS, 2008, AM J PHYSIOL-HEART C, V295, pH1067, DOI 10.1152/ajpheart.91421.2007; Hoffman LM, 2020, MOL BIOL CELL, V31, P1774, DOI 10.1091/mbc.E19-01-0027; Hu X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09636-6; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Ishikawa M, 2013, FEBS OPEN BIO, V3, P387, DOI 10.1016/j.fob.2013.09.001; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Ji H, 2014, BIOMED REP, V2, P787, DOI 10.3892/br.2014.323; Khan Irum, 2011, Critical Reviews in Oncogenesis, V16, P25; Kircher P, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad2959; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Laurent AP, 2020, LEUKEMIA, V34, P1984, DOI 10.1038/s41375-020-0854-5; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042965; Leitner L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-60; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Ma XY, 2007, MOL CELL BIOL, V27, P3056, DOI 10.1128/MCB.01339-06; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; MacKinnon Ruth N., 2013, Evolution Medicine and Public Health, P225, DOI 10.1093/emph/eot020; McGee KM, 2011, EMBO REP, V12, P963, DOI 10.1038/embor.2011.141; McNeill MC, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118691; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Mercher T, 2009, J CLIN INVEST, V119, P852, DOI 10.1172/JCI35901; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mizuguchi M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05224; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; O'Connor JW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083188, 10.1371/journal.pone.0080504]; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Panayiotou R, 2016, ELIFE, V5, DOI 10.7554/eLife.15460; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; RABELLINO EM, 1981, J EXP MED, V154, P88, DOI 10.1084/jem.154.1.88; Ragu C, 2010, LEUKEMIA, V24, P1227, DOI 10.1038/leu.2010.80; Rahman NT, 2018, BLOOD ADV, V2, P2691, DOI 10.1182/bloodadvances.2018019448; Record J, 2015, BLOOD, V126, P1527, DOI 10.1182/blood-2014-12-611012; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Salvany L, 2014, GENE DEV, V28, P1048, DOI 10.1101/gad.237743.114; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Sawada T, 2008, J BIOL CHEM, V283, P26820, DOI 10.1074/jbc.M802315200; Scharenberg MA, 2014, J CELL SCI, V127, P1079, DOI 10.1242/jcs.142075; Scharenberg MA, 2010, INT J BIOCHEM CELL B, V42, P1911, DOI 10.1016/j.biocel.2010.08.014; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Smith EC, 2012, BLOOD, V120, P2317, DOI 10.1182/blood-2012-04-420828; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Sprenkeler EGG, 2020, BLOOD, V135, P2171, DOI 10.1182/blood.2019002633; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Sullivan AL, 2011, MOL CELL BIOL, V31, P861, DOI 10.1128/MCB.00836-10; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Szalai G, 2006, CELL MOL LIFE SCI, V63, P2460, DOI 10.1007/s00018-006-6190-8; Talwar S, 2014, BIOMATERIALS, V35, P2411, DOI 10.1016/j.biomaterials.2013.12.010; Thakar Ketan, 2019, Small GTPases, V10, P433, DOI 10.1080/21541248.2017.1328303; Tijssen MR, 2013, J THROMB HAEMOST, V11, P593, DOI 10.1111/jth.12131; Uranishi H, 2009, J BIOL CHEM, V284, P26106, DOI 10.1074/jbc.M109.040113; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wei K, 2007, DEV DYNAM, V236, P416, DOI 10.1002/dvdy.21041; Xavier-Ferrucio J, 2018, STEM CELLS, V36, P1138, DOI 10.1002/stem.2834; Xiang Y, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00574-1; Xu WP, 2019, J BIOMED RES, V33, P164, DOI 10.7555/JBR.32.20170025; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zhang HQ, 2011, J NEUROSCI, V31, P15894, DOI 10.1523/JNEUROSCI.3943-11.2011; Zimmet J, 2000, EXP HEMATOL, V28, P3, DOI 10.1016/S0301-472X(99)00124-1	90	3	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100543	10.1016/j.jbc.2021.100543	http://dx.doi.org/10.1016/j.jbc.2021.100543			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33722605	Green Published, gold			2022-12-28	WOS:000672866400516
J	Sakurai, K; Tomiyama, R				Sakurai, Kazumasa; Tomiyama, Ryosuke			Enhanced accessibility and hydrophobicity of amyloidogenic intermediates of the beta 2-microglobulin D76N mutant revealed by high-pressure experiments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYSIOLOGICAL CONDITIONS; BETA(2)-MICROGLOBULIN; PROTEIN; FIBRIL; MODEL; CORE	beta 2-Microglobulin (beta 2m) is the causative protein of dialysisrelated amyloidosis. Its unfolding mainly proceeds along the pathway of N-C -> U-C (sic) U-T, whereas refolding follows the U-T. I-T (-> N-T) -> N-C pathway, in which N, I, and U are the native, intermediate, and unfolded states, respectively, with the Pro32 peptidyl-prolyl bond in cis or trans conformation as indicated by the subscript. It is noted that the IT state is a putative amyloidogenic precursor state. Several aggregation-prone variants of beta 2m have been reported to date. One of these variants is D76N beta 2m, which is a naturally occurring amyloidogenic mutant. To elucidate the molecular mechanisms contributing to the enhanced amyloidogenicity of the mutant, we investigated the equilibrium and kinetic transitions of pressure-induced folding/unfolding equilibria in the wild type and D76N mutant by monitoring intrinsic tryptophan and 1-anilino-8-naphthalene sulfonate fluorescence. An analysis of kinetic data revealed that the different folding/unfolding behaviors of the wild type and D76N mutant were due to differences in the activation energy between the unfolded and the intermediate states as well as stability of the native state, leading to more rapid accumulation of IT state for D76N in the refolding process. In addition, the IT state was found to assume more hydrophobic nature. These changes induced the enhanced amyloidogenicity of the D76N mutant and the distinct pathogenic symptoms of patients. Our results suggest that the stabilization of the native state will be an effective approach for suppressing amyloid fibril formation of this mutant.	[Sakurai, Kazumasa] Kindai Univ, Fac Biol Oriented Sci & Technol, Inst Adv Technol, High Pressure Prot Res Ctr, Wakayama, Japan; [Sakurai, Kazumasa; Tomiyama, Ryosuke] Kindai Univ, Fac Biol Oriented Sci & Technol, Dept Biotechnol, Wakayama, Japan		Sakurai, K (corresponding author), Kindai Univ, Fac Biol Oriented Sci & Technol, Inst Adv Technol, High Pressure Prot Res Ctr, Wakayama, Japan.; Sakurai, K (corresponding author), Kindai Univ, Fac Biol Oriented Sci & Technol, Dept Biotechnol, Wakayama, Japan.	sakurai@waka.kindai.ac.jp			JSPS KAKENHI [JP15K07038]; JSPS Core-to-Core Program A (Advanced Research Networks)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Core-to-Core Program A (Advanced Research Networks)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI Grant Number JP15K07038 (to K. S.) and JSPS Core-to-Core Program A (Advanced Research Networks).	Akasaka K, 2006, CHEM REV, V106, P1814, DOI 10.1021/cr040440z; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Cattoni DI, 2009, BBA-PROTEINS PROTEOM, V1794, P1700, DOI 10.1016/j.bbapap.2009.08.007; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chen CR, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14561, 10.1038/ncomms15523]; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Chong SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13631; CHOU WY, 1989, J BIOL CHEM, V264, P18309; Corazza A, 2004, J BIOL CHEM, V279, P9176, DOI 10.1074/jbc.M310779200; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Hasegawa K, 2013, BBA-PROTEINS PROTEOM, V1834, P1624, DOI 10.1016/j.bbapap.2013.04.011; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Iadanza MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06761-6; Iwata K, 2007, J BIOCHEM, V142, P413, DOI 10.1093/jb/mvm148; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kameda A, 2005, J MOL BIOL, V348, P383, DOI 10.1016/j.jmb.2005.02.050; Kitahara R, 2013, PROG NUCL MAG RES SP, V71, P35, DOI 10.1016/j.pnmrs.2012.12.001; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Maeno A, 2013, BIOPHYS CHEM, V183, P57, DOI 10.1016/j.bpc.2013.07.008; Maeno Akihiro, 2009, Biophysics (Nagoya-shi), V5, P1; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Natalello A, 2016, J BIOL CHEM, V291, P9678, DOI 10.1074/jbc.M116.720573; Roche J, 2012, P NATL ACAD SCI USA, V109, P6945, DOI 10.1073/pnas.1200915109; Rouget JB, 2011, J AM CHEM SOC, V133, P6020, DOI 10.1021/ja200228w; Sakata M, 2008, J MOL BIOL, V382, P1242, DOI 10.1016/j.jmb.2008.08.003; Sakurai K, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090491; Smith HI, 2020, J BIOL CHEM, V295, P12474, DOI 10.1074/jbc.RA120.014901; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067	33	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100333	10.1016/j.jbc.2021.100333	http://dx.doi.org/10.1016/j.jbc.2021.100333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33508321	Green Published, gold			2022-12-28	WOS:000672866400307
J	Song, DS; Bigham, AW; Lee, FS				Song, Daisheng; Bigham, Abigail W.; Lee, Frank S.			High-altitude deer mouse hypoxia-inducible factor-2 alpha shows defective interaction with CREB-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINYL HYDROXYLATION; STRUCTURAL BASIS; TIBETAN PHD2; DOMAIN; HIF; ERYTHROCYTOSIS; ADAPTATION; MUTATIONS; HIF-2-ALPHA; EPISTASIS	Numerous mammalian species have adapted to the chronic hypoxia of high altitude. Recent genomic studies have identified evidence for natural selection of genes and associated genetic changes in these species. A major gap in our knowledge is an understanding of the functional significance, if any, of these changes. Deer mice (Peromyscus maniculatus) live at both low and high altitudes in North America, providing an opportunity to identify functionally important genetic changes. High-altitude deer mice show evidence of natural selection on the Epas1 gene, which encodes for hypoxia-inducible factor-2 alpha (Hif-2 alpha), a central transcription factor of the hypoxia-inducible factor pathway. An SNP encoding for a T755M change in the Hif-2 alpha protein is highly enriched in high-altitude deer mice, but its functional significance is unknown. Here, using coimmunoprecipitation and transcriptional activity assays, we show that the T755M mutation produces a defect in the interaction of Hif-2 alpha with the transcriptional coactivator CREB-binding protein. This results in a loss of function because of decreased transcriptional activity. Intriguingly, the effect of this mutation depends on the amino acid context. Interchanges between methionine and threonine at the corresponding position in house mouse (Mus musculus) Hif-2 alpha are without effects on CREB-binding protein binding. Furthermore, transfer of a set of deer mouse-specific Hif-2 alpha amino acids to house mouse Hif-2 alpha is sufficient to confer sensitivity of house mouse Hif-2 alpha to the T755M substitution. These findings provide insight into high-altitude adaptation in deer mice and evolution at the Epas1 locus.	[Song, Daisheng; Lee, Frank S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Bigham, Abigail W.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA	University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Los Angeles	Lee, FS (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	franklee@pennmedicine.upenn.edu		Lee, Frank/0000-0003-2511-1834; Song, daisheng/0000-0003-1960-8246	NIH [R01-DK104796, R33-HL120751]; University of Pennsylvania Research Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation	This work was supported by NIH Grants R01-DK104796 (to F. S. L.) and R33-HL120751 (to F. S. L. and A. W. B.) and a grant from the University of Pennsylvania Research Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arsenault PR, 2013, J BIOL CHEM, V288, P33571, DOI 10.1074/jbc.M113.482364; Attar N, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026534; Bigham AW, 2014, GENE DEV, V28, P2189, DOI 10.1101/gad.250167.114; Bouthelier A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249401; Brown ST, 2009, J NEUROCHEM, V110, P622, DOI 10.1111/j.1471-4159.2009.06153.x; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Furlow PW, 2009, J BIOL CHEM, V284, P9050, DOI 10.1074/jbc.M808737200; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lappin TR, 2019, BLOOD REV, V37, DOI 10.1016/j.blre.2019.100590; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Natarajan C, 2013, SCIENCE, V340, P1324, DOI 10.1126/science.1236862; Pamenter ME, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00743; Schodel J, 2013, BIOL CHEM, V394, P507, DOI 10.1515/hsz-2012-0351; Schweizer RM, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008420; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Song DS, 2020, P NATL ACAD SCI USA, V117, P12230, DOI [10.1073/pnas.1920546117/-/DCSupplemental, 10.1073/pnas.1920546117]; Song D, 2014, J BIOL CHEM, V289, P14656, DOI 10.1074/jbc.M113.541227; Song DS, 2013, J BIOL CHEM, V288, P9662, DOI 10.1074/jbc.M112.440552; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Storz JF, 2019, J MAMMAL, V100, P910, DOI 10.1093/jmammal/gyy173; Storz JF, 2018, CURR OPIN STRUC BIOL, V50, P18, DOI 10.1016/j.sbi.2017.10.009; Strowitzki MJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050384; Tan QL, 2013, J BIOL CHEM, V288, P17134, DOI 10.1074/jbc.M112.444059; Wenger RH, 2010, AM J PHYSIOL-RENAL, V298, pF1287, DOI 10.1152/ajprenal.00736.2009; Witt KE, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0235; Yu F, 2001, CANCER RES, V61, P4136; Zhao Q, 2003, BIOCHEMISTRY-US, V42, P3627, DOI 10.1021/bi027117f	36	5	5	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100461	10.1016/j.jbc.2021.100461	http://dx.doi.org/10.1016/j.jbc.2021.100461			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33639161	gold, Green Published			2022-12-28	WOS:000672866400435
J	Prole, DL; Chinnery, PF; Jones, NS				Prole, David L.; Chinnery, Patrick F.; Jones, Nick S.			Visualizing, quantifying, and manipulating mitochondrial DNA in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						aging; mitochondrial DNA (mtDNA); mitochondrial disease; mitochondria; microscopy; mitophagy; gene editing	SUPERRESOLUTION MICROSCOPY; TRANSCRIPTION FACTOR; NUCLEOSIDE ANALOGS; MTDNA MAINTENANCE; MUTANT MTDNA; COPY NUMBER; SINGLE-COPY; NUCLEOIDS; CELLS; FLUORESCENCE	Mitochondrial DNA (mtDNA) encodes proteins and RNAs that support the functions of mitochondria and thereby numerous physiological processes. Mutations of mtDNA can cause mitochondrial diseases and are implicated in aging. The mtDNA within cells is organized into nucleoids within the mitochondrial matrix, but how mtDNA nucleoids are formed and regulated within cells remains incompletely resolved. Visualization of mtDNA within cells is a powerful means by which mechanistic insight can be gained. Manipulation of the amount and sequence of mtDNA within cells is important experimentally and for developing therapeutic interventions to treat mitochondrial disease. This review details recent developments and opportunities for improvements in the experimental tools and techniques that can be used to visualize, quantify, and manipulate the properties of mtDNA within cells.	[Prole, David L.; Jones, Nick S.] Imperial Coll London, Dept Math, London, England; [Prole, David L.; Chinnery, Patrick F.] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge, England; [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Jones, NS (corresponding author), Imperial Coll London, Dept Math, London, England.; Chinnery, PF (corresponding author), Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Cambridge, England.; Chinnery, PF (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	pfc25@medschl.cam.ac.uk; nick.jones@imperial.ac.uk		Chinnery, Patrick/0000-0002-7065-6617	Leverhulme Trust [RPG-2018-408]; EPSRC; NERC [EP/N014529/1, NE/V010387/1]; Wellcome Trust [212219/Z/18/Z)]; Medical Research Council (MRC) Mitochondrial Biology Unit [MC_UU_00015/9]; MRC International Centre for Genomic Medicine in Neuromuscular Disease [MR/S005021/1]; MRC [MR/S035699/1]; Alzheimer's Society [AS-PG-18b-022]; NIHR Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; EPSRC [EP/N014529/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome Trust); Medical Research Council (MRC) Mitochondrial Biology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC International Centre for Genomic Medicine in Neuromuscular Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Society; NIHR Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust; University of Cambridge(University of Cambridge); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Leverhulme Trust Grant RPG-2018-408 (to N. S. J. and P. F. C.). N. S. J. was supported by EPSRC and NERC Grants EP/N014529/1 and NE/V010387/1. P. F. C. is a Wellcome Trust Principal Research Fellow (212219/Z/18/Z) and a UK National Institute for Health Research (NIHR) Senior Investigator, who receives support from the Medical Research Council (MRC) Mitochondrial Biology Unit (MC_UU_00015/9), the MRC International Centre for Genomic Medicine in Neuromuscular Disease (MR/S005021/1), MRC Research Grant MR/S035699/1, Alzheimer's Society Project Grant AS-PG-18b-022, and the NIHR Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; Alsina D, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911659; Arbeithuber B, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000745; Aretz I, 2020, BIOL CHEM, V401, P533, DOI 10.1515/hsz-2019-0337; Aryaman J, 2019, GENETICS, V212, P1429, DOI 10.1534/genetics.119.302423; Aryaman J, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00718; Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8; Bacman SR, 2014, METHOD ENZYMOL, V547, P373, DOI 10.1016/B978-0-12-801415-8.00018-7; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Baddeley D, 2018, ANNU REV BIOCHEM, V87, P965, DOI 10.1146/annurev-biochem-060815-014801; Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110; Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011; Benke A, 2012, CHEMBIOCHEM, V13, P298, DOI 10.1002/cbic.201100679; Bros H, 2015, TRAFFIC, V16, P906, DOI 10.1111/tra.12291; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Burgstaller JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04797-2; Burke CS, 2018, ANGEW CHEM INT EDIT, V57, P12420, DOI 10.1002/anie.201806002; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; CHEN CH, 1991, MOL PHARMACOL, V39, P625; Chen JY, 2020, AM J PATHOL, V190, P1565, DOI 10.1016/j.ajpath.2020.03.018; Chen PL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16335-0; Chevrollier A, 2012, INT J BIOCHEM CELL B, V44, P980, DOI 10.1016/j.biocel.2012.03.006; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; Dellinger M, 2001, J MICROSC-OXFORD, V204, P196, DOI 10.1046/j.1365-2818.2001.00954.x; Desdin-Mico G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Diot A, 2016, MAMM GENOME, V27, P381, DOI 10.1007/s00335-016-9651-x; Dombi E, 2018, CURR MED CHEM, V25, P5597, DOI 10.2174/0929867324666170616101741; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437; Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9; Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001; Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676; Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7; Gilkerson R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011080; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; Glancy B, 2020, TRENDS MOL MED, V26, P58, DOI 10.1016/j.molmed.2019.09.009; Goh JJL, 2020, NAT METHODS, V17, P947, DOI 10.1038/s41592-020-0931-8; Gokerkucuk EB, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020125; Hahn A, 2019, TRENDS CELL BIOL, V29, P227, DOI 10.1016/j.tcb.2018.11.004; Hao ZY, 2020, MOL CELL, V78, P382, DOI 10.1016/j.molcel.2020.02.018; Harwig MC, 2018, ANAL BIOCHEM, V552, P81, DOI 10.1016/j.ab.2018.02.022; Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Higuchi-Sanabria R, 2016, MOL BIOL CELL, V27, P776, DOI 10.1091/mbc.E15-07-0455; Hoglinger D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12152-2; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Ikeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119687; Jackson CB, 2020, TRENDS MOL MED, V26, P698, DOI 10.1016/j.molmed.2020.02.006; Jacquemet G, 2020, J CELL SCI, V133, DOI 10.1242/jcs.240713; Jajoo R, 2016, SCIENCE, V351, P169, DOI 10.1126/science.aaa8714; Jevtic V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203956; Jo A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/305716; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Katayama H, 2020, CELL, V181, P1176, DOI 10.1016/j.cell.2020.04.025; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Kaur G, 2019, MOLECULES, V24, DOI 10.3390/molecules24030491; Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337; Kempfer R, 2020, NAT REV GENET, V21, P207, DOI 10.1038/s41576-019-0195-2; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067227; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kohlmeier F, 2013, CHROMOSOME RES, V21, P87, DOI 10.1007/s10577-013-9340-5; Kondadi AK, 2020, EMBO REP, V21, DOI 10.15252/embr.201949776; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kowalska M, 2020, DNA CELL BIOL, V39, P1410, DOI 10.1089/dna.2019.5347; Kukat A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn124; Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lakadamyali M, 2020, NAT METHODS, V17, P371, DOI 10.1038/s41592-020-0758-3; Lakadamyali M, 2015, FEBS LETT, V589, P3023, DOI 10.1016/j.febslet.2015.04.012; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lawless C, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200061; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Legut M, 2020, CELL REP, V30, P2859, DOI 10.1016/j.celrep.2020.02.010; Lentz SI, 2010, J HISTOCHEM CYTOCHEM, V58, P207, DOI 10.1369/jhc.2009.954701; Levet F, 2015, NAT METHODS, V12, P1065, DOI [10.1038/NMETH.3579, 10.1038/nmeth.3579]; Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549; Li CF, 2021, AUTOPHAGY, V17, P948, DOI [10.1080/15548627.2020.1739447, 10.1145/3421766.3421867]; Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4; Ligasova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052584; Longchamps RJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228166; Lukinavicius G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9497; MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039; Mei H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.78; Miller SM, 2020, NAT BIOTECHNOL, V38, P471, DOI 10.1038/s41587-020-0412-8; Modi S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12382-4; Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4; Nissanka N, 2020, EMBO REP, V21, DOI 10.15252/embr.201949612; Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001; Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1; O'Hara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119; Okayama Satoko, 2014, Microscopy (Oxf), V63 Suppl 1, pi35, DOI 10.1093/jmicro/dfu079; Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024; Peng XH, 2019, BIOCHEM SOC T, V47, P1635, DOI 10.1042/BST20190020; Pereira CV, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708084; Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014; Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sasaki T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10843-8; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Seibel P, 2008, NUCLEIC ACIDS RES, V36, P5872, DOI 10.1093/nar/gkn592; Shah SI, 2020, CELL CALCIUM, V89, DOI 10.1016/j.ceca.2020.102224; Shen H, 2020, NEURO-ONCOLOGY, V22, P139, DOI 10.1093/neuonc/noz140; Sigal YM, 2018, SCIENCE, V361, P880, DOI 10.1126/science.aau1044; Slone J, 2020, NPJ GENOM MED, V5, DOI 10.1038/s41525-020-0116-5; Spadafora D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154684; STARNES MC, 1987, J BIOL CHEM, V262, P988; Stephan T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48838-2; Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Thillaiappan NB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01644-8; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Traenkle B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01030; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Uno K., 2020, BIORXIV, DOI [10.1101/2020.05.26.116335, DOI 10.1101/2020.05.26.116335]; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001; Villa AM, 2009, EUR J CANCER, V45, P2588, DOI 10.1016/j.ejca.2009.06.022; Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939; Wagner J, 2017, FEBS LETT, V591, P2520, DOI 10.1002/1873-3468.12757; WALLACE DC, 1976, IN VITRO CELL DEV B, V12, P758, DOI 10.1007/BF02835451; Wallace KB, 2008, TRENDS PHARMACOL SCI, V29, P361, DOI 10.1016/j.tips.2008.04.001; Walton RT, 2020, SCIENCE, V368, P290, DOI 10.1126/science.aba8853; Wang L, 2020, NAT CHEM, V12, P165, DOI 10.1038/s41557-019-0371-1; Wen Y, 2015, ANAL CHEM, V87, P10579, DOI 10.1021/acs.analchem.5b03326; Yahata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15871-y; Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y; Yaroslavsky AI, 2013, CHEM BIOL, V20, P445, DOI 10.1016/j.chembiol.2013.02.012; Yoo BC, 2020, PEERJ, V8, DOI 10.7717/peerj.8362; Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005; Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240; Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010; Yuan Y, 2020, NAT GENET, V52, P342, DOI 10.1038/s41588-019-0557-x; Zhang KX, 2018, J AM CHEM SOC, V140, P11293, DOI 10.1021/jacs.8b05309; Zhang YD, 2020, NAT METHODS, V17, P225, DOI 10.1038/s41592-019-0676-4; Zou XX, 2019, ANAL CHEM, V91, P15899, DOI 10.1021/acs.analchem.9b04364	150	8	8	4	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17588	17601		10.1074/jbc.REV120.015101	http://dx.doi.org/10.1074/jbc.REV120.015101			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454000	Green Published, hybrid			2022-12-28	WOS:000603272300016
J	Sy, M; Brandt, AU; Lee, SU; Newton, BL; Pawling, J; Golzar, A; Rahman, AMA; Yu, ZX; Cooper, G; Scheel, M; Paul, F; Dennis, JW; Demetriou, M				Sy, Michael; Brandt, Alexander U.; Lee, Sung-Uk; Newton, Barbara L.; Pawling, Judy; Golzar, Autreen; Rahman, Anas M. A.; Yu, Zhaoxia; Cooper, Graham; Scheel, Michael; Paul, Friedemann; Dennis, James W.; Demetriou, Michael			N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-glycan branching; N-acetylglucosamine; oligodendrocytes; myelination; myelin repair; multiple sclerosis; N-linked glycosylation; oligodendrocyte; myelin; metabolism; oligodendrocyte precursor cell	MULTIPLE-SCLEROSIS; WHITE-MATTER; AXONAL INJURY; REMYELINATION; DEMYELINATION; ACTIVATION; AUTOIMMUNITY; GLUCOSAMINE; DIETARY; DISEASE	Myelination plays an important role in cognitive development and in demyelinating diseases like multiple sclerosis (MS), where failure of remyelination promotes permanent neuro-axonal damage. Modification of cell surface receptors with branched N-glycans coordinates cell growth and differentiation by controlling glycoprotein clustering, signaling, and endocytosis. GlcNAc is a rate-limiting metabolite for N-glycan branching. Here we report that GlcNAc and N-glycan branching trigger oligodendrogenesis from precursor cells by inhibiting platelet-derived growth factor receptor-alpha cell endocytosis. Supplying oral GlcNAc to lactating mice drives primary myelination in newborn pups via secretion in breast milk, whereas genetically blocking N-glycan branching markedly inhibits primary myelination. In adult mice with toxin (cuprizone)-induced demyelination, oral GlcNAc prevents neuro-axonal damage by driving myelin repair. In MS patients, endogenous serum GlcNAc levels inversely correlated with imaging measures of demyelination and microstructural damage. Our data identify N-glycan branching and GlcNAc as critical regulators of primary myelination and myelin repair and suggest that oral GlcNAc may be neuroprotective in demyelinating diseases like MS.	[Sy, Michael; Brandt, Alexander U.; Lee, Sung-Uk; Newton, Barbara L.; Golzar, Autreen; Demetriou, Michael] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Brandt, Alexander U.; Cooper, Graham; Paul, Friedemann] Charite Univ Med Berlin, Expt & Clin Res Ctr, Berlin, Germany; [Brandt, Alexander U.; Cooper, Graham; Paul, Friedemann] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Brandt, Alexander U.; Cooper, Graham; Scheel, Michael; Paul, Friedemann] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Irvine, CA USA; [Brandt, Alexander U.; Cooper, Graham; Scheel, Michael; Paul, Friedemann] Free Univ Berlin, Berlin, Germany; [Brandt, Alexander U.; Cooper, Graham; Scheel, Michael; Paul, Friedemann] Humboldt Univ, Berlin, Germany; [Brandt, Alexander U.; Cooper, Graham; Scheel, Michael; Paul, Friedemann] Berlin Inst Hlth, Berlin, Germany; [Pawling, Judy; Dennis, James W.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON, Canada; [Demetriou, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Rahman, Anas M. A.; Dennis, James W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Yu, Zhaoxia] Univ Calif Irvine, Donald Bren Sch Informat & Comp Sci, Dept Stat, Irvine, CA USA; [Cooper, Graham] Einstein Ctr Neurosci, Berlin, Germany; [Cooper, Graham; Paul, Friedemann] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany; [Cooper, Graham; Paul, Friedemann] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany	University of California System; University of California Irvine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of California System; University of California Irvine; University of Toronto; University of California System; University of California Irvine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA.; Demetriou, M (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	mdemetriou@uci.edu	Cooper, Graham/AAF-5762-2021; Abdel Rahman, Anas/AEC-1515-2022	Cooper, Graham/0000-0001-8383-6476; Abdel Rahman, Anas/0000-0002-9527-9424; LEE, SUNG-UK/0000-0002-2324-0918; paul, friedemann/0000-0002-6378-0070; Golzar, Autreen/0000-0003-1827-7166; Scheel, Michael/0000-0002-3505-2914	Marilyn Hilton innovator award; NIAID National Institutes of Health [R01AT007452]; NCCIH National Institutes of Health [R01AI144403]; Deutsche Forschungsgemeinschaft [Exc. 257]	Marilyn Hilton innovator award; NIAID National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCCIH National Institutes of Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research was supported by a Marilyn Hilton innovator award to M. Sy, NIAID National Institutes of Health Grant R01AT007452 (to M. D.), and NCCIH National Institutes of Health Grant R01AI144403 (to M. D.). The multiple sclerosis cohort and MRI study were supported by Deutsche Forschungsgemeinschaft Grant Exc. 257 to F. P. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Araujo L, 2017, ELIFE, V6, DOI 10.7554/eLife.21330; Backer-Koduah P, 2020, ANN CLIN TRANSL NEUR, V7, P1628, DOI 10.1002/acn3.51148; Bahaie NS, 2011, J BIOL CHEM, V286, P38231, DOI 10.1074/jbc.M111.279554; Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Beer A, 2016, J NEUROL, V263, P1495, DOI 10.1007/s00415-016-8156-6; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Brynedal B, 2010, J NEUROIMMUNOL, V220, P120, DOI 10.1016/j.jneuroim.2010.01.003; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Deoni SCL, 2013, NEUROIMAGE, V82, P77, DOI 10.1016/j.neuroimage.2013.05.090; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Galloway DA, 2020, GLIA, V68, P859, DOI 10.1002/glia.23711; GAULDEN EC, 1964, METABOLISM, V13, P466, DOI 10.1016/0026-0495(64)90120-9; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Gonzalez GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31599; Granovsky M, 2000, NAT MED, V6, P306; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grigorian Ani, 2011, ISRN Neurol, V2011, P374314, DOI 10.5402/2011/374314; Grigorian A, 2011, J BIOL CHEM, V286, P40133, DOI 10.1074/jbc.M111.277814; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Hu JG, 2008, NEUROSCIENCE, V151, P138, DOI 10.1016/j.neuroscience.2007.10.050; Hughes EG, 2018, NAT NEUROSCI, V21, P696, DOI 10.1038/s41593-018-0121-5; Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da; Jakel S, 2019, NATURE, V566, P543, DOI 10.1038/s41586-019-0903-2; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lawson MAE, 2020, ISME J, V14, P635, DOI 10.1038/s41396-019-0553-2; Lee KY, 2004, FOOD CHEM TOXICOL, V42, P687, DOI 10.1016/j.fct.2003.12.005; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; LEVIN RM, 1961, J LAB CLIN MED, V58, P927; Li CF, 2013, J NEUROIMMUNOL, V256, P71, DOI 10.1016/j.jneuroim.2012.12.008; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Mei F, 2016, ELIFE, V5, DOI 10.7554/eLife.18246; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Michalski JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019772; MILLER JB, 1994, J PEDIATR GASTR NUTR, V19, P371, DOI 10.1097/00005176-199411000-00001; Mkhikian H, 2016, ELIFE, V5, DOI 10.7554/eLife.14814; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Mortales CL, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101380; Mortales CL, 2020, J IMMUNOL, V205, P630, DOI 10.4049/jimmunol.2000101; Nakamura K, 2017, ANN NEUROL, V82, P635, DOI 10.1002/ana.25019; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pasquini LA, 2011, CELL DEATH DIFFER, V18, P1746, DOI 10.1038/cdd.2011.40; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Paul F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001928; Prineas J. W., 1997, GREENFIELDS NEUROPAT, P813; Rahman AMA, 2013, ACS CHEM BIOL, V8, P2053, DOI 10.1021/cb4004173; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Righart R, 2017, ANN NEUROL, V82, P519, DOI 10.1002/ana.25020; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Saab AS, 2016, NEURON, V91, P119, DOI 10.1016/j.neuron.2016.05.016; Sachs HH, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551955; Salvatore S, 2000, ALIMENT PHARM THER, V14, P1567, DOI 10.1046/j.1365-2036.2000.00883.x; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Stoffels JMJ, 2013, BRAIN, V136, P116, DOI 10.1093/brain/aws313; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Takahashi M, 2009, FOOD CHEM TOXICOL, V47, P462, DOI 10.1016/j.fct.2008.12.002; Ye ZY, 2004, GLYCOBIOLOGY, V14, P547, DOI 10.1093/glycob/cwh069; Yeung MSY, 2019, NATURE, V566, P538, DOI 10.1038/s41586-018-0842-3; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013; Zhou RW, 2014, NAT IMMUNOL, V15, P1038, DOI 10.1038/ni.3007	76	16	16	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17413	17424		10.1074/jbc.RA120.015595	http://dx.doi.org/10.1074/jbc.RA120.015595			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	32978254	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000603272300004
J	Sharpe, LJ; Coates, HW; Brown, AJ				Sharpe, Laura J.; Coates, Hudson W.; Brown, Andrew J.			Post-translational control of the long and winding road to cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cholesterol; post-translational regulation; HMGCR; SM; cholesterol synthesis; ubiquitination; phosphorylation; acetylation; proteasome; post-translational modification; cholesterol metabolism; cholesterol regulation; protein degradation; post-translational modification (PTM); E3 ubiquitin ligase; ubiquitylation (ubiquitination); ubiquitin ligase	HMG-COA REDUCTASE; STEROL-REGULATED DEGRADATION; COENZYME-A REDUCTASE; LAMIN-B RECEPTOR; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; SQUALENE MONOOXYGENASE; ENDOPLASMIC-RETICULUM; PROTEIN-KINASE; ACCELERATED DEGRADATION; MEDIATED DEGRADATION	The synthesis of cholesterol requires more than 20 enzymes, many of which are intricately regulated. Post-translational control of these enzymes provides a rapid means for modifying flux through the pathway. So far, several enzymes have been shown to be rapidly degraded through the ubiquitin-proteasome pathway in response to cholesterol and other sterol intermediates. Additionally, several enzymes have their activity altered through phosphorylation mechanisms. Most work has focused on the two rate-limiting enzymes: 3-hydroxy-3-methylglutaryl CoA reductase and squalene monooxygenase. Here, we review current literature in the area to define some common themes in the regulation of the entire cholesterol synthesis pathway. We highlight the rich variety of inputs controlling each enzyme, discuss the interplay that exists between regulatory mechanisms, and summarize findings that reveal an intricately coordinated network of regulation along the cholesterol synthesis pathway. We provide a roadmap for future research into the post-translational control of cholesterol synthesis, and no doubt the road ahead will reveal further twists and turns for this fascinating pathway crucial for human health and disease.	[Sharpe, Laura J.; Coates, Hudson W.; Brown, Andrew J.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Brown, AJ (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	aj.brown@unsw.edu.au		Sharpe, Laura/0000-0002-9896-294X; Coates, Hudson/0000-0002-6506-5249	Australian Research Council [DP170101178]; New South Wales Health Investigator Development Grant; University of New South Wales Gold Star award	Australian Research Council(Australian Research Council); New South Wales Health Investigator Development Grant; University of New South Wales Gold Star award	This work was supported by Australian Research Council Discovery Project Grant DP170101178, a New South Wales Health Investigator Development Grant, and a University of New South Wales Gold Star award.	Allen LB, 2020, ACS CHEM NEUROSCI, V11, P1413, DOI 10.1021/acschemneuro.0c00042; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Bersuker K, 2018, DEV CELL, V44, P97, DOI 10.1016/j.devcel.2017.11.020; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Brown A. J., 2016, BIOCH LIPIDS LIPOPRO, P327, DOI DOI 10.1016/B978-0-444-63438-2.00011-0; Brown AJ, 2021, BRIT J PHARMACOL, V178, P3089, DOI 10.1111/bph.15073; Brown AJ, 2014, CURR OPIN LIPIDOL, V25, P133, DOI 10.1097/MOL.0000000000000038; Brown MS, 2018, ANNU REV BIOCHEM, V87, P783, DOI 10.1146/annurev-biochem-062917-011852; Capell-Hattam IM, 2020, J BIOL CHEM, V295, P2850, DOI 10.1074/jbc.RA119.011323; Chen L, 2019, J LIPID RES, V60, P1765, DOI 10.1194/jlr.RA119000201; Chua NK, 2020, PROG LIPID RES, V79, DOI 10.1016/j.plipres.2020.101033; Chua NK, 2019, BIOCHEM J, V476, P2545, DOI 10.1042/BCJ20190418; Chua NK, 2019, J BIOL CHEM, V294, P8134, DOI 10.1074/jbc.RA119.007798; Chua NK, 2017, J BIOL CHEM, V292, P19959, DOI 10.1074/jbc.M117.794230; Clague MJ, 2019, NAT REV MOL CELL BIO, V20, P338, DOI 10.1038/s41580-019-0099-1; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; Clizbe DB, 2007, J BIOL CHEM, V282, P6668, DOI 10.1074/jbc.M610922200; Coates HW, 2019, J LIPID RES, V60, P1643, DOI 10.1194/jlr.C119000358; Cook ECL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172721; Favier LA, 2016, APPL CLIN GENET, V9, DOI 10.2147/TACG.S93933; Gabitova L, 2015, CELL REP, V12, P1927, DOI 10.1016/j.celrep.2015.08.023; Gaylor JL, 2002, BIOCHEM BIOPH RES CO, V292, P1139, DOI 10.1006/bbrc.2001.2008; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; GILLESPIE JG, 1992, FEBS LETT, V306, P59, DOI 10.1016/0014-5793(92)80837-7; Harada K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111829; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang BL, 2020, NAT METAB, V2, P132, DOI 10.1038/s42255-020-0174-0; Hwang S, 2016, J BIOL CHEM, V291, P13479, DOI 10.1074/jbc.M116.728469; Jansen M, 2013, FASEB J, V27, P865, DOI 10.1096/fj.12-211235; Jiang SY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07590-3; Jo Y, 2020, ELIFE, V9, DOI 10.7554/eLife.54841; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; JONES PJH, 1990, CAN J PHYSIOL PHARM, V68, P955, DOI 10.1139/y90-145; Kasbekar DP, 2018, J BIOSCIENCES, V43, P235, DOI 10.1007/s12038-018-9757-2; Kedjouar B, 2004, J BIOL CHEM, V279, P34048, DOI 10.1074/jbc.M405230200; Koczok K, 2019, J MOL HISTOL, V50, P63, DOI 10.1007/s10735-018-9807-y; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Leichner GS, 2011, J BIOL CHEM, V286, P32150, DOI 10.1074/jbc.M111.278036; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; Luu W, 2015, J LIPID RES, V56, P888, DOI 10.1194/jlr.M056986; Luu W, 2014, J LIPID RES, V55, P410, DOI 10.1194/jlr.M043257; Martin MG, 2014, EMBO REP, V15, P1036, DOI 10.15252/embr.201439225; Menzies SA, 2018, ELIFE, V7, DOI [10.7554/eLife.40009.001, 10.7554/eLife.40009]; Mitsche MA, 2015, ELIFE, V4, DOI 10.7554/eLife.07999; Mo CQ, 2005, BBA-MOL CELL BIOL L, V1737, P152, DOI 10.1016/j.bbalip.2005.11.002; Morris LL, 2014, J BIOL CHEM, V289, P19053, DOI 10.1074/jbc.M114.576652; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Nakamura N, 2014, EXP CELL RES, V328, P207, DOI 10.1016/j.yexcr.2014.07.025; Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3; Ochoa D, 2020, NAT BIOTECHNOL, V38, P365, DOI 10.1038/s41587-019-0344-3; Ohashi M, 2003, J BIOL CHEM, V278, P36819, DOI 10.1074/jbc.M301408200; Park JW, 2017, BIOCHEM J, V474, P3241, DOI 10.1042/BCJ20170459; Pineda A, 2011, CURR ATHEROSCLER REP, V13, P23, DOI 10.1007/s11883-010-0148-x; Prabhu AV, 2017, J STEROID BIOCHEM, V165, P363, DOI 10.1016/j.jsbmb.2016.08.003; Prabhu AV, 2016, J BIOL CHEM, V291, P8363, DOI 10.1074/jbc.M115.699546; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Sapir A, 2014, P NATL ACAD SCI USA, V111, pE3880, DOI 10.1073/pnas.1414748111; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; Schumacher MM, 2015, ELIFE, V4, DOI [10.7554/eLife.05560, 10.7554/eLife.04490]; Scott NA, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2020.158837; Scott NA, 2020, BIOCHEM J, V477, P541, DOI 10.1042/BCJ20190647; Segatto M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133317; Sellis D, 2012, BBA-GEN SUBJECTS, V1820, P44, DOI 10.1016/j.bbagen.2011.10.010; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Sharpe LJ, 2019, J BIOL CHEM, V294, P2436, DOI 10.1074/jbc.RA118.005069; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Simonen P, 2020, J INTERN MED, V288, P560, DOI 10.1111/joim.13095; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Takano M, 2004, J BIOL CHEM, V279, P13265, DOI 10.1074/jbc.M308854200; Tallorin L, 2020, J BIOL CHEM, V295, P12426, DOI 10.1074/jbc.RA120.013455; Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; van de Weijer ML, 2020, MOL CELL, V79, P768, DOI 10.1016/j.molcel.2020.07.009; Voukkalis N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154198; Wages PA, 2018, J LIPID RES, V59, P1916, DOI 10.1194/jlr.M086991; Wang L, 2010, BBA-MOL CELL RES, V1803, P591, DOI 10.1016/j.bbamcr.2010.02.003; Wang N, 2020, LANCET DIABETES ENDO, V8, P36, DOI 10.1016/S2213-8587(19)30388-2; Wassif CA, 2017, GENET MED, V19, P297, DOI 10.1038/gim.2016.102; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yoshioka H, 2020, P NATL ACAD SCI USA, V117, P7150, DOI 10.1073/pnas.1915923117; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1269, DOI 10.1016/j.bbalip.2011.11.009; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zhu T, 2019, BRIT J DERMATOL, V181, P304, DOI 10.1111/bjd.17596; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	97	12	13	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17549	17559		10.1074/jbc.REV120.010723	http://dx.doi.org/10.1074/jbc.REV120.010723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453997	Green Published, hybrid			2022-12-28	WOS:000603272300013
J	Munford, RS; Weiss, JP; Lu, MF				Munford, Robert S.; Weiss, Jerrold P.; Lu, Mingfang			Biochemical transformation of bacterial lipopolysaccharides by acyloxyacyl hydrolase reduces host injury and promotes recovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						lipid A; lipopolysaccharide (LPS); Toll-like receptor 4 (TLR4); inflammation; tolerance; macrophage; natural killer cells (NK cells); colitis; acyloxyacyl hydrolase; AOAH; CD14	ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; TOLL-LIKE RECEPTOR-4; DEACYLATED LIPOPOLYSACCHARIDE; METABOLIC ENDOTOXEMIA; LEUKOCYTE ENZYME; LPS RECOGNITION; LIPID-A; EXTRACELLULAR COMPONENTS; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURE	Animals can sense the presence of microbes in their tissues and mobilize their own defenses by recognizing and responding to conserved microbial structures (often called microbe-associated molecular patterns (MAMPs)). Successful host defenses may kill the invaders, yet the host animal may fail to restore homeostasis if the stimulatory microbial structures are not silenced. Although mice have many mechanisms for limiting their responses to lipopolysaccharide (LPS), a major Gram-negative bacterial MAMP, a highly conserved host lipase is required to extinguish LPS sensing in tissues and restore homeostasis. We review recent progress in understanding how this enzyme, acyloxyacyl hydrolase (AOAH), transforms LPS from stimulus to inhibitor, reduces tissue injury and death from infection, prevents prolonged post-infection immunosuppression, and keeps stimulatory LPS from entering the bloodstream. We also discuss how AOAH may increase sensitivity to pulmonary allergens. Better appreciation of how host enzymes modify LPS and other MAMPs may help prevent tissue injury and hasten recovery from infection.	[Munford, Robert S.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Weiss, Jerrold P.] Univ Iowa, Inflammat Program, Iowa City, IA USA; [Lu, Mingfang] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai, Peoples R China; [Lu, Mingfang] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Iowa; Fudan University; Fudan University	Munford, RS (corresponding author), NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Lu, MF (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai, Peoples R China.; Lu, MF (corresponding author), Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China.	munfordrs@niaid.nih.gov; mingfanglu@fudan.edu.cn			National Natural Science Foundation of China [31570910, 31770993, 91742104]; National Institutes of Health [R01 AI18188, R01 AI059372]; Division of Intramural Research, NIAID, National Institutes of Health; Veterans Affairs Grant [I01 BX000949/BX/BLRD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs Grant(US Department of Veterans Affairs)	This work was supported by National Natural Science Foundation of China Grants 31570910, 31770993, and 91742104 (to M. L.) (Fudan), National Institutes of Health Grants R01 AI18188 (to R. S. M.) and R01 AI059372 (to J. P. W.), the Division of Intramural Research, NIAID, National Institutes of Health (to R. S. M.), and Veterans Affairs Grant I01 BX000949/BX/BLRD (to J. P. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barker JH, 2019, J LEUKOCYTE BIOL, V106, P127, DOI 10.1002/JLB.3MIR1118-434R; Barnes KC, 2006, J ALLERGY CLIN IMMUN, V118, P70, DOI 10.1016/j.jaci.2006.03.036; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chandler CE, 2020, P NATL ACAD SCI USA, V117, P22984, DOI 10.1073/pnas.1917504117; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Cody MJ, 1997, J ENDOTOXIN RES, V4, P371, DOI 10.1177/096805199700400509; Collins PE, 2015, CRIT REV IMMUNOL, V35, P293, DOI 10.1615/CritRevImmunol.2015015495; d'Hennezel E, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00046-17; DALNOGARE AR, 1990, J IMMUNOL, V144, P1404; de Boer JD, 2013, AM J RESP CELL MOL, V48, P382, DOI 10.1165/rcmb.2012-0331OC; Di Lorenzo F, 2019, FEMS MICROBIOL REV, V43, P257, DOI 10.1093/femsre/fuz002; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; ELSBACH P, 1980, REV INFECT DIS, V2, P106; Elsbach P, 2000, MICROBES INFECT, V2, P1171, DOI 10.1016/S1286-4579(00)01271-5; ELSBACH P, 1979, J BIOL CHEM, V254, P1000; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; ERWIN AL, 1991, INFECT IMMUN, V59, P1881, DOI 10.1128/IAI.59.6.1881-1887.1991; ERWIN AL, 1990, J BIOL CHEM, V265, P16444; Esparza GA, 2012, INNATE IMMUN-LONDON, V18, P478, DOI 10.1177/1753425911422723; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Faraj TA, 2017, INT REV IMMUNOL, V36, P125, DOI 10.1080/08830185.2017.1280483; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Ferreira MAR, 2017, J ALLERGY CLIN IMMUN, V139, P1148, DOI 10.1016/j.jaci.2016.07.017; Feulner JA, 2004, INFECT IMMUN, V72, P3171, DOI 10.1128/IAI.72.6.3171-3178.2004; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Gautier T, 2008, J BIOL CHEM, V283, P18702, DOI 10.1074/jbc.M802802200; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; Gioannini TL, 2014, IMMUNOL RES, V59, P3, DOI 10.1007/s12026-014-8543-y; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gorelik A, 2018, P NATL ACAD SCI USA, V115, pE896, DOI 10.1073/pnas.1719834115; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Guerville M, 2017, AM J PHYSIOL-ENDOC M, V313, pE107, DOI 10.1152/ajpendo.00372.2016; Guerville M, 2016, AM J PHYSIOL-GASTR L, V311, pG1, DOI 10.1152/ajpgi.00098.2016; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; HAGEN FS, 1991, BIOCHEMISTRY-US, V30, P8415, DOI 10.1021/bi00098a020; HALL CL, 1983, P NATL ACAD SCI-BIOL, V80, P6671, DOI 10.1073/pnas.80.21.6671; Hankins JV, 2011, MOL MICROBIOL, V81, P1313, DOI 10.1111/j.1365-2958.2011.07765.x; HENRICSON BE, 1990, INFECT IMMUN, V58, P2429, DOI 10.1128/IAI.58.8.2429-2437.1990; Janelsins BM, 2014, P NATL ACAD SCI USA, V111, P373, DOI 10.1073/pnas.1311987111; Jimenez MF, 2001, INTENS CARE MED, V27, pS49, DOI 10.1007/PL00003797; Jutras BL, 2019, P NATL ACAD SCI USA, V116, P13498, DOI 10.1073/pnas.1904170116; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaliannan K, 2013, P NATL ACAD SCI USA, V110, P7003, DOI 10.1073/pnas.1220180110; Katz SS, 1999, J BIOL CHEM, V274, P36579, DOI 10.1074/jbc.274.51.36579; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; KITCHENS RL, 1995, J BIOL CHEM, V270, P9904, DOI 10.1074/jbc.270.17.9904; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; Komazin G, 2019, J BIOL CHEM, V294, P19405, DOI 10.1074/jbc.RA119.010836; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Lagrange B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02682-y; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Latty SL, 2018, ELIFE, V7, DOI 10.7554/eLife.31377; LINDBERG AA, 1990, REV INFECT DIS, V12, pS133; Lo Sciuto A, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040291; Lu MF, 2005, NAT IMMUNOL, V6, P989, DOI 10.1038/ni1246; Lu MF, 2003, J EXP MED, V197, P1745, DOI 10.1084/jem.20030420; Lu MF, 2008, CELL HOST MICROBE, V4, P293, DOI 10.1016/j.chom.2008.06.009; Lu MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003339; Lu MF, 2011, J IMMUNOL, V187, P3314, DOI 10.4049/jimmunol.1004087; LUCHI M, 1993, J IMMUNOL, V151, P959; Mages J, 2007, IMMUNOBIOLOGY, V212, P723, DOI 10.1016/j.imbio.2007.09.015; MAGNUSON DK, 1989, J IMMUNOL, V143, P3025; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Munford R, 2009, ADV IMMUNOL, V103, P29, DOI 10.1016/S0065-2776(09)03002-8; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Munford RS, 2016, J LEUKOCYTE BIOL, V100, P687, DOI 10.1189/jlb.3RU0316-151R; MUNFORD RS, 1986, SCIENCE, V234, P203, DOI 10.1126/science.3529396; MUNFORD RS, 1992, J BIOL CHEM, V267, P10116; MUNFORD RS, 1995, J LIPID RES, V36, P1653; MUNFORD RS, 1989, J BIOL CHEM, V264, P15613; Murray SM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00261; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; NIGAM VN, 1970, H-S Z PHYSIOL CHEM, V351, P1123, DOI 10.1515/bchm2.1970.351.2.1123; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ojogun N, 2009, J INFECT DIS, V200, P1685, DOI 10.1086/646616; Paciello I, 2013, P NATL ACAD SCI USA, V110, pE4345, DOI 10.1073/pnas.1303641110; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pekalski ML, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93739; PETERSON AA, 1987, INFECT IMMUN, V55, P974, DOI 10.1128/IAI.55.4.974-978.1987; POHLMAN TH, 1987, J EXP MED, V165, P1393, DOI 10.1084/jem.165.5.1393; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; POXTON IR, 1995, CLIN INFECT DIS, V20, pS149, DOI 10.1093/clinids/20.Supplement_2.S149; Qian GJ, 2018, J EXP MED, V215, P2397, DOI 10.1084/jem.20172225; Rader BA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00897; RIEDO FX, 1990, J IMMUNOL, V144, P3506; Rodriguez D, 2003, J IMMUNOL, V171, P1001, DOI 10.4049/jimmunol.171.2.1001; Ryu JK, 2017, IMMUNITY, V46, P38, DOI 10.1016/j.immuni.2016.11.007; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Shao BM, 2007, J BIOL CHEM, V282, P13726, DOI 10.1074/jbc.M609462200; Shao BM, 2011, HEPATOLOGY, V54, P1051, DOI 10.1002/hep.24488; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Simpson BW, 2019, NAT REV MICROBIOL, V17, P403, DOI 10.1038/s41579-019-0201-x; STAAB JF, 1994, J BIOL CHEM, V269, P23736; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Thomas Lewis, 1974, LIVES CELL; Torgersen C, 2009, ANESTH ANALG, V108, P1841, DOI 10.1213/ane.0b013e318195e11d; Van Dyken SJ, 2018, J ALLERGY CLIN IMMUN, V142, P364, DOI 10.1016/j.jaci.2018.06.017; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Velasco G, 2005, AM J RESP CELL MOL, V32, P218, DOI 10.1165/rcmb.2003-0435OC; Velez JI, 2016, MOL PSYCHIATR, V21, P916, DOI 10.1038/mp.2015.177; VERRET CR, 1982, J BIOL CHEM, V257, P228; Vesy CJ, 2000, INFECT IMMUN, V68, P2410, DOI 10.1128/IAI.68.5.2410-2417.2000; Weinrauch Y, 1999, INFECT IMMUN, V67, P3376, DOI 10.1128/IAI.67.7.3376-3382.1999; Whitfield C, 2020, J BIOL CHEM, V295, P10593, DOI 10.1074/jbc.REV120.009402; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039247; Zou BK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006436	114	8	9	3	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17842	17851		10.1074/jbc.REV120.015254	http://dx.doi.org/10.1074/jbc.REV120.015254			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454018	Green Published, hybrid			2022-12-28	WOS:000603272300034
J	Bradley, JM; Svistunenko, DA; Wilson, MT; Hemmings, AM; Moore, GR; Le Brun, NE				Bradley, Justin M.; Svistunenko, Dimitri A.; Wilson, Michael T.; Hemmings, Andrew M.; Moore, Geoffrey R.; Le Brun, Nick E.			Bacterial iron detoxification at the molecular level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						iron regulation; Fur; DtxR; RirA; Irr; iron toxicity; iron storage; ferritin; bacterioferritin; Ftn; Dps; encapsulin; iron; iron metabolism; gene regulation; reactive oxygen species (ROS); Bfr; encapsulins	FERRIC UPTAKE REGULATOR; ESCHERICHIA-COLI BACTERIOFERRITIN; DNA-BINDING PROTEIN; EXTRACELLULAR HEME UPTAKE; MEMBRANE RECEPTORS PHUR; METAL-ION-ACTIVATION; FERROUS IRON; CRYSTAL-STRUCTURE; DIPHTHERIA-TOXIN; OUTER-MEMBRANE	Iron is an essential micronutrient, and, in the case of bacteria, its availability is commonly a growth-limiting factor. However, correct functioning of cells requires that the labile pool of chelatable "free" iron be tightly regulated. Correct metalation of proteins requiring iron as a cofactor demands that such a readily accessible source of iron exist, but overaccumulation results in an oxidative burden that, if unchecked, would lead to cell death. The toxicity of iron stems from its potential to catalyze formation of reactive oxygen species that, in addition to causing damage to biological molecules, can also lead to the formation of reactive nitrogen species. To avoid iron-mediated oxidative stress, bacteria utilize iron-dependent global regulators to sense the iron status of the cell and regulate the expression of proteins involved in the acquisition, storage, and efflux of iron accordingly. Here, we survey the current understanding of the structure and mechanism of the important members of each of these classes of protein. Diversity in the details of iron homeostasis mechanisms reflect the differing nutritional stresses resulting from the wide variety of ecological niches that bacteria inhabit. However, in this review, we seek to highlight the similarities of iron homeostasis between different bacteria, while acknowledging important variations. In this way, we hope to illustrate how bacteria have evolved common approaches to overcome the dual problems of the insolubility and potential toxicity of iron.	[Bradley, Justin M.; Hemmings, Andrew M.; Moore, Geoffrey R.; Le Brun, Nick E.] Univ East Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich, Norfolk, England; [Hemmings, Andrew M.] Univ East Anglia, Sch Biol Sci, Ctr Mol & Struct Biochem, Norwich, Norfolk, England; [Svistunenko, Dimitri A.; Wilson, Michael T.] Univ Essex, Sch Life Sci, Colchester, Essex, England	University of East Anglia; University of East Anglia; University of Essex	Bradley, JM; Le Brun, NE (corresponding author), Univ East Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich, Norfolk, England.	justin.bradley@uea.ac.uk; n.le-brun@uea.ac.uk	HEMMINGS, ANDREW MICHAEL/E-5517-2011	HEMMINGS, ANDREW MICHAEL/0000-0003-3053-3134; Svistunenko, Dimitri/0000-0001-8060-2738; Bradley, Justin/0000-0003-1635-4455	Biotechnology and Biological Sciences Research Council [BB/R002363/1, BB/R003203/1]; BBSRC [BB/R003203/1, BB/R002363/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/R002363/1 and BB/R003203/1.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Akita F, 2007, J MOL BIOL, V368, P1469, DOI 10.1016/j.jmb.2007.02.075; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Ash MR, 2010, J BIOL CHEM, V285, P14594, DOI 10.1074/jbc.M110.111914; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Baaghil S, 2003, BIOCHEMISTRY-US, V42, P14047, DOI 10.1021/bi035253u; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Beauchene NA, 2017, P NATL ACAD SCI USA, V114, P12261, DOI 10.1073/pnas.1707189114; Beaufay F, 2020, MBIO, V11, DOI 10.1128/mBio.01017-20; Behera RK, 2014, P NATL ACAD SCI USA, V111, P7925, DOI 10.1073/pnas.1318417111; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bennett BD, 2015, APPL ENVIRON MICROB, V81, P7938, DOI 10.1128/AEM.02835-15; Berges M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03183; Berks BC, 1995, BBA-BIOENERGETICS, V1232, P97, DOI 10.1016/0005-2728(95)00092-5; Bhubhanil S, 2012, FEMS MICROBIOL LETT, V335, P68, DOI 10.1111/j.1574-6968.2012.02638.x; Bou-Abdallah F, 2014, BIOCHEMISTRY-US, V53, P483, DOI 10.1021/bi401517f; Bou-Abdallah F, 2002, J BIOL CHEM, V277, P37064, DOI 10.1074/jbc.M205712200; BOYD J, 1990, P NATL ACAD SCI USA, V87, P5968, DOI 10.1073/pnas.87.15.5968; Bradley JM, 2020, DALTON T, V49, P1545, DOI 10.1039/c9dt03570b; Bradley JM, 2019, P NATL ACAD SCI USA, V116, P2058, DOI 10.1073/pnas.1809913116; Bradley JM, 2017, METALLOMICS, V9, P1421, DOI 10.1039/c7mt00187h; Bradley JM, 2017, CURR OPIN CHEM BIOL, V37, P122, DOI 10.1016/j.cbpa.2017.02.027; Bradley JM, 2015, ANGEW CHEM INT EDIT, V54, P14763, DOI 10.1002/anie.201507486; Bradley JM, 2014, J BIOL INORG CHEM, V19, P775, DOI 10.1007/s00775-014-1136-3; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; Carpenter BM, 2013, J BACTERIOL, V195, P5526, DOI 10.1128/JB.01026-13; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Chandrangsu P, 2018, ANTIOXID REDOX SIGN, V28, P445, DOI 10.1089/ars.2017.7057; Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Chao TC, 2005, APPL ENVIRON MICROB, V71, P5969, DOI 10.1128/AEM.71.10.5969-5982.2005; Chao TC, 2004, J BACTERIOL, V186, P3609, DOI 10.1128/JB.186.11.3609-3620.2004; Cheng YQ, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01503-18; Choi J, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.03026-18; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Contreras H, 2014, J BIOL CHEM, V289, P18279, DOI 10.1074/jbc.M114.570119; Costa D, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00895-17, 10.1128/aem.00895-17]; Crow A, 2009, J AM CHEM SOC, V131, P6808, DOI 10.1021/ja8093444; D'Aquino JA, 2005, P NATL ACAD SCI USA, V102, P18408, DOI 10.1073/pnas.0500908102; Neto JFD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-549; Davies BW, 2011, P NATL ACAD SCI USA, V108, P12467, DOI 10.1073/pnas.1107894108; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; Deng ZQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8642; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Diaz-Mireles E, 2004, MICROBIOL-SGM, V150, P1447, DOI 10.1099/mic.0.26961-0; Ding X, 1996, NAT STRUCT BIOL, V3, P382, DOI 10.1038/nsb0496-382; Do H, 2019, NUCLEIC ACIDS RES, V47, P7476, DOI 10.1093/nar/gkz524; Ebrahimi KH, 2015, CHEM REV, V115, P295, DOI 10.1021/cr5004908; Ebrahimi KH, 2013, CHEMBIOCHEM, V14, P1123, DOI 10.1002/cbic.201300149; Ekman M, 2014, ENVIRON MICROBIOL, V16, P829, DOI 10.1111/1462-2920.12233; Ellermann M, 2017, FREE RADICAL BIO MED, V105, P68, DOI 10.1016/j.freeradbiomed.2016.10.489; Embree M, 2014, APPL ENVIRON MICROB, V80, P2918, DOI 10.1128/AEM.03916-13; Eng ET, 2008, J MOL BIOL, V375, P1086, DOI 10.1016/j.jmb.2007.11.027; Escolar L, 1997, MOL MICROBIOL, V26, P799, DOI 10.1046/j.1365-2958.1997.6211987.x; Eshelman K, 2017, METALLOMICS, V9, P646, DOI 10.1039/c7mt00042a; Figueiredo MCO, 2012, ANAEROBE, V18, P454, DOI 10.1016/j.anaerobe.2012.06.001; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Frawley ER, 2013, P NATL ACAD SCI USA, V110, P12054, DOI 10.1073/pnas.1218274110; Frenkiel-Krispin D, 2004, MOL MICROBIOL, V51, P395, DOI 10.1046/j.1365-2958.2003.03855.x; Fuangthong M, 2003, J BACTERIOL, V185, P6348, DOI 10.1128/JB.185.21.6348-6357.2003; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; Gamba I, 2017, COORDIN CHEM REV, V334, P2, DOI 10.1016/j.ccr.2016.11.007; Giessen TW, 2019, ELIFE, V8, DOI 10.7554/eLife.46070; Giessen TW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.29; Giessen TW, 2016, CURR OPIN CHEM BIOL, V34, P1, DOI 10.1016/j.cbpa.2016.05.013; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Greenwald J, 2007, J BIOL CHEM, V282, P2987, DOI 10.1074/jbc.M609238200; Guan GH, 2015, MOL MICROBIOL, V98, P787, DOI 10.1111/mmi.13158; Hagen WR, 2017, METALLOMICS, V9, P595, DOI 10.1039/c7mt00124j; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; He DD, 2019, BIOCHEM J, V476, P975, DOI 10.1042/BCJ20180922; He DD, 2016, ELIFE, V5, DOI 10.7554/eLife.18972; He X, 2017, MOL CELL PROTEOMICS, V16, P2243, DOI 10.1074/mcp.RA117.000296; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hider RC, 2011, BIOMETALS, V24, P1179, DOI 10.1007/s10534-011-9476-8; Howe C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218300; Howe C, 2018, J BIOL CHEM, V293, P16635, DOI 10.1074/jbc.RA118.002425; Hristova D, 2008, BIOCHEMISTRY-US, V47, P3989, DOI 10.1021/bi702408k; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Hung KW, 2012, J BACTERIOL, V194, P6518, DOI 10.1128/JB.01228-12; Hung KW, 2012, J BIOMOL NMR, V53, P161, DOI 10.1007/s10858-012-9633-6; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Imperi F, 2009, P NATL ACAD SCI USA, V106, P20440, DOI 10.1073/pnas.0908760106; Ingrassia R, 2006, J BIOCHEM, V139, P881, DOI 10.1093/jb/mvj101; Isabella V, 2008, MICROBIOL-SGM, V154, P226, DOI 10.1099/mic.0.2007/010470-0; Jacques JF, 2006, MOL MICROBIOL, V62, P1181, DOI 10.1111/j.1365-2958.2006.05439.x; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Kappler U, 2013, CELL MOL LIFE SCI, V70, P977, DOI 10.1007/s00018-012-1098-y; Karas VO, 2015, J BACTERIOL, V197, P3206, DOI 10.1128/JB.00475-15; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P823, DOI 10.1093/pcp/pce106; Kauko A, 2006, J MOL BIOL, V364, P97, DOI 10.1016/j.jmb.2006.08.061; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Khare G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169545; Kim S, 2016, J MOL BIOL, V428, P5007, DOI 10.1016/j.jmb.2016.10.022; Kobayashi K, 2016, BIOCHEMISTRY-US, V55, P4047, DOI 10.1021/acs.biochem.6b00512; Koh EI, 2017, NAT CHEM BIOL, V13, P1016, DOI [10.1038/nchembio.2441, 10.1038/NCHEMBIO.2441]; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Kwak Y, 2015, BIOCHEMISTRY-US, V54, P7010, DOI 10.1021/acs.biochem.5b01033; Lau CKY, 2016, FEMS MICROBIOL REV, V40, P273, DOI 10.1093/femsre/fuv049; LAULHERE JP, 1992, BIOCHEM J, V281, P785, DOI 10.1042/bj2810785; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; LEVI S, 1988, J BIOL CHEM, V263, P18086; Li X, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny198; Li X, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv017; Llamas MA, 2014, FEMS MICROBIOL REV, V38, P569, DOI 10.1111/1574-6976.12078; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; Martinez MTP, 2019, ELIFE, V8, DOI 10.7554/eLife.47804; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masuda T, 2010, BIOCHEM BIOPH RES CO, V400, P94, DOI 10.1016/j.bbrc.2010.08.017; Mattle D, 2010, J MOL BIOL, V404, P220, DOI 10.1016/j.jmb.2010.09.005; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McHugh CA, 2014, EMBO J, V33, P1896, DOI 10.15252/embj.201488566; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; McRose DL, 2018, J BIOL INORG CHEM, V23, P983, DOI 10.1007/s00775-018-1617-x; Meeks JC, 2001, PHOTOSYNTH RES, V70, P85, DOI 10.1023/A:1013840025518; Miethke M, 2013, METALLOMICS, V5, P15, DOI 10.1039/c2mt20193c; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Mohanty A, 2019, INORG CHEM, V58, P4741, DOI 10.1021/acs.inorgchem.8b02758; Moparthi VK, 2019, BBA-BIOENERGETICS, V1860, DOI 10.1016/j.bbabio.2019.148063; Moparthi VK, 2016, BBA-BIOENERGETICS, V1857, P1766, DOI 10.1016/j.bbabio.2016.08.003; Moriwaki Y, 2013, BIOCHEMISTRY-US, V52, P8866, DOI 10.1021/bi4008325; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nandal A, 2010, MOL MICROBIOL, V75, P637, DOI 10.1111/j.1365-2958.2009.06977.x; O'Brian MR, 2015, ANNU REV MICROBIOL, V69, P229, DOI 10.1146/annurev-micro-091014-104432; Ohtomo H, 2015, BIOCHEMISTRY-US, V54, P6243, DOI 10.1021/acs.biochem.5b00723; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; Patel SJ, 2016, J BIOL CHEM, V291, P11529, DOI 10.1074/jbc.M116.718239; Pecqueur L, 2006, J BIOL CHEM, V281, P21286, DOI 10.1074/jbc.M601278200; Martinez MTP, 2017, CHEM SCI, V8, P8451, DOI 10.1039/c7sc02801f; Perard J, 2016, BIOCHEMISTRY-US, V55, P1503, DOI 10.1021/acs.biochem.5b01061; Perry RD, 2007, BIOMETALS, V20, P699, DOI 10.1007/s10534-006-9051-x; Pi HL, 2017, METALLOMICS, V9, P840, DOI 10.1039/c7mt00112f; Pi HL, 2016, MOL MICROBIOL, V100, P1066, DOI 10.1111/mmi.13368; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pinochet-Barros A, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00697-19; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Pohl E, 1999, J MOL BIOL, V285, P1145, DOI 10.1006/jmbi.1998.2339; Pohl E, 1999, J MOL BIOL, V292, P653, DOI 10.1006/jmbi.1999.3073; Posey JE, 1999, P NATL ACAD SCI USA, V96, P10887, DOI 10.1073/pnas.96.19.10887; Poulos TL, 2014, CHEM REV, V114, P3919, DOI 10.1021/cr400415k; Pourciau C, 2019, MBIO, V10, DOI 10.1128/mBio.01034-19; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Ren B, 2003, J MOL BIOL, V329, P467, DOI 10.1016/S0022-2836(03)00466-2; Reniere ML, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00128-18; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Roy S, 2004, J MOL BIOL, V339, P1103, DOI 10.1016/j.jmb.2004.04.042; Ruangkiattikul N, 2012, FEMS MICROBIOL LETT, V329, P87, DOI 10.1111/j.1574-6968.2012.02509.x; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x; Salusso A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00084; Sankari S, 2014, J BIOL CHEM, V289, P16498, DOI 10.1074/jbc.M114.571562; Santos JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1101, DOI 10.1016/j.bbapap.2015.01.010; Sarvan S, 2018, BIOMETALS, V31, P681, DOI 10.1007/s10534-018-0120-8; Sarvan S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25157-6; Sato N, 2012, MICROBIOL-SGM, V158, P2527, DOI 10.1099/mic.0.060657-0; SCHAFFER S, 1985, MOL GEN GENET, V200, P110, DOI 10.1007/BF00383321; Schalk IJ, 2013, AMINO ACIDS, V44, P1267, DOI 10.1007/s00726-013-1468-2; Schalk IJ, 2012, CURR TOP MEMBR, V69, P37, DOI 10.1016/B978-0-12-394390-3.00002-1; SCHMITT MP, 1991, INFECT IMMUN, V59, P1899, DOI 10.1128/IAI.59.6.1899-1904.1991; Seo SW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5910; Sestok AE, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00097b; Seyedmohammad S, 2014, PROTEIN EXPRES PURIF, V101, P138, DOI 10.1016/j.pep.2014.06.012; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Smith AD, 2015, BIOCHEMISTRY-US, V54, P2601, DOI 10.1021/acs.biochem.5b00017; Smith AD, 2015, J BIOL CHEM, V290, P7756, DOI 10.1074/jbc.M114.633495; Smith AD, 2012, CURR TOP MEMBR, V69, P359, DOI 10.1016/B978-0-12-394390-3.00013-6; Smith AT, 2018, PROTEIN EXPRES PURIF, V142, P1, DOI 10.1016/j.pep.2017.09.007; Spiering MM, 2003, P NATL ACAD SCI USA, V100, P3808, DOI 10.1073/pnas.0737977100; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; Su MH, 2005, BIOCHEMISTRY-US, V44, P5572, DOI 10.1021/bi0472705; Su YC, 2010, ACTA CRYSTALLOGR F, V66, P636, DOI 10.1107/S1744309110013941; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; TAO X, 1992, P NATL ACAD SCI USA, V89, P5897, DOI 10.1073/pnas.89.13.5897; TAO X, 1994, P NATL ACAD SCI USA, V91, P9646, DOI 10.1073/pnas.91.20.9646; Theil EC, 2013, COORDIN CHEM REV, V257, P579, DOI 10.1016/j.ccr.2012.05.013; Theil EC, 2011, CURR OPIN CHEM BIOL, V15, P304, DOI 10.1016/j.cbpa.2011.01.004; Todd JD, 2005, MOL GENET GENOMICS, V273, P197, DOI 10.1007/s00438-005-1127-8; Todd JD, 2002, MICROBIOL-SGM, V148, P4059, DOI 10.1099/00221287-148-12-4059; Todd JD, 2006, MOL GENET GENOMICS, V275, P564, DOI 10.1007/s00438-006-0115-y; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; Tsou CC, 2010, INT J MED MICROBIOL, V300, P259, DOI 10.1016/j.ijmm.2009.09.002; Turner AG, 2019, BIOCHEM J, V476, P595, DOI 10.1042/BCJ20180902; Ulijasz AT, 2004, J BACTERIOL, V186, P8123, DOI 10.1128/JB.186.23.8123-8136.2004; VanderWal AR, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00091-17; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; Weeratunga SK, 2010, BIOCHEMISTRY-US, V49, P1160, DOI 10.1021/bi9015204; White A, 1998, NATURE, V394, P502, DOI 10.1038/28893; White GF, 2011, FEBS J, V278, P2011, DOI 10.1111/j.1742-4658.2011.08117.x; Wilks A, 2014, ACCOUNTS CHEM RES, V47, P2291, DOI 10.1021/ar500028n; WILLIAMS RJP, 1982, FEBS LETT, V140, P3, DOI 10.1016/0014-5793(82)80508-5; Williams SM, 2017, METALLOMICS, V9, P685, DOI 10.1039/c7mt00008a; Wilson BR, 2016, TRENDS MOL MED, V22, P1077, DOI 10.1016/j.molmed.2016.10.005; Wofford JD, 2019, J BIOL CHEM, V294, P50, DOI 10.1074/jbc.RA118.005233; Wolf SG, 1999, NATURE, V400, P83, DOI 10.1038/21918; Wong SG, 2015, J BIOL CHEM, V290, P3732, DOI 10.1074/jbc.M114.623082; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Yao HL, 2012, J AM CHEM SOC, V134, P13470, DOI 10.1021/ja305180n; Yasmin S, 2011, J BIOL CHEM, V286, P3473, DOI 10.1074/jbc.M110.175034; Yeoman KH, 2004, MICROBIOL-SGM, V150, P4065, DOI 10.1099/mic.0.27419-0; Yu CX, 2012, J BACTERIOL, V194, P1730, DOI 10.1128/JB.06176-11; Zeth K, 2004, P NATL ACAD SCI USA, V101, P13780, DOI 10.1073/pnas.0401821101; Zhang YF, 2020, CHEMBIOCHEM, V21, P1955, DOI 10.1002/cbic.201900778; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200; Zielazinski EL, 2013, METALLOMICS, V5, P1614, DOI 10.1039/c3mt00195d	226	21	23	12	41	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17602	17623		10.1074/jbc.REV120.007746	http://dx.doi.org/10.1074/jbc.REV120.007746			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454001	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000603272300017
J	Di Muzio, M; Wildner, S; Huber, S; Hauser, M; Vejvar, E; Auzinger, W; Regl, C; Laimer, J; Zennaro, D; Wopfner, N; Huber, CG; van Ree, R; Mari, A; Lackner, P; Ferreira, F; Schubert, M; Gadermaier, G				Di Muzio, Martina; Wildner, Sabrina; Huber, Sara; Hauser, Michael; Vejvar, Eva; Auzinger, Werner; Regl, Christof; Laimer, Josef; Zennaro, Danila; Wopfner, Nicole; Huber, Christian G.; van Ree, Ronald; Mari, Adriano; Lackner, Peter; Ferreira, Fatima; Schubert, Mario; Gadermaier, Gabriele			Hydrogen/deuterium exchange memory NMR reveals structural epitopes involved in IgE cross-reactivity of allergenic lipid transfer proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergen; monoclonal antibody; epitope mapping; NMR spectroscopy; lipid transfer protein; hydrogen; deuterium exchange; Art v 3; mugwort pollen; allergen; epitope mapping; nuclear magnetic resonance (NMR); immunoglobulin E (IgE); immunoglobulin G (IgG)	B-CELL EPITOPES; ART V 3; HYDROGEN-EXCHANGE; CONFORMATIONAL EPITOPE; ANTIBODY EPITOPES; MAJOR ALLERGEN; POLLEN; ANTIGEN; IDENTIFICATION; RECOGNITION	Identification of antibody-binding epitopes is crucial to understand immunological mechanisms. It is of particular interest for allergenic proteins with high cross-reactivity as observed in the lipid transfer protein (LTP) syndrome, which is characterized by severe allergic reactions. Art v 3, a pollen LTP from mugwort, is frequently involved in this cross-reactivity, but no antibody-binding epitopes have been determined so far. To reveal human IgE-binding regions of Art v 3, we produced three murine high-affinity mAbs, which showed 70-90% coverage of the allergenic epitopes from mugwort pollen-allergic patients. As reliable methods to determine structural epitopes with tightly interacting intact antibodies under native conditions are lacking, we developed a straightforward NMR approach termed hydrogen/deuterium exchange memory (HDXMEM). It relies on the slow exchange between the invisible antigen-mAb complex and the free N-15-labeled antigen whose H-1-N-15 correlations are detected. Due to a memory effect, changes of NH protection during antibody binding are measured. Differences in H/D exchange rates and analyses of mAb reactivity to homologous LTPs revealed three structural epitopes: two partially cross-reactive regions around alpha-helices 2 and 4 as well as a novel Art v 3-specific epitope at the C terminus. Protein variants with exchanged epitope residues confirmed the antibody-binding sites and revealed strongly reduced IgE reactivity. Using the novel HDXMEM for NMR epitope mapping allowed identification of the first structural epitopes of an allergenic pollen LTP. This knowledge enables improved cross-reactivity prediction for patients suffering from LTP allergy and facilitates design of therapeutics.	[Di Muzio, Martina; Wildner, Sabrina; Huber, Sara; Hauser, Michael; Vejvar, Eva; Auzinger, Werner; Regl, Christof; Laimer, Josef; Wopfner, Nicole; Huber, Christian G.; Lackner, Peter; Ferreira, Fatima; Schubert, Mario; Gadermaier, Gabriele] Univ Salzburg, Dept Biosci, Salzburg, Austria; [Di Muzio, Martina; Wildner, Sabrina; Regl, Christof; Huber, Christian G.; Schubert, Mario; Gadermaier, Gabriele] Univ Salzburg, Christian Doppler Lab Innovat Took Biosimilar Cha, Salzburg, Austria; [Zennaro, Danila; Mari, Adriano] Centri Associati Allergolog Mol CAAM, Latina, Italy; [van Ree, Ronald] Univ Amsterdam, Dept Expt Immunol & Otorhinolaryngol, Med Ctr, Amsterdam, Netherlands; [Di Muzio, Martina] Inst Bioengn Catalunya IBEC, Barcelona, Spain	Salzburg University; Salzburg University; University of Amsterdam; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya	Schubert, M; Gadermaier, G (corresponding author), Univ Salzburg, Dept Biosci, Salzburg, Austria.; Schubert, M; Gadermaier, G (corresponding author), Univ Salzburg, Christian Doppler Lab Innovat Took Biosimilar Cha, Salzburg, Austria.	Mario.Schubert@sbg.ac.at; Gabriele.Gadermaier@sbg.ac.at	Huber, Sara/AAG-6474-2019; Schubert, Mario/B-3972-2008; Ferreira, Fatima/AAB-4321-2019; Laimer, Josef/H-3226-2016; Huber, Christian G./E-5445-2011; Gadermaier, Gabriele/L-5997-2015	Huber, Sara/0000-0003-3589-4924; Schubert, Mario/0000-0003-0278-4091; Ferreira, Fatima/0000-0003-0989-2335; Laimer, Josef/0000-0001-6413-4268; Huber, Christian G./0000-0001-8358-1880; Gadermaier, Gabriele/0000-0002-4886-417X; Hauser, Michael/0000-0001-6558-755X; Di Muzio, Martina/0000-0001-6525-7972	Austrian Federal Ministry for Digital and Economic Affairs; National Foundation for Research, Technology, and Development; Start-up Grant of the Province of Salzburg; Austrian Science Fund (FWF) [P26125]	Austrian Federal Ministry for Digital and Economic Affairs; National Foundation for Research, Technology, and Development; Start-up Grant of the Province of Salzburg; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Federal Ministry for Digital and Economic Affairs; the National Foundation for Research, Technology, and Development; a Start-up Grant of the Province of Salzburg; and Austrian Science Fund (FWF) Grant P26125.	Abbott WM, 2014, IMMUNOLOGY, V142, P526, DOI 10.1111/imm.12284; Asam C, 2014, CLIN EXP ALLERGY, V44, P1083, DOI 10.1111/cea.12361; Asero R, 2018, EUR ANN ALLERGY CLIN, V50, P156, DOI 10.23822/EurAnnACI.1764-1489.57; Asero R, 2018, CLIN EXP ALLERGY, V48, P6, DOI 10.1111/cea.13053; Asturias JA, 2003, CLIN EXP ALLERGY, V33, P518, DOI 10.1046/j.1365-2222.2003.01631.x; Azofra J, 2016, INT ARCH ALLERGY IMM, V169, P181, DOI 10.1159/000445893; BENJAMIN DC, 1992, BIOCHEMISTRY-US, V31, P9539, DOI 10.1021/bi00155a005; Boschert V, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160120; Egger M, 2010, CURR ALLERGY ASTHM R, V10, P326, DOI 10.1007/s11882-010-0128-9; Eichhorn S, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900336; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Gadermaier G, 2008, ALLERGY, V63, P1543, DOI 10.1111/j.1398-9995.2008.01780.x; Gadermaier G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024150; Gadermaier G, 2011, MOL NUTR FOOD RES, V55, P568, DOI 10.1002/mnfr.201000443; Gadermaier G, 2009, MOL IMMUNOL, V46, P1919, DOI 10.1016/j.molimm.2009.03.021; Gao ZS, 2013, J ALLERGY CLIN IMMUN, V131, P224, DOI 10.1016/j.jaci.2012.07.015; Garcia-Casado G, 2003, J ALLERGY CLIN IMMUN, V112, P599, DOI 10.1037/mai.2003.1638; Gessner C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03922-3; Gomez-Casado C, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/385615; Gouda H, 1998, BIOCHEMISTRY-US, V37, P129, DOI 10.1021/bi970923f; Ichikawa S, 2005, J BIOCHEM, V137, P255, DOI 10.1093/jb/mvi039; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Laimer J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0548-6; Liu CQ, 2018, J AGR FOOD CHEM, V66, P7238, DOI 10.1021/acs.jafc.8b01967; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Mueller GA, 2001, J BIOL CHEM, V276, P9359, DOI 10.1074/jbc.M010812200; Mueller GA, 2019, CURR ALLERGY ASTHM R, V19, DOI 10.1007/s11882-019-0848-4; Naik MT, 2008, STRUCTURE, V16, P125, DOI 10.1016/j.str.2007.10.022; Oezguen N, 2008, MOL IMMUNOL, V45, P3740, DOI 10.1016/j.molimm.2008.05.026; Pacios LF, 2008, MOL IMMUNOL, V45, P2269, DOI 10.1016/j.molimm.2007.11.022; Padavattan S, 2009, J IMMUNOL, V182, P2141, DOI 10.4049/jimmunol.0803018; Palacin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050799; PATERSON Y, 1990, SCIENCE, V249, P755, DOI 10.1126/science.1697101; Percy AJ, 2012, ANAL CHIM ACTA, V721, P7, DOI 10.1016/j.aca.2012.01.037; Peri S, 2001, TRENDS BIOCHEM SCI, V26, P687, DOI 10.1016/S0968-0004(01)01954-5; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pomes A, 2015, J ALLERGY CLIN IMMUN, V136, P29, DOI 10.1016/j.jaci.2015.05.016; Pomes Anna, 2015, Curr Allergy Asthma Rep, V15, P506, DOI 10.1007/s11882-014-0506-9; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012; Salcedo G, 2004, CLIN EXP ALLERGY, V34, P1336, DOI 10.1111/j.1365-2222.2004.02018.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Trincado JL, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2680160; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scala E, 2015, ALLERGY, V70, P933, DOI 10.1111/all.12635; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Schmutzler G., 2005, THESIS; Schocker F, 2004, J ALLERGY CLIN IMMUN, V113, P141, DOI 10.1016/j.jaci.2003.09.013; Schwarz R., 2004, THESIS; Simonelli L, 2018, METHODS MOL BIOL, V1785, P29, DOI 10.1007/978-1-4939-7841-0_3; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Tordesillas L, 2011, INT ARCH ALLERGY IMM, V156, P291, DOI 10.1159/000323503; Tordesillas L, 2009, MOL IMMUNOL, V47, P534, DOI 10.1016/j.molimm.2009.07.028; Tscheppe A, 2017, INT ARCH ALLERGY IMM, V172, P187, DOI 10.1159/000464104; Vallurupalli P, 2012, J AM CHEM SOC, V134, P8148, DOI 10.1021/ja3001419; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Wildner S, 2019, MOL IMMUNOL, V116, P140, DOI 10.1016/j.molimm.2019.10.012; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Williams DC, 1996, J MOL BIOL, V257, P866, DOI 10.1006/jmbi.1996.0207; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Willison LN, 2013, MOL IMMUNOL, V55, P253, DOI 10.1016/j.molimm.2013.02.004; Zhang Q, 2018, ANAL CHEM, V90, P11315, DOI 10.1021/acs.analchem.8b01864; Zuidmeer L, 2005, INT ARCH ALLERGY IMM, V137, P273, DOI 10.1159/000086420	64	4	4	2	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17398	17410		10.1074/jbc.RA120.014243	http://dx.doi.org/10.1074/jbc.RA120.014243			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33453986	Green Published, hybrid			2022-12-28	WOS:000603272300002
J	Klickstein, JA; Mukkavalli, S; Raman, M				Klickstein, Jacob Aaron; Mukkavalli, Sirisha; Raman, Malavika			AggreCount: an unbiased image analysis tool for identifying and quantifying cellular aggregates in a spatially defined manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein quality control; proteostasis; misfolded protein; aggregate; inclusion body; stress granule; polyQ inclusion body; ubiquitin; image-based analysis; ImageJ; p97; valosin-containing protein; microscopic imaging; polyubiquitin chain; aggregation; aggresome; protein aggregation; Huntington disease; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); protein misfolding; p97; valosin-containing protein	AGGRESOME FORMATION; PROTEIN; HUNTINGTIN; DEGRADATION; DISRUPTION; PROTEASOME; CANCER	Protein quality control is maintained by a number of integrated cellular pathways that monitor the folding and functionality of the cellular proteome. Defects in these pathways lead to the accumulation of misfolded or faulty proteins that may become insoluble and aggregate over time. Protein aggregates significantly contribute to the development of a number of human diseases such as amyotrophic lateral sclerosis, Huntington's disease, and Alzheimer's disease. In vitro, imaging-based, cellular studies have defined key biomolecular components that recognize and clear aggregates; however, no unifying method is available to quantify cellular aggregates, limiting our ability to reproducibly and accurately quantify these structures. Here we describe an ImageJ macro called AggreCount to identify and measure protein aggregates in cells. AggreCount is designed to be intuitive, easy to use, and customizable for different types of aggregates observed in cells. Minimal experience in coding is required to utilize the script. Based on a user-defined image, AggreCount will report a number of metrics: (i) total number of cellular aggregates, (ii) percentage of cells with aggregates, (iii) aggregates per cell, (iv) area of aggregates, and (v) localization of aggregates (cytosol, perinuclear, or nuclear). A data table of aggregate information on a per cell basis, as well as a summary table, is provided for further data analysis. We demonstrate the versatility of AggreCount by analyzing a number of different cellular aggregates including aggresomes, stress granules, and inclusion bodies caused by huntingtin polyglutamine expansion.	[Klickstein, Jacob Aaron; Mukkavalli, Sirisha; Raman, Malavika] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA	Tufts University	Raman, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	malavika.raman@tufts.edu	mukkavalli, sirisha/GNH-6227-2022	Klickstein, Jacob/0000-0002-0759-4724; Mukkavalli, Sirisha V./0000-0002-8875-7985; raman, malavika/0000-0002-4773-8673	National Institutes of Health [R01GM127557]; American Cancer Society [RSG-19-022-01-CSM]; Russo Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Russo Award	This work is supported by National Institutes of Health Grant R01GM127557, American Cancer Society Research Scholar Grant RSG-19-022-01-CSM, and a Russo Award (to M. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Aviner R, 2020, COMPUT STRUCT BIOTEC, V18, P1074, DOI 10.1016/j.csbj.2020.04.014; Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Bersuker K, 2016, J CELL BIOL, V213, P229, DOI 10.1083/jcb.201511024; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; den Engelsman J, 2011, PHARM RES-DORDR, V28, P920, DOI 10.1007/s11095-010-0297-1; Ganji R, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00154-18; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Guo Q, 2018, CELL, V172, P696, DOI 10.1016/j.cell.2017.12.030; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hoffner G, 2002, J CELL SCI, V115, P941; Iwabuchi S, 2014, J NEUROSCI METH, V223, P92, DOI 10.1016/j.jneumeth.2013.12.003; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Joazeiro CAP, 2019, NAT REV MOL CELL BIO, V20, P368, DOI 10.1038/s41580-019-0118-2; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Leeman DS, 2018, SCIENCE, V359, P1277, DOI 10.1126/science.aag3048; Matus Soledad, 2013, Int J Cell Biol, V2013, P674751, DOI 10.1155/2013/674751; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Moen E, 2019, NAT METHODS, V16, P1233, DOI 10.1038/s41592-019-0403-1; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Park J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15730; Peters LZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005178; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Raman M, 2015, NAT CELL BIOL, V17, P1356, DOI 10.1038/ncb3238; Roodveldt C, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00565; Salemi LM, 2014, BIOL OPEN, V3, P418, DOI 10.1242/bio.20147021; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sontag EM, 2017, ANNU REV BIOCHEM, V86, P97, DOI 10.1146/annurev-biochem-060815-014616; Stroo E, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00064; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Turakhiya A, 2018, MOL CELL, V70, P906, DOI 10.1016/j.molcel.2018.04.021; Wang B, 2019, MOL CELL, V74, P742, DOI 10.1016/j.molcel.2019.03.027; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Wiesmann V, 2015, J MICROSC-OXFORD, V257, P39, DOI 10.1111/jmi.12184; Wolozin B, 2019, NAT REV NEUROSCI, V20, P649, DOI 10.1038/s41583-019-0222-5; Xu Z, 2013, J CELL SCI, V126, P4173, DOI 10.1242/jcs.126102; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106	45	6	6	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17672	17683		10.1074/jbc.RA120.015398	http://dx.doi.org/10.1074/jbc.RA120.015398			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454006	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000603272300022
J	Xu, F; Qi, H; Li, JQ; Sun, L; Gong, JJ; Chen, YY; Shen, AD; Li, W				Xu, Fang; Qi, Hui; Li, Jieqiong; Sun, Lin; Gong, Juanjuan; Chen, Yuanying; Shen, Adong; Li, Wei			Mycobacterium tuberculosis infection up-regulates MFN2 expression to promote NLRP3 inflammasome formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; microarray; mitochondria; mitofusin 2; Mycobacterium tuberculosis; NLRP3 inflammasome; cytokine; inflammasome; microarray; mitochondria	ENDOPLASMIC-RETICULUM; INTERLEUKIN-1-BETA RELEASE; PULMONARY TUBERCULOSIS; GENE-EXPRESSION; MITOFUSIN 2; ACTIVATION; MITOCHONDRIA; MORPHOLOGY; SIGNATURE; ESAT-6	Tuberculosis (TB), caused by the infection of Mycobacterium tuberculosis (MTB), is one of the leading causes of death worldwide, especially in children. However, the mechanisms by which MTB infects its cellular host, activates an immune response, and triggers inflammation remain unknown. Mitochondria play important roles in the initiation and activation of the nucleotide-binding oligomerization domain-like receptor with a pyrin domain 3 (NLRP3) inflammasome, where mitochondria-associated endoplasmic reticulum membranes (MAMs) may serve as the platform for inflammasome assembly and activation. Additionally, mitofusin 2 (MFN2) is implicated in the formation of MAMs, but, the roles of mitochondria and MFN2 in MTB infection have not been elucidated. Using mircroarry profiling of TB patients and in vitro MTB stimulation of macrophages, we observed an up-regulation of MFN2 in the peripheral blood mononuclear cells of active TB patients. Furthermore, we found that MTB stimulation by MTB-specific antigen ESAT-6 or lysate of MTB promoted MFN2 interaction with NLRP3 inflammasomes, resulting in the assembly and activation of the inflammasome and, subsequently, IL-1 beta secretion. These findings suggest that MFN2 and mitochondria play important role in the pathogen-host interaction during MTB infection.	[Xu, Fang; Qi, Hui; Li, Jieqiong; Sun, Lin; Shen, Adong] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing Pediat Res Inst,Beijing Key Lab Resp & In, Beijing, Peoples R China; [Gong, Juanjuan; Chen, Yuanying; Li, Wei] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing Pediat Res Inst,Beijing Key Lab Genet Bir, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Shen, AD (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing Pediat Res Inst,Beijing Key Lab Resp & In, Beijing, Peoples R China.; Li, W (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing Pediat Res Inst,Beijing Key Lab Genet Bir, Beijing, Peoples R China.	shenad16@hotmail.com; liwei@bch.com.cn	孙, 琳/HGE-6966-2022	Li, Wei/0000-0002-0248-5510	Ministry of Science and Technology of China [2019YFA0802104]; National Natural Science Foundation of China [31830054, 91954000, 81871617, 81701971]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2019YFA0802104 and National Natural Science Foundation of China Grants 31830054, 91954000, 81871617, and 81701971.	Basu S, 2018, MICROB PATHOGENESIS, V114, P219, DOI 10.1016/j.micpath.2017.11.044; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Briken V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00062; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dubey RK, 2016, INT J MYCOBACT, V5, P379, DOI 10.1016/j.ijmyco.2016.06.001; Fine-Coulson K, 2015, MICROBES INFECT, V17, P689, DOI 10.1016/j.micinf.2015.06.003; Francisco NM, 2017, J INFECTION, V75, P499, DOI 10.1016/j.jinf.2017.09.012; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Kim BR, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008294; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003722; Lebeau J, 2018, CELL REP, V22, P2827, DOI 10.1016/j.celrep.2018.02.055; Maertzdorf J, 2016, EMBO MOL MED, V8, P86, DOI 10.15252/emmm.201505790; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Misawa T, 2017, ADV EXP MED BIOL, V997, P187, DOI 10.1007/978-981-10-4567-7_14; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Qi H, 2017, HUM MOL GENET, V26, P4752, DOI 10.1093/hmg/ddx365; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Sarup P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015644; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sohn H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002435; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Sweeney TE, 2016, LANCET RESP MED, V4, P213, DOI 10.1016/S2213-2600(16)00048-5; Wang JP, 2003, FEMS IMMUNOL MED MIC, V39, P163, DOI 10.1016/S0928-8244(03)00223-2; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; World Health Organization (WHO), 2019, TUBERCULOSIS; Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350; Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	38	10	11	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17684	17697		10.1074/jbc.RA120.014077	http://dx.doi.org/10.1074/jbc.RA120.014077			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454007	hybrid, Green Published			2022-12-28	WOS:000603272300023
J	Grill, S; Nandakumar, J				Grill, Sherilyn; Nandakumar, Jayakrishnan			Molecular mechanisms of telomere biology disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BONE-MARROW FAILURE; DYSKERATOSIS-CONGENITA MUTATIONS; MAINTENANCE COMPONENT 1; ELONGATION HELICASE 1; REVERSE-TRANSCRIPTASE; PULMONARY-FIBROSIS; HUMAN CST; TIN2 PROTEIN; FUNCTIONAL-CHARACTERIZATION; DUPLEX REPLICATION	Genetic mutations that affect telomerase function or telomere maintenance result in a variety of diseases collectively called telomeropathies. This wide spectrum of disorders, which include dyskeratosis congenita, pulmonary fibrosis, and aplastic anemia, is characterized by severely short telomeres, often resulting in hematopoietic stem cell failure in the most severe cases. Recent work has focused on understanding the molecular basis of these diseases. Mutations in the catalytic TERT and TR subunits of telomerase compromise activity, while others, such as those found in the telomeric protein TPP1, reduce the recruitment of telomerase to the telomere. Mutant telomerase-associated proteins TCAB1 and dyskerin and the telomerase RNA maturation component poly(A)-specific ribonuclease affect the maturation and stability of telomerase. In contrast, disease-associated mutations in either CTC1 or RTEL1 are more broadly associated with telomere replication defects. Yet even with the recent surge in studies decoding the mechanisms underlying these diseases, a significant proportion of dyskeratosis congenita mutations remain uncharacterized or poorly understood. Here we review the current understanding of the molecular basis of telomeropathies and highlight experimental data that illustrate how genetic mutations drive telomere shortening and dysfunction in these patients. This review connects insights from both clinical and molecular studies to create a comprehensive view of the underlying mechanisms that drive these diseases. Through this, we emphasize recent advances in therapeutics and pinpoint disease-associated variants that remain poorly defined in their mechanism of action. Finally, we suggest future avenues of research that will deepen our understanding of telomere biology and telomere-related disease.	[Grill, Sherilyn; Nandakumar, Jayakrishnan] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Grill, Sherilyn] Whitehead Inst Biomed Res, 455 Main St, Cambridge, MA USA	University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Whitehead Institute	Nandakumar, J (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	jknanda@umich.edu		Grill, Sherilyn/0000-0003-3201-0214	National Institutes of Health [R01GM120094, R01AG050509]; American Cancer Society [RSG-17-037-01-DMC]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society)	Although we attempted to credit and cite all relevant publications, we apologize if any important contributions may have been missed. We thank members of the Nandakumar lab for providing critical feedback at various stages of the writing process. During the writing of this review, the Nandakumar lab was supported by National Institutes of Health grants R01GM120094 and R01AG050509 and the American Cancer Society Research Scholar grant RSG-17-037-01-DMC (to J. N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam MP, 2011, GENEREVIEWS; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Alder JK, 2015, CHEST, V147, P1361, DOI 10.1378/chest.14-1947; Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; Anderson BH, 2012, NAT GENET, V44, P338, DOI 10.1038/ng.1084; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Ballew BJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003695; Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Bertuch AA, 2016, RNA BIOL, V13, P696, DOI 10.1080/15476286.2015.1094596; Bhattacharjee A, 2017, NUCLEIC ACIDS RES, V45, P12311, DOI 10.1093/nar/gkx878; Bisht K, 2016, P NATL ACAD SCI USA, V113, P13021, DOI 10.1073/pnas.1605685113; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; Blackburn EH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003558; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Boyraz B, 2016, J CLIN INVEST, V126, P3377, DOI 10.1172/JCI87547; Canudas S, 2011, GENE DEV, V25, P1807, DOI 10.1101/gad.17325211; Cerone MA, 2005, CELL CYCLE, V4, P585; Chastain M, 2016, CELL REP, V16, P1300, DOI 10.1016/j.celrep.2016.06.077; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Chen LY, 2013, GENE DEV, V27, P2099, DOI 10.1101/gad.222893.113; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Chen L, 2018, CELL, V174, P218, DOI 10.1016/j.cell.2018.04.039; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Chu TW, 2016, J BIOL CHEM, V291, P8374, DOI 10.1074/jbc.M116.714782; Chu TW, 2016, MOL CELL BIOL, V36, P210, DOI 10.1128/MCB.00746-15; Collopy LC, 2015, BLOOD, V126, P176, DOI 10.1182/blood-2015-03-633388; de Lange T, 2018, ANNU REV GENET, V52, P223, DOI 10.1146/annurev-genet-032918-021921; Deng Z, 2013, P NATL ACAD SCI USA, V110, pE3408, DOI 10.1073/pnas.1300600110; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Nguyen D, 2015, CELL REP, V13, P2244, DOI 10.1016/j.celrep.2015.11.003; Errington TM, 2008, MOL CELL BIOL, V28, P6510, DOI 10.1128/MCB.00777-08; Fedick AM, 2015, CLIN GENET, V88, P177, DOI 10.1111/cge.12459; Fok WC, 2019, BLOOD, V133, P1308, DOI 10.1182/blood-2018-11-885368; Frank AK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005410; Frescas D, 2014, J BIOL CHEM, V289, P24180, DOI 10.1074/jbc.M114.592592; Frescas D, 2014, GENE DEV, V28, P153, DOI 10.1101/gad.233395.113; Freund A, 2014, CELL, V159, P1389, DOI 10.1016/j.cell.2014.10.059; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Fukuhara A, 2013, EUR RESPIR J, V42, P1757, DOI 10.1183/09031936.00149113; Gable DL, 2019, GENE DEV, V33, P1381, DOI 10.1101/gad.326785.119; Gramatges MM, 2013, BLOOD, V121, P3586, DOI 10.1182/blood-2012-08-447755; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Grill S, 2019, CELL REP, V27, P3511, DOI 10.1016/j.celrep.2019.05.073; Grill S, 2018, CELL REP, V22, P1132, DOI 10.1016/j.celrep.2018.01.012; Gu PL, 2018, AGING CELL, V17, DOI 10.1111/acel.12783; Gu PL, 2013, AGING CELL, V12, P1100, DOI 10.1111/acel.12139; Guo YR, 2014, BLOOD, V124, P2767, DOI 10.1182/blood-2014-08-596445; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hoffman H, 2017, J BIOL CHEM, V292, P4593, DOI 10.1074/jbc.M116.771204; Hu CY, 2017, CELL RES, V27, P1485, DOI 10.1038/cr.2017.144; Jiang JS, 2018, CELL, V173, P1179, DOI 10.1016/j.cell.2018.04.038; Jones M, 2016, J CLIN INVEST, V126, P1621, DOI 10.1172/JCI84547; Jones M, 2014, J CLIN INVEST, V124, P353, DOI 10.1172/JCI67871; Kaminker PG, 2009, CELL CYCLE, V8, P931, DOI 10.4161/cc.8.6.7941; Kannengiesser C, 2014, EUR RESPIR J, V44, P269, DOI 10.1183/09031936.00038714; Keller RB, 2012, PEDIATR BLOOD CANCER, V59, P311, DOI 10.1002/pbc.24193; Kilchert C, 2016, NAT REV MOL CELL BIO, V17, P227, DOI 10.1038/nrm.2015.15; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kocak H, 2014, GENE DEV, V28, P2090, DOI 10.1101/gad.248567.114; Lai CK, 2003, MOL CELL, V11, P1673, DOI 10.1016/S1097-2765(03)00232-6; Le Guen T, 2013, HUM MOL GENET, V22, P3239, DOI 10.1093/hmg/ddt178; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Li L, 2006, NATURE, V443, P302, DOI 10.1038/nature05151; Lim CJ, 2020, SCIENCE, V368, P1081, DOI 10.1126/science.aaz9649; Lim CJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01313-w; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; MacNeil DE, 2019, NUCLEIC ACIDS RES, V47, P5368, DOI 10.1093/nar/gkz233; MacNeil DE, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090064; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Marrone A, 2007, BLOOD, V110, P4198, DOI 10.1182/blood-2006-12-062851; Martinez P, 2017, J CELL BIOL, V216, P875, DOI 10.1083/jcb.201610111; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Moon DH, 2015, NAT GENET, V47, P1482, DOI 10.1038/ng.3423; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Mueller H, 2019, HEPATOLOGY, V69, P1398, DOI 10.1002/hep.30329; Nagpal N, 2020, CELL STEM CELL, V26, P896, DOI 10.1016/j.stem.2020.03.016; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nelson ND, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00025-18; Niewisch MR, 2019, EXPERT REV HEMATOL, V12, P1037, DOI 10.1080/17474086.2019.1662720; Ohga S, 1997, EUR J PEDIATR, V156, P80; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pike AM, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00593-18; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Porreca RM, 2018, NUCLEIC ACIDS RES, V46, P4533, DOI 10.1093/nar/gky173; Povedano JM, 2015, CELL REP, V12, P286, DOI 10.1016/j.celrep.2015.06.028; PRICE CM, 1987, GENE DEV, V1, P783, DOI 10.1101/gad.1.8.783; Qiao F, 2008, NAT STRUCT MOL BIOL, V15, P634, DOI 10.1038/nsmb.1420; Rashid R, 2006, MOL CELL, V21, P249, DOI 10.1016/j.molcel.2005.11.017; Rice C, 2016, COMPUT STRUCT BIOTEC, V14, P161, DOI 10.1016/j.csbj.2016.04.002; Roake CM, 2020, NAT REV MOL CELL BIO, V21, P384, DOI 10.1038/s41580-020-0234-z; Roake CM, 2019, MOL CELL, V74, P688, DOI 10.1016/j.molcel.2019.02.033; Robart AR, 2010, J BIOL CHEM, V285, P4375, DOI 10.1074/jbc.M109.088575; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sagie S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14015; Sarek G, 2019, NATURE, V575, P523, DOI 10.1038/s41586-019-1744-8; Sarek G, 2016, MOL CELL, V61, P788, DOI 10.1016/j.molcel.2016.02.016; Sarek G, 2015, MOL CELL, V57, P622, DOI 10.1016/j.molcel.2014.12.024; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Schertzer M, 2015, NUCLEIC ACIDS RES, V43, P1834, DOI 10.1093/nar/gku1402; Schmidt JC, 2014, ELIFE, V3, DOI 10.7554/eLife.03563; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Shefer K, 2007, MOL CELL BIOL, V27, P2130, DOI 10.1128/MCB.01826-06; Shukla S, 2020, BLOOD ADV, V4, P2717, DOI 10.1182/bloodadvances.2020001848; Shukla S, 2016, NAT STRUCT MOL BIOL, V23, P286, DOI 10.1038/nsmb.3184; Simon AJ, 2016, J EXP MED, V213, P1429, DOI 10.1084/jem.20151618; Stanley SE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7837; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Stuart BD, 2015, NAT GENET, V47, P512, DOI 10.1038/ng.3278; Sun J, 2009, GENE DEV, V23, P2900, DOI 10.1101/gad.1851909; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Takai H, 2016, GENE DEV, V30, P812, DOI 10.1101/gad.276873.115; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tesmer VM, 2019, P NATL ACAD SCI USA, V116, P26505, DOI 10.1073/pnas.1911912116; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Theimer CA, 2003, RNA, V9, P1446, DOI 10.1261/rna.5152303; Theimer CA, 2003, P NATL ACAD SCI USA, V100, P449, DOI 10.1073/pnas.242720799; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; Nguyen THD, 2018, NATURE, V557, P190, DOI 10.1038/s41586-018-0062-x; Toubiana S, 2018, HUM MOL GENET, V27, P3568, DOI 10.1093/hmg/ddy265; Trahan C, 2010, HUM MOL GENET, V19, P825, DOI 10.1093/hmg/ddp551; Trahan C, 2009, RNA, V15, P235, DOI 10.1261/rna.1354009; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tseng CK, 2015, CELL REP, V13, P2232, DOI 10.1016/j.celrep.2015.10.075; Tummala H, 2018, BLOOD, V132, P1349, DOI 10.1182/blood-2018-03-837799; Tummala H, 2015, J CLIN INVEST, V125, P2151, DOI 10.1172/JCI78963; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Vannier JB, 2014, TRENDS CELL BIOL, V24, P416, DOI 10.1016/j.tcb.2014.01.004; Vannier JB, 2013, SCIENCE, V342, P239, DOI 10.1126/science.1241779; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Vulliamy TJ, 1997, BLOOD, V90, P2213; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Vulliamy TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024383; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Walne AJ, 2013, AM J HUM GENET, V92, P448, DOI 10.1016/j.ajhg.2013.02.001; Walne AJ, 2013, HAEMATOLOGICA, V98, P334, DOI 10.3324/haematol.2012.071068; Wang F, 2012, CELL REP, V2, P1096, DOI 10.1016/j.celrep.2012.10.007; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Wu P, 2012, CELL, V150, P39, DOI 10.1016/j.cell.2012.05.026; Xin ZT, 2012, CLIN GENET, V81, P301, DOI 10.1111/j.1399-0004.2011.01784.x; Xin ZT, 2007, BLOOD, V109, P524, DOI 10.1182/blood-2006-07-035089; Xu J, 2016, AM J HEMATOL, V91, P1215, DOI 10.1002/ajh.24545; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Yang D, 2011, J BIOL CHEM, V286, P23022, DOI 10.1074/jbc.M111.225870; Zaug AJ, 2013, NUCLEIC ACIDS RES, V41, P8969, DOI 10.1093/nar/gkt653; Zeng XL, 2012, HUM MOL GENET, V21, P721, DOI 10.1093/hmg/ddr504; Zhang MM, 2019, NUCLEIC ACIDS RES, V47, P5243, DOI 10.1093/nar/gkz264; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	165	20	21	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100064	10.1074/jbc.REV120.014017	http://dx.doi.org/10.1074/jbc.REV120.014017			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33184060	Green Published, gold			2022-12-28	WOS:000672866400045
J	Gunther, LK; Rohde, JA; Tang, WJ; Cirilo, JA; Marang, CP; Scott, BD; Thomas, DD; Debold, EP; Yengo, CM				Gunther, Laura K.; Rohde, John A.; Tang, Wanjian; Cirilo, Joseph A., Jr.; Marang, Christopher P.; Scott, Brent D.; Thomas, David D.; Debold, Edward P.; Yengo, Christopher M.			FRET and optical trapping reveal mechanisms of actin activation of the power stroke and phosphate release in myosin V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; actin; ATPase; fluorescence resonance energy transfer (FRET); optical tweezers; single-molecule biophysics	RABBIT SKELETAL ACTOMYOSIN; REAL-TIME DETECTION; FORCE-GENERATION; TROPONIN-TROPOMYOSIN; STRUCTURAL KINETICS; MOTOR-ACTIVITY; BINDING-SITE; WEAK BINDING; MUSCLE; NUCLEOTIDE	Myosins generate force and motion by precisely coordinating their mechanical and chemical cycles, but the nature and timing of this coordination remains controversial. We utilized a FRET approach to examine the kinetics of structural changes in the force-generating lever arm in myosin V. We directly compared the FRET results with single-molecule mechanical events examined by optical trapping. We introduced a mutation (S217A) in the conserved switch I region of the active site to examine how myosin couples structural changes in the actin- and nucleotide-binding regions with force generation. Specifically, S217A enhanced the maximum rate of lever arm priming (recovery stroke) while slowing ATP hydrolysis, demonstrating that it uncouples these two steps. We determined that the mutation dramatically slows both actin-induced rotation of the lever arm (power stroke) and phosphate release (>= 10-fold), whereas our simulations suggest that the maximum rate of both steps is unchanged by the mutation. Time-resolved FRET revealed that the structure of the pre- and post-power stroke conformations and mole fractions of these conformations were not altered by the mutation. Optical trapping results demonstrated that S217A does not dramatically alter unitary displacements or slow the working stroke rate constant, consistent with the mutation disrupting an actin-induced conformational change prior to the power stroke. We propose that communication between the actin- and nucleotide-binding regions of myosin assures a proper actin-binding interface and active site have formed before producing a power stroke. Variability in this coupling is likely crucial for mediating motor-based functions such as muscle contraction and intracellular transport.	[Gunther, Laura K.; Tang, Wanjian; Cirilo, Joseph A., Jr.; Yengo, Christopher M.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Rohde, John A.; Thomas, David D.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Marang, Christopher P.; Scott, Brent D.; Debold, Edward P.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Minnesota System; University of Minnesota Twin Cities; University of Massachusetts System; University of Massachusetts Amherst	Yengo, CM (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	cmy11@psu.edu		Yengo, Christopher/0000-0003-3987-9019; Tang, Wanjian/0000-0001-7374-6442; Cirilo, Joseph/0000-0003-2135-5831	National Institutes of Health [HL127699, R01AR32961, R01AG26160]; National Research Service Award Postdoctoral Fellowship [F32DC016788]; American Heart Association [19PRE34380569, 14GRNT20450002, 18IPA34170048]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by an National Institutes of Health Grants HL127699 (to C. M. Y.) and R01AR32961 and R01AG26160 (to D.D.T.). L. K. G. is supported by National Research Service Award Postdoctoral Fellowship F32DC016788, and W. T. is supported by American Heart Association Predoctoral Fellowship 19PRE34380569. This work was also supported by American Heart Association Grants 14GRNT20450002 and 18IPA34170048 (to E. P. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Batters C, 2016, TRAFFIC, V17, P860, DOI 10.1111/tra.12400; Beausang JF, 2011, METHOD ENZYMOL, P431, DOI [10.1016/S0076-6879(11)87015-1, 10.1016/B978-0-12-381270-4.00015-9]; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Capitanio M, 2012, NAT METHODS, V9, P1013, DOI [10.1038/nmeth.2152, 10.1038/NMETH.2152]; Caremani M, 2015, J PHYSIOL-LONDON, V593, P3313, DOI 10.1113/JP270265; Caremani M, 2013, J PHYSIOL-LONDON, V591, P5187, DOI 10.1113/jphysiol.2013.257410; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Debold EP, 2013, BIOPHYS J, V105, P2374, DOI 10.1016/j.bpj.2013.09.046; Debold EP, 2011, AM J PHYSIOL-REG I, V300, pR1401, DOI 10.1152/ajpregu.00772.2010; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Geeves MA, 2016, BIOPOLYMERS, V105, P483, DOI 10.1002/bip.22853; Gunther LK, 2019, J BIOL CHEM, V294, P1554, DOI 10.1074/jbc.RA118.006128; Hartman MA, 2012, J CELL SCI, V125, P1627, DOI 10.1242/jcs.094300; Heissler SM, 2016, J MOL BIOL, V428, P1927, DOI 10.1016/j.jmb.2016.01.022; Holmes KC, 1997, CURR BIOL, V7, pR112, DOI 10.1016/S0960-9822(06)00051-0; Houdusse A, 2016, TRENDS BIOCHEM SCI, V41, P989, DOI 10.1016/j.tibs.2016.09.006; Huxley AF, 2000, PHILOS T ROY SOC B, V355, P433, DOI 10.1098/rstb.2000.0584; Ishii Y, 2001, TRENDS BIOTECHNOL, V19, P211, DOI 10.1016/S0167-7799(01)01635-3; Joel PB, 2003, BIOCHEMISTRY-US, V42, P9160, DOI 10.1021/bi034415j; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; Kiani FA, 2016, CYTOSKELETON, V73, P643, DOI 10.1002/cm.21333; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; Llinas P, 2015, DEV CELL, V33, P401, DOI 10.1016/j.devcel.2015.03.025; Lombardi V, 2004, PHILOS T R SOC B, V359, P1883, DOI 10.1098/rstb.2004.1557; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; MCKILLOP DFA, 1991, BIOCHEM J, V279, P711, DOI 10.1042/bj2790711; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Muretta JM, 2013, P NATL ACAD SCI USA, V110, P7211, DOI 10.1073/pnas.1222257110; Murphy CT, 2000, J MUSCLE RES CELL M, V21, P139, DOI 10.1023/A:1005610007209; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Robert-Paganin J, 2020, CHEM REV, V120, P5, DOI 10.1021/acs.chemrev.9b00264; Rohde JA, 2017, P NATL ACAD SCI USA, V114, pE1796, DOI 10.1073/pnas.1611698114; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Smith DA, 2001, BIOPHYS J, V81, P2795, DOI 10.1016/S0006-3495(01)75922-X; Stehle R, 2017, J MUSCLE RES CELL M, V38, P275, DOI 10.1007/s10974-017-9482-8; Sun MX, 2008, P NATL ACAD SCI USA, V105, P8631, DOI 10.1073/pnas.0710793105; Sun YJ, 2011, BIOPHYS J, V101, P1, DOI 10.1016/j.bpj.2011.05.026; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Swenson AM, 2014, J BIOL CHEM, V289, P23977, DOI 10.1074/jbc.M114.562231; Trivedi DV, 2020, ANNU REV BIOCHEM, V89, P667, DOI [10.1146/annurev-biochem-011520-105234, 10.1146/annurev-biochem-011520105234]; Trivedi DV, 2015, P NATL ACAD SCI USA, V112, P14593, DOI 10.1073/pnas.1517566112; Trivedi DV, 2013, BIOCHEMISTRY-US, V52, P4710, DOI 10.1021/bi4004364; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Unger M, 2019, AM J PHYSIOL-CELL PH, V317, pC714, DOI 10.1152/ajpcell.00196.2019; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Visser I, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i07; WALKER JW, 1992, J BIOL CHEM, V267, P2459; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Woody MS, 2019, ELIFE, V8, DOI 10.7554/eLife.49266; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u	70	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17383	17397		10.1074/jbc.RA120.015632	http://dx.doi.org/10.1074/jbc.RA120.015632			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33055236	hybrid, Green Published			2022-12-28	WOS:000603272300001
J	Shukla, MK; Watanabe, A; Wilson, S; Giovagnetti, V; Moustafa, EI; Minagawa, J; Ruban, AV				Shukla, Mahendra K.; Watanabe, Akimasa; Wilson, Sam; Giovagnetti, Vasco; Moustafa, Ece Imam; Minagawa, Jun; Ruban, Alexander, V			A novel method produces native light-harvesting complex II aggregates from the photosynthetic membrane revealing their role in nonphotochemical quenching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NoM; lincomycin; LHCII trimer; LHCII aggregate; amphipol A8-35; nonphotochemical quenching; photosystem II; plant biochemistry; light-harvesting complex (antenna complex); chlorophyll; fluorescence; NPQ	PHOTOPROTECTIVE ENERGY-DISSIPATION; ABSORBED EXCITATION-ENERGY; PH-DEPENDENT DISSIPATION; EXCITED-STATE LIFETIME; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; PSBS PROTEIN; CHLOROPLAST MEMBRANES; THYLAKOID MEMBRANES; MOLECULAR-BASIS	Nonphotochemical quenching (NPQ) is a mechanism of regulating light harvesting that protects the photosynthetic apparatus from photodamage by dissipating excess absorbed excitation energy as heat. In higher plants, the major light-harvesting antenna complex (LHCII) of photosystem (PS) II is directly involved in NPQ. The aggregation of LHCII is proposed to be involved in quenching. However, the lack of success in isolating native LHCII aggregates has limited the direct interrogation of this process. The isolation of LHCII in its native state from thylakoid membranes has been problematic because of the use of detergent, which tends to dissociate loosely bound proteins, and the abundance of pigment-protein complexes (e.g. PSI and PSII) embedded in the photosynthetic membrane, which hinders the preparation of aggregated LHCII. Here, we used a novel purification method employing detergent and amphipols to entrap LHCII in its natural states. To enrich the photosynthetic membrane with the major LHCII, we used Arabidopsis thaliana plants lacking the PSII minor antenna complexes (NoM), treated with lincomycin to inhibit the synthesis of PSI and PSII core proteins. Using sucrose density gradients, we succeeded in isolating the trimeric and aggregated forms of LHCII antenna. Violaxanthin- and zeaxanthin-enriched complexes were investigated in dark-adapted, NPQ, and dark recovery states. Zeaxanthin-enriched antenna complexes showed the greatest amount of aggregated LHCII. Notably, the amount of aggregated LHCII decreased upon relaxation of NPQ. Employing this novel preparative method, we obtained a direct evidence for the role of in vivo LHCII aggregation in NPQ.	[Shukla, Mahendra K.; Wilson, Sam; Giovagnetti, Vasco; Moustafa, Ece Imam; Ruban, Alexander, V] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Watanabe, Akimasa; Minagawa, Jun] Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi, Japan; [Watanabe, Akimasa; Minagawa, Jun] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, SOKENDAI, Okazaki, Aichi, Japan	University of London; Queen Mary University London; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Ruban, AV (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.; Minagawa, J (corresponding author), Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi, Japan.; Minagawa, J (corresponding author), Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, SOKENDAI, Okazaki, Aichi, Japan.	minagawa@nibb.ac.jp; a.ruban@qmul.ac.uk	Shukla, Mahendra Kumar/J-5994-2014	Shukla, Mahendra Kumar/0000-0002-6858-1441; Watanabe, Akimasa/0000-0001-6068-1328; Wilson, Sam/0000-0002-1273-3071; Minagawa, Jun/0000-0002-3028-3203; Giovagnetti, Vasco/0000-0002-3298-4310	Biotechnology and Biological Sciences Research Council [BB/R015694/1]; Leverhulme Trust [RPG-2018-199]; Royal Society International Exchanges Standard Scheme [IES\R2\170087]; Royal Society [IES\R2\170087]; BBSRC [BB/R015694/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Royal Society International Exchanges Standard Scheme; Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/R015694/1, Leverhulme Trust Grant RPG-2018-199, and Royal Society International Exchanges Standard Scheme Grant IES\R2\170087 (to A. V. R.). The collaboration between the Ruban and Minagawa laboratories was supported by Royal Society Grant IES\R2\170087.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; BARBER J, 1995, AUST J PLANT PHYSIOL, V22, P201, DOI 10.1071/PP9950201; Belgio E, 2012, BIOPHYS J, V102, P2761, DOI 10.1016/j.bpj.2012.05.004; Bergantino E, 2003, P NATL ACAD SCI USA, V100, P15265, DOI 10.1073/pnas.2533072100; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Burton-Smith RN, 2019, J BIOL CHEM, V294, P15003, DOI 10.1074/jbc.RA119.009341; Champeil P, 2000, J BIOL CHEM, V275, P18623, DOI 10.1074/jbc.M000470200; Chmeliov J, 2019, J PHYS CHEM LETT, V10, P7340, DOI 10.1021/acs.jpclett.9b03100; Chmeliov J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.45, 10.1038/nplants.2016.45]; Correa-Galvis V, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.225, 10.1038/nplants.2015.225]; Dall'Osto L, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.33; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; Eijckelhoff C, 1997, BBA-BIOENERGETICS, V1321, P10, DOI 10.1016/S0005-2728(97)00040-6; Enriquez MM, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4919239; Goral TK, 2012, PLANT J, V69, P289, DOI 10.1111/j.1365-313X.2011.04790.x; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; HORTON P, 1992, PHOTOSYNTH RES, V34, P375, DOI 10.1007/BF00029812; Ilioaia C, 2013, J PHYS CHEM B, V117, P5841, DOI 10.1021/jp402469d; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Johnson MP, 2011, J BIOL CHEM, V286, P19973, DOI 10.1074/jbc.M111.237255; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Johnson MP, 2010, CHEM PHYS, V373, P23, DOI 10.1016/j.chemphys.2009.12.012; Johnson MP, 2009, J BIOL CHEM, V284, P23592, DOI 10.1074/jbc.M109.013557; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Kim E, 2020, J BIOL CHEM, V295, P14537, DOI 10.1074/jbc.RA120.014198; KRIEGER A, 1992, BIOCHIM BIOPHYS ACTA, V1102, P167, DOI 10.1016/0005-2728(92)90097-L; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Magdaong NM, 2013, PHOTOSYNTH RES, V118, P259, DOI 10.1007/s11120-013-9924-0; Martinez KL, 2002, FEBS LETT, V528, P251, DOI 10.1016/S0014-5793(02)03306-9; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; NISHIMURA M, 1975, PLANT PHYSIOL, V55, P712, DOI 10.1104/pp.55.4.712; NOCTOR G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P339, DOI 10.1016/0005-2728(93)90237-A; NOCTOR G, 1991, BIOCHIM BIOPHYS ACTA, V1057, P320, DOI 10.1016/S0005-2728(05)80143-4; Ostroumov EE, 2020, PHOTOSYNTH RES, V144, P171, DOI 10.1007/s11120-020-00745-8; Pandit A, 2011, BIOPHYS J, V101, P2507, DOI 10.1016/j.bpj.2011.09.055; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Petrou K, 2014, BBA-BIOENERGETICS, V1837, P1533, DOI 10.1016/j.bbabio.2013.11.018; Phillip D, 1996, P NATL ACAD SCI USA, V93, P1492, DOI 10.1073/pnas.93.4.1492; Picard M, 2004, PROTEIN SCI, V13, P3056, DOI 10.1110/ps.04962104; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Popot JL, 2003, CELL MOL LIFE SCI, V60, P1559, DOI 10.1007/s00018-003-3169-6; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2018, FEBS LETT, V592, P3030, DOI 10.1002/1873-3468.13111; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ruban AV, 2009, PHOTOSYNTH RES, V99, P173, DOI 10.1007/s11120-008-9387-x; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; RUBAN AV, 1994, BBA-BIOENERGETICS, V1186, P123, DOI 10.1016/0005-2728(94)90143-0; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; RUBAN AV, 1991, BIOCHIM BIOPHYS ACTA, V1059, P355, DOI 10.1016/S0005-2728(05)80221-X; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Ruban AV, 1997, BIOCHEMISTRY-US, V36, P7855, DOI 10.1021/bi9630725; Saccon F, 2020, J EXP BOT, V71, P3626, DOI 10.1093/jxb/eraa126; Sacharz J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.225; Sheng X, 2019, NAT PLANTS, V5, P1320, DOI 10.1038/s41477-019-0543-4; Townsend AJ, 2018, BBA-BIOENERGETICS, V1859, P666, DOI 10.1016/j.bbabio.2018.03.005; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Tribet C, 2009, LANGMUIR, V25, P12623, DOI 10.1021/la9018772; Ware MA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00841; Ware MA, 2015, J PHOTOCH PHOTOBIO B, V152, P301, DOI 10.1016/j.jphotobiol.2015.07.016; Ware MA, 2015, J EXP BOT, V66, P1259, DOI 10.1093/jxb/eru477; Watanabe A, 2019, FEBS LETT, V593, P1072, DOI 10.1002/1873-3468.13394; Zoonens M, 2005, P NATL ACAD SCI USA, V102, P8893, DOI 10.1073/pnas.0503750102; Zoonens M, 2007, BIOCHEMISTRY-US, V46, P10392, DOI 10.1021/bi7007596	74	8	8	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17816	17826		10.1074/jbc.RA120.016181	http://dx.doi.org/10.1074/jbc.RA120.016181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454016	Green Published, hybrid			2022-12-28	WOS:000603272300032
J	Watanabe, Y; Seya, D; Ihara, D; Ishii, S; Uemoto, T; Kubo, A; Arai, Y; Isomoto, Y; Nakano, A; Abe, T; Shigeta, M; Kawamura, T; Saito, Y; Ogura, T; Nakagawa, O				Watanabe, Yusuke; Seya, Daiki; Ihara, Dai; Ishii, Shuhei; Uemoto, Taiki; Kubo, Atsushi; Arai, Yuji; Isomoto, Yoshie; Nakano, Atsushi; Abe, Takaya; Shigeta, Mayo; Kawamura, Teruhisa; Saito, Yoshihiko; Ogura, Toshihiko; Nakagawa, Osamu			Importance of endothelial Hey1 expression for thoracic great vessel development and its distal enhancer for Notch-dependent endothelial transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hey1; pharyngeal arch artery; great vessel morphogenesis; development; cardiovascular disease; transcription regulation; gene knockout; embryo; endothelial cell; great vessel morphogenesis; Hey1; Notch signaling	CONGENITAL HEART-DEFECTS; ARCH ARTERY DEFECTS; AORTIC-ARCH; PHARYNGEAL ARCH; DIGEORGE-SYNDROME; MICE DEFICIENT; NEURAL CREST; PHENOTYPIC ROBUSTNESS; HEY1-NCOA2 FUSION; ESSENTIAL ROLES	Thoracic great vessels such as the aorta and subclavian arteries are formed through dynamic remodeling of embryonic pharyngeal arch arteries (PAAs). Previous work has shown that loss of a basic helix-loop-helix transcription factor Hey1 in mice causes abnormal fourth PAA development and lethal great vessel anomalies resembling congenital malformations in humans. However, how Hey1 mediates vascular formation remains unclear. In this study, we revealed that Hey1 in vascular endothelial cells, but not in smooth muscle cells, played essential roles for PAA development and great vessel morphogenesis in mouse embryos. Tek-Cre-mediated Hey1 deletion in endothelial cells affected endothelial tube formation and smooth muscle differentiation in embryonic fourth PAAs and resulted in interruption of the aortic arch and other great vessel malformations. Cell specificity and signal responsiveness of Hey1 expression were controlled through multiple cis-regulatory regions. We found two distal genomic regions that had enhancer activity in endothelial cells and in the pharyngeal epithelium and somites, respectively. The novel endothelial enhancer was conserved across species and was specific to large-caliber arteries. Its transcriptional activity was regulated by Notch signaling in vitro and in vivo, but not by ALK1 signaling and other transcription factors implicated in endothelial cell specificity. The distal endothelial enhancer was not essential for basal Hey1 expression in mouse embryos but may likely serve for Notch-dependent transcriptional control in endothelial cells together with the proximal regulatory region. These findings help in understanding the significance and regulation of endothelial Hey1 as a mediator of multiple signaling pathways in embryonic vascular formation.	[Watanabe, Yusuke; Seya, Daiki; Ihara, Dai; Ishii, Shuhei; Uemoto, Taiki; Arai, Yuji; Nakagawa, Osamu] Natl Cerebral & Cardiovasc Ctr, Dept Mol Physiol Natl, Res Inst, Suita, Osaka, Japan; [Watanabe, Yusuke; Ishii, Shuhei; Uemoto, Taiki; Saito, Yoshihiko; Nakagawa, Osamu] Nara Med Univ, Grad Sch Med Sci, Kashihara, Nara, Japan; [Ihara, Dai; Kawamura, Teruhisa] Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Lab Stem Cell & Regenerat Med, Kusatsu, Shiga, Japan; [Kubo, Atsushi; Ogura, Toshihiko] Tohoku Univ, Inst Dev Aging & Canc, Dept Dev Neurobiol, Sendai, Miyagi, Japan; [Arai, Yuji; Isomoto, Yoshie; Nakano, Atsushi] Natl Cerebral & Cardiovasc Ctr, Lab Anim Expt & Med Management, Res Inst, Suita, Osaka, Japan; [Abe, Takaya; Shigeta, Mayo] RIKEN Ctr Biosyst Dynam Res, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan; [Saito, Yoshihiko] Nara Med Univ, Dept Cardiovasc Med, Kashihara, Nara, Japan	National Cerebral & Cardiovascular Center - Japan; Nara Medical University; Ritsumeikan University; Tohoku University; National Cerebral & Cardiovascular Center - Japan; RIKEN; Nara Medical University	Watanabe, Y; Nakagawa, O (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Physiol Natl, Res Inst, Suita, Osaka, Japan.; Watanabe, Y; Nakagawa, O (corresponding author), Nara Med Univ, Grad Sch Med Sci, Kashihara, Nara, Japan.	ywatanabe@ncvc.go.jp; osamu.nakagawa@ncvc.go.jp		Watanabe, Yusuke/0000-0001-9486-4085; Seya, Daiki/0000-0002-1319-177X	Japan Society for the Promotion of Science [15H04883, 15K15407, 16K08605, 18H02787, 19H03398]; Takeda Science Foundation; NOVARTIS Foundation for the Promotion of Science; Miyata Cardiac Research Promotion Foundation; Smoking Research Foundation; Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University; Japan Agency for Medical Research and Development (AMED-CREST) [JP19gm0810001]; Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); NOVARTIS Foundation for the Promotion of Science; Miyata Cardiac Research Promotion Foundation; Smoking Research Foundation; Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University; Japan Agency for Medical Research and Development (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center	This work was supported in part by the grants from the Japan Society for the Promotion of Science (Grants-in Aid for Scientific Research 15H04883, 15K15407, 16K08605, 18H02787, and 19H03398) (to Y. W. and O. N.), the Takeda Science Foundation (to Y. W. and O. N.), the NOVARTIS Foundation for the Promotion of Science (to Y. W. and O. N.), the Miyata Cardiac Research Promotion Foundation (to Y. W.), the Smoking Research Foundation (to O. N.), the Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University (to Y. W.), Japan Agency for Medical Research and Development (AMED-CREST) Grant JP19gm0810001) (to T. O.), and the Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center (to Y. W. and O. N.).	Barhoumi T, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00534; BARRY A, 1951, ANAT RECORD, V111, P221, DOI 10.1002/ar.1091110207; Becker PW, 2016, ARTERIOSCL THROM VAS, V36, P1209, DOI 10.1161/ATVBAHA.116.307517; Belyea BC, 2011, CLIN CANCER RES, V17, P7324, DOI 10.1158/1078-0432.CCR-11-1004; Bergwerff M, 1999, CARDIOVASC RES, V44, P185, DOI 10.1016/S0008-6363(99)00186-8; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Byrd NA, 2005, DEV BIOL, V284, P233, DOI 10.1016/j.ydbio.2005.05.023; Calmont A, 2009, DEVELOPMENT, V136, P3173, DOI 10.1242/dev.028902; Candy PA, 2013, BRIT J CANCER, V109, P1023, DOI 10.1038/bjc.2013.431; Chiang IKN, 2017, DEVELOPMENT, V144, P2629, DOI 10.1242/dev.146241; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Churko JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07333-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Copeland JN, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-12; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Fang JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01742-7; Feiner L, 2001, DEVELOPMENT, V128, P3061; Fischer A, 2004, MAMM GENOME, V15, P711, DOI 10.1007/s00335-004-2389-x; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Frank DU, 2002, DEVELOPMENT, V129, P4591; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fujita M, 2016, MECH DEVELOP, V139, P65, DOI 10.1016/j.mod.2015.11.002; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12658; Heisig J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002728; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; High FA, 2009, J CLIN INVEST, V119, P1986, DOI 10.1172/JCI38922; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Ihara D, 2020, DEV BIOL, V461, P124, DOI 10.1016/j.ydbio.2020.02.001; Iida K, 1997, DEVELOPMENT, V124, P4627; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kokubo H, 2005, DEV BIOL, V278, P301, DOI 10.1016/j.ydbio.2004.10.025; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lau EYT, 2016, CELL REP, V15, P1175, DOI 10.1016/j.celrep.2016.04.019; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li G, 2018, J MOL CELL CARDIOL, V123, P92, DOI 10.1016/j.yjmcc.2018.09.002; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Molin DGM, 2004, CIRC RES, V95, P1109, DOI 10.1161/01.RES.0000150047.16909.ab; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Morioka T, 2014, GENESIS, V52, P897, DOI 10.1002/dvg.22825; Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nakayama R, 2012, PATHOL INT, V62, P823, DOI 10.1111/pin.12022; Osterwalder M, 2018, NATURE, V554, P239, DOI 10.1038/nature25461; Payne S, 2015, DEV BIOL, V405, P82, DOI 10.1016/j.ydbio.2015.06.017; Robinson AS, 2014, DEV BIOL, V395, P379, DOI 10.1016/j.ydbio.2014.08.027; Sacilotto N, 2013, P NATL ACAD SCI USA, V110, P11893, DOI 10.1073/pnas.1300805110; Simrick S, 2012, DEV DYNAM, V241, P1310, DOI 10.1002/dvdy.23812; Southgate L, 2015, CIRC-CARDIOVASC GENE, V8, P572, DOI 10.1161/CIRCGENETICS.115.001086; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Tsuru A, 2015, BRIT J CANCER, V112, P1232, DOI 10.1038/bjc.2015.84; van Bueren KL, 2010, DEV BIOL, V340, P369, DOI 10.1016/j.ydbio.2010.01.020; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Wang L, 2012, GENE CHROMOSOME CANC, V51, P127, DOI 10.1002/gcc.20937; Watanabe Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep46135; Watanabe Y, 2012, P NATL ACAD SCI USA, V109, P18273, DOI 10.1073/pnas.1215360109; Weber D, 2015, J MOL CELL CARDIOL, V79, P79, DOI 10.1016/j.yjmcc.2014.11.004; Wurdak H, 2006, BIOESSAYS, V28, P1078, DOI 10.1002/bies.20484; Wythe JD, 2013, DEV CELL, V26, P45, DOI 10.1016/j.devcel.2013.06.007; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang Z, 2005, DEVELOPMENT, V132, P5307, DOI 10.1242/dev.02086; Zhang Z, 2006, DEVELOPMENT, V133, P3587, DOI 10.1242/dev.02539; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zhou JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032429; Zhou PZ, 2017, ELIFE, V6, DOI 10.7554/eLife.22039	86	5	6	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17632	17645		10.1074/jbc.RA120.015003	http://dx.doi.org/10.1074/jbc.RA120.015003			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33454003	hybrid, Green Published			2022-12-28	WOS:000603272300019
J	Jiang, XG; Zhang, LJ; Teng, MK; Li, X				Jiang, Xuguang; Zhang, Linjuan; Teng, Maikun; Li, Xu			Antibiotic binding releases autoinhibition of the TipA multidrug-resistance transcriptional regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						multidrug resistance (MDR); transcriptional regulator; TipA; autoinhibition; drug resistance; antibiotic resistance; transcription regulation; transcription promoter; DNA-binding protein; crystal structure; activation mechanism; structure biology	THIOSTREPTON-INDUCED GENE; STRUCTURAL BASIS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; RECOGNITION; PROTEIN; ACTIVATION; MECHANISM; EXPRESSION; SEQUENCE	Investigations of bacterial resistance strategies can aid in the development of new antimicrobial drugs as a countermeasure to the increasing worldwide prevalence of bacterial antibiotic resistance. One such strategy involves the TipA class of transcription factors, which constitute minimal autoregulated multidrug resistance (MDR) systems against diverse antibiotics. However, we have insufficient information regarding how antibiotic binding induces transcriptional activation to design molecules that could interfere with this process. To learn more, we determined the crystal structure of SkgA from Caulobacter crescentus as a representative TipA protein. We identified an unexpected spatial orientation and location of the antibiotic-binding TipAS effector domain in the apo state. We observed that the alpha 6-alpha 7 region of the TipAS domain, which is canonically responsible for forming the lid of antibiotic-binding cleft to tightly enclose the bound antibiotic, is involved in the dimeric interface and stabilized via interaction with the DNA-binding domain in the apo state. Further structural and biochemical analyses demonstrated that the unliganded TipAS domain sterically hinders promoter DNA binding but undergoes a remarkable conformational shift upon antibiotic binding to release this autoinhibition via a switch of its alpha 6-alpha 7 region. Hence, the promoters for MDR genes including tipA and RNA polymerases become available for transcription, enabling efficient antibiotic resistance. These insights into the molecular mechanism of activation of TipA proteins advance our understanding of TipA proteins, as well as bacterial MDR systems, and may provide important clues to block bacterial resistance.	[Jiang, Xuguang; Zhang, Linjuan; Teng, Maikun; Li, Xu] Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Jiang, Xuguang] Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo, Japan	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Tokyo	Jiang, XG; Li, X (corresponding author), Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.; Jiang, XG (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo, Japan.	xgjiang@m.u-tokyo.ac.jp; sachem@ustc.edu.cn	Jiang, Xuguang/J-8345-2019	Jiang, Xuguang/0000-0001-7997-872X	Chinese National Natural Science Foundation [31971124, U1732114, 31770788, 31770895]; National Key Research and Development Program of China [2017YFA0503600]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by Chinese National Natural Science Foundation Grants 31971124, U1732114, 31770788, and 31770895 and National Key Research and Development Program of China Grant 2017YFA0503600.	Bachas S, 2011, P NATL ACAD SCI USA, V108, P11046, DOI 10.1073/pnas.1104850108; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baranova NN, 1999, MOL MICROBIOL, V31, P1549, DOI 10.1046/j.1365-2958.1999.01301.x; BARRINEAU P, 1984, Journal of Molecular and Applied Genetics, V2, P601; Chiu ML, 1996, BIOCHEMISTRY-US, V35, P2332, DOI 10.1021/bi952073e; Chiu ML, 2001, BIOCHEMISTRY-US, V40, P12950, DOI 10.1021/bi010328k; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Deng WY, 2013, CELL SIGNAL, V25, P1608, DOI 10.1016/j.cellsig.2013.04.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Godsey MH, 2001, J BIOL CHEM, V276, P47178, DOI 10.1074/jbc.M105819200; Habazettl J, 2014, P NATL ACAD SCI USA, V111, pE5498, DOI 10.1073/pnas.1412070111; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HOLMES DJ, 1993, EMBO J, V12, P3183, DOI 10.1002/j.1460-2075.1993.tb05987.x; Jiang XG, 2020, FEBS J, V287, P2292, DOI 10.1111/febs.15138; Kahmann JD, 2003, EMBO J, V22, P1824, DOI 10.1093/emboj/cdg181; KELLEY SL, 1988, SCIENCE, V241, P1813, DOI 10.1126/science.3175622; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; MURAKAMI T, 1989, J BACTERIOL, V171, P1459, DOI 10.1128/jb.171.3.1459-1466.1989; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myers CL, 2014, CHEMBIOCHEM, V15, P681, DOI 10.1002/cbic.201300724; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; NEYFAKH AA, 1991, P NATL ACAD SCI USA, V88, P4781, DOI 10.1073/pnas.88.11.4781; Neyfakh AA, 2002, MOL MICROBIOL, V44, P1123, DOI 10.1046/j.1365-2958.2002.02965.x; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Paulsen IT, 2003, CURR OPIN MICROBIOL, V6, P446, DOI 10.1016/j.mib.2003.08.005; Rava PS, 1999, J BACTERIOL, V181, P6152, DOI 10.1128/JB.181.19.6152-6159.1999; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rostock L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05551-4; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Sikandar A, 2018, J AM CHEM SOC, V140, P16641, DOI 10.1021/jacs.8b08895; SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wade H, 2010, CURR OPIN STRUC BIOL, V20, P489, DOI 10.1016/j.sbi.2010.06.003; Wang QS, 2018, NUCL SCI TECH, V29, DOI 10.1007/s41365-018-0398-9; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6; Zhu YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep23147	41	1	1	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17865	17876		10.1074/jbc.RA120.016295	http://dx.doi.org/10.1074/jbc.RA120.016295			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33093172	Green Published, hybrid			2022-12-28	WOS:000603272300036
J	Acquistapace, IM; Zietek, MA; Li, AWH; Salmon, M; Kuhn, I; Bedford, MR; Brearley, CA; Hemmings, AM				Acquistapace, Isabella M.; Zietek, Monika A.; Li, Arthur W. H.; Salmon, Melissa; Kuhn, Imke; Bedford, Mike R.; Brearley, Charles A.; Hemmings, Andrew M.			Snapshots during the catalytic cycle of a histidine acid phytase reveal an induced-fit structural mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phytase; cell surface protein; induced fit; enzyme mechanism; enzyme structure; crystallography; thermostabilization; stereospecificity; inositol phosphate; cell surface enzyme; enzyme mechanism; substrate specificity; enzyme mutation; structural biology; structure-function; induced fit; phytase; phytic acid; thermostabilization	INOSITOL-POLYPHOSPHATE PHOSPHATASE; MYOINOSITOL HEXAKISPHOSPHATE DEPHOSPHORYLATION; MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; ENDOPLASMIC-RETICULUM; ASPERGILLUS-FUMIGATUS; DEGRADING ENZYME; COLI PHYTASE; ACTIVE-SITE; 1 MINPP1	Highly engineered phytases, which sequentially hydrolyze the hexakisphosphate ester of inositol known as phytic acid, are routinely added to the feeds of monogastric animals to improve phosphate bioavailability. New phytases are sought as starting points to further optimize the rate and extent of dephosphorylation of phytate in the animal digestive tract. Multiple inositol polyphosphate phosphatases (MINPPs) are clade 2 histidine phosphatases (HP2P) able to carry out the stepwise hydrolysis of phytate. MINPPs are not restricted by a strong positional specificity making them attractive targets for development as feed enzymes. Here, we describe the characterization of a MINPP from the Gram-positive bacterium Bifidobacterium longum (BlMINPP). BlMINPP has a typical HP2P-fold but, unusually, possesses a large alpha-domain polypeptide insertion relative to other MINPPs. This insertion, termed the U-loop, spans the active site and contributes to substrate specificity pockets underpopulated in other HP2Ps. Mutagenesis of U-loop residues reveals its contribution to enzyme kinetics and thermostability. Moreover, four crystal structures of the protein along the catalytic cycle capture, for the first time in an HP2P, a large ligand-driven alpha-domain motion essential to allow substrate access to the active site. This motion recruits residues both downstream of a molecular hinge and on the U-loop to participate in specificity subsites, and mutagenesis identified a mobile lysine residue as a key determinant of positional specificity of the enzyme. Taken together, these data provide important new insights to the factors determining stability, substrate recognition, and the structural mechanism of hydrolysis in this industrially important group of enzymes.	[Acquistapace, Isabella M.; Zietek, Monika A.; Li, Arthur W. H.; Salmon, Melissa; Brearley, Charles A.; Hemmings, Andrew M.] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Hemmings, Andrew M.] Univ East Anglia, Sch Chem, Norwich, Norfolk, England; [Kuhn, Imke] AB Vista, Darmstadt, Germany; [Bedford, Mike R.] AB Vista, Marlborough, Wilts, England	University of East Anglia; University of East Anglia	Hemmings, AM (corresponding author), Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England.; Hemmings, AM (corresponding author), Univ East Anglia, Sch Chem, Norwich, Norfolk, England.	a.hemmings@uea.ac.uk	Bedford, Michael/AAV-8204-2020; HEMMINGS, ANDREW MICHAEL/E-5517-2011	Bedford, Michael/0000-0002-5308-4290; HEMMINGS, ANDREW MICHAEL/0000-0003-3053-3134; Li, Arthur Wing Hang/0000-0003-4291-3900; Brearley, Charles/0000-0001-6179-9109; Acquistapace, Isabella Maria/0000-0002-5820-7683	Biotechnology and Biological Sciences Research Council; AB Vista Ltd. through IPA Award [BB/M022978/1]; joint UEA-AB Vista Ltd. Ph.D. studentships; BBSRC [BB/M022978/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AB Vista Ltd. through IPA Award; joint UEA-AB Vista Ltd. Ph.D. studentships; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and AB Vista Ltd. through IPA Award BB/M022978/1 and joint UEA-AB Vista Ltd. Ph.D. studentships (to I. M. A. and M. Z.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Tamayo-Ramos JA, 2012, APPL ENVIRON MICROB, V78, P5013, DOI 10.1128/AEM.00782-12; Arboleya S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01204; Ariza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065062; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; BARRIENTOS L, 1994, PLANT PHYSIOL, V106, P1489, DOI 10.1104/pp.106.4.1489; Bohm K, 2010, FEBS J, V277, P1284, DOI 10.1111/j.1742-4658.2010.07559.x; Cheng YL, 2015, CELL REP, V13, P2174, DOI 10.1016/j.celrep.2015.10.071; Chi HB, 1999, GENOMICS, V56, P324, DOI 10.1006/geno.1998.5736; Cho J, 2008, P NATL ACAD SCI USA, V105, P5998, DOI 10.1073/pnas.0710980105; Cho J, 2006, J BIOTECHNOL, V126, P248, DOI 10.1016/j.jbiotec.2006.04.028; Craxton A, 1997, BIOCHEM J, V328, P75, DOI 10.1042/bj3280075; Dersjant-Li Y, 2015, J SCI FOOD AGR, V95, P878, DOI 10.1002/jsfa.6998; Dhatwalia R, 2015, ARCH BIOCHEM BIOPHYS, V585, P32, DOI 10.1016/j.abb.2015.09.010; Dror DK, 2018, ADV NUTR, V9, p278S, DOI 10.1093/advances/nmy022; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferranti P, 2004, J DAIRY RES, V71, P74, DOI 10.1017/S0022029903006599; Forsberg CW, 2013, TRANSGENIC RES, V22, P379, DOI 10.1007/s11248-012-9646-7; Goris J, 2001, INT J SYST EVOL MICR, V51, P1773, DOI 10.1099/00207713-51-5-1773; Greiner R, 2001, J AGR FOOD CHEM, V49, P2228, DOI 10.1021/jf0100090; Greiner R, 2000, J BIOTECHNOL, V84, P53, DOI 10.1016/S0168-1656(00)00331-X; Humer E, 2015, J ANIM PHYSIOL AN N, V99, P605, DOI 10.1111/jpn.12258; Indyk HE, 2016, INT DAIRY J, V56, P33, DOI 10.1016/j.idairyj.2016.01.002; Irving G. C. J., 1980, INOSITOL PHOSPHATES, P99; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kilaparty SP, 2016, CELL STRESS CHAPERON, V21, P593, DOI 10.1007/s12192-016-0684-6; Kilaparty SP, 2014, EVOL BIOINFORM, V10, P239, DOI 10.4137/EBO.S18948; Kostrewa D, 1999, J MOL BIOL, V288, P965, DOI 10.1006/jmbi.1999.2736; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lei XG, 2013, ANNU REV ANIM BIOSCI, V1, P283, DOI 10.1146/annurev-animal-031412-103717; LENSTRUP EINAR, 1926, JOUR BIOL CHEM, V70, P193; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Lim D, 2000, NAT STRUCT BIOL, V7, P108; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu O, 2004, STRUCTURE, V12, P1575, DOI 10.1016/j.str.2004.06.015; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Ma XF, 2012, MOL BREEDING, V30, P377, DOI 10.1007/s11032-011-9628-0; Mallin MA, 2020, BIOSCIENCE, V70, P315, DOI 10.1093/biosci/biaa001; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Menezes-Blackburn D, 2015, J AGR FOOD CHEM, V63, P6142, DOI 10.1021/acs.jafc.5b01996; Nagul EA, 2015, ANAL CHIM ACTA, V890, P60, DOI 10.1016/j.aca.2015.07.030; NOGIMORI K, 1991, J BIOL CHEM, V266, P16499; Oakley AJ, 2010, BIOCHEM BIOPH RES CO, V397, P745, DOI 10.1016/j.bbrc.2010.06.024; Oh BC, 2004, APPL MICROBIOL BIOT, V63, P362, DOI 10.1007/s00253-003-1345-0; Ortlund E, 2003, BIOCHEMISTRY-US, V42, P383, DOI 10.1021/bi0265067; OSTANIN K, 1993, J BIOL CHEM, V268, P20778; OSTANIN K, 1992, J BIOL CHEM, V267, P22830; Prenafeta-Boldu FX, 2012, FEMS MICROBIOL ECOL, V80, P722, DOI 10.1111/j.1574-6941.2012.01344.x; Qi GY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-13; Ragon M, 2009, ACTA CRYSTALLOGR F, V65, P321, DOI 10.1107/S1744309109008653; Ragon M, 2008, APPL MICROBIOL BIOT, V78, P47, DOI 10.1007/s00253-007-1275-3; Riedel K., 2011, ENCY GEOBIOLOGY, P355, DOI [10.1007/978-1-4020-9212-1_85, DOI 10.1007/978-1-4020-9212-1_85]; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Romano N., 2018, Enzymes in human and animal nutrition, P73; Romano PR, 1998, J CELL SCI, V111, P803; Sanchez-Romero I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070013; Satola B, 2013, APPL MICROBIOL BIOT, V97, P541, DOI 10.1007/s00253-012-4585-z; Schippers A, 2005, INT J SYST EVOL MICR, V55, P655, DOI 10.1099/ijs.0.63305-0; Shivange A.V., 2017, DIRECTED ENZYME EVOL, P145, DOI [10.1007/978-3-319-50413-16, DOI 10.1007/978-3-319-50413-16, DOI 10.1007/978-3-319-50413-1_6]; Stentz R, 2014, CELL REP, V6, P646, DOI 10.1016/j.celrep.2014.01.021; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Underwood MA, 2015, PEDIATR RES, V77, P229, DOI 10.1038/pr.2014.156; VANETTEN RL, 1991, J BIOL CHEM, V266, P2313; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; Wang YL, 2006, J BIOL CHEM, V281, P39642, DOI 10.1074/jbc.M606421200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Windhorst S, 2013, BIOCHEM J, V450, P115, DOI 10.1042/BJ20121524; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wyss M, 1999, APPL ENVIRON MICROB, V65, P367; Xiang T, 2004, J MOL BIOL, V339, P437, DOI 10.1016/j.jmb.2004.03.057; Yao MZ, 2012, J APPL MICROBIOL, V112, P1, DOI 10.1111/j.1365-2672.2011.05181.x; Yu J, 2003, J BIOL CHEM, V278, P46210, DOI 10.1074/jbc.M303743200; Zhao YF, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9010132	74	4	4	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17724	17737		10.1074/jbc.RA120.015925	http://dx.doi.org/10.1074/jbc.RA120.015925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33055237	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000603272300026
J	Karlsson, E; Paissoni, C; Erkelens, AM; Tehranizadeh, ZA; Sorgenfrei, FA; Andersson, E; Ye, WH; Camilloni, C; Jemth, P				Karlsson, Elin; Paissoni, Cristina; Erkelens, Amanda M.; Tehranizadeh, Zeinab A.; Sorgenfrei, Frieda A.; Andersson, Eva; Ye, Weihua; Camilloni, Carlo; Jemth, Per			Mapping the transition state for a binding reaction between ancient intrinsically disordered proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intrinsically disordered proteins; phi value analysis; transition state; protein evolution; coupled binding and folding; protein folding; pre-steady-state kinetics; protein complex; IDP; protein binding	DOMAIN; COACTIVATOR; DYNAMICS; COMPLEX; MODEL; KIX; CBP; ASSOCIATION; INTERFACE; MECHANISM	Intrinsically disordered protein domains often have multiple binding partners. It is plausible that the strength of pairing with specific partners evolves from an initial low affinity to a higher affinity. However, little is known about the molecular changes in the binding mechanism that would facilitate such a transition. We previously showed that the interaction between two intrinsically disordered domains, NCBD and CID, likely emerged in an ancestral deuterostome organism as a low-affinity interaction that subsequently evolved into a higher-affinity interaction before the radiation of modern vertebrate groups. Here we map native contacts in the transition states of the low-affinity ancestral and high-affinity human NCBD/CID interactions. We show that the coupled binding and folding mechanism is overall similar but with a higher degree of native hydrophobic contact formation in the transition state of the ancestral complex and more heterogeneous transient interactions, including electrostatic pairings, and an increased disorder for the human complex. Adaptation to new binding partners may be facilitated by this ability to exploit multiple alternative transient interactions while retaining the overall binding and folding pathway.	[Karlsson, Elin; Erkelens, Amanda M.; Tehranizadeh, Zeinab A.; Sorgenfrei, Frieda A.; Andersson, Eva; Ye, Weihua; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Paissoni, Cristina; Camilloni, Carlo] Univ Milan, Dipartimento Biosci, Milan, Italy; [Tehranizadeh, Zeinab A.] Mashhad Univ Med Sci, Sch Pharm, Dept Med Chem, Mashhad, Razavi Khorasan, Iran; [Erkelens, Amanda M.] Leiden Univ, Dept Chem, Leiden, Netherlands; [Sorgenfrei, Frieda A.] Karl Franzens Univ Graz, Inst Organ & Bioorgan Chem, Dept Chem, Heinrichstr, Graz, Austria	Uppsala University; University of Milan; Mashhad University Medical Science; Leiden University; Leiden University - Excl LUMC; University of Graz	Jemth, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.; Camilloni, C (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	carlo.camilloni@unimi.it; PerJemth@imbim.uu.se	Camilloni, Carlo/A-4395-2009; Paissoni, Cristina/AAH-3181-2020	Camilloni, Carlo/0000-0002-9923-8590; Paissoni, Cristina/0000-0002-3101-6705; Sorgenfrei, Frieda A./0000-0002-0690-7848; Karlsson, Elin/0000-0001-5526-4968; Erkelens, Amanda M/0000-0001-9369-5814; Jemth, Per/0000-0003-1516-7228	Swedish Research Council [2016-04134]; Knut and Alice Wallenberg Foundation (evolution of new genes and proteins); Department of Chemistry - BMC; Disciplinary Domain of Medicine and Pharmacy; CINECA under the ISCRA initiative	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation (evolution of new genes and proteins); Department of Chemistry - BMC; Disciplinary Domain of Medicine and Pharmacy; CINECA under the ISCRA initiative(CINECA, Italy)	This work was funded by the Swedish Research Council Grant 2016-04134 (to P. J.) and the Knut and Alice Wallenberg Foundation (evolution of new genes and proteins) (to P. J.). We used the NMR Uppsala infrastructure, which is funded by the Department of Chemistry - BMC and the Disciplinary Domain of Medicine and Pharmacy. C. C. acknowledges CINECA for an award under the ISCRA initiative, for the availability of high-performance computing resources and support.	Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; [Anonymous], PYMOL MOL GRAPH SYST; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2010, J PHYS CHEM B, V114, P14916, DOI 10.1021/jp108618d; Bokhovchuk F, 2020, BIOCHEMISTRY-US, V59, P1804, DOI 10.1021/acs.biochem.0c00217; Bonetti D, 2018, BIOPHYS J, V114, P1889, DOI 10.1016/j.bpj.2018.03.017; Bonomi M, 2019, NAT METHODS, V16, P670, DOI 10.1038/s41592-019-0506-8; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Camilloni C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28285; Campbell E, 2016, NAT CHEM BIOL, V12, P944, DOI [10.1038/NCHEMBIO.2175, 10.1038/nchembio.2175]; Crabtree MD, 2018, J BIOL CHEM, V293, P9718, DOI 10.1074/jbc.RA118.002791; Dahal L, 2017, BIOPHYS J, V113, P2713, DOI 10.1016/j.bpj.2017.10.016; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dogan J, 2012, J BIOL CHEM, V287, P34316, DOI 10.1074/jbc.M112.399436; Dyson HJ, 2016, J BIOL CHEM, V291, P6714, DOI 10.1074/jbc.R115.692020; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ebert MO, 2008, BIOCHEMISTRY-US, V47, P1299, DOI 10.1021/bi701767j; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FERSHT AR, 1994, P NATL ACAD SCI USA, V91, P10426, DOI 10.1073/pnas.91.22.10426; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110; Haq SR, 2012, J AM CHEM SOC, V134, P599, DOI 10.1021/ja209341w; Harman JL, 2020, ELIFE, V9, DOI 10.7554/eLife.54100; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hiscott J, 2005, STRUCTURE, V13, P1235, DOI 10.1016/j.str.2005.08.001; Hultqvist G, 2017, ELIFE, V6, DOI 10.7554/eLife.16059; Iesmantavicius V, 2014, ANGEW CHEM INT EDIT, V53, P1548, DOI 10.1002/anie.201307712; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Jemth P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau4130; Jemth P, 2014, J BIOL CHEM, V289, P5528, DOI 10.1074/jbc.M113.537068; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karlsson E, 2019, BIOPHYS J, V117, P729, DOI 10.1016/j.bpj.2019.07.014; Karlsson E, 2020, PROTEIN SCI, V29, P1687, DOI 10.1002/pro.3868; Karlsson E, 2019, J BIOL CHEM, V294, P1230, DOI 10.1074/jbc.RA118.005854; Karlsson OA, 2012, J MOL BIOL, V417, P253, DOI 10.1016/j.jmb.2012.01.042; KARPLUS M, 1994, PROTEIN SCI, V3, P650; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lindstrom I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26213-x; Lindstrom I, 2017, BIOCHEMISTRY-US, V56, P4145, DOI 10.1021/acs.biochem.7b00428; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Paci E, 2002, J MOL BIOL, V324, P151, DOI 10.1016/S0022-2836(02)00944-0; Pancsa R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113315; Pillai AS, 2020, NATURE, V581, P480, DOI 10.1038/s41586-020-2292-y; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Rogers JM, 2014, P NATL ACAD SCI USA, V111, P15420, DOI 10.1073/pnas.1409122111; Rouet R, 2017, P NATL ACAD SCI USA, V114, P3897, DOI 10.1073/pnas.1613477114; Sato S, 2006, J MOL BIOL, V360, P850, DOI 10.1016/j.jmb.2006.05.051; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Stiffler MA, 2015, CELL, V160, P882, DOI 10.1016/j.cell.2015.01.035; Sturzenegger F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07043-x; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Toto A, 2020, J BIOL CHEM, V295, P6586, DOI 10.1074/jbc.REV120.012413; Toto A, 2019, ARCH BIOCHEM BIOPHYS, V671, P255, DOI 10.1016/j.abb.2019.07.011; Toto A, 2016, BIOCHEMISTRY-US, V55, P3957, DOI 10.1021/acs.biochem.6b00505; Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Nguyen V, 2017, SCIENCE, V355, P289, DOI 10.1126/science.aah3717; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wu D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42717-6; Xia Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000413; Yang J, 2019, PROTEIN SCI, V28, P1952, DOI 10.1002/pro.3718; Zosel F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05725-0	78	6	6	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2020	295	51					17698	17712		10.1074/jbc.RA120.015645	http://dx.doi.org/10.1074/jbc.RA120.015645			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PL7BK	33067355	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000603272300024
